activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	105841	CHEMBL686321	Inhibitory activity against human glycogen synthase kinase-3beta (GSK3-beta) at 100 uM ATP	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	IC50	nM	380.0	CHEMBL262	Homo sapiens	IC50	uM	0.38
	105841	CHEMBL686321	Inhibitory activity against human glycogen synthase kinase-3beta (GSK3-beta) at 100 uM ATP	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	IC50	nM	380.0	CHEMBL262	Homo sapiens	IC50	uM	0.38
	105843	CHEMBL698973	Stimulation of glycogen synthase in CHO cells expressing human insulin receptor	F	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	EC50	nM	45600.0	CHEMBL262	Homo sapiens	EC50	uM	45.6
	105844	CHEMBL654667	Induced beta-casein protein expression in the CHO-hIR cell line	F	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	EC50	nM	30620.0	CHEMBL262	Homo sapiens	EC50	uM	30.62
	105845	CHEMBL800828	Increased glucose incorporation into glycogen at 0.2 nM insulin in isolated rat soleus muscle at 10 uM	F	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	Fold stimulation		1.3	CHEMBL262	Homo sapiens	Fold stimulation		1.3
	114696	CHEMBL686321	Inhibitory activity against human glycogen synthase kinase-3beta (GSK3-beta) at 100 uM ATP	B	CN(C)Cc1c(-c2n[nH]c(-c3ccncc3)n2)nnn1-c1nonc1N		CHEMBL112564	=	IC50	nM	6920.0	CHEMBL262	Homo sapiens	IC50	uM	6.92
	118600	CHEMBL686321	Inhibitory activity against human glycogen synthase kinase-3beta (GSK3-beta) at 100 uM ATP	B	CCN(CC)Cc1c(C(=O)N/N=C/c2ccncc2)nnn1-c1nonc1N		CHEMBL321421	=	IC50	nM	410.0	CHEMBL262	Homo sapiens	IC50	uM	0.41
	118601	CHEMBL686321	Inhibitory activity against human glycogen synthase kinase-3beta (GSK3-beta) at 100 uM ATP	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	160.0	CHEMBL262	Homo sapiens	IC50	uM	0.16
	118602	CHEMBL686321	Inhibitory activity against human glycogen synthase kinase-3beta (GSK3-beta) at 100 uM ATP	B	CC(C)CNCc1c(C(=O)NCc2ccncc2)nnn1-c1nonc1N	Outside typical range	CHEMBL114582	>	IC50	nM	250000.0	CHEMBL262	Homo sapiens	IC50	uM	250.0
	119794	CHEMBL682326	Inhibition of Glycogen synthase kinase-3 beta at 1 uM	B	COC[C@H](C)Nc1nccc(-c2c(-c3ccc(F)cc3)c(=O)n3n2CCC3)n1		CHEMBL316065	=	Activity	%	72.0	CHEMBL262	Homo sapiens	Activity	%	72.0
	124758	CHEMBL686321	Inhibitory activity against human glycogen synthase kinase-3beta (GSK3-beta) at 100 uM ATP	B	NNC(=O)c1nnn(-c2nonc2N)c1CN1CCCCC1		CHEMBL115875	=	IC50	nM	9600.0	CHEMBL262	Homo sapiens	IC50	uM	9.6
	126092	CHEMBL686321	Inhibitory activity against human glycogen synthase kinase-3beta (GSK3-beta) at 100 uM ATP	B	CN(CCc1ccncc1)C(=O)c1nnn(-c2nonc2N)c1CN1CCCCC1	Outside typical range	CHEMBL113447	>	IC50	nM	250000.0	CHEMBL262	Homo sapiens	IC50	uM	250.0
	127559	CHEMBL686321	Inhibitory activity against human glycogen synthase kinase-3beta (GSK3-beta) at 100 uM ATP	B	Nc1nonc1-n1nnc(C(=O)N/N=C/c2ccncc2)c1CN1CCCCC1		CHEMBL325353	=	IC50	nM	100.0	CHEMBL262	Homo sapiens	IC50	uM	0.1
	127561	CHEMBL698973	Stimulation of glycogen synthase in CHO cells expressing human insulin receptor	F	Nc1nonc1-n1nnc(C(=O)N/N=C/c2ccncc2)c1CN1CCCCC1		CHEMBL325353	=	EC50	nM	2850.0	CHEMBL262	Homo sapiens	EC50	uM	2.85
	127562	CHEMBL654667	Induced beta-casein protein expression in the CHO-hIR cell line	F	Nc1nonc1-n1nnc(C(=O)N/N=C/c2ccncc2)c1CN1CCCCC1		CHEMBL325353	=	EC50	nM	4540.0	CHEMBL262	Homo sapiens	EC50	uM	4.54
	127563	CHEMBL800828	Increased glucose incorporation into glycogen at 0.2 nM insulin in isolated rat soleus muscle at 10 uM	F	Nc1nonc1-n1nnc(C(=O)N/N=C/c2ccncc2)c1CN1CCCCC1		CHEMBL325353	=	Fold stimulation		3.1	CHEMBL262	Homo sapiens	Fold stimulation		3.1
	127564	CHEMBL686321	Inhibitory activity against human glycogen synthase kinase-3beta (GSK3-beta) at 100 uM ATP	B	Nc1nonc1-n1nnc(C(=O)NCCc2ccncc2)c1CN1CCCCC1		CHEMBL113168	=	IC50	nM	1160.0	CHEMBL262	Homo sapiens	IC50	uM	1.16
	127566	CHEMBL698973	Stimulation of glycogen synthase in CHO cells expressing human insulin receptor	F	Nc1nonc1-n1nnc(C(=O)NCCc2ccncc2)c1CN1CCCCC1		CHEMBL113168	=	EC50	nM	19070.0	CHEMBL262	Homo sapiens	EC50	uM	19.07
	127567	CHEMBL654667	Induced beta-casein protein expression in the CHO-hIR cell line	F	Nc1nonc1-n1nnc(C(=O)NCCc2ccncc2)c1CN1CCCCC1		CHEMBL113168	=	EC50	nM	57530.0	CHEMBL262	Homo sapiens	EC50	uM	57.53
	127568	CHEMBL800828	Increased glucose incorporation into glycogen at 0.2 nM insulin in isolated rat soleus muscle at 10 uM	F	Nc1nonc1-n1nnc(C(=O)NCCc2ccncc2)c1CN1CCCCC1		CHEMBL113168	=	Fold stimulation		2.2	CHEMBL262	Homo sapiens	Fold stimulation		2.2
	128504	CHEMBL686321	Inhibitory activity against human glycogen synthase kinase-3beta (GSK3-beta) at 100 uM ATP	B	Nc1nonc1-n1nnc(C(=O)NCc2ccncc2)c1CN1CCCCC1		CHEMBL112483	=	IC50	nM	9300.0	CHEMBL262	Homo sapiens	IC50	uM	9.3
	134878	CHEMBL686321	Inhibitory activity against human glycogen synthase kinase-3beta (GSK3-beta) at 100 uM ATP	B	Nc1nonc1-n1nnc(-c2n[nH]c(-c3ccncc3)n2)c1CN1CCCC1		CHEMBL323944	=	IC50	nM	240.0	CHEMBL262	Homo sapiens	IC50	uM	0.24
	134974	CHEMBL682326	Inhibition of Glycogen synthase kinase-3 beta at 1 uM	B	C[C@H](Nc1nccc(-c2c(-c3ccc(F)cc3)c(=O)n3n2CCC3)n1)C(C)(C)O		CHEMBL93281	=	Activity	%	99.0	CHEMBL262	Homo sapiens	Activity	%	99.0
	136172	CHEMBL686321	Inhibitory activity against human glycogen synthase kinase-3beta (GSK3-beta) at 100 uM ATP	B	Nc1nonc1-n1nnc(C(=O)N/N=C/c2ccncc2)c1CN1CCCC1		CHEMBL113272	=	IC50	nM	100.0	CHEMBL262	Homo sapiens	IC50	uM	0.1
	137223	CHEMBL686321	Inhibitory activity against human glycogen synthase kinase-3beta (GSK3-beta) at 100 uM ATP	B	Nc1nonc1-n1nnc(C(=O)NCCc2ccncc2)c1CN1CCCC1		CHEMBL112819	=	IC50	nM	2100.0	CHEMBL262	Homo sapiens	IC50	uM	2.1
	139692	CHEMBL686319	Inhibition of human Glycogen synthase kinase-3 beta (GSK3-beta) at 100 uM ATP	B	CCN(CC)Cc1c(C(=O)NN)nnn1-c1nonc1N		CHEMBL111895	=	IC50	nM	17000.0	CHEMBL262	Homo sapiens	IC50	uM	17.0
	139801	CHEMBL682326	Inhibition of Glycogen synthase kinase-3 beta at 1 uM	B	C[C@H](Nc1nccc(-c2c(-c3ccc(F)cc3)c(=O)n3n2CCC3)n1)c1ccccc1		CHEMBL92082	=	Activity	%	101.0	CHEMBL262	Homo sapiens	Activity	%	101.0
	142010	CHEMBL686321	Inhibitory activity against human glycogen synthase kinase-3beta (GSK3-beta) at 100 uM ATP	B	CCN(CC)Cc1c(C(=O)NCCc2ccncc2)nnn1-c1nonc1N		CHEMBL323012	=	IC50	nM	11700.0	CHEMBL262	Homo sapiens	IC50	uM	11.7
	142011	CHEMBL686321	Inhibitory activity against human glycogen synthase kinase-3beta (GSK3-beta) at 100 uM ATP	B	Nc1nonc1-n1nnc(-c2n[nH]c(-c3ccncc3)n2)c1CN1CCCCC1		CHEMBL326705	=	IC50	nM	280.0	CHEMBL262	Homo sapiens	IC50	uM	0.28
	142013	CHEMBL698973	Stimulation of glycogen synthase in CHO cells expressing human insulin receptor	F	Nc1nonc1-n1nnc(-c2n[nH]c(-c3ccncc3)n2)c1CN1CCCCC1		CHEMBL326705	=	EC50	nM	1850.0	CHEMBL262	Homo sapiens	EC50	uM	1.85
	142014	CHEMBL654667	Induced beta-casein protein expression in the CHO-hIR cell line	F	Nc1nonc1-n1nnc(-c2n[nH]c(-c3ccncc3)n2)c1CN1CCCCC1		CHEMBL326705	=	EC50	nM	11050.0	CHEMBL262	Homo sapiens	EC50	uM	11.05
	142015	CHEMBL800828	Increased glucose incorporation into glycogen at 0.2 nM insulin in isolated rat soleus muscle at 10 uM	F	Nc1nonc1-n1nnc(-c2n[nH]c(-c3ccncc3)n2)c1CN1CCCCC1		CHEMBL326705	=	Fold stimulation		3.2	CHEMBL262	Homo sapiens	Fold stimulation		3.2
	145865	CHEMBL682323	Inhibitory concentration against rabbit glycogen synthase kinase-3 beta using protein phosphatase inhibitor-2 as substrate	B	COc1ccccc1C1=C(c2cn(CCCO)c3ncccc23)C(=O)NC1=O		CHEMBL111298	=	IC50	nM	4.0	CHEMBL262	Homo sapiens	IC50	uM	0.004
	145869	CHEMBL682323	Inhibitory concentration against rabbit glycogen synthase kinase-3 beta using protein phosphatase inhibitor-2 as substrate	B	CN(C)CCCn1cc(C2=C(c3cccc4ccccc34)C(=O)NC2=O)c2cccnc21		CHEMBL326688	=	IC50	nM	140.0	CHEMBL262	Homo sapiens	IC50	uM	0.14
	147024	CHEMBL682323	Inhibitory concentration against rabbit glycogen synthase kinase-3 beta using protein phosphatase inhibitor-2 as substrate	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1ccccc1C(F)(F)F		CHEMBL325817	=	IC50	nM	14.0	CHEMBL262	Homo sapiens	IC50	uM	0.014
	147028	CHEMBL682323	Inhibitory concentration against rabbit glycogen synthase kinase-3 beta using protein phosphatase inhibitor-2 as substrate	B	COc1ccccc1C1=C(c2cn(CCCNS(C)(=O)=O)c3ncccc23)C(=O)NC1=O		CHEMBL326208	=	IC50	nM	14.0	CHEMBL262	Homo sapiens	IC50	uM	0.014
	157957	CHEMBL682323	Inhibitory concentration against rabbit glycogen synthase kinase-3 beta using protein phosphatase inhibitor-2 as substrate	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cccs1		CHEMBL333829	=	IC50	nM	31.0	CHEMBL262	Homo sapiens	IC50	uM	0.031
	159120	CHEMBL682323	Inhibitory concentration against rabbit glycogen synthase kinase-3 beta using protein phosphatase inhibitor-2 as substrate	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1ccc(F)cc1Cl		CHEMBL111005	=	IC50	nM	6.0	CHEMBL262	Homo sapiens	IC50	uM	0.006
	165230	CHEMBL682323	Inhibitory concentration against rabbit glycogen synthase kinase-3 beta using protein phosphatase inhibitor-2 as substrate	B	COc1ccccc1C1=C(c2cn(CCCN)c3ncccc23)C(=O)NC1=O		CHEMBL324268	=	IC50	nM	37.0	CHEMBL262	Homo sapiens	IC50	uM	0.037
	170244	CHEMBL682323	Inhibitory concentration against rabbit glycogen synthase kinase-3 beta using protein phosphatase inhibitor-2 as substrate	B	CCn1cc(C2=C(c3cn(CCCO)c4ncccc34)C(=O)NC2=O)c2cccnc21		CHEMBL110000	=	IC50	nM	65.0	CHEMBL262	Homo sapiens	IC50	uM	0.065
	171443	CHEMBL682323	Inhibitory concentration against rabbit glycogen synthase kinase-3 beta using protein phosphatase inhibitor-2 as substrate	B	COc1ccccc1C1=C(c2cn(CCCNC=O)c3ncccc23)C(=O)NC1=O		CHEMBL109977	=	IC50	nM	8.0	CHEMBL262	Homo sapiens	IC50	uM	0.008
	173752	CHEMBL682323	Inhibitory concentration against rabbit glycogen synthase kinase-3 beta using protein phosphatase inhibitor-2 as substrate	B	CN(C)CCCn1cc(C2=C(c3ccccc3Cl)C(=O)NC2=O)c2cccnc21		CHEMBL109834	=	IC50	nM	15.0	CHEMBL262	Homo sapiens	IC50	uM	0.015
	174918	CHEMBL682323	Inhibitory concentration against rabbit glycogen synthase kinase-3 beta using protein phosphatase inhibitor-2 as substrate	B	COc1ccccc1C1=C(c2cn(CCCNS(N)(=O)=O)c3ncccc23)C(=O)NC1=O		CHEMBL423323	=	IC50	nM	20.0	CHEMBL262	Homo sapiens	IC50	uM	0.02
	177432	CHEMBL682323	Inhibitory concentration against rabbit glycogen synthase kinase-3 beta using protein phosphatase inhibitor-2 as substrate	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1ncc(C(F)(F)F)cc1Cl		CHEMBL111620	=	IC50	nM	26.0	CHEMBL262	Homo sapiens	IC50	uM	0.026
	177436	CHEMBL686316	Inhibition of glycogen synthase kinase-3 beta	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1ncc(C(F)(F)F)cc1Cl		CHEMBL111620	=	Activity	%	3.0	CHEMBL262	Homo sapiens	Activity	%	3.0
	177508	CHEMBL691714	Effective concentration of compound against glycogen synthase kinase-3 in HEK293 cells	F	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1ncc(C(F)(F)F)cc1Cl		CHEMBL111620	=	EC50	nM	620.0	CHEMBL262	Homo sapiens	EC50	uM	0.62
	178741	CHEMBL682323	Inhibitory concentration against rabbit glycogen synthase kinase-3 beta using protein phosphatase inhibitor-2 as substrate	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1ccccc1Cl		CHEMBL326971	=	IC50	nM	10.0	CHEMBL262	Homo sapiens	IC50	uM	0.01
	178745	CHEMBL682323	Inhibitory concentration against rabbit glycogen synthase kinase-3 beta using protein phosphatase inhibitor-2 as substrate	B	COCCCn1cc(C2=C(c3ccccc3O)C(=O)NC2=O)c2cccnc21		CHEMBL109944	=	IC50	nM	45.0	CHEMBL262	Homo sapiens	IC50	uM	0.045
	178749	CHEMBL686316	Inhibition of glycogen synthase kinase-3 beta	B	COCCCn1cc(C2=C(c3ccccc3O)C(=O)NC2=O)c2cccnc21		CHEMBL109944	=	Activity	%	1.0	CHEMBL262	Homo sapiens	Activity	%	1.0
	178822	CHEMBL691714	Effective concentration of compound against glycogen synthase kinase-3 in HEK293 cells	F	COCCCn1cc(C2=C(c3ccccc3O)C(=O)NC2=O)c2cccnc21		CHEMBL109944	=	EC50	nM	390.0	CHEMBL262	Homo sapiens	EC50	uM	0.39
	178823	CHEMBL682323	Inhibitory concentration against rabbit glycogen synthase kinase-3 beta using protein phosphatase inhibitor-2 as substrate	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1ccccn1		CHEMBL450340	=	IC50	nM	480.0	CHEMBL262	Homo sapiens	IC50	uM	0.48
	178827	CHEMBL691714	Effective concentration of compound against glycogen synthase kinase-3 in HEK293 cells	F	[Cl-].[Li+]	Outside typical range	CHEMBL69710	>	EC50	nM	3000000.0	CHEMBL262	Homo sapiens	EC50	uM	3000.0
	180004	CHEMBL682323	Inhibitory concentration against rabbit glycogen synthase kinase-3 beta using protein phosphatase inhibitor-2 as substrate	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cccc2ccccc12		CHEMBL430694	=	IC50	nM	31.0	CHEMBL262	Homo sapiens	IC50	uM	0.031
	180008	CHEMBL691714	Effective concentration of compound against glycogen synthase kinase-3 in HEK293 cells	F	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714	=	EC50	nM	200.0	CHEMBL262	Homo sapiens	EC50	uM	0.2
	182492	CHEMBL682323	Inhibitory concentration against rabbit glycogen synthase kinase-3 beta using protein phosphatase inhibitor-2 as substrate	B	COc1ccccc1C1=C(c2cn(CCCNC(=O)OC(C)(C)C)c3ncccc23)C(=O)NC1=O		CHEMBL109981	=	IC50	nM	7.0	CHEMBL262	Homo sapiens	IC50	uM	0.007
	182496	CHEMBL686316	Inhibition of glycogen synthase kinase-3 beta	B	COc1ccccc1C1=C(c2cn(CCCNC(=O)OC(C)(C)C)c3ncccc23)C(=O)NC1=O		CHEMBL109981	=	Activity	%	0.0	CHEMBL262	Homo sapiens	Activity	%	0.0
	182571	CHEMBL691714	Effective concentration of compound against glycogen synthase kinase-3 in HEK293 cells	F	COc1ccccc1C1=C(c2cn(CCCNC(=O)OC(C)(C)C)c3ncccc23)C(=O)NC1=O		CHEMBL109981	=	EC50	nM	40.0	CHEMBL262	Homo sapiens	EC50	uM	0.04
	183865	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	Cc1ccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)cc1		CHEMBL303879	<	IC50	nM	31622.78	CHEMBL262	Homo sapiens	pIC50		4.5
	183866	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)n1		CHEMBL302490	=	IC50	nM	39.81	CHEMBL262	Homo sapiens	pIC50		7.4
	183867	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	IC50	nM	7.943	CHEMBL262	Homo sapiens	pIC50		8.1
	183868	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(NC(C)=O)cc4)ncnc32)c1		CHEMBL304172	=	IC50	nM	12.59	CHEMBL262	Homo sapiens	pIC50		7.9
	185157	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	IC50	nM	6.31	CHEMBL262	Homo sapiens	pIC50		8.2
	185158	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1		CHEMBL67374	=	IC50	nM	15.85	CHEMBL262	Homo sapiens	pIC50		7.8
	186616	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	COc1cc(/C=N/Nc2nc(-c3ccccc3)nc3c2cnn3-c2ccccc2)ccc1O		CHEMBL66780	<	IC50	nM	10000.0	CHEMBL262	Homo sapiens	pIC50		5.0
	186617	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	IC50	nM	3981.07	CHEMBL262	Homo sapiens	pIC50		5.4
	187842	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	CCCC(=O)Nc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL410319	=	IC50	nM	630.96	CHEMBL262	Homo sapiens	pIC50		6.2
	187843	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	IC50	nM	7.943	CHEMBL262	Homo sapiens	pIC50		8.1
	189072	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	Cc1ccccc1-n1ncc2c(N/N=C/c3ccncc3)ncnc21		CHEMBL67733	=	IC50	nM	158.49	CHEMBL262	Homo sapiens	pIC50		6.8
	189073	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	COc1cccc(-n2ncc3c(N/N=C/c4ccccc4OC)ncnc32)c1		CHEMBL67855	<	IC50	nM	25118.86	CHEMBL262	Homo sapiens	pIC50		4.6
	189074	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	CCN(CC)c1ccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)cc1		CHEMBL294595	=	IC50	nM	2511.89	CHEMBL262	Homo sapiens	pIC50		5.6
	189075	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(CN(C)C)cc4)ncnc32)c1		CHEMBL63915	=	IC50	nM	5.012	CHEMBL262	Homo sapiens	pIC50		8.3
	190194	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C#N)cc4)ncnc32)c1		CHEMBL66543	=	IC50	nM	15.85	CHEMBL262	Homo sapiens	pIC50		7.8
	190195	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	COc1cccc(-n2nc(C(C)C)c3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL63414	=	IC50	nM	31.62	CHEMBL262	Homo sapiens	pIC50		7.5
	191467	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	O=[N+]([O-])c1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL68944	<	IC50	nM	31622.78	CHEMBL262	Homo sapiens	pIC50		4.5
	192595	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	CCc1nn(-c2cccc(OC)c2)c2ncnc(N/N=C/c3ccncc3)c12		CHEMBL66900	=	IC50	nM	12.59	CHEMBL262	Homo sapiens	pIC50		7.9
	192596	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	CCCc1nn(-c2cccc(OC)c2)c2ncnc(N/N=C/c3ccncc3)c12		CHEMBL308455	=	IC50	nM	10.0	CHEMBL262	Homo sapiens	pIC50		8.0
	193784	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	COc1ccccc1-n1ncc2c(N/N=C/c3ccncc3)ncnc21		CHEMBL63595	=	IC50	nM	2511.89	CHEMBL262	Homo sapiens	pIC50		5.6
	193785	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	IC50	nM	2.512	CHEMBL262	Homo sapiens	pIC50		8.6
	194913	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(NC(=O)CCN(C)C)cc4)ncnc32)c1		CHEMBL309152	=	IC50	nM	5.012	CHEMBL262	Homo sapiens	pIC50		8.3
	196125	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	C(=N/Nc1ncnc2c1cnn2-c1ccncc1)\c1ccncc1		CHEMBL308454	=	IC50	nM	3.162	CHEMBL262	Homo sapiens	pIC50		8.5
	196126	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(NS(C)(=O)=O)cc4)ncnc32)c1		CHEMBL303433	=	IC50	nM	15.85	CHEMBL262	Homo sapiens	pIC50		7.8
	197206	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	COc1cc(/C=N/N(C)c2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL68063	<	IC50	nM	10000.0	CHEMBL262	Homo sapiens	pIC50		5.0
	197207	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	IC50	nM	2511.89	CHEMBL262	Homo sapiens	pIC50		5.6
	197208	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	COc1cc(/C=N/Nc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL65945	<	IC50	nM	10000.0	CHEMBL262	Homo sapiens	pIC50		5.0
	197209	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	C=CCOc1ccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)cc1		CHEMBL63348	=	IC50	nM	158.49	CHEMBL262	Homo sapiens	pIC50		6.8
	199630	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	COc1cc(/C=N/Nc2nc(Cl)nc3c2cnn3-c2ccccc2)ccc1O		CHEMBL66003	<	IC50	nM	10000.0	CHEMBL262	Homo sapiens	pIC50		5.0
	199631	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	Cc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL294592	=	IC50	nM	158.49	CHEMBL262	Homo sapiens	pIC50		6.8
	199632	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	COc1ccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)cc1		CHEMBL68242	=	IC50	nM	1000.0	CHEMBL262	Homo sapiens	pIC50		6.0
	199633	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	CCOc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL66510	=	IC50	nM	100.0	CHEMBL262	Homo sapiens	pIC50		7.0
	199634	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	COc1cccc(-n2ncc3c(N/N=C/c4ccccc4F)ncnc32)c1		CHEMBL307311	=	IC50	nM	125.89	CHEMBL262	Homo sapiens	pIC50		6.9
	200834	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	CC(=O)Nc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL291425	=	IC50	nM	158.49	CHEMBL262	Homo sapiens	pIC50		6.8
	200835	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	Brc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67310	=	IC50	nM	251.19	CHEMBL262	Homo sapiens	pIC50		6.6
	202149	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(-c5ccccc5)cc4)ncnc32)c1		CHEMBL65538	<	IC50	nM	31622.78	CHEMBL262	Homo sapiens	pIC50		4.5
	203308	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	COc1ccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)cc1		CHEMBL302048	=	IC50	nM	31.62	CHEMBL262	Homo sapiens	pIC50		7.5
	203309	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	COc1cccc(-n2nc(C)c3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL68450	=	IC50	nM	10.0	CHEMBL262	Homo sapiens	pIC50		8.0
	204540	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	C(=N/Nc1ncnc2c1cnn2-c1ccccc1)\c1ccncc1		CHEMBL63727	=	IC50	nM	100.0	CHEMBL262	Homo sapiens	pIC50		7.0
	204541	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(N)c4)ncnc32)c1		CHEMBL69588	=	IC50	nM	10.0	CHEMBL262	Homo sapiens	pIC50		8.0
	206915	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)c(F)c4)ncnc32)c1		CHEMBL67799	=	IC50	nM	15.85	CHEMBL262	Homo sapiens	pIC50		7.8
	206916	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(OCCN(C)C)cc4)ncnc32)c1		CHEMBL303321	=	IC50	nM	6.31	CHEMBL262	Homo sapiens	pIC50		8.2
	208074	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	C(=N/Nc1ncnc2c1cnn2-c1nccs1)\c1ccncc1		CHEMBL68397	=	IC50	nM	39.81	CHEMBL262	Homo sapiens	pIC50		7.4
	209244	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	C(=N/Nc1ncnc2c1cnn2-c1cccc(NCC2CC2)c1)\c1ccncc1		CHEMBL69526	=	IC50	nM	1995.26	CHEMBL262	Homo sapiens	pIC50		5.7
	209245	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(O)cc4)ncnc32)c1		CHEMBL308430	=	IC50	nM	12.59	CHEMBL262	Homo sapiens	pIC50		7.9
	210421	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	IC50	nM	3162.28	CHEMBL262	Homo sapiens	pIC50		5.5
	211601	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	C(=N/Nc1ncnc2c1cnn2-c1cccnc1)\c1ccncc1		CHEMBL66910	=	IC50	nM	31.62	CHEMBL262	Homo sapiens	pIC50		7.5
	211602	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	CCNCc1ccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)cc1		CHEMBL66791	=	IC50	nM	3.981	CHEMBL262	Homo sapiens	pIC50		8.4
	211603	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(=O)(=O)NCCN(C)C)cc4)ncnc32)c1		CHEMBL418690	=	IC50	nM	10.0	CHEMBL262	Homo sapiens	pIC50		8.0
	211604	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	IC50	nM	6309.57	CHEMBL262	Homo sapiens	pIC50		5.2
	212752	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	COc1cccc(-n2ncc3c(N/N=C/c4ccccc4)ncnc32)c1		CHEMBL66170	=	IC50	nM	10.0	CHEMBL262	Homo sapiens	pIC50		8.0
	212753	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)O)cc4)ncnc32)c1		CHEMBL65988	=	IC50	nM	31.62	CHEMBL262	Homo sapiens	pIC50		7.5
	213927	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(OCc5ccc(F)cc5)cc4)ncnc32)c1		CHEMBL293191	=	IC50	nM	2511.89	CHEMBL262	Homo sapiens	pIC50		5.6
	213928	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	<	IC50	nM	31622.78	CHEMBL262	Homo sapiens	pIC50		4.5
	215028	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	COc1cc(/C=N/Nc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL63803	=	IC50	nM	100.0	CHEMBL262	Homo sapiens	pIC50		7.0
	215029	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	FC(F)(F)Oc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306692	=	IC50	nM	316.23	CHEMBL262	Homo sapiens	pIC50		6.5
	215030	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(S(C)(=O)=O)c4)ncnc32)c1		CHEMBL66453	=	IC50	nM	3.981	CHEMBL262	Homo sapiens	pIC50		8.4
	216259	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	C(=N/Nc1ncnc2c1cnn2-c1ccccn1)\c1ccncc1		CHEMBL304339	=	IC50	nM	1258.93	CHEMBL262	Homo sapiens	pIC50		5.9
	216260	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCS(C)(=O)=O)cc4)ncnc32)c1		CHEMBL65987	=	IC50	nM	7.943	CHEMBL262	Homo sapiens	pIC50		8.1
	218732	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	COc1cccc(-n2ncc3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL302969	=	IC50	nM	63.1	CHEMBL262	Homo sapiens	pIC50		7.2
	219982	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	Fc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67562	=	IC50	nM	316.23	CHEMBL262	Homo sapiens	pIC50		6.5
	219983	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	IC50	nM	25.12	CHEMBL262	Homo sapiens	pIC50		7.6
	221055	CHEMBL684359	Ability to inhibit 50% glycogen synthase kinase-3 beta of recombinant human, expressed as log of concentration	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(N)cc4)ncnc32)c1		CHEMBL303630	=	IC50	nM	2.512	CHEMBL262	Homo sapiens	pIC50		8.6
	281895	CHEMBL685261	Inhibition of protein kinase Glycogen synthase kinase-3 beta	B	Cc1nc(N)sc1-c1ccnc(Nc2cccc([N+](=O)[O-])c2)n1		CHEMBL298445	=	Ki	nM	20.0	CHEMBL262	Homo sapiens	Ki	nM	20.0
	393894	CHEMBL684977	Inhibition of glycogen synthase kinase-3 beta, purified from porcine brain or expressed in and purified from insect Sf9 cells	B	CCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL308293	=	IC50	nM	400.0	CHEMBL262	Homo sapiens	IC50	uM	0.4
	393897	CHEMBL684977	Inhibition of glycogen synthase kinase-3 beta, purified from porcine brain or expressed in and purified from insect Sf9 cells	B	CCCCCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL76741	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	395322	CHEMBL684977	Inhibition of glycogen synthase kinase-3 beta, purified from porcine brain or expressed in and purified from insect Sf9 cells	B	COc1ccc(-c2[nH]c3nccnc3c2C)cc1		CHEMBL77264	=	IC50	nM	460.0	CHEMBL262	Homo sapiens	IC50	uM	0.46
	395325	CHEMBL684977	Inhibition of glycogen synthase kinase-3 beta, purified from porcine brain or expressed in and purified from insect Sf9 cells	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	IC50	nM	650.0	CHEMBL262	Homo sapiens	IC50	uM	0.65
	395346	CHEMBL685265	Inhibition of Glycogen synthase kinase-3 beta	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	IC50	nM	1500.0	CHEMBL262	Homo sapiens	IC50	uM	1.5
	396630	CHEMBL684977	Inhibition of glycogen synthase kinase-3 beta, purified from porcine brain or expressed in and purified from insect Sf9 cells	B	Clc1ccc(C2(c3cc4[nH]ccnc-4n3)CC2)cc1		CHEMBL307941	=	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	uM	1.0
	397837	CHEMBL684977	Inhibition of glycogen synthase kinase-3 beta, purified from porcine brain or expressed in and purified from insect Sf9 cells	B	c1coc(-c2cc3[nH]ccnc-3n2)c1		CHEMBL305627	=	IC50	nM	15000.0	CHEMBL262	Homo sapiens	IC50	uM	15.0
	399097	CHEMBL684977	Inhibition of glycogen synthase kinase-3 beta, purified from porcine brain or expressed in and purified from insect Sf9 cells	B	Clc1ccc(-c2[nH]c3nccnc3c2Cc2ccccc2)cc1		CHEMBL310036	=	IC50	nM	6800.0	CHEMBL262	Homo sapiens	IC50	uM	6.8
	401766	CHEMBL684977	Inhibition of glycogen synthase kinase-3 beta, purified from porcine brain or expressed in and purified from insect Sf9 cells	B	c1c[nH]c2cc(-c3ccc(C4OCCO4)cc3)nc-2n1		CHEMBL77267	=	IC50	nM	20000.0	CHEMBL262	Homo sapiens	IC50	uM	20.0
	403173	CHEMBL684977	Inhibition of glycogen synthase kinase-3 beta, purified from porcine brain or expressed in and purified from insect Sf9 cells	B	COc1ccc(-c2[nH]c3nccnc3c2CCCCl)cc1		CHEMBL76942	=	IC50	nM	2500.0	CHEMBL262	Homo sapiens	IC50	uM	2.5
	403176	CHEMBL684977	Inhibition of glycogen synthase kinase-3 beta, purified from porcine brain or expressed in and purified from insect Sf9 cells	B	COc1ccc(-c2[nH]c3nccnc3c2CC2CC2)cc1		CHEMBL76740	=	IC50	nM	1100.0	CHEMBL262	Homo sapiens	IC50	uM	1.1
	404772	CHEMBL684977	Inhibition of glycogen synthase kinase-3 beta, purified from porcine brain or expressed in and purified from insect Sf9 cells	B	Oc1ccccc1-c1cc2[nH]ccnc-2n1		CHEMBL77584	=	IC50	nM	6500.0	CHEMBL262	Homo sapiens	IC50	uM	6.5
	404775	CHEMBL684977	Inhibition of glycogen synthase kinase-3 beta, purified from porcine brain or expressed in and purified from insect Sf9 cells	B	Oc1ccc(-c2cc3[nH]ccnc-3n2)cc1		CHEMBL80785	=	IC50	nM	1200.0	CHEMBL262	Homo sapiens	IC50	uM	1.2
	405917	CHEMBL684977	Inhibition of glycogen synthase kinase-3 beta, purified from porcine brain or expressed in and purified from insect Sf9 cells	B	c1ccc(-c2cc3[nH]ccnc-3n2)nc1		CHEMBL77416	=	IC50	nM	15000.0	CHEMBL262	Homo sapiens	IC50	uM	15.0
	407223	CHEMBL684977	Inhibition of glycogen synthase kinase-3 beta, purified from porcine brain or expressed in and purified from insect Sf9 cells	B	COc1ccc(-c2cc3[nH]ccnc-3n2)cc1		CHEMBL77066	=	IC50	nM	1100.0	CHEMBL262	Homo sapiens	IC50	uM	1.1
	407226	CHEMBL684977	Inhibition of glycogen synthase kinase-3 beta, purified from porcine brain or expressed in and purified from insect Sf9 cells	B	COc1cc(OC)cc(-c2cc3[nH]ccnc-3n2)c1		CHEMBL77002	=	IC50	nM	60000.0	CHEMBL262	Homo sapiens	IC50	uM	60.0
	407229	CHEMBL684977	Inhibition of glycogen synthase kinase-3 beta, purified from porcine brain or expressed in and purified from insect Sf9 cells	B	C=CCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL76941	=	IC50	nM	600.0	CHEMBL262	Homo sapiens	IC50	uM	0.6
	407232	CHEMBL684977	Inhibition of glycogen synthase kinase-3 beta, purified from porcine brain or expressed in and purified from insect Sf9 cells	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	IC50	nM	920.0	CHEMBL262	Homo sapiens	IC50	uM	0.92
	408329	CHEMBL684977	Inhibition of glycogen synthase kinase-3 beta, purified from porcine brain or expressed in and purified from insect Sf9 cells	B	Cc1c(-c2ccc(OS(=O)(=O)N(C)C)cc2)[nH]c2nccnc12		CHEMBL77540	=	IC50	nM	500.0	CHEMBL262	Homo sapiens	IC50	uM	0.5
	409543	CHEMBL684977	Inhibition of glycogen synthase kinase-3 beta, purified from porcine brain or expressed in and purified from insect Sf9 cells	B	c1ccc(-c2cc3[nH]ccnc-3n2)cc1		CHEMBL305901	=	IC50	nM	2300.0	CHEMBL262	Homo sapiens	IC50	uM	2.3
	409546	CHEMBL684977	Inhibition of glycogen synthase kinase-3 beta, purified from porcine brain or expressed in and purified from insect Sf9 cells	B	c1ccc(Cc2c(-c3ccccc3)[nH]c3nccnc23)cc1		CHEMBL77469	=	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	uM	1.0
	410747	CHEMBL684977	Inhibition of glycogen synthase kinase-3 beta, purified from porcine brain or expressed in and purified from insect Sf9 cells	B	Clc1cc(Cl)cc(-c2cc3[nH]ccnc-3n2)c1		CHEMBL76660	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	410750	CHEMBL684977	Inhibition of glycogen synthase kinase-3 beta, purified from porcine brain or expressed in and purified from insect Sf9 cells	B	FC(F)(F)c1ccc(-c2cc3[nH]ccnc-3n2)cc1		CHEMBL77210	=	IC50	nM	7200.0	CHEMBL262	Homo sapiens	IC50	uM	7.2
	412044	CHEMBL684977	Inhibition of glycogen synthase kinase-3 beta, purified from porcine brain or expressed in and purified from insect Sf9 cells	B	Fc1ccc(-c2cc3[nH]ccnc-3n2)cc1		CHEMBL306263	=	IC50	nM	1900.0	CHEMBL262	Homo sapiens	IC50	uM	1.9
	413233	CHEMBL684977	Inhibition of glycogen synthase kinase-3 beta, purified from porcine brain or expressed in and purified from insect Sf9 cells	B	COc1cc(-c2cc3[nH]ccnc-3n2)cc(OC)c1OC		CHEMBL312065	=	IC50	nM	85000.0	CHEMBL262	Homo sapiens	IC50	uM	85.0
	414386	CHEMBL684977	Inhibition of glycogen synthase kinase-3 beta, purified from porcine brain or expressed in and purified from insect Sf9 cells	B	CCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL77095	=	IC50	nM	1800.0	CHEMBL262	Homo sapiens	IC50	uM	1.8
	414389	CHEMBL684977	Inhibition of glycogen synthase kinase-3 beta, purified from porcine brain or expressed in and purified from insect Sf9 cells	B	c1csc(-c2cc3[nH]ccnc-3n2)c1		CHEMBL74015	=	IC50	nM	1200.0	CHEMBL262	Homo sapiens	IC50	uM	1.2
	414392	CHEMBL684977	Inhibition of glycogen synthase kinase-3 beta, purified from porcine brain or expressed in and purified from insect Sf9 cells	B	c1ccc2c(-c3cc4[nH]ccnc-4n3)cccc2c1		CHEMBL78264	=	IC50	nM	27000.0	CHEMBL262	Homo sapiens	IC50	uM	27.0
	415695	CHEMBL684977	Inhibition of glycogen synthase kinase-3 beta, purified from porcine brain or expressed in and purified from insect Sf9 cells	B	COc1ccc(-c2[nH]c3nccnc3c2C)cc1OC		CHEMBL419273	=	IC50	nM	2000.0	CHEMBL262	Homo sapiens	IC50	uM	2.0
	415698	CHEMBL684977	Inhibition of glycogen synthase kinase-3 beta, purified from porcine brain or expressed in and purified from insect Sf9 cells	B	Cc1c[nH]c2cc(-c3ccccc3)nc-2n1		CHEMBL311935	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	416926	CHEMBL684977	Inhibition of glycogen synthase kinase-3 beta, purified from porcine brain or expressed in and purified from insect Sf9 cells	B	N#Cc1ccc(-c2cc3[nH]ccnc-3n2)cc1		CHEMBL77697	=	IC50	nM	4800.0	CHEMBL262	Homo sapiens	IC50	uM	4.8
	416929	CHEMBL684977	Inhibition of glycogen synthase kinase-3 beta, purified from porcine brain or expressed in and purified from insect Sf9 cells	B	CC(C)c1c(-c2ccc(Cl)cc2)[nH]c2nccnc12		CHEMBL77217	=	IC50	nM	750.0	CHEMBL262	Homo sapiens	IC50	uM	0.75
	416932	CHEMBL684977	Inhibition of glycogen synthase kinase-3 beta, purified from porcine brain or expressed in and purified from insect Sf9 cells	B	Cc1c(C2(c3ccc(Cl)cc3)CC2)[nH]c2nccnc12		CHEMBL76427	=	IC50	nM	18000.0	CHEMBL262	Homo sapiens	IC50	uM	18.0
	418136	CHEMBL684977	Inhibition of glycogen synthase kinase-3 beta, purified from porcine brain or expressed in and purified from insect Sf9 cells	B	Clc1ccc(-c2[nH]c3nccnc3c2CC2CCCCC2)cc1		CHEMBL306347	=	IC50	nM	8000.0	CHEMBL262	Homo sapiens	IC50	uM	8.0
	419153	CHEMBL684977	Inhibition of glycogen synthase kinase-3 beta, purified from porcine brain or expressed in and purified from insect Sf9 cells	B	CCCCc1c(-c2ccc(Cl)cc2)[nH]c2nccnc12		CHEMBL306355	=	IC50	nM	5900.0	CHEMBL262	Homo sapiens	IC50	uM	5.9
	420516	CHEMBL684977	Inhibition of glycogen synthase kinase-3 beta, purified from porcine brain or expressed in and purified from insect Sf9 cells	B	Cc1c(-c2ccc(Cl)cc2)[nH]c2nccnc12		CHEMBL78165	=	IC50	nM	1700.0	CHEMBL262	Homo sapiens	IC50	uM	1.7
	420519	CHEMBL684977	Inhibition of glycogen synthase kinase-3 beta, purified from porcine brain or expressed in and purified from insect Sf9 cells	B	Oc1ccc(-c2[nH]c3nccnc3c2CC2CC2)cc1		CHEMBL74133	=	IC50	nM	3000.0	CHEMBL262	Homo sapiens	IC50	uM	3.0
	421971	CHEMBL684977	Inhibition of glycogen synthase kinase-3 beta, purified from porcine brain or expressed in and purified from insect Sf9 cells	B	COc1cccc(-c2cc3[nH]ccnc-3n2)c1		CHEMBL80644	=	IC50	nM	3200.0	CHEMBL262	Homo sapiens	IC50	uM	3.2
	421974	CHEMBL684977	Inhibition of glycogen synthase kinase-3 beta, purified from porcine brain or expressed in and purified from insect Sf9 cells	B	CN(C)c1ccc(-c2cc3[nH]ccnc-3n2)cc1		CHEMBL77458	=	IC50	nM	12000.0	CHEMBL262	Homo sapiens	IC50	uM	12.0
	421977	CHEMBL684977	Inhibition of glycogen synthase kinase-3 beta, purified from porcine brain or expressed in and purified from insect Sf9 cells	B	Cn1c(-c2ccccc2)cc2nccnc21		CHEMBL78232	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	423364	CHEMBL684977	Inhibition of glycogen synthase kinase-3 beta, purified from porcine brain or expressed in and purified from insect Sf9 cells	B	COc1ccc(-c2[nH]c3nccnc3c2CC2CCCCC2)cc1		CHEMBL77947	=	IC50	nM	6800.0	CHEMBL262	Homo sapiens	IC50	uM	6.8
	424512	CHEMBL684977	Inhibition of glycogen synthase kinase-3 beta, purified from porcine brain or expressed in and purified from insect Sf9 cells	B	Cc1ccc(-c2cc3[nH]ccnc-3n2)cc1		CHEMBL307943	=	IC50	nM	2600.0	CHEMBL262	Homo sapiens	IC50	uM	2.6
	425718	CHEMBL684977	Inhibition of glycogen synthase kinase-3 beta, purified from porcine brain or expressed in and purified from insect Sf9 cells	B	COc1ccccc1-c1cc2[nH]ccnc-2n1		CHEMBL77590	=	IC50	nM	3300.0	CHEMBL262	Homo sapiens	IC50	uM	3.3
	425721	CHEMBL684977	Inhibition of glycogen synthase kinase-3 beta, purified from porcine brain or expressed in and purified from insect Sf9 cells	B	COc1ccc(-c2[nH]c3nccnc3c2C(C)C)cc1		CHEMBL309347	=	IC50	nM	500.0	CHEMBL262	Homo sapiens	IC50	uM	0.5
	425724	CHEMBL684977	Inhibition of glycogen synthase kinase-3 beta, purified from porcine brain or expressed in and purified from insect Sf9 cells	B	Cc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL77641	=	IC50	nM	520.0	CHEMBL262	Homo sapiens	IC50	uM	0.52
	425727	CHEMBL684977	Inhibition of glycogen synthase kinase-3 beta, purified from porcine brain or expressed in and purified from insect Sf9 cells	B	c1ccc(-c2cc3[nH]c4ccccc4nc-3n2)cc1		CHEMBL307392	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	429657	CHEMBL684977	Inhibition of glycogen synthase kinase-3 beta, purified from porcine brain or expressed in and purified from insect Sf9 cells	B	c1c[nH]c2cc(-c3ccsc3)nc-2n1		CHEMBL76559	=	IC50	nM	800.0	CHEMBL262	Homo sapiens	IC50	uM	0.8
	430823	CHEMBL684977	Inhibition of glycogen synthase kinase-3 beta, purified from porcine brain or expressed in and purified from insect Sf9 cells	B	Brc1ccc(-c2cc3[nH]ccnc-3n2)cc1		CHEMBL77211	=	IC50	nM	6000.0	CHEMBL262	Homo sapiens	IC50	uM	6.0
	474054	CHEMBL683002	Inhibitory concentration against human Glycogen synthase kinase-3	B	Fc1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL37811	=	IC50	nM	1400.0	CHEMBL262	Homo sapiens	IC50	uM	1.4
	475187	CHEMBL683002	Inhibitory concentration against human Glycogen synthase kinase-3	B	O=C(Cc1ccc(CSc2nnc(-c3ccncc3)o2)cc1)NCCc1ccccc1F		CHEMBL37342	=	IC50	nM	1200.0	CHEMBL262	Homo sapiens	IC50	uM	1.2
	476330	CHEMBL683002	Inhibitory concentration against human Glycogen synthase kinase-3	B	O=C(O)Cc1ccc(CSc2nnc(-c3ccncc3)o2)cc1		CHEMBL416975	=	IC50	nM	8000.0	CHEMBL262	Homo sapiens	IC50	uM	8.0
	476331	CHEMBL683002	Inhibitory concentration against human Glycogen synthase kinase-3	B	c1ccc(CSc2nnc(-c3ccncc3)o2)cc1		CHEMBL40439	=	IC50	nM	6700.0	CHEMBL262	Homo sapiens	IC50	uM	6.7
	477457	CHEMBL683002	Inhibitory concentration against human Glycogen synthase kinase-3	B	O=C(O)Cc1ccc(CSc2n[nH]c(-c3ccncc3)n2)cc1	Outside typical range	CHEMBL40842	>	IC50	nM	250000.0	CHEMBL262	Homo sapiens	IC50	uM	250.0
	483804	CHEMBL683002	Inhibitory concentration against human Glycogen synthase kinase-3	B	O=C(O)Cc1ccc(CSc2nnc(-c3ccccn3)s2)cc1	Outside typical range	CHEMBL39357	>	IC50	nM	250000.0	CHEMBL262	Homo sapiens	IC50	uM	250.0
	485014	CHEMBL683002	Inhibitory concentration against human Glycogen synthase kinase-3	B	O=C(O)c1cccc(CSc2nnc(-c3ccncc3)o2)c1	Outside typical range	CHEMBL288588	=	IC50	nM	235000.0	CHEMBL262	Homo sapiens	IC50	uM	235.0
	487272	CHEMBL683002	Inhibitory concentration against human Glycogen synthase kinase-3	B	Cc1nc(-c2cccc(CSc3nnc(-c4ccncc4)o3)c2)no1	Outside typical range	CHEMBL37826	>	IC50	nM	250000.0	CHEMBL262	Homo sapiens	IC50	uM	250.0
	488460	CHEMBL683002	Inhibitory concentration against human Glycogen synthase kinase-3	B	O=C(O)c1ccc(CSc2nnc(-c3ccncc3)o2)cc1		CHEMBL290436	=	IC50	nM	29000.0	CHEMBL262	Homo sapiens	IC50	uM	29.0
	493225	CHEMBL683002	Inhibitory concentration against human Glycogen synthase kinase-3	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	IC50	nM	390.0	CHEMBL262	Homo sapiens	IC50	uM	0.39
	494395	CHEMBL683002	Inhibitory concentration against human Glycogen synthase kinase-3	B	c1ccc(CCSc2nnc(-c3ccncc3)o2)cc1		CHEMBL40022	=	IC50	nM	29000.0	CHEMBL262	Homo sapiens	IC50	uM	29.0
	495452	CHEMBL683002	Inhibitory concentration against human Glycogen synthase kinase-3	B	Clc1ccccc1CSc1nnc(-c2ccncc2)o1		CHEMBL40004	=	IC50	nM	12000.0	CHEMBL262	Homo sapiens	IC50	uM	12.0
	502622	CHEMBL683002	Inhibitory concentration against human Glycogen synthase kinase-3	B	O=C(O)Cc1ccc(CSc2nnc(-c3ccncc3)s2)cc1		CHEMBL290211	=	IC50	nM	11000.0	CHEMBL262	Homo sapiens	IC50	uM	11.0
	506306	CHEMBL683002	Inhibitory concentration against human Glycogen synthase kinase-3	B	Clc1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL40021	=	IC50	nM	820.0	CHEMBL262	Homo sapiens	IC50	uM	0.82
	507480	CHEMBL683002	Inhibitory concentration against human Glycogen synthase kinase-3	B	Ic1ccc(CSc2nnc(-c3ccncc3)o2)cc1	Outside typical range	CHEMBL37652	=	IC50	nM	198000.0	CHEMBL262	Homo sapiens	IC50	uM	198.0
	507481	CHEMBL683002	Inhibitory concentration against human Glycogen synthase kinase-3	B	COC(=O)c1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL37689	=	IC50	nM	1100.0	CHEMBL262	Homo sapiens	IC50	uM	1.1
	511120	CHEMBL683002	Inhibitory concentration against human Glycogen synthase kinase-3	B	O=C(O)Cc1ccc(CSc2nnc(-c3cccnc3)s2)cc1	Outside typical range	CHEMBL39803	>	IC50	nM	250000.0	CHEMBL262	Homo sapiens	IC50	uM	250.0
	554125	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1Cc1ccccc1		CHEMBL99779	=	IC50	nM	10000.0	CHEMBL262	Homo sapiens	pIC50		5.0
	554128	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	O=C1Cc2c([nH]c3ccc(C(F)(F)F)cc23)-c2cc(CC#CO)ccc2N1		CHEMBL121543	=	IC50	nM	199.99	CHEMBL262	Homo sapiens	pIC50		6.699
	554912	CHEMBL686325	Inhibition of GSK3-beta in presence of 10 uM ATP	B	CCCC(=O)Nc1n[nH]c2ncc(-c3cccnc3)cc12		CHEMBL407002	=	Inhibition	%	94.0	CHEMBL262	Homo sapiens	Inhibition	%	94.0
	555378	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	CN1C(=O)Cc2c([nH]c3ccc(Br)cc23)-c2ccccc21		CHEMBL316485	=	IC50	nM	2098.94	CHEMBL262	Homo sapiens	pIC50		5.678
	555381	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	Cn1c2c(c3cc(Br)ccc31)CC(=O)Nc1ccccc1-2		CHEMBL318208	=	IC50	nM	399.94	CHEMBL262	Homo sapiens	pIC50		6.398
	555384	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	O=C1Cc2c([nH]c3ccccc23)-c2ccccc2N1		CHEMBL430574	=	IC50	nM	619.44	CHEMBL262	Homo sapiens	pIC50		6.208
	556509	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	Cc1ccc2[nH]c3c(c2c1)CC(=O)Nc1ccccc1-3		CHEMBL317964	=	IC50	nM	130.02	CHEMBL262	Homo sapiens	pIC50		6.886
	556512	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	CC(=O)OCN1C(=O)Cc2c([nH]c3ccc(Br)cc23)-c2ccccc21		CHEMBL120030	=	IC50	nM	500.03	CHEMBL262	Homo sapiens	pIC50		6.301
	556515	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	O=C1Cc2c([nH]c3ccc(Cl)cc23)-c2cccnc2N1	Outside typical range	CHEMBL331722	=	IC50	nM	500034.53	CHEMBL262	Homo sapiens	pIC50		3.301
	556518	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	CSC1=Nc2ccccc2-c2c(c3cc([N+](=O)[O-])ccc3n2C)C1	Outside typical range	CHEMBL331120	=	IC50	nM	1000000.0	CHEMBL262	Homo sapiens	pIC50		3.0
	557723	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2cccc(O)c2N1		CHEMBL95477	=	IC50	nM	4295.36	CHEMBL262	Homo sapiens	pIC50		5.367
	559000	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	Cl.NCCCCOc1ccc2c(c1)NC(=O)Cc1c-2[nH]c2ccc(Br)cc12		CHEMBL545053	=	IC50	nM	29.99	CHEMBL262	Homo sapiens	pIC50		7.523
	559756	CHEMBL683729	Inhibition of glycogen synthase kinase-3beta in presence of 10 uM	B	CCCC(=O)Nc1n[nH]c2nnc(-c3ccccc3)cc12		CHEMBL288143	=	Inhibition	%	99.0	CHEMBL262	Homo sapiens	Inhibition	%	99.0
	560247	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	CCN1C(=O)Cc2c([nH]c3ccc(Br)cc23)-c2ccccc21		CHEMBL97844	=	IC50	nM	23988.33	CHEMBL262	Homo sapiens	pIC50		4.62
	560250	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	COC(=O)/C=C/c1ccc2c(c1)-c1[nH]c3ccc(C(F)(F)F)cc3c1CC(=O)N2		CHEMBL121958	=	IC50	nM	349.95	CHEMBL262	Homo sapiens	pIC50		6.456
	560253	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	COc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL325403	=	IC50	nM	21.98	CHEMBL262	Homo sapiens	pIC50		7.658
	561152	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2cc(Br)ccc2N1		CHEMBL98360	=	IC50	nM	799.83	CHEMBL262	Homo sapiens	pIC50		6.097
	562393	CHEMBL686300	Inhibition of Glycogen synthase kinase-3 beta purified from insect sf9 cells	B	O=C1Cc2c([nH]c3cc(Br)ccc23)-c2ccccc2N1		CHEMBL98554	=	IC50	nM	139.96	CHEMBL262	Homo sapiens	pIC50		6.854
	562396	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	CC(=O)OCn1c2c(c3cc(Br)ccc31)CC(=O)Nc1ccccc1-2		CHEMBL332678	=	IC50	nM	74.99	CHEMBL262	Homo sapiens	pIC50		7.125
	562399	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	O=C1Cc2c([nH]c3ccc(C(F)(F)F)cc23)-c2cc(I)ccc2N1		CHEMBL121957	=	IC50	nM	2197.86	CHEMBL262	Homo sapiens	pIC50		5.658
	563547	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	O=C1Cc2c([nH]c3ccc(F)cc23)-c2ccccc2N1		CHEMBL99037	=	IC50	nM	79.98	CHEMBL262	Homo sapiens	pIC50		7.097
	563550	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	COc1cc2c(cc1OC)-c1[nH]c3ccc(C(F)(F)F)cc3c1CC(=O)N2		CHEMBL328194	=	IC50	nM	74.99	CHEMBL262	Homo sapiens	pIC50		7.125
	563553	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	C=C(C)n1c2c(c3cc(Br)ccc31)CC(=O)Nc1ccccc1-2		CHEMBL324064	=	IC50	nM	3999.45	CHEMBL262	Homo sapiens	pIC50		5.398
	564772	CHEMBL686300	Inhibition of Glycogen synthase kinase-3 beta purified from insect sf9 cells	B	O=C1Cc2c([nH]c3ccc(Cl)cc23)-c2ccccc2N1		CHEMBL98153	=	IC50	nM	23.99	CHEMBL262	Homo sapiens	pIC50		7.62
	564775	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	COc1cc2c(cc1OC)-c1[nH]c3ccc(Br)cc3c1CC(=O)N2		CHEMBL319373	=	IC50	nM	100.0	CHEMBL262	Homo sapiens	pIC50		7.0
	564778	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	COc1ccc2c(c1)NC(=O)Cc1c-2[nH]c2ccc([N+](=O)[O-])cc12		CHEMBL116545	=	IC50	nM	69.98	CHEMBL262	Homo sapiens	pIC50		7.155
	567052	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccc(O)cc2N1		CHEMBL331000	=	IC50	nM	17.99	CHEMBL262	Homo sapiens	pIC50		7.745
	569672	CHEMBL686300	Inhibition of Glycogen synthase kinase-3 beta purified from insect sf9 cells	B	O=C1Cc2c([nH]c3c(Cl)cccc23)-c2ccccc2N1		CHEMBL318471	=	IC50	nM	199.99	CHEMBL262	Homo sapiens	pIC50		6.699
	569675	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	COc1cc2c(cc1OC)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL331190	=	IC50	nM	13.0	CHEMBL262	Homo sapiens	pIC50		7.886
	571002	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	COc1ccc2c(c1)NC(=O)Cc1c-2[nH]c2ccc(C(F)(F)F)cc12		CHEMBL334084	=	IC50	nM	239.88	CHEMBL262	Homo sapiens	pIC50		6.62
	572252	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc(C(F)(F)F)cc3c1CC(=O)N2		CHEMBL121492	=	IC50	nM	33.04	CHEMBL262	Homo sapiens	pIC50		7.481
	572999	CHEMBL683729	Inhibition of glycogen synthase kinase-3beta in presence of 10 uM	B	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3ccccc3)cc12		CHEMBL259744	=	Inhibition	%	93.0	CHEMBL262	Homo sapiens	Inhibition	%	93.0
	573466	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2cc(O)c(O)cc2N1		CHEMBL329063	=	IC50	nM	119.95	CHEMBL262	Homo sapiens	pIC50		6.921
	574608	CHEMBL686300	Inhibition of Glycogen synthase kinase-3 beta purified from insect sf9 cells	B	O=C1Cc2c([nH]c3ccccc23)-c2cc(Br)ccc2N1		CHEMBL316940	=	IC50	nM	199.99	CHEMBL262	Homo sapiens	pIC50		6.699
	574611	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	COc1cc2c(cc1OC)-c1[nH]c3ccccc3c1CC(=O)N2		CHEMBL431634	=	IC50	nM	899.5	CHEMBL262	Homo sapiens	pIC50		6.046
	574614	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	O=C1Cc2c(n(CCO)c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL99803	=	IC50	nM	299.92	CHEMBL262	Homo sapiens	pIC50		6.523
	574617	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	O=C1Cc2c([nH]c3ccccc23)-c2cc(I)ccc2N1		CHEMBL116832	=	IC50	nM	250.03	CHEMBL262	Homo sapiens	pIC50		6.602
	574620	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	Nc1ccc2[nH]c3c(c2c1)CC(=O)Nc1ccccc1-3		CHEMBL120355	=	IC50	nM	11994.99	CHEMBL262	Homo sapiens	pIC50		4.921
	574623	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	O=C1Cc2c([nH]c3ncccc23)-c2ccccc2N1		CHEMBL331783	=	IC50	nM	5495.41	CHEMBL262	Homo sapiens	pIC50		5.26
	574626	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	O=C1Cc2c([nH]c3ccc(Cl)cc23)-c2sccc2N1		CHEMBL334031	=	IC50	nM	399.94	CHEMBL262	Homo sapiens	pIC50		6.398
	575739	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	O=C1Cc2c([nH]c3ccc(C(F)(F)F)cc23)-c2cc(Br)ccc2N1		CHEMBL100309	=	IC50	nM	1999.86	CHEMBL262	Homo sapiens	pIC50		5.699
	575742	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	CCc1cccc2c3c([nH]c12)-c1ccccc1NC(=O)C3		CHEMBL317150	=	IC50	nM	699.84	CHEMBL262	Homo sapiens	pIC50		6.155
Not Determined	575745	CHEMBL686301	Inhibition of glycogen synthase kinase 3-beta (GSK3-beta) purified from insect sf9 cells	B	COc1ccc2[nH]c3c(c2c1)CC(=O)Nc1ncccc1-3		CHEMBL120137		pIC50			CHEMBL262	Homo sapiens	pIC50		
Not Determined	575748	CHEMBL686301	Inhibition of glycogen synthase kinase 3-beta (GSK3-beta) purified from insect sf9 cells	B	Cc1ccc2[nH]c3c(c2c1)CC(=O)Nc1ncccc1-3		CHEMBL121953		pIC50			CHEMBL262	Homo sapiens	pIC50		
	577136	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	NCC(=O)c1ccc2[nH]c3c(c2c1)CC(=O)Nc1ccccc1-3		CHEMBL120941	=	IC50	nM	41020.41	CHEMBL262	Homo sapiens	pIC50		4.387
	577139	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	O=C1Cc2c([nH]c3ccc(C(F)(F)F)cc23)-c2cccnc2N1		CHEMBL120078	=	IC50	nM	5296.63	CHEMBL262	Homo sapiens	pIC50		5.276
	578324	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	O=C1Cc2c([nH]c3ccc(C(F)(F)F)cc23)-c2ccccc2N1		CHEMBL329505	=	IC50	nM	29.99	CHEMBL262	Homo sapiens	pIC50		7.523
	578327	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	O=C1Cc2c([nH]c3cc(Cl)cc(Cl)c23)-c2ccccc2N1		CHEMBL316512	=	IC50	nM	5000.35	CHEMBL262	Homo sapiens	pIC50		5.301
	578330	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	SC1=Nc2ccccc2-c2cc(-c3ccccn3)cc(-c3cccs3)c2C1	Outside typical range	CHEMBL331502	=	IC50	nM	349945.17	CHEMBL262	Homo sapiens	pIC50		3.456
	578333	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	CC(=O)Cc1ccc2c(c1)-c1[nH]c3ccc(C(F)(F)F)cc3c1CC(=O)N2		CHEMBL333894	=	IC50	nM	89.95	CHEMBL262	Homo sapiens	pIC50		7.046
	579626	CHEMBL684360	Inhibition of Glycogen synthase kinase-3 beta purified from insect sf9 cells	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	IC50	nM	3.999	CHEMBL262	Homo sapiens	pIC50		8.398
	579629	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	O=C1Cc2c([nH]c3c(Br)cccc23)-c2ccccc2N1		CHEMBL318911	=	IC50	nM	599.79	CHEMBL262	Homo sapiens	pIC50		6.222
	579632	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	CC(C)(C)OC(=O)N1C(=O)Cc2c(n(C(=O)OC(C)(C)C)c3ccc(Br)cc23)-c2ccccc21	Outside typical range	CHEMBL317562	=	IC50	nM	639734.84	CHEMBL262	Homo sapiens	pIC50		3.194
	579635	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	N#Cc1ccc2[nH]c3c(c2c1)CC(=O)Nc1ccccc1-3		CHEMBL299756	=	IC50	nM	10.0	CHEMBL262	Homo sapiens	pIC50		8.0
	579638	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	Cc1cccc2c3c([nH]c12)-c1ccccc1NC(=O)C3		CHEMBL98501	=	IC50	nM	500.03	CHEMBL262	Homo sapiens	pIC50		6.301
	580728	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	SC1=Nc2ccccc2-c2[nH]c3ccc(Br)cc3c2C1		CHEMBL52551	=	IC50	nM	1999.86	CHEMBL262	Homo sapiens	pIC50		5.699
	580731	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	CSC1=Nc2ccccc2-c2[nH]c3ccc(Br)cc3c2C1		CHEMBL328164	=	IC50	nM	1199.5	CHEMBL262	Homo sapiens	pIC50		5.921
	580734	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2sccc2N1		CHEMBL323657	=	IC50	nM	119.95	CHEMBL262	Homo sapiens	pIC50		6.921
	581887	CHEMBL686300	Inhibition of Glycogen synthase kinase-3 beta purified from insect sf9 cells	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	IC50	nM	23.01	CHEMBL262	Homo sapiens	pIC50		7.638
	581890	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	COc1ccc2[nH]c3c(c2c1)CC(=O)Nc1ccccc1-3		CHEMBL95827	=	IC50	nM	2197.86	CHEMBL262	Homo sapiens	pIC50		5.658
	581893	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	COc1cccc2c1NC(=O)Cc1c-2[nH]c2ccccc12	Outside typical range	CHEMBL99423	=	IC50	nM	139958.73	CHEMBL262	Homo sapiens	pIC50		3.854
	584411	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2cc(Br)ccc2N1		CHEMBL333006	=	IC50	nM	199.99	CHEMBL262	Homo sapiens	pIC50		6.699
	584414	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	COc1ccc2c(c1)NC(=O)Cc1c-2[nH]c2ccc(C#N)cc12		CHEMBL332359	=	IC50	nM	130.02	CHEMBL262	Homo sapiens	pIC50		6.886
	584417	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	O=[N+]([O-])c1ccc2[nH]c3c(c2c1)CC(S)=Nc1ccccc1-3		CHEMBL120497	=	IC50	nM	599.79	CHEMBL262	Homo sapiens	pIC50		6.222
	585673	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	CC(C)(C)OC(=O)n1c2c(c3cc(Br)ccc31)CC(=O)Nc1ccccc1-2		CHEMBL100312	=	IC50	nM	2301.44	CHEMBL262	Homo sapiens	pIC50		5.638
	585676	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	N#C/C=C/c1ccc2c(c1)-c1[nH]c3ccc(C(F)(F)F)cc3c1CC(=O)N2		CHEMBL419054	=	IC50	nM	399.94	CHEMBL262	Homo sapiens	pIC50		6.398
	585679	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2cc(I)ccc2N1		CHEMBL333066	=	IC50	nM	4197.59	CHEMBL262	Homo sapiens	pIC50		5.377
	586390	CHEMBL686326	Inhibition of GSK3-beta in presence of 10 uM ATP	B	CCCC(=O)Nc1n[nH]c2ncc(-c3ccccc3)cc12		CHEMBL258701	=	Inhibition	%	90.0	CHEMBL262	Homo sapiens	Inhibition	%	90.0
	586878	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	COc1cc2c(cc1OC)-c1[nH]c3ccc(C#N)cc3c1CC(=O)N2		CHEMBL325654	=	IC50	nM	17.99	CHEMBL262	Homo sapiens	pIC50		7.745
	586881	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	CC(=O)/C=C/c1ccc2c(c1)-c1[nH]c3ccc(C(F)(F)F)cc3c1CC(=O)N2		CHEMBL119989	=	IC50	nM	1399.59	CHEMBL262	Homo sapiens	pIC50		5.854
	586884	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	Brc1ccc2[nH]c3c(c2c1)CCCc1ccccc1-3	Outside typical range	CHEMBL331759	=	IC50	nM	179887.09	CHEMBL262	Homo sapiens	pIC50		3.745
	586887	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	N#Cc1ccc2c(c1)-c1[nH]c3ccccc3c1CC(=O)N2		CHEMBL119932	=	IC50	nM	1300.17	CHEMBL262	Homo sapiens	pIC50		5.886
Not Determined	588086	CHEMBL686301	Inhibition of glycogen synthase kinase 3-beta (GSK3-beta) purified from insect sf9 cells	B	c1ccc2c(c1)CCCc1c-2[nH]c2ccccc12		CHEMBL120547		pIC50			CHEMBL262	Homo sapiens	pIC50		
	588089	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2sccc2N1		CHEMBL119963	=	IC50	nM	34.99	CHEMBL262	Homo sapiens	pIC50		7.456
	589408	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	CCn1c2c(c3cc(Br)ccc31)CC(=O)Nc1ccccc1-2		CHEMBL328627	=	IC50	nM	1499.68	CHEMBL262	Homo sapiens	pIC50		5.824
	590228	CHEMBL686326	Inhibition of GSK3-beta in presence of 10 uM ATP	B	CCCC(=O)Nc1n[nH]c2ncc(-c3ccccc3F)cc12		CHEMBL407373	=	Inhibition	%	99.0	CHEMBL262	Homo sapiens	Inhibition	%	99.0
	590712	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	COc1cccc2c1NC(=O)Cc1c-2[nH]c2ccc(Br)cc12		CHEMBL330398	=	IC50	nM	15995.58	CHEMBL262	Homo sapiens	pIC50		4.796
	590715	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	Cc1ccc2[nH]c3c(c2c1)CC(=O)Nc1ccsc1-3		CHEMBL118406	=	IC50	nM	1300.17	CHEMBL262	Homo sapiens	pIC50		5.886
	592053	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	O=C1Cc2c([nH]c3ccc(C(F)(F)F)cc23)-c2cc(C#CC3(O)CCCCC3)ccc2N1		CHEMBL120664	=	IC50	nM	1999.86	CHEMBL262	Homo sapiens	pIC50		5.699
	592056	CHEMBL684976	Inhibitory activity against glycogen synthase kinase-3 beta purified from insect sf9 cells	B	N#Cc1ccc2[nH]c3c(c2c1)CC(=O)Nc1ccsc1-3		CHEMBL118162	=	IC50	nM	330.37	CHEMBL262	Homo sapiens	pIC50		6.481
	616600	CHEMBL685258	Inhibition of Glycogen synthase kinase-3 beta	B	Cn1ccc2ccc3c4[nH]c5c(CCCN[C@H]6CC[C@H](O)CC6)cccc5c4c4c(c3c21)C(=O)NC4=O		CHEMBL307152	>	IC50	nM	20000.0	CHEMBL262	Homo sapiens	IC50	uM	20.0
	631772	CHEMBL685264	Selectivity for GSK3-beta	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(P(=O)(O)CP(=O)(O)O)cc3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL3084838	>	Selectivity		500.0	CHEMBL262	Homo sapiens	Selectivity		500.0
	633548	CHEMBL684978	Inhibitory activity against recombinant rabbit Glycogen synthase kinase-3 beta	B	CCn1c(=S)n(C)s/c1=N\c1cccnc1		CHEMBL26616	=	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	633816	CHEMBL686320	Inhibition of human glycogen synthase kinase-3 beta	B	O=Nc1c(-c2c(O)[nH]c3ccc(I)cc23)[nH]c2ccccc12		CHEMBL337300	=	IC50	nM	9.0	CHEMBL262	Homo sapiens	IC50	uM	0.009
	634622	CHEMBL684978	Inhibitory activity against recombinant rabbit Glycogen synthase kinase-3 beta	B	Cn1sc(=O)n(-c2ccc(Cl)cc2)c1=O		CHEMBL24537	=	IC50	nM	4000.0	CHEMBL262	Homo sapiens	IC50	uM	4.0
	635737	CHEMBL684978	Inhibitory activity against recombinant rabbit Glycogen synthase kinase-3 beta	B	CCn1sc(=O)n(CC)c1=S		CHEMBL26101	=	IC50	nM	20000.0	CHEMBL262	Homo sapiens	IC50	uM	20.0
	635738	CHEMBL684978	Inhibitory activity against recombinant rabbit Glycogen synthase kinase-3 beta	B	CCn1sc(=O)n(Cc2ccccc2)c1=S		CHEMBL24311	=	IC50	nM	6000.0	CHEMBL262	Homo sapiens	IC50	uM	6.0
	636071	CHEMBL686320	Inhibition of human glycogen synthase kinase-3 beta	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	IC50	nM	23.0	CHEMBL262	Homo sapiens	IC50	uM	0.023
	636941	CHEMBL684978	Inhibitory activity against recombinant rabbit Glycogen synthase kinase-3 beta	B	Cc1ccc(-n2c(=O)sn(C)c2=O)cc1		CHEMBL24753	=	IC50	nM	5000.0	CHEMBL262	Homo sapiens	IC50	uM	5.0
	636942	CHEMBL684978	Inhibitory activity against recombinant rabbit Glycogen synthase kinase-3 beta	B	CCn1sc(=N)n(-c2ccccc2)c1=O		CHEMBL284125	=	IC50	nM	65000.0	CHEMBL262	Homo sapiens	IC50	uM	65.0
	638282	CHEMBL684978	Inhibitory activity against recombinant rabbit Glycogen synthase kinase-3 beta	B	CCn1c(=O)sn(C)c1=O		CHEMBL26218	=	IC50	nM	5000.0	CHEMBL262	Homo sapiens	IC50	uM	5.0
	642034	CHEMBL684978	Inhibitory activity against recombinant rabbit Glycogen synthase kinase-3 beta	B	Cn1sc(=O)n(-c2ccc(Br)cc2)c1=O		CHEMBL24721	=	IC50	nM	3000.0	CHEMBL262	Homo sapiens	IC50	uM	3.0
	642035	CHEMBL684978	Inhibitory activity against recombinant rabbit Glycogen synthase kinase-3 beta	B	O=c1sn(Cc2ccccc2)c(=S)n1Cc1ccccc1		CHEMBL24338	=	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	642305	CHEMBL686320	Inhibition of human glycogen synthase kinase-3 beta	B	NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c(Br)cc32)N1		CHEMBL361708	=	IC50	nM	10.0	CHEMBL262	Homo sapiens	IC50	uM	0.01
	644367	CHEMBL684978	Inhibitory activity against recombinant rabbit Glycogen synthase kinase-3 beta	B	CCCn1sc(=O)n(CC)c1=O		CHEMBL286009	=	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	645860	CHEMBL686320	Inhibition of human glycogen synthase kinase-3 beta	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ncccc2N1		CHEMBL336961	=	IC50	nM	18.0	CHEMBL262	Homo sapiens	IC50	uM	0.018
	647873	CHEMBL684978	Inhibitory activity against recombinant rabbit Glycogen synthase kinase-3 beta	B	CCOC(=O)/N=c1\sn(C(=O)OCC)c(=S)n1-c1ccccc1		CHEMBL26000	=	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	649158	CHEMBL684978	Inhibitory activity against recombinant rabbit Glycogen synthase kinase-3 beta	B	CCn1c(=O)sn(C(C)C)c1=O		CHEMBL26551	=	IC50	nM	35000.0	CHEMBL262	Homo sapiens	IC50	uM	35.0
	649159	CHEMBL684978	Inhibitory activity against recombinant rabbit Glycogen synthase kinase-3 beta	B	CCn1c(=O)sn(C2CCCCC2)c1=O		CHEMBL24693	=	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	651566	CHEMBL684978	Inhibitory activity against recombinant rabbit Glycogen synthase kinase-3 beta	B	Cn1sc(=O)n(-c2ccccc2Br)c1=O		CHEMBL23840	=	IC50	nM	6000.0	CHEMBL262	Homo sapiens	IC50	uM	6.0
	651567	CHEMBL684978	Inhibitory activity against recombinant rabbit Glycogen synthase kinase-3 beta	B	Cn1sc(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL25820	=	IC50	nM	4000.0	CHEMBL262	Homo sapiens	IC50	uM	4.0
	651568	CHEMBL684978	Inhibitory activity against recombinant rabbit Glycogen synthase kinase-3 beta	B	Cn1sc(=O)n(-c2ccc(C(F)(F)F)cc2)c1=O		CHEMBL417835	=	IC50	nM	6000.0	CHEMBL262	Homo sapiens	IC50	uM	6.0
	651569	CHEMBL684978	Inhibitory activity against recombinant rabbit Glycogen synthase kinase-3 beta	B	Cn1sc(=O)n(-c2cccc3ccccc23)c1=O		CHEMBL26274	=	IC50	nM	3000.0	CHEMBL262	Homo sapiens	IC50	uM	3.0
	652666	CHEMBL684978	Inhibitory activity against recombinant rabbit Glycogen synthase kinase-3 beta	B	O=c1sn(-c2ccccc2)c(=S)n1-c1ccccc1		CHEMBL24073	=	IC50	nM	8000.0	CHEMBL262	Homo sapiens	IC50	uM	8.0
	652667	CHEMBL684978	Inhibitory activity against recombinant rabbit Glycogen synthase kinase-3 beta	B	CCNC(=O)/N=c1\sn(CC)c(=O)n1-c1ccccc1		CHEMBL25927	=	IC50	nM	75000.0	CHEMBL262	Homo sapiens	IC50	uM	75.0
	653039	CHEMBL686320	Inhibition of human glycogen synthase kinase-3 beta	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2sccc2N1		CHEMBL323657	=	IC50	nM	120.0	CHEMBL262	Homo sapiens	IC50	uM	0.12
	655340	CHEMBL686320	Inhibition of human glycogen synthase kinase-3 beta	B	CC(C)c1c(-c2ccc(Cl)cc2)[nH]c2nccnc12		CHEMBL77217	=	IC50	nM	750.0	CHEMBL262	Homo sapiens	IC50	uM	0.75
	656233	CHEMBL684978	Inhibitory activity against recombinant rabbit Glycogen synthase kinase-3 beta	B	CCCCn1c(=O)sn(CC)c1=O		CHEMBL24773	=	IC50	nM	70000.0	CHEMBL262	Homo sapiens	IC50	uM	70.0
	657364	CHEMBL684978	Inhibitory activity against recombinant rabbit Glycogen synthase kinase-3 beta	B	Cn1sc(=O)n(-c2ccccc2)c1=O		CHEMBL287864	=	IC50	nM	2000.0	CHEMBL262	Homo sapiens	IC50	uM	2.0
	658670	CHEMBL684978	Inhibitory activity against recombinant rabbit Glycogen synthase kinase-3 beta	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	IC50	nM	2000.0	CHEMBL262	Homo sapiens	IC50	uM	2.0
	658677	CHEMBL685266	Inhibition of Glycogen synthase kinase-3 beta	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	658678	CHEMBL685268	Specific activity against Glycogen synthase kinase-3 beta	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Specific activity	nM Pi min-1 (mg of protein)-1	0.5	CHEMBL262	Homo sapiens	Specific activity	nM Pi min-1 (mg of protein)-1	0.5
	659917	CHEMBL684978	Inhibitory activity against recombinant rabbit Glycogen synthase kinase-3 beta	B	Cn1sc(=O)n(-c2cccc(Br)c2)c1=O		CHEMBL24494	=	IC50	nM	4000.0	CHEMBL262	Homo sapiens	IC50	uM	4.0
	663625	CHEMBL684978	Inhibitory activity against recombinant rabbit Glycogen synthase kinase-3 beta	B	O=c1sn(Cc2ccccc2)c(=O)n1Cc1ccccc1		CHEMBL284365	=	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	664939	CHEMBL684978	Inhibitory activity against recombinant rabbit Glycogen synthase kinase-3 beta	B	CCn1sc(=O)n(CC)c1=O		CHEMBL25829	=	IC50	nM	25000.0	CHEMBL262	Homo sapiens	IC50	uM	25.0
	666198	CHEMBL684978	Inhibitory activity against recombinant rabbit Glycogen synthase kinase-3 beta	B	CCn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL26241	=	IC50	nM	7000.0	CHEMBL262	Homo sapiens	IC50	uM	7.0
	666602	CHEMBL686320	Inhibition of human glycogen synthase kinase-3 beta	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2cccnc2N1		CHEMBL134501	=	IC50	nM	6000.0	CHEMBL262	Homo sapiens	IC50	uM	6.0
	667456	CHEMBL684978	Inhibitory activity against recombinant rabbit Glycogen synthase kinase-3 beta	B	COc1ccc(-n2c(=O)sn(C)c2=O)cc1		CHEMBL26515	=	IC50	nM	2000.0	CHEMBL262	Homo sapiens	IC50	uM	2.0
	669988	CHEMBL684978	Inhibitory activity against recombinant rabbit Glycogen synthase kinase-3 beta	B	Cn1sc(=O)n(C2CCCCC2)c1=O		CHEMBL24167	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	750641	CHEMBL685259	Inhibition of Glycogen synthase kinase-3 beta	B	O=C(Cc1ccc2ccccc2c1)Nc1cc(C2CC2)n[nH]1		CHEMBL115220	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	nM	10000.0
	755803	CHEMBL686322	Inhibition of Glycogen synthase kinase-3 beta	B	CN1CCOCCOCCN(C)CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CC1		CHEMBL105620	=	IC50	nM	8.0	CHEMBL262	Homo sapiens	IC50	uM	0.008
	759124	CHEMBL686322	Inhibition of Glycogen synthase kinase-3 beta	B	CCN1CCOCCOCCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CC1		CHEMBL103506	=	IC50	nM	4.0	CHEMBL262	Homo sapiens	IC50	uM	0.004
Not Determined	765664	CHEMBL686323	Inhibition of Glycogen synthase kinase-3 beta (Not determined)	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978		IC50	nM		CHEMBL262	Homo sapiens	IC50	uM	
	765674	CHEMBL685260	Inhibition of Glycogen synthase kinase-3 beta	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	89.0	CHEMBL262	Homo sapiens	IC50	uM	0.089
Not Determined	771126	CHEMBL686324	Inhibition of Glycogen synthase kinase-3 beta (not determined)	B	CC(C)N1CCOCCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCOCC1		CHEMBL421217		IC50	nM		CHEMBL262	Homo sapiens	IC50	uM	
	771134	CHEMBL686322	Inhibition of Glycogen synthase kinase-3 beta	B	CN1CCOCCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCN(C)CC1		CHEMBL106384	=	IC50	nM	33.0	CHEMBL262	Homo sapiens	IC50	uM	0.033
	771144	CHEMBL686322	Inhibition of Glycogen synthase kinase-3 beta	B	CCN1CCOCCN(CC)CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCOCC1		CHEMBL103421	=	IC50	nM	31.0	CHEMBL262	Homo sapiens	IC50	uM	0.031
	773562	CHEMBL686322	Inhibition of Glycogen synthase kinase-3 beta	B	CN1CCCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCOCCOCC1		CHEMBL321315	=	IC50	nM	4.0	CHEMBL262	Homo sapiens	IC50	uM	0.004
	773572	CHEMBL686322	Inhibition of Glycogen synthase kinase-3 beta	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714	=	IC50	nM	7.0	CHEMBL262	Homo sapiens	IC50	uM	0.007
	776794	CHEMBL686322	Inhibition of Glycogen synthase kinase-3 beta	B	CCN1CCOCCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCOCC1		CHEMBL103055	=	IC50	nM	25.0	CHEMBL262	Homo sapiens	IC50	uM	0.025
	776804	CHEMBL685260	Inhibition of Glycogen synthase kinase-3 beta	B	CCN1CCOCCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCOCC1		CHEMBL103055	=	IC50	nM	18.0	CHEMBL262	Homo sapiens	IC50	uM	0.018
	780274	CHEMBL686322	Inhibition of Glycogen synthase kinase-3 beta	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCOCCN(CCO)CCOCCn1cc2c2ccccc21		CHEMBL321529	=	IC50	nM	40.0	CHEMBL262	Homo sapiens	IC50	uM	0.04
	782451	CHEMBL686322	Inhibition of Glycogen synthase kinase-3 beta	B	CN1CCOCCN(C)CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CC1		CHEMBL105477	=	IC50	nM	6.0	CHEMBL262	Homo sapiens	IC50	uM	0.006
	783565	CHEMBL686322	Inhibition of Glycogen synthase kinase-3 beta	B	CN1CCOCCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCOCC1		CHEMBL106061	=	IC50	nM	71.0	CHEMBL262	Homo sapiens	IC50	uM	0.071
	783573	CHEMBL686322	Inhibition of Glycogen synthase kinase-3 beta	B	CN1CCN(C)CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CC1		CHEMBL319265	=	IC50	nM	110.0	CHEMBL262	Homo sapiens	IC50	uM	0.11
	788150	CHEMBL686322	Inhibition of Glycogen synthase kinase-3 beta	B	CN1CCN(C)CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCN(C)CC1		CHEMBL103628	=	IC50	nM	43.0	CHEMBL262	Homo sapiens	IC50	uM	0.043
	828450	CHEMBL686303	Inhibitory activity against glycogen synthase kinase-3 (GSK-3beta).	B	O=C(CCl)c1cc(Cl)c(Cl)s1		CHEMBL342402	=	IC50	nM	2500.0	CHEMBL262	Homo sapiens	IC50	uM	2.5
	828451	CHEMBL686303	Inhibitory activity against glycogen synthase kinase-3 (GSK-3beta).	B	Cc1cc(C(=O)CCl)c(C)s1		CHEMBL344719	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	828452	CHEMBL686303	Inhibitory activity against glycogen synthase kinase-3 (GSK-3beta).	B	O=C(CBr)c1ccc(Br)cc1		CHEMBL142826	=	IC50	nM	500.0	CHEMBL262	Homo sapiens	IC50	uM	0.5
	831898	CHEMBL686303	Inhibitory activity against glycogen synthase kinase-3 (GSK-3beta).	B	Cc1sc(C(=O)CCl)cc1C(=O)CCl		CHEMBL143743	=	IC50	nM	5000.0	CHEMBL262	Homo sapiens	IC50	uM	5.0
	831899	CHEMBL686303	Inhibitory activity against glycogen synthase kinase-3 (GSK-3beta).	B	O=C(CCl)c1ccc(Cl)s1		CHEMBL140045	=	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	831901	CHEMBL686303	Inhibitory activity against glycogen synthase kinase-3 (GSK-3beta).	B	O=C(CBr)c1ccc([N+](=O)[O-])cc1		CHEMBL106072	=	IC50	nM	2000.0	CHEMBL262	Homo sapiens	IC50	uM	2.0
	832962	CHEMBL686303	Inhibitory activity against glycogen synthase kinase-3 (GSK-3beta).	B	Cc1csc(C(=O)CCl)c1		CHEMBL423377	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	838664	CHEMBL686318	Inhibition of Glycogen synthase kinase-3 beta	B	O=C1NC(=O)c2c1c1c3ccccc3ccc1c1[nH]c3ccccc3c21		CHEMBL332575	=	IC50	nM	4380.0	CHEMBL262	Homo sapiens	IC50	uM	4.38
	839041	CHEMBL686303	Inhibitory activity against glycogen synthase kinase-3 (GSK-3beta).	B	COc1ccc(C(=O)CBr)cc1		CHEMBL103009	=	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	uM	1.0
	840240	CHEMBL686303	Inhibitory activity against glycogen synthase kinase-3 (GSK-3beta).	B	O=C(CCl)c1c(Br)sc(Cl)c1Cl		CHEMBL143273	=	IC50	nM	2000.0	CHEMBL262	Homo sapiens	IC50	uM	2.0
	843907	CHEMBL686303	Inhibitory activity against glycogen synthase kinase-3 (GSK-3beta).	B	O=C(CBr)c1ccccc1		CHEMBL102953	=	IC50	nM	5000.0	CHEMBL262	Homo sapiens	IC50	uM	5.0
	845194	CHEMBL686303	Inhibitory activity against glycogen synthase kinase-3 (GSK-3beta).	B	O=C(CCl)c1c(Br)sc(Br)c1Br		CHEMBL341572	=	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	uM	1.0
	846358	CHEMBL686303	Inhibitory activity against glycogen synthase kinase-3 (GSK-3beta).	B	CC(=O)c1csc(C(=O)CCl)c1		CHEMBL341655	=	IC50	nM	8000.0	CHEMBL262	Homo sapiens	IC50	uM	8.0
	847488	CHEMBL686303	Inhibitory activity against glycogen synthase kinase-3 (GSK-3beta).	B	Cc1c(C(=O)CCl)csc1C(=O)CCl		CHEMBL143419	=	IC50	nM	5000.0	CHEMBL262	Homo sapiens	IC50	uM	5.0
	847490	CHEMBL686303	Inhibitory activity against glycogen synthase kinase-3 (GSK-3beta).	B	CC(=O)c1ccc(C(=O)CCl)s1		CHEMBL143525	=	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	847491	CHEMBL686303	Inhibitory activity against glycogen synthase kinase-3 (GSK-3beta).	B	O=C(CCl)c1ccc(Cl)cc1		CHEMBL143090	=	IC50	nM	2500.0	CHEMBL262	Homo sapiens	IC50	uM	2.5
	849809	CHEMBL686303	Inhibitory activity against glycogen synthase kinase-3 (GSK-3beta).	B	Cc1ccc(C(=O)CCl)s1		CHEMBL142415	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	850975	CHEMBL686303	Inhibitory activity against glycogen synthase kinase-3 (GSK-3beta).	B	O=C(CCl)c1cc(Br)cs1		CHEMBL335357	=	IC50	nM	3000.0	CHEMBL262	Homo sapiens	IC50	uM	3.0
	853125	CHEMBL686303	Inhibitory activity against glycogen synthase kinase-3 (GSK-3beta).	B	O=C(CCl)c1scc(Br)c1Br		CHEMBL357136	=	IC50	nM	500.0	CHEMBL262	Homo sapiens	IC50	uM	0.5
	854348	CHEMBL686303	Inhibitory activity against glycogen synthase kinase-3 (GSK-3beta).	B	Cc1ccc(C(=O)CBr)cc1		CHEMBL142824	=	IC50	nM	2500.0	CHEMBL262	Homo sapiens	IC50	uM	2.5
	855455	CHEMBL686303	Inhibitory activity against glycogen synthase kinase-3 (GSK-3beta).	B	O=C(CCl)c1cc(Br)c(Br)s1		CHEMBL142711	=	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	uM	1.0
	856567	CHEMBL686303	Inhibitory activity against glycogen synthase kinase-3 (GSK-3beta).	B	O=C(CCl)c1cccs1		CHEMBL359135	=	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	856568	CHEMBL686303	Inhibitory activity against glycogen synthase kinase-3 (GSK-3beta).	B	Cc1ccsc1C(=O)CCl		CHEMBL142327	=	IC50	nM	75000.0	CHEMBL262	Homo sapiens	IC50	uM	75.0
	857664	CHEMBL686303	Inhibitory activity against glycogen synthase kinase-3 (GSK-3beta).	B	O=C(CCl)c1csc(C(=O)CCl)c1		CHEMBL141190	=	IC50	nM	1500.0	CHEMBL262	Homo sapiens	IC50	uM	1.5
	857666	CHEMBL686303	Inhibitory activity against glycogen synthase kinase-3 (GSK-3beta).	B	O=C(CBr)c1ccc(-c2ccccc2)cc1		CHEMBL413032	=	IC50	nM	2500.0	CHEMBL262	Homo sapiens	IC50	uM	2.5
	858947	CHEMBL686303	Inhibitory activity against glycogen synthase kinase-3 (GSK-3beta).	B	O=C(CCl)c1cc(Cl)sc1Cl		CHEMBL356459	=	IC50	nM	5000.0	CHEMBL262	Homo sapiens	IC50	uM	5.0
	858949	CHEMBL686303	Inhibitory activity against glycogen synthase kinase-3 (GSK-3beta).	B	O=C(CBr)c1ccc(Cl)cc1		CHEMBL140061	=	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	uM	1.0
	862269	CHEMBL686303	Inhibitory activity against glycogen synthase kinase-3 (GSK-3beta).	B	O=C(CCl)c1cscc1Cl		CHEMBL343821	=	IC50	nM	25000.0	CHEMBL262	Homo sapiens	IC50	uM	25.0
	864851	CHEMBL686303	Inhibitory activity against glycogen synthase kinase-3 (GSK-3beta).	B	O=C(CCl)c1ccc(Br)s1		CHEMBL142764	=	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	864853	CHEMBL686303	Inhibitory activity against glycogen synthase kinase-3 (GSK-3beta).	B	O=C(CCl)c1ccccc1		CHEMBL105712	=	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	906548	CHEMBL684979	Inhibition of Glycogen synthase kinase-3beta (GSK3-beta)	B	O=C1NC(=O)C2=C1c1cn(c3ncccc13)CCOCCOCCn1cc2c2cccnc21		CHEMBL132223	=	IC50	nM	620.0	CHEMBL262	Homo sapiens	IC50	uM	0.62
	910410	CHEMBL684979	Inhibition of Glycogen synthase kinase-3beta (GSK3-beta)	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCOCCOCCOCCn1cc2c2cccnc21		CHEMBL340935	=	IC50	nM	17.0	CHEMBL262	Homo sapiens	IC50	uM	0.017
	915717	CHEMBL684979	Inhibition of Glycogen synthase kinase-3beta (GSK3-beta)	B	O=C1NC(=O)C2=C1c1cn(c3ncccc13)CCOCCOCCOCCn1cc2c2cccnc21		CHEMBL340776	=	IC50	nM	34.0	CHEMBL262	Homo sapiens	IC50	uM	0.034
	915727	CHEMBL686317	Inhibition of human glycogen synthase kinase-3beta (GSK3-beta) at 10 uM	B	O=C1NC(=O)C2=C1c1cn(c3ncccc13)CCOCCOCCOCCn1cc2c2cccnc21		CHEMBL340776	=	Activity	%	0.0	CHEMBL262	Homo sapiens	Activity	%	0.0
	916978	CHEMBL682324	Inhibition of Glycogen synthase kinase-3beta (GSK3-beta) at 1 uM	B	CN1C(=O)C2=C(C1=O)c1cn(c3ccccc13)CCOCCOCCOCCn1cc2c2ccccc21		CHEMBL131952	=	Inhibition	%	54.0	CHEMBL262	Homo sapiens	Inhibition	%	54.0
	918237	CHEMBL684979	Inhibition of Glycogen synthase kinase-3beta (GSK3-beta)	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCOCCOCCOCCn1cc2c2ccccc21		CHEMBL340259	=	IC50	nM	220.0	CHEMBL262	Homo sapiens	IC50	uM	0.22
	919457	CHEMBL684979	Inhibition of Glycogen synthase kinase-3beta (GSK3-beta)	B	O=C1NC(=O)C2=C1c1cn(c3ncccc13)CCOCCOCCOCCOCCOCCn1cc2c2cccnc21		CHEMBL131254	=	IC50	nM	403.0	CHEMBL262	Homo sapiens	IC50	uM	0.403
	921741	CHEMBL684979	Inhibition of Glycogen synthase kinase-3beta (GSK3-beta)	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCOCCOCCOCCOCCOCCn1cc2c2ccccc21		CHEMBL130774	=	IC50	nM	51.0	CHEMBL262	Homo sapiens	IC50	uM	0.051
	923024	CHEMBL684979	Inhibition of Glycogen synthase kinase-3beta (GSK3-beta)	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCOCCOCCOCCOCCn1cc2c2ccccc21		CHEMBL336179	=	IC50	nM	26.0	CHEMBL262	Homo sapiens	IC50	uM	0.026
	925777	CHEMBL684979	Inhibition of Glycogen synthase kinase-3beta (GSK3-beta)	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCOCCOCCn1cc2c2cccnc21		CHEMBL334555	=	IC50	nM	138.0	CHEMBL262	Homo sapiens	IC50	uM	0.138
	927126	CHEMBL682324	Inhibition of Glycogen synthase kinase-3beta (GSK3-beta) at 1 uM	B	CN1C(=O)C2=C(C1=O)c1cn(c3ncccc13)CCOCCOCCn1cc2c2ccccc21		CHEMBL340889	=	Inhibition	%	51.0	CHEMBL262	Homo sapiens	Inhibition	%	51.0
	931178	CHEMBL684979	Inhibition of Glycogen synthase kinase-3beta (GSK3-beta)	B	O=C1NC(=O)C2=C1c1cn(c3ncccc13)CCOCCOCCOCCOCCn1cc2c2cccnc21		CHEMBL337642	=	IC50	nM	48.0	CHEMBL262	Homo sapiens	IC50	uM	0.048
	931188	CHEMBL686317	Inhibition of human glycogen synthase kinase-3beta (GSK3-beta) at 10 uM	B	O=C1NC(=O)C2=C1c1cn(c3ncccc13)CCOCCOCCOCCOCCn1cc2c2cccnc21		CHEMBL337642	=	Activity	%	0.0	CHEMBL262	Homo sapiens	Activity	%	0.0
	932560	CHEMBL684979	Inhibition of Glycogen synthase kinase-3beta (GSK3-beta)	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCOCCOCCn1cc2c2ccccc21		CHEMBL131035	=	IC50	nM	136.0	CHEMBL262	Homo sapiens	IC50	uM	0.136
Not Determined	939605	CHEMBL682325	Inhibition of Glycogen synthase kinase-3beta (GSK3-beta) (Not tested)	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829		Inhibition	%		CHEMBL262	Homo sapiens	Inhibition	%	
	951629	CHEMBL680577	Inhibition of glycogen synthase kinase-3 beta	B	Nc1nccc(-c2cc3ccccc3[nH]2)n1	Outside typical range	CHEMBL50226	=	IC50	nM	420000.0	CHEMBL262	Homo sapiens	IC50	uM	420.0
	953079	CHEMBL680577	Inhibition of glycogen synthase kinase-3 beta	B	Nc1nccc(-c2c[nH]c3c(Br)ccc(O)c23)n1		CHEMBL296682	=	IC50	nM	2500.0	CHEMBL262	Homo sapiens	IC50	uM	2.5
	953107	CHEMBL680577	Inhibition of glycogen synthase kinase-3 beta	B	Nc1nccc(-c2c[nH]c3c(Br)ccc(O)c23)n1		CHEMBL296682	=	IC50	nM	2500.0	CHEMBL262	Homo sapiens	IC50	uM	2.5
	954295	CHEMBL680577	Inhibition of glycogen synthase kinase-3 beta	B	Nc1nccc(-c2c[nH]c3cc(Br)cc(O)c23)n1		CHEMBL44545	=	IC50	nM	500.0	CHEMBL262	Homo sapiens	IC50	uM	0.5
	955740	CHEMBL680577	Inhibition of glycogen synthase kinase-3 beta	B	Nc1nccc(-c2c[nH]c3cc(Br)ccc23)n1		CHEMBL46440	=	IC50	nM	2500.0	CHEMBL262	Homo sapiens	IC50	uM	2.5
	958243	CHEMBL680577	Inhibition of glycogen synthase kinase-3 beta	B	Nc1nccc(-c2cc3cc(Br)ccc3[nH]2)n1	Outside typical range	CHEMBL48081	>	IC50	nM	1000000.0	CHEMBL262	Homo sapiens	IC50	uM	1000.0
	965981	CHEMBL680577	Inhibition of glycogen synthase kinase-3 beta	B	Nc1nccc(-c2c[nH]c3ccccc23)n1	Outside typical range	CHEMBL48082	=	IC50	nM	350000.0	CHEMBL262	Homo sapiens	IC50	uM	350.0
	967262	CHEMBL680577	Inhibition of glycogen synthase kinase-3 beta	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1	Outside typical range	CHEMBL14762	=	IC50	nM	130000.0	CHEMBL262	Homo sapiens	IC50	uM	130.0
	974642	CHEMBL680577	Inhibition of glycogen synthase kinase-3 beta	B	Nc1nccc(-c2c[nH]c3cccc(O)c23)n1		CHEMBL50498	=	IC50	nM	1300.0	CHEMBL262	Homo sapiens	IC50	uM	1.3
	974654	CHEMBL680577	Inhibition of glycogen synthase kinase-3 beta	B	Nc1nccc(-c2c[nH]c3cc(Br)c(Br)cc23)n1		CHEMBL296271	=	IC50	nM	2000.0	CHEMBL262	Homo sapiens	IC50	uM	2.0
	980833	CHEMBL680577	Inhibition of glycogen synthase kinase-3 beta	B	Nc1nccc(-c2c[nH]c3ccc(Br)cc23)n1		CHEMBL44541	=	IC50	nM	2000.0	CHEMBL262	Homo sapiens	IC50	uM	2.0
	1034898	CHEMBL684358	Inhibition of Glycogen synthase kinase-3 beta at 10 uM	B	COc1ccc(C2=C(Nc3cccc(Cl)c3)C(=O)NC2=O)cc1		CHEMBL158208	=	Inhibition	%	81.0	CHEMBL262	Homo sapiens	Inhibition	%	81.0
	1036293	CHEMBL684358	Inhibition of Glycogen synthase kinase-3 beta at 10 uM	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	Inhibition	%	83.0	CHEMBL262	Homo sapiens	Inhibition	%	83.0
	1048359	CHEMBL684358	Inhibition of Glycogen synthase kinase-3 beta at 10 uM	B	COc1ccccc1C1=C(N2CCc3ccccc32)C(=O)NC1=O		CHEMBL160585	=	Inhibition	%	90.0	CHEMBL262	Homo sapiens	Inhibition	%	90.0
	1055605	CHEMBL684358	Inhibition of Glycogen synthase kinase-3 beta at 10 uM	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160586	=	Inhibition	%	87.0	CHEMBL262	Homo sapiens	Inhibition	%	87.0
	1058291	CHEMBL684358	Inhibition of Glycogen synthase kinase-3 beta at 10 uM	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156379	=	Inhibition	%	100.0	CHEMBL262	Homo sapiens	Inhibition	%	100.0
	1173970	CHEMBL685267	Inhibition of Glycogen synthase kinase-3 beta	B	CCN(CC)C/C=C/c1nc(O)c2c(ccc3nc(Nc4c(Cl)cccc4Cl)n(C)c32)c1C		CHEMBL281957	>	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	uM	1.0
Not Active	1226398	CHEMBL685263	Inhibitory activity against Glycogen synthase kinase-3 beta using pCREB as substrate; NA means Inactive at a concentration of 5 uM	B	Cc1ccc2c(c1)[nH]c1c3[nH]c4ccccc4c3c3c(c21)C(=O)NC3=O		CHEMBL292021		NA			CHEMBL262	Homo sapiens	NA		
Not Active	1227712	CHEMBL685263	Inhibitory activity against Glycogen synthase kinase-3 beta using pCREB as substrate; NA means Inactive at a concentration of 5 uM	B	Cn1c2ccccc2c2c3c(c4c5ccc(Br)cc5[nH]c4c21)C(=O)NC3=O		CHEMBL293898		NA			CHEMBL262	Homo sapiens	NA		
Not Active	1227721	CHEMBL685263	Inhibitory activity against Glycogen synthase kinase-3 beta using pCREB as substrate; NA means Inactive at a concentration of 5 uM	B	COc1ccc2c(c1)[nH]c1c3[nH]c4cc(Br)ccc4c3c3c(c21)C(=O)NC3=O		CHEMBL302854		NA			CHEMBL262	Homo sapiens	NA		
Not Active	1237764	CHEMBL685262	Inhibitory activity against Glycogen synthase kinase-3 beta using pCREB as substrate; NA means Inactive at a concentration of 20 uM	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3ccc(Br)cc3c21		CHEMBL60564		NA			CHEMBL262	Homo sapiens	NA		
Not Active	1237773	CHEMBL685263	Inhibitory activity against Glycogen synthase kinase-3 beta using pCREB as substrate; NA means Inactive at a concentration of 5 uM	B	COc1ccc2c(c1)[nH]c1c3[nH]c4ccccc4c3c3c(c21)C(=O)NC3=O		CHEMBL64742		NA			CHEMBL262	Homo sapiens	NA		
Not Active	1240255	CHEMBL685263	Inhibitory activity against Glycogen synthase kinase-3 beta using pCREB as substrate; NA means Inactive at a concentration of 5 uM	B	Cn1c2ccccc2c2c3c(c4c5ccc(F)cc5[nH]c4c21)C(=O)NC3=O		CHEMBL62253		NA			CHEMBL262	Homo sapiens	NA		
Not Active	1243045	CHEMBL685262	Inhibitory activity against Glycogen synthase kinase-3 beta using pCREB as substrate; NA means Inactive at a concentration of 20 uM	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3ccccc3c21		CHEMBL268368		NA			CHEMBL262	Homo sapiens	NA		
Not Active	1244241	CHEMBL685263	Inhibitory activity against Glycogen synthase kinase-3 beta using pCREB as substrate; NA means Inactive at a concentration of 5 uM	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(C(F)(F)F)ccc3c21		CHEMBL61790		NA			CHEMBL262	Homo sapiens	NA		
Not Active	1249509	CHEMBL685262	Inhibitory activity against Glycogen synthase kinase-3 beta using pCREB as substrate; NA means Inactive at a concentration of 20 uM	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3c(Br)cccc3c21		CHEMBL432715		NA			CHEMBL262	Homo sapiens	NA		
Not Active	1255642	CHEMBL685262	Inhibitory activity against Glycogen synthase kinase-3 beta using pCREB as substrate; NA means Inactive at a concentration of 20 uM	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cccc(Br)c3c21		CHEMBL59785		NA			CHEMBL262	Homo sapiens	NA		
Not Active	1257096	CHEMBL685263	Inhibitory activity against Glycogen synthase kinase-3 beta using pCREB as substrate; NA means Inactive at a concentration of 5 uM	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Cl)ccc3c21		CHEMBL291402		NA			CHEMBL262	Homo sapiens	NA		
Not Active	1258370	CHEMBL685263	Inhibitory activity against Glycogen synthase kinase-3 beta using pCREB as substrate; NA means Inactive at a concentration of 5 uM	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(F)ccc3c21		CHEMBL293157		NA			CHEMBL262	Homo sapiens	NA		
Not Active	1263229	CHEMBL685262	Inhibitory activity against Glycogen synthase kinase-3 beta using pCREB as substrate; NA means Inactive at a concentration of 20 uM	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758		NA			CHEMBL262	Homo sapiens	NA		
	1403553	CHEMBL830960	Inhibition of rabbit Glycogen synthase kinase-3 beta	B	C=Cn1cc(C2=C(c3nn(CCCN(C)C)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL368193	=	IC50	nM	49.0	CHEMBL262	Homo sapiens	IC50	uM	0.049
	1403558	CHEMBL830960	Inhibition of rabbit Glycogen synthase kinase-3 beta	B	CN(C)CCCn1nc(C2=C(c3cn(-c4ccccc4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL366668	=	IC50	nM	270.0	CHEMBL262	Homo sapiens	IC50	uM	0.27
	1403563	CHEMBL830960	Inhibition of rabbit Glycogen synthase kinase-3 beta	B	CN(C)CCCn1nc(C2=C(c3cn(-c4cccs4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL178945	=	IC50	nM	370.0	CHEMBL262	Homo sapiens	IC50	uM	0.37
	1403583	CHEMBL830960	Inhibition of rabbit Glycogen synthase kinase-3 beta	B	CN(C)CCCn1nc(C2=C(c3cn(-c4cccnc4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL368416	=	IC50	nM	150.0	CHEMBL262	Homo sapiens	IC50	uM	0.15
	1403603	CHEMBL830960	Inhibition of rabbit Glycogen synthase kinase-3 beta	B	O=C1NC(=O)C(c2cn(-c3cccnc3)c3ccccc23)=C1c1[nH]nc2ccccc12		CHEMBL175956	=	IC50	nM	200.0	CHEMBL262	Homo sapiens	IC50	uM	0.2
	1403608	CHEMBL830960	Inhibition of rabbit Glycogen synthase kinase-3 beta	B	CN(C)CCCn1nc(C2=C(c3cn(-c4ccc5ccccc5c4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL368895	=	IC50	nM	1900.0	CHEMBL262	Homo sapiens	IC50	uM	1.9
	1403629	CHEMBL830960	Inhibition of rabbit Glycogen synthase kinase-3 beta	B	CN(C)CCCn1nc(C2=C(c3cn(-c4cccc5ccccc45)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL360304	=	IC50	nM	890.0	CHEMBL262	Homo sapiens	IC50	uM	0.89
	1403653	CHEMBL830960	Inhibition of rabbit Glycogen synthase kinase-3 beta	B	CN(C)CCCn1nc(C2=C(c3cn(-c4cncc5ccccc45)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL359808	=	IC50	nM	1300.0	CHEMBL262	Homo sapiens	IC50	uM	1.3
	1403660	CHEMBL830960	Inhibition of rabbit Glycogen synthase kinase-3 beta	B	CN(C)CCCn1nc(C2=C(c3cn(-c4cnc5ccccc5c4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL359486	=	IC50	nM	3900.0	CHEMBL262	Homo sapiens	IC50	uM	3.9
	1403680	CHEMBL830960	Inhibition of rabbit Glycogen synthase kinase-3 beta	B	CN(C)CCCn1nc(C2=C(c3cn(-c4csc5ccccc45)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL426587	=	IC50	nM	4800.0	CHEMBL262	Homo sapiens	IC50	uM	4.8
	1404548	CHEMBL830960	Inhibition of rabbit Glycogen synthase kinase-3 beta	B	O=C1NC(=O)C(c2nn(CCCN3CCOCC3)c3ccccc23)=C1c1cn(-c2ccc3ccccc3c2)c2ccccc12		CHEMBL367106	=	IC50	nM	2400.0	CHEMBL262	Homo sapiens	IC50	uM	2.4
	1404555	CHEMBL830960	Inhibition of rabbit Glycogen synthase kinase-3 beta	B	O=C1NC(=O)C(c2nn(CCCN3CCCC3)c3ccccc23)=C1c1cn(-c2ccc3ccccc3c2)c2ccccc12		CHEMBL367107	=	IC50	nM	2500.0	CHEMBL262	Homo sapiens	IC50	uM	2.5
	1404562	CHEMBL830960	Inhibition of rabbit Glycogen synthase kinase-3 beta	B	CN1CCN(CCCn2nc(C3=C(c4cn(-c5ccc6ccccc6c5)c5ccccc45)C(=O)NC3=O)c3ccccc32)CC1		CHEMBL175845	=	IC50	nM	1200.0	CHEMBL262	Homo sapiens	IC50	uM	1.2
	1406052	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	Cn1cnc2c(-c3ccccc3)ncnc21		CHEMBL179217	=	Inhibition	%	11.0	CHEMBL262	Homo sapiens	Inhibition	%	11.0
	1406067	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	Cn1cnc2c(-c3ccc(F)cc3)ncnc21		CHEMBL539424	=	Inhibition	%	3.0	CHEMBL262	Homo sapiens	Inhibition	%	3.0
	1406082	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	Cn1c(-c2ccccc2)nc2c(-c3ccc(F)cc3)ncnc21		CHEMBL368896	=	Inhibition	%	26.0	CHEMBL262	Homo sapiens	Inhibition	%	26.0
	1406203	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	Cn1c(-c2ccccc2)nc2c(Sc3ccccc3)ncnc21		CHEMBL367389	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	Inhibition	%	0.0
	1406218	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	Cn1c(-c2ccccc2)nc2c(Sc3ccc(F)cc3)ncnc21		CHEMBL175541	=	Inhibition	%	22.0	CHEMBL262	Homo sapiens	Inhibition	%	22.0
	1406343	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	CSc1ccc(-c2nc3c(Sc4ccccc4)ncnc3n2C)cc1		CHEMBL175868	=	Inhibition	%	3.0	CHEMBL262	Homo sapiens	Inhibition	%	3.0
	1406358	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	CSc1ccc(-c2nc3c(Sc4ccc(F)cc4)ncnc3n2C)cc1		CHEMBL175619	=	Inhibition	%	5.0	CHEMBL262	Homo sapiens	Inhibition	%	5.0
	1406461	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	c1ccc(Nc2ncnc3[nH]cnc23)cc1		CHEMBL359730	=	Inhibition	%	13.0	CHEMBL262	Homo sapiens	Inhibition	%	13.0
	1406476	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	Fc1ccc(Nc2[nH]cnc3ncnc2-3)cc1		CHEMBL361227	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	Inhibition	%	0.0
	1406490	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	Cn1c(-c2ccc([S+](C)[O-])cc2)nc2c(Sc3ccccc3)ncnc21		CHEMBL353740	=	Inhibition	%	4.0	CHEMBL262	Homo sapiens	Inhibition	%	4.0
	1406505	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	Cn1c(-c2ccc([S+](C)[O-])cc2)nc2c(Sc3ccc(F)cc3)ncnc21		CHEMBL180373	=	Inhibition	%	4.0	CHEMBL262	Homo sapiens	Inhibition	%	4.0
	1406520	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	Cn1c(-c2ccc(S(C)(=O)=O)cc2)nc2c(Sc3ccccc3)ncnc21		CHEMBL177060	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	Inhibition	%	0.0
	1406608	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	c1ccc(Oc2ncnc3[nH]cnc23)cc1		CHEMBL366984	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	Inhibition	%	0.0
	1406623	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	Fc1ccc(Oc2[nH]cnc3ncnc2-3)cc1		CHEMBL367695	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	Inhibition	%	0.0
	1406638	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	Cn1cnc2c(Nc3ccccc3)ncnc21		CHEMBL321749	=	Inhibition	%	26.0	CHEMBL262	Homo sapiens	Inhibition	%	26.0
	1406652	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	Cn1c(-c2ccc(S(C)(=O)=O)cc2)nc2c(Sc3ccc(F)cc3)ncnc21		CHEMBL367018	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	Inhibition	%	0.0
	1406667	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	Cn1c(Br)nc2c(Sc3ccccc3)ncnc21		CHEMBL177289	=	Inhibition	%	19.0	CHEMBL262	Homo sapiens	Inhibition	%	19.0
	1406773	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	Cn1cnc2c(Nc3ccc(F)cc3)ncnc21		CHEMBL362629	=	Inhibition	%	14.0	CHEMBL262	Homo sapiens	Inhibition	%	14.0
	1406788	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	c1ccc(Sc2ncnc3[nH]cnc23)cc1		CHEMBL175600	=	Inhibition	%	1.0	CHEMBL262	Homo sapiens	Inhibition	%	1.0
	1406906	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	Fc1ccc(Sc2ncnc3[nH]cnc23)cc1		CHEMBL175603	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	Inhibition	%	0.0
	1406921	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	c1ccc(Sc2[nH]cnc3nccc2-3)cc1		CHEMBL360302	=	Inhibition	%	11.0	CHEMBL262	Homo sapiens	Inhibition	%	11.0
	1407032	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	Fc1ccc(Sc2[nH]cnc3nccc2-3)cc1		CHEMBL367533	=	Inhibition	%	4.0	CHEMBL262	Homo sapiens	Inhibition	%	4.0
	1407047	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	Cn1cnc2c(Sc3ccccc3)ncnc21		CHEMBL179751	=	Inhibition	%	3.0	CHEMBL262	Homo sapiens	Inhibition	%	3.0
	1407152	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	Cn1cnc2c(Sc3ccc(F)cc3)ncnc21		CHEMBL175622	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	Inhibition	%	0.0
	1407167	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	c1ccc(CSc2ncnc3[nH]cnc23)cc1		CHEMBL397434	=	Inhibition	%	35.0	CHEMBL262	Homo sapiens	Inhibition	%	35.0
	1407182	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	Fc1ccc(CSc2[nH]cnc3ncnc2-3)cc1		CHEMBL175451	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	Inhibition	%	0.0
	1407293	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	Cn1cnc2c(SCc3ccccc3)ncnc21		CHEMBL176384	=	Inhibition	%	10.0	CHEMBL262	Homo sapiens	Inhibition	%	10.0
	1407308	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	Cn1cnc2c(SCc3ccc(F)cc3)ncnc21		CHEMBL175730	=	Inhibition	%	14.0	CHEMBL262	Homo sapiens	Inhibition	%	14.0
	1407424	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	c1ccc(-[n+]2c[nH]c3ncncc32)cc1		CHEMBL175816	=	Inhibition	%	4.0	CHEMBL262	Homo sapiens	Inhibition	%	4.0
	1407439	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	Fc1ccc(-[n+]2c[nH]c3ncncc32)cc1		CHEMBL175817	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	Inhibition	%	0.0
	1407555	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	c1ccc(C[n+]2c[nH]c3ncncc32)cc1		CHEMBL369622	=	Inhibition	%	13.0	CHEMBL262	Homo sapiens	Inhibition	%	13.0
	1407570	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	Fc1ccc(C[n+]2c[nH]c3ncncc32)cc1		CHEMBL179515	=	Inhibition	%	10.0	CHEMBL262	Homo sapiens	Inhibition	%	10.0
	1407585	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	Clc1ncnc2c1ncn2Cc1ccccc1		CHEMBL7944	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	Inhibition	%	0.0
	1407696	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	Clc1ncnc2ncn(Cc3ccccc3)c12		CHEMBL368715	=	Inhibition	%	9.0	CHEMBL262	Homo sapiens	Inhibition	%	9.0
	1407711	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	Fc1ccc(Cn2cnc3c(Cl)ncnc32)cc1		CHEMBL369181	=	Inhibition	%	8.0	CHEMBL262	Homo sapiens	Inhibition	%	8.0
	1407819	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	Fc1ccc(Cn2cnc3ncnc(Cl)c32)cc1		CHEMBL175528	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	Inhibition	%	0.0
	1407834	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	Nc1ncnc2c1ncn2Cc1ccccc1		CHEMBL266094	=	Inhibition	%	7.0	CHEMBL262	Homo sapiens	Inhibition	%	7.0
	1407947	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	Nc1ncnc2c1ncn2Cc1ccc(F)cc1		CHEMBL426037	=	Inhibition	%	5.0	CHEMBL262	Homo sapiens	Inhibition	%	5.0
	1407962	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	Nc1ncnc2ncn(Cc3ccc(F)cc3)c12		CHEMBL180422	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	Inhibition	%	0.0
	1407977	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	COc1ncnc2ncn(Cc3ccc(F)cc3)c12		CHEMBL368714	=	Inhibition	%	5.0	CHEMBL262	Homo sapiens	Inhibition	%	5.0
	1408092	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	c1ccc(Cc2[nH]cnc3ncnc2-3)cc1		CHEMBL367930	=	Inhibition	%	5.0	CHEMBL262	Homo sapiens	Inhibition	%	5.0
	1408107	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	Fc1ccc(Cc2[nH]cnc3ncnc2-3)cc1		CHEMBL179158	=	Inhibition	%	2.0	CHEMBL262	Homo sapiens	Inhibition	%	2.0
	1408221	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	Fc1ccc(/C=C/c2[nH]cnc3ncnc2-3)cc1		CHEMBL367470	=	Inhibition	%	20.0	CHEMBL262	Homo sapiens	Inhibition	%	20.0
	1408236	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	Cn1cnc2c(/C=C/c3ccccc3)ncnc21		CHEMBL176186	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	Inhibition	%	0.0
	1408887	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	Cn1c(C#CCCO)nc2c(Sc3ccccc3)ncnc21		CHEMBL177784	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	Inhibition	%	0.0
	1408902	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	c1ccc(Cn2cnc3c(Sc4ccccc4)ncnc32)cc1		CHEMBL180020	=	Inhibition	%	1.0	CHEMBL262	Homo sapiens	Inhibition	%	1.0
	1409012	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	Fc1ccc(Sc2ncnc3c2ncn3Cc2ccccc2)cc1		CHEMBL179768	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	Inhibition	%	0.0
	1409027	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	Fc1ccc(Cn2cnc3c(Sc4ccccc4)ncnc32)cc1		CHEMBL176245	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	Inhibition	%	0.0
	1409042	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	Fc1ccc(Cn2cnc3c(Sc4ccc(F)cc4)ncnc32)cc1		CHEMBL175665	=	Inhibition	%	8.0	CHEMBL262	Homo sapiens	Inhibition	%	8.0
	1409153	CHEMBL831995	Inhibition of human Glycogen synthase kinase-3 beta at 30 uM	B	Nc1ncnc2[nH]cnc12		CHEMBL226345	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	Inhibition	%	0.0
	1420767	CHEMBL832927	Inhibitory concentration for Glycogen synthase kinase-3 beta was determined in the presence of 10 um ATP (Km 50 uM)	B	CN(C)S(=O)(=O)c1ccc(Nc2cc(N[C@H]3CC[C@H](N)CC3)nc3c(C#N)cnn23)cc1		CHEMBL360573	=	IC50	nM	460.0	CHEMBL262	Homo sapiens	IC50	uM	0.46
	1420770	CHEMBL832927	Inhibitory concentration for Glycogen synthase kinase-3 beta was determined in the presence of 10 um ATP (Km 50 uM)	B	CN(C)S(=O)(=O)c1ccc(Nc2cc(N[C@H]3CC[C@H](N)CC3)nc3c(Cl)cnn23)cc1		CHEMBL367150	=	IC50	nM	5100.0	CHEMBL262	Homo sapiens	IC50	uM	5.1
	1420773	CHEMBL832927	Inhibitory concentration for Glycogen synthase kinase-3 beta was determined in the presence of 10 um ATP (Km 50 uM)	B	CN(C)S(=O)(=O)c1ccc(Nc2cc(N[C@H]3CC[C@H](N)CC3)nc3c(Br)cnn23)cc1		CHEMBL178785	=	IC50	nM	3400.0	CHEMBL262	Homo sapiens	IC50	uM	3.4
	1420776	CHEMBL832927	Inhibitory concentration for Glycogen synthase kinase-3 beta was determined in the presence of 10 um ATP (Km 50 uM)	B	CCN[C@H]1CC[C@H](Nc2cc(Nc3ccc(S(=O)(=O)N(C)C)cc3)n3ncc(C(C)C)c3n2)CC1		CHEMBL181293	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	1420870	CHEMBL832927	Inhibitory concentration for Glycogen synthase kinase-3 beta was determined in the presence of 10 um ATP (Km 50 uM)	B	CCN(CC)[C@H]1CC[C@H](Nc2cc(Nc3ccc(S(=O)(=O)N(C)C)cc3)n3ncc(C(C)C)c3n2)CC1		CHEMBL180714	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	1420873	CHEMBL832927	Inhibitory concentration for Glycogen synthase kinase-3 beta was determined in the presence of 10 um ATP (Km 50 uM)	B	CC(C)c1cnn2c(Nc3ccc(S(=O)(=O)N(C)C)cc3)cc(O[C@H]3CC[C@H](N)CC3)nc12		CHEMBL180814	=	IC50	nM	28000.0	CHEMBL262	Homo sapiens	IC50	uM	28.0
	1420876	CHEMBL832927	Inhibitory concentration for Glycogen synthase kinase-3 beta was determined in the presence of 10 um ATP (Km 50 uM)	B	CC(C)c1cnn2c(Nc3ccc(S(=O)(=O)N(C)C)cc3)cc(NC3CCCC(N)C3)nc12		CHEMBL181606	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	1420879	CHEMBL832927	Inhibitory concentration for Glycogen synthase kinase-3 beta was determined in the presence of 10 um ATP (Km 50 uM)	B	CC(C)COc1cc(Nc2ccc(S(=O)(=O)N(C)C)cc2)n2ncc(C(C)C)c2n1		CHEMBL361231	=	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	1420882	CHEMBL832927	Inhibitory concentration for Glycogen synthase kinase-3 beta was determined in the presence of 10 um ATP (Km 50 uM)	B	CC(C)COc1cc(Nc2ccc(S(C)(=O)=O)cc2)n2ncc(C(C)C)c2n1		CHEMBL178268	=	IC50	nM	12000.0	CHEMBL262	Homo sapiens	IC50	uM	12.0
	1420885	CHEMBL832927	Inhibitory concentration for Glycogen synthase kinase-3 beta was determined in the presence of 10 um ATP (Km 50 uM)	B	CN(C)S(=O)(=O)c1ccc(Nc2cc(N[C@H]3CC[C@H](N)CC3)nc3c(Br)cnn23)cc1Cl		CHEMBL178769	=	IC50	nM	8700.0	CHEMBL262	Homo sapiens	IC50	uM	8.7
	1421300	CHEMBL832927	Inhibitory concentration for Glycogen synthase kinase-3 beta was determined in the presence of 10 um ATP (Km 50 uM)	B	N[C@H]1CC[C@H](Nc2cc(Nc3ccc(S(=O)(=O)c4cccs4)cc3)n3ncc(Cl)c3n2)CC1		CHEMBL181114	=	IC50	nM	4000.0	CHEMBL262	Homo sapiens	IC50	uM	4.0
	1421303	CHEMBL832927	Inhibitory concentration for Glycogen synthase kinase-3 beta was determined in the presence of 10 um ATP (Km 50 uM)	B	N[C@H]1CC[C@H](Nc2cc(Nc3ccc(S(=O)(=O)c4ccccc4)cc3)n3ncc(Br)c3n2)CC1		CHEMBL361833	=	IC50	nM	5300.0	CHEMBL262	Homo sapiens	IC50	uM	5.3
	1422457	CHEMBL832927	Inhibitory concentration for Glycogen synthase kinase-3 beta was determined in the presence of 10 um ATP (Km 50 uM)	B	CC(C)c1cnn2c(Nc3ccc(S(=O)(=O)N(C)C)cc3)cc(N[C@H]3CC[C@H](N)CC3)nc12		CHEMBL361348	=	IC50	nM	40000.0	CHEMBL262	Homo sapiens	IC50	uM	40.0
	1422460	CHEMBL832927	Inhibitory concentration for Glycogen synthase kinase-3 beta was determined in the presence of 10 um ATP (Km 50 uM)	B	CN(C)S(=O)(=O)c1ccc(Nc2cc(N[C@H]3CC[C@H](N)CC3)nc3c(C4CCCC4)cnn23)cc1		CHEMBL178179	=	IC50	nM	22000.0	CHEMBL262	Homo sapiens	IC50	uM	22.0
	1423083	CHEMBL833438	Inhibitory concentration to inhibit Ser396 phosphorylation of tau, a natural substrate of GSK-3 in SY5Y cells	F	CN(C)C(=O)N1CCn2cc(C3=C(c4cnc5ccccn45)C(=O)NC3=O)c3cccc(c32)C1		CHEMBL362814	=	IC50	nM	12.0	CHEMBL262	Homo sapiens	IC50	nM	12.0
	1423088	CHEMBL833438	Inhibitory concentration to inhibit Ser396 phosphorylation of tau, a natural substrate of GSK-3 in SY5Y cells	F	CN(C)C(=O)N1CCn2cc(C3=C(c4ccn5ncccc45)C(=O)NC3=O)c3cccc(c32)C1		CHEMBL181464	=	IC50	nM	38.0	CHEMBL262	Homo sapiens	IC50	nM	38.0
	1423209	CHEMBL833438	Inhibitory concentration to inhibit Ser396 phosphorylation of tau, a natural substrate of GSK-3 in SY5Y cells	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cccc13)CN(C(=O)N1CCOCC1)CC2		CHEMBL178737	=	IC50	nM	2.6	CHEMBL262	Homo sapiens	IC50	nM	2.6
Not Determined	1423214	CHEMBL827478	Inhibitory concentration to inhibit Ser396 phosphorylation of tau, a natural substrate of GSK-3 in SY5Y cells; nd=Not Determined	F	O=C1NC(=O)C(c2cnc3ccncn23)=C1c1cn2c3c(cccc13)CN(C(=O)N1CCOCC1)CC2		CHEMBL361204		IC50	nM		CHEMBL262	Homo sapiens	IC50	nM	
	1423219	CHEMBL833438	Inhibitory concentration to inhibit Ser396 phosphorylation of tau, a natural substrate of GSK-3 in SY5Y cells	F	O=C1NC(=O)C(c2cnc3cnccn23)=C1c1cn2c3c(cccc13)CN(C(=O)N1CCOCC1)CC2		CHEMBL361007	=	IC50	nM	11.0	CHEMBL262	Homo sapiens	IC50	nM	11.0
	1423224	CHEMBL833438	Inhibitory concentration to inhibit Ser396 phosphorylation of tau, a natural substrate of GSK-3 in SY5Y cells	F	O=C1NC(=O)C(c2cnc3ncccn23)=C1c1cn2c3c(cccc13)CN(C(=O)N1CCOCC1)CC2		CHEMBL369316	=	IC50	nM	297.0	CHEMBL262	Homo sapiens	IC50	nM	297.0
	1423649	CHEMBL833438	Inhibitory concentration to inhibit Ser396 phosphorylation of tau, a natural substrate of GSK-3 in SY5Y cells	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cccc13)CN(C(=O)N1CCCCC1)CC2		CHEMBL362588	=	IC50	nM	1.6	CHEMBL262	Homo sapiens	IC50	nM	1.6
	1423760	CHEMBL833438	Inhibitory concentration to inhibit Ser396 phosphorylation of tau, a natural substrate of GSK-3 in SY5Y cells	F	O=C1NC(=O)C(c2cnc3cccnn23)=C1c1cn2c3c(cccc13)CN(C(=O)N1CCCCC1)CC2		CHEMBL181031	=	IC50	nM	0.3	CHEMBL262	Homo sapiens	IC50	nM	0.3
	1423765	CHEMBL833438	Inhibitory concentration to inhibit Ser396 phosphorylation of tau, a natural substrate of GSK-3 in SY5Y cells	F	O=C1NC(=O)C(c2cnc3cnccn23)=C1c1cn2c3c(cccc13)CN(C(=O)N1CCCCC1)CC2		CHEMBL178851	=	IC50	nM	8.7	CHEMBL262	Homo sapiens	IC50	nM	8.7
	1423770	CHEMBL833438	Inhibitory concentration to inhibit Ser396 phosphorylation of tau, a natural substrate of GSK-3 in SY5Y cells	F	O=C1NC(=O)C(c2cnc3ncccn23)=C1c1cn2c3c(cccc13)CN(C(=O)N1CCCCC1)CC2		CHEMBL369572	=	IC50	nM	53.0	CHEMBL262	Homo sapiens	IC50	nM	53.0
	1423775	CHEMBL833438	Inhibitory concentration to inhibit Ser396 phosphorylation of tau, a natural substrate of GSK-3 in SY5Y cells	F	CC(=O)N1CCn2cc(C3=C(c4cnc5ccccn45)C(=O)NC3=O)c3cccc(c32)C1		CHEMBL361948	=	IC50	nM	111.0	CHEMBL262	Homo sapiens	IC50	nM	111.0
	1424190	CHEMBL833438	Inhibitory concentration to inhibit Ser396 phosphorylation of tau, a natural substrate of GSK-3 in SY5Y cells	F	CC(C)C(=O)N1CCn2cc(C3=C(c4cnc5ccccn45)C(=O)NC3=O)c3cccc(c32)C1		CHEMBL368246	=	IC50	nM	5.0	CHEMBL262	Homo sapiens	IC50	nM	5.0
	1424195	CHEMBL833438	Inhibitory concentration to inhibit Ser396 phosphorylation of tau, a natural substrate of GSK-3 in SY5Y cells	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cccc13)CN(C(=O)C1CCOCC1)CC2		CHEMBL181339	=	IC50	nM	7.7	CHEMBL262	Homo sapiens	IC50	nM	7.7
	1424200	CHEMBL833438	Inhibitory concentration to inhibit Ser396 phosphorylation of tau, a natural substrate of GSK-3 in SY5Y cells	F	CC(C)C(=O)N1CCn2cc(C3=C(C4=CN=[N+]5C=CC=CC45)C(=O)NC3=O)c3cccc(c32)C1		CHEMBL179725	=	IC50	nM	13.0	CHEMBL262	Homo sapiens	IC50	nM	13.0
	1438957	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL182493	=	Ki	nM	20.0	CHEMBL262	Homo sapiens	Ki	uM	0.02
	1438961	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	Cc1ccc2c(-c3ccnc(Nc4ccc(F)c(F)c4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL182326	=	Ki	nM	10.0	CHEMBL262	Homo sapiens	Ki	uM	0.01
	1438963	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL183064	=	Ki	nM	10.0	CHEMBL262	Homo sapiens	Ki	uM	0.01
	1439062	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	Cc1ccc2c(-c3ccnc(Nc4ccc(Cl)c(C(F)(F)F)c4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL361038	=	Ki	nM	50.0	CHEMBL262	Homo sapiens	Ki	uM	0.05
	1439064	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	c1ccc(Nc2nccc(-c3c(C4CC4)nn4ncccc34)n2)cc1		CHEMBL362296	=	Ki	nM	19000.0	CHEMBL262	Homo sapiens	Ki	uM	19.0
	1439066	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	Fc1ccc(Nc2nccc(-c3c(C4CC4)nn4ncccc34)n2)cc1F		CHEMBL185516	=	Ki	nM	23000.0	CHEMBL262	Homo sapiens	Ki	uM	23.0
	1439068	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	c1ccc(Nc2nccc(-c3c(C4CCCCC4)nn4ncccc34)n2)cc1		CHEMBL273870	>	Ki	nM	19950.0	CHEMBL262	Homo sapiens	Ki	uM	19.95
	1439070	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	Fc1ccc(Nc2nccc(-c3c(C4CCCCC4)nn4ncccc34)n2)cc1F		CHEMBL185044	>	Ki	nM	19950.0	CHEMBL262	Homo sapiens	Ki	uM	19.95
	1439072	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	COCCOc1cnn2ncc(-c3ccnc(Nc4cccc(OC)c4)n3)c2c1		CHEMBL180593	=	Ki	nM	80.0	CHEMBL262	Homo sapiens	Ki	uM	0.08
	1440431	CHEMBL827786	Inhibition of human Glycogen synthase kinase-3 beta	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2cccnc2)cc1		CHEMBL361567	=	IC50	nM	80.0	CHEMBL262	Homo sapiens	IC50	uM	0.08
	1440864	CHEMBL827786	Inhibition of human Glycogen synthase kinase-3 beta	B	CCCCCC(=O)Nc1ncnc2oc(-c3ccc(OC)cc3)cc12		CHEMBL360878	=	IC50	nM	437.0	CHEMBL262	Homo sapiens	IC50	uM	0.437
	1440867	CHEMBL827786	Inhibition of human Glycogen synthase kinase-3 beta	B	COc1ccc(-c2cc3c(NC(=O)CCSC)ncnc3o2)cc1		CHEMBL182560	=	IC50	nM	537.0	CHEMBL262	Homo sapiens	IC50	uM	0.537
	1440870	CHEMBL827786	Inhibition of human Glycogen synthase kinase-3 beta	B	COc1ccc(-c2cc3c(NC(=O)C(C)C)ncnc3o2)cc1		CHEMBL183077	=	IC50	nM	130.0	CHEMBL262	Homo sapiens	IC50	uM	0.13
	1440873	CHEMBL827786	Inhibition of human Glycogen synthase kinase-3 beta	B	COc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL362030	=	IC50	nM	316.0	CHEMBL262	Homo sapiens	IC50	uM	0.316
	1440876	CHEMBL827786	Inhibition of human Glycogen synthase kinase-3 beta	B	COc1ccc(-c2cc3c(NC(=O)C4CCCC4)ncnc3o2)cc1		CHEMBL181959	=	IC50	nM	30.0	CHEMBL262	Homo sapiens	IC50	uM	0.03
	1440879	CHEMBL827786	Inhibition of human Glycogen synthase kinase-3 beta	B	COc1ccc(-c2cc3c(NC(=O)CC4CCCC4)ncnc3o2)cc1		CHEMBL182891	=	IC50	nM	320.0	CHEMBL262	Homo sapiens	IC50	uM	0.32
	1440882	CHEMBL827786	Inhibition of human Glycogen synthase kinase-3 beta	B	COc1ccc(-c2cc3c(NC(=O)C4CCCCC4)ncnc3o2)cc1		CHEMBL360340	=	IC50	nM	1820.0	CHEMBL262	Homo sapiens	IC50	uM	1.82
	1440885	CHEMBL827786	Inhibition of human Glycogen synthase kinase-3 beta	B	COc1ccc(-c2cc3c(NC(=O)N4CCOCC4)ncnc3o2)cc1		CHEMBL181147	>	IC50	nM	34000.0	CHEMBL262	Homo sapiens	IC50	uM	34.0
	1440888	CHEMBL827786	Inhibition of human Glycogen synthase kinase-3 beta	B	COc1ccc(-c2cc3c(NC(=O)N4CCCC4)ncnc3o2)cc1		CHEMBL181856	=	IC50	nM	1950.0	CHEMBL262	Homo sapiens	IC50	uM	1.95
	1440891	CHEMBL827786	Inhibition of human Glycogen synthase kinase-3 beta	B	COc1ccc(-c2cc3c(NC(=O)c4cccc(F)c4)ncnc3o2)cc1		CHEMBL427325	>	IC50	nM	35000.0	CHEMBL262	Homo sapiens	IC50	uM	35.0
	1441319	CHEMBL827786	Inhibition of human Glycogen synthase kinase-3 beta	B	COc1ccc(-c2cc3c(NC(=O)c4ccco4)ncnc3o2)cc1		CHEMBL183742	=	IC50	nM	2400.0	CHEMBL262	Homo sapiens	IC50	uM	2.4
	1441322	CHEMBL827786	Inhibition of human Glycogen synthase kinase-3 beta	B	O=C(Nc1ncnc2oc(-c3ccccc3)cc12)C1CC1		CHEMBL360534	=	IC50	nM	170.0	CHEMBL262	Homo sapiens	IC50	uM	0.17
	1441325	CHEMBL827786	Inhibition of human Glycogen synthase kinase-3 beta	B	O=C(Nc1ncnc2oc(-c3ccc(Cl)cc3)cc12)C1CC1		CHEMBL182904	=	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	uM	1.0
	1441328	CHEMBL827786	Inhibition of human Glycogen synthase kinase-3 beta	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	IC50	nM	617.0	CHEMBL262	Homo sapiens	IC50	uM	0.617
	1441331	CHEMBL827786	Inhibition of human Glycogen synthase kinase-3 beta	B	O=C(Nc1ncnc2oc(-c3ccc(F)cc3)cc12)C1CC1		CHEMBL183504	=	IC50	nM	575.0	CHEMBL262	Homo sapiens	IC50	uM	0.575
	1441334	CHEMBL827786	Inhibition of human Glycogen synthase kinase-3 beta	B	O=C(Nc1ncnc2oc(-c3cccnc3)cc12)C1CC1		CHEMBL361196	=	IC50	nM	5.0	CHEMBL262	Homo sapiens	IC50	uM	0.005
	1441338	CHEMBL827786	Inhibition of human Glycogen synthase kinase-3 beta	B	O=C(Nc1ncnc2oc(-c3ccccc3)cc12)C1CCCC1		CHEMBL183038	=	IC50	nM	20.0	CHEMBL262	Homo sapiens	IC50	uM	0.02
	1441451	CHEMBL827786	Inhibition of human Glycogen synthase kinase-3 beta	B	O=C(Nc1ncnc2oc(-c3ccc(Cl)cc3)cc12)C1CCCC1		CHEMBL183171	=	IC50	nM	550.0	CHEMBL262	Homo sapiens	IC50	uM	0.55
	1441454	CHEMBL827786	Inhibition of human Glycogen synthase kinase-3 beta	B	Cc1ccc(-c2cc3c(NC(=O)C4CCCC4)ncnc3o2)cc1		CHEMBL182007	=	IC50	nM	240.0	CHEMBL262	Homo sapiens	IC50	uM	0.24
	1441457	CHEMBL827786	Inhibition of human Glycogen synthase kinase-3 beta	B	O=C(Nc1ncnc2oc(-c3ccc(F)cc3)cc12)C1CCCC1		CHEMBL185922	=	IC50	nM	219.0	CHEMBL262	Homo sapiens	IC50	uM	0.219
	1441460	CHEMBL827786	Inhibition of human Glycogen synthase kinase-3 beta	B	O=C(Nc1ncnc2oc(-c3cccnc3)cc12)C1CCCC1		CHEMBL182419	=	IC50	nM	5.0	CHEMBL262	Homo sapiens	IC50	uM	0.005
	1441919	CHEMBL830643	Inhibition of Glycogen synthase kinase-3 beta at 10 uM with 100 uM ATP	B	O=C(Nc1ncnc2oc(-c3cccnc3)cc12)C1CCCC1		CHEMBL182419	=	Inhibition	%	91.0	CHEMBL262	Homo sapiens	Inhibition	%	91.0
	1462022	CHEMBL833508	Inhibition of human Glycogen synthase kinase-3 beta	B	CC(C)OC(=O)N1CCn2cc(C3=C(c4cnc5ccccn45)C(=O)NC3=O)c3cccc(c32)C1		CHEMBL363058	=	IC50	nM	1.3	CHEMBL262	Homo sapiens	IC50	nM	1.3
	1462030	CHEMBL830848	Inhibition of Glycogen synthase kinase-3 beta dependent Tau protein serine-396 phosphorylation in human SY5Y cells	F	CC(C)OC(=O)N1CCn2cc(C3=C(c4cnc5ccccn45)C(=O)NC3=O)c3cccc(c32)C1		CHEMBL363058	=	IC50	nM	15.0	CHEMBL262	Homo sapiens	IC50	nM	15.0
	1462038	CHEMBL833508	Inhibition of human Glycogen synthase kinase-3 beta	B	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cccc13)CN(C(=O)N1CCCCC1)CC2		CHEMBL362588	=	IC50	nM	2.0	CHEMBL262	Homo sapiens	IC50	nM	2.0
	1462146	CHEMBL830848	Inhibition of Glycogen synthase kinase-3 beta dependent Tau protein serine-396 phosphorylation in human SY5Y cells	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cccc13)CN(C(=O)N1CCCCC1)CC2		CHEMBL362588	=	IC50	nM	1.6	CHEMBL262	Homo sapiens	IC50	nM	1.6
	1462154	CHEMBL833508	Inhibition of human Glycogen synthase kinase-3 beta	B	Cc1cc2c3c(c1)c(C1=C(c4cnc5ccccn45)C(=O)NC1=O)cn3CCN(C(=O)N1CCCCC1)C2		CHEMBL186290	=	IC50	nM	5.2	CHEMBL262	Homo sapiens	IC50	nM	5.2
	1462165	CHEMBL830848	Inhibition of Glycogen synthase kinase-3 beta dependent Tau protein serine-396 phosphorylation in human SY5Y cells	F	Cc1cc2c3c(c1)c(C1=C(c4cnc5ccccn45)C(=O)NC1=O)cn3CCN(C(=O)N1CCCCC1)C2		CHEMBL186290	=	IC50	nM	41.0	CHEMBL262	Homo sapiens	IC50	nM	41.0
	1462176	CHEMBL833508	Inhibition of human Glycogen synthase kinase-3 beta	B	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cccc13)CN(C(=O)N1CCOCC1)CC2		CHEMBL178737	=	IC50	nM	1.3	CHEMBL262	Homo sapiens	IC50	nM	1.3
	1462281	CHEMBL830848	Inhibition of Glycogen synthase kinase-3 beta dependent Tau protein serine-396 phosphorylation in human SY5Y cells	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cccc13)CN(C(=O)N1CCOCC1)CC2		CHEMBL178737	=	IC50	nM	2.6	CHEMBL262	Homo sapiens	IC50	nM	2.6
	1462289	CHEMBL833508	Inhibition of human Glycogen synthase kinase-3 beta	B	CN(C)C(=O)N1CCn2cc(C3=C(c4cnc5ccccn45)C(=O)NC3=O)c3cccc(c32)C1		CHEMBL362814	=	IC50	nM	1.6	CHEMBL262	Homo sapiens	IC50	nM	1.6
	1462297	CHEMBL830848	Inhibition of Glycogen synthase kinase-3 beta dependent Tau protein serine-396 phosphorylation in human SY5Y cells	F	CN(C)C(=O)N1CCn2cc(C3=C(c4cnc5ccccn45)C(=O)NC3=O)c3cccc(c32)C1		CHEMBL362814	=	IC50	nM	12.0	CHEMBL262	Homo sapiens	IC50	nM	12.0
	1462305	CHEMBL833508	Inhibition of human Glycogen synthase kinase-3 beta	B	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2		CHEMBL362558	=	IC50	nM	1.1	CHEMBL262	Homo sapiens	IC50	nM	1.1
	1462316	CHEMBL830848	Inhibition of Glycogen synthase kinase-3 beta dependent Tau protein serine-396 phosphorylation in human SY5Y cells	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2		CHEMBL362558	=	IC50	nM	0.7	CHEMBL262	Homo sapiens	IC50	nM	0.7
	1465915	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	Cc1ccc2c(-c3ccnc(Nc4ccc(F)c(F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL364197	=	Ki	nM	30.0	CHEMBL262	Homo sapiens	Ki	uM	0.03
	1465919	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	Cc1ccc2c(-c3ccnc(Nc4ccc(Cl)c(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL186010	=	Ki	nM	100.0	CHEMBL262	Homo sapiens	Ki	uM	0.1
	1465921	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccccc3)nn2n1		CHEMBL361723	=	Ki	nM	30.0	CHEMBL262	Homo sapiens	Ki	uM	0.03
	1465923	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3cccc(C(F)(F)F)c3)nn2n1		CHEMBL364539	=	Ki	nM	790.0	CHEMBL262	Homo sapiens	Ki	uM	0.79
	1465926	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	Cc1ccc2c(-c3ccnc(Nc4ccc(F)c(F)c4)n3)c(-c3cccc(C(F)(F)F)c3)nn2n1		CHEMBL186195	=	Ki	nM	1580.0	CHEMBL262	Homo sapiens	Ki	uM	1.58
	1465928	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	Cc1ccc2c(-c3ccnc(Nc4ccc(Cl)c(C(F)(F)F)c4)n3)c(-c3cccc(C(F)(F)F)c3)nn2n1		CHEMBL184657	=	Ki	nM	630.0	CHEMBL262	Homo sapiens	Ki	uM	0.63
	1465930	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3cccc(C(F)(F)F)c3)nn2n1		CHEMBL189617	=	Ki	nM	150.0	CHEMBL262	Homo sapiens	Ki	uM	0.15
	1465932	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL187272	>	Ki	nM	31600.0	CHEMBL262	Homo sapiens	Ki	uM	31.6
	1465934	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	>	Ki	nM	31600.0	CHEMBL262	Homo sapiens	Ki	uM	31.6
	1465936	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Ki	nM	20.0	CHEMBL262	Homo sapiens	Ki	uM	0.02
	1467145	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359554	=	Ki	nM	10.0	CHEMBL262	Homo sapiens	Ki	uM	0.01
	1467150	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	CN(c1ccccc1)c1nccc(-c2cnn3ncccc23)n1		CHEMBL360866	=	Ki	nM	19900.0	CHEMBL262	Homo sapiens	Ki	uM	19.9
	1467153	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	Cc1ccccc1Nc1nccc(-c2cnn3ncccc23)n1		CHEMBL366259	=	Ki	nM	6000.0	CHEMBL262	Homo sapiens	Ki	uM	6.0
	1467156	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Ki	nM	10.0	CHEMBL262	Homo sapiens	Ki	uM	0.01
	1467161	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	N#Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359794	<	Ki	nM	10.0	CHEMBL262	Homo sapiens	Ki	uM	0.01
	1467267	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	O=[N+]([O-])c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL188938	<	Ki	nM	10.0	CHEMBL262	Homo sapiens	Ki	uM	0.01
	1467270	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Ki	nM	30.0	CHEMBL262	Homo sapiens	Ki	uM	0.03
	1467274	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	CCC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL185871	=	Ki	nM	120.0	CHEMBL262	Homo sapiens	Ki	uM	0.12
	1467277	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	CC(C)(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL364587	=	Ki	nM	50.0	CHEMBL262	Homo sapiens	Ki	uM	0.05
	1467280	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	COc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1OC		CHEMBL186054	=	Ki	nM	10.0	CHEMBL262	Homo sapiens	Ki	uM	0.01
	1467285	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCO5)n3)c2c1		CHEMBL189455	<	Ki	nM	10.0	CHEMBL262	Homo sapiens	Ki	uM	0.01
	1467288	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	<	Ki	nM	10.0	CHEMBL262	Homo sapiens	Ki	uM	0.01
	1467293	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	Fc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1F		CHEMBL364370	=	Ki	nM	10.0	CHEMBL262	Homo sapiens	Ki	uM	0.01
	1467296	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCCO5)n3)c2c1		CHEMBL186708	<	Ki	nM	10.0	CHEMBL262	Homo sapiens	Ki	uM	0.01
	1467299	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	Clc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1Cl		CHEMBL186890	=	Ki	nM	10.0	CHEMBL262	Homo sapiens	Ki	uM	0.01
	1467404	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	FC(F)(F)c1cc(Nc2nccc(-c3cnn4ncccc34)n2)ccc1Cl		CHEMBL188665	<	Ki	nM	10.0	CHEMBL262	Homo sapiens	Ki	uM	0.01
	1467409	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Ki	nM	10.0	CHEMBL262	Homo sapiens	Ki	uM	0.01
	1467413	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(C(F)(F)F)c1		CHEMBL360206	<	Ki	nM	10.0	CHEMBL262	Homo sapiens	Ki	uM	0.01
	1467418	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	FC(F)(F)c1cc(Br)cc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL365229	<	Ki	nM	10.0	CHEMBL262	Homo sapiens	Ki	uM	0.01
	1467421	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	Fc1cc(F)cc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL184510	<	Ki	nM	10.0	CHEMBL262	Homo sapiens	Ki	uM	0.01
	1467426	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	Clc1cc(Cl)cc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL361697	<	Ki	nM	10.0	CHEMBL262	Homo sapiens	Ki	uM	0.01
	1467431	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	Cc1cc(C)cc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL186101	<	Ki	nM	10.0	CHEMBL262	Homo sapiens	Ki	uM	0.01
	1467436	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	Oc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL187750	=	Ki	nM	10.0	CHEMBL262	Homo sapiens	Ki	uM	0.01
	1467539	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	COc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL189235	=	Ki	nM	50.0	CHEMBL262	Homo sapiens	Ki	uM	0.05
	1467542	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Ki	nM	190.0	CHEMBL262	Homo sapiens	Ki	uM	0.19
	1467545	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	CCCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL187287	=	Ki	nM	790.0	CHEMBL262	Homo sapiens	Ki	uM	0.79
	1467548	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	COc1cccc(Nc2nccc(-c3cnn4nc(OC)ccc34)n2)c1		CHEMBL188312	=	Ki	nM	100.0	CHEMBL262	Homo sapiens	Ki	uM	0.1
	1467552	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Ki	nM	50.0	CHEMBL262	Homo sapiens	Ki	uM	0.05
	1467555	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	COc1ccc2c(-c3ccnc(Nc4ccc(C#N)cc4)n3)cnn2n1		CHEMBL189352	=	Ki	nM	50.0	CHEMBL262	Homo sapiens	Ki	uM	0.05
	1467558	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	COc1ccc2c(-c3ccnc(Nc4ccc([N+](=O)[O-])cc4)n3)cnn2n1		CHEMBL186288	=	Ki	nM	70.0	CHEMBL262	Homo sapiens	Ki	uM	0.07
	1467561	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	COc1cc(Nc2nccc(-c3cnn4nc(OC)ccc34)n2)cc(OC)c1		CHEMBL188417	=	Ki	nM	120.0	CHEMBL262	Homo sapiens	Ki	uM	0.12
	1467564	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	COc1cc(Nc2nccc(-c3cnn4nc(OC)ccc34)n2)cc(C(F)(F)F)c1		CHEMBL187139	=	Ki	nM	190.0	CHEMBL262	Homo sapiens	Ki	uM	0.19
	1467567	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Ki	nM	3160.0	CHEMBL262	Homo sapiens	Ki	uM	3.16
	1467570	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	COc1ccc2c(-c3ccnc(Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188205	=	Ki	nM	630.0	CHEMBL262	Homo sapiens	Ki	uM	0.63
	1467573	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	COc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)cnn2n1		CHEMBL188785	=	Ki	nM	30.0	CHEMBL262	Homo sapiens	Ki	uM	0.03
	1467673	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL187006	<	Ki	nM	10.0	CHEMBL262	Homo sapiens	Ki	uM	0.01
	1467676	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	Cc1ccc2c(-c3ccnc(Nc4ccc(C(F)(F)F)cc4)n3)cnn2n1		CHEMBL188303	=	Ki	nM	50.0	CHEMBL262	Homo sapiens	Ki	uM	0.05
	1467680	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	COc1cc(Nc2nccc(-c3cnn4nc(C)ccc34)n2)cc(C(F)(F)F)c1		CHEMBL186680	=	Ki	nM	10.0	CHEMBL262	Homo sapiens	Ki	uM	0.01
	1467683	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)cnn2n1		CHEMBL434337	=	Ki	nM	10.0	CHEMBL262	Homo sapiens	Ki	uM	0.01
	1467686	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Ki	nM	150.0	CHEMBL262	Homo sapiens	Ki	uM	0.15
	1467689	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	c1ccc(-c2ccc3c(-c4ccnc(Nc5ccc6c(c5)OCCO6)n4)cnn3n2)cc1		CHEMBL186606	=	Ki	nM	120.0	CHEMBL262	Homo sapiens	Ki	uM	0.12
	1467692	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	c1ccc(Nc2nccc(-c3c(-c4ccccc4)nn4ncccc34)n2)cc1		CHEMBL360408	=	Ki	nM	10.0	CHEMBL262	Homo sapiens	Ki	uM	0.01
	1467696	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	FC(F)(F)c1cccc(Nc2nccc(-c3c(-c4ccccc4)nn4ncccc34)n2)c1		CHEMBL263448	=	Ki	nM	10.0	CHEMBL262	Homo sapiens	Ki	uM	0.01
	1467700	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	Fc1ccc(Nc2nccc(-c3c(-c4ccccc4)nn4ncccc34)n2)cc1F		CHEMBL439850	=	Ki	nM	10.0	CHEMBL262	Homo sapiens	Ki	uM	0.01
	1467704	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	Fc1cc(F)cc(Nc2nccc(-c3c(-c4ccccc4)nn4ncccc34)n2)c1		CHEMBL186476	=	Ki	nM	10.0	CHEMBL262	Homo sapiens	Ki	uM	0.01
	1467806	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	FC(F)(F)c1cc(Nc2nccc(-c3c(-c4ccccc4)nn4ncccc34)n2)ccc1Cl		CHEMBL365251	=	Ki	nM	20.0	CHEMBL262	Homo sapiens	Ki	uM	0.02
	1467808	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL363125	<	Ki	nM	10.0	CHEMBL262	Homo sapiens	Ki	uM	0.01
	1467813	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL186425	=	Ki	nM	20.0	CHEMBL262	Homo sapiens	Ki	uM	0.02
	1467815	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL189343	=	Ki	nM	20.0	CHEMBL262	Homo sapiens	Ki	uM	0.02
	1467819	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL186166	=	Ki	nM	20.0	CHEMBL262	Homo sapiens	Ki	uM	0.02
	1467821	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL189288	=	Ki	nM	40.0	CHEMBL262	Homo sapiens	Ki	uM	0.04
	1467823	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Ki	nM	10.0	CHEMBL262	Homo sapiens	Ki	uM	0.01
	1467825	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL186116	=	Ki	nM	5010.0	CHEMBL262	Homo sapiens	Ki	uM	5.01
	1467827	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Ki	nM	31600.0	CHEMBL262	Homo sapiens	Ki	uM	31.6
	1467829	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Ki	nM	7940.0	CHEMBL262	Homo sapiens	Ki	uM	7.94
	1467831	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Ki	nM	31000.0	CHEMBL262	Homo sapiens	Ki	uM	31.0
	1467833	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Ki	nM	5010.0	CHEMBL262	Homo sapiens	Ki	uM	5.01
	1467836	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189665	>	Ki	nM	31600.0	CHEMBL262	Homo sapiens	Ki	uM	31.6
	1467838	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL365840	>	Ki	nM	31600.0	CHEMBL262	Homo sapiens	Ki	uM	31.6
	1467840	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	>	Ki	nM	31600.0	CHEMBL262	Homo sapiens	Ki	uM	31.6
	1467947	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	>	Ki	nM	31600.0	CHEMBL262	Homo sapiens	Ki	uM	31.6
	1467949	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL189135	>	Ki	nM	31600.0	CHEMBL262	Homo sapiens	Ki	uM	31.6
	1467951	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)c1		CHEMBL185910	=	Ki	nM	150.0	CHEMBL262	Homo sapiens	Ki	uM	0.15
	1467953	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	Fc1ccc(Nc2nccc(-c3c(-c4cccc(C(F)(F)F)c4)nn4ncccc34)n2)cc1F		CHEMBL184656	=	Ki	nM	310.0	CHEMBL262	Homo sapiens	Ki	uM	0.31
	1467955	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Ki	nM	50.0	CHEMBL262	Homo sapiens	Ki	uM	0.05
	1467957	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)c1		CHEMBL187135	=	Ki	nM	1000.0	CHEMBL262	Homo sapiens	Ki	uM	1.0
	1467959	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Ki	nM	1250.0	CHEMBL262	Homo sapiens	Ki	uM	1.25
	1467961	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	FC(F)(F)c1cccc(Nc2nccc(-c3c(-c4ccc(Cl)cc4)nn4ncccc34)n2)c1		CHEMBL362086	=	Ki	nM	2510.0	CHEMBL262	Homo sapiens	Ki	uM	2.51
	1467963	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(Cl)cc4)nn4ncccc34)n2)cc1F		CHEMBL364646	=	Ki	nM	1000.0	CHEMBL262	Homo sapiens	Ki	uM	1.0
	1467965	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	FC(F)(F)c1cc(Nc2nccc(-c3c(-c4ccc(Cl)cc4)nn4ncccc34)n2)ccc1Cl		CHEMBL189874	=	Ki	nM	3980.0	CHEMBL262	Homo sapiens	Ki	uM	3.98
	1467967	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL186826	=	Ki	nM	790.0	CHEMBL262	Homo sapiens	Ki	uM	0.79
	1467969	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccccc3)nn2n1		CHEMBL434158	=	Ki	nM	50.0	CHEMBL262	Homo sapiens	Ki	uM	0.05
	1467973	CHEMBL839940	Binding affinity for human glycogen synthase kinase 3 beta	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Ki	nM	40.0	CHEMBL262	Homo sapiens	Ki	uM	0.04
	1473193	CHEMBL833508	Inhibition of human Glycogen synthase kinase-3 beta	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	56.0	CHEMBL262	Homo sapiens	IC50	nM	56.0
Not Determined	1473194	CHEMBL832375	Inhibition of Glycogen synthase kinase-3 beta dependent Tau protein serine-396 phosphorylation in human SY5Y cells; NT= not tested	F	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978		IC50	nM		CHEMBL262	Homo sapiens	IC50	nM	
	1476113	CHEMBL830603	Percent inhibition against GSK3-beta at 10 uM using 100 uM ATP	B	CCn1c(-c2nonc2N)nc2cnccc21		CHEMBL189657	=	Inhibition	%	90.0	CHEMBL262	Homo sapiens	Inhibition	%	90.0
	1479414	CHEMBL830638	Inhibition of Glycogen synthase kinase-3 beta (GSK3-beta) at 1 uM	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Inhibition	%	50.0	CHEMBL262	Homo sapiens	Inhibition	%	50.0
	1479422	CHEMBL830646	Inhibition of Glycogen synthase kinase-3 beta (GSK3-beta) at 50 uM	B	CN1C(=O)C(c2c[nH]c3ccccc23)=C(c2cn(CCCN)c3ccccc23)C1=O		CHEMBL188282	=	Inhibition	%	94.0	CHEMBL262	Homo sapiens	Inhibition	%	94.0
	1481528	CHEMBL834909	In vitro percent inhibition of Glycogen synthase kinase 3 beta at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	O=C(O)c1ccc2cc3nc(-c4cccs4)c(-c4cccs4)nc3cc2c1		CHEMBL426445	=	Inhibition	%	4.0	CHEMBL262	Homo sapiens	Inhibition	%	4.0
	1481657	CHEMBL834909	In vitro percent inhibition of Glycogen synthase kinase 3 beta at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	COc1cc2nc(-c3cccs3)c(-c3cccs3)nc2cc1OC	Outside typical range	CHEMBL373367	=	Inhibition	%	-13.0	CHEMBL262	Homo sapiens	Inhibition	%	-13.0
	1481678	CHEMBL834909	In vitro percent inhibition of Glycogen synthase kinase 3 beta at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	Oc1cc2nc(-c3cccs3)c(-c3cccs3)nc2cc1O		CHEMBL190039	=	Inhibition	%	5.0	CHEMBL262	Homo sapiens	Inhibition	%	5.0
	1481807	CHEMBL834909	In vitro percent inhibition of Glycogen synthase kinase 3 beta at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	c1csc(-c2nc3cc4c(cc3nc2-c2cccs2)OCO4)c1		CHEMBL189940	=	Inhibition	%	-1.0	CHEMBL262	Homo sapiens	Inhibition	%	-1.0
	1481928	CHEMBL834909	In vitro percent inhibition of Glycogen synthase kinase 3 beta at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	c1csc(-c2nc3cc4c(cc3nc2-c2cccs2)OCCCO4)c1	Outside typical range	CHEMBL191410	=	Inhibition	%	-12.0	CHEMBL262	Homo sapiens	Inhibition	%	-12.0
	1481949	CHEMBL834909	In vitro percent inhibition of Glycogen synthase kinase 3 beta at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	O=C(O)C1COc2cc3nc(-c4cccs4)c(-c4cccs4)nc3cc2O1		CHEMBL193232	=	Inhibition	%	33.0	CHEMBL262	Homo sapiens	Inhibition	%	33.0
	1482060	CHEMBL834909	In vitro percent inhibition of Glycogen synthase kinase 3 beta at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	c1csc(-c2nc3cc4c(cc3nc2-c2cccs2)OCCO4)c1	Outside typical range	CHEMBL192489	=	Inhibition	%	-15.0	CHEMBL262	Homo sapiens	Inhibition	%	-15.0
	1482727	CHEMBL834909	In vitro percent inhibition of Glycogen synthase kinase 3 beta at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	c1csc(-c2nc3cc4ccccc4cc3nc2-c2cccs2)c1		CHEMBL364499	=	Inhibition	%	6.0	CHEMBL262	Homo sapiens	Inhibition	%	6.0
	1482856	CHEMBL834909	In vitro percent inhibition of Glycogen synthase kinase 3 beta at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	COC(=O)Cc1csc(-c2nc3cc4ccccc4cc3nc2-c2cc(CC(=O)OC)cs2)c1		CHEMBL192974	=	Inhibition	%	2.0	CHEMBL262	Homo sapiens	Inhibition	%	2.0
	1482987	CHEMBL834909	In vitro percent inhibition of Glycogen synthase kinase 3 beta at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	COC(=O)CCc1ccc(-c2nc3cc4ccccc4cc3nc2-c2ccc(CCC(=O)OC)s2)s1		CHEMBL190143	=	Inhibition	%	7.0	CHEMBL262	Homo sapiens	Inhibition	%	7.0
	1483008	CHEMBL834909	In vitro percent inhibition of Glycogen synthase kinase 3 beta at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	COC(=O)CCCc1ccc(-c2nc3cc4ccccc4cc3nc2-c2ccc(CCCC(=O)OC)s2)s1		CHEMBL189104	=	Inhibition	%	24.0	CHEMBL262	Homo sapiens	Inhibition	%	24.0
	1483138	CHEMBL834909	In vitro percent inhibition of Glycogen synthase kinase 3 beta at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	O=C(O)Cc1ccc(-c2nc3cc4ccccc4cc3nc2-c2ccc(CC(=O)O)s2)s1		CHEMBL193162	=	Inhibition	%	47.0	CHEMBL262	Homo sapiens	Inhibition	%	47.0
	1483269	CHEMBL834909	In vitro percent inhibition of Glycogen synthase kinase 3 beta at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	O=C(O)Cc1csc(-c2nc3cc4ccccc4cc3nc2-c2cc(CC(=O)O)cs2)c1		CHEMBL192909	=	Inhibition	%	22.0	CHEMBL262	Homo sapiens	Inhibition	%	22.0
	1483385	CHEMBL834909	In vitro percent inhibition of Glycogen synthase kinase 3 beta at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	O=C(O)CCc1ccc(-c2nc3cc4ccccc4cc3nc2-c2ccc(CCC(=O)O)s2)s1		CHEMBL366201	=	Inhibition	%	23.0	CHEMBL262	Homo sapiens	Inhibition	%	23.0
	1483406	CHEMBL834909	In vitro percent inhibition of Glycogen synthase kinase 3 beta at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	O=C(O)CCCc1ccc(-c2nc3cc4ccccc4cc3nc2-c2ccc(CCCC(=O)O)s2)s1		CHEMBL190057	=	Inhibition	%	13.0	CHEMBL262	Homo sapiens	Inhibition	%	13.0
	1483526	CHEMBL834909	In vitro percent inhibition of Glycogen synthase kinase 3 beta at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	O=C(O)c1ccc(-c2nc3cc4ccccc4cc3nc2-c2ccc(C(=O)O)s2)s1		CHEMBL366185	=	Inhibition	%	51.0	CHEMBL262	Homo sapiens	Inhibition	%	51.0
	1484583	CHEMBL834909	In vitro percent inhibition of Glycogen synthase kinase 3 beta at 10 uM concentration of compound dissolved in 100% DMSO using 5''-[gamma-33P]-triphosphate	B	COc1cc2nc3nc(-c4cccs4)c(-c4cccs4)nc3nc2cc1OC		CHEMBL193172	=	Inhibition	%	4.0	CHEMBL262	Homo sapiens	Inhibition	%	4.0
Not Determined	1494378	CHEMBL832468	Inhibition of human GSK3-beta; NT=Not tested	B	O=C(O)Cc1cccc(OCCCN(Cc2cccc(C(F)(F)F)c2Cl)CC(c2ccccc2)c2ccccc2)c1		CHEMBL59030		IC50	nM		CHEMBL262	Homo sapiens	IC50	nM	
Not Determined	1494385	CHEMBL832468	Inhibition of human GSK3-beta; NT=Not tested	B	O=S(=O)(c1ccccc1)N(CC(F)(F)F)c1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1		CHEMBL62136		IC50	nM		CHEMBL262	Homo sapiens	IC50	nM	
	1494392	CHEMBL828535	Inhibition of human GSK3-beta	B	COc1ccc(NC2=C(c3ccccc3)C(=O)N(Cc3ccccc3)C2=O)cc1		CHEMBL189938	>	IC50	nM	5000.0	CHEMBL262	Homo sapiens	IC50	nM	5000.0
	1494497	CHEMBL828535	Inhibition of human GSK3-beta	B	O=C1C(Nc2ccccc2)=C(c2ccccc2)C(=O)N1Cc1ccccc1		CHEMBL364666	>	IC50	nM	5000.0	CHEMBL262	Homo sapiens	IC50	nM	5000.0
	1494507	CHEMBL828535	Inhibition of human GSK3-beta	B	O=C1C(Nc2ccc(Cl)cc2)=C(c2ccccc2)C(=O)N1Cc1ccccc1		CHEMBL190901	>	IC50	nM	5000.0	CHEMBL262	Homo sapiens	IC50	nM	5000.0
	1494514	CHEMBL828535	Inhibition of human GSK3-beta	B	CCN1C(=O)C(Nc2ccc(OC)cc2)=C(c2ccccc2)C1=O		CHEMBL191263	>	IC50	nM	5000.0	CHEMBL262	Homo sapiens	IC50	nM	5000.0
	1494521	CHEMBL828535	Inhibition of human GSK3-beta	B	COc1ccc(NC2=C(c3ccccc3)C(=O)N(c3ccccc3)C2=O)cc1		CHEMBL189228	>	IC50	nM	5000.0	CHEMBL262	Homo sapiens	IC50	nM	5000.0
	1494626	CHEMBL828535	Inhibition of human GSK3-beta	B	COc1ccc(NC2=C(c3ccccc3)C(=O)N(C)C2=O)cc1		CHEMBL191419	>	IC50	nM	2000.0	CHEMBL262	Homo sapiens	IC50	nM	2000.0
	1494633	CHEMBL828535	Inhibition of human GSK3-beta	B	CCN1C(=O)C(Nc2ccccc2)=C(c2ccccc2)C1=O		CHEMBL370285	>	IC50	nM	5000.0	CHEMBL262	Homo sapiens	IC50	nM	5000.0
	1494640	CHEMBL828535	Inhibition of human GSK3-beta	B	CCN1C(=O)C(Nc2ccc(Cl)cc2)=C(c2ccccc2)C1=O		CHEMBL189532	>	IC50	nM	5000.0	CHEMBL262	Homo sapiens	IC50	nM	5000.0
	1494647	CHEMBL828535	Inhibition of human GSK3-beta	B	CN1C(=O)C(Nc2ccccc2)=C(c2ccccc2)C1=O		CHEMBL158781	>	IC50	nM	5000.0	CHEMBL262	Homo sapiens	IC50	nM	5000.0
	1498771	CHEMBL829359	Inhibition of Glycogen synthase kinase 3 beta	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cc3)nc2n(C2CCCC2)c1=O		CHEMBL365847	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	1658657	CHEMBL860299	Inhibitory activity against GSK3-beta	B	NC1=NONC1N1N=NC(C(=O)N/N=C/c2ccncc2)C1CN1CCCCC1		CHEMBL197077	=	IC50	nM	100.0	CHEMBL262	Homo sapiens	IC50	uM	0.1
	1658671	CHEMBL860299	Inhibitory activity against GSK3-beta	B	NC1=NONC1N1N=NC(c2n[nH]c(-c3ccncc3)n2)C1CN1CCCCC1		CHEMBL197226	=	IC50	nM	280.0	CHEMBL262	Homo sapiens	IC50	uM	0.28
Not Active	1658688	CHEMBL860381	Inhibitory activity against GSK3-beta at 10 uM	B	O=c1cc(N2CCOCC2)oc2c(-c3cccc4c3sc3ccccc34)cccc12		CHEMBL188678		Activity			CHEMBL262	Homo sapiens	Activity		
	1665746	CHEMBL859137	Inhibition of GSK3-beta at 10 uM	B	CN1C(=O)C(C(=O)Nc2nncs2)c2cc3occc3cc21		CHEMBL200906	=	Inhibition	%	16.0	CHEMBL262	Homo sapiens	Inhibition	%	16.0
	1666360	CHEMBL865760	Inhibition of GSK3-beta activity at 10 uM	B	Oc1cc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)ccc1Cl		CHEMBL373011	=	Inhibition	%	83.0	CHEMBL262	Homo sapiens	Inhibition	%	83.0
	1666361	CHEMBL865760	Inhibition of GSK3-beta activity at 10 uM	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1		CHEMBL477989	=	Inhibition	%	25.0	CHEMBL262	Homo sapiens	Inhibition	%	25.0
	1671503	CHEMBL869964	Inhibition of GSK3b at 10 uM	B	Cc1c(Nc2ccc(Br)cc2F)c(C(=O)NOCCO)cn(C)c1=O		CHEMBL199860	=	Inhibition	%	17.0	CHEMBL262	Homo sapiens	Inhibition	%	17.0
	1671529	CHEMBL869964	Inhibition of GSK3b at 10 uM	B	CCONC(=O)c1cn(C)c(=O)c(F)c1Nc1ccc(Br)cc1F		CHEMBL201426	=	Inhibition	%	21.0	CHEMBL262	Homo sapiens	Inhibition	%	21.0
	1671565	CHEMBL869964	Inhibition of GSK3b at 10 uM	B	CONC(=O)c1cn(C)c(=O)c(C)c1Nc1ccc(Br)cc1F		CHEMBL426840	=	Inhibition	%	12.0	CHEMBL262	Homo sapiens	Inhibition	%	12.0
	1671645	CHEMBL869964	Inhibition of GSK3b at 10 uM	B	CCONC(=O)c1cn(C)c(=O)c(C)c1Nc1ccc(Br)cc1F		CHEMBL203138	=	Inhibition	%	15.0	CHEMBL262	Homo sapiens	Inhibition	%	15.0
	1684755	CHEMBL859256	Inhibitory activity against GSK3-beta	B	CCCCNC(=O)N1Cc2n[nH]c(NC(=O)Cc3ccc(N4CCCC4)cc3)c2C1		CHEMBL383104	=	IC50	nM	300.0	CHEMBL262	Homo sapiens	IC50	uM	0.3
	1684756	CHEMBL859256	Inhibitory activity against GSK3-beta	B	CCCCNC(=O)N1Cc2n[nH]c(NC(=O)[C@@H](C)c3ccc4ccccc4c3)c2C1		CHEMBL380946	=	IC50	nM	50.0	CHEMBL262	Homo sapiens	IC50	uM	0.05
	1693282	CHEMBL867701	Inhibition of GSK3-beta using 10 uM ATP	B	NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL319467	=	IC50	nM	40.0	CHEMBL262	Homo sapiens	IC50	nM	40.0
	1693283	CHEMBL867701	Inhibition of GSK3-beta using 10 uM ATP	B	NS(=O)(=O)c1ccc(Nc2cc(N[C@H]3CC[C@H](N)CC3)nc3ncnn23)cc1		CHEMBL380331	=	IC50	nM	780.0	CHEMBL262	Homo sapiens	IC50	uM	0.78
	1693284	CHEMBL867701	Inhibition of GSK3-beta using 10 uM ATP	B	N[C@H]1CC[C@H](Nc2cc(Nc3ccc(S(=O)(=O)c4ccccc4)cc3)n3ncnc3n2)CC1		CHEMBL382607	=	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	1693285	CHEMBL867701	Inhibition of GSK3-beta using 10 uM ATP	B	CS(=O)(=O)c1ccc(Nc2cc(N[C@H]3CC[C@H](N)CC3)nc3ncnn23)cc1		CHEMBL206659	=	IC50	nM	43000.0	CHEMBL262	Homo sapiens	IC50	uM	43.0
	1693286	CHEMBL867701	Inhibition of GSK3-beta using 10 uM ATP	B	CN(C)S(=O)(=O)c1ccc(Nc2cc(N[C@H]3CC[C@H](N)CC3)nc3ncnn23)cc1		CHEMBL202695	=	IC50	nM	20000.0	CHEMBL262	Homo sapiens	IC50	uM	20.0
	1693287	CHEMBL867701	Inhibition of GSK3-beta using 10 uM ATP	B	CCN(CC)c1cc(Nc2ccc(S(N)(=O)=O)cc2)n2ncnc2n1		CHEMBL203571	=	IC50	nM	11000.0	CHEMBL262	Homo sapiens	IC50	uM	11.0
	1693288	CHEMBL867701	Inhibition of GSK3-beta using 10 uM ATP	B	NS(=O)(=O)c1ccc(Nc2cc(NC3CCCCC3)nc3ncnn23)cc1		CHEMBL203569	=	IC50	nM	970.0	CHEMBL262	Homo sapiens	IC50	uM	0.97
	1693289	CHEMBL867701	Inhibition of GSK3-beta using 10 uM ATP	B	NS(=O)(=O)c1ccc(Nc2cc(OC3CCCCC3)nc3ncnn23)cc1		CHEMBL203407	=	IC50	nM	190.0	CHEMBL262	Homo sapiens	IC50	uM	0.19
	1693290	CHEMBL867701	Inhibition of GSK3-beta using 10 uM ATP	B	NS(=O)(=O)c1ccc(Nc2cc(OCC3CCCCC3)nc3ncnn23)cc1		CHEMBL206109	=	IC50	nM	29000.0	CHEMBL262	Homo sapiens	IC50	uM	29.0
	1697683	CHEMBL866554	Protective index against GSK3-beta at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(Cl)cc2)o1		CHEMBL203056	<	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1697925	CHEMBL866554	Protective index against GSK3-beta at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(Cc3ccccc3)cc2)o1		CHEMBL383126	<	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1697926	CHEMBL866554	Protective index against GSK3-beta at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(Oc3ccccc3)cc2)o1		CHEMBL206267	<	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1697927	CHEMBL866554	Protective index against GSK3-beta at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(-c3ccccc3)cc2)o1		CHEMBL205464	<	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1697928	CHEMBL866554	Protective index against GSK3-beta at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(Br)cc2)o1		CHEMBL205463	<	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1697929	CHEMBL866554	Protective index against GSK3-beta at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(NCc2ccc3c(c2)OCO3)o1		CHEMBL202892	<	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1697930	CHEMBL866554	Protective index against GSK3-beta at 10 uM by HTRF method	B	Cc1ccc(Nc2nnc(-c3c(NCc4ccncc4)ncn3C)o2)c(F)c1		CHEMBL379908	<	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1697931	CHEMBL866554	Protective index against GSK3-beta at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(Cl)c(C(F)(F)F)c2)o1		CHEMBL205127	<	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1697932	CHEMBL866554	Protective index against GSK3-beta at 10 uM by HTRF method	B	COc1ccc(Nc2nnc(-c3c(NCc4ccncc4)ncn3C)o2)cc1OC		CHEMBL378592	<	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1697933	CHEMBL866554	Protective index against GSK3-beta at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(Cl)c(Cl)c2)o1		CHEMBL204874	<	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1697934	CHEMBL866554	Protective index against GSK3-beta at 10 uM by HTRF method	B	Cc1ccccc1Nc1nnc(-c2c(NCc3ccncc3)ncn2C)o1		CHEMBL379239	<	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1697935	CHEMBL866554	Protective index against GSK3-beta at 10 uM by HTRF method	B	COc1ccccc1Nc1nnc(-c2c(NCc3ccncc3)ncn2C)o1		CHEMBL204312	<	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1697936	CHEMBL866554	Protective index against GSK3-beta at 10 uM by HTRF method	B	COc1cccc(Nc2nnc(-c3c(NCc4ccncc4)ncn3C)o2)c1		CHEMBL203796	<	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1697937	CHEMBL866554	Protective index against GSK3-beta at 10 uM by HTRF method	B	Cc1cccc(Nc2nnc(-c3c(NCc4ccncc4)ncn3C)o2)c1		CHEMBL203789	<	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1697938	CHEMBL866554	Protective index against GSK3-beta at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2cccc(OC(F)(F)F)c2)o1		CHEMBL206538	<	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1697939	CHEMBL866554	Protective index against GSK3-beta at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(C(F)(F)F)cc2)o1		CHEMBL380131	<	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1697940	CHEMBL866554	Protective index against GSK3-beta at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(OC(F)(F)F)cc2)o1		CHEMBL383255	<	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1697941	CHEMBL866554	Protective index against GSK3-beta at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(OC(F)(F)Cl)cc2)o1		CHEMBL205884	<	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1697942	CHEMBL866554	Protective index against GSK3-beta at 10 uM by HTRF method	B	CC(C)c1ccc(Nc2nnc(-c3c(NCc4ccncc4)ncn3C)o2)cc1		CHEMBL203119	<	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1697943	CHEMBL866554	Protective index against GSK3-beta at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(C(C)(C)C)cc2)o1		CHEMBL203731	<	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1697944	CHEMBL866554	Protective index against GSK3-beta at 10 uM by HTRF method	B	Cn1cnc(NCc2cccc3ncccc23)c1-c1nnc(Nc2ccc(Cl)cc2)o1		CHEMBL378165	<	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1697945	CHEMBL866554	Protective index against GSK3-beta at 10 uM by HTRF method	B	Cn1cnc(NCc2ccc3ccccc3n2)c1-c1nnc(Nc2ccc(Cl)cc2)o1		CHEMBL204718	<	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1697946	CHEMBL866554	Protective index against GSK3-beta at 10 uM by HTRF method	B	Cn1cnc(NCc2ccc3[nH]ncc3c2)c1-c1nnc(Nc2ccc(Cl)cc2)o1		CHEMBL206118	<	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1697947	CHEMBL866554	Protective index against GSK3-beta at 10 uM by HTRF method	B	Cn1cnc(NCc2ccc(F)c(F)c2)c1-c1nnc(Nc2ccc(Cl)cc2)o1		CHEMBL203394	<	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1697948	CHEMBL866554	Protective index against GSK3-beta at 10 uM by HTRF method	B	Cn1cnc(NCCc2ccc3c(c2)OCO3)c1-c1nnc(Nc2ccc(Cl)cc2)o1		CHEMBL382672	<	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1697949	CHEMBL866554	Protective index against GSK3-beta at 10 uM by HTRF method	B	Cn1cnc(NCc2ccccn2)c1-c1nnc(Nc2ccc(Cl)cc2)o1		CHEMBL202904	<	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1697950	CHEMBL866554	Protective index against GSK3-beta at 10 uM by HTRF method	B	Cn1cnc(NCc2cccnc2)c1-c1nnc(Nc2ccc(Cl)cc2)o1		CHEMBL206742	<	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1701839	CHEMBL861009	Inhibition of human recombinant GSK3-beta	B	O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23		CHEMBL6246	=	IC50	nM	7500.0	CHEMBL262	Homo sapiens	IC50	uM	7.5
	1715700	CHEMBL870116	Inhibition of GSK3-beta	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN1CCCC1		CHEMBL437885	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	1715970	CHEMBL870116	Inhibition of GSK3-beta	B	COCCN1CC(C(N)=O)(N(C)Cc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)C1		CHEMBL207815	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	1715971	CHEMBL870116	Inhibition of GSK3-beta	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN(C)C1(C(N)=O)CN(C(C)C)C1		CHEMBL425601	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	1715972	CHEMBL870116	Inhibition of GSK3-beta	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN(C)C1(C(N)=O)CN(C)C1		CHEMBL207718	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	1715973	CHEMBL870116	Inhibition of GSK3-beta	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN(C)C1(C(N)=O)CCN(C(C)C)CC1		CHEMBL383246	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	1715974	CHEMBL870116	Inhibition of GSK3-beta	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN(C)C1(C(N)=O)CCN(C)CC1		CHEMBL207130	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	1715975	CHEMBL870116	Inhibition of GSK3-beta	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN(C)[C@@H](CN(C)C)C(N)=O		CHEMBL380889	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	1715976	CHEMBL870116	Inhibition of GSK3-beta	B	COCC[C@@H](C(N)=O)N(C)Cc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OC		CHEMBL207445	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	1715977	CHEMBL870116	Inhibition of GSK3-beta	B	COC[C@@H](C(N)=O)N(C)Cc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OC		CHEMBL379905	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	1715978	CHEMBL870116	Inhibition of GSK3-beta	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN(C)[C@@H](CO)C(N)=O		CHEMBL208286	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	1715979	CHEMBL870116	Inhibition of GSK3-beta	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN(CCN(C)C)[C@@H](C)C(N)=O		CHEMBL376967	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	1715980	CHEMBL870116	Inhibition of GSK3-beta	B	COCCN(Cc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OC)[C@@H](C)C(N)=O		CHEMBL382823	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	1715981	CHEMBL870116	Inhibition of GSK3-beta	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN(C(C)C)[C@@H](C)C(N)=O		CHEMBL208048	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	1715982	CHEMBL870116	Inhibition of GSK3-beta	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN(C)C1CCNC1=O		CHEMBL378370	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	1715983	CHEMBL870116	Inhibition of GSK3-beta	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN(C)[C@H](C)C(=O)N(C)C		CHEMBL380006	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	1715984	CHEMBL870116	Inhibition of GSK3-beta	B	CNC(=O)[C@@H](C)N(C)Cc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OC		CHEMBL211003	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	1715985	CHEMBL870116	Inhibition of GSK3-beta	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN(C)[C@@H](C)C(N)=O		CHEMBL207687	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	1715986	CHEMBL870116	Inhibition of GSK3-beta	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN(C)[C@H](C)C(N)=O		CHEMBL208118	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	1715987	CHEMBL870116	Inhibition of GSK3-beta	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN(C)CC(N)=O		CHEMBL379601	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	1715988	CHEMBL870116	Inhibition of GSK3-beta	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN[C@H](C)C(N)=O		CHEMBL380386	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	1715989	CHEMBL870116	Inhibition of GSK3-beta	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN1CC(C(N)=O)C1		CHEMBL207037	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	1715990	CHEMBL870116	Inhibition of GSK3-beta	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN1CCC1C(N)=O		CHEMBL207246	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	1715991	CHEMBL870116	Inhibition of GSK3-beta	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN1CCOCC1C(N)=O		CHEMBL207674	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	1715992	CHEMBL870116	Inhibition of GSK3-beta	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN1CCCC[C@@H]1C(N)=O		CHEMBL206783	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	1715993	CHEMBL870116	Inhibition of GSK3-beta	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN1CCN(C)CC1C(N)=O		CHEMBL204420	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	1715994	CHEMBL870116	Inhibition of GSK3-beta	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN1CCC[C@H]1CC(N)=O		CHEMBL377772	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	1715995	CHEMBL870116	Inhibition of GSK3-beta	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN1CC[C@H](C(N)=O)C1		CHEMBL380454	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	1715996	CHEMBL870116	Inhibition of GSK3-beta	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN1CCC[C@@H]1C(=O)N(C)C		CHEMBL382822	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	1715997	CHEMBL870116	Inhibition of GSK3-beta	B	CNC(=O)[C@H]1CCCN1Cc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OC		CHEMBL383760	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	1715998	CHEMBL870116	Inhibition of GSK3-beta	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN1C[C@H](OC)C[C@@H]1C(N)=O		CHEMBL207235	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	1715999	CHEMBL870116	Inhibition of GSK3-beta	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN1CCC[C@@H]1C(N)=O		CHEMBL208292	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	1716000	CHEMBL870116	Inhibition of GSK3-beta	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1CN1CCC[C@H]1C(N)=O		CHEMBL207584	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	1716001	CHEMBL870116	Inhibition of GSK3-beta	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1CN1CCC[C@H]1C(N)=O		CHEMBL382638	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	1716002	CHEMBL870116	Inhibition of GSK3-beta	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1CN1CCC[C@@H]1C(N)=O		CHEMBL206955	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	1723219	CHEMBL861302	Inhibition of GSK3-beta	B	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	>	Ki	nM	7100.0	CHEMBL262	Homo sapiens	Ki	nM	7100.0
	1723230	CHEMBL861302	Inhibition of GSK3-beta	B	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	>	Ki	nM	7100.0	CHEMBL262	Homo sapiens	Ki	nM	7100.0
	1723257	CHEMBL861302	Inhibition of GSK3-beta	B	CC(=O)Nc1cc(N)c(C#N)c(-c2ccccc2)n1		CHEMBL210032	>	Ki	nM	7100.0	CHEMBL262	Homo sapiens	Ki	nM	7100.0
	1723262	CHEMBL861302	Inhibition of GSK3-beta	B	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	>	Ki	nM	7100.0	CHEMBL262	Homo sapiens	Ki	nM	7100.0
	1723270	CHEMBL861302	Inhibition of GSK3-beta	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	>	Ki	nM	7100.0	CHEMBL262	Homo sapiens	Ki	nM	7100.0
	1723273	CHEMBL861302	Inhibition of GSK3-beta	B	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	>	Ki	nM	7100.0	CHEMBL262	Homo sapiens	Ki	nM	7100.0
Not Determined	1726249	CHEMBL860056	Inhibition of GSK3-beta	B	CCC(C)(O)C#Cc1nc(NCc2ccc(OC)cc2)c2ncn(C(C)C)c2n1		CHEMBL422759		IC50			CHEMBL262	Homo sapiens	IC50		
	1726263	CHEMBL860056	Inhibition of GSK3-beta	B	COCCNc1nc(-c2ccc(C=O)cc2)nc2c1ncn2C(C)C		CHEMBL379029	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
Not Determined	1726291	CHEMBL860056	Inhibition of GSK3-beta	B	CCC(C)(O)C#Cc1nc(NCc2ccc(Cl)cc2)c2ncn(C(C)C)c2n1		CHEMBL24484		IC50			CHEMBL262	Homo sapiens	IC50		
	1726294	CHEMBL860056	Inhibition of GSK3-beta	B	COc1ccc(CNc2nc(-c3ccc(C=O)cc3)nc3c2ncn3C(C)C)cc1		CHEMBL377061	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	1726295	CHEMBL860056	Inhibition of GSK3-beta	B	COCCNc1nc(-c2ccc(C#N)s2)nc2c1ncn2C(C)C		CHEMBL209404	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	1726296	CHEMBL860056	Inhibition of GSK3-beta	B	COCCNc1nc(-c2ccc(C(C)=O)s2)nc2c1ncn2C(C)C		CHEMBL379618	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	1726297	CHEMBL860056	Inhibition of GSK3-beta	B	COCCNc1nc(-c2ccc(NC(=O)OC)cc2)nc2c1ncn2C(C)C		CHEMBL379811	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	1726298	CHEMBL860056	Inhibition of GSK3-beta	B	COCCNc1nc(-c2ccc(C(=O)NCCC#N)cc2)nc2c1ncn2C(C)C		CHEMBL207426	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	1726299	CHEMBL860056	Inhibition of GSK3-beta	B	CNC(=O)c1ccc(-c2nc(NCCOC)c3ncn(C(C)C)c3n2)cc1		CHEMBL437325	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	1726300	CHEMBL860056	Inhibition of GSK3-beta	B	COCCNc1nc(-c2ccc(NS(C)(=O)=O)cc2)nc2c1ncn2C(C)C		CHEMBL210839	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	1726301	CHEMBL860056	Inhibition of GSK3-beta	B	COCCNc1nc(-c2ccc(C(C)=O)cc2)nc2c1ncn2C(C)C		CHEMBL208017	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	1727573	CHEMBL859762	Inhibition of human GSK3-beta at 3 uM in presence of 10 uM ATP	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Inhibition	%	-2.0	CHEMBL262	Homo sapiens	Inhibition	%	-2.0
Not Determined	1728714	CHEMBL860381	Inhibitory activity against GSK3-beta at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccco3)ccc12		CHEMBL196964		Activity			CHEMBL262	Homo sapiens	Activity		
Not Determined	1728757	CHEMBL860381	Inhibitory activity against GSK3-beta at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccc(F)cc3)ccc12		CHEMBL197439		Activity			CHEMBL262	Homo sapiens	Activity		
Not Determined	1728800	CHEMBL860381	Inhibitory activity against GSK3-beta at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccsc3)ccc12		CHEMBL196764		Activity			CHEMBL262	Homo sapiens	Activity		
Not Determined	1728843	CHEMBL860381	Inhibitory activity against GSK3-beta at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cccc4c3oc3ccccc34)ccc12		CHEMBL196759		Activity			CHEMBL262	Homo sapiens	Activity		
Not Determined	1728886	CHEMBL860381	Inhibitory activity against GSK3-beta at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cc4ccccc4s3)ccc12		CHEMBL381025		Activity			CHEMBL262	Homo sapiens	Activity		
Not Determined	1728939	CHEMBL860381	Inhibitory activity against GSK3-beta at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cccc4c3Sc3ccccc3S4)ccc12		CHEMBL199216		Activity			CHEMBL262	Homo sapiens	Activity		
Not Determined	1728982	CHEMBL860381	Inhibitory activity against GSK3-beta at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)ccc12		CHEMBL436767		Activity			CHEMBL262	Homo sapiens	Activity		
Not Determined	1729025	CHEMBL860381	Inhibitory activity against GSK3-beta at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cccc4ccccc34)ccc12		CHEMBL199050		Activity			CHEMBL262	Homo sapiens	Activity		
Not Determined	1729068	CHEMBL860381	Inhibitory activity against GSK3-beta at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(/C=C/c3ccc(Cl)cc3)ccc12		CHEMBL199051		Activity			CHEMBL262	Homo sapiens	Activity		
Not Determined	1729111	CHEMBL860381	Inhibitory activity against GSK3-beta at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccc4[nH]ccc4c3)ccc12		CHEMBL369969		Activity			CHEMBL262	Homo sapiens	Activity		
Not Determined	1729154	CHEMBL860381	Inhibitory activity against GSK3-beta at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccc4ncccc4c3)ccc12		CHEMBL198740		Activity			CHEMBL262	Homo sapiens	Activity		
Not Determined	1729197	CHEMBL860381	Inhibitory activity against GSK3-beta at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cccc4c3Oc3ccccc3S4)ccc12		CHEMBL197239		Activity			CHEMBL262	Homo sapiens	Activity		
Not Determined	1729240	CHEMBL860381	Inhibitory activity against GSK3-beta at 10 uM	B	Nc1cc(C(=O)O)cc(-c2ccc3c(=O)cc(N4CCOCC4)oc3c2)c1		CHEMBL370108		Activity			CHEMBL262	Homo sapiens	Activity		
Not Determined	1729283	CHEMBL860381	Inhibitory activity against GSK3-beta at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cccc4c3sc3ccccc34)ccc12		CHEMBL198801		Activity			CHEMBL262	Homo sapiens	Activity		
Not Determined	1729329	CHEMBL860381	Inhibitory activity against GSK3-beta at 10 uM	B	O=C1c2ccccc2C(=O)N1Cc1cccc(-c2ccc3c(=O)cc(N4CCOCC4)oc3c2)c1		CHEMBL197219		Activity			CHEMBL262	Homo sapiens	Activity		
Not Determined	1729372	CHEMBL860381	Inhibitory activity against GSK3-beta at 10 uM	B	O=C1c2ccccc2C(=O)N1Cc1ccc(-c2ccc3c(=O)cc(N4CCOCC4)oc3c2)cc1		CHEMBL197227		Activity			CHEMBL262	Homo sapiens	Activity		
Not Determined	1729415	CHEMBL860381	Inhibitory activity against GSK3-beta at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cccs3)ccc12		CHEMBL371968		Activity			CHEMBL262	Homo sapiens	Activity		
Not Determined	1729458	CHEMBL860381	Inhibitory activity against GSK3-beta at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccc4ccccc4c3)ccc12		CHEMBL200299		Activity			CHEMBL262	Homo sapiens	Activity		
Not Determined	1729501	CHEMBL860381	Inhibitory activity against GSK3-beta at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3csc4ccccc34)ccc12		CHEMBL199416		Activity			CHEMBL262	Homo sapiens	Activity		
Not Determined	1729544	CHEMBL860381	Inhibitory activity against GSK3-beta at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccc(OCc4ccccc4)cc3)ccc12		CHEMBL382501		Activity			CHEMBL262	Homo sapiens	Activity		
Not Determined	1729602	CHEMBL860381	Inhibitory activity against GSK3-beta at 10 uM	B	Cc1ccc(-c2ccc3c(=O)cc(N4CCOCC4)oc3c2)c2ccccc12		CHEMBL200275		Activity			CHEMBL262	Homo sapiens	Activity		
Not Determined	1729645	CHEMBL860381	Inhibitory activity against GSK3-beta at 10 uM	B	COC(=O)/C=C/c1ccccc1-c1ccc2c(=O)cc(N3CCOCC3)oc2c1		CHEMBL199424		Activity			CHEMBL262	Homo sapiens	Activity		
	1734187	CHEMBL862478	Residual activity at human GSK3-beta at 10 uM in presence of 10 uM ATP relative to control	B	O=C1NC(=O)/C(=C/c2ccc(-c3ccc(F)cc3O)o2)S1		CHEMBL379156	=	Activity	%	84.0	CHEMBL262	Homo sapiens	Activity	%	84.0
	1734714	CHEMBL865426	Inhibition of GSK3-beta	B	COc1cc(C)c(Sc2cnc(NC(=O)c3ccc(CNC(C)C(C)(C)C)cc3)s2)cc1C(=O)N1CCN(C(C)=O)CC1		CHEMBL209148	=	IC50	nM	36000.0	CHEMBL262	Homo sapiens	IC50	uM	36.0
	1735029	CHEMBL854491	Activity against GSK3-beta at 10 uM in the presence of 100 uM ATP relative to control	B	COc1cc(/C=C2\C(=O)NN(c3ccc(Cl)c(Cl)c3)C2=O)ccc1O		CHEMBL380093	=	Activity	%	69.0	CHEMBL262	Homo sapiens	Activity	%	69.0
	1735047	CHEMBL854491	Activity against GSK3-beta at 10 uM in the presence of 100 uM ATP relative to control	B	COc1cccc(NC(=O)Nc2nnc(-c3ccncc3)s2)c1		CHEMBL377430	=	Activity	%	47.0	CHEMBL262	Homo sapiens	Activity	%	47.0
	1739113	CHEMBL866210	Inhibition of GSK3-beta	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	=	Ki	nM	110.0	CHEMBL262	Homo sapiens	Ki	nM	110.0
	1744456	CHEMBL867318	Inhibition of GSK3-beta	B	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	>	Ki	nM	7000.0	CHEMBL262	Homo sapiens	Ki	uM	7.0
	1751530	CHEMBL869148	Inhibition of GSK3-beta	B	CC(C)c1nnc2ccc(-c3ocnc3-c3ccc(F)cc3Cl)cn12		CHEMBL215652	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	1751531	CHEMBL869148	Inhibition of GSK3-beta	B	CC(C)c1nnc2ccc(-c3ocnc3-c3cc(F)c(F)cc3F)cn12		CHEMBL213423	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	1751532	CHEMBL869148	Inhibition of GSK3-beta	B	CCNc1nnc2ccc(-c3ocnc3-c3ccc(F)cc3)cn12		CHEMBL213451	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	1751533	CHEMBL869148	Inhibition of GSK3-beta	B	CC(C)(C)c1nnc2ccc(-c3ocnc3-c3ccc(F)cc3F)cn12		CHEMBL212382	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	1751534	CHEMBL869148	Inhibition of GSK3-beta	B	CC(C)(C)c1nnc2ccc(-c3ocnc3-c3cc(F)c(F)cc3F)cn12		CHEMBL212968	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	1751535	CHEMBL869148	Inhibition of GSK3-beta	B	CC(C)c1nnc2ccc(-c3c[nH]nc3-c3cc(F)ccc3F)cn12		CHEMBL214198	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	1751648	CHEMBL869148	Inhibition of GSK3-beta	B	CC(C)c1nnc2ccc(-c3ocnc3-c3ccccc3)cn12		CHEMBL379929	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	1769375	CHEMBL910895	Inhibition of GSK3-beta	B	C[C@@H]1C[C@H]2CN1CCn1nc3c(cccc3c1O)-c1nc3c(cccc3nc1O)O2		CHEMBL215803	=	IC50	nM	13.0	CHEMBL262	Homo sapiens	IC50	nM	13.0
	1777534	CHEMBL908840	Inhibition of GSK3-beta	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	=	Ki	nM	8000.0	CHEMBL262	Homo sapiens	Ki	uM	8.0
	1779375	CHEMBL854979	Inhibition of GSK3-beta	B	Clc1ccc2c(c1Nc1ncnc3cc(OCCCN4CCCC4)cc(OC4CCOCC4)c13)OCO2		CHEMBL217090	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	1779390	CHEMBL854979	Inhibition of GSK3-beta	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	1780419	CHEMBL911809	Activity of GSK3-beta at 10 uM	B	Nc1n[nH]c(N)c1/N=N/c1ccc(O)cc1		CHEMBL215205	=	Inhibition	%	81.0	CHEMBL262	Homo sapiens	Inhibition	%	81.0
	1782042	CHEMBL911849	Inhibition of GSK3-beta	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	1790323	CHEMBL873763	Percent residual activity, relative to control, of GSK3 beta at 1uM concentration of inhibitor in presence of 5uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)NC(=O)CCCCCNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL413460	=	Activity	%	94.0	CHEMBL262	Homo sapiens	Activity	%	94.0
	1790377	CHEMBL873763	Percent residual activity, relative to control, of GSK3 beta at 1uM concentration of inhibitor in presence of 5uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL279185	=	Activity	%	56.0	CHEMBL262	Homo sapiens	Activity	%	56.0
	1790434	CHEMBL912722	Inhibition of human GSK3 beta	B	COc1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL201511	=	IC50	nM	1100.0	CHEMBL262	Homo sapiens	IC50	M	0.0000011
	1837901	CHEMBL920465	Inhibition of GSKbeta at 10 uM relative to control	B	CN(C)c1nc2c(Br)c(Br)c(Br)c(Br)c2[nH]1		CHEMBL376505	=	Inhibition	%	103.0	CHEMBL262	Homo sapiens	Inhibition	%	103.0
	1837940	CHEMBL920465	Inhibition of GSKbeta at 10 uM relative to control	B	Brc1c(Br)c(Br)c2[nH]nnc2c1Br		CHEMBL177820	=	Inhibition	%	64.0	CHEMBL262	Homo sapiens	Inhibition	%	64.0
Active	1910490	CHEMBL890521	Inhibition of GSK3-beta activity in PC3 cells	B	CCOC(=O)c1ccc2[nH]c3c(OC)c4[nH]c5ccc(C(=O)OCC)cc5c4cc3c2c1		CHEMBL245030		Activity			CHEMBL262	Homo sapiens	Activity		
Not Determined	1916301	CHEMBL894161	Inhibition of recombinant GSK3-beta by radiometric assay	B	COc1cc(-c2ccc3c(c2)Nc2ccc(CC(=O)Nc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1N		CHEMBL395080		IC50			CHEMBL262	Homo sapiens	IC50		
	1916359	CHEMBL894161	Inhibition of recombinant GSK3-beta by radiometric assay	B	COc1cc(-c2ccc3c(c2)Nc2ccc(C(C)(C)C(=O)Nc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1N		CHEMBL389745	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	1917477	CHEMBL895133	Inhibition of GSK3-beta at 1 uM	B	O=c1ccc(=O)c2c1c1[nH]c3ccc(O)cc3c1c1c(=O)[nH]c(=O)c21		CHEMBL243931	=	Inhibition	%	19.0	CHEMBL262	Homo sapiens	Inhibition	%	19.0
	1917500	CHEMBL895133	Inhibition of GSK3-beta at 1 uM	B	Cc1ccc2[nH]c3c4c(O)ccc(O)c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL244141	=	Inhibition	%	60.0	CHEMBL262	Homo sapiens	Inhibition	%	60.0
	1922417	CHEMBL895920	Inhibition of GSK3b	B	CNC(=O)c1cc(Oc2ccc3oc(Nc4ccc(Cl)c(OC[C@@H]5CCCN5C)c4)nc3c2)ccn1		CHEMBL231568	>	IC50	nM	40000.0	CHEMBL262	Homo sapiens	IC50	uM	40.0
	1923428	CHEMBL896205	Inhibition of GSKbeta	B	Cn1cnc(CNc2cc(Br)c3ncc(C#N)c(Nc4ccc(F)c(Cl)c4)c3c2)c1		CHEMBL230761	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	1964239	CHEMBL897077	Inhibition of GSK3-beta	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	<	IC50	nM	10000.0	CHEMBL262	Homo sapiens	pIC50		5.0
	1964249	CHEMBL897077	Inhibition of GSK3-beta	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	<	IC50	nM	10000.0	CHEMBL262	Homo sapiens	pIC50		5.0
	1966319	CHEMBL897519	Inhibition of GSK3-beta at 10 uM	B	O=C(Nc1ccc(Cl)cc1)c1ccnn1CCc1ccccn1		CHEMBL232800	>	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1966720	CHEMBL897519	Inhibition of GSK3-beta at 10 uM	B	O=C(Nc1ccc(C(F)(F)F)c(Cl)c1)c1nnnn1CCc1ccncc1		CHEMBL233829	>	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1966721	CHEMBL897519	Inhibition of GSK3-beta at 10 uM	B	CC(C)(C)c1ccc(NC(=O)c2nnnn2CCc2ccncc2)cc1		CHEMBL233828	>	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1966722	CHEMBL897519	Inhibition of GSK3-beta at 10 uM	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1nnnn1CCc1ccncc1		CHEMBL233827	>	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1966723	CHEMBL897519	Inhibition of GSK3-beta at 10 uM	B	O=C(Nc1ccc(C(F)(F)F)cc1)c1nnnn1CCc1ccncc1		CHEMBL234205	>	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1966724	CHEMBL897519	Inhibition of GSK3-beta at 10 uM	B	O=C(Nc1ccc(Cl)cc1)c1nnnn1CCc1ccncc1		CHEMBL393001	>	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1966725	CHEMBL897519	Inhibition of GSK3-beta at 10 uM	B	O=C(Nc1ccc(C(F)(F)F)c(Cl)c1)c1nc2ccccc2n1CCc1ccncc1		CHEMBL234013	>	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1966726	CHEMBL897519	Inhibition of GSK3-beta at 10 uM	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1nc2ccccc2n1CCc1ccncc1		CHEMBL234012	>	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1966727	CHEMBL897519	Inhibition of GSK3-beta at 10 uM	B	O=C(Nc1ccc(Cl)cc1)c1nc2ccccc2n1CCc1ccncc1		CHEMBL233826	>	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1966728	CHEMBL897519	Inhibition of GSK3-beta at 10 uM	B	O=C(Nc1ccc(C(F)(F)F)c(Cl)c1)c1nccn1CCc1ccncc1		CHEMBL233825	>	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1966729	CHEMBL897519	Inhibition of GSK3-beta at 10 uM	B	CC(C)(C)c1ccc(NC(=O)c2nccn2CCc2ccncc2)cc1		CHEMBL233824	>	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1966730	CHEMBL897519	Inhibition of GSK3-beta at 10 uM	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1nccn1CCc1ccncc1		CHEMBL391104	>	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1966731	CHEMBL897519	Inhibition of GSK3-beta at 10 uM	B	O=C(Nc1ccc(C(F)(F)F)cc1)c1nccn1CCc1ccncc1		CHEMBL234203	>	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1966732	CHEMBL897519	Inhibition of GSK3-beta at 10 uM	B	O=C(Nc1ccc(Cl)cc1)c1nccn1CCc1ccncc1		CHEMBL234202	>	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1966733	CHEMBL897519	Inhibition of GSK3-beta at 10 uM	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1cc2ccccc2n1CCc1ccncc1		CHEMBL391103	>	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1966734	CHEMBL897519	Inhibition of GSK3-beta at 10 uM	B	O=C(Nc1ccc(Cl)cc1)c1cc2ccccc2n1CCc1ccncc1		CHEMBL234201	>	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1966735	CHEMBL897519	Inhibition of GSK3-beta at 10 uM	B	Cc1nn(CCc2ccncc2)c(C(=O)Nc2ccc(OC(F)(F)F)cc2)c1C		CHEMBL234011	>	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1966736	CHEMBL897519	Inhibition of GSK3-beta at 10 uM	B	Cc1nn(CCc2ccncc2)c(C(=O)Nc2ccc(Cl)cc2)c1C		CHEMBL391102	>	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1966737	CHEMBL897519	Inhibition of GSK3-beta at 10 uM	B	Cc1cc(C(=O)Nc2ccc(OC(F)(F)F)cc2)n(CCc2ccncc2)n1		CHEMBL392331	>	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1966738	CHEMBL897519	Inhibition of GSK3-beta at 10 uM	B	Cc1cc(C(=O)Nc2ccc(Cl)cc2)n(CCc2ccncc2)n1		CHEMBL234010	>	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1966739	CHEMBL897519	Inhibition of GSK3-beta at 10 uM	B	COc1ccc(NC(=O)c2ccnn2CCc2ccncc2)cc1OC		CHEMBL234009	>	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1966740	CHEMBL897519	Inhibition of GSK3-beta at 10 uM	B	O=C(Nc1ccc(Cl)c(Cl)c1)c1ccnn1CCc1ccncc1		CHEMBL392330	>	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1966741	CHEMBL897519	Inhibition of GSK3-beta at 10 uM	B	O=C(Nc1ccc(C(F)(F)F)c(Cl)c1)c1ccnn1CCc1ccncc1		CHEMBL233823	>	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1966742	CHEMBL897519	Inhibition of GSK3-beta at 10 uM	B	O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)c1ccnn1CCc1ccncc1		CHEMBL233822	>	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1966743	CHEMBL897519	Inhibition of GSK3-beta at 10 uM	B	O=C(Nc1ccc2cn[nH]c2c1)c1ccnn1CCc1ccncc1		CHEMBL392329	>	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1966744	CHEMBL897519	Inhibition of GSK3-beta at 10 uM	B	O=C(Nc1ccc2[nH]ncc2c1)c1ccnn1CCc1ccncc1		CHEMBL233821	>	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1966745	CHEMBL897519	Inhibition of GSK3-beta at 10 uM	B	O=C(Nc1cnc2ccccc2c1)c1ccnn1CCc1ccncc1		CHEMBL391069	>	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1966746	CHEMBL897519	Inhibition of GSK3-beta at 10 uM	B	O=C(Nc1ccc(OCc2ccccc2)cc1)c1ccnn1CCc1ccncc1		CHEMBL233631	>	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1966747	CHEMBL897519	Inhibition of GSK3-beta at 10 uM	B	O=C(Nc1ccc(Oc2ccccc2)cc1)c1ccnn1CCc1ccncc1		CHEMBL392313	>	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1966748	CHEMBL897519	Inhibition of GSK3-beta at 10 uM	B	O=C(Nc1ccc(-c2ccccc2)cc1)c1ccnn1CCc1ccncc1		CHEMBL399606	>	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1966749	CHEMBL897519	Inhibition of GSK3-beta at 10 uM	B	CC(C)c1ccc(NC(=O)c2ccnn2CCc2ccncc2)cc1		CHEMBL236420	>	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1966750	CHEMBL897519	Inhibition of GSK3-beta at 10 uM	B	CC(C)(C)c1ccc(NC(=O)c2ccnn2CCc2ccncc2)cc1		CHEMBL399605	>	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1966751	CHEMBL897519	Inhibition of GSK3-beta at 10 uM	B	O=C(Nc1cccc(OC(F)(F)Cl)c1)c1ccnn1CCc1ccncc1		CHEMBL236419	>	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1966752	CHEMBL897519	Inhibition of GSK3-beta at 10 uM	B	O=C(Nc1cccc(OC(F)(F)F)c1)c1ccnn1CCc1ccncc1		CHEMBL236206	>	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1966753	CHEMBL897519	Inhibition of GSK3-beta at 10 uM	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1ccnn1CCc1ccncc1		CHEMBL236205	>	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1966754	CHEMBL897519	Inhibition of GSK3-beta at 10 uM	B	CCc1ccc(NC(=O)c2ccnn2CCc2ccncc2)cc1		CHEMBL392935	>	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1966755	CHEMBL897519	Inhibition of GSK3-beta at 10 uM	B	O=C(Nc1ccc(C(F)(F)F)cc1)c1ccnn1CCc1ccncc1		CHEMBL392934	>	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1966756	CHEMBL897519	Inhibition of GSK3-beta at 10 uM	B	O=C(Nc1ccc(Cl)cc1)c1ccnn1CCc1c[nH]cn1		CHEMBL237680	>	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1966757	CHEMBL897519	Inhibition of GSK3-beta at 10 uM	B	O=C(Nc1ccc(Cl)cc1)c1ccnn1CCc1noc2ccccc12		CHEMBL237679	>	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1966758	CHEMBL897519	Inhibition of GSK3-beta at 10 uM	B	O=C(Nc1ccc(Cl)cc1)c1ccnn1CCc1cnoc1		CHEMBL232802	>	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1966759	CHEMBL897519	Inhibition of GSK3-beta at 10 uM	B	COc1ccc(CCn2nccc2C(=O)Nc2ccc(Cl)cc2)cc1OC		CHEMBL234864	>	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1966760	CHEMBL897519	Inhibition of GSK3-beta at 10 uM	B	O=C(Nc1ccc(Cl)cc1)c1ccnn1CCc1ccc(F)c(F)c1		CHEMBL393006	>	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1966761	CHEMBL897519	Inhibition of GSK3-beta at 10 uM	B	CC1C=C2OCOC2=C(CCn2nccc2C(=O)Nc2ccc(Cl)cc2)C1		CHEMBL234863	>	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1966762	CHEMBL897519	Inhibition of GSK3-beta at 10 uM	B	O=C(Nc1ccc(Cl)cc1)c1ccnn1CCc1ccncc1		CHEMBL397323	>	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1966763	CHEMBL897519	Inhibition of GSK3-beta at 10 uM	B	O=C(Nc1ccc(Cl)cc1)c1ccnn1CCc1cccnc1		CHEMBL397322	>	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	1968067	CHEMBL895287	Inhibition of GSK3-beta at 10 uM	B	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1cccs1)n2CCCN	Outside typical range	CHEMBL233338	=	Inhibition	%	-18.0	CHEMBL262	Homo sapiens	Inhibition	%	-18.0
	1970677	CHEMBL896674	Inhibition of GSK3-beta at 2 mM relative to control	B	CCCC(CCC)C(=O)O		CHEMBL109	=	Inhibition	%	65.2	CHEMBL262	Homo sapiens	Inhibition	%	65.2
	1970678	CHEMBL896674	Inhibition of GSK3-beta at 2 mM relative to control	B	O=C(O)CCCc1ccccc1		CHEMBL1469	=	Inhibition	%	125.6	CHEMBL262	Homo sapiens	Inhibition	%	125.6
	1970679	CHEMBL896674	Inhibition of GSK3-beta at 2 mM relative to control	B	CC/C=C(\CCC)C(=O)O		CHEMBL117487	=	Inhibition	%	91.3	CHEMBL262	Homo sapiens	Inhibition	%	91.3
	1970680	CHEMBL896674	Inhibition of GSK3-beta at 2 mM relative to control	B	CCC(CC)C(=O)O		CHEMBL184290	=	Inhibition	%	2.9	CHEMBL262	Homo sapiens	Inhibition	%	2.9
	1970863	CHEMBL896713	Inhibition of GSK3-beta	B	N=C1NC(=O)/C(=C/c2ccc(-c3ccc(S(N)(=O)=O)cc3)o2)S1		CHEMBL233149	=	IC50	nM	250.0	CHEMBL262	Homo sapiens	IC50	uM	0.25
	1970864	CHEMBL896713	Inhibition of GSK3-beta	B	C/C(=C1/SC(=N)NC1=O)c1ccc(-c2ccc(S(N)(=O)=O)cc2)o1		CHEMBL231950	=	IC50	nM	430.0	CHEMBL262	Homo sapiens	IC50	uM	0.43
	1970865	CHEMBL896713	Inhibition of GSK3-beta	B	N=C1NC(=O)/C(=C/c2ccc(-c3ccc(S(N)(=O)=O)c(Cl)c3)o2)S1		CHEMBL396614	=	IC50	nM	14.0	CHEMBL262	Homo sapiens	IC50	uM	0.014
	1970866	CHEMBL896713	Inhibition of GSK3-beta	B	N=C1NC(=O)/C(=C/c2ccc(-c3ccc(S(N)(=O)=O)c(C(F)(F)F)c3)o2)S1		CHEMBL233970	=	IC50	nM	2.0	CHEMBL262	Homo sapiens	IC50	uM	0.002
	1970867	CHEMBL896713	Inhibition of GSK3-beta	B	CN(C)CCNS(=O)(=O)c1ccc(-c2ccc(/C=C3\SC(=N)NC3=O)o2)cc1		CHEMBL233554	=	IC50	nM	510.0	CHEMBL262	Homo sapiens	IC50	uM	0.51
	1970868	CHEMBL896713	Inhibition of GSK3-beta	B	CNS(=O)(=O)c1ccc(-c2ccc(/C=C3\SC(=N)NC3=O)o2)cc1		CHEMBL233553	=	IC50	nM	80.0	CHEMBL262	Homo sapiens	IC50	uM	0.08
	1981739	CHEMBL899279	Inhibition of GSK3-beta assessed as residual activity at 0.01 uM	B	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H]1C[C@@H](O)[C@H](n2cnc3c(N)ncnc32)C1)C(N)=O		CHEMBL397521	=	Activity	%	82.0	CHEMBL262	Homo sapiens	Activity	%	82.0
	1981763	CHEMBL899280	Inhibition of GSK3-beta assessed as residual activity at 1 uM	B	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H]1C[C@@H](O)[C@H](n2cnc3c(N)ncnc32)C1)C(N)=O		CHEMBL397521	=	Activity	%	88.0	CHEMBL262	Homo sapiens	Activity	%	88.0
	1989345	CHEMBL899091	Inhibition of GSK3-beta at 1 uM	B	CC(C)NCc1ccc(Nc2cc(-c3ccc(-c4ccc(O)cc4O)cc3)[nH]n2)cc1		CHEMBL398606	=	Inhibition	%	30.0	CHEMBL262	Homo sapiens	Inhibition	%	30.0
	2011592	CHEMBL902110	Inhibition of GSK3b	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	2011599	CHEMBL902110	Inhibition of GSK3b	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL241682	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	2025106	CHEMBL886931	Inhibition of human recombinant GSK3-beta	B	CN(C)c1cc2cc(n1)CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CCC2		CHEMBL247067	=	IC50	nM	7.0	CHEMBL262	Homo sapiens	IC50	uM	0.007
	2025145	CHEMBL886972	Inhibition of human GSK3-beta at 1 uM relative to control	B	CN(C)c1cc2cc(n1)CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CCC2		CHEMBL247067	=	Inhibition	%	1.0	CHEMBL262	Homo sapiens	Inhibition	%	1.0
	2025208	CHEMBL886931	Inhibition of human recombinant GSK3-beta	B	CN(C)c1nc2ccc1CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CC2		CHEMBL1162963	=	IC50	nM	3.0	CHEMBL262	Homo sapiens	IC50	uM	0.003
	2025209	CHEMBL886931	Inhibition of human recombinant GSK3-beta	B	CN(C)c1nc2ccc1CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CCC2		CHEMBL392167	=	IC50	nM	37.0	CHEMBL262	Homo sapiens	IC50	uM	0.037
	2025210	CHEMBL886931	Inhibition of human recombinant GSK3-beta	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1ccc(c(N3CCCC3)n1)CCCn1cc2c2ccccc21		CHEMBL396327	=	IC50	nM	30.0	CHEMBL262	Homo sapiens	IC50	uM	0.03
	2025211	CHEMBL886931	Inhibition of human recombinant GSK3-beta	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1cc(nc(N3CCCC3)c1)CCCn1cc2c2ccccc21		CHEMBL397771	=	IC50	nM	11.0	CHEMBL262	Homo sapiens	IC50	uM	0.011
	2025327	CHEMBL886972	Inhibition of human GSK3-beta at 1 uM relative to control	B	CN(C)c1nc2ccc1CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CC2		CHEMBL1162963	=	Inhibition	%	1.0	CHEMBL262	Homo sapiens	Inhibition	%	1.0
	2025328	CHEMBL886972	Inhibition of human GSK3-beta at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1ccc(c(N3CCCC3)n1)CCCn1cc2c2ccccc21		CHEMBL396327	=	Inhibition	%	7.0	CHEMBL262	Homo sapiens	Inhibition	%	7.0
	2025329	CHEMBL886972	Inhibition of human GSK3-beta at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1cc(nc(N3CCCC3)c1)CCCn1cc2c2ccccc21		CHEMBL397771	=	Inhibition	%	3.0	CHEMBL262	Homo sapiens	Inhibition	%	3.0
	2025524	CHEMBL886931	Inhibition of human recombinant GSK3-beta	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCCc1ccc(c(N3CCCC3)n1)CCCCn1cc2c2ccccc21		CHEMBL247271	=	IC50	nM	24.0	CHEMBL262	Homo sapiens	IC50	uM	0.024
	2042732	CHEMBL941839	Inhibition of GSK3-beta	B	Cn1cc(C2=C(c3cccc(OCCN)c3)C(=O)NC2=O)c2ccccc21		CHEMBL250509	=	Inhibition	%	99.0	CHEMBL262	Homo sapiens	Inhibition	%	99.0
	2042733	CHEMBL941839	Inhibition of GSK3-beta	B	CS(=O)(=O)Nc1ccc(CCNC(=O)c2ccc(O)c3nc(-c4ccc(Cl)cc4Cl)[nH]c23)cc1		CHEMBL436837	=	Inhibition	%	99.0	CHEMBL262	Homo sapiens	Inhibition	%	99.0
	2042734	CHEMBL941839	Inhibition of GSK3-beta	B	O=C(NCCc1ccccc1)c1ccc(O)c2[nH]c(-c3ccc(Cl)cc3Cl)nc12		CHEMBL400745	=	Inhibition	%	87.0	CHEMBL262	Homo sapiens	Inhibition	%	87.0
	2042735	CHEMBL941839	Inhibition of GSK3-beta	B	O=C(NCc1ccccc1)c1ccc(O)c2[nH]c(-c3ccc(Cl)cc3Cl)nc12		CHEMBL428939	=	Inhibition	%	64.0	CHEMBL262	Homo sapiens	Inhibition	%	64.0
	2042736	CHEMBL941839	Inhibition of GSK3-beta	B	O=C(Nc1ccccc1)c1ccc(O)c2[nH]c(-c3ccc(Cl)cc3Cl)nc12		CHEMBL251302	=	Inhibition	%	64.0	CHEMBL262	Homo sapiens	Inhibition	%	64.0
	2042737	CHEMBL941839	Inhibition of GSK3-beta	B	CS(=O)(=O)Nc1ccc(CCNC(=O)c2ccc(O)c3[nH]c(-c4ccccc4)nc23)cc1		CHEMBL399140	=	Inhibition	%	100.0	CHEMBL262	Homo sapiens	Inhibition	%	100.0
	2042738	CHEMBL941839	Inhibition of GSK3-beta	B	O=C(NCCc1ccccc1)c1ccc(O)c2[nH]c(-c3ccccc3)nc12		CHEMBL399139	=	Inhibition	%	91.0	CHEMBL262	Homo sapiens	Inhibition	%	91.0
	2042739	CHEMBL941839	Inhibition of GSK3-beta	B	O=C(NCc1ccccc1)c1ccc(O)c2[nH]c(-c3ccccc3)nc12		CHEMBL250714	=	Inhibition	%	93.0	CHEMBL262	Homo sapiens	Inhibition	%	93.0
	2042740	CHEMBL941839	Inhibition of GSK3-beta	B	O=C(Nc1ccccc1)c1ccc(O)c2[nH]c(-c3ccccc3)nc12		CHEMBL250511	=	Inhibition	%	86.0	CHEMBL262	Homo sapiens	Inhibition	%	86.0
	2042741	CHEMBL941840	Inhibition of GSK3-beta at 5 uM	B	Cn1cc(C2=C(c3cccc(OCCN)c3)C(=O)NC2=O)c2ccccc21		CHEMBL250509	=	IC50	nM	70.0	CHEMBL262	Homo sapiens	IC50	nM	70.0
	2042742	CHEMBL941840	Inhibition of GSK3-beta at 5 uM	B	CS(=O)(=O)Nc1ccc(CCNC(=O)c2ccc(O)c3nc(-c4ccc(Cl)cc4Cl)[nH]c23)cc1		CHEMBL436837	=	IC50	nM	15.0	CHEMBL262	Homo sapiens	IC50	nM	15.0
	2042743	CHEMBL941840	Inhibition of GSK3-beta at 5 uM	B	O=C(NCCc1ccccc1)c1ccc(O)c2[nH]c(-c3ccc(Cl)cc3Cl)nc12		CHEMBL400745	=	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	nM	1000.0
	2042744	CHEMBL941840	Inhibition of GSK3-beta at 5 uM	B	CS(=O)(=O)Nc1ccc(CCNC(=O)c2ccc(O)c3[nH]c(-c4ccccc4)nc23)cc1		CHEMBL399140	=	IC50	nM	25.0	CHEMBL262	Homo sapiens	IC50	nM	25.0
	2042745	CHEMBL941840	Inhibition of GSK3-beta at 5 uM	B	O=C(NCCc1ccccc1)c1ccc(O)c2[nH]c(-c3ccccc3)nc12		CHEMBL399139	=	IC50	nM	580.0	CHEMBL262	Homo sapiens	IC50	nM	580.0
	2042746	CHEMBL941840	Inhibition of GSK3-beta at 5 uM	B	O=C(NCc1ccccc1)c1ccc(O)c2[nH]c(-c3ccccc3)nc12		CHEMBL250714	=	IC50	nM	870.0	CHEMBL262	Homo sapiens	IC50	nM	870.0
	2049892	CHEMBL924443	Inhibition of human GSK3-beta	B	Brc1cnn2c(NCc3cccnc3)cc(-c3ccccc3)nc12		CHEMBL249530	=	IC50	nM	570.0	CHEMBL262	Homo sapiens	IC50	uM	0.57
	2049894	CHEMBL924443	Inhibition of human GSK3-beta	B	Brc1cnn2c(NCOc3cccnc3)cc(-c3ccccc3)nc12		CHEMBL250148	=	IC50	nM	600.0	CHEMBL262	Homo sapiens	IC50	uM	0.6
	2049895	CHEMBL924443	Inhibition of human GSK3-beta	B	Fc1ccccc1-c1cc(NCOc2cccnc2)n2ncc(Br)c2n1		CHEMBL398622	=	IC50	nM	130.0	CHEMBL262	Homo sapiens	IC50	uM	0.13
	2049896	CHEMBL924443	Inhibition of human GSK3-beta	B	Clc1ccccc1-c1cc(NCOc2cccnc2)n2ncc(Br)c2n1		CHEMBL398621	=	IC50	nM	35.0	CHEMBL262	Homo sapiens	IC50	uM	0.035
	2049897	CHEMBL924443	Inhibition of human GSK3-beta	B	Clc1ccccc1-c1cc(NCc2cccnc2)n2ncc(Br)c2n1		CHEMBL401303	=	IC50	nM	54.0	CHEMBL262	Homo sapiens	IC50	uM	0.054
	2049898	CHEMBL924443	Inhibition of human GSK3-beta	B	Fc1ccccc1-c1cc(NCc2ccccc2)n2ncc(Br)c2n1		CHEMBL249947	=	IC50	nM	15200.0	CHEMBL262	Homo sapiens	IC50	uM	15.2
	2049899	CHEMBL924443	Inhibition of human GSK3-beta	B	CS(=O)(=O)c1ccc(Nc2cc(-c3ccccc3Cl)nc3c(Br)cnn23)cc1		CHEMBL400240	=	IC50	nM	450.0	CHEMBL262	Homo sapiens	IC50	uM	0.45
	2049900	CHEMBL924443	Inhibition of human GSK3-beta	B	Fc1ccccc1-c1cc(Nc2ccccc2)n2ncc(Br)c2n1		CHEMBL400239	=	IC50	nM	13310.0	CHEMBL262	Homo sapiens	IC50	uM	13.31
	2049901	CHEMBL924443	Inhibition of human GSK3-beta	B	CNc1cc(-c2ccccc2Cl)nc2c(Br)cnn12		CHEMBL248219	=	IC50	nM	247.0	CHEMBL262	Homo sapiens	IC50	uM	0.247
	2049902	CHEMBL924443	Inhibition of human GSK3-beta	B	Brc1cnn2c(NCc3cccnc3)cc(-c3cccs3)nc12		CHEMBL404208	=	IC50	nM	480.0	CHEMBL262	Homo sapiens	IC50	uM	0.48
	2049903	CHEMBL924443	Inhibition of human GSK3-beta	B	Brc1cnn2c(NCc3cccnc3)cc(-c3ccco3)nc12		CHEMBL250145	=	IC50	nM	310.0	CHEMBL262	Homo sapiens	IC50	uM	0.31
	2049904	CHEMBL924443	Inhibition of human GSK3-beta	B	Brc1cnn2c(NCc3cccnc3)cc(C3CCNCC3)nc12		CHEMBL251196	=	IC50	nM	410.0	CHEMBL262	Homo sapiens	IC50	uM	0.41
	2049905	CHEMBL924443	Inhibition of human GSK3-beta	B	Brc1cnn2c(NCc3cccnc3)cc(C3CCCNC3)nc12		CHEMBL251601	=	IC50	nM	180.0	CHEMBL262	Homo sapiens	IC50	uM	0.18
	2049906	CHEMBL924443	Inhibition of human GSK3-beta	B	Brc1cnn2c(NCc3cccnc3)cc(C3CCCCC3)nc12		CHEMBL251393	=	IC50	nM	27.0	CHEMBL262	Homo sapiens	IC50	uM	0.027
	2049907	CHEMBL924443	Inhibition of human GSK3-beta	B	Clc1ccccc1-c1cc(NCc2cccnc2)n2ncc(Br)c2n1		CHEMBL401303	=	IC50	nM	54.0	CHEMBL262	Homo sapiens	IC50	uM	0.054
	2049908	CHEMBL924443	Inhibition of human GSK3-beta	B	CSc1cc(NCc2cccnc2)n2ncc(Br)c2n1		CHEMBL249165	=	IC50	nM	1180.0	CHEMBL262	Homo sapiens	IC50	uM	1.18
	2049909	CHEMBL924443	Inhibition of human GSK3-beta	B	COc1cc(NCc2cccnc2)n2ncc(Br)c2n1		CHEMBL250386	=	IC50	nM	1410.0	CHEMBL262	Homo sapiens	IC50	uM	1.41
	2049910	CHEMBL924443	Inhibition of human GSK3-beta	B	CNc1cc(NCc2cccnc2)n2ncc(Br)c2n1		CHEMBL399078	=	IC50	nM	4600.0	CHEMBL262	Homo sapiens	IC50	uM	4.6
	2049911	CHEMBL924443	Inhibition of human GSK3-beta	B	CCOC(=O)c1cc(NCc2cccnc2)n2ncc(Br)c2n1		CHEMBL250183	=	IC50	nM	790.0	CHEMBL262	Homo sapiens	IC50	uM	0.79
	2049912	CHEMBL924443	Inhibition of human GSK3-beta	B	CC(O)c1cc(NCc2cccnc2)n2ncc(Br)c2n1		CHEMBL251375	=	IC50	nM	500.0	CHEMBL262	Homo sapiens	IC50	uM	0.5
	2049913	CHEMBL924443	Inhibition of human GSK3-beta	B	Brc1cnn2c(NCc3cccnc3)cc(C3CC3)nc12		CHEMBL401056	=	IC50	nM	1130.0	CHEMBL262	Homo sapiens	IC50	uM	1.13
	2049914	CHEMBL924443	Inhibition of human GSK3-beta	B	CC(C)c1cc(NCc2cccnc2)n2ncc(Br)c2n1		CHEMBL250369	=	IC50	nM	420.0	CHEMBL262	Homo sapiens	IC50	uM	0.42
	2049915	CHEMBL924443	Inhibition of human GSK3-beta	B	CCc1cc(NCc2cccnc2)n2ncc(Br)c2n1		CHEMBL398670	=	IC50	nM	920.0	CHEMBL262	Homo sapiens	IC50	uM	0.92
	2049916	CHEMBL924443	Inhibition of human GSK3-beta	B	Cc1cc(NCc2cccnc2)n2ncc(Br)c2n1		CHEMBL249141	=	IC50	nM	3530.0	CHEMBL262	Homo sapiens	IC50	uM	3.53
	2049917	CHEMBL924443	Inhibition of human GSK3-beta	B	N#CCc1cnn2c(NCc3cccnc3)cc(-c3ccccc3)nc12		CHEMBL398647	=	IC50	nM	1100.0	CHEMBL262	Homo sapiens	IC50	uM	1.1
	2049918	CHEMBL924443	Inhibition of human GSK3-beta	B	CC(=O)NCCSc1cnn2c(NCc3cccnc3)cc(-c3ccccc3)nc12		CHEMBL442802	=	IC50	nM	34.0	CHEMBL262	Homo sapiens	IC50	uM	0.034
	2049919	CHEMBL924443	Inhibition of human GSK3-beta	B	CSc1cnn2c(NCc3cccnc3)cc(-c3ccccc3)nc12		CHEMBL399287	=	IC50	nM	1800.0	CHEMBL262	Homo sapiens	IC50	uM	1.8
	2049920	CHEMBL924443	Inhibition of human GSK3-beta	B	C#Cc1cnn2c(NCc3cccnc3)cc(-c3ccccc3)nc12		CHEMBL249734	=	IC50	nM	9820.0	CHEMBL262	Homo sapiens	IC50	uM	9.82
	2049921	CHEMBL924443	Inhibition of human GSK3-beta	B	CCc1cnn2c(NCc3cccnc3)cc(-c3ccccc3)nc12		CHEMBL249531	=	IC50	nM	2800.0	CHEMBL262	Homo sapiens	IC50	uM	2.8
	2050274	CHEMBL925571	Inhibition of GSK3-beta at 1 uM	B	CC1CCN(c2ccc(CO)cc2NC(=O)c2ccc(C#N)o2)CC1		CHEMBL400754	=	Inhibition	%	-9.0	CHEMBL262	Homo sapiens	Inhibition	%	-9.0
	2051625	CHEMBL941763	Inhibition of GSK3 beta	B	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	>	Ki	nM	7059.0	CHEMBL262	Homo sapiens	Ki	uM	7.059
	2058353	CHEMBL926490	Inhibition of human recombinant GSKbeta at 25 uM	B	O[C@]12C=C(c3nccc4c3[nH]c3ccccc34)[C@@H]3CCN(CCCC/C=C\CC1)C[C@@]31C[C@@H]3/C=C\CCCCN3[C@@H]21		CHEMBL403233	=	Inhibition	%	73.2	CHEMBL262	Homo sapiens	Inhibition	%	73.2
	2058354	CHEMBL926490	Inhibition of human recombinant GSKbeta at 25 uM	B	CC(=O)Oc1cccc2c1[nH]c1c(C3=C/C4=C/C/C=C\CCCCN5CCC3[C@]3(C[C@@H]6/C=C\CCCCN6[C@@H]43)C5)nccc12		CHEMBL252520	=	Inhibition	%	79.1	CHEMBL262	Homo sapiens	Inhibition	%	79.1
	2058355	CHEMBL926490	Inhibition of human recombinant GSKbeta at 25 uM	B	C1=C(c2nccc3c2[nH]c2ccccc23)C2CCN3CCCC/C=C\C/C=C/1[C@@H]1N4CCCC/C=C\[C@H]4C[C@]21C3		CHEMBL268202	=	Inhibition	%	71.2	CHEMBL262	Homo sapiens	Inhibition	%	71.2
	2058356	CHEMBL926490	Inhibition of human recombinant GSKbeta at 25 uM	B	O=C1CCCN2[C@@H](CC1)C[C@]13CN4CCCC/C=C\CC[C@](O)(C=C(c5nccc6c5[nH]c5c(OS(=O)(=O)c7ccc(Br)cc7)cccc56)C1CC4)[C@H]23		CHEMBL414128	=	Inhibition	%	63.0	CHEMBL262	Homo sapiens	Inhibition	%	63.0
	2058357	CHEMBL926490	Inhibition of human recombinant GSKbeta at 25 uM	B	O=C1CCCN2[C@@H](CC1)C[C@]13CN4CCCC/C=C\CC[C@](O)(C=C(c5nccc6c5[nH]c5c(OS(=O)(=O)c7ccc(Cl)cc7)cccc56)C1CC4)[C@H]23		CHEMBL400717	=	Inhibition	%	76.7	CHEMBL262	Homo sapiens	Inhibition	%	76.7
	2058358	CHEMBL926490	Inhibition of human recombinant GSKbeta at 25 uM	B	CC(=O)Nc1nc(C)c(S(=O)(=O)Oc2cccc3c2[nH]c2c(C4=C[C@@]5(O)CC/C=C\CCCCN6CCC4[C@]4(C[C@@H]7CCC(=O)CCCN7[C@@H]54)C6)nccc23)s1		CHEMBL399696	=	Inhibition	%	78.8	CHEMBL262	Homo sapiens	Inhibition	%	78.8
	2058359	CHEMBL926490	Inhibition of human recombinant GSKbeta at 25 uM	B	O[C@]12C=C(c3nccc4c3[nH]c3ccccc34)[C@@H]3CCN(CCCCCCCC1)C[C@@]31C[C@@H]3CCCCCCN3[C@@H]21		CHEMBL437596	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	Inhibition	%	0.0
	2058360	CHEMBL926490	Inhibition of human recombinant GSKbeta at 25 uM	B	O=C1CCCN2[C@@H](CC1)C[C@]13CN4CCCC/C=C\CC[C@](O)(C=C(c5nccc6c5[nH]c5c(O)cccc56)C1CC4)[C@H]23		CHEMBL399694	=	Inhibition	%	30.0	CHEMBL262	Homo sapiens	Inhibition	%	30.0
	2058361	CHEMBL926490	Inhibition of human recombinant GSKbeta at 25 uM	B	O=C1CCCN2[C@@H](CC1)C[C@]13CN4CCCC/C=C\CC[C@](O)(C=C(c5nccc6c5[nH]c5ccccc56)C1CC4)[C@H]23		CHEMBL399493	=	Inhibition	%	53.6	CHEMBL262	Homo sapiens	Inhibition	%	53.6
	2058362	CHEMBL926490	Inhibition of human recombinant GSKbeta at 25 uM	B	Oc1cccc2c1[nH]c1c(C3=C[C@@]4(O)CCCCCCCCN5CCC3[C@]3(C[C@@H]6CCCCCCN6[C@@H]43)C5)nccc12		CHEMBL253510	=	Inhibition	%	29.0	CHEMBL262	Homo sapiens	Inhibition	%	29.0
	2058363	CHEMBL926490	Inhibition of human recombinant GSKbeta at 25 uM	B	O[C@]12C=C(c3nccc4c3[nH]c3ccccc34)C3CCN(CCCC/C=C\CC1)C[C@@]31C[C@]34CC[C@H](CCCN3[C@@H]21)O4		CHEMBL253548	=	Inhibition	%	88.4	CHEMBL262	Homo sapiens	Inhibition	%	88.4
	2058364	CHEMBL926490	Inhibition of human recombinant GSKbeta at 25 uM	B	CC(=O)OCC(C)(C)n1c2ccccc2c2ccnc(C3=C[C@@]4(O)CC/C=C\CCCCN5CCC3[C@]3(C[C@@H]6/C=C\CCCCN6[C@@H]43)C5)c21		CHEMBL254391	=	Inhibition	%	3.0	CHEMBL262	Homo sapiens	Inhibition	%	3.0
	2058365	CHEMBL926490	Inhibition of human recombinant GSKbeta at 25 uM	B	CCCCCCCCCCCCn1c2ccccc2c2ccnc(C3=C[C@@]4(O)CC/C=C\CCCCN5CC[C@@H]3[C@]3(C[C@@H]6/C=C\CCCCN6[C@@H]43)C5)c21		CHEMBL592630	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	Inhibition	%	0.0
	2058366	CHEMBL926490	Inhibition of human recombinant GSKbeta at 25 uM	B	CC(C)COc1cccc2c3ccnc(C4=C[C@@]5(O)CC/C=C\CCCCN6CCC4[C@]4(C[C@@H]7/C=C\CCCCN7[C@@H]54)C6)c3n(CC(C)C)c12		CHEMBL402273	=	Inhibition	%	24.2	CHEMBL262	Homo sapiens	Inhibition	%	24.2
	2058367	CHEMBL926490	Inhibition of human recombinant GSKbeta at 25 uM	B	CCOc1cccc2c3ccnc(C4=C[C@@]5(O)CC/C=C\CCCCN6CCC4[C@]4(C[C@@H]7/C=C\CCCCN7[C@@H]54)C6)c3n(CC)c12		CHEMBL403562	=	Inhibition	%	78.0	CHEMBL262	Homo sapiens	Inhibition	%	78.0
	2058368	CHEMBL926490	Inhibition of human recombinant GSKbeta at 25 uM	B	COc1cccc2c3ccnc(C4=C[C@@]5(O)CC/C=C\CCCCN6CCC4[C@]4(C[C@@H]7/C=C\CCCCN7[C@@H]54)C6)c3n(C)c12		CHEMBL267700	=	Inhibition	%	72.4	CHEMBL262	Homo sapiens	Inhibition	%	72.4
	2058369	CHEMBL926490	Inhibition of human recombinant GSKbeta at 25 uM	B	Cc1ccc(S(=O)(=O)Oc2cccc3c2[nH]c2c(C4=C[C@@]5(O)CC/C=C\CCCCN6CCC4[C@]4(C[C@H]7/C=C\CCCCN7[C@@H]54)C6)nccc23)cc1		CHEMBL403561	=	Inhibition	%	80.4	CHEMBL262	Homo sapiens	Inhibition	%	80.4
	2058370	CHEMBL926490	Inhibition of human recombinant GSKbeta at 25 uM	B	Oc1ccc2[nH]c3c(C4=C[C@@]5(O)CC/C=C\CCCCN6CCC4[C@]4(C[C@@H]7/C=C\CCCCN7[C@@H]54)C6)nccc3c2c1		CHEMBL252672	=	Inhibition	%	74.3	CHEMBL262	Homo sapiens	Inhibition	%	74.3
	2058371	CHEMBL926490	Inhibition of human recombinant GSKbeta at 25 uM	B	Oc1cccc2c1[nH]c1c(C3=C[C@@]4(O)CC/C=C\CCCCN5CC[C@@H]3[C@]3(CC6/C=C\CCCCN6[C@@H]43)C5)nccc12		CHEMBL612054	=	Inhibition	%	86.7	CHEMBL262	Homo sapiens	Inhibition	%	86.7
	2058372	CHEMBL926489	Inhibition of human recombinant GSKbeta	B	O[C@]12C=C(c3nccc4c3[nH]c3ccccc34)[C@@H]3CCN(CCCC/C=C\CC1)C[C@@]31C[C@@H]3/C=C\CCCCN3[C@@H]21		CHEMBL403233	=	IC50	nM	10200.0	CHEMBL262	Homo sapiens	IC50	uM	10.2
Not Determined	2058373	CHEMBL926489	Inhibition of human recombinant GSKbeta	B	COc1cccc2c3ccnc(C4=C[C@@]5(O)CC/C=C\CCCCN6CCC4[C@]4(C[C@@H]7/C=C\CCCCN7[C@@H]54)C6)c3n(C)c12		CHEMBL267700		IC50			CHEMBL262	Homo sapiens	IC50		
Not Determined	2058374	CHEMBL926489	Inhibition of human recombinant GSKbeta	B	O[C@]12C=C(c3nccc4c3[nH]c3ccccc34)[C@@H]3CCN(CCCCCCCC1)C[C@@]31C[C@@H]3CCCCCCN3[C@@H]21		CHEMBL437596		IC50			CHEMBL262	Homo sapiens	IC50		
Not Determined	2058375	CHEMBL926489	Inhibition of human recombinant GSKbeta	B	O=C1CCCN2[C@@H](CC1)C[C@]13CN4CCCC/C=C\CC[C@](O)(C=C(c5nccc6c5[nH]c5c(O)cccc56)C1CC4)[C@H]23		CHEMBL399694		IC50			CHEMBL262	Homo sapiens	IC50		
Not Determined	2058376	CHEMBL926489	Inhibition of human recombinant GSKbeta	B	Oc1cccc2c1[nH]c1c(C3=C[C@@]4(O)CCCCCCCCN5CCC3[C@]3(C[C@@H]6CCCCCCN6[C@@H]43)C5)nccc12		CHEMBL253510		IC50			CHEMBL262	Homo sapiens	IC50		
Not Determined	2058377	CHEMBL926489	Inhibition of human recombinant GSKbeta	B	O[C@]12C=C(c3nccc4c3[nH]c3ccccc34)C3CCN(CCCC/C=C\CC1)C[C@@]31C[C@]34CC[C@H](CCCN3[C@@H]21)O4		CHEMBL253548		IC50			CHEMBL262	Homo sapiens	IC50		
Not Determined	2058378	CHEMBL926489	Inhibition of human recombinant GSKbeta	B	CC(=O)OCC(C)(C)n1c2ccccc2c2ccnc(C3=C[C@@]4(O)CC/C=C\CCCCN5CCC3[C@]3(C[C@@H]6/C=C\CCCCN6[C@@H]43)C5)c21		CHEMBL254391		IC50			CHEMBL262	Homo sapiens	IC50		
Not Determined	2058379	CHEMBL926489	Inhibition of human recombinant GSKbeta	B	CCCCCCCCCCCCn1c2ccccc2c2ccnc(C3=C[C@@]4(O)CC/C=C\CCCCN5CC[C@@H]3[C@]3(C[C@@H]6/C=C\CCCCN6[C@@H]43)C5)c21		CHEMBL592630		IC50			CHEMBL262	Homo sapiens	IC50		
Not Determined	2058380	CHEMBL926489	Inhibition of human recombinant GSKbeta	B	CC(C)COc1cccc2c3ccnc(C4=C[C@@]5(O)CC/C=C\CCCCN6CCC4[C@]4(C[C@@H]7/C=C\CCCCN7[C@@H]54)C6)c3n(CC(C)C)c12		CHEMBL402273		IC50			CHEMBL262	Homo sapiens	IC50		
	2058381	CHEMBL926489	Inhibition of human recombinant GSKbeta	B	CC(=O)Oc1cccc2c1[nH]c1c(C3=C/C4=C/C/C=C\CCCCN5CCC3[C@]3(C[C@@H]6/C=C\CCCCN6[C@@H]43)C5)nccc12		CHEMBL252520	=	IC50	nM	4800.0	CHEMBL262	Homo sapiens	IC50	uM	4.8
	2058382	CHEMBL926489	Inhibition of human recombinant GSKbeta	B	C1=C(c2nccc3c2[nH]c2ccccc23)C2CCN3CCCC/C=C\C/C=C/1[C@@H]1N4CCCC/C=C\[C@H]4C[C@]21C3		CHEMBL268202	=	IC50	nM	5400.0	CHEMBL262	Homo sapiens	IC50	uM	5.4
	2058383	CHEMBL926489	Inhibition of human recombinant GSKbeta	B	O=C1CCCN2[C@@H](CC1)C[C@]13CN4CCCC/C=C\CC[C@](O)(C=C(c5nccc6c5[nH]c5c(OS(=O)(=O)c7ccc(Br)cc7)cccc56)C1CC4)[C@H]23		CHEMBL414128	=	IC50	nM	23000.0	CHEMBL262	Homo sapiens	IC50	uM	23.0
	2058384	CHEMBL926489	Inhibition of human recombinant GSKbeta	B	O=C1CCCN2[C@@H](CC1)C[C@]13CN4CCCC/C=C\CC[C@](O)(C=C(c5nccc6c5[nH]c5c(OS(=O)(=O)c7ccc(Cl)cc7)cccc56)C1CC4)[C@H]23		CHEMBL400717	=	IC50	nM	7200.0	CHEMBL262	Homo sapiens	IC50	uM	7.2
	2058385	CHEMBL926489	Inhibition of human recombinant GSKbeta	B	CC(=O)Nc1nc(C)c(S(=O)(=O)Oc2cccc3c2[nH]c2c(C4=C[C@@]5(O)CC/C=C\CCCCN6CCC4[C@]4(C[C@@H]7CCC(=O)CCCN7[C@@H]54)C6)nccc23)s1		CHEMBL399696	=	IC50	nM	8500.0	CHEMBL262	Homo sapiens	IC50	uM	8.5
	2058386	CHEMBL926489	Inhibition of human recombinant GSKbeta	B	O=C1CCCN2[C@@H](CC1)C[C@]13CN4CCCC/C=C\CC[C@](O)(C=C(c5nccc6c5[nH]c5ccccc56)C1CC4)[C@H]23		CHEMBL399493	=	IC50	nM	25000.0	CHEMBL262	Homo sapiens	IC50	uM	25.0
	2058387	CHEMBL926489	Inhibition of human recombinant GSKbeta	B	CCOc1cccc2c3ccnc(C4=C[C@@]5(O)CC/C=C\CCCCN6CCC4[C@]4(C[C@@H]7/C=C\CCCCN7[C@@H]54)C6)c3n(CC)c12		CHEMBL403562	=	IC50	nM	10400.0	CHEMBL262	Homo sapiens	IC50	uM	10.4
	2058388	CHEMBL926489	Inhibition of human recombinant GSKbeta	B	Oc1ccc2[nH]c3c(C4=C[C@@]5(O)CC/C=C\CCCCN6CCC4[C@]4(C[C@@H]7/C=C\CCCCN7[C@@H]54)C6)nccc3c2c1		CHEMBL252672	=	IC50	nM	16600.0	CHEMBL262	Homo sapiens	IC50	uM	16.6
	2058389	CHEMBL926489	Inhibition of human recombinant GSKbeta	B	Oc1cccc2c1[nH]c1c(C3=C[C@@]4(O)CC/C=C\CCCCN5CC[C@@H]3[C@]3(CC6/C=C\CCCCN6[C@@H]43)C5)nccc12		CHEMBL612054	=	IC50	nM	4800.0	CHEMBL262	Homo sapiens	IC50	uM	4.8
Not Active	2073626	CHEMBL928863	Inhibition of GSK3-beta	B	O=C(Nc1n[nH]c2nc(N3CCNCC3)c(F)cc12)C1CC1		CHEMBL252863		Activity			CHEMBL262	Homo sapiens	Activity		
Not Active	2073627	CHEMBL928863	Inhibition of GSK3-beta	B	O=C(Nc1n[nH]c2nc(N3CCN(S(=O)(=O)c4ccccc4C(F)(F)F)CC3)c(F)cc12)C1CC1		CHEMBL253069		Activity			CHEMBL262	Homo sapiens	Activity		
Not Active	2073628	CHEMBL928863	Inhibition of GSK3-beta	B	O=C(Nc1n[nH]c2nc(N3CCN(C(=O)c4ccc(F)cc4F)CC3)c(F)cc12)C1CC1		CHEMBL404717		Activity			CHEMBL262	Homo sapiens	Activity		
Not Active	2073629	CHEMBL928863	Inhibition of GSK3-beta	B	COc1ccccc1C(=O)N1CCN(c2nc3[nH]nc(NC(=O)C4CC4)c3cc2F)CC1		CHEMBL253068		Activity			CHEMBL262	Homo sapiens	Activity		
Not Active	2073630	CHEMBL928863	Inhibition of GSK3-beta	B	COc1ccccc1N1CCN(c2nc3[nH]nc(NC(=O)C4CC4)c3cc2F)CC1		CHEMBL404537		Activity			CHEMBL262	Homo sapiens	Activity		
	2073641	CHEMBL928863	Inhibition of GSK3-beta	B	C1=CC2C(c3ccnc(Nc4ccccc4)n3)=CNN2C=C1		CHEMBL253272	=	IC50	nM	150.0	CHEMBL262	Homo sapiens	IC50	uM	0.15
	2073642	CHEMBL928863	Inhibition of GSK3-beta	B	COCCn1cc(-c2ccnc(Nc3cccc(OC)c3)n2)c2ccccc21		CHEMBL402560	=	IC50	nM	140.0	CHEMBL262	Homo sapiens	IC50	uM	0.14
	2073643	CHEMBL928863	Inhibition of GSK3-beta	B	COCCn1cc(-c2ccnc(Nc3ccccc3)n2)c2ccccc21		CHEMBL251886	=	IC50	nM	320.0	CHEMBL262	Homo sapiens	IC50	uM	0.32
	2073644	CHEMBL928863	Inhibition of GSK3-beta	B	COCCn1cc(-c2ccnc(Nc3cccc(OC)c3)n2)c2cccnc21		CHEMBL251885	=	IC50	nM	2200.0	CHEMBL262	Homo sapiens	IC50	uM	2.2
	2073645	CHEMBL928863	Inhibition of GSK3-beta	B	COCCn1cc(-c2ccnc(Nc3ccccc3)n2)c2cccnc21		CHEMBL403406	=	IC50	nM	1050.0	CHEMBL262	Homo sapiens	IC50	uM	1.05
	2073646	CHEMBL928863	Inhibition of GSK3-beta	B	COc1cccc(Nc2nccc(C3=C(c4ccccc4)NN4C=CC=CC34)n2)c1		CHEMBL403405	=	IC50	nM	30.0	CHEMBL262	Homo sapiens	IC50	uM	0.03
	2073647	CHEMBL928863	Inhibition of GSK3-beta	B	C1=CC2C(c3ccnc(Nc4ccccc4)n3)=C(c3ccccc3)NN2C=C1		CHEMBL252669	=	IC50	nM	60.0	CHEMBL262	Homo sapiens	IC50	uM	0.06
	2073648	CHEMBL928863	Inhibition of GSK3-beta	B	Cc1ccc(Cl)cc1Nc1nccc(C2=CNN3C=CC=CC23)n1		CHEMBL403404	=	IC50	nM	10600.0	CHEMBL262	Homo sapiens	IC50	uM	10.6
	2073649	CHEMBL928863	Inhibition of GSK3-beta	B	COc1cccc(Nc2nccc(C3=CNN4C=CC=CC34)n2)c1		CHEMBL402367	=	IC50	nM	100.0	CHEMBL262	Homo sapiens	IC50	uM	0.1
	2081795	CHEMBL928818	Inhibition of GSK3-beta at 10 uM	B	CC[C@@H](C)Nc1nc2ccc(-c3c(-c4ccccc4F)n[nH]c3N)cc2s1		CHEMBL404115	<=	Inhibition	%	20.0	CHEMBL262	Homo sapiens	Inhibition	%	20.0
	2086303	CHEMBL946929	Inhibition of GSK3-beta	B	COc1cccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)c1		CHEMBL271271	<	IC50	nM	16000.0	CHEMBL262	Homo sapiens	IC50	uM	16.0
	2087884	CHEMBL929988	Inhibition of human GSK3-beta	B	CCCC1=C(c2nnc(C)o2)C(c2cccc(C#N)c2Br)c2c[nH]nc2N1		CHEMBL270265	=	IC50	nM	0.7	CHEMBL262	Homo sapiens	IC50	nM	0.7
	2087885	CHEMBL929988	Inhibition of human GSK3-beta	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	IC50	nM	76.0	CHEMBL262	Homo sapiens	IC50	nM	76.0
	2087886	CHEMBL929988	Inhibition of human GSK3-beta	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	IC50	nM	7.0	CHEMBL262	Homo sapiens	IC50	nM	7.0
	2087887	CHEMBL929988	Inhibition of human GSK3-beta	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	IC50	nM	5.0	CHEMBL262	Homo sapiens	IC50	nM	5.0
	2087888	CHEMBL929988	Inhibition of human GSK3-beta	B	CN1CCC(C2=C(C#N)[C@H](c3cccc4nonc34)c3c[nH]nc3N2)CC1		CHEMBL3085387	=	IC50	nM	2.5	CHEMBL262	Homo sapiens	IC50	nM	2.5
	2087889	CHEMBL929988	Inhibition of human GSK3-beta	B	Cc1cc(-c2cc(-c3nc4ccc(CN5CCN(C)CC5)cc4[nH]3)c(=O)[nH]n2)cc(C)c1O		CHEMBL270473	=	IC50	nM	1.5	CHEMBL262	Homo sapiens	IC50	nM	1.5
	2087890	CHEMBL929988	Inhibition of human GSK3-beta	B	O=C1NC(=S)S/C1=C\c1ccccc1OS(=O)(=O)c1ccccc1[N+](=O)[O-]		CHEMBL270046	=	IC50	nM	1560.0	CHEMBL262	Homo sapiens	IC50	uM	1.56
	2087891	CHEMBL929988	Inhibition of human GSK3-beta	B	O=C1NC(=O)/C(=C/c2ccc(-c3cc([N+](=O)[O-])ccc3Cl)o2)S1		CHEMBL270044	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	2087892	CHEMBL929988	Inhibition of human GSK3-beta	B	COc1ccc(-c2ccc(/C=C3\SC(=S)NC3=O)o2)c([N+](=O)[O-])c1		CHEMBL270262	=	IC50	nM	5560.0	CHEMBL262	Homo sapiens	IC50	uM	5.56
	2087893	CHEMBL929988	Inhibition of human GSK3-beta	B	O=C1NC(=S)S/C1=C\c1ccc(O)c([N+](=O)[O-])c1		CHEMBL270045	=	IC50	nM	3970.0	CHEMBL262	Homo sapiens	IC50	uM	3.97
	2087894	CHEMBL929988	Inhibition of human GSK3-beta	B	Cc1ccc(S(=O)(=O)n2cc(/C=C3\SC(=S)NC3=O)c3ccccc32)cc1		CHEMBL259893	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	2087895	CHEMBL929988	Inhibition of human GSK3-beta	B	COc1cc(/C=C2\SC(=S)NC2=O)cc(Br)c1OCc1ccccc1C		CHEMBL260099	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	2087896	CHEMBL929988	Inhibition of human GSK3-beta	B	Cc1ccc(/N=C2/NC(=O)S/C2=C\c2ccccc2Cl)cc1		CHEMBL410233	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	2087897	CHEMBL929989	Inhibition of human GSK3-beta assessed as remaining enzyme activity at 10 uM	B	O=C1NC(=S)S/C1=C\c1ccccc1OS(=O)(=O)c1ccccc1[N+](=O)[O-]		CHEMBL270046	=	Activity	%	14.0	CHEMBL262	Homo sapiens	Activity	%	14.0
	2087898	CHEMBL929988	Inhibition of human GSK3-beta	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	IC50	nM	520.0	CHEMBL262	Homo sapiens	IC50	uM	0.52
	2087899	CHEMBL929989	Inhibition of human GSK3-beta assessed as remaining enzyme activity at 10 uM	B	CC1=NCCNC2=C1[C@H](c1ccc(F)cc1)N(c1ccccn1)C2=O		CHEMBL408219	=	Activity	%	99.0	CHEMBL262	Homo sapiens	Activity	%	99.0
	2087900	CHEMBL929989	Inhibition of human GSK3-beta assessed as remaining enzyme activity at 10 uM	B	CCOc1cc(C=C2C(=O)NC(=S)NC2=O)cc(I)c1OC		CHEMBL272625	=	Activity	%	58.0	CHEMBL262	Homo sapiens	Activity	%	58.0
	2087901	CHEMBL929989	Inhibition of human GSK3-beta assessed as remaining enzyme activity at 10 uM	B	Cc1cc(/C=C2\SC(=S)NC2=O)c(C)n1-c1cccc([N+](=O)[O-])c1		CHEMBL406394	=	Activity	%	41.0	CHEMBL262	Homo sapiens	Activity	%	41.0
	2087902	CHEMBL929989	Inhibition of human GSK3-beta assessed as remaining enzyme activity at 10 uM	B	CCCNc1nc2ccccn2c(=O)c1/C=C1\SC(=S)NC1=O		CHEMBL270322	=	Activity	%	95.0	CHEMBL262	Homo sapiens	Activity	%	95.0
	2087903	CHEMBL929989	Inhibition of human GSK3-beta assessed as remaining enzyme activity at 10 uM	B	O=C1CC(C(F)(F)F)=NC(Sc2c(-c3ccccc3)c3cc([N+](=O)[O-])ccc3[nH]c2=O)=N1		CHEMBL269905	=	Activity	%	41.0	CHEMBL262	Homo sapiens	Activity	%	41.0
	2087904	CHEMBL929989	Inhibition of human GSK3-beta assessed as remaining enzyme activity at 10 uM	B	COc1ccc2c(c1)/C(=C1/SC(=S)NC1=O)C(=O)N2		CHEMBL130414	=	Activity	%	84.0	CHEMBL262	Homo sapiens	Activity	%	84.0
	2087905	CHEMBL929989	Inhibition of human GSK3-beta assessed as remaining enzyme activity at 10 uM	B	Cc1ccc(S(=O)(=O)n2cc(/C=C3\SC(=S)NC3=O)c3ccccc32)cc1		CHEMBL259893	=	Activity	%	67.0	CHEMBL262	Homo sapiens	Activity	%	67.0
	2087906	CHEMBL929989	Inhibition of human GSK3-beta assessed as remaining enzyme activity at 10 uM	B	COc1cc(/C=C2\SC(=S)NC2=O)cc(Br)c1OCc1ccccc1C		CHEMBL260099	=	Activity	%	6.0	CHEMBL262	Homo sapiens	Activity	%	6.0
	2087907	CHEMBL929989	Inhibition of human GSK3-beta assessed as remaining enzyme activity at 10 uM	B	Cc1ccc(/N=C2/NC(=O)S/C2=C\c2ccccc2Cl)cc1		CHEMBL410233	=	Activity	%	18.0	CHEMBL262	Homo sapiens	Activity	%	18.0
	2087908	CHEMBL929989	Inhibition of human GSK3-beta assessed as remaining enzyme activity at 10 uM	B	O=C1NC(=O)/C(=C/c2ccc(-c3cc([N+](=O)[O-])ccc3Cl)o2)S1		CHEMBL270044	=	Activity	%	8.0	CHEMBL262	Homo sapiens	Activity	%	8.0
	2087909	CHEMBL929989	Inhibition of human GSK3-beta assessed as remaining enzyme activity at 10 uM	B	COc1ccc(-c2ccc(/C=C3\SC(=S)NC3=O)o2)c([N+](=O)[O-])c1		CHEMBL270262	=	Activity	%	5.0	CHEMBL262	Homo sapiens	Activity	%	5.0
	2087910	CHEMBL929989	Inhibition of human GSK3-beta assessed as remaining enzyme activity at 10 uM	B	O=C1NC(=S)S/C1=C\c1ccc(O)c([N+](=O)[O-])c1		CHEMBL270045	=	Activity	%	7.0	CHEMBL262	Homo sapiens	Activity	%	7.0
	2099525	CHEMBL948239	Inhibition of GSK3-beta at 10 uM	B	CN(C)CCCOc1cc2c(cc1O)c1c3c(c(-c4ccccc4Cl)cc1n2C)C(=O)NC3=O		CHEMBL410261	=	Inhibition	%	55.0	CHEMBL262	Homo sapiens	Inhibition	%	55.0
	2099621	CHEMBL948239	Inhibition of GSK3-beta at 10 uM	B	Cn1c2cc(C(=O)NCCN3CCCC3)c(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL272267	=	Inhibition	%	22.0	CHEMBL262	Homo sapiens	Inhibition	%	22.0
	2099622	CHEMBL948239	Inhibition of GSK3-beta at 10 uM	B	Cn1c2cc(SCCCN3CCCC3)c(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL404335	=	Inhibition	%	16.0	CHEMBL262	Homo sapiens	Inhibition	%	16.0
	2099623	CHEMBL948239	Inhibition of GSK3-beta at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1c2c2cc(O)c(OCCCN3CCOCC3)cc2n1CCO		CHEMBL271715	=	Inhibition	%	43.0	CHEMBL262	Homo sapiens	Inhibition	%	43.0
	2099624	CHEMBL948239	Inhibition of GSK3-beta at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1c2c2cc(O)c(OCCCN3CCCC3)cc2n1CCO		CHEMBL270021	=	Inhibition	%	31.0	CHEMBL262	Homo sapiens	Inhibition	%	31.0
	2099625	CHEMBL948239	Inhibition of GSK3-beta at 10 uM	B	Cn1c2cc(OCCCN3CCCC3)c(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL255427	=	Inhibition	%	70.0	CHEMBL262	Homo sapiens	Inhibition	%	70.0
	2101328	CHEMBL949036	Inhibition of GSK3-beta	B	CC(C)(C)CN1CCC(NC(=O)c2csc(NC(=O)c3ccc4cc5n(c4c3)C3(CCC3)CNC5=O)n2)CC1		CHEMBL257834	=	IC50	nM	920.0	CHEMBL262	Homo sapiens	IC50	nM	920.0
	2112553	CHEMBL951013	Inhibition of human GSK3-beta by fluorescence anisotropy binding assay	B	CC(=O)Nc1ccc(-c2c(-c3cccnc3)oc3ncnc(N)c23)cc1		CHEMBL403238	=	IC50	nM	1628.0	CHEMBL262	Homo sapiens	IC50	nM	1628.0
	2112554	CHEMBL951013	Inhibition of human GSK3-beta by fluorescence anisotropy binding assay	B	Nc1ncnc2oc(-c3cccnc3)c(-c3ccc(NS(=O)(=O)c4cccs4)cc3)c12		CHEMBL404507	=	IC50	nM	23.0	CHEMBL262	Homo sapiens	IC50	nM	23.0
	2112555	CHEMBL951013	Inhibition of human GSK3-beta by fluorescence anisotropy binding assay	B	Nc1ncnc2oc(-c3cccnc3)c(-c3ccc(NS(=O)(=O)c4ccccc4)cc3)c12		CHEMBL258081	=	IC50	nM	30.0	CHEMBL262	Homo sapiens	IC50	nM	30.0
	2112556	CHEMBL951013	Inhibition of human GSK3-beta by fluorescence anisotropy binding assay	B	CS(=O)(=O)Nc1ccc(-c2c(-c3cccnc3)oc3ncnc(N)c23)cc1		CHEMBL404488	=	IC50	nM	475.0	CHEMBL262	Homo sapiens	IC50	nM	475.0
	2112557	CHEMBL951013	Inhibition of human GSK3-beta by fluorescence anisotropy binding assay	B	Nc1ncnc2oc(-c3cccnc3)c(-c3ccc(NC(=O)c4cccc(F)c4)cc3)c12		CHEMBL258259	=	IC50	nM	1585.0	CHEMBL262	Homo sapiens	IC50	nM	1585.0
	2112559	CHEMBL951013	Inhibition of human GSK3-beta by fluorescence anisotropy binding assay	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(OC)cc2)cc1		CHEMBL196021	>	IC50	nM	15000.0	CHEMBL262	Homo sapiens	IC50	uM	15.0
	2112560	CHEMBL951013	Inhibition of human GSK3-beta by fluorescence anisotropy binding assay	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NS(=O)(=O)c3ccccc3)cc2)cc1		CHEMBL257090	>	IC50	nM	15000.0	CHEMBL262	Homo sapiens	IC50	uM	15.0
	2136783	CHEMBL937654	Inhibition of GSK3-beta	B	O=C1Nc2ccc(S(=O)(=O)O)cc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL440411	=	IC50	nM	80.0	CHEMBL262	Homo sapiens	IC50	nM	80.0
	2136788	CHEMBL937654	Inhibition of GSK3-beta	B	O=Nc1c(-c2c(O)[nH]c3ccc(I)cc23)[nH]c2ccccc12		CHEMBL337300	=	IC50	nM	9.0	CHEMBL262	Homo sapiens	IC50	nM	9.0
	2136808	CHEMBL937654	Inhibition of GSK3-beta	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	IC50	nM	104.0	CHEMBL262	Homo sapiens	IC50	nM	104.0
	2136809	CHEMBL937654	Inhibition of GSK3-beta	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Ki	nM	38.0	CHEMBL262	Homo sapiens	Ki	nM	38.0
	2136867	CHEMBL937654	Inhibition of GSK3-beta	B	Cc1nc(N)sc1-c1ccnc(Nc2cccc([N+](=O)[O-])c2)n1		CHEMBL298445	=	Ki	nM	20.0	CHEMBL262	Homo sapiens	Ki	nM	20.0
	2136880	CHEMBL937654	Inhibition of GSK3-beta	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	IC50	nM	0.8	CHEMBL262	Homo sapiens	IC50	pM	800.0
	2136881	CHEMBL937654	Inhibition of GSK3-beta	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	IC50	nM	20.0	CHEMBL262	Homo sapiens	IC50	nM	20.0
	2136885	CHEMBL937654	Inhibition of GSK3-beta	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	IC50	nM	100.0	CHEMBL262	Homo sapiens	Log IC50		-7.0
	2136896	CHEMBL937654	Inhibition of GSK3-beta	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	IC50	nM	1500.0	CHEMBL262	Homo sapiens	IC50	nM	1500.0
	2137000	CHEMBL937188	Binding affinity to GSK3-beta	B	O=C1CC(=O)c2[nH]c3c4[nH]c5c(c4c4cn(Br)cc4c3c2C1)CCC=C5		CHEMBL264685	>=	IC50	nM	12400.0	CHEMBL262	Homo sapiens	IC50	nM	12400.0
	2137042	CHEMBL937654	Inhibition of GSK3-beta	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	IC50	nM	22.0	CHEMBL262	Homo sapiens	IC50	nM	22.0
	2137075	CHEMBL937654	Inhibition of GSK3-beta	B	O=C1CC(=O)c2[nH]c3c4[nH]c5c(c4c4cn(Br)cc4c3c2C1)CCC=C5		CHEMBL264685	>=	IC50	nM	12400.0	CHEMBL262	Homo sapiens	IC50	nM	12400.0
	2137087	CHEMBL937654	Inhibition of GSK3-beta	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	IC50	nM	500.0	CHEMBL262	Homo sapiens	IC50	nM	500.0
	2137102	CHEMBL937654	Inhibition of GSK3-beta	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	IC50	nM	230.0	CHEMBL262	Homo sapiens	IC50	nM	230.0
	2137167	CHEMBL937654	Inhibition of GSK3-beta	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	IC50	nM	140.0	CHEMBL262	Homo sapiens	IC50	nM	140.0
	2137182	CHEMBL937654	Inhibition of GSK3-beta	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	IC50	nM	30.0	CHEMBL262	Homo sapiens	IC50	nM	30.0
	2137183	CHEMBL937073	Binding affinity to GSK3-beta	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Kd	nM	126.0	CHEMBL262	Homo sapiens	Kd	nM	126.0
	2137248	CHEMBL937188	Binding affinity to GSK3-beta	B	O=Nc1c(-c2c(O)[nH]c3ccc(I)cc23)[nH]c2ccccc12		CHEMBL337300	=	IC50	nM	9.0	CHEMBL262	Homo sapiens	IC50	nM	9.0
	2137297	CHEMBL937654	Inhibition of GSK3-beta	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	nM	1000.0
	2137307	CHEMBL937654	Inhibition of GSK3-beta	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	IC50	nM	754.0	CHEMBL262	Homo sapiens	IC50	nM	754.0
	2147275	CHEMBL921865	Activity of human GSK3-beta kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	102.0	CHEMBL262	Homo sapiens	Activity	%	102.0
Not Evaluated	2149596	CHEMBL931293	Inhibition of human GSK3 beta	B	NC(=O)c1c(NC(=O)C2CC2)sc2c1CCCC2		CHEMBL379367		Activity			CHEMBL262	Homo sapiens	Activity		
	2153705	CHEMBL928272	Inhibition of GSK3-beta at 20 uM	B	CN(C)CCOc1ccc2c(-c3c(-c4ccccn4)nn4c3CCC4)ccnc2c1		CHEMBL409525	<	Inhibition	%	50.0	CHEMBL262	Homo sapiens	Inhibition	%	50.0
	2153740	CHEMBL928272	Inhibition of GSK3-beta at 20 uM	B	c1ccc(-c2nn3c(c2-c2ccnc4cc(OCCN5CCOCC5)ccc24)CCC3)nc1		CHEMBL260015	<	Inhibition	%	50.0	CHEMBL262	Homo sapiens	Inhibition	%	50.0
	2154840	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	IC50	nM	590.0	CHEMBL262	Homo sapiens	IC50	nM	590.0
	2154841	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	Nc1c[nH]c2ncc(-c3ccccc3)cc12		CHEMBL40493	=	IC50	nM	23000.0	CHEMBL262	Homo sapiens	IC50	nM	23000.0
	2154842	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	Nc1noc2ncc(-c3ccccc3)cc12		CHEMBL290147	=	IC50	nM	23000.0	CHEMBL262	Homo sapiens	IC50	nM	23000.0
	2154843	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	Cn1nc(N)c2cc(-c3ccccc3)cnc21		CHEMBL40835	=	IC50	nM	23000.0	CHEMBL262	Homo sapiens	IC50	nM	23000.0
	2154844	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	CS(=O)(=O)Nc1n[nH]c2ncc(-c3ccccc3)cc12		CHEMBL287731	=	IC50	nM	3572.0	CHEMBL262	Homo sapiens	IC50	nM	3572.0
	2154845	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	Nc1n[nH]c2nccc(-c3ccccc3)c12		CHEMBL428968	=	IC50	nM	23000.0	CHEMBL262	Homo sapiens	IC50	nM	23000.0
	2154846	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	Nc1n[nH]c2cnc(-c3ccccc3)cc12		CHEMBL259925	=	IC50	nM	1260.0	CHEMBL262	Homo sapiens	IC50	nM	1260.0
	2154847	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	Nc1n[nH]c2ncc(-c3ccccc3)cc12		CHEMBL261439	=	IC50	nM	430.0	CHEMBL262	Homo sapiens	IC50	nM	430.0
	2154848	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	Nc1n[nH]c2nnc(-c3ccccc3)cc12		CHEMBL408634	=	IC50	nM	530.0	CHEMBL262	Homo sapiens	IC50	nM	530.0
	2154849	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL260135	=	IC50	nM	250.0	CHEMBL262	Homo sapiens	IC50	nM	250.0
	2154850	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	nM	1000.0
	2154851	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C(Nc1n[nH]c2cc(-c3ccsc3)ccc12)C1CC1		CHEMBL260928	=	IC50	nM	329.0	CHEMBL262	Homo sapiens	IC50	nM	329.0
	2154852	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C(Nc1n[nH]c2cc(-c3cccs3)ccc12)C1CC1		CHEMBL318522	=	IC50	nM	215.0	CHEMBL262	Homo sapiens	IC50	nM	215.0
	2154853	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C(Nc1n[nH]c2cc(-c3ccoc3)ccc12)C1CC1		CHEMBL260243	=	IC50	nM	35.0	CHEMBL262	Homo sapiens	IC50	nM	35.0
	2154854	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C(Nc1n[nH]c2cc(-c3ccc[nH]3)ccc12)C1CC1		CHEMBL260929	=	IC50	nM	320.0	CHEMBL262	Homo sapiens	IC50	nM	320.0
	2154855	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C(Nc1n[nH]c2cc(-c3cccc(F)c3)ccc12)C1CC1		CHEMBL261660	=	IC50	nM	828.0	CHEMBL262	Homo sapiens	IC50	nM	828.0
	2154856	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	IC50	nM	481.0	CHEMBL262	Homo sapiens	IC50	nM	481.0
	2154857	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C(Nc1n[nH]c2cc(-c3ccc4[nH]ccc4c3)ccc12)C1CC1		CHEMBL261659	=	IC50	nM	42.0	CHEMBL262	Homo sapiens	IC50	nM	42.0
	2154858	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C(Nc1n[nH]c2cc(-c3ccc(O)cc3)ccc12)C1CC1		CHEMBL260163	=	IC50	nM	15.0	CHEMBL262	Homo sapiens	IC50	nM	15.0
	2154859	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	IC50	nM	498.0	CHEMBL262	Homo sapiens	IC50	nM	498.0
	2154860	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	IC50	nM	23000.0	CHEMBL262	Homo sapiens	IC50	nM	23000.0
	2154861	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	CCN1CCN(CCCC(=O)Nc2n[nH]c3nc(-c4cccc(O)c4)ccc23)CC1		CHEMBL407730	=	IC50	nM	21.0	CHEMBL262	Homo sapiens	IC50	nM	21.0
	2154862	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	IC50	nM	1.0	CHEMBL262	Homo sapiens	IC50	nM	1.0
	2154863	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)ccc23)CC1		CHEMBL410926	=	IC50	nM	12.0	CHEMBL262	Homo sapiens	IC50	nM	12.0
	2154864	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccccc4)c(Br)cc23)CC1		CHEMBL261882	=	IC50	nM	383.0	CHEMBL262	Homo sapiens	IC50	nM	383.0
	2154865	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	N#Cc1cc2c(NC(=O)C3CC3)n[nH]c2nc1-c1ccccc1		CHEMBL261881	=	IC50	nM	87.0	CHEMBL262	Homo sapiens	IC50	nM	87.0
	2154866	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C(Nc1n[nH]c2nc(-c3ccccc3)c(Cl)cc12)C1CC1		CHEMBL261883	=	IC50	nM	234.0	CHEMBL262	Homo sapiens	IC50	nM	234.0
	2154867	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C(Nc1n[nH]c2nc(-c3ccccc3)c(-c3ccccc3)cc12)C1CC1		CHEMBL407958	=	IC50	nM	415.0	CHEMBL262	Homo sapiens	IC50	nM	415.0
	2154868	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	Cc1cc2c(NC(=O)C3CC3)n[nH]c2nc1-c1ccc(O)cc1		CHEMBL260662	=	IC50	nM	6.0	CHEMBL262	Homo sapiens	IC50	nM	6.0
	2154869	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Cl)cc12)C1CC1		CHEMBL260664	=	IC50	nM	1.0	CHEMBL262	Homo sapiens	IC50	nM	1.0
	2154870	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	COc1ccccc1-c1ccc2c(NC(=O)C3CC3)n[nH]c2n1		CHEMBL408979	=	IC50	nM	1593.0	CHEMBL262	Homo sapiens	IC50	nM	1593.0
	2154871	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C(Nc1n[nH]c2nc(-c3ccccc3O)ccc12)C1CC1		CHEMBL260663	=	IC50	nM	36.0	CHEMBL262	Homo sapiens	IC50	nM	36.0
	2154872	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	COc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)c1		CHEMBL406620	=	IC50	nM	125.0	CHEMBL262	Homo sapiens	IC50	nM	125.0
	2154873	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)c(O)c3)ccc12)C1CC1		CHEMBL260345	=	IC50	nM	8.0	CHEMBL262	Homo sapiens	IC50	nM	8.0
	2154874	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C(Nc1n[nH]c2nc(-c3ccccc3)ccc12)C1CC1		CHEMBL260344	=	IC50	nM	425.0	CHEMBL262	Homo sapiens	IC50	nM	425.0
	2154875	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	CCCC(=O)Nc1n[nH]c2ncc(-c3cccc4ccccc34)cc12		CHEMBL260329	=	IC50	nM	241.0	CHEMBL262	Homo sapiens	IC50	nM	241.0
	2154876	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	CCCC(=O)Nc1n[nH]c2ncc(-c3ccc4ccccc4c3)cc12		CHEMBL406062	=	IC50	nM	169.0	CHEMBL262	Homo sapiens	IC50	nM	169.0
	2154877	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	CCCC(=O)Nc1n[nH]c2ncc(-c3ccc(-c4ccccc4)cc3)cc12		CHEMBL261052	=	IC50	nM	851.0	CHEMBL262	Homo sapiens	IC50	nM	851.0
	2154878	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	CCCC(=O)Nc1n[nH]c2ncc(-c3ccncc3)cc12		CHEMBL261264	=	IC50	nM	443.0	CHEMBL262	Homo sapiens	IC50	nM	443.0
	2154879	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	CCCC(=O)Nc1n[nH]c2ncc(-c3cccnc3)cc12		CHEMBL407002	=	IC50	nM	11.0	CHEMBL262	Homo sapiens	IC50	nM	11.0
	2154880	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	CCCC(=O)Nc1n[nH]c2ncc(-c3ccccc3Cl)cc12		CHEMBL407003	=	IC50	nM	27.0	CHEMBL262	Homo sapiens	IC50	nM	27.0
	2154881	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	CCCC(=O)Nc1n[nH]c2ncc(-c3cccc(F)c3F)cc12		CHEMBL264161	=	IC50	nM	7.0	CHEMBL262	Homo sapiens	IC50	nM	7.0
	2154882	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	CCCC(=O)Nc1n[nH]c2ncc(-c3cccc(F)c3)cc12		CHEMBL263907	=	IC50	nM	20.0	CHEMBL262	Homo sapiens	IC50	nM	20.0
	2154883	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	CCCC(=O)Nc1n[nH]c2ncc(-c3ccccc3F)cc12		CHEMBL407373	=	IC50	nM	18.0	CHEMBL262	Homo sapiens	IC50	nM	18.0
	2154884	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	CCCC(=O)Nc1n[nH]c2ncccc12		CHEMBL407374	=	IC50	nM	2343.0	CHEMBL262	Homo sapiens	IC50	nM	2343.0
	2154885	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	CCCC(=O)Nc1n[nH]c2ncc(B3OC(C)(C)C(C)(C)O3)cc12		CHEMBL264162	=	IC50	nM	356.0	CHEMBL262	Homo sapiens	IC50	nM	356.0
	2154886	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	CCNC(=O)Nc1n[nH]c2ncc(-c3ccccc3)cc12		CHEMBL408809	=	IC50	nM	2810.0	CHEMBL262	Homo sapiens	IC50	nM	2810.0
	2154887	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C(Nc1n[nH]c2ncc(-c3ccccc3)cc12)C1CCCC1		CHEMBL258483	=	IC50	nM	5.0	CHEMBL262	Homo sapiens	IC50	nM	5.0
	2154888	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	CC(C)C(=O)Nc1n[nH]c2ncc(-c3ccccc3)cc12		CHEMBL261596	=	IC50	nM	19.0	CHEMBL262	Homo sapiens	IC50	nM	19.0
	2154889	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	CCCC(=O)Nc1n[nH]c2ncc(-c3ccccc3)cc12		CHEMBL258701	=	IC50	nM	56.0	CHEMBL262	Homo sapiens	IC50	nM	56.0
	2154890	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	CCC(=O)Nc1n[nH]c2ncc(-c3ccccc3)cc12		CHEMBL406701	=	IC50	nM	43.0	CHEMBL262	Homo sapiens	IC50	nM	43.0
	2154891	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	CC(=O)Nc1n[nH]c2ncc(-c3ccccc3)cc12		CHEMBL288448	=	IC50	nM	291.0	CHEMBL262	Homo sapiens	IC50	nM	291.0
	2154892	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CCN(Cc2ccccc2)C1		CHEMBL317657	=	IC50	nM	14.0	CHEMBL262	Homo sapiens	IC50	nM	14.0
	2154893	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	CN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1		CHEMBL260680	=	IC50	nM	18.0	CHEMBL262	Homo sapiens	IC50	nM	18.0
	2154894	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C(Nc1n[nH]c2nc(-c3nccs3)c(Br)cc12)C1CCCC1		CHEMBL406644	=	IC50	nM	16.0	CHEMBL262	Homo sapiens	IC50	nM	16.0
	2154895	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C(Nc1n[nH]c2nc(-c3nccs3)c(Br)cc12)C1CC1		CHEMBL261690	=	IC50	nM	99.0	CHEMBL262	Homo sapiens	IC50	nM	99.0
	2154896	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	IC50	nM	7.0	CHEMBL262	Homo sapiens	IC50	nM	7.0
	2154897	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	IC50	nM	141.0	CHEMBL262	Homo sapiens	IC50	nM	141.0
	2154898	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C(Nc1n[nH]c2nc(-c3cccs3)c(Br)cc12)C1CCCC1		CHEMBL407980	=	IC50	nM	7.0	CHEMBL262	Homo sapiens	IC50	nM	7.0
	2154899	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C(Nc1n[nH]c2nc(-c3cccs3)c(Br)cc12)C1CC1		CHEMBL260231	=	IC50	nM	39.0	CHEMBL262	Homo sapiens	IC50	nM	39.0
	2154900	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019	=	IC50	nM	12.0	CHEMBL262	Homo sapiens	IC50	nM	12.0
	2154901	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	CCN1CCN(CCCC(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL407981	=	IC50	nM	4.0	CHEMBL262	Homo sapiens	IC50	nM	4.0
	2154902	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(-c3ccccc3)cc12)C1CC1		CHEMBL427909	=	IC50	nM	24.0	CHEMBL262	Homo sapiens	IC50	nM	24.0
	2154903	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)c(Cl)c3)ccc12)C1CC1		CHEMBL259838	=	IC50	nM	7.0	CHEMBL262	Homo sapiens	IC50	nM	7.0
	2154904	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)c(Br)c3)ccc12)C1CC1		CHEMBL260416	=	IC50	nM	5.0	CHEMBL262	Homo sapiens	IC50	nM	5.0
	2154905	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)ccc12)C1CC1		CHEMBL405145	=	IC50	nM	8.0	CHEMBL262	Homo sapiens	IC50	nM	8.0
	2154906	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	IC50	nM	0.8	CHEMBL262	Homo sapiens	IC50	nM	0.8
	2154907	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C(Nc1n[nH]c2nc(-c3ccccc3)c(Br)cc12)C1CC1		CHEMBL259270	=	IC50	nM	75.0	CHEMBL262	Homo sapiens	IC50	nM	75.0
	2154908	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	CCN1CCN(CCCCC(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1		CHEMBL259271	=	IC50	nM	5.0	CHEMBL262	Homo sapiens	IC50	nM	5.0
	2154909	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1		CHEMBL406125	=	IC50	nM	9.0	CHEMBL262	Homo sapiens	IC50	nM	9.0
	2154910	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C(CCCN1CCOCC1)Nc1n[nH]c2nnc(-c3ccccc3)cc12		CHEMBL261518	=	IC50	nM	5.0	CHEMBL262	Homo sapiens	IC50	nM	5.0
	2154911	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	CCN1CCN(CCCC(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1		CHEMBL409738	=	IC50	nM	7.0	CHEMBL262	Homo sapiens	IC50	nM	7.0
	2154912	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C(CCCN1CCCC1)Nc1n[nH]c2nnc(-c3ccccc3)cc12		CHEMBL261441	=	IC50	nM	11.0	CHEMBL262	Homo sapiens	IC50	nM	11.0
	2154913	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3ccccc3)cc12		CHEMBL259744	=	IC50	nM	22.0	CHEMBL262	Homo sapiens	IC50	nM	22.0
	2154914	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	CCCC(=O)Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL261127	=	IC50	nM	691.0	CHEMBL262	Homo sapiens	IC50	nM	691.0
	2154915	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	CCCC(=O)Nc1n[nH]c2cnc(-c3ccccc3)nc12		CHEMBL261661	=	IC50	nM	2697.0	CHEMBL262	Homo sapiens	IC50	nM	2697.0
	2154916	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	CCCC(=O)Nc1n[nH]c2cnc(-c3ccccc3)cc12		CHEMBL261549	=	IC50	nM	7.0	CHEMBL262	Homo sapiens	IC50	nM	7.0
	2154917	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	CCCC(=O)Nc1n[nH]c2ccc(-c3ccccc3)cc12		CHEMBL261366	=	IC50	nM	99.0	CHEMBL262	Homo sapiens	IC50	nM	99.0
	2154918	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	IC50	nM	694.0	CHEMBL262	Homo sapiens	IC50	nM	694.0
	2154919	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	IC50	nM	1412.0	CHEMBL262	Homo sapiens	IC50	nM	1412.0
	2154920	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1cccc([N+](=O)[O-])c1		CHEMBL156153	=	IC50	nM	161.0	CHEMBL262	Homo sapiens	IC50	nM	161.0
	2154921	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1cccc(Cl)c1		CHEMBL346107	=	IC50	nM	460.0	CHEMBL262	Homo sapiens	IC50	nM	460.0
	2154922	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccccc1[N+](=O)[O-]		CHEMBL158719	=	IC50	nM	131.0	CHEMBL262	Homo sapiens	IC50	nM	131.0
	2154923	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	COc1ccccc1C1=C(N2CCc3ccccc32)C(=O)NC1=O		CHEMBL160585	=	IC50	nM	187.0	CHEMBL262	Homo sapiens	IC50	nM	187.0
	2154924	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccccc1Cl		CHEMBL155967	=	IC50	nM	337.0	CHEMBL262	Homo sapiens	IC50	nM	337.0
	2154925	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	CN(C1=C(c2ccc(Cl)cc2)C(=O)NC1=O)c1ccccc1		CHEMBL435045	=	IC50	nM	2285.0	CHEMBL262	Homo sapiens	IC50	nM	2285.0
	2154926	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	CN(C1=C(c2cccc([N+](=O)[O-])c2)C(=O)NC1=O)c1ccccc1		CHEMBL156801	=	IC50	nM	1398.0	CHEMBL262	Homo sapiens	IC50	nM	1398.0
	2154927	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	CN(C1=C(c2ccccc2)C(=O)NC1=O)c1ccccc1		CHEMBL351334	=	IC50	nM	2613.0	CHEMBL262	Homo sapiens	IC50	nM	2613.0
	2154928	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	CSc1ccc(NC2=C(c3ccc([N+](=O)[O-])cc3)C(=O)NC2=O)cc1		CHEMBL158835	=	IC50	nM	392.0	CHEMBL262	Homo sapiens	IC50	nM	392.0
	2154929	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C1NC(=O)C(c2ccc([N+](=O)[O-])cc2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL347681	=	IC50	nM	71.0	CHEMBL262	Homo sapiens	IC50	nM	71.0
	2154930	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	COc1ccc(C2=C(Nc3ccc(SC)cc3)C(=O)NC2=O)cc1		CHEMBL160598	=	IC50	nM	243.0	CHEMBL262	Homo sapiens	IC50	nM	243.0
	2154931	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	COc1ccc(C2=C(Nc3cccc(C(=O)O)c3)C(=O)NC2=O)cc1		CHEMBL156218	=	IC50	nM	214.0	CHEMBL262	Homo sapiens	IC50	nM	214.0
	2154932	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	COc1ccc(C2=C(Nc3cc(Cl)c(O)c(Cl)c3)C(=O)NC2=O)cc1		CHEMBL346721	=	IC50	nM	83.0	CHEMBL262	Homo sapiens	IC50	nM	83.0
	2154933	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	COc1ccc(C2=C(Nc3cccc(O)c3)C(=O)NC2=O)cc1		CHEMBL160829	=	IC50	nM	481.0	CHEMBL262	Homo sapiens	IC50	nM	481.0
	2154934	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	COc1ccc(C2=C(Nc3cccc(Cl)c3)C(=O)NC2=O)cc1		CHEMBL158208	=	IC50	nM	156.0	CHEMBL262	Homo sapiens	IC50	nM	156.0
	2154935	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	COc1ccc(C2=C(Nc3ccccc3)C(=O)NC2=O)cc1		CHEMBL156807	=	IC50	nM	390.0	CHEMBL262	Homo sapiens	IC50	nM	390.0
	2154936	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	CSc1ccc(NC2=C(c3ccc(Cl)cc3)C(=O)NC2=O)cc1		CHEMBL351342	=	IC50	nM	529.0	CHEMBL262	Homo sapiens	IC50	nM	529.0
	2154937	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	IC50	nM	109.0	CHEMBL262	Homo sapiens	IC50	nM	109.0
	2154938	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1cccc(C(=O)O)c1		CHEMBL347632	=	IC50	nM	186.0	CHEMBL262	Homo sapiens	IC50	nM	186.0
	2154939	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL347134	=	IC50	nM	91.0	CHEMBL262	Homo sapiens	IC50	nM	91.0
	2154940	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL156684	=	IC50	nM	173.0	CHEMBL262	Homo sapiens	IC50	nM	173.0
	2154941	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(O)cc1		CHEMBL156808	=	IC50	nM	317.0	CHEMBL262	Homo sapiens	IC50	nM	317.0
	2154942	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1cccc(O)c1		CHEMBL347419	=	IC50	nM	407.0	CHEMBL262	Homo sapiens	IC50	nM	407.0
	2154943	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1cccc(Cl)c1		CHEMBL160938	=	IC50	nM	447.0	CHEMBL262	Homo sapiens	IC50	nM	447.0
	2154944	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccccc1		CHEMBL160968	=	IC50	nM	514.0	CHEMBL262	Homo sapiens	IC50	nM	514.0
	2154945	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	CSc1ccc(NC2=C(c3cccc([N+](=O)[O-])c3)C(=O)NC2=O)cc1		CHEMBL346996	=	IC50	nM	152.0	CHEMBL262	Homo sapiens	IC50	nM	152.0
	2154946	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156379	=	IC50	nM	26.0	CHEMBL262	Homo sapiens	IC50	nM	26.0
	2154947	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cccc(C(=O)O)c1		CHEMBL159149	=	IC50	nM	79.0	CHEMBL262	Homo sapiens	IC50	nM	79.0
	2154948	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	IC50	nM	20.0	CHEMBL262	Homo sapiens	IC50	nM	20.0
	2154949	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL345348	=	IC50	nM	59.0	CHEMBL262	Homo sapiens	IC50	nM	59.0
	2154950	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1ccc(O)cc1		CHEMBL155680	=	IC50	nM	123.0	CHEMBL262	Homo sapiens	IC50	nM	123.0
	2154951	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cccc(O)c1		CHEMBL158559	=	IC50	nM	236.0	CHEMBL262	Homo sapiens	IC50	nM	236.0
	2154952	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cccc(Cl)c1		CHEMBL345801	=	IC50	nM	70.0	CHEMBL262	Homo sapiens	IC50	nM	70.0
	2154953	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1ccccc1		CHEMBL346371	=	IC50	nM	141.0	CHEMBL262	Homo sapiens	IC50	nM	141.0
	2154954	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	COc1cccc(C2=C(Nc3ccc(SC)cc3)C(=O)NC2=O)c1		CHEMBL158526	=	IC50	nM	203.0	CHEMBL262	Homo sapiens	IC50	nM	203.0
	2154955	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	COc1cccc(C2=C(Nc3ccc(Cl)c(C(=O)O)c3)C(=O)NC2=O)c1		CHEMBL349810	=	IC50	nM	85.0	CHEMBL262	Homo sapiens	IC50	nM	85.0
	2154956	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	COc1cccc(C2=C(Nc3cccc(C(=O)O)c3)C(=O)NC2=O)c1		CHEMBL346493	=	IC50	nM	195.0	CHEMBL262	Homo sapiens	IC50	nM	195.0
	2154957	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	COc1cccc(C2=C(Nc3cc(Cl)c(O)c(Cl)c3)C(=O)NC2=O)c1		CHEMBL157348	=	IC50	nM	142.0	CHEMBL262	Homo sapiens	IC50	nM	142.0
	2154958	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	COc1cccc(C2=C(Nc3cccc(O)c3)C(=O)NC2=O)c1		CHEMBL160373	=	IC50	nM	472.0	CHEMBL262	Homo sapiens	IC50	nM	472.0
	2154959	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	COc1cccc(C2=C(Nc3cccc(Cl)c3)C(=O)NC2=O)c1		CHEMBL346829	=	IC50	nM	257.0	CHEMBL262	Homo sapiens	IC50	nM	257.0
	2154960	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	CSc1ccc(NC2=C(c3cccc(Cl)c3)C(=O)NC2=O)cc1		CHEMBL160743	=	IC50	nM	532.0	CHEMBL262	Homo sapiens	IC50	nM	532.0
	2154961	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	IC50	nM	76.0	CHEMBL262	Homo sapiens	IC50	nM	76.0
	2154962	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1cccc(C(=O)O)c1		CHEMBL345364	=	IC50	nM	134.0	CHEMBL262	Homo sapiens	IC50	nM	134.0
	2154963	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL422714	=	IC50	nM	58.0	CHEMBL262	Homo sapiens	IC50	nM	58.0
	2154964	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	IC50	nM	94.0	CHEMBL262	Homo sapiens	IC50	nM	94.0
	2154965	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1cccc(O)c1		CHEMBL351801	=	IC50	nM	1478.0	CHEMBL262	Homo sapiens	IC50	nM	1478.0
	2154966	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160586	=	IC50	nM	28.0	CHEMBL262	Homo sapiens	IC50	nM	28.0
	2154967	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL158885	=	IC50	nM	52.0	CHEMBL262	Homo sapiens	IC50	nM	52.0
	2154968	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	IC50	nM	104.0	CHEMBL262	Homo sapiens	IC50	nM	104.0
	2154969	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1cccc(O)c1		CHEMBL155931	=	IC50	nM	251.0	CHEMBL262	Homo sapiens	IC50	nM	251.0
	2154970	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1cccc(Cl)c1		CHEMBL346066	=	IC50	nM	104.0	CHEMBL262	Homo sapiens	IC50	nM	104.0
	2154971	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	COc1ccccc1C1=C(Nc2ccc(SC)cc2)C(=O)NC1=O		CHEMBL349540	=	IC50	nM	110.0	CHEMBL262	Homo sapiens	IC50	nM	110.0
	2154972	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	COc1ccccc1C1=C(Nc2cc(Cl)c(O)c(Cl)c2)C(=O)NC1=O		CHEMBL345800	=	IC50	nM	82.0	CHEMBL262	Homo sapiens	IC50	nM	82.0
	2154973	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	COc1ccccc1C1=C(Nc2ccc(O)c(Cl)c2)C(=O)NC1=O		CHEMBL157089	=	IC50	nM	139.0	CHEMBL262	Homo sapiens	IC50	nM	139.0
	2154974	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	COc1ccccc1C1=C(Nc2cccc(O)c2)C(=O)NC1=O		CHEMBL160231	=	IC50	nM	259.0	CHEMBL262	Homo sapiens	IC50	nM	259.0
	2154975	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	COc1ccccc1C1=C(Nc2cccc(Cl)c2)C(=O)NC1=O		CHEMBL156277	=	IC50	nM	114.0	CHEMBL262	Homo sapiens	IC50	nM	114.0
	2154976	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	IC50	nM	216.0	CHEMBL262	Homo sapiens	IC50	nM	216.0
	2154977	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	CSc1ccc(NC2=C(c3ccccc3Cl)C(=O)NC2=O)cc1		CHEMBL156563	=	IC50	nM	161.0	CHEMBL262	Homo sapiens	IC50	nM	161.0
	2154978	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL345212	=	IC50	nM	74.0	CHEMBL262	Homo sapiens	IC50	nM	74.0
	2154979	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(C(=O)O)c1		CHEMBL350702	=	IC50	nM	136.0	CHEMBL262	Homo sapiens	IC50	nM	136.0
	2154980	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	IC50	nM	93.0	CHEMBL262	Homo sapiens	IC50	nM	93.0
	2154981	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1ccc(O)c(Cl)c1		CHEMBL157141	=	IC50	nM	152.0	CHEMBL262	Homo sapiens	IC50	nM	152.0
	2154982	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	IC50	nM	374.0	CHEMBL262	Homo sapiens	IC50	nM	374.0
	2154983	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(Cl)c1		CHEMBL156506	=	IC50	nM	195.0	CHEMBL262	Homo sapiens	IC50	nM	195.0
	2154984	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1ccccc1		CHEMBL347647	=	IC50	nM	216.0	CHEMBL262	Homo sapiens	IC50	nM	216.0
	2154985	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	CSc1ccc(NC2=C(c3ccccc3)C(=O)NC2=O)cc1		CHEMBL434484	=	IC50	nM	404.0	CHEMBL262	Homo sapiens	IC50	nM	404.0
	2154986	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160251	=	IC50	nM	143.0	CHEMBL262	Homo sapiens	IC50	nM	143.0
	2154987	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1cccc(C(=O)O)c1		CHEMBL348505	=	IC50	nM	291.0	CHEMBL262	Homo sapiens	IC50	nM	291.0
	2154988	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL347857	=	IC50	nM	149.0	CHEMBL262	Homo sapiens	IC50	nM	149.0
	2154989	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1cccc(O)c1		CHEMBL350435	=	IC50	nM	704.0	CHEMBL262	Homo sapiens	IC50	nM	704.0
	2154990	CHEMBL930273	Inhibition of recombinant GSK3-beta	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1cccc(Cl)c1		CHEMBL351356	=	IC50	nM	301.0	CHEMBL262	Homo sapiens	IC50	nM	301.0
Not Determined	2157552	CHEMBL932638	Inhibition of GSK3-beta in human PC3M cells by ELISA	B	c1nc(N2CCCCC2)c2nc[nH]c2n1		CHEMBL264666		IC50			CHEMBL262	Homo sapiens	IC50		
Not Determined	2157566	CHEMBL932638	Inhibition of GSK3-beta in human PC3M cells by ELISA	B	NC1CCN(c2ccnc3[nH]ccc23)CC1		CHEMBL264965		IC50			CHEMBL262	Homo sapiens	IC50		
Not Determined	2157567	CHEMBL932638	Inhibition of GSK3-beta in human PC3M cells by ELISA	B	Cc1nc2c(N3CCC(N)CC3)ncnc2[nH]1		CHEMBL265194		IC50			CHEMBL262	Homo sapiens	IC50		
Not Determined	2157568	CHEMBL932638	Inhibition of GSK3-beta in human PC3M cells by ELISA	B	NC1CCN(c2ncnc3[nH]cnc23)CC1		CHEMBL261260		IC50			CHEMBL262	Homo sapiens	IC50		
Not Determined	2157569	CHEMBL932638	Inhibition of GSK3-beta in human PC3M cells by ELISA	B	NCC1CCN(c2ncnc3[nH]cnc23)CC1		CHEMBL259356		IC50			CHEMBL262	Homo sapiens	IC50		
Not Determined	2157570	CHEMBL932638	Inhibition of GSK3-beta in human PC3M cells by ELISA	B	NC(=O)C1CCN(c2ncnc3[nH]cnc23)CC1		CHEMBL264667		IC50			CHEMBL262	Homo sapiens	IC50		
	2157577	CHEMBL932638	Inhibition of GSK3-beta in human PC3M cells by ELISA	B	NC1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL265451	>	IC50	nM	30000.0	CHEMBL262	Homo sapiens	IC50	uM	30.0
	2157580	CHEMBL932638	Inhibition of GSK3-beta in human PC3M cells by ELISA	B	NCC1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL265193	>	IC50	nM	30000.0	CHEMBL262	Homo sapiens	IC50	uM	30.0
	2157583	CHEMBL932638	Inhibition of GSK3-beta in human PC3M cells by ELISA	B	NC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL259141	=	IC50	nM	15000.0	CHEMBL262	Homo sapiens	IC50	uM	15.0
	2157586	CHEMBL932638	Inhibition of GSK3-beta in human PC3M cells by ELISA	B	NCC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL261249	=	IC50	nM	11000.0	CHEMBL262	Homo sapiens	IC50	uM	11.0
	2157631	CHEMBL932638	Inhibition of GSK3-beta in human PC3M cells by ELISA	B	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL263664	=	IC50	nM	3000.0	CHEMBL262	Homo sapiens	IC50	uM	3.0
	2157632	CHEMBL932638	Inhibition of GSK3-beta in human PC3M cells by ELISA	B	NC1(c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL259998	=	IC50	nM	600.0	CHEMBL262	Homo sapiens	IC50	uM	0.6
	2157633	CHEMBL932638	Inhibition of GSK3-beta in human PC3M cells by ELISA	B	NCC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL260000	=	IC50	nM	1400.0	CHEMBL262	Homo sapiens	IC50	uM	1.4
	2157634	CHEMBL932638	Inhibition of GSK3-beta in human PC3M cells by ELISA	B	NCC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]cnc23)CC1		CHEMBL409503	=	IC50	nM	1700.0	CHEMBL262	Homo sapiens	IC50	uM	1.7
	2157635	CHEMBL932638	Inhibition of GSK3-beta in human PC3M cells by ELISA	B	NCC1(c2ccc(Cl)cc2)CCN(c2ccnc3[nH]ccc23)CC1		CHEMBL260463	=	IC50	nM	1400.0	CHEMBL262	Homo sapiens	IC50	uM	1.4
	2157636	CHEMBL932638	Inhibition of GSK3-beta in human PC3M cells by ELISA	B	NCC1(c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL406863	=	IC50	nM	500.0	CHEMBL262	Homo sapiens	IC50	uM	0.5
	2157637	CHEMBL932638	Inhibition of GSK3-beta in human PC3M cells by ELISA	B	NCC1(c2ccc(Cl)cc2)CCN(c2ncnc3[nH]cnc23)CC1		CHEMBL260358	=	IC50	nM	1300.0	CHEMBL262	Homo sapiens	IC50	uM	1.3
	2157638	CHEMBL932638	Inhibition of GSK3-beta in human PC3M cells by ELISA	B	NC(c1ccc(Cl)cc1)C1CCN(c2ccnc3[nH]ccc23)CC1		CHEMBL260577	=	IC50	nM	2000.0	CHEMBL262	Homo sapiens	IC50	uM	2.0
	2157639	CHEMBL932638	Inhibition of GSK3-beta in human PC3M cells by ELISA	B	NC(c1ccc(Cl)cc1)C1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL405384	=	IC50	nM	7500.0	CHEMBL262	Homo sapiens	IC50	uM	7.5
	2157640	CHEMBL932638	Inhibition of GSK3-beta in human PC3M cells by ELISA	B	NC(c1ccccc1)C1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL261247	>	IC50	nM	30000.0	CHEMBL262	Homo sapiens	IC50	uM	30.0
Not Determined	2157654	CHEMBL932638	Inhibition of GSK3-beta in human PC3M cells by ELISA	B	NC(c1ccc(Cl)cc1)C1CCN(c2ncnc3[nH]cnc23)CC1		CHEMBL261034		IC50			CHEMBL262	Homo sapiens	IC50		
	2157655	CHEMBL932639	Inhibition of GSK3-beta in human U87MG cells by ELISA	B	NCC1(c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL406863	=	IC50	nM	590.0	CHEMBL262	Homo sapiens	IC50	uM	0.59
	2157656	CHEMBL932639	Inhibition of GSK3-beta in human U87MG cells by ELISA	B	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL263664	=	IC50	nM	660.0	CHEMBL262	Homo sapiens	IC50	uM	0.66
	2157657	CHEMBL932639	Inhibition of GSK3-beta in human U87MG cells by ELISA	B	NC1(c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL259998	<	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	uM	1.0
	2157658	CHEMBL932639	Inhibition of GSK3-beta in human U87MG cells by ELISA	B	NCC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL260000	=	IC50	nM	450.0	CHEMBL262	Homo sapiens	IC50	uM	0.45
	2157659	CHEMBL932639	Inhibition of GSK3-beta in human U87MG cells by ELISA	B	NC(c1ccc(Cl)cc1)C1CCN(c2ccnc3[nH]ccc23)CC1		CHEMBL260577	=	IC50	nM	590.0	CHEMBL262	Homo sapiens	IC50	uM	0.59
	2157660	CHEMBL932639	Inhibition of GSK3-beta in human U87MG cells by ELISA	B	NC(c1ccc(Cl)cc1)C1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL405384	=	IC50	nM	590.0	CHEMBL262	Homo sapiens	IC50	uM	0.59
Not Determined	2157661	CHEMBL932639	Inhibition of GSK3-beta in human U87MG cells by ELISA	B	NCC1(c2ccc(Cl)cc2)CCN(c2ccnc3[nH]ccc23)CC1		CHEMBL260463		IC50			CHEMBL262	Homo sapiens	IC50		
Not Determined	2157662	CHEMBL932639	Inhibition of GSK3-beta in human U87MG cells by ELISA	B	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]cnc23)CC1		CHEMBL259999		IC50			CHEMBL262	Homo sapiens	IC50		
Not Determined	2157663	CHEMBL932639	Inhibition of GSK3-beta in human U87MG cells by ELISA	B	NC1(c2ccc(Cl)cc2)CCN(c2ncnc3[nH]cnc23)CC1		CHEMBL407504		IC50			CHEMBL262	Homo sapiens	IC50		
Not Determined	2157664	CHEMBL932639	Inhibition of GSK3-beta in human U87MG cells by ELISA	B	NCC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]cnc23)CC1		CHEMBL409503		IC50			CHEMBL262	Homo sapiens	IC50		
Not Determined	2157665	CHEMBL932639	Inhibition of GSK3-beta in human U87MG cells by ELISA	B	NCC1(c2ccc(Cl)cc2)CCN(c2ncnc3[nH]cnc23)CC1		CHEMBL260358		IC50			CHEMBL262	Homo sapiens	IC50		
Not Determined	2157666	CHEMBL932639	Inhibition of GSK3-beta in human U87MG cells by ELISA	B	NC(c1ccc(Cl)cc1)C1CCN(c2ncnc3[nH]cnc23)CC1		CHEMBL261034		IC50			CHEMBL262	Homo sapiens	IC50		
Not Determined	2157667	CHEMBL932639	Inhibition of GSK3-beta in human U87MG cells by ELISA	B	NC(c1ccccc1)C1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL261247		IC50			CHEMBL262	Homo sapiens	IC50		
Not Determined	2157668	CHEMBL932638	Inhibition of GSK3-beta in human PC3M cells by ELISA	B	NC1(c2ccc(Cl)cc2)CCN(c2ncnc3[nH]cnc23)CC1		CHEMBL407504		IC50			CHEMBL262	Homo sapiens	IC50		
	2157682	CHEMBL932638	Inhibition of GSK3-beta in human PC3M cells by ELISA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	IC50	nM	15000.0	CHEMBL262	Homo sapiens	IC50	uM	15.0
	2157686	CHEMBL932639	Inhibition of GSK3-beta in human U87MG cells by ELISA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	IC50	nM	8100.0	CHEMBL262	Homo sapiens	IC50	uM	8.1
Not Determined	2157689	CHEMBL932638	Inhibition of GSK3-beta in human PC3M cells by ELISA	B	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]cnc23)CC1		CHEMBL259999		IC50			CHEMBL262	Homo sapiens	IC50		
	2167945	CHEMBL924788	Inhibition of GSK3-beta at 100 nM	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	<	Inhibition	%	5.0	CHEMBL262	Homo sapiens	Inhibition	%	5.0
Not Active	2170342	CHEMBL927901	Activity at GSK3-beta at 3 uM	B	COc1c(NC(=O)c2ccc(C)c(N3C=C(C(=O)NCC(C)(C)CN(C)C)NN3)c2)cc(C(C)(C)C)cc1NS(C)(=O)=O		CHEMBL254992		Activity			CHEMBL262	Homo sapiens	Activity		
	2172589	CHEMBL921632	Inhibition of GSK3-beta assessed as breakdown of glycogen synthase derived substrate peptide by ADP hunter assay in presence of 100 uM ATP	B	Cc1ccc(N2CCN(CCCNC(=O)c3nc(-c4cccnc4)no3)CC2)cc1C		CHEMBL427726	=	IC50	nM	350.0	CHEMBL262	Homo sapiens	IC50	uM	0.35
	2172590	CHEMBL921632	Inhibition of GSK3-beta assessed as breakdown of glycogen synthase derived substrate peptide by ADP hunter assay in presence of 100 uM ATP	B	O=C(NCCCN1CCN(c2ccccc2)CC1)c1nc(-c2ccncc2)no1		CHEMBL257821	=	IC50	nM	5000.0	CHEMBL262	Homo sapiens	IC50	uM	5.0
	2172591	CHEMBL921632	Inhibition of GSK3-beta assessed as breakdown of glycogen synthase derived substrate peptide by ADP hunter assay in presence of 100 uM ATP	B	O=C(NCCCN1CCN(c2cccc(Cl)c2)CC1)c1nc(-c2ccncc2)no1		CHEMBL256367	=	IC50	nM	4000.0	CHEMBL262	Homo sapiens	IC50	uM	4.0
	2172592	CHEMBL921632	Inhibition of GSK3-beta assessed as breakdown of glycogen synthase derived substrate peptide by ADP hunter assay in presence of 100 uM ATP	B	Cc1cccc(N2CCN(CCCNC(=O)c3nc(-c4ccncc4)no3)CC2C)c1		CHEMBL428252	=	IC50	nM	1130.0	CHEMBL262	Homo sapiens	IC50	uM	1.13
	2172593	CHEMBL921632	Inhibition of GSK3-beta assessed as breakdown of glycogen synthase derived substrate peptide by ADP hunter assay in presence of 100 uM ATP	B	Cc1ccc(N2CCN(CCCNC(=O)c3nc(-c4cncnc4)no3)CC2)cc1C		CHEMBL257979	=	IC50	nM	3500.0	CHEMBL262	Homo sapiens	IC50	uM	3.5
	2172594	CHEMBL921632	Inhibition of GSK3-beta assessed as breakdown of glycogen synthase derived substrate peptide by ADP hunter assay in presence of 100 uM ATP	B	Cc1ccc(Cl)cc1N1CCN(CCCNC(=O)c2nc(-c3cncnc3)no2)CC1		CHEMBL257980	=	IC50	nM	3480.0	CHEMBL262	Homo sapiens	IC50	uM	3.48
	2172595	CHEMBL921632	Inhibition of GSK3-beta assessed as breakdown of glycogen synthase derived substrate peptide by ADP hunter assay in presence of 100 uM ATP	B	Cc1ccc(C)c(N2CCN(CCCNC(=O)c3nc(-c4cncnc4)no3)CC2)c1		CHEMBL256559	=	IC50	nM	3380.0	CHEMBL262	Homo sapiens	IC50	uM	3.38
	2172596	CHEMBL921632	Inhibition of GSK3-beta assessed as breakdown of glycogen synthase derived substrate peptide by ADP hunter assay in presence of 100 uM ATP	B	Cc1ccc(N2CCN(CCCNC(=O)c3nc(-c4cncnc4)no3)CC2)c(C)c1		CHEMBL403640	=	IC50	nM	3000.0	CHEMBL262	Homo sapiens	IC50	uM	3.0
	2172597	CHEMBL921632	Inhibition of GSK3-beta assessed as breakdown of glycogen synthase derived substrate peptide by ADP hunter assay in presence of 100 uM ATP	B	O=C(NCCCN1CCN(c2ccccc2F)CC1)c1nc(-c2cncnc2)no1		CHEMBL257823	=	IC50	nM	2990.0	CHEMBL262	Homo sapiens	IC50	uM	2.99
	2172598	CHEMBL921632	Inhibition of GSK3-beta assessed as breakdown of glycogen synthase derived substrate peptide by ADP hunter assay in presence of 100 uM ATP	B	Cc1cccc(N2CCN(CCCNC(=O)c3nc(-c4cncnc4)no3)C(C)C2)c1		CHEMBL258029	=	IC50	nM	2610.0	CHEMBL262	Homo sapiens	IC50	uM	2.61
	2172599	CHEMBL921632	Inhibition of GSK3-beta assessed as breakdown of glycogen synthase derived substrate peptide by ADP hunter assay in presence of 100 uM ATP	B	Cc1ccc(Cl)cc1N1CCN(CCCNC(=O)c2nc(-c3cccnc3)no2)CC1		CHEMBL402324	=	IC50	nM	2000.0	CHEMBL262	Homo sapiens	IC50	uM	2.0
	2172600	CHEMBL921632	Inhibition of GSK3-beta assessed as breakdown of glycogen synthase derived substrate peptide by ADP hunter assay in presence of 100 uM ATP	B	O=C(NCCCN1CCN(c2ccccc2F)CC1)c1nc(-c2cccnc2)no1		CHEMBL402325	=	IC50	nM	1480.0	CHEMBL262	Homo sapiens	IC50	uM	1.48
	2172601	CHEMBL921632	Inhibition of GSK3-beta assessed as breakdown of glycogen synthase derived substrate peptide by ADP hunter assay in presence of 100 uM ATP	B	Cc1ccc(N2CCN(CCCNC(=O)c3nc(-c4cccnc4)no3)CC2)c(C)c1		CHEMBL255284	=	IC50	nM	1430.0	CHEMBL262	Homo sapiens	IC50	uM	1.43
	2172602	CHEMBL921632	Inhibition of GSK3-beta assessed as breakdown of glycogen synthase derived substrate peptide by ADP hunter assay in presence of 100 uM ATP	B	Cc1ccc(N2CCN(CCCNC(=O)c3nc(-c4cccnc4)no3)CC2)cc1		CHEMBL254794	=	IC50	nM	1330.0	CHEMBL262	Homo sapiens	IC50	uM	1.33
	2172603	CHEMBL921632	Inhibition of GSK3-beta assessed as breakdown of glycogen synthase derived substrate peptide by ADP hunter assay in presence of 100 uM ATP	B	Cc1cccc(N2CCN(CCCNC(=O)c3nc(-c4cccnc4)no3)CC2)c1		CHEMBL255915	=	IC50	nM	1060.0	CHEMBL262	Homo sapiens	IC50	uM	1.06
	2172604	CHEMBL921632	Inhibition of GSK3-beta assessed as breakdown of glycogen synthase derived substrate peptide by ADP hunter assay in presence of 100 uM ATP	B	Cc1cc(C)cc(N2CCN(CCCNC(=O)c3nc(-c4cccnc4)no3)CC2)c1		CHEMBL254758	=	IC50	nM	900.0	CHEMBL262	Homo sapiens	IC50	uM	0.9
	2172605	CHEMBL921632	Inhibition of GSK3-beta assessed as breakdown of glycogen synthase derived substrate peptide by ADP hunter assay in presence of 100 uM ATP	B	O=C(NCCCN1CCN(c2cccc(Cl)c2)CC1)c1nc(-c2cccnc2)no1		CHEMBL401654	=	IC50	nM	890.0	CHEMBL262	Homo sapiens	IC50	uM	0.89
	2172606	CHEMBL921632	Inhibition of GSK3-beta assessed as breakdown of glycogen synthase derived substrate peptide by ADP hunter assay in presence of 100 uM ATP	B	Cc1ccc(C)c(N2CCN(CCCNC(=O)c3nc(-c4cccnc4)no3)CC2)c1		CHEMBL254961	=	IC50	nM	860.0	CHEMBL262	Homo sapiens	IC50	uM	0.86
	2172607	CHEMBL921632	Inhibition of GSK3-beta assessed as breakdown of glycogen synthase derived substrate peptide by ADP hunter assay in presence of 100 uM ATP	B	O=C(NCCCN1CCN(c2ccccc2)CC1)c1nc(-c2cccnc2)no1		CHEMBL403309	=	IC50	nM	860.0	CHEMBL262	Homo sapiens	IC50	uM	0.86
	2172608	CHEMBL921632	Inhibition of GSK3-beta assessed as breakdown of glycogen synthase derived substrate peptide by ADP hunter assay in presence of 100 uM ATP	B	Cc1cccc(N2CCN(CCCNC(=O)c3nc(-c4cccnc4)no3)CC2C)c1		CHEMBL257993	=	IC50	nM	710.0	CHEMBL262	Homo sapiens	IC50	uM	0.71
	2172609	CHEMBL921632	Inhibition of GSK3-beta assessed as breakdown of glycogen synthase derived substrate peptide by ADP hunter assay in presence of 100 uM ATP	B	Cc1ccccc1N1CCN(CCCNC(=O)c2nc(-c3cccnc3)no2)CC1		CHEMBL257992	=	IC50	nM	710.0	CHEMBL262	Homo sapiens	IC50	uM	0.71
	2172610	CHEMBL921632	Inhibition of GSK3-beta assessed as breakdown of glycogen synthase derived substrate peptide by ADP hunter assay in presence of 100 uM ATP	B	Cc1cccc(N2CCN(CCCNC(=O)c3nc(-c4cccnc4)no3)C(C)C2)c1		CHEMBL254582	=	IC50	nM	690.0	CHEMBL262	Homo sapiens	IC50	uM	0.69
	2172611	CHEMBL921632	Inhibition of GSK3-beta assessed as breakdown of glycogen synthase derived substrate peptide by ADP hunter assay in presence of 100 uM ATP	B	Cc1cccc(N2CCN(CCCNC(=O)c3nc(-c4cccnc4)no3)CC2)c1C		CHEMBL253532	=	IC50	nM	630.0	CHEMBL262	Homo sapiens	IC50	uM	0.63
	2172612	CHEMBL921632	Inhibition of GSK3-beta assessed as breakdown of glycogen synthase derived substrate peptide by ADP hunter assay in presence of 100 uM ATP	B	COc1ccccc1N1CCN(CCCNC(=O)c2nc(-c3cccnc3)no2)CC1		CHEMBL402228	=	IC50	nM	410.0	CHEMBL262	Homo sapiens	IC50	uM	0.41
	2172613	CHEMBL921633	Inhibition of GSK3-beta assessed as beta-casein level by RKO-cell based assay	B	Cc1ccc(N2CCN(CCCNC(=O)c3nc(-c4cccnc4)no3)CC2)cc1C		CHEMBL427726	=	IC50	nM	16000.0	CHEMBL262	Homo sapiens	IC50	uM	16.0
	2172614	CHEMBL921633	Inhibition of GSK3-beta assessed as beta-casein level by RKO-cell based assay	B	Cc1cccc(N2CCN(CCCNC(=O)c3nc(-c4ccncc4)no3)CC2C)c1		CHEMBL428252	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	2172615	CHEMBL921633	Inhibition of GSK3-beta assessed as beta-casein level by RKO-cell based assay	B	Cc1cccc(N2CCN(CCCNC(=O)c3nc(-c4cccnc4)no3)CC2C)c1		CHEMBL257993	=	IC50	nM	19150.0	CHEMBL262	Homo sapiens	IC50	uM	19.15
	2172616	CHEMBL921633	Inhibition of GSK3-beta assessed as beta-casein level by RKO-cell based assay	B	Cc1cccc(N2CCN(CCCNC(=O)c3nc(-c4cccnc4)no3)C(C)C2)c1		CHEMBL254582	=	IC50	nM	17000.0	CHEMBL262	Homo sapiens	IC50	uM	17.0
	2172630	CHEMBL921633	Inhibition of GSK3-beta assessed as beta-casein level by RKO-cell based assay	B	COc1ccccc1N1CCN(CCCNC(=O)c2nc(-c3cccnc3)no2)CC1		CHEMBL402228	=	IC50	nM	23000.0	CHEMBL262	Homo sapiens	IC50	uM	23.0
	2172642	CHEMBL921634	Inhibition of GSK3-beta by ATP-based competitive assay	B	Cc1cccc(N2CCN(CCCNC(=O)c3nc(-c4cccnc4)no3)C(C)C2)c1		CHEMBL254582	=	IC50	nM	200.0	CHEMBL262	Homo sapiens	IC50	uM	0.2
	2172851	CHEMBL928209	Inhibition of GSK3-beta at 10 uM	B	CC(C)(C)n1c(=O)n(-c2ccccc2)c2nc(Nc3ccccc3)ncc21		CHEMBL404689	=	Inhibition	%	93.0	CHEMBL262	Homo sapiens	Inhibition	%	93.0
	2172852	CHEMBL928210	Inhibition of GSK3-beta	B	CC(C)(C)n1c(=O)n(-c2ccccc2)c2nc(Nc3ccccc3)ncc21		CHEMBL404689	=	IC50	nM	2400.0	CHEMBL262	Homo sapiens	IC50	uM	2.4
	2172860	CHEMBL928209	Inhibition of GSK3-beta at 10 uM	B	O=C(O)c1cccc(Nc2ncc3[nH]c(=O)n(-c4ccccc4)c3n2)c1		CHEMBL257401	=	Inhibition	%	3.0	CHEMBL262	Homo sapiens	Inhibition	%	3.0
	2172861	CHEMBL928209	Inhibition of GSK3-beta at 10 uM	B	O=C(O)c1ccc(Nc2ncc3[nH]c(=O)n(-c4ccccc4)c3n2)cc1		CHEMBL257562	=	Inhibition	%	88.0	CHEMBL262	Homo sapiens	Inhibition	%	88.0
	2172862	CHEMBL928209	Inhibition of GSK3-beta at 10 uM	B	CCCCOC(=O)c1ccc(Nc2ncc3[nH]c(=O)n(-c4ccccc4)c3n2)cc1		CHEMBL257564	=	Inhibition	%	-5.0	CHEMBL262	Homo sapiens	Inhibition	%	-5.0
	2172863	CHEMBL928209	Inhibition of GSK3-beta at 10 uM	B	O=c1[nH]c2cnc(Nc3ccccc3)nc2n1-c1ccccc1		CHEMBL402529	=	Inhibition	%	20.0	CHEMBL262	Homo sapiens	Inhibition	%	20.0
	2172864	CHEMBL928209	Inhibition of GSK3-beta at 10 uM	B	O=c1n(-c2ccccc2)c2nc(Nc3ccccc3)ncc2n1C1CCCCC1		CHEMBL404049	=	Inhibition	%	14.0	CHEMBL262	Homo sapiens	Inhibition	%	14.0
	2172865	CHEMBL928209	Inhibition of GSK3-beta at 10 uM	B	Cn1c(=O)n(-c2ccccc2)c2nc(Nc3ccccc3)ncc21		CHEMBL256139	=	Inhibition	%	96.0	CHEMBL262	Homo sapiens	Inhibition	%	96.0
	2172866	CHEMBL928209	Inhibition of GSK3-beta at 10 uM	B	CCn1c(=O)n(-c2ccccc2)c2nc(Nc3ccccc3)ncc21		CHEMBL256346	=	Inhibition	%	78.0	CHEMBL262	Homo sapiens	Inhibition	%	78.0
	2172867	CHEMBL928209	Inhibition of GSK3-beta at 10 uM	B	CC(C)n1c(=O)n(-c2ccccc2)c2nc(Nc3ccccc3)ncc21		CHEMBL403948	=	Inhibition	%	71.0	CHEMBL262	Homo sapiens	Inhibition	%	71.0
	2172868	CHEMBL928210	Inhibition of GSK3-beta	B	O=C(O)c1ccc(Nc2ncc3[nH]c(=O)n(-c4ccccc4)c3n2)cc1		CHEMBL257562	=	IC50	nM	4000.0	CHEMBL262	Homo sapiens	IC50	uM	4.0
	2172869	CHEMBL928210	Inhibition of GSK3-beta	B	Cn1c(=O)n(-c2ccccc2)c2nc(Nc3ccccc3)ncc21		CHEMBL256139	=	IC50	nM	1700.0	CHEMBL262	Homo sapiens	IC50	uM	1.7
	2172870	CHEMBL928210	Inhibition of GSK3-beta	B	CCn1c(=O)n(-c2ccccc2)c2nc(Nc3ccccc3)ncc21		CHEMBL256346	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	2172871	CHEMBL928210	Inhibition of GSK3-beta	B	CC(C)n1c(=O)n(-c2ccccc2)c2nc(Nc3ccccc3)ncc21		CHEMBL403948	=	IC50	nM	2900.0	CHEMBL262	Homo sapiens	IC50	uM	2.9
	2172872	CHEMBL928210	Inhibition of GSK3-beta	B	O=C(O)c1ccc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3)n2)cc1		CHEMBL257188	=	IC50	nM	150.0	CHEMBL262	Homo sapiens	IC50	uM	0.15
	2172874	CHEMBL928210	Inhibition of GSK3-beta	B	O=C1CN(c2ccccc2)c2nc(Nc3ccc(C(=O)O)cc3)ncc2N1		CHEMBL403856	=	IC50	nM	3500.0	CHEMBL262	Homo sapiens	IC50	uM	3.5
	2172875	CHEMBL928210	Inhibition of GSK3-beta	B	O=C(O)c1ccc(Nc2ncc3c(Cl)nn(-c4ccccc4)c3n2)cc1		CHEMBL253740	=	IC50	nM	180.0	CHEMBL262	Homo sapiens	IC50	uM	0.18
	2172876	CHEMBL928210	Inhibition of GSK3-beta	B	COc1nn(-c2ccccc2)c2nc(Nc3ccc(C(=O)O)cc3)ncc12		CHEMBL253533	=	IC50	nM	760.0	CHEMBL262	Homo sapiens	IC50	uM	0.76
	2172877	CHEMBL928210	Inhibition of GSK3-beta	B	Cn1c(=O)c2cnc(Nc3ccc(C(=O)O)cc3)nc2n1-c1ccccc1		CHEMBL401918	=	IC50	nM	960.0	CHEMBL262	Homo sapiens	IC50	uM	0.96
	2172878	CHEMBL928210	Inhibition of GSK3-beta	B	O=C(O)c1ccc(Nc2ncc(F)c(Nc3ccccc3)n2)cc1		CHEMBL256307	=	IC50	nM	4170.0	CHEMBL262	Homo sapiens	IC50	uM	4.17
	2172879	CHEMBL928210	Inhibition of GSK3-beta	B	O=C(O)c1ccc(Nc2ncc(C(F)(F)F)c(Nc3ccccc3)n2)cc1		CHEMBL256306	=	IC50	nM	490.0	CHEMBL262	Homo sapiens	IC50	uM	0.49
	2172880	CHEMBL928210	Inhibition of GSK3-beta	B	O=C(O)c1ccc(Nc2ncc(C3C=NN=N3)c(Nc3ccccc3)n2)cc1		CHEMBL428596	=	IC50	nM	1170.0	CHEMBL262	Homo sapiens	IC50	uM	1.17
	2172881	CHEMBL928210	Inhibition of GSK3-beta	B	O=C(O)c1ccc(Nc2ncc(-c3ccncc3)c(Nc3ccccc3)n2)cc1		CHEMBL256987	=	IC50	nM	540.0	CHEMBL262	Homo sapiens	IC50	uM	0.54
	2172882	CHEMBL928210	Inhibition of GSK3-beta	B	O=C(O)c1ccc(Nc2ncc(Br)c(Nc3ccccc3)n2)cc1		CHEMBL404687	=	IC50	nM	3200.0	CHEMBL262	Homo sapiens	IC50	uM	3.2
Not Determined	2172892	CHEMBL928210	Inhibition of GSK3-beta	B	OC12CC3CC(C1)CC(Nc1nc(N[C@H]4CC[C@H](O)CC4)ncc1F)(C3)C2		CHEMBL254587		IC50			CHEMBL262	Homo sapiens	IC50		
	2172893	CHEMBL928210	Inhibition of GSK3-beta	B	OC12CC3CC(C1)CC(Nc1nc(N[C@H]4CC[C@H](O)CC4)ncc1Cl)(C3)C2		CHEMBL257370	=	IC50	nM	230.0	CHEMBL262	Homo sapiens	IC50	nM	230.0
	2172894	CHEMBL928210	Inhibition of GSK3-beta	B	OC12CC3CC(C1)CC(Nc1nc(N[C@H]4CC[C@H](O)CC4)ncc1Br)(C3)C2		CHEMBL403385	=	IC50	nM	125.0	CHEMBL262	Homo sapiens	IC50	nM	125.0
	2172895	CHEMBL928210	Inhibition of GSK3-beta	B	OC12CC3CC(C1)CC(Nc1nc(N[C@H]4CC[C@H](O)CC4)ncc1C(F)(F)F)(C3)C2		CHEMBL255905	=	IC50	nM	41.0	CHEMBL262	Homo sapiens	IC50	nM	41.0
	2172896	CHEMBL928210	Inhibition of GSK3-beta	B	OC12CC3CC(C1)CC(n1nnc4cnc(N[C@H]5CC[C@H](O)CC5)nc41)(C3)C2		CHEMBL254155	=	IC50	nM	744.0	CHEMBL262	Homo sapiens	IC50	nM	744.0
	2172897	CHEMBL928210	Inhibition of GSK3-beta	B	O=[N+]([O-])c1cnc(N[C@H]2CC[C@H](O)CC2)nc1NC12CC3CC(CC(O)(C3)C1)C2		CHEMBL404174	=	IC50	nM	198.0	CHEMBL262	Homo sapiens	IC50	nM	198.0
	2172898	CHEMBL928210	Inhibition of GSK3-beta	B	O=C(O)COc1ccc(Nc2ncc3nnn(C45CC6CC(CC(O)(C6)C4)C5)c3n2)cc1		CHEMBL254350	=	IC50	nM	169.0	CHEMBL262	Homo sapiens	IC50	nM	169.0
	2172899	CHEMBL928210	Inhibition of GSK3-beta	B	O=C(O)CCc1ccc(Nc2ncc([N+](=O)[O-])c(NC34CC5CC(CC(C5)C3)C4)n2)cc1		CHEMBL404175	=	IC50	nM	105.0	CHEMBL262	Homo sapiens	IC50	nM	105.0
	2172900	CHEMBL928210	Inhibition of GSK3-beta	B	O=C(O)c1ccc(Nc2ncc3nnn(C45CC6CC(CC(O)(C6)C4)C5)c3n2)cc1		CHEMBL257575	=	IC50	nM	51.0	CHEMBL262	Homo sapiens	IC50	nM	51.0
	2172901	CHEMBL928210	Inhibition of GSK3-beta	B	O=C(O)c1ccc(Nc2ncc3nnn(C45CC6CC(CC(C6)C4)C5)c3n2)cc1		CHEMBL257577	=	IC50	nM	75.0	CHEMBL262	Homo sapiens	IC50	nM	75.0
	2172902	CHEMBL928210	Inhibition of GSK3-beta	B	O=C(O)c1ccc(Nc2ncc([N+](=O)[O-])c(NC34CC5CC(CC(C5)C3)C4)n2)cc1		CHEMBL253748	=	IC50	nM	26.0	CHEMBL262	Homo sapiens	IC50	nM	26.0
	2172903	CHEMBL928210	Inhibition of GSK3-beta	B	O=C1OC(Nc2ncc3nnn(-c4ccccc4)c3n2)c2ccccc21		CHEMBL253956	=	IC50	nM	23.0	CHEMBL262	Homo sapiens	IC50	nM	23.0
	2172904	CHEMBL928210	Inhibition of GSK3-beta	B	COC(=O)COc1ccc(Nc2ncc3nnn(-c4ccccc4)c3n2)cc1		CHEMBL404242	=	IC50	nM	477.0	CHEMBL262	Homo sapiens	IC50	nM	477.0
	2172905	CHEMBL928210	Inhibition of GSK3-beta	B	O=C(O)COc1ccc(Nc2ncc3nnn(-c4ccccc4)c3n2)cc1		CHEMBL402541	=	IC50	nM	13.0	CHEMBL262	Homo sapiens	IC50	nM	13.0
	2172906	CHEMBL928210	Inhibition of GSK3-beta	B	O=C(O)COc1ccc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3)n2)cc1		CHEMBL402969	=	IC50	nM	92.0	CHEMBL262	Homo sapiens	IC50	nM	92.0
	2172907	CHEMBL928210	Inhibition of GSK3-beta	B	O=C(O)/C=C\c1ccc(Nc2ncc3nnn(-c4ccccc4)c3n2)cc1		CHEMBL255735	=	IC50	nM	7.0	CHEMBL262	Homo sapiens	IC50	nM	7.0
	2172908	CHEMBL928210	Inhibition of GSK3-beta	B	O[C@H]1CC[C@H](Nc2ncc3nnn(-c4ccccc4)c3n2)CC1		CHEMBL255948	=	IC50	nM	279.0	CHEMBL262	Homo sapiens	IC50	nM	279.0
	2172909	CHEMBL928210	Inhibition of GSK3-beta	B	O=[N+]([O-])c1cnc(N[C@H]2CC[C@H](O)CC2)nc1Nc1ccccc1		CHEMBL256517	=	IC50	nM	281.0	CHEMBL262	Homo sapiens	IC50	nM	281.0
	2172910	CHEMBL928210	Inhibition of GSK3-beta	B	O=C(O)CCc1ccc(Nc2ncc3nnn(-c4ccccc4)c3n2)cc1		CHEMBL404565	=	IC50	nM	24.0	CHEMBL262	Homo sapiens	IC50	nM	24.0
	2172911	CHEMBL928210	Inhibition of GSK3-beta	B	O=C(O)c1ccc(Nc2ncc3nnn(-c4ccccc4)c3n2)cc1		CHEMBL402932	=	IC50	nM	49.0	CHEMBL262	Homo sapiens	IC50	nM	49.0
	2172912	CHEMBL928210	Inhibition of GSK3-beta	B	c1ccc(Nc2ncc3nnn(-c4ccccc4)c3n2)cc1		CHEMBL256518	=	IC50	nM	628.0	CHEMBL262	Homo sapiens	IC50	nM	628.0
	2172913	CHEMBL928210	Inhibition of GSK3-beta	B	O=[N+]([O-])c1cnc(Nc2ccccc2)nc1Nc1ccccc1		CHEMBL256366	=	IC50	nM	2800.0	CHEMBL262	Homo sapiens	IC50	nM	2800.0
	2172963	CHEMBL928209	Inhibition of GSK3-beta at 10 uM	B	COC(=O)COc1ccc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3)n2)cc1		CHEMBL253958	=	Inhibition	%	41.0	CHEMBL262	Homo sapiens	Inhibition	%	41.0
	2172964	CHEMBL928210	Inhibition of GSK3-beta	B	O=C(O)c1ccc(Nc2ncc([N+](=O)[O-])c(NC34CC5CC(CC(O)(C5)C3)C4)n2)cc1		CHEMBL402902	=	IC50	nM	3.0	CHEMBL262	Homo sapiens	IC50	nM	3.0
	2182424	CHEMBL941322	Inhibition of human GSK3-beta at 1 uM	B	CS(=O)(=O)c1cccc(CNc2nc(Nc3ccc4c(c3)CCC(=O)N4)ncc2C(F)(F)F)c1		CHEMBL514554	=	Inhibition	%	64.0	CHEMBL262	Homo sapiens	INH	%	64.0
	2182453	CHEMBL941346	Inhibition of human GSK3-beta	B	CS(=O)(=O)c1cccc(CNc2nc(Nc3ccc4c(c3)CCC(=O)N4)ncc2C(F)(F)F)c1		CHEMBL514554	>	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	nM	1000.0
	2182811	CHEMBL941437	Inhibition of GSK3B at 5 uM	B	O=c1cc(N2CCOCC2)nc2c3ccccc3ccn12		CHEMBL179242	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	INH	%	0.0
	2206787	CHEMBL966744	Inhibition of GSK3-beta	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	2239380	CHEMBL980069	Inhibition of GSK3-beta assessed as residual enzyme activity at 1 uM	B	Cc1ncc(NC(=O)c2cc(NC(=O)c3cccc(C(F)(F)F)c3)ccc2Cl)s1		CHEMBL462132	=	Activity	%	91.0	CHEMBL262	Homo sapiens	Activity	%	91.0
	2239722	CHEMBL996951	Inhibition of GSK3-beta at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1c2c2cc(O)ccc2n1CCCc1nnn[nH]1		CHEMBL471329	=	Inhibition	%	1.0	CHEMBL262	Homo sapiens	INH	%	1.0
	2239750	CHEMBL996951	Inhibition of GSK3-beta at 10 uM	B	CS(=O)(=O)NC(=O)CCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL460940	=	Inhibition	%	17.0	CHEMBL262	Homo sapiens	INH	%	17.0
	2239778	CHEMBL996951	Inhibition of GSK3-beta at 10 uM	B	CN(C)CCNC(=O)CCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL462011	=	Inhibition	%	93.0	CHEMBL262	Homo sapiens	INH	%	93.0
	2239806	CHEMBL996951	Inhibition of GSK3-beta at 10 uM	B	CNCCCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL508541	=	Inhibition	%	72.0	CHEMBL262	Homo sapiens	INH	%	72.0
	2239834	CHEMBL996951	Inhibition of GSK3-beta at 10 uM	B	CNCCCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4)cc21)C(=O)NC3=O		CHEMBL455192	=	Inhibition	%	61.0	CHEMBL262	Homo sapiens	INH	%	61.0
	2239862	CHEMBL996951	Inhibition of GSK3-beta at 10 uM	B	O=C1NC(=O)c2c1c(-c1c(Cl)cccc1Cl)cc1c2c2cc(O)ccc2n1CCCO		CHEMBL471163	=	Inhibition	%	37.0	CHEMBL262	Homo sapiens	INH	%	37.0
	2239889	CHEMBL996951	Inhibition of GSK3-beta at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1c2c2cc(O)ccc2n1CCCO		CHEMBL411662	=	Inhibition	%	4.0	CHEMBL262	Homo sapiens	INH	%	4.0
	2239917	CHEMBL996951	Inhibition of GSK3-beta at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1[nH]c3ccc(O)cc3c21		CHEMBL379975	=	Inhibition	%	35.0	CHEMBL262	Homo sapiens	INH	%	35.0
Not Active	2240598	CHEMBL972661	Inhibition of GSK3b at 30 uM	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(C(F)(F)F)cc3)c2)n1		CHEMBL523411		Activity			CHEMBL262	Homo sapiens	Activity		
	2248207	CHEMBL1012690	Inhibition of GSK3-beta at 5 uM	B	O=C1NC(=O)/C(=C/c2cccc(C(F)(F)F)c2)S1		CHEMBL183906	=	Inhibition	%	-1.0	CHEMBL262	Homo sapiens	INH	%	-1.0
	2248236	CHEMBL1012690	Inhibition of GSK3-beta at 5 uM	B	CCCOc1ccc(/C=C2\SC(=O)NC2=O)cc1		CHEMBL84558	=	Inhibition	%	3.0	CHEMBL262	Homo sapiens	INH	%	3.0
	2250920	CHEMBL1022464	Inhibition of GSK3-beta	B	Nc1nccc(-c2cc3c([nH]2)[C@@H](CCF)CNC3=O)n1		CHEMBL524266	=	IC50	nM	146.0	CHEMBL262	Homo sapiens	IC50	uM	0.146
	2251042	CHEMBL1011917	Inhibition of GSK3-beta at 100 nM relative to control	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL525385	=	Inhibition	%	16.0	CHEMBL262	Homo sapiens	INH	%	16.0
	2251200	CHEMBL1009899	Inhibition of GSK3-beta	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	IC50	nM	1.0	CHEMBL262	Homo sapiens	IC50	nM	1.0
	2254028	CHEMBL1002020	Inhibition of GSK3-beta by scintillation proximity assay	B	c1cnn2ncc(-c3ccnc(NC4CC4)n3)c2c1		CHEMBL525194	=	IC50	nM	1600.0	CHEMBL262	Homo sapiens	IC50	uM	1.6
	2254029	CHEMBL1002020	Inhibition of GSK3-beta by scintillation proximity assay	B	COc1ccc2c(-c3ccnc(NC4CC4)n3)cnn2n1		CHEMBL523747	=	IC50	nM	25000.0	CHEMBL262	Homo sapiens	IC50	uM	25.0
	2254030	CHEMBL1002020	Inhibition of GSK3-beta by scintillation proximity assay	B	c1cc(-c2cnn3nc(NC4CCCC4)ccc23)nc(NC2CC2)n1		CHEMBL496778	=	IC50	nM	25000.0	CHEMBL262	Homo sapiens	IC50	uM	25.0
	2254031	CHEMBL1002020	Inhibition of GSK3-beta by scintillation proximity assay	B	C=Cc1ccc2c(-c3ccnc(NC4CC4)n3)cnn2n1		CHEMBL496779	=	IC50	nM	3200.0	CHEMBL262	Homo sapiens	IC50	uM	3.2
	2254032	CHEMBL1002020	Inhibition of GSK3-beta by scintillation proximity assay	B	c1csc(-c2ccc3c(-c4ccnc(NC5CC5)n4)cnn3n2)c1		CHEMBL503212	>	IC50	nM	32000.0	CHEMBL262	Homo sapiens	IC50	uM	32.0
	2254033	CHEMBL1002020	Inhibition of GSK3-beta by scintillation proximity assay	B	Fc1ccc(-c2ccc3c(-c4ccnc(NC5CC5)n4)cnn3n2)cc1		CHEMBL495570	>	IC50	nM	32000.0	CHEMBL262	Homo sapiens	IC50	uM	32.0
	2254034	CHEMBL1002020	Inhibition of GSK3-beta by scintillation proximity assay	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	IC50	nM	25000.0	CHEMBL262	Homo sapiens	IC50	uM	25.0
	2254035	CHEMBL1002020	Inhibition of GSK3-beta by scintillation proximity assay	B	c1cc(-c2cnn3nc(N4CCCC4)ccc23)nc(NC2CC2)n1		CHEMBL497196	=	IC50	nM	25000.0	CHEMBL262	Homo sapiens	IC50	uM	25.0
	2254036	CHEMBL1002020	Inhibition of GSK3-beta by scintillation proximity assay	B	Oc1ccc2c(-c3ccnc(NC4CC4)n3)cnn2n1		CHEMBL497398	=	IC50	nM	25000.0	CHEMBL262	Homo sapiens	IC50	uM	25.0
	2254037	CHEMBL1002020	Inhibition of GSK3-beta by scintillation proximity assay	B	CC(C)Oc1ccc2c(-c3ccnc(NC4CC4)n3)cnn2n1		CHEMBL445757	=	IC50	nM	25000.0	CHEMBL262	Homo sapiens	IC50	uM	25.0
	2254038	CHEMBL1002020	Inhibition of GSK3-beta by scintillation proximity assay	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	>	IC50	nM	32000.0	CHEMBL262	Homo sapiens	IC50	uM	32.0
	2254039	CHEMBL1002020	Inhibition of GSK3-beta by scintillation proximity assay	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	2254040	CHEMBL1002020	Inhibition of GSK3-beta by scintillation proximity assay	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	IC50	nM	32000.0	CHEMBL262	Homo sapiens	IC50	uM	32.0
	2254041	CHEMBL1002020	Inhibition of GSK3-beta by scintillation proximity assay	B	c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359554	=	IC50	nM	32.0	CHEMBL262	Homo sapiens	IC50	uM	0.032
	2254042	CHEMBL1002020	Inhibition of GSK3-beta by scintillation proximity assay	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	IC50	nM	16.0	CHEMBL262	Homo sapiens	IC50	uM	0.016
	2254043	CHEMBL1002020	Inhibition of GSK3-beta by scintillation proximity assay	B	CCN(CC)Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL513354	=	IC50	nM	79.0	CHEMBL262	Homo sapiens	IC50	uM	0.079
	2254044	CHEMBL1002020	Inhibition of GSK3-beta by scintillation proximity assay	B	O=[N+]([O-])c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL188938	=	IC50	nM	5.0	CHEMBL262	Homo sapiens	IC50	uM	0.005
	2254045	CHEMBL1002020	Inhibition of GSK3-beta by scintillation proximity assay	B	O=[N+]([O-])c1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL526110	=	IC50	nM	2.0	CHEMBL262	Homo sapiens	IC50	uM	0.002
	2254046	CHEMBL1002020	Inhibition of GSK3-beta by scintillation proximity assay	B	N#Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359794	=	IC50	nM	5.0	CHEMBL262	Homo sapiens	IC50	uM	0.005
	2254047	CHEMBL1002020	Inhibition of GSK3-beta by scintillation proximity assay	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	IC50	nM	10.0	CHEMBL262	Homo sapiens	IC50	uM	0.01
	2254048	CHEMBL1002020	Inhibition of GSK3-beta by scintillation proximity assay	B	c1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(-c2cocn2)c1		CHEMBL497564	=	IC50	nM	8.0	CHEMBL262	Homo sapiens	IC50	uM	0.008
	2254049	CHEMBL1002020	Inhibition of GSK3-beta by scintillation proximity assay	B	NC(=O)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL523735	=	IC50	nM	20.0	CHEMBL262	Homo sapiens	IC50	uM	0.02
	2254050	CHEMBL1002020	Inhibition of GSK3-beta by scintillation proximity assay	B	O=C(O)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL524059	=	IC50	nM	50.0	CHEMBL262	Homo sapiens	IC50	uM	0.05
	2254051	CHEMBL1002020	Inhibition of GSK3-beta by scintillation proximity assay	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	IC50	nM	16.0	CHEMBL262	Homo sapiens	IC50	uM	0.016
	2254052	CHEMBL1002020	Inhibition of GSK3-beta by scintillation proximity assay	B	CCN(CC)CCNC(=O)c1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495751	=	IC50	nM	20.0	CHEMBL262	Homo sapiens	IC50	uM	0.02
	2254053	CHEMBL1002020	Inhibition of GSK3-beta by scintillation proximity assay	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5nc(-c6ccc(F)cc6)ccc45)n3)cc2)CC1		CHEMBL522718	>	IC50	nM	25000.0	CHEMBL262	Homo sapiens	IC50	uM	25.0
	2254054	CHEMBL1002020	Inhibition of GSK3-beta by scintillation proximity assay	B	CC(C)Oc1ccc2c(-c3ccnc(Nc4ccc(N5CCN(C)CC5)cc4)n3)cnn2n1		CHEMBL496162	=	IC50	nM	850.0	CHEMBL262	Homo sapiens	IC50	uM	0.85
	2254055	CHEMBL1002020	Inhibition of GSK3-beta by scintillation proximity assay	B	CN(C)CC(O)COc1ccc(Nc2nccc(-c3cnn4nc(N5CCOCC5)ccc34)n2)cc1		CHEMBL521871	=	IC50	nM	690.0	CHEMBL262	Homo sapiens	IC50	uM	0.69
	2254074	CHEMBL1002020	Inhibition of GSK3-beta by scintillation proximity assay	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2)CC1		CHEMBL495545	=	IC50	nM	200.0	CHEMBL262	Homo sapiens	IC50	uM	0.2
	2256989	CHEMBL1001222	Inhibition of GSK3-beta	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	IC50	nM	2200.0	CHEMBL262	Homo sapiens	IC50	uM	2.2
	2268421	CHEMBL960825	Inhibition of GSK3-beta at 10 uM	B	Clc1cccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)c1		CHEMBL522629	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2268669	CHEMBL960825	Inhibition of GSK3-beta at 10 uM	B	Clc1cccc(-n2cc(-c3ccccc3NCc3c[nH]cn3)nn2)c1		CHEMBL464619	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2268670	CHEMBL960825	Inhibition of GSK3-beta at 10 uM	B	FC(F)(F)c1cccc(-n2cc(-c3ccccc3NCc3ccnc4ccccc34)nn2)c1		CHEMBL517021	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2268671	CHEMBL960825	Inhibition of GSK3-beta at 10 uM	B	Clc1cccc(-n2cc(-c3ccccc3NCc3ccnc4ccccc34)nn2)c1		CHEMBL516635	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2268672	CHEMBL960825	Inhibition of GSK3-beta at 10 uM	B	FC(F)(F)c1cccc(-n2cc(-c3ccccc3NCc3ccc4c(c3)OCO4)nn2)c1		CHEMBL460959	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2268673	CHEMBL960825	Inhibition of GSK3-beta at 10 uM	B	Clc1cccc(-n2cc(-c3ccccc3NCc3ccc4c(c3)OCO4)nn2)c1		CHEMBL460958	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2268674	CHEMBL960825	Inhibition of GSK3-beta at 10 uM	B	Fc1ccc(CNc2ccccc2-c2cn(-c3cccc(Cl)c3)nn2)cc1F		CHEMBL460751	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2268675	CHEMBL960825	Inhibition of GSK3-beta at 10 uM	B	Cc1cc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)ccc1C(F)(F)F		CHEMBL454403	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2268676	CHEMBL960825	Inhibition of GSK3-beta at 10 uM	B	Cc1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1C(F)(F)F		CHEMBL523320	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2268677	CHEMBL960825	Inhibition of GSK3-beta at 10 uM	B	Clc1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1Cl		CHEMBL491872	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2268678	CHEMBL960825	Inhibition of GSK3-beta at 10 uM	B	FC(F)(F)c1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1Cl		CHEMBL491871	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2268679	CHEMBL960825	Inhibition of GSK3-beta at 10 uM	B	FC(F)(F)c1cc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)ccc1Cl		CHEMBL522133	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2268680	CHEMBL960825	Inhibition of GSK3-beta at 10 uM	B	c1ccc(-c2cn(-c3ccc4[nH]ncc4c3)nn2)c(NCc2ccncc2)c1		CHEMBL516645	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2268681	CHEMBL960825	Inhibition of GSK3-beta at 10 uM	B	c1ccc(-c2cn(-c3ccc4ccccc4n3)nn2)c(NCc2ccncc2)c1		CHEMBL461605	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2268682	CHEMBL960825	Inhibition of GSK3-beta at 10 uM	B	CC(C)(C)c1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1		CHEMBL461392	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2268683	CHEMBL960825	Inhibition of GSK3-beta at 10 uM	B	CC(C)(C)c1cccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)c1		CHEMBL461391	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2268684	CHEMBL960825	Inhibition of GSK3-beta at 10 uM	B	CC(C)c1cccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)c1		CHEMBL518652	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2268685	CHEMBL960825	Inhibition of GSK3-beta at 10 uM	B	FC(F)(F)Oc1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1		CHEMBL491681	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2268686	CHEMBL960825	Inhibition of GSK3-beta at 10 uM	B	FC(F)(F)c1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1		CHEMBL522304	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2268687	CHEMBL960825	Inhibition of GSK3-beta at 10 uM	B	Clc1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1		CHEMBL491680	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2268688	CHEMBL960825	Inhibition of GSK3-beta at 10 uM	B	FC(F)(F)Oc1cccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)c1		CHEMBL491502	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2268689	CHEMBL960825	Inhibition of GSK3-beta at 10 uM	B	FC(F)(F)c1cccc(-n2cc(-c3ccccc3NCc3ccccn3)nn2)c1		CHEMBL523133	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2268690	CHEMBL960825	Inhibition of GSK3-beta at 10 uM	B	FC(F)(F)c1cccc(-n2cc(-c3ccccc3NCc3cccnc3)nn2)c1		CHEMBL490969	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2268691	CHEMBL960825	Inhibition of GSK3-beta at 10 uM	B	FC(F)(F)c1cccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)c1		CHEMBL490968	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2268692	CHEMBL960825	Inhibition of GSK3-beta at 10 uM	B	Clc1cccc(-n2cc(-c3ccccc3NCc3ccccn3)nn2)c1		CHEMBL523301	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2268693	CHEMBL960825	Inhibition of GSK3-beta at 10 uM	B	Clc1cccc(-n2cc(-c3ccccc3NCc3cccnc3)nn2)c1		CHEMBL489329	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2279735	CHEMBL958300	Inhibition of GSK3-beta at 10 uM	B	CN1CCCN(c2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1		CHEMBL493937	>	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
Not Active	2298911	CHEMBL1018057	Inhibition of human GSK3-beta at 10 umol/L	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C(=O)N(C)C)cc1)c1ccccc1		CHEMBL525203		Activity			CHEMBL262	Homo sapiens	Activity		
Not Active	2298921	CHEMBL1018057	Inhibition of human GSK3-beta at 10 umol/L	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL497049		Activity			CHEMBL262	Homo sapiens	Activity		
Not Active	2298935	CHEMBL1018057	Inhibition of human GSK3-beta at 10 umol/L	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835		Activity			CHEMBL262	Homo sapiens	Activity		
Not Active	2302162	CHEMBL950831	Inhibition of GSK3-beta at 10 uM	B	Nc1ncnc2ncn(CC(=O)c3c[nH]c4ccccc34)c12		CHEMBL485246		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	2356953	CHEMBL955844	Inhibition of GSK3-beta at 1 uM relative to control	B	Cc1ccn(-c2cccc(C(F)(F)F)c2)c(=O)c1-c1ccc2nc(N)ncc2c1		CHEMBL504805	>	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	2356998	CHEMBL964652	Inhibition of GSK3-beta at 1 uM relative to control	B	Cc1ccn(-c2ccc(-c3ncco3)cc2)c(=O)c1-c1ccc2nc(N)ncc2c1		CHEMBL525893	>	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	2395409	CHEMBL957089	Inhibition of GSK3-beta	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	IC50	nM	2000.0	CHEMBL262	Homo sapiens	IC50	nM	2000.0
	2396088	CHEMBL1006327	Inhibition of GSK3-beta at 1 uM relative to control	B	COc1ccc(/C=N/Nc2[nH]nc(C)c2C(=O)Nc2cccc(NC(C)=O)c2)cc1		CHEMBL515560	=	Inhibition	%	32.0	CHEMBL262	Homo sapiens	INH	%	32.0
	2402833	CHEMBL963374	Inhibition of human GSK3-beta by scintillation counting	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	IC50	nM	41.8	CHEMBL262	Homo sapiens	IC50	nM	41.8
	2402834	CHEMBL963374	Inhibition of human GSK3-beta by scintillation counting	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714	=	IC50	nM	50.0	CHEMBL262	Homo sapiens	IC50	nM	50.0
	2402835	CHEMBL963374	Inhibition of human GSK3-beta by scintillation counting	B	Cn1cc(C2=C(c3coc4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL301138	=	IC50	nM	35.0	CHEMBL262	Homo sapiens	IC50	nM	35.0
	2402836	CHEMBL963374	Inhibition of human GSK3-beta by scintillation counting	B	Cn1cc(C2=C(c3coc4cc(CO)ccc34)C(=O)NC2=O)c2cc(F)ccc21		CHEMBL477038	=	IC50	nM	0.35	CHEMBL262	Homo sapiens	IC50	nM	0.35
	2402837	CHEMBL963374	Inhibition of human GSK3-beta by scintillation counting	B	COCc1ccc2c(C3=C(c4cn(C)c5ccc(F)cc45)C(=O)NC3=O)coc2c1		CHEMBL516261	=	IC50	nM	23.8	CHEMBL262	Homo sapiens	IC50	nM	23.8
	2402838	CHEMBL963374	Inhibition of human GSK3-beta by scintillation counting	B	Cn1cc(C2=C(c3coc4cc(O)ccc34)C(=O)NC2=O)c2cc(F)ccc21		CHEMBL489210	=	IC50	nM	3.5	CHEMBL262	Homo sapiens	IC50	nM	3.5
	2402839	CHEMBL963374	Inhibition of human GSK3-beta by scintillation counting	B	COc1cccc2c(C3=C(c4cn(C)c5cc(I)c(F)cc45)C(=O)NC3=O)coc12		CHEMBL523435	=	IC50	nM	247.0	CHEMBL262	Homo sapiens	IC50	nM	247.0
	2402840	CHEMBL963374	Inhibition of human GSK3-beta by scintillation counting	B	Cn1cc(C2=C(c3coc4ccccc34)C(=O)NC2=O)c2cc(F)c(Cl)cc21		CHEMBL489407	=	IC50	nM	184.0	CHEMBL262	Homo sapiens	IC50	nM	184.0
	2402841	CHEMBL963374	Inhibition of human GSK3-beta by scintillation counting	B	Cn1cc(C2=C(c3coc4cc(CO)ccc34)C(=O)NC2=O)c2cc(F)c(Cl)cc21		CHEMBL522590	=	IC50	nM	0.95	CHEMBL262	Homo sapiens	IC50	nM	0.95
	2402842	CHEMBL963374	Inhibition of human GSK3-beta by scintillation counting	B	COc1ccc2c(C3=C(c4cn(C)c5cc(Cl)c(F)cc45)C(=O)NC3=O)coc2c1		CHEMBL521774	=	IC50	nM	870.0	CHEMBL262	Homo sapiens	IC50	nM	870.0
	2402843	CHEMBL963374	Inhibition of human GSK3-beta by scintillation counting	B	Cn1cc(C2=C(c3coc4cc(OCC5CC5)ccc34)C(=O)NC2=O)c2cc(F)c(Cl)cc21		CHEMBL490639	=	IC50	nM	1290.0	CHEMBL262	Homo sapiens	IC50	nM	1290.0
	2402844	CHEMBL963374	Inhibition of human GSK3-beta by scintillation counting	B	Cn1cc(C2=C(c3coc4cc(OCC5CCC5)ccc34)C(=O)NC2=O)c2cc(F)c(Cl)cc21		CHEMBL489413	=	IC50	nM	4090.0	CHEMBL262	Homo sapiens	IC50	nM	4090.0
	2402845	CHEMBL963374	Inhibition of human GSK3-beta by scintillation counting	B	COc1cccc2c(C3=C(c4cn(C)c5cc(Cl)c(F)cc45)C(=O)NC3=O)coc12		CHEMBL522760	=	IC50	nM	260.0	CHEMBL262	Homo sapiens	IC50	nM	260.0
	2402846	CHEMBL963374	Inhibition of human GSK3-beta by scintillation counting	B	COc1cccc2c(C3=C(c4cn(C)c5cc(-c6ccc(Cl)cc6)c(F)cc45)C(=O)NC3=O)coc12		CHEMBL489421	=	IC50	nM	7160.0	CHEMBL262	Homo sapiens	IC50	nM	7160.0
	2402847	CHEMBL963374	Inhibition of human GSK3-beta by scintillation counting	B	Cn1cc(C2=C(c3coc4ccccc34)C(=O)NC2=O)c2cc(Br)ccc21		CHEMBL489422	=	IC50	nM	7.0	CHEMBL262	Homo sapiens	IC50	nM	7.0
	2402848	CHEMBL963374	Inhibition of human GSK3-beta by scintillation counting	B	COc1cccc2c(C3=C(c4cn(C)c5ccc(Br)cc45)C(=O)NC3=O)coc12		CHEMBL505673	=	IC50	nM	7.5	CHEMBL262	Homo sapiens	IC50	nM	7.5
	2402849	CHEMBL963374	Inhibition of human GSK3-beta by scintillation counting	B	Cn1cc(C2=C(c3coc4cc(CO)ccc34)C(=O)NC2=O)c2cc(Br)ccc21		CHEMBL489833	=	IC50	nM	0.51	CHEMBL262	Homo sapiens	IC50	nM	0.51
	2402850	CHEMBL963374	Inhibition of human GSK3-beta by scintillation counting	B	C#CCOc1ccc2c(C3=C(c4cn(C)c5ccc(Br)cc45)C(=O)NC3=O)coc2c1		CHEMBL489435	=	IC50	nM	25.3	CHEMBL262	Homo sapiens	IC50	nM	25.3
	2402851	CHEMBL963374	Inhibition of human GSK3-beta by scintillation counting	B	C=CCOc1ccc2c(C3=C(c4cn(C)c5ccc(Br)cc45)C(=O)NC3=O)coc2c1		CHEMBL489845	=	IC50	nM	48.3	CHEMBL262	Homo sapiens	IC50	nM	48.3
	2402852	CHEMBL963374	Inhibition of human GSK3-beta by scintillation counting	B	COc1ccc(COc2ccc3c(C4=C(c5cn(C)c6ccc(Br)cc56)C(=O)NC4=O)coc3c2)cc1		CHEMBL490044	=	IC50	nM	335.0	CHEMBL262	Homo sapiens	IC50	nM	335.0
	2402853	CHEMBL963374	Inhibition of human GSK3-beta by scintillation counting	B	Cn1cc(C2=C(c3coc4ccc(F)cc34)C(=O)NC2=O)c2cc(Cl)ccc21		CHEMBL523113	=	IC50	nM	42.0	CHEMBL262	Homo sapiens	IC50	nM	42.0
	2402854	CHEMBL963374	Inhibition of human GSK3-beta by scintillation counting	B	COc1cccc2c(C3=C(c4cn(C)c5c(Br)cc(Br)cc45)C(=O)NC3=O)coc12		CHEMBL489043	=	IC50	nM	88.7	CHEMBL262	Homo sapiens	IC50	nM	88.7
	2402855	CHEMBL963374	Inhibition of human GSK3-beta by scintillation counting	B	Cn1cc(C2=C(c3coc4ccccc34)C(=O)NC2=O)c2cc(I)ccc21		CHEMBL522751	=	IC50	nM	34.5	CHEMBL262	Homo sapiens	IC50	nM	34.5
	2402856	CHEMBL963374	Inhibition of human GSK3-beta by scintillation counting	B	Cn1cc(C2=C(c3coc4ccc(F)cc34)C(=O)NC2=O)c2cc(I)ccc21		CHEMBL490860	=	IC50	nM	180.0	CHEMBL262	Homo sapiens	IC50	nM	180.0
	2402857	CHEMBL963374	Inhibition of human GSK3-beta by scintillation counting	B	Cn1cc(C2=C(c3coc4cc(CO)ccc34)C(=O)NC2=O)c2cc(C#N)ccc21		CHEMBL490861	=	IC50	nM	13.2	CHEMBL262	Homo sapiens	IC50	nM	13.2
	2402858	CHEMBL963374	Inhibition of human GSK3-beta by scintillation counting	B	Cn1cc(C2=C(c3coc4ccccc34)C(=O)NC2=O)c2cc(C3CC3)ccc21		CHEMBL491064	=	IC50	nM	235.0	CHEMBL262	Homo sapiens	IC50	nM	235.0
	2402859	CHEMBL963374	Inhibition of human GSK3-beta by scintillation counting	B	Cn1cc(C2=C(c3coc4ccc(F)cc34)C(=O)NC2=O)c2cc(C#CC3CC3)ccc21		CHEMBL484685	=	IC50	nM	16.1	CHEMBL262	Homo sapiens	IC50	nM	16.1
	2402860	CHEMBL963374	Inhibition of human GSK3-beta by scintillation counting	B	Cn1cc(C2=C(c3coc4ccc(F)cc34)C(=O)NC2=O)c2cc3c(cc21)OCO3		CHEMBL483465	=	IC50	nM	710.0	CHEMBL262	Homo sapiens	IC50	nM	710.0
	2402861	CHEMBL963374	Inhibition of human GSK3-beta by scintillation counting	B	COc1cc2c(C3=C(c4coc5ccccc45)C(=O)NC3=O)cn(C)c2cc1Cl		CHEMBL483669	=	IC50	nM	440.0	CHEMBL262	Homo sapiens	IC50	nM	440.0
	2402862	CHEMBL963374	Inhibition of human GSK3-beta by scintillation counting	B	COc1cc2c(C3=C(c4coc5ccccc45)C(=O)NC3=O)cn(C)c2cc1I		CHEMBL520147	=	IC50	nM	223.0	CHEMBL262	Homo sapiens	IC50	nM	223.0
	2402863	CHEMBL963374	Inhibition of human GSK3-beta by scintillation counting	B	Cn1cc(C2=C(c3coc4ccccc34)C(=O)NC2=O)c2ccc(O)cc21		CHEMBL503469	=	IC50	nM	15.0	CHEMBL262	Homo sapiens	IC50	nM	15.0
	2402864	CHEMBL963374	Inhibition of human GSK3-beta by scintillation counting	B	COc1cccc2c(C3=C(c4cn(C)c5cc(C(F)(F)F)ccc45)C(=O)NC3=O)coc12		CHEMBL482632	=	IC50	nM	830.0	CHEMBL262	Homo sapiens	IC50	nM	830.0
	2402865	CHEMBL963374	Inhibition of human GSK3-beta by scintillation counting	B	Cn1cc(C2=C(c3coc4ccccc34)C(=O)NC2=O)c2cccc(CO)c21		CHEMBL522464	=	IC50	nM	5.4	CHEMBL262	Homo sapiens	IC50	nM	5.4
	2402866	CHEMBL963374	Inhibition of human GSK3-beta by scintillation counting	B	Cn1cc(C2=C(c3coc4cc(CO)ccc34)C(=O)NC2=O)c2cccc(CO)c21		CHEMBL491447	=	IC50	nM	5.1	CHEMBL262	Homo sapiens	IC50	nM	5.1
	2402867	CHEMBL963374	Inhibition of human GSK3-beta by scintillation counting	B	COCc1cccc2c(C3=C(c4coc5ccccc45)C(=O)NC3=O)cn(C)c12		CHEMBL491647	=	IC50	nM	0.23	CHEMBL262	Homo sapiens	IC50	nM	0.23
	2402868	CHEMBL963374	Inhibition of human GSK3-beta by scintillation counting	B	COCc1cccc2c(C3=C(c4coc5cc(CO)ccc45)C(=O)NC3=O)cn(C)c12		CHEMBL490636	=	IC50	nM	0.73	CHEMBL262	Homo sapiens	IC50	nM	0.73
	2402869	CHEMBL963374	Inhibition of human GSK3-beta by scintillation counting	B	CCOC(=O)CCc1cccc2c(C3=C(c4coc5ccccc45)C(=O)NC3=O)cn(C)c12		CHEMBL490637	=	IC50	nM	10.2	CHEMBL262	Homo sapiens	IC50	nM	10.2
	2402870	CHEMBL963374	Inhibition of human GSK3-beta by scintillation counting	B	Cn1cc(C2=C(c3coc4ccccc34)C(=O)NC2=O)c2cccc(CCC(=O)O)c21		CHEMBL490842	=	IC50	nM	1.2	CHEMBL262	Homo sapiens	IC50	nM	1.2
	2402871	CHEMBL963374	Inhibition of human GSK3-beta by scintillation counting	B	Cn1cc(C2=C(c3coc4ccccc34)C(=O)NC2=O)c2cccc(O)c21		CHEMBL489410	=	IC50	nM	55.0	CHEMBL262	Homo sapiens	IC50	nM	55.0
	2402872	CHEMBL963374	Inhibition of human GSK3-beta by scintillation counting	B	Cn1cc(C2=C(c3coc4cc(F)c(F)cc34)C(=O)NC2=O)c2ccc3ccccc3c21		CHEMBL491859	=	IC50	nM	314.0	CHEMBL262	Homo sapiens	IC50	nM	314.0
	2405686	CHEMBL953453	Inhibition of GSK3-beta	B	O=c1[nH]c2[nH]cc(-c3ccc(Cl)cc3)c2n2cccc12		CHEMBL516901	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	2405687	CHEMBL953453	Inhibition of GSK3-beta	B	COc1ccc(-c2c[nH]c3[nH]c(=O)c4cccn4c23)cc1OC		CHEMBL453402	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	2405688	CHEMBL953453	Inhibition of GSK3-beta	B	O=c1[nH]c2occ(-c3ccc(Br)cc3)c2n2cccc12		CHEMBL477954	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	2405689	CHEMBL953453	Inhibition of GSK3-beta	B	O=c1[nH]c2occ(-c3ccc(F)cc3)c2n2cccc12		CHEMBL517818	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	2405690	CHEMBL953453	Inhibition of GSK3-beta	B	Cc1ccc(-c2coc3[nH]c(=O)c4cccn4c23)cc1		CHEMBL517669	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	2405691	CHEMBL953453	Inhibition of GSK3-beta	B	COc1ccc(-c2coc3[nH]c(=O)c4cccn4c23)cc1		CHEMBL478516	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	2405692	CHEMBL953453	Inhibition of GSK3-beta	B	O=c1[nH]c2occ(-c3ccc(Cl)c(Cl)c3)c2n2cccc12		CHEMBL478517	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	2405693	CHEMBL953453	Inhibition of GSK3-beta	B	COc1ccc(-c2coc3[nH]c(=O)c4cccn4c23)cc1OC		CHEMBL478704	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	2405694	CHEMBL953453	Inhibition of GSK3-beta	B	COc1ccc(-c2csc3c2-n2cccc2C3=O)cc1OCc1ccccc1		CHEMBL34267	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	2405695	CHEMBL953453	Inhibition of GSK3-beta	B	COc1ccc(-c2csc3c2-n2cccc2C3=O)cc1O		CHEMBL287508	=	IC50	nM	1500.0	CHEMBL262	Homo sapiens	IC50	uM	1.5
	2405696	CHEMBL953453	Inhibition of GSK3-beta	B	O=C1c2[nH]cc(-c3ccc(Cl)cc3)c2-n2cccc21		CHEMBL476236	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	2405697	CHEMBL953453	Inhibition of GSK3-beta	B	COc1ccc(-c2c[nH]c3c2-n2cccc2C3=O)cc1OC		CHEMBL35864	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	2405698	CHEMBL953453	Inhibition of GSK3-beta	B	COc1ccc(-c2c[nH]c3c2-n2cccc2C3=O)cc1OCc1ccccc1		CHEMBL507162	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	2405699	CHEMBL953453	Inhibition of GSK3-beta	B	COc1ccc(-c2c[nH]c3c2-n2cccc2C3=O)cc1O		CHEMBL518732	=	IC50	nM	11000.0	CHEMBL262	Homo sapiens	IC50	uM	11.0
	2405700	CHEMBL953453	Inhibition of GSK3-beta	B	COc1ccc(-c2coc3c2-n2cccc2C3=O)cc1OC		CHEMBL286423	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	2405701	CHEMBL953453	Inhibition of GSK3-beta	B	COc1ccc(-c2c[nH]c3c2-n2cccc2/C3=N/O)cc1OCc1ccccc1		CHEMBL476851	=	IC50	nM	17000.0	CHEMBL262	Homo sapiens	IC50	uM	17.0
	2405702	CHEMBL953453	Inhibition of GSK3-beta	B	COc1ccc(-c2c[nH]c3c2-n2cccc2/C3=N/O)cc1O		CHEMBL444169	=	IC50	nM	5500.0	CHEMBL262	Homo sapiens	IC50	uM	5.5
	2409517	CHEMBL959252	Inhibition of GSK3-beta	B	NC[C@H](Cc1cccc(F)c1)NC(=O)c1cc(Br)c(-c2ccnc3[nH]ccc23)s1		CHEMBL523586	=	IC50	nM	20000.0	CHEMBL262	Homo sapiens	IC50	nM	20000.0
	2417661	CHEMBL954303	Inhibition of human GSK3-beta at 10 uM	B	O=C1NN(c2ccc(Cl)c(Cl)c2)C(=O)/C1=C/c1ccc(O)c([N+](=O)[O-])c1		CHEMBL511636	=	Activity	%	102.0	CHEMBL262	Homo sapiens	Activity	%	102.0
	2417662	CHEMBL954303	Inhibition of human GSK3-beta at 10 uM	B	COc1cc(/C=C2\C(=O)NN(c3ccc(C#N)cc3)C2=O)ccc1O		CHEMBL498718	=	Activity	%	76.0	CHEMBL262	Homo sapiens	Activity	%	76.0
Active	2418826	CHEMBL963396	Inhibition of GSK3-beta in human BxPC3 cells assessed as decrease in phosphorylation of glycogen synthase at 5 uM by Western immunoblotting	B	COc1cccc2c(C3=C(c4cn(C)c5cc(I)c(F)cc45)C(=O)NC3=O)coc12		CHEMBL523435		Activity			CHEMBL262	Homo sapiens	Activity		
Active	2418827	CHEMBL963396	Inhibition of GSK3-beta in human BxPC3 cells assessed as decrease in phosphorylation of glycogen synthase at 5 uM by Western immunoblotting	B	Cn1cc(C2=C(c3coc4ccc(F)cc34)C(=O)NC2=O)c2cc3c(cc21)OCO3		CHEMBL483465		Activity			CHEMBL262	Homo sapiens	Activity		
Not Active	2418828	CHEMBL963397	Inhibition of GSK3-beta in human BxPC3 cells assessed as decrease in phosphorylation of glycogen synthase after 36 hrs by Western immunoblotting	B	COc1cc2c(C3=C(c4coc5ccccc45)C(=O)NC3=O)cn(C)c2cc1Cl		CHEMBL483669		Activity			CHEMBL262	Homo sapiens	Activity		
	2420249	CHEMBL994318	Inhibition of human GSK3-beta	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	nM	10000.0
	2420258	CHEMBL994318	Inhibition of human GSK3-beta	B	CC(C)[C@H](CO)Nc1nc(Nc2ccc(C(=O)O)c(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23254	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	nM	10000.0
	2451261	CHEMBL1013132	Inhibition of human GSK3-beta at 10 uM	B	CCC(Nc1cc(-c2[nH]c(SC)nc2-c2ccc(F)cc2)ccn1)c1ccccc1		CHEMBL494666	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	INH	%	0.0
	2452057	CHEMBL1013132	Inhibition of human GSK3-beta at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	INH	%	0.0
	2452058	CHEMBL1013132	Inhibition of human GSK3-beta at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Inhibition	%	39.0	CHEMBL262	Homo sapiens	INH	%	39.0
	2452059	CHEMBL1013132	Inhibition of human GSK3-beta at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Inhibition	%	34.0	CHEMBL262	Homo sapiens	INH	%	34.0
	2452060	CHEMBL1013132	Inhibition of human GSK3-beta at 10 uM	B	COCCn1c(SC)nc(-c2ccc(F)cc2)c1-c1ccnc(NC2CCCCC2)c1		CHEMBL481943	=	Inhibition	%	7.0	CHEMBL262	Homo sapiens	INH	%	7.0
	2452061	CHEMBL1013132	Inhibition of human GSK3-beta at 10 uM	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NCC3CCCO3)c2)[nH]1		CHEMBL480952	=	Inhibition	%	10.0	CHEMBL262	Homo sapiens	INH	%	10.0
	2452062	CHEMBL1013132	Inhibition of human GSK3-beta at 10 uM	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)CCCC(C)C)c2)[nH]1		CHEMBL518964	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	INH	%	0.0
	2452063	CHEMBL1013132	Inhibition of human GSK3-beta at 10 uM	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NCCc3cccs3)c2)[nH]1		CHEMBL519617	=	Inhibition	%	1.0	CHEMBL262	Homo sapiens	INH	%	1.0
	2452064	CHEMBL1013132	Inhibition of human GSK3-beta at 10 uM	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)CCc3ccccc3)c2)[nH]1		CHEMBL493669	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	INH	%	0.0
	2452065	CHEMBL1013132	Inhibition of human GSK3-beta at 10 uM	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC3CCc4ccccc43)c2)[nH]1		CHEMBL494871	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	INH	%	0.0
	2470238	CHEMBL984524	Inhibition of GSK3B at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL262	Homo sapiens	INH	%	10.0
	2479584	CHEMBL1025771	Inhibition of GSK3-beta	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019	=	IC50	nM	8.0	CHEMBL262	Homo sapiens	IC50	nM	8.0
Active	2489296	CHEMBL990375	Inhibition of GSK3-beta	B	NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c4c(Br)csc4c32)N1		CHEMBL507188		Activity			CHEMBL262	Homo sapiens	Activity		
	2489759	CHEMBL1035624	Inhibition of GSK3-beta at 1 uM	B	COc1cc2ncc(C(N)=O)c(Nc3ccc(F)cc3F)c2cc1OC		CHEMBL479847	=	Inhibition	%	87.0	CHEMBL262	Homo sapiens	INH	%	87.0
Not Active	2504251	CHEMBL939809	Inhibition of GSK3-beta in human HeLa cells by immunoprecipitation kinase assay	B	C=CC1CC2(O)CC3(O)CCC=CC3C2(O)C1(O)CCC		CHEMBL475046		Activity			CHEMBL262	Homo sapiens	Activity		
	2506953	CHEMBL942616	Inhibition of GSK3-beta at 10 uM	B	COc1cc(O)ccc1-c1ccc2c(-c3nc4c(N5CCN(C)CC5)cccc4[nH]3)n[nH]c2c1		CHEMBL474619	<	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	2506954	CHEMBL942616	Inhibition of GSK3-beta at 10 uM	B	CN1CCN(c2cccc3nc(-c4n[nH]c5cc(-c6ccc(N)cc6)ccc45)[nH]c23)CC1		CHEMBL480391	<	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	2511586	CHEMBL972544	Inhibition of GSK3B	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	5.2	CHEMBL262	Homo sapiens	IC50	uM	0.0052
	2511952	CHEMBL969678	Inhibition of human GSK3-beta at 1 uM assessed as residual enzyme activity	B	O=C(Nc1ccccc1Cl)c1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1		CHEMBL521949	=	Activity	%	90.0	CHEMBL262	Homo sapiens	Activity	%	90.0
	2512001	CHEMBL970594	Inhibition of GSK3-beta at 1 uM	B	CC(=O)N1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL508307	=	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2525607	CHEMBL983960	Inhibition of GSK3-beta kinase	B	Cc1cc2c(-c3ccc(S(=O)(=O)N(C)CCO)cc3)ccnc2[nH]1		CHEMBL520308	<	IC50	nM	25118.86	CHEMBL262	Homo sapiens	pIC50		4.6
	2526387	CHEMBL981421	Inhibition of Gsk3beta	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Ki	nM	22.0	CHEMBL262	Homo sapiens	Ki	nM	22.0
	2526388	CHEMBL981421	Inhibition of Gsk3beta	B	CC(=O)Nc1ccc(Sc2nc(Nc3cc(C)n[nH]3)c3ccccc3n2)cc1		CHEMBL484950	=	Ki	nM	1034.0	CHEMBL262	Homo sapiens	Ki	nM	1034.0
Not Active	2527109	CHEMBL984146	Inhibition of GSK3-beta at => 3 ug/mL	B	COc1c(NC(=O)Nc2ccc(-c3ccc(CN4CCOCC4)nc3)c3ccccc23)cc(C(C)(C)C)cc1NS(C)(=O)=O		CHEMBL451523		Activity			CHEMBL262	Homo sapiens	Activity		
	2528133	CHEMBL985022	Inhibition of GSK3-beta	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OC2CCNCC2)cc1		CHEMBL519693	<	IC50	nM	25118.86	CHEMBL262	Homo sapiens	pIC50		4.6
	2528134	CHEMBL985022	Inhibition of GSK3-beta	B	NCc1ccc(-c2cc3ccncc3cc2OC2CCNCC2)cc1		CHEMBL484967	<	IC50	nM	25118.86	CHEMBL262	Homo sapiens	pIC50		4.6
	2528135	CHEMBL985022	Inhibition of GSK3-beta	B	c1ccc(-c2cc3ccncc3cc2OC2CCNCC2)cc1		CHEMBL484968	<	IC50	nM	25118.86	CHEMBL262	Homo sapiens	pIC50		4.6
	2528947	CHEMBL985882	Inhibition of GSK3-beta	B	O[C@H]1CC[C@H](c2n[nH]cc2-c2ccnc(NC3CCCC3)n2)CC1		CHEMBL507249	=	IC50	nM	1900.0	CHEMBL262	Homo sapiens	IC50	uM	1.9
	2550852	CHEMBL966427	Inhibition of human recombinant GSK3-beta assessed as incorporation of [33P]gammaATP into G2S peptide at 25 uM	B	O[C@]12C=C(c3nccc4c3[nH]c3ccccc34)[C@@H]3CCN(CCCC/C=C\CC1)C[C@@]31C[C@@H]3/C=C\CCCCN3[C@@H]21		CHEMBL403233	=	Inhibition	%	73.2	CHEMBL262	Homo sapiens	INH	%	73.2
	2550853	CHEMBL966427	Inhibition of human recombinant GSK3-beta assessed as incorporation of [33P]gammaATP into G2S peptide at 25 uM	B	Oc1cccc2c1[nH]c1c(C3=C[C@@]4(O)CC/C=C\CCCCN5CC[C@@H]3[C@]3(CC6/C=C\CCCCN6[C@@H]43)C5)nccc12		CHEMBL612054	=	Inhibition	%	86.7	CHEMBL262	Homo sapiens	INH	%	86.7
	2550854	CHEMBL966427	Inhibition of human recombinant GSK3-beta assessed as incorporation of [33P]gammaATP into G2S peptide at 25 uM	B	Oc1ccc2[nH]c3c(C4=C[C@@]5(O)CC/C=C\CCCCN6CC[C@@H]4[C@]4(C[C@@H]7/C=C\CCCCN7[C@@H]54)C6)nccc3c2c1		CHEMBL503295	=	Inhibition	%	74.29	CHEMBL262	Homo sapiens	INH	%	74.29
	2550855	CHEMBL966427	Inhibition of human recombinant GSK3-beta assessed as incorporation of [33P]gammaATP into G2S peptide at 25 uM	B	O=C1CCCN2[C@@H](CC1)C[C@]13CN4CCCC/C=C\CC[C@](O)(C=C(c5nccc6c5[nH]c5ccccc56)C1CC4)[C@H]23		CHEMBL399493	=	Inhibition	%	53.6	CHEMBL262	Homo sapiens	INH	%	53.6
	2550856	CHEMBL966427	Inhibition of human recombinant GSK3-beta assessed as incorporation of [33P]gammaATP into G2S peptide at 25 uM	B	O=C1CCCN2[C@@H](CC1)C[C@]13CN4CCCC/C=C\CC[C@](O)(C=C(c5nccc6c5[nH]c5c(O)cccc56)C1CC4)[C@H]23		CHEMBL399694	=	Inhibition	%	29.9	CHEMBL262	Homo sapiens	INH	%	29.9
	2550857	CHEMBL966427	Inhibition of human recombinant GSK3-beta assessed as incorporation of [33P]gammaATP into G2S peptide at 25 uM	B	O[C@H]1CCN2[C@H]3[C@@]4(O)C=C(c5nccc6c5[nH]c5ccccc56)[C@@H]5CCN(CCCC/C=C\CC4)C[C@@]53C[C@]23CC[C@H]1OC[C@]12CN4CCCC/C=C\CC[C@](O)(C=C(c5nccc6c5[nH]c5ccccc56)[C@@H]1CC4)[C@@H]2N1CCC[C@@H](O)[C@H](CC1)O3		CHEMBL258020	=	Inhibition	%	82.0	CHEMBL262	Homo sapiens	INH	%	82.0
	2550858	CHEMBL966427	Inhibition of human recombinant GSK3-beta assessed as incorporation of [33P]gammaATP into G2S peptide at 25 uM	B	O=CC1=C[C@@]2(O)CC/C=C\CCCCN3CC[C@@H]1[C@]1(C[C@@H]4/C=C\CCCCN4[C@@H]21)C3		CHEMBL332054	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	INH	%	0.0
Active	2550922	CHEMBL966428	Inhibition of GSK3-beta in human SH-SY5Y cells assessed as inhibition of tau phosphorylation at Ser396 at 5 uM after 24 hrs by ELISA sandwich method	B	O[C@]12C=C(c3nccc4c3[nH]c3ccccc34)[C@@H]3CCN(CCCC/C=C\CC1)C[C@@]31C[C@@H]3/C=C\CCCCN3[C@@H]21		CHEMBL403233		Activity			CHEMBL262	Homo sapiens	Activity		
Active	2550923	CHEMBL966428	Inhibition of GSK3-beta in human SH-SY5Y cells assessed as inhibition of tau phosphorylation at Ser396 at 5 uM after 24 hrs by ELISA sandwich method	B	Oc1cccc2c1[nH]c1c(C3=C[C@@]4(O)CC/C=C\CCCCN5CC[C@@H]3[C@]3(CC6/C=C\CCCCN6[C@@H]43)C5)nccc12		CHEMBL612054		Activity			CHEMBL262	Homo sapiens	Activity		
	2556085	CHEMBL982881	Inhibition of human GSK3-beta	B	O[C@]12C=C(c3nccc4c3[nH]c3ccccc34)[C@@H]3CCN(CCCC/C=C\CC1)C[C@@]31C[C@@H]3/C=C\CCCCN3[C@@H]21		CHEMBL403233	=	IC50	nM	10200.0	CHEMBL262	Homo sapiens	IC50	uM	10.2
	2562273	CHEMBL984687	Inhibition of human GSK3-beta expressed in insect Sf21 cells at 10 uM	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1		CHEMBL477989	=	Inhibition	%	25.0	CHEMBL262	Homo sapiens	INH	%	25.0
	2562295	CHEMBL984687	Inhibition of human GSK3-beta expressed in insect Sf21 cells at 10 uM	B	O/N=C1\CCc2cc(-c3cc(CN4CCOCC4)oc3-c3ccncc3)ccc21		CHEMBL476732	=	Inhibition	%	-9.0	CHEMBL262	Homo sapiens	INH	%	-9.0
	2567202	CHEMBL970788	Inhibition of GSK3-beta	B	CCN1C(=O)C(C)(C)c2cc3[nH]c4c(c3cc21)CCCc1c(C)n[nH]c1-4		CHEMBL223147	=	IC50	nM	7700.0	CHEMBL262	Homo sapiens	IC50	uM	7.7
	2572352	CHEMBL984844	Inhibition of GSK3-beta	B	O[C@]12C=C(c3nccc4c3[nH]c3ccccc34)[C@@H]3CCN(CCCC/C=C\CC1)C[C@@]31C[C@@H]3/C=C\CCCCN3[C@@H]21		CHEMBL403233	=	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	2584875	CHEMBL955785	Inhibition of GSK3b	B	O=c1[nH]cnc2[nH]c(-c3ccnc(/C=C/c4ccc(CN5CCOCC5)cc4)c3)cc12		CHEMBL461139	=	IC50	nM	300.0	CHEMBL262	Homo sapiens	IC50	uM	0.3
	2584903	CHEMBL955785	Inhibition of GSK3b	B	CN(C)CCOc1ccc(/C=C/c2cc(-c3cc4c(=O)[nH]cnc4[nH]3)ccn2)cc1		CHEMBL461140	=	IC50	nM	530.0	CHEMBL262	Homo sapiens	IC50	uM	0.53
	2602481	CHEMBL1034037	Inhibition of GSK3-beta at 10 uM by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1nscc1NCc1ccncc1		CHEMBL515880	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2602751	CHEMBL1034037	Inhibition of GSK3-beta at 10 uM by HTRF assay	B	O=C(Nc1cccc(Br)c1)c1nscc1NCc1ccc2ccccc2n1		CHEMBL458532	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2602752	CHEMBL1034037	Inhibition of GSK3-beta at 10 uM by HTRF assay	B	O=C(Nc1cccc(Br)c1)c1nscc1NCc1cnoc1		CHEMBL512380	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2602753	CHEMBL1034037	Inhibition of GSK3-beta at 10 uM by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1nscc1NCc1ccnc2ccccc12		CHEMBL458531	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2602754	CHEMBL1034037	Inhibition of GSK3-beta at 10 uM by HTRF assay	B	O=C(Nc1cccc(Br)c1)c1nscc1NCc1ccnc2ccccc12		CHEMBL517399	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2602755	CHEMBL1034037	Inhibition of GSK3-beta at 10 uM by HTRF assay	B	O=C(Nc1cccc(Br)c1)c1nscc1NCCc1ccc2c(c1)OCO2		CHEMBL462528	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2602756	CHEMBL1034037	Inhibition of GSK3-beta at 10 uM by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1nscc1NCCc1ccc2c(c1)OCO2		CHEMBL462527	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2602757	CHEMBL1034037	Inhibition of GSK3-beta at 10 uM by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1nscc1NCc1ccc(F)c(F)c1		CHEMBL518204	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2602758	CHEMBL1034037	Inhibition of GSK3-beta at 10 uM by HTRF assay	B	O=C(NCc1ccc2c(c1)OCO2)c1nscc1NCc1ccncc1		CHEMBL462315	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2602759	CHEMBL1034037	Inhibition of GSK3-beta at 10 uM by HTRF assay	B	Cc1ccc(NC(=O)c2nscc2NCc2ccncc2)c(F)c1		CHEMBL460191	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2602760	CHEMBL1034037	Inhibition of GSK3-beta at 10 uM by HTRF assay	B	Cc1cc(NC(=O)c2nscc2NCc2ccncc2)ccc1C(F)(F)F		CHEMBL512863	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2602761	CHEMBL1034037	Inhibition of GSK3-beta at 10 uM by HTRF assay	B	Cc1ccc(NC(=O)c2nscc2NCc2ccncc2)cc1C(F)(F)F		CHEMBL470441	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2602762	CHEMBL1034037	Inhibition of GSK3-beta at 10 uM by HTRF assay	B	O=C(Nc1ccc(Cl)c(Cl)c1)c1nscc1NCc1ccncc1		CHEMBL470440	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2602763	CHEMBL1034037	Inhibition of GSK3-beta at 10 uM by HTRF assay	B	O=C(Nc1ccc(C(F)(F)F)c(Cl)c1)c1nscc1NCc1ccncc1		CHEMBL512862	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2602764	CHEMBL1034037	Inhibition of GSK3-beta at 10 uM by HTRF assay	B	O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)c1nscc1NCc1ccncc1		CHEMBL473268	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2602765	CHEMBL1034037	Inhibition of GSK3-beta at 10 uM by HTRF assay	B	O=C(NC1=CC2C=NNC2C=C1)c1nscc1NCc1ccncc1		CHEMBL443921	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2602766	CHEMBL1034037	Inhibition of GSK3-beta at 10 uM by HTRF assay	B	O=C(Nc1ccc2ccccc2n1)c1nscc1NCc1ccncc1		CHEMBL474709	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2602767	CHEMBL1034037	Inhibition of GSK3-beta at 10 uM by HTRF assay	B	O=C(Nc1ccccc1Br)c1nscc1NCc1ccncc1		CHEMBL509737	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2602768	CHEMBL1034037	Inhibition of GSK3-beta at 10 uM by HTRF assay	B	O=C(Nc1ccc(Br)cc1)c1nscc1NCc1ccncc1		CHEMBL473288	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2602769	CHEMBL1034037	Inhibition of GSK3-beta at 10 uM by HTRF assay	B	O=C(Nc1cccc(Br)c1)c1nscc1NCc1ccncc1		CHEMBL473287	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2602770	CHEMBL1034037	Inhibition of GSK3-beta at 10 uM by HTRF assay	B	O=C(Nc1ccc(Cl)cc1)c1nscc1NCc1ccncc1		CHEMBL475709	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2602771	CHEMBL1034037	Inhibition of GSK3-beta at 10 uM by HTRF assay	B	CC(C)(C)c1ccc(NC(=O)c2nscc2NCc2ccncc2)cc1		CHEMBL475708	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2602772	CHEMBL1034037	Inhibition of GSK3-beta at 10 uM by HTRF assay	B	CC(C)(C)c1cccc(NC(=O)c2nscc2NCc2ccncc2)c1		CHEMBL475510	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2602773	CHEMBL1034037	Inhibition of GSK3-beta at 10 uM by HTRF assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1nscc1NCc1ccncc1		CHEMBL516243	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2602774	CHEMBL1034037	Inhibition of GSK3-beta at 10 uM by HTRF assay	B	O=C(Nc1cccc(OC(F)(F)F)c1)c1nscc1NCc1ccncc1		CHEMBL475509	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2602775	CHEMBL1034037	Inhibition of GSK3-beta at 10 uM by HTRF assay	B	O=C(Nc1ccc(C(F)(F)F)cc1)c1nscc1NCc1ccccn1		CHEMBL474494	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2602776	CHEMBL1034037	Inhibition of GSK3-beta at 10 uM by HTRF assay	B	O=C(Nc1ccc(C(F)(F)F)cc1)c1nscc1NCc1cccnc1		CHEMBL474293	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2602777	CHEMBL1034037	Inhibition of GSK3-beta at 10 uM by HTRF assay	B	O=C(Nc1ccc(C(F)(F)F)cc1)c1nscc1NCc1ccncc1		CHEMBL475704	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2602778	CHEMBL1034037	Inhibition of GSK3-beta at 10 uM by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1nscc1NCc1ccccn1		CHEMBL475703	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2602779	CHEMBL1034037	Inhibition of GSK3-beta at 10 uM by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1nscc1NCc1cccnc1		CHEMBL514986	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	2605642	CHEMBL1022217	Inhibition of GSK3-beta expressed in Sf9 cells	B	CC1(C)CNC(=O)c2cc3n(c2C1)CCc1cc(F)ccc1-3		CHEMBL500783	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	2605647	CHEMBL1022217	Inhibition of GSK3-beta expressed in Sf9 cells	B	CC1(C)CNC(=O)c2cc3n(c2C1)CCc1cc([N+](=O)[O-])ccc1-3		CHEMBL514247	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	2605648	CHEMBL1022217	Inhibition of GSK3-beta expressed in Sf9 cells	B	CC1(C)CNC(=O)c2cc3n(c2C1)CCc1cc(Br)ccc1-3		CHEMBL456208	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	2613340	CHEMBL1015227	Inhibition of GSK3-beta	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	nM	10000.0
	2613441	CHEMBL1031513	Inhibition of human GSK3-beta	B	COc1ccc(CSc2nnc(-c3ccc4c(c3)OCO4)o2)cc1F		CHEMBL456218	=	IC50	nM	65.0	CHEMBL262	Homo sapiens	IC50	nM	65.0
	2613442	CHEMBL1031513	Inhibition of human GSK3-beta	B	COc1ccc(CSc2nnc(-c3ccc4c(c3)CCO4)o2)cc1F		CHEMBL514401	=	IC50	nM	44.0	CHEMBL262	Homo sapiens	IC50	nM	44.0
	2613443	CHEMBL1031513	Inhibition of human GSK3-beta	B	c1ccc(CSc2nnc(-c3ccc4c(c3)CCO4)o2)cc1		CHEMBL456219	=	IC50	nM	210.0	CHEMBL262	Homo sapiens	IC50	nM	210.0
	2613444	CHEMBL1031513	Inhibition of human GSK3-beta	B	Fc1cccc(CSc2nnc(-c3ccc4c(c3)CCO4)o2)c1		CHEMBL470360	=	IC50	nM	54.0	CHEMBL262	Homo sapiens	IC50	nM	54.0
	2613445	CHEMBL1031513	Inhibition of human GSK3-beta	B	COc1ccc(CSc2nnc(-c3ccc4c(c3)CCO4)o2)cc1		CHEMBL470565	=	IC50	nM	220.0	CHEMBL262	Homo sapiens	IC50	nM	220.0
	2613446	CHEMBL1031513	Inhibition of human GSK3-beta	B	Clc1cccc(CSc2nnc(-c3ccc4c(c3)CCO4)o2)c1		CHEMBL470566	=	IC50	nM	94.0	CHEMBL262	Homo sapiens	IC50	nM	94.0
	2613447	CHEMBL1031513	Inhibition of human GSK3-beta	B	Clc1ccccc1CSc1nnc(-c2ccc3c(c2)CCO3)o1		CHEMBL513040	=	IC50	nM	200.0	CHEMBL262	Homo sapiens	IC50	nM	200.0
	2613448	CHEMBL1031513	Inhibition of human GSK3-beta	B	Clc1ccc(CSc2nnc(-c3ccc4c(c3)CCO4)o2)cc1		CHEMBL470567	=	IC50	nM	280.0	CHEMBL262	Homo sapiens	IC50	nM	280.0
	2613449	CHEMBL1031513	Inhibition of human GSK3-beta	B	N#Cc1cccc(CSc2nnc(-c3ccc4c(c3)CCO4)o2)c1		CHEMBL469736	=	IC50	nM	91.0	CHEMBL262	Homo sapiens	IC50	nM	91.0
	2613450	CHEMBL1031513	Inhibition of human GSK3-beta	B	FC(F)(F)c1cccc(CSc2nnc(-c3ccc4c(c3)CCO4)o2)c1		CHEMBL472249	=	IC50	nM	68.0	CHEMBL262	Homo sapiens	IC50	nM	68.0
	2613451	CHEMBL1031513	Inhibition of human GSK3-beta	B	COC(=O)c1cccc(CSc2nnc(-c3ccc4c(c3)CCO4)o2)c1		CHEMBL471015	=	IC50	nM	630.0	CHEMBL262	Homo sapiens	IC50	nM	630.0
	2613452	CHEMBL1031513	Inhibition of human GSK3-beta	B	COc1ccc(CSc2nnc(-c3ccc4c(c3)CCO4)o2)cc1Cl		CHEMBL470167	=	IC50	nM	13.0	CHEMBL262	Homo sapiens	IC50	nM	13.0
	2613453	CHEMBL1031513	Inhibition of human GSK3-beta	B	COc1ccc(CSc2nnc(-c3ccc4c(c3)CCO4)o2)cc1C#N		CHEMBL470168	=	IC50	nM	28.0	CHEMBL262	Homo sapiens	IC50	nM	28.0
	2613454	CHEMBL1031513	Inhibition of human GSK3-beta	B	COc1ccc(CSc2nnc(-c3ccc4c(c3)CCO4)o2)cc1C(F)(F)F		CHEMBL512144	=	IC50	nM	5.7	CHEMBL262	Homo sapiens	IC50	nM	5.7
	2613455	CHEMBL1031513	Inhibition of human GSK3-beta	B	Fc1cccc(CCc2nnc(-c3ccc4c(c3)CCO4)o2)c1		CHEMBL470380	=	IC50	nM	340.0	CHEMBL262	Homo sapiens	IC50	nM	340.0
	2613456	CHEMBL1031513	Inhibition of human GSK3-beta	B	Fc1cccc(CNc2nnc(-c3ccc4c(c3)CCO4)o2)c1		CHEMBL451857	=	IC50	nM	330.0	CHEMBL262	Homo sapiens	IC50	nM	330.0
	2613457	CHEMBL1031513	Inhibition of human GSK3-beta	B	Fc1cccc(COc2nnc(-c3ccc4c(c3)CCO4)o2)c1		CHEMBL454974	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	nM	10000.0
	2613458	CHEMBL1031513	Inhibition of human GSK3-beta	B	Fc1cccc(SCc2nnc(-c3ccc4c(c3)CCO4)o2)c1		CHEMBL513576	=	IC50	nM	680.0	CHEMBL262	Homo sapiens	IC50	nM	680.0
	2613459	CHEMBL1031513	Inhibition of human GSK3-beta	B	COc1ccc(CSc2nnc(-c3ccc4occc4c3)o2)cc1C(F)(F)F		CHEMBL471430	=	IC50	nM	4.9	CHEMBL262	Homo sapiens	IC50	nM	4.9
	2613460	CHEMBL1031513	Inhibition of human GSK3-beta	B	COc1ccc(CSc2nnc(-c3ccc4ncsc4c3)o2)cc1C(F)(F)F		CHEMBL499006	=	IC50	nM	3.1	CHEMBL262	Homo sapiens	IC50	nM	3.1
	2613461	CHEMBL1031513	Inhibition of human GSK3-beta	B	COc1ccc(CSc2nnc(-c3ccc4[nH]ncc4c3)o2)cc1C(F)(F)F		CHEMBL469507	=	IC50	nM	16.0	CHEMBL262	Homo sapiens	IC50	nM	16.0
	2613462	CHEMBL1031513	Inhibition of human GSK3-beta	B	COc1ccc(CSc2nnc(C3=CC=C4NC=CN4C3)o2)cc1C(F)(F)F		CHEMBL513878	=	IC50	nM	6.5	CHEMBL262	Homo sapiens	IC50	nM	6.5
	2613463	CHEMBL1031513	Inhibition of human GSK3-beta	B	COc1ccc(CSc2nnc(-c3ccc4ncccc4c3)o2)cc1C(F)(F)F		CHEMBL469508	=	IC50	nM	18.0	CHEMBL262	Homo sapiens	IC50	nM	18.0
	2613464	CHEMBL1031513	Inhibition of human GSK3-beta	B	COc1ccc(-c2coc3ccc(-c4nnc(SCc5ccc(OC)c(C(F)(F)F)c5)o4)cc23)cc1		CHEMBL469509	=	IC50	nM	25.0	CHEMBL262	Homo sapiens	IC50	nM	25.0
	2613465	CHEMBL1031513	Inhibition of human GSK3-beta	B	COc1ccc(-c2coc3ccc(-c4nnc(SCc5cccc(C(F)(F)F)c5)o4)cc23)cc1		CHEMBL471832	=	IC50	nM	8.4	CHEMBL262	Homo sapiens	IC50	nM	8.4
	2613466	CHEMBL1031513	Inhibition of human GSK3-beta	B	COc1ccc(-c2coc3ccc(-c4nnc(SCc5cccc(C#N)c5)o4)cc23)cc1		CHEMBL471833	=	IC50	nM	3.5	CHEMBL262	Homo sapiens	IC50	nM	3.5
	2613467	CHEMBL1031513	Inhibition of human GSK3-beta	B	COc1ccc(-n2cnc3ccc(-c4nnc(SCc5ccc(OC)c(C(F)(F)F)c5)o4)cc32)cc1		CHEMBL472043	=	IC50	nM	8.6	CHEMBL262	Homo sapiens	IC50	nM	8.6
	2613468	CHEMBL1031513	Inhibition of human GSK3-beta	B	COc1ccc(-n2cnc3ccc(-c4nnc(SCc5cccc(C(F)(F)F)c5)o4)cc32)cc1		CHEMBL513570	=	IC50	nM	2.5	CHEMBL262	Homo sapiens	IC50	nM	2.5
	2613469	CHEMBL1031513	Inhibition of human GSK3-beta	B	COc1ccc(-n2cnc3ccc(-c4nnc(SCc5cccc(C#N)c5)o4)cc32)cc1		CHEMBL516640	=	IC50	nM	2.3	CHEMBL262	Homo sapiens	IC50	nM	2.3
	2613470	CHEMBL1031513	Inhibition of human GSK3-beta	B	Cn1cnc2ccc(-c3nnc(SCc4cccc(C(F)(F)F)c4)o3)cc21		CHEMBL461261	=	IC50	nM	9.4	CHEMBL262	Homo sapiens	IC50	nM	9.4
	2613501	CHEMBL1031513	Inhibition of human GSK3-beta	B	O=[N+]([O-])c1ccc(NCCNc2ncc(-c3ncc[nH]3)c(-c3ccc(Cl)cc3Cl)n2)nc1		CHEMBL461262	=	IC50	nM	10.0	CHEMBL262	Homo sapiens	IC50	nM	10.0
	2620304	CHEMBL1036680	Inhibition of GSK3-beta at 10 uM by Z'-LYTE kinase assay	B	CCn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL26241	=	Inhibition	%	65.0	CHEMBL262	Homo sapiens	INH	%	65.0
	2620305	CHEMBL1036680	Inhibition of GSK3-beta at 10 uM by Z'-LYTE kinase assay	B	O=c1sn(-c2ccccc2)c(=O)n1CCCl		CHEMBL449063	=	Inhibition	%	74.0	CHEMBL262	Homo sapiens	INH	%	74.0
	2620306	CHEMBL1036680	Inhibition of GSK3-beta at 10 uM by Z'-LYTE kinase assay	B	CCOC(=O)Cn1sc(=O)n(-c2cccc(C(=O)OCC)c2)c1=O		CHEMBL458636	=	Inhibition	%	84.0	CHEMBL262	Homo sapiens	INH	%	84.0
	2620307	CHEMBL1036680	Inhibition of GSK3-beta at 10 uM by Z'-LYTE kinase assay	B	CCOC(=O)Cn1sc(=O)n(-c2ccc(C(=O)OCC)cc2)c1=O		CHEMBL458857	=	Inhibition	%	75.0	CHEMBL262	Homo sapiens	INH	%	75.0
	2620308	CHEMBL1036680	Inhibition of GSK3-beta at 10 uM by Z'-LYTE kinase assay	B	O=c1sn(CCc2ccccc2)c(=O)n1Cc1ccc(F)cc1		CHEMBL512208	=	Inhibition	%	80.0	CHEMBL262	Homo sapiens	INH	%	80.0
	2620309	CHEMBL1036680	Inhibition of GSK3-beta at 10 uM by Z'-LYTE kinase assay	B	CCOC(=O)Cn1sc(=O)n(CC(=O)N2CCCCC2)c1=O		CHEMBL458210	=	Inhibition	%	65.0	CHEMBL262	Homo sapiens	INH	%	65.0
	2620310	CHEMBL1036681	Inhibition of GSK3-beta by Z'-LYTE kinase assay	B	CCn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL26241	=	IC50	nM	7149.0	CHEMBL262	Homo sapiens	IC50	nM	7149.0
	2620311	CHEMBL1036681	Inhibition of GSK3-beta by Z'-LYTE kinase assay	B	O=c1sn(-c2ccccc2)c(=O)n1CCCl		CHEMBL449063	=	IC50	nM	548.0	CHEMBL262	Homo sapiens	IC50	nM	548.0
	2620312	CHEMBL1036681	Inhibition of GSK3-beta by Z'-LYTE kinase assay	B	CCOC(=O)Cn1sc(=O)n(-c2cccc(C(=O)OCC)c2)c1=O		CHEMBL458636	=	IC50	nM	467.0	CHEMBL262	Homo sapiens	IC50	nM	467.0
	2620313	CHEMBL1036681	Inhibition of GSK3-beta by Z'-LYTE kinase assay	B	CCOC(=O)Cn1sc(=O)n(-c2ccc(C(=O)OCC)cc2)c1=O		CHEMBL458857	=	IC50	nM	1012.0	CHEMBL262	Homo sapiens	IC50	nM	1012.0
	2620314	CHEMBL1036681	Inhibition of GSK3-beta by Z'-LYTE kinase assay	B	O=c1sn(CCc2ccccc2)c(=O)n1Cc1ccc(F)cc1		CHEMBL512208	=	IC50	nM	1863.0	CHEMBL262	Homo sapiens	IC50	nM	1863.0
	2620315	CHEMBL1036681	Inhibition of GSK3-beta by Z'-LYTE kinase assay	B	CCOC(=O)Cn1sc(=O)n(CC(=O)N2CCCCC2)c1=O		CHEMBL458210	=	IC50	nM	539.0	CHEMBL262	Homo sapiens	IC50	nM	539.0
Active	2620349	CHEMBL1036688	Inhibition of GSK3-beta by ATP competitive inhibition based assay	B	O=c1sn(-c2ccccc2)c(=O)n1CCCl		CHEMBL449063		Activity			CHEMBL262	Homo sapiens	Activity		
Active	2620350	CHEMBL1036688	Inhibition of GSK3-beta by ATP competitive inhibition based assay	B	CCOC(=O)Cn1sc(=O)n(-c2cccc(C(=O)OCC)c2)c1=O		CHEMBL458636		Activity			CHEMBL262	Homo sapiens	Activity		
Active	2620351	CHEMBL1036689	Inhibition of GSK3-beta in myoblasts assessed as beta-casein accumulation at 2 uM after 3 hrs by immunoblot	B	CCOC(=O)Cn1sc(=O)n(-c2cccc(C(=O)OCC)c2)c1=O		CHEMBL458636		Activity			CHEMBL262	Homo sapiens	Activity		
	2626898	CHEMBL999782	Binding affinity to human GSK3-beta at 5 uM	B	Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Nc3ncnc4ccc(N)cc34)cc2)c1		CHEMBL497033	=	Activity	%	100.0	CHEMBL262	Homo sapiens	Activity	%	100.0
	2626925	CHEMBL999782	Binding affinity to human GSK3-beta at 5 uM	B	Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc(Nc3ncnc4ccc(N)cc34)c2)c1		CHEMBL497615	=	Activity	%	80.0	CHEMBL262	Homo sapiens	Activity	%	80.0
	2635207	CHEMBL1003312	Inhibition of GSK3-beta at 1 uM relative to control	B	CSc1cc(Oc2ccnc3[nH]c(=O)[nH]c23)ccc1NC(=O)Nc1cccc(C(F)(F)F)c1		CHEMBL496009	=	Residual_activity	%	100.0	CHEMBL262	Homo sapiens	Residual_activity	%	100.0
	2635950	CHEMBL1003312	Inhibition of GSK3-beta at 1 uM relative to control	B	O=C(Nc1cc(C(F)(F)F)ccc1F)Nc1ccc(Oc2ccnc3[nH]c(=O)[nH]c23)c2ccccc12		CHEMBL498112	=	Residual_activity	%	75.0	CHEMBL262	Homo sapiens	Residual_activity	%	75.0
	2636018	CHEMBL1003312	Inhibition of GSK3-beta at 1 uM relative to control	B	CC(C)(C)c1cccc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c3ccccc23)c1		CHEMBL496073	=	Residual_activity	%	75.0	CHEMBL262	Homo sapiens	Residual_activity	%	75.0
	2639183	CHEMBL970458	Inhibition of GSK3-beta	B	O[C@H]1CC[C@H](Nc2ccc3nnc(-c4cccc(C(F)(F)F)c4)n3n2)CC1		CHEMBL494221	=	Ki	nM	230.0	CHEMBL262	Homo sapiens	Ki	nM	230.0
	2639184	CHEMBL970458	Inhibition of GSK3-beta	B	FC(F)(F)c1cccc(-c2nnc3ccc(NC4CCNCC4)nn23)c1		CHEMBL493169	=	Ki	nM	2900.0	CHEMBL262	Homo sapiens	Ki	nM	2900.0
	2643847	CHEMBL1034478	Inhibition of human GSK3-beta	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	IC50	nM	100.0	CHEMBL262	Homo sapiens	IC50	uM	0.1
	2643848	CHEMBL1034478	Inhibition of human GSK3-beta	B	O=[N+]([O-])c1ccc(NCCNc2ncc(-c3ncc[nH]3)c(-c3ccc(Cl)cc3Cl)n2)nc1		CHEMBL461262	=	Ki	nM	0.09	CHEMBL262	Homo sapiens	Ki	nM	0.09
	2643849	CHEMBL1034478	Inhibition of human GSK3-beta	B	Nc1nonc1-n1nnc(C(=O)N/N=C/c2ccncc2)c1CN1CCCCC1		CHEMBL325353	=	IC50	nM	100.0	CHEMBL262	Homo sapiens	IC50	nM	100.0
	2643850	CHEMBL1034478	Inhibition of human GSK3-beta	B	O=C(Nc1ncnc2oc(-c3cccnc3)cc12)C1CCCC1		CHEMBL182419	=	IC50	nM	5.0	CHEMBL262	Homo sapiens	IC50	nM	5.0
	2643851	CHEMBL1034478	Inhibition of human GSK3-beta	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714	=	IC50	nM	34.0	CHEMBL262	Homo sapiens	IC50	nM	34.0
	2643852	CHEMBL1034478	Inhibition of human GSK3-beta	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	IC50	nM	78.0	CHEMBL262	Homo sapiens	IC50	nM	78.0
	2643853	CHEMBL1034478	Inhibition of human GSK3-beta	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	IC50	nM	2.8	CHEMBL262	Homo sapiens	IC50	nM	2.8
	2643854	CHEMBL1034478	Inhibition of human GSK3-beta	B	NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c(Br)cc32)N1		CHEMBL361708	=	IC50	nM	10.0	CHEMBL262	Homo sapiens	IC50	nM	10.0
	2643855	CHEMBL1034478	Inhibition of human GSK3-beta	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	15.0	CHEMBL262	Homo sapiens	IC50	nM	15.0
	2643856	CHEMBL1034478	Inhibition of human GSK3-beta	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	IC50	nM	22.0	CHEMBL262	Homo sapiens	IC50	nM	22.0
	2643857	CHEMBL1034478	Inhibition of human GSK3-beta	B	COc1cc(C2=C(c3cn(CCN4CCN(C)CC4)c4ccccc34)C(=O)NC2=O)c2occc2c1		CHEMBL564450	=	IC50	nM	0.14	CHEMBL262	Homo sapiens	IC50	uM	0.00014
	2643858	CHEMBL1034478	Inhibition of human GSK3-beta	B	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2		CHEMBL362558	=	IC50	nM	1.1	CHEMBL262	Homo sapiens	IC50	uM	0.0011
	2643859	CHEMBL1034478	Inhibition of human GSK3-beta	B	CN(C)C(=O)N1CCn2cc(C3=C(c4cnc5ccccn45)C(=O)NC3=O)c3cccc(c32)C1		CHEMBL362814	=	IC50	nM	1.6	CHEMBL262	Homo sapiens	IC50	uM	0.0016
	2643860	CHEMBL1034478	Inhibition of human GSK3-beta	B	CCS(=O)(=O)Nc1ccc(CCNC(=O)c2ccc(O)c3[nH]c(-c4ccc(F)cc4Cl)nc23)cc1		CHEMBL549953	=	IC50	nM	2.0	CHEMBL262	Homo sapiens	IC50	uM	0.002
	2643861	CHEMBL1034478	Inhibition of human GSK3-beta	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	IC50	nM	2.8	CHEMBL262	Homo sapiens	IC50	uM	0.0028
	2643862	CHEMBL1034478	Inhibition of human GSK3-beta	B	CN1CCOCCN(C)CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CC1		CHEMBL105477	=	IC50	nM	6.0	CHEMBL262	Homo sapiens	IC50	uM	0.006
	2643863	CHEMBL1034478	Inhibition of human GSK3-beta	B	Cn1cc(C2=C(c3cc(Cl)ccc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL562023	=	IC50	nM	7.0	CHEMBL262	Homo sapiens	IC50	uM	0.007
	2643864	CHEMBL1034478	Inhibition of human GSK3-beta	B	O=Nc1c(-c2c(O)[nH]c3ccc(I)cc23)[nH]c2ccccc12		CHEMBL337300	=	IC50	nM	9.0	CHEMBL262	Homo sapiens	IC50	uM	0.009
	2643865	CHEMBL1034478	Inhibition of human GSK3-beta	B	CCS(=O)(=O)Nc1ccc(CCNC(=O)c2ccc(O)c3[nH]c(-c4ccc(Cl)cc4Cl)nc23)cc1		CHEMBL559559	=	IC50	nM	30.0	CHEMBL262	Homo sapiens	IC50	uM	0.03
	2643866	CHEMBL1034478	Inhibition of human GSK3-beta	B	CCCCNc1nccc(-c2cc(C(=O)NCCCc3cccnc3)c(=O)[nH]n2)n1		CHEMBL549804	=	IC50	nM	36.0	CHEMBL262	Homo sapiens	IC50	uM	0.036
	2643867	CHEMBL1034478	Inhibition of human GSK3-beta	B	O=C(NCc1ccc(Cl)cc1)c1cc(-c2ccc(O)c(F)c2)n[nH]c1=O		CHEMBL540245	=	IC50	nM	39.0	CHEMBL262	Homo sapiens	IC50	uM	0.039
	2643868	CHEMBL1034478	Inhibition of human GSK3-beta	B	O=C(CN1CCOCC1)Nc1ccc(CCNC(=O)c2ccc(O)c3[nH]c(-c4ccc(F)cc4)nc23)cc1		CHEMBL562089	=	IC50	nM	40.0	CHEMBL262	Homo sapiens	IC50	uM	0.04
	2643869	CHEMBL1034478	Inhibition of human GSK3-beta	B	O=C(NCc1ccc(F)cc1F)c1cc(-c2ccncc2)n[nH]c1=O		CHEMBL557354	=	IC50	nM	65.0	CHEMBL262	Homo sapiens	IC50	uM	0.065
	2643870	CHEMBL1034478	Inhibition of human GSK3-beta	B	CS(=O)(=O)NCCc1ccc(NC(=O)c2ccc(O)c3[nH]c(-c4ccc(Cl)cc4Cl)nc23)cc1		CHEMBL564006	=	IC50	nM	80.0	CHEMBL262	Homo sapiens	IC50	uM	0.08
	2643871	CHEMBL1034478	Inhibition of human GSK3-beta	B	Cn1cc(-c2cc(-c3nc4ccccc4[nH]3)c(=O)[nH]n2)ccc1=O		CHEMBL557273	=	IC50	nM	160.0	CHEMBL262	Homo sapiens	IC50	uM	0.16
	2643872	CHEMBL1034478	Inhibition of human GSK3-beta	B	Nc1nccc(-c2c[nH]c3ccc(Br)cc23)n1		CHEMBL44541	=	IC50	nM	2000.0	CHEMBL262	Homo sapiens	IC50	uM	2.0
	2643873	CHEMBL1034478	Inhibition of human GSK3-beta	B	Nc1nc(Nc2ccccc2)sc1C(=O)C1CC1		CHEMBL554082	=	IC50	nM	2400.0	CHEMBL262	Homo sapiens	IC50	uM	2.4
	2643874	CHEMBL1034478	Inhibition of human GSK3-beta	B	O=c1sn(CCc2ccccc2)c(=O)n1Cc1ccccc1		CHEMBL554295	=	IC50	nM	3000.0	CHEMBL262	Homo sapiens	IC50	uM	3.0
	2643875	CHEMBL1034478	Inhibition of human GSK3-beta	B	CNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCN(Cc5ccccc5)CC4)cc3)n2)s1		CHEMBL550950	=	IC50	nM	6000.0	CHEMBL262	Homo sapiens	IC50	uM	6.0
	2644196	CHEMBL1034478	Inhibition of human GSK3-beta	B	CN(C)S(=O)(=O)c1ccc(Nc2cc(N[C@H]3CC[C@H](N)CC3)nc3c(C4CCCC4)cnn23)cc1		CHEMBL178179	=	IC50	nM	22000.0	CHEMBL262	Homo sapiens	IC50	uM	22.0
	2644197	CHEMBL1034478	Inhibition of human GSK3-beta	B	COc1cc(OC)cc(-c2cc3[nH]ccnc-3n2)c1		CHEMBL77002	=	IC50	nM	60000.0	CHEMBL262	Homo sapiens	IC50	uM	60.0
	2644198	CHEMBL1034478	Inhibition of human GSK3-beta	B	Nc1nccc(-c2c[nH]c3ccccc23)n1		CHEMBL48082	=	IC50	nM	350000.0	CHEMBL262	Homo sapiens	IC50	uM	350.0
	2644199	CHEMBL1034478	Inhibition of human GSK3-beta	B	Nc1nccc(-c2cc3ccccc3[nH]2)n1		CHEMBL50226	=	IC50	nM	420000.0	CHEMBL262	Homo sapiens	IC50	uM	420.0
	2644569	CHEMBL1031298	Inhibition of GSK3-beta	B	Cc1cc(Nc2nc(-c3ccncc3)nc3ccccc23)n[nH]1		CHEMBL549536	=	Ki	nM	73.0	CHEMBL262	Homo sapiens	Ki	nM	73.0
	2651603	CHEMBL1030226	Inhibition of histidine-tagged human GSK3-beta expressed in Sf21 cells at 10 uM	B	Cc1cccc(-c2nc(Nc3ccncc3)c3ccccc3n2)n1		CHEMBL570533	=	Inhibition	%	38.0	CHEMBL262	Homo sapiens	INH	%	38.0
	2658165	CHEMBL1031298	Inhibition of GSK3-beta	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Ki	nM	22.0	CHEMBL262	Homo sapiens	Ki	nM	22.0
	2658166	CHEMBL1031298	Inhibition of GSK3-beta	B	Cc1cc(Nc2nc(Nc3ccccc3)nc3ccccc23)n[nH]1		CHEMBL552038	=	Ki	nM	24.0	CHEMBL262	Homo sapiens	Ki	nM	24.0
	2658167	CHEMBL1031298	Inhibition of GSK3-beta	B	Cc1cc(Nc2nc(N(C)c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL550825	=	Ki	nM	312.0	CHEMBL262	Homo sapiens	Ki	nM	312.0
	2658168	CHEMBL1031298	Inhibition of GSK3-beta	B	Cc1cc(Nc2nc(Oc3ccccc3)nc3ccccc23)n[nH]1		CHEMBL565205	=	Ki	nM	51.0	CHEMBL262	Homo sapiens	Ki	nM	51.0
	2658169	CHEMBL1031298	Inhibition of GSK3-beta	B	Cc1cc(Nc2nc(Sc3ccccc3)nc3ccccc23)n[nH]1		CHEMBL549322	=	Ki	nM	171.0	CHEMBL262	Homo sapiens	Ki	nM	171.0
	2658170	CHEMBL1031298	Inhibition of GSK3-beta	B	Cc1cc(Nc2nc(Sc3ccccc3Cl)nc3ccccc23)n[nH]1		CHEMBL562415	=	Ki	nM	126.0	CHEMBL262	Homo sapiens	Ki	nM	126.0
	2658171	CHEMBL1031298	Inhibition of GSK3-beta	B	Cc1cc(Nc2nc(Sc3cccc(Cl)c3)nc3ccccc23)n[nH]1		CHEMBL562416	=	Ki	nM	33.0	CHEMBL262	Homo sapiens	Ki	nM	33.0
	2658172	CHEMBL1031298	Inhibition of GSK3-beta	B	Cc1cc(Nc2nc(Sc3ccc(Cl)cc3)nc3ccccc23)n[nH]1		CHEMBL562157	=	Ki	nM	44.0	CHEMBL262	Homo sapiens	Ki	nM	44.0
	2658173	CHEMBL1031298	Inhibition of GSK3-beta	B	Cc1cc(Nc2nc(Sc3cccc(Cl)c3Cl)nc3ccccc23)n[nH]1		CHEMBL564459	=	Ki	nM	48.0	CHEMBL262	Homo sapiens	Ki	nM	48.0
	2658174	CHEMBL1031298	Inhibition of GSK3-beta	B	Cc1cc(Nc2nc(Sc3ccc(Cl)cc3Cl)nc3ccccc23)n[nH]1		CHEMBL551633	=	Ki	nM	8.0	CHEMBL262	Homo sapiens	Ki	nM	8.0
	2658175	CHEMBL1031298	Inhibition of GSK3-beta	B	Cc1cc(Nc2nc(Sc3c(Cl)cccc3Cl)nc3ccccc23)n[nH]1		CHEMBL561834	=	Ki	nM	113.0	CHEMBL262	Homo sapiens	Ki	nM	113.0
	2658176	CHEMBL1031298	Inhibition of GSK3-beta	B	Cc1cc(Nc2nc(Sc3ccc(Cl)c(Cl)c3)nc3ccccc23)n[nH]1		CHEMBL552385	>	Ki	nM	15.0	CHEMBL262	Homo sapiens	Ki	nM	15.0
	2658177	CHEMBL1031298	Inhibition of GSK3-beta	B	COc1ccccc1Sc1nc(Nc2cc(C)[nH]n2)c2ccccc2n1		CHEMBL551634	=	Ki	nM	216.0	CHEMBL262	Homo sapiens	Ki	nM	216.0
	2658178	CHEMBL1031298	Inhibition of GSK3-beta	B	COc1ccc(Sc2nc(Nc3cc(C)[nH]n3)c3ccccc3n2)cc1		CHEMBL552500	=	Ki	nM	124.0	CHEMBL262	Homo sapiens	Ki	nM	124.0
	2658179	CHEMBL1031298	Inhibition of GSK3-beta	B	COc1ccc(Sc2nc(Nc3cc(C)[nH]n3)c3ccccc3n2)cc1OC		CHEMBL564290	=	Ki	nM	1168.0	CHEMBL262	Homo sapiens	Ki	nM	1168.0
	2658180	CHEMBL1031298	Inhibition of GSK3-beta	B	Cc1cc(Nc2nc(Sc3ccc4ccccc4c3)nc3ccccc23)n[nH]1		CHEMBL559900	>	Ki	nM	150.0	CHEMBL262	Homo sapiens	Ki	nM	150.0
	2658181	CHEMBL1031298	Inhibition of GSK3-beta	B	Cc1cc(Nc2nc(Sc3ccc(NS(C)(=O)=O)cc3)nc3ccccc23)n[nH]1		CHEMBL552033	=	Ki	nM	67.0	CHEMBL262	Homo sapiens	Ki	nM	67.0
	2658182	CHEMBL1031298	Inhibition of GSK3-beta	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)OC(C)(C)C)cc3)nc3ccccc23)n[nH]1		CHEMBL556460	>	Ki	nM	4000.0	CHEMBL262	Homo sapiens	Ki	nM	4000.0
	2658183	CHEMBL1031298	Inhibition of GSK3-beta	B	CC(=O)Nc1ccc(Sc2nc(Nc3cc(C)n[nH]3)c3ccccc3n2)cc1		CHEMBL484950	=	Ki	nM	1034.0	CHEMBL262	Homo sapiens	Ki	nM	1034.0
	2658184	CHEMBL1031298	Inhibition of GSK3-beta	B	CC(=O)N(C)c1ccc(Sc2nc(Nc3cc(C)[nH]n3)c3ccccc3n2)cc1		CHEMBL549668	=	Ki	nM	17.0	CHEMBL262	Homo sapiens	Ki	nM	17.0
	2658185	CHEMBL1031298	Inhibition of GSK3-beta	B	CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)c3ccccc3n2)cc1		CHEMBL564941	=	Ki	nM	1500.0	CHEMBL262	Homo sapiens	Ki	nM	1500.0
	2658186	CHEMBL1031298	Inhibition of GSK3-beta	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)C4CC4)cc3)nc3ccccc23)n[nH]1		CHEMBL564449	=	Ki	nM	1314.0	CHEMBL262	Homo sapiens	Ki	nM	1314.0
	2658187	CHEMBL1031298	Inhibition of GSK3-beta	B	CC(=O)Nc1ccc(Sc2nc(Nc3cc[nH]n3)c3ccccc3n2)cc1		CHEMBL560158	=	Ki	nM	605.0	CHEMBL262	Homo sapiens	Ki	nM	605.0
	2658188	CHEMBL1031298	Inhibition of GSK3-beta	B	CC(=O)Nc1ccc(Sc2nc(Nc3cc(C4CC4)[nH]n3)c3ccccc3n2)cc1		CHEMBL561421	=	Ki	nM	338.0	CHEMBL262	Homo sapiens	Ki	nM	338.0
	2661413	CHEMBL1058619	Inhibition of GSK3-beta	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	2691859	CHEMBL1054683	Inhibition of human GSK3-beta assessed as remaining activity at 10 uM	B	Cc1ccccc1-c1c(N)c(C(=O)c2ccc(F)cc2F)cc[n+]1[O-]		CHEMBL551717	=	Activity	%	100.0	CHEMBL262	Homo sapiens	Activity	%	100.0
Active	2696395	CHEMBL1061418	Inhibition of GSK3-beta in human SH-Sy5Y cells assessed as reduction of amyloid beta (25-35)-induced Tau hyperphosphorylation at Ser396 at 10 uM treated 1 hr before amyloid beta (25-35) challenge measured after 6 hrs by Western blotting	B	Cn1cc(C2=C(c3cn(CCCN4CCOCC4)c4ccccc34)C(=O)NC2=O)c2ncccc21		CHEMBL552265		Activity			CHEMBL262	Homo sapiens	Activity		
Not Active	2696396	CHEMBL1061418	Inhibition of GSK3-beta in human SH-Sy5Y cells assessed as reduction of amyloid beta (25-35)-induced Tau hyperphosphorylation at Ser396 at 10 uM treated 1 hr before amyloid beta (25-35) challenge measured after 6 hrs by Western blotting	B	COc1ccc2c(c1)c(C1=C(n3ccc4ncccc43)C(=O)NC1=O)cn2CCCn1ccnc1		CHEMBL561929		Activity			CHEMBL262	Homo sapiens	Activity		
Active	2696397	CHEMBL1061418	Inhibition of GSK3-beta in human SH-Sy5Y cells assessed as reduction of amyloid beta (25-35)-induced Tau hyperphosphorylation at Ser396 at 10 uM treated 1 hr before amyloid beta (25-35) challenge measured after 6 hrs by Western blotting	B	O=C1NC(=O)C(n2ccc3ncccc32)=C1c1cn(CCCn2ccnc2)c2ccc(Br)cc12		CHEMBL561066		Activity			CHEMBL262	Homo sapiens	Activity		
Not Active	2696398	CHEMBL1061418	Inhibition of GSK3-beta in human SH-Sy5Y cells assessed as reduction of amyloid beta (25-35)-induced Tau hyperphosphorylation at Ser396 at 10 uM treated 1 hr before amyloid beta (25-35) challenge measured after 6 hrs by Western blotting	B	O=C1NC(=O)C(n2ccc3ncccc32)=C1c1cn(CCCn2ccnc2)c2cc(Br)ccc12		CHEMBL561930		Activity			CHEMBL262	Homo sapiens	Activity		
Not Active	2696399	CHEMBL1061418	Inhibition of GSK3-beta in human SH-Sy5Y cells assessed as reduction of amyloid beta (25-35)-induced Tau hyperphosphorylation at Ser396 at 10 uM treated 1 hr before amyloid beta (25-35) challenge measured after 6 hrs by Western blotting	B	O=C1NC(=O)C(n2ccc3ncccc32)=C1c1cn(CCn2ccnc2)c2ccccc12		CHEMBL558512		Activity			CHEMBL262	Homo sapiens	Activity		
	2696400	CHEMBL1064034	Inhibition of recombinant GST-GSK3beta expressed in Escherichia coli BL21 (DE3)	B	O=C1C(c2cn(CCCn3ccnc3)c3ccccc23)=C(n2ccc3ncccc32)C(=O)N1c1ccccc1		CHEMBL560467	>	IC50	nM	73340.0	CHEMBL262	Homo sapiens	IC50	uM	73.34
	2696416	CHEMBL1064034	Inhibition of recombinant GST-GSK3beta expressed in Escherichia coli BL21 (DE3)	B	O=C1NC(=O)C(n2ccc3ncccc32)=C1c1c[nH]c2ccccc12		CHEMBL563143	=	IC50	nM	30600.0	CHEMBL262	Homo sapiens	IC50	uM	30.6
	2696417	CHEMBL1064034	Inhibition of recombinant GST-GSK3beta expressed in Escherichia coli BL21 (DE3)	B	Cn1cc(C2=C(c3cn(CCCN4CCOCC4)c4ccccc34)C(=O)NC2=O)c2ncccc21		CHEMBL552265	=	IC50	nM	760.0	CHEMBL262	Homo sapiens	IC50	uM	0.76
	2696418	CHEMBL1064034	Inhibition of recombinant GST-GSK3beta expressed in Escherichia coli BL21 (DE3)	B	Cn1cc(C2=C(c3cn(CCCn4ccnc4)c4ccccc34)C(=O)NC2=O)c2ncccc21		CHEMBL559472	=	IC50	nM	660.0	CHEMBL262	Homo sapiens	IC50	uM	0.66
	2696419	CHEMBL1064034	Inhibition of recombinant GST-GSK3beta expressed in Escherichia coli BL21 (DE3)	B	Cn1cc(C2=C(c3cn(CCN4CCOCC4)c4ccccc34)C(=O)NC2=O)c2ncccc21		CHEMBL549286	=	IC50	nM	900.0	CHEMBL262	Homo sapiens	IC50	uM	0.9
	2696420	CHEMBL1064034	Inhibition of recombinant GST-GSK3beta expressed in Escherichia coli BL21 (DE3)	B	Cn1cc(C2=C(c3cn(CCCO)c4ccccc34)C(=O)NC2=O)c2ncccc21		CHEMBL552470	=	IC50	nM	1140.0	CHEMBL262	Homo sapiens	IC50	uM	1.14
	2696421	CHEMBL1064034	Inhibition of recombinant GST-GSK3beta expressed in Escherichia coli BL21 (DE3)	B	O=C1NC(=O)C(n2ccc3ncccc32)=C1c1cn(CCCn2ccnc2)c2ccccc12		CHEMBL560187	=	IC50	nM	550.0	CHEMBL262	Homo sapiens	IC50	uM	0.55
	2696422	CHEMBL1064034	Inhibition of recombinant GST-GSK3beta expressed in Escherichia coli BL21 (DE3)	B	COc1ccc2c(c1)c(C1=C(n3ccc4ncccc43)C(=O)NC1=O)cn2CCCn1ccnc1		CHEMBL561929	=	IC50	nM	480.0	CHEMBL262	Homo sapiens	IC50	uM	0.48
	2696423	CHEMBL1064034	Inhibition of recombinant GST-GSK3beta expressed in Escherichia coli BL21 (DE3)	B	O=C1NC(=O)C(n2ccc3ncccc32)=C1c1cn(CCCn2ccnc2)c2ccc(Br)cc12		CHEMBL561066	=	IC50	nM	140.0	CHEMBL262	Homo sapiens	IC50	uM	0.14
	2696424	CHEMBL1064034	Inhibition of recombinant GST-GSK3beta expressed in Escherichia coli BL21 (DE3)	B	O=C1NC(=O)C(n2ccc3ncccc32)=C1c1cn(CCCn2ccnc2)c2cc(Br)ccc12		CHEMBL561930	=	IC50	nM	950.0	CHEMBL262	Homo sapiens	IC50	uM	0.95
	2696425	CHEMBL1064034	Inhibition of recombinant GST-GSK3beta expressed in Escherichia coli BL21 (DE3)	B	O=C1NC(=O)C(n2ccc3ncccc32)=C1c1cn(CCCn2ccnc2)c2cc(F)ccc12		CHEMBL550925	=	IC50	nM	310.0	CHEMBL262	Homo sapiens	IC50	uM	0.31
	2696426	CHEMBL1064034	Inhibition of recombinant GST-GSK3beta expressed in Escherichia coli BL21 (DE3)	B	CN(C)CCCn1cc(C2=C(n3ccc4ncccc43)C(=O)NC2=O)c2ccccc21		CHEMBL559040	=	IC50	nM	13580.0	CHEMBL262	Homo sapiens	IC50	uM	13.58
	2696427	CHEMBL1064034	Inhibition of recombinant GST-GSK3beta expressed in Escherichia coli BL21 (DE3)	B	COc1ccc2c(c1)c(C1=C(n3ccc4ncccc43)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL552406	=	IC50	nM	22460.0	CHEMBL262	Homo sapiens	IC50	uM	22.46
	2696428	CHEMBL1064034	Inhibition of recombinant GST-GSK3beta expressed in Escherichia coli BL21 (DE3)	B	CN(C)CCCn1cc(C2=C(n3ccc4ncccc43)C(=O)NC2=O)c2ccc(Br)cc21		CHEMBL562814	=	IC50	nM	2260.0	CHEMBL262	Homo sapiens	IC50	uM	2.26
	2696429	CHEMBL1064034	Inhibition of recombinant GST-GSK3beta expressed in Escherichia coli BL21 (DE3)	B	CN(C)CCCn1cc(C2=C(n3ccc4ncccc43)C(=O)NC2=O)c2ccc(F)cc21		CHEMBL559241	=	IC50	nM	12440.0	CHEMBL262	Homo sapiens	IC50	uM	12.44
	2696430	CHEMBL1064034	Inhibition of recombinant GST-GSK3beta expressed in Escherichia coli BL21 (DE3)	B	O=C1NC(=O)C(n2ccc3ncccc32)=C1c1cn(CCCN2CCCCC2)c2ccccc12		CHEMBL558317	=	IC50	nM	12450.0	CHEMBL262	Homo sapiens	IC50	uM	12.45
	2696431	CHEMBL1064034	Inhibition of recombinant GST-GSK3beta expressed in Escherichia coli BL21 (DE3)	B	O=C1NC(=O)C(n2ccc3ncccc32)=C1c1cn(CCCN2CCOCC2)c2ccccc12		CHEMBL564437	=	IC50	nM	1790.0	CHEMBL262	Homo sapiens	IC50	uM	1.79
	2696432	CHEMBL1064034	Inhibition of recombinant GST-GSK3beta expressed in Escherichia coli BL21 (DE3)	B	O=C1NC(=O)C(n2ccc3ncccc32)=C1c1cn(CCn2ccnc2)c2ccccc12		CHEMBL558512	=	IC50	nM	260.0	CHEMBL262	Homo sapiens	IC50	uM	0.26
	2696433	CHEMBL1064034	Inhibition of recombinant GST-GSK3beta expressed in Escherichia coli BL21 (DE3)	B	O=C1NC(=O)C(n2ccc3ncccc32)=C1c1cn(CCCCn2ccnc2)c2ccccc12		CHEMBL557647	=	IC50	nM	850.0	CHEMBL262	Homo sapiens	IC50	uM	0.85
	2696434	CHEMBL1064034	Inhibition of recombinant GST-GSK3beta expressed in Escherichia coli BL21 (DE3)	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	200.0	CHEMBL262	Homo sapiens	IC50	uM	0.2
	2696440	CHEMBL1061419	Inhibition of GST-GSK3beta	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	56.0	CHEMBL262	Homo sapiens	IC50	uM	0.056
Not Active	2696441	CHEMBL1061418	Inhibition of GSK3-beta in human SH-Sy5Y cells assessed as reduction of amyloid beta (25-35)-induced Tau hyperphosphorylation at Ser396 at 10 uM treated 1 hr before amyloid beta (25-35) challenge measured after 6 hrs by Western blotting	B	O=C1NC(=O)C(n2ccc3ncccc32)=C1c1cn(CCCCn2ccnc2)c2ccccc12		CHEMBL557647		Activity			CHEMBL262	Homo sapiens	Activity		
	2701987	CHEMBL1053309	Inhibition of recombinant GSK3-beta by ELISA	B	O=C1NC(=O)/C(=C/c2ccc(O)cc2)N1		CHEMBL432684	=	IC50	nM	13700.0	CHEMBL262	Homo sapiens	IC50	uM	13.7
	2701988	CHEMBL1053309	Inhibition of recombinant GSK3-beta by ELISA	B	CCSc1ccc(/C=C2\NC(=O)NC2=O)cc1		CHEMBL459575	=	IC50	nM	7800.0	CHEMBL262	Homo sapiens	IC50	uM	7.8
	2701989	CHEMBL1053309	Inhibition of recombinant GSK3-beta by ELISA	B	CCN(CC)c1ccc(/C=C2\NC(=O)NC2=O)cc1		CHEMBL41016	=	IC50	nM	4200.0	CHEMBL262	Homo sapiens	IC50	uM	4.2
	2701990	CHEMBL1053309	Inhibition of recombinant GSK3-beta by ELISA	B	COc1ccc(/C=C2\NC(=O)NC2=O)cc1		CHEMBL38043	=	IC50	nM	14100.0	CHEMBL262	Homo sapiens	IC50	uM	14.1
	2701991	CHEMBL1053309	Inhibition of recombinant GSK3-beta by ELISA	B	CSc1ccc(/C=C2\NC(=O)NC2=O)cc1		CHEMBL569595	=	IC50	nM	6900.0	CHEMBL262	Homo sapiens	IC50	uM	6.9
	2701992	CHEMBL1053309	Inhibition of recombinant GSK3-beta by ELISA	B	O=C1NC(=O)/C(=C/c2ccc(-c3cccs3)cc2)N1		CHEMBL460627	=	IC50	nM	13500.0	CHEMBL262	Homo sapiens	IC50	uM	13.5
	2701993	CHEMBL1053309	Inhibition of recombinant GSK3-beta by ELISA	B	O=C1NC(=O)/C(=C/c2ccc(-c3ccsc3)cc2)N1		CHEMBL568905	=	IC50	nM	6400.0	CHEMBL262	Homo sapiens	IC50	uM	6.4
	2701994	CHEMBL1053309	Inhibition of recombinant GSK3-beta by ELISA	B	O=C1NC(=O)/C(=C/c2ccc(Cl)cc2)N1		CHEMBL290184	=	IC50	nM	18200.0	CHEMBL262	Homo sapiens	IC50	uM	18.2
	2701995	CHEMBL1053309	Inhibition of recombinant GSK3-beta by ELISA	B	O[C@]12C=C(c3nccc4c3[nH]c3ccccc34)[C@@H]3CCN(CCCC/C=C\CC1)C[C@@]31C[C@@H]3/C=C\CCCCN3[C@@H]21		CHEMBL403233	=	IC50	nM	12300.0	CHEMBL262	Homo sapiens	IC50	uM	12.3
	2721620	CHEMBL1057448	Inhibition of GSK3-beta at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	2722270	CHEMBL1063587	Inhibition of GSK3-beta	B	Cc1ccc2c(c1)N(Cc1cc(F)cc3c1OCOC3)C(=O)/C2=N\O		CHEMBL551140	>	Ki	nM	30000.0	CHEMBL262	Homo sapiens	Ki	uM	30.0
	2893581	CHEMBL1061074	Binding constant for full-length GSK3B	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	uM	10.0
	2893582	CHEMBL1061074	Binding constant for full-length GSK3B	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	uM	10.0
	2893583	CHEMBL1061074	Binding constant for full-length GSK3B	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	uM	10.0
	2893584	CHEMBL1061074	Binding constant for full-length GSK3B	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	uM	10.0
	2893585	CHEMBL1061074	Binding constant for full-length GSK3B	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	uM	10.0
	2893586	CHEMBL1061074	Binding constant for full-length GSK3B	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	Kd	nM	37.0	CHEMBL262	Homo sapiens	Kd	nM	37.0
	2893587	CHEMBL1061074	Binding constant for full-length GSK3B	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	350.0	CHEMBL262	Homo sapiens	Kd	nM	350.0
	2893588	CHEMBL1061074	Binding constant for full-length GSK3B	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	uM	10.0
	2893589	CHEMBL1061074	Binding constant for full-length GSK3B	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	uM	10.0
	2893590	CHEMBL1061074	Binding constant for full-length GSK3B	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	uM	10.0
	2893591	CHEMBL1061074	Binding constant for full-length GSK3B	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	uM	10.0
	2893592	CHEMBL1061074	Binding constant for full-length GSK3B	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	uM	10.0
	2893593	CHEMBL1061074	Binding constant for full-length GSK3B	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	uM	10.0
	2893594	CHEMBL1061074	Binding constant for full-length GSK3B	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	uM	10.0
	2893595	CHEMBL1061074	Binding constant for full-length GSK3B	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	730.0	CHEMBL262	Homo sapiens	Kd	nM	730.0
	2893596	CHEMBL1061074	Binding constant for full-length GSK3B	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	uM	10.0
	2893597	CHEMBL1061074	Binding constant for full-length GSK3B	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	uM	10.0
	2893598	CHEMBL1061074	Binding constant for full-length GSK3B	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	uM	10.0
	2893599	CHEMBL1061074	Binding constant for full-length GSK3B	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	uM	10.0
	2893600	CHEMBL1061074	Binding constant for full-length GSK3B	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	950.0	CHEMBL262	Homo sapiens	Kd	nM	950.0
	2893601	CHEMBL1061074	Binding constant for full-length GSK3B	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	uM	10.0
	2893602	CHEMBL1061074	Binding constant for full-length GSK3B	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	2600.0	CHEMBL262	Homo sapiens	Kd	nM	2600.0
	2893603	CHEMBL1061074	Binding constant for full-length GSK3B	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	uM	10.0
	2893604	CHEMBL1061074	Binding constant for full-length GSK3B	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	uM	10.0
	2893605	CHEMBL1061074	Binding constant for full-length GSK3B	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	uM	10.0
	2893606	CHEMBL1061074	Binding constant for full-length GSK3B	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	1800.0	CHEMBL262	Homo sapiens	Kd	nM	1800.0
	2893607	CHEMBL1061074	Binding constant for full-length GSK3B	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	uM	10.0
	2893608	CHEMBL1061074	Binding constant for full-length GSK3B	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	uM	10.0
	2893609	CHEMBL1061074	Binding constant for full-length GSK3B	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Kd	nM	2700.0	CHEMBL262	Homo sapiens	Kd	nM	2700.0
	2893610	CHEMBL1061074	Binding constant for full-length GSK3B	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Kd	nM	1700.0	CHEMBL262	Homo sapiens	Kd	nM	1700.0
	2893611	CHEMBL1061074	Binding constant for full-length GSK3B	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	uM	10.0
	2893612	CHEMBL1061074	Binding constant for full-length GSK3B	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	uM	10.0
	2893613	CHEMBL1061074	Binding constant for full-length GSK3B	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	69.0	CHEMBL262	Homo sapiens	Kd	nM	69.0
	2893614	CHEMBL1061074	Binding constant for full-length GSK3B	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	uM	10.0
	2893615	CHEMBL1061074	Binding constant for full-length GSK3B	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	uM	10.0
	2893616	CHEMBL1061074	Binding constant for full-length GSK3B	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	uM	10.0
	2893617	CHEMBL1061074	Binding constant for full-length GSK3B	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	uM	10.0
	2893618	CHEMBL1061074	Binding constant for full-length GSK3B	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	uM	10.0
	2897096	CHEMBL1062036	Inhibition of GSK3-beta	B	O=C(O)Cc1c2ccccc2n2c1[nH]c(=O)c1ccccc12		CHEMBL92361	=	IC50	nM	14000.0	CHEMBL262	Homo sapiens	IC50	uM	14.0
	2897186	CHEMBL1063786	Percent residual GSK3-beta activity in the presence of 10uM inhibitor	B	O=C(O)Cc1c2ccccc2n2c1[nH]c(=O)c1ccccc12		CHEMBL92361	=	Activity	%	66.0	CHEMBL262	Homo sapiens	Activity	%	66.0
	2897187	CHEMBL1063786	Percent residual GSK3-beta activity in the presence of 10uM inhibitor	B	O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12		CHEMBL28	=	Activity	%	54.0	CHEMBL262	Homo sapiens	Activity	%	54.0
	2897188	CHEMBL1063786	Percent residual GSK3-beta activity in the presence of 10uM inhibitor	B	Cc1cc(O)c2c(c1)C(=O)c1cc(O)cc(O)c1C2=O		CHEMBL289277	=	Activity	%	68.0	CHEMBL262	Homo sapiens	Activity	%	68.0
Antagonist	2897298	CHEMBL1062883	Inhibition of GSK3-beta in the presence of 20uM ATP	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	IC50	nM	40.0	CHEMBL262	Homo sapiens	IC50	uM	0.04
	2902207	CHEMBL1062808	Percentage GSK3-beta activity remaining in the presence of 0.01uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	82.0	CHEMBL262	Homo sapiens	Activity	%	82.0
	2902208	CHEMBL1062808	Percentage GSK3-beta activity remaining in the presence of 0.01uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	81.0	CHEMBL262	Homo sapiens	Activity	%	81.0
	2902209	CHEMBL1062808	Percentage GSK3-beta activity remaining in the presence of 0.01uM inhibitor	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	Activity	%	77.0	CHEMBL262	Homo sapiens	Activity	%	77.0
	2902210	CHEMBL1061961	Percentage GSK3-beta activity remaining in the presence of 0.1uM inhibitor	B	CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C		CHEMBL573107	=	Activity	%	77.0	CHEMBL262	Homo sapiens	Activity	%	77.0
Antagonist	2902211	CHEMBL1061961	Percentage GSK3-beta activity remaining in the presence of 0.1uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	48.0	CHEMBL262	Homo sapiens	Activity	%	48.0
Antagonist	2902212	CHEMBL1061961	Percentage GSK3-beta activity remaining in the presence of 0.1uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	33.0	CHEMBL262	Homo sapiens	Activity	%	33.0
	2902213	CHEMBL1061961	Percentage GSK3-beta activity remaining in the presence of 0.1uM inhibitor	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Activity	%	79.0	CHEMBL262	Homo sapiens	Activity	%	79.0
Antagonist	2902214	CHEMBL1061961	Percentage GSK3-beta activity remaining in the presence of 0.1uM inhibitor	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	Activity	%	4.0	CHEMBL262	Homo sapiens	Activity	%	4.0
Antagonist	2902215	CHEMBL1061961	Percentage GSK3-beta activity remaining in the presence of 0.1uM inhibitor	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Activity	%	18.0	CHEMBL262	Homo sapiens	Activity	%	18.0
Antagonist	2902216	CHEMBL1061961	Percentage GSK3-beta activity remaining in the presence of 0.1uM inhibitor	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Activity	%	43.0	CHEMBL262	Homo sapiens	Activity	%	43.0
	2902217	CHEMBL1052077	Percentage GSK3-beta activity remaining in the presence of 10uM inhibitor	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	=	Activity	%	78.0	CHEMBL262	Homo sapiens	Activity	%	78.0
Antagonist	2903077	CHEMBL1052077	Percentage GSK3-beta activity remaining in the presence of 10uM inhibitor	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Activity	%	37.0	CHEMBL262	Homo sapiens	Activity	%	37.0
Antagonist	2903078	CHEMBL1052077	Percentage GSK3-beta activity remaining in the presence of 10uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	1.0	CHEMBL262	Homo sapiens	Activity	%	1.0
	2903079	CHEMBL1052077	Percentage GSK3-beta activity remaining in the presence of 10uM inhibitor	B	CC(=O)c1c(O)c(C)c(O)c(Cc2c(O)c3c(c(C(=O)/C=C/c4ccccc4)c2O)OC(C)(C)C=C3)c1O		CHEMBL34241	=	Activity	%	82.0	CHEMBL262	Homo sapiens	Activity	%	82.0
	2903080	CHEMBL1052077	Percentage GSK3-beta activity remaining in the presence of 10uM inhibitor	B	C[C@H]1CNCCN1S(=O)(=O)c1cccc2cnccc12		CHEMBL1233654	=	Activity	%	76.0	CHEMBL262	Homo sapiens	Activity	%	76.0
Antagonist	2903081	CHEMBL1052077	Percentage GSK3-beta activity remaining in the presence of 10uM inhibitor	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	Activity	%	4.0	CHEMBL262	Homo sapiens	Activity	%	4.0
	2903082	CHEMBL1052077	Percentage GSK3-beta activity remaining in the presence of 10uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	59.0	CHEMBL262	Homo sapiens	Activity	%	59.0
	2903083	CHEMBL1052077	Percentage GSK3-beta activity remaining in the presence of 10uM inhibitor	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Activity	%	78.0	CHEMBL262	Homo sapiens	Activity	%	78.0
	2903084	CHEMBL1052077	Percentage GSK3-beta activity remaining in the presence of 10uM inhibitor	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Activity	%	86.0	CHEMBL262	Homo sapiens	Activity	%	86.0
	2903085	CHEMBL1052077	Percentage GSK3-beta activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1sc(-c2ccsc2)cc1N		CHEMBL193093	=	Activity	%	76.0	CHEMBL262	Homo sapiens	Activity	%	76.0
	2903086	CHEMBL1052077	Percentage GSK3-beta activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	77.0	CHEMBL262	Homo sapiens	Activity	%	77.0
	2903087	CHEMBL1052077	Percentage GSK3-beta activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	93.0	CHEMBL262	Homo sapiens	Activity	%	93.0
	2903088	CHEMBL1052077	Percentage GSK3-beta activity remaining in the presence of 10uM inhibitor	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	Activity	%	107.0	CHEMBL262	Homo sapiens	Activity	%	107.0
	2903434	CHEMBL1052077	Percentage GSK3-beta activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	=	Activity	%	100.0	CHEMBL262	Homo sapiens	Activity	%	100.0
Antagonist	2903435	CHEMBL1052077	Percentage GSK3-beta activity remaining in the presence of 10uM inhibitor	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Activity	%	3.0	CHEMBL262	Homo sapiens	Activity	%	3.0
Antagonist	2903436	CHEMBL1052077	Percentage GSK3-beta activity remaining in the presence of 10uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	23.0	CHEMBL262	Homo sapiens	Activity	%	23.0
	2903437	CHEMBL1052077	Percentage GSK3-beta activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Activity	%	88.0	CHEMBL262	Homo sapiens	Activity	%	88.0
	2903438	CHEMBL1052077	Percentage GSK3-beta activity remaining in the presence of 10uM inhibitor	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	=	Activity	%	82.0	CHEMBL262	Homo sapiens	Activity	%	82.0
	2904326	CHEMBL1052077	Percentage GSK3-beta activity remaining in the presence of 10uM inhibitor	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Activity	%	64.0	CHEMBL262	Homo sapiens	Activity	%	64.0
	2904327	CHEMBL1052077	Percentage GSK3-beta activity remaining in the presence of 10uM inhibitor	B	CC(=O)O[C@H]1[C@H](C)O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H]1OC(C)=O		CHEMBL240954	=	Activity	%	87.0	CHEMBL262	Homo sapiens	Activity	%	87.0
Antagonist	2904328	CHEMBL1052077	Percentage GSK3-beta activity remaining in the presence of 10uM inhibitor	B	O=C(Nc1cc(Cl)cc2c1[nH]c1cnccc12)c1cccnc1		CHEMBL79004	=	Activity	%	46.0	CHEMBL262	Homo sapiens	Activity	%	46.0
	2904329	CHEMBL1052077	Percentage GSK3-beta activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl.O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL540501	=	Activity	%	76.0	CHEMBL262	Homo sapiens	Activity	%	76.0
	2904330	CHEMBL1052077	Percentage GSK3-beta activity remaining in the presence of 10uM inhibitor	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N		CHEMBL34704	=	Activity	%	82.0	CHEMBL262	Homo sapiens	Activity	%	82.0
	2904331	CHEMBL1052077	Percentage GSK3-beta activity remaining in the presence of 10uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	78.0	CHEMBL262	Homo sapiens	Activity	%	78.0
	2904332	CHEMBL1060118	Percentage GSK3-beta activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Activity	%	54.0	CHEMBL262	Homo sapiens	Activity	%	54.0
Antagonist	2904333	CHEMBL1060118	Percentage GSK3-beta activity remaining in the presence of 1uM inhibitor	B	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	=	Activity	%	1.0	CHEMBL262	Homo sapiens	Activity	%	1.0
	2904334	CHEMBL1060118	Percentage GSK3-beta activity remaining in the presence of 1uM inhibitor	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Activity	%	84.0	CHEMBL262	Homo sapiens	Activity	%	84.0
	2904335	CHEMBL1060118	Percentage GSK3-beta activity remaining in the presence of 1uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	55.0	CHEMBL262	Homo sapiens	Activity	%	55.0
	2904336	CHEMBL1060118	Percentage GSK3-beta activity remaining in the presence of 1uM inhibitor	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	78.0	CHEMBL262	Homo sapiens	Activity	%	78.0
	2904337	CHEMBL1060118	Percentage GSK3-beta activity remaining in the presence of 1uM inhibitor	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	Activity	%	83.0	CHEMBL262	Homo sapiens	Activity	%	83.0
	2904338	CHEMBL1060118	Percentage GSK3-beta activity remaining in the presence of 1uM inhibitor	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Activity	%	87.0	CHEMBL262	Homo sapiens	Activity	%	87.0
Antagonist	2904339	CHEMBL1060118	Percentage GSK3-beta activity remaining in the presence of 1uM inhibitor	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Activity	%	34.0	CHEMBL262	Homo sapiens	Activity	%	34.0
Antagonist	2904340	CHEMBL1060118	Percentage GSK3-beta activity remaining in the presence of 1uM inhibitor	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Activity	%	27.0	CHEMBL262	Homo sapiens	Activity	%	27.0
	2904341	CHEMBL1060118	Percentage GSK3-beta activity remaining in the presence of 1uM inhibitor	B	COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C(C3=O)[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O		CHEMBL428496	=	Activity	%	65.0	CHEMBL262	Homo sapiens	Activity	%	65.0
	2904342	CHEMBL1060118	Percentage GSK3-beta activity remaining in the presence of 1uM inhibitor	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Activity	%	76.0	CHEMBL262	Homo sapiens	Activity	%	76.0
Antagonist	2904343	CHEMBL1060118	Percentage GSK3-beta activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Activity	%	3.0	CHEMBL262	Homo sapiens	Activity	%	3.0
Antagonist	2904344	CHEMBL1060118	Percentage GSK3-beta activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Activity	%	3.0	CHEMBL262	Homo sapiens	Activity	%	3.0
Antagonist	2904345	CHEMBL1060118	Percentage GSK3-beta activity remaining in the presence of 1uM inhibitor	B	CC(=O)O.O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL265470	=	Activity	%	43.0	CHEMBL262	Homo sapiens	Activity	%	43.0
	2904346	CHEMBL1060118	Percentage GSK3-beta activity remaining in the presence of 1uM inhibitor	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Activity	%	81.0	CHEMBL262	Homo sapiens	Activity	%	81.0
Antagonist	2904347	CHEMBL1060118	Percentage GSK3-beta activity remaining in the presence of 1uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	2.0	CHEMBL262	Homo sapiens	Activity	%	2.0
	2904348	CHEMBL1060118	Percentage GSK3-beta activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	Activity	%	87.0	CHEMBL262	Homo sapiens	Activity	%	87.0
	2904349	CHEMBL1060118	Percentage GSK3-beta activity remaining in the presence of 1uM inhibitor	B	CC1=NCCc2c1[nH]c1cc(O)ccc21		CHEMBL129177	=	Activity	%	88.0	CHEMBL262	Homo sapiens	Activity	%	88.0
	2904350	CHEMBL1060118	Percentage GSK3-beta activity remaining in the presence of 1uM inhibitor	B	Cc1nccc2c1[nH]c1ccccc12		CHEMBL12014	=	Activity	%	108.0	CHEMBL262	Homo sapiens	Activity	%	108.0
	2904351	CHEMBL1060118	Percentage GSK3-beta activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c3c([nH]c2c1)C(C)=NCC3		CHEMBL340807	=	Activity	%	100.0	CHEMBL262	Homo sapiens	Activity	%	100.0
	2904352	CHEMBL1060118	Percentage GSK3-beta activity remaining in the presence of 1uM inhibitor	B	Oc1c(Br)cc(C=C2c3cc(I)ccc3NC2O)cc1Br		CHEMBL1794051	=	Activity	%	54.0	CHEMBL262	Homo sapiens	Activity	%	54.0
	2904353	CHEMBL1060118	Percentage GSK3-beta activity remaining in the presence of 1uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	88.0	CHEMBL262	Homo sapiens	Activity	%	88.0
	2904354	CHEMBL1060118	Percentage GSK3-beta activity remaining in the presence of 1uM inhibitor	B	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12		CHEMBL406821	=	Activity	%	92.0	CHEMBL262	Homo sapiens	Activity	%	92.0
	2904355	CHEMBL1060118	Percentage GSK3-beta activity remaining in the presence of 1uM inhibitor	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Activity	%	81.0	CHEMBL262	Homo sapiens	Activity	%	81.0
	2904356	CHEMBL1060118	Percentage GSK3-beta activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	95.0	CHEMBL262	Homo sapiens	Activity	%	95.0
	2904357	CHEMBL1060118	Percentage GSK3-beta activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Activity	%	107.0	CHEMBL262	Homo sapiens	Activity	%	107.0
	2904358	CHEMBL1060118	Percentage GSK3-beta activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	90.0	CHEMBL262	Homo sapiens	Activity	%	90.0
	2904359	CHEMBL1060118	Percentage GSK3-beta activity remaining in the presence of 1uM inhibitor	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Activity	%	83.0	CHEMBL262	Homo sapiens	Activity	%	83.0
	2904360	CHEMBL1060118	Percentage GSK3-beta activity remaining in the presence of 1uM inhibitor	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Activity	%	88.0	CHEMBL262	Homo sapiens	Activity	%	88.0
	2904361	CHEMBL1060118	Percentage GSK3-beta activity remaining in the presence of 1uM inhibitor	B	CCCCCCOC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608532	=	Activity	%	73.0	CHEMBL262	Homo sapiens	Activity	%	73.0
	2904362	CHEMBL1060118	Percentage GSK3-beta activity remaining in the presence of 1uM inhibitor	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Activity	%	89.0	CHEMBL262	Homo sapiens	Activity	%	89.0
	2904363	CHEMBL1060118	Percentage GSK3-beta activity remaining in the presence of 1uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	89.0	CHEMBL262	Homo sapiens	Activity	%	89.0
	2904364	CHEMBL1060118	Percentage GSK3-beta activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	Activity	%	94.0	CHEMBL262	Homo sapiens	Activity	%	94.0
	2904365	CHEMBL1061962	Percentage GSK3-beta activity remaining in the presence of 25uM inhibitor	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349	=	Activity	%	74.0	CHEMBL262	Homo sapiens	Activity	%	74.0
	2904366	CHEMBL1061962	Percentage GSK3-beta activity remaining in the presence of 25uM inhibitor	B	NCCNS(=O)(=O)c1ccc(Cl)c2ccncc12		CHEMBL489157	=	Activity	%	75.0	CHEMBL262	Homo sapiens	Activity	%	75.0
Antagonist	2904367	CHEMBL1063747	Percentage GSK3-beta activity remaining in the presence of 2uM inhibitor	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714	=	Activity	%	2.0	CHEMBL262	Homo sapiens	Activity	%	2.0
	2904368	CHEMBL1063748	Percentage GSK3-beta activity remaining in the presence of 3uM inhibitor	B	Cc1ccc(-c2c(C(=O)CF)n(CCCO)c3ncnc(N)c23)cc1		CHEMBL515414	=	Activity	%	65.0	CHEMBL262	Homo sapiens	Activity	%	65.0
	2921319	CHEMBL1053746	Inhibition of GSK3B assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	100.0	CHEMBL262	Homo sapiens	Activity	%	100.0
	2923911	CHEMBL1042364	Inhibition of human recombinant GSK3-beta	B	Cc1ccc(-c2ccc3occ(-c4ccc([S+](C)[O-])cc4)c3c2)o1		CHEMBL574591	=	IC50	nM	35.0	CHEMBL262	Homo sapiens	IC50	nM	35.0
	2923912	CHEMBL1042364	Inhibition of human recombinant GSK3-beta	B	CC[S+]([O-])c1ccc(-c2coc3ccc(-c4ccc(C)o4)cc23)cc1		CHEMBL574159	=	IC50	nM	35.0	CHEMBL262	Homo sapiens	IC50	nM	35.0
	2923913	CHEMBL1042364	Inhibition of human recombinant GSK3-beta	B	CCS(=O)(=O)c1ccc(-c2coc3ccc(-c4ccc(C)o4)cc23)cc1		CHEMBL578628	=	IC50	nM	38.0	CHEMBL262	Homo sapiens	IC50	nM	38.0
	2923914	CHEMBL1042364	Inhibition of human recombinant GSK3-beta	B	Cc1ccc(-c2ccc3occ(-c4ccc(S(C)(=O)=O)cc4)c3c2)o1		CHEMBL584757	=	IC50	nM	42.0	CHEMBL262	Homo sapiens	IC50	nM	42.0
	2923915	CHEMBL1042364	Inhibition of human recombinant GSK3-beta	B	Cc1ccc(-c2ccc3occ(-c4ccc(C(=O)O)cc4)c3c2)o1		CHEMBL573257	=	IC50	nM	50.0	CHEMBL262	Homo sapiens	IC50	nM	50.0
	2923916	CHEMBL1042364	Inhibition of human recombinant GSK3-beta	B	COc1ccc(-c2coc3ccc(-c4ccc(C)o4)cc23)cc1		CHEMBL576183	=	IC50	nM	54.0	CHEMBL262	Homo sapiens	IC50	nM	54.0
	2923917	CHEMBL1042364	Inhibition of human recombinant GSK3-beta	B	CSc1ccc(-c2coc3ccc(-c4ccc(C)o4)cc23)cc1		CHEMBL572973	=	IC50	nM	66.0	CHEMBL262	Homo sapiens	IC50	nM	66.0
	2923918	CHEMBL1042364	Inhibition of human recombinant GSK3-beta	B	Cc1ccc(-c2ccc3occ(-c4ccc(C(N)=O)cc4)c3c2)o1		CHEMBL576165	=	IC50	nM	69.0	CHEMBL262	Homo sapiens	IC50	nM	69.0
	2923919	CHEMBL1042364	Inhibition of human recombinant GSK3-beta	B	COc1cccc(-c2coc3ccc(-c4ccc(C)o4)cc23)c1		CHEMBL573486	=	IC50	nM	74.0	CHEMBL262	Homo sapiens	IC50	nM	74.0
	2923920	CHEMBL1042364	Inhibition of human recombinant GSK3-beta	B	Cc1ccc(-c2ccc3occ(-c4ccncc4)c3c2)o1		CHEMBL582853	=	IC50	nM	77.0	CHEMBL262	Homo sapiens	IC50	nM	77.0
	2923921	CHEMBL1042364	Inhibition of human recombinant GSK3-beta	B	CC(=O)c1ccc(-c2coc3ccc(-c4ccc(C)o4)cc23)cc1		CHEMBL572779	=	IC50	nM	100.0	CHEMBL262	Homo sapiens	IC50	nM	100.0
	2923922	CHEMBL1042364	Inhibition of human recombinant GSK3-beta	B	Cc1ccc(-c2ccc3occ(-c4ccc(F)cc4)c3c2)o1		CHEMBL573007	=	IC50	nM	110.0	CHEMBL262	Homo sapiens	IC50	nM	110.0
	2923923	CHEMBL1042364	Inhibition of human recombinant GSK3-beta	B	Cc1ccc(-c2ccc3occ(-c4ccc(C(C)O)cc4)c3c2)o1		CHEMBL573933	=	IC50	nM	160.0	CHEMBL262	Homo sapiens	IC50	nM	160.0
	2923924	CHEMBL1042364	Inhibition of human recombinant GSK3-beta	B	Cc1ccc(-c2ccc3occ(-c4ccc(O)cc4)c3c2)o1		CHEMBL573192	=	IC50	nM	180.0	CHEMBL262	Homo sapiens	IC50	nM	180.0
	2923925	CHEMBL1042364	Inhibition of human recombinant GSK3-beta	B	COC(=O)c1ccc(-c2coc3ccc(-c4ccc(C)o4)cc23)cc1		CHEMBL573480	=	IC50	nM	200.0	CHEMBL262	Homo sapiens	IC50	nM	200.0
	2923926	CHEMBL1042364	Inhibition of human recombinant GSK3-beta	B	Cc1ccc(-c2ccc3occ(-c4cccc([S+](C)[O-])c4)c3c2)o1		CHEMBL573487	=	IC50	nM	210.0	CHEMBL262	Homo sapiens	IC50	nM	210.0
	2923927	CHEMBL1042364	Inhibition of human recombinant GSK3-beta	B	COP(=O)(OC)c1ccc(-c2coc3ccc(-c4ccc(C)o4)cc23)cc1		CHEMBL578861	=	IC50	nM	280.0	CHEMBL262	Homo sapiens	IC50	nM	280.0
	2923996	CHEMBL1042364	Inhibition of human recombinant GSK3-beta	B	Cc1ccc(-c2ccc3ncn(-c4ccc([S+](C)[O-])cc4)c3c2)o1		CHEMBL578427	=	IC50	nM	200.0	CHEMBL262	Homo sapiens	IC50	nM	200.0
	2923997	CHEMBL1042364	Inhibition of human recombinant GSK3-beta	B	Cc1ccc(-c2ccc3scc(-c4ccc([S+](C)[O-])cc4)c3c2)o1		CHEMBL573266	=	IC50	nM	790.0	CHEMBL262	Homo sapiens	IC50	nM	790.0
	2923998	CHEMBL1042364	Inhibition of human recombinant GSK3-beta	B	Cc1ccc(-c2ccc3ncc(-c4ccc([S+](C)[O-])cc4)n3c2)o1		CHEMBL576336	>	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	nM	1000.0
	2923999	CHEMBL1042364	Inhibition of human recombinant GSK3-beta	B	Cc1ccc(-c2ccc3occ(-c4ccc([S+](C)[O-])cc4)c3n2)o1		CHEMBL572560	=	IC50	nM	270.0	CHEMBL262	Homo sapiens	IC50	nM	270.0
	2924000	CHEMBL1042364	Inhibition of human recombinant GSK3-beta	B	Cc1ccc(-c2cnc3occ(-c4ccc([S+](C)[O-])cc4)c3c2)o1		CHEMBL584146	>	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	nM	1000.0
	2924001	CHEMBL1042364	Inhibition of human recombinant GSK3-beta	B	Cc1ccc(-c2cc3c(-c4ccc([S+](C)[O-])cc4)coc3cn2)o1		CHEMBL578634	>	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	nM	1000.0
	2924002	CHEMBL1042364	Inhibition of human recombinant GSK3-beta	B	Cc1nnc(-c2ccc3occ(-c4ccc([S+](C)[O-])cc4)c3c2)s1		CHEMBL572793	=	IC50	nM	72.0	CHEMBL262	Homo sapiens	IC50	nM	72.0
	2924003	CHEMBL1042364	Inhibition of human recombinant GSK3-beta	B	Cc1nnc(-c2ccc3occ(-c4ccc([S+](C)[O-])cc4)c3c2)[nH]1		CHEMBL576540	=	IC50	nM	81.0	CHEMBL262	Homo sapiens	IC50	nM	81.0
	2924004	CHEMBL1042364	Inhibition of human recombinant GSK3-beta	B	Cc1ccc(-c2ccc3occ(-c4ccc([S+](C)[O-])cc4)c3c2)nn1		CHEMBL573716	>	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	nM	1000.0
	2924005	CHEMBL1042364	Inhibition of human recombinant GSK3-beta	B	Cc1nc(-c2ccc3occ(-c4ccc([S+](C)[O-])cc4)c3c2)no1		CHEMBL574600	=	IC50	nM	680.0	CHEMBL262	Homo sapiens	IC50	nM	680.0
	2924006	CHEMBL1042364	Inhibition of human recombinant GSK3-beta	B	Cc1noc(-c2ccc3occ(-c4ccc([S+](C)[O-])cc4)c3c2)n1		CHEMBL578428	>	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	nM	1000.0
	2924007	CHEMBL1042364	Inhibition of human recombinant GSK3-beta	B	C[S+]([O-])c1ccc(-c2coc3ccc(-c4nnc(S)o4)cc23)cc1		CHEMBL574601	=	IC50	nM	94.0	CHEMBL262	Homo sapiens	IC50	nM	94.0
	2924008	CHEMBL1042364	Inhibition of human recombinant GSK3-beta	B	C[S+]([O-])c1ccc(-c2coc3ccc(-c4nnc(O)o4)cc23)cc1		CHEMBL573267	=	IC50	nM	130.0	CHEMBL262	Homo sapiens	IC50	nM	130.0
	2924009	CHEMBL1042364	Inhibition of human recombinant GSK3-beta	B	C[S+]([O-])c1ccc(-c2coc3ccc(-c4nnc(N)o4)cc23)cc1		CHEMBL584976	=	IC50	nM	13.0	CHEMBL262	Homo sapiens	IC50	nM	13.0
	2924010	CHEMBL1042364	Inhibition of human recombinant GSK3-beta	B	Cc1ccc(-c2ccc3occ(-c4ccc([S@@+](C)[O-])cc4)c3c2)o1		CHEMBL575021	=	IC50	nM	140.0	CHEMBL262	Homo sapiens	IC50	nM	140.0
	2924011	CHEMBL1042364	Inhibition of human recombinant GSK3-beta	B	Cc1ccc(-c2ccc3occ(-c4ccc([S@+](C)[O-])cc4)c3c2)o1		CHEMBL574588	=	IC50	nM	34.0	CHEMBL262	Homo sapiens	IC50	nM	34.0
	2924012	CHEMBL1042364	Inhibition of human recombinant GSK3-beta	B	CC[S@@+]([O-])c1ccc(-c2coc3ccc(-c4ccc(C)o4)cc23)cc1		CHEMBL575882	=	IC50	nM	190.0	CHEMBL262	Homo sapiens	IC50	nM	190.0
	2924013	CHEMBL1042364	Inhibition of human recombinant GSK3-beta	B	CC[S@+]([O-])c1ccc(-c2coc3ccc(-c4ccc(C)o4)cc23)cc1		CHEMBL574613	=	IC50	nM	20.0	CHEMBL262	Homo sapiens	IC50	nM	20.0
	2924809	CHEMBL1056875	Inhibition of GSK3-beta assessed as residual enzyme activity at 10 uM relative to untreated control	B	c1ccc2c(c1)[nH]c1c3cc[nH]c3ccc21		CHEMBL567173	=	Activity	%	102.0	CHEMBL262	Homo sapiens	Activity	%	102.0
	2924810	CHEMBL1056875	Inhibition of GSK3-beta assessed as residual enzyme activity at 10 uM relative to untreated control	B	c1ccc2c(c1)[nH]c1c2ccc2cc[nH]c21		CHEMBL584980	=	Activity	%	111.0	CHEMBL262	Homo sapiens	Activity	%	111.0
	2924811	CHEMBL1056875	Inhibition of GSK3-beta assessed as residual enzyme activity at 10 uM relative to untreated control	B	O=Cc1c[nH]c2ccc3c4ccccc4[nH]c3c12		CHEMBL575754	=	Activity	%	96.0	CHEMBL262	Homo sapiens	Activity	%	96.0
	2924812	CHEMBL1056875	Inhibition of GSK3-beta assessed as residual enzyme activity at 10 uM relative to untreated control	B	O=Cc1c[nH]c2c1ccc1c3ccccc3[nH]c12		CHEMBL583972	=	Activity	%	88.0	CHEMBL262	Homo sapiens	Activity	%	88.0
Active	2925643	CHEMBL1053705	Induction of GSK3-beta phosphorylation in human HepG2 cells at 10 uM by Western blot analysis in presence of 33 mM glucose	B	C=C1CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)[C@@](C)(CO)[C@@H]5CC[C@]43C)[C@@H]2C1		CHEMBL1081326		Activity			CHEMBL262	Homo sapiens	Activity		
Active	2925644	CHEMBL1053705	Induction of GSK3-beta phosphorylation in human HepG2 cells at 10 uM by Western blot analysis in presence of 33 mM glucose	B	CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C)C(C)C		CHEMBL221542		Activity			CHEMBL262	Homo sapiens	Activity		
Active	2925645	CHEMBL1053705	Induction of GSK3-beta phosphorylation in human HepG2 cells at 10 uM by Western blot analysis in presence of 33 mM glucose	B	CC1(C)CC[C@]2(C(=O)O)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1		CHEMBL168		Activity			CHEMBL262	Homo sapiens	Activity		
Active	2925646	CHEMBL1053705	Induction of GSK3-beta phosphorylation in human HepG2 cells at 10 uM by Western blot analysis in presence of 33 mM glucose	B	CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)CC[C@]4(C)[C@H]3CC[C@@]21C)C(C)C		CHEMBL506678		Activity			CHEMBL262	Homo sapiens	Activity		
Active	2925647	CHEMBL1053705	Induction of GSK3-beta phosphorylation in human HepG2 cells at 10 uM by Western blot analysis in presence of 33 mM glucose	B	C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12		CHEMBL269277		Activity			CHEMBL262	Homo sapiens	Activity		
Active	2925648	CHEMBL1053705	Induction of GSK3-beta phosphorylation in human HepG2 cells at 10 uM by Western blot analysis in presence of 33 mM glucose	B	C[C@@H]1[C@H]2C3=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)CC[C@@]2(C(=O)O)CC[C@H]1C		CHEMBL169		Activity			CHEMBL262	Homo sapiens	Activity		
Active	2925649	CHEMBL1053705	Induction of GSK3-beta phosphorylation in human HepG2 cells at 10 uM by Western blot analysis in presence of 33 mM glucose	B	CC1(C)[C@@H](O)CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C=CC2=C(O)C(=O)C(=O)[C@]21C		CHEMBL575924		Activity			CHEMBL262	Homo sapiens	Activity		
Dose-dependent effect	2925694	CHEMBL1053699	Induction of GSK3-beta phosphorylation in human HepG2 cells by Western blot analysis in presence of 33 mM glucose	B	CC1(C)[C@@H](O)CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C=CC2=C(O)C(=O)C(=O)[C@]21C		CHEMBL575924		Activity			CHEMBL262	Homo sapiens	Activity		
	2926221	CHEMBL1050233	Inhibition of GSK3-beta assessed as remaining enzyme activity at 3 uM relative to DMSO	B	COc1ccccc1-n1c(-c2ccccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL574236	=	Activity	%	102.0	CHEMBL262	Homo sapiens	Activity	%	102.0
	2928407	CHEMBL1060305	Inhibition of GSK3-beta assessed as remaining enzyme activity at 1 uM relative to DMSO	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Activity	%	89.0	CHEMBL262	Homo sapiens	Activity	%	89.0
Not Active	2938596	CHEMBL1040609	Inhibition of GSK3-beta at 10 uM	B	O=C1OC(/C=C/c2ccccc2)=N/C1=C\c1cccnc1		CHEMBL565286		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	2946383	CHEMBL1040547	Inhibition of GSK3-beta expressed in insect Sf9 cells	B	Cn1c2c(c3cc(Br)ccc31)CC(=O)Nc1ccccc1-2		CHEMBL318208	=	IC50	nM	400.0	CHEMBL262	Homo sapiens	IC50	microM	0.4
	2946384	CHEMBL1040547	Inhibition of GSK3-beta expressed in insect Sf9 cells	B	CN1C(=O)Cc2c([nH]c3ccc(Br)cc23)-c2ccccc21		CHEMBL316485	=	IC50	nM	2100.0	CHEMBL262	Homo sapiens	IC50	microM	2.1
	2946385	CHEMBL1040547	Inhibition of GSK3-beta expressed in insect Sf9 cells	B	C=CCn1c2c(c3cc(Br)ccc31)CC(=O)Nc1ccccc1-2		CHEMBL99280	=	IC50	nM	4000.0	CHEMBL262	Homo sapiens	IC50	microM	4.0
	2946386	CHEMBL1040547	Inhibition of GSK3-beta expressed in insect Sf9 cells	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1Cc1ccccc1		CHEMBL99779	=	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	microM	10.0
	2946387	CHEMBL1040547	Inhibition of GSK3-beta expressed in insect Sf9 cells	B	O=C1Cc2c([nH]c3cc(Cl)cc(Cl)c23)-c2ccccc2N1		CHEMBL316512	=	IC50	nM	5000.0	CHEMBL262	Homo sapiens	IC50	microM	5.0
	2946388	CHEMBL1040547	Inhibition of GSK3-beta expressed in insect Sf9 cells	B	O=C1Cc2c([nH]c3c(Cl)cccc23)-c2ccccc2N1		CHEMBL318471	=	IC50	nM	200.0	CHEMBL262	Homo sapiens	IC50	microM	0.2
	2946389	CHEMBL1040547	Inhibition of GSK3-beta expressed in insect Sf9 cells	B	COc1cccc2c1NC(=O)Cc1c-2[nH]c2ccccc12	Outside typical range	CHEMBL99423	=	IC50	nM	140000.0	CHEMBL262	Homo sapiens	IC50	microM	140.0
	2946390	CHEMBL1040547	Inhibition of GSK3-beta expressed in insect Sf9 cells	B	COc1cc2c(cc1OC)-c1[nH]c3ccc(C#N)cc3c1CC(=O)N2		CHEMBL325654	=	IC50	nM	18.0	CHEMBL262	Homo sapiens	IC50	microM	0.018
	2946391	CHEMBL1040547	Inhibition of GSK3-beta expressed in insect Sf9 cells	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2cccc(O)c2N1		CHEMBL95477	=	IC50	nM	4300.0	CHEMBL262	Homo sapiens	IC50	microM	4.3
	2946392	CHEMBL1040547	Inhibition of GSK3-beta expressed in insect Sf9 cells	B	COc1cccc2c1NC(=O)Cc1c-2[nH]c2ccc(Br)cc12		CHEMBL330398	=	IC50	nM	16000.0	CHEMBL262	Homo sapiens	IC50	microM	16.0
	2946393	CHEMBL1040547	Inhibition of GSK3-beta expressed in insect Sf9 cells	B	COc1cc2c(cc1OC)-c1[nH]c3ccc(Br)cc3c1CC(=O)N2		CHEMBL319373	=	IC50	nM	100.0	CHEMBL262	Homo sapiens	IC50	microM	0.1
	2946394	CHEMBL1040547	Inhibition of GSK3-beta expressed in insect Sf9 cells	B	Cc1ccc2[nH]c3c(c2c1)CC(=O)Nc1ccccc1-3		CHEMBL317964	=	IC50	nM	130.0	CHEMBL262	Homo sapiens	IC50	microM	0.13
	2946395	CHEMBL1040547	Inhibition of GSK3-beta expressed in insect Sf9 cells	B	N#Cc1ccc2[nH]c3c(c2c1)CC(=O)Nc1ccccc1-3		CHEMBL299756	=	IC50	nM	10.0	CHEMBL262	Homo sapiens	IC50	microM	0.01
	2946396	CHEMBL1040547	Inhibition of GSK3-beta expressed in insect Sf9 cells	B	O=C1Cc2c([nH]c3ccc(C(F)(F)F)cc23)-c2ccccc2N1		CHEMBL329505	=	IC50	nM	30.0	CHEMBL262	Homo sapiens	IC50	microM	0.03
	2946397	CHEMBL1040547	Inhibition of GSK3-beta expressed in insect Sf9 cells	B	O=C1Cc2c([nH]c3ccc(F)cc23)-c2ccccc2N1		CHEMBL99037	=	IC50	nM	80.0	CHEMBL262	Homo sapiens	IC50	microM	0.08
	2946398	CHEMBL1040547	Inhibition of GSK3-beta expressed in insect Sf9 cells	B	O=C1Cc2c([nH]c3ccc(Cl)cc23)-c2ccccc2N1		CHEMBL98153	=	IC50	nM	24.0	CHEMBL262	Homo sapiens	IC50	microM	0.024
	2946399	CHEMBL1040547	Inhibition of GSK3-beta expressed in insect Sf9 cells	B	O=C1Cc2c([nH]c3ccccc23)-c2ccccc2N1		CHEMBL430574	=	IC50	nM	620.0	CHEMBL262	Homo sapiens	IC50	microM	0.62
	2946400	CHEMBL1040547	Inhibition of GSK3-beta expressed in insect Sf9 cells	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	IC50	nM	4.0	CHEMBL262	Homo sapiens	IC50	microM	0.004
	2946401	CHEMBL1040547	Inhibition of GSK3-beta expressed in insect Sf9 cells	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	IC50	nM	23.0	CHEMBL262	Homo sapiens	IC50	microM	0.023
	2946403	CHEMBL1040549	Inhibition of GSK3-beta	B	COc1cc2c(cc1OC)-c1[nH]c3ccc(C(F)(F)F)cc3c1CC(=O)N2		CHEMBL328194	=	IC50	nM	75.0	CHEMBL262	Homo sapiens	IC50	microM	0.075
	2946442	CHEMBL1040549	Inhibition of GSK3-beta	B	CCCCCCCCOC(=O)c1ccc2[nH]c3c(c2c1)CC(=O)Nc1ccccc1-3	Outside typical range	CHEMBL578640	>	IC50	nM	1000000.0	CHEMBL262	Homo sapiens	IC50	microM	1000.0
	2946443	CHEMBL1040549	Inhibition of GSK3-beta	B	CCCCCCOC(=O)c1ccc2[nH]c3c(c2c1)CC(=O)Nc1ccccc1-3		CHEMBL575107	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	microM	10.0
	2946444	CHEMBL1040549	Inhibition of GSK3-beta	B	CCCCCOC(=O)c1ccc2[nH]c3c(c2c1)CC(=O)Nc1ccccc1-3	Outside typical range	CHEMBL583199	=	IC50	nM	600000.0	CHEMBL262	Homo sapiens	IC50	microM	600.0
	2946445	CHEMBL1040549	Inhibition of GSK3-beta	B	CCCCOC(=O)c1ccc2[nH]c3c(c2c1)CC(=O)Nc1ccccc1-3		CHEMBL565663	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	microM	10.0
	2946446	CHEMBL1040549	Inhibition of GSK3-beta	B	CCCOC(=O)c1ccc2[nH]c3c(c2c1)CC(=O)Nc1ccccc1-3	Outside typical range	CHEMBL573145	=	IC50	nM	700000.0	CHEMBL262	Homo sapiens	IC50	microM	700.0
	2946447	CHEMBL1040549	Inhibition of GSK3-beta	B	CCOC(=O)c1ccc2[nH]c3c(c2c1)CC(=O)Nc1ccccc1-3		CHEMBL573425	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	microM	100.0
	2946448	CHEMBL1040549	Inhibition of GSK3-beta	B	CC(C)(C)c1ccc2[nH]c3c(c2c1)CC(=O)N(Cc1ccc(Cl)c(Cl)c1)c1ccccc1-3		CHEMBL577395	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	microM	10.0
	2946449	CHEMBL1040549	Inhibition of GSK3-beta	B	O=C1Cc2c([nH]c3ccccc23)-c2ccccc2N1Cc1ccc(Cl)c(Cl)c1		CHEMBL575951	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	microM	10.0
	2946450	CHEMBL1040549	Inhibition of GSK3-beta	B	Cc1ccc(CN2C(=O)Cc3c([nH]c4ccccc34)-c3ccccc32)cc1		CHEMBL572923	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	microM	10.0
	2946451	CHEMBL1040549	Inhibition of GSK3-beta	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1Cc1ccc(Cl)c(Cl)c1		CHEMBL577566	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	microM	10.0
	2946452	CHEMBL1040549	Inhibition of GSK3-beta	B	COc1ccc(CN2C(=O)Cc3c([nH]c4ccc(Br)cc34)-c3ccccc32)cc1		CHEMBL568703	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	microM	10.0
	2946453	CHEMBL1040549	Inhibition of GSK3-beta	B	Cc1ccc(CN2C(=O)Cc3c([nH]c4ccc(Br)cc34)-c3ccccc32)cc1		CHEMBL586055	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	microM	10.0
	2946454	CHEMBL1040549	Inhibition of GSK3-beta	B	COc1ccc2[nH]c3c(c2c1)CC(=O)N(Cc1ccccc1)c1ccccc1-3		CHEMBL575583	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	microM	10.0
	2946455	CHEMBL1040549	Inhibition of GSK3-beta	B	Cc1ccc2[nH]c3c(c2c1)CC(=O)N(Cc1ccccc1)c1ccccc1-3		CHEMBL574919	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	microM	10.0
	2946456	CHEMBL1040549	Inhibition of GSK3-beta	B	O=C1Cc2c([nH]c3ccc(C(F)(F)F)cc23)-c2ccccc2N1Cc1ccccc1		CHEMBL574918	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	microM	10.0
	2946457	CHEMBL1040549	Inhibition of GSK3-beta	B	CC(C)(C)c1ccc2[nH]c3c(c2c1)CC(=O)N(Cc1ccccc1)c1ccccc1-3		CHEMBL575106	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	microM	10.0
	2946458	CHEMBL1040549	Inhibition of GSK3-beta	B	O=C1Cc2c([nH]c3ccc(Cl)cc23)-c2ccccc2N1Cc1ccccc1		CHEMBL574898	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	microM	10.0
	2946459	CHEMBL1040549	Inhibition of GSK3-beta	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1Cc1ccccc1		CHEMBL99779	=	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	microM	10.0
	2946467	CHEMBL1040549	Inhibition of GSK3-beta	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccc(O)cc2N1		CHEMBL331000	=	IC50	nM	18.0	CHEMBL262	Homo sapiens	IC50	microM	0.018
	2946468	CHEMBL1040549	Inhibition of GSK3-beta	B	COc1ccc2c(c1)-c1[nH]c3ccc(Br)cc3c1CC(=O)N2		CHEMBL575138	=	IC50	nM	15.0	CHEMBL262	Homo sapiens	IC50	microM	0.015
	2946469	CHEMBL1040549	Inhibition of GSK3-beta	B	COc1ccc2c(c1)NC(=O)Cc1c-2[nH]c2ccc(C(F)(F)F)cc12		CHEMBL334084	=	IC50	nM	240.0	CHEMBL262	Homo sapiens	IC50	microM	0.24
	2946470	CHEMBL1040549	Inhibition of GSK3-beta	B	C[S+]([O-])c1ccc2[nH]c3c(c2c1)CC(=O)Nc1ccccc1-3		CHEMBL567824	=	IC50	nM	13000.0	CHEMBL262	Homo sapiens	IC50	microM	13.0
	2946471	CHEMBL1040549	Inhibition of GSK3-beta	B	CSc1ccc2[nH]c3c(c2c1)CC(=O)Nc1ccccc1-3		CHEMBL574233	=	IC50	nM	1200.0	CHEMBL262	Homo sapiens	IC50	microM	1.2
	2946472	CHEMBL1040549	Inhibition of GSK3-beta	B	COC(=O)c1ccc2[nH]c3c(c2c1)CC(=O)Nc1ccccc1-3		CHEMBL582893	=	IC50	nM	7200.0	CHEMBL262	Homo sapiens	IC50	microM	7.2
	2946473	CHEMBL1040549	Inhibition of GSK3-beta	B	O=C1Cc2c([nH]c3ccc(C(=O)O)cc23)-c2ccccc2N1		CHEMBL572922	=	IC50	nM	30000.0	CHEMBL262	Homo sapiens	IC50	microM	30.0
	2946935	CHEMBL1054419	Inhibition of GSK3-beta at 2 uM	B	c1ccc2c(c1)CC(Nc1nc(Nc3ccncc3)nc(N3CCNCC3)n1)C2		CHEMBL575741	<	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	2947561	CHEMBL1047357	Inhibition of GSK3-beta at 100 uM	B	COc1cc2nccc(Oc3ccc(NC(=O)N4CCN(c5ccccc5)C4=O)cc3F)c2cc1OC		CHEMBL573761	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	INH	%	0.0
Active	2949526	CHEMBL1048399	Inhibition of human recombinant GSK3-beta at 1 uM by ELISA	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714		Activity			CHEMBL262	Homo sapiens	Activity		
Active	2949527	CHEMBL1048399	Inhibition of human recombinant GSK3-beta at 1 uM by ELISA	B	COC(=O)c1cccc2c3c(c(C)cc12)C(=O)NC3=O		CHEMBL577082		Activity			CHEMBL262	Homo sapiens	Activity		
Active	2949528	CHEMBL1048399	Inhibition of human recombinant GSK3-beta at 1 uM by ELISA	B	COC(=O)c1cccc2c3c(c(CC(C)C)cc12)C(=O)NC3=O		CHEMBL578803		Activity			CHEMBL262	Homo sapiens	Activity		
Active	2949529	CHEMBL1048399	Inhibition of human recombinant GSK3-beta at 1 uM by ELISA	B	COC(=O)c1cccc2c3c(c(C(C)C)cc12)C(=O)NC3=O		CHEMBL567827		Activity			CHEMBL262	Homo sapiens	Activity		
Active	2949530	CHEMBL1048399	Inhibition of human recombinant GSK3-beta at 1 uM by ELISA	B	CCCc1cc2c(C(=O)OC)cccc2c2c1C(=O)NC2=O		CHEMBL576672		Activity			CHEMBL262	Homo sapiens	Activity		
Active	2949531	CHEMBL1048399	Inhibition of human recombinant GSK3-beta at 1 uM by ELISA	B	CCc1cc2c(C(=O)OC)cccc2c2c1C(=O)NC2=O		CHEMBL574805		Activity			CHEMBL262	Homo sapiens	Activity		
Active	2949532	CHEMBL1048399	Inhibition of human recombinant GSK3-beta at 1 uM by ELISA	B	COC(=O)c1cccc2c3c(c(C)c(C)c12)C(=O)NC3=O		CHEMBL583983		Activity			CHEMBL262	Homo sapiens	Activity		
Active	2949533	CHEMBL1048399	Inhibition of human recombinant GSK3-beta at 1 uM by ELISA	B	COC(=O)c1ccc2c3c(c(CC(C)O)cc2c1)C(=O)NC3=O		CHEMBL571033		Activity			CHEMBL262	Homo sapiens	Activity		
Active	2949534	CHEMBL1048399	Inhibition of human recombinant GSK3-beta at 1 uM by ELISA	B	COC(=O)c1ccc2c3c(c(CCO)cc2c1)C(=O)NC3=O		CHEMBL571028		Activity			CHEMBL262	Homo sapiens	Activity		
Active	2949535	CHEMBL1048399	Inhibition of human recombinant GSK3-beta at 1 uM by ELISA	B	COC(=O)c1ccc2c3c(c(CC(C)OCc4ccccc4)cc2c1)C(=O)NC3=O		CHEMBL584500		Activity			CHEMBL262	Homo sapiens	Activity		
Active	2949536	CHEMBL1048399	Inhibition of human recombinant GSK3-beta at 1 uM by ELISA	B	COC(=O)c1ccc2c3c(c(CCOCc4ccccc4)cc2c1)C(=O)NC3=O		CHEMBL570582		Activity			CHEMBL262	Homo sapiens	Activity		
Active	2949537	CHEMBL1048399	Inhibition of human recombinant GSK3-beta at 1 uM by ELISA	B	COC(=O)c1ccc2c3c(c(C)c(C)c2c1)C(=O)NC3=O		CHEMBL568948		Activity			CHEMBL262	Homo sapiens	Activity		
Active	2949538	CHEMBL1048399	Inhibition of human recombinant GSK3-beta at 1 uM by ELISA	B	COC(=O)c1ccc2c3c(c(CC(C)C)cc2c1)C(=O)NC3=O		CHEMBL570112		Activity			CHEMBL262	Homo sapiens	Activity		
Active	2949539	CHEMBL1048399	Inhibition of human recombinant GSK3-beta at 1 uM by ELISA	B	COC(=O)c1ccc2c3c(c(C(C)C)cc2c1)C(=O)NC3=O		CHEMBL577331		Activity			CHEMBL262	Homo sapiens	Activity		
Active	2949540	CHEMBL1048399	Inhibition of human recombinant GSK3-beta at 1 uM by ELISA	B	CCc1cc2cc(C(=O)OC)ccc2c2c1C(=O)NC2=O		CHEMBL574806		Activity			CHEMBL262	Homo sapiens	Activity		
Active	2949541	CHEMBL1048399	Inhibition of human recombinant GSK3-beta at 1 uM by ELISA	B	CCc1c(C)c2c(c3cc(C(=O)OC)ccc13)C(=O)NC2=O		CHEMBL583984		Activity			CHEMBL262	Homo sapiens	Activity		
Active	2949542	CHEMBL1048399	Inhibition of human recombinant GSK3-beta at 1 uM by ELISA	B	COC(=O)c1ccc2cc(CC(C)C)c3c(c2c1)C(=O)NC3=O		CHEMBL576080		Activity			CHEMBL262	Homo sapiens	Activity		
Active	2949543	CHEMBL1048399	Inhibition of human recombinant GSK3-beta at 1 uM by ELISA	B	COC(=O)c1ccc2cc(C(C)C)c3c(c2c1)C(=O)NC3=O		CHEMBL568714		Activity			CHEMBL262	Homo sapiens	Activity		
Active	2949544	CHEMBL1048399	Inhibition of human recombinant GSK3-beta at 1 uM by ELISA	B	CCc1cc2ccc(C(=O)OC)cc2c2c1C(=O)NC2=O		CHEMBL568711		Activity			CHEMBL262	Homo sapiens	Activity		
Active	2949545	CHEMBL1048399	Inhibition of human recombinant GSK3-beta at 1 uM by ELISA	B	Cc1cc2ccccc2c2c1C(=O)NC2=O		CHEMBL571027		Activity			CHEMBL262	Homo sapiens	Activity		
Active	2949546	CHEMBL1048399	Inhibition of human recombinant GSK3-beta at 1 uM by ELISA	B	COc1ccc2cc(C)c3c(c2c1)C(=O)NC3=O		CHEMBL567613		Activity			CHEMBL262	Homo sapiens	Activity		
Active	2949547	CHEMBL1048399	Inhibition of human recombinant GSK3-beta at 1 uM by ELISA	B	Cc1cc2ccc(Cl)cc2c2c1C(=O)NC2=O		CHEMBL567612		Activity			CHEMBL262	Homo sapiens	Activity		
Active	2949548	CHEMBL1048399	Inhibition of human recombinant GSK3-beta at 1 uM by ELISA	B	COC(=O)c1ccc2cc(C)c3c(c2c1)C(=O)NC3=O		CHEMBL570581		Activity			CHEMBL262	Homo sapiens	Activity		
Active	2949549	CHEMBL1048399	Inhibition of human recombinant GSK3-beta at 1 uM by ELISA	B	CCc1cc2c(c3cc(OC)c(OC)cc13)C(=O)NC2=O		CHEMBL570580		Activity			CHEMBL262	Homo sapiens	Activity		
Active	2949550	CHEMBL1048399	Inhibition of human recombinant GSK3-beta at 1 uM by ELISA	B	COc1cc2c(C)cc3c(c2cc1OC)C(=O)NC3=O		CHEMBL571486		Activity			CHEMBL262	Homo sapiens	Activity		
	2949551	CHEMBL1048403	Inhibition of human recombinant GSK3-beta at 1 uM by ATP competitive assay	B	COc1cc2c(C)cc3c(c2cc1OC)C(=O)NC3=O		CHEMBL571486	=	Ki	nM	259.0	CHEMBL262	Homo sapiens	Ki	nM	259.0
	2949555	CHEMBL1048400	Inhibition of human recombinant GSK3-beta	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714	=	IC50	nM	48.0	CHEMBL262	Homo sapiens	IC50	microM	0.048
	2949556	CHEMBL1048400	Inhibition of human recombinant GSK3-beta	B	CCc1cc2c(c3cc(OC)c(OC)cc13)C(=O)NC2=O		CHEMBL570580	=	IC50	nM	92.0	CHEMBL262	Homo sapiens	IC50	microM	0.092
	2949558	CHEMBL1048400	Inhibition of human recombinant GSK3-beta	B	COc1cc2c(C)cc3c(c2cc1OC)C(=O)NC3=O		CHEMBL571486	=	IC50	nM	270.0	CHEMBL262	Homo sapiens	IC50	microM	0.27
	2949559	CHEMBL1048400	Inhibition of human recombinant GSK3-beta	B	COC(=O)c1cccc2c3c(c(CC(C)C)cc12)C(=O)NC3=O		CHEMBL578803	=	IC50	nM	486.0	CHEMBL262	Homo sapiens	IC50	microM	0.486
	2980286	CHEMBL1043428	Inhibition of GSK3-beta	B	Cc1ccc(-c2ccnc(Nc3ccc(S(N)(=O)=O)cc3)n2)s1		CHEMBL569998	=	IC50	nM	200.0	CHEMBL262	Homo sapiens	IC50	uM	0.2
	2980293	CHEMBL1043428	Inhibition of GSK3-beta	B	CC(=O)NCC1CCN(c2nccc(-c3ccc4ccccc4c3)n2)CC1		CHEMBL569986	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	2980294	CHEMBL1043428	Inhibition of GSK3-beta	B	NCC1CCN(c2nccc(-c3ccc4ccccc4c3)n2)CC1		CHEMBL570667	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	2980295	CHEMBL1043428	Inhibition of GSK3-beta	B	NC1CCN(c2nccc(-c3ccc4ccccc4c3)n2)CC1		CHEMBL570666	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	2980296	CHEMBL1043428	Inhibition of GSK3-beta	B	NS(=O)(=O)c1ccc(Nc2nccc(-c3ccc4ccccc4c3)n2)cc1		CHEMBL569046	=	IC50	nM	310.0	CHEMBL262	Homo sapiens	IC50	uM	0.31
	2980297	CHEMBL1043428	Inhibition of GSK3-beta	B	Cc1ccc(-c2ccnc(N(C)c3ccc(S(N)(=O)=O)cc3)n2)s1		CHEMBL571525	=	IC50	nM	65000.0	CHEMBL262	Homo sapiens	IC50	uM	65.0
	2989964	CHEMBL1039190	Inhibition of GSK3-beta at 100 nM by radiometric protein kinase assay	B	CCn1cnc(-c2cc3nccc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccccc6)CC5)cc4F)c3s2)c1		CHEMBL565807	<	Inhibition	%	5.0	CHEMBL262	Homo sapiens	INH	%	5.0
	2992210	CHEMBL1044513	Inhibition of human GSK3-beta at 20 uM by FRET assay	B	C#Cn1c(C#CCCO)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL576620	=	Inhibition	%	44.0	CHEMBL262	Homo sapiens	INH	%	44.0
	2992419	CHEMBL1040117	Inhibition of human recombinant GSK3-beta	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	=	IC50	nM	870.0	CHEMBL262	Homo sapiens	IC50	nM	870.0
	2999015	CHEMBL1043718	Inhibition of GSK3-beta assessed as residual activity at 10 uM by Cherenkov counting relative to control in presence of 5 uM ATP	B	CC(C)c1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL220227	=	Activity	%	75.0	CHEMBL262	Homo sapiens	Activity	%	75.0
	2999805	CHEMBL1043718	Inhibition of GSK3-beta assessed as residual activity at 10 uM by Cherenkov counting relative to control in presence of 5 uM ATP	B	CC(C)c1noc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL375428	=	Activity	%	85.0	CHEMBL262	Homo sapiens	Activity	%	85.0
	2999880	CHEMBL1049882	Inhibition of GSK3-beta assessed as residual activity at 0.1 uM by Cherenkov counting relative to control in presence of 5 uM ATP	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL569114	=	Activity	%	81.0	CHEMBL262	Homo sapiens	Activity	%	81.0
	2999956	CHEMBL1049882	Inhibition of GSK3-beta assessed as residual activity at 0.1 uM by Cherenkov counting relative to control in presence of 5 uM ATP	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c([S+](C)[O-])nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL572006	=	Activity	%	101.0	CHEMBL262	Homo sapiens	Activity	%	101.0
Not Active	3005084	CHEMBL1047308	Inhibition of GSK3-beta at 10 uM	B	CCCc1cc(N2CCC(N)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL578601		Activity			CHEMBL262	Homo sapiens	Activity		
Not Active	3005085	CHEMBL1047308	Inhibition of GSK3-beta at 10 uM	B	CCCc1cc(N2CCNCC2)nc2sc(C(N)=O)c(N)c12		CHEMBL568922		Activity			CHEMBL262	Homo sapiens	Activity		
Not Active	3005086	CHEMBL1047308	Inhibition of GSK3-beta at 10 uM	B	CCCc1cc(N2CCC(O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL576887		Activity			CHEMBL262	Homo sapiens	Activity		
Not Active	3005087	CHEMBL1047308	Inhibition of GSK3-beta at 10 uM	B	CCCc1cc(N2CCCC(O)C2)nc2sc(C(N)=O)c(N)c12		CHEMBL576989		Activity			CHEMBL262	Homo sapiens	Activity		
	3021771	CHEMBL1048134	Inhibition of GSK3-beta at 10 uM by scintillation proximity assay	B	COc1ccc(CC(=O)Nc2cn(C3CCC3)cn2)cc1		CHEMBL578621	=	Inhibition	%	34.0	CHEMBL262	Homo sapiens	INH	%	34.0
	3021774	CHEMBL1048134	Inhibition of GSK3-beta at 10 uM by scintillation proximity assay	B	COc1ccc(CC(=O)Nc2cn([C@H]3C[C@@H](NC(C)=O)C3)cn2)cc1		CHEMBL576502	=	Inhibition	%	100.0	CHEMBL262	Homo sapiens	INH	%	100.0
	3021775	CHEMBL1048140	Inhibition of GSK3-beta at 1 uM by scintillation proximity assay	B	COc1ccc(CC(=O)Nc2cn([C@H]3C[C@@H](NC(C)=O)C3)cn2)cc1		CHEMBL576502	=	Inhibition	%	94.0	CHEMBL262	Homo sapiens	INH	%	94.0
	3021784	CHEMBL1048140	Inhibition of GSK3-beta at 1 uM by scintillation proximity assay	B	COc1ccc(CC(=O)Nc2cn(C3CCC3)cn2)cc1		CHEMBL578621	=	Inhibition	%	94.0	CHEMBL262	Homo sapiens	INH	%	94.0
	3052624	CHEMBL1038410	Residual activity of GSK3-beta at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	93.0	CHEMBL262	Homo sapiens	Residual activity	%	93.0
	3053933	CHEMBL1046825	Residual activity of GSK3-beta at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	98.0	CHEMBL262	Homo sapiens	Residual activity	%	98.0
	3054185	CHEMBL1040653	Residual activity of GSK3-beta at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	96.0	CHEMBL262	Homo sapiens	Residual activity	%	96.0
	3054512	CHEMBL1042446	Inhibition of GSK3-beta by liquid scintillation counting	B	CCSC1=NC(c2ccccc2)=NN(c2ccccc2)c2ccccc21		CHEMBL595496	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	3054513	CHEMBL1042446	Inhibition of GSK3-beta by liquid scintillation counting	B	N=C(c1ccccc1Cl)c1ccccc1N(NC(=O)c1ccccc1)c1ccccc1		CHEMBL595727	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	3054514	CHEMBL1042446	Inhibition of GSK3-beta by liquid scintillation counting	B	c1ccc(-c2nc(-c3ccccc3)n(-c3ccccc3)n2)cc1		CHEMBL596411	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	3054515	CHEMBL1042446	Inhibition of GSK3-beta by liquid scintillation counting	B	CC(N)Cc1cc(Cl)cs1.Cl		CHEMBL596399	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	3054516	CHEMBL1042446	Inhibition of GSK3-beta by liquid scintillation counting	B	OC(CCl)c1sc(Br)c(Br)c1Br		CHEMBL596364	=	IC50	nM	75000.0	CHEMBL262	Homo sapiens	IC50	uM	75.0
	3054517	CHEMBL1042446	Inhibition of GSK3-beta by liquid scintillation counting	B	O=C(Nn1c2ccccc2c2ccccc21)c1ccccc1		CHEMBL592930	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	3054518	CHEMBL1042446	Inhibition of GSK3-beta by liquid scintillation counting	B	O=Nn1c2ccccc2c2cc(Cl)ccc21		CHEMBL595748	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	3054519	CHEMBL1042446	Inhibition of GSK3-beta by liquid scintillation counting	B	O=C(CCl)c1cc(Cl)c(Cl)s1		CHEMBL342402	=	IC50	nM	2500.0	CHEMBL262	Homo sapiens	IC50	uM	2.5
	3054520	CHEMBL1042446	Inhibition of GSK3-beta by liquid scintillation counting	B	COc1cc2c(cc1OC)C(=O)CC2		CHEMBL611356	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	3054521	CHEMBL1042446	Inhibition of GSK3-beta by liquid scintillation counting	B	CC(=O)c1ccc(Cl)cc1		CHEMBL608419	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	3054522	CHEMBL1042446	Inhibition of GSK3-beta by liquid scintillation counting	B	CC(=O)c1ccccc1		CHEMBL274467	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	3054523	CHEMBL1042446	Inhibition of GSK3-beta by liquid scintillation counting	B	CCOC(=O)c1ccccc1		CHEMBL510714	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	3054524	CHEMBL1042446	Inhibition of GSK3-beta by liquid scintillation counting	B	O=Cc1cc(Br)c(Br)s1		CHEMBL596225	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	3054525	CHEMBL1042446	Inhibition of GSK3-beta by liquid scintillation counting	B	CCOC(=O)c1sc(C)c(C)c1O		CHEMBL594822	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	3054526	CHEMBL1042446	Inhibition of GSK3-beta by liquid scintillation counting	B	CCOC(=O)c1sc(SC(C)=O)cc1O		CHEMBL595061	=	IC50	nM	25000.0	CHEMBL262	Homo sapiens	IC50	uM	25.0
	3054527	CHEMBL1042446	Inhibition of GSK3-beta by liquid scintillation counting	B	O=Cc1cccs1		CHEMBL328441	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	3054528	CHEMBL1042446	Inhibition of GSK3-beta by liquid scintillation counting	B	CCOC(=O)c1cccs1		CHEMBL595062	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	3054529	CHEMBL1042446	Inhibition of GSK3-beta by liquid scintillation counting	B	O=C(CCl)c1cscc1Cl		CHEMBL343821	=	IC50	nM	25000.0	CHEMBL262	Homo sapiens	IC50	uM	25.0
	3054530	CHEMBL1042446	Inhibition of GSK3-beta by liquid scintillation counting	B	O=C(CCl)c1c(Br)sc(Cl)c1Cl		CHEMBL143273	=	IC50	nM	2000.0	CHEMBL262	Homo sapiens	IC50	uM	2.0
	3054531	CHEMBL1042446	Inhibition of GSK3-beta by liquid scintillation counting	B	O=C(CCl)c1c(Br)sc(Br)c1Br		CHEMBL341572	=	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	uM	1.0
	3054532	CHEMBL1042446	Inhibition of GSK3-beta by liquid scintillation counting	B	O=C(CCl)c1cc(Br)cs1		CHEMBL335357	=	IC50	nM	3000.0	CHEMBL262	Homo sapiens	IC50	uM	3.0
	3054533	CHEMBL1042446	Inhibition of GSK3-beta by liquid scintillation counting	B	O=C(CCl)c1cccs1		CHEMBL359135	=	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	3054534	CHEMBL1042446	Inhibition of GSK3-beta by liquid scintillation counting	B	O=C(CCl)c1csc(C(=O)CCl)c1		CHEMBL141190	=	IC50	nM	1500.0	CHEMBL262	Homo sapiens	IC50	uM	1.5
	3054535	CHEMBL1042446	Inhibition of GSK3-beta by liquid scintillation counting	B	Cc1ccc(C(=O)CCl)s1		CHEMBL142415	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	3054536	CHEMBL1042446	Inhibition of GSK3-beta by liquid scintillation counting	B	Cc1sc(C(=O)CCl)cc1C(=O)CCl		CHEMBL143743	=	IC50	nM	5000.0	CHEMBL262	Homo sapiens	IC50	uM	5.0
	3054537	CHEMBL1042446	Inhibition of GSK3-beta by liquid scintillation counting	B	Cc1ccsc1C(=O)CCl		CHEMBL142327	=	IC50	nM	75000.0	CHEMBL262	Homo sapiens	IC50	uM	75.0
	3054538	CHEMBL1042446	Inhibition of GSK3-beta by liquid scintillation counting	B	Cc1csc(C(=O)CCl)c1		CHEMBL423377	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	3054539	CHEMBL1042446	Inhibition of GSK3-beta by liquid scintillation counting	B	Cc1c(CC(=O)Cl)csc1C(=O)CCl		CHEMBL611357	=	IC50	nM	5000.0	CHEMBL262	Homo sapiens	IC50	uM	5.0
	3054540	CHEMBL1042446	Inhibition of GSK3-beta by liquid scintillation counting	B	O=C(CCl)c1ccc(Cl)s1		CHEMBL140045	=	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	3054541	CHEMBL1042446	Inhibition of GSK3-beta by liquid scintillation counting	B	O=C(CCl)c1ccc(Br)s1		CHEMBL142764	=	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	3054542	CHEMBL1042446	Inhibition of GSK3-beta by liquid scintillation counting	B	O=C(CCl)c1scc(Br)c1Br		CHEMBL357136	=	IC50	nM	500.0	CHEMBL262	Homo sapiens	IC50	uM	0.5
	3054543	CHEMBL1042446	Inhibition of GSK3-beta by liquid scintillation counting	B	O=C(CCl)c1cc(Br)c(Br)s1		CHEMBL142711	=	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	uM	1.0
	3054544	CHEMBL1042446	Inhibition of GSK3-beta by liquid scintillation counting	B	CC(=O)c1ccc(C(=O)CCl)s1		CHEMBL143525	=	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	3054545	CHEMBL1042446	Inhibition of GSK3-beta by liquid scintillation counting	B	CC(=O)c1csc(C(=O)CCl)c1		CHEMBL341655	=	IC50	nM	8000.0	CHEMBL262	Homo sapiens	IC50	uM	8.0
	3054546	CHEMBL1042446	Inhibition of GSK3-beta by liquid scintillation counting	B	O=C(CCl)c1cc(Cl)sc1Cl		CHEMBL356459	=	IC50	nM	5000.0	CHEMBL262	Homo sapiens	IC50	uM	5.0
	3054547	CHEMBL1042446	Inhibition of GSK3-beta by liquid scintillation counting	B	Cc1cc(C(=O)CCl)c(C)s1		CHEMBL344719	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	3054548	CHEMBL1042446	Inhibition of GSK3-beta by liquid scintillation counting	B	O=C(CCCCl)c1ccc(Cl)s1		CHEMBL596446	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	3054549	CHEMBL1042446	Inhibition of GSK3-beta by liquid scintillation counting	B	O=C(CCCCl)c1ccc(Br)s1		CHEMBL594556	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	3054550	CHEMBL1042446	Inhibition of GSK3-beta by liquid scintillation counting	B	O=C(CBr)c1scc(Br)c1Br		CHEMBL596352	=	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	uM	1.0
	3054551	CHEMBL1042446	Inhibition of GSK3-beta by liquid scintillation counting	B	O=C(CBr)c1cc(Br)c(Br)s1		CHEMBL593628	=	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	uM	1.0
	3054552	CHEMBL1042446	Inhibition of GSK3-beta by liquid scintillation counting	B	O=C(CBr)c1ccc(Br)s1		CHEMBL593629	=	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	uM	1.0
	3054553	CHEMBL1042446	Inhibition of GSK3-beta by liquid scintillation counting	B	O=C(CBr)c1sc(Br)cc1Br		CHEMBL596006	=	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	uM	1.0
	3054554	CHEMBL1042446	Inhibition of GSK3-beta by liquid scintillation counting	B	O=C(CCCCl)c1csc(Cl)c1Cl		CHEMBL595728	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	3054555	CHEMBL1042446	Inhibition of GSK3-beta by liquid scintillation counting	B	CC(=O)OCC(=O)c1csc(Cl)c1Cl		CHEMBL595729	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	3055472	CHEMBL1038410	Residual activity of GSK3-beta at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	84.0	CHEMBL262	Homo sapiens	Residual activity	%	84.0
Active	3055849	CHEMBL1042447	Noncompetitive inhibition of GSK3-beta by double-reciprocal plotting in presence of increasing ATP	B	O=C(CCl)c1c(Br)sc(Cl)c1Cl		CHEMBL143273		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	3055850	CHEMBL1042447	Noncompetitive inhibition of GSK3-beta by double-reciprocal plotting in presence of increasing ATP	B	O=C(CCl)c1csc(C(=O)CCl)c1		CHEMBL141190		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	3055851	CHEMBL1042448	Noncompetitive inhibition of GSK3-beta by double-reciprocal plotting in presence of 15 uM ATP	B	O=C(CCl)c1c(Br)sc(Cl)c1Cl		CHEMBL143273		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	3055852	CHEMBL1042448	Noncompetitive inhibition of GSK3-beta by double-reciprocal plotting in presence of 15 uM ATP	B	O=C(CCl)c1csc(C(=O)CCl)c1		CHEMBL141190		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	3055855	CHEMBL1048691	Irreversible inhibition of GSK3-beta mediated phosphorylation measured after careful washes by liquid scintillation counting	B	O=C(CCl)c1c(Br)sc(Cl)c1Cl		CHEMBL143273		Activity			CHEMBL262	Homo sapiens	Activity		
Active	3055856	CHEMBL1048691	Irreversible inhibition of GSK3-beta mediated phosphorylation measured after careful washes by liquid scintillation counting	B	O=C(CCl)c1cc(Br)c(Br)s1		CHEMBL142711		Activity			CHEMBL262	Homo sapiens	Activity		
	3056777	CHEMBL1046825	Residual activity of GSK3-beta at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	123.0	CHEMBL262	Homo sapiens	Residual activity	%	123.0
	3057029	CHEMBL1040653	Residual activity of GSK3-beta at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	98.0	CHEMBL262	Homo sapiens	Residual activity	%	98.0
	3058349	CHEMBL1038410	Residual activity of GSK3-beta at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	91.0	CHEMBL262	Homo sapiens	Residual activity	%	91.0
	3058601	CHEMBL1046825	Residual activity of GSK3-beta at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	104.0	CHEMBL262	Homo sapiens	Residual activity	%	104.0
	3062469	CHEMBL1037152	Binding affinity to human GSK3-beta at 200 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CSSC[C@@H](C(=O)NCC(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595545	=	Activity	%	100.0	CHEMBL262	Homo sapiens	Activity	%	100.0
	3063604	CHEMBL1074870	Binding affinity to human GSK3-beta at 500 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(N)=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595546	=	Activity	%	94.0	CHEMBL262	Homo sapiens	Activity	%	94.0
	3063694	CHEMBL1047846	Binding affinity to human GSK3-beta at 50 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CNC(=O)C[C@@H](C(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL609010	=	Activity	%	74.0	CHEMBL262	Homo sapiens	Activity	%	74.0
	3063753	CHEMBL1048621	Ratio of compound to staurosporine binding affinity to human GSK3-beta in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(N)=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595546	=	Selectivity ratio		7.0	CHEMBL262	Homo sapiens	Selectivity ratio		7.0
	3065873	CHEMBL1070697	Inhibition of GSK3-beta at 10 uM	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Inhibition	%	16.0	CHEMBL262	Homo sapiens	INH	%	16.0
	3066939	CHEMBL1070697	Inhibition of GSK3-beta at 10 uM	B	O=C1Nc2ccccc2/C1=C1\C(=O)N(CCCc2ccccc2)c2ccccc21		CHEMBL607196	=	Inhibition	%	5.0	CHEMBL262	Homo sapiens	INH	%	5.0
	3072947	CHEMBL1040653	Residual activity of GSK3-beta at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	86.0	CHEMBL262	Homo sapiens	Residual activity	%	86.0
	3076644	CHEMBL1071989	Inhibition of GSK2beta phosphorylation in human BT474 cells	B	Cc1occc1-c1ncc(OC[C@@H](N)Cc2c[nH]c3ccccc23)cc1-c1cnc2[nH]nc(C)c2n1		CHEMBL596583	=	IC50	nM	210.0	CHEMBL262	Homo sapiens	IC50	uM	0.21
	3076650	CHEMBL1071989	Inhibition of GSK2beta phosphorylation in human BT474 cells	B	Cc1occc1-c1nc(N)c(OC[C@@H](N)Cc2c[nH]c3ccccc23)cc1-c1ccc2[nH]nc(C)c2c1		CHEMBL593374	=	IC50	nM	220.0	CHEMBL262	Homo sapiens	IC50	uM	0.22
	3076656	CHEMBL1071989	Inhibition of GSK2beta phosphorylation in human BT474 cells	B	Cc1occc1-c1nc(N)c(OC[C@@H](N)Cc2c[nH]c3ccccc23)cc1-c1cnc2[nH]nc(C)c2c1		CHEMBL593375	=	IC50	nM	470.0	CHEMBL262	Homo sapiens	IC50	uM	0.47
	3076662	CHEMBL1071989	Inhibition of GSK2beta phosphorylation in human BT474 cells	B	Cc1occc1-c1nc(N)c(OC[C@@H](N)Cc2c[nH]c3ccccc23)cc1-c1cnc2[nH]nc(C)c2n1		CHEMBL595944	=	IC50	nM	560.0	CHEMBL262	Homo sapiens	IC50	uM	0.56
	3076668	CHEMBL1071989	Inhibition of GSK2beta phosphorylation in human BT474 cells	B	Cc1occc1-c1nc(N)c(OC[C@@H](N)Cc2c[nH]c3ccccc23)cc1-c1cc2c(C)n[nH]c2cn1		CHEMBL595459	=	IC50	nM	680.0	CHEMBL262	Homo sapiens	IC50	uM	0.68
	3076674	CHEMBL1071989	Inhibition of GSK2beta phosphorylation in human BT474 cells	B	Cc1n[nH]c2ncc(-c3cc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c(C#N)nc3-c3ccoc3)nc12		CHEMBL606467	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	3076680	CHEMBL1071989	Inhibition of GSK2beta phosphorylation in human BT474 cells	B	Cc1nc(-c2ccoc2)c(-c2cnc3[nH]nc(C)c3n2)cc1OC[C@@H](N)Cc1c[nH]c2ccccc12		CHEMBL594523	=	IC50	nM	280.0	CHEMBL262	Homo sapiens	IC50	uM	0.28
	3076686	CHEMBL1071989	Inhibition of GSK2beta phosphorylation in human BT474 cells	B	Cc1occc1-c1nc(N)c(OC[C@@H](N)Cc2ccccc2)cc1-c1cnc2[nH]nc(C)c2n1		CHEMBL594755	=	IC50	nM	280.0	CHEMBL262	Homo sapiens	IC50	uM	0.28
	3076692	CHEMBL1071989	Inhibition of GSK2beta phosphorylation in human BT474 cells	B	CCNc1nc(-c2ccoc2)c(-c2cnc3[nH]nc(C)c3n2)cc1OC[C@@H](N)Cc1ccccc1		CHEMBL593573	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	3076698	CHEMBL1071989	Inhibition of GSK2beta phosphorylation in human BT474 cells	B	Cc1occc1-c1nc(N)c(OC[C@@H](N)Cc2c(Cl)[nH]c3ccccc23)cc1-c1cnc2[nH]nc(C)c2n1		CHEMBL593813	=	IC50	nM	300.0	CHEMBL262	Homo sapiens	IC50	uM	0.3
	3076704	CHEMBL1071989	Inhibition of GSK2beta phosphorylation in human BT474 cells	B	Cc1occc1-c1nc(N)c(OC[C@@H](N)Cc2c(C#N)[nH]c3ccccc23)cc1-c1cnc2[nH]nc(C)c2n1		CHEMBL605410	>	IC50	nM	30000.0	CHEMBL262	Homo sapiens	IC50	uM	30.0
	3076710	CHEMBL1071989	Inhibition of GSK2beta phosphorylation in human BT474 cells	B	Cc1occc1-c1nc(N)c(OC[C@@H](N)Cc2c(C(N)=O)[nH]c3ccccc23)cc1-c1cnc2[nH]nc(C)c2n1		CHEMBL594072	>	IC50	nM	30000.0	CHEMBL262	Homo sapiens	IC50	uM	30.0
	3084403	CHEMBL1072682	Inhibition of GSK3Beta	B	NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL590109	=	IC50	nM	1300.0	CHEMBL262	Homo sapiens	IC50	uM	1.3
	3086993	CHEMBL1071317	Inhibition of GSK3-beta phosphorylation in human BT474 cells	B	Cc1[nH]nc2ccc(-c3cc(OC[C@@H](N)Cc4c[nH]c5ccccc45)cnc3-c3ccoc3)cc12		CHEMBL593490	=	IC50	nM	500.0	CHEMBL262	Homo sapiens	IC50	uM	0.5
	3086994	CHEMBL1071317	Inhibition of GSK3-beta phosphorylation in human BT474 cells	B	Cc1n[nH]c2ncc(-c3cc(OC[C@@H](N)Cc4c[nH]c5ccccc45)cnc3-c3ccoc3)cc12		CHEMBL596072	=	IC50	nM	260.0	CHEMBL262	Homo sapiens	IC50	uM	0.26
	3086995	CHEMBL1071317	Inhibition of GSK3-beta phosphorylation in human BT474 cells	B	Cc1n[nH]c2ccc(-c3cc(OC[C@@H](N)Cc4c[nH]c5ccccc45)cnc3-c3ccoc3)nc12		CHEMBL596073	=	IC50	nM	3860.0	CHEMBL262	Homo sapiens	IC50	uM	3.86
	3086996	CHEMBL1071317	Inhibition of GSK3-beta phosphorylation in human BT474 cells	B	Cc1n[nH]c2ncc(-c3cc(OC[C@@H](N)Cc4c[nH]c5ccccc45)cnc3-c3ccoc3)nc12		CHEMBL596290	=	IC50	nM	160.0	CHEMBL262	Homo sapiens	IC50	uM	0.16
	3086997	CHEMBL1071317	Inhibition of GSK3-beta phosphorylation in human BT474 cells	B	Cc1n[nH]c2cnc(-c3cc(OC[C@@H](N)Cc4c[nH]c5ccccc45)cnc3-c3ccoc3)nc12		CHEMBL603197	=	IC50	nM	670.0	CHEMBL262	Homo sapiens	IC50	uM	0.67
	3086998	CHEMBL1071317	Inhibition of GSK3-beta phosphorylation in human BT474 cells	B	Cc1n[nH]c2cnc(-c3cc(OC[C@@H](N)Cc4c[nH]c5ccccc45)cnc3-c3ccoc3)cc12		CHEMBL594933	=	IC50	nM	64.0	CHEMBL262	Homo sapiens	IC50	uM	0.064
	3094747	CHEMBL1069046	Inhibition of GSK3-beta at 1 uM by microfluidic substrate phosphorylation assay	B	NCCNC(=O)c1cc(-c2ccsc2)cnc1N		CHEMBL610226	=	Inhibition	%	-3.0	CHEMBL262	Homo sapiens	INH	%	-3.0
	3094759	CHEMBL1069046	Inhibition of GSK3-beta at 1 uM by microfluidic substrate phosphorylation assay	B	NCCNC(=O)c1cc(-c2scc3c2OCCO3)cnc1N		CHEMBL599171	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	INH	%	0.0
	3094824	CHEMBL1069046	Inhibition of GSK3-beta at 1 uM by microfluidic substrate phosphorylation assay	B	NC(=O)c1ccc(-c2cc(-c3cccc4c3OCO4)cnc2N)cc1		CHEMBL590335	=	Inhibition	%	49.0	CHEMBL262	Homo sapiens	INH	%	49.0
	3094827	CHEMBL1069046	Inhibition of GSK3-beta at 1 uM by microfluidic substrate phosphorylation assay	B	NC(=O)c1ccc(-c2cc(-c3scc4c3OCCO4)cnc2N)cc1		CHEMBL602931	=	Inhibition	%	51.0	CHEMBL262	Homo sapiens	INH	%	51.0
	3098428	CHEMBL1067025	Inhibition of human GSK3-beta at 0.1 uM	B	COc1ccccc1NC(=O)CC(Nc1ccc(Oc2ccnc3cc(-c4cn(C)cn4)sc23)c(F)c1)C(F)(F)F		CHEMBL591924	<	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	3117909	CHEMBL1072185	Inhibition of GSK3-beta	B	CC(=O)N1CCC(Nc2ncc3c(n2)-c2c(c(C(N)=O)nn2C)CC3)CC1		CHEMBL599224	=	IC50	nM	28.0	CHEMBL262	Homo sapiens	IC50	uM	0.028
	3117962	CHEMBL1072185	Inhibition of GSK3-beta	B	Cn1nc(C(N)=O)c2c1-c1nc(NC3CCN(C(=O)c4ccccc4)CC3)ncc1CC2		CHEMBL599428	=	IC50	nM	48.0	CHEMBL262	Homo sapiens	IC50	uM	0.048
	3118015	CHEMBL1072185	Inhibition of GSK3-beta	B	CNC(=O)c1nn(C)c2c1CCc1cnc(NC3CCN(C(=O)C4CCN(S(C)(=O)=O)CC4)CC3)nc1-2		CHEMBL597754	=	IC50	nM	358.0	CHEMBL262	Homo sapiens	IC50	uM	0.358
	3127295	CHEMBL1074373	Inhibition of GSK3-beta at 1 uM	B	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL263664	=	Inhibition	%	3.0	CHEMBL262	Homo sapiens	INH	%	3.0
	3127314	CHEMBL1074373	Inhibition of GSK3-beta at 1 uM	B	CC(C)(C)c1ccc(CC2(N)CCN(c3ncnc4[nH]ccc34)CC2)cc1		CHEMBL597211	=	Inhibition	%	2.0	CHEMBL262	Homo sapiens	INH	%	2.0
	3127333	CHEMBL1074373	Inhibition of GSK3-beta at 1 uM	B	NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL598194	=	Inhibition	%	15.0	CHEMBL262	Homo sapiens	INH	%	15.0
	3128252	CHEMBL1074426	Inhibition of GSK3-beta by scintillation proximity assay	B	CC(C)(C)C(=O)N1Cc2c(NC(=O)c3cc(F)cc(F)c3)n[nH]c2C1(C)C		CHEMBL604712	=	IC50	nM	3630.0	CHEMBL262	Homo sapiens	IC50	uM	3.63
	3128264	CHEMBL1074426	Inhibition of GSK3-beta by scintillation proximity assay	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	=	IC50	nM	79.0	CHEMBL262	Homo sapiens	IC50	uM	0.079
	3130814	CHEMBL1073725	Inhibition of GSK3-beta at 3 to 6 uM relative to control	B	COc1ccc(C(=O)NCc2cccc(C(=O)Nc3ccc4c(c3)CNCC4)c2)cc1OC		CHEMBL604087	>	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	3131754	CHEMBL1065759	Inhibition of GSK3-beta at 3 uM relative to control	B	NC(=O)c1ccc(NC(=O)NCc2cccc(C(=O)Nc3ccc4c(c3)CNCC4)c2)cc1		CHEMBL600852	>	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	3186286	CHEMBL1114224	Inhibition of GSK3-beta	B	CCC(CO)Nc1nc(Nc2cccc(-c3ccccn3)c2)c2ncn(C(C)C)c2n1		CHEMBL1080583	=	IC50	nM	4100.0	CHEMBL262	Homo sapiens	IC50	nM	4100.0
	3186374	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	O=C(O)CCC(=O)Nc1n[nH]c2cc(Cl)ccc12		CHEMBL1084134	=	IC50	nM	1180.0	CHEMBL262	Homo sapiens	IC50	uM	1.18
	3186375	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(Cl)ccc12		CHEMBL1082235	=	IC50	nM	354.0	CHEMBL262	Homo sapiens	IC50	uM	0.354
	3186376	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(-c3ccc(O)c(O)c3)ccc12		CHEMBL1082236	=	IC50	nM	27.0	CHEMBL262	Homo sapiens	IC50	uM	0.027
	3186377	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(-c3ccc(O)cc3)ccc12		CHEMBL1082237	=	IC50	nM	44.0	CHEMBL262	Homo sapiens	IC50	uM	0.044
	3186378	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(-c3ccc(O)cc3Cl)ccc12		CHEMBL1088618	=	IC50	nM	55.0	CHEMBL262	Homo sapiens	IC50	uM	0.055
	3186379	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(-c3ccc(N)cc3)ccc12		CHEMBL1086638	=	IC50	nM	76.0	CHEMBL262	Homo sapiens	IC50	uM	0.076
	3186380	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(-c3cccc(O)c3)ccc12		CHEMBL1086639	=	IC50	nM	94.0	CHEMBL262	Homo sapiens	IC50	uM	0.094
	3186381	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(C(F)(F)F)ccc12		CHEMBL1086640	=	IC50	nM	195.0	CHEMBL262	Homo sapiens	IC50	uM	0.195
	3186382	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(Br)ccc12		CHEMBL1086780	=	IC50	nM	198.0	CHEMBL262	Homo sapiens	IC50	uM	0.198
	3186383	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(-c3ccoc3)ccc12		CHEMBL1086781	=	IC50	nM	260.0	CHEMBL262	Homo sapiens	IC50	uM	0.26
	3186384	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(-c3ccncc3)ccc12		CHEMBL1086782	=	IC50	nM	661.0	CHEMBL262	Homo sapiens	IC50	uM	0.661
	3186385	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(-c3ccsc3)ccc12		CHEMBL1083208	=	IC50	nM	935.0	CHEMBL262	Homo sapiens	IC50	uM	0.935
	3186386	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(-c3ccc(N)nc3)ccc12		CHEMBL1083209	=	IC50	nM	1088.0	CHEMBL262	Homo sapiens	IC50	uM	1.088
	3186387	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(-c3ccc(OCc4ccccc4)cc3)ccc12		CHEMBL1085927	=	IC50	nM	1184.0	CHEMBL262	Homo sapiens	IC50	uM	1.184
	3186388	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(-c3ccccc3)ccc12		CHEMBL1086174	=	IC50	nM	1281.0	CHEMBL262	Homo sapiens	IC50	uM	1.281
	3186389	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(-c3ccccc3Cl)ccc12		CHEMBL1086175	=	IC50	nM	1353.0	CHEMBL262	Homo sapiens	IC50	uM	1.353
	3186390	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	C/C=C/c1ccc2c(NC(=O)CCC)n[nH]c2c1		CHEMBL1086176	=	IC50	nM	2459.0	CHEMBL262	Homo sapiens	IC50	uM	2.459
	3186391	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(-c3cc(F)cc(F)c3)ccc12		CHEMBL1095038	=	IC50	nM	2894.0	CHEMBL262	Homo sapiens	IC50	uM	2.894
	3186392	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(-c3ccc(C(C)(C)C)cc3)ccc12		CHEMBL1095039	=	IC50	nM	3808.0	CHEMBL262	Homo sapiens	IC50	uM	3.808
	3186393	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(Cl)c(-c3ccccc3)cc12		CHEMBL1095040	=	IC50	nM	7.0	CHEMBL262	Homo sapiens	IC50	nM	7.0
	3186394	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(Cl)c(-c3ccc(N)cc3)cc12		CHEMBL1095041	=	IC50	nM	8.0	CHEMBL262	Homo sapiens	IC50	nM	8.0
	3186395	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(Cl)c(-c3ccc(O)cc3)cc12		CHEMBL1095366	=	IC50	nM	10.0	CHEMBL262	Homo sapiens	IC50	nM	10.0
	3186396	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(Cl)c(-c3ccoc3)cc12		CHEMBL1077218	=	IC50	nM	11.0	CHEMBL262	Homo sapiens	IC50	nM	11.0
	3186397	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(Cl)c(-c3ccc(CC)cc3)cc12		CHEMBL1077213	=	IC50	nM	12.0	CHEMBL262	Homo sapiens	IC50	nM	12.0
	3186398	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(Cl)c(-c3ccc(C)cc3)cc12		CHEMBL1097694	=	IC50	nM	14.0	CHEMBL262	Homo sapiens	IC50	nM	14.0
	3186399	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(Cl)c(-c3ccc([N+](=O)[O-])cc3)cc12		CHEMBL1091081	=	IC50	nM	18.0	CHEMBL262	Homo sapiens	IC50	nM	18.0
	3186400	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(Cl)c(-c3ccc(F)cc3)cc12		CHEMBL1091082	=	IC50	nM	22.0	CHEMBL262	Homo sapiens	IC50	nM	22.0
	3186401	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(Cl)c(-c3ccc(OCc4ccccc4)cc3)cc12		CHEMBL1091083	=	IC50	nM	23.0	CHEMBL262	Homo sapiens	IC50	nM	23.0
	3186402	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(Cl)c(-c3ccncc3)cc12		CHEMBL1077233	=	IC50	nM	50.0	CHEMBL262	Homo sapiens	IC50	nM	50.0
	3186403	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(Cl)c(Br)cc12		CHEMBL1089722	=	IC50	nM	55.0	CHEMBL262	Homo sapiens	IC50	nM	55.0
	3186404	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(-c3ccc(O)cc3)c(-c3ccco3)cc12		CHEMBL1089723	=	IC50	nM	14.0	CHEMBL262	Homo sapiens	IC50	nM	14.0
	3186405	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(-c3ccc(O)cc3)c(-c3cccnc3)cc12		CHEMBL1092802	=	IC50	nM	149.0	CHEMBL262	Homo sapiens	IC50	nM	149.0
	3186406	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(-c3ccc(O)cc3)c(-c3ccc(CC)cc3)cc12		CHEMBL1093079	=	IC50	nM	49.0	CHEMBL262	Homo sapiens	IC50	nM	49.0
	3186407	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(-c3ccc(O)cc3)c(-c3ccoc3)cc12		CHEMBL1077243	=	IC50	nM	98.0	CHEMBL262	Homo sapiens	IC50	nM	98.0
	3186408	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(-c3ccc(O)cc3)c(-c3ccc(O)cc3)cc12		CHEMBL1093390	=	IC50	nM	56.0	CHEMBL262	Homo sapiens	IC50	nM	56.0
	3186409	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(-c3ccc(Oc4ccccc4)cc3)c(-c3ccc(Oc4ccccc4)cc3)cc12		CHEMBL1077244	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	nM	10000.0
	3186410	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(-c3ccc(O)cc3)c(-c3ccccc3)cc12		CHEMBL1093745	=	IC50	nM	55.0	CHEMBL262	Homo sapiens	IC50	nM	55.0
	3186411	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(-c3ccccc3)c(-c3ccccc3)cc12		CHEMBL1093746	=	IC50	nM	1720.0	CHEMBL262	Homo sapiens	IC50	nM	1720.0
	3186412	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(-c3ccc(O)cc3)c(Br)cc12		CHEMBL1093747	=	IC50	nM	5.0	CHEMBL262	Homo sapiens	IC50	nM	5.0
	3186413	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(Cc3ccccc3)ccc12		CHEMBL1077260	=	IC50	nM	4140.0	CHEMBL262	Homo sapiens	IC50	uM	4.14
	3186414	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12		CHEMBL1084681	=	IC50	nM	5008.0	CHEMBL262	Homo sapiens	IC50	uM	5.008
	3186415	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(-c3cc(Cl)cc(Cl)c3)ccc12		CHEMBL1084682	=	IC50	nM	5413.0	CHEMBL262	Homo sapiens	IC50	uM	5.413
	3186416	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(-c3ccc(OC(F)(F)F)cc3)ccc12		CHEMBL1084683	=	IC50	nM	5498.0	CHEMBL262	Homo sapiens	IC50	uM	5.498
	3186417	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(-c3ccc(SC)cc3)ccc12		CHEMBL1077258	=	IC50	nM	7165.0	CHEMBL262	Homo sapiens	IC50	uM	7.165
	3186418	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(CCc3ccccc3)ccc12		CHEMBL1084684	=	IC50	nM	8525.0	CHEMBL262	Homo sapiens	IC50	uM	8.525
	3186419	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(-c3ccc(C(F)(F)F)cc3)ccc12		CHEMBL1077282	=	IC50	nM	10546.0	CHEMBL262	Homo sapiens	IC50	uM	10.546
	3186420	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(-c3cccnc3)ccc12		CHEMBL1085918	=	IC50	nM	10892.0	CHEMBL262	Homo sapiens	IC50	uM	10.892
	3186421	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(-c3ccc(N(C)C)cc3)ccc12		CHEMBL1085919	=	IC50	nM	12247.0	CHEMBL262	Homo sapiens	IC50	uM	12.247
	3186422	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(-c3ccc(O)nc3)ccc12		CHEMBL1085920	=	IC50	nM	16784.0	CHEMBL262	Homo sapiens	IC50	uM	16.784
	3186423	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	Cc1ccc(-c2ccc3c(NC(=O)CCC(=O)O)n[nH]c3c2)cc1		CHEMBL1084692	=	IC50	nM	17103.0	CHEMBL262	Homo sapiens	IC50	uM	17.103
	3186424	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	N#Cc1ccc(-c2ccc3c(NC(=O)CCC(=O)O)n[nH]c3c2)cc1		CHEMBL1084693	=	IC50	nM	20532.0	CHEMBL262	Homo sapiens	IC50	uM	20.532
	3186425	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(-c3ccc4c(c3)COO4)ccc12		CHEMBL1083528	=	IC50	nM	25038.0	CHEMBL262	Homo sapiens	IC50	uM	25.038
	3186426	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(-c3ccc([N+](=O)[O-])cc3)ccc12		CHEMBL1083837	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	3186427	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(-c3ccc(OC)cc3)ccc12		CHEMBL1086425	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	3186428	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(-c3ccc(CC)cc3)ccc12		CHEMBL1077270	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	3186429	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(-c3ccc(Cl)cc3)ccc12		CHEMBL1086426	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	3186453	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2c(F)c(Cl)c(-c3ccccc3)cc12		CHEMBL1086427	=	IC50	nM	6.0	CHEMBL262	Homo sapiens	IC50	nM	6.0
	3186454	CHEMBL1113275	Inhibition of human recombinant GSK3-beta using gamma[33P]-ATP after 30 mins by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2c(Cl)c(Cl)c(-c3ccccc3)cc12		CHEMBL1097003	=	IC50	nM	12.0	CHEMBL262	Homo sapiens	IC50	nM	12.0
	3191057	CHEMBL1101924	Inhibition of GSK3-beta at 10 uM	B	C[C@H](O)CNc1nccc(-n2ccnc2-c2cccc(NC(=O)c3ccc(Cl)c(C(F)(F)F)c3)c2)n1		CHEMBL1082876	=	Inhibition	%	14.0	CHEMBL262	Homo sapiens	INH	%	14.0
	3200246	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	O=C1NN=C(c2cccnc2)/C1=N/Nc1ccccc1Cl		CHEMBL1080376	=	Ki	nM	200.0	CHEMBL262	Homo sapiens	Ki	nM	200.0
	3200247	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	O=C1NN=C(c2ccncc2)/C1=N/Nc1ccccc1Cl		CHEMBL1080377	=	Ki	nM	250.0	CHEMBL262	Homo sapiens	Ki	nM	250.0
	3200248	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1cccc(C2=NNC(=O)/C2=N\Nc2ccccc2Cl)c1		CHEMBL1081063	=	Ki	nM	850.0	CHEMBL262	Homo sapiens	Ki	nM	850.0
	3200249	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1ccc(C2=NNC(=O)/C2=N\Nc2ccccc2Cl)cc1OC		CHEMBL1081429	=	Ki	nM	44.0	CHEMBL262	Homo sapiens	Ki	nM	44.0
	3200250	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	O=C1NN=C(c2ccccc2)/C1=N/Nc1ccccc1		CHEMBL1081430	=	Ki	nM	99.0	CHEMBL262	Homo sapiens	Ki	nM	99.0
	3200251	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	O=C1NN=C(c2ccccc2)/C1=N/Nc1cccc(Cl)c1		CHEMBL1081431	=	Ki	nM	120.0	CHEMBL262	Homo sapiens	Ki	nM	120.0
	3200252	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	O=C1NN=C(c2ccccc2)/C1=N/Nc1ccc(Cl)cc1		CHEMBL1081432	=	Ki	nM	23.0	CHEMBL262	Homo sapiens	Ki	nM	23.0
	3200253	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1ccccc1N/N=C1\C(=O)NN=C1c1ccccc1		CHEMBL1081277	>	Ki	nM	4000.0	CHEMBL262	Homo sapiens	Ki	nM	4000.0
	3200254	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1cccc(N/N=C2\C(=O)NN=C2c2ccccc2)c1		CHEMBL1081278	=	Ki	nM	35.0	CHEMBL262	Homo sapiens	Ki	nM	35.0
	3200255	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1ccc(N/N=C2\C(=O)NN=C2c2ccccc2)cc1		CHEMBL1076682	=	Ki	nM	20.0	CHEMBL262	Homo sapiens	Ki	nM	20.0
	3200256	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1ccc(N/N=C2\C(=O)NN=C2c2ccccn2)cc1		CHEMBL1081454	=	Ki	nM	640.0	CHEMBL262	Homo sapiens	Ki	nM	640.0
	3200257	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1ccc(N/N=C2\C(=O)NN=C2c2cccnc2)cc1		CHEMBL1081630	=	Ki	nM	20.0	CHEMBL262	Homo sapiens	Ki	nM	20.0
	3200258	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1ccc(N/N=C2\C(=O)NN=C2c2ccncc2)cc1		CHEMBL1081631	=	Ki	nM	30.0	CHEMBL262	Homo sapiens	Ki	nM	30.0
	3200259	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1ccc(N/N=C2\C(=O)NN=C2c2cccc(OC)c2)cc1		CHEMBL1081632	=	Ki	nM	18.0	CHEMBL262	Homo sapiens	Ki	nM	18.0
	3200260	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1ccc(N/N=C2\C(=O)NN=C2c2ccc(OC)cc2)cc1		CHEMBL1081633	=	Ki	nM	2.0	CHEMBL262	Homo sapiens	Ki	nM	2.0
	3200261	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1ccc(N/N=C2\C(=O)NN=C2c2ccc(OC)c(OC)c2)cc1		CHEMBL1082156	<	Ki	nM	2.0	CHEMBL262	Homo sapiens	Ki	nM	2.0
	3200262	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1ccc(N/N=C2\C(=O)NN=C2c2cc(OC)c(OC)c(OC)c2)cc1		CHEMBL1082157	=	Ki	nM	9.0	CHEMBL262	Homo sapiens	Ki	nM	9.0
	3200263	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1ccc(N/N=C2\C(=O)NN=C2c2cnccc2OC)cc1		CHEMBL1079966	=	Ki	nM	2.0	CHEMBL262	Homo sapiens	Ki	nM	2.0
	3200264	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1cccc(C2=NNC(=O)/C2=N\Nc2ccccc2)c1		CHEMBL1079967	=	Ki	nM	39.0	CHEMBL262	Homo sapiens	Ki	nM	39.0
	3200265	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1cccc(C2=NNC(=O)/C2=N\Nc2cccc(Cl)c2)c1		CHEMBL1079968	=	Ki	nM	8.0	CHEMBL262	Homo sapiens	Ki	nM	8.0
	3200266	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1cccc(C2=NNC(=O)/C2=N\Nc2ccc(Cl)cc2)c1		CHEMBL1076695	=	Ki	nM	9.0	CHEMBL262	Homo sapiens	Ki	nM	9.0
	3200267	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1cccc(N/N=C2\C(=O)NN=C2c2cccc(OC)c2)c1		CHEMBL1081833	=	Ki	nM	5.0	CHEMBL262	Homo sapiens	Ki	nM	5.0
	3200268	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1cccc(C2=NNC(=O)/C2=N\Nc2ccc(C#N)cc2)c1		CHEMBL1082009	=	Ki	nM	4.0	CHEMBL262	Homo sapiens	Ki	nM	4.0
	3200269	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1cccc(C2=NNC(=O)/C2=N\Nc2ccccn2)c1		CHEMBL1082010	=	Ki	nM	8.0	CHEMBL262	Homo sapiens	Ki	nM	8.0
	3200270	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1cccc(C2=NNC(=O)/C2=N\Nc2cccnc2)c1		CHEMBL1082011	=	Ki	nM	30.0	CHEMBL262	Homo sapiens	Ki	nM	30.0
	3200271	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1cccc(C2=NNC(=O)/C2=N\Nc2ccncc2)c1		CHEMBL1082176	=	Ki	nM	23.0	CHEMBL262	Homo sapiens	Ki	nM	23.0
	3200272	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1cccc(C2=NNC(=O)/C2=N\Nc2ccc(C(=O)O)cc2)c1		CHEMBL1082188	=	Ki	nM	6.5	CHEMBL262	Homo sapiens	Ki	nM	6.5
	3200273	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1cccc(C2=NNC(=O)/C2=N\Nc2ccc(N(C)C)cc2)c1		CHEMBL1080847	=	Ki	nM	9.0	CHEMBL262	Homo sapiens	Ki	nM	9.0
	3200274	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1cccc(C2=NNC(=O)/C2=N\Nc2ccc(N3CCOCC3)cc2)c1		CHEMBL1080848	=	Ki	nM	59.0	CHEMBL262	Homo sapiens	Ki	nM	59.0
	3200275	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1ccc(C2=NNC(=O)/C2=N\Nc2cccc(Cl)c2)cc1		CHEMBL1076701	=	Ki	nM	1.9	CHEMBL262	Homo sapiens	Ki	nM	1.9
	3200276	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1ccc(C2=NNC(=O)/C2=N\Nc2ccc(Cl)cc2)cc1		CHEMBL1080849	=	Ki	nM	2.0	CHEMBL262	Homo sapiens	Ki	nM	2.0
	3200277	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1ccc(C2=NNC(=O)/C2=N\Nc2cccc(OC)c2)cc1		CHEMBL1080902	=	Ki	nM	0.8	CHEMBL262	Homo sapiens	Ki	nM	0.8
	3200278	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1ccc(C2=NNC(=O)/C2=N\Nc2ccc(C#N)cc2)cc1		CHEMBL1081068	<	Ki	nM	2.0	CHEMBL262	Homo sapiens	Ki	nM	2.0
	3200279	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1ccc(C2=NNC(=O)/C2=N\Nc2cccnc2)cc1		CHEMBL1076721	=	Ki	nM	2.0	CHEMBL262	Homo sapiens	Ki	nM	2.0
	3200280	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1ccc(C2=NNC(=O)/C2=N\Nc2ccncc2)cc1		CHEMBL1081069	=	Ki	nM	14.0	CHEMBL262	Homo sapiens	Ki	nM	14.0
	3200281	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1ccc(C2=NNC(=O)/C2=N\Nc2ccc(N(C)C)cc2)cc1		CHEMBL1081070	=	Ki	nM	110.0	CHEMBL262	Homo sapiens	Ki	nM	110.0
	3200282	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	CCN(CC)c1ccc(N/N=C2\C(=O)NN=C2c2ccc(OC)cc2)cc1		CHEMBL1081071	=	Ki	nM	16.0	CHEMBL262	Homo sapiens	Ki	nM	16.0
	3200283	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1ccc(C2=NNC(=O)/C2=N\Nc2ccc(N3CCOCC3)cc2)cc1		CHEMBL1088725	=	Ki	nM	8.0	CHEMBL262	Homo sapiens	Ki	nM	8.0
	3200284	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1ccc(C2=NNC(=O)/C2=N\Nc2ccccc2)cc1OC		CHEMBL1088726	<	Ki	nM	3.5	CHEMBL262	Homo sapiens	Ki	nM	3.5
	3200285	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1ccc(C2=NNC(=O)/C2=N\Nc2cccc(Cl)c2)cc1OC		CHEMBL1088011	=	Ki	nM	0.4	CHEMBL262	Homo sapiens	Ki	nM	0.4
	3200286	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1ccc(C2=NNC(=O)/C2=N/Nc2ccc(Cl)cc2)cc1OC		CHEMBL1088012	<	Ki	nM	2.0	CHEMBL262	Homo sapiens	Ki	nM	2.0
	3200287	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1cccc(N/N=C2\C(=O)NN=C2c2ccc(OC)c(OC)c2)c1		CHEMBL1088145	=	Ki	nM	0.4	CHEMBL262	Homo sapiens	Ki	nM	0.4
	3200288	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1ccc(C2=NNC(=O)/C2=N\Nc2ccc(C#N)cc2)cc1OC		CHEMBL1087244	<	Ki	nM	2.0	CHEMBL262	Homo sapiens	Ki	nM	2.0
	3200289	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1ccc(C2=NNC(=O)/C2=N\Nc2cccnc2)cc1OC		CHEMBL1087245	<	Ki	nM	3.5	CHEMBL262	Homo sapiens	Ki	nM	3.5
	3200290	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1ccc(C2=NNC(=O)/C2=N\Nc2ccncc2)cc1OC		CHEMBL1087246	<	Ki	nM	3.5	CHEMBL262	Homo sapiens	Ki	nM	3.5
	3200291	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1ccc(C2=NNC(=O)/C2=N\Nc2ccc(N(C)C)cc2)cc1OC		CHEMBL1086601	=	Ki	nM	87.0	CHEMBL262	Homo sapiens	Ki	nM	87.0
	3200292	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	CCN(CC)c1ccc(N/N=C2\C(=O)NN=C2c2ccc(OC)c(OC)c2)cc1		CHEMBL1086602	=	Ki	nM	2.0	CHEMBL262	Homo sapiens	Ki	nM	2.0
	3200293	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1ccc(C2=NNC(=O)/C2=N\Nc2ccc(N3CCOCC3)cc2)cc1OC		CHEMBL1086735	=	Ki	nM	3.0	CHEMBL262	Homo sapiens	Ki	nM	3.0
	3200294	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1ccncc1C1=NNC(=O)/C1=N\Nc1ccccc1		CHEMBL1086736	=	Ki	nM	4.5	CHEMBL262	Homo sapiens	Ki	nM	4.5
	3200295	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1ccncc1C1=NNC(=O)/C1=N\Nc1ccc(Cl)cc1		CHEMBL1088021	=	Ki	nM	3.0	CHEMBL262	Homo sapiens	Ki	nM	3.0
	3200296	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1ccccc1N/N=C1\C(=O)NN=C1c1cnccc1OC		CHEMBL1088154	=	Ki	nM	270.0	CHEMBL262	Homo sapiens	Ki	nM	270.0
	3200297	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1cccc(N/N=C2\C(=O)NN=C2c2cnccc2OC)c1		CHEMBL1076755	=	Ki	nM	3.7	CHEMBL262	Homo sapiens	Ki	nM	3.7
	3200298	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1ccncc1C1=NNC(=O)/C1=N\Nc1ccc(C#N)cc1		CHEMBL1081102	=	Ki	nM	8.3	CHEMBL262	Homo sapiens	Ki	nM	8.3
	3200299	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1ccncc1C1=NNC(=O)/C1=N\Nc1cccnc1		CHEMBL1081103	=	Ki	nM	23.0	CHEMBL262	Homo sapiens	Ki	nM	23.0
	3200300	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1ccncc1C1=NNC(=O)/C1=N\Nc1ccncc1		CHEMBL1076552	=	Ki	nM	16.0	CHEMBL262	Homo sapiens	Ki	nM	16.0
	3200301	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1ccncc1C1=NNC(=O)/C1=N\Nc1ccc(C(=O)O)cc1		CHEMBL1081446	=	Ki	nM	7.7	CHEMBL262	Homo sapiens	Ki	nM	7.7
	3200302	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	COc1ccncc1C1=NNC(=O)/C1=N\Nc1ccc(N2CCOCC2)cc1		CHEMBL1081447	=	Ki	nM	50.0	CHEMBL262	Homo sapiens	Ki	nM	50.0
	3200381	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Ki	nM	22.0	CHEMBL262	Homo sapiens	Ki	nM	22.0
	3200382	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	Ki	nM	24.0	CHEMBL262	Homo sapiens	Ki	nM	24.0
	3201274	CHEMBL1108606	Inhibition of human GSK3-beta assessed as residual enzyme activity at 0.3 uM after 40 mins by scintillation counting	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Activity	%	7.0	CHEMBL262	Homo sapiens	Activity	%	7.0
	3201276	CHEMBL1108607	Inhibition of human GSK3-beta assessed as residual enzyme activity at 3 uM after 40 mins by scintillation counting	B	O=C1Nc2ncccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL1082552	=	Activity	%	18.0	CHEMBL262	Homo sapiens	Activity	%	18.0
	3201283	CHEMBL1108606	Inhibition of human GSK3-beta assessed as residual enzyme activity at 0.3 uM after 40 mins by scintillation counting	B	O=C1Nc2ncccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL1082552	=	Activity	%	64.0	CHEMBL262	Homo sapiens	Activity	%	64.0
	3201286	CHEMBL1108605	Inhibition of human GSK3-beta assessed as residual enzyme activity at 0.01 uM after 40 mins by scintillation counting	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Activity	%	66.0	CHEMBL262	Homo sapiens	Activity	%	66.0
	3201293	CHEMBL1108605	Inhibition of human GSK3-beta assessed as residual enzyme activity at 0.01 uM after 40 mins by scintillation counting	B	O=C1Nc2ncccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL1082552	=	Activity	%	88.0	CHEMBL262	Homo sapiens	Activity	%	88.0
	3201295	CHEMBL1108606	Inhibition of human GSK3-beta assessed as residual enzyme activity at 0.3 uM after 40 mins by scintillation counting	B	CN1C(=O)/C(=C2\Nc3ccccc3\C2=N/O)c2cccnc21		CHEMBL1077005	=	Activity	%	89.0	CHEMBL262	Homo sapiens	Activity	%	89.0
	3201297	CHEMBL1108606	Inhibition of human GSK3-beta assessed as residual enzyme activity at 0.3 uM after 40 mins by scintillation counting	B	O=C1Nc2ncccc2/C1=C1/Nc2ccccc2C1=O		CHEMBL1076931	=	Activity	%	93.0	CHEMBL262	Homo sapiens	Activity	%	93.0
	3201298	CHEMBL1108605	Inhibition of human GSK3-beta assessed as residual enzyme activity at 0.01 uM after 40 mins by scintillation counting	B	CN1C(=O)/C(=C2/C(=O)N(C)c3ncccc32)c2cccnc21		CHEMBL1089048	=	Activity	%	94.0	CHEMBL262	Homo sapiens	Activity	%	94.0
	3201300	CHEMBL1108605	Inhibition of human GSK3-beta assessed as residual enzyme activity at 0.01 uM after 40 mins by scintillation counting	B	CN1C(=O)/C(=C2\Nc3ccccc3\C2=N/O)c2cccnc21		CHEMBL1077005	=	Activity	%	95.0	CHEMBL262	Homo sapiens	Activity	%	95.0
	3201302	CHEMBL1108605	Inhibition of human GSK3-beta assessed as residual enzyme activity at 0.01 uM after 40 mins by scintillation counting	B	O=C1Nc2ncccc2/C1=C1/Nc2ccccc2C1=O		CHEMBL1076931	=	Activity	%	96.0	CHEMBL262	Homo sapiens	Activity	%	96.0
	3201303	CHEMBL1108606	Inhibition of human GSK3-beta assessed as residual enzyme activity at 0.3 uM after 40 mins by scintillation counting	B	CN1C(=O)/C(=C2\Nc3ccccc3C2=O)c2cccnc21		CHEMBL1082553	=	Activity	%	96.0	CHEMBL262	Homo sapiens	Activity	%	96.0
	3201822	CHEMBL1102669	Inhibition of human GSK3-beta assessed as remaining enzyme activity at 10 uM	B	CCCCc1nc2c(-c3ccc(Cl)cc3)n[nH]c2c(=O)n1NC(=O)c1ccccc1		CHEMBL1080920	=	Inhibition	%	11.0	CHEMBL262	Homo sapiens	INH	%	11.0
	3201826	CHEMBL1102669	Inhibition of human GSK3-beta assessed as remaining enzyme activity at 10 uM	B	CCCCCc1nc2c(-c3ccc(Cl)cc3)n[nH]c2c(=O)n1NC(=O)c1ccccc1		CHEMBL1080921	=	Inhibition	%	8.0	CHEMBL262	Homo sapiens	INH	%	8.0
	3201829	CHEMBL1102669	Inhibition of human GSK3-beta assessed as remaining enzyme activity at 10 uM	B	O=C(Cc1ccccc1)Nn1c(CC2CCCCC2)nc2c(-c3ccc(Cl)cc3)n[nH]c2c1=O		CHEMBL1088576	=	Inhibition	%	11.0	CHEMBL262	Homo sapiens	INH	%	11.0
	3201833	CHEMBL1102669	Inhibition of human GSK3-beta assessed as remaining enzyme activity at 10 uM	B	CCCCCc1nc2c(-c3ccc(Cl)cc3)n[nH]c2c(=O)n1NC(=O)c1cccc(C)c1		CHEMBL1087759	=	Inhibition	%	6.0	CHEMBL262	Homo sapiens	INH	%	6.0
	3201836	CHEMBL1102669	Inhibition of human GSK3-beta assessed as remaining enzyme activity at 10 uM	B	Cc1cccc(C(=O)Nn2c(CC3CCCCC3)nc3c(-c4ccc(Cl)cc4)n[nH]c3c2=O)c1		CHEMBL1087760	=	Inhibition	%	11.0	CHEMBL262	Homo sapiens	INH	%	11.0
	3201841	CHEMBL1102670	Inhibition of human GSK3-beta at 10 uM	B	CCCCc1nc2c(-c3ccc(Cl)cc3)n[nH]c2c(=O)n1NC(=O)c1ccccc1		CHEMBL1080920	=	Inhibition	%	89.0	CHEMBL262	Homo sapiens	INH	%	89.0
	3201842	CHEMBL1102670	Inhibition of human GSK3-beta at 10 uM	B	CCCCCc1nc2c(-c3ccc(Cl)cc3)n[nH]c2c(=O)n1NC(=O)c1ccccc1		CHEMBL1080921	=	Inhibition	%	89.0	CHEMBL262	Homo sapiens	INH	%	89.0
	3201843	CHEMBL1102670	Inhibition of human GSK3-beta at 10 uM	B	O=C(Cc1ccccc1)Nn1c(CC2CCCCC2)nc2c(-c3ccc(Cl)cc3)n[nH]c2c1=O		CHEMBL1088576	=	Inhibition	%	89.0	CHEMBL262	Homo sapiens	INH	%	89.0
	3201844	CHEMBL1102670	Inhibition of human GSK3-beta at 10 uM	B	CCCCCc1nc2c(-c3ccc(Cl)cc3)n[nH]c2c(=O)n1NC(=O)c1cccc(C)c1		CHEMBL1087759	=	Inhibition	%	89.0	CHEMBL262	Homo sapiens	INH	%	89.0
	3201845	CHEMBL1102670	Inhibition of human GSK3-beta at 10 uM	B	Cc1cccc(C(=O)Nn2c(CC3CCCCC3)nc3c(-c4ccc(Cl)cc4)n[nH]c3c2=O)c1		CHEMBL1087760	=	Inhibition	%	89.0	CHEMBL262	Homo sapiens	INH	%	89.0
	3202370	CHEMBL1108605	Inhibition of human GSK3-beta assessed as residual enzyme activity at 0.01 uM after 40 mins by scintillation counting	B	CN1C(=O)/C(=C2\Nc3ccccc3C2=O)c2cccnc21		CHEMBL1082553	=	Activity	%	101.0	CHEMBL262	Homo sapiens	Activity	%	101.0
	3202374	CHEMBL1108606	Inhibition of human GSK3-beta assessed as residual enzyme activity at 0.3 uM after 40 mins by scintillation counting	B	CN1C(=O)/C(=C2/C(=O)N(C)c3ncccc32)c2cccnc21		CHEMBL1089048	=	Activity	%	105.0	CHEMBL262	Homo sapiens	Activity	%	105.0
Not Determined	3202385	CHEMBL1108607	Inhibition of human GSK3-beta assessed as residual enzyme activity at 3 uM after 40 mins by scintillation counting	B	O=C1Nc2ncccc2/C1=C1/Nc2ccccc2C1=O		CHEMBL1076931		Activity			CHEMBL262	Homo sapiens	Activity		
Not Determined	3202386	CHEMBL1108607	Inhibition of human GSK3-beta assessed as residual enzyme activity at 3 uM after 40 mins by scintillation counting	B	CN1C(=O)/C(=C2\Nc3ccccc3C2=O)c2cccnc21		CHEMBL1082553		Activity			CHEMBL262	Homo sapiens	Activity		
Not Determined	3202387	CHEMBL1108607	Inhibition of human GSK3-beta assessed as residual enzyme activity at 3 uM after 40 mins by scintillation counting	B	CN1C(=O)/C(=C2/C(=O)N(C)c3ncccc32)c2cccnc21		CHEMBL1089048		Activity			CHEMBL262	Homo sapiens	Activity		
Not Determined	3202388	CHEMBL1108607	Inhibition of human GSK3-beta assessed as residual enzyme activity at 3 uM after 40 mins by scintillation counting	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450		Activity			CHEMBL262	Homo sapiens	Activity		
Not Determined	3202389	CHEMBL1108607	Inhibition of human GSK3-beta assessed as residual enzyme activity at 3 uM after 40 mins by scintillation counting	B	CN1C(=O)/C(=C2\Nc3ccccc3\C2=N/O)c2cccnc21		CHEMBL1077005		Activity			CHEMBL262	Homo sapiens	Activity		
	3202390	CHEMBL1108608	Inhibition of human GSK3-beta at 3 uM after 40 mins by scintillation counting	B	O=C1Nc2ncccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL1082552	=	Inhibition	%	81.0	CHEMBL262	Homo sapiens	INH	%	81.0
	3203257	CHEMBL1102983	Inhibition of human recombinant GSK3-beta assessed as [gamma33]ATP transfer to biotinylated CREB-peptide substrate after 1 hr by scintillation counting	B	Cn1cc(C2=C(c3cccc(NCC(O)CO)c3)C(=O)NC2=O)c2cc(F)ccc21		CHEMBL1082152	=	Kd	nM	0.053	CHEMBL262	Homo sapiens	Kd	uM	0.000053
	3203270	CHEMBL1102983	Inhibition of human recombinant GSK3-beta assessed as [gamma33]ATP transfer to biotinylated CREB-peptide substrate after 1 hr by scintillation counting	B	Cn1cc(C2=C(N3CCOCC3)C(=O)NC2=O)c2ccccc21		CHEMBL1080932	=	IC50	nM	8200.0	CHEMBL262	Homo sapiens	IC50	nM	8200.0
	3203271	CHEMBL1102983	Inhibition of human recombinant GSK3-beta assessed as [gamma33]ATP transfer to biotinylated CREB-peptide substrate after 1 hr by scintillation counting	B	Cn1cc(C2=C(N(C(=O)OC(C)(C)C)c3ccccc3)C(=O)NC2=O)c2ccccc21		CHEMBL1081261	=	IC50	nM	3100.0	CHEMBL262	Homo sapiens	IC50	nM	3100.0
	3203272	CHEMBL1102983	Inhibition of human recombinant GSK3-beta assessed as [gamma33]ATP transfer to biotinylated CREB-peptide substrate after 1 hr by scintillation counting	B	Cn1cc(C2=C(Oc3ccccc3)C(=O)NC2=O)c2ccccc21		CHEMBL1081260	=	IC50	nM	2800.0	CHEMBL262	Homo sapiens	IC50	nM	2800.0
	3203273	CHEMBL1102983	Inhibition of human recombinant GSK3-beta assessed as [gamma33]ATP transfer to biotinylated CREB-peptide substrate after 1 hr by scintillation counting	B	Cn1cc(C2=C(Nc3ccccc3)C(=O)NC2=O)c2ccccc21		CHEMBL1086734	=	IC50	nM	350.0	CHEMBL262	Homo sapiens	IC50	nM	350.0
	3203274	CHEMBL1102983	Inhibition of human recombinant GSK3-beta assessed as [gamma33]ATP transfer to biotinylated CREB-peptide substrate after 1 hr by scintillation counting	B	Cn1cc(C2=C(Sc3ccccc3)C(=O)NC2=O)c2ccccc21		CHEMBL1086733	=	IC50	nM	2000.0	CHEMBL262	Homo sapiens	IC50	nM	2000.0
	3203276	CHEMBL1102983	Inhibition of human recombinant GSK3-beta assessed as [gamma33]ATP transfer to biotinylated CREB-peptide substrate after 1 hr by scintillation counting	B	Cn1cc(C2=C(c3cccc(NCC(O)CO)c3)C(=O)NC2=O)c2cc(Cl)ccc21		CHEMBL1082153	=	IC50	nM	0.4	CHEMBL262	Homo sapiens	IC50	nM	0.4
	3203278	CHEMBL1102983	Inhibition of human recombinant GSK3-beta assessed as [gamma33]ATP transfer to biotinylated CREB-peptide substrate after 1 hr by scintillation counting	B	Cn1cc(C2=C(c3cccc(NCC(O)CO)c3)C(=O)NC2=O)c2cc(F)ccc21		CHEMBL1082152	=	IC50	nM	0.6	CHEMBL262	Homo sapiens	IC50	nM	0.6
	3203280	CHEMBL1102983	Inhibition of human recombinant GSK3-beta assessed as [gamma33]ATP transfer to biotinylated CREB-peptide substrate after 1 hr by scintillation counting	B	Cn1cc(C2=C(c3cccc(NCCCO)c3)C(=O)NC2=O)c2ccccc21		CHEMBL1082151	=	IC50	nM	1.0	CHEMBL262	Homo sapiens	IC50	nM	1.0
	3203282	CHEMBL1102983	Inhibition of human recombinant GSK3-beta assessed as [gamma33]ATP transfer to biotinylated CREB-peptide substrate after 1 hr by scintillation counting	B	Cn1cc(C2=C(c3cccc(CC(O)CO)c3)C(=O)NC2=O)c2cc(F)ccc21		CHEMBL1081973	=	IC50	nM	1.8	CHEMBL262	Homo sapiens	IC50	nM	1.8
	3203284	CHEMBL1102983	Inhibition of human recombinant GSK3-beta assessed as [gamma33]ATP transfer to biotinylated CREB-peptide substrate after 1 hr by scintillation counting	B	Cn1cc(C2=C(c3cccc(C[C@H](O)CO)c3)C(=O)NC2=O)c2ccccc21		CHEMBL1081972	=	IC50	nM	8.2	CHEMBL262	Homo sapiens	IC50	nM	8.2
	3203286	CHEMBL1102983	Inhibition of human recombinant GSK3-beta assessed as [gamma33]ATP transfer to biotinylated CREB-peptide substrate after 1 hr by scintillation counting	B	Cn1cc(C2=C(c3cccc(C[C@@H](O)CO)c3)C(=O)NC2=O)c2ccccc21		CHEMBL1081294	=	IC50	nM	3.2	CHEMBL262	Homo sapiens	IC50	nM	3.2
	3203288	CHEMBL1102983	Inhibition of human recombinant GSK3-beta assessed as [gamma33]ATP transfer to biotinylated CREB-peptide substrate after 1 hr by scintillation counting	B	COc1cccc(C2=C(c3cn(C)c4cccc(OC)c34)C(=O)NC2=O)c1		CHEMBL1081293	=	IC50	nM	1300.0	CHEMBL262	Homo sapiens	IC50	nM	1300.0
	3203290	CHEMBL1102983	Inhibition of human recombinant GSK3-beta assessed as [gamma33]ATP transfer to biotinylated CREB-peptide substrate after 1 hr by scintillation counting	B	COc1cccc(C2=C(c3cn(C)c4cc(C)ccc34)C(=O)NC2=O)c1		CHEMBL1081128	=	IC50	nM	35.0	CHEMBL262	Homo sapiens	IC50	nM	35.0
	3203292	CHEMBL1102983	Inhibition of human recombinant GSK3-beta assessed as [gamma33]ATP transfer to biotinylated CREB-peptide substrate after 1 hr by scintillation counting	B	COc1cccc(C2=C(c3cn(C)c4ccc(Cl)cc34)C(=O)NC2=O)c1		CHEMBL1081617	=	IC50	nM	6.4	CHEMBL262	Homo sapiens	IC50	nM	6.4
	3203294	CHEMBL1102983	Inhibition of human recombinant GSK3-beta assessed as [gamma33]ATP transfer to biotinylated CREB-peptide substrate after 1 hr by scintillation counting	B	COc1cccc(C2=C(c3cn(C)c4cc(F)ccc34)C(=O)NC2=O)c1		CHEMBL1081616	=	IC50	nM	31.0	CHEMBL262	Homo sapiens	IC50	nM	31.0
	3203296	CHEMBL1102983	Inhibition of human recombinant GSK3-beta assessed as [gamma33]ATP transfer to biotinylated CREB-peptide substrate after 1 hr by scintillation counting	B	COc1cccc(C2=C(c3c(C)n(C)c4ccccc34)C(=O)NC2=O)c1		CHEMBL1080933	=	IC50	nM	220.0	CHEMBL262	Homo sapiens	IC50	nM	220.0
	3203298	CHEMBL1102983	Inhibition of human recombinant GSK3-beta assessed as [gamma33]ATP transfer to biotinylated CREB-peptide substrate after 1 hr by scintillation counting	B	COc1cccc(C2=C(c3cn(C)c4ccccc34)C(=O)NC2=O)c1		CHEMBL293542	=	IC50	nM	90.0	CHEMBL262	Homo sapiens	IC50	nM	90.0
	3203300	CHEMBL1102983	Inhibition of human recombinant GSK3-beta assessed as [gamma33]ATP transfer to biotinylated CREB-peptide substrate after 1 hr by scintillation counting	B	Cn1cc(C2=C(c3ccc(-c4ccccc4)cc3)C(=O)NC2=O)c2ccccc21		CHEMBL1086732	=	IC50	nM	730.0	CHEMBL262	Homo sapiens	IC50	nM	730.0
	3203302	CHEMBL1102983	Inhibition of human recombinant GSK3-beta assessed as [gamma33]ATP transfer to biotinylated CREB-peptide substrate after 1 hr by scintillation counting	B	Cn1cc(C2=C(c3cccnc3)C(=O)NC2=O)c2ccccc21		CHEMBL1087380	=	IC50	nM	42.0	CHEMBL262	Homo sapiens	IC50	nM	42.0
	3203304	CHEMBL1102983	Inhibition of human recombinant GSK3-beta assessed as [gamma33]ATP transfer to biotinylated CREB-peptide substrate after 1 hr by scintillation counting	B	Cn1cc(C2=C(c3cccs3)C(=O)NC2=O)c2ccccc21		CHEMBL53745	=	IC50	nM	22.0	CHEMBL262	Homo sapiens	IC50	nM	22.0
	3203306	CHEMBL1102983	Inhibition of human recombinant GSK3-beta assessed as [gamma33]ATP transfer to biotinylated CREB-peptide substrate after 1 hr by scintillation counting	B	COc1ccc(OC)c(C2=C(c3cn(C)c4ccccc34)C(=O)NC2=O)c1		CHEMBL1087243	=	IC50	nM	22.0	CHEMBL262	Homo sapiens	IC50	nM	22.0
	3203308	CHEMBL1102983	Inhibition of human recombinant GSK3-beta assessed as [gamma33]ATP transfer to biotinylated CREB-peptide substrate after 1 hr by scintillation counting	B	COc1ccc(C2=C(c3cn(C)c4ccccc34)C(=O)NC2=O)cc1OC		CHEMBL1087242	=	IC50	nM	6.6	CHEMBL262	Homo sapiens	IC50	nM	6.6
	3203310	CHEMBL1102983	Inhibition of human recombinant GSK3-beta assessed as [gamma33]ATP transfer to biotinylated CREB-peptide substrate after 1 hr by scintillation counting	B	COc1ccc(C2=C(c3cn(C)c4ccccc34)C(=O)NC2=O)c(OC)c1		CHEMBL1088149	=	IC50	nM	2.4	CHEMBL262	Homo sapiens	IC50	nM	2.4
	3203312	CHEMBL1102983	Inhibition of human recombinant GSK3-beta assessed as [gamma33]ATP transfer to biotinylated CREB-peptide substrate after 1 hr by scintillation counting	B	Cn1cc(C2=C(c3cccc(N)c3)C(=O)NC2=O)c2ccccc21		CHEMBL54547	=	IC50	nM	1.8	CHEMBL262	Homo sapiens	IC50	nM	1.8
	3203314	CHEMBL1102983	Inhibition of human recombinant GSK3-beta assessed as [gamma33]ATP transfer to biotinylated CREB-peptide substrate after 1 hr by scintillation counting	B	Cn1cc(C2=C(c3ccccc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL431933	=	IC50	nM	3.6	CHEMBL262	Homo sapiens	IC50	nM	3.6
	3203315	CHEMBL1102983	Inhibition of human recombinant GSK3-beta assessed as [gamma33]ATP transfer to biotinylated CREB-peptide substrate after 1 hr by scintillation counting	B	O=C1Cc2c([nH]c3ccccc23)-c2ccccc2N1		CHEMBL430574	=	IC50	nM	100.0	CHEMBL262	Homo sapiens	IC50	nM	100.0
	3203316	CHEMBL1102983	Inhibition of human recombinant GSK3-beta assessed as [gamma33]ATP transfer to biotinylated CREB-peptide substrate after 1 hr by scintillation counting	B	CN(C)c1nc2ccc1CCCN1C=C(C3=C(C(=O)NC3=O)c3cn(c4ccccc34)CCC2)N2C=CC=CC12		CHEMBL1087499	=	IC50	nM	7.0	CHEMBL262	Homo sapiens	IC50	nM	7.0
	3203339	CHEMBL1102983	Inhibition of human recombinant GSK3-beta assessed as [gamma33]ATP transfer to biotinylated CREB-peptide substrate after 1 hr by scintillation counting	B	CN(C)C[C@H]1CCn2c(c(C3=C(c4cn(C)c5ccccc45)C(=O)NC3=O)c3ccccc32)C1		CHEMBL26501	=	IC50	nM	20.0	CHEMBL262	Homo sapiens	IC50	nM	20.0
	3203341	CHEMBL1102983	Inhibition of human recombinant GSK3-beta assessed as [gamma33]ATP transfer to biotinylated CREB-peptide substrate after 1 hr by scintillation counting	B	Cn1cc(C2=C(c3c4n(c5ccccc35)CCN(C(N)=S)C4)C(=O)NC2=O)c2ccccc21		CHEMBL1088724	=	IC50	nM	10.0	CHEMBL262	Homo sapiens	IC50	nM	10.0
	3203343	CHEMBL1102983	Inhibition of human recombinant GSK3-beta assessed as [gamma33]ATP transfer to biotinylated CREB-peptide substrate after 1 hr by scintillation counting	B	Nc1nc(NCCNc2ncc(-c3ncc[nH]3)c(-c3ccc(Cl)cc3Cl)n2)ccc1[N+](=O)[O-]		CHEMBL1080901	=	IC50	nM	0.56	CHEMBL262	Homo sapiens	IC50	nM	0.56
	3203344	CHEMBL1102983	Inhibition of human recombinant GSK3-beta assessed as [gamma33]ATP transfer to biotinylated CREB-peptide substrate after 1 hr by scintillation counting	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	IC50	nM	77.0	CHEMBL262	Homo sapiens	IC50	nM	77.0
	3203453	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	O=C1NN=C/C1=N/Nc1ccccc1Cl		CHEMBL1080868	=	Ki	nM	1490.0	CHEMBL262	Homo sapiens	Ki	nM	1490.0
	3203454	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	CC1=NNC(=O)/C1=N\Nc1ccccc1Cl		CHEMBL1076619	=	Ki	nM	460.0	CHEMBL262	Homo sapiens	Ki	nM	460.0
	3203455	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	CC(C)C1=NNC(=O)/C1=N\Nc1ccccc1Cl		CHEMBL1080374	>	Ki	nM	3700.0	CHEMBL262	Homo sapiens	Ki	nM	3700.0
	3203456	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	O=C1NN=C(c2ccccc2)/C1=N/Nc1ccccc1Cl		CHEMBL1080544	=	Ki	nM	720.0	CHEMBL262	Homo sapiens	Ki	nM	720.0
	3203457	CHEMBL1102102	Inhibition of GSK3-beta assessed as NADH level after 10 mins by pyruvate kinase/lactate dehydrogenase coupled spectrophotometric assay	B	O=C1NN=C(c2ccccn2)/C1=N/Nc1ccccc1Cl		CHEMBL1080375	=	Ki	nM	650.0	CHEMBL262	Homo sapiens	Ki	nM	650.0
	3210395	CHEMBL1109430	Inhibition of GSK3-beta after 1 hr	B	O=C(Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1)Nc1cccc(C(F)(F)F)c1		CHEMBL1081198	=	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	3213926	CHEMBL1114882	Inhibition of GSK3-beta at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	4.0	CHEMBL262	Homo sapiens	INH	%	4.0
	3216493	CHEMBL1113072	Inhibition of GSK3-beta expressed in H10075 yeast assessed as growth inhibition at 5 ug/disk after 72 hrs at 24 degreeC by disc diffusion method	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	IZ	mm	8.0	CHEMBL262	Homo sapiens	IZ	mm	8.0
	3216494	CHEMBL1113071	Inhibition of GSK3-beta expressed in H10075 yeast assessed as growth inhibition at 10 ug/disk after 72 hrs at 24 degreeC by disc diffusion method	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	IZ	mm	9.0	CHEMBL262	Homo sapiens	IZ	mm	9.0
	3216495	CHEMBL1113073	Inhibition of GSK3-beta expressed in H10075 yeast assessed as growth inhibition at 5 ug/disk after 72 hrs at 37 degreeC by disc diffusion method	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	IZ	mm	9.0	CHEMBL262	Homo sapiens	IZ	mm	9.0
	3216496	CHEMBL1113068	Inhibition of GSK3-beta expressed in H10075 yeast assessed as growth inhibition at 20 ug/disk after 72 hrs at 25 degreeC by disc diffusion method	B	CC/C=C(\C)C(=O)CC(O)CC1CC(=O)NC(=O)C1		CHEMBL1081889	=	IZ	mm	10.0	CHEMBL262	Homo sapiens	IZ	mm	10.0
	3216497	CHEMBL1113068	Inhibition of GSK3-beta expressed in H10075 yeast assessed as growth inhibition at 20 ug/disk after 72 hrs at 25 degreeC by disc diffusion method	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	IZ	mm	10.0	CHEMBL262	Homo sapiens	IZ	mm	10.0
	3216498	CHEMBL1113070	Inhibition of GSK3-beta expressed in H10075 yeast assessed as growth inhibition at 10 ug/disk after 72 hrs at 37 degreeC by disc diffusion method	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	IZ	mm	10.0	CHEMBL262	Homo sapiens	IZ	mm	10.0
	3216499	CHEMBL1113069	Inhibition of GSK3-beta expressed in H10075 yeast assessed as growth inhibition at 20 ug/disk after 72 hrs at 37 degreeC by disc diffusion method	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	IZ	mm	11.0	CHEMBL262	Homo sapiens	IZ	mm	11.0
	3216500	CHEMBL1113072	Inhibition of GSK3-beta expressed in H10075 yeast assessed as growth inhibition at 5 ug/disk after 72 hrs at 24 degreeC by disc diffusion method	B	C[C@H]1C[C@H](C)C(=O)[C@@H]([C@H](O)CC2CC(=O)NC(=O)C2)C1		CHEMBL1078564	=	IZ	mm	12.0	CHEMBL262	Homo sapiens	IZ	mm	12.0
	3216501	CHEMBL1113076	Inhibition of GSK3-beta expressed in H10075 yeast assessed as growth inhibition at 80 ug/disk after 72 hrs at 37 degreeC by disc diffusion method	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IZ	mm	13.0	CHEMBL262	Homo sapiens	IZ	mm	13.0
	3216502	CHEMBL1113073	Inhibition of GSK3-beta expressed in H10075 yeast assessed as growth inhibition at 5 ug/disk after 72 hrs at 37 degreeC by disc diffusion method	B	C[C@H]1C[C@H](C)C(=O)[C@@H]([C@H](O)CC2CC(=O)NC(=O)C2)C1		CHEMBL1078564	=	IZ	mm	15.0	CHEMBL262	Homo sapiens	IZ	mm	15.0
	3216503	CHEMBL1113071	Inhibition of GSK3-beta expressed in H10075 yeast assessed as growth inhibition at 10 ug/disk after 72 hrs at 24 degreeC by disc diffusion method	B	C[C@H]1C[C@H](C)C(=O)[C@@H]([C@H](O)CC2CC(=O)NC(=O)C2)C1		CHEMBL1078564	=	IZ	mm	16.0	CHEMBL262	Homo sapiens	IZ	mm	16.0
	3216504	CHEMBL1113068	Inhibition of GSK3-beta expressed in H10075 yeast assessed as growth inhibition at 20 ug/disk after 72 hrs at 25 degreeC by disc diffusion method	B	C[C@H]1C[C@H](C)C(=O)[C@@H]([C@H](O)CC2CC(=O)NC(=O)C2)C1		CHEMBL1078564	=	IZ	mm	22.0	CHEMBL262	Homo sapiens	IZ	mm	22.0
	3216505	CHEMBL1113074	Inhibition of GSK3-beta expressed in H10075 yeast assessed as growth inhibition at 2.5 ug/disk after 72 hrs at 24 degreeC by disc diffusion method	B	C[C@H]1C[C@H](C)C(=O)[C@H]([C@H](O)CC2CC(=O)NC(=O)C2)C1		CHEMBL123292	=	IZ	mm	25.0	CHEMBL262	Homo sapiens	IZ	mm	25.0
	3216506	CHEMBL1113070	Inhibition of GSK3-beta expressed in H10075 yeast assessed as growth inhibition at 10 ug/disk after 72 hrs at 37 degreeC by disc diffusion method	B	C[C@H]1C[C@H](C)C(=O)[C@@H]([C@H](O)CC2CC(=O)NC(=O)C2)C1		CHEMBL1078564	=	IZ	mm	25.0	CHEMBL262	Homo sapiens	IZ	mm	25.0
	3216507	CHEMBL1113075	Inhibition of GSK3-beta expressed in H10075 yeast assessed as growth inhibition at 2.5 ug/disk after 72 hrs at 37 degreeC by disc diffusion method	B	CC/C=C(\C)C(=O)CC(O)CC1CC(=O)NC(=O)C1		CHEMBL1081889	=	IZ	mm	28.0	CHEMBL262	Homo sapiens	IZ	mm	28.0
	3216508	CHEMBL1113073	Inhibition of GSK3-beta expressed in H10075 yeast assessed as growth inhibition at 5 ug/disk after 72 hrs at 37 degreeC by disc diffusion method	B	CC/C=C(\C)C(=O)CC(O)CC1CC(=O)NC(=O)C1		CHEMBL1081889	=	IZ	mm	30.0	CHEMBL262	Homo sapiens	IZ	mm	30.0
	3216509	CHEMBL1113072	Inhibition of GSK3-beta expressed in H10075 yeast assessed as growth inhibition at 5 ug/disk after 72 hrs at 24 degreeC by disc diffusion method	B	C[C@H]1C[C@H](C)C(=O)[C@H]([C@H](O)CC2CC(=O)NC(=O)C2)C1		CHEMBL123292	=	IZ	mm	30.0	CHEMBL262	Homo sapiens	IZ	mm	30.0
	3216510	CHEMBL1113071	Inhibition of GSK3-beta expressed in H10075 yeast assessed as growth inhibition at 10 ug/disk after 72 hrs at 24 degreeC by disc diffusion method	B	C[C@H]1C[C@H](C)C(=O)[C@H]([C@H](O)CC2CC(=O)NC(=O)C2)C1		CHEMBL123292	=	IZ	mm	33.0	CHEMBL262	Homo sapiens	IZ	mm	33.0
	3216511	CHEMBL1113069	Inhibition of GSK3-beta expressed in H10075 yeast assessed as growth inhibition at 20 ug/disk after 72 hrs at 37 degreeC by disc diffusion method	B	C[C@H]1C[C@H](C)C(=O)[C@@H]([C@H](O)CC2CC(=O)NC(=O)C2)C1		CHEMBL1078564	=	IZ	mm	33.0	CHEMBL262	Homo sapiens	IZ	mm	33.0
	3216512	CHEMBL1113070	Inhibition of GSK3-beta expressed in H10075 yeast assessed as growth inhibition at 10 ug/disk after 72 hrs at 37 degreeC by disc diffusion method	B	CC/C=C(\C)C(=O)CC(O)CC1CC(=O)NC(=O)C1		CHEMBL1081889	=	IZ	mm	34.0	CHEMBL262	Homo sapiens	IZ	mm	34.0
	3216513	CHEMBL1113068	Inhibition of GSK3-beta expressed in H10075 yeast assessed as growth inhibition at 20 ug/disk after 72 hrs at 25 degreeC by disc diffusion method	B	C[C@H]1C[C@H](C)C(=O)[C@H]([C@H](O)CC2CC(=O)NC(=O)C2)C1		CHEMBL123292	=	IZ	mm	36.0	CHEMBL262	Homo sapiens	IZ	mm	36.0
	3216514	CHEMBL1113069	Inhibition of GSK3-beta expressed in H10075 yeast assessed as growth inhibition at 20 ug/disk after 72 hrs at 37 degreeC by disc diffusion method	B	CC/C=C(\C)C(=O)CC(O)CC1CC(=O)NC(=O)C1		CHEMBL1081889	=	IZ	mm	38.0	CHEMBL262	Homo sapiens	IZ	mm	38.0
	3216515	CHEMBL1113075	Inhibition of GSK3-beta expressed in H10075 yeast assessed as growth inhibition at 2.5 ug/disk after 72 hrs at 37 degreeC by disc diffusion method	B	C[C@H]1C[C@H](C)C(=O)[C@H]([C@H](O)CC2CC(=O)NC(=O)C2)C1		CHEMBL123292	=	IZ	mm	42.0	CHEMBL262	Homo sapiens	IZ	mm	42.0
	3216516	CHEMBL1113073	Inhibition of GSK3-beta expressed in H10075 yeast assessed as growth inhibition at 5 ug/disk after 72 hrs at 37 degreeC by disc diffusion method	B	C[C@H]1C[C@H](C)C(=O)[C@H]([C@H](O)CC2CC(=O)NC(=O)C2)C1		CHEMBL123292	=	IZ	mm	48.0	CHEMBL262	Homo sapiens	IZ	mm	48.0
	3216517	CHEMBL1113070	Inhibition of GSK3-beta expressed in H10075 yeast assessed as growth inhibition at 10 ug/disk after 72 hrs at 37 degreeC by disc diffusion method	B	C[C@H]1C[C@H](C)C(=O)[C@H]([C@H](O)CC2CC(=O)NC(=O)C2)C1	Outside typical range	CHEMBL123292	=	IZ	mm	51.0	CHEMBL262	Homo sapiens	IZ	mm	51.0
	3216518	CHEMBL1113069	Inhibition of GSK3-beta expressed in H10075 yeast assessed as growth inhibition at 20 ug/disk after 72 hrs at 37 degreeC by disc diffusion method	B	C[C@H]1C[C@H](C)C(=O)[C@H]([C@H](O)CC2CC(=O)NC(=O)C2)C1	Outside typical range	CHEMBL123292	=	IZ	mm	55.0	CHEMBL262	Homo sapiens	IZ	mm	55.0
Not Active	3216519	CHEMBL1113071	Inhibition of GSK3-beta expressed in H10075 yeast assessed as growth inhibition at 10 ug/disk after 72 hrs at 24 degreeC by disc diffusion method	B	CC/C=C(\C)C(=O)CC(O)CC1CC(=O)NC(=O)C1		CHEMBL1081889		IZ			CHEMBL262	Homo sapiens	IZ		
Not Active	3216520	CHEMBL1113072	Inhibition of GSK3-beta expressed in H10075 yeast assessed as growth inhibition at 5 ug/disk after 72 hrs at 24 degreeC by disc diffusion method	B	CC/C=C(\C)C(=O)CC(O)CC1CC(=O)NC(=O)C1		CHEMBL1081889		IZ			CHEMBL262	Homo sapiens	IZ		
Not Active	3216521	CHEMBL1113074	Inhibition of GSK3-beta expressed in H10075 yeast assessed as growth inhibition at 2.5 ug/disk after 72 hrs at 24 degreeC by disc diffusion method	B	CC/C=C(\C)C(=O)CC(O)CC1CC(=O)NC(=O)C1		CHEMBL1081889		IZ			CHEMBL262	Homo sapiens	IZ		
Not Active	3216522	CHEMBL1113074	Inhibition of GSK3-beta expressed in H10075 yeast assessed as growth inhibition at 2.5 ug/disk after 72 hrs at 24 degreeC by disc diffusion method	B	C[C@H]1C[C@H](C)C(=O)[C@@H]([C@H](O)CC2CC(=O)NC(=O)C2)C1		CHEMBL1078564		IZ			CHEMBL262	Homo sapiens	IZ		
Not Active	3216523	CHEMBL1113075	Inhibition of GSK3-beta expressed in H10075 yeast assessed as growth inhibition at 2.5 ug/disk after 72 hrs at 37 degreeC by disc diffusion method	B	C[C@H]1C[C@H](C)C(=O)[C@@H]([C@H](O)CC2CC(=O)NC(=O)C2)C1		CHEMBL1078564		IZ			CHEMBL262	Homo sapiens	IZ		
Not Active	3216524	CHEMBL1113074	Inhibition of GSK3-beta expressed in H10075 yeast assessed as growth inhibition at 2.5 ug/disk after 72 hrs at 24 degreeC by disc diffusion method	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861		IZ			CHEMBL262	Homo sapiens	IZ		
Not Active	3216525	CHEMBL1113075	Inhibition of GSK3-beta expressed in H10075 yeast assessed as growth inhibition at 2.5 ug/disk after 72 hrs at 37 degreeC by disc diffusion method	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861		IZ			CHEMBL262	Homo sapiens	IZ		
Not Active	3216526	CHEMBL1113077	Inhibition of GSK3-beta expressed in H10075 yeast assessed as growth inhibition at 80 ug/disk after 72 hrs at 25 degreeC by disc diffusion method	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978		IZ			CHEMBL262	Homo sapiens	IZ		
	3219674	CHEMBL1110425	Inhibition of GSK3-beta at 100 nM relative to control	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)c1ccc(-c2ccnc(N)n2)s1)C(N)=O		CHEMBL1077375	=	Inhibition	%	4.0	CHEMBL262	Homo sapiens	INH	%	4.0
	3221886	CHEMBL1104158	Inhibition of GSK3-beta assessed as decrease in NADH absorbance at 340 nm in the presence of	B	Cn1c(-c2nonc2N)nc2ccccc21		CHEMBL1078717	=	Ki	nM	7300.0	CHEMBL262	Homo sapiens	Ki	uM	7.3
	3221890	CHEMBL1104158	Inhibition of GSK3-beta assessed as decrease in NADH absorbance at 340 nm in the presence of	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Ki	nM	700.0	CHEMBL262	Homo sapiens	Ki	uM	0.7
	3221894	CHEMBL1104158	Inhibition of GSK3-beta assessed as decrease in NADH absorbance at 340 nm in the presence of	B	CC(C)n1c(-c2nonc2N)nc2ccccc21		CHEMBL1079208	=	Ki	nM	1500.0	CHEMBL262	Homo sapiens	Ki	uM	1.5
	3221898	CHEMBL1104158	Inhibition of GSK3-beta assessed as decrease in NADH absorbance at 340 nm in the presence of	B	Nc1nonc1-c1nc2ccccc2n1C1CC1		CHEMBL1079293	>	Ki	nM	3300.0	CHEMBL262	Homo sapiens	Ki	uM	3.3
	3221902	CHEMBL1104158	Inhibition of GSK3-beta assessed as decrease in NADH absorbance at 340 nm in the presence of	B	Nc1nonc1-c1nc2ccccc2n1C1CCC1		CHEMBL1079294	=	Ki	nM	380.0	CHEMBL262	Homo sapiens	Ki	uM	0.38
	3221906	CHEMBL1104158	Inhibition of GSK3-beta assessed as decrease in NADH absorbance at 340 nm in the presence of	B	Nc1nonc1-c1nc2ccccc2n1C1CCCC1		CHEMBL1079295	=	Ki	nM	210.0	CHEMBL262	Homo sapiens	Ki	uM	0.21
	3221910	CHEMBL1104158	Inhibition of GSK3-beta assessed as decrease in NADH absorbance at 340 nm in the presence of	B	Nc1nonc1-c1nc2ccccc2n1C1CCCCC1		CHEMBL1078929	=	Ki	nM	240.0	CHEMBL262	Homo sapiens	Ki	uM	0.24
	3221914	CHEMBL1104158	Inhibition of GSK3-beta assessed as decrease in NADH absorbance at 340 nm in the presence of	B	Nc1nonc1-c1nc2ccccc2n1CC1CC1		CHEMBL1078930	=	Ki	nM	290.0	CHEMBL262	Homo sapiens	Ki	uM	0.29
	3221918	CHEMBL1104158	Inhibition of GSK3-beta assessed as decrease in NADH absorbance at 340 nm in the presence of	B	Nc1nonc1-c1nc2ccccc2n1CC1CCC1		CHEMBL1078820	=	Ki	nM	690.0	CHEMBL262	Homo sapiens	Ki	uM	0.69
	3221922	CHEMBL1104158	Inhibition of GSK3-beta assessed as decrease in NADH absorbance at 340 nm in the presence of	B	CC(C)Cn1c(-c2nonc2N)nc2ccccc21		CHEMBL1079040	=	Ki	nM	390.0	CHEMBL262	Homo sapiens	Ki	uM	0.39
	3223000	CHEMBL1104158	Inhibition of GSK3-beta assessed as decrease in NADH absorbance at 340 nm in the presence of	B	Nc1nonc1-c1nc2ccccc2n1-c1ccccc1		CHEMBL1078426	=	Ki	nM	620.0	CHEMBL262	Homo sapiens	Ki	uM	0.62
	3223004	CHEMBL1104158	Inhibition of GSK3-beta assessed as decrease in NADH absorbance at 340 nm in the presence of	B	N#Cc1ccccc1-n1c(-c2nonc2N)nc2ccccc21		CHEMBL1078427	>	Ki	nM	3300.0	CHEMBL262	Homo sapiens	Ki	uM	3.3
	3223008	CHEMBL1104158	Inhibition of GSK3-beta assessed as decrease in NADH absorbance at 340 nm in the presence of	B	N#Cc1cccc(-n2c(-c3nonc3N)nc3ccccc32)c1		CHEMBL1078537	>	Ki	nM	2500.0	CHEMBL262	Homo sapiens	Ki	uM	2.5
	3223012	CHEMBL1104158	Inhibition of GSK3-beta assessed as decrease in NADH absorbance at 340 nm in the presence of	B	N#Cc1ccc(-n2c(-c3nonc3N)nc3ccccc32)cc1		CHEMBL1078538	=	Ki	nM	1000.0	CHEMBL262	Homo sapiens	Ki	uM	1.0
	3223016	CHEMBL1104158	Inhibition of GSK3-beta assessed as decrease in NADH absorbance at 340 nm in the presence of	B	COc1ccccc1-n1c(-c2nonc2N)nc2ccccc21		CHEMBL1078539	>	Ki	nM	5000.0	CHEMBL262	Homo sapiens	Ki	uM	5.0
	3223020	CHEMBL1104158	Inhibition of GSK3-beta assessed as decrease in NADH absorbance at 340 nm in the presence of	B	COc1cccc(-n2c(-c3nonc3N)nc3ccccc32)c1		CHEMBL1078155	>	Ki	nM	5000.0	CHEMBL262	Homo sapiens	Ki	uM	5.0
	3223024	CHEMBL1104158	Inhibition of GSK3-beta assessed as decrease in NADH absorbance at 340 nm in the presence of	B	COc1ccc(-n2c(-c3nonc3N)nc3ccccc32)cc1		CHEMBL1078245	>	Ki	nM	5000.0	CHEMBL262	Homo sapiens	Ki	uM	5.0
	3223028	CHEMBL1104158	Inhibition of GSK3-beta assessed as decrease in NADH absorbance at 340 nm in the presence of	B	Nc1nonc1-c1nc2cc(O)ccc2n1C1CCC1		CHEMBL1079032	=	Ki	nM	1100.0	CHEMBL262	Homo sapiens	Ki	uM	1.1
	3223032	CHEMBL1104158	Inhibition of GSK3-beta assessed as decrease in NADH absorbance at 340 nm in the presence of	B	Nc1ccc2c(c1)nc(-c1nonc1N)n2C1CCC1		CHEMBL1080071	=	Ki	nM	2100.0	CHEMBL262	Homo sapiens	Ki	uM	2.1
	3223036	CHEMBL1104158	Inhibition of GSK3-beta assessed as decrease in NADH absorbance at 340 nm in the presence of	B	COc1ccc2c(c1)nc(-c1nonc1N)n2C1CCC1		CHEMBL1080072	=	Ki	nM	460.0	CHEMBL262	Homo sapiens	Ki	uM	0.46
	3223040	CHEMBL1104158	Inhibition of GSK3-beta assessed as decrease in NADH absorbance at 340 nm in the presence of	B	COC(=O)c1ccc2c(c1)nc(-c1nonc1N)n2C1CCC1		CHEMBL1080073	>	Ki	nM	3300.0	CHEMBL262	Homo sapiens	Ki	uM	3.3
	3223044	CHEMBL1104158	Inhibition of GSK3-beta assessed as decrease in NADH absorbance at 340 nm in the presence of	B	CC(=O)Nc1ccc2c(c1)nc(-c1nonc1N)n2C1CCC1		CHEMBL1080245	>	Ki	nM	3300.0	CHEMBL262	Homo sapiens	Ki	uM	3.3
	3223048	CHEMBL1104158	Inhibition of GSK3-beta assessed as decrease in NADH absorbance at 340 nm in the presence of	B	Cc1ccc2c(c1)nc(-c1nonc1N)n2C1CCC1		CHEMBL1079135	=	Ki	nM	3200.0	CHEMBL262	Homo sapiens	Ki	uM	3.2
	3223052	CHEMBL1104158	Inhibition of GSK3-beta assessed as decrease in NADH absorbance at 340 nm in the presence of	B	Nc1nonc1-c1nc2cc(CO)ccc2n1C1CCC1		CHEMBL1080970	>	Ki	nM	3300.0	CHEMBL262	Homo sapiens	Ki	uM	3.3
	3223056	CHEMBL1104158	Inhibition of GSK3-beta assessed as decrease in NADH absorbance at 340 nm in the presence of	B	CC(C)Cn1cc(-c2ccccc2)nc1-c1nonc1N		CHEMBL1079243	>	Ki	nM	3300.0	CHEMBL262	Homo sapiens	Ki	uM	3.3
	3223060	CHEMBL1104158	Inhibition of GSK3-beta assessed as decrease in NADH absorbance at 340 nm in the presence of	B	Cc1cn(CC(C)C)c(-c2nonc2N)n1		CHEMBL1077670	=	Ki	nM	690.0	CHEMBL262	Homo sapiens	Ki	uM	0.69
	3223064	CHEMBL1104158	Inhibition of GSK3-beta assessed as decrease in NADH absorbance at 340 nm in the presence of	B	CC(C)Cn1cc(C#N)nc1-c1nonc1N		CHEMBL1082061	>	Ki	nM	3300.0	CHEMBL262	Homo sapiens	Ki	uM	3.3
	3224837	CHEMBL1100488	Inhibition of GSK3-beta at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	3225087	CHEMBL1100488	Inhibition of GSK3-beta at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	3229268	CHEMBL1108488	Inhibition of GSK3-beta	B	COc1cc2c(cc1Cl)C(c1ccc(Cl)c(Cl)c1)=NCC2		CHEMBL1087421	<	IC50	nM	10000.0	CHEMBL262	Homo sapiens	pIC50		5.0
	3229281	CHEMBL1108488	Inhibition of GSK3-beta	B	COc1cc2c(cc1Cl)C(c1cccc(Cl)c1)=NCC2		CHEMBL1088633	<	IC50	nM	10000.0	CHEMBL262	Homo sapiens	pIC50		5.0
	3240809	CHEMBL1109695	Inhibition of GSK3-beta	B	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	>	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	uM	1.0
	3251251	CHEMBL1107906	Inhibition of GSK3-beta	B	Cn1cc(/C=C2\Oc3cccc(O)c3C2=O)c2c(-c3ccc(C(=O)NCCO)cc3)ccnc21		CHEMBL1092754	=	IC50	nM	5.9	CHEMBL262	Homo sapiens	IC50	nM	5.9
	3253886	CHEMBL1111575	Inhibition of human recombinant GSK3-beta in presence of gamma[33P]ATP by scintillation proximity assay	B	O=C(Nc1ccccc1)Nc1n[nH]c2cc(Cl)c(-c3ccccc3)cc12	Non standard unit for type	CHEMBL1092134	=	INH	uM	65.0	CHEMBL262	Homo sapiens	INH	uM	65.0
	3253887	CHEMBL1111575	Inhibition of human recombinant GSK3-beta in presence of gamma[33P]ATP by scintillation proximity assay	B	O=C(Nc1n[nH]c2cc(Cl)c(-c3ccccc3)cc12)N1CCCC1	Non standard unit for type	CHEMBL1092133	=	INH	uM	29.0	CHEMBL262	Homo sapiens	INH	uM	29.0
	3253888	CHEMBL1111575	Inhibition of human recombinant GSK3-beta in presence of gamma[33P]ATP by scintillation proximity assay	B	CN1CCN(CCCNC(=O)Nc2n[nH]c3cc(Cl)c(-c4ccccc4)cc23)CC1	Non standard unit for type	CHEMBL1092132	=	INH	uM	25.0	CHEMBL262	Homo sapiens	INH	uM	25.0
	3253889	CHEMBL1111575	Inhibition of human recombinant GSK3-beta in presence of gamma[33P]ATP by scintillation proximity assay	B	O=C(NCCCn1ccnc1)Nc1n[nH]c2cc(Cl)c(-c3ccccc3)cc12	Non standard unit for type	CHEMBL1092780	=	INH	uM	12.0	CHEMBL262	Homo sapiens	INH	uM	12.0
	3253890	CHEMBL1111575	Inhibition of human recombinant GSK3-beta in presence of gamma[33P]ATP by scintillation proximity assay	B	CC(C)NC(=O)Nc1n[nH]c2cc(Cl)c(-c3ccccc3)cc12	Non standard unit for type	CHEMBL1092779	=	INH	uM	0.05	CHEMBL262	Homo sapiens	INH	uM	0.05
	3253891	CHEMBL1111575	Inhibition of human recombinant GSK3-beta in presence of gamma[33P]ATP by scintillation proximity assay	B	O=C(NCc1ccccc1)Nc1n[nH]c2cc(Cl)c(-c3ccccc3)cc12	Non standard unit for type	CHEMBL1094012	=	INH	uM	0.055	CHEMBL262	Homo sapiens	INH	uM	0.055
	3253892	CHEMBL1111575	Inhibition of human recombinant GSK3-beta in presence of gamma[33P]ATP by scintillation proximity assay	B	NC(=O)Nc1n[nH]c2cc(Cl)c(-c3ccccc3)cc12	Non standard unit for type	CHEMBL1094011	=	INH	uM	0.125	CHEMBL262	Homo sapiens	INH	uM	0.125
	3253893	CHEMBL1111575	Inhibition of human recombinant GSK3-beta in presence of gamma[33P]ATP by scintillation proximity assay	B	COC(=O)Nc1n[nH]c2cc(Cl)c(-c3ccccc3)cc12	Non standard unit for type	CHEMBL1094010	=	INH	uM	0.21	CHEMBL262	Homo sapiens	INH	uM	0.21
	3253894	CHEMBL1111575	Inhibition of human recombinant GSK3-beta in presence of gamma[33P]ATP by scintillation proximity assay	B	O=C(Nc1n[nH]c2cc(Cl)c(-c3ccccc3)cc12)OCc1ccccc1	Non standard unit for type	CHEMBL1093702	=	INH	uM	0.13	CHEMBL262	Homo sapiens	INH	uM	0.13
	3253895	CHEMBL1111575	Inhibition of human recombinant GSK3-beta in presence of gamma[33P]ATP by scintillation proximity assay	B	C=CCOC(=O)Nc1n[nH]c2cc(Cl)c(-c3ccccc3)cc12	Non standard unit for type	CHEMBL1093701	=	INH	uM	0.1	CHEMBL262	Homo sapiens	INH	uM	0.1
	3253896	CHEMBL1111575	Inhibition of human recombinant GSK3-beta in presence of gamma[33P]ATP by scintillation proximity assay	B	CC(C)COC(=O)Nc1n[nH]c2cc(Cl)c(-c3ccccc3)cc12	Non standard unit for type	CHEMBL1090376	=	INH	uM	0.12	CHEMBL262	Homo sapiens	INH	uM	0.12
	3253897	CHEMBL1111575	Inhibition of human recombinant GSK3-beta in presence of gamma[33P]ATP by scintillation proximity assay	B	O=[N+]([O-])c1ccc(Nc2n[nH]c3cc(Cl)c(-c4ccccc4)cc23)nc1	Non standard unit for type	CHEMBL1092518	=	INH	uM	0.74	CHEMBL262	Homo sapiens	INH	uM	0.74
	3253898	CHEMBL1111575	Inhibition of human recombinant GSK3-beta in presence of gamma[33P]ATP by scintillation proximity assay	B	COc1cccc(Nc2n[nH]c3cc(Cl)c(-c4ccccc4)cc23)n1	Non standard unit for type	CHEMBL1092517	=	INH	uM	0.1	CHEMBL262	Homo sapiens	INH	uM	0.1
	3253899	CHEMBL1111575	Inhibition of human recombinant GSK3-beta in presence of gamma[33P]ATP by scintillation proximity assay	B	FC(F)(F)c1ccc(Nc2n[nH]c3cc(Cl)c(-c4ccccc4)cc23)cc1	Non standard unit for type	CHEMBL1092516	=	INH	uM	2.0	CHEMBL262	Homo sapiens	INH	uM	2.0
	3253900	CHEMBL1111575	Inhibition of human recombinant GSK3-beta in presence of gamma[33P]ATP by scintillation proximity assay	B	Clc1cc2[nH]nc(Nc3ccccn3)c2cc1-c1ccccc1	Non standard unit for type	CHEMBL1092493	=	INH	uM	0.21	CHEMBL262	Homo sapiens	INH	uM	0.21
	3253901	CHEMBL1111575	Inhibition of human recombinant GSK3-beta in presence of gamma[33P]ATP by scintillation proximity assay	B	CCCCNc1n[nH]c2cc(Cl)c(-c3ccccc3)cc12	Non standard unit for type	CHEMBL1092492	=	INH	uM	0.8	CHEMBL262	Homo sapiens	INH	uM	0.8
	3253902	CHEMBL1111575	Inhibition of human recombinant GSK3-beta in presence of gamma[33P]ATP by scintillation proximity assay	B	Nc1n[nH]c2cc(Cl)c(-c3ccccc3)cc12	Non standard unit for type	CHEMBL1091067	=	INH	uM	0.47	CHEMBL262	Homo sapiens	INH	uM	0.47
	3253903	CHEMBL1111575	Inhibition of human recombinant GSK3-beta in presence of gamma[33P]ATP by scintillation proximity assay	B	O=C(CN1CCOCC1)Nc1n[nH]c2cc(Cl)c(-c3ccccc3)cc12	Non standard unit for type	CHEMBL1090724	=	INH	uM	0.051	CHEMBL262	Homo sapiens	INH	uM	0.051
	3253904	CHEMBL1111575	Inhibition of human recombinant GSK3-beta in presence of gamma[33P]ATP by scintillation proximity assay	B	CC(C(=O)Nc1n[nH]c2cc(Cl)c(-c3ccccc3)cc12)N1CCCCC1	Non standard unit for type	CHEMBL1090723	=	INH	uM	0.025	CHEMBL262	Homo sapiens	INH	uM	0.025
	3253905	CHEMBL1111575	Inhibition of human recombinant GSK3-beta in presence of gamma[33P]ATP by scintillation proximity assay	B	O=C(CN1CCOCC1)Nc1n[nH]c2cc(Cl)ccc12	Non standard unit for type	CHEMBL1090722	=	INH	uM	0.99	CHEMBL262	Homo sapiens	INH	uM	0.99
	3253906	CHEMBL1111575	Inhibition of human recombinant GSK3-beta in presence of gamma[33P]ATP by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2c(F)c(F)ccc12	Non standard unit for type	CHEMBL1091789	=	INH	uM	0.27	CHEMBL262	Homo sapiens	INH	uM	0.27
	3253907	CHEMBL1111575	Inhibition of human recombinant GSK3-beta in presence of gamma[33P]ATP by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2c(F)c(F)c(-c3ccccc3)cc12	Non standard unit for type	CHEMBL1091788	=	INH	uM	0.005	CHEMBL262	Homo sapiens	INH	uM	0.005
	3253908	CHEMBL1111575	Inhibition of human recombinant GSK3-beta in presence of gamma[33P]ATP by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(-c3cccnc3)ccc12	Non standard unit for type	CHEMBL1085918	=	INH	uM	11.0	CHEMBL262	Homo sapiens	INH	uM	11.0
	3253909	CHEMBL1111575	Inhibition of human recombinant GSK3-beta in presence of gamma[33P]ATP by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(-c3cc(F)cc(F)c3)ccc12	Non standard unit for type	CHEMBL1095038	=	INH	uM	2.9	CHEMBL262	Homo sapiens	INH	uM	2.9
	3253910	CHEMBL1111575	Inhibition of human recombinant GSK3-beta in presence of gamma[33P]ATP by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(-c3ccccc3)ccc12	Non standard unit for type	CHEMBL1086174	=	INH	uM	1.28	CHEMBL262	Homo sapiens	INH	uM	1.28
	3253911	CHEMBL1111575	Inhibition of human recombinant GSK3-beta in presence of gamma[33P]ATP by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(-c3ccsc3)ccc12	Non standard unit for type	CHEMBL1083208	=	INH	uM	0.93	CHEMBL262	Homo sapiens	INH	uM	0.93
	3253912	CHEMBL1111575	Inhibition of human recombinant GSK3-beta in presence of gamma[33P]ATP by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(-c3ccc(O)cc3)ccc12	Non standard unit for type	CHEMBL1082237	=	INH	uM	0.036	CHEMBL262	Homo sapiens	INH	uM	0.036
	3253913	CHEMBL1111575	Inhibition of human recombinant GSK3-beta in presence of gamma[33P]ATP by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(Cl)c(Br)cc12	Non standard unit for type	CHEMBL1089722	=	INH	uM	0.055	CHEMBL262	Homo sapiens	INH	uM	0.055
	3253914	CHEMBL1111575	Inhibition of human recombinant GSK3-beta in presence of gamma[33P]ATP by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(Cl)c(-c3ccc(OCc4ccccc4)cc3)cc12	Non standard unit for type	CHEMBL1091083	=	INH	uM	0.022	CHEMBL262	Homo sapiens	INH	uM	0.022
	3253915	CHEMBL1111575	Inhibition of human recombinant GSK3-beta in presence of gamma[33P]ATP by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(Cl)c(-c3ccc([N+](=O)[O-])cc3)cc12	Non standard unit for type	CHEMBL1091081	=	INH	uM	0.017	CHEMBL262	Homo sapiens	INH	uM	0.017
	3253916	CHEMBL1111575	Inhibition of human recombinant GSK3-beta in presence of gamma[33P]ATP by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(Cl)c(-c3ccc(F)cc3)cc12	Non standard unit for type	CHEMBL1091082	=	INH	uM	0.016	CHEMBL262	Homo sapiens	INH	uM	0.016
	3253917	CHEMBL1111575	Inhibition of human recombinant GSK3-beta in presence of gamma[33P]ATP by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(Cl)c(-c3ccc(C)cc3)cc12	Non standard unit for type	CHEMBL1097694	=	INH	uM	0.012	CHEMBL262	Homo sapiens	INH	uM	0.012
	3253918	CHEMBL1111575	Inhibition of human recombinant GSK3-beta in presence of gamma[33P]ATP by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(Cl)c(-c3ccoc3)cc12	Non standard unit for type	CHEMBL1077218	=	INH	uM	0.011	CHEMBL262	Homo sapiens	INH	uM	0.011
	3253919	CHEMBL1111575	Inhibition of human recombinant GSK3-beta in presence of gamma[33P]ATP by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(Cl)c(-c3ccc(O)cc3)cc12	Non standard unit for type	CHEMBL1095366	=	INH	uM	0.008	CHEMBL262	Homo sapiens	INH	uM	0.008
	3253920	CHEMBL1111575	Inhibition of human recombinant GSK3-beta in presence of gamma[33P]ATP by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(Cl)c(-c3ccc(N)cc3)cc12	Non standard unit for type	CHEMBL1095041	=	INH	uM	0.007	CHEMBL262	Homo sapiens	INH	uM	0.007
	3253921	CHEMBL1111575	Inhibition of human recombinant GSK3-beta in presence of gamma[33P]ATP by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(Cl)c(-c3ccccc3)cc12	Non standard unit for type	CHEMBL1095040	=	INH	uM	0.006	CHEMBL262	Homo sapiens	INH	uM	0.006
	3253922	CHEMBL1111575	Inhibition of human recombinant GSK3-beta in presence of gamma[33P]ATP by scintillation proximity assay	B	CCCC(=O)Nc1n[nH]c2cc(-c3ccc(O)cc3)c(Br)cc12	Non standard unit for type	CHEMBL1093747	=	INH	uM	0.005	CHEMBL262	Homo sapiens	INH	uM	0.005
	3253923	CHEMBL1111575	Inhibition of human recombinant GSK3-beta in presence of gamma[33P]ATP by scintillation proximity assay	B	CCC(=O)Nc1n[nH]c2cc(Cl)ccc12	Non standard unit for type	CHEMBL1089605	=	INH	uM	0.44	CHEMBL262	Homo sapiens	INH	uM	0.44
	3253924	CHEMBL1111575	Inhibition of human recombinant GSK3-beta in presence of gamma[33P]ATP by scintillation proximity assay	B	O=C(O)CCC(=O)Nc1n[nH]c2cc(Cl)ccc12	Non standard unit for type	CHEMBL1084134	=	INH	uM	0.94	CHEMBL262	Homo sapiens	INH	uM	0.94
	3253934	CHEMBL1111594	Inhibition of human recombinant GSK3-beta by kinetic assay	B	CCCC(=O)Nc1n[nH]c2cc(-c3ccc(O)cc3)c(Br)cc12		CHEMBL1093747	=	IC50	nM	70.0	CHEMBL262	Homo sapiens	IC50	uM	0.07
	3253935	CHEMBL1111594	Inhibition of human recombinant GSK3-beta by kinetic assay	B	CCCC(=O)Nc1n[nH]c2cc(Cl)c(-c3ccccc3)cc12		CHEMBL1095040	=	IC50	nM	80.0	CHEMBL262	Homo sapiens	IC50	uM	0.08
	3253936	CHEMBL1111594	Inhibition of human recombinant GSK3-beta by kinetic assay	B	CCCC(=O)Nc1n[nH]c2cc(Cl)c(-c3ccc(O)cc3)cc12		CHEMBL1095366	=	IC50	nM	80.0	CHEMBL262	Homo sapiens	IC50	uM	0.08
	3253937	CHEMBL1111594	Inhibition of human recombinant GSK3-beta by kinetic assay	B	CCCC(=O)Nc1n[nH]c2cc(Cl)c(-c3ccoc3)cc12		CHEMBL1077218	=	IC50	nM	30.0	CHEMBL262	Homo sapiens	IC50	uM	0.03
	3253938	CHEMBL1111594	Inhibition of human recombinant GSK3-beta by kinetic assay	B	CCCC(=O)Nc1n[nH]c2cc(Cl)c(-c3ccc(F)cc3)cc12		CHEMBL1091082	=	IC50	nM	130.0	CHEMBL262	Homo sapiens	IC50	uM	0.13
	3253939	CHEMBL1111594	Inhibition of human recombinant GSK3-beta by kinetic assay	B	CCCC(=O)Nc1n[nH]c2cc(-c3ccc(O)cc3)ccc12		CHEMBL1082237	=	IC50	nM	22000.0	CHEMBL262	Homo sapiens	IC50	uM	22.0
	3253940	CHEMBL1111594	Inhibition of human recombinant GSK3-beta by kinetic assay	B	CCCC(=O)Nc1n[nH]c2cc(-c3ccccc3)ccc12		CHEMBL1086174	=	IC50	nM	390.0	CHEMBL262	Homo sapiens	IC50	uM	0.39
	3253941	CHEMBL1111594	Inhibition of human recombinant GSK3-beta by kinetic assay	B	CCCC(=O)Nc1n[nH]c2cc(-c3cc(F)cc(F)c3)ccc12		CHEMBL1095038	=	IC50	nM	2700.0	CHEMBL262	Homo sapiens	IC50	uM	2.7
	3253942	CHEMBL1111594	Inhibition of human recombinant GSK3-beta by kinetic assay	B	CCCC(=O)Nc1n[nH]c2cc(-c3cccnc3)ccc12		CHEMBL1085918	=	IC50	nM	5900.0	CHEMBL262	Homo sapiens	IC50	uM	5.9
	3253947	CHEMBL1111593	Inhibition of GSK3-beta assessed as tau phosphorylation	B	O=C(Nc1ccccc1)Nc1n[nH]c2cc(Cl)c(-c3ccccc3)cc12		CHEMBL1092134	=	IC50	nM	270.0	CHEMBL262	Homo sapiens	IC50	nM	270.0
	3261236	CHEMBL1113457	Inhibition of GSK3-beta at 10 uM	B	O=C1OC(c2ccccc2)=N/C1=C\c1cccnc1		CHEMBL579387	=	Inhibition	%	9.0	CHEMBL262	Homo sapiens	INH	%	9.0
Not Determined	3261237	CHEMBL1113457	Inhibition of GSK3-beta at 10 uM	B	Cc1cccc(C2=N/C(=C\c3cccnc3)C(=O)O2)c1		CHEMBL1091786		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	3261238	CHEMBL1113457	Inhibition of GSK3-beta at 10 uM	B	O=C1OC(c2ccc(Cl)cc2)=N/C1=C\c1cccnc1		CHEMBL1091787	=	Inhibition	%	7.0	CHEMBL262	Homo sapiens	INH	%	7.0
	3261239	CHEMBL1113457	Inhibition of GSK3-beta at 10 uM	B	O=C1OC(/C=C/c2ccccc2)=N/C1=C\c1cccnc1		CHEMBL565286	=	Inhibition	%	3.0	CHEMBL262	Homo sapiens	INH	%	3.0
	3261240	CHEMBL1113457	Inhibition of GSK3-beta at 10 uM	B	O=C1OC(c2ccc(F)c(F)c2)=N/C1=C\c1cccnc1		CHEMBL1091764	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	INH	%	0.0
Not Determined	3261241	CHEMBL1113457	Inhibition of GSK3-beta at 10 uM	B	Cc1cc(C2=N/C(=C\c3cccnc3)C(=O)O2)ccc1Br		CHEMBL1091766		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	3261346	CHEMBL1105202	Inhibition of GSK3-beta at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2nccc(Nc3cccc(Br)c3)c2c1		CHEMBL1089524	=	Activity	%	89.0	CHEMBL262	Homo sapiens	Activity	%	89.0
	3261440	CHEMBL1105202	Inhibition of GSK3-beta at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL1088901	=	Activity	%	96.0	CHEMBL262	Homo sapiens	Activity	%	96.0
	3269095	CHEMBL1109955	Inhibition of GSK3-beta phosphorylation in human BT474 cells	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	=	IC50	nM	138.0	CHEMBL262	Homo sapiens	IC50	nM	138.0
	3269096	CHEMBL1109955	Inhibition of GSK3-beta phosphorylation in human BT474 cells	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CCN)cc21		CHEMBL1095624	=	IC50	nM	4000.0	CHEMBL262	Homo sapiens	IC50	nM	4000.0
	3269097	CHEMBL1109955	Inhibition of GSK3-beta phosphorylation in human BT474 cells	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN)cc21		CHEMBL1098241	=	IC50	nM	1020.0	CHEMBL262	Homo sapiens	IC50	nM	1020.0
	3269098	CHEMBL1109955	Inhibition of GSK3-beta phosphorylation in human BT474 cells	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CCCN)cc21		CHEMBL1097974	=	IC50	nM	13200.0	CHEMBL262	Homo sapiens	IC50	nM	13200.0
	3269099	CHEMBL1109955	Inhibition of GSK3-beta phosphorylation in human BT474 cells	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CNC)cc21		CHEMBL1098316	=	IC50	nM	303.0	CHEMBL262	Homo sapiens	IC50	nM	303.0
	3269100	CHEMBL1109955	Inhibition of GSK3-beta phosphorylation in human BT474 cells	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN(C)C)cc21		CHEMBL1099290	=	IC50	nM	375.0	CHEMBL262	Homo sapiens	IC50	nM	375.0
	3269101	CHEMBL1109955	Inhibition of GSK3-beta phosphorylation in human BT474 cells	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCN)cc21		CHEMBL1096291	=	IC50	nM	1140.0	CHEMBL262	Homo sapiens	IC50	nM	1140.0
	3269102	CHEMBL1109955	Inhibition of GSK3-beta phosphorylation in human BT474 cells	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	IC50	nM	2700.0	CHEMBL262	Homo sapiens	IC50	nM	2700.0
	3269103	CHEMBL1109955	Inhibition of GSK3-beta phosphorylation in human BT474 cells	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCCCN)cc21		CHEMBL1096636	=	IC50	nM	30000.0	CHEMBL262	Homo sapiens	IC50	nM	30000.0
	3269104	CHEMBL1109955	Inhibition of GSK3-beta phosphorylation in human BT474 cells	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCCN)cc21		CHEMBL1096292	=	IC50	nM	30000.0	CHEMBL262	Homo sapiens	IC50	nM	30000.0
	3269105	CHEMBL1109955	Inhibition of GSK3-beta phosphorylation in human BT474 cells	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21		CHEMBL1098943	=	IC50	nM	2600.0	CHEMBL262	Homo sapiens	IC50	nM	2600.0
	3269106	CHEMBL1109955	Inhibition of GSK3-beta phosphorylation in human BT474 cells	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](C)N)cc21		CHEMBL1098944	=	IC50	nM	400.0	CHEMBL262	Homo sapiens	IC50	nM	400.0
	3269107	CHEMBL1109955	Inhibition of GSK3-beta phosphorylation in human BT474 cells	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](C)N)cc21		CHEMBL1099281	=	IC50	nM	1210.0	CHEMBL262	Homo sapiens	IC50	nM	1210.0
	3269108	CHEMBL1109955	Inhibition of GSK3-beta phosphorylation in human BT474 cells	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	IC50	nM	1110.0	CHEMBL262	Homo sapiens	IC50	nM	1110.0
	3269109	CHEMBL1109955	Inhibition of GSK3-beta phosphorylation in human BT474 cells	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	IC50	nM	1040.0	CHEMBL262	Homo sapiens	IC50	nM	1040.0
	3269110	CHEMBL1109955	Inhibition of GSK3-beta phosphorylation in human BT474 cells	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)Cc3ccccc3)cc21		CHEMBL1098938	=	IC50	nM	80.0	CHEMBL262	Homo sapiens	IC50	nM	80.0
	3269111	CHEMBL1109955	Inhibition of GSK3-beta phosphorylation in human BT474 cells	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)Cc3ccccc3)cc21		CHEMBL1098939	=	IC50	nM	310.0	CHEMBL262	Homo sapiens	IC50	nM	310.0
	3269112	CHEMBL1109955	Inhibition of GSK3-beta phosphorylation in human BT474 cells	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21		CHEMBL1099276	=	IC50	nM	40.0	CHEMBL262	Homo sapiens	IC50	nM	40.0
	3269113	CHEMBL1109955	Inhibition of GSK3-beta phosphorylation in human BT474 cells	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@H](CN)c3ccccc3)cc21		CHEMBL1099296	=	IC50	nM	190.0	CHEMBL262	Homo sapiens	IC50	nM	190.0
	3269114	CHEMBL1109955	Inhibition of GSK3-beta phosphorylation in human BT474 cells	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CCN)c3ccccc3)cc21		CHEMBL1099297	=	IC50	nM	41.0	CHEMBL262	Homo sapiens	IC50	nM	41.0
	3269115	CHEMBL1109955	Inhibition of GSK3-beta phosphorylation in human BT474 cells	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@H](CCN)c3ccccc3)cc21		CHEMBL1099298	=	IC50	nM	1570.0	CHEMBL262	Homo sapiens	IC50	nM	1570.0
Not Active	3271940	CHEMBL1113764	Inhibition of GSK3-beta	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	3271941	CHEMBL1113764	Inhibition of GSK3-beta	B	COc1ccccc1/C=C1/C(=O)Nc2ccccc21		CHEMBL444673		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	3271942	CHEMBL1113764	Inhibition of GSK3-beta	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1F		CHEMBL1088391		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	3271943	CHEMBL1113764	Inhibition of GSK3-beta	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1[N+](=O)[O-]		CHEMBL1088392		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	3271944	CHEMBL1113764	Inhibition of GSK3-beta	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1S(=O)(=O)O		CHEMBL1088529		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	3271945	CHEMBL1113764	Inhibition of GSK3-beta	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccc2c(c1)OCO2		CHEMBL1086669		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	3271946	CHEMBL1113764	Inhibition of GSK3-beta	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1cc(F)cc(F)c1		CHEMBL1086670		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	3271947	CHEMBL1113764	Inhibition of GSK3-beta	B	NC(=O)Cc1ccc(/C=C2/C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL1086795		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	3271948	CHEMBL1113764	Inhibition of GSK3-beta	B	COc1ccc(/C=C2/C(=O)Nc3ccc(Cl)cc32)c(OC)c1OC		CHEMBL1086796		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	3271949	CHEMBL1113764	Inhibition of GSK3-beta	B	COc1cc(/C=C2/C(=O)Nc3ccc(Cl)cc32)cc(OC)c1OC		CHEMBL383871		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	3271950	CHEMBL1113764	Inhibition of GSK3-beta	B	COc1cc(OC)c(/C=C2/C(=O)Nc3ccc(Cl)cc32)c(OC)c1		CHEMBL1086939	<	Inhibition	%	20.0	CHEMBL262	Homo sapiens	INH	%	20.0
Not Active	3271951	CHEMBL1113764	Inhibition of GSK3-beta	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	3291456	CHEMBL1111955	Inhibition of GSK3-beta assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	3294617	CHEMBL1103929	Inhibition of GSK3-beta	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=O)c5cnn(-c6ccccc6)c5C(F)(F)F)cc4F)c3s2)c1		CHEMBL1094718	<	Inhibition	%	40.0	CHEMBL262	Homo sapiens	INH	%	40.0
	3304852	CHEMBL1120003	Inhibition of GSK3-beta	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Ki	nM	10000.0	CHEMBL262	Homo sapiens	Ki	uM	10.0
	3306934	CHEMBL1118058	Inhibition of GSK3-beta at 3 uM	B	O=C(Nc1cc2cc[nH]c(=O)c2cc1Cl)C(NC1CC1)c1ccccc1		CHEMBL1084106	=	Inhibition	%	103.0	CHEMBL262	Homo sapiens	INH	%	103.0
Not Active	3308375	CHEMBL1119648	Inhibition of GSK3-beta at 3 uM	B	CCCCn1c2ccc(C3CCCCO3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL1082829		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	3308376	CHEMBL1119648	Inhibition of GSK3-beta at 3 uM	B	CC(C)Cn1c2ccc(C3CCCCO3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL1084337		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	3316561	CHEMBL1120689	Inhibition of GSK3-beta	B	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cccc13)CN(C(=O)N1CCOCC1)CC2		CHEMBL178737	=	IC50	nM	1.3	CHEMBL262	Homo sapiens	IC50	nM	1.3
	3316783	CHEMBL1120342	Inhibition of GSK3-beta at 1 uM	B	O=C(Nc1cccc(-n2ccc3c(NC(=O)c4ccccc4)nccc32)c1)c1ccc(N2CCOCC2)c(C(F)(F)F)c1		CHEMBL1084450	=	Inhibition	%	4.0	CHEMBL262	Homo sapiens	INH	%	4.0
	3327238	CHEMBL1168286	Inhibition of GSK3-beta at 10 uM by HotSpot assay	B	CC(=O)Nc1cccc(-c2ccc(-c3ccnc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)n3)cn2)c1.Cl		CHEMBL1164847	<	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	3330411	CHEMBL1167772	Inhibition of GST-tagged full length GSK3-beta assessed as inhibition of ATP consumption after 60 mins by luminescence assay	B	Cn1cncc1CNC(=O)c1ccc2cc(-c3n[nH]cc3-c3ccccc3)[nH]c2c1		CHEMBL1164177	=	IC50	nM	540.0	CHEMBL262	Homo sapiens	IC50	uM	0.54
	3330412	CHEMBL1167772	Inhibition of GST-tagged full length GSK3-beta assessed as inhibition of ATP consumption after 60 mins by luminescence assay	B	Cn1nccc1CNC(=O)c1ccc2cc(-c3n[nH]cc3-c3ccccc3)[nH]c2c1		CHEMBL1164262	=	IC50	nM	1260.0	CHEMBL262	Homo sapiens	IC50	uM	1.26
	3330413	CHEMBL1167772	Inhibition of GST-tagged full length GSK3-beta assessed as inhibition of ATP consumption after 60 mins by luminescence assay	B	Cc1oncc1CNC(=O)c1ccc2cc(-c3n[nH]cc3-c3ccccc3)[nH]c2c1		CHEMBL1164264	=	IC50	nM	2290.0	CHEMBL262	Homo sapiens	IC50	uM	2.29
	3330414	CHEMBL1167772	Inhibition of GST-tagged full length GSK3-beta assessed as inhibition of ATP consumption after 60 mins by luminescence assay	B	CC(C)CN(C)C(=O)c1ccc2cc(-c3n[nH]cc3-c3ccccc3)[nH]c2c1		CHEMBL1164353	=	IC50	nM	6760.0	CHEMBL262	Homo sapiens	IC50	uM	6.76
Not Active	3330438	CHEMBL1167772	Inhibition of GST-tagged full length GSK3-beta assessed as inhibition of ATP consumption after 60 mins by luminescence assay	B	Cn1cncc1CNC(=O)c1ccc2cc(-c3cc(Cc4ccccc4)[nH]n3)[nH]c2c1		CHEMBL1164453		IC50			CHEMBL262	Homo sapiens	IC50		
Not Active	3330439	CHEMBL1167772	Inhibition of GST-tagged full length GSK3-beta assessed as inhibition of ATP consumption after 60 mins by luminescence assay	B	Cn1nccc1CNC(=O)c1ccc2cc(-c3cc(Cc4ccccc4)[nH]n3)[nH]c2c1		CHEMBL1165507		IC50			CHEMBL262	Homo sapiens	IC50		
Not Active	3330440	CHEMBL1167772	Inhibition of GST-tagged full length GSK3-beta assessed as inhibition of ATP consumption after 60 mins by luminescence assay	B	CC(C)CN(C)C(=O)c1ccc2cc(-c3cc(Cc4ccccc4)[nH]n3)[nH]c2c1		CHEMBL1164457		IC50			CHEMBL262	Homo sapiens	IC50		
	3331963	CHEMBL1169253	Inhibition of GSK3B at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	3333378	CHEMBL1169253	Inhibition of GSK3B at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	3334783	CHEMBL1169253	Inhibition of GSK3B at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	3336203	CHEMBL1169253	Inhibition of GSK3B at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	3337546	CHEMBL1169253	Inhibition of GSK3B at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	3337796	CHEMBL1169253	Inhibition of GSK3B at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	3339130	CHEMBL1169253	Inhibition of GSK3B at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	3340432	CHEMBL1169253	Inhibition of GSK3B at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	3340731	CHEMBL1169253	Inhibition of GSK3B at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	3342147	CHEMBL1169253	Inhibition of GSK3B at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	3344654	CHEMBL1168344	Inhibition of GSK3-beta assessed as inhibition of [33Pi] incorporation after 80 mins by microplate scintillation counting	B	CN1CCN(c2ccc(NC(=O)c3ccc4c(c3)/C(=C3/Nc5ccccc5C3=O)C(=O)N4)cc2)CC1		CHEMBL1164526	=	IC50	nM	100.0	CHEMBL262	Homo sapiens	IC50	uM	0.1
	3344691	CHEMBL1168112	Inhibition of GSK3-beta assessed as residual activity at 10 uM after 80 mins by microplate scintillation counting	B	CN1CCN(c2ccc(NC(=O)c3ccc4c(c3)/C(=C3/Nc5ccccc5C3=O)C(=O)N4)cc2)CC1		CHEMBL1164526	=	Activity	%	6.0	CHEMBL262	Homo sapiens	Activity	%	6.0
	3344692	CHEMBL1168113	Inhibition of GSK3-beta assessed as residual activity at 1 uM after 80 mins by microplate scintillation counting	B	CN1CCN(c2ccc(NC(=O)c3ccc4c(c3)/C(=C3/Nc5ccccc5C3=O)C(=O)N4)cc2)CC1		CHEMBL1164526	=	Activity	%	27.0	CHEMBL262	Homo sapiens	Activity	%	27.0
Not Active	3352219	CHEMBL1175399	Inhibition of GSK3-beta at 10 uM	B	CC(=O)c1cc(C(=O)N2CC(O)C2)c(Nc2ccc(I)cc2F)n1C		CHEMBL1170191		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	3352220	CHEMBL1175399	Inhibition of GSK3-beta at 10 uM	B	CC(=O)c1cc(C(=O)N2CC(N)C2)c(Nc2ccc(I)cc2F)n1C		CHEMBL1172521		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	3352221	CHEMBL1175399	Inhibition of GSK3-beta at 10 uM	B	CC(=O)c1cc(C(=O)N2CC[C@@H](O)C2)c(Nc2ccc(I)cc2F)n1C		CHEMBL1169631		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	3354406	CHEMBL1173991	Inhibition of GSK3-beta at 10 uM by mobility shift assay	B	c1ccc(-c2cnc3cnc(-c4cc[nH]n4)cn23)cc1		CHEMBL1170750	=	Inhibition	%	22.0	CHEMBL262	Homo sapiens	INH	%	22.0
	3354407	CHEMBL1173991	Inhibition of GSK3-beta at 10 uM by mobility shift assay	B	c1ccc(-c2cnc3cnc(-c4cn[nH]c4)cn23)cc1		CHEMBL1172464	=	Inhibition	%	54.0	CHEMBL262	Homo sapiens	INH	%	54.0
	3354408	CHEMBL1173991	Inhibition of GSK3-beta at 10 uM by mobility shift assay	B	c1ccc(-c2cnc3cnc(-c4ccncc4)cn23)cc1		CHEMBL1170317	=	Inhibition	%	80.0	CHEMBL262	Homo sapiens	INH	%	80.0
	3354409	CHEMBL1173991	Inhibition of GSK3-beta at 10 uM by mobility shift assay	B	c1n[nH]cc1-c1cnc2ncc(-c3cn[nH]c3)n2c1		CHEMBL1171532	=	Inhibition	%	31.0	CHEMBL262	Homo sapiens	INH	%	31.0
	3354410	CHEMBL1173991	Inhibition of GSK3-beta at 10 uM by mobility shift assay	B	Cn1cc(-c2cnc3ncc(-c4cn[nH]c4)cn23)cn1		CHEMBL1171533	=	Inhibition	%	53.0	CHEMBL262	Homo sapiens	INH	%	53.0
	3354411	CHEMBL1173991	Inhibition of GSK3-beta at 10 uM by mobility shift assay	B	c1cc(-c2cnc3ncc(-c4cn[nH]c4)cn23)n[nH]1		CHEMBL1171534	=	Inhibition	%	58.0	CHEMBL262	Homo sapiens	INH	%	58.0
	3354412	CHEMBL1173991	Inhibition of GSK3-beta at 10 uM by mobility shift assay	B	OCc1cccc(-c2cnc3ncc(-c4cn[nH]c4)cn23)c1		CHEMBL1171699	=	Inhibition	%	57.0	CHEMBL262	Homo sapiens	INH	%	57.0
	3354413	CHEMBL1173991	Inhibition of GSK3-beta at 10 uM by mobility shift assay	B	c1ccc2c(-c3cnc4cnc(-c5cn[nH]c5)cn34)c[nH]c2c1		CHEMBL1170126	=	Inhibition	%	87.0	CHEMBL262	Homo sapiens	INH	%	87.0
	3354414	CHEMBL1173991	Inhibition of GSK3-beta at 10 uM by mobility shift assay	B	NCc1ccc(-c2cn3c(-c4cn[nH]c4)cnc3cn2)cc1		CHEMBL1170747	=	Inhibition	%	17.0	CHEMBL262	Homo sapiens	INH	%	17.0
	3354415	CHEMBL1173991	Inhibition of GSK3-beta at 10 uM by mobility shift assay	B	OCc1cccc(-c2cn3c(-c4cn[nH]c4)cnc3cn2)c1		CHEMBL1170748	=	Inhibition	%	57.0	CHEMBL262	Homo sapiens	INH	%	57.0
	3354416	CHEMBL1173991	Inhibition of GSK3-beta at 10 uM by mobility shift assay	B	OCc1ccc(-c2cn3c(-c4cn[nH]c4)cnc3cn2)cc1		CHEMBL1170749	=	Inhibition	%	44.0	CHEMBL262	Homo sapiens	INH	%	44.0
	3354417	CHEMBL1173990	Inhibition of GSK3-beta at 10 uM by mobility shift assay	B	c1ccc(-c2cnc3cnc(-c4ccncc4)cn23)cc1		CHEMBL1170317	=	IC50	nM	3100.0	CHEMBL262	Homo sapiens	IC50	uM	3.1
	3354418	CHEMBL1173990	Inhibition of GSK3-beta at 10 uM by mobility shift assay	B	c1ccc2c(-c3cnc4cnc(-c5cn[nH]c5)cn34)c[nH]c2c1		CHEMBL1170126	=	IC50	nM	5900.0	CHEMBL262	Homo sapiens	IC50	uM	5.9
	3354934	CHEMBL1173991	Inhibition of GSK3-beta at 10 uM by mobility shift assay	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Inhibition	%	11.0	CHEMBL262	Homo sapiens	INH	%	11.0
	3358599	CHEMBL1174444	Inhibition of GSK3B at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	99.0	CHEMBL262	Homo sapiens	INH	%	99.0
	3359041	CHEMBL1174444	Inhibition of GSK3B at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	90.0	CHEMBL262	Homo sapiens	INH	%	90.0
	3370902	CHEMBL1211211	Inhibition of human GSK3-beta assessed as residual activity at 1 uM relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Activity	%	99.9	CHEMBL262	Homo sapiens	Activity	%	99.9
	3370903	CHEMBL1211211	Inhibition of human GSK3-beta assessed as residual activity at 1 uM relative to control	B	Cn1c(-c2ccc([N+](=O)[O-])cc2)nc2ncnc(N3CCCC3)c21		CHEMBL1210871	=	Activity	%	103.0	CHEMBL262	Homo sapiens	Activity	%	103.0
	3370904	CHEMBL1211211	Inhibition of human GSK3-beta assessed as residual activity at 1 uM relative to control	B	Cn1c(-c2ccc(Cl)cc2)nc2ncnc(N3CCCC3)c21		CHEMBL1210812	=	Activity	%	100.0	CHEMBL262	Homo sapiens	Activity	%	100.0
	3370905	CHEMBL1211211	Inhibition of human GSK3-beta assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3ncnc(NCc4ccccc4)c3n2C)cc1		CHEMBL1210811	=	Activity	%	101.0	CHEMBL262	Homo sapiens	Activity	%	101.0
	3370906	CHEMBL1211211	Inhibition of human GSK3-beta assessed as residual activity at 1 uM relative to control	B	Cn1c(-c2ccc([N+](=O)[O-])cc2)nc2ncnc(NCc3ccccc3)c21		CHEMBL1210810	=	Activity	%	102.0	CHEMBL262	Homo sapiens	Activity	%	102.0
	3370907	CHEMBL1211211	Inhibition of human GSK3-beta assessed as residual activity at 1 uM relative to control	B	COc1ccc(CNc2ncnc3nc(-c4cccc(F)c4)n(C)c23)cc1		CHEMBL1210809	=	Activity	%	101.0	CHEMBL262	Homo sapiens	Activity	%	101.0
	3370908	CHEMBL1211211	Inhibition of human GSK3-beta assessed as residual activity at 1 uM relative to control	B	COc1ccc(CNc2ncnc3nc(-c4ccc(Cl)cc4)n(C)c23)cc1		CHEMBL1210808	=	Activity	%	102.0	CHEMBL262	Homo sapiens	Activity	%	102.0
	3370909	CHEMBL1211211	Inhibition of human GSK3-beta assessed as residual activity at 1 uM relative to control	B	Cn1c(-c2cccc(F)c2)nc2c(NC(=O)C3CC3)ncnc21		CHEMBL1210727	=	Activity	%	100.0	CHEMBL262	Homo sapiens	Activity	%	100.0
	3370910	CHEMBL1211211	Inhibition of human GSK3-beta assessed as residual activity at 1 uM relative to control	B	Cn1c(-c2cccc(F)c2)nc2c(N3CCCC3)ncnc21		CHEMBL1210726	=	Activity	%	98.0	CHEMBL262	Homo sapiens	Activity	%	98.0
	3370911	CHEMBL1211211	Inhibition of human GSK3-beta assessed as residual activity at 1 uM relative to control	B	COc1ccc(CNc2ncnc3c2nc(-c2cccc(F)c2)n3C)cc1		CHEMBL1210725	=	Activity	%	101.0	CHEMBL262	Homo sapiens	Activity	%	101.0
	3370912	CHEMBL1211211	Inhibition of human GSK3-beta assessed as residual activity at 1 uM relative to control	B	Cn1c(-c2cccc(F)c2)nc2c(NCc3ccccc3)ncnc21		CHEMBL1210724	=	Activity	%	101.0	CHEMBL262	Homo sapiens	Activity	%	101.0
	3370913	CHEMBL1211211	Inhibition of human GSK3-beta assessed as residual activity at 1 uM relative to control	B	Cn1c(-c2ccccc2)nc2c(N3CCCC3)ncnc21		CHEMBL1210723	=	Activity	%	100.0	CHEMBL262	Homo sapiens	Activity	%	100.0
	3370914	CHEMBL1211211	Inhibition of human GSK3-beta assessed as residual activity at 1 uM relative to control	B	Cn1c(-c2ccccc2)nc2c(NCc3cccnc3)ncnc21		CHEMBL1210666	=	Activity	%	104.0	CHEMBL262	Homo sapiens	Activity	%	104.0
	3370915	CHEMBL1211211	Inhibition of human GSK3-beta assessed as residual activity at 1 uM relative to control	B	COc1ccc(CNc2ncnc3c2nc(-c2ccccc2)n3C)cc1		CHEMBL1210665	=	Activity	%	101.0	CHEMBL262	Homo sapiens	Activity	%	101.0
	3370916	CHEMBL1211211	Inhibition of human GSK3-beta assessed as residual activity at 1 uM relative to control	B	c1cncc(-c2nc3c(OCC4CCCCC4)ncnc3[nH]2)c1		CHEMBL1210664	=	Activity	%	74.0	CHEMBL262	Homo sapiens	Activity	%	74.0
	3370917	CHEMBL1211211	Inhibition of human GSK3-beta assessed as residual activity at 1 uM relative to control	B	c1ccc(-c2nc3c(OC4CCCC4)ncnc3[nH]2)cc1		CHEMBL1210662	=	Activity	%	82.0	CHEMBL262	Homo sapiens	Activity	%	82.0
	3370918	CHEMBL1211211	Inhibition of human GSK3-beta assessed as residual activity at 1 uM relative to control	B	CC(=O)Nc1ncnc2[nH]c(-c3ccccc3)nc12		CHEMBL1210601	=	Activity	%	68.0	CHEMBL262	Homo sapiens	Activity	%	68.0
	3370919	CHEMBL1211211	Inhibition of human GSK3-beta assessed as residual activity at 1 uM relative to control	B	O=C(Nc1ncnc2[nH]c(-c3ccccc3)nc12)C1CCCCN1		CHEMBL1210600	=	Activity	%	91.0	CHEMBL262	Homo sapiens	Activity	%	91.0
	3370920	CHEMBL1211211	Inhibition of human GSK3-beta assessed as residual activity at 1 uM relative to control	B	O=C(Nc1ncnc2[nH]c(-c3ccccc3)nc12)C1CCCN1		CHEMBL1210599	=	Activity	%	100.0	CHEMBL262	Homo sapiens	Activity	%	100.0
	3370921	CHEMBL1211211	Inhibition of human GSK3-beta assessed as residual activity at 1 uM relative to control	B	CCCCC(=O)Nc1ncnc2[nH]c(-c3ccccc3)nc12		CHEMBL1210409	=	Activity	%	63.0	CHEMBL262	Homo sapiens	Activity	%	63.0
	3370922	CHEMBL1211211	Inhibition of human GSK3-beta assessed as residual activity at 1 uM relative to control	B	CC(C)CC(=O)Nc1ncnc2[nH]c(-c3ccccc3)nc12		CHEMBL1210408	=	Activity	%	82.0	CHEMBL262	Homo sapiens	Activity	%	82.0
	3370923	CHEMBL1211211	Inhibition of human GSK3-beta assessed as residual activity at 1 uM relative to control	B	CC(C)C(=O)Nc1ncnc2[nH]c(-c3ccccc3)nc12		CHEMBL1210407	=	Activity	%	69.0	CHEMBL262	Homo sapiens	Activity	%	69.0
	3370924	CHEMBL1211211	Inhibition of human GSK3-beta assessed as residual activity at 1 uM relative to control	B	O=C(Nc1ncnc2[nH]c(-c3ccc4ccccc4c3)nc12)C1CC1		CHEMBL1210406	=	Activity	%	9.0	CHEMBL262	Homo sapiens	Activity	%	9.0
	3370925	CHEMBL1211211	Inhibition of human GSK3-beta assessed as residual activity at 1 uM relative to control	B	O=C(Nc1ncnc2[nH]c(-c3ccccc3)nc12)C1CC1		CHEMBL1210308	=	Activity	%	51.0	CHEMBL262	Homo sapiens	Activity	%	51.0
	3370926	CHEMBL1211211	Inhibition of human GSK3-beta assessed as residual activity at 1 uM relative to control	B	c1cncc(CNc2ncnc3[nH]c(-c4cccnc4)nc23)c1		CHEMBL1210306	=	Activity	%	72.0	CHEMBL262	Homo sapiens	Activity	%	72.0
	3370927	CHEMBL1211211	Inhibition of human GSK3-beta assessed as residual activity at 1 uM relative to control	B	c1ccc(-c2nc3c(NCc4cccnc4)ncnc3[nH]2)cc1		CHEMBL1210240	=	Activity	%	74.0	CHEMBL262	Homo sapiens	Activity	%	74.0
	3370928	CHEMBL1211211	Inhibition of human GSK3-beta assessed as residual activity at 1 uM relative to control	B	COc1ccc(CNc2ncnc3[nH]c(-c4cccnc4)nc23)cc1		CHEMBL1210239	=	Activity	%	99.0	CHEMBL262	Homo sapiens	Activity	%	99.0
	3370929	CHEMBL1211211	Inhibition of human GSK3-beta assessed as residual activity at 1 uM relative to control	B	COc1ccc(CNc2ncnc3[nH]c(-c4ccccc4)nc23)cc1		CHEMBL1210238	=	Activity	%	101.0	CHEMBL262	Homo sapiens	Activity	%	101.0
	3370930	CHEMBL1211211	Inhibition of human GSK3-beta assessed as residual activity at 1 uM relative to control	B	c1ccc(CNc2ncnc3[nH]c(-c4ccccc4)nc23)cc1		CHEMBL1210237	=	Activity	%	97.0	CHEMBL262	Homo sapiens	Activity	%	97.0
	3370931	CHEMBL1211211	Inhibition of human GSK3-beta assessed as residual activity at 1 uM relative to control	B	c1cncc(-c2nc3c(N4CCOCC4)ncnc3[nH]2)c1		CHEMBL1210173	=	Activity	%	94.0	CHEMBL262	Homo sapiens	Activity	%	94.0
	3370932	CHEMBL1211211	Inhibition of human GSK3-beta assessed as residual activity at 1 uM relative to control	B	CN(C)c1ncnc2[nH]c(-c3ccccc3)nc12		CHEMBL1210172	=	Activity	%	97.0	CHEMBL262	Homo sapiens	Activity	%	97.0
	3370933	CHEMBL1211211	Inhibition of human GSK3-beta assessed as residual activity at 1 uM relative to control	B	c1cncc(-c2nc3c(N4CCCC4)ncnc3[nH]2)c1		CHEMBL1210171	=	Activity	%	76.0	CHEMBL262	Homo sapiens	Activity	%	76.0
	3370963	CHEMBL1211219	Inhibition of human GSK3-beta assessed as residual activity at 10 uM relative to control	B	c1ccc(Nc2ncnc3[nH]c(-c4ccccc4)nc23)cc1		CHEMBL1210175	=	Activity	%	18.57	CHEMBL262	Homo sapiens	Activity	%	18.57
	3370964	CHEMBL1211219	Inhibition of human GSK3-beta assessed as residual activity at 10 uM relative to control	B	O=C(Nc1ncnc2[nH]c(-c3ccc4ccccc4c3)nc12)C1CC1		CHEMBL1210406	=	Activity	%	18.4	CHEMBL262	Homo sapiens	Activity	%	18.4
	3375335	CHEMBL1211213	Inhibition of human GSK3-beta	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	5.0	CHEMBL262	Homo sapiens	IC50	uM	0.005
	3375336	CHEMBL1211213	Inhibition of human GSK3-beta	B	CCCCC(=O)Nc1ncnc2[nH]c(-c3ccc4ccccc4c3)nc12		CHEMBL1210477	>	IC50	nM	20000.0	CHEMBL262	Homo sapiens	IC50	uM	20.0
	3375337	CHEMBL1211213	Inhibition of human GSK3-beta	B	CCCCC(=O)Nc1ncnc2[nH]c(-c3cccc(C#N)c3)nc12		CHEMBL1210476	=	IC50	nM	1220.0	CHEMBL262	Homo sapiens	IC50	uM	1.22
	3375338	CHEMBL1211213	Inhibition of human GSK3-beta	B	O=C(Nc1ncnc2[nH]c(-c3ccc4ccccc4c3)nc12)C1CC1		CHEMBL1210406	=	IC50	nM	169.0	CHEMBL262	Homo sapiens	IC50	uM	0.169
	3375339	CHEMBL1211213	Inhibition of human GSK3-beta	B	N#Cc1cccc(-c2nc3c(NC(=O)C4CC4)ncnc3[nH]2)c1		CHEMBL1210405	=	IC50	nM	781.0	CHEMBL262	Homo sapiens	IC50	uM	0.781
	3375340	CHEMBL1211213	Inhibition of human GSK3-beta	B	O=C(Nc1ncnc2[nH]c(-c3cccc(Cl)c3)nc12)C1CC1		CHEMBL1210310	=	IC50	nM	365.0	CHEMBL262	Homo sapiens	IC50	uM	0.365
	3375341	CHEMBL1211213	Inhibition of human GSK3-beta	B	N#Cc1cccc(-c2nc3c(Nc4ccccc4)ncnc3[nH]2)c1		CHEMBL1210236	=	IC50	nM	26.0	CHEMBL262	Homo sapiens	IC50	uM	0.026
	3375342	CHEMBL1211213	Inhibition of human GSK3-beta	B	c1ccc(Nc2ncnc3[nH]c(-c4ccccc4)nc23)cc1		CHEMBL1210175	=	IC50	nM	16.0	CHEMBL262	Homo sapiens	IC50	uM	0.016
Not Active	3398891	CHEMBL1219431	Inhibition of GSK3-beta	B	COc1oc(CCCCC(C)(C)O)c(C)c(=O)c1C		CHEMBL1215870		Activity			CHEMBL262	Homo sapiens	Activity		
Not Active	3398896	CHEMBL1219431	Inhibition of GSK3-beta	B	COc1oc(CCCCC(C)C)c(C)c(=O)c1C		CHEMBL1215876		Activity			CHEMBL262	Homo sapiens	Activity		
	3407706	CHEMBL1219766	Inhibition of GSK3B at 1 uM by radiometric method	B	CCOC(=O)CCc1c(/C=C2\C(=O)Nc3ccc(NS(=O)(=O)c4ccccc4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215218	=	Inhibition	%	47.0	CHEMBL262	Homo sapiens	INH	%	47.0
	3407707	CHEMBL1219766	Inhibition of GSK3B at 1 uM by radiometric method	B	CN(C)CCCc1c(/C=C2\C(=O)Nc3ccc(NS(=O)(=O)c4ccccc4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215346	=	Inhibition	%	24.0	CHEMBL262	Homo sapiens	INH	%	24.0
	3409013	CHEMBL1219840	Inhibition of GSK3-beta ( assessed as residual activity at 1 uM )	B	c1cc2c(N3CCNCC3)nc(-c3ccnc(NC4CCCCC4)c3)cc2cn1		CHEMBL1214998	=	Activity	%	3.0	CHEMBL262	Homo sapiens	Activity	%	3.0
	3409026	CHEMBL1219840	Inhibition of GSK3-beta ( assessed as residual activity at 1 uM )	B	CC(C)NC(=O)C1CCN(c2nc(-c3ccnc(NC4CCOCC4)c3)cc3cnccc23)CC1		CHEMBL1214857	=	Activity	%	38.0	CHEMBL262	Homo sapiens	Activity	%	38.0
	3410584	CHEMBL1228247	Inhibition of recombinant GSK3-beta after 15 mins	B	CN(C)CCNC(=O)c1ccc(-c2cnc3ccc(NCc4ccc(Cl)c(Cl)c4)nn23)cc1		CHEMBL588573	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	3410585	CHEMBL1228247	Inhibition of recombinant GSK3-beta after 15 mins	B	O=C(NCCN1CCCC1)c1ccc(-c2cnc3ccc(NCc4ccc(Cl)c(Cl)c4)nn23)cc1		CHEMBL1222474	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	3410586	CHEMBL1228247	Inhibition of recombinant GSK3-beta after 15 mins	B	O=C(NC[C@@H]1CCCN1)c1ccc(-c2cnc3ccc(NCc4ccc(Cl)c(Cl)c4)nn23)cc1		CHEMBL1222565	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	3410587	CHEMBL1228247	Inhibition of recombinant GSK3-beta after 15 mins	B	O=C(NC[C@@H]1CCCN1)c1ccc(-c2cnc3ccc(NCC4CC4)nn23)cc1		CHEMBL1222990	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	3410588	CHEMBL1228247	Inhibition of recombinant GSK3-beta after 15 mins	B	O=C(NC[C@@H]1CCCN1)c1ccc(-c2cnc3ccc(NCc4cccc(Cl)c4)nn23)cc1		CHEMBL1222992	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	3410589	CHEMBL1228247	Inhibition of recombinant GSK3-beta after 15 mins	B	CN(C)CCNC(=O)c1ccc(-c2cnc3ccc(NCC4CC4)nn23)cc1		CHEMBL1223203	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
Not Determined	3410590	CHEMBL1228247	Inhibition of recombinant GSK3-beta after 15 mins	B	CCN(CC)CCNC(=O)c1ccc(-c2cnc3ccc(NCC4CC4)nn23)cc1		CHEMBL1223204		IC50			CHEMBL262	Homo sapiens	IC50		
Not Determined	3410591	CHEMBL1228247	Inhibition of recombinant GSK3-beta after 15 mins	B	CC(CN(C)C)NC(=O)c1ccc(-c2cnc3ccc(NCC4CC4)nn23)cc1		CHEMBL1223207		IC50			CHEMBL262	Homo sapiens	IC50		
	3420218	CHEMBL1226912	Inhibition of GSK3-beta	B	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	=	IC50	nM	220.0	CHEMBL262	Homo sapiens	IC50	nM	220.0
	3443412	CHEMBL1244445	Inhibition of GSK3-beta at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	9.0	CHEMBL262	Homo sapiens	INH	%	9.0
	3443629	CHEMBL1244445	Inhibition of GSK3-beta at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	10.0	CHEMBL262	Homo sapiens	INH	%	10.0
	3444784	CHEMBL1244445	Inhibition of GSK3-beta at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	5.0	CHEMBL262	Homo sapiens	INH	%	5.0
	3445408	CHEMBL1244445	Inhibition of GSK3-beta at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	3.0	CHEMBL262	Homo sapiens	INH	%	3.0
	3445625	CHEMBL1244445	Inhibition of GSK3-beta at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	18.0	CHEMBL262	Homo sapiens	INH	%	18.0
	3445833	CHEMBL1244445	Inhibition of GSK3-beta at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	10.0	CHEMBL262	Homo sapiens	INH	%	10.0
	3446023	CHEMBL1244445	Inhibition of GSK3-beta at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	1.0	CHEMBL262	Homo sapiens	INH	%	1.0
	3446552	CHEMBL1249814	Inhibition of His-tagged human GSK3b expressed in Sf21 cells	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	IC50	nM	38.0	CHEMBL262	Homo sapiens	IC50	nM	38.0
	3446562	CHEMBL1249583	Inhibition of His-tagged human GSK3b expressed in Sf21 cells at 1 uM	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	Inhibition	%	5.0	CHEMBL262	Homo sapiens	INH	%	5.0
	3446586	CHEMBL1249583	Inhibition of His-tagged human GSK3b expressed in Sf21 cells at 1 uM	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Inhibition	%	89.0	CHEMBL262	Homo sapiens	INH	%	89.0
	3446611	CHEMBL1249535	Inhibition of His-tagged human GSK3b expressed in Sf21 cells at 20 uM	B	O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12		CHEMBL50	=	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	3446638	CHEMBL1249559	Inhibition of His-tagged human GSK3b expressed in Sf21 cells at 50 uM	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Inhibition	%	53.0	CHEMBL262	Homo sapiens	INH	%	53.0
	3446666	CHEMBL1249583	Inhibition of His-tagged human GSK3b expressed in Sf21 cells at 1 uM	B	COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C(C3=O)[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O		CHEMBL428496	=	Inhibition	%	85.0	CHEMBL262	Homo sapiens	INH	%	85.0
	3446692	CHEMBL1247623	Inhibition of His-tagged human GSK3b expressed in Sf21 cells at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Inhibition	%	61.0	CHEMBL262	Homo sapiens	INH	%	61.0
	3446716	CHEMBL1247623	Inhibition of His-tagged human GSK3b expressed in Sf21 cells at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Inhibition	%	66.0	CHEMBL262	Homo sapiens	INH	%	66.0
	3446740	CHEMBL1249559	Inhibition of His-tagged human GSK3b expressed in Sf21 cells at 50 uM	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Inhibition	%	101.0	CHEMBL262	Homo sapiens	INH	%	101.0
	3446765	CHEMBL1247623	Inhibition of His-tagged human GSK3b expressed in Sf21 cells at 10 uM	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	=	Inhibition	%	83.0	CHEMBL262	Homo sapiens	INH	%	83.0
	3446797	CHEMBL1247623	Inhibition of His-tagged human GSK3b expressed in Sf21 cells at 10 uM	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N		CHEMBL34704	=	Inhibition	%	105.0	CHEMBL262	Homo sapiens	INH	%	105.0
	3446824	CHEMBL1247623	Inhibition of His-tagged human GSK3b expressed in Sf21 cells at 10 uM	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Inhibition	%	38.0	CHEMBL262	Homo sapiens	INH	%	38.0
	3446851	CHEMBL1249535	Inhibition of His-tagged human GSK3b expressed in Sf21 cells at 20 uM	B	CC(=O)c1c(O)c(C)c(O)c(Cc2c(O)c3c(c(C(=O)/C=C/c4ccccc4)c2O)OC(C)(C)C=C3)c1O		CHEMBL34241	=	Inhibition	%	13.0	CHEMBL262	Homo sapiens	INH	%	13.0
	3446882	CHEMBL1249535	Inhibition of His-tagged human GSK3b expressed in Sf21 cells at 20 uM	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Inhibition	%	90.0	CHEMBL262	Homo sapiens	INH	%	90.0
	3447259	CHEMBL1247623	Inhibition of His-tagged human GSK3b expressed in Sf21 cells at 10 uM	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Inhibition	%	92.0	CHEMBL262	Homo sapiens	INH	%	92.0
	3447292	CHEMBL1247623	Inhibition of His-tagged human GSK3b expressed in Sf21 cells at 10 uM	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Inhibition	%	107.0	CHEMBL262	Homo sapiens	INH	%	107.0
	3447312	CHEMBL1249583	Inhibition of His-tagged human GSK3b expressed in Sf21 cells at 1 uM	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	3447336	CHEMBL1249583	Inhibition of His-tagged human GSK3b expressed in Sf21 cells at 1 uM	B	NCCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL270875	=	Inhibition	%	46.0	CHEMBL262	Homo sapiens	INH	%	46.0
	3447360	CHEMBL1249583	Inhibition of His-tagged human GSK3b expressed in Sf21 cells at 1 uM	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Inhibition	%	49.0	CHEMBL262	Homo sapiens	INH	%	49.0
	3447384	CHEMBL1249583	Inhibition of His-tagged human GSK3b expressed in Sf21 cells at 1 uM	B	CN1C(=O)C(c2c[nH]c3ccccc23)=C(c2c[nH]c3ccccc23)C1=O		CHEMBL291725	=	Inhibition	%	109.0	CHEMBL262	Homo sapiens	INH	%	109.0
	3447408	CHEMBL1249583	Inhibition of His-tagged human GSK3b expressed in Sf21 cells at 1 uM	B	Cn1cc(C2=C(c3cn(CCCN)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL269264	=	Inhibition	%	21.0	CHEMBL262	Homo sapiens	INH	%	21.0
	3447432	CHEMBL1249583	Inhibition of His-tagged human GSK3b expressed in Sf21 cells at 1 uM	B	Cn1cc(C2=C(c3c4n(c5ccccc35)CCC(CN)C4)C(=O)NC2=O)c2ccccc21		CHEMBL421565	=	Inhibition	%	42.0	CHEMBL262	Homo sapiens	INH	%	42.0
	3447456	CHEMBL1249583	Inhibition of His-tagged human GSK3b expressed in Sf21 cells at 1 uM	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Inhibition	%	33.0	CHEMBL262	Homo sapiens	INH	%	33.0
	3447480	CHEMBL1247623	Inhibition of His-tagged human GSK3b expressed in Sf21 cells at 10 uM	B	O=C1NCc2c1c1c3ccccc3[nH]c1c1[nH]c3ccccc3c21		CHEMBL16958	=	Inhibition	%	84.0	CHEMBL262	Homo sapiens	INH	%	84.0
	3447504	CHEMBL1247623	Inhibition of His-tagged human GSK3b expressed in Sf21 cells at 10 uM	B	CCCCCCOC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608532	=	Inhibition	%	39.0	CHEMBL262	Homo sapiens	INH	%	39.0
	3447530	CHEMBL1249583	Inhibition of His-tagged human GSK3b expressed in Sf21 cells at 1 uM	B	CC[C@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@@H]4O		CHEMBL1242366	=	Inhibition	%	83.0	CHEMBL262	Homo sapiens	INH	%	83.0
	3447551	CHEMBL1249829	Inhibition of GSK3-beta	B	NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c(Br)cc32)N1		CHEMBL361708	=	IC50	nM	10.0	CHEMBL262	Homo sapiens	IC50	uM	0.01
	3447552	CHEMBL1249829	Inhibition of GSK3-beta	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	IC50	nM	23.0	CHEMBL262	Homo sapiens	IC50	uM	0.023
	3447553	CHEMBL1249829	Inhibition of GSK3-beta	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	IC50	nM	4.0	CHEMBL262	Homo sapiens	IC50	uM	0.004
	3447554	CHEMBL1249829	Inhibition of GSK3-beta	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ncccc2N1		CHEMBL336961	=	IC50	nM	18.0	CHEMBL262	Homo sapiens	IC50	uM	0.018
	3447555	CHEMBL1249829	Inhibition of GSK3-beta	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	IC50	nM	22.0	CHEMBL262	Homo sapiens	IC50	uM	0.022
	3447556	CHEMBL1249829	Inhibition of GSK3-beta	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	IC50	nM	2000.0	CHEMBL262	Homo sapiens	IC50	uM	2.0
	3447557	CHEMBL1249829	Inhibition of GSK3-beta	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	IC50	nM	390.0	CHEMBL262	Homo sapiens	IC50	uM	0.39
	3447558	CHEMBL1249829	Inhibition of GSK3-beta	B	Nc1nc(NCCNc2ncc(-c3ncc[nH]3)c(-c3ccc(Cl)cc3Cl)n2)ccc1[N+](=O)[O-]		CHEMBL1080901	=	IC50	nM	0.58	CHEMBL262	Homo sapiens	IC50	uM	0.00058
	3447559	CHEMBL1249829	Inhibition of GSK3-beta	B	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	=	IC50	nM	7.0	CHEMBL262	Homo sapiens	IC50	uM	0.007
	3447560	CHEMBL1249829	Inhibition of GSK3-beta	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	IC50	nM	104.0	CHEMBL262	Homo sapiens	IC50	uM	0.104
	3447561	CHEMBL1249829	Inhibition of GSK3-beta	B	CCN1CCOCCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCOCC1		CHEMBL103055	=	IC50	nM	18.0	CHEMBL262	Homo sapiens	IC50	uM	0.018
	3447562	CHEMBL1249829	Inhibition of GSK3-beta	B	O=C1NC(=O)C2=C1c1cn(c3ncccc13)CCOCCOCCOCCOCCn1cc2c2cccnc21		CHEMBL337642	=	IC50	nM	34.0	CHEMBL262	Homo sapiens	IC50	uM	0.034
	3447563	CHEMBL1249829	Inhibition of GSK3-beta	B	O=C1NC(=O)C2=C1c1cn(c3ncccc13)CCCc1ccc(s1)CCCn1cc2c2cccnc21		CHEMBL1241659	=	IC50	nM	36.0	CHEMBL262	Homo sapiens	IC50	uM	0.036
	3447564	CHEMBL1249829	Inhibition of GSK3-beta	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	IC50	nM	190.0	CHEMBL262	Homo sapiens	IC50	uM	0.19
	3447565	CHEMBL1249829	Inhibition of GSK3-beta	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	IC50	nM	3.0	CHEMBL262	Homo sapiens	IC50	uM	0.003
	3447566	CHEMBL1249829	Inhibition of GSK3-beta	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	IC50	nM	160.0	CHEMBL262	Homo sapiens	IC50	uM	0.16
	3447567	CHEMBL1249829	Inhibition of GSK3-beta	B	Nc1nonc1-n1nnc(-c2n[nH]c(-c3ccncc3)n2)c1CN1CCCCC1		CHEMBL326705	=	IC50	nM	280.0	CHEMBL262	Homo sapiens	IC50	uM	0.28
	3447568	CHEMBL1249829	Inhibition of GSK3-beta	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	IC50	nM	30.0	CHEMBL262	Homo sapiens	IC50	uM	0.03
	3447569	CHEMBL1249829	Inhibition of GSK3-beta	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	IC50	nM	16.0	CHEMBL262	Homo sapiens	IC50	uM	0.016
	3447570	CHEMBL1249829	Inhibition of GSK3-beta	B	O=C(CCl)c1cc(Br)c(Br)s1		CHEMBL142711	=	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	uM	1.0
	3448023	CHEMBL1249702	Inhibition of human GSK3-beta activity at 10 uM by radiometric assay	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	INH	%	0.0
	3448099	CHEMBL1249702	Inhibition of human GSK3-beta activity at 10 uM by radiometric assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	INH	%	0.0
	3448449	CHEMBL1244860	Binding affinity to GSK3B	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	uM	10.0
	3448946	CHEMBL1244860	Binding affinity to GSK3B	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	1800.0	CHEMBL262	Homo sapiens	Kd	nM	1800.0
	3449682	CHEMBL1244860	Binding affinity to GSK3B	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	uM	10.0
	3449935	CHEMBL1244860	Binding affinity to GSK3B	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	uM	10.0
	3450092	CHEMBL1244860	Binding affinity to GSK3B	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	uM	10.0
	3450344	CHEMBL1244860	Binding affinity to GSK3B	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	uM	10.0
	3451010	CHEMBL1244860	Binding affinity to GSK3B	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	uM	10.0
	3462949	CHEMBL1251255	Inhibition of GSK-3-beta-mediated Wnt signaling in human ReNcell VM cells assessed as increase in accumulation of beta-casein at 3 uM after 2 hrs by ELISA relative to control	B	Cc1[nH]c2ccccc2c1C1=C(NCCc2ccc(F)cc2)C(=O)N(C)C1=O		CHEMBL1254896	=	Inhibition	%	27.0	CHEMBL262	Homo sapiens	INH	%	27.0
Not Active	3462950	CHEMBL1251255	Inhibition of GSK-3-beta-mediated Wnt signaling in human ReNcell VM cells assessed as increase in accumulation of beta-casein at 3 uM after 2 hrs by ELISA relative to control	B	CCOC(=O)C1=C(c2c(C)[nH]c3ccccc23)C(=O)N(C)C1=O		CHEMBL1254486		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	3462951	CHEMBL1251255	Inhibition of GSK-3-beta-mediated Wnt signaling in human ReNcell VM cells assessed as increase in accumulation of beta-casein at 3 uM after 2 hrs by ELISA relative to control	B	Cc1[nH]c2ccccc2c1C1=C(NCCc2ccc(O)cc2)C(=O)N(C)C1=O		CHEMBL1254986		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	3462952	CHEMBL1251255	Inhibition of GSK-3-beta-mediated Wnt signaling in human ReNcell VM cells assessed as increase in accumulation of beta-casein at 3 uM after 2 hrs by ELISA relative to control	B	Cc1[nH]c2ccccc2c1C1=C(NCCc2c[nH]c3ccccc23)C(=O)N(C)C1=O		CHEMBL1254985		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	3462953	CHEMBL1251255	Inhibition of GSK-3-beta-mediated Wnt signaling in human ReNcell VM cells assessed as increase in accumulation of beta-casein at 3 uM after 2 hrs by ELISA relative to control	B	Cc1[nH]c2ccccc2c1C1=C(N2CCN(c3ccccc3)CC2)C(=O)N(C)C1=O		CHEMBL1254897		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	3462954	CHEMBL1251255	Inhibition of GSK-3-beta-mediated Wnt signaling in human ReNcell VM cells assessed as increase in accumulation of beta-casein at 3 uM after 2 hrs by ELISA relative to control	B	Cc1[nH]c2ccccc2c1C1=C(N2CCOCC2)C(=O)N(C)C1=O		CHEMBL1254812		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	3462955	CHEMBL1251255	Inhibition of GSK-3-beta-mediated Wnt signaling in human ReNcell VM cells assessed as increase in accumulation of beta-casein at 3 uM after 2 hrs by ELISA relative to control	B	CCCCNC1=C(c2c(C)[nH]c3ccccc23)C(=O)N(CCCC)C1=O		CHEMBL1254811		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	3462956	CHEMBL1251255	Inhibition of GSK-3-beta-mediated Wnt signaling in human ReNcell VM cells assessed as increase in accumulation of beta-casein at 3 uM after 2 hrs by ELISA relative to control	B	CCCCNC1=C(c2c(C)[nH]c3ccccc23)C(=O)N(C)C1=O		CHEMBL1254810		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	3462957	CHEMBL1251255	Inhibition of GSK-3-beta-mediated Wnt signaling in human ReNcell VM cells assessed as increase in accumulation of beta-casein at 3 uM after 2 hrs by ELISA relative to control	B	Cc1[nH]c2ccccc2c1C1=C(N2CCCCC2)C(=O)N(C)C1=O		CHEMBL1254728		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	3462958	CHEMBL1251255	Inhibition of GSK-3-beta-mediated Wnt signaling in human ReNcell VM cells assessed as increase in accumulation of beta-casein at 3 uM after 2 hrs by ELISA relative to control	B	Cc1[nH]c2ccccc2c1C1=C(C(=O)N2CCN(c3ccccc3)CC2)C(=O)N(C)C1=O		CHEMBL1254727		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	3462959	CHEMBL1251255	Inhibition of GSK-3-beta-mediated Wnt signaling in human ReNcell VM cells assessed as increase in accumulation of beta-casein at 3 uM after 2 hrs by ELISA relative to control	B	Cc1[nH]c2ccccc2c1C1=C(C(=O)N2CCOCC2)C(=O)N(C)C1=O		CHEMBL1254644		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	3462960	CHEMBL1251255	Inhibition of GSK-3-beta-mediated Wnt signaling in human ReNcell VM cells assessed as increase in accumulation of beta-casein at 3 uM after 2 hrs by ELISA relative to control	B	CCCCNC(=O)C1=C(c2c(C)[nH]c3ccccc23)C(=O)N(CCCC)C1=O		CHEMBL1254643		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	3462961	CHEMBL1251255	Inhibition of GSK-3-beta-mediated Wnt signaling in human ReNcell VM cells assessed as increase in accumulation of beta-casein at 3 uM after 2 hrs by ELISA relative to control	B	CCCCNC(=O)C1=C(c2c(C)[nH]c3ccccc23)C(=O)N(C)C1=O		CHEMBL1254569		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	3462962	CHEMBL1251255	Inhibition of GSK-3-beta-mediated Wnt signaling in human ReNcell VM cells assessed as increase in accumulation of beta-casein at 3 uM after 2 hrs by ELISA relative to control	B	Cc1[nH]c2ccccc2c1C1=C(C(=O)N2CCCCC2)C(=O)N(C)C1=O		CHEMBL1254568		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	3462963	CHEMBL1251255	Inhibition of GSK-3-beta-mediated Wnt signaling in human ReNcell VM cells assessed as increase in accumulation of beta-casein at 3 uM after 2 hrs by ELISA relative to control	B	CCCCOC(=O)C1=C(c2c(C)[nH]c3ccccc23)C(=O)N(C)C1=O		CHEMBL1254487		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	3462964	CHEMBL1251256	Inhibition of GSK-3-beta-mediated Wnt signaling in human ReNcell VM cells assessed as increase in accumulation of beta-casein at 1 uM after 2 hrs by ELISA relative to control	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	3462965	CHEMBL1251255	Inhibition of GSK-3-beta-mediated Wnt signaling in human ReNcell VM cells assessed as increase in accumulation of beta-casein at 3 uM after 2 hrs by ELISA relative to control	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714	=	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
Not Active	3462966	CHEMBL1251255	Inhibition of GSK-3-beta-mediated Wnt signaling in human ReNcell VM cells assessed as increase in accumulation of beta-casein at 3 uM after 2 hrs by ELISA relative to control	B	CN1C(=O)C(NCCc2ccc(F)cc2)=C(c2c[nH]c3ccc(F)cc23)C1=O		CHEMBL1253977		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	3462967	CHEMBL1251255	Inhibition of GSK-3-beta-mediated Wnt signaling in human ReNcell VM cells assessed as increase in accumulation of beta-casein at 3 uM after 2 hrs by ELISA relative to control	B	COc1ccc2[nH]cc(C3=C(NCCc4ccc(F)cc4)C(=O)N(C)C3=O)c2c1		CHEMBL1253891		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	3462968	CHEMBL1251255	Inhibition of GSK-3-beta-mediated Wnt signaling in human ReNcell VM cells assessed as increase in accumulation of beta-casein at 3 uM after 2 hrs by ELISA relative to control	B	CN1C(=O)C(NCCc2ccc(F)cc2)=C(c2c[nH]c3ccccc23)C1=O		CHEMBL1253890		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	3462969	CHEMBL1251255	Inhibition of GSK-3-beta-mediated Wnt signaling in human ReNcell VM cells assessed as increase in accumulation of beta-casein at 3 uM after 2 hrs by ELISA relative to control	B	Cc1[nH]c2ccccc2c1C1=C(NCCc2ccc(F)c(F)c2)C(=O)N(C)C1=O		CHEMBL1253809		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	3462970	CHEMBL1251255	Inhibition of GSK-3-beta-mediated Wnt signaling in human ReNcell VM cells assessed as increase in accumulation of beta-casein at 3 uM after 2 hrs by ELISA relative to control	B	Cc1[nH]c2ccccc2c1C1=C(NCCc2ccccc2)C(=O)N(C)C1=O		CHEMBL1253808		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	3462971	CHEMBL1251255	Inhibition of GSK-3-beta-mediated Wnt signaling in human ReNcell VM cells assessed as increase in accumulation of beta-casein at 3 uM after 2 hrs by ELISA relative to control	B	Cc1[nH]c2ccccc2c1C1=C(NCCc2ccc(Cl)cc2)C(=O)N(C)C1=O		CHEMBL1255070		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	3462972	CHEMBL1251255	Inhibition of GSK-3-beta-mediated Wnt signaling in human ReNcell VM cells assessed as increase in accumulation of beta-casein at 3 uM after 2 hrs by ELISA relative to control	B	COc1ccc(CCNC2=C(c3c(C)[nH]c4ccccc34)C(=O)N(C)C2=O)cc1		CHEMBL1255069		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	3462973	CHEMBL1251259	Inhibition of GSK-3-beta-mediated Wnt signaling in human ReNcell VM cells assessed as increase in accumulation of beta-casein at up to 10 uM after 2 hrs by ELISA relative to control	B	Cc1[nH]c2ccccc2c1C1=C(NCCc2ccc(F)cc2)C(=O)N(C)C1=O		CHEMBL1254896		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	3462974	CHEMBL1251306	Inhibition of GSK3-beta after 30 mins by luminescence assay	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714	=	IC50	nM	92.0	CHEMBL262	Homo sapiens	IC50	nM	92.0
	3462975	CHEMBL1251306	Inhibition of GSK3-beta after 30 mins by luminescence assay	B	Cc1[nH]c2ccccc2c1C1=C(NCCc2ccc(F)cc2)C(=O)N(C)C1=O		CHEMBL1254896	=	IC50	nM	53.0	CHEMBL262	Homo sapiens	IC50	nM	53.0
	3462976	CHEMBL1251307	Inhibition of GSK3-beta in human ReNcell VM cells assessed as residual activity at 3 uM after 2 hrs by immunoprecipitation analysis relative to control	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714	=	Inhibition	%	22.0	CHEMBL262	Homo sapiens	INH	%	22.0
	3462977	CHEMBL1251307	Inhibition of GSK3-beta in human ReNcell VM cells assessed as residual activity at 3 uM after 2 hrs by immunoprecipitation analysis relative to control	B	Cc1[nH]c2ccccc2c1C1=C(NCCc2ccc(F)cc2)C(=O)N(C)C1=O		CHEMBL1254896	=	Inhibition	%	27.0	CHEMBL262	Homo sapiens	INH	%	27.0
Active	3462983	CHEMBL1251260	Inhibition of GSK-3-beta-mediated Wnt signaling in human ST14A cells assessed as increase in accumulation of beta-casein around nucleus after 6 hrs by microscopic analysis	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	3462984	CHEMBL1251260	Inhibition of GSK-3-beta-mediated Wnt signaling in human ST14A cells assessed as increase in accumulation of beta-casein around nucleus after 6 hrs by microscopic analysis	B	Cc1[nH]c2ccccc2c1C1=C(NCCc2ccc(F)cc2)C(=O)N(C)C1=O		CHEMBL1254896		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	3462985	CHEMBL1251310	Inhibition of GSK-3-beta-mediated Wnt signaling in human ReNcell VM cells transfected with TOPFlash assessed as increase of TCF activity at 3 uM after 24 hrs by luciferase assay relative to control	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	3462986	CHEMBL1251310	Inhibition of GSK-3-beta-mediated Wnt signaling in human ReNcell VM cells transfected with TOPFlash assessed as increase of TCF activity at 3 uM after 24 hrs by luciferase assay relative to control	B	Cc1[nH]c2ccccc2c1C1=C(NCCc2ccc(F)cc2)C(=O)N(C)C1=O		CHEMBL1254896		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	3462987	CHEMBL1251309	Inhibition of GSK-3-beta-mediated Wnt signaling in human ReNcell VM cells transfected with TOPFlash with pCAGGS-S33Y assessed as increase of TCF activity at 3 uM after 24 hrs by luciferase assay relative to control	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714	=	Inhibition	%	55.0	CHEMBL262	Homo sapiens	INH	%	55.0
	3462988	CHEMBL1251309	Inhibition of GSK-3-beta-mediated Wnt signaling in human ReNcell VM cells transfected with TOPFlash with pCAGGS-S33Y assessed as increase of TCF activity at 3 uM after 24 hrs by luciferase assay relative to control	B	Cc1[nH]c2ccccc2c1C1=C(NCCc2ccc(F)cc2)C(=O)N(C)C1=O	Outside typical range	CHEMBL1254896	=	Inhibition	%	270.0	CHEMBL262	Homo sapiens	INH	%	270.0
Not Active	3462991	CHEMBL1251261	Inhibition of GSK-3-beta-mediated Wnt signaling in human ReNcell VM cells assessed as increase in accumulation of beta-casein at <3 uM after 2 hrs by ELISA relative to control	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	3462992	CHEMBL1251261	Inhibition of GSK-3-beta-mediated Wnt signaling in human ReNcell VM cells assessed as increase in accumulation of beta-casein at <3 uM after 2 hrs by ELISA relative to control	B	Cc1[nH]c2ccccc2c1C1=C(NCCc2ccc(F)cc2)C(=O)N(C)C1=O		CHEMBL1254896		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	3463246	CHEMBL1252434	Inhibition of GSK3B at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	92.0	CHEMBL262	Homo sapiens	INH	%	92.0
	3463790	CHEMBL1252434	Inhibition of GSK3B at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	67.0	CHEMBL262	Homo sapiens	INH	%	67.0
	3464009	CHEMBL1252434	Inhibition of GSK3B at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	69.0	CHEMBL262	Homo sapiens	INH	%	69.0
	3471618	CHEMBL1250659	Inhibition of GSK3-beta	B	Cn1ccc2ncnc(Oc3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)c(F)c3)c21		CHEMBL1254007	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	nM	10000.0
	3504316	CHEMBL1260198	Inhibition of GSK3-beta	B	O=C(Nc1n[nH]c2cc(C(=O)N[C@H](CN3CCCC3)c3ccccc3)sc12)c1ccc(N2CCOCC2)cc1		CHEMBL1258913	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	3523907	CHEMBL1273645	Inhibition of GSK3-beta	B	CC(C)c1n[nH]c(Cl)c1-c1ccnc(Nc2ccc(N3CCC(N(C)C)CC3)cn2)n1		CHEMBL1272116	=	IC50	nM	9600.0	CHEMBL262	Homo sapiens	IC50	uM	9.6
	3523908	CHEMBL1273645	Inhibition of GSK3-beta	B	CC(C)c1n[nH]c(C(F)(F)F)c1-c1ccnc(Nc2ccc(N3CCC(N(C)C)CC3)cn2)n1		CHEMBL1272171	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	3525155	CHEMBL1274115	Inhibition of GSK3-beta at 1 uM	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL496862	=	Inhibition	%	82.0	CHEMBL262	Homo sapiens	INH	%	82.0
	3525185	CHEMBL1274115	Inhibition of GSK3-beta at 1 uM	B	O=C1Nc2ccccc2/C1=C(/Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL500435	=	Inhibition	%	1.0	CHEMBL262	Homo sapiens	INH	%	1.0
	3525215	CHEMBL1274115	Inhibition of GSK3-beta at 1 uM	B	CN(C)C(=O)c1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL1272078	=	Inhibition	%	5.0	CHEMBL262	Homo sapiens	INH	%	5.0
	3525245	CHEMBL1274115	Inhibition of GSK3-beta at 1 uM	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(CCN(C)C)S(C)(=O)=O)cc1)c1ccccc1		CHEMBL1272128	=	Inhibition	%	124.0	CHEMBL262	Homo sapiens	INH	%	124.0
	3525275	CHEMBL1274115	Inhibition of GSK3-beta at 1 uM	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL1272289	=	Inhibition	%	114.0	CHEMBL262	Homo sapiens	INH	%	114.0
	3525305	CHEMBL1274115	Inhibition of GSK3-beta at 1 uM	B	CCNCc1ccc(N/C(=C2\C(=O)Nc3cc(C(=O)N(C)CC)ccc32)c2ccccc2)cc1		CHEMBL1271471	=	Inhibition	%	56.0	CHEMBL262	Homo sapiens	INH	%	56.0
	3527006	CHEMBL1274136	Inhibition of GSK3-beta	B	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccccc1		CHEMBL1270230	=	IC50	nM	1390.0	CHEMBL262	Homo sapiens	IC50	uM	1.39
	3527012	CHEMBL1274168	Inhibition of GSK3-beta	B	NC(=O)c1cc(-c2ccncc2F)[nH]c1-c1ccccc1		CHEMBL1271441	<	IC50	nM	100.0	CHEMBL262	Homo sapiens	IC50	nM	100.0
	3527013	CHEMBL1274168	Inhibition of GSK3-beta	B	NC(=O)c1cc(-c2ccnc(Nc3ccccc3)n2)[nH]c1-c1ccccc1		CHEMBL1270324	<	IC50	nM	100.0	CHEMBL262	Homo sapiens	IC50	nM	100.0
	3556509	CHEMBL1285589	Inhibition of GSK3B at 1 uM	B	CN1C[C@@H]2C[C@H]1CN2c1cc(F)c(-c2ccnc3c(-c4cccc5[nH]ncc45)c(-c4ccncc4)nn23)c(F)c1		CHEMBL1276179	=	Inhibition	%	35.0	CHEMBL262	Homo sapiens	INH	%	35.0
	3603108	CHEMBL1291205	Inhibition of GSK3-beta at 10 uM	B	O=C(Cc1cccc2cnccc12)Nc1scnc1-c1cscn1		CHEMBL1288160	=	Inihibition	%	13.0	CHEMBL262	Homo sapiens	Inihibition	%	13.0
	5116436	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	O=C1NC(=O)/C(=C/c2ccc(OCc3ccccc3)c(OCc3ccccc3)c2)N1		CHEMBL1630431	=	IC50	nM	1378.0	CHEMBL262	Homo sapiens	IC50	nM	1378.0
Not Determined	5116437	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	COc1ccc2nc3c(=O)[nH]c(=O)nc-3n(C[C@@H](O)[C@@H](O)[C@@H](O)CO)c2c1		CHEMBL1630432		IC50			CHEMBL262	Homo sapiens	IC50		
Not Determined	5116438	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	COC(=O)C(=O)c1c(C(=O)OC)nc2n[nH]c(=N)n2c1-c1cccc([N+](=O)[O-])c1		CHEMBL1630433		IC50			CHEMBL262	Homo sapiens	IC50		
	5116439	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	Oc1ccc(Nc2ncnc3[nH]cnc23)cc1CN(CCCl)CCCl		CHEMBL1630434	=	IC50	nM	10.8	CHEMBL262	Homo sapiens	IC50	nM	10.8
Not Determined	5116440	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	COc1ccc([C@H]2c3cc4c(cc3OC(O)(CO)[C@H]2C(=O)O)OCO4)c(OC)c1		CHEMBL1630435		IC50			CHEMBL262	Homo sapiens	IC50		
	5116441	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	CSc1nc(N[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c(Cl)c(=O)[nH]1		CHEMBL1630436	=	IC50	nM	2400.0	CHEMBL262	Homo sapiens	IC50	nM	2400.0
Not Determined	5116442	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	COC(=O)c1cc(-c2ccc(N)cc2)c2c(=O)n(-c3ccccc3)[nH]c2c1		CHEMBL1630437		IC50			CHEMBL262	Homo sapiens	IC50		
	5116443	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	COc1ccc(-c2c3c(nc4nc(SCCc5ccccc5)nc(N)c24)CCCC3)cc1OC		CHEMBL1630438	=	IC50	nM	4700.0	CHEMBL262	Homo sapiens	IC50	nM	4700.0
Not Determined	5116444	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	COc1nc(N[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c(Cl)c(=O)[nH]1		CHEMBL1630439		IC50			CHEMBL262	Homo sapiens	IC50		
Not Determined	5116445	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	CN1C=NC([N+](=O)[O-])C1NCCN1CCNC1=O		CHEMBL1630440		IC50			CHEMBL262	Homo sapiens	IC50		
Not Determined	5116446	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	Nc1n[nH]c(Sc2ncccc2[N+](=O)[O-])n1		CHEMBL1486850		IC50			CHEMBL262	Homo sapiens	IC50		
Not Determined	5116447	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	N=C(N)NCCC[C@H]1NC(=O)[C@@H](Cc2ccc(O)cc2)NC1=O		CHEMBL1630441		IC50			CHEMBL262	Homo sapiens	IC50		
	5116448	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	COc1cc(/C=C2/NC(=O)NC2=O)cc(OC)c1OC		CHEMBL1630442	=	IC50	nM	214.0	CHEMBL262	Homo sapiens	IC50	nM	214.0
Not Determined	5116449	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	COc1cc(/C=C2\CCNC2=O)ccc1Oc1ccccc1		CHEMBL1630443		IC50			CHEMBL262	Homo sapiens	IC50		
Not Determined	5116450	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	COc1cc2c(cc1Cl)nc1c(=O)[nH]c(=O)nc-1n2CCN1CCCC1		CHEMBL1630444		IC50			CHEMBL262	Homo sapiens	IC50		
	5116451	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	O=C(O)CCN(CCC(=O)O)c1ccc(/C=C2\SC(=S)NC2=O)cc1		CHEMBL1630445	=	IC50	nM	263.0	CHEMBL262	Homo sapiens	IC50	nM	263.0
	5116452	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	COc1cc(-c2cc(-c3cc(C)cc(Cl)c3O)nc3ncnc(N)c23)ccc1O		CHEMBL1630446	=	IC50	nM	113.0	CHEMBL262	Homo sapiens	IC50	nM	113.0
Not Determined	5116453	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	COc1ccc(-c2c3c(nc4nc(SCC(=O)c5ccc(Br)cc5)nc(N)c24)CCCC3)cc1OC		CHEMBL1630447		IC50			CHEMBL262	Homo sapiens	IC50		
	5116454	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	COc1ccc(/C=C2\SC(=O)NC2=O)cc1S(=O)(=O)O		CHEMBL1630448	=	IC50	nM	537.0	CHEMBL262	Homo sapiens	IC50	nM	537.0
Not Determined	5116455	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	CNc1nnc(Sc2ncccc2[N+](=O)[O-])s1		CHEMBL1589102		IC50			CHEMBL262	Homo sapiens	IC50		
	5116456	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	COC(=O)C(=O)c1c(C(=O)OC)nc2n[nH]c(=N)n2c1-c1ccc(O)c(OC)c1		CHEMBL1630449	=	IC50	nM	2456.0	CHEMBL262	Homo sapiens	IC50	nM	2456.0
Not Determined	5116457	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	O=C1NC(N2CCC[C@H](CO)C2)=N/C1=C\c1ccccc1		CHEMBL1630450		IC50			CHEMBL262	Homo sapiens	IC50		
	5116458	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	COc1ccc(-c2cc(-c3ccc(F)cc3)[nH]c(=O)c2O)cc1		CHEMBL1630451	=	IC50	nM	325.0	CHEMBL262	Homo sapiens	IC50	nM	325.0
	5116459	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	Cc1ccc(Nc2nnc(-c3ccc([N+](=O)[O-])cc3)o2)cc1Cl		CHEMBL1630452	=	IC50	nM	17.0	CHEMBL262	Homo sapiens	IC50	nM	17.0
Not Determined	5116460	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1		CHEMBL1643		IC50			CHEMBL262	Homo sapiens	IC50		
Not Determined	5116461	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	COc1cc(/C=C2\NC(=O)NC2=O)ccc1OCC(=O)c1ccccc1		CHEMBL1290815		IC50			CHEMBL262	Homo sapiens	IC50		
	5116462	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	COc1cc(/C=C2\NC(=O)NC2=O)ccc1OCC(=O)C1CCOCC1		CHEMBL1630453	=	IC50	nM	1975.0	CHEMBL262	Homo sapiens	IC50	nM	1975.0
	5116463	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	O=C1NC(=O)/C(=C/c2cccc3c2OCO3)N1		CHEMBL1288549	=	IC50	nM	138.0	CHEMBL262	Homo sapiens	IC50	nM	138.0
Not Determined	5116464	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)CN(CCO)CO3)N1		CHEMBL1630454		IC50			CHEMBL262	Homo sapiens	IC50		
	5116465	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	COc1ccc(CCN2COc3c([C@@H](C)CCC=C(C)C)ccc(C)c3C2)cc1OC		CHEMBL1630455	=	IC50	nM	1270.0	CHEMBL262	Homo sapiens	IC50	nM	1270.0
Not Determined	5116466	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	CC(C)=CCC[C@H](C)c1ccc(C)c2c1OCN(CCCCCO)C2		CHEMBL1630456		IC50			CHEMBL262	Homo sapiens	IC50		
Not Determined	5116467	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	O=C1NC(=O)/C(=C/c2ccc(N(CCO)CCO)cc2)N1		CHEMBL1630457		IC50			CHEMBL262	Homo sapiens	IC50		
	5116468	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	O=C1NC(=O)/C(=C/c2ccc(/C=C3/NC(=O)NC3=O)cc2)N1		CHEMBL1630458	=	IC50	nM	2810.0	CHEMBL262	Homo sapiens	IC50	nM	2810.0
Not Determined	5116469	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	CCCCOc1ccc(/C=C2\NC(=O)NC2=O)cc1[N+](=O)[O-]		CHEMBL1630459		IC50			CHEMBL262	Homo sapiens	IC50		
	5116470	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	O[C@]12C=C(c3[nH]ccc4c5ccccc5nc3-4)[C@@H]3CCN(CCCC/C=C\CC1)C[C@@]31C[C@@H]3/C=C\CCCCN3[C@@H]21		CHEMBL326531	=	IC50	nM	8400.0	CHEMBL262	Homo sapiens	IC50	nM	8400.0
	5116471	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	c1ccc(Nc2nnc(-c3ccccc3)o2)cc1		CHEMBL1630460	=	IC50	nM	980.0	CHEMBL262	Homo sapiens	IC50	nM	980.0
	5116472	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	Clc1ccc(-c2nnc(Nc3ccccc3)o2)cc1		CHEMBL1630461	>	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	nM	1000.0
	5116473	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	FC(F)(F)c1ccc(-c2nnc(Nc3ccccc3)o2)cc1		CHEMBL1630462	=	IC50	nM	632.0	CHEMBL262	Homo sapiens	IC50	nM	632.0
	5116474	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	Cc1ccc(-c2nnc(Nc3ccccc3)o2)cc1		CHEMBL1444124	>	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	nM	1000.0
	5116475	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	CSc1ccc(-c2nnc(Nc3ccccc3)o2)cc1		CHEMBL1630463	>	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	nM	1000.0
	5116476	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	CS(=O)(=O)c1ccc(-c2nnc(Nc3ccccc3)o2)cc1		CHEMBL1630464	=	IC50	nM	439.0	CHEMBL262	Homo sapiens	IC50	nM	439.0
	5116477	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	CN(C)c1ccc(-c2nnc(Nc3ccccc3)o2)cc1		CHEMBL1630465	>	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	nM	1000.0
	5116478	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	N#Cc1ccc(-c2nnc(Nc3ccccc3)o2)cc1		CHEMBL1630466	=	IC50	nM	247.0	CHEMBL262	Homo sapiens	IC50	nM	247.0
	5116479	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	O=[N+]([O-])c1ccc(-c2nnc(Nc3ccccc3)o2)cc1		CHEMBL1630467	=	IC50	nM	209.0	CHEMBL262	Homo sapiens	IC50	nM	209.0
	5116480	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	COc1ccc(-c2nnc(Nc3ccccc3)o2)cc1		CHEMBL1630468	>	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	nM	1000.0
	5116481	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	Oc1ccc(-c2nnc(Nc3ccccc3)o2)cc1		CHEMBL1630469	>	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	nM	1000.0
	5116482	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	Clc1ccc(Nc2nnc(-c3ccccc3)o2)cc1		CHEMBL1630470	>	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	nM	1000.0
	5116483	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	Clc1ccc(Nc2nnc(-c3ccc(Cl)cc3)o2)cc1		CHEMBL1630471	>	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	nM	1000.0
	5116484	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	FC(F)(F)c1ccc(-c2nnc(Nc3ccc(Cl)cc3)o2)cc1		CHEMBL1630472	>	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	nM	1000.0
	5116485	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	Cc1ccc(-c2nnc(Nc3ccc(Cl)cc3)o2)cc1		CHEMBL1630473	>	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	nM	1000.0
	5116486	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	CSc1ccc(-c2nnc(Nc3ccc(Cl)cc3)o2)cc1		CHEMBL1630474	=	IC50	nM	855.0	CHEMBL262	Homo sapiens	IC50	nM	855.0
	5116487	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	CS(=O)(=O)c1ccc(-c2nnc(Nc3ccc(Cl)cc3)o2)cc1		CHEMBL1630475	=	IC50	nM	671.0	CHEMBL262	Homo sapiens	IC50	nM	671.0
	5116488	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	CN(C)c1ccc(-c2nnc(Nc3ccc(Cl)cc3)o2)cc1		CHEMBL1630476	>	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	nM	1000.0
	5116489	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	N#Cc1ccc(-c2nnc(Nc3ccc(Cl)cc3)o2)cc1		CHEMBL1630477	=	IC50	nM	719.0	CHEMBL262	Homo sapiens	IC50	nM	719.0
	5116490	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	O=[N+]([O-])c1ccc(-c2nnc(Nc3ccc(Cl)cc3)o2)cc1		CHEMBL1630478	=	IC50	nM	811.0	CHEMBL262	Homo sapiens	IC50	nM	811.0
	5116491	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	COc1ccc(-c2nnc(Nc3ccc(Cl)cc3)o2)cc1		CHEMBL1630479	>	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	nM	1000.0
	5116492	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	Oc1ccc(-c2nnc(Nc3ccc(Cl)cc3)o2)cc1		CHEMBL1630480	>	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	nM	1000.0
	5116493	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	COc1ccc(Nc2nnc(-c3ccccc3)o2)cc1		CHEMBL1630481	>	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	nM	1000.0
	5116494	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	COc1ccc(Nc2nnc(-c3ccc(Cl)cc3)o2)cc1		CHEMBL1630482	=	IC50	nM	534.0	CHEMBL262	Homo sapiens	IC50	nM	534.0
	5116495	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	COc1ccc(Nc2nnc(-c3ccc(C(F)(F)F)cc3)o2)cc1		CHEMBL1630483	=	IC50	nM	53.0	CHEMBL262	Homo sapiens	IC50	nM	53.0
	5116496	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	COc1ccc(Nc2nnc(-c3ccc(C)cc3)o2)cc1		CHEMBL1630484	=	IC50	nM	805.0	CHEMBL262	Homo sapiens	IC50	nM	805.0
	5116497	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	COc1ccc(Nc2nnc(-c3ccc(SC)cc3)o2)cc1		CHEMBL1630485	>	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	nM	1000.0
	5116498	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	COc1ccc(Nc2nnc(-c3ccc(S(C)(=O)=O)cc3)o2)cc1		CHEMBL1630486	=	IC50	nM	314.0	CHEMBL262	Homo sapiens	IC50	nM	314.0
	5116499	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	COc1ccc(Nc2nnc(-c3ccc(N(C)C)cc3)o2)cc1		CHEMBL1629721	>	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	nM	1000.0
	5116500	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	COc1ccc(Nc2nnc(-c3ccc(C#N)cc3)o2)cc1		CHEMBL1630487	=	IC50	nM	18.0	CHEMBL262	Homo sapiens	IC50	nM	18.0
	5116501	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	COc1ccc(Nc2nnc(-c3ccc([N+](=O)[O-])cc3)o2)cc1		CHEMBL1630488	=	IC50	nM	7.0	CHEMBL262	Homo sapiens	IC50	nM	7.0
	5116502	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	COc1ccc(Nc2nnc(-c3ccc(OC)cc3)o2)cc1		CHEMBL1630489	=	IC50	nM	662.0	CHEMBL262	Homo sapiens	IC50	nM	662.0
	5116503	CHEMBL1640851	Inhibition of recombinant GSK3-beta Z'-LYTE kinase assay kit method	B	O=[N+]([O-])c1ccc(Nc2nnc(-c3ccc([N+](=O)[O-])cc3)o2)cc1		CHEMBL1630490	=	IC50	nM	710.0	CHEMBL262	Homo sapiens	IC50	nM	710.0
	5116504	CHEMBL1640850	Inhibition of recombinant GSK3-beta at 10 uM by Z'-LYTE kinase assay kit method	B	O=C1NC(=O)/C(=C/c2ccc(OCc3ccccc3)c(OCc3ccccc3)c2)N1		CHEMBL1630431	=	Inhibition	%	71.5	CHEMBL262	Homo sapiens	INH	%	71.5
	5116505	CHEMBL1640850	Inhibition of recombinant GSK3-beta at 10 uM by Z'-LYTE kinase assay kit method	B	COc1ccc2nc3c(=O)[nH]c(=O)nc-3n(C[C@@H](O)[C@@H](O)[C@@H](O)CO)c2c1		CHEMBL1630432	=	Inhibition	%	33.9	CHEMBL262	Homo sapiens	INH	%	33.9
	5116506	CHEMBL1640850	Inhibition of recombinant GSK3-beta at 10 uM by Z'-LYTE kinase assay kit method	B	COC(=O)C(=O)c1c(C(=O)OC)nc2n[nH]c(=N)n2c1-c1cccc([N+](=O)[O-])c1		CHEMBL1630433	=	Inhibition	%	48.5	CHEMBL262	Homo sapiens	INH	%	48.5
	5116507	CHEMBL1640850	Inhibition of recombinant GSK3-beta at 10 uM by Z'-LYTE kinase assay kit method	B	Oc1ccc(Nc2ncnc3[nH]cnc23)cc1CN(CCCl)CCCl		CHEMBL1630434	=	Inhibition	%	100.0	CHEMBL262	Homo sapiens	INH	%	100.0
	5116508	CHEMBL1640850	Inhibition of recombinant GSK3-beta at 10 uM by Z'-LYTE kinase assay kit method	B	COc1ccc([C@H]2c3cc4c(cc3OC(O)(CO)[C@H]2C(=O)O)OCO4)c(OC)c1		CHEMBL1630435	=	Inhibition	%	49.4	CHEMBL262	Homo sapiens	INH	%	49.4
	5116509	CHEMBL1640850	Inhibition of recombinant GSK3-beta at 10 uM by Z'-LYTE kinase assay kit method	B	CSc1nc(N[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c(Cl)c(=O)[nH]1		CHEMBL1630436	=	Inhibition	%	71.3	CHEMBL262	Homo sapiens	INH	%	71.3
	5116510	CHEMBL1640850	Inhibition of recombinant GSK3-beta at 10 uM by Z'-LYTE kinase assay kit method	B	COC(=O)c1cc(-c2ccc(N)cc2)c2c(=O)n(-c3ccccc3)[nH]c2c1		CHEMBL1630437	=	Inhibition	%	34.8	CHEMBL262	Homo sapiens	INH	%	34.8
	5116511	CHEMBL1640850	Inhibition of recombinant GSK3-beta at 10 uM by Z'-LYTE kinase assay kit method	B	COc1ccc(-c2c3c(nc4nc(SCCc5ccccc5)nc(N)c24)CCCC3)cc1OC		CHEMBL1630438	=	Inhibition	%	75.0	CHEMBL262	Homo sapiens	INH	%	75.0
	5116512	CHEMBL1640850	Inhibition of recombinant GSK3-beta at 10 uM by Z'-LYTE kinase assay kit method	B	COc1nc(N[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c(Cl)c(=O)[nH]1		CHEMBL1630439	=	Inhibition	%	35.2	CHEMBL262	Homo sapiens	INH	%	35.2
	5116513	CHEMBL1640850	Inhibition of recombinant GSK3-beta at 10 uM by Z'-LYTE kinase assay kit method	B	CN1C=NC([N+](=O)[O-])C1NCCN1CCNC1=O		CHEMBL1630440	=	Inhibition	%	36.9	CHEMBL262	Homo sapiens	INH	%	36.9
	5116514	CHEMBL1640850	Inhibition of recombinant GSK3-beta at 10 uM by Z'-LYTE kinase assay kit method	B	Nc1n[nH]c(Sc2ncccc2[N+](=O)[O-])n1		CHEMBL1486850	=	Inhibition	%	47.6	CHEMBL262	Homo sapiens	INH	%	47.6
	5116515	CHEMBL1640850	Inhibition of recombinant GSK3-beta at 10 uM by Z'-LYTE kinase assay kit method	B	N=C(N)NCCC[C@H]1NC(=O)[C@@H](Cc2ccc(O)cc2)NC1=O		CHEMBL1630441	=	Inhibition	%	43.2	CHEMBL262	Homo sapiens	INH	%	43.2
	5116516	CHEMBL1640850	Inhibition of recombinant GSK3-beta at 10 uM by Z'-LYTE kinase assay kit method	B	COc1cc(/C=C2/NC(=O)NC2=O)cc(OC)c1OC		CHEMBL1630442	=	Inhibition	%	81.9	CHEMBL262	Homo sapiens	INH	%	81.9
	5116517	CHEMBL1640850	Inhibition of recombinant GSK3-beta at 10 uM by Z'-LYTE kinase assay kit method	B	COc1cc(/C=C2\CCNC2=O)ccc1Oc1ccccc1		CHEMBL1630443	=	Inhibition	%	45.4	CHEMBL262	Homo sapiens	INH	%	45.4
	5116518	CHEMBL1640850	Inhibition of recombinant GSK3-beta at 10 uM by Z'-LYTE kinase assay kit method	B	COc1cc2c(cc1Cl)nc1c(=O)[nH]c(=O)nc-1n2CCN1CCCC1		CHEMBL1630444	=	Inhibition	%	43.0	CHEMBL262	Homo sapiens	INH	%	43.0
	5116519	CHEMBL1640850	Inhibition of recombinant GSK3-beta at 10 uM by Z'-LYTE kinase assay kit method	B	O=C(O)CCN(CCC(=O)O)c1ccc(/C=C2\SC(=S)NC2=O)cc1		CHEMBL1630445	=	Inhibition	%	90.2	CHEMBL262	Homo sapiens	INH	%	90.2
	5116520	CHEMBL1640850	Inhibition of recombinant GSK3-beta at 10 uM by Z'-LYTE kinase assay kit method	B	COc1cc(-c2cc(-c3cc(C)cc(Cl)c3O)nc3ncnc(N)c23)ccc1O		CHEMBL1630446	=	Inhibition	%	100.0	CHEMBL262	Homo sapiens	INH	%	100.0
	5116521	CHEMBL1640850	Inhibition of recombinant GSK3-beta at 10 uM by Z'-LYTE kinase assay kit method	B	COc1ccc(-c2c3c(nc4nc(SCC(=O)c5ccc(Br)cc5)nc(N)c24)CCCC3)cc1OC		CHEMBL1630447	=	Inhibition	%	35.5	CHEMBL262	Homo sapiens	INH	%	35.5
	5116522	CHEMBL1640850	Inhibition of recombinant GSK3-beta at 10 uM by Z'-LYTE kinase assay kit method	B	COc1ccc(/C=C2\SC(=O)NC2=O)cc1S(=O)(=O)O		CHEMBL1630448	=	Inhibition	%	90.4	CHEMBL262	Homo sapiens	INH	%	90.4
	5116523	CHEMBL1640850	Inhibition of recombinant GSK3-beta at 10 uM by Z'-LYTE kinase assay kit method	B	CNc1nnc(Sc2ncccc2[N+](=O)[O-])s1		CHEMBL1589102	=	Inhibition	%	56.2	CHEMBL262	Homo sapiens	INH	%	56.2
	5116524	CHEMBL1640850	Inhibition of recombinant GSK3-beta at 10 uM by Z'-LYTE kinase assay kit method	B	COC(=O)C(=O)c1c(C(=O)OC)nc2n[nH]c(=N)n2c1-c1ccc(O)c(OC)c1		CHEMBL1630449	=	Inhibition	%	71.8	CHEMBL262	Homo sapiens	INH	%	71.8
	5116525	CHEMBL1640850	Inhibition of recombinant GSK3-beta at 10 uM by Z'-LYTE kinase assay kit method	B	O=C1NC(N2CCC[C@H](CO)C2)=N/C1=C\c1ccccc1		CHEMBL1630450	=	Inhibition	%	37.9	CHEMBL262	Homo sapiens	INH	%	37.9
	5116526	CHEMBL1640850	Inhibition of recombinant GSK3-beta at 10 uM by Z'-LYTE kinase assay kit method	B	COc1ccc(-c2cc(-c3ccc(F)cc3)[nH]c(=O)c2O)cc1		CHEMBL1630451	=	Inhibition	%	96.9	CHEMBL262	Homo sapiens	INH	%	96.9
	5116527	CHEMBL1640850	Inhibition of recombinant GSK3-beta at 10 uM by Z'-LYTE kinase assay kit method	B	Cc1ccc(Nc2nnc(-c3ccc([N+](=O)[O-])cc3)o2)cc1Cl		CHEMBL1630452	=	Inhibition	%	100.0	CHEMBL262	Homo sapiens	INH	%	100.0
	5116528	CHEMBL1640850	Inhibition of recombinant GSK3-beta at 10 uM by Z'-LYTE kinase assay kit method	B	NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1		CHEMBL1643	=	Inhibition	%	33.3	CHEMBL262	Homo sapiens	INH	%	33.3
	5116529	CHEMBL1640850	Inhibition of recombinant GSK3-beta at 10 uM by Z'-LYTE kinase assay kit method	B	COc1cc(/C=C2\NC(=O)NC2=O)ccc1OCC(=O)c1ccccc1		CHEMBL1290815	=	Inhibition	%	37.6	CHEMBL262	Homo sapiens	INH	%	37.6
	5116530	CHEMBL1640850	Inhibition of recombinant GSK3-beta at 10 uM by Z'-LYTE kinase assay kit method	B	COc1cc(/C=C2\NC(=O)NC2=O)ccc1OCC(=O)C1CCOCC1		CHEMBL1630453	=	Inhibition	%	75.5	CHEMBL262	Homo sapiens	INH	%	75.5
	5116531	CHEMBL1640850	Inhibition of recombinant GSK3-beta at 10 uM by Z'-LYTE kinase assay kit method	B	O=C1NC(=O)/C(=C/c2cccc3c2OCO3)N1		CHEMBL1288549	=	Inhibition	%	94.4	CHEMBL262	Homo sapiens	INH	%	94.4
	5116532	CHEMBL1640850	Inhibition of recombinant GSK3-beta at 10 uM by Z'-LYTE kinase assay kit method	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)CN(CCO)CO3)N1		CHEMBL1630454	=	Inhibition	%	45.5	CHEMBL262	Homo sapiens	INH	%	45.5
	5116533	CHEMBL1640850	Inhibition of recombinant GSK3-beta at 10 uM by Z'-LYTE kinase assay kit method	B	COc1ccc(CCN2COc3c([C@@H](C)CCC=C(C)C)ccc(C)c3C2)cc1OC		CHEMBL1630455	=	Inhibition	%	91.4	CHEMBL262	Homo sapiens	INH	%	91.4
	5116534	CHEMBL1640850	Inhibition of recombinant GSK3-beta at 10 uM by Z'-LYTE kinase assay kit method	B	CC(C)=CCC[C@H](C)c1ccc(C)c2c1OCN(CCCCCO)C2		CHEMBL1630456	=	Inhibition	%	33.1	CHEMBL262	Homo sapiens	INH	%	33.1
	5116535	CHEMBL1640850	Inhibition of recombinant GSK3-beta at 10 uM by Z'-LYTE kinase assay kit method	B	O=C1NC(=O)/C(=C/c2ccc(N(CCO)CCO)cc2)N1		CHEMBL1630457	=	Inhibition	%	42.2	CHEMBL262	Homo sapiens	INH	%	42.2
	5116536	CHEMBL1640850	Inhibition of recombinant GSK3-beta at 10 uM by Z'-LYTE kinase assay kit method	B	O=C1NC(=O)/C(=C/c2ccc(/C=C3/NC(=O)NC3=O)cc2)N1		CHEMBL1630458	=	Inhibition	%	89.9	CHEMBL262	Homo sapiens	INH	%	89.9
	5116537	CHEMBL1640850	Inhibition of recombinant GSK3-beta at 10 uM by Z'-LYTE kinase assay kit method	B	CCCCOc1ccc(/C=C2\NC(=O)NC2=O)cc1[N+](=O)[O-]		CHEMBL1630459	=	Inhibition	%	38.6	CHEMBL262	Homo sapiens	INH	%	38.6
	5116538	CHEMBL1640850	Inhibition of recombinant GSK3-beta at 10 uM by Z'-LYTE kinase assay kit method	B	O[C@]12C=C(c3[nH]ccc4c5ccccc5nc3-4)[C@@H]3CCN(CCCC/C=C\CC1)C[C@@]31C[C@@H]3/C=C\CCCCN3[C@@H]21		CHEMBL326531	=	Inhibition	%	76.8	CHEMBL262	Homo sapiens	INH	%	76.8
	5120133	CHEMBL1648801	Inhibition of GSK3B at 10 uM after 60 mins by TR-FRET assay	B	O=c1n(Cc2ccccn2)nc(-c2ccnc(NC3CCOCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644615	=	Inhibition	%	7.0	CHEMBL262	Homo sapiens	INH	%	7.0
	5120175	CHEMBL1648801	Inhibition of GSK3B at 10 uM after 60 mins by TR-FRET assay	B	O=c1n(Cc2ccncc2)nc(-c2ccnc(NC3CCCCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644642	=	Inhibition	%	13.0	CHEMBL262	Homo sapiens	INH	%	13.0
	5120183	CHEMBL1648801	Inhibition of GSK3B at 10 uM after 60 mins by TR-FRET assay	B	O=c1n(C2CCOCC2)nc(-c2ccnc(NC3CCCCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644639	=	Inhibition	%	15.0	CHEMBL262	Homo sapiens	INH	%	15.0
	5120225	CHEMBL1648801	Inhibition of GSK3B at 10 uM after 60 mins by TR-FRET assay	B	O=c1[nH]nc(-c2ccnc(NC3CCCCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644618	=	Inhibition	%	38.0	CHEMBL262	Homo sapiens	INH	%	38.0
	5120244	CHEMBL1648801	Inhibition of GSK3B at 10 uM after 60 mins by TR-FRET assay	B	O=c1[nH]nc(-c2ccnc(NC3CCOCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644620	=	Inhibition	%	73.0	CHEMBL262	Homo sapiens	INH	%	73.0
	5120256	CHEMBL1648801	Inhibition of GSK3B at 10 uM after 60 mins by TR-FRET assay	B	O=c1[nH]nc(-c2ccnc(NC3CCCOC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644619	=	Inhibition	%	81.0	CHEMBL262	Homo sapiens	INH	%	81.0
	5120270	CHEMBL1645980	Inhibition of human GSK3-beta at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	90.0	CHEMBL262	Homo sapiens	INH	%	90.0
	5120843	CHEMBL1646928	Inhibition of GSK3b at 10 uM	B	CC(C)(C)c1cc(C(=O)O)c(NC(=O)Nc2ccc3[nH]ncc3c2)s1		CHEMBL1641799	=	Inhibition	%	10.0	CHEMBL262	Homo sapiens	INH	%	10.0
	5132602	CHEMBL1648763	Inhibition of GSK3-beta assessed as residual activity at 10 uM	B	CN(C)C/C=C/C(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641990	=	Activity	%	78.0	CHEMBL262	Homo sapiens	Activity	%	78.0
	5133745	CHEMBL1648763	Inhibition of GSK3-beta assessed as residual activity at 10 uM	B	CN(C)CCCC(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641989	=	Activity	%	100.0	CHEMBL262	Homo sapiens	Activity	%	100.0
	5133926	CHEMBL1648763	Inhibition of GSK3-beta assessed as residual activity at 10 uM	B	CN1CCN(CCC(=O)Nc2ccc3c(C#N)cnc(Nc4cccc(Br)c4)c3c2)CC1		CHEMBL1641992	=	Activity	%	100.0	CHEMBL262	Homo sapiens	Activity	%	100.0
	5140503	CHEMBL1646784	Inhibition of GSK3b at 1 uM	B	CC(C)(C)c1cc(C(=O)O)c(NC(=O)Nc2ccc3[nH]ncc3c2)s1		CHEMBL1641799	=	Inhibition	%	10.0	CHEMBL262	Homo sapiens	INH	%	10.0
	5146710	CHEMBL1657318	Inhibition of GSK3-beta	B	CC(C)(O)C(=O)N1CCN(c2ccc(C(F)(F)F)c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL1650951	=	IC50	nM	3.0	CHEMBL262	Homo sapiens	IC50	nM	3.0
	5152481	CHEMBL1656526	Inhibition of GSK3-beta by TR-FRET based LanthaScreen assay	B	COc1cc(O)c2c(c1)CCC[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL2012519	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	5152506	CHEMBL1656526	Inhibition of GSK3-beta by TR-FRET based LanthaScreen assay	B	COc1cc(O)c2c(c1)CCC[C@H](O)CC(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1651521	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	5191395	CHEMBL1664054	Inhibition of GSK3b at 1 uM	B	COc1cc2nc(-c3cc(F)ccc3O)nc(N[C@@H]3CNC[C@H]3C(C)(C)O)c2cc1OC		CHEMBL1236782	=	Inhibition	%	27.0	CHEMBL262	Homo sapiens	INH	%	27.0
	5191396	CHEMBL1664054	Inhibition of GSK3b at 1 uM	B	CC(C)(O)[C@@H]1CNC[C@H]1Nc1nc(-c2cc(-c3cc[nH]n3)ccc2O)nc2ccccc12		CHEMBL1650131	=	Inhibition	%	47.0	CHEMBL262	Homo sapiens	INH	%	47.0
	5201768	CHEMBL1669884	Inhibition of GSK3-beta by luminescent assay	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	IC50	nM	90.0	CHEMBL262	Homo sapiens	IC50	uM	0.09
	5201769	CHEMBL1669884	Inhibition of GSK3-beta by luminescent assay	B	O=C1OCC(Cc2ccc(O)cc2)=C1c1ccc(O)cc1		CHEMBL1669585	=	IC50	nM	780.0	CHEMBL262	Homo sapiens	IC50	uM	0.78
	5201770	CHEMBL1669884	Inhibition of GSK3-beta by luminescent assay	B	O=C1OCC(Cc2ccc(O)c(O)c2)=C1c1ccc(O)cc1		CHEMBL1669586	=	IC50	nM	670.0	CHEMBL262	Homo sapiens	IC50	uM	0.67
	5201771	CHEMBL1669884	Inhibition of GSK3-beta by luminescent assay	B	O=C1OCC(Cc2ccc(O)cc2)=C1c1cc(O)cc(O)c1		CHEMBL1669587	=	IC50	nM	4080.0	CHEMBL262	Homo sapiens	IC50	uM	4.08
	5201772	CHEMBL1669884	Inhibition of GSK3-beta by luminescent assay	B	O=C1OCC(Cc2ccc(O)c(O)c2)=C1c1cc(O)cc(O)c1		CHEMBL1669588	=	IC50	nM	2260.0	CHEMBL262	Homo sapiens	IC50	uM	2.26
	5203068	CHEMBL1670832	Inhibition of human recombinant GSK3-beta in cell free system after 90 mins	B	COc1cc(O)c2c(c1)/C=C/C[C@@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1668411	=	IC50	nM	18000.0	CHEMBL262	Homo sapiens	IC50	uM	18.0
	5203069	CHEMBL1670832	Inhibition of human recombinant GSK3-beta in cell free system after 90 mins	B	COc1cc(O)c2c(c1)/C=C/CCCC(=O)/C=C/C[C@H](C)OC2=O		CHEMBL1668418	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
Not Active	5239586	CHEMBL1686872	Inhibition of GSK3-beta up to 10 uM	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	5240071	CHEMBL1685403	Inhibition of GSK3-beta after 1 hr	B	CCCc1cn(-c2ccc3[nH]ncc3c2)nn1		CHEMBL1682335	=	Ki	nM	2026.0	CHEMBL262	Homo sapiens	Ki	uM	2.026
	5240072	CHEMBL1685403	Inhibition of GSK3-beta after 1 hr	B	COCc1cn(-c2ccc3[nH]ncc3c2)nn1		CHEMBL1682336	>	Ki	nM	5450.0	CHEMBL262	Homo sapiens	Ki	uM	5.45
	5240073	CHEMBL1685403	Inhibition of GSK3-beta after 1 hr	B	OCCCc1cn(-c2ccc3[nH]ncc3c2)nn1		CHEMBL1682337	=	Ki	nM	5216.0	CHEMBL262	Homo sapiens	Ki	uM	5.216
	5240074	CHEMBL1685403	Inhibition of GSK3-beta after 1 hr	B	c1cc2[nH]ncc2cc1-n1cc(C2CC2)nn1		CHEMBL1682338	=	Ki	nM	3466.0	CHEMBL262	Homo sapiens	Ki	uM	3.466
	5240075	CHEMBL1685403	Inhibition of GSK3-beta after 1 hr	B	c1cc2[nH]ncc2cc1-n1cc(C2CCCC2)nn1		CHEMBL1682339	=	Ki	nM	1298.0	CHEMBL262	Homo sapiens	Ki	uM	1.298
	5240076	CHEMBL1685403	Inhibition of GSK3-beta after 1 hr	B	c1cc2[nH]ncc2cc1-n1cc(CC2CCCCC2)nn1		CHEMBL1682340	=	Ki	nM	891.0	CHEMBL262	Homo sapiens	Ki	uM	0.891
	5240077	CHEMBL1685403	Inhibition of GSK3-beta after 1 hr	B	c1ccc(Cc2cn(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682341	=	Ki	nM	542.0	CHEMBL262	Homo sapiens	Ki	uM	0.542
	5240078	CHEMBL1685403	Inhibition of GSK3-beta after 1 hr	B	c1ccc(CCc2cn(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682342	=	Ki	nM	446.0	CHEMBL262	Homo sapiens	Ki	uM	0.446
	5240079	CHEMBL1685403	Inhibition of GSK3-beta after 1 hr	B	c1ccc(CCCc2cn(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682343	=	Ki	nM	528.0	CHEMBL262	Homo sapiens	Ki	uM	0.528
	5240080	CHEMBL1685403	Inhibition of GSK3-beta after 1 hr	B	c1cc2[nH]ncc2cc1-c1c[nH]nn1		CHEMBL1682344	=	Ki	nM	448.0	CHEMBL262	Homo sapiens	Ki	uM	0.448
	5240081	CHEMBL1685403	Inhibition of GSK3-beta after 1 hr	B	c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682345	=	Ki	nM	39.0	CHEMBL262	Homo sapiens	Ki	uM	0.039
	5240082	CHEMBL1685403	Inhibition of GSK3-beta after 1 hr	B	Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1682346	=	Ki	nM	265.0	CHEMBL262	Homo sapiens	Ki	uM	0.265
	5240083	CHEMBL1685403	Inhibition of GSK3-beta after 1 hr	B	Clc1ccccc1Cn1cc(-c2ccc3[nH]ncc3c2)nn1		CHEMBL1682347	=	Ki	nM	45.0	CHEMBL262	Homo sapiens	Ki	uM	0.045
	5240084	CHEMBL1685403	Inhibition of GSK3-beta after 1 hr	B	Clc1cccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c1		CHEMBL1682348	=	Ki	nM	23.0	CHEMBL262	Homo sapiens	Ki	uM	0.023
	5240085	CHEMBL1685403	Inhibition of GSK3-beta after 1 hr	B	Clc1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682349	=	Ki	nM	197.0	CHEMBL262	Homo sapiens	Ki	uM	0.197
	5240086	CHEMBL1685403	Inhibition of GSK3-beta after 1 hr	B	Fc1ccccc1Cn1cc(-c2ccc3[nH]ncc3c2)nn1		CHEMBL1682350	=	Ki	nM	91.0	CHEMBL262	Homo sapiens	Ki	uM	0.091
	5240087	CHEMBL1685403	Inhibition of GSK3-beta after 1 hr	B	Fc1cccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c1		CHEMBL1682351	=	Ki	nM	26.0	CHEMBL262	Homo sapiens	Ki	uM	0.026
	5240088	CHEMBL1685403	Inhibition of GSK3-beta after 1 hr	B	Fc1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682352	=	Ki	nM	70.0	CHEMBL262	Homo sapiens	Ki	uM	0.07
	5240089	CHEMBL1685403	Inhibition of GSK3-beta after 1 hr	B	Cc1cccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c1		CHEMBL1682353	=	Ki	nM	70.0	CHEMBL262	Homo sapiens	Ki	uM	0.07
	5240090	CHEMBL1685403	Inhibition of GSK3-beta after 1 hr	B	Clc1cccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c1Cl		CHEMBL1682354	=	Ki	nM	48.0	CHEMBL262	Homo sapiens	Ki	uM	0.048
	5240091	CHEMBL1685403	Inhibition of GSK3-beta after 1 hr	B	Clc1ccc(Cl)c(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c1		CHEMBL1682355	=	Ki	nM	16.0	CHEMBL262	Homo sapiens	Ki	uM	0.016
	5240092	CHEMBL1685403	Inhibition of GSK3-beta after 1 hr	B	Clc1cc(Cl)cc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c1		CHEMBL1682356	=	Ki	nM	28.0	CHEMBL262	Homo sapiens	Ki	uM	0.028
	5240093	CHEMBL1685403	Inhibition of GSK3-beta after 1 hr	B	c1ccc(Cc2cc(-c3ccc4[nH]ncc4c3)on2)cc1		CHEMBL1682357	=	Ki	nM	572.0	CHEMBL262	Homo sapiens	Ki	uM	0.572
	5240094	CHEMBL1685403	Inhibition of GSK3-beta after 1 hr	B	Nc1n[nH]c2ccc(-c3cc(Cc4ccccc4)no3)cc12		CHEMBL1682358	=	Ki	nM	450.0	CHEMBL262	Homo sapiens	Ki	uM	0.45
	5240095	CHEMBL1685403	Inhibition of GSK3-beta after 1 hr	B	CCCc1cc(-c2ccc3[nH]ncc3c2)on1		CHEMBL1682359	=	Ki	nM	2530.0	CHEMBL262	Homo sapiens	Ki	uM	2.53
	5240096	CHEMBL1685403	Inhibition of GSK3-beta after 1 hr	B	CNC(=O)c1cc(-c2ccc3[nH]ncc3c2)on1		CHEMBL1681795	=	Ki	nM	4272.0	CHEMBL262	Homo sapiens	Ki	uM	4.272
	5240097	CHEMBL1685403	Inhibition of GSK3-beta after 1 hr	B	c1cc2[nH]ncc2cc1-c1cc(CN2CCCCC2)no1		CHEMBL1682360	=	Ki	nM	3810.0	CHEMBL262	Homo sapiens	Ki	uM	3.81
	5241297	CHEMBL1685431	Inhibition of GSK3-beta	B	c1cnc2nc(-c3ccc4[nH]ncc4c3)cn2c1		CHEMBL1682540	=	Ki	nM	141.0	CHEMBL262	Homo sapiens	Ki	uM	0.141
	5241298	CHEMBL1685431	Inhibition of GSK3-beta	B	c1ccc(-c2c(-c3ccc4[nH]ncc4c3)nc3ncccn23)cc1		CHEMBL1682541	=	Ki	nM	10.0	CHEMBL262	Homo sapiens	Ki	uM	0.01
	5241299	CHEMBL1685431	Inhibition of GSK3-beta	B	Cc1nc(-c2ccc3[nH]ncc3c2)cs1		CHEMBL1682542	=	Ki	nM	2861.0	CHEMBL262	Homo sapiens	Ki	uM	2.861
	5241300	CHEMBL1685431	Inhibition of GSK3-beta	B	Nc1nc(-c2ccc3[nH]ncc3c2)cs1		CHEMBL1682543	=	Ki	nM	4472.0	CHEMBL262	Homo sapiens	Ki	uM	4.472
	5241301	CHEMBL1685431	Inhibition of GSK3-beta	B	CCNc1nc(-c2ccc3[nH]ncc3c2)cs1		CHEMBL1682544	=	Ki	nM	3925.0	CHEMBL262	Homo sapiens	Ki	uM	3.925
	5241302	CHEMBL1685431	Inhibition of GSK3-beta	B	c1ccc(Nc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682545	=	Ki	nM	289.0	CHEMBL262	Homo sapiens	Ki	uM	0.289
	5241303	CHEMBL1685431	Inhibition of GSK3-beta	B	c1ccc(CNc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682546	>	Ki	nM	5450.0	CHEMBL262	Homo sapiens	Ki	uM	5.45
	5241304	CHEMBL1685431	Inhibition of GSK3-beta	B	c1ccc(CCNc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682547	>	Ki	nM	5450.0	CHEMBL262	Homo sapiens	Ki	uM	5.45
	5241305	CHEMBL1685431	Inhibition of GSK3-beta	B	c1ccc(Nc2nc(-c3ccc4[nH]ncc4c3)c(-c3ccccc3)s2)cc1		CHEMBL1682548	>	Ki	nM	5450.0	CHEMBL262	Homo sapiens	Ki	uM	5.45
	5241306	CHEMBL1685431	Inhibition of GSK3-beta	B	c1ccc(CNc2nc(-c3ccc4[nH]ncc4c3)c(-c3ccccc3)s2)cc1		CHEMBL1682549	=	Ki	nM	3402.0	CHEMBL262	Homo sapiens	Ki	uM	3.402
	5241307	CHEMBL1685431	Inhibition of GSK3-beta	B	c1ccn2c(NC3CCCCC3)c(-c3ccc4[nH]ncc4c3)nc2c1		CHEMBL1682550	=	Ki	nM	2611.0	CHEMBL262	Homo sapiens	Ki	uM	2.611
Not Determined	5241308	CHEMBL1685431	Inhibition of GSK3-beta	B	c1cn2c(NC3CCCCC3)c(-c3ccc4[nH]ncc4c3)nc2cn1		CHEMBL1682551		Ki			CHEMBL262	Homo sapiens	Ki		
	5241309	CHEMBL1685431	Inhibition of GSK3-beta	B	c1cnc2nc(-c3ccc4[nH]ncc4c3)c(NC3CCCCC3)n2c1		CHEMBL1682552	=	Ki	nM	10.0	CHEMBL262	Homo sapiens	Ki	uM	0.01
	5241310	CHEMBL1685431	Inhibition of GSK3-beta	B	CC(C)Nc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12		CHEMBL1682553	=	Ki	nM	17.0	CHEMBL262	Homo sapiens	Ki	uM	0.017
	5241311	CHEMBL1685431	Inhibition of GSK3-beta	B	CCCCNc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12		CHEMBL1682554	=	Ki	nM	19.0	CHEMBL262	Homo sapiens	Ki	uM	0.019
	5241312	CHEMBL1685431	Inhibition of GSK3-beta	B	Clc1ccc(Nc2c(-c3ccc4[nH]ncc4c3)nc3ncccn23)cc1		CHEMBL1682555	=	Ki	nM	121.0	CHEMBL262	Homo sapiens	Ki	uM	0.121
	5241313	CHEMBL1685431	Inhibition of GSK3-beta	B	c1cn2c(NC3CCCCC3)c(-c3ccc4[nH]ncc4c3)nc2s1		CHEMBL1682556	=	Ki	nM	642.0	CHEMBL262	Homo sapiens	Ki	uM	0.642
	5241314	CHEMBL1685431	Inhibition of GSK3-beta	B	CN(C)CCn1cnc(-c2ccc(F)cc2)c1-c1ccc2[nH]ncc2c1		CHEMBL1682557	>	Ki	nM	5450.0	CHEMBL262	Homo sapiens	Ki	uM	5.45
	5241315	CHEMBL1685431	Inhibition of GSK3-beta	B	Fc1ccc(-c2ncn(CCN3CCOCC3)c2-c2ccc3[nH]ncc3c2)cc1		CHEMBL1682558	>	Ki	nM	5450.0	CHEMBL262	Homo sapiens	Ki	uM	5.45
	5241316	CHEMBL1685431	Inhibition of GSK3-beta	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccc3[nH]ncc3c2)cc1		CHEMBL1682559	>	Ki	nM	5450.0	CHEMBL262	Homo sapiens	Ki	uM	5.45
	5241317	CHEMBL1685431	Inhibition of GSK3-beta	B	Fc1ccc(-c2ncn(C3CCN(Cc4ccccc4)C3)c2-c2ccc3[nH]ncc3c2)cc1		CHEMBL1682560	>	Ki	nM	5450.0	CHEMBL262	Homo sapiens	Ki	uM	5.45
	5243713	CHEMBL1685676	Inhibition of GSK3-beta at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	97.0	CHEMBL262	Homo sapiens	INH	%	97.0
	5243821	CHEMBL1685925	Inhibition of GSK3-beta at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	95.0	CHEMBL262	Homo sapiens	INH	%	95.0
	5243934	CHEMBL1685676	Inhibition of GSK3-beta at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	97.0	CHEMBL262	Homo sapiens	INH	%	97.0
	5244042	CHEMBL1685925	Inhibition of GSK3-beta at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	69.0	CHEMBL262	Homo sapiens	INH	%	69.0
	5244915	CHEMBL1685676	Inhibition of GSK3-beta at 0.1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	102.0	CHEMBL262	Homo sapiens	INH	%	102.0
	5245023	CHEMBL1685925	Inhibition of GSK3-beta at 1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	83.0	CHEMBL262	Homo sapiens	INH	%	83.0
	5245174	CHEMBL1685676	Inhibition of GSK3-beta at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	104.0	CHEMBL262	Homo sapiens	INH	%	104.0
	5246004	CHEMBL1685925	Inhibition of GSK3-beta at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	69.0	CHEMBL262	Homo sapiens	INH	%	69.0
	5248897	CHEMBL1685181	Inhibition of human recombinant GSK3-beta expressed in baculovirus infected SF9 cells after 60 mins	B	Cc1cc(-c2cc(-c3ccccc3)[nH]c(=O)n2)ccc1O		CHEMBL501724	=	IC50	nM	17.2	CHEMBL262	Homo sapiens	IC50	nM	17.2
	5248898	CHEMBL1685181	Inhibition of human recombinant GSK3-beta expressed in baculovirus infected SF9 cells after 60 mins	B	Cn1c(-c2ccccc2)cc(-c2ccncn2)cc1=O		CHEMBL1682837	>	IC50	nM	894.0	CHEMBL262	Homo sapiens	IC50	nM	894.0
	5248899	CHEMBL1685181	Inhibition of human recombinant GSK3-beta expressed in baculovirus infected SF9 cells after 60 mins	B	CCN(CC)c1cc(-c2ccncn2)cc(=O)n1C		CHEMBL1682838	=	IC50	nM	50.1	CHEMBL262	Homo sapiens	IC50	nM	50.1
	5248900	CHEMBL1685181	Inhibition of human recombinant GSK3-beta expressed in baculovirus infected SF9 cells after 60 mins	B	Cn1c(N2CCCCC2)cc(-c2ccncn2)cc1=O		CHEMBL1682839	=	IC50	nM	62.0	CHEMBL262	Homo sapiens	IC50	nM	62.0
	5248901	CHEMBL1685181	Inhibition of human recombinant GSK3-beta expressed in baculovirus infected SF9 cells after 60 mins	B	Cn1c(N2CCOCC2)cc(-c2ccncn2)cc1=O		CHEMBL1682840	=	IC50	nM	233.0	CHEMBL262	Homo sapiens	IC50	nM	233.0
	5248902	CHEMBL1685181	Inhibition of human recombinant GSK3-beta expressed in baculovirus infected SF9 cells after 60 mins	B	Cn1c(NCCc2ccccc2)cc(-c2ccncn2)cc1=O		CHEMBL1682841	>	IC50	nM	592.0	CHEMBL262	Homo sapiens	IC50	nM	592.0
	5248903	CHEMBL1685181	Inhibition of human recombinant GSK3-beta expressed in baculovirus infected SF9 cells after 60 mins	B	COc1ccccc1CCNc1cc(-c2ccncn2)cc(=O)n1C		CHEMBL1682842	=	IC50	nM	17.4	CHEMBL262	Homo sapiens	IC50	nM	17.4
	5248904	CHEMBL1685181	Inhibition of human recombinant GSK3-beta expressed in baculovirus infected SF9 cells after 60 mins	B	COc1cccc(CCNc2cc(-c3ccncn3)cc(=O)n2C)c1		CHEMBL1682843	>	IC50	nM	401.0	CHEMBL262	Homo sapiens	IC50	nM	401.0
	5248905	CHEMBL1685181	Inhibition of human recombinant GSK3-beta expressed in baculovirus infected SF9 cells after 60 mins	B	COc1ccc(CCNc2cc(-c3ccncn3)cc(=O)n2C)cc1		CHEMBL1682844	>	IC50	nM	731.0	CHEMBL262	Homo sapiens	IC50	nM	731.0
	5248906	CHEMBL1685181	Inhibition of human recombinant GSK3-beta expressed in baculovirus infected SF9 cells after 60 mins	B	COc1ccccc1CNc1cc(-c2ccncn2)cc(=O)n1C		CHEMBL1682845	>	IC50	nM	252.0	CHEMBL262	Homo sapiens	IC50	nM	252.0
	5248907	CHEMBL1685181	Inhibition of human recombinant GSK3-beta expressed in baculovirus infected SF9 cells after 60 mins	B	COc1ccccc1CCCNc1cc(-c2ccncn2)cc(=O)n1C		CHEMBL1682846	>	IC50	nM	260.0	CHEMBL262	Homo sapiens	IC50	nM	260.0
	5248908	CHEMBL1685181	Inhibition of human recombinant GSK3-beta expressed in baculovirus infected SF9 cells after 60 mins	B	COc1ccccc1CCN(C)c1cc(-c2ccncn2)cc(=O)n1C		CHEMBL1682847	=	IC50	nM	133.0	CHEMBL262	Homo sapiens	IC50	nM	133.0
	5248909	CHEMBL1685181	Inhibition of human recombinant GSK3-beta expressed in baculovirus infected SF9 cells after 60 mins	B	COc1ccccc1C1CCCN(c2cc(-c3ccncn3)cc(=O)n2C)C1		CHEMBL1682848	=	IC50	nM	84.1	CHEMBL262	Homo sapiens	IC50	nM	84.1
	5248910	CHEMBL1685181	Inhibition of human recombinant GSK3-beta expressed in baculovirus infected SF9 cells after 60 mins	B	COc1ccccc1C1CCN(c2cc(-c3ccncn3)cc(=O)n2C)CC1		CHEMBL1682849	=	IC50	nM	51.0	CHEMBL262	Homo sapiens	IC50	nM	51.0
	5248911	CHEMBL1685181	Inhibition of human recombinant GSK3-beta expressed in baculovirus infected SF9 cells after 60 mins	B	Cn1c(N2CCC(O)(c3ccccc3)CC2)cc(-c2ccncn2)cc1=O		CHEMBL1682850	=	IC50	nM	8.5	CHEMBL262	Homo sapiens	IC50	nM	8.5
	5248912	CHEMBL1685181	Inhibition of human recombinant GSK3-beta expressed in baculovirus infected SF9 cells after 60 mins	B	COc1ccccc1[C@H]1CN(c2cc(-c3ccncn3)cc(=O)n2C)CCO1		CHEMBL1682851	=	IC50	nM	6.1	CHEMBL262	Homo sapiens	IC50	nM	6.1
	5248913	CHEMBL1685181	Inhibition of human recombinant GSK3-beta expressed in baculovirus infected SF9 cells after 60 mins	B	COc1ccccc1[C@@H]1CN(c2cc(-c3ccncn3)cc(=O)n2C)CCO1		CHEMBL1682852	=	IC50	nM	62.8	CHEMBL262	Homo sapiens	IC50	nM	62.8
	5248936	CHEMBL1685187	Inhibition of human GSK3-beta expressed in CHO AA8 cells co-expressing human tau protein after 2 hrs	B	Cc1cc(-c2cc(-c3ccccc3)[nH]c(=O)n2)ccc1O		CHEMBL501724	>	IC50	nM	5280.0	CHEMBL262	Homo sapiens	IC50	nM	5280.0
	5248937	CHEMBL1685187	Inhibition of human GSK3-beta expressed in CHO AA8 cells co-expressing human tau protein after 2 hrs	B	Cn1c(-c2ccccc2)cc(-c2ccncn2)cc1=O		CHEMBL1682837	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	nM	10000.0
	5248938	CHEMBL1685187	Inhibition of human GSK3-beta expressed in CHO AA8 cells co-expressing human tau protein after 2 hrs	B	CCN(CC)c1cc(-c2ccncn2)cc(=O)n1C		CHEMBL1682838	=	IC50	nM	2210.0	CHEMBL262	Homo sapiens	IC50	nM	2210.0
	5248939	CHEMBL1685187	Inhibition of human GSK3-beta expressed in CHO AA8 cells co-expressing human tau protein after 2 hrs	B	Cn1c(N2CCCCC2)cc(-c2ccncn2)cc1=O		CHEMBL1682839	>	IC50	nM	910.0	CHEMBL262	Homo sapiens	IC50	nM	910.0
	5248940	CHEMBL1685187	Inhibition of human GSK3-beta expressed in CHO AA8 cells co-expressing human tau protein after 2 hrs	B	Cn1c(N2CCOCC2)cc(-c2ccncn2)cc1=O		CHEMBL1682840	>	IC50	nM	5040.0	CHEMBL262	Homo sapiens	IC50	nM	5040.0
	5248941	CHEMBL1685187	Inhibition of human GSK3-beta expressed in CHO AA8 cells co-expressing human tau protein after 2 hrs	B	Cn1c(NCCc2ccccc2)cc(-c2ccncn2)cc1=O		CHEMBL1682841	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	nM	10000.0
	5248942	CHEMBL1685187	Inhibition of human GSK3-beta expressed in CHO AA8 cells co-expressing human tau protein after 2 hrs	B	COc1ccccc1CCNc1cc(-c2ccncn2)cc(=O)n1C		CHEMBL1682842	=	IC50	nM	800.0	CHEMBL262	Homo sapiens	IC50	nM	800.0
	5248943	CHEMBL1685187	Inhibition of human GSK3-beta expressed in CHO AA8 cells co-expressing human tau protein after 2 hrs	B	COc1cccc(CCNc2cc(-c3ccncn3)cc(=O)n2C)c1		CHEMBL1682843	>	IC50	nM	9000.0	CHEMBL262	Homo sapiens	IC50	nM	9000.0
	5248944	CHEMBL1685187	Inhibition of human GSK3-beta expressed in CHO AA8 cells co-expressing human tau protein after 2 hrs	B	COc1ccc(CCNc2cc(-c3ccncn3)cc(=O)n2C)cc1		CHEMBL1682844	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	nM	10000.0
	5248945	CHEMBL1685187	Inhibition of human GSK3-beta expressed in CHO AA8 cells co-expressing human tau protein after 2 hrs	B	COc1ccccc1CNc1cc(-c2ccncn2)cc(=O)n1C		CHEMBL1682845	>	IC50	nM	9000.0	CHEMBL262	Homo sapiens	IC50	nM	9000.0
	5248946	CHEMBL1685187	Inhibition of human GSK3-beta expressed in CHO AA8 cells co-expressing human tau protein after 2 hrs	B	COc1ccccc1CCCNc1cc(-c2ccncn2)cc(=O)n1C		CHEMBL1682846	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	nM	10000.0
	5248947	CHEMBL1685187	Inhibition of human GSK3-beta expressed in CHO AA8 cells co-expressing human tau protein after 2 hrs	B	COc1ccccc1CCN(C)c1cc(-c2ccncn2)cc(=O)n1C		CHEMBL1682847	=	IC50	nM	1690.0	CHEMBL262	Homo sapiens	IC50	nM	1690.0
	5248948	CHEMBL1685187	Inhibition of human GSK3-beta expressed in CHO AA8 cells co-expressing human tau protein after 2 hrs	B	COc1ccccc1C1CCCN(c2cc(-c3ccncn3)cc(=O)n2C)C1		CHEMBL1682848	=	IC50	nM	2320.0	CHEMBL262	Homo sapiens	IC50	nM	2320.0
	5248949	CHEMBL1685187	Inhibition of human GSK3-beta expressed in CHO AA8 cells co-expressing human tau protein after 2 hrs	B	COc1ccccc1C1CCN(c2cc(-c3ccncn3)cc(=O)n2C)CC1		CHEMBL1682849	=	IC50	nM	3210.0	CHEMBL262	Homo sapiens	IC50	nM	3210.0
	5248950	CHEMBL1685187	Inhibition of human GSK3-beta expressed in CHO AA8 cells co-expressing human tau protein after 2 hrs	B	Cn1c(N2CCC(O)(c3ccccc3)CC2)cc(-c2ccncn2)cc1=O		CHEMBL1682850	=	IC50	nM	610.0	CHEMBL262	Homo sapiens	IC50	nM	610.0
	5248951	CHEMBL1685187	Inhibition of human GSK3-beta expressed in CHO AA8 cells co-expressing human tau protein after 2 hrs	B	COc1ccccc1[C@H]1CN(c2cc(-c3ccncn3)cc(=O)n2C)CCO1		CHEMBL1682851	=	IC50	nM	840.0	CHEMBL262	Homo sapiens	IC50	nM	840.0
	5248952	CHEMBL1685187	Inhibition of human GSK3-beta expressed in CHO AA8 cells co-expressing human tau protein after 2 hrs	B	COc1ccccc1[C@@H]1CN(c2cc(-c3ccncn3)cc(=O)n2C)CCO1		CHEMBL1682852	=	IC50	nM	1530.0	CHEMBL262	Homo sapiens	IC50	nM	1530.0
	5248965	CHEMBL1685181	Inhibition of human recombinant GSK3-beta expressed in baculovirus infected SF9 cells after 60 mins	B	Cn1c(N2CCCC(c3ccccc3)C2)cc(-c2ccncn2)cc1=O		CHEMBL1682853	=	IC50	nM	115.0	CHEMBL262	Homo sapiens	IC50	nM	115.0
	5248966	CHEMBL1685187	Inhibition of human GSK3-beta expressed in CHO AA8 cells co-expressing human tau protein after 2 hrs	B	Cn1c(N2CCCC(c3ccccc3)C2)cc(-c2ccncn2)cc1=O		CHEMBL1682853	=	IC50	nM	4640.0	CHEMBL262	Homo sapiens	IC50	nM	4640.0
	5249431	CHEMBL1686782	Inhibition of GSK3B at 10 uM	B	O=C(Cc1cccc2cnccc12)Nc1scc(Cl)c1-c1ncn[nH]1		CHEMBL1682017	=	Inhibition	%	25.0	CHEMBL262	Homo sapiens	INH	%	25.0
	5249818	CHEMBL1687338	inhibition of GSK3-beta at 10 uM	B	COc1ccc(Cn2ncc(NC(=O)c3cc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)ccc3C)c2N)cc1		CHEMBL1684800	=	Inhibition	%	1.4	CHEMBL262	Homo sapiens	INH	%	1.4
	5249822	CHEMBL1687364	inhibition of GSK3-beta	B	COc1ccc(Cn2ncc(NC(=O)c3cc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)ccc3C)c2N)cc1		CHEMBL1684800	=	IC50	nM	2.73	CHEMBL262	Homo sapiens	IC50	nM	2.73
	5293878	CHEMBL1697116	Inhibition of GSK3-beta after 60 mins by radiometric assay	B	O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O		CHEMBL1448	=	IC50	nM	77500.0	CHEMBL262	Homo sapiens	IC50	uM	77.5
Not Active	6150854	CHEMBL1764764	Inhibition of GSK3b	B	C[C@H]1C(=O)N(c2ccc(S(=O)(=O)C(F)(F)F)cc2)C(=O)N1Cc1ccnc2ccccc12		CHEMBL1738841		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	6153359	CHEMBL1763547	Inhibition of GSK3-beta in presence of 60 uM ATP	B	Nc1nc(Nc2cccnc2)sc1C(=O)c1ccccc1F		CHEMBL1761791	=	IC50	nM	45.0	CHEMBL262	Homo sapiens	IC50	nM	45.0
	6167644	CHEMBL1768910	Inhibition of GSK3-beta	B	CNc1cncc(-c2c[nH]c(=O)c(NC(=O)c3ccc(N4CCC[C@H]4CN4CCCC4)cc3)c2)n1		CHEMBL1765781	>	Ki	nM	1000.0	CHEMBL262	Homo sapiens	Ki	uM	1.0
	6169214	CHEMBL1769082	Inhibition of GSK3B	B	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@@H](C(=O)NC3CCCCC3)CC[C@H]2C)n1		CHEMBL1765740	>	IC50	nM	25118.0	CHEMBL262	Homo sapiens	IC50	nM	25118.0
	6175000	CHEMBL1767717	Inhibition of human recombinant GSK3B at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2[nH]nc(C(C)C)c2n1		CHEMBL1738742	=	Inhibition	%	54.0	CHEMBL262	Homo sapiens	INH	%	54.0
	6175017	CHEMBL1767717	Inhibition of human recombinant GSK3B at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Inhibition	%	25.0	CHEMBL262	Homo sapiens	INH	%	25.0
	6180245	CHEMBL1772610	Inhibition of GSK3-beta assessed as residual activity of enzyme at 10 uM	B	Cc1cc(N/N=C/c2ccncc2)nc2ccccc12		CHEMBL1771411	=	Activity	%	99.0	CHEMBL262	Homo sapiens	Activity	%	99.0
	6180246	CHEMBL1772611	Inhibition of GSK3-beta assessed as residual activity of enzyme at 25 uM	B	Cc1cc(N/N=C/c2ccncc2)nc2ccccc12		CHEMBL1771411	=	Activity	%	94.0	CHEMBL262	Homo sapiens	Activity	%	94.0
	6193943	CHEMBL1776533	Inhibition of GSK3-beta at 1 uM	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	Inhibition	%	95.0	CHEMBL262	Homo sapiens	INH	%	95.0
	6198120	CHEMBL1776211	Inhibition of GSK3-beta assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3CCO)CC4)c2)CC1		CHEMBL1738758	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	6221249	CHEMBL1787674	Inhibition of GSK3B at 10 uM	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	28.0	CHEMBL262	Homo sapiens	INH	%	28.0
Not Active	6230337	CHEMBL1785284	Inhibition of human GSK3-beta	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	6268331	CHEMBL1803565	Inhibition of GSK3-beta using GS1 as substrate and [gamma-32P]ATP after 20 mins by radiometric assay	B	O=C(CBr)c1ccccc1		CHEMBL102953	=	IC50	nM	5000.0	CHEMBL262	Homo sapiens	IC50	uM	5.0
	6268332	CHEMBL1803565	Inhibition of GSK3-beta using GS1 as substrate and [gamma-32P]ATP after 20 mins by radiometric assay	B	O=C(CCl)c1ccc(Cl)cc1		CHEMBL143090	=	IC50	nM	2500.0	CHEMBL262	Homo sapiens	IC50	uM	2.5
	6268333	CHEMBL1803565	Inhibition of GSK3-beta using GS1 as substrate and [gamma-32P]ATP after 20 mins by radiometric assay	B	O=C(CBr)c1ccc(Cl)cc1		CHEMBL140061	=	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	uM	1.0
	6268334	CHEMBL1803565	Inhibition of GSK3-beta using GS1 as substrate and [gamma-32P]ATP after 20 mins by radiometric assay	B	O=C(CBr)c1ccc(Br)cc1		CHEMBL142826	=	IC50	nM	500.0	CHEMBL262	Homo sapiens	IC50	uM	0.5
	6268335	CHEMBL1803565	Inhibition of GSK3-beta using GS1 as substrate and [gamma-32P]ATP after 20 mins by radiometric assay	B	Cc1ccc(C(=O)CBr)cc1		CHEMBL142824	=	IC50	nM	2500.0	CHEMBL262	Homo sapiens	IC50	uM	2.5
	6268336	CHEMBL1803565	Inhibition of GSK3-beta using GS1 as substrate and [gamma-32P]ATP after 20 mins by radiometric assay	B	O=C(CBr)c1ccc(-c2ccccc2)cc1		CHEMBL413032	=	IC50	nM	2500.0	CHEMBL262	Homo sapiens	IC50	uM	2.5
	6268337	CHEMBL1803565	Inhibition of GSK3-beta using GS1 as substrate and [gamma-32P]ATP after 20 mins by radiometric assay	B	COc1ccc(C(=O)CBr)cc1		CHEMBL103009	=	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	uM	1.0
	6268338	CHEMBL1803565	Inhibition of GSK3-beta using GS1 as substrate and [gamma-32P]ATP after 20 mins by radiometric assay	B	O=C(CBr)c1ccc([N+](=O)[O-])cc1		CHEMBL106072	=	IC50	nM	2000.0	CHEMBL262	Homo sapiens	IC50	uM	2.0
	6268339	CHEMBL1803565	Inhibition of GSK3-beta using GS1 as substrate and [gamma-32P]ATP after 20 mins by radiometric assay	B	O=C(CI)c1ccc(Br)cc1		CHEMBL1801611	=	IC50	nM	3000.0	CHEMBL262	Homo sapiens	IC50	uM	3.0
	6268340	CHEMBL1803565	Inhibition of GSK3-beta using GS1 as substrate and [gamma-32P]ATP after 20 mins by radiometric assay	B	O=C(CN1C(=O)c2ccccc2C1=O)c1ccc(Br)cc1		CHEMBL1801612	=	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	6268341	CHEMBL1803565	Inhibition of GSK3-beta using GS1 as substrate and [gamma-32P]ATP after 20 mins by radiometric assay	B	Cl.NCC(=O)c1ccc(Br)cc1		CHEMBL1801613	=	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	6268342	CHEMBL1803565	Inhibition of GSK3-beta using GS1 as substrate and [gamma-32P]ATP after 20 mins by radiometric assay	B	CCSCC(=O)c1ccc(Br)cc1		CHEMBL1801614	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	6268343	CHEMBL1803565	Inhibition of GSK3-beta using GS1 as substrate and [gamma-32P]ATP after 20 mins by radiometric assay	B	O=C(CSc1ccccc1)c1ccc(Br)cc1		CHEMBL1801615	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	6268344	CHEMBL1803565	Inhibition of GSK3-beta using GS1 as substrate and [gamma-32P]ATP after 20 mins by radiometric assay	B	O=C(CSCc1ccccc1)c1ccc(Br)cc1		CHEMBL1801616	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	6268345	CHEMBL1803565	Inhibition of GSK3-beta using GS1 as substrate and [gamma-32P]ATP after 20 mins by radiometric assay	B	CC(=O)OCC(=O)c1ccc(Br)cc1		CHEMBL1801617	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	6268346	CHEMBL1803565	Inhibition of GSK3-beta using GS1 as substrate and [gamma-32P]ATP after 20 mins by radiometric assay	B	O=C(CO)c1ccc(Br)cc1		CHEMBL1801618	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	6268347	CHEMBL1803565	Inhibition of GSK3-beta using GS1 as substrate and [gamma-32P]ATP after 20 mins by radiometric assay	B	O/N=C(\CBr)c1ccc(Br)cc1		CHEMBL1801619	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	6268348	CHEMBL1803565	Inhibition of GSK3-beta using GS1 as substrate and [gamma-32P]ATP after 20 mins by radiometric assay	B	CO/N=C(\CBr)c1ccc(Br)cc1		CHEMBL1801620	=	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	6268349	CHEMBL1803565	Inhibition of GSK3-beta using GS1 as substrate and [gamma-32P]ATP after 20 mins by radiometric assay	B	[O-][S+](CCl)c1ccc(Br)cc1		CHEMBL1801621	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	6268350	CHEMBL1803565	Inhibition of GSK3-beta using GS1 as substrate and [gamma-32P]ATP after 20 mins by radiometric assay	B	N#Cc1ccc(C(=O)CBr)cc1		CHEMBL1801622	=	IC50	nM	1500.0	CHEMBL262	Homo sapiens	IC50	uM	1.5
	6268351	CHEMBL1803565	Inhibition of GSK3-beta using GS1 as substrate and [gamma-32P]ATP after 20 mins by radiometric assay	B	N#Cc1ccc(C(=O)C(Br)Br)cc1		CHEMBL1801623	=	IC50	nM	1500.0	CHEMBL262	Homo sapiens	IC50	uM	1.5
	6268352	CHEMBL1803565	Inhibition of GSK3-beta using GS1 as substrate and [gamma-32P]ATP after 20 mins by radiometric assay	B	O=C(CBr)c1ccc(C(F)(F)F)cc1		CHEMBL105348	=	IC50	nM	5000.0	CHEMBL262	Homo sapiens	IC50	uM	5.0
	6268353	CHEMBL1803565	Inhibition of GSK3-beta using GS1 as substrate and [gamma-32P]ATP after 20 mins by radiometric assay	B	O=C(c1ccc(C(F)(F)F)cc1)C(Br)Br		CHEMBL1800091	=	IC50	nM	5000.0	CHEMBL262	Homo sapiens	IC50	uM	5.0
	6268354	CHEMBL1803565	Inhibition of GSK3-beta using GS1 as substrate and [gamma-32P]ATP after 20 mins by radiometric assay	B	O=C(CBr)c1ccc(N2CCOCC2)cc1		CHEMBL1801624	=	IC50	nM	6000.0	CHEMBL262	Homo sapiens	IC50	uM	6.0
	6268355	CHEMBL1803565	Inhibition of GSK3-beta using GS1 as substrate and [gamma-32P]ATP after 20 mins by radiometric assay	B	O=C(c1ccc(I)cc1)C(Br)Br		CHEMBL1801625	=	IC50	nM	2000.0	CHEMBL262	Homo sapiens	IC50	uM	2.0
	6268356	CHEMBL1803565	Inhibition of GSK3-beta using GS1 as substrate and [gamma-32P]ATP after 20 mins by radiometric assay	B	N#Cc1cccc(C(=O)CBr)c1		CHEMBL1801626	=	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	uM	1.0
	6268357	CHEMBL1803565	Inhibition of GSK3-beta using GS1 as substrate and [gamma-32P]ATP after 20 mins by radiometric assay	B	N#Cc1cccc(C(=O)C(Br)Br)c1		CHEMBL1801627	=	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	uM	1.0
	6268358	CHEMBL1803565	Inhibition of GSK3-beta using GS1 as substrate and [gamma-32P]ATP after 20 mins by radiometric assay	B	Nc1c(Br)cc(C(=O)C(Br)Br)cc1Br		CHEMBL1801628	=	IC50	nM	500.0	CHEMBL262	Homo sapiens	IC50	uM	0.5
	6268359	CHEMBL1803565	Inhibition of GSK3-beta using GS1 as substrate and [gamma-32P]ATP after 20 mins by radiometric assay	B	O=C(c1ccccn1)C(Br)Br		CHEMBL1801629	=	IC50	nM	2500.0	CHEMBL262	Homo sapiens	IC50	uM	2.5
	6268360	CHEMBL1803566	Inhibition of human recombinant GSK3-beta using prephosphorylated polypeptide substrate after 30 mins by Glow-type luminescence assay in presence of 1 uM ATP	B	CC(=O)n1cnc2c(N)ncnc21		CHEMBL1801630	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	6268361	CHEMBL1803566	Inhibition of human recombinant GSK3-beta using prephosphorylated polypeptide substrate after 30 mins by Glow-type luminescence assay in presence of 1 uM ATP	B	Nc1ncnc2c1ncn2C(=O)CCl		CHEMBL1801631	=	IC50	nM	13400.0	CHEMBL262	Homo sapiens	IC50	uM	13.4
	6268362	CHEMBL1803566	Inhibition of human recombinant GSK3-beta using prephosphorylated polypeptide substrate after 30 mins by Glow-type luminescence assay in presence of 1 uM ATP	B	CC(=O)C1=C(c2c[nH]c3ccccc23)C(=O)NC1=O		CHEMBL1801632	=	IC50	nM	4470.0	CHEMBL262	Homo sapiens	IC50	uM	4.47
	6268363	CHEMBL1803566	Inhibition of human recombinant GSK3-beta using prephosphorylated polypeptide substrate after 30 mins by Glow-type luminescence assay in presence of 1 uM ATP	B	O=C(CBr)C1=C(c2c[nH]c3ccccc23)C(=O)NC1=O		CHEMBL1801633	=	IC50	nM	47.0	CHEMBL262	Homo sapiens	IC50	uM	0.047
	6268364	CHEMBL1803566	Inhibition of human recombinant GSK3-beta using prephosphorylated polypeptide substrate after 30 mins by Glow-type luminescence assay in presence of 1 uM ATP	B	COc1ccc(-n2cnc3cc(C(C)=O)ccc32)cc1		CHEMBL1801634	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	6268365	CHEMBL1803566	Inhibition of human recombinant GSK3-beta using prephosphorylated polypeptide substrate after 30 mins by Glow-type luminescence assay in presence of 1 uM ATP	B	COc1ccc(-n2cnc3cc(C(=O)CBr)ccc32)cc1		CHEMBL1801635	=	IC50	nM	580.0	CHEMBL262	Homo sapiens	IC50	uM	0.58
	6268366	CHEMBL1803566	Inhibition of human recombinant GSK3-beta using prephosphorylated polypeptide substrate after 30 mins by Glow-type luminescence assay in presence of 1 uM ATP	B	CC(=O)C1=C(c2cn(C)c3ccccc23)C(=O)NC1=O		CHEMBL1801636	=	IC50	nM	890.0	CHEMBL262	Homo sapiens	IC50	uM	0.89
	6268367	CHEMBL1803566	Inhibition of human recombinant GSK3-beta using prephosphorylated polypeptide substrate after 30 mins by Glow-type luminescence assay in presence of 1 uM ATP	B	Cn1cc(C2=C(C(=O)CBr)C(=O)NC2=O)c2ccccc21		CHEMBL1801637	=	IC50	nM	5.0	CHEMBL262	Homo sapiens	IC50	uM	0.005
Active	6268428	CHEMBL1803836	Reversible inhibition of human recombinant GSK3-beta using prephosphorylated polypeptide substrate preincubated with enzyme for 5 to 10 mins measured after 30 mins by Glow-type luminescence assay in presence of 1 uM ATP	B	CC(=O)C1=C(c2c[nH]c3ccccc23)C(=O)NC1=O		CHEMBL1801632		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	6268429	CHEMBL1803836	Reversible inhibition of human recombinant GSK3-beta using prephosphorylated polypeptide substrate preincubated with enzyme for 5 to 10 mins measured after 30 mins by Glow-type luminescence assay in presence of 1 uM ATP	B	CC(=O)C1=C(c2cn(C)c3ccccc23)C(=O)NC1=O		CHEMBL1801636		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	6268430	CHEMBL1803837	Irreversible inhibition of human recombinant GSK3-beta using prephosphorylated polypeptide substrate preincubated with enzyme for 5 to 10 mins measured after 30 mins by Glow-type luminescence assay in presence of 1 uM ATP	B	O=C(CBr)C1=C(c2c[nH]c3ccccc23)C(=O)NC1=O		CHEMBL1801633		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	6268431	CHEMBL1803837	Irreversible inhibition of human recombinant GSK3-beta using prephosphorylated polypeptide substrate preincubated with enzyme for 5 to 10 mins measured after 30 mins by Glow-type luminescence assay in presence of 1 uM ATP	B	COc1ccc(-n2cnc3cc(C(=O)CBr)ccc32)cc1		CHEMBL1801635		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	6268432	CHEMBL1803837	Irreversible inhibition of human recombinant GSK3-beta using prephosphorylated polypeptide substrate preincubated with enzyme for 5 to 10 mins measured after 30 mins by Glow-type luminescence assay in presence of 1 uM ATP	B	Cn1cc(C2=C(C(=O)CBr)C(=O)NC2=O)c2ccccc21		CHEMBL1801637		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	6268433	CHEMBL1803835	Covalent binding affinity to human recombinant GSK3-beta by MALDI-TOF analysis	B	CC(=O)C1=C(c2cn(C)c3ccccc23)C(=O)NC1=O		CHEMBL1801636		Activity			CHEMBL262	Homo sapiens	Activity		
Active	6268434	CHEMBL1803835	Covalent binding affinity to human recombinant GSK3-beta by MALDI-TOF analysis	B	Cn1cc(C2=C(C(=O)CBr)C(=O)NC2=O)c2ccccc21		CHEMBL1801637		Activity			CHEMBL262	Homo sapiens	Activity		
	6274425	CHEMBL1806155	Inhibition of GSK3-beta assessed as residual enzyme activity at 10 uM	B	CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12		CHEMBL1234833	=	Activity	%	63.0	CHEMBL262	Homo sapiens	Activity	%	63.0
	6281495	CHEMBL1803565	Inhibition of GSK3-beta using GS1 as substrate and [gamma-32P]ATP after 20 mins by radiometric assay	B	O=C(CCl)c1ccccc1		CHEMBL105712	=	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	6295121	CHEMBL1809805	Inhibition of human GSK3-beta expressed in baculovirus by fluorescence polarization assay	B	O=c1[nH]cc(-c2ccc(N3CCOCC3)cc2)c2sc(-c3ccncc3)cc12		CHEMBL1809107	=	IC50	nM	501.19	CHEMBL262	Homo sapiens	pIC50		6.3
	6295122	CHEMBL1809805	Inhibition of human GSK3-beta expressed in baculovirus by fluorescence polarization assay	B	O=c1[nH]ccc2oc(-c3ccncc3)cc12		CHEMBL1738951	=	IC50	nM	125.89	CHEMBL262	Homo sapiens	pIC50		6.9
	6295123	CHEMBL1809805	Inhibition of human GSK3-beta expressed in baculovirus by fluorescence polarization assay	B	O=c1[nH]cc(-c2ccc(O)cc2)c2sc(-c3ccncc3)cc12		CHEMBL1738953	=	IC50	nM	125.89	CHEMBL262	Homo sapiens	pIC50		6.9
	6295124	CHEMBL1809805	Inhibition of human GSK3-beta expressed in baculovirus by fluorescence polarization assay	B	Cc1cc(-c2cc3c(=O)[nH]cc(-c4cccc(NS(C)(=O)=O)c4)c3s2)ccn1		CHEMBL1809108	=	IC50	nM	2511.89	CHEMBL262	Homo sapiens	pIC50		5.6
	6295125	CHEMBL1809805	Inhibition of human GSK3-beta expressed in baculovirus by fluorescence polarization assay	B	N#Cc1ccc(F)c(-c2c[nH]c(=O)c3cc(-c4ccncc4)sc23)c1		CHEMBL1809113	=	IC50	nM	5.012	CHEMBL262	Homo sapiens	pIC50		8.3
	6295126	CHEMBL1809805	Inhibition of human GSK3-beta expressed in baculovirus by fluorescence polarization assay	B	O=c1[nH]cc(-c2ccc3c(c2)OCCO3)c2sc(-c3ccncc3)cc12		CHEMBL1809114	=	IC50	nM	6.31	CHEMBL262	Homo sapiens	pIC50		8.2
	6295127	CHEMBL1809805	Inhibition of human GSK3-beta expressed in baculovirus by fluorescence polarization assay	B	N#CCc1cccc(-c2c[nH]c(=O)c3cc(-c4ccncc4)sc23)c1		CHEMBL1809115	=	IC50	nM	10.0	CHEMBL262	Homo sapiens	pIC50		8.0
	6295128	CHEMBL1809805	Inhibition of human GSK3-beta expressed in baculovirus by fluorescence polarization assay	B	O=c1[nH]cc(-c2cccc(Cl)n2)c2sc(-c3ccncc3)cc12		CHEMBL1809116	=	IC50	nM	10.0	CHEMBL262	Homo sapiens	pIC50		8.0
	6295129	CHEMBL1809805	Inhibition of human GSK3-beta expressed in baculovirus by fluorescence polarization assay	B	N#Cc1cscc1-c1c[nH]c(=O)c2cc(-c3ccncc3)sc12		CHEMBL1809117	=	IC50	nM	12.59	CHEMBL262	Homo sapiens	pIC50		7.9
	6295130	CHEMBL1809805	Inhibition of human GSK3-beta expressed in baculovirus by fluorescence polarization assay	B	COCc1ccccc1-c1c[nH]c(=O)c2cc(-c3ccncc3)sc12		CHEMBL1809118	=	IC50	nM	100.0	CHEMBL262	Homo sapiens	pIC50		7.0
	6295131	CHEMBL1809805	Inhibition of human GSK3-beta expressed in baculovirus by fluorescence polarization assay	B	CCOc1ccc(-c2c[nH]c(=O)c3cc(-c4ccncc4)sc23)cn1		CHEMBL1809119	=	IC50	nM	125.89	CHEMBL262	Homo sapiens	pIC50		6.9
	6295132	CHEMBL1809805	Inhibition of human GSK3-beta expressed in baculovirus by fluorescence polarization assay	B	COc1cc(F)ccc1-c1c[nH]c(=O)c2cc(-c3ccncc3)sc12		CHEMBL1809120	=	IC50	nM	158.49	CHEMBL262	Homo sapiens	pIC50		6.8
	6295133	CHEMBL1809805	Inhibition of human GSK3-beta expressed in baculovirus by fluorescence polarization assay	B	CN(C)C(=O)c1ccccc1-c1c[nH]c(=O)c2cc(-c3ccncc3)sc12		CHEMBL1809121	=	IC50	nM	316.23	CHEMBL262	Homo sapiens	pIC50		6.5
	6295134	CHEMBL1809805	Inhibition of human GSK3-beta expressed in baculovirus by fluorescence polarization assay	B	O=c1[nH]cc(-c2cccc3cccnc23)c2sc(-c3ccncc3)cc12		CHEMBL1809122	=	IC50	nM	316.23	CHEMBL262	Homo sapiens	pIC50		6.5
	6295135	CHEMBL1810765	Inhibition of human full length His-tagged GSK3-beta expressed in baculovirus by alphaLISA assay	B	O=c1[nH]cc(-c2ccc(N3CCOCC3)cc2)c2sc(-c3ccncc3)cc12		CHEMBL1809107	=	IC50	nM	63.1	CHEMBL262	Homo sapiens	pIC50		7.2
	6295136	CHEMBL1810765	Inhibition of human full length His-tagged GSK3-beta expressed in baculovirus by alphaLISA assay	B	O=c1[nH]cc(Br)c2sc(-c3ccncc3)cc12		CHEMBL1738952	=	IC50	nM	158.49	CHEMBL262	Homo sapiens	pIC50		6.8
	6295137	CHEMBL1810765	Inhibition of human full length His-tagged GSK3-beta expressed in baculovirus by alphaLISA assay	B	CS(=O)(=O)Nc1cccc(-c2c[nH]c(=O)c3cc(-c4ccnc5[nH]ccc45)sc23)c1		CHEMBL1809109	=	IC50	nM	19.95	CHEMBL262	Homo sapiens	pIC50		7.7
	6295138	CHEMBL1810765	Inhibition of human full length His-tagged GSK3-beta expressed in baculovirus by alphaLISA assay	B	O=c1[nH]cc(-c2ccc(N3CCOCC3)cc2)c2sc(-c3cn[nH]c3)cc12		CHEMBL1809110	=	IC50	nM	12.59	CHEMBL262	Homo sapiens	pIC50		7.9
	6295139	CHEMBL1810765	Inhibition of human full length His-tagged GSK3-beta expressed in baculovirus by alphaLISA assay	B	Cn1cc(-c2ccc(N3CCOCC3)cc2)c2sc(-c3ccncc3)cc2c1=O		CHEMBL1809111	=	IC50	nM	251.19	CHEMBL262	Homo sapiens	pIC50		6.6
	6295140	CHEMBL1810765	Inhibition of human full length His-tagged GSK3-beta expressed in baculovirus by alphaLISA assay	B	COc1ncc(-c2ccc(N3CCOCC3)cc2)c2sc(-c3ccncc3)cc12		CHEMBL1809112	=	IC50	nM	10000.0	CHEMBL262	Homo sapiens	pIC50		5.0
	6295157	CHEMBL1810767	Inhibition of human flag-tagged GSK3-beta expressed in HEK-MSRII cells assessed as CRMP-2 phosphorylation by alphaLISA assay	B	O=c1[nH]cc(-c2ccc(N3CCOCC3)cc2)c2sc(-c3ccncc3)cc12		CHEMBL1809107	=	IC50	nM	1258.93	CHEMBL262	Homo sapiens	pIC50		5.9
	6295158	CHEMBL1810767	Inhibition of human flag-tagged GSK3-beta expressed in HEK-MSRII cells assessed as CRMP-2 phosphorylation by alphaLISA assay	B	Cc1cc(-c2cc3c(=O)[nH]cc(-c4cccc(NS(C)(=O)=O)c4)c3s2)ccn1		CHEMBL1809108	<	IC50	nM	100000.0	CHEMBL262	Homo sapiens	pIC50		4.0
	6295159	CHEMBL1810767	Inhibition of human flag-tagged GSK3-beta expressed in HEK-MSRII cells assessed as CRMP-2 phosphorylation by alphaLISA assay	B	CS(=O)(=O)Nc1cccc(-c2c[nH]c(=O)c3cc(-c4ccnc5[nH]ccc45)sc23)c1		CHEMBL1809109	<	IC50	nM	100000.0	CHEMBL262	Homo sapiens	pIC50		4.0
	6295160	CHEMBL1810767	Inhibition of human flag-tagged GSK3-beta expressed in HEK-MSRII cells assessed as CRMP-2 phosphorylation by alphaLISA assay	B	O=c1[nH]cc(-c2ccc(N3CCOCC3)cc2)c2sc(-c3cn[nH]c3)cc12		CHEMBL1809110	=	IC50	nM	398.11	CHEMBL262	Homo sapiens	pIC50		6.4
	6295161	CHEMBL1810767	Inhibition of human flag-tagged GSK3-beta expressed in HEK-MSRII cells assessed as CRMP-2 phosphorylation by alphaLISA assay	B	Cn1cc(-c2ccc(N3CCOCC3)cc2)c2sc(-c3ccncc3)cc2c1=O		CHEMBL1809111	<	IC50	nM	100000.0	CHEMBL262	Homo sapiens	pIC50		4.0
	6295162	CHEMBL1810767	Inhibition of human flag-tagged GSK3-beta expressed in HEK-MSRII cells assessed as CRMP-2 phosphorylation by alphaLISA assay	B	COc1ncc(-c2ccc(N3CCOCC3)cc2)c2sc(-c3ccncc3)cc12		CHEMBL1809112	<	IC50	nM	100000.0	CHEMBL262	Homo sapiens	pIC50		4.0
	6295163	CHEMBL1810767	Inhibition of human flag-tagged GSK3-beta expressed in HEK-MSRII cells assessed as CRMP-2 phosphorylation by alphaLISA assay	B	N#Cc1ccc(F)c(-c2c[nH]c(=O)c3cc(-c4ccncc4)sc23)c1		CHEMBL1809113	=	IC50	nM	79.43	CHEMBL262	Homo sapiens	pIC50		7.1
	6295164	CHEMBL1810767	Inhibition of human flag-tagged GSK3-beta expressed in HEK-MSRII cells assessed as CRMP-2 phosphorylation by alphaLISA assay	B	O=c1[nH]cc(-c2ccc3c(c2)OCCO3)c2sc(-c3ccncc3)cc12		CHEMBL1809114	=	IC50	nM	630.96	CHEMBL262	Homo sapiens	pIC50		6.2
	6295165	CHEMBL1810767	Inhibition of human flag-tagged GSK3-beta expressed in HEK-MSRII cells assessed as CRMP-2 phosphorylation by alphaLISA assay	B	N#CCc1cccc(-c2c[nH]c(=O)c3cc(-c4ccncc4)sc23)c1		CHEMBL1809115	=	IC50	nM	630.96	CHEMBL262	Homo sapiens	pIC50		6.2
	6295166	CHEMBL1810767	Inhibition of human flag-tagged GSK3-beta expressed in HEK-MSRII cells assessed as CRMP-2 phosphorylation by alphaLISA assay	B	O=c1[nH]cc(-c2cccc(Cl)n2)c2sc(-c3ccncc3)cc12		CHEMBL1809116	=	IC50	nM	3981.07	CHEMBL262	Homo sapiens	pIC50		5.4
	6295167	CHEMBL1810767	Inhibition of human flag-tagged GSK3-beta expressed in HEK-MSRII cells assessed as CRMP-2 phosphorylation by alphaLISA assay	B	N#Cc1cscc1-c1c[nH]c(=O)c2cc(-c3ccncc3)sc12		CHEMBL1809117	=	IC50	nM	316.23	CHEMBL262	Homo sapiens	pIC50		6.5
	6295168	CHEMBL1810767	Inhibition of human flag-tagged GSK3-beta expressed in HEK-MSRII cells assessed as CRMP-2 phosphorylation by alphaLISA assay	B	COCc1ccccc1-c1c[nH]c(=O)c2cc(-c3ccncc3)sc12		CHEMBL1809118	=	IC50	nM	3981.07	CHEMBL262	Homo sapiens	pIC50		5.4
	6295169	CHEMBL1810767	Inhibition of human flag-tagged GSK3-beta expressed in HEK-MSRII cells assessed as CRMP-2 phosphorylation by alphaLISA assay	B	CCOc1ccc(-c2c[nH]c(=O)c3cc(-c4ccncc4)sc23)cn1		CHEMBL1809119	=	IC50	nM	3162.28	CHEMBL262	Homo sapiens	pIC50		5.5
	6295170	CHEMBL1810767	Inhibition of human flag-tagged GSK3-beta expressed in HEK-MSRII cells assessed as CRMP-2 phosphorylation by alphaLISA assay	B	COc1cc(F)ccc1-c1c[nH]c(=O)c2cc(-c3ccncc3)sc12		CHEMBL1809120	=	IC50	nM	5011.87	CHEMBL262	Homo sapiens	pIC50		5.3
	6295171	CHEMBL1810767	Inhibition of human flag-tagged GSK3-beta expressed in HEK-MSRII cells assessed as CRMP-2 phosphorylation by alphaLISA assay	B	CN(C)C(=O)c1ccccc1-c1c[nH]c(=O)c2cc(-c3ccncc3)sc12		CHEMBL1809121	=	IC50	nM	6309.57	CHEMBL262	Homo sapiens	pIC50		5.2
	6295172	CHEMBL1810767	Inhibition of human flag-tagged GSK3-beta expressed in HEK-MSRII cells assessed as CRMP-2 phosphorylation by alphaLISA assay	B	O=c1[nH]cc(-c2cccc3cccnc23)c2sc(-c3ccncc3)cc12		CHEMBL1809122	=	IC50	nM	7943.28	CHEMBL262	Homo sapiens	pIC50		5.1
	6316588	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]nc(N)c2c(=O)[nH]1		CHEMBL1813604	=	Inhibition	%	18.0	CHEMBL262	Homo sapiens	INH	%	18.0
	6316589	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3cccnc3)[nH]c(=O)c12		CHEMBL1813606	=	Inhibition	%	71.0	CHEMBL262	Homo sapiens	INH	%	71.0
	6316590	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3ccccn3)[nH]c(=O)c12		CHEMBL1813607	=	Inhibition	%	60.0	CHEMBL262	Homo sapiens	INH	%	60.0
	6316591	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3ccncc3)[nH]c(=O)c12		CHEMBL1813608	=	Inhibition	%	95.0	CHEMBL262	Homo sapiens	INH	%	95.0
	6316592	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	COc1cccc(-c2cc3[nH]nc(N)c3c(=O)[nH]2)c1		CHEMBL1813609	=	Inhibition	%	58.0	CHEMBL262	Homo sapiens	INH	%	58.0
	6316593	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	COc1ccc(-c2cc3[nH]nc(N)c3c(=O)[nH]2)cc1		CHEMBL1813610	=	Inhibition	%	78.0	CHEMBL262	Homo sapiens	INH	%	78.0
	6316594	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	CN1CCN(c2ccc(-c3cc4[nH]nc(N)c4c(=O)[nH]3)cc2)CC1		CHEMBL1813611	=	Inhibition	%	42.0	CHEMBL262	Homo sapiens	INH	%	42.0
	6316595	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3cccs3)[nH]c(=O)c12		CHEMBL1813612	=	Inhibition	%	89.0	CHEMBL262	Homo sapiens	INH	%	89.0
	6316596	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	CC(C)(C)c1cc2[nH]nc(N)c2c(=O)[nH]1		CHEMBL1813613	=	Inhibition	%	41.0	CHEMBL262	Homo sapiens	INH	%	41.0
	6316597	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3ccc(N4CCOCC4)cc3)[nH]c(=O)c12		CHEMBL1813614	=	Inhibition	%	41.0	CHEMBL262	Homo sapiens	INH	%	41.0
	6316598	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(CC3CCNCC3)[nH]c(=O)c12		CHEMBL1813615	=	Inhibition	%	4.0	CHEMBL262	Homo sapiens	INH	%	4.0
	6316599	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2c3c([nH]c(=O)c12)CCCC3		CHEMBL1813617	=	Inhibition	%	23.0	CHEMBL262	Homo sapiens	INH	%	23.0
	6316600	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]nc(N)c2c(N2CCCCC2)n1		CHEMBL1813618	=	Inhibition	%	55.0	CHEMBL262	Homo sapiens	INH	%	55.0
	6316601	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]nc(N)c2c(N2CCOCC2)n1		CHEMBL1813619	=	Inhibition	%	73.0	CHEMBL262	Homo sapiens	INH	%	73.0
	6316602	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(N)nn2C)c(=O)[nH]1		CHEMBL1813620	=	Inhibition	%	1.0	CHEMBL262	Homo sapiens	INH	%	1.0
	6316603	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	Cn1nc(N)c2c(=O)[nH]c(-c3ccccc3)cc21		CHEMBL1813621	=	Inhibition	%	66.0	CHEMBL262	Homo sapiens	INH	%	66.0
	6316604	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	Cn1nc(N)c2c(=O)[nH]c(-c3ccccn3)cc21		CHEMBL1813622	=	Inhibition	%	46.0	CHEMBL262	Homo sapiens	INH	%	46.0
	6316605	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	COc1ccc(-c2cc3c(c(N)nn3C)c(=O)[nH]2)cc1		CHEMBL1813623	=	Inhibition	%	81.0	CHEMBL262	Homo sapiens	INH	%	81.0
	6316606	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	COc1cccc(-c2cc3c(c(N)nn3C)c(=O)[nH]2)c1		CHEMBL1813624	=	Inhibition	%	61.0	CHEMBL262	Homo sapiens	INH	%	61.0
	6316607	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	CN1CCN(c2ccc(-c3cc4c(c(N)nn4C)c(=O)[nH]3)cc2)CC1		CHEMBL1813625	=	Inhibition	%	45.0	CHEMBL262	Homo sapiens	INH	%	45.0
	6316608	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	COC(=O)CCc1c(C)[nH]c(=O)c2c(N)nn(C)c12		CHEMBL1813627	=	Inhibition	%	17.0	CHEMBL262	Homo sapiens	INH	%	17.0
	6316609	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	COc1ccc(-c2c(C)[nH]c(=O)c3c(N)nn(C)c23)cc1		CHEMBL1813628	=	Inhibition	%	58.0	CHEMBL262	Homo sapiens	INH	%	58.0
	6316610	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(NC(=O)Nc3ccccc3)nn2C)c(=O)[nH]1		CHEMBL1813630	=	Inhibition	%	2.0	CHEMBL262	Homo sapiens	INH	%	2.0
	6316611	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	CC(=O)Nc1nn(C)c2cc(-c3ccccc3)[nH]c(=O)c12		CHEMBL1813777	=	Inhibition	%	17.0	CHEMBL262	Homo sapiens	INH	%	17.0
	6316612	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(NS(C)(=O)=O)nn2C)c(=O)[nH]1		CHEMBL1813778	=	Inhibition	%	13.0	CHEMBL262	Homo sapiens	INH	%	13.0
	6316613	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	COc1ccc(S(=O)(=O)Nc2nn(C)c3cc(C)[nH]c(=O)c23)c(OC)c1		CHEMBL1813779	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	INH	%	0.0
	6316614	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	CC(=O)Nc1nn(C)c2cc(-c3ccc(N4CCN(C)CC4)cc3)[nH]c(=O)c12		CHEMBL1813780	=	Inhibition	%	-3.0	CHEMBL262	Homo sapiens	INH	%	-3.0
	6316615	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(N)nn2C)c(N2CCCCC2)n1		CHEMBL1813781	=	Inhibition	%	8.0	CHEMBL262	Homo sapiens	INH	%	8.0
	6316616	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(N)nn2C)c(N2CCOCC2)n1		CHEMBL1813782	=	Inhibition	%	8.0	CHEMBL262	Homo sapiens	INH	%	8.0
	6316617	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(N)nn2C)c(N2CC[C@H](O)C2)n1		CHEMBL1813784	=	Inhibition	%	-6.0	CHEMBL262	Homo sapiens	INH	%	-6.0
	6316618	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	COCCNc1nc(C)cc2c1c(N)nn2C		CHEMBL1813785	=	Inhibition	%	1.0	CHEMBL262	Homo sapiens	INH	%	1.0
	6316619	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	COCCNc1nc(-c2ccccc2)cc2c1c(N)nn2C		CHEMBL1813786	=	Inhibition	%	3.0	CHEMBL262	Homo sapiens	INH	%	3.0
	6316620	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	COCCNc1nc(C)cc2nn(-c3ccccc3)c(N)c12		CHEMBL1813787	=	Inhibition	%	10.0	CHEMBL262	Homo sapiens	INH	%	10.0
	6316621	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	Cc1cc2nn(-c3ccccc3)c(N)c2c(=O)[nH]1		CHEMBL1813788	=	Inhibition	%	9.0	CHEMBL262	Homo sapiens	INH	%	9.0
	6316622	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	CC(C)(C)c1cc2nn(-c3ccccc3)c(N)c2c(=O)[nH]1		CHEMBL1813789	=	Inhibition	%	31.0	CHEMBL262	Homo sapiens	INH	%	31.0
	6316623	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	Nc1c2c(=O)[nH]c(-c3ccccc3)cc2nn1-c1ccccc1		CHEMBL1813790	=	Inhibition	%	29.0	CHEMBL262	Homo sapiens	INH	%	29.0
	6316624	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	Nc1c2c(=O)[nH]c(-c3ccccn3)cc2nn1-c1ccccc1		CHEMBL1813791	=	Inhibition	%	11.0	CHEMBL262	Homo sapiens	INH	%	11.0
	6316625	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	COc1ccccc1-c1cc2nn(-c3ccccc3)c(N)c2c(=O)[nH]1		CHEMBL1813792	=	Inhibition	%	3.0	CHEMBL262	Homo sapiens	INH	%	3.0
	6316626	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	COc1ccc(-c2cc3nn(-c4ccccc4)c(N)c3c(=O)[nH]2)cc1		CHEMBL1813793	=	Inhibition	%	14.0	CHEMBL262	Homo sapiens	INH	%	14.0
	6316627	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	CN1CCN(c2ccc(-c3cc4nn(-c5ccccc5)c(N)c4c(=O)[nH]3)cc2)CC1		CHEMBL1813795	=	Inhibition	%	12.0	CHEMBL262	Homo sapiens	INH	%	12.0
	6316628	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	Nc1c2c(=O)[nH]c(-c3ccccc3)cc2nn1-c1ccccn1		CHEMBL1813796	=	Inhibition	%	41.0	CHEMBL262	Homo sapiens	INH	%	41.0
	6316629	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	Cc1cc2nn(-c3ccccc3)c(N)c2c(N2CCCCC2)n1		CHEMBL1813797	=	Inhibition	%	7.0	CHEMBL262	Homo sapiens	INH	%	7.0
	6316630	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	Cc1[nH]c(=O)c2c(N)n(-c3ccccc3)nc2c1-c1ccccc1		CHEMBL1813798	=	Inhibition	%	16.0	CHEMBL262	Homo sapiens	INH	%	16.0
	6316631	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	Cn1nc2c3c(nc(-c4ccccc4)cc31)NCC(=O)N2		CHEMBL1813799	=	Inhibition	%	14.0	CHEMBL262	Homo sapiens	INH	%	14.0
	6316632	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	Cn1nc(N)c2cnc(-c3ccccc3)cc21		CHEMBL1813800	=	Inhibition	%	17.0	CHEMBL262	Homo sapiens	INH	%	17.0
	6316633	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(cn1)c(N)nn2C		CHEMBL1813801	=	Inhibition	%	6.0	CHEMBL262	Homo sapiens	INH	%	6.0
	6316634	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	Nc1c2cnc(-c3ccccc3)cc2nn1-c1ccccc1		CHEMBL1813802	=	Inhibition	%	4.0	CHEMBL262	Homo sapiens	INH	%	4.0
	6316635	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]nc(N)c2cn1		CHEMBL1813803	=	Inhibition	%	9.0	CHEMBL262	Homo sapiens	INH	%	9.0
	6316636	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]ncc2c(=O)[nH]1		CHEMBL1813804	=	Inhibition	%	13.0	CHEMBL262	Homo sapiens	INH	%	13.0
	6316637	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	Cc1cc2nc(N)nc(N)c2c(=O)[nH]1		CHEMBL1813805	=	Inhibition	%	36.0	CHEMBL262	Homo sapiens	INH	%	36.0
	6316638	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	Cc1cc2nc(-c3ccccc3)nc(N)c2c(=O)[nH]1		CHEMBL1813806	=	Inhibition	%	86.0	CHEMBL262	Homo sapiens	INH	%	86.0
	6316639	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	Cc1nc(N)c2c(=O)[nH]c(C)cc2n1		CHEMBL1813807	=	Inhibition	%	52.0	CHEMBL262	Homo sapiens	INH	%	52.0
	6316640	CHEMBL1815733	Inhibition of GSK3B at 30 uM by microfluidic mobility shift assay	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Inhibition	%	10.0	CHEMBL262	Homo sapiens	INH	%	10.0
	6325313	CHEMBL1819992	Inhibition of GSK3-beta expressed in Escherichia coli or baculovirus-infected insect cells using ATP as substrate at 667 uM by fluorescence polarization assay	B	Nc1ncnc2[nH]cnc12		CHEMBL226345	=	Inhibition	%	57.0	CHEMBL262	Homo sapiens	INH	%	57.0
	6325342	CHEMBL1819992	Inhibition of GSK3-beta expressed in Escherichia coli or baculovirus-infected insect cells using ATP as substrate at 667 uM by fluorescence polarization assay	B	c1ccc(Nc2ncccn2)cc1		CHEMBL1650061	=	Inhibition	%	55.0	CHEMBL262	Homo sapiens	INH	%	55.0
	6325374	CHEMBL1819992	Inhibition of GSK3-beta expressed in Escherichia coli or baculovirus-infected insect cells using ATP as substrate at 667 uM by fluorescence polarization assay	B	c1cnc2[nH]ccc2c1		CHEMBL389685	=	Inhibition	%	21.0	CHEMBL262	Homo sapiens	INH	%	21.0
	6325406	CHEMBL1819992	Inhibition of GSK3-beta expressed in Escherichia coli or baculovirus-infected insect cells using ATP as substrate at 667 uM by fluorescence polarization assay	B	c1ccc2[nH]ncc2c1		CHEMBL86795	=	Inhibition	%	35.0	CHEMBL262	Homo sapiens	INH	%	35.0
	6325438	CHEMBL1819992	Inhibition of GSK3-beta expressed in Escherichia coli or baculovirus-infected insect cells using ATP as substrate at 667 uM by fluorescence polarization assay	B	Nc1ncccc1OCc1ccccc1		CHEMBL194009	=	Inhibition	%	92.0	CHEMBL262	Homo sapiens	INH	%	92.0
	6325467	CHEMBL1819992	Inhibition of GSK3-beta expressed in Escherichia coli or baculovirus-infected insect cells using ATP as substrate at 667 uM by fluorescence polarization assay	B	Nc1[nH]nc2ccccc12		CHEMBL1331627	=	Inhibition	%	34.0	CHEMBL262	Homo sapiens	INH	%	34.0
	6325497	CHEMBL1819992	Inhibition of GSK3-beta expressed in Escherichia coli or baculovirus-infected insect cells using ATP as substrate at 667 uM by fluorescence polarization assay	B	Nc1n[nH]c2ncccc12		CHEMBL1817865	=	Inhibition	%	59.0	CHEMBL262	Homo sapiens	INH	%	59.0
	6325525	CHEMBL1819992	Inhibition of GSK3-beta expressed in Escherichia coli or baculovirus-infected insect cells using ATP as substrate at 667 uM by fluorescence polarization assay	B	c1n[nH]c2c1CCCC2		CHEMBL1817866	=	Inhibition	%	41.0	CHEMBL262	Homo sapiens	INH	%	41.0
	6325868	CHEMBL1819992	Inhibition of GSK3-beta expressed in Escherichia coli or baculovirus-infected insect cells using ATP as substrate at 667 uM by fluorescence polarization assay	B	Nc1ccc2ncc(-c3ccccc3)n2n1		CHEMBL1817867	=	Inhibition	%	66.0	CHEMBL262	Homo sapiens	INH	%	66.0
	6325898	CHEMBL1819992	Inhibition of GSK3-beta expressed in Escherichia coli or baculovirus-infected insect cells using ATP as substrate at 667 uM by fluorescence polarization assay	B	c1ccc(-c2cnc3nccnn23)cc1		CHEMBL1817868	=	Inhibition	%	19.0	CHEMBL262	Homo sapiens	INH	%	19.0
	6325928	CHEMBL1819992	Inhibition of GSK3-beta expressed in Escherichia coli or baculovirus-infected insect cells using ATP as substrate at 667 uM by fluorescence polarization assay	B	Cc1ccc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)cc1		CHEMBL1817869	=	Inhibition	%	34.0	CHEMBL262	Homo sapiens	INH	%	34.0
	6325957	CHEMBL1819992	Inhibition of GSK3-beta expressed in Escherichia coli or baculovirus-infected insect cells using ATP as substrate at 667 uM by fluorescence polarization assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)no1		CHEMBL292785	=	Inhibition	%	19.0	CHEMBL262	Homo sapiens	INH	%	19.0
	6325986	CHEMBL1819992	Inhibition of GSK3-beta expressed in Escherichia coli or baculovirus-infected insect cells using ATP as substrate at 667 uM by fluorescence polarization assay	B	Cc1ccc(NC(=O)Nc2cccc(C(F)(F)F)c2)cc1		CHEMBL1817870	=	Inhibition	%	22.0	CHEMBL262	Homo sapiens	INH	%	22.0
	6326015	CHEMBL1819992	Inhibition of GSK3-beta expressed in Escherichia coli or baculovirus-infected insect cells using ATP as substrate at 667 uM by fluorescence polarization assay	B	O=C(Nc1ccccc1)Nc1cccc(C(F)(F)F)c1		CHEMBL1605296	=	Inhibition	%	19.0	CHEMBL262	Homo sapiens	INH	%	19.0
	6326044	CHEMBL1819992	Inhibition of GSK3-beta expressed in Escherichia coli or baculovirus-infected insect cells using ATP as substrate at 667 uM by fluorescence polarization assay	B	O=C(Nc1ccccc1)Nc1ccccc1		CHEMBL354676	=	Inhibition	%	11.0	CHEMBL262	Homo sapiens	INH	%	11.0
	6326074	CHEMBL1819992	Inhibition of GSK3-beta expressed in Escherichia coli or baculovirus-infected insect cells using ATP as substrate at 667 uM by fluorescence polarization assay	B	Cc1ccc(C(=O)NC2CC2)cc1F		CHEMBL1817871	=	Inhibition	%	23.0	CHEMBL262	Homo sapiens	INH	%	23.0
	6326102	CHEMBL1819992	Inhibition of GSK3-beta expressed in Escherichia coli or baculovirus-infected insect cells using ATP as substrate at 667 uM by fluorescence polarization assay	B	c1ccc(Nc2ccccc2)cc1		CHEMBL38688	=	Inhibition	%	13.0	CHEMBL262	Homo sapiens	INH	%	13.0
	6326122	CHEMBL1819976	Inhibition of GSK3-beta expressed in Escherichia coli or baculovirus-infected insect cells using ATP as substrate by fluorescence polarization assay	B	c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359554	=	Ki	nM	19.0	CHEMBL262	Homo sapiens	Ki	nM	19.0
	6339957	CHEMBL1826894	Activity of GSK3B kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	81.0	CHEMBL262	Homo sapiens	Activity	%	81.0
	6347887	CHEMBL1828471	Inhibition of GSK3-beta assessed as [32P]gamma-ATP incorporation into substrate at 10 uM after 15 mins by gamma counting	B	COc1ccc(CNC(=O)Nc2cc(-c3cccnc3F)ccn2)cc1		CHEMBL1824331	=	Inhibition	%	12.0	CHEMBL262	Homo sapiens	INH	%	12.0
	6347888	CHEMBL1828470	Inhibition of GSK3-beta assessed as [32P]gamma-ATP incorporation into substrate at 1 uM after 15 mins by gamma counting	B	COc1ccc(CNC(=O)Nc2nc3ccc(-c4nnn[nH]4)cc3s2)cc1		CHEMBL1824332	=	Inhibition	%	69.0	CHEMBL262	Homo sapiens	INH	%	69.0
	6347889	CHEMBL1828471	Inhibition of GSK3-beta assessed as [32P]gamma-ATP incorporation into substrate at 10 uM after 15 mins by gamma counting	B	COc1ccc(CNC(=O)Nc2nc3ccc(-c4nnn[nH]4)cc3s2)cc1		CHEMBL1824332	=	Inhibition	%	18.0	CHEMBL262	Homo sapiens	INH	%	18.0
	6347890	CHEMBL1828470	Inhibition of GSK3-beta assessed as [32P]gamma-ATP incorporation into substrate at 1 uM after 15 mins by gamma counting	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Inhibition	%	55.0	CHEMBL262	Homo sapiens	INH	%	55.0
	6347891	CHEMBL1828471	Inhibition of GSK3-beta assessed as [32P]gamma-ATP incorporation into substrate at 10 uM after 15 mins by gamma counting	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Inhibition	%	20.0	CHEMBL262	Homo sapiens	INH	%	20.0
	6347892	CHEMBL1828470	Inhibition of GSK3-beta assessed as [32P]gamma-ATP incorporation into substrate at 1 uM after 15 mins by gamma counting	B	COc1ccc(CNC(=O)Nc2nc3ccc(C#N)cc3s2)cc1		CHEMBL1824333	=	Inhibition	%	57.0	CHEMBL262	Homo sapiens	INH	%	57.0
	6347893	CHEMBL1828471	Inhibition of GSK3-beta assessed as [32P]gamma-ATP incorporation into substrate at 10 uM after 15 mins by gamma counting	B	COc1ccc(CNC(=O)Nc2nc3ccc(C#N)cc3s2)cc1		CHEMBL1824333	=	Inhibition	%	24.0	CHEMBL262	Homo sapiens	INH	%	24.0
	6347894	CHEMBL1828470	Inhibition of GSK3-beta assessed as [32P]gamma-ATP incorporation into substrate at 1 uM after 15 mins by gamma counting	B	COc1ccc(CNC(=O)Nc2cc(-c3nnn[nH]3)ccn2)cc1		CHEMBL1824334	=	Inhibition	%	82.0	CHEMBL262	Homo sapiens	INH	%	82.0
	6347895	CHEMBL1828471	Inhibition of GSK3-beta assessed as [32P]gamma-ATP incorporation into substrate at 10 uM after 15 mins by gamma counting	B	COc1ccc(CNC(=O)Nc2cc(-c3nnn[nH]3)ccn2)cc1		CHEMBL1824334	=	Inhibition	%	24.0	CHEMBL262	Homo sapiens	INH	%	24.0
	6347896	CHEMBL1828470	Inhibition of GSK3-beta assessed as [32P]gamma-ATP incorporation into substrate at 1 uM after 15 mins by gamma counting	B	COc1ccc(CNC(=O)Nc2ccc([N+](=O)[O-])cn2)cc1		CHEMBL1824536	=	Inhibition	%	75.0	CHEMBL262	Homo sapiens	INH	%	75.0
	6347897	CHEMBL1828471	Inhibition of GSK3-beta assessed as [32P]gamma-ATP incorporation into substrate at 10 uM after 15 mins by gamma counting	B	COc1ccc(CNC(=O)Nc2ccc([N+](=O)[O-])cn2)cc1		CHEMBL1824536	=	Inhibition	%	31.0	CHEMBL262	Homo sapiens	INH	%	31.0
	6347898	CHEMBL1828470	Inhibition of GSK3-beta assessed as [32P]gamma-ATP incorporation into substrate at 1 uM after 15 mins by gamma counting	B	COc1ccc(CNC(=O)Nc2cc(-c3ccccc3OC)ccn2)cc1		CHEMBL1824537	=	Inhibition	%	91.0	CHEMBL262	Homo sapiens	INH	%	91.0
	6347899	CHEMBL1828471	Inhibition of GSK3-beta assessed as [32P]gamma-ATP incorporation into substrate at 10 uM after 15 mins by gamma counting	B	COc1ccc(CNC(=O)Nc2cc(-c3ccccc3OC)ccn2)cc1		CHEMBL1824537	=	Inhibition	%	32.0	CHEMBL262	Homo sapiens	INH	%	32.0
	6347900	CHEMBL1828470	Inhibition of GSK3-beta assessed as [32P]gamma-ATP incorporation into substrate at 1 uM after 15 mins by gamma counting	B	COc1ccc(CNC(=O)Nc2ccc(C#N)cn2)cc1		CHEMBL1824538	=	Inhibition	%	79.0	CHEMBL262	Homo sapiens	INH	%	79.0
	6347901	CHEMBL1828471	Inhibition of GSK3-beta assessed as [32P]gamma-ATP incorporation into substrate at 10 uM after 15 mins by gamma counting	B	COc1ccc(CNC(=O)Nc2ccc(C#N)cn2)cc1		CHEMBL1824538	=	Inhibition	%	40.0	CHEMBL262	Homo sapiens	INH	%	40.0
	6347902	CHEMBL1828470	Inhibition of GSK3-beta assessed as [32P]gamma-ATP incorporation into substrate at 1 uM after 15 mins by gamma counting	B	COc1ccc(CNC(=O)Nc2cc(C#N)ccn2)cc1		CHEMBL1824539	=	Inhibition	%	101.0	CHEMBL262	Homo sapiens	INH	%	101.0
	6347903	CHEMBL1828471	Inhibition of GSK3-beta assessed as [32P]gamma-ATP incorporation into substrate at 10 uM after 15 mins by gamma counting	B	COc1ccc(CNC(=O)Nc2cc(C#N)ccn2)cc1		CHEMBL1824539	=	Inhibition	%	42.0	CHEMBL262	Homo sapiens	INH	%	42.0
	6347904	CHEMBL1828472	Inhibition of human GSK3-beta activity using Ser/Thr 9 peptide as substrate by FRET assay	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1	Outside typical range	CHEMBL259850	=	IC50	nM	330000.0	CHEMBL262	Homo sapiens	IC50	mM	0.33
	6347910	CHEMBL1828472	Inhibition of human GSK3-beta activity using Ser/Thr 9 peptide as substrate by FRET assay	B	COc1ccc(CNC(=O)Nc2cc(C#N)ccn2)cc1	Outside typical range	CHEMBL1824539	=	IC50	nM	1430000.0	CHEMBL262	Homo sapiens	IC50	mM	1.43
	6347916	CHEMBL1828472	Inhibition of human GSK3-beta activity using Ser/Thr 9 peptide as substrate by FRET assay	B	COc1ccc(CNC(=O)Nc2nc3ccc([N+](=O)[O-])cc3s2)cc1	Outside typical range	CHEMBL1824540	=	IC50	nM	3640000.0	CHEMBL262	Homo sapiens	IC50	mM	3.64
	6347922	CHEMBL1828472	Inhibition of human GSK3-beta activity using Ser/Thr 9 peptide as substrate by FRET assay	B	COc1ccc(CNC(=O)Nc2cc(-c3nnn[nH]3)ccn2)cc1	Outside typical range	CHEMBL1824334	=	IC50	nM	510000.0	CHEMBL262	Homo sapiens	IC50	mM	0.51
	6347928	CHEMBL1828472	Inhibition of human GSK3-beta activity using Ser/Thr 9 peptide as substrate by FRET assay	B	COc1ccc(CNC(=O)Nc2nc3ccc(-c4nnn[nH]4)cc3s2)cc1	Outside typical range	CHEMBL1824332	=	IC50	nM	140000.0	CHEMBL262	Homo sapiens	IC50	mM	0.14
	6348854	CHEMBL1828472	Inhibition of human GSK3-beta activity using Ser/Thr 9 peptide as substrate by FRET assay	B	COc1ccc(CNC(=O)Nc2cc(-c3cccnc3F)ccn2)cc1		CHEMBL1824331	=	IC50	nM	98.0	CHEMBL262	Homo sapiens	IC50	nM	98.0
	6352211	CHEMBL1825748	Inhibition of GSK3b assessed as residual activity at 10 uM by radioactivity assay in presence of 5 uM ATP	B	Nc1n[nH]c(N)c1/N=N/c1ccc(O)cc1		CHEMBL215205	=	Activity	%	64.0	CHEMBL262	Homo sapiens	Activity	%	64.0
	6353460	CHEMBL1825706	Inhibition of GSK3-beta at 10 uM	B	O=C(Cn1c(=O)ccc2cc(C(F)(F)F)ccc21)Nc1scc(Br)c1-c1ncn[nH]1		CHEMBL1822146	=	Inhibition	%	5.0	CHEMBL262	Homo sapiens	INH	%	5.0
	6356166	CHEMBL1831553	Inhibition of GSK3-beta	B	Nc1nccc(-c2c[nH]c3cccc(O)c23)n1		CHEMBL50498	=	IC50	nM	1300.0	CHEMBL262	Homo sapiens	IC50	uM	1.3
	6360087	CHEMBL1832345	Inhibition of GSK3-beta at 5 uM assessed as remaining activity	B	CNC(=O)CCc1cc(-c2ccc(-c3ccc(C(F)(F)F)cc3)cc2)n(-c2ccc(N3CCNCC3)cc2)n1		CHEMBL1830587	=	Activity	%	142.0	CHEMBL262	Homo sapiens	Activity	%	142.0
	6375154	CHEMBL1838158	Inhibition of GSK3B at 1 uM	B	CC(=O)Nc1ccc(-c2cc3ncnc(SCC(=O)O)c3s2)cc1		CHEMBL1836724	=	Inhibition	%	50.5	CHEMBL262	Homo sapiens	INH	%	50.5
	6375155	CHEMBL1838158	Inhibition of GSK3B at 1 uM	B	O=C(O)COc1ncnc2cc(-c3ccc4[nH]ncc4c3)sc12		CHEMBL1836641	=	Inhibition	%	56.5	CHEMBL262	Homo sapiens	INH	%	56.5
	6384399	CHEMBL1837408	Inhibition of human recombinant full length GSK3-beta after 1 hrs by luminescence assay	B	CC(C)Nc1c(F)c(N)c2c(=O)c(C(=O)O)cn(C3CC3)c2c1F		CHEMBL1834109	=	IC50	nM	1200.0	CHEMBL262	Homo sapiens	IC50	nM	1200.0
	6384400	CHEMBL1837408	Inhibition of human recombinant full length GSK3-beta after 1 hrs by luminescence assay	B	Nc1c(F)c(NC2CCCCC2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CC1		CHEMBL1834110	=	IC50	nM	600.0	CHEMBL262	Homo sapiens	IC50	nM	600.0
	6384401	CHEMBL1837408	Inhibition of human recombinant full length GSK3-beta after 1 hrs by luminescence assay	B	Nc1c(F)c(NCCc2c[nH]c3ccccc23)c(F)c2c1c(=O)c(C(=O)O)cn2C1CC1		CHEMBL1834111	=	IC50	nM	660.0	CHEMBL262	Homo sapiens	IC50	nM	660.0
	6384402	CHEMBL1837408	Inhibition of human recombinant full length GSK3-beta after 1 hrs by luminescence assay	B	Nc1c(F)c(NCCN2CCOCC2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CC1		CHEMBL1834112	=	IC50	nM	2100.0	CHEMBL262	Homo sapiens	IC50	nM	2100.0
	6384403	CHEMBL1837408	Inhibition of human recombinant full length GSK3-beta after 1 hrs by luminescence assay	B	Nc1c(F)c(NCCc2ccccc2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CC1		CHEMBL1834113	=	IC50	nM	440.0	CHEMBL262	Homo sapiens	IC50	nM	440.0
	6384404	CHEMBL1837408	Inhibition of human recombinant full length GSK3-beta after 1 hrs by luminescence assay	B	Nc1c(F)c(NCCCc2ccccc2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CC1		CHEMBL1834114	=	IC50	nM	45.0	CHEMBL262	Homo sapiens	IC50	nM	45.0
	6384405	CHEMBL1837408	Inhibition of human recombinant full length GSK3-beta after 1 hrs by luminescence assay	B	Nc1c(F)c(NCCCCc2ccccc2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CC1		CHEMBL1834115	=	IC50	nM	290.0	CHEMBL262	Homo sapiens	IC50	nM	290.0
	6384406	CHEMBL1837408	Inhibition of human recombinant full length GSK3-beta after 1 hrs by luminescence assay	B	Nc1c(F)c(NCCn2ccnc2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CC1		CHEMBL1834116	=	IC50	nM	3400.0	CHEMBL262	Homo sapiens	IC50	nM	3400.0
	6384407	CHEMBL1837408	Inhibition of human recombinant full length GSK3-beta after 1 hrs by luminescence assay	B	Nc1c(F)c(NCCCn2ccnc2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CC1		CHEMBL1834117	=	IC50	nM	45.0	CHEMBL262	Homo sapiens	IC50	nM	45.0
	6384408	CHEMBL1837408	Inhibition of human recombinant full length GSK3-beta after 1 hrs by luminescence assay	B	Nc1c(F)c(NCCNc2cccc3ccccc23)c(F)c2c1c(=O)c(C(=O)O)cn2C1CC1		CHEMBL1834118	=	IC50	nM	47.0	CHEMBL262	Homo sapiens	IC50	nM	47.0
	6384409	CHEMBL1837408	Inhibition of human recombinant full length GSK3-beta after 1 hrs by luminescence assay	B	Nc1c(F)c(NCCc2ccncc2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CC1		CHEMBL1834119	=	IC50	nM	100.0	CHEMBL262	Homo sapiens	IC50	nM	100.0
	6384410	CHEMBL1837408	Inhibition of human recombinant full length GSK3-beta after 1 hrs by luminescence assay	B	Nc1c(F)c(NCCNc2ccccn2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CC1		CHEMBL1834120	=	IC50	nM	190.0	CHEMBL262	Homo sapiens	IC50	nM	190.0
	6384411	CHEMBL1837408	Inhibition of human recombinant full length GSK3-beta after 1 hrs by luminescence assay	B	CC(C)OCCCNc1c(F)c(N)c2c(=O)c(C(=O)O)cn(C3CC3)c2c1F		CHEMBL1834121	=	IC50	nM	110.0	CHEMBL262	Homo sapiens	IC50	nM	110.0
	6384412	CHEMBL1837408	Inhibition of human recombinant full length GSK3-beta after 1 hrs by luminescence assay	B	COc1c(NCCCc2ccccc2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12		CHEMBL1834122	=	IC50	nM	17000.0	CHEMBL262	Homo sapiens	IC50	nM	17000.0
	6384413	CHEMBL1837408	Inhibition of human recombinant full length GSK3-beta after 1 hrs by luminescence assay	B	COc1c(NCCCc2ccccc2)c(F)c(N)c2c(=O)c(C(=O)O)cn(C3CC3)c12		CHEMBL1834123	=	IC50	nM	65.0	CHEMBL262	Homo sapiens	IC50	nM	65.0
	6384414	CHEMBL1837408	Inhibition of human recombinant full length GSK3-beta after 1 hrs by luminescence assay	B	COc1c(NCCNc2cccc3ccccc23)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12		CHEMBL1834124	=	IC50	nM	26000.0	CHEMBL262	Homo sapiens	IC50	nM	26000.0
	6384415	CHEMBL1837408	Inhibition of human recombinant full length GSK3-beta after 1 hrs by luminescence assay	B	COc1c(NCCNc2cccc3ccccc23)c(F)c(N)c2c(=O)c(C(=O)O)cn(C3CC3)c12		CHEMBL1834125	=	IC50	nM	31.0	CHEMBL262	Homo sapiens	IC50	nM	31.0
	6384416	CHEMBL1837408	Inhibition of human recombinant full length GSK3-beta after 1 hrs by luminescence assay	B	Nc1c(F)c(NCCNc2ccccn2)cc2c1c(=O)c(C(=O)O)cn2C1CC1		CHEMBL1834315	=	IC50	nM	13.0	CHEMBL262	Homo sapiens	IC50	nM	13.0
	6384417	CHEMBL1837408	Inhibition of human recombinant full length GSK3-beta after 1 hrs by luminescence assay	B	COc1c(NCCNc2ccccn2)c(F)c(N)c2c(=O)c(C(=O)O)cn(C3CC3)c12		CHEMBL1834316	=	IC50	nM	160.0	CHEMBL262	Homo sapiens	IC50	nM	160.0
	6384418	CHEMBL1837408	Inhibition of human recombinant full length GSK3-beta after 1 hrs by luminescence assay	B	COc1c(NCCNc2ccccn2)c(F)c(N)c2c(=O)c(C(=O)O)cn(C3CCCC3)c12		CHEMBL1834317	=	IC50	nM	1500.0	CHEMBL262	Homo sapiens	IC50	nM	1500.0
	6384419	CHEMBL1837408	Inhibition of human recombinant full length GSK3-beta after 1 hrs by luminescence assay	B	Nc1c(F)c(NCCNc2ccccn2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CCCC1		CHEMBL1834318	=	IC50	nM	22.0	CHEMBL262	Homo sapiens	IC50	nM	22.0
	6384420	CHEMBL1837408	Inhibition of human recombinant full length GSK3-beta after 1 hrs by luminescence assay	B	COc1c(NCCNc2ccccn2)c(F)c(N)c2c(=O)c(C(=O)O)c[nH]c12		CHEMBL1834319	=	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	nM	1000.0
	6384421	CHEMBL1837408	Inhibition of human recombinant full length GSK3-beta after 1 hrs by luminescence assay	B	COc1c(NCCNc2ccccn2)c(F)c(N)c2c(=O)c(C(=O)O)cn(C)c12		CHEMBL1834320	=	IC50	nM	270.0	CHEMBL262	Homo sapiens	IC50	nM	270.0
	6384422	CHEMBL1837408	Inhibition of human recombinant full length GSK3-beta after 1 hrs by luminescence assay	B	COc1c(NCCNc2ccccn2)c(F)c(N)c2c(=O)c(C(=O)O)cn(CCC(C)C)c12		CHEMBL1834321	=	IC50	nM	16000.0	CHEMBL262	Homo sapiens	IC50	nM	16000.0
	6384423	CHEMBL1837408	Inhibition of human recombinant full length GSK3-beta after 1 hrs by luminescence assay	B	C[C@@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834322	=	IC50	nM	560.0	CHEMBL262	Homo sapiens	IC50	nM	560.0
	6384424	CHEMBL1837408	Inhibition of human recombinant full length GSK3-beta after 1 hrs by luminescence assay	B	C[C@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834323	=	IC50	nM	44.0	CHEMBL262	Homo sapiens	IC50	nM	44.0
	6384425	CHEMBL1837408	Inhibition of human recombinant full length GSK3-beta after 1 hrs by luminescence assay	B	CC(C)[C@@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834324	=	IC50	nM	31.0	CHEMBL262	Homo sapiens	IC50	nM	31.0
	6384426	CHEMBL1837408	Inhibition of human recombinant full length GSK3-beta after 1 hrs by luminescence assay	B	CC(C)[C@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834325	=	IC50	nM	75.0	CHEMBL262	Homo sapiens	IC50	nM	75.0
	6384427	CHEMBL1837408	Inhibition of human recombinant full length GSK3-beta after 1 hrs by luminescence assay	B	CC1(C)COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834326	=	IC50	nM	49.0	CHEMBL262	Homo sapiens	IC50	nM	49.0
	6384428	CHEMBL1837408	Inhibition of human recombinant full length GSK3-beta after 1 hrs by luminescence assay	B	CC1(C)Cn2cc(C(=O)O)c(=O)c3c(N)c(F)c(NCCNc4ccccn4)c(c32)O1		CHEMBL1834327	=	IC50	nM	440.0	CHEMBL262	Homo sapiens	IC50	nM	440.0
	6384429	CHEMBL1837408	Inhibition of human recombinant full length GSK3-beta after 1 hrs by luminescence assay	B	CC1(C)COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn(c23)C1		CHEMBL1834328	=	IC50	nM	160.0	CHEMBL262	Homo sapiens	IC50	nM	160.0
	6384430	CHEMBL1837408	Inhibition of human recombinant full length GSK3-beta after 1 hrs by luminescence assay	B	Nc1c(F)c(NCCNc2ccccn2)c2c3c1c(=O)c(C(=O)O)cn3C1(CCC1)CO2		CHEMBL1834329	=	IC50	nM	57.0	CHEMBL262	Homo sapiens	IC50	nM	57.0
	6384431	CHEMBL1837408	Inhibition of human recombinant full length GSK3-beta after 1 hrs by luminescence assay	B	Nc1c(F)c(NCCNc2ccccn2)c2c3c1c(=O)c(C(=O)O)cn3C1(CCCC1)CO2		CHEMBL1834330	=	IC50	nM	12.0	CHEMBL262	Homo sapiens	IC50	nM	12.0
	6384469	CHEMBL1837572	Inhibition of human GSK3-beta in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCCc2ccccc2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CC1		CHEMBL1834114	=	Inhibition	%	82.2	CHEMBL262	Homo sapiens	INH	%	82.2
	6384470	CHEMBL1837572	Inhibition of human GSK3-beta in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CCCC1		CHEMBL1834318	=	Inhibition	%	97.3	CHEMBL262	Homo sapiens	INH	%	97.3
	6384471	CHEMBL1837572	Inhibition of human GSK3-beta in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	C[C@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834323	=	Inhibition	%	98.2	CHEMBL262	Homo sapiens	INH	%	98.2
	6384472	CHEMBL1837572	Inhibition of human GSK3-beta in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	CC(C)[C@@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834324	=	Inhibition	%	95.9	CHEMBL262	Homo sapiens	INH	%	95.9
	6384473	CHEMBL1837572	Inhibition of human GSK3-beta in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c2c3c1c(=O)c(C(=O)O)cn3C1(CCCC1)CO2		CHEMBL1834330	=	Inhibition	%	97.2	CHEMBL262	Homo sapiens	INH	%	97.2
	6385863	CHEMBL1837408	Inhibition of human recombinant full length GSK3-beta after 1 hrs by luminescence assay	B	Nc1ccc(CCNc2c(F)c(N)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)cc1		CHEMBL1834331	=	IC50	nM	900.0	CHEMBL262	Homo sapiens	IC50	nM	900.0
	6386338	CHEMBL1839877	Inhibition of recombinant GSK3-beta	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O		CHEMBL1834657	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
active	6967636	CHEMBL1794576	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	O=C1Nc2cc(C(=O)NCCN3CCCCCC3)ccc2S/C1=C\c1ccccc1		CHEMBL1431441	=	AC50	nM	2290.0	CHEMBL262	Homo sapiens	AC50	uM	2.29
active	6967637	CHEMBL1794576	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	Nc1nc(Nc2cccc(F)c2)nc(NCCO)c1[N+](=O)[O-]		CHEMBL1405580	=	AC50	nM	228.0	CHEMBL262	Homo sapiens	AC50	uM	0.228
active	6967638	CHEMBL1794576	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	COc1ccc2nc(NC(=O)CCNC(=O)c3ccccc3Cl)sc2c1		CHEMBL1498228	=	AC50	nM	1530.0	CHEMBL262	Homo sapiens	AC50	uM	1.53
active	6967639	CHEMBL1794576	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	c1ccc2c(CSc3nnc(-c4ccncc4)o3)cccc2c1		CHEMBL1547788	=	AC50	nM	143.0	CHEMBL262	Homo sapiens	AC50	uM	0.143
active	6967640	CHEMBL1794576	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	O/N=C/c1cn(-c2ccccc2)nc1-c1cccnc1		CHEMBL1870845	=	AC50	nM	246.0	CHEMBL262	Homo sapiens	AC50	uM	0.246
active	6967641	CHEMBL1794576	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	COC(=O)c1ccc(CSc2ccc3nnc(-c4ccc(OC)cc4)n3n2)o1		CHEMBL1585498	=	AC50	nM	1940.0	CHEMBL262	Homo sapiens	AC50	uM	1.94
active	6967642	CHEMBL1794576	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	Nc1nc(NCCCN2CCOCC2)nc(Nc2ccc(F)cc2)c1[N+](=O)[O-]		CHEMBL1382985	=	AC50	nM	406.0	CHEMBL262	Homo sapiens	AC50	uM	0.406
active	6967643	CHEMBL1794576	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	Cc1ccc(-n2c(C)c([N+](=O)[O-])c3ccc(O)cc32)cc1		CHEMBL1520241	<	AC50	nM	68.0	CHEMBL262	Homo sapiens	AC50	uM	0.068
active	6967644	CHEMBL1794576	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	c1cncc(-c2nc(NCCCn3cccc3)c3ccccc3n2)c1		CHEMBL1895793	=	AC50	nM	2970.0	CHEMBL262	Homo sapiens	AC50	uM	2.97
active	7154116	CHEMBL1794576	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	Nc1nc(NCCCN2CCOCC2)nc(Nc2cccc(F)c2)c1[N+](=O)[O-]		CHEMBL1521195	=	AC50	nM	208.0	CHEMBL262	Homo sapiens	AC50	uM	0.208
active	7154117	CHEMBL1794576	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	CCCn1nc(NC(=O)c2cccs2)c2cc3cc(OC)ccc3nc21		CHEMBL1534168	=	AC50	nM	445.0	CHEMBL262	Homo sapiens	AC50	uM	0.445
active	7154118	CHEMBL1794576	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	CCOC(=O)c1nnn(-c2nonc2N)c1CSc1ccc(C)cc1		CHEMBL1580903	=	AC50	nM	1190.0	CHEMBL262	Homo sapiens	AC50	uM	1.19
active	7154119	CHEMBL1794576	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	C=CCNc1nc(N)c([N+](=O)[O-])c(Nc2ccccc2OC)n1		CHEMBL1433424	=	AC50	nM	54.4	CHEMBL262	Homo sapiens	AC50	uM	0.0544
active	7154120	CHEMBL1794576	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	CCCn1nc(NC(=O)C(C)C)c2cc3cc(OC)ccc3nc21		CHEMBL1301070	=	AC50	nM	3250.0	CHEMBL262	Homo sapiens	AC50	uM	3.25
active	7154121	CHEMBL1794576	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	COC(=O)c1ccc(CSc2nnc(-c3ccncc3)o2)cc1		CHEMBL1700288	=	AC50	nM	395.0	CHEMBL262	Homo sapiens	AC50	uM	0.395
active	7154122	CHEMBL1794576	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	CCCCOC(=O)C1C(C)=Nc2ncnn2C1c1cccc(OC)c1OC		CHEMBL1905464	=	AC50	nM	538.0	CHEMBL262	Homo sapiens	AC50	uM	0.538
active	7552270	CHEMBL1794446	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	COC(=O)c1nnn(-c2nonc2N)c1CSc1nc2ccccc2s1		CHEMBL1310209	=	AC50	nM	1310.0	CHEMBL262	Homo sapiens	AC50	uM	1.31
active	7552271	CHEMBL1794446	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	COc1ccc2nc3c(cc2c1)c(NC(=O)CC(C)C)nn3CC(C)C		CHEMBL1731237	=	AC50	nM	228.0	CHEMBL262	Homo sapiens	AC50	uM	0.228
active	7552272	CHEMBL1794446	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	CCCN(CCC)Cc1c(C(=O)N/N=C/c2ccoc2)nnn1-c1nonc1N		CHEMBL1890348	=	AC50	nM	457.0	CHEMBL262	Homo sapiens	AC50	uM	0.457
active	7552273	CHEMBL1794446	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	c1ccc(-c2nc(NCCCn3ccnc3)c3ccccc3n2)cc1		CHEMBL1399850	=	AC50	nM	8780.0	CHEMBL262	Homo sapiens	AC50	uM	8.78
active	7552274	CHEMBL1794446	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	O=C(Nc1ccsc1C(=O)NC1CCCCC1)c1ccc(F)cc1		CHEMBL588859	=	AC50	nM	6280.0	CHEMBL262	Homo sapiens	AC50	uM	6.28
active	7552275	CHEMBL1794446	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	O=C1Nc2ccc3ncsc3c2/C1=C/Nc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1276446	=	AC50	nM	12.4	CHEMBL262	Homo sapiens	AC50	uM	0.0124
active	7552276	CHEMBL1794446	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	Nc1nonc1-n1nnc(C(=O)N/N=C/c2ccccc2Cl)c1CN1CCOCC1		CHEMBL1871132	=	AC50	nM	2000.0	CHEMBL262	Homo sapiens	AC50	uM	2.0
active	7552277	CHEMBL1794446	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	COc1cccc(C(=O)c2sc(NC(C)C)nc2N)c1		CHEMBL1464354	=	AC50	nM	252.0	CHEMBL262	Homo sapiens	AC50	uM	0.252
active	7552278	CHEMBL1794446	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	CCNc1nc(N)c(C(=O)c2ccc(Cl)s2)s1		CHEMBL1448605	<	AC50	nM	16.0	CHEMBL262	Homo sapiens	AC50	uM	0.016
active	7552279	CHEMBL1794446	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	COc1ccccc1Nc1nc(NCCO)nc(N)c1[N+](=O)[O-]		CHEMBL1369106	=	AC50	nM	134.0	CHEMBL262	Homo sapiens	AC50	uM	0.134
active	7552280	CHEMBL1794446	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	O/N=C/c1cn(-c2ccccc2)nc1-c1ccc2c(c1)OCCO2		CHEMBL1896042	=	AC50	nM	351.0	CHEMBL262	Homo sapiens	AC50	uM	0.351
active	7552281	CHEMBL1794446	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	Nc1nonc1-n1nnc(C(=O)N/N=C/c2ccccc2F)c1-c1cccs1		CHEMBL1896181	=	AC50	nM	325.0	CHEMBL262	Homo sapiens	AC50	uM	0.325
active	7552282	CHEMBL1794446	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	CCOC(=O)c1ccc2ncc(C(=O)OCC)c(Nc3ccc(N4CCOCC4)cc3)c2c1		CHEMBL1300063	=	AC50	nM	1160.0	CHEMBL262	Homo sapiens	AC50	uM	1.16
active	7552283	CHEMBL1794446	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	O=C1Nc2ccc3ncsc3c2/C1=C/Nc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1276446	<	AC50	nM	16.0	CHEMBL262	Homo sapiens	AC50	uM	0.016
active	7552284	CHEMBL1794446	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	Cn1c(SCc2nnc(-c3ccc(F)cc3)o2)nnc1C1COc2ccccc2O1		CHEMBL1547186	=	AC50	nM	700.0	CHEMBL262	Homo sapiens	AC50	uM	0.7
active	7552285	CHEMBL1794446	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	O=C(CSc1ccc2nnc(-c3cccs3)n2n1)N1CCCC1		CHEMBL1344120	=	AC50	nM	742.0	CHEMBL262	Homo sapiens	AC50	uM	0.742
active	7552286	CHEMBL1794446	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	O=C(Nc1cccc(Cl)c1)Nc1ccnc(-c2cccnc2)n1		CHEMBL1341040	=	AC50	nM	716.0	CHEMBL262	Homo sapiens	AC50	uM	0.716
active	7552287	CHEMBL1794446	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	Nc1nc(Nc2ccccc2)nc(NC2CCCCC2)c1[N+](=O)[O-]		CHEMBL1538986	=	AC50	nM	1040.0	CHEMBL262	Homo sapiens	AC50	uM	1.04
active	7552288	CHEMBL1794446	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	O=C(CN1C(=O)CCC1=O)Nc1cccc2c1C(=O)NC2=O		CHEMBL1545694	=	AC50	nM	261.0	CHEMBL262	Homo sapiens	AC50	uM	0.261
active	7552289	CHEMBL1794446	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	CN(C)Cc1c(C(=O)N/N=C/c2ccncc2)nnn1-c1nonc1N		CHEMBL1903171	=	AC50	nM	255.0	CHEMBL262	Homo sapiens	AC50	uM	0.255
active	7552290	CHEMBL1794446	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	O=C1c2ccccc2-c2onc3ccc(NCCCN4CCNC4)c1c23		CHEMBL1881885	=	AC50	nM	161.0	CHEMBL262	Homo sapiens	AC50	uM	0.161
active	7552291	CHEMBL1794446	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	Nc1nc(NCCCN2CCOCC2)nc(Nc2cccc(Cl)c2)c1[N+](=O)[O-]		CHEMBL1447858	=	AC50	nM	253.0	CHEMBL262	Homo sapiens	AC50	uM	0.253
active	7552292	CHEMBL1794446	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	CCOc1ccccc1/C=N/NC(=O)c1nnn(-c2nonc2N)c1CN1CCC(C)CC1		CHEMBL1904855	<	AC50	nM	16.0	CHEMBL262	Homo sapiens	AC50	uM	0.016
active	7552293	CHEMBL1794446	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	Fc1ccc(CSc2nnc(-c3ccncc3)o2)cc1		CHEMBL1471916	=	AC50	nM	578.0	CHEMBL262	Homo sapiens	AC50	uM	0.578
active	7552294	CHEMBL1794446	PUBCHEM_BIOASSAY: Inhibition of Human GSK-3 beta Activity Measured in Biochemical System Using Microfluidics - 2063-05_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2709]	B	COc1cc(/C=N/Nc2ccc([N+](=O)[O-])cn2)cc(OC)c1O		CHEMBL1884163	=	AC50	nM	95.0	CHEMBL262	Homo sapiens	AC50	uM	0.095
	7567251	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7567710	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7568181	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7568639	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7569224	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7569684	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7570177	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7570604	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7571200	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7571657	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7571691	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7572154	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7572570	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7573181	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	83.0	CHEMBL262	Homo sapiens	Kd	nM	83.0
	7573672	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	720.0	CHEMBL262	Homo sapiens	Kd	nM	720.0
	7574141	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	1800.0	CHEMBL262	Homo sapiens	Kd	nM	1800.0
	7574549	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7575178	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7575649	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7576114	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7576522	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7576691	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7577150	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7577628	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7578098	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7578503	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7578699	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	=	Kd	nM	350.0	CHEMBL262	Homo sapiens	Kd	nM	350.0
	7579073	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7579523	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	730.0	CHEMBL262	Homo sapiens	Kd	nM	730.0
	7579997	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7580466	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7580869	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7581057	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7581442	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7581887	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7582358	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	=	Kd	nM	8.3	CHEMBL262	Homo sapiens	Kd	nM	8.3
	7582822	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	120.0	CHEMBL262	Homo sapiens	Kd	nM	120.0
	7583403	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7583800	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	Kd	nM	37.0	CHEMBL262	Homo sapiens	Kd	nM	37.0
	7584245	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7584716	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	2600.0	CHEMBL262	Homo sapiens	Kd	nM	2600.0
	7585140	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7585733	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7586141	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7586587	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7587070	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	=	Kd	nM	230.0	CHEMBL262	Homo sapiens	Kd	nM	230.0
	7587694	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7588113	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	1300.0	CHEMBL262	Homo sapiens	Kd	nM	1300.0
	7588595	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7589046	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Kd	nM	1700.0	CHEMBL262	Homo sapiens	Kd	nM	1700.0
	7589659	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7590083	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	350.0	CHEMBL262	Homo sapiens	Kd	nM	350.0
	7590108	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7590582	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7591033	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7592084	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7592557	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7593010	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7593157	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7593592	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7594064	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	=	Kd	nM	100.0	CHEMBL262	Homo sapiens	Kd	nM	100.0
	7594537	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7594989	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7595125	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	=	Kd	nM	11.0	CHEMBL262	Homo sapiens	Kd	nM	11.0
	7595569	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7596043	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7596514	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7596961	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	69.0	CHEMBL262	Homo sapiens	Kd	nM	69.0
	7597097	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7597550	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7598023	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
	7598493	CHEMBL1908553	Binding constant for GSK3B kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL262	Homo sapiens	Kd	nM	10000.0
Dose-dependent effect	7850750	CHEMBL1913784	Inhibition of GSK3-beta in human A549 cells after 24 hrs by Western blot analysis	B	C=C(C)[C@@]12O[C@@]3(/C=C/C=C/CCCCC)O[C@@H]1[C@@H]1[C@@H]4O[C@]4(CO)[C@@H](O)[C@]4(O)C(=O)C(C)=C[C@H]4[C@@]1(O3)[C@H](C)[C@H]2OC(C)=O		CHEMBL1911631		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	7922660	CHEMBL1918893	Inhibition of human recombinant GSK3-beta at 0.5 uM by radiometric filter-binding assay	B	Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12		CHEMBL1915438	=	Inhibition	%	77.0	CHEMBL262	Homo sapiens	INH	%	77.0
	7931095	CHEMBL1919270	Inhibition of GSK3B relative to control	B	Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916891	=	Inhibition	%	6.0	CHEMBL262	Homo sapiens	INH	%	6.0
	7939640	CHEMBL1919600	Inhibition of human GSK3-beta	B	[O-][n+]1ccc2c(-c3ccc(F)cc3Cl)ccnc2c1-c1c(Cl)cccc1Cl		CHEMBL1916359	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	7943737	CHEMBL1921580	Inhibition of GSK3-beta	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	9.23	CHEMBL262	Homo sapiens	IC50	nM	9.23
	7943777	CHEMBL1921545	Inhibition of GSK3-beta at 10 uM	B	O=C1CC(c2cccc(NC(=O)c3ccc(Cl)c(C(F)(F)F)c3)c2)=Nc2cnn(Cc3ccccc3)c2N1		CHEMBL1917776	=	Inhibition	%	17.8	CHEMBL262	Homo sapiens	INH	%	17.8
	7956243	CHEMBL1925202	Inhibition of N-terminus flag-tagged GSK3-beta expressed in baculovirus infected insect cells using [gamma33P]ATP as substrate after 60 mins by scintillation counting	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	nM	10000.0
	7959789	CHEMBL1932869	Inhibition of GSK3-beta	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	>	IC50	nM	30000.0	CHEMBL262	Homo sapiens	IC50	uM	30.0
	7959790	CHEMBL1932869	Inhibition of GSK3-beta	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	IC50	nM	30000.0	CHEMBL262	Homo sapiens	IC50	uM	30.0
	7969725	CHEMBL1931225	Inhibition of GSK3b assessed as residual activity at 10 uM using [33P-ATP] by radiometric filter binding assay	B	Cc1ccc(F)cc1-c1nc2[nH]nc(N)c2c2c1CCCC2		CHEMBL1927262	=	Activity	%	73.0	CHEMBL262	Homo sapiens	Activity	%	73.0
	7970429	CHEMBL1930188	Inhibition of GSK3-beta at 10 uM	B	NCCN1C(=O)S/C(=C\CCC2CCCCC2)C1=O		CHEMBL1929247	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	INH	%	0.0
	7984080	CHEMBL1936516	Inhibition of GSK3-beta	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3nccc(-c4cc(C(N)=O)cn4C)n3)c2)CC1		CHEMBL1933576	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	7984081	CHEMBL1936516	Inhibition of GSK3-beta	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3nccc(-c4cc5c(n4C)CCNC5=O)n3)c2)CC1		CHEMBL1933582	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	7987120	CHEMBL1936073	Inhibition of Gsk3beta	B	O=C(c1cc2cc(F)ccc2[nH]1)N1C[C@]2(CCN(C3CCCNC3)C2)c2ccccc21		CHEMBL1933538	>	IC50	nM	30000.0	CHEMBL262	Homo sapiens	IC50	uM	30.0
	7987142	CHEMBL1936073	Inhibition of Gsk3beta	B	O=C(c1cc2ccc(F)cc2[nH]1)N1C[C@]2(CCN(C3CCNC3)C2)c2ccccc21		CHEMBL1933550	>	IC50	nM	30000.0	CHEMBL262	Homo sapiens	IC50	uM	30.0
	7987164	CHEMBL1936073	Inhibition of Gsk3beta	B	C[C@@H]1CCC(N2CC[C@]3(CN(C(=O)c4cc5ccccc5[nH]4)c4ccccc43)C2)CN1		CHEMBL1933551	>	IC50	nM	30000.0	CHEMBL262	Homo sapiens	IC50	uM	30.0
	7987196	CHEMBL1936073	Inhibition of Gsk3beta	B	C[C@@H]1CCC(N2CC[C@]3(CN(C(=O)c4cc5ccc(F)cc5[nH]4)c4ccccc43)C2)CN1		CHEMBL1933552	>	IC50	nM	30000.0	CHEMBL262	Homo sapiens	IC50	uM	30.0
	7992190	CHEMBL1935888	Inhibition of GSK3 beta at 1 uM	B	CN(c1ccccc1-c1cc(Cl)c2cnc(Nc3ccc(C4CCN(CC(N)=O)CC4)cc3)nn12)S(C)(=O)=O		CHEMBL1934353	=	Inhibition	%	101.0	CHEMBL262	Homo sapiens	INH	%	101.0
Active	7996796	CHEMBL1941723	Inhibition of GSK3-beta at 10 uM by colorimetric analysis	B	Clc1ccc(-n2cc(-c3ccncc3)nn2)cc1		CHEMBL1938953		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	7996797	CHEMBL1941723	Inhibition of GSK3-beta at 10 uM by colorimetric analysis	B	Clc1cccc(-n2cc(-c3ccncc3)nn2)c1		CHEMBL1938954		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	7996798	CHEMBL1941723	Inhibition of GSK3-beta at 10 uM by colorimetric analysis	B	Clc1ccc(-n2nncc2-c2ccncc2)cc1		CHEMBL62965		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	7996799	CHEMBL1941723	Inhibition of GSK3-beta at 10 uM by colorimetric analysis	B	Clc1cccc(-n2nncc2-c2ccncc2)c1		CHEMBL303351		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	7996880	CHEMBL1941740	Inhibition of GSK3-beta by colorimetric analysis	B	Clc1ccc(-n2cc(-c3ccncc3)nn2)cc1		CHEMBL1938953	=	IC50	nM	1100.0	CHEMBL262	Homo sapiens	IC50	uM	1.1
	7996881	CHEMBL1941740	Inhibition of GSK3-beta by colorimetric analysis	B	Clc1cccc(-n2cc(-c3ccncc3)nn2)c1		CHEMBL1938954	=	IC50	nM	1800.0	CHEMBL262	Homo sapiens	IC50	uM	1.8
	7996882	CHEMBL1941740	Inhibition of GSK3-beta by colorimetric analysis	B	Cc1ccc(-n2cc(-c3ccccn3)nn2)cc1		CHEMBL1938958	>	IC50	nM	30000.0	CHEMBL262	Homo sapiens	IC50	uM	30.0
	7996883	CHEMBL1941740	Inhibition of GSK3-beta by colorimetric analysis	B	Cc1ccccc1-n1cc(-c2ccccn2)nn1		CHEMBL1938959	=	IC50	nM	490.0	CHEMBL262	Homo sapiens	IC50	uM	0.49
	7996884	CHEMBL1941740	Inhibition of GSK3-beta by colorimetric analysis	B	c1ccc(Cn2cc(-c3ccc4nccnc4c3)nn2)cc1		CHEMBL1938402	=	IC50	nM	9500.0	CHEMBL262	Homo sapiens	IC50	uM	9.5
	7996885	CHEMBL1941740	Inhibition of GSK3-beta by colorimetric analysis	B	Cc1ccccc1-n1nncc1-c1ccncc1		CHEMBL1938963	=	IC50	nM	6300.0	CHEMBL262	Homo sapiens	IC50	uM	6.3
	7996886	CHEMBL1941740	Inhibition of GSK3-beta by colorimetric analysis	B	c1cc(-c2cnnn2C2C3CC4CC(C3)CC2C4)ccn1		CHEMBL1938964	=	IC50	nM	2600.0	CHEMBL262	Homo sapiens	IC50	uM	2.6
	7996887	CHEMBL1941740	Inhibition of GSK3-beta by colorimetric analysis	B	c1cnc2cc(-c3cnnn3C3C4CC5CC(C4)CC3C5)ccc2n1		CHEMBL1938966	=	IC50	nM	2800.0	CHEMBL262	Homo sapiens	IC50	uM	2.8
	7996888	CHEMBL1941740	Inhibition of GSK3-beta by colorimetric analysis	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	11.0	CHEMBL262	Homo sapiens	IC50	uM	0.011
	7999689	CHEMBL1942618	Inhibition of GSK3-beta in human HepG2 cells assessed as incorporation of [3H]glucose into glycogen at 30 uM after 3 hrs by liquid scintillation counting relative to CHIR99021	B	Nc1c(F)c(NCCNc2ccccn2)c2c3c1c(=O)c(C(=O)O)cn3C1(CCO2)CC1		CHEMBL1940906	=	Efficacy	%	42.0	CHEMBL262	Homo sapiens	Efficacy	%	42.0
	7999690	CHEMBL1942618	Inhibition of GSK3-beta in human HepG2 cells assessed as incorporation of [3H]glucose into glycogen at 30 uM after 3 hrs by liquid scintillation counting relative to CHIR99021	B	CC1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn(c23)C12CCC2		CHEMBL1940907	=	Efficacy	%	48.0	CHEMBL262	Homo sapiens	Efficacy	%	48.0
	7999691	CHEMBL1942618	Inhibition of GSK3-beta in human HepG2 cells assessed as incorporation of [3H]glucose into glycogen at 30 uM after 3 hrs by liquid scintillation counting relative to CHIR99021	B	CC1CC2(CCC2)n2cc(C(=O)O)c(=O)c3c(N)c(F)c(NCCNc4ccccn4)c(c32)O1		CHEMBL1940908	=	Efficacy	%	94.0	CHEMBL262	Homo sapiens	Efficacy	%	94.0
	7999692	CHEMBL1942618	Inhibition of GSK3-beta in human HepG2 cells assessed as incorporation of [3H]glucose into glycogen at 30 uM after 3 hrs by liquid scintillation counting relative to CHIR99021	B	Nc1c(F)c(NCCNc2ccccn2)c2c3c1c(=O)c(C(=O)O)cn3C1(CCC1)CCN2		CHEMBL1940909	=	Efficacy	%	12.0	CHEMBL262	Homo sapiens	Efficacy	%	12.0
	7999693	CHEMBL1942618	Inhibition of GSK3-beta in human HepG2 cells assessed as incorporation of [3H]glucose into glycogen at 30 uM after 3 hrs by liquid scintillation counting relative to CHIR99021	B	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	=	Efficacy	%	100.0	CHEMBL262	Homo sapiens	Efficacy	%	100.0
	7999725	CHEMBL1942617	Inhibition of GSK3-beta in human HepG2 cells assessed as incorporation of [3H]glucose into glycogen after 3 hrs by liquid scintillation counting	B	Nc1c(F)c(NCCNc2ccccn2)c2c3c1c(=O)c(C(=O)O)cn3C1(CCCC1)CO2		CHEMBL1834330	=	EC50	nM	20000.0	CHEMBL262	Homo sapiens	EC50	uM	20.0
	7999726	CHEMBL1942615	Inhibition of GSK3-beta	B	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	=	IC50	nM	30.0	CHEMBL262	Homo sapiens	IC50	nM	30.0
	8001828	CHEMBL1942616	Inhibition of human recombinant GSK3-beta after 1 hr by KinaseGlo luciferase assay	B	Nc1c(F)c(NCCNc2ccccn2)c2c3c1c(=O)c(C(=O)O)cn3C1(CCCC1)CCO2		CHEMBL1940904	=	IC50	nM	250.0	CHEMBL262	Homo sapiens	IC50	nM	250.0
	8001829	CHEMBL1942616	Inhibition of human recombinant GSK3-beta after 1 hr by KinaseGlo luciferase assay	B	Nc1c(F)c(NCCNc2ccccn2)c2c3c1c(=O)c(C(=O)O)cn3C1(CCC1)CCO2		CHEMBL1940905	=	IC50	nM	36.0	CHEMBL262	Homo sapiens	IC50	nM	36.0
	8001830	CHEMBL1942616	Inhibition of human recombinant GSK3-beta after 1 hr by KinaseGlo luciferase assay	B	Nc1c(F)c(NCCNc2ccccn2)c2c3c1c(=O)c(C(=O)O)cn3C1(CCO2)CC1		CHEMBL1940906	=	IC50	nM	37.0	CHEMBL262	Homo sapiens	IC50	nM	37.0
	8001831	CHEMBL1942616	Inhibition of human recombinant GSK3-beta after 1 hr by KinaseGlo luciferase assay	B	CC1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn(c23)C12CCC2		CHEMBL1940907	=	IC50	nM	10.0	CHEMBL262	Homo sapiens	IC50	nM	10.0
	8001832	CHEMBL1942616	Inhibition of human recombinant GSK3-beta after 1 hr by KinaseGlo luciferase assay	B	CC1CC2(CCC2)n2cc(C(=O)O)c(=O)c3c(N)c(F)c(NCCNc4ccccn4)c(c32)O1		CHEMBL1940908	=	IC50	nM	250.0	CHEMBL262	Homo sapiens	IC50	nM	250.0
	8001833	CHEMBL1942616	Inhibition of human recombinant GSK3-beta after 1 hr by KinaseGlo luciferase assay	B	Nc1c(F)c(NCCNc2ccccn2)c2c3c1c(=O)c(C(=O)O)cn3C1(CCC1)CCN2		CHEMBL1940909	=	IC50	nM	550.0	CHEMBL262	Homo sapiens	IC50	nM	550.0
	8001834	CHEMBL1942616	Inhibition of human recombinant GSK3-beta after 1 hr by KinaseGlo luciferase assay	B	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	=	IC50	nM	30.0	CHEMBL262	Homo sapiens	IC50	nM	30.0
	8001835	CHEMBL1942617	Inhibition of GSK3-beta in human HepG2 cells assessed as incorporation of [3H]glucose into glycogen after 3 hrs by liquid scintillation counting	B	Nc1c(F)c(NCCNc2ccccn2)c2c3c1c(=O)c(C(=O)O)cn3C1(CCCC1)CCO2		CHEMBL1940904	=	EC50	nM	13000.0	CHEMBL262	Homo sapiens	EC50	uM	13.0
	8001836	CHEMBL1942617	Inhibition of GSK3-beta in human HepG2 cells assessed as incorporation of [3H]glucose into glycogen after 3 hrs by liquid scintillation counting	B	Nc1c(F)c(NCCNc2ccccn2)c2c3c1c(=O)c(C(=O)O)cn3C1(CCC1)CCO2		CHEMBL1940905	=	EC50	nM	3200.0	CHEMBL262	Homo sapiens	EC50	uM	3.2
	8001837	CHEMBL1942617	Inhibition of GSK3-beta in human HepG2 cells assessed as incorporation of [3H]glucose into glycogen after 3 hrs by liquid scintillation counting	B	CC1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn(c23)C12CCC2		CHEMBL1940907	=	EC50	nM	1400.0	CHEMBL262	Homo sapiens	EC50	uM	1.4
	8001838	CHEMBL1942617	Inhibition of GSK3-beta in human HepG2 cells assessed as incorporation of [3H]glucose into glycogen after 3 hrs by liquid scintillation counting	B	CC1CC2(CCC2)n2cc(C(=O)O)c(=O)c3c(N)c(F)c(NCCNc4ccccn4)c(c32)O1		CHEMBL1940908	=	EC50	nM	2100.0	CHEMBL262	Homo sapiens	EC50	uM	2.1
	8001839	CHEMBL1942617	Inhibition of GSK3-beta in human HepG2 cells assessed as incorporation of [3H]glucose into glycogen after 3 hrs by liquid scintillation counting	B	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	=	EC50	nM	1500.0	CHEMBL262	Homo sapiens	EC50	uM	1.5
	8001840	CHEMBL1942618	Inhibition of GSK3-beta in human HepG2 cells assessed as incorporation of [3H]glucose into glycogen at 30 uM after 3 hrs by liquid scintillation counting relative to CHIR99021	B	Nc1c(F)c(NCCNc2ccccn2)c2c3c1c(=O)c(C(=O)O)cn3C1(CCCC1)CCO2		CHEMBL1940904	=	Efficacy	%	85.0	CHEMBL262	Homo sapiens	Efficacy	%	85.0
	8001841	CHEMBL1942618	Inhibition of GSK3-beta in human HepG2 cells assessed as incorporation of [3H]glucose into glycogen at 30 uM after 3 hrs by liquid scintillation counting relative to CHIR99021	B	Nc1c(F)c(NCCNc2ccccn2)c2c3c1c(=O)c(C(=O)O)cn3C1(CCC1)CCO2		CHEMBL1940905	=	Efficacy	%	65.0	CHEMBL262	Homo sapiens	Efficacy	%	65.0
	8002080	CHEMBL1942176	Inhibition of GSK3B at 1 uM	B	CC(C)n1cc(C(=O)c2cncc(N[C@@H]3CCN(C=O)[C@@H]3c3ccc(F)cc3)n2)c2c(N)ncnc21		CHEMBL1940251	=	Inhibition	%	66.0	CHEMBL262	Homo sapiens	INH	%	66.0
	8002081	CHEMBL1942176	Inhibition of GSK3B at 1 uM	B	CC(=O)N1CC[C@@H](Nc2cncc(C(=O)c3cn(C(C)C)c4ncnc(N)c34)n2)[C@H]1c1ccc(F)cc1		CHEMBL1940252	=	Inhibition	%	76.0	CHEMBL262	Homo sapiens	INH	%	76.0
	8002082	CHEMBL1942176	Inhibition of GSK3B at 1 uM	B	CC(=O)N1CC[C@@H](Nc2cncc(C(=O)c3cn(C(C)C)c4ncnc(N)c34)n2)[C@H]1c1ccccc1		CHEMBL1940253	=	Inhibition	%	42.0	CHEMBL262	Homo sapiens	INH	%	42.0
	8002735	CHEMBL1942296	Inhibition of GSK3-beta	B	CC(C)n1cc(C(=O)c2cncc(N[C@@H]3CCN(C=O)[C@@H]3c3ccc(F)cc3)n2)c2c(N)ncnc21		CHEMBL1940251	=	IC50	nM	180.0	CHEMBL262	Homo sapiens	IC50	nM	180.0
	8002736	CHEMBL1942296	Inhibition of GSK3-beta	B	CC(=O)N1CC[C@@H](Nc2cncc(C(=O)c3cn(C(C)C)c4ncnc(N)c34)n2)[C@H]1c1ccc(F)cc1		CHEMBL1940252	=	IC50	nM	340.0	CHEMBL262	Homo sapiens	IC50	nM	340.0
	8002737	CHEMBL1942296	Inhibition of GSK3-beta	B	CC(=O)N1CC[C@@H](Nc2cncc(C(=O)c3cn(C(C)C)c4ncnc(N)c34)n2)[C@H]1c1ccccc1		CHEMBL1940253	=	IC50	nM	860.0	CHEMBL262	Homo sapiens	IC50	nM	860.0
	8003349	CHEMBL1944323	Inhibition of GSK3-beta	B	C[C@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834323	=	IC50	nM	44.0	CHEMBL262	Homo sapiens	IC50	nM	44.0
	8003350	CHEMBL1944323	Inhibition of GSK3-beta	B	C[C@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(N)=O)cn1c23		CHEMBL1940900	=	IC50	nM	33.0	CHEMBL262	Homo sapiens	IC50	nM	33.0
	8003351	CHEMBL1944323	Inhibition of GSK3-beta	B	C[C@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940976	=	IC50	nM	0.57	CHEMBL262	Homo sapiens	IC50	nM	0.57
	8003352	CHEMBL1944323	Inhibition of GSK3-beta	B	C[C@H]1COc2c(NCCCc3ccccc3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940977	=	IC50	nM	40.0	CHEMBL262	Homo sapiens	IC50	nM	40.0
	8003353	CHEMBL1944323	Inhibition of GSK3-beta	B	C[C@H]1COc2c(NCCCc3ccccc3)c(F)c(N)c3c(=O)c(C(N)=O)cn1c23		CHEMBL1940978	=	IC50	nM	67.0	CHEMBL262	Homo sapiens	IC50	nM	67.0
	8003354	CHEMBL1944323	Inhibition of GSK3-beta	B	C[C@H]1COc2c(NCCCc3ccccc3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940979	=	IC50	nM	1.4	CHEMBL262	Homo sapiens	IC50	nM	1.4
	8003355	CHEMBL1944323	Inhibition of GSK3-beta	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940980	=	IC50	nM	16.0	CHEMBL262	Homo sapiens	IC50	nM	16.0
	8003356	CHEMBL1944323	Inhibition of GSK3-beta	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940981	=	IC50	nM	0.86	CHEMBL262	Homo sapiens	IC50	nM	0.86
	8003357	CHEMBL1944323	Inhibition of GSK3-beta	B	C[C@H]1COc2c(NCCCn3ccnc3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940982	=	IC50	nM	150.0	CHEMBL262	Homo sapiens	IC50	nM	150.0
	8003358	CHEMBL1944323	Inhibition of GSK3-beta	B	C[C@H]1COc2c(NCCCn3ccnc3)c(F)c(N)c3c(=O)c(C(N)=O)cn1c23		CHEMBL1940983	=	IC50	nM	180.0	CHEMBL262	Homo sapiens	IC50	nM	180.0
	8003359	CHEMBL1944323	Inhibition of GSK3-beta	B	C[C@H]1COc2c(NCCCn3ccnc3)c(F)c(N)c3c(=O)c(C(=N)NO)cn1c23		CHEMBL1940984	=	IC50	nM	140.0	CHEMBL262	Homo sapiens	IC50	nM	140.0
	8003360	CHEMBL1944323	Inhibition of GSK3-beta	B	C[C@H]1COc2c(NCCCn3ccnc3)c(F)c(N)c3c(=O)c(-c4nnn[nH]4)cn1c23		CHEMBL1940985	=	IC50	nM	20.0	CHEMBL262	Homo sapiens	IC50	nM	20.0
	8003361	CHEMBL1944323	Inhibition of GSK3-beta	B	C[C@H]1COc2c(NCCCn3ccnc3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940986	=	IC50	nM	1.0	CHEMBL262	Homo sapiens	IC50	nM	1.0
	8003362	CHEMBL1944323	Inhibition of GSK3-beta	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940987	=	IC50	nM	10.0	CHEMBL262	Homo sapiens	IC50	nM	10.0
	8003363	CHEMBL1944323	Inhibition of GSK3-beta	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C(=N)NO)cn1c23		CHEMBL1940988	=	IC50	nM	71.0	CHEMBL262	Homo sapiens	IC50	nM	71.0
	8003364	CHEMBL1944323	Inhibition of GSK3-beta	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(-c4nnn[nH]4)cn1c23		CHEMBL1940989	=	IC50	nM	2.4	CHEMBL262	Homo sapiens	IC50	nM	2.4
	8003365	CHEMBL1944323	Inhibition of GSK3-beta	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940990	=	IC50	nM	0.6	CHEMBL262	Homo sapiens	IC50	nM	0.6
	8003400	CHEMBL1944411	Inhibition of human GSK3-beta in HL-60 cells lysate assessed as reduction of labelling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940980	=	Inhibition	%	87.8	CHEMBL262	Homo sapiens	INH	%	87.8
	8003401	CHEMBL1944411	Inhibition of human GSK3-beta in HL-60 cells lysate assessed as reduction of labelling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940981	=	Inhibition	%	99.2	CHEMBL262	Homo sapiens	INH	%	99.2
	8003402	CHEMBL1944411	Inhibition of human GSK3-beta in HL-60 cells lysate assessed as reduction of labelling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940987	=	Inhibition	%	82.9	CHEMBL262	Homo sapiens	INH	%	82.9
	8003403	CHEMBL1944411	Inhibition of human GSK3-beta in HL-60 cells lysate assessed as reduction of labelling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940990	>	Inhibition	%	99.5	CHEMBL262	Homo sapiens	INH	%	99.5
	8012910	CHEMBL1947281	Binding affinity to GSK3-beta assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	CCN1CCC2(CC1)NC(=O)c1c(c3ccc(Cl)c(Cl)c3n1C)C2C#N		CHEMBL1945557	=	Delta Tm	degrees C	1.5	CHEMBL262	Homo sapiens	deltaTm	degrees C	1.5
	8012935	CHEMBL1947281	Binding affinity to GSK3-beta assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCN(C(=O)OC(C)(C)C)CC1)NC2=O		CHEMBL1945558	=	Delta Tm	degrees C	-0.2	CHEMBL262	Homo sapiens	deltaTm	degrees C	-0.2
	8012959	CHEMBL1947281	Binding affinity to GSK3-beta assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCNCC1)NC2=O		CHEMBL1945559	=	Delta Tm	degrees C	3.9	CHEMBL262	Homo sapiens	deltaTm	degrees C	3.9
	8012983	CHEMBL1947281	Binding affinity to GSK3-beta assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	N#CC1c2c([nH]c3c(Cl)c(Cl)ccc23)C(=O)NC12CCCCC2		CHEMBL1945560	=	Delta Tm	degrees C	2.6	CHEMBL262	Homo sapiens	deltaTm	degrees C	2.6
	8013007	CHEMBL1947281	Binding affinity to GSK3-beta assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(CN)C(C)(C)NC2=O		CHEMBL1945561	=	Delta Tm	degrees C	0.6	CHEMBL262	Homo sapiens	deltaTm	degrees C	0.6
	8013032	CHEMBL1947281	Binding affinity to GSK3-beta assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	CC(=O)NCC1c2c(n(C)c3c(Cl)c(Cl)ccc23)C(=O)NC1(C)C		CHEMBL1945562	=	Delta Tm	degrees C	0.2	CHEMBL262	Homo sapiens	deltaTm	degrees C	0.2
	8013088	CHEMBL1948022	Inhibition of GSK3-beta using ATP as substrate	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCNCC1)NC2=O		CHEMBL1945559	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	8018783	CHEMBL1948831	Inhibition of GSK3-beta assessed as activity remaining at 10 uM	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CC1CCOCC1		CHEMBL1945953	=	Activity	%	70.0	CHEMBL262	Homo sapiens	Activity	%	70.0
	8018784	CHEMBL1948831	Inhibition of GSK3-beta assessed as activity remaining at 10 uM	B	CC(C)(O)c1ccc(-c2cnc3[nH]c(=O)n(CC4CCCCC4)c3n2)cc1		CHEMBL1945950	=	Activity	%	31.0	CHEMBL262	Homo sapiens	Activity	%	31.0
	8018785	CHEMBL1948831	Inhibition of GSK3-beta assessed as activity remaining at 10 uM	B	O=c1[nH]c2ncc(-c3ccc4[nH]cnc4c3)nc2n1CC1CCCCC1		CHEMBL1946262	=	Activity	%	10.0	CHEMBL262	Homo sapiens	Activity	%	10.0
	8027511	CHEMBL1947281	Binding affinity to GSK3-beta assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(Cl)c(Cl)ccc2c2cc[nH]c(=O)c21		CHEMBL474872	=	Delta Tm	degrees C	1.4	CHEMBL262	Homo sapiens	deltaTm	degrees C	1.4
	8027536	CHEMBL1947281	Binding affinity to GSK3-beta assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(Cl)c(Cl)ccc2c2cc(N)[nH]c(=O)c21		CHEMBL1945336	=	Delta Tm	degrees C	2.9	CHEMBL262	Homo sapiens	deltaTm	degrees C	2.9
	8027561	CHEMBL1947281	Binding affinity to GSK3-beta assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C(C)(C)NC2=O		CHEMBL1945337	=	Delta Tm	degrees C	5.6	CHEMBL262	Homo sapiens	deltaTm	degrees C	5.6
	8027586	CHEMBL1947281	Binding affinity to GSK3-beta assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	CC1(C)NC(=O)c2[nH]c3c(Cl)c(Cl)ccc3c2C1C#N		CHEMBL1945338	=	Delta Tm	degrees C	4.7	CHEMBL262	Homo sapiens	deltaTm	degrees C	4.7
	8027611	CHEMBL1947281	Binding affinity to GSK3-beta assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	CCC1(CC)NC(=O)c2c(c3ccc(Cl)c(Cl)c3n2C)C1C#N		CHEMBL1945339	=	Delta Tm	degrees C	2.0	CHEMBL262	Homo sapiens	deltaTm	degrees C	2.0
	8027636	CHEMBL1947281	Binding affinity to GSK3-beta assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(c3ccccc31)C(C#N)C(C)(C)NC2=O		CHEMBL1945340	=	Delta Tm	degrees C	1.8	CHEMBL262	Homo sapiens	deltaTm	degrees C	1.8
	8027672	CHEMBL1947281	Binding affinity to GSK3-beta assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCCC1)NC2=O		CHEMBL1945554	=	Delta Tm	degrees C	2.5	CHEMBL262	Homo sapiens	deltaTm	degrees C	2.5
	8027697	CHEMBL1947281	Binding affinity to GSK3-beta assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCOCC1)NC2=O		CHEMBL1945335	=	Delta Tm	degrees C	3.4	CHEMBL262	Homo sapiens	deltaTm	degrees C	3.4
	8027722	CHEMBL1947281	Binding affinity to GSK3-beta assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	Cn1c2c(Cl)c(Cl)ccc2c2cn[nH]c(=O)c21		CHEMBL1945555	=	Delta Tm	degrees C	4.6	CHEMBL262	Homo sapiens	deltaTm	degrees C	4.6
	8027747	CHEMBL1947281	Binding affinity to GSK3-beta assessed as change in thermal denaturation at 10 uM by thermal stability shift assay	B	CN1CCC2(CC1)NC(=O)c1c(c3ccc(Cl)c(Cl)c3n1C)C2C#N		CHEMBL1945556	=	Delta Tm	degrees C	2.2	CHEMBL262	Homo sapiens	deltaTm	degrees C	2.2
	8039308	CHEMBL1953283	Inhibition of GSK3-beta	B	COc1ccc(C(=O)NC[C@@H](O)CO)cc1/C=C/c1ccc(Cl)cc1		CHEMBL1949788	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	8039309	CHEMBL1953283	Inhibition of GSK3-beta	B	COc1ccc(C(=O)NC[C@H](O)CO)cc1/C=C/c1ccc(Cl)cc1		CHEMBL1949789	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	8045854	CHEMBL1959333	Inhibition of human His-tagged GSK-3b using biotin-6-amino caproic acid-AAAKRREILSRRPS(PO3)YR-amide as substrate after 19 mins by NXT scintillation counting	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	IC50	nM	32000.0	CHEMBL262	Homo sapiens	IC50	uM	32.0
	8046149	CHEMBL1960375	Inhibition of GSK3-beta by fluorescence polarization assay	B	CNC(=O)C1CCC(CNC(=O)c2ncoc2-c2ccc(OC)cc2)CC1		CHEMBL1957078	=	IC50	nM	316.23	CHEMBL262	Homo sapiens	pIC50		6.5
	8046150	CHEMBL1960375	Inhibition of GSK3-beta by fluorescence polarization assay	B	COc1ccc(-c2ocnc2C(=O)NCC2CCC(C(=O)N(C)C)CC2)cc1		CHEMBL1957079	=	IC50	nM	316.23	CHEMBL262	Homo sapiens	pIC50		6.5
	8046151	CHEMBL1960375	Inhibition of GSK3-beta by fluorescence polarization assay	B	CNC(=O)c1ccc(CNC(=O)c2ncoc2-c2ccc(OC)cc2)cc1		CHEMBL1957080	=	IC50	nM	251.19	CHEMBL262	Homo sapiens	pIC50		6.6
	8046152	CHEMBL1960375	Inhibition of GSK3-beta by fluorescence polarization assay	B	CNC(=O)c1ccc(CN(C)C(=O)c2ncoc2-c2ccc(OC)cc2)cc1		CHEMBL1957081	<	IC50	nM	25118.86	CHEMBL262	Homo sapiens	pIC50		4.6
	8046153	CHEMBL1960375	Inhibition of GSK3-beta by fluorescence polarization assay	B	COc1ccc(-c2ocnc2C(=O)NCc2ccccc2)cc1		CHEMBL1957082	=	IC50	nM	1000.0	CHEMBL262	Homo sapiens	pIC50		6.0
	8046154	CHEMBL1960375	Inhibition of GSK3-beta by fluorescence polarization assay	B	COc1ccc(-c2ocnc2C(=O)NCc2ccccn2)cc1		CHEMBL1957083	=	IC50	nM	1995.26	CHEMBL262	Homo sapiens	pIC50		5.7
	8046155	CHEMBL1960375	Inhibition of GSK3-beta by fluorescence polarization assay	B	COc1ccc(-c2ocnc2C(=O)NCc2cccnc2)cc1		CHEMBL1957084	=	IC50	nM	251.19	CHEMBL262	Homo sapiens	pIC50		6.6
	8046156	CHEMBL1960375	Inhibition of GSK3-beta by fluorescence polarization assay	B	COc1ccc(-c2ocnc2C(=O)NCc2ccncc2)cc1		CHEMBL1957085	=	IC50	nM	398.11	CHEMBL262	Homo sapiens	pIC50		6.4
	8046157	CHEMBL1960375	Inhibition of GSK3-beta by fluorescence polarization assay	B	O=C(NCc1ccncc1)c1ncoc1-c1cccc(O)c1		CHEMBL1957086	=	IC50	nM	630.96	CHEMBL262	Homo sapiens	pIC50		6.2
	8046158	CHEMBL1960375	Inhibition of GSK3-beta by fluorescence polarization assay	B	O=C(NCc1ccncc1)c1ncoc1-c1ccc(C(F)(F)F)cc1		CHEMBL1957087	=	IC50	nM	6309.57	CHEMBL262	Homo sapiens	pIC50		5.2
	8046159	CHEMBL1960375	Inhibition of GSK3-beta by fluorescence polarization assay	B	N#Cc1ccc(-c2ocnc2C(=O)NCc2ccncc2)cc1		CHEMBL1957088	=	IC50	nM	3162.28	CHEMBL262	Homo sapiens	pIC50		5.5
	8046160	CHEMBL1960375	Inhibition of GSK3-beta by fluorescence polarization assay	B	COc1cccc(-c2ocnc2C(=O)NCc2ccncc2)c1		CHEMBL1957089	=	IC50	nM	2511.89	CHEMBL262	Homo sapiens	pIC50		5.6
	8046161	CHEMBL1960375	Inhibition of GSK3-beta by fluorescence polarization assay	B	NC(=O)c1cccc(-c2ocnc2C(=O)NCc2ccncc2)c1		CHEMBL1957090	=	IC50	nM	7943.28	CHEMBL262	Homo sapiens	pIC50		5.1
	8046179	CHEMBL1960393	Inhibition of catalytic activity of GSK3-beta by AlphaLISA assay	B	COc1ccc(-c2ocnc2C(=O)NCc2ccncc2)cc1		CHEMBL1957085	=	IC50	nM	79.43	CHEMBL262	Homo sapiens	pIC50		7.1
	8046180	CHEMBL1960393	Inhibition of catalytic activity of GSK3-beta by AlphaLISA assay	B	COc1ccc(-c2ocnc2C(=O)NCc2ccncc2)cc1Cl		CHEMBL1957091	=	IC50	nM	12.59	CHEMBL262	Homo sapiens	pIC50		7.9
	8046181	CHEMBL1960393	Inhibition of catalytic activity of GSK3-beta by AlphaLISA assay	B	COc1ccc(-c2ocnc2C(=O)NCc2ccncc2)cc1F		CHEMBL1957092	=	IC50	nM	31.62	CHEMBL262	Homo sapiens	pIC50		7.5
	8046182	CHEMBL1960393	Inhibition of catalytic activity of GSK3-beta by AlphaLISA assay	B	COc1ccc(-c2ocnc2C(=O)NCc2ccncc2)c(F)c1		CHEMBL1957093	=	IC50	nM	398.11	CHEMBL262	Homo sapiens	pIC50		6.4
	8046183	CHEMBL1960393	Inhibition of catalytic activity of GSK3-beta by AlphaLISA assay	B	COc1ccc(-c2ocnc2C(=O)NCc2ccncc2)c(C)c1		CHEMBL1957094	=	IC50	nM	3162.28	CHEMBL262	Homo sapiens	pIC50		5.5
	8046184	CHEMBL1960393	Inhibition of catalytic activity of GSK3-beta by AlphaLISA assay	B	COc1ccc(-c2ocnc2C(=O)NCc2ccncc2)cc1-c1ccncc1		CHEMBL1957095	=	IC50	nM	1258.93	CHEMBL262	Homo sapiens	pIC50		5.9
	8046185	CHEMBL1960393	Inhibition of catalytic activity of GSK3-beta by AlphaLISA assay	B	COc1ccc(-c2ocnc2C(=O)NCc2ccncc2)cc1N1CCOCC1		CHEMBL1957096	=	IC50	nM	1995.26	CHEMBL262	Homo sapiens	pIC50		5.7
	8046186	CHEMBL1960393	Inhibition of catalytic activity of GSK3-beta by AlphaLISA assay	B	O=C(NCc1ccncc1)c1ncoc1-c1ccc(Oc2ccccc2)c(Cl)c1		CHEMBL1957097	=	IC50	nM	794.33	CHEMBL262	Homo sapiens	pIC50		6.1
	8046187	CHEMBL1960393	Inhibition of catalytic activity of GSK3-beta by AlphaLISA assay	B	COc1ccc(-c2ocnc2C(=O)NCc2ccncc2)cn1		CHEMBL1957098	=	IC50	nM	79.43	CHEMBL262	Homo sapiens	pIC50		7.1
	8046188	CHEMBL1960393	Inhibition of catalytic activity of GSK3-beta by AlphaLISA assay	B	COc1ncc(-c2ocnc2C(=O)NCc2ccncc2)cc1Cl		CHEMBL1957099	=	IC50	nM	63.1	CHEMBL262	Homo sapiens	pIC50		7.2
	8046189	CHEMBL1960393	Inhibition of catalytic activity of GSK3-beta by AlphaLISA assay	B	COc1ccc(-c2ocnc2C(=O)NCc2ccncc2)nc1Cl		CHEMBL1957100	=	IC50	nM	398.11	CHEMBL262	Homo sapiens	pIC50		6.4
	8046190	CHEMBL1960393	Inhibition of catalytic activity of GSK3-beta by AlphaLISA assay	B	COc1cnc(-c2ocnc2C(=O)NCc2ccncc2)cc1Cl		CHEMBL1957101	=	IC50	nM	10000.0	CHEMBL262	Homo sapiens	pIC50		5.0
	8046191	CHEMBL1960393	Inhibition of catalytic activity of GSK3-beta by AlphaLISA assay	B	COc1ccc(-c2ocnc2C(=O)NCc2ccnc(Cl)c2)cc1Cl		CHEMBL1957102	=	IC50	nM	19.95	CHEMBL262	Homo sapiens	pIC50		7.7
	8046192	CHEMBL1960393	Inhibition of catalytic activity of GSK3-beta by AlphaLISA assay	B	COc1ccc(-c2ocnc2C(=O)NCc2ccnc(C)c2)cc1Cl		CHEMBL1957225	=	IC50	nM	31.62	CHEMBL262	Homo sapiens	pIC50		7.5
	8046193	CHEMBL1960393	Inhibition of catalytic activity of GSK3-beta by AlphaLISA assay	B	COc1cc(CNC(=O)c2ncoc2-c2ccc(OC)c(Cl)c2)ccn1		CHEMBL1957226	=	IC50	nM	31.62	CHEMBL262	Homo sapiens	pIC50		7.5
	8046194	CHEMBL1960393	Inhibition of catalytic activity of GSK3-beta by AlphaLISA assay	B	COc1ccc(-c2ocnc2C(=O)NCc2ccnc(C(F)(F)F)c2)cc1Cl		CHEMBL1957227	=	IC50	nM	100.0	CHEMBL262	Homo sapiens	pIC50		7.0
	8046195	CHEMBL1960393	Inhibition of catalytic activity of GSK3-beta by AlphaLISA assay	B	COc1ccc(-c2ocnc2C(=O)NCc2ccnnc2)cc1Cl		CHEMBL1957228	=	IC50	nM	19.95	CHEMBL262	Homo sapiens	pIC50		7.7
	8046196	CHEMBL1960393	Inhibition of catalytic activity of GSK3-beta by AlphaLISA assay	B	COc1ccc(-c2ocnc2C(=O)NCc2ccnc(C)n2)cc1Cl		CHEMBL1957229	=	IC50	nM	39.81	CHEMBL262	Homo sapiens	pIC50		7.4
	8046197	CHEMBL1960393	Inhibition of catalytic activity of GSK3-beta by AlphaLISA assay	B	COc1ccc(-c2ocnc2C(=O)NCCc2ccncc2)cc1Cl		CHEMBL1957230	=	IC50	nM	19.95	CHEMBL262	Homo sapiens	pIC50		7.7
	8046198	CHEMBL1960393	Inhibition of catalytic activity of GSK3-beta by AlphaLISA assay	B	COc1ccc(-c2ocnc2C(=O)NCc2ccn3ccnc3c2)cc1Cl		CHEMBL1957231	=	IC50	nM	5.012	CHEMBL262	Homo sapiens	pIC50		8.3
	8046199	CHEMBL1960394	Inhibition of GSK3beta-mediated CRMP-2 phosphorylation by cell based assay	B	COc1ccc(-c2ocnc2C(=O)NCc2ccncc2)cc1		CHEMBL1957085	=	IC50	nM	1995.26	CHEMBL262	Homo sapiens	pIC50		5.7
	8046200	CHEMBL1960394	Inhibition of GSK3beta-mediated CRMP-2 phosphorylation by cell based assay	B	COc1ccc(-c2ocnc2C(=O)NCc2ccncc2)cc1Cl		CHEMBL1957091	=	IC50	nM	794.33	CHEMBL262	Homo sapiens	pIC50		6.1
	8046201	CHEMBL1960394	Inhibition of GSK3beta-mediated CRMP-2 phosphorylation by cell based assay	B	COc1ccc(-c2ocnc2C(=O)NCc2ccncc2)cc1F		CHEMBL1957092	=	IC50	nM	1000.0	CHEMBL262	Homo sapiens	pIC50		6.0
	8046202	CHEMBL1960394	Inhibition of GSK3beta-mediated CRMP-2 phosphorylation by cell based assay	B	COc1ccc(-c2ocnc2C(=O)NCc2ccncc2)c(F)c1		CHEMBL1957093	=	IC50	nM	6309.57	CHEMBL262	Homo sapiens	pIC50		5.2
	8046203	CHEMBL1960394	Inhibition of GSK3beta-mediated CRMP-2 phosphorylation by cell based assay	B	COc1ccc(-c2ocnc2C(=O)NCc2ccncc2)c(C)c1		CHEMBL1957094	<=	IC50	nM	50118.72	CHEMBL262	Homo sapiens	pIC50		4.3
	8046204	CHEMBL1960394	Inhibition of GSK3beta-mediated CRMP-2 phosphorylation by cell based assay	B	COc1ccc(-c2ocnc2C(=O)NCc2ccncc2)cc1-c1ccncc1		CHEMBL1957095	=	IC50	nM	39810.72	CHEMBL262	Homo sapiens	pIC50		4.4
	8046205	CHEMBL1960394	Inhibition of GSK3beta-mediated CRMP-2 phosphorylation by cell based assay	B	COc1ccc(-c2ocnc2C(=O)NCc2ccncc2)cc1N1CCOCC1		CHEMBL1957096	=	IC50	nM	31622.78	CHEMBL262	Homo sapiens	pIC50		4.5
	8046206	CHEMBL1960394	Inhibition of GSK3beta-mediated CRMP-2 phosphorylation by cell based assay	B	O=C(NCc1ccncc1)c1ncoc1-c1ccc(Oc2ccccc2)c(Cl)c1		CHEMBL1957097	=	IC50	nM	31622.78	CHEMBL262	Homo sapiens	pIC50		4.5
	8046207	CHEMBL1960394	Inhibition of GSK3beta-mediated CRMP-2 phosphorylation by cell based assay	B	COc1ccc(-c2ocnc2C(=O)NCc2ccncc2)cn1		CHEMBL1957098	=	IC50	nM	1995.26	CHEMBL262	Homo sapiens	pIC50		5.7
	8046208	CHEMBL1960394	Inhibition of GSK3beta-mediated CRMP-2 phosphorylation by cell based assay	B	COc1ncc(-c2ocnc2C(=O)NCc2ccncc2)cc1Cl		CHEMBL1957099	=	IC50	nM	1995.26	CHEMBL262	Homo sapiens	pIC50		5.7
	8046209	CHEMBL1960394	Inhibition of GSK3beta-mediated CRMP-2 phosphorylation by cell based assay	B	COc1ccc(-c2ocnc2C(=O)NCc2ccncc2)nc1Cl		CHEMBL1957100	=	IC50	nM	3162.28	CHEMBL262	Homo sapiens	pIC50		5.5
	8046210	CHEMBL1960394	Inhibition of GSK3beta-mediated CRMP-2 phosphorylation by cell based assay	B	COc1cnc(-c2ocnc2C(=O)NCc2ccncc2)cc1Cl		CHEMBL1957101	=	IC50	nM	63095.73	CHEMBL262	Homo sapiens	pIC50		4.2
	8046211	CHEMBL1960394	Inhibition of GSK3beta-mediated CRMP-2 phosphorylation by cell based assay	B	COc1ccc(-c2ocnc2C(=O)NCc2ccnc(Cl)c2)cc1Cl		CHEMBL1957102	=	IC50	nM	5011.87	CHEMBL262	Homo sapiens	pIC50		5.3
	8046212	CHEMBL1960394	Inhibition of GSK3beta-mediated CRMP-2 phosphorylation by cell based assay	B	COc1ccc(-c2ocnc2C(=O)NCc2ccnc(C)c2)cc1Cl		CHEMBL1957225	=	IC50	nM	2511.89	CHEMBL262	Homo sapiens	pIC50		5.6
	8046213	CHEMBL1960394	Inhibition of GSK3beta-mediated CRMP-2 phosphorylation by cell based assay	B	COc1cc(CNC(=O)c2ncoc2-c2ccc(OC)c(Cl)c2)ccn1		CHEMBL1957226	=	IC50	nM	6309.57	CHEMBL262	Homo sapiens	pIC50		5.2
	8046214	CHEMBL1960394	Inhibition of GSK3beta-mediated CRMP-2 phosphorylation by cell based assay	B	COc1ccc(-c2ocnc2C(=O)NCc2ccnc(C(F)(F)F)c2)cc1Cl		CHEMBL1957227	=	IC50	nM	5011.87	CHEMBL262	Homo sapiens	pIC50		5.3
	8046215	CHEMBL1960394	Inhibition of GSK3beta-mediated CRMP-2 phosphorylation by cell based assay	B	COc1ccc(-c2ocnc2C(=O)NCc2ccnnc2)cc1Cl		CHEMBL1957228	=	IC50	nM	630.96	CHEMBL262	Homo sapiens	pIC50		6.2
	8046216	CHEMBL1960394	Inhibition of GSK3beta-mediated CRMP-2 phosphorylation by cell based assay	B	COc1ccc(-c2ocnc2C(=O)NCc2ccnc(C)n2)cc1Cl		CHEMBL1957229	=	IC50	nM	1995.26	CHEMBL262	Homo sapiens	pIC50		5.7
	8046217	CHEMBL1960394	Inhibition of GSK3beta-mediated CRMP-2 phosphorylation by cell based assay	B	COc1ccc(-c2ocnc2C(=O)NCCc2ccncc2)cc1Cl		CHEMBL1957230	=	IC50	nM	1995.26	CHEMBL262	Homo sapiens	pIC50		5.7
	8046218	CHEMBL1960394	Inhibition of GSK3beta-mediated CRMP-2 phosphorylation by cell based assay	B	COc1ccc(-c2ocnc2C(=O)NCc2ccn3ccnc3c2)cc1Cl		CHEMBL1957231	=	IC50	nM	630.96	CHEMBL262	Homo sapiens	pIC50		6.2
Not Determined	8051216	CHEMBL1961118	Inhibition of GSK3-beta	B	NC(=O)c1ccc(O)c2[nH]c(Cc3ccccc3)nc12		CHEMBL1957938		IC50			CHEMBL262	Homo sapiens	IC50		
Not Determined	8051217	CHEMBL1961118	Inhibition of GSK3-beta	B	CCCCNC(=O)c1ccc(O)c2[nH]c(Cc3ccccc3)nc12		CHEMBL1957939		IC50			CHEMBL262	Homo sapiens	IC50		
Not Determined	8051218	CHEMBL1961118	Inhibition of GSK3-beta	B	O=C(NCc1cccc(O)c1)c1ccc(O)c2[nH]c(Cc3ccccc3)nc12		CHEMBL1957940		IC50			CHEMBL262	Homo sapiens	IC50		
	8051219	CHEMBL1961118	Inhibition of GSK3-beta	B	O=C(NCCc1ccc([N+](=O)[O-])cc1)c1ccc(O)c2[nH]c(Cc3ccccc3)nc12		CHEMBL1957941	=	IC50	nM	2000.0	CHEMBL262	Homo sapiens	IC50	uM	2.0
	8051220	CHEMBL1961118	Inhibition of GSK3-beta	B	Cc1ccc(S(=O)(=O)Nc2ccc(CCNC(=O)c3ccc(O)c4[nH]c(Cc5ccccc5)nc34)cc2)cc1		CHEMBL1957942	=	IC50	nM	2800.0	CHEMBL262	Homo sapiens	IC50	uM	2.8
	8051221	CHEMBL1961118	Inhibition of GSK3-beta	B	CS(=O)(=O)Nc1ccc(CCNC(=O)c2ccc(O)c3[nH]c(Cc4ccccc4)nc23)cc1		CHEMBL1957943	=	IC50	nM	1600.0	CHEMBL262	Homo sapiens	IC50	uM	1.6
Not Determined	8051222	CHEMBL1961118	Inhibition of GSK3-beta	B	Cc1nc2c(C(=O)NCCc3ccc(NS(C)(=O)=O)cc3)ccc(O)c2[nH]1		CHEMBL1957944		IC50			CHEMBL262	Homo sapiens	IC50		
	8051223	CHEMBL1961118	Inhibition of GSK3-beta	B	CS(=O)(=O)Nc1ccc(CCNC(=O)c2ccc(O)c3[nH]c(C4CC4)nc23)cc1		CHEMBL1957945	=	IC50	nM	140.0	CHEMBL262	Homo sapiens	IC50	uM	0.14
	8051224	CHEMBL1961118	Inhibition of GSK3-beta	B	CS(=O)(=O)Nc1ccc(CCNC(=O)c2ccc(O)c3[nH]c(C4CCCC4)nc23)cc1		CHEMBL1957946	=	IC50	nM	44.0	CHEMBL262	Homo sapiens	IC50	uM	0.044
	8051225	CHEMBL1961118	Inhibition of GSK3-beta	B	CS(=O)(=O)Nc1ccc(CCNC(=O)c2ccc(O)c3[nH]c(-c4ccc(Cl)cc4)nc23)cc1		CHEMBL1957947	=	IC50	nM	7.0	CHEMBL262	Homo sapiens	IC50	uM	0.007
Not Determined	8051226	CHEMBL1961118	Inhibition of GSK3-beta	B	CS(=O)(=O)Nc1ccc(CCNC(=O)c2ccc(O)c3[nH]c(-c4ccc(F)cc4F)nc23)cc1		CHEMBL1957948		IC50			CHEMBL262	Homo sapiens	IC50		
	8051227	CHEMBL1961118	Inhibition of GSK3-beta	B	CS(=O)(=O)Nc1ccc(CCNC(=O)c2ccc(O)c3[nH]c(-c4ccc(F)cc4)nc23)cc1		CHEMBL1957949	=	IC50	nM	1.0	CHEMBL262	Homo sapiens	IC50	uM	0.001
	8051228	CHEMBL1961118	Inhibition of GSK3-beta	B	CS(=O)(=O)Nc1ccc(CCNC(=O)c2ccc(O)c3[nH]c(-c4ccc(F)cc4Cl)nc23)cc1		CHEMBL1957950	=	IC50	nM	20.0	CHEMBL262	Homo sapiens	IC50	uM	0.02
	8051229	CHEMBL1961118	Inhibition of GSK3-beta	B	CS(=O)(=O)Nc1ccc(CCNC(=O)c2ccc(O)c3[nH]c(-c4ccncc4)nc23)cc1		CHEMBL1957951	=	IC50	nM	110.0	CHEMBL262	Homo sapiens	IC50	uM	0.11
	8051230	CHEMBL1961118	Inhibition of GSK3-beta	B	Cc1ccc(S(=O)(=O)Nc2ccc(CCNC(=O)c3ccc(O)c4[nH]c(-c5ccc(F)cc5)nc34)cc2)cc1		CHEMBL1957952	=	IC50	nM	26.0	CHEMBL262	Homo sapiens	IC50	uM	0.026
	8051231	CHEMBL1961118	Inhibition of GSK3-beta	B	O=C(O)COc1cccc(CCCNC(=O)c2ccc(O)c3[nH]c(-c4ccc(Cl)cc4)nc23)c1		CHEMBL1957953	=	IC50	nM	31.0	CHEMBL262	Homo sapiens	IC50	uM	0.031
	8051232	CHEMBL1961118	Inhibition of GSK3-beta	B	O=C(NCCCn1ccnc1)c1ccc(O)c2[nH]c(-c3ccc(Cl)cc3Cl)nc12		CHEMBL1957954	=	IC50	nM	15.0	CHEMBL262	Homo sapiens	IC50	uM	0.015
	8051233	CHEMBL1961118	Inhibition of GSK3-beta	B	O=C(NCCCn1cnc(Cl)c1Cl)c1ccc(O)c2[nH]c(-c3ccc(Cl)cc3Cl)nc12		CHEMBL1957955	=	IC50	nM	6.0	CHEMBL262	Homo sapiens	IC50	uM	0.006
	8051234	CHEMBL1961118	Inhibition of GSK3-beta	B	O=C(NCCCn1ccnc1)c1ccc(O)c2[nH]c(-c3ccc(F)c(Cl)c3)nc12		CHEMBL1957956	=	IC50	nM	3.0	CHEMBL262	Homo sapiens	IC50	uM	0.003
	8051235	CHEMBL1961118	Inhibition of GSK3-beta	B	Cc1cn(CCCNC(=O)c2ccc(O)c3[nH]c(-c4cccs4)nc23)cn1		CHEMBL1957957	=	IC50	nM	50.0	CHEMBL262	Homo sapiens	IC50	uM	0.05
	8051236	CHEMBL1961118	Inhibition of GSK3-beta	B	CCN1CCN(C(=O)c2ccc(CCNC(=O)c3ccc(O)c4[nH]c(-c5cccs5)nc34)cc2)CC1		CHEMBL1957958	=	IC50	nM	46.0	CHEMBL262	Homo sapiens	IC50	uM	0.046
	8051237	CHEMBL1961118	Inhibition of GSK3-beta	B	O=C(NCCCn1cnc(Cl)c1Cl)c1ccc(O)c2[nH]c(-c3cccs3)nc12		CHEMBL1957959	=	IC50	nM	8.0	CHEMBL262	Homo sapiens	IC50	uM	0.008
	8051238	CHEMBL1961118	Inhibition of GSK3-beta	B	O=C(NCCCn1cnc(Cl)c1Cl)c1ccc(O)c2[nH]c(-c3ccco3)nc12		CHEMBL1957960	=	IC50	nM	10.0	CHEMBL262	Homo sapiens	IC50	uM	0.01
	8051239	CHEMBL1961117	Inhibition of GSK3-beta in human RD cells	B	Cc1nc2c(C(=O)NCCc3ccc(NS(C)(=O)=O)cc3)ccc(O)c2[nH]1		CHEMBL1957944	=	EC50	nM	21000.0	CHEMBL262	Homo sapiens	EC50	uM	21.0
	8051240	CHEMBL1961117	Inhibition of GSK3-beta in human RD cells	B	CS(=O)(=O)Nc1ccc(CCNC(=O)c2ccc(O)c3[nH]c(C4CC4)nc23)cc1		CHEMBL1957945	=	EC50	nM	4800.0	CHEMBL262	Homo sapiens	EC50	uM	4.8
	8051241	CHEMBL1961117	Inhibition of GSK3-beta in human RD cells	B	CS(=O)(=O)Nc1ccc(CCNC(=O)c2ccc(O)c3[nH]c(C4CCCC4)nc23)cc1		CHEMBL1957946	=	EC50	nM	2700.0	CHEMBL262	Homo sapiens	EC50	uM	2.7
	8051242	CHEMBL1961117	Inhibition of GSK3-beta in human RD cells	B	CS(=O)(=O)Nc1ccc(CCNC(=O)c2ccc(O)c3[nH]c(-c4ccc(Cl)cc4)nc23)cc1		CHEMBL1957947	=	EC50	nM	120.0	CHEMBL262	Homo sapiens	EC50	uM	0.12
	8051243	CHEMBL1961117	Inhibition of GSK3-beta in human RD cells	B	CS(=O)(=O)Nc1ccc(CCNC(=O)c2ccc(O)c3[nH]c(-c4ccc(F)cc4F)nc23)cc1		CHEMBL1957948	=	EC50	nM	580.0	CHEMBL262	Homo sapiens	EC50	uM	0.58
	8051244	CHEMBL1961117	Inhibition of GSK3-beta in human RD cells	B	CS(=O)(=O)Nc1ccc(CCNC(=O)c2ccc(O)c3[nH]c(-c4ccc(F)cc4)nc23)cc1		CHEMBL1957949	=	EC50	nM	400.0	CHEMBL262	Homo sapiens	EC50	uM	0.4
	8051245	CHEMBL1961117	Inhibition of GSK3-beta in human RD cells	B	CS(=O)(=O)Nc1ccc(CCNC(=O)c2ccc(O)c3[nH]c(-c4ccc(F)cc4Cl)nc23)cc1		CHEMBL1957950	=	EC50	nM	230.0	CHEMBL262	Homo sapiens	EC50	uM	0.23
	8051246	CHEMBL1961117	Inhibition of GSK3-beta in human RD cells	B	CS(=O)(=O)Nc1ccc(CCNC(=O)c2ccc(O)c3[nH]c(-c4ccncc4)nc23)cc1		CHEMBL1957951	=	EC50	nM	25000.0	CHEMBL262	Homo sapiens	EC50	uM	25.0
	8051247	CHEMBL1961117	Inhibition of GSK3-beta in human RD cells	B	Cc1ccc(S(=O)(=O)Nc2ccc(CCNC(=O)c3ccc(O)c4[nH]c(-c5ccc(F)cc5)nc34)cc2)cc1		CHEMBL1957952	=	EC50	nM	95.0	CHEMBL262	Homo sapiens	EC50	uM	0.095
	8051248	CHEMBL1961117	Inhibition of GSK3-beta in human RD cells	B	O=C(O)COc1cccc(CCCNC(=O)c2ccc(O)c3[nH]c(-c4ccc(Cl)cc4)nc23)c1		CHEMBL1957953	=	EC50	nM	250.0	CHEMBL262	Homo sapiens	EC50	uM	0.25
	8051249	CHEMBL1961117	Inhibition of GSK3-beta in human RD cells	B	O=C(NCCCn1ccnc1)c1ccc(O)c2[nH]c(-c3ccc(Cl)cc3Cl)nc12		CHEMBL1957954	=	EC50	nM	240.0	CHEMBL262	Homo sapiens	EC50	uM	0.24
	8051250	CHEMBL1961117	Inhibition of GSK3-beta in human RD cells	B	O=C(NCCCn1cnc(Cl)c1Cl)c1ccc(O)c2[nH]c(-c3ccc(Cl)cc3Cl)nc12		CHEMBL1957955	=	EC50	nM	110.0	CHEMBL262	Homo sapiens	EC50	uM	0.11
	8051251	CHEMBL1961117	Inhibition of GSK3-beta in human RD cells	B	O=C(NCCCn1ccnc1)c1ccc(O)c2[nH]c(-c3ccc(F)c(Cl)c3)nc12		CHEMBL1957956	=	EC50	nM	490.0	CHEMBL262	Homo sapiens	EC50	uM	0.49
	8051252	CHEMBL1961117	Inhibition of GSK3-beta in human RD cells	B	Cc1cn(CCCNC(=O)c2ccc(O)c3[nH]c(-c4cccs4)nc23)cn1		CHEMBL1957957	=	EC50	nM	310.0	CHEMBL262	Homo sapiens	EC50	uM	0.31
	8051253	CHEMBL1961117	Inhibition of GSK3-beta in human RD cells	B	CCN1CCN(C(=O)c2ccc(CCNC(=O)c3ccc(O)c4[nH]c(-c5cccs5)nc34)cc2)CC1		CHEMBL1957958	=	EC50	nM	400.0	CHEMBL262	Homo sapiens	EC50	uM	0.4
	8051254	CHEMBL1961117	Inhibition of GSK3-beta in human RD cells	B	O=C(NCCCn1cnc(Cl)c1Cl)c1ccc(O)c2[nH]c(-c3cccs3)nc12		CHEMBL1957959	=	EC50	nM	34.0	CHEMBL262	Homo sapiens	EC50	uM	0.034
	8051255	CHEMBL1961117	Inhibition of GSK3-beta in human RD cells	B	O=C(NCCCn1cnc(Cl)c1Cl)c1ccc(O)c2[nH]c(-c3ccco3)nc12		CHEMBL1957960	=	EC50	nM	50.0	CHEMBL262	Homo sapiens	EC50	uM	0.05
	8051256	CHEMBL1961121	Inhibition of GSK3-beta assessed as residual activity at 5 uM	B	NC(=O)c1ccc(O)c2[nH]c(Cc3ccccc3)nc12		CHEMBL1957938	=	Activity	%	75.0	CHEMBL262	Homo sapiens	Activity	%	75.0
	8051257	CHEMBL1961121	Inhibition of GSK3-beta assessed as residual activity at 5 uM	B	CCCCNC(=O)c1ccc(O)c2[nH]c(Cc3ccccc3)nc12		CHEMBL1957939	=	Activity	%	63.0	CHEMBL262	Homo sapiens	Activity	%	63.0
	8051258	CHEMBL1961121	Inhibition of GSK3-beta assessed as residual activity at 5 uM	B	O=C(NCc1cccc(O)c1)c1ccc(O)c2[nH]c(Cc3ccccc3)nc12		CHEMBL1957940	=	Activity	%	53.0	CHEMBL262	Homo sapiens	Activity	%	53.0
	8051259	CHEMBL1961121	Inhibition of GSK3-beta assessed as residual activity at 5 uM	B	O=C(NCCc1ccc([N+](=O)[O-])cc1)c1ccc(O)c2[nH]c(Cc3ccccc3)nc12		CHEMBL1957941	=	Activity	%	32.0	CHEMBL262	Homo sapiens	Activity	%	32.0
	8051260	CHEMBL1961121	Inhibition of GSK3-beta assessed as residual activity at 5 uM	B	Cc1ccc(S(=O)(=O)Nc2ccc(CCNC(=O)c3ccc(O)c4[nH]c(Cc5ccccc5)nc34)cc2)cc1		CHEMBL1957942	=	Activity	%	36.0	CHEMBL262	Homo sapiens	Activity	%	36.0
	8051261	CHEMBL1961121	Inhibition of GSK3-beta assessed as residual activity at 5 uM	B	CS(=O)(=O)Nc1ccc(CCNC(=O)c2ccc(O)c3[nH]c(Cc4ccccc4)nc23)cc1		CHEMBL1957943	=	Activity	%	18.0	CHEMBL262	Homo sapiens	Activity	%	18.0
	8051262	CHEMBL1961121	Inhibition of GSK3-beta assessed as residual activity at 5 uM	B	CS(=O)(=O)Nc1ccc(CCNC(=O)c2ccc(O)c3[nH]c(-c4ccc(F)cc4F)nc23)cc1		CHEMBL1957948	=	Activity	%	-0.58	CHEMBL262	Homo sapiens	Activity	%	-0.58
	8051263	CHEMBL1961121	Inhibition of GSK3-beta assessed as residual activity at 5 uM	B	O=C(O)COc1cccc(CCCNC(=O)c2ccc(O)c3[nH]c(-c4ccc(Cl)cc4)nc23)c1		CHEMBL1957953	=	Activity	%	0.3	CHEMBL262	Homo sapiens	Activity	%	0.3
	8051264	CHEMBL1961121	Inhibition of GSK3-beta assessed as residual activity at 5 uM	B	O=C(NCCCn1cnc(Cl)c1Cl)c1ccc(O)c2[nH]c(-c3ccc(Cl)cc3Cl)nc12		CHEMBL1957955	=	Activity	%	0.0	CHEMBL262	Homo sapiens	Activity	%	0.0
	8051265	CHEMBL1961121	Inhibition of GSK3-beta assessed as residual activity at 5 uM	B	O=C(NCCCn1ccnc1)c1ccc(O)c2[nH]c(-c3ccc(F)c(Cl)c3)nc12		CHEMBL1957956	=	Activity	%	1.0	CHEMBL262	Homo sapiens	Activity	%	1.0
	8051266	CHEMBL1961121	Inhibition of GSK3-beta assessed as residual activity at 5 uM	B	CCN1CCN(C(=O)c2ccc(CCNC(=O)c3ccc(O)c4[nH]c(-c5cccs5)nc34)cc2)CC1		CHEMBL1957958	=	Activity	%	0.9	CHEMBL262	Homo sapiens	Activity	%	0.9
	8051267	CHEMBL1961121	Inhibition of GSK3-beta assessed as residual activity at 5 uM	B	O=C(NCCCn1cnc(Cl)c1Cl)c1ccc(O)c2[nH]c(-c3ccco3)nc12		CHEMBL1957960	=	Activity	%	-1.7	CHEMBL262	Homo sapiens	Activity	%	-1.7
	8052201	CHEMBL1961110	Inhibition of GSK3-beta in human RD cells assessed as glycogen synthase activation measured after 24 hrs under serum starving condition	B	CS(=O)(=O)Nc1ccc(CCNC(=O)c2ccc(O)c3[nH]c(-c4ccc(F)cc4F)nc23)cc1		CHEMBL1957948	=	EC50	nM	13.0	CHEMBL262	Homo sapiens	EC50	uM	0.013
	8052202	CHEMBL1961110	Inhibition of GSK3-beta in human RD cells assessed as glycogen synthase activation measured after 24 hrs under serum starving condition	B	O=C(O)COc1cccc(CCCNC(=O)c2ccc(O)c3[nH]c(-c4ccc(Cl)cc4)nc23)c1		CHEMBL1957953	=	EC50	nM	80.0	CHEMBL262	Homo sapiens	EC50	uM	0.08
	8052203	CHEMBL1961110	Inhibition of GSK3-beta in human RD cells assessed as glycogen synthase activation measured after 24 hrs under serum starving condition	B	O=C(NCCCn1cnc(Cl)c1Cl)c1ccc(O)c2[nH]c(-c3ccc(Cl)cc3Cl)nc12		CHEMBL1957955	=	EC50	nM	170.0	CHEMBL262	Homo sapiens	EC50	uM	0.17
	8052204	CHEMBL1961110	Inhibition of GSK3-beta in human RD cells assessed as glycogen synthase activation measured after 24 hrs under serum starving condition	B	O=C(NCCCn1ccnc1)c1ccc(O)c2[nH]c(-c3ccc(F)c(Cl)c3)nc12		CHEMBL1957956	=	EC50	nM	100.0	CHEMBL262	Homo sapiens	EC50	uM	0.1
	8052205	CHEMBL1961110	Inhibition of GSK3-beta in human RD cells assessed as glycogen synthase activation measured after 24 hrs under serum starving condition	B	O=C(NCCCn1cnc(Cl)c1Cl)c1ccc(O)c2[nH]c(-c3ccco3)nc12		CHEMBL1957960	=	EC50	nM	40.0	CHEMBL262	Homo sapiens	EC50	uM	0.04
	8052248	CHEMBL1961117	Inhibition of GSK3-beta in human RD cells	B	CS(=O)(=O)Nc1ccc(CCNC(=O)c2ccc(O)c3[nH]c(Cc4ccccc4)nc23)cc1		CHEMBL1957943	=	EC50	nM	3900.0	CHEMBL262	Homo sapiens	EC50	uM	3.9
	8061303	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	16.94	CHEMBL262	Homo sapiens	Inhibition	%	16.94
	8061480	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	17.74	CHEMBL262	Homo sapiens	Inhibition	%	17.74
	8061811	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	34.3	CHEMBL262	Homo sapiens	Inhibition	%	34.3
	8062002	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	3.54	CHEMBL262	Homo sapiens	Inhibition	%	3.54
	8062342	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	5.71	CHEMBL262	Homo sapiens	Inhibition	%	5.71
	8062504	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	81.68	CHEMBL262	Homo sapiens	Inhibition	%	81.68
	8062728	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	15.3	CHEMBL262	Homo sapiens	Inhibition	%	15.3
	8062826	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	5.32	CHEMBL262	Homo sapiens	Inhibition	%	5.32
	8063182	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	65.43	CHEMBL262	Homo sapiens	Inhibition	%	65.43
	8063349	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	1.3	CHEMBL262	Homo sapiens	Inhibition	%	1.3
	8063681	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	1.88	CHEMBL262	Homo sapiens	Inhibition	%	1.88
	8063863	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	8.9	CHEMBL262	Homo sapiens	Inhibition	%	8.9
	8064087	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	5.36	CHEMBL262	Homo sapiens	Inhibition	%	5.36
	8064202	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	41.64	CHEMBL262	Homo sapiens	Inhibition	%	41.64
	8064412	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	1.37	CHEMBL262	Homo sapiens	Inhibition	%	1.37
	8064636	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	7.41	CHEMBL262	Homo sapiens	Inhibition	%	7.41
	8064774	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	7.94	CHEMBL262	Homo sapiens	Inhibition	%	7.94
	8064940	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	4.05	CHEMBL262	Homo sapiens	Inhibition	%	4.05
	8065164	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	1.39	CHEMBL262	Homo sapiens	Inhibition	%	1.39
	8065280	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	6.9	CHEMBL262	Homo sapiens	Inhibition	%	6.9
	8065679	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	33.33	CHEMBL262	Homo sapiens	Inhibition	%	33.33
	8065794	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	6.2	CHEMBL262	Homo sapiens	Inhibition	%	6.2
	8066018	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	40.98	CHEMBL262	Homo sapiens	Inhibition	%	40.98
	8066228	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	2.74	CHEMBL262	Homo sapiens	Inhibition	%	2.74
	8066364	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	32.98	CHEMBL262	Homo sapiens	Inhibition	%	32.98
	8066754	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	6.8	CHEMBL262	Homo sapiens	Inhibition	%	6.8
	8066878	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	1.01	CHEMBL262	Homo sapiens	Inhibition	%	1.01
	8067102	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	6.86	CHEMBL262	Homo sapiens	Inhibition	%	6.86
	8067277	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	0.8	CHEMBL262	Homo sapiens	Inhibition	%	0.8
	8067622	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	1.33	CHEMBL262	Homo sapiens	Inhibition	%	1.33
	8067832	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	8.38	CHEMBL262	Homo sapiens	Inhibition	%	8.38
	8067967	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	60.16	CHEMBL262	Homo sapiens	Inhibition	%	60.16
	8068191	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	89.93	CHEMBL262	Homo sapiens	Inhibition	%	89.93
	8068355	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	2.85	CHEMBL262	Homo sapiens	Inhibition	%	2.85
	8068704	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	-0.51	CHEMBL262	Homo sapiens	Inhibition	%	-0.51
	8068878	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	7.61	CHEMBL262	Homo sapiens	Inhibition	%	7.61
	8069227	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	10.73	CHEMBL262	Homo sapiens	Inhibition	%	10.73
	8069522	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	75.0	CHEMBL262	Homo sapiens	Inhibition	%	75.0
	8069683	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	16.86	CHEMBL262	Homo sapiens	Inhibition	%	16.86
	8070033	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	3.45	CHEMBL262	Homo sapiens	Inhibition	%	3.45
	8070205	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	2.47	CHEMBL262	Homo sapiens	Inhibition	%	2.47
	8070429	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	9.29	CHEMBL262	Homo sapiens	Inhibition	%	9.29
	8070554	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	-0.15	CHEMBL262	Homo sapiens	Inhibition	%	-0.15
	8070852	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	93.33	CHEMBL262	Homo sapiens	Inhibition	%	93.33
	8071009	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	1.19	CHEMBL262	Homo sapiens	Inhibition	%	1.19
	8071233	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	5.76	CHEMBL262	Homo sapiens	Inhibition	%	5.76
	8071359	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	-0.14	CHEMBL262	Homo sapiens	Inhibition	%	-0.14
	8071756	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	16.7	CHEMBL262	Homo sapiens	Inhibition	%	16.7
	8071881	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	3.51	CHEMBL262	Homo sapiens	Inhibition	%	3.51
	8072195	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	0.73	CHEMBL262	Homo sapiens	Inhibition	%	0.73
	8072576	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	3.5	CHEMBL262	Homo sapiens	Inhibition	%	3.5
	8072701	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.05	CHEMBL262	Homo sapiens	Inhibition	%	0.05
	8072925	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.03	CHEMBL262	Homo sapiens	Inhibition	%	0.03
	8073092	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	65.65	CHEMBL262	Homo sapiens	Inhibition	%	65.65
	8073217	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	-0.46	CHEMBL262	Homo sapiens	Inhibition	%	-0.46
	8073441	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	5.68	CHEMBL262	Homo sapiens	Inhibition	%	5.68
	8073560	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	1.9	CHEMBL262	Homo sapiens	Inhibition	%	1.9
	8073793	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	6.36	CHEMBL262	Homo sapiens	Inhibition	%	6.36
	8074017	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	4.97	CHEMBL262	Homo sapiens	Inhibition	%	4.97
	8074169	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	8.21	CHEMBL262	Homo sapiens	Inhibition	%	8.21
	8074523	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	1.99	CHEMBL262	Homo sapiens	Inhibition	%	1.99
	8074680	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	-0.25	CHEMBL262	Homo sapiens	Inhibition	%	-0.25
	8075031	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	0.31	CHEMBL262	Homo sapiens	Inhibition	%	0.31
	8075142	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	23.68	CHEMBL262	Homo sapiens	Inhibition	%	23.68
	8075366	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-0.54	CHEMBL262	Homo sapiens	Inhibition	%	-0.54
	8075603	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	18.93	CHEMBL262	Homo sapiens	Inhibition	%	18.93
	8075744	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	26.18	CHEMBL262	Homo sapiens	Inhibition	%	26.18
	8076110	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-0.14	CHEMBL262	Homo sapiens	Inhibition	%	-0.14
	8076258	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	1.98	CHEMBL262	Homo sapiens	Inhibition	%	1.98
	8076482	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	0.44	CHEMBL262	Homo sapiens	Inhibition	%	0.44
	8076616	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	5.17	CHEMBL262	Homo sapiens	Inhibition	%	5.17
	8076942	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	1.01	CHEMBL262	Homo sapiens	Inhibition	%	1.01
	8077189	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	53.4	CHEMBL262	Homo sapiens	Inhibition	%	53.4
	8077317	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	75.5	CHEMBL262	Homo sapiens	Inhibition	%	75.5
	8077541	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	2.45	CHEMBL262	Homo sapiens	Inhibition	%	2.45
	8077692	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	4.75	CHEMBL262	Homo sapiens	Inhibition	%	4.75
	8078059	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	0.1	CHEMBL262	Homo sapiens	Inhibition	%	0.1
	8078198	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	4.44	CHEMBL262	Homo sapiens	Inhibition	%	4.44
	8078524	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	0.85	CHEMBL262	Homo sapiens	Inhibition	%	0.85
	8078774	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	84.6	CHEMBL262	Homo sapiens	Inhibition	%	84.6
	8079114	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	3.29	CHEMBL262	Homo sapiens	Inhibition	%	3.29
	8079272	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	0.42	CHEMBL262	Homo sapiens	Inhibition	%	0.42
	8079638	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	-0.3	CHEMBL262	Homo sapiens	Inhibition	%	-0.3
	8079777	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	38.04	CHEMBL262	Homo sapiens	Inhibition	%	38.04
	8080001	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	4.67	CHEMBL262	Homo sapiens	Inhibition	%	4.67
	8080106	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	4.56	CHEMBL262	Homo sapiens	Inhibition	%	4.56
	8080358	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	36.15	CHEMBL262	Homo sapiens	Inhibition	%	36.15
	8080697	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	1.06	CHEMBL262	Homo sapiens	Inhibition	%	1.06
	8080861	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	4.23	CHEMBL262	Homo sapiens	Inhibition	%	4.23
	8081085	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-1.49	CHEMBL262	Homo sapiens	Inhibition	%	-1.49
	8081220	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	1.56	CHEMBL262	Homo sapiens	Inhibition	%	1.56
	8081588	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	9.55	CHEMBL262	Homo sapiens	Inhibition	%	9.55
	8081691	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	18.79	CHEMBL262	Homo sapiens	Inhibition	%	18.79
	8081943	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	82.73	CHEMBL262	Homo sapiens	Inhibition	%	82.73
	8082167	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	62.48	CHEMBL262	Homo sapiens	Inhibition	%	62.48
	8082280	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	0.7	CHEMBL262	Homo sapiens	Inhibition	%	0.7
	8082677	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	2.45	CHEMBL262	Homo sapiens	Inhibition	%	2.45
	8082800	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	0.28	CHEMBL262	Homo sapiens	Inhibition	%	0.28
	8083180	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	39.74	CHEMBL262	Homo sapiens	Inhibition	%	39.74
	8083279	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	65.07	CHEMBL262	Homo sapiens	Inhibition	%	65.07
	8083503	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	1.76	CHEMBL262	Homo sapiens	Inhibition	%	1.76
	8083757	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	90.05	CHEMBL262	Homo sapiens	Inhibition	%	90.05
	8083867	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	1.11	CHEMBL262	Homo sapiens	Inhibition	%	1.11
	8084091	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	8.08	CHEMBL262	Homo sapiens	Inhibition	%	8.08
	8084276	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	53.53	CHEMBL262	Homo sapiens	Inhibition	%	53.53
	8084394	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	3.43	CHEMBL262	Homo sapiens	Inhibition	%	3.43
	8084618	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	1.16	CHEMBL262	Homo sapiens	Inhibition	%	1.16
	8084779	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	77.67	CHEMBL262	Homo sapiens	Inhibition	%	77.67
	8085101	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	9.5	CHEMBL262	Homo sapiens	Inhibition	%	9.5
	8085357	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	5.36	CHEMBL262	Homo sapiens	Inhibition	%	5.36
	8085689	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	4.95	CHEMBL262	Homo sapiens	Inhibition	%	4.95
	8085878	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	80.24	CHEMBL262	Homo sapiens	Inhibition	%	80.24
	8086217	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	4.25	CHEMBL262	Homo sapiens	Inhibition	%	4.25
	8086379	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	74.91	CHEMBL262	Homo sapiens	Inhibition	%	74.91
	8086702	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	0.08	CHEMBL262	Homo sapiens	Inhibition	%	0.08
	8086913	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	-1.21	CHEMBL262	Homo sapiens	Inhibition	%	-1.21
	8087295	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	0.54	CHEMBL262	Homo sapiens	Inhibition	%	0.54
	8087409	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	1.7	CHEMBL262	Homo sapiens	Inhibition	%	1.7
	8087633	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	2.57	CHEMBL262	Homo sapiens	Inhibition	%	2.57
	8087771	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	4.12	CHEMBL262	Homo sapiens	Inhibition	%	4.12
	8088137	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	1.94	CHEMBL262	Homo sapiens	Inhibition	%	1.94
	8088285	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	0.94	CHEMBL262	Homo sapiens	Inhibition	%	0.94
	8088637	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	2.25	CHEMBL262	Homo sapiens	Inhibition	%	2.25
	8088954	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	17.44	CHEMBL262	Homo sapiens	Inhibition	%	17.44
	8089082	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	3.22	CHEMBL262	Homo sapiens	Inhibition	%	3.22
	8089306	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	9.38	CHEMBL262	Homo sapiens	Inhibition	%	9.38
	8089454	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	7.42	CHEMBL262	Homo sapiens	Inhibition	%	7.42
	8089798	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	1.56	CHEMBL262	Homo sapiens	Inhibition	%	1.56
	8089978	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-1.01	CHEMBL262	Homo sapiens	Inhibition	%	-1.01
	8090143	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	0.46	CHEMBL262	Homo sapiens	Inhibition	%	0.46
	8090367	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	3.89	CHEMBL262	Homo sapiens	Inhibition	%	3.89
	8090534	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	4.78	CHEMBL262	Homo sapiens	Inhibition	%	4.78
	8090897	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	0.92	CHEMBL262	Homo sapiens	Inhibition	%	0.92
	8091102	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	1.65	CHEMBL262	Homo sapiens	Inhibition	%	1.65
	8091239	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	1.92	CHEMBL262	Homo sapiens	Inhibition	%	1.92
	8091463	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	3.05	CHEMBL262	Homo sapiens	Inhibition	%	3.05
	8091618	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	2.31	CHEMBL262	Homo sapiens	Inhibition	%	2.31
	8091958	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	2.74	CHEMBL262	Homo sapiens	Inhibition	%	2.74
	8092095	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-2.46	CHEMBL262	Homo sapiens	Inhibition	%	-2.46
	8092319	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-1.88	CHEMBL262	Homo sapiens	Inhibition	%	-1.88
	8092470	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	1.53	CHEMBL262	Homo sapiens	Inhibition	%	1.53
	8092618	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	3.26	CHEMBL262	Homo sapiens	Inhibition	%	3.26
	8092842	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	1.97	CHEMBL262	Homo sapiens	Inhibition	%	1.97
	8092971	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	5.97	CHEMBL262	Homo sapiens	Inhibition	%	5.97
	8093283	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	8.01	CHEMBL262	Homo sapiens	Inhibition	%	8.01
	8093647	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	32.14	CHEMBL262	Homo sapiens	Inhibition	%	32.14
	8093786	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	44.03	CHEMBL262	Homo sapiens	Inhibition	%	44.03
	8094130	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	1.12	CHEMBL262	Homo sapiens	Inhibition	%	1.12
	8094310	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	0.5	CHEMBL262	Homo sapiens	Inhibition	%	0.5
	8094709	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	2.71	CHEMBL262	Homo sapiens	Inhibition	%	2.71
	8094865	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	18.49	CHEMBL262	Homo sapiens	Inhibition	%	18.49
	8095229	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	13.6	CHEMBL262	Homo sapiens	Inhibition	%	13.6
	8095432	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	3.37	CHEMBL262	Homo sapiens	Inhibition	%	3.37
	8095797	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	17.12	CHEMBL262	Homo sapiens	Inhibition	%	17.12
	8095945	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	4.13	CHEMBL262	Homo sapiens	Inhibition	%	4.13
	8096286	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	2.57	CHEMBL262	Homo sapiens	Inhibition	%	2.57
	8096649	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	0.33	CHEMBL262	Homo sapiens	Inhibition	%	0.33
	8096805	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	1.78	CHEMBL262	Homo sapiens	Inhibition	%	1.78
	8097176	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	5.88	CHEMBL262	Homo sapiens	Inhibition	%	5.88
	8097483	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	31.21	CHEMBL262	Homo sapiens	Inhibition	%	31.21
	8097857	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	76.02	CHEMBL262	Homo sapiens	Inhibition	%	76.02
	8097990	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-2.48	CHEMBL262	Homo sapiens	Inhibition	%	-2.48
	8098214	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	2.13	CHEMBL262	Homo sapiens	Inhibition	%	2.13
	8098334	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	0.09	CHEMBL262	Homo sapiens	Inhibition	%	0.09
	8098514	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	0.28	CHEMBL262	Homo sapiens	Inhibition	%	0.28
	8098738	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	0.28	CHEMBL262	Homo sapiens	Inhibition	%	0.28
	8098923	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	7.27	CHEMBL262	Homo sapiens	Inhibition	%	7.27
	8099067	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	2.21	CHEMBL262	Homo sapiens	Inhibition	%	2.21
	8099291	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	6.33	CHEMBL262	Homo sapiens	Inhibition	%	6.33
	8099433	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	1.43	CHEMBL262	Homo sapiens	Inhibition	%	1.43
	8099627	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	8.49	CHEMBL262	Homo sapiens	Inhibition	%	8.49
	8099851	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	45.13	CHEMBL262	Homo sapiens	Inhibition	%	45.13
	8099998	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	13.07	CHEMBL262	Homo sapiens	Inhibition	%	13.07
	8100144	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	7.35	CHEMBL262	Homo sapiens	Inhibition	%	7.35
	8100368	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	26.35	CHEMBL262	Homo sapiens	Inhibition	%	26.35
	8100484	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	2.16	CHEMBL262	Homo sapiens	Inhibition	%	2.16
	8100848	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	1.33	CHEMBL262	Homo sapiens	Inhibition	%	1.33
	8101008	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	2.89	CHEMBL262	Homo sapiens	Inhibition	%	2.89
	8101232	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	4.32	CHEMBL262	Homo sapiens	Inhibition	%	4.32
	8101374	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	5.44	CHEMBL262	Homo sapiens	Inhibition	%	5.44
	8101559	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	-1.37	CHEMBL262	Homo sapiens	Inhibition	%	-1.37
	8101783	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	-0.28	CHEMBL262	Homo sapiens	Inhibition	%	-0.28
	8101812	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	76.61	CHEMBL262	Homo sapiens	Inhibition	%	76.61
	8102036	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	83.51	CHEMBL262	Homo sapiens	Inhibition	%	83.51
	8102191	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	8.67	CHEMBL262	Homo sapiens	Inhibition	%	8.67
	8102546	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	0.79	CHEMBL262	Homo sapiens	Inhibition	%	0.79
	8102666	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	2.12	CHEMBL262	Homo sapiens	Inhibition	%	2.12
	8103068	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	2.25	CHEMBL262	Homo sapiens	Inhibition	%	2.25
	8103264	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	30.01	CHEMBL262	Homo sapiens	Inhibition	%	30.01
	8103626	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	2.25	CHEMBL262	Homo sapiens	Inhibition	%	2.25
	8103776	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	2.85	CHEMBL262	Homo sapiens	Inhibition	%	2.85
	8104185	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	2.92	CHEMBL262	Homo sapiens	Inhibition	%	2.92
	8104333	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	47.03	CHEMBL262	Homo sapiens	Inhibition	%	47.03
	8104703	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	65.23	CHEMBL262	Homo sapiens	Inhibition	%	65.23
	8104817	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	0.3	CHEMBL262	Homo sapiens	Inhibition	%	0.3
	8105041	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	1.96	CHEMBL262	Homo sapiens	Inhibition	%	1.96
	8105181	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	1.01	CHEMBL262	Homo sapiens	Inhibition	%	1.01
	8105571	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	-1.76	CHEMBL262	Homo sapiens	Inhibition	%	-1.76
	8105709	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	35.8	CHEMBL262	Homo sapiens	Inhibition	%	35.8
	8105989	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	1.98	CHEMBL262	Homo sapiens	Inhibition	%	1.98
	8106378	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	3.14	CHEMBL262	Homo sapiens	Inhibition	%	3.14
	8106534	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	35.05	CHEMBL262	Homo sapiens	Inhibition	%	35.05
	8106887	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	3.89	CHEMBL262	Homo sapiens	Inhibition	%	3.89
	8107008	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	1.77	CHEMBL262	Homo sapiens	Inhibition	%	1.77
	8107232	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	3.94	CHEMBL262	Homo sapiens	Inhibition	%	3.94
	8107404	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	1.16	CHEMBL262	Homo sapiens	Inhibition	%	1.16
	8107605	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	71.18	CHEMBL262	Homo sapiens	Inhibition	%	71.18
	8107964	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	15.77	CHEMBL262	Homo sapiens	Inhibition	%	15.77
	8108122	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	1.12	CHEMBL262	Homo sapiens	Inhibition	%	1.12
	8108346	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	3.56	CHEMBL262	Homo sapiens	Inhibition	%	3.56
	8108521	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	4.55	CHEMBL262	Homo sapiens	Inhibition	%	4.55
	8108668	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	2.71	CHEMBL262	Homo sapiens	Inhibition	%	2.71
	8108892	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	8.9	CHEMBL262	Homo sapiens	Inhibition	%	8.9
	8109034	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	2.14	CHEMBL262	Homo sapiens	Inhibition	%	2.14
	8109372	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	2.52	CHEMBL262	Homo sapiens	Inhibition	%	2.52
	8109502	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	1.86	CHEMBL262	Homo sapiens	Inhibition	%	1.86
	8109897	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	-0.12	CHEMBL262	Homo sapiens	Inhibition	%	-0.12
	8110029	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	2.47	CHEMBL262	Homo sapiens	Inhibition	%	2.47
	8110253	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	11.51	CHEMBL262	Homo sapiens	Inhibition	%	11.51
	8110308	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	4.53	CHEMBL262	Homo sapiens	Inhibition	%	4.53
	8110532	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	1.78	CHEMBL262	Homo sapiens	Inhibition	%	1.78
	8110698	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	7.7	CHEMBL262	Homo sapiens	Inhibition	%	7.7
	8110856	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	3.41	CHEMBL262	Homo sapiens	Inhibition	%	3.41
	8111080	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	14.4	CHEMBL262	Homo sapiens	Inhibition	%	14.4
	8111203	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	1.88	CHEMBL262	Homo sapiens	Inhibition	%	1.88
	8111554	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	9.2	CHEMBL262	Homo sapiens	Inhibition	%	9.2
	8111720	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	2.38	CHEMBL262	Homo sapiens	Inhibition	%	2.38
	8111925	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	3.23	CHEMBL262	Homo sapiens	Inhibition	%	3.23
	8112149	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	11.97	CHEMBL262	Homo sapiens	Inhibition	%	11.97
	8112286	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	3.08	CHEMBL262	Homo sapiens	Inhibition	%	3.08
	8112678	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	2.78	CHEMBL262	Homo sapiens	Inhibition	%	2.78
	8112850	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	2.8	CHEMBL262	Homo sapiens	Inhibition	%	2.8
	8113226	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	8.59	CHEMBL262	Homo sapiens	Inhibition	%	8.59
	8113362	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	5.91	CHEMBL262	Homo sapiens	Inhibition	%	5.91
	8113710	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	4.28	CHEMBL262	Homo sapiens	Inhibition	%	4.28
	8113826	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	0.1	CHEMBL262	Homo sapiens	Inhibition	%	0.1
	8114050	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-0.49	CHEMBL262	Homo sapiens	Inhibition	%	-0.49
	8114226	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	1.65	CHEMBL262	Homo sapiens	Inhibition	%	1.65
	8114582	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	2.77	CHEMBL262	Homo sapiens	Inhibition	%	2.77
	8114858	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	0.33	CHEMBL262	Homo sapiens	Inhibition	%	0.33
	8115024	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	7.23	CHEMBL262	Homo sapiens	Inhibition	%	7.23
	8115413	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	1.37	CHEMBL262	Homo sapiens	Inhibition	%	1.37
	8115533	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	6.49	CHEMBL262	Homo sapiens	Inhibition	%	6.49
	8115890	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	46.85	CHEMBL262	Homo sapiens	Inhibition	%	46.85
	8116049	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	22.45	CHEMBL262	Homo sapiens	Inhibition	%	22.45
	8116273	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	66.84	CHEMBL262	Homo sapiens	Inhibition	%	66.84
	8116476	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	10.01	CHEMBL262	Homo sapiens	Inhibition	%	10.01
	8116610	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	9.41	CHEMBL262	Homo sapiens	Inhibition	%	9.41
	8116834	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	4.19	CHEMBL262	Homo sapiens	Inhibition	%	4.19
	8117006	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	3.65	CHEMBL262	Homo sapiens	Inhibition	%	3.65
	8117177	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	4.28	CHEMBL262	Homo sapiens	Inhibition	%	4.28
	8117559	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	46.77	CHEMBL262	Homo sapiens	Inhibition	%	46.77
	8117689	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	2.15	CHEMBL262	Homo sapiens	Inhibition	%	2.15
	8117913	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	3.95	CHEMBL262	Homo sapiens	Inhibition	%	3.95
	8118051	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	-0.48	CHEMBL262	Homo sapiens	Inhibition	%	-0.48
	8118391	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	0.69	CHEMBL262	Homo sapiens	Inhibition	%	0.69
	8118563	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	3.05	CHEMBL262	Homo sapiens	Inhibition	%	3.05
	8118923	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	4.97	CHEMBL262	Homo sapiens	Inhibition	%	4.97
	8119194	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	-1.22	CHEMBL262	Homo sapiens	Inhibition	%	-1.22
	8119353	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	17.0	CHEMBL262	Homo sapiens	Inhibition	%	17.0
	8119577	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	41.64	CHEMBL262	Homo sapiens	Inhibition	%	41.64
	8119744	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	3.63	CHEMBL262	Homo sapiens	Inhibition	%	3.63
	8119863	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	1.2	CHEMBL262	Homo sapiens	Inhibition	%	1.2
	8120087	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	1.99	CHEMBL262	Homo sapiens	Inhibition	%	1.99
	8120226	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	4.65	CHEMBL262	Homo sapiens	Inhibition	%	4.65
	8120610	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	1.44	CHEMBL262	Homo sapiens	Inhibition	%	1.44
	8120811	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	51.78	CHEMBL262	Homo sapiens	Inhibition	%	51.78
	8121163	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	16.82	CHEMBL262	Homo sapiens	Inhibition	%	16.82
	8121335	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	0.78	CHEMBL262	Homo sapiens	Inhibition	%	0.78
	8121502	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	34.09	CHEMBL262	Homo sapiens	Inhibition	%	34.09
	8121726	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	56.4	CHEMBL262	Homo sapiens	Inhibition	%	56.4
	8121889	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	4.55	CHEMBL262	Homo sapiens	Inhibition	%	4.55
	8122234	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	1.21	CHEMBL262	Homo sapiens	Inhibition	%	1.21
	8122372	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	2.53	CHEMBL262	Homo sapiens	Inhibition	%	2.53
	8122716	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	2.65	CHEMBL262	Homo sapiens	Inhibition	%	2.65
	8122883	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	3.1	CHEMBL262	Homo sapiens	Inhibition	%	3.1
	8123107	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	3.91	CHEMBL262	Homo sapiens	Inhibition	%	3.91
	8123249	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	-0.65	CHEMBL262	Homo sapiens	Inhibition	%	-0.65
	8123527	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	0.98	CHEMBL262	Homo sapiens	Inhibition	%	0.98
	8123901	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	78.07	CHEMBL262	Homo sapiens	Inhibition	%	78.07
	8124068	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	3.02	CHEMBL262	Homo sapiens	Inhibition	%	3.02
	8124411	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	59.72	CHEMBL262	Homo sapiens	Inhibition	%	59.72
	8124550	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	10.18	CHEMBL262	Homo sapiens	Inhibition	%	10.18
	8124774	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	34.71	CHEMBL262	Homo sapiens	Inhibition	%	34.71
	8124939	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	3.77	CHEMBL262	Homo sapiens	Inhibition	%	3.77
	8125140	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	2.44	CHEMBL262	Homo sapiens	Inhibition	%	2.44
	8125494	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	80.0	CHEMBL262	Homo sapiens	Inhibition	%	80.0
	8125662	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	2.73	CHEMBL262	Homo sapiens	Inhibition	%	2.73
	8126050	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	80.87	CHEMBL262	Homo sapiens	Inhibition	%	80.87
	8126214	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	11.81	CHEMBL262	Homo sapiens	Inhibition	%	11.81
	8126553	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	5.38	CHEMBL262	Homo sapiens	Inhibition	%	5.38
	8126689	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	26.08	CHEMBL262	Homo sapiens	Inhibition	%	26.08
	8126913	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	65.14	CHEMBL262	Homo sapiens	Inhibition	%	65.14
	8127035	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	2.21	CHEMBL262	Homo sapiens	Inhibition	%	2.21
	8127426	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	2.72	CHEMBL262	Homo sapiens	Inhibition	%	2.72
	8127568	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	7.21	CHEMBL262	Homo sapiens	Inhibition	%	7.21
	8127856	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	-0.59	CHEMBL262	Homo sapiens	Inhibition	%	-0.59
	8128232	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	6.11	CHEMBL262	Homo sapiens	Inhibition	%	6.11
	8128399	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	32.38	CHEMBL262	Homo sapiens	Inhibition	%	32.38
	8128742	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	79.02	CHEMBL262	Homo sapiens	Inhibition	%	79.02
	8129103	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	80.72	CHEMBL262	Homo sapiens	Inhibition	%	80.72
	8129274	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-0.79	CHEMBL262	Homo sapiens	Inhibition	%	-0.79
	8129463	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	7.29	CHEMBL262	Homo sapiens	Inhibition	%	7.29
	8129687	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	1.98	CHEMBL262	Homo sapiens	Inhibition	%	1.98
	8129826	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	81.5	CHEMBL262	Homo sapiens	Inhibition	%	81.5
	8129987	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	2.33	CHEMBL262	Homo sapiens	Inhibition	%	2.33
	8130211	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	6.02	CHEMBL262	Homo sapiens	Inhibition	%	6.02
	8130383	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	88.69	CHEMBL262	Homo sapiens	Inhibition	%	88.69
	8130543	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	18.0	CHEMBL262	Homo sapiens	Inhibition	%	18.0
	8130767	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	62.32	CHEMBL262	Homo sapiens	Inhibition	%	62.32
	8130883	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	0.64	CHEMBL262	Homo sapiens	Inhibition	%	0.64
	8131246	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	4.08	CHEMBL262	Homo sapiens	Inhibition	%	4.08
	8131366	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	3.65	CHEMBL262	Homo sapiens	Inhibition	%	3.65
	8131590	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	-1.98	CHEMBL262	Homo sapiens	Inhibition	%	-1.98
	8131757	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	4.08	CHEMBL262	Homo sapiens	Inhibition	%	4.08
	8131898	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	2.89	CHEMBL262	Homo sapiens	Inhibition	%	2.89
	8132122	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	11.02	CHEMBL262	Homo sapiens	Inhibition	%	11.02
	8132184	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	0.75	CHEMBL262	Homo sapiens	Inhibition	%	0.75
	8132408	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-3.79	CHEMBL262	Homo sapiens	Inhibition	%	-3.79
	8132555	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	9.44	CHEMBL262	Homo sapiens	Inhibition	%	9.44
	8132723	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	3.39	CHEMBL262	Homo sapiens	Inhibition	%	3.39
	8132947	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	10.0	CHEMBL262	Homo sapiens	Inhibition	%	10.0
	8133068	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	2.82	CHEMBL262	Homo sapiens	Inhibition	%	2.82
	8133430	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	85.04	CHEMBL262	Homo sapiens	Inhibition	%	85.04
	8133602	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	0.28	CHEMBL262	Homo sapiens	Inhibition	%	0.28
	8134006	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	4.51	CHEMBL262	Homo sapiens	Inhibition	%	4.51
	8134154	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	5.53	CHEMBL262	Homo sapiens	Inhibition	%	5.53
	8134538	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	6.09	CHEMBL262	Homo sapiens	Inhibition	%	6.09
	8134722	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	6.71	CHEMBL262	Homo sapiens	Inhibition	%	6.71
	8135106	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	5.72	CHEMBL262	Homo sapiens	Inhibition	%	5.72
	8135221	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	2.96	CHEMBL262	Homo sapiens	Inhibition	%	2.96
	8135445	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	3.13	CHEMBL262	Homo sapiens	Inhibition	%	3.13
	8135586	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	7.45	CHEMBL262	Homo sapiens	Inhibition	%	7.45
	8135931	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	-1.66	CHEMBL262	Homo sapiens	Inhibition	%	-1.66
	8136099	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	10.28	CHEMBL262	Homo sapiens	Inhibition	%	10.28
	8136467	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	2.71	CHEMBL262	Homo sapiens	Inhibition	%	2.71
	8136757	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-3.33	CHEMBL262	Homo sapiens	Inhibition	%	-3.33
	8136892	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	-0.24	CHEMBL262	Homo sapiens	Inhibition	%	-0.24
	8137279	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	23.96	CHEMBL262	Homo sapiens	Inhibition	%	23.96
	8137399	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	11.59	CHEMBL262	Homo sapiens	Inhibition	%	11.59
	8137623	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-1.93	CHEMBL262	Homo sapiens	Inhibition	%	-1.93
	8137771	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	94.41	CHEMBL262	Homo sapiens	Inhibition	%	94.41
	8137937	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-0.5	CHEMBL262	Homo sapiens	Inhibition	%	-0.5
	8138161	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-0.09	CHEMBL262	Homo sapiens	Inhibition	%	-0.09
	8138340	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	5.25	CHEMBL262	Homo sapiens	Inhibition	%	5.25
	8138488	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	8.0	CHEMBL262	Homo sapiens	Inhibition	%	8.0
	8138712	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	1.46	CHEMBL262	Homo sapiens	Inhibition	%	1.46
	8138870	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	-0.68	CHEMBL262	Homo sapiens	Inhibition	%	-0.68
	8139055	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	17.25	CHEMBL262	Homo sapiens	Inhibition	%	17.25
	8139279	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	0.29	CHEMBL262	Homo sapiens	Inhibition	%	0.29
	8139438	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	13.66	CHEMBL262	Homo sapiens	Inhibition	%	13.66
	8139776	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	3.51	CHEMBL262	Homo sapiens	Inhibition	%	3.51
	8139917	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	3.06	CHEMBL262	Homo sapiens	Inhibition	%	3.06
	8140264	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	1.1	CHEMBL262	Homo sapiens	Inhibition	%	1.1
	8140423	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	51.06	CHEMBL262	Homo sapiens	Inhibition	%	51.06
	8140647	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	2.65	CHEMBL262	Homo sapiens	Inhibition	%	2.65
	8140790	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	4.03	CHEMBL262	Homo sapiens	Inhibition	%	4.03
	8141092	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	0.15	CHEMBL262	Homo sapiens	Inhibition	%	0.15
	8141222	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	4.85	CHEMBL262	Homo sapiens	Inhibition	%	4.85
	8141446	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	6.13	CHEMBL262	Homo sapiens	Inhibition	%	6.13
	8141606	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	68.7	CHEMBL262	Homo sapiens	Inhibition	%	68.7
	8141949	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-0.33	CHEMBL262	Homo sapiens	Inhibition	%	-0.33
	8142110	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	-0.07	CHEMBL262	Homo sapiens	Inhibition	%	-0.07
	8142502	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-0.31	CHEMBL262	Homo sapiens	Inhibition	%	-0.31
	8142678	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	4.85	CHEMBL262	Homo sapiens	Inhibition	%	4.85
	8143051	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	3.01	CHEMBL262	Homo sapiens	Inhibition	%	3.01
	8143206	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	1.95	CHEMBL262	Homo sapiens	Inhibition	%	1.95
	8143617	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	5.98	CHEMBL262	Homo sapiens	Inhibition	%	5.98
	8143776	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	35.67	CHEMBL262	Homo sapiens	Inhibition	%	35.67
	8144114	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-1.65	CHEMBL262	Homo sapiens	Inhibition	%	-1.65
	8144253	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	4.76	CHEMBL262	Homo sapiens	Inhibition	%	4.76
	8144477	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	1.77	CHEMBL262	Homo sapiens	Inhibition	%	1.77
	8144607	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	1.41	CHEMBL262	Homo sapiens	Inhibition	%	1.41
	8144984	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	4.74	CHEMBL262	Homo sapiens	Inhibition	%	4.74
	8145121	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	2.66	CHEMBL262	Homo sapiens	Inhibition	%	2.66
	8145434	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	0.72	CHEMBL262	Homo sapiens	Inhibition	%	0.72
	8145782	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	41.34	CHEMBL262	Homo sapiens	Inhibition	%	41.34
	8145943	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	4.11	CHEMBL262	Homo sapiens	Inhibition	%	4.11
	8146287	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	2.16	CHEMBL262	Homo sapiens	Inhibition	%	2.16
	8146447	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	5.33	CHEMBL262	Homo sapiens	Inhibition	%	5.33
	8146671	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	1.05	CHEMBL262	Homo sapiens	Inhibition	%	1.05
	8146838	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	2.74	CHEMBL262	Homo sapiens	Inhibition	%	2.74
	8147007	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	77.0	CHEMBL262	Homo sapiens	Inhibition	%	77.0
	8147373	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	10.31	CHEMBL262	Homo sapiens	Inhibition	%	10.31
	8147526	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	0.21	CHEMBL262	Homo sapiens	Inhibition	%	0.21
	8147750	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	1.41	CHEMBL262	Homo sapiens	Inhibition	%	1.41
	8147937	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	9.77	CHEMBL262	Homo sapiens	Inhibition	%	9.77
	8148095	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	75.99	CHEMBL262	Homo sapiens	Inhibition	%	75.99
	8148319	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	5.53	CHEMBL262	Homo sapiens	Inhibition	%	5.53
	8148433	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-1.69	CHEMBL262	Homo sapiens	Inhibition	%	-1.69
	8148796	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	4.99	CHEMBL262	Homo sapiens	Inhibition	%	4.99
	8148934	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	2.57	CHEMBL262	Homo sapiens	Inhibition	%	2.57
	8149317	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-2.26	CHEMBL262	Homo sapiens	Inhibition	%	-2.26
	8149451	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	2.57	CHEMBL262	Homo sapiens	Inhibition	%	2.57
	8149675	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	6.83	CHEMBL262	Homo sapiens	Inhibition	%	6.83
	8149773	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	1.23	CHEMBL262	Homo sapiens	Inhibition	%	1.23
	8150122	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	-2.51	CHEMBL262	Homo sapiens	Inhibition	%	-2.51
	8150282	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	9.63	CHEMBL262	Homo sapiens	Inhibition	%	9.63
	8150506	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	0.4	CHEMBL262	Homo sapiens	Inhibition	%	0.4
	8150626	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	1.89	CHEMBL262	Homo sapiens	Inhibition	%	1.89
	8151015	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	2.63	CHEMBL262	Homo sapiens	Inhibition	%	2.63
	8151178	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-0.96	CHEMBL262	Homo sapiens	Inhibition	%	-0.96
	8151355	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	80.04	CHEMBL262	Homo sapiens	Inhibition	%	80.04
	8151579	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	6.18	CHEMBL262	Homo sapiens	Inhibition	%	6.18
	8151717	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	53.51	CHEMBL262	Homo sapiens	Inhibition	%	53.51
	8152095	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	3.78	CHEMBL262	Homo sapiens	Inhibition	%	3.78
	8152283	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	44.19	CHEMBL262	Homo sapiens	Inhibition	%	44.19
	8152665	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	13.3	CHEMBL262	Homo sapiens	Inhibition	%	13.3
	8152779	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	1.45	CHEMBL262	Homo sapiens	Inhibition	%	1.45
	8153142	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	2.82	CHEMBL262	Homo sapiens	Inhibition	%	2.82
	8153279	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	3.17	CHEMBL262	Homo sapiens	Inhibition	%	3.17
	8153503	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	1.93	CHEMBL262	Homo sapiens	Inhibition	%	1.93
	8153660	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-0.38	CHEMBL262	Homo sapiens	Inhibition	%	-0.38
	8154017	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	42.33	CHEMBL262	Homo sapiens	Inhibition	%	42.33
	8154114	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	4.75	CHEMBL262	Homo sapiens	Inhibition	%	4.75
	8154338	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	3.21	CHEMBL262	Homo sapiens	Inhibition	%	3.21
	8154464	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	1.83	CHEMBL262	Homo sapiens	Inhibition	%	1.83
	8154847	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	6.56	CHEMBL262	Homo sapiens	Inhibition	%	6.56
	8154967	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	1.97	CHEMBL262	Homo sapiens	Inhibition	%	1.97
	8155191	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	3.81	CHEMBL262	Homo sapiens	Inhibition	%	3.81
	8155367	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-1.01	CHEMBL262	Homo sapiens	Inhibition	%	-1.01
	8155528	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	1.14	CHEMBL262	Homo sapiens	Inhibition	%	1.14
	8155930	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	7.53	CHEMBL262	Homo sapiens	Inhibition	%	7.53
	8156068	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	5.68	CHEMBL262	Homo sapiens	Inhibition	%	5.68
	8156292	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	33.64	CHEMBL262	Homo sapiens	Inhibition	%	33.64
	8156504	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	7.9	CHEMBL262	Homo sapiens	Inhibition	%	7.9
	8156654	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	12.36	CHEMBL262	Homo sapiens	Inhibition	%	12.36
	8157021	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	35.43	CHEMBL262	Homo sapiens	Inhibition	%	35.43
	8157141	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	6.08	CHEMBL262	Homo sapiens	Inhibition	%	6.08
	8157365	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	10.33	CHEMBL262	Homo sapiens	Inhibition	%	10.33
	8157506	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	4.09	CHEMBL262	Homo sapiens	Inhibition	%	4.09
	8157860	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	22.0	CHEMBL262	Homo sapiens	Inhibition	%	22.0
	8158021	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	0.94	CHEMBL262	Homo sapiens	Inhibition	%	0.94
	8158271	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	6.76	CHEMBL262	Homo sapiens	Inhibition	%	6.76
	8158495	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	2.36	CHEMBL262	Homo sapiens	Inhibition	%	2.36
	8158653	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	3.68	CHEMBL262	Homo sapiens	Inhibition	%	3.68
	8158822	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	3.48	CHEMBL262	Homo sapiens	Inhibition	%	3.48
	8159046	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	23.89	CHEMBL262	Homo sapiens	Inhibition	%	23.89
	8159181	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	2.75	CHEMBL262	Homo sapiens	Inhibition	%	2.75
	8159525	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	-2.25	CHEMBL262	Homo sapiens	Inhibition	%	-2.25
	8159656	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	5.21	CHEMBL262	Homo sapiens	Inhibition	%	5.21
	8160021	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	6.89	CHEMBL262	Homo sapiens	Inhibition	%	6.89
	8160158	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	10.97	CHEMBL262	Homo sapiens	Inhibition	%	10.97
	8160382	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	7.42	CHEMBL262	Homo sapiens	Inhibition	%	7.42
	8160532	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	1.63	CHEMBL262	Homo sapiens	Inhibition	%	1.63
	8160826	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	38.18	CHEMBL262	Homo sapiens	Inhibition	%	38.18
	8160976	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	4.49	CHEMBL262	Homo sapiens	Inhibition	%	4.49
	8161200	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	5.02	CHEMBL262	Homo sapiens	Inhibition	%	5.02
	8161343	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	74.39	CHEMBL262	Homo sapiens	Inhibition	%	74.39
	8161692	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	14.04	CHEMBL262	Homo sapiens	Inhibition	%	14.04
	8161830	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	28.08	CHEMBL262	Homo sapiens	Inhibition	%	28.08
	8162184	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	67.11	CHEMBL262	Homo sapiens	Inhibition	%	67.11
	8162344	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-2.95	CHEMBL262	Homo sapiens	Inhibition	%	-2.95
	8162568	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-1.5	CHEMBL262	Homo sapiens	Inhibition	%	-1.5
	8162821	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	12.12	CHEMBL262	Homo sapiens	Inhibition	%	12.12
	8162969	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	41.06	CHEMBL262	Homo sapiens	Inhibition	%	41.06
	8163362	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	3.72	CHEMBL262	Homo sapiens	Inhibition	%	3.72
	8163496	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	4.2	CHEMBL262	Homo sapiens	Inhibition	%	4.2
	8163843	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	3.12	CHEMBL262	Homo sapiens	Inhibition	%	3.12
	8163977	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	0.7	CHEMBL262	Homo sapiens	Inhibition	%	0.7
	8164201	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	4.25	CHEMBL262	Homo sapiens	Inhibition	%	4.25
	8164341	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	1.6	CHEMBL262	Homo sapiens	Inhibition	%	1.6
	8164720	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	84.07	CHEMBL262	Homo sapiens	Inhibition	%	84.07
	8164864	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	14.12	CHEMBL262	Homo sapiens	Inhibition	%	14.12
	8165158	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	6.12	CHEMBL262	Homo sapiens	Inhibition	%	6.12
	8165523	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	11.1	CHEMBL262	Homo sapiens	Inhibition	%	11.1
	8165666	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	91.02	CHEMBL262	Homo sapiens	Inhibition	%	91.02
	8166016	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	55.21	CHEMBL262	Homo sapiens	Inhibition	%	55.21
	8166154	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	2.84	CHEMBL262	Homo sapiens	Inhibition	%	2.84
	8166378	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	9.59	CHEMBL262	Homo sapiens	Inhibition	%	9.59
	8166508	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	5.61	CHEMBL262	Homo sapiens	Inhibition	%	5.61
	8166833	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	16.09	CHEMBL262	Homo sapiens	Inhibition	%	16.09
	8167145	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	10.25	CHEMBL262	Homo sapiens	Inhibition	%	10.25
	8167286	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	71.77	CHEMBL262	Homo sapiens	Inhibition	%	71.77
	8167674	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	6.89	CHEMBL262	Homo sapiens	Inhibition	%	6.89
	8167807	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	3.0	CHEMBL262	Homo sapiens	Inhibition	%	3.0
	8168031	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	3.37	CHEMBL262	Homo sapiens	Inhibition	%	3.37
	8168155	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	-0.1	CHEMBL262	Homo sapiens	Inhibition	%	-0.1
	8168520	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	7.03	CHEMBL262	Homo sapiens	Inhibition	%	7.03
	8168656	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	6.07	CHEMBL262	Homo sapiens	Inhibition	%	6.07
	8168880	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	1.04	CHEMBL262	Homo sapiens	Inhibition	%	1.04
	8169044	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	88.08	CHEMBL262	Homo sapiens	Inhibition	%	88.08
	8169186	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	1.51	CHEMBL262	Homo sapiens	Inhibition	%	1.51
	8169410	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	5.37	CHEMBL262	Homo sapiens	Inhibition	%	5.37
	8169490	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	14.57	CHEMBL262	Homo sapiens	Inhibition	%	14.57
	8169848	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	49.09	CHEMBL262	Homo sapiens	Inhibition	%	49.09
	8169993	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	1.08	CHEMBL262	Homo sapiens	Inhibition	%	1.08
	8170217	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	7.52	CHEMBL262	Homo sapiens	Inhibition	%	7.52
	8170342	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	3.71	CHEMBL262	Homo sapiens	Inhibition	%	3.71
	8170706	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	11.89	CHEMBL262	Homo sapiens	Inhibition	%	11.89
	8170841	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	18.85	CHEMBL262	Homo sapiens	Inhibition	%	18.85
	8171065	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	31.31	CHEMBL262	Homo sapiens	Inhibition	%	31.31
	8171262	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	2.73	CHEMBL262	Homo sapiens	Inhibition	%	2.73
	8171479	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	53.85	CHEMBL262	Homo sapiens	Inhibition	%	53.85
	8171620	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	5.85	CHEMBL262	Homo sapiens	Inhibition	%	5.85
	8171844	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	16.98	CHEMBL262	Homo sapiens	Inhibition	%	16.98
	8171997	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	44.68	CHEMBL262	Homo sapiens	Inhibition	%	44.68
	8172353	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	2.99	CHEMBL262	Homo sapiens	Inhibition	%	2.99
	8172481	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	1.6	CHEMBL262	Homo sapiens	Inhibition	%	1.6
	8172705	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	1.16	CHEMBL262	Homo sapiens	Inhibition	%	1.16
	8172847	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	41.32	CHEMBL262	Homo sapiens	Inhibition	%	41.32
	8173207	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	3.28	CHEMBL262	Homo sapiens	Inhibition	%	3.28
	8173372	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	83.36	CHEMBL262	Homo sapiens	Inhibition	%	83.36
	8173737	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	3.87	CHEMBL262	Homo sapiens	Inhibition	%	3.87
	8173824	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	50.95	CHEMBL262	Homo sapiens	Inhibition	%	50.95
	8174048	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	86.57	CHEMBL262	Homo sapiens	Inhibition	%	86.57
	8174180	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	6.58	CHEMBL262	Homo sapiens	Inhibition	%	6.58
	8174552	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	1.32	CHEMBL262	Homo sapiens	Inhibition	%	1.32
	8174674	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	7.38	CHEMBL262	Homo sapiens	Inhibition	%	7.38
	8174898	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	2.01	CHEMBL262	Homo sapiens	Inhibition	%	2.01
	8175041	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	55.41	CHEMBL262	Homo sapiens	Inhibition	%	55.41
	8175401	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	75.41	CHEMBL262	Homo sapiens	Inhibition	%	75.41
	8175657	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	25.39	CHEMBL262	Homo sapiens	Inhibition	%	25.39
	8175820	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	0.37	CHEMBL262	Homo sapiens	Inhibition	%	0.37
	8176197	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	18.14	CHEMBL262	Homo sapiens	Inhibition	%	18.14
	8176346	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	72.65	CHEMBL262	Homo sapiens	Inhibition	%	72.65
	8176702	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	11.98	CHEMBL262	Homo sapiens	Inhibition	%	11.98
	8177056	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	4.83	CHEMBL262	Homo sapiens	Inhibition	%	4.83
	8177198	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	-2.15	CHEMBL262	Homo sapiens	Inhibition	%	-2.15
	8177560	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	3.92	CHEMBL262	Homo sapiens	Inhibition	%	3.92
	8177724	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	89.21	CHEMBL262	Homo sapiens	Inhibition	%	89.21
	8178088	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	21.39	CHEMBL262	Homo sapiens	Inhibition	%	21.39
	8178400	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	1.31	CHEMBL262	Homo sapiens	Inhibition	%	1.31
	8178527	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	12.91	CHEMBL262	Homo sapiens	Inhibition	%	12.91
	8178751	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	54.65	CHEMBL262	Homo sapiens	Inhibition	%	54.65
	8178900	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	0.48	CHEMBL262	Homo sapiens	Inhibition	%	0.48
	8179247	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	8.04	CHEMBL262	Homo sapiens	Inhibition	%	8.04
	8179391	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	38.4	CHEMBL262	Homo sapiens	Inhibition	%	38.4
	8179752	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	6.85	CHEMBL262	Homo sapiens	Inhibition	%	6.85
	8180009	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	70.81	CHEMBL262	Homo sapiens	Inhibition	%	70.81
	8180163	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	5.82	CHEMBL262	Homo sapiens	Inhibition	%	5.82
	8180387	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-2.64	CHEMBL262	Homo sapiens	Inhibition	%	-2.64
	8180543	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	60.09	CHEMBL262	Homo sapiens	Inhibition	%	60.09
	8180691	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	6.03	CHEMBL262	Homo sapiens	Inhibition	%	6.03
	8180915	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	24.17	CHEMBL262	Homo sapiens	Inhibition	%	24.17
	8181048	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	1.89	CHEMBL262	Homo sapiens	Inhibition	%	1.89
	8181403	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	1.17	CHEMBL262	Homo sapiens	Inhibition	%	1.17
	8181543	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	2.36	CHEMBL262	Homo sapiens	Inhibition	%	2.36
	8181767	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	5.37	CHEMBL262	Homo sapiens	Inhibition	%	5.37
	8181906	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	14.68	CHEMBL262	Homo sapiens	Inhibition	%	14.68
	8182069	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	10.98	CHEMBL262	Homo sapiens	Inhibition	%	10.98
	8182293	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	19.64	CHEMBL262	Homo sapiens	Inhibition	%	19.64
	8182433	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	1.37	CHEMBL262	Homo sapiens	Inhibition	%	1.37
	8182749	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	4.1	CHEMBL262	Homo sapiens	Inhibition	%	4.1
	8183095	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	83.04	CHEMBL262	Homo sapiens	Inhibition	%	83.04
	8183244	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	2.23	CHEMBL262	Homo sapiens	Inhibition	%	2.23
	8183597	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	7.6	CHEMBL262	Homo sapiens	Inhibition	%	7.6
	8183739	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	77.07	CHEMBL262	Homo sapiens	Inhibition	%	77.07
	8183963	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	13.46	CHEMBL262	Homo sapiens	Inhibition	%	13.46
	8184099	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	10.19	CHEMBL262	Homo sapiens	Inhibition	%	10.19
	8184365	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	84.18	CHEMBL262	Homo sapiens	Inhibition	%	84.18
	8184736	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	1.92	CHEMBL262	Homo sapiens	Inhibition	%	1.92
	8184893	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	39.02	CHEMBL262	Homo sapiens	Inhibition	%	39.02
	8185266	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	2.82	CHEMBL262	Homo sapiens	Inhibition	%	2.82
	8185397	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	3.47	CHEMBL262	Homo sapiens	Inhibition	%	3.47
	8185621	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	-0.71	CHEMBL262	Homo sapiens	Inhibition	%	-0.71
	8185752	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	9.04	CHEMBL262	Homo sapiens	Inhibition	%	9.04
	8186115	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	28.38	CHEMBL262	Homo sapiens	Inhibition	%	28.38
	8186256	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	3.16	CHEMBL262	Homo sapiens	Inhibition	%	3.16
	8186644	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	8.32	CHEMBL262	Homo sapiens	Inhibition	%	8.32
	8186783	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	3.82	CHEMBL262	Homo sapiens	Inhibition	%	3.82
	8187007	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	0.61	CHEMBL262	Homo sapiens	Inhibition	%	0.61
	8187105	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	1.76	CHEMBL262	Homo sapiens	Inhibition	%	1.76
	8187453	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	21.24	CHEMBL262	Homo sapiens	Inhibition	%	21.24
	8187601	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	11.15	CHEMBL262	Homo sapiens	Inhibition	%	11.15
	8187825	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	2.21	CHEMBL262	Homo sapiens	Inhibition	%	2.21
	8187954	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	9.99	CHEMBL262	Homo sapiens	Inhibition	%	9.99
	8188321	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	54.13	CHEMBL262	Homo sapiens	Inhibition	%	54.13
	8188456	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	70.38	CHEMBL262	Homo sapiens	Inhibition	%	70.38
	8188730	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	10.59	CHEMBL262	Homo sapiens	Inhibition	%	10.59
	8189102	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	4.9	CHEMBL262	Homo sapiens	Inhibition	%	4.9
	8189258	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	76.14	CHEMBL262	Homo sapiens	Inhibition	%	76.14
	8189482	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	3.36	CHEMBL262	Homo sapiens	Inhibition	%	3.36
	8189631	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	7.42	CHEMBL262	Homo sapiens	Inhibition	%	7.42
	8189987	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	1.89	CHEMBL262	Homo sapiens	Inhibition	%	1.89
	8190119	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	5.17	CHEMBL262	Homo sapiens	Inhibition	%	5.17
	8190483	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	2.53	CHEMBL262	Homo sapiens	Inhibition	%	2.53
	8190620	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	5.0	CHEMBL262	Homo sapiens	Inhibition	%	5.0
	8190844	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	3.17	CHEMBL262	Homo sapiens	Inhibition	%	3.17
	8191008	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	34.02	CHEMBL262	Homo sapiens	Inhibition	%	34.02
	8191370	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	4.47	CHEMBL262	Homo sapiens	Inhibition	%	4.47
	8191466	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	1.95	CHEMBL262	Homo sapiens	Inhibition	%	1.95
	8191690	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	1.95	CHEMBL262	Homo sapiens	Inhibition	%	1.95
	8191812	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	73.25	CHEMBL262	Homo sapiens	Inhibition	%	73.25
	8192185	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	7.96	CHEMBL262	Homo sapiens	Inhibition	%	7.96
	8192314	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	5.31	CHEMBL262	Homo sapiens	Inhibition	%	5.31
	8192682	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	5.07	CHEMBL262	Homo sapiens	Inhibition	%	5.07
	8192818	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	78.96	CHEMBL262	Homo sapiens	Inhibition	%	78.96
	8193042	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	9.12	CHEMBL262	Homo sapiens	Inhibition	%	9.12
	8193090	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	11.3	CHEMBL262	Homo sapiens	Inhibition	%	11.3
	8193314	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	0.05	CHEMBL262	Homo sapiens	Inhibition	%	0.05
	8193459	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	32.93	CHEMBL262	Homo sapiens	Inhibition	%	32.93
	8193840	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	19.71	CHEMBL262	Homo sapiens	Inhibition	%	19.71
	8193989	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	2.0	CHEMBL262	Homo sapiens	Inhibition	%	2.0
	8194344	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	4.62	CHEMBL262	Homo sapiens	Inhibition	%	4.62
	8194475	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	8.88	CHEMBL262	Homo sapiens	Inhibition	%	8.88
	8194699	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	2.39	CHEMBL262	Homo sapiens	Inhibition	%	2.39
	8194842	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	9.17	CHEMBL262	Homo sapiens	Inhibition	%	9.17
	8195199	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	7.21	CHEMBL262	Homo sapiens	Inhibition	%	7.21
	8195363	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	31.12	CHEMBL262	Homo sapiens	Inhibition	%	31.12
	8195726	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	2.21	CHEMBL262	Homo sapiens	Inhibition	%	2.21
	8196048	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	4.71	CHEMBL262	Homo sapiens	Inhibition	%	4.71
	8196165	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	5.99	CHEMBL262	Homo sapiens	Inhibition	%	5.99
	8196539	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	22.35	CHEMBL262	Homo sapiens	Inhibition	%	22.35
	8196667	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	13.56	CHEMBL262	Homo sapiens	Inhibition	%	13.56
	8196891	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	0.55	CHEMBL262	Homo sapiens	Inhibition	%	0.55
	8197032	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	10.8	CHEMBL262	Homo sapiens	Inhibition	%	10.8
	8197393	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	28.02	CHEMBL262	Homo sapiens	Inhibition	%	28.02
	8197668	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	1.12	CHEMBL262	Homo sapiens	Inhibition	%	1.12
	8197808	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	1.21	CHEMBL262	Homo sapiens	Inhibition	%	1.21
	8198032	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	9.93	CHEMBL262	Homo sapiens	Inhibition	%	9.93
	8198189	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	-1.43	CHEMBL262	Homo sapiens	Inhibition	%	-1.43
	8198327	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	3.59	CHEMBL262	Homo sapiens	Inhibition	%	3.59
	8198551	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	1.39	CHEMBL262	Homo sapiens	Inhibition	%	1.39
	8198681	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	11.18	CHEMBL262	Homo sapiens	Inhibition	%	11.18
	8199036	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	9.23	CHEMBL262	Homo sapiens	Inhibition	%	9.23
	8199184	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	1.6	CHEMBL262	Homo sapiens	Inhibition	%	1.6
	8199542	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	2.3	CHEMBL262	Homo sapiens	Inhibition	%	2.3
	8199705	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	75.85	CHEMBL262	Homo sapiens	Inhibition	%	75.85
	8199929	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	4.6	CHEMBL262	Homo sapiens	Inhibition	%	4.6
	8200067	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	3.44	CHEMBL262	Homo sapiens	Inhibition	%	3.44
	8200395	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	2.61	CHEMBL262	Homo sapiens	Inhibition	%	2.61
	8200510	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	7.73	CHEMBL262	Homo sapiens	Inhibition	%	7.73
	8200734	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	7.0	CHEMBL262	Homo sapiens	Inhibition	%	7.0
	8200884	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	66.67	CHEMBL262	Homo sapiens	Inhibition	%	66.67
	8201238	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	7.28	CHEMBL262	Homo sapiens	Inhibition	%	7.28
	8201373	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	2.08	CHEMBL262	Homo sapiens	Inhibition	%	2.08
	8201597	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	3.98	CHEMBL262	Homo sapiens	Inhibition	%	3.98
	8201730	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	5.99	CHEMBL262	Homo sapiens	Inhibition	%	5.99
	8202009	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	0.25	CHEMBL262	Homo sapiens	Inhibition	%	0.25
	8202373	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	0.83	CHEMBL262	Homo sapiens	Inhibition	%	0.83
	8202540	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	7.8	CHEMBL262	Homo sapiens	Inhibition	%	7.8
	8202889	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	2.88	CHEMBL262	Homo sapiens	Inhibition	%	2.88
	8203019	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	15.15	CHEMBL262	Homo sapiens	Inhibition	%	15.15
	8203374	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	-0.25	CHEMBL262	Homo sapiens	Inhibition	%	-0.25
	8203520	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	2.68	CHEMBL262	Homo sapiens	Inhibition	%	2.68
	8203744	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	1.44	CHEMBL262	Homo sapiens	Inhibition	%	1.44
	8203878	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	6.26	CHEMBL262	Homo sapiens	Inhibition	%	6.26
	8204268	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	7.76	CHEMBL262	Homo sapiens	Inhibition	%	7.76
	8204405	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	1.23	CHEMBL262	Homo sapiens	Inhibition	%	1.23
	8204734	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	26.25	CHEMBL262	Homo sapiens	Inhibition	%	26.25
	8205073	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	24.49	CHEMBL262	Homo sapiens	Inhibition	%	24.49
	8205222	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	2.95	CHEMBL262	Homo sapiens	Inhibition	%	2.95
	8205446	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	18.21	CHEMBL262	Homo sapiens	Inhibition	%	18.21
	8205582	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	3.37	CHEMBL262	Homo sapiens	Inhibition	%	3.37
	8205945	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	1.75	CHEMBL262	Homo sapiens	Inhibition	%	1.75
	8206077	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	14.65	CHEMBL262	Homo sapiens	Inhibition	%	14.65
	8206353	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	-0.18	CHEMBL262	Homo sapiens	Inhibition	%	-0.18
	8206720	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	4.42	CHEMBL262	Homo sapiens	Inhibition	%	4.42
	8206900	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	2.77	CHEMBL262	Homo sapiens	Inhibition	%	2.77
	8207250	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	2.21	CHEMBL262	Homo sapiens	Inhibition	%	2.21
	8207380	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	47.49	CHEMBL262	Homo sapiens	Inhibition	%	47.49
	8207604	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	80.23	CHEMBL262	Homo sapiens	Inhibition	%	80.23
	8207736	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	10.72	CHEMBL262	Homo sapiens	Inhibition	%	10.72
	8208105	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	13.01	CHEMBL262	Homo sapiens	Inhibition	%	13.01
	8208237	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	3.56	CHEMBL262	Homo sapiens	Inhibition	%	3.56
	8208461	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	6.22	CHEMBL262	Homo sapiens	Inhibition	%	6.22
	8208627	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	2.72	CHEMBL262	Homo sapiens	Inhibition	%	2.72
	8208760	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	5.65	CHEMBL262	Homo sapiens	Inhibition	%	5.65
	8208984	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	21.5	CHEMBL262	Homo sapiens	Inhibition	%	21.5
	8209089	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	1.65	CHEMBL262	Homo sapiens	Inhibition	%	1.65
	8209429	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	3.76	CHEMBL262	Homo sapiens	Inhibition	%	3.76
	8209803	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	4.15	CHEMBL262	Homo sapiens	Inhibition	%	4.15
	8209939	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	11.87	CHEMBL262	Homo sapiens	Inhibition	%	11.87
	8210304	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	3.08	CHEMBL262	Homo sapiens	Inhibition	%	3.08
	8210440	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	26.62	CHEMBL262	Homo sapiens	Inhibition	%	26.62
	8210664	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	68.74	CHEMBL262	Homo sapiens	Inhibition	%	68.74
	8210699	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	-0.31	CHEMBL262	Homo sapiens	Inhibition	%	-0.31
	8210923	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	4.25	CHEMBL262	Homo sapiens	Inhibition	%	4.25
	8211067	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	-0.28	CHEMBL262	Homo sapiens	Inhibition	%	-0.28
	8211237	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	12.35	CHEMBL262	Homo sapiens	Inhibition	%	12.35
	8211461	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	1.76	CHEMBL262	Homo sapiens	Inhibition	%	1.76
	8211584	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	7.52	CHEMBL262	Homo sapiens	Inhibition	%	7.52
	8211937	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	83.12	CHEMBL262	Homo sapiens	Inhibition	%	83.12
	8212069	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	0.8	CHEMBL262	Homo sapiens	Inhibition	%	0.8
	8212293	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	3.55	CHEMBL262	Homo sapiens	Inhibition	%	3.55
	8212434	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	2.61	CHEMBL262	Homo sapiens	Inhibition	%	2.61
	8212791	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	3.05	CHEMBL262	Homo sapiens	Inhibition	%	3.05
	8212961	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	7.81	CHEMBL262	Homo sapiens	Inhibition	%	7.81
	8213314	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	68.13	CHEMBL262	Homo sapiens	Inhibition	%	68.13
	8213418	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	7.6	CHEMBL262	Homo sapiens	Inhibition	%	7.6
	8213642	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	7.88	CHEMBL262	Homo sapiens	Inhibition	%	7.88
	8213755	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	8.29	CHEMBL262	Homo sapiens	Inhibition	%	8.29
	8214126	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	7.66	CHEMBL262	Homo sapiens	Inhibition	%	7.66
	8214263	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	5.07	CHEMBL262	Homo sapiens	Inhibition	%	5.07
	8214487	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	22.96	CHEMBL262	Homo sapiens	Inhibition	%	22.96
	8214621	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	0.74	CHEMBL262	Homo sapiens	Inhibition	%	0.74
	8214997	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	4.18	CHEMBL262	Homo sapiens	Inhibition	%	4.18
	8215248	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	0.93	CHEMBL262	Homo sapiens	Inhibition	%	0.93
	8215401	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	3.49	CHEMBL262	Homo sapiens	Inhibition	%	3.49
	8215789	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	5.52	CHEMBL262	Homo sapiens	Inhibition	%	5.52
	8215908	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	-0.78	CHEMBL262	Homo sapiens	Inhibition	%	-0.78
	8216251	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	-0.61	CHEMBL262	Homo sapiens	Inhibition	%	-0.61
	8216611	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	1.77	CHEMBL262	Homo sapiens	Inhibition	%	1.77
	8216749	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	14.92	CHEMBL262	Homo sapiens	Inhibition	%	14.92
	8217107	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	11.57	CHEMBL262	Homo sapiens	Inhibition	%	11.57
	8217281	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	1.83	CHEMBL262	Homo sapiens	Inhibition	%	1.83
	8217505	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	7.42	CHEMBL262	Homo sapiens	Inhibition	%	7.42
	8217636	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	4.26	CHEMBL262	Homo sapiens	Inhibition	%	4.26
	8217961	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	49.05	CHEMBL262	Homo sapiens	Inhibition	%	49.05
	8218076	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	4.7	CHEMBL262	Homo sapiens	Inhibition	%	4.7
	8218300	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	9.68	CHEMBL262	Homo sapiens	Inhibition	%	9.68
	8218427	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	66.31	CHEMBL262	Homo sapiens	Inhibition	%	66.31
	8218794	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	3.17	CHEMBL262	Homo sapiens	Inhibition	%	3.17
	8218925	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	17.44	CHEMBL262	Homo sapiens	Inhibition	%	17.44
	8219309	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	5.85	CHEMBL262	Homo sapiens	Inhibition	%	5.85
	8219559	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	4.68	CHEMBL262	Homo sapiens	Inhibition	%	4.68
	8219720	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	0.71	CHEMBL262	Homo sapiens	Inhibition	%	0.71
	8219944	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	2.62	CHEMBL262	Homo sapiens	Inhibition	%	2.62
	8220113	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	1.66	CHEMBL262	Homo sapiens	Inhibition	%	1.66
	8220242	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	-0.58	CHEMBL262	Homo sapiens	Inhibition	%	-0.58
	8220466	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	2.04	CHEMBL262	Homo sapiens	Inhibition	%	2.04
	8220580	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	3.8	CHEMBL262	Homo sapiens	Inhibition	%	3.8
	8220942	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	7.64	CHEMBL262	Homo sapiens	Inhibition	%	7.64
	8221078	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	17.65	CHEMBL262	Homo sapiens	Inhibition	%	17.65
	8221302	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	62.11	CHEMBL262	Homo sapiens	Inhibition	%	62.11
	8221435	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	3.95	CHEMBL262	Homo sapiens	Inhibition	%	3.95
	8221824	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	2.54	CHEMBL262	Homo sapiens	Inhibition	%	2.54
	8221955	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	8.83	CHEMBL262	Homo sapiens	Inhibition	%	8.83
	8222277	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	4.38	CHEMBL262	Homo sapiens	Inhibition	%	4.38
	8222635	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	11.39	CHEMBL262	Homo sapiens	Inhibition	%	11.39
	8222753	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	79.38	CHEMBL262	Homo sapiens	Inhibition	%	79.38
	8223121	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	15.24	CHEMBL262	Homo sapiens	Inhibition	%	15.24
	8223250	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	3.19	CHEMBL262	Homo sapiens	Inhibition	%	3.19
	8223474	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	7.73	CHEMBL262	Homo sapiens	Inhibition	%	7.73
	8223635	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	0.96	CHEMBL262	Homo sapiens	Inhibition	%	0.96
	8223885	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	2.27	CHEMBL262	Homo sapiens	Inhibition	%	2.27
	8224271	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	0.07	CHEMBL262	Homo sapiens	Inhibition	%	0.07
	8224441	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	1.43	CHEMBL262	Homo sapiens	Inhibition	%	1.43
	8224800	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	1.14	CHEMBL262	Homo sapiens	Inhibition	%	1.14
	8224914	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	0.14	CHEMBL262	Homo sapiens	Inhibition	%	0.14
	8225138	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	2.19	CHEMBL262	Homo sapiens	Inhibition	%	2.19
	8225272	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	2.02	CHEMBL262	Homo sapiens	Inhibition	%	2.02
	8225634	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	2.03	CHEMBL262	Homo sapiens	Inhibition	%	2.03
	8225769	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	6.19	CHEMBL262	Homo sapiens	Inhibition	%	6.19
	8226151	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	5.63	CHEMBL262	Homo sapiens	Inhibition	%	5.63
	8226276	CHEMBL1962044	GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	2.94	CHEMBL262	Homo sapiens	Inhibition	%	2.94
	8226500	CHEMBL1962045	GSK_PKIS: GSK3B mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	10.46	CHEMBL262	Homo sapiens	Inhibition	%	10.46
active	8603226	CHEMBL1964027	PUBCHEM_BIOASSAY: Inhibition of Human GSK3 beta Activity Measured in Biochemical System Using Plate Reader - 2083-02_Inhibitor_Dose_DryPowder_Activity. (Class of assay: confirmatory) 	F			CHEMBL2145922	=	AC50	nM	18860.0	CHEMBL262	Homo sapiens	AC50_uM	uM	18.86
active	9632435	CHEMBL1963839	PUBCHEM_BIOASSAY: Inhibition of Human GSK3 beta Activity Measured in Biochemical System Using Microfluidics - 2046-10_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) 	F	Cc1cccc(OCC(=O)Nc2ccc3c(c2)C(=O)NC3=O)c1		CHEMBL1462726	=	AC50	nM	1360.0	CHEMBL262	Homo sapiens	AC50_uM	uM	1.36
active	9632436	CHEMBL1963839	PUBCHEM_BIOASSAY: Inhibition of Human GSK3 beta Activity Measured in Biochemical System Using Microfluidics - 2046-10_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) 	F	COc1ccc(S(=O)(=O)Nc2c(C(=O)O)[nH]c3ccc(OC)cc23)cc1		CHEMBL1313269	=	AC50	nM	1460.0	CHEMBL262	Homo sapiens	AC50_uM	uM	1.46
active	9632437	CHEMBL1963839	PUBCHEM_BIOASSAY: Inhibition of Human GSK3 beta Activity Measured in Biochemical System Using Microfluidics - 2046-10_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) 	F	O=C(Cc1cccc2ccccc12)Nc1cn(C2CCC2)cn1		CHEMBL571565	=	AC50	nM	8410.0	CHEMBL262	Homo sapiens	AC50_uM	uM	8.41
active	9632438	CHEMBL1963839	PUBCHEM_BIOASSAY: Inhibition of Human GSK3 beta Activity Measured in Biochemical System Using Microfluidics - 2046-10_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) 	F	O=C1Nc2ccc3ncsc3c2/C1=C/Nc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1276446	=	AC50	nM	11.3	CHEMBL262	Homo sapiens	AC50_uM	uM	0.0113
active	9632439	CHEMBL1963839	PUBCHEM_BIOASSAY: Inhibition of Human GSK3 beta Activity Measured in Biochemical System Using Microfluidics - 2046-10_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) 	F	COC(=O)C(C)Sc1ccc2nnc(-c3ccc(F)cc3)n2n1		CHEMBL1426716	=	AC50	nM	1240.0	CHEMBL262	Homo sapiens	AC50_uM	uM	1.24
active	9632440	CHEMBL1963839	PUBCHEM_BIOASSAY: Inhibition of Human GSK3 beta Activity Measured in Biochemical System Using Microfluidics - 2046-10_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) 	F	CCOc1ccccc1/C=N/NC(=O)c1nnn(-c2nonc2N)c1CN1CCCCCC1		CHEMBL1970835	<	AC50	nM	16.0	CHEMBL262	Homo sapiens	AC50_uM	uM	0.016
active	9632441	CHEMBL1963839	PUBCHEM_BIOASSAY: Inhibition of Human GSK3 beta Activity Measured in Biochemical System Using Microfluidics - 2046-10_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) 	F	O=C1Nc2ccc3ncsc3c2/C1=C/Nc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1276446	<	AC50	nM	30.0	CHEMBL262	Homo sapiens	AC50_uM	uM	0.03
active	9632442	CHEMBL1963839	PUBCHEM_BIOASSAY: Inhibition of Human GSK3 beta Activity Measured in Biochemical System Using Microfluidics - 2046-10_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) 	F	Nc1nc(Nc2ccccc2)sc1C(=O)c1ccccc1		CHEMBL561114	=	AC50	nM	36.0	CHEMBL262	Homo sapiens	AC50_uM	uM	0.036
active	9632443	CHEMBL1963839	PUBCHEM_BIOASSAY: Inhibition of Human GSK3 beta Activity Measured in Biochemical System Using Microfluidics - 2046-10_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) 	F	COc1cccc(/C=C2/Sc3ccc(C(=O)NCCCN4CCCC4)cc3NC2=O)c1		CHEMBL1339810	=	AC50	nM	4460.0	CHEMBL262	Homo sapiens	AC50_uM	uM	4.46
active	9632444	CHEMBL1963839	PUBCHEM_BIOASSAY: Inhibition of Human GSK3 beta Activity Measured in Biochemical System Using Microfluidics - 2046-10_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) 	F	CCOc1cccc(-c2c(C(=O)N/N=C/c3sccc3C)nnn2-c2nonc2N)c1		CHEMBL1996263	=	AC50	nM	197.0	CHEMBL262	Homo sapiens	AC50_uM	uM	0.197
active	9632445	CHEMBL1963839	PUBCHEM_BIOASSAY: Inhibition of Human GSK3 beta Activity Measured in Biochemical System Using Microfluidics - 2046-10_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) 	F	Cc1ccc(-c2nnc(S)n2/N=C/c2ccncc2)cc1		CHEMBL1996315	=	AC50	nM	1480.0	CHEMBL262	Homo sapiens	AC50_uM	uM	1.48
active	9632446	CHEMBL1963839	PUBCHEM_BIOASSAY: Inhibition of Human GSK3 beta Activity Measured in Biochemical System Using Microfluidics - 2046-10_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) 	F	Clc1ccc(CSc2nnc(-c3ccncc3)o2)c(Cl)c1		CHEMBL1341221	=	AC50	nM	1830.0	CHEMBL262	Homo sapiens	AC50_uM	uM	1.83
active	9632447	CHEMBL1963839	PUBCHEM_BIOASSAY: Inhibition of Human GSK3 beta Activity Measured in Biochemical System Using Microfluidics - 2046-10_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) 	F	Cc1cccc(C(=O)N[C@H]2C[C@@H](n3cnc(NC(=O)Cc4cccc5ccccc45)c3)C2)n1		CHEMBL583658	=	AC50	nM	107.0	CHEMBL262	Homo sapiens	AC50_uM	uM	0.107
active	9632448	CHEMBL1963839	PUBCHEM_BIOASSAY: Inhibition of Human GSK3 beta Activity Measured in Biochemical System Using Microfluidics - 2046-10_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) 	F	COC(=O)c1ccc(CSc2ccc3nnc(-c4ccc(F)cc4)n3n2)o1		CHEMBL1467011	=	AC50	nM	509.0	CHEMBL262	Homo sapiens	AC50_uM	uM	0.509
active	9632449	CHEMBL1963839	PUBCHEM_BIOASSAY: Inhibition of Human GSK3 beta Activity Measured in Biochemical System Using Microfluidics - 2046-10_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) 	F	Nc1nc(NCC2CCCO2)nc(Nc2ccc(Cl)cc2)c1[N+](=O)[O-]		CHEMBL1343500	=	AC50	nM	429.0	CHEMBL262	Homo sapiens	AC50_uM	uM	0.429
active	9632450	CHEMBL1963839	PUBCHEM_BIOASSAY: Inhibition of Human GSK3 beta Activity Measured in Biochemical System Using Microfluidics - 2046-10_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) 	F	COc1cc(/C=N/n2c(S)nnc2C2CCCCC2)cc(Br)c1O		CHEMBL1978079	=	AC50	nM	958.0	CHEMBL262	Homo sapiens	AC50_uM	uM	0.958
active	9632451	CHEMBL1963839	PUBCHEM_BIOASSAY: Inhibition of Human GSK3 beta Activity Measured in Biochemical System Using Microfluidics - 2046-10_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) 	F	COc1ccc(/C=C2\SC(NCc3ccccc3)=NC2=O)cc1		CHEMBL1546852	=	AC50	nM	6020.0	CHEMBL262	Homo sapiens	AC50_uM	uM	6.02
active	9632452	CHEMBL1963839	PUBCHEM_BIOASSAY: Inhibition of Human GSK3 beta Activity Measured in Biochemical System Using Microfluidics - 2046-10_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) 	F	Nc1nc(NCC2CCCO2)nc(Nc2ccc(F)cc2)c1[N+](=O)[O-]		CHEMBL1450439	=	AC50	nM	802.0	CHEMBL262	Homo sapiens	AC50_uM	uM	0.802
active	9632453	CHEMBL1963839	PUBCHEM_BIOASSAY: Inhibition of Human GSK3 beta Activity Measured in Biochemical System Using Microfluidics - 2046-10_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) 	F	COc1cccc(Nc2nc(-c3ccc(O)cc3)cs2)c1		CHEMBL1326359	=	AC50	nM	2800.0	CHEMBL262	Homo sapiens	AC50_uM	uM	2.8
active	9632454	CHEMBL1963839	PUBCHEM_BIOASSAY: Inhibition of Human GSK3 beta Activity Measured in Biochemical System Using Microfluidics - 2046-10_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) 	F	Cc1ccc(S(=O)(=O)N2CCN(CC(=O)N/N=C/c3ccccn3)CC2)cc1		CHEMBL2006095	=	AC50	nM	13700.0	CHEMBL262	Homo sapiens	AC50_uM	uM	13.7
active	9632455	CHEMBL1963839	PUBCHEM_BIOASSAY: Inhibition of Human GSK3 beta Activity Measured in Biochemical System Using Microfluidics - 2046-10_Inhibitor_Dose_DryPowder_Activity_Set2. (Class of assay: confirmatory) 	F	Fc1cccc(Nc2nc(-c3ccncc3)nc3ccccc23)c1		CHEMBL1568626	=	AC50	nM	894.0	CHEMBL262	Homo sapiens	AC50_uM	uM	0.894
active	9640481	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cccc(-c2[nH]c(-c3ccnc(N)n3)cc2C(N)=O)c1C		CHEMBL1964290	=	Ki	nM	25.12	CHEMBL262	Homo sapiens	pKi		7.6
active	9640482	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)c(OC)c1		CHEMBL2003768	=	Ki	nM	501.19	CHEMBL262	Homo sapiens	pKi		6.3
active	9640483	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1ncnc2onc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL213505	=	Ki	nM	1995.26	CHEMBL262	Homo sapiens	pKi		5.7
inactive	9640484	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1ccc(OC)c(Nc2ccc3nnc(-c4ccccc4)n3n2)c1		CHEMBL1982880	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9640485	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCCn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1993941	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9640486	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C1Nc2ccccc2Nc2cc(-c3ccncc3F)ccc21		CHEMBL1989293	=	Ki	nM	158.49	CHEMBL262	Homo sapiens	pKi		6.8
inactive	9640487	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9640488	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(=O)Nc1c(C(N)=O)sc2ccc(Cl)c(Cl)c12		CHEMBL1973142	=	Ki	nM	5011.87	CHEMBL262	Homo sapiens	pKi		5.3
inactive	9640489	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4nc(N)nc(N)c34)cc2)c1		CHEMBL1973145	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9640490	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982924	=	Ki	nM	501.19	CHEMBL262	Homo sapiens	pKi		6.3
inactive	9640491	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN(C)CCCN(C)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1964948	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9640492	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc(C(N)=O)c3)cc2)c1		CHEMBL1971141	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9640493	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC1CCCCC1Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL1995813	=	Ki	nM	199.53	CHEMBL262	Homo sapiens	pKi		6.7
active	9640494	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1c(C)n(Cc2ccccc2)c2ccc(C(=O)Nc3nc[nH]n3)cc12		CHEMBL1979718	=	Ki	nM	630.96	CHEMBL262	Homo sapiens	pKi		6.2
active	9640495	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(COCc1ccccc1)COc1cncc(C=Cc2ccncc2)c1		CHEMBL1993781	=	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9640496	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1ncnn2ccc(C(=O)Nc3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1990583	=	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9640497	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	50.12	CHEMBL262	Homo sapiens	pKi		7.3
active	9640498	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1nc2ccc(NS(=O)(=O)c3ccc(N)cc3)cc2nc1C		CHEMBL2006263	=	Ki	nM	100.0	CHEMBL262	Homo sapiens	pKi		7.0
active	9640499	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1ccccc1-c1cccc2c1c(Nc1ccccc1)c(C(=O)O)n2CCCOc1cccc2ccccc12		CHEMBL2001646	=	Ki	nM	1995.26	CHEMBL262	Homo sapiens	pKi		5.7
active	9640500	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	OC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1993584	=	Ki	nM	794.33	CHEMBL262	Homo sapiens	pKi		6.1
active	9640501	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CSc1c[nH]c2ncnc(NCCCO)c12		CHEMBL2000114	=	Ki	nM	2511.89	CHEMBL262	Homo sapiens	pKi		5.6
inactive	9640502	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9640503	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)(CNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)CNS(C)(=O)=O		CHEMBL1971172	=	Ki	nM	1584.89	CHEMBL262	Homo sapiens	pKi		5.8
active	9640504	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cccc12		CHEMBL1975647	=	Ki	nM	5.012	CHEMBL262	Homo sapiens	pKi		8.3
inactive	9640505	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1968380	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9640506	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1ccccc1C(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1997643	=	Ki	nM	5.012	CHEMBL262	Homo sapiens	pKi		8.3
active	9640507	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN1c2ccc(N)cc2C(c2ccccc2)c2cc(N)ccc21		CHEMBL1991734	=	Ki	nM	1258.93	CHEMBL262	Homo sapiens	pKi		5.9
active	9640508	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	OCCNc1cc2cc(-c3cccnc3)ccc2cn1		CHEMBL1990912	=	Ki	nM	1000.0	CHEMBL262	Homo sapiens	pKi		6.0
inactive	9640509	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C1NCc2c1cccc2-c1cccs1		CHEMBL1991782	<	Ki	nM	79432.82	CHEMBL262	Homo sapiens	pKi		4.1
inactive	9640510	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9640511	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(-c4ccccc4)c3n2)c1		CHEMBL1988163	=	Ki	nM	100.0	CHEMBL262	Homo sapiens	pKi		7.0
active	9640512	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCOC(=O)Cc1nc2c3cc(Br)ccc3[nH]c(=O)n2n1		CHEMBL1974480	=	Ki	nM	1000.0	CHEMBL262	Homo sapiens	pKi		6.0
active	9640513	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1ncnc2c1C(=O)Nc1ccccc1N2		CHEMBL1980671	=	Ki	nM	5011.87	CHEMBL262	Homo sapiens	pKi		5.3
inactive	9640514	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C1CCCc2oc3cc(C(F)(F)F)ccc3c(=O)c21		CHEMBL2006493	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9640515	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Clc1cc2nn[nH]c2cc1Cl		CHEMBL1996923	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9640516	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(Cl)nccn23)n1		CHEMBL1969735	=	Ki	nM	3162.28	CHEMBL262	Homo sapiens	pKi		5.5
active	9640517	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCc1nc2c(c3cc(OC)c(OC)cc13)C(=O)NC2=O		CHEMBL2003524	=	Ki	nM	79.43	CHEMBL262	Homo sapiens	pKi		7.1
active	9640518	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1ccc2c(c1)C(=Cc1c[nH]cn1)C(=O)N2		CHEMBL2002649	=	Ki	nM	158.49	CHEMBL262	Homo sapiens	pKi		6.8
active	9640519	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1ccnc(Nc2cc(C)nc(-c3ccccc3)n2)c1		CHEMBL1985367	=	Ki	nM	316.23	CHEMBL262	Homo sapiens	pKi		6.5
inactive	9640520	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	<	Ki	nM	3162.28	CHEMBL262	Homo sapiens	pKi		5.5
active	9640521	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=CN(O)C(CS(=O)(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)cc1)c1ccc(O)cc1		CHEMBL1971227	=	Ki	nM	1584.89	CHEMBL262	Homo sapiens	pKi		5.8
active	9640522	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCNS(C)(=O)=O)cnc(N)c34)cc2)c1		CHEMBL1994321	=	Ki	nM	1995.26	CHEMBL262	Homo sapiens	pKi		5.7
active	9640523	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2cc(C#N)ccc21		CHEMBL1978562	=	Ki	nM	630.96	CHEMBL262	Homo sapiens	pKi		6.2
inactive	9640524	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cccc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL1964307	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9640525	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1ccnc2[nH]c3cc(C(C)C)ccc3c(=O)c12		CHEMBL1989471	=	Ki	nM	251.19	CHEMBL262	Homo sapiens	pKi		6.6
active	9640526	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Fc1ccc(-c2nc3sccn3c2-c2ccncc2)cc1		CHEMBL2000508	=	Ki	nM	1584.89	CHEMBL262	Homo sapiens	pKi		5.8
inactive	9640527	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCCCNc1n[s+]([O-])nc1Nc1ccc(F)cc1		CHEMBL1971694	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9640528	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(=O)c1cc2c(-c3ccc(Br)cc3)cncc2s1		CHEMBL1978195	=	Ki	nM	100.0	CHEMBL262	Homo sapiens	pKi		7.0
inactive	9640529	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cc(NC(=O)CCNC(=O)Nc2nc(C)c(-c3ccc(-n4cccn4)cc3)s2)no1		CHEMBL1986603	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9640530	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CCO)c5)cnc(N)c34)cc2)cc1		CHEMBL1977148	=	Ki	nM	1995.26	CHEMBL262	Homo sapiens	pKi		5.7
active	9640531	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1ccc(CN(C)C)cc1Nc1nccc(-c2c(-c3cccc(NC(=O)Cc4ccccc4)c3)nc3sccn23)n1		CHEMBL1966842	=	Ki	nM	1584.89	CHEMBL262	Homo sapiens	pKi		5.8
active	9640532	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=c1cc(-c2ccc(F)cc2)[nH]c2c(-c3ccc(F)cc3)cnn12		CHEMBL2004443	=	Ki	nM	501.19	CHEMBL262	Homo sapiens	pKi		6.3
active	9640533	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cc(C=C2SC(=O)NC2=O)ccc1O		CHEMBL2003286	=	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9640534	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccn1		CHEMBL1992306	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9640535	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(O)Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL2002165	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9640536	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1n[nH]c2c1C(c1ccccc1I)C(C#N)=C(N)O2		CHEMBL1979318	=	Ki	nM	3162.28	CHEMBL262	Homo sapiens	pKi		5.5
inactive	9640537	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1989518	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9640538	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cn1cncc1C(OCc1c(-c2ccc(OC(F)(F)F)cc2)cc(C#N)c(=O)n1C)c1ccc(C#N)cc1		CHEMBL127898	=	Ki	nM	2511.89	CHEMBL262	Homo sapiens	pKi		5.6
active	9640539	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2C		CHEMBL519697	=	Ki	nM	5011.87	CHEMBL262	Homo sapiens	pKi		5.3
active	9640540	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCCCNc1cc(-c2c[nH]c3ncccc23)ncn1		CHEMBL1968459	=	Ki	nM	50.12	CHEMBL262	Homo sapiens	pKi		7.3
active	9644541	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCN1CCN(c2ccc(Nc3ncc(C#N)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1973516	=	Ki	nM	1584.89	CHEMBL262	Homo sapiens	pKi		5.8
inactive	9644542	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	N#Cc1ccc2nc(N)n(-c3nc4c(s3)CCCC4)c2c1		CHEMBL1996345	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9644543	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3I)cc12		CHEMBL1975128	=	Ki	nM	19.95	CHEMBL262	Homo sapiens	pKi		7.7
inactive	9644544	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(=O)C1CCCN(C(=O)c2cc(-c3ccc4[nH]ncc4c3)on2)C1		CHEMBL1970369	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9644545	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cc(=O)[nH]nc1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)cc1		CHEMBL1965033	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9644546	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C(C)C(=O)N(C)C)c5)cnc(N)c34)cc2)cc1		CHEMBL2001485	=	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9644547	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	<	Ki	nM	5011.87	CHEMBL262	Homo sapiens	pKi		5.3
inactive	9644548	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cc(C)c2c(n1)sc1c(N)ncnc12		CHEMBL504950	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9644549	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN(C)CCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1966425	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9644550	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(=O)Nc1cccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)c1		CHEMBL1988608	=	Ki	nM	79.43	CHEMBL262	Homo sapiens	pKi		7.1
active	9644551	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1ccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)cc1C		CHEMBL184847	=	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9644552	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COCC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(C)nccn23)n1		CHEMBL1982563	=	Ki	nM	1000.0	CHEMBL262	Homo sapiens	pKi		6.0
active	9644553	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C1CCCN1Cc1ccc2c(c1)[nH]c(=O)c1cccn12		CHEMBL539474	=	Ki	nM	50.12	CHEMBL262	Homo sapiens	pKi		7.3
active	9644554	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(COc1cncc(-c2ccc3[nH]c(=O)oc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1987679	=	Ki	nM	630.96	CHEMBL262	Homo sapiens	pKi		6.2
active	9644555	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(OC(F)F)cc5)cc4)csc23)cn1		CHEMBL1988387	=	Ki	nM	199.53	CHEMBL262	Homo sapiens	pKi		6.7
inactive	9644556	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Oc1cnc2ccc(-c3ccncc3)cc2c1		CHEMBL1973868	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9644557	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCCCC#Cc1ccc(CN2CC(C(=O)O)C2)cc1		CHEMBL1972462	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9644558	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	=	Ki	nM	630.96	CHEMBL262	Homo sapiens	pKi		6.2
inactive	9644559	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	<	Ki	nM	5011.87	CHEMBL262	Homo sapiens	pKi		5.3
inactive	9644560	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN(C)C1CCCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)C1		CHEMBL1965702	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9644561	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	<	Ki	nM	1995.26	CHEMBL262	Homo sapiens	pKi		5.7
inactive	9644562	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9644563	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COCCN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1986970	=	Ki	nM	100.0	CHEMBL262	Homo sapiens	pKi		7.0
active	9644564	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)(C)Oc1cc(-c2ccncc2)cc2[nH]nc(N)c12		CHEMBL2002456	=	Ki	nM	630.96	CHEMBL262	Homo sapiens	pKi		6.2
active	9644565	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=c1cc(-c2ccncc2)nc(NC2CCCCC2)[nH]1		CHEMBL1958401	=	Ki	nM	199.53	CHEMBL262	Homo sapiens	pKi		6.7
inactive	9644566	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9644567	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCN(CC)CCOc1ccc(-c2nc3c(C(N)=O)cccc3[nH]2)cc1		CHEMBL1984044	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9644568	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9644569	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCCCNC(=O)c1cn(C(CC)CC)c(=O)c2cc(OC)c(OC)cc12		CHEMBL1982700	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9644570	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C1CC(c2ccc(Cl)cc2Cl)Cc2nc3cc(Cl)ccc3c(O)c21		CHEMBL326282	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9644571	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCOc1ccccc1C=NNC(=O)c1nnn(-c2nonc2N)c1N1CCCC1		CHEMBL1992732	=	Ki	nM	39.81	CHEMBL262	Homo sapiens	pKi		7.4
active	9644572	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Fc1ccc(-c2nc3occn3c2-c2ccnc(NC3CCNCC3)n2)cc1		CHEMBL1971186	=	Ki	nM	199.53	CHEMBL262	Homo sapiens	pKi		6.7
active	9644573	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Cc1ccc(Cl)cc1)Nc1[nH]nc2c1CCC2		CHEMBL2003482	=	Ki	nM	199.53	CHEMBL262	Homo sapiens	pKi		6.7
active	9644574	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)CNC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL2006456	=	Ki	nM	630.96	CHEMBL262	Homo sapiens	pKi		6.2
active	9644575	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCCC5)cnc(N)c34)cc2)c1		CHEMBL1973211	=	Ki	nM	794.33	CHEMBL262	Homo sapiens	pKi		6.1
active	9644576	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COCCNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1964340	=	Ki	nM	125.89	CHEMBL262	Homo sapiens	pKi		6.9
active	9644577	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	c1cc2cc(-c3ccc4cn[nH]c4c3)cnc2[nH]1		CHEMBL1976134	=	Ki	nM	5011.87	CHEMBL262	Homo sapiens	pKi		5.3
active	9644578	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1ccc(C(=O)Nc2c(C(N)=O)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL1965131	=	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9644579	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(OC(F)F)ccc12		CHEMBL1981215	=	Ki	nM	12.59	CHEMBL262	Homo sapiens	pKi		7.9
active	9644580	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1974457	=	Ki	nM	251.19	CHEMBL262	Homo sapiens	pKi		6.6
active	9644581	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)(CO)CCCNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1967662	=	Ki	nM	31.62	CHEMBL262	Homo sapiens	pKi		7.5
inactive	9644582	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9644583	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Oc1ccc(Nc2ncnc3scc(Cl)c23)cc1		CHEMBL2006580	=	Ki	nM	1258.93	CHEMBL262	Homo sapiens	pKi		5.9
inactive	9644584	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1Cl)c1ccccc1F		CHEMBL2001228	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9644585	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1Cl		CHEMBL2006581	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9644586	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCC#N)c2)n1		CHEMBL1979855	=	Ki	nM	1258.93	CHEMBL262	Homo sapiens	pKi		5.9
inactive	9644587	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1noc2cccc(-c3cccc(O)c3)c12		CHEMBL1970340	<	Ki	nM	50118.72	CHEMBL262	Homo sapiens	pKi		4.3
inactive	9644588	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)NC(=O)COc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)c1		CHEMBL2005186	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9644589	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCNc1nc2cc(Cl)c(OC)cc2nc1NCC		CHEMBL1995927	=	Ki	nM	501.19	CHEMBL262	Homo sapiens	pKi		6.3
inactive	9644590	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCCCC(=O)Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL2006450	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9644591	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)ccc(F)c12		CHEMBL2001987	=	Ki	nM	7.943	CHEMBL262	Homo sapiens	pKi		8.1
active	9644592	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1ccc(Nc2nccc(Nc3ccccc3C(=O)O)n2)cc1F		CHEMBL243518	=	Ki	nM	3.162	CHEMBL262	Homo sapiens	pKi		8.5
active	9644593	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCc1c(-c2ccc(C(C)=O)cc2)[nH]c2nccnc12		CHEMBL1994555	=	Ki	nM	794.33	CHEMBL262	Homo sapiens	pKi		6.1
active	9644594	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	=	Ki	nM	630.96	CHEMBL262	Homo sapiens	pKi		6.2
active	9644595	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN(C)c1cc2sncc2cc1NC(=O)C(=O)O		CHEMBL1997023	=	Ki	nM	398.11	CHEMBL262	Homo sapiens	pKi		6.4
inactive	9644596	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943	<	Ki	nM	1584.89	CHEMBL262	Homo sapiens	pKi		5.8
active	9644597	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	c1ccc(CNc2nc(Nc3cc(C4CC4)[nH]n3)c3sccc3n2)cc1		CHEMBL1997924	=	Ki	nM	7.943	CHEMBL262	Homo sapiens	pKi		8.1
active	9644598	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(C)c2)c1		CHEMBL1969049	=	Ki	nM	100.0	CHEMBL262	Homo sapiens	pKi		7.0
active	9644599	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1ccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)cc1		CHEMBL2005828	=	Ki	nM	5011.87	CHEMBL262	Homo sapiens	pKi		5.3
active	9644600	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1ccc(-n2nc(C)c3c(=O)c4cc(Cl)ccc4n(O)c32)cc1		CHEMBL1991143	=	Ki	nM	3162.28	CHEMBL262	Homo sapiens	pKi		5.5
active	9644601	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(=O)c1sc2c(Br)ccc(Cl)c2c1N		CHEMBL1998611	=	Ki	nM	2511.89	CHEMBL262	Homo sapiens	pKi		5.6
active	9644602	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=c1c(NCc2ccc(Cl)c(Cl)c2)c(Nc2ccncc2)c1=O		CHEMBL1975900	=	Ki	nM	63.1	CHEMBL262	Homo sapiens	pKi		7.2
active	9644603	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cc(C=C2SC(=S)NC2=O)ccc1O		CHEMBL1973098	=	Ki	nM	794.33	CHEMBL262	Homo sapiens	pKi		6.1
inactive	9644604	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CNC(=O)C=Cc1cnc(N)c2c(-c3cc(F)c4[nH]c(C)cc4c3)csc12		CHEMBL2006778	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9644605	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9644606	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1c(F)cccc1F		CHEMBL1996979	=	Ki	nM	501.19	CHEMBL262	Homo sapiens	pKi		6.3
inactive	9644607	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(=O)c1cccc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1997025	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9644608	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1968406	=	Ki	nM	1000.0	CHEMBL262	Homo sapiens	pKi		6.0
active	9644609	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=c1[nH]c2cc(Br)cnc2[nH]1		CHEMBL1975921	=	Ki	nM	63095.73	CHEMBL262	Homo sapiens	pKi		4.2
inactive	9644610	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)csc12		CHEMBL1982476	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9644611	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(CCC(=O)O)(c1ccc(O)c(N)c1)c1ccc(O)c(N)c1		CHEMBL1975923	<	Ki	nM	1995.26	CHEMBL262	Homo sapiens	pKi		5.7
active	9644612	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cc(Nc2nc(Cl)cc(NCc3ccccc3)n2)n[nH]1		CHEMBL2005449	=	Ki	nM	50.12	CHEMBL262	Homo sapiens	pKi		7.3
inactive	9644613	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Fc1ccc(-c2ncn(CCN3CCOCC3)c2-c2ccc3[nH]ncc3c2)cc1		CHEMBL1682558	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9644614	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	<	Ki	nM	5011.87	CHEMBL262	Homo sapiens	pKi		5.3
active	9644615	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COCC(C)Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1998068	=	Ki	nM	251.19	CHEMBL262	Homo sapiens	pKi		6.6
inactive	9644616	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(=NNC(=N)N)c1cc(NC(=O)NCCCN(C)CCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL1993166	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9644617	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(NCc1ccc(Cl)cc1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL1967094	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9644618	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(NC(CO)c1cc(Cl)cc(Cl)c1)c1ccc(-c2ccncc2)cc1		CHEMBL2003341	=	Ki	nM	1000.0	CHEMBL262	Homo sapiens	pKi		6.0
active	9644619	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	c1ccc(-c2n[nH]cc2-c2ccncc2)cc1		CHEMBL1992644	=	Ki	nM	251.19	CHEMBL262	Homo sapiens	pKi		6.6
inactive	9644620	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(NS(=O)(=O)c1ccc(NCCSc2ccc(O)cc2)c([N+](=O)[O-])c1)c1ccc(-c2ccc(F)cc2)cc1		CHEMBL1992645	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9644621	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	[2H]C([2H])([2H])Oc1cccc(C(C)NC(=O)c2sc(-c3ccncc3)nc2C)c1		CHEMBL1998110	=	Ki	nM	1995.26	CHEMBL262	Homo sapiens	pKi		5.7
active	9644622	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cc(-c2ccccc2)n(-c2cc(NN=Cc3ccco3)ncn2)n1		CHEMBL1999590	=	Ki	nM	100.0	CHEMBL262	Homo sapiens	pKi		7.0
active	9644623	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1F		CHEMBL1981079	=	Ki	nM	25.12	CHEMBL262	Homo sapiens	pKi		7.6
active	9644624	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCCCCCCCCN)cnc(N)c34)cc2)c1		CHEMBL1978166	=	Ki	nM	630.96	CHEMBL262	Homo sapiens	pKi		6.2
active	9644625	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=c1c(NCc2ccc(Cl)cc2)c(Nc2ccncc2)c1=O		CHEMBL1980489	=	Ki	nM	316.23	CHEMBL262	Homo sapiens	pKi		6.5
active	9644626	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCc4cccc(F)c4)cc2NC3=O)ccc1O		CHEMBL2000832	=	Ki	nM	251.19	CHEMBL262	Homo sapiens	pKi		6.6
inactive	9644627	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)c1		CHEMBL1967116	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9644628	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cc(O)nc2[nH]nc(-c3cccc(-c4ccc(Cl)cc4)c3)c12		CHEMBL1990590	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9644629	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1nn(C)c2c1c(=O)c1cc(Cl)ccc1n2OCC(C)C		CHEMBL1977814	<	Ki	nM	5011.87	CHEMBL262	Homo sapiens	pKi		5.3
active	9644630	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1nc2ccccn2c1-c1csc(Nc2ccc(O)cc2)n1		CHEMBL513846	=	Ki	nM	3162.28	CHEMBL262	Homo sapiens	pKi		5.5
active	9644631	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	OCc1cc(-c2ccc3[nH]ncc3c2)on1		CHEMBL1974617	=	Ki	nM	3162.28	CHEMBL262	Homo sapiens	pKi		5.5
active	9644632	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	=	Ki	nM	6.31	CHEMBL262	Homo sapiens	pKi		8.2
inactive	9644633	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1ccc(-c2cc3nccn3c(Nc3ccccc3C(N)=O)n2)cc1OC		CHEMBL1998112	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9644634	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)n1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)cc21		CHEMBL1969126	=	Ki	nM	1258.93	CHEMBL262	Homo sapiens	pKi		5.9
inactive	9644635	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1ncnc2sc(Br)c(-c3ccc(NC(=O)Cc4cccc(Cl)c4)cc3)c12		CHEMBL1980896	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9644636	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(=O)NC1CCN(c2nc3[nH]cc(C(=O)O)c(=O)c3c(C)c2F)C1		CHEMBL1975208	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9644637	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1		CHEMBL1991429	=	Ki	nM	50.12	CHEMBL262	Homo sapiens	pKi		7.3
active	9644638	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)C(=O)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1971149	=	Ki	nM	1995.26	CHEMBL262	Homo sapiens	pKi		5.7
inactive	9644639	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1ccc2c(c1)NC(=O)c1ccccc1N2		CHEMBL1999714	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9644640	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)(O)CNc1nccc(-c2c(-c3ccc(F)cc3F)nc3c(CC4CC4)nccn23)n1		CHEMBL1994040	=	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9644641	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CNC1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL1980995	=	Ki	nM	31.62	CHEMBL262	Homo sapiens	pKi		7.5
inactive	9644642	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCN(CC)CCNC(=O)C=Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2004716	<	Ki	nM	3162.28	CHEMBL262	Homo sapiens	pKi		5.5
active	9644643	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cc(C)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1975233	=	Ki	nM	1995.26	CHEMBL262	Homo sapiens	pKi		5.7
active	9644644	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Cc1cccs1)Nc1nc2ccccc2s1		CHEMBL1421720	=	Ki	nM	501.19	CHEMBL262	Homo sapiens	pKi		6.3
active	9644645	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1ccccc1NC(=O)Nc1ccc2c(c1)CCc1sc3ncnc(N)c3c1-2		CHEMBL1982135	=	Ki	nM	1995.26	CHEMBL262	Homo sapiens	pKi		5.7
active	9644646	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1ncnc2c1sc1ncnc(N)c12		CHEMBL1976090	=	Ki	nM	1584.89	CHEMBL262	Homo sapiens	pKi		5.8
active	9644647	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3o2)cc1		CHEMBL2004771	=	Ki	nM	3162.28	CHEMBL262	Homo sapiens	pKi		5.5
active	9644648	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	OCC(CO)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1992922	=	Ki	nM	1584.89	CHEMBL262	Homo sapiens	pKi		5.8
inactive	9644649	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1997597	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9644650	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1976093	=	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9644651	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(COc1cncc(-c2ccc(F)cc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1996543	=	Ki	nM	1995.26	CHEMBL262	Homo sapiens	pKi		5.7
active	9644652	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1cccs1		CHEMBL1975256	=	Ki	nM	158.49	CHEMBL262	Homo sapiens	pKi		6.8
active	9644653	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=c1[nH]cnc2c(Cl)cccc12		CHEMBL1949855	=	Ki	nM	19952.62	CHEMBL262	Homo sapiens	pKi		4.7
active	9644654	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC1=NN(c2ccccc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL1999126	=	Ki	nM	1584.89	CHEMBL262	Homo sapiens	pKi		5.8
inactive	9644655	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)Oc1ccc(-c2noc(-c3ccc(NC4CCC(C(=O)O)C4)cc3)n2)cc1Cl		CHEMBL1997503	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9644656	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(=O)c1cc2c(Oc3ccc(Br)cc3)cncc2s1		CHEMBL116070	=	Ki	nM	158.49	CHEMBL262	Homo sapiens	pKi		6.8
inactive	9644657	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cc(C)c(C)c(OCCCc2c(C(=O)O)[nH]c3c(-c4ccccc4C)cccc23)c1		CHEMBL1990821	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9644658	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	OCCCn1cnc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL2004871	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9644659	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncn3)cc2)c1		CHEMBL2004872	=	Ki	nM	398.11	CHEMBL262	Homo sapiens	pKi		6.4
inactive	9644660	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C1Nc2ccccc2Nc2ccccc21		CHEMBL1727312	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9644661	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cc(OCc2ccc(Cl)c(Cl)c2)ccc1CN1CC(C(=O)O)C1		CHEMBL1990223	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9644662	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC1CCN(C(=O)CO)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL1969879	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9644663	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cccc(CNc2cc(-c3c[nH]c4ncccc34)ncn2)c1		CHEMBL1995932	=	Ki	nM	7.943	CHEMBL262	Homo sapiens	pKi		8.1
inactive	9644664	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)(c1cc(Br)c(O)c(I)c1)c1cc(Br)c(O)c(I)c1		CHEMBL1964382	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9644665	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN(C)CC(O)COc1ccc(Nc2nccc(Nc3cc(Cl)ccc3Cl)n2)cc1		CHEMBL101311	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9644666	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Nc1cnccn1)Nc1ccnc2ccccc12		CHEMBL1981720	=	Ki	nM	7.943	CHEMBL262	Homo sapiens	pKi		8.1
active	9644667	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1n[nH]c2ccc(-c3cncc(OCCNS(C)(=O)=O)c3)cc12		CHEMBL1967704	=	Ki	nM	1000.0	CHEMBL262	Homo sapiens	pKi		6.0
active	9644668	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(N)COc1cnc(Cl)c(C=Cc2ccncc2)c1		CHEMBL1993548	=	Ki	nM	1584.89	CHEMBL262	Homo sapiens	pKi		5.8
inactive	9644669	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCC(=O)O)cc2)n1		CHEMBL2005699	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9644670	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4snc(N)c34)cc2)c1		CHEMBL1976328	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9644671	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1ccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)cc1OC		CHEMBL1964399	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9644672	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(O)c1c2c(nc3ccccc13)C(=C1CCCC1)CC2		CHEMBL1996831	=	Ki	nM	794.33	CHEMBL262	Homo sapiens	pKi		6.1
active	9644673	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCOCC2)n1		CHEMBL1980253	=	Ki	nM	251.19	CHEMBL262	Homo sapiens	pKi		6.6
active	9644674	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCCCCCCCCN)cnc(N)c34)cc2)c1		CHEMBL1978166	=	Ki	nM	630.96	CHEMBL262	Homo sapiens	pKi		6.2
active	9644675	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2ccccc21		CHEMBL1978167	=	Ki	nM	3162.28	CHEMBL262	Homo sapiens	pKi		5.5
active	9644676	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN(C)c1ccc(-c2c(-c3ccc4[nH]nc(N)c4c3)nnn2Cc2ccccc2)cc1		CHEMBL1969221	=	Ki	nM	25.12	CHEMBL262	Homo sapiens	pKi		7.6
active	9644677	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	c1ccc(Cc2cc(-c3ccc4[nH]ncc4c3)on2)cc1		CHEMBL1682357	=	Ki	nM	1000.0	CHEMBL262	Homo sapiens	pKi		6.0
active	9644678	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	=	Ki	nM	39.81	CHEMBL262	Homo sapiens	pKi		7.4
active	9644679	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1nccn2c(-c3ccnc(NCCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1978200	=	Ki	nM	1258.93	CHEMBL262	Homo sapiens	pKi		5.9
inactive	9644680	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cc(C=C2SC(=Nc3ccccc3)NC2=O)ccc1O		CHEMBL1970522	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9644681	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Nc1n[nH]c2nc3ccccc3cc12)c1ccncc1		CHEMBL1990415	=	Ki	nM	316.23	CHEMBL262	Homo sapiens	pKi		6.5
inactive	9644682	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(NC(CO)Cc1ccc(Cl)cc1)c1ccc(-c2ccncc2)cc1		CHEMBL1996931	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9644683	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	FC(F)(F)c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C(F)(F)F)c1		CHEMBL1964413	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9644684	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C)c1		CHEMBL1984432	=	Ki	nM	501.19	CHEMBL262	Homo sapiens	pKi		6.3
inactive	9644685	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCCC(=O)Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1998470	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9644686	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CNCC(=O)NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1996980	=	Ki	nM	125.89	CHEMBL262	Homo sapiens	pKi		6.9
active	9644687	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN(Cc1ccccc1)c1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1969920	=	Ki	nM	39.81	CHEMBL262	Homo sapiens	pKi		7.4
active	9644688	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1ccccc1-c1ccnc(Nc2cccc(S(C)(=O)=O)c2)n1		CHEMBL1975903	=	Ki	nM	398.11	CHEMBL262	Homo sapiens	pKi		6.4
active	9644689	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCOC(=O)C1=C(N)n2c(sc(=Cc3cccs3)c2=O)=C(C(N)=O)C1c1cccs1		CHEMBL2004365	=	Ki	nM	1000.0	CHEMBL262	Homo sapiens	pKi		6.0
inactive	9644690	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cccc(Nc2ncnc3ccccc23)c1		CHEMBL117697	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9644691	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cn1cc(-c2ccncn2)c(-c2ccc(F)cc2)n1		CHEMBL1989474	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9644692	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	=	Ki	nM	794.33	CHEMBL262	Homo sapiens	pKi		6.1
active	9644693	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Nc1nc2ccccc2n1CCCO)c1cccc([N+](=O)[O-])c1		CHEMBL210887	=	Ki	nM	1995.26	CHEMBL262	Homo sapiens	pKi		5.7
active	9644694	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(OC(F)(F)F)c4)c3)cc12		CHEMBL1965836	=	Ki	nM	19.95	CHEMBL262	Homo sapiens	pKi		7.7
inactive	9644695	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Nc1ccc(-c2ccc3cn[nH]c3c2)cc1)Nc1cccc(F)c1		CHEMBL1969942	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9644696	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cccc(C(C)NC(=O)c2sc(-c3ccncc3)nc2C)c1		CHEMBL1978567	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9644697	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1ncnc2sc3c(c12)-c1ccc(NC(=O)Nc2ccccc2)cc1CC3		CHEMBL1994693	=	Ki	nM	1995.26	CHEMBL262	Homo sapiens	pKi		5.7
inactive	9644698	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C1Nc2ccccc2C1=Cc1ccc[nH]1		CHEMBL1996176	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9644699	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(NNC(=S)Nc1ccc(F)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1975138	=	Ki	nM	794.33	CHEMBL262	Homo sapiens	pKi		6.1
inactive	9644700	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1C#N		CHEMBL424872	<	Ki	nM	5011.87	CHEMBL262	Homo sapiens	pKi		5.3
inactive	9644701	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#Cc5cccnc5)cnc(N)c34)cc2)c1		CHEMBL1971947	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9644702	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9644703	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)(C)c1n[nH]c2c1C(c1ccccc1F)C(C#N)=C(N)O2		CHEMBL2004447	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9644704	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(O)c1ccccc1Nc1ncnc(Nc2ccc(F)cc2)n1		CHEMBL1992231	=	Ki	nM	100.0	CHEMBL262	Homo sapiens	pKi		7.0
active	9644705	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Ki	nM	398.11	CHEMBL262	Homo sapiens	pKi		6.4
inactive	9644706	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	OCCNc1cc2cc(-c3ccsc3)ccc2cn1		CHEMBL1973860	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9644707	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCCCNc1cc(-c2ccncc2)cc2[nH]nc(N)c12		CHEMBL1983157	=	Ki	nM	398.11	CHEMBL262	Homo sapiens	pKi		6.4
active	9644708	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=c1[nH]cc(I)c2nc(-c3cccc(Cl)c3)cn12		CHEMBL1982610	=	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9644709	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cccc(C2(c3cccc(C)c3)CC2C(=O)Nc2ccncc2)c1		CHEMBL1999496	=	Ki	nM	398.11	CHEMBL262	Homo sapiens	pKi		6.4
inactive	9644710	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1ccc(-c2csc3c(C=Cc4nc5ccccc5[nH]4)cnc(N)c23)cc1		CHEMBL1988300	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9644711	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1ncnc2scc(-c3ccccc3)c12		CHEMBL1975212	=	Ki	nM	39810.72	CHEMBL262	Homo sapiens	pKi		4.4
active	9644712	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=c1[nH][nH]c2ccc(Br)cc12		CHEMBL2001613	=	Ki	nM	19952.62	CHEMBL262	Homo sapiens	pKi		4.7
active	9644713	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	=	Ki	nM	199.53	CHEMBL262	Homo sapiens	pKi		6.7
inactive	9644714	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1ccc2[nH]cc(C=C3C(=O)Nc4ccccc43)c2c1		CHEMBL1997275	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9644715	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(=O)c1cc2c(-c3ccc(Nc4nc5ccccc5o4)cc3)cnc(N)c2s1		CHEMBL1993904	=	Ki	nM	630.96	CHEMBL262	Homo sapiens	pKi		6.2
active	9644716	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)cc3n21		CHEMBL1989265	=	Ki	nM	1584.89	CHEMBL262	Homo sapiens	pKi		5.8
inactive	9644717	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CCC(N2CCCC2)CC1		CHEMBL1965910	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9644718	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCCCOc1cc(-c2ccncc2)cc2[nH]nc(N)c12		CHEMBL1996447	=	Ki	nM	630.96	CHEMBL262	Homo sapiens	pKi		6.2
inactive	9644719	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1		CHEMBL1983963	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9644720	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Oc1ccc(-c2n[nH]c(Nc3cccc(Cl)c3)c2-c2ccc(O)cc2)cc1		CHEMBL1985092	=	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9644721	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CNc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL1981410	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9644722	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1981133	=	Ki	nM	158.49	CHEMBL262	Homo sapiens	pKi		6.8
inactive	9644723	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)Oc1cc(Nc2nc(NC(C)c3ccc(F)cn3)ncc2Cl)n[nH]1		CHEMBL2007421	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9644724	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1ccc(C=C2C(=O)ON=C2c2ccc(Br)cc2)cc1OC		CHEMBL1991434	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9644725	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c(=O)n(C)c1		CHEMBL1973138	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9644726	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(=O)c1cn(-c2ccc(O)cc2Cl)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL340384	=	Ki	nM	125.89	CHEMBL262	Homo sapiens	pKi		6.9
active	9644727	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN(C)C1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1969151	=	Ki	nM	1584.89	CHEMBL262	Homo sapiens	pKi		5.8
inactive	9644728	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1996587	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9644729	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)NC1=NNC(=O)C1=Cc1cc2ccccc2[nH]1		CHEMBL1988692	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9644730	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	=	Ki	nM	316.23	CHEMBL262	Homo sapiens	pKi		6.5
active	9644731	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	OCCCNc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL2000071	=	Ki	nM	1584.89	CHEMBL262	Homo sapiens	pKi		5.8
active	9644732	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cc(OC)cc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)c1		CHEMBL2002613	=	Ki	nM	39.81	CHEMBL262	Homo sapiens	pKi		7.4
active	9644733	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCN(CC)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1983195	=	Ki	nM	501.19	CHEMBL262	Homo sapiens	pKi		6.3
inactive	9644734	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	<	Ki	nM	2511.89	CHEMBL262	Homo sapiens	pKi		5.6
active	9644735	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(C)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1984162	=	Ki	nM	79.43	CHEMBL262	Homo sapiens	pKi		7.1
active	9644736	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC1CCCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)C1		CHEMBL1998432	=	Ki	nM	3162.28	CHEMBL262	Homo sapiens	pKi		5.5
active	9644737	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCC(N)C3)c21		CHEMBL1870106	=	Ki	nM	501.19	CHEMBL262	Homo sapiens	pKi		6.3
active	9644738	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1ncnc2c1c(I)nn2C1CCC(O)CC1		CHEMBL1996791	=	Ki	nM	3162.28	CHEMBL262	Homo sapiens	pKi		5.5
active	9644739	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL371206	=	Ki	nM	1995.26	CHEMBL262	Homo sapiens	pKi		5.7
active	9644740	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1ccc(C=NNc2ncnc3c2[nH]c2ccccc23)cc1OC		CHEMBL1974664	=	Ki	nM	125.89	CHEMBL262	Homo sapiens	pKi		6.9
active	9644741	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CS(=O)(=O)c1cccc(-c2cnn3c(C(N)=O)cc(-c4ccccc4)nc23)c1		CHEMBL1998477	=	Ki	nM	1258.93	CHEMBL262	Homo sapiens	pKi		5.9
active	9644742	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	1258.93	CHEMBL262	Homo sapiens	pKi		5.9
active	9644743	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1ccc(C)c(NC(=O)c2cc(-c3ccco3)nc3ccccc23)c1		CHEMBL1984296	=	Ki	nM	1584.89	CHEMBL262	Homo sapiens	pKi		5.8
inactive	9644744	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1		CHEMBL196363	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9644745	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC		CHEMBL1190711	=	Ki	nM	19.95	CHEMBL262	Homo sapiens	pKi		7.7
inactive	9644746	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CNCC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL1964441	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9644747	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	ON=C(c1nc2ccccc2[nH]1)c1nc2ccccc2[nH]1		CHEMBL546797	=	Ki	nM	1258.93	CHEMBL262	Homo sapiens	pKi		5.9
inactive	9644748	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cccc(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL404367	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9644749	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)Cc1cc(-c2ccc3[nH]nc(N)c3c2)on1		CHEMBL1966343	=	Ki	nM	1258.93	CHEMBL262	Homo sapiens	pKi		5.9
active	9644750	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1n[nH]c2ccc(-c3cncc(OCCN)c3)cc12		CHEMBL1967887	=	Ki	nM	2511.89	CHEMBL262	Homo sapiens	pKi		5.6
inactive	9644751	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(=O)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL2000568	<	Ki	nM	5011.87	CHEMBL262	Homo sapiens	pKi		5.3
active	9644752	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)cc1C		CHEMBL2000335	=	Ki	nM	316.23	CHEMBL262	Homo sapiens	pKi		6.5
active	9644753	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1nc(=O)[nH]c2sccc12		CHEMBL2007097	=	Ki	nM	39810.72	CHEMBL262	Homo sapiens	pKi		4.4
active	9644754	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Fc1cccc(-c2c[nH]c3ncccc23)c1		CHEMBL1993648	=	Ki	nM	1995.26	CHEMBL262	Homo sapiens	pKi		5.7
active	9644755	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Ki	nM	100.0	CHEMBL262	Homo sapiens	pKi		7.0
active	9644756	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(O)c1ccccc1Nc1ccnc(Nc2cccc(F)c2)n1		CHEMBL243298	=	Ki	nM	31.62	CHEMBL262	Homo sapiens	pKi		7.5
active	9644757	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(=O)c1ccc(-c2ccnc(N)n2)cc1N1CCCCC1		CHEMBL1971951	=	Ki	nM	1000.0	CHEMBL262	Homo sapiens	pKi		6.0
inactive	9644758	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Nc1ccc2[nH]ncc2c1)c1ccc(Cl)cc1		CHEMBL1973808	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9644759	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2000429	=	Ki	nM	2511.89	CHEMBL262	Homo sapiens	pKi		5.6
inactive	9644760	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1ccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)cc1		CHEMBL1972576	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9644761	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(NN=Cc1ccc(Sc2nc3ccccc3[nH]2)o1)c1cccc([N+](=O)[O-])c1		CHEMBL1992555	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9644762	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	=	Ki	nM	63.1	CHEMBL262	Homo sapiens	pKi		7.2
active	9644763	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=c1cc(-c2ccncc2)nc(NCc2cc(F)cc(F)c2)[nH]1		CHEMBL2003682	=	Ki	nM	199.53	CHEMBL262	Homo sapiens	pKi		6.7
active	9644764	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cc(Cl)ccc1NC(=S)NNC(=O)C(O)(c1ccccc1)c1ccccc1		CHEMBL1988173	=	Ki	nM	794.33	CHEMBL262	Homo sapiens	pKi		6.1
inactive	9644765	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	C(=NNc1nc2ccccc2[nH]1)c1c[nH]c2ccccc12		CHEMBL535331	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9644766	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	N#CC1=C(N)n2c(sc(=Cc3ccco3)c2=O)=C(C(N)=O)C1c1ccco1		CHEMBL1989805	=	Ki	nM	251.19	CHEMBL262	Homo sapiens	pKi		6.6
inactive	9644767	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	<	Ki	nM	2511.89	CHEMBL262	Homo sapiens	pKi		5.6
inactive	9644768	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)=C(C)c1cccc2c(CCCOc3cccc(Cl)c3Cl)c(C(=O)O)[nH]c12		CHEMBL1982980	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9644769	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCC(N)(C#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12)CC		CHEMBL1983025	=	Ki	nM	1584.89	CHEMBL262	Homo sapiens	pKi		5.8
inactive	9644770	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1ccc(-n2ccc3cnc(Nc4cc(OC)c(OC)c(OC)c4)nc32)cc1		CHEMBL1975927	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9644771	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(=O)c1cc2c(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)cncc2s1		CHEMBL2002322	=	Ki	nM	100.0	CHEMBL262	Homo sapiens	pKi		7.0
active	9644772	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COCCN(CCOC)c1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1985654	=	Ki	nM	1000.0	CHEMBL262	Homo sapiens	pKi		6.0
active	9644773	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1ncc2cccc(-c3ccccc3)n12		CHEMBL1997119	=	Ki	nM	19952.62	CHEMBL262	Homo sapiens	pKi		4.7
inactive	9644774	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1ccc(F)c(-c2ccc3nnc(N)n3c2)c1		CHEMBL2002323	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9644775	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	c1ccc(C2CCc3[nH]ncc3C2)cc1		CHEMBL2000879	=	Ki	nM	63095.73	CHEMBL262	Homo sapiens	pKi		4.2
active	9644776	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CNCCOc1cncc(-c2ccc3[nH]nc(C)c3c2)c1		CHEMBL1983855	=	Ki	nM	2511.89	CHEMBL262	Homo sapiens	pKi		5.6
active	9644777	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1ccccc1-c1c(C(=O)O)n(CCCOc2cccc3ccccc23)c2ccccc12		CHEMBL1987793	=	Ki	nM	2511.89	CHEMBL262	Homo sapiens	pKi		5.6
inactive	9644778	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9644779	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCN1CCN(CCCC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1		CHEMBL1992740	=	Ki	nM	25.12	CHEMBL262	Homo sapiens	pKi		7.6
active	9644780	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cc(-c2csc3c(C=CC(=O)NCCN(C)C)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL1989267	=	Ki	nM	3162.28	CHEMBL262	Homo sapiens	pKi		5.5
active	9644781	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	OCCCn1cnc(-c2ccccc2)c1-c1ccncc1		CHEMBL2002373	=	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9648793	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1cccc(Cl)c1		CHEMBL1973348	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9648794	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2NCCCN)c1		CHEMBL2006188	=	Ki	nM	1258.93	CHEMBL262	Homo sapiens	pKi		5.9
active	9648795	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(C)=O)c3c2)cc1		CHEMBL1973893	=	Ki	nM	251.19	CHEMBL262	Homo sapiens	pKi		6.6
active	9648796	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3C3CC3)cc12		CHEMBL2004631	=	Ki	nM	7.943	CHEMBL262	Homo sapiens	pKi		8.1
inactive	9648797	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCOC(=O)c1cccc2[nH]c(-c3ccc(N4CCC(N)C4)cc3)nc12		CHEMBL1995736	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9648798	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Ki	nM	5011.87	CHEMBL262	Homo sapiens	pKi		5.3
active	9648799	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(=O)Cn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL1985095	=	Ki	nM	100.0	CHEMBL262	Homo sapiens	pKi		7.0
inactive	9648800	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1996500	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9648801	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cccc(NC(=O)N2CCC(c3nc4c(C(N)=O)cccc4[nH]3)CC2)c1		CHEMBL1973363	=	Ki	nM	3162.28	CHEMBL262	Homo sapiens	pKi		5.5
inactive	9648802	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9648803	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)cn2c1		CHEMBL1682540	=	Ki	nM	63.1	CHEMBL262	Homo sapiens	pKi		7.2
inactive	9648804	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN(C)c1ccc(N)c2ccccc12		CHEMBL1998253	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9648805	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCO)c(Cl)cc1NC(=O)N2		CHEMBL413779	=	Ki	nM	199.53	CHEMBL262	Homo sapiens	pKi		6.7
active	9648806	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=c1nc(-c2cc3c(Oc4ccc(I)cc4)cncc3s2)[nH]o1		CHEMBL497151	=	Ki	nM	31.62	CHEMBL262	Homo sapiens	pKi		7.5
active	9648807	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1ccccc1-c1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL2000029	=	Ki	nM	125.89	CHEMBL262	Homo sapiens	pKi		6.9
inactive	9648808	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cc(N2CCN(C)CC2)ccc1C(=O)Nc1n[nH]c2ccc(Cc3cc(F)cc(F)c3)cc12		CHEMBL1973961	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9648809	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCCCO)c2)n1		CHEMBL1994977	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9648810	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2		CHEMBL373598	=	Ki	nM	251.19	CHEMBL262	Homo sapiens	pKi		6.6
inactive	9648811	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Oc1ccc2nc(-c3ccc(Sc4ccc(-c5nc6ccc(O)cc6[nH]5)cc4)cc3)[nH]c2c1		CHEMBL2001149	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9648812	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	N#Cc1ccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)nc1		CHEMBL1999718	=	Ki	nM	3.981	CHEMBL262	Homo sapiens	pKi		8.4
inactive	9648813	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCOc1ccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)cc1NC(=O)Cc1ccccc1		CHEMBL2000078	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9648814	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cccc(OC)c1CNc1nc(NC2CCCCC2)nc2ccc(Cl)cc12		CHEMBL1996646	=	Ki	nM	1258.93	CHEMBL262	Homo sapiens	pKi		5.9
inactive	9648815	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN(CCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1979773	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9648816	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C1Nc2ccccc2Nc2nnc(I)cc21		CHEMBL1977346	=	Ki	nM	100.0	CHEMBL262	Homo sapiens	pKi		7.0
inactive	9648817	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCCN(C)C)cc2NC3=O)ccc1O		CHEMBL1996702	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9648818	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(=O)c1ccc(Nc2ncnc3[nH]cc(-c4ccccc4)c23)cc1		CHEMBL1975440	=	Ki	nM	158.49	CHEMBL262	Homo sapiens	pKi		6.8
active	9648819	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	OCCNc1cc2cc(-c3ccncc3)ccc2cn1		CHEMBL1998435	=	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9648820	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1ccc(-c2ccc(NC(=O)Nc3cc(F)cc(F)c3)cc2)c2c(N)noc12		CHEMBL1969190	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9648821	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)n[nH]c12		CHEMBL1973937	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9648822	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	N#CCC(C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL2002099	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9648823	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(=O)c1ccc(-c2c[nH]c3nccc(Cl)c23)cc1		CHEMBL1982711	=	Ki	nM	794.33	CHEMBL262	Homo sapiens	pKi		6.1
inactive	9648824	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	FC(F)(F)Oc1ccc(-c2ccc3[nH]cc(C4=CCNCC4)c3c2)cc1		CHEMBL1987982	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9648825	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cn[nH]c5)cnc(N)c34)cc2)c1		CHEMBL1969102	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9648826	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2[nH]ccc12		CHEMBL2004118	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9648827	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cc(C=C(C#N)c2nc3ccccc3[nH]2)c(Br)cc1O		CHEMBL1994241	=	Ki	nM	501.19	CHEMBL262	Homo sapiens	pKi		6.3
inactive	9648828	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCN(CC)CC#Cc1ccc2c(c1)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL2007044	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9648829	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CNC(=O)N1CCN(CCCOc2ccc3c(c2)-c2[nH]nc(-c4ccc(C#N)nc4)c2C3)CC1		CHEMBL2001998	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9648830	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC1c2cccn2CCN1Cc1nc2scc(-c3ccco3)c2c(=O)[nH]1		CHEMBL2003119	=	Ki	nM	3162.28	CHEMBL262	Homo sapiens	pKi		5.5
active	9648831	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Ki	nM	15.85	CHEMBL262	Homo sapiens	pKi		7.8
active	9648832	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)(C)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1995211	=	Ki	nM	630.96	CHEMBL262	Homo sapiens	pKi		6.2
active	9648833	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cnc(Nc2cccc(S(N)(=O)=O)c2)nc1Nc1ccc(OCC(N)=O)cc1		CHEMBL1988838	=	Ki	nM	1995.26	CHEMBL262	Homo sapiens	pKi		5.7
inactive	9648834	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCN1CCN(c2ccc(Nc3nccc(-c4c(-c5cccc(C(=O)Nc6ccccc6F)c5)nc5ccccn45)n3)cc2)CC1		CHEMBL1981725	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9648835	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(=O)c1ccc(NC2CCCCC2N)nc1Nc1cccc(Cl)c1		CHEMBL1982753	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9648836	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1ccc(-c2cc3nc(Br)cnc3[nH]2)cc1		CHEMBL1965169	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9648837	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	<	Ki	nM	1995.26	CHEMBL262	Homo sapiens	pKi		5.7
active	9648838	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(O)CO)c5)cnc(N)c34)cc2)cc1		CHEMBL1965170	=	Ki	nM	2511.89	CHEMBL262	Homo sapiens	pKi		5.6
active	9648839	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=c1cc(-c2cccc(F)c2)[nH]c2c(-c3ccc(F)cc3)cnn12		CHEMBL2004156	=	Ki	nM	1995.26	CHEMBL262	Homo sapiens	pKi		5.7
inactive	9648840	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2005792	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9648841	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCOc1nc(C(=O)NCc2ccncc2)cc(N)c1C#N		CHEMBL1984206	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9648842	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1c(-c2ccccc2)c2cc(Cl)ccc2[nH]c1=O		CHEMBL462120	=	Ki	nM	2511.89	CHEMBL262	Homo sapiens	pKi		5.6
inactive	9648843	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C1CCCCC1		CHEMBL1991577	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9648844	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccccc4)nn12)CCCC3		CHEMBL2007592	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9648845	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cc(=O)[nH]nc1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)c(Cl)c1		CHEMBL1997892	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9648846	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	OC1CCCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)C1		CHEMBL1976936	=	Ki	nM	100.0	CHEMBL262	Homo sapiens	pKi		7.0
inactive	9648847	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9648848	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)s2)c1		CHEMBL1984633	=	Ki	nM	630.96	CHEMBL262	Homo sapiens	pKi		6.2
active	9648849	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	c1ccc(Cn2cc(-c3ccc4[nH]nc(-c5ccccc5)c4c3)nn2)cc1		CHEMBL1982400	=	Ki	nM	19.95	CHEMBL262	Homo sapiens	pKi		7.7
inactive	9648850	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9648851	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cccc(C(C)NC(=O)N2CC=C(c3c[nH]c4ncccc34)CC2)c1		CHEMBL1965845	=	Ki	nM	251.19	CHEMBL262	Homo sapiens	pKi		6.6
active	9648852	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3)n2)s1		CHEMBL1983715	=	Ki	nM	1584.89	CHEMBL262	Homo sapiens	pKi		5.8
inactive	9648853	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9648854	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9648855	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	c1ccc(Nc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682545	=	Ki	nM	630.96	CHEMBL262	Homo sapiens	pKi		6.2
active	9648856	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)(O)Cc1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1976732	=	Ki	nM	630.96	CHEMBL262	Homo sapiens	pKi		6.2
active	9648857	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(=O)c1ccc(-c2ccncc2)cc1NCc1cccc(F)c1		CHEMBL1982982	=	Ki	nM	794.33	CHEMBL262	Homo sapiens	pKi		6.1
inactive	9648858	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	c1ccc(COc2ccc(Nc3ncnc4ccccc34)cc2)cc1		CHEMBL1980163	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9648859	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1c(C=O)c(O)n2c(nc3ccccc32)c1C#N		CHEMBL1989856	=	Ki	nM	3162.28	CHEMBL262	Homo sapiens	pKi		5.5
inactive	9648860	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cncc(C=Cc2ccncc2)c1		CHEMBL1972568	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9648861	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Ki	nM	25.12	CHEMBL262	Homo sapiens	pKi		7.6
inactive	9648862	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CCO)c5)cnc(N)c34)cc2F)c1		CHEMBL1986851	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9648863	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C1Nc2ccccc2Nc2cc(-c3ccncc3Cl)ccc21		CHEMBL1987745	=	Ki	nM	251.19	CHEMBL262	Homo sapiens	pKi		6.6
inactive	9648864	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)C(CO)NC(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1971223	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9648865	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cc(C)c(C=C2C(=O)Nc3ccccc32)[nH]1		CHEMBL2002702	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9648866	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1ccccc1		CHEMBL1991846	=	Ki	nM	5011.87	CHEMBL262	Homo sapiens	pKi		5.3
active	9648867	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Fc1cccc(CNc2ncnc3[nH]cnc23)c1		CHEMBL2003785	=	Ki	nM	50118.72	CHEMBL262	Homo sapiens	pKi		4.3
inactive	9648868	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCOc1ccccc1-c1cccc(-c2n[nH]c3nc(O)cc(C)c23)c1		CHEMBL1983070	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9648869	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9648870	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	Ki	nM	251.19	CHEMBL262	Homo sapiens	pKi		6.6
active	9648871	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C1CN=C(c2cccc(Cl)c2)c2c(sc3c2CCCC3)N1		CHEMBL2002470	=	Ki	nM	3162.28	CHEMBL262	Homo sapiens	pKi		5.5
active	9648872	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1OCC(O)CO		CHEMBL1981045	=	Ki	nM	630.96	CHEMBL262	Homo sapiens	pKi		6.2
inactive	9648873	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COCCOCC#Cc1cc(-c2n[nH]c3c2C(=O)c2cc(CN4CCN(C)CC4)ccc2-3)cs1		CHEMBL387971	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9648874	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=c1[nH]c2ccc(Cl)cc2c(-c2ccccc2)c1C1=NNC(c2ccccc2)C1		CHEMBL1992796	=	Ki	nM	3162.28	CHEMBL262	Homo sapiens	pKi		5.5
active	9648875	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C1CN2C(=NN1)COc1ccccc12		CHEMBL1968515	=	Ki	nM	31622.78	CHEMBL262	Homo sapiens	pKi		4.5
inactive	9648876	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9648877	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCC(O)CO)c(Cl)cc1NC(=O)N2		CHEMBL223257	=	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9648878	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCOC(=O)c1nc2c(=O)[nH]c3cc([N+](=O)[O-])c(NC(C)=O)cc3n2c1C		CHEMBL1997611	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9648879	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Ki	nM	1995.26	CHEMBL262	Homo sapiens	pKi		5.7
active	9648880	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccco2)C(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL2001751	=	Ki	nM	63.1	CHEMBL262	Homo sapiens	pKi		7.2
inactive	9648881	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1ccccc1NC(=O)Nc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL1984586	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9648882	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1c(Cl)c(N2CCC(CN)C2)nc2[nH]cc(C(=O)O)c(=O)c12		CHEMBL1999774	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9648883	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1c(O)ccc2c1CCCC2=NNC(=O)Cc1cccc2ccccc12		CHEMBL1972659	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9648884	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	OC1CCN(c2ncnc3[nH]cc(-c4ccccc4)c23)CC1		CHEMBL1973395	=	Ki	nM	1584.89	CHEMBL262	Homo sapiens	pKi		5.8
inactive	9648885	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Brc1ccc2cnc(Nc3ccncn3)cc2c1		CHEMBL1984686	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9648886	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	c1cc2[nH]ncc2cc1-c1cn(CC2CCOCC2)nn1		CHEMBL1969843	=	Ki	nM	794.33	CHEMBL262	Homo sapiens	pKi		6.1
active	9648887	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cc(-c2ccc3[nH]nc(C(=O)Nc4ccccc4)c3c2)ccc1O		CHEMBL2007002	=	Ki	nM	398.11	CHEMBL262	Homo sapiens	pKi		6.4
active	9648888	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	=	Ki	nM	5011.87	CHEMBL262	Homo sapiens	pKi		5.3
inactive	9648889	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1		CHEMBL1967878	<	Ki	nM	3162.28	CHEMBL262	Homo sapiens	pKi		5.5
inactive	9648890	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCC1CC(NS(=O)(=O)C2CC2)CC1c1ncc2cnc3[nH]ccc3n12		CHEMBL1992073	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9648891	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCCCn1c(NC(=O)c2ccc(C#N)cc2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL484390	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9648892	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3sccc3n2)cc1		CHEMBL2007559	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9648893	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)(C)O)c5)cnc(N)c34)cc2)cc1		CHEMBL2004290	<	Ki	nM	5011.87	CHEMBL262	Homo sapiens	pKi		5.3
active	9648894	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1C1CCOc2c(F)cccc21		CHEMBL2000393	=	Ki	nM	5011.87	CHEMBL262	Homo sapiens	pKi		5.3
active	9648895	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COC(=O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL2004072	=	Ki	nM	630.96	CHEMBL262	Homo sapiens	pKi		6.2
active	9648896	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	C=Cc1ccc(-c2cccc3nnc(N)n23)cc1		CHEMBL1983573	=	Ki	nM	12589.25	CHEMBL262	Homo sapiens	pKi		4.9
active	9648897	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1242373	=	Ki	nM	3162.28	CHEMBL262	Homo sapiens	pKi		5.5
active	9648898	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	N#CC(=Cc1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL1974157	=	Ki	nM	1258.93	CHEMBL262	Homo sapiens	pKi		5.9
active	9648899	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(=O)c1c(-c2ccccc2)nn(C)c(=O)c1N		CHEMBL1984402	=	Ki	nM	1258.93	CHEMBL262	Homo sapiens	pKi		5.9
inactive	9648900	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1ccc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1988075	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9648901	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1ccccc1Nc1nccc(-c2c(-c3cccc(NC(=O)c4ccccc4)c3)nc3sccn23)n1		CHEMBL1988076	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9648902	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1ncnc(Nc2cc(CNC(=O)C(F)(F)F)c(O)c(-c3ccc(Cl)cc3)c2)n1		CHEMBL2001239	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9648903	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1ncnc2c1c(I)nn2C1OC(CO)C(O)C1O		CHEMBL2001288	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9648904	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(NN=Cc1ccc(O)cc1O)Nc1cccc2nsnc12		CHEMBL1999811	=	Ki	nM	1000.0	CHEMBL262	Homo sapiens	pKi		6.0
inactive	9648905	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cc2ncc3c(N)nc4c(C)c(N)ccc4c3c2cc1OC		CHEMBL235157	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9648906	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL2000481	=	Ki	nM	1995.26	CHEMBL262	Homo sapiens	pKi		5.7
inactive	9648907	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1		CHEMBL1173055	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9648908	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4sncc34)cc2)c1		CHEMBL1992242	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9648909	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN(C)CC(=O)NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1982271	=	Ki	nM	251.19	CHEMBL262	Homo sapiens	pKi		6.6
active	9648910	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C1NC(=O)C(Nc2ccccc2)=C1Cl		CHEMBL2007138	=	Ki	nM	1000.0	CHEMBL262	Homo sapiens	pKi		6.0
inactive	9648911	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cccc(CNC(=O)c2cnc(-c3ccncc3)nc2)c1		CHEMBL2004159	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9648912	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(c1cc(Cc2n[nH]c(=O)c3c2CCCC3)ccc1F)N1CCN(c2ncccn2)CC1		CHEMBL1986530	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9648913	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9648914	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=c1c(NCCc2ccc(Oc3ccccc3)cc2)c(Nc2ccncc2)c1=O		CHEMBL1999321	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9648915	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4sc(C)nc4c3)csc12		CHEMBL1968590	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9648916	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCCC4)cc3OC)nc2N1C1CCCC1		CHEMBL2005375	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9648917	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN1CCCC1COc1cncc(CCc2ccccc2)c1		CHEMBL1972183	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9648918	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)Nc1n[nH]c2ccc(N)cc12		CHEMBL1995391	=	Ki	nM	794.33	CHEMBL262	Homo sapiens	pKi		6.1
active	9648919	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1sc2[nH]c(=O)n3nc(-c4ccncc4)nc3c2c1C		CHEMBL1980592	=	Ki	nM	630.96	CHEMBL262	Homo sapiens	pKi		6.2
active	9648920	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1nc2c(sc3c(Br)ccc(Cl)c32)c(=O)o1		CHEMBL1974702	=	Ki	nM	1995.26	CHEMBL262	Homo sapiens	pKi		5.7
active	9648921	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)O)s3)c2cc1OC		CHEMBL474432	=	Ki	nM	1584.89	CHEMBL262	Homo sapiens	pKi		5.8
inactive	9648922	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1n[nH]c2c(OCCCn3cccc3)ccc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL1965387	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9648923	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	c1cc2c(s1)CCc1cn[nH]c1-2		CHEMBL2001539	=	Ki	nM	63095.73	CHEMBL262	Homo sapiens	pKi		4.2
active	9648924	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cc(-c2ncnc3[nH]ccc23)ccc1F		CHEMBL1997041	=	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9648925	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Nc1ccccc1)Nc1nccs1		CHEMBL1487428	=	Ki	nM	10000.0	CHEMBL262	Homo sapiens	pKi		5.0
inactive	9648926	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cc(-c2ccc3c(c2)Nc2c(O)cccc2NC3=O)ccc1O		CHEMBL550418	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9648927	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=[N+]([O-])c1cccc(-c2nnc3ccc(N4CCCCC4)nn23)c1		CHEMBL2003637	=	Ki	nM	39.81	CHEMBL262	Homo sapiens	pKi		7.4
active	9648928	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(O)c1ccccc1Nc1ncnc(Nc2ccc3cn[nH]c3c2)n1		CHEMBL1986666	=	Ki	nM	15.85	CHEMBL262	Homo sapiens	pKi		7.8
inactive	9648929	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9648930	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCOc1ccc(C=C2SC(=N)NC2=O)c(O)c1		CHEMBL1971289	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9648931	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(=O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1999556	=	Ki	nM	100.0	CHEMBL262	Homo sapiens	pKi		7.0
inactive	9648932	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1		CHEMBL1988437	<	Ki	nM	3162.28	CHEMBL262	Homo sapiens	pKi		5.5
active	9648933	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NCCC(C(=O)Nc1ccc2[nH]ncc2c1)c1ccc(Cl)c(Cl)c1		CHEMBL1998121	=	Ki	nM	794.33	CHEMBL262	Homo sapiens	pKi		6.1
inactive	9648934	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCCC(=O)O)cc2)n1		CHEMBL2003689	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9648935	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1nn(-c2ccccc2)c2c1c(=O)c1cc(Cl)ccc1n2O		CHEMBL379835	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9648936	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	N#Cc1ncc2nc1OCC(O)C(O)COc1ccc(Cl)cc1NC(=O)N2		CHEMBL1980802	=	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9648937	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCN(CC)CCCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1996649	<	Ki	nM	3162.28	CHEMBL262	Homo sapiens	pKi		5.5
active	9648938	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1986756	=	Ki	nM	31.62	CHEMBL262	Homo sapiens	pKi		7.5
active	9648939	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2ccncc2)c1-c1ccccc1		CHEMBL1419458	=	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9648940	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCn1c2cc(Cl)c(F)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL468280	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9648941	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cc(C)c2oc(Nc3ccc(-c4cccc(C(N)=O)c4N)cc3F)nc2c1		CHEMBL1990884	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9648942	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	<	Ki	nM	2511.89	CHEMBL262	Homo sapiens	pKi		5.6
inactive	9648943	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cccc2c1Nc1cc(Nc3ccncc3)ccc1C(=O)N2		CHEMBL2006276	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9648944	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Ki	nM	158.49	CHEMBL262	Homo sapiens	pKi		6.8
inactive	9648945	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1ccc(C(=O)Nc2c(C#N)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL2006785	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9648946	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(=O)c1ccc2nc(-c3ccc([N+](=O)[O-])o3)cn2c1		CHEMBL1973359	=	Ki	nM	398.11	CHEMBL262	Homo sapiens	pKi		6.4
active	9648947	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cc(-c2ccc3c(c2)Nc2ccc([N+](=O)[O-])cc2NC3=O)ccc1O		CHEMBL1995740	=	Ki	nM	501.19	CHEMBL262	Homo sapiens	pKi		6.3
active	9648948	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	50.12	CHEMBL262	Homo sapiens	pKi		7.3
inactive	9648949	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1979690	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9648950	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1995832	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9648951	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cc(C=C(C#N)c2nc3cc(C)ccc3[nH]2)c(Br)cc1O		CHEMBL2000345	=	Ki	nM	1584.89	CHEMBL262	Homo sapiens	pKi		5.8
active	9648952	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(NN=Cc1cc(Br)c(O)c(Br)c1)Nc1ccccc1		CHEMBL1983575	=	Ki	nM	794.33	CHEMBL262	Homo sapiens	pKi		6.1
active	9648953	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1375418	=	Ki	nM	5011.87	CHEMBL262	Homo sapiens	pKi		5.3
active	9648954	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Ki	nM	15.85	CHEMBL262	Homo sapiens	pKi		7.8
inactive	9648955	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL1981047	<	Ki	nM	1995.26	CHEMBL262	Homo sapiens	pKi		5.7
active	9648956	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccc(Cl)c(Cl)c4)c3)cc12		CHEMBL1991063	=	Ki	nM	31.62	CHEMBL262	Homo sapiens	pKi		7.5
active	9648957	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Nc1ccc([N+](=O)[O-])cc1)N1CCc2[nH]c3c(Cl)cc(Cl)cc3c2C1		CHEMBL1976196	=	Ki	nM	3162.28	CHEMBL262	Homo sapiens	pKi		5.5
active	9648958	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cccc(C(CN)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1976240	=	Ki	nM	79.43	CHEMBL262	Homo sapiens	pKi		7.1
active	9648959	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CS(=O)(=O)NC1CCCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)C1		CHEMBL1987948	=	Ki	nM	794.33	CHEMBL262	Homo sapiens	pKi		6.1
active	9648960	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C1Cc2cc(-c3ccccc3)cnc2N1		CHEMBL1983630	=	Ki	nM	15848.93	CHEMBL262	Homo sapiens	pKi		4.8
active	9648961	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1ccc(-c2ccc(NC(=O)Nc3ccc(F)c(C)c3)cc2)c2c(N)noc12		CHEMBL1979093	=	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9648962	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ncccc2N1		CHEMBL336961	=	Ki	nM	10.0	CHEMBL262	Homo sapiens	pKi		8.0
active	9648963	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1ncc(-c2ccncc2)c2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1970083	=	Ki	nM	1000.0	CHEMBL262	Homo sapiens	pKi		6.0
inactive	9648964	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1ncc(C=CC(=O)NCCCn2ccnc2)c2scc(-c3ccc(Br)cc3)c12		CHEMBL1994938	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9648965	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1977223	=	Ki	nM	2.512	CHEMBL262	Homo sapiens	pKi		8.6
active	9648966	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cc(-c2ccc3c(c2)CNC3=O)ccc1F		CHEMBL1976290	=	Ki	nM	79432.82	CHEMBL262	Homo sapiens	pKi		4.1
inactive	9648967	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)(C)C(=O)Oc1ccc2c(c1)nc(NC(=O)c1cccc([N+](=O)[O-])c1)n2CCCO		CHEMBL1236126	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9648968	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Clc1cc(NC2CCCCC2)nc(-c2c[nH]c3ncccc23)n1		CHEMBL1997846	=	Ki	nM	1258.93	CHEMBL262	Homo sapiens	pKi		5.9
inactive	9648969	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)Cn1c(N)nc2c(F)cc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2004419	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9648970	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)nc1		CHEMBL1992937	=	Ki	nM	2511.89	CHEMBL262	Homo sapiens	pKi		5.6
inactive	9648971	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1CC#N		CHEMBL1985566	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9648972	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Nc1cccc(N2CCOCC2)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1972119	=	Ki	nM	10.0	CHEMBL262	Homo sapiens	pKi		8.0
inactive	9648973	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95692	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9648974	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(C(F)(F)F)cc12		CHEMBL1976455	=	Ki	nM	3.981	CHEMBL262	Homo sapiens	pKi		8.4
active	9648975	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1		CHEMBL1983923	=	Ki	nM	1258.93	CHEMBL262	Homo sapiens	pKi		5.9
inactive	9648976	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	c1ccc(CNc2nc3ccc(-c4ccncc4)cc3s2)cc1		CHEMBL1983534	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9648977	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=c1c(NCc2ccccc2F)c(Nc2ccncc2)c1=O		CHEMBL1982361	=	Ki	nM	158.49	CHEMBL262	Homo sapiens	pKi		6.8
inactive	9648978	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Nc1ccc(-c2cccc3sncc23)cc1)Nc1ccc(F)c(C(F)(F)F)c1		CHEMBL2000801	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9648979	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1991395	<	Ki	nM	5011.87	CHEMBL262	Homo sapiens	pKi		5.3
active	9648980	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN1CCN(c2cccc(Nc3nccc(-c4c(C(N)=O)nc5ccccn45)n3)c2)CC1		CHEMBL1971245	=	Ki	nM	1584.89	CHEMBL262	Homo sapiens	pKi		5.8
active	9648981	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COC(=O)c1csc2ccc(=O)[nH]c12		CHEMBL2003545	=	Ki	nM	79432.82	CHEMBL262	Homo sapiens	pKi		4.1
inactive	9648982	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(NCc1ccccc1)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL1972142	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9648983	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1966514	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9648984	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Nc1cccc(F)c1)Nc1cccc(-c2ccc3cn[nH]c3c2)c1		CHEMBL1983393	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9648985	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(COc1cncc(-c2cc3ccncc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1966524	=	Ki	nM	12.59	CHEMBL262	Homo sapiens	pKi		7.9
inactive	9648986	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=c1[nH]c2sc3c(c2c2nc(-c4cccnc4)nn12)CCCC3		CHEMBL1970806	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9648987	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Nc1cnccn1)Nc1cccc2c(O)cccc12		CHEMBL1992371	=	Ki	nM	1000.0	CHEMBL262	Homo sapiens	pKi		6.0
active	9648988	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1n[nH]c2ccc(-c3cccnc3)cc12		CHEMBL1967252	=	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9648989	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	OCCCCNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1970821	=	Ki	nM	100.0	CHEMBL262	Homo sapiens	pKi		7.0
active	9648990	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCN(CCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL2004637	=	Ki	nM	1995.26	CHEMBL262	Homo sapiens	pKi		5.7
inactive	9648991	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)C(C)Nc1ncc(Cl)c(Nc2nccs2)n1		CHEMBL1993374	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9648992	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)(C)NC(=O)c1ccc2nc3[nH]c4ccccc4c3nc2c1		CHEMBL1969264	=	Ki	nM	398.11	CHEMBL262	Homo sapiens	pKi		6.4
inactive	9648993	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN1CCN(CCCNc2cccc(-c3nc4c(C(N)=O)cccc4[nH]3)n2)CC1		CHEMBL2006237	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9648994	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCCCC(=O)O)c2)n1		CHEMBL1999506	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9648995	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CNC(=O)NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL2005509	=	Ki	nM	100.0	CHEMBL262	Homo sapiens	pKi		7.0
active	9648996	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC1C2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)CC12		CHEMBL1624529	=	Ki	nM	31.62	CHEMBL262	Homo sapiens	pKi		7.5
inactive	9648997	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1979516	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9648998	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(O)c1ccc(N2C(=O)c3ccccc3C2=O)cc1O		CHEMBL1972820	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9648999	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(N)C1CCC(C(=O)Nc2ccncc2)CC1		CHEMBL1994526	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9649000	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)OC1=NNC(=O)C1=Cc1c[nH]c2ccccc12		CHEMBL1989029	=	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9649001	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CSc1ccccc1CNc1ncc([N+](=O)[O-])c(NCC2CCC(CN)CC2)n1		CHEMBL392642	=	Ki	nM	1995.26	CHEMBL262	Homo sapiens	pKi		5.7
active	9649002	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCCCNc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12		CHEMBL1682554	=	Ki	nM	15.85	CHEMBL262	Homo sapiens	pKi		7.8
active	9649003	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN(C)c1ccc(-c2cc(-c3ccc([N+](=O)[O-])cc3)nc(NS(=O)(=O)c3ccc(N)cc3)n2)cc1		CHEMBL1980167	=	Ki	nM	316.23	CHEMBL262	Homo sapiens	pKi		6.5
inactive	9649004	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1972849	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9649005	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1ccc(CNc2cc(-c3c[nH]c4ncccc34)cc(F)n2)cc1		CHEMBL1986855	=	Ki	nM	31.62	CHEMBL262	Homo sapiens	pKi		7.5
inactive	9649006	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)(C)OC(=O)n1cc(-c2cncn2C2CCCCC2)c2ccccc21		CHEMBL1975357	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9649007	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C1Nc2ccccc2Nc2cc(-c3ccncc3)ccc21		CHEMBL1989136	=	Ki	nM	398.11	CHEMBL262	Homo sapiens	pKi		6.4
inactive	9649008	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL259922	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9649009	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN1CCN(C2CCC(n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1997617	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9649010	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCCCn1c(NC(=O)c2cccc(C#N)c2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL1969301	=	Ki	nM	5011.87	CHEMBL262	Homo sapiens	pKi		5.3
inactive	9649011	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4ccccc4C(F)(F)F)cc3)c12		CHEMBL1987910	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9649012	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1nc(C(=O)O)c(-c3ccc(CO)cc3)s1)CC2		CHEMBL1983980	=	Ki	nM	630.96	CHEMBL262	Homo sapiens	pKi		6.2
inactive	9649013	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1ccc(NCc2ccc(-c3ccc(F)cc3)nc2)cc1		CHEMBL1986899	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9649014	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(O)c1ccccc1Nc1ccnc(Nc2cccc(O)c2)n1		CHEMBL243088	=	Ki	nM	12.59	CHEMBL262	Homo sapiens	pKi		7.9
inactive	9649015	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1Cl		CHEMBL1993661	<	Ki	nM	794.33	CHEMBL262	Homo sapiens	pKi		6.1
active	9649016	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=c1cc(C(F)(F)F)c2c(-c3cccc(C(F)(F)F)c3)n[nH]c2[nH]1		CHEMBL1230164	=	Ki	nM	5011.87	CHEMBL262	Homo sapiens	pKi		5.3
inactive	9649017	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721	<	Ki	nM	1995.26	CHEMBL262	Homo sapiens	pKi		5.7
inactive	9649018	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	<	Ki	nM	5011.87	CHEMBL262	Homo sapiens	pKi		5.3
inactive	9649019	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9649020	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	N#CCOc1ccc(Nc2nc(Nc3cccc(S(N)(=O)=O)c3)ncc2Br)cc1		CHEMBL1987034	=	Ki	nM	125.89	CHEMBL262	Homo sapiens	pKi		6.9
active	9649021	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCC(O)c4cccc(Cl)c4)cc[nH]c3=O)nc12		CHEMBL2005886	=	Ki	nM	3162.28	CHEMBL262	Homo sapiens	pKi		5.5
active	9649022	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682345	=	Ki	nM	199.53	CHEMBL262	Homo sapiens	pKi		6.7
inactive	9649023	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL481491	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9649024	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccc[nH]2)C(=O)N3)c1)Cc1ccccc1		CHEMBL1980407	=	Ki	nM	2.512	CHEMBL262	Homo sapiens	pKi		8.6
active	9649025	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC1CCC(Nc2nccc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1966628	=	Ki	nM	199.53	CHEMBL262	Homo sapiens	pKi		6.7
active	9649026	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCCC(=O)Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL2005936	=	Ki	nM	3.162	CHEMBL262	Homo sapiens	pKi		8.5
active	9649027	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1nc(N)c(C#N)c(-c2ccc(Cl)cc2Cl)c1C#N		CHEMBL1999778	=	Ki	nM	2511.89	CHEMBL262	Homo sapiens	pKi		5.6
active	9649028	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCCc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1987430	=	Ki	nM	6.31	CHEMBL262	Homo sapiens	pKi		8.2
active	9649029	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC1(C)CC2=Nc3cc(Cl)ccc3SC2=C(O)C1		CHEMBL1562756	=	Ki	nM	2511.89	CHEMBL262	Homo sapiens	pKi		5.6
inactive	9649030	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)c1ccccc1		CHEMBL1993413	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9649031	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1969372	=	Ki	nM	630.96	CHEMBL262	Homo sapiens	pKi		6.2
inactive	9649032	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(OCC(F)(F)F)nccn23)n1		CHEMBL2001957	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9653045	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN(C)CCCOc1cc(-c2ccncc2)cc2[nH]nc(N)c12		CHEMBL1988662	=	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9653046	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCn1c(C)c(-c2ccnc(Nc3cccc(OC)c3)n2)sc1=O		CHEMBL1986263	=	Ki	nM	12.59	CHEMBL262	Homo sapiens	pKi		7.9
inactive	9653047	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(O)C1CN(Cc2ccc(OCc3cccc(C(F)(F)F)c3)cc2Cl)C1		CHEMBL1986265	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9653048	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(NCc1ccccc1)Nc1ncc([N+](=O)[O-])s1		CHEMBL1964644	=	Ki	nM	199.53	CHEMBL262	Homo sapiens	pKi		6.7
active	9653049	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(NCc1ccc(Cl)c(Cl)c1)Nc1ccc2[nH]ncc2c1		CHEMBL1981782	=	Ki	nM	3162.28	CHEMBL262	Homo sapiens	pKi		5.5
active	9653050	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CNC(=O)C(C)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(C)cc5)cc4)csc23)cn1		CHEMBL1970142	=	Ki	nM	5011.87	CHEMBL262	Homo sapiens	pKi		5.3
active	9653051	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CNC(=O)c1cc2c(-c3ccccc3F)n[nH]c2s1		CHEMBL1977681	=	Ki	nM	794.33	CHEMBL262	Homo sapiens	pKi		6.1
inactive	9653052	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	<	Ki	nM	5011.87	CHEMBL262	Homo sapiens	pKi		5.3
inactive	9653053	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9653054	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCCCN(CCC#N)C(=O)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1983348	=	Ki	nM	501.19	CHEMBL262	Homo sapiens	pKi		6.3
active	9653055	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cc(O)ccc1-n1c2cc(Cl)ccc2c(=O)c2c(N)nc(N)nc21		CHEMBL1995592	=	Ki	nM	1995.26	CHEMBL262	Homo sapiens	pKi		5.7
active	9653056	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1ccc(OC)c(CNC(=O)c2cc(N)c(C#N)c(OC(C)C)n2)c1		CHEMBL1982541	=	Ki	nM	1584.89	CHEMBL262	Homo sapiens	pKi		5.8
inactive	9653057	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Nc1cccc(Cl)c1)Nc1nc(CCNc2ncnc3ccsc23)cs1		CHEMBL1986177	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9653058	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=c1[nH]cnc2c1oc1ccc(Cl)cc12		CHEMBL1992323	=	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9653059	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1C		CHEMBL1983449	=	Ki	nM	158.49	CHEMBL262	Homo sapiens	pKi		6.8
active	9653060	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1983589	=	Ki	nM	794.33	CHEMBL262	Homo sapiens	pKi		6.1
inactive	9653061	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1nc(N2CCNCC2)nc2ccccc12		CHEMBL1996510	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9653062	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CS(=O)(=O)NCCNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL2005718	=	Ki	nM	398.11	CHEMBL262	Homo sapiens	pKi		6.4
active	9653063	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCCn1c(C2CCNCC2)nc(-c2ccc(Cl)c(Cl)c2)c1-c1ccnc(NC2CCCCC2)n1		CHEMBL437747	=	Ki	nM	2511.89	CHEMBL262	Homo sapiens	pKi		5.6
inactive	9653064	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cccc(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL507936	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9653065	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cn1cc(-c2cccc(NC(=O)c3ccc(C(C)(C)C)cc3)c2CO)cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c1=O		CHEMBL2001584	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9653066	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Brc1ccc2c(c1)-c1[nH]ncc1C2		CHEMBL1995172	<	Ki	nM	5011.87	CHEMBL262	Homo sapiens	pKi		5.3
inactive	9653067	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1967998	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9653068	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=S(=O)(NCCNCC=Cc1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL1987756	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9653069	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C1NCCc2[nH]c(-c3ccnc(C=Cc4ccccc4)c3)cc21		CHEMBL1997129	=	Ki	nM	3162.28	CHEMBL262	Homo sapiens	pKi		5.5
inactive	9653070	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(=O)c1cc(Cl)cc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1984788	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9653071	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(O)c1csc2c1NCCNC2=O		CHEMBL1974875	=	Ki	nM	50118.72	CHEMBL262	Homo sapiens	pKi		4.3
active	9653072	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	N#CCC(C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL2002099	=	Ki	nM	2511.89	CHEMBL262	Homo sapiens	pKi		5.6
inactive	9653073	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2001547	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9653074	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9653075	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9653076	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(COc1cncc(-c2cc3cnccc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1972840	=	Ki	nM	199.53	CHEMBL262	Homo sapiens	pKi		6.7
inactive	9653077	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=c1[nH]cc(I)c2nc(-c3ccccc3)cn12		CHEMBL2001668	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9653078	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1998585	=	Ki	nM	1000.0	CHEMBL262	Homo sapiens	pKi		6.0
active	9653079	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(F)c2)c1		CHEMBL2004934	=	Ki	nM	125.89	CHEMBL262	Homo sapiens	pKi		6.9
active	9653080	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)(CN)CNc1cc(-c2c[nH]c3ncccc23)cc(F)n1		CHEMBL1987261	=	Ki	nM	1995.26	CHEMBL262	Homo sapiens	pKi		5.7
inactive	9653081	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1ccc(-c2cc3c(NCCN)ccc(C(N)=O)c3[nH]2)cc1		CHEMBL1996048	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9653082	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COCOc1cccc(OCOC)c1-c1ccc(NS(C)(=O)=O)cc1C(=O)OC		CHEMBL2004025	=	Ki	nM	398.11	CHEMBL262	Homo sapiens	pKi		6.4
inactive	9653083	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL461876	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9653084	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1n[nH]c2cccc(-c3ccc(F)cc3)c12		CHEMBL1971519	=	Ki	nM	19952.62	CHEMBL262	Homo sapiens	pKi		4.7
inactive	9653085	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1ccc(C2=NNc3cccc4c(OC)ccc2c34)cc1OC		CHEMBL1997335	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9653086	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CNC(=O)COc1ccc(Nc2nc(Nc3ccc(C)c(S(N)(=O)=O)c3)ncc2F)cc1		CHEMBL1978099	=	Ki	nM	794.33	CHEMBL262	Homo sapiens	pKi		6.1
active	9653087	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL1984363	=	Ki	nM	5011.87	CHEMBL262	Homo sapiens	pKi		5.3
active	9653088	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COC(=O)c1c(-c2ccc(NC(=O)Nc3ccccc3)cc2)c2c(N)ncnn2c1C		CHEMBL1977041	=	Ki	nM	1000.0	CHEMBL262	Homo sapiens	pKi		6.0
active	9653089	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(=O)c1cccc2c1Nc1nnc(Cl)cc1C(=O)N2		CHEMBL1968070	=	Ki	nM	100.0	CHEMBL262	Homo sapiens	pKi		7.0
active	9653090	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1nnc(-c2ccccc2)c(C#N)n1		CHEMBL1994808	=	Ki	nM	100000.0	CHEMBL262	Homo sapiens	pKi		4.0
inactive	9653091	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)(CN)CNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1985723	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9653092	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN(C)c1ccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)cc1		CHEMBL1984367	=	Ki	nM	5011.87	CHEMBL262	Homo sapiens	pKi		5.3
active	9653093	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	N#Cc1cccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)c1		CHEMBL1977128	=	Ki	nM	3.981	CHEMBL262	Homo sapiens	pKi		8.4
inactive	9653094	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cccc(NC(=O)c2cnn3c(-c4ccccc4)ccnc23)c1		CHEMBL1997759	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9653095	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL1970074	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9653096	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=c1[nH]c2cc(Cl)cc(Cl)c2c(-c2cc(Cl)ccc2O)c1O		CHEMBL1974803	=	Ki	nM	3162.28	CHEMBL262	Homo sapiens	pKi		5.5
inactive	9653097	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C1NCc2c(Br)cccc21		CHEMBL1984500	<	Ki	nM	79432.82	CHEMBL262	Homo sapiens	pKi		4.1
inactive	9653098	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC1=NN(c2cccc(Br)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2005112	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9653099	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=c1[nH]c2cc(-c3ccccc3)cnc2[nH]1		CHEMBL2003456	=	Ki	nM	2511.89	CHEMBL262	Homo sapiens	pKi		5.6
inactive	9653100	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(N)C1CCC(C(=O)Nc2ccnc3[nH]ccc23)CC1		CHEMBL2002992	<	Ki	nM	5011.87	CHEMBL262	Homo sapiens	pKi		5.3
active	9653101	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	N#Cc1cnc(NC(=O)Nc2ccc3cc(C(=O)O)ccc3c2)cn1		CHEMBL560813	=	Ki	nM	3162.28	CHEMBL262	Homo sapiens	pKi		5.5
active	9653102	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(=NNC(=O)c1nnn(-c2nonc2N)c1-c1ccccc1)c1ccco1		CHEMBL1890036	=	Ki	nM	1995.26	CHEMBL262	Homo sapiens	pKi		5.7
inactive	9653103	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCCOn1c2ccc(Cl)cc2c(=O)c2c(C)nn(C)c21		CHEMBL207253	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9653104	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CC(CN2CCCC2)C1		CHEMBL1968791	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9653105	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cccc(Cl)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)NCCOCCOCCN)[nH]c12		CHEMBL2002682	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9653106	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCC(N)=O)cc2)n1		CHEMBL1977634	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9653107	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1984700	=	Ki	nM	2511.89	CHEMBL262	Homo sapiens	pKi		5.6
inactive	9653108	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9653109	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	c1ccc(-c2c[nH]c3ncnc(N4CCCCC4)c23)cc1		CHEMBL1998953	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9653110	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CCC(N2CCCC2)CC1		CHEMBL2007151	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9653111	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2)c1		CHEMBL1971606	=	Ki	nM	2511.89	CHEMBL262	Homo sapiens	pKi		5.6
inactive	9653112	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1		CHEMBL1972125	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9653113	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Nc1ccc2[nH]ncc2c1)c1cccc(F)c1		CHEMBL1461728	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9653114	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)(Nc1nccc(-c2c[nH]c3ncccc23)n1)c1ccccc1		CHEMBL1999279	=	Ki	nM	125.89	CHEMBL262	Homo sapiens	pKi		6.9
inactive	9653115	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NCCOc1cccc(Nc2ccnc(N)n2)c1		CHEMBL1995448	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9653116	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	<	Ki	nM	5011.87	CHEMBL262	Homo sapiens	pKi		5.3
active	9653117	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL1972158	=	Ki	nM	12.59	CHEMBL262	Homo sapiens	pKi		7.9
inactive	9653118	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCN(CC)CCCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL1999414	<	Ki	nM	3162.28	CHEMBL262	Homo sapiens	pKi		5.5
active	9653119	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cc(F)cc12		CHEMBL1967336	=	Ki	nM	25.12	CHEMBL262	Homo sapiens	pKi		7.6
inactive	9653120	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCCC1		CHEMBL2006481	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9653121	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1ccc(Nc2c(C(=O)O)n(CCCOc3cccc4ccccc34)c3cccc(-c4ccccc4C)c23)cc1		CHEMBL1978645	=	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9653122	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	N#Cc1ccc(-c2ccncc2)cc1NCc1ccccc1		CHEMBL1967992	=	Ki	nM	501.19	CHEMBL262	Homo sapiens	pKi		6.3
inactive	9653123	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9653124	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(Cc4ccccc4)c3n2)c1		CHEMBL1993424	=	Ki	nM	501.19	CHEMBL262	Homo sapiens	pKi		6.3
inactive	9653125	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NCC(O)C(O)Cn1cc(I)c2c(N)ncnc21		CHEMBL1975534	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9653126	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1n[nH]c2c1C(c1ccccc1F)C1=C(CC(C)(C)CC1=O)N2		CHEMBL1966703	=	Ki	nM	19.95	CHEMBL262	Homo sapiens	pKi		7.7
active	9653127	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)N(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1969561	=	Ki	nM	15.85	CHEMBL262	Homo sapiens	pKi		7.8
active	9653128	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3coc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1983640	=	Ki	nM	3162.28	CHEMBL262	Homo sapiens	pKi		5.5
active	9653129	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cc(C)cc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1964687	=	Ki	nM	1584.89	CHEMBL262	Homo sapiens	pKi		5.8
active	9653130	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(=O)c1cc2c(-c3ccc(Br)c(F)c3F)cncc2s1		CHEMBL1999918	=	Ki	nM	6.31	CHEMBL262	Homo sapiens	pKi		8.2
inactive	9653131	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCOc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1974254	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9653132	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1ccc(C(=O)N2c3ccccc3Sc3c(Cl)cncc32)cc1		CHEMBL1988537	=	Ki	nM	5011.87	CHEMBL262	Homo sapiens	pKi		5.3
active	9653133	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccc3ccccc3c2)n1		CHEMBL2002240	=	Ki	nM	1258.93	CHEMBL262	Homo sapiens	pKi		5.9
inactive	9653134	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN(C)c1ccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)cc1NC(=O)c1ccccc1		CHEMBL1978267	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9653135	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL363648	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9653136	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(=O)NC1CCCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)C1		CHEMBL1980178	=	Ki	nM	794.33	CHEMBL262	Homo sapiens	pKi		6.1
inactive	9653137	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	<	Ki	nM	3162.28	CHEMBL262	Homo sapiens	pKi		5.5
inactive	9653138	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2CCC(N)=O		CHEMBL485556	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9653139	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cc(-c2ccc3c(c2)Nc2ccccc2NC3=O)ccn1		CHEMBL1981511	=	Ki	nM	630.96	CHEMBL262	Homo sapiens	pKi		6.2
active	9653140	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(=O)CC)c3c2)cc1		CHEMBL1972221	=	Ki	nM	63.1	CHEMBL262	Homo sapiens	pKi		7.2
inactive	9653141	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C1C(=NNc2cccc3c(=O)[nH][nH]c(=O)c23)C(c2ccccc2)=NN1c1ccccc1		CHEMBL1984274	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9653142	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1998545	=	Ki	nM	1995.26	CHEMBL262	Homo sapiens	pKi		5.7
active	9653143	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=c1[nH]n2ccccc2c1Br		CHEMBL2004033	=	Ki	nM	3162.28	CHEMBL262	Homo sapiens	pKi		5.5
inactive	9653144	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1csc(NC(=O)c2sc3nc(-c4ccncc4)ccc3c2N)n1		CHEMBL1986869	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9653145	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(O)C1CN(Cc2ccc(OCc3ccccc3)cc2Cl)C1		CHEMBL1987998	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9653146	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(=O)c1cc2ccncc2s1		CHEMBL1971534	=	Ki	nM	5011.87	CHEMBL262	Homo sapiens	pKi		5.3
active	9653147	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc([N+](=O)[O-])cc2)n1		CHEMBL242865	=	Ki	nM	10.0	CHEMBL262	Homo sapiens	pKi		8.0
inactive	9653148	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1n[nH]c2cc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)ccc12		CHEMBL1997623	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9653149	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccc(Cl)cc5o4)cc3)c1)CNC2=O		CHEMBL2002479	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9653150	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)c1ccccc1		CHEMBL1966035	=	Ki	nM	398.11	CHEMBL262	Homo sapiens	pKi		6.4
active	9653151	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCOC(=O)c1c[nH]n2c(=O)cc(-c3ccncc3)nc12		CHEMBL1990708	=	Ki	nM	316.23	CHEMBL262	Homo sapiens	pKi		6.5
active	9653152	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Oc1cccc(Nc2ncnc3scc(Cl)c23)c1		CHEMBL1982992	=	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9653153	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)c(F)c3n21		CHEMBL1977604	=	Ki	nM	1995.26	CHEMBL262	Homo sapiens	pKi		5.7
inactive	9653154	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCN(CC)CCCNc1cccc(-c2nc3c(C(N)=O)cccc3[nH]2)n1		CHEMBL1972276	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9653155	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(NCc1ccc(Br)cc1)Nc1ccc2[nH]ncc2c1		CHEMBL1970709	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9653156	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C1Nc2ccccc2C1=Cc1ccc[nH]1		CHEMBL1996176	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9653157	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cc(Nc2ncnc(N3CCCc4cc(C)ccc43)n2)cc(OC)c1OC		CHEMBL1992125	=	Ki	nM	2511.89	CHEMBL262	Homo sapiens	pKi		5.6
active	9653158	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NCCNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1972290	=	Ki	nM	794.33	CHEMBL262	Homo sapiens	pKi		6.1
active	9653159	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	1258.93	CHEMBL262	Homo sapiens	pKi		5.9
active	9653160	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(=O)c1cc2c(Oc3cccc(F)c3)cncc2s1		CHEMBL1964777	=	Ki	nM	251.19	CHEMBL262	Homo sapiens	pKi		6.6
inactive	9653161	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Cc1ccccc1Cl)Nc1ccc2cn[nH]c2c1		CHEMBL1987533	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9653162	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cn1cc(Nc2ncc(Cl)c(Nc3ccccc3C(N)=O)n2)cn1		CHEMBL1984548	=	Ki	nM	7.943	CHEMBL262	Homo sapiens	pKi		8.1
active	9653163	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(COc1cncc(-c2ccc3c(c2)CC(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL1967302	=	Ki	nM	100.0	CHEMBL262	Homo sapiens	pKi		7.0
inactive	9653164	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCCCN4CCOCC4)cc2-3)cn1		CHEMBL398951	<	Ki	nM	5011.87	CHEMBL262	Homo sapiens	pKi		5.3
active	9653165	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cc2cnc3c(c2cc1OC)C(=O)NC3=O		CHEMBL1982506	=	Ki	nM	125.89	CHEMBL262	Homo sapiens	pKi		6.9
active	9653166	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1		CHEMBL1968127	=	Ki	nM	5011.87	CHEMBL262	Homo sapiens	pKi		5.3
active	9653167	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL1985406	=	Ki	nM	2.512	CHEMBL262	Homo sapiens	pKi		8.6
active	9653168	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cc(O)ccc1-n1cc(C(=O)NN)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL2000894	=	Ki	nM	630.96	CHEMBL262	Homo sapiens	pKi		6.2
inactive	9653169	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cn1nc(C(F)(F)F)c2c(=O)c3cc(Cl)ccc3n(O)c21		CHEMBL207400	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9653170	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1nnc2cncc(Cl)n12		CHEMBL1968130	=	Ki	nM	31622.78	CHEMBL262	Homo sapiens	pKi		4.5
inactive	9653171	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4c(c3)OCO4)csc12		CHEMBL1993243	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9653172	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CC(CN2CCCC2)C1		CHEMBL1988370	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9653173	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	S=c1[nH]nc2c3c4c(sc3n3c(=S)[nH]nc3n12)CCC4		CHEMBL1969537	=	Ki	nM	316.23	CHEMBL262	Homo sapiens	pKi		6.5
inactive	9653174	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccccc2)n1		CHEMBL210032	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9653175	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5cnn(C)c5)cnn4c3N)cc2)c1		CHEMBL508928	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9653176	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cccc(-c2cc3c(=O)[nH]c4ccccc4n3c2)c1		CHEMBL1991356	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9653177	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1ccc(C(=O)Nc2nc3ccc(Cl)cc3s2)c(OC)c1		CHEMBL1983309	=	Ki	nM	501.19	CHEMBL262	Homo sapiens	pKi		6.3
inactive	9653178	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL2004892	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9653179	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccc(F)cc3)cc12		CHEMBL1972339	=	Ki	nM	19.95	CHEMBL262	Homo sapiens	pKi		7.7
inactive	9653180	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(=O)c1cc(-c2cccc(N)c2)cc2cccnc12		CHEMBL1970314	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9653181	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3nsc4ncnc(N)c34)cc2)c1		CHEMBL262433	=	Ki	nM	5011.87	CHEMBL262	Homo sapiens	pKi		5.3
inactive	9653182	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9653183	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(NNC(=S)Nc1ccc(Cl)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1966722	=	Ki	nM	501.19	CHEMBL262	Homo sapiens	pKi		6.3
active	9653184	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cccc(Cl)c1		CHEMBL1983595	=	Ki	nM	3.981	CHEMBL262	Homo sapiens	pKi		8.4
active	9653185	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cc(=O)n2ccc(CN(C)C)c(O)c2n1		CHEMBL1988581	=	Ki	nM	79.43	CHEMBL262	Homo sapiens	pKi		7.1
active	9653186	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCNC(C)=O)cc2NC3=O)ccc1O		CHEMBL1975500	=	Ki	nM	501.19	CHEMBL262	Homo sapiens	pKi		6.3
inactive	9653187	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1		CHEMBL394619	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9653188	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCN(C(C)=O)c1ccc(Nc2nc(NC3CC3)c3nc[nH]c3n2)cc1		CHEMBL2006564	=	Ki	nM	1995.26	CHEMBL262	Homo sapiens	pKi		5.7
active	9653189	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc1)CCN2		CHEMBL411903	=	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9653190	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN)cnc(N)c34)cc2)c1		CHEMBL1965988	=	Ki	nM	3162.28	CHEMBL262	Homo sapiens	pKi		5.5
active	9653191	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	=	Ki	nM	398.11	CHEMBL262	Homo sapiens	pKi		6.4
active	9653192	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL1989646	=	Ki	nM	63.1	CHEMBL262	Homo sapiens	pKi		7.2
inactive	9653193	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	<	Ki	nM	3162.28	CHEMBL262	Homo sapiens	pKi		5.5
inactive	9653194	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCOc1nc(C(=O)NCc2cccnc2)cc(N)c1C#N		CHEMBL209534	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9653195	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(=O)c1cccc(-c2ccc3nccn3n2)c1		CHEMBL1994159	=	Ki	nM	25118.86	CHEMBL262	Homo sapiens	pKi		4.6
inactive	9653196	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9653197	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	C(=Cc1cncc(OC2CCNC2)c1)c1ccncc1		CHEMBL1966087	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9653198	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cncc21		CHEMBL1964692	=	Ki	nM	1995.26	CHEMBL262	Homo sapiens	pKi		5.7
active	9653199	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cn1cc(-c2ccccc2)c2nc(-c3ccncc3)cc(=O)n21		CHEMBL1986767	=	Ki	nM	125.89	CHEMBL262	Homo sapiens	pKi		6.9
active	9653200	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL1973483	=	Ki	nM	7.943	CHEMBL262	Homo sapiens	pKi		8.1
active	9653201	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL219722	=	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9653202	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL1970735	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9653203	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCC(O)C1		CHEMBL1997340	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9653204	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cn1cc(Nc2ncc(Br)c(Nc3ccccc3C(N)=O)n2)cn1		CHEMBL1994669	=	Ki	nM	5.012	CHEMBL262	Homo sapiens	pKi		8.3
active	9653205	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Ki	nM	1584.89	CHEMBL262	Homo sapiens	pKi		5.8
active	9653206	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C1NCCc2[nH]c(-c3ccnc(Cl)c3)cc21		CHEMBL226232	=	Ki	nM	794.33	CHEMBL262	Homo sapiens	pKi		6.1
inactive	9653207	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	<	Ki	nM	5011.87	CHEMBL262	Homo sapiens	pKi		5.3
inactive	9653208	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	N#Cc1ccc2nc(N)n(-c3nccs3)c2c1		CHEMBL1988805	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9653209	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C(F)(F)F)c2)c1		CHEMBL1971021	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9653210	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(=O)c1cc2c(-c3ccc(F)cc3)cncc2s1		CHEMBL1974310	=	Ki	nM	79.43	CHEMBL262	Homo sapiens	pKi		7.1
active	9653211	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=c1[nH]cnc2c1sc1c(Cl)ccc(Cl)c12		CHEMBL583144	=	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9653212	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(=O)c1cccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982957	=	Ki	nM	158.49	CHEMBL262	Homo sapiens	pKi		6.8
active	9653213	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Ki	nM	316.23	CHEMBL262	Homo sapiens	pKi		6.5
active	9653214	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	c1ccc(CNc2cc(-c3c[nH]c4ncccc34)ncn2)cc1		CHEMBL2002346	=	Ki	nM	7.943	CHEMBL262	Homo sapiens	pKi		8.1
active	9653215	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC1=NN(c2ccc(C(=O)O)cc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2006836	=	Ki	nM	5011.87	CHEMBL262	Homo sapiens	pKi		5.3
active	9653216	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	=	Ki	nM	3.981	CHEMBL262	Homo sapiens	pKi		8.4
active	9653217	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC1CCCCC1Nc1nccc(Nc2ccccc2C(=O)O)n1		CHEMBL1985153	=	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9653218	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(=O)c1sc2ccc(Cl)c(Cl)c2c1NC(=O)c1ccc(Cl)cc1		CHEMBL2003271	=	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9653219	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cc2nnc(SCc3cn4ccccc4n3)n2c2ccccc12		CHEMBL1980704	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9653220	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccncc4)nn12)CCCC3		CHEMBL1966808	=	Ki	nM	125.89	CHEMBL262	Homo sapiens	pKi		6.9
inactive	9653221	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL49120	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9653222	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL260135	=	Ki	nM	158.49	CHEMBL262	Homo sapiens	pKi		6.8
active	9653223	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21		CHEMBL220241	=	Ki	nM	63.1	CHEMBL262	Homo sapiens	pKi		7.2
active	9653224	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=S(=O)(O)c1ccc(NCc2ccc3c(c2)OCO3)c2c(O)cccc12		CHEMBL2004544	=	Ki	nM	630.96	CHEMBL262	Homo sapiens	pKi		6.2
active	9653225	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	FC(F)(F)c1cccc(CNc2cc(-c3c[nH]c4ncccc34)ncn2)c1		CHEMBL1966040	=	Ki	nM	100.0	CHEMBL262	Homo sapiens	pKi		7.0
active	9653226	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCC(=O)Nc1ccc(C(=O)N2CCNCC2)c(O)c1		CHEMBL1988141	=	Ki	nM	100.0	CHEMBL262	Homo sapiens	pKi		7.0
inactive	9653227	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)cnc2c(-c3ccc4c(c3)OCO4)cnn12		CHEMBL1977134	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9653228	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COCC#Cc1cccc2c1Cc1c(-c3cccs3)n[nH]c1-2		CHEMBL1985206	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9653229	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CSc1cnc2c(ccc3cnccc32)c1O		CHEMBL2006933	=	Ki	nM	125.89	CHEMBL262	Homo sapiens	pKi		6.9
inactive	9653230	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1OC		CHEMBL1991078	<	Ki	nM	100.0	CHEMBL262	Homo sapiens	pKi		7.0
inactive	9653231	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9653232	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCCCNc1ccc2c3c(cccc13)C(=O)N(CCNCCO)C2=O		CHEMBL1987359	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9653233	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	C=CCc1cccc2c(=NO)cc(-c3ccccc3)oc12		CHEMBL1977749	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9653234	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(=NNC(=N)N)c1cc(NC(=O)c2cccc(C(=O)Nc3cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c3)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL2000685	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9653235	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC1CCCCC1Nc1nc(Cl)cc(-c2c[nH]c3ncccc23)n1		CHEMBL1994438	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9653236	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2ccc(Cl)cc12		CHEMBL1967513	=	Ki	nM	39.81	CHEMBL262	Homo sapiens	pKi		7.4
active	9653237	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cccc(-c2cccc3onc(N)c23)c1		CHEMBL1980376	=	Ki	nM	39810.72	CHEMBL262	Homo sapiens	pKi		4.4
inactive	9653238	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(CO)ccc4F)cc3)c12		CHEMBL1985311	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9653239	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cc(O)nc2[nH]nc(-c3cccc(-c4ccc(C#N)cc4)c3)c12		CHEMBL2000724	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9653240	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	=	Ki	nM	6.31	CHEMBL262	Homo sapiens	pKi		8.2
active	9653241	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN(Cc1cc(Cl)c(O)c2ncccc12)C1CCCCC1		CHEMBL1982413	=	Ki	nM	2511.89	CHEMBL262	Homo sapiens	pKi		5.6
active	9653242	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)Nc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12		CHEMBL1682553	=	Ki	nM	39.81	CHEMBL262	Homo sapiens	pKi		7.4
active	9653243	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C1NN=Cc2c[nH]c3cc(NC(=O)C4CC4c4ccccc4)cc1c23		CHEMBL1969502	=	Ki	nM	5011.87	CHEMBL262	Homo sapiens	pKi		5.3
inactive	9653244	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cccc(-c2c(-c3ccncc3)nc(NCC(N)Cc3ccccc3)n(C)c2=O)c1		CHEMBL1971430	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9653245	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1n[nH]c2ccc(-c3cncc(OCC(CN)Cc4ccccc4)c3)cc12		CHEMBL2000271	=	Ki	nM	794.33	CHEMBL262	Homo sapiens	pKi		6.1
active	9653246	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1ccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)cc1		CHEMBL1997764	=	Ki	nM	1995.26	CHEMBL262	Homo sapiens	pKi		5.7
active	9653247	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(NCCc1cccs1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1987535	=	Ki	nM	3162.28	CHEMBL262	Homo sapiens	pKi		5.5
active	9653248	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(F)c(F)cc12		CHEMBL1981792	=	Ki	nM	25.12	CHEMBL262	Homo sapiens	pKi		7.6
inactive	9653249	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Clc1cc(Nc2nc(NC3CC3)c3sccc3n2)ccc1N1CCOCC1		CHEMBL2002586	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9653250	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1ccccc1		CHEMBL2004692	=	Ki	nM	1258.93	CHEMBL262	Homo sapiens	pKi		5.9
active	9653251	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(=O)c1cc(-c2cccs2)n2nccc2n1		CHEMBL1987815	=	Ki	nM	39810.72	CHEMBL262	Homo sapiens	pKi		4.4
inactive	9653252	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC1(O)CC(c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn23)C1		CHEMBL1996234	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9653253	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN(C)c1cccc2c(S(=O)(=O)N(CCN)c3cncc(-c4ccc5cnccc5c4)c3)cccc12		CHEMBL1967544	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9653254	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=c1[nH]c2ccc(Cl)cc2c2ncnn12		CHEMBL1992673	=	Ki	nM	39810.72	CHEMBL262	Homo sapiens	pKi		4.4
active	9653255	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	=	Ki	nM	158.49	CHEMBL262	Homo sapiens	pKi		6.8
inactive	9653256	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9653257	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2cc(F)ccc21		CHEMBL1993335	=	Ki	nM	398.11	CHEMBL262	Homo sapiens	pKi		6.4
active	9653258	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1nc(Cl)cc(-c2c[nH]c3ncccc23)n1		CHEMBL2007574	=	Ki	nM	31.62	CHEMBL262	Homo sapiens	pKi		7.5
active	9653259	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CS(=O)(=O)NCCOc1cncc(-c2ccc3cnccc3c2)c1		CHEMBL1964804	=	Ki	nM	630.96	CHEMBL262	Homo sapiens	pKi		6.2
active	9653260	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	C(=Cc1cncc(OCCc2c[nH]c3ccccc23)c1)c1ccncc1		CHEMBL1996282	=	Ki	nM	5011.87	CHEMBL262	Homo sapiens	pKi		5.3
active	9653261	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1ccc(-c2cnc3c(Br)cnn3c2)cc1		CHEMBL443962	=	Ki	nM	3162.28	CHEMBL262	Homo sapiens	pKi		5.5
inactive	9653262	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1965507	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9653263	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1ccc(C=C2SC(=Nc3ccccc3)NC2=O)cc1O		CHEMBL2000354	=	Ki	nM	3162.28	CHEMBL262	Homo sapiens	pKi		5.5
inactive	9653264	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2cccc(OCC(=O)NCCO)c2)n1		CHEMBL1998680	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9653265	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9653266	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCCC(=O)Nc1n[nH]c2nc3ccccc3cc12		CHEMBL1967564	=	Ki	nM	158.49	CHEMBL262	Homo sapiens	pKi		6.8
inactive	9653267	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1970317	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9653268	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc2c(C)n1		CHEMBL2000408	=	Ki	nM	3162.28	CHEMBL262	Homo sapiens	pKi		5.5
active	9653269	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN1CCC(C(=O)n2nc(N)c3cc(-c4cn(Cc5ccccc5)nn4)ccc32)CC1		CHEMBL1978014	=	Ki	nM	31.62	CHEMBL262	Homo sapiens	pKi		7.5
inactive	9653270	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9653271	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(NCc1ccccc1)c1c[nH]n2c(=O)cc(-c3ccncc3)nc12		CHEMBL1974250	=	Ki	nM	2.512	CHEMBL262	Homo sapiens	pKi		8.6
inactive	9653272	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCCNC(=O)c1ccc(Nc2nc(CC)c3cc[nH]c3n2)cc1		CHEMBL1997007	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9653273	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Nc1cnccn1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1994538	=	Ki	nM	15.85	CHEMBL262	Homo sapiens	pKi		7.8
inactive	9653274	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1975490	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9653275	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Nc1nc2c(O)cccc2s1)Nc1ccccc1-c1ccccc1		CHEMBL2002690	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9653276	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(Cc1cccc2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1985580	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9653277	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Clc1csc2ncnc(Nc3ccccc3)c12		CHEMBL1986139	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9653278	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccsc2)n1		CHEMBL2006567	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9653279	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN(C)c1cc(-c2ccncc2)cc2[nH]nc(N)c12		CHEMBL2003229	=	Ki	nM	1258.93	CHEMBL262	Homo sapiens	pKi		5.9
active	9653280	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN(C)C)cnc(N)c34)cc2)c1		CHEMBL1979883	=	Ki	nM	2511.89	CHEMBL262	Homo sapiens	pKi		5.6
inactive	9653281	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1ccc(CN(C)C)cc1Nc1nccc(-c2c(-c3cccc(NC(=O)c4c(F)cccc4F)c3)nc3sccn23)n1		CHEMBL1997051	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9653282	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cccc(CNc2cc(-c3c[nH]c4ncccc34)cc(Cl)n2)c1C		CHEMBL1988331	=	Ki	nM	25.12	CHEMBL262	Homo sapiens	pKi		7.6
active	9653283	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Fc1cnc(Nc2ccccc2)nc1Nc1ccccc1		CHEMBL491758	=	Ki	nM	1995.26	CHEMBL262	Homo sapiens	pKi		5.7
inactive	9653284	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C1Nc2ccccc2C1=Cc1c[nH]c2ccccc12		CHEMBL1986590	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9657292	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1n[nH]c2ccc(-c3cncc(OCCN(C)S(C)(=O)=O)c3)cc12		CHEMBL1998826	=	Ki	nM	398.11	CHEMBL262	Homo sapiens	pKi		6.4
active	9657293	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C(C)(C)C		CHEMBL1986186	=	Ki	nM	2511.89	CHEMBL262	Homo sapiens	pKi		5.6
active	9657294	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1n[nH]c2c1C(c1ccccc1Cl)C(C#N)=C(N)O2		CHEMBL1970189	=	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9657295	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9657296	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(NC(CO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1974288	=	Ki	nM	158.49	CHEMBL262	Homo sapiens	pKi		6.8
active	9657297	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	c1cnc2[nH]cc(-c3ccnc(NCC4CCCCC4)n3)c2c1		CHEMBL213207	=	Ki	nM	125.89	CHEMBL262	Homo sapiens	pKi		6.9
inactive	9657298	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1n[nH]c2cccc(-c3ccc(Br)cc3)c12		CHEMBL1990346	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9657299	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)c1c(F)cccc1F		CHEMBL1991410	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9657300	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCCC(=O)Nc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3cc(OCCN4CCCC4)ccc3n2)c1		CHEMBL1968705	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9657301	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCOCCO)c2)n1		CHEMBL1978271	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9657302	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc(OCCCn4cccc4)c4[nH]nc(N)c34)cc2)c1		CHEMBL2007266	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9657303	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(CCC(=O)Nc1cc(C(F)(F)F)ccc1Cl)NN=Cc1c[nH]c2ccccc12		CHEMBL1994308	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9657304	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)c(F)c3n21		CHEMBL1977604	=	Ki	nM	1258.93	CHEMBL262	Homo sapiens	pKi		5.9
inactive	9657305	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cccc(Nc2nc(NC3CCCCC3N)cnc2C(N)=O)c1		CHEMBL1974328	<	Ki	nM	3162.28	CHEMBL262	Homo sapiens	pKi		5.5
inactive	9657306	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cn1cc(-c2cnn3c(N)c(-c4ccc(NC(=O)Nc5cccc(C(F)(F)F)c5)cc4)cnc23)cn1		CHEMBL1988717	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9657307	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCN1CCN(c2ccc(Nc3ncc(C#N)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1973516	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9657308	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9657309	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1992342	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9657310	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C1NCc2ccc(-c3ccc(Cl)cc3)cc21		CHEMBL2002202	=	Ki	nM	63095.73	CHEMBL262	Homo sapiens	pKi		4.2
active	9657311	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cnc(Nc2nc(NC(C)C)ncc2Br)s1		CHEMBL1973013	=	Ki	nM	2511.89	CHEMBL262	Homo sapiens	pKi		5.6
inactive	9657312	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)Cn1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL1965423	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9657313	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1983945	=	Ki	nM	1995.26	CHEMBL262	Homo sapiens	pKi		5.7
active	9657314	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(NCc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1977135	=	Ki	nM	199.53	CHEMBL262	Homo sapiens	pKi		6.7
active	9657315	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	c1ccc(Cn2nnc(-c3ccc4[nH]ncc4c3)c2-c2ccccc2)cc1		CHEMBL1969473	=	Ki	nM	10.0	CHEMBL262	Homo sapiens	pKi		8.0
active	9657316	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	FC(F)(F)c1ccccc1CNc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL1999153	=	Ki	nM	12.59	CHEMBL262	Homo sapiens	pKi		7.9
active	9657317	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C1NC(=S)SC1=C1C(=O)Nc2ccc(Br)cc21		CHEMBL2001920	=	Ki	nM	501.19	CHEMBL262	Homo sapiens	pKi		6.3
active	9657318	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(Nc1cncc(-n2cnc3ccc(C#N)cc32)n1)c1ccccc1F		CHEMBL1977138	=	Ki	nM	630.96	CHEMBL262	Homo sapiens	pKi		6.2
active	9657319	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3C(N)=O)n2)cc(OC)c1OC		CHEMBL1241473	=	Ki	nM	6.31	CHEMBL262	Homo sapiens	pKi		8.2
inactive	9657320	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CS(=O)(=O)N(Cc1ccc2[nH]c(=O)c3cccn3c2c1)C1CC1		CHEMBL1978448	<	Ki	nM	1995.26	CHEMBL262	Homo sapiens	pKi		5.7
active	9657321	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COC(=O)c1ccccc1-c1ccc2c(c1)Nc1ccccc1NC2=O		CHEMBL2004513	=	Ki	nM	3162.28	CHEMBL262	Homo sapiens	pKi		5.5
inactive	9657322	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NCCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1972258	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9657323	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN(C)c1ccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)cc1NC(=O)Cc1ccccc1		CHEMBL1969483	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9657324	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCN(CC)CC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2001257	<	Ki	nM	3162.28	CHEMBL262	Homo sapiens	pKi		5.5
active	9657325	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	c1nc(-c2ccc3c(c2)OCO3)c2cc[nH]c2n1		CHEMBL2004515	=	Ki	nM	25118.86	CHEMBL262	Homo sapiens	pKi		4.6
active	9657326	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C1Nc2cc(-c3ccc(O)cc3)ccc2C1=Cc1ccc[nH]1		CHEMBL1980329	=	Ki	nM	501.19	CHEMBL262	Homo sapiens	pKi		6.3
active	9657327	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Nc1cccc(C2Nc3ccc4ccccc4c3C3C=CCC32)c1)c1ccc(F)cc1		CHEMBL1992042	=	Ki	nM	398.11	CHEMBL262	Homo sapiens	pKi		6.4
active	9657328	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1ccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)cc1		CHEMBL1992536	=	Ki	nM	63.1	CHEMBL262	Homo sapiens	pKi		7.2
active	9657329	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)s2)c1		CHEMBL1994724	=	Ki	nM	1258.93	CHEMBL262	Homo sapiens	pKi		5.9
active	9657330	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCN(CC)CCNC(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1970290	=	Ki	nM	1258.93	CHEMBL262	Homo sapiens	pKi		5.9
active	9657331	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1967531	=	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9657332	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCCC(=O)Nc1nn(C(=O)CC)c2nc3ccccc3cc12		CHEMBL1970913	=	Ki	nM	125.89	CHEMBL262	Homo sapiens	pKi		6.9
active	9657333	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cccc(C(C)NC(=O)c2cc(C)c(-c3ccc4[nH]nc(C)c4c3)s2)c1		CHEMBL1997534	=	Ki	nM	50.12	CHEMBL262	Homo sapiens	pKi		7.3
inactive	9657334	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	C#Cc1cn(C2CCCC2)c2ncnc(N)c12		CHEMBL1993877	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9657335	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1977374	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9657336	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)(O)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1998551	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9657337	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COCc1nnn(-c2nonc2N)c1C(=O)NN=C(C)c1ccc(O)cc1O		CHEMBL1991180	=	Ki	nM	398.11	CHEMBL262	Homo sapiens	pKi		6.4
active	9657338	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1ccccc1-c1c(-c2ccc3[nH]nc(C)c3c2)nnn1Cc1ccccc1		CHEMBL1983315	=	Ki	nM	12.59	CHEMBL262	Homo sapiens	pKi		7.9
inactive	9657339	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1c(O)cccc1NC(=O)c1cnn2c(-c3ccccc3)ccnc12		CHEMBL1978656	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9657340	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCc1c(-c2ccc(C(C)(C)O)cc2)[nH]c2nccnc12		CHEMBL1976420	=	Ki	nM	1995.26	CHEMBL262	Homo sapiens	pKi		5.7
active	9657341	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(Cl)ccc12		CHEMBL1981744	=	Ki	nM	7.943	CHEMBL262	Homo sapiens	pKi		8.1
active	9657342	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1		CHEMBL1994864	=	Ki	nM	398.11	CHEMBL262	Homo sapiens	pKi		6.4
active	9657343	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOCC5CC5)c4)n[nH]c2-3)CC1		CHEMBL2002446	=	Ki	nM	2511.89	CHEMBL262	Homo sapiens	pKi		5.6
active	9657344	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NCC1CCC(CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])CC1		CHEMBL246970	=	Ki	nM	630.96	CHEMBL262	Homo sapiens	pKi		6.2
active	9657345	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cc(O)ccc1-n1cc(C(N)=O)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL340921	=	Ki	nM	3162.28	CHEMBL262	Homo sapiens	pKi		5.5
active	9657346	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1ccc2c(c1)c(-c1cc3nc(Br)cnc3[nH]1)cn2C		CHEMBL2005478	=	Ki	nM	398.11	CHEMBL262	Homo sapiens	pKi		6.4
active	9657347	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C1Nc2ccc3ncsc3c2C1=CNc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1973540	=	Ki	nM	3.162	CHEMBL262	Homo sapiens	pKi		8.5
active	9657348	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN(C)CC(=O)NC1CCCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)C1		CHEMBL1995712	=	Ki	nM	794.33	CHEMBL262	Homo sapiens	pKi		6.1
inactive	9657349	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL1971649	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9657350	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)S(=O)(=O)n1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2003657	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9657351	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Cc1ccccc1)Nc1cc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)ccc1Cl		CHEMBL2005482	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9657352	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9657353	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Nc1ccc(-c2ccc(=O)[nH]n2)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL2007124	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9657354	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1ccccc1Nc1nccc(-c2c(-c3cccc(NC(=O)Cc4ccccc4)c3)nc3sccn23)n1		CHEMBL1997909	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9657355	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCCCC2)n1		CHEMBL2006439	<	Ki	nM	1000.0	CHEMBL262	Homo sapiens	pKi		6.0
inactive	9657356	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)N(C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1)C(C)C		CHEMBL2006156	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9657357	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	N#Cc1ccc2c(c1)C(c1ccc3c(n1)CCCC3O)C(=O)N2		CHEMBL1985681	=	Ki	nM	31.62	CHEMBL262	Homo sapiens	pKi		7.5
inactive	9657358	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	<	Ki	nM	1995.26	CHEMBL262	Homo sapiens	pKi		5.7
active	9657359	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	OC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1991674	=	Ki	nM	63.1	CHEMBL262	Homo sapiens	pKi		7.2
active	9657360	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1ncnc2c1N=C(c1ccccc1)CCN2		CHEMBL262623	=	Ki	nM	50118.72	CHEMBL262	Homo sapiens	pKi		4.3
inactive	9657361	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1984842	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9657362	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	=	Ki	nM	794.33	CHEMBL262	Homo sapiens	pKi		6.1
inactive	9657363	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1ccc(Cl)cc1		CHEMBL1998829	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9657364	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cccc(CNC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2006299	=	Ki	nM	1995.26	CHEMBL262	Homo sapiens	pKi		5.7
inactive	9657365	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]ncc34)cc2)c1		CHEMBL375284	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9657366	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Oc1cc(O)cc(C=Cc2ccc(O)c(O)c2)c1		CHEMBL1972346	=	Ki	nM	1000.0	CHEMBL262	Homo sapiens	pKi		6.0
active	9657367	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CS(=O)(=O)NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1980562	=	Ki	nM	79.43	CHEMBL262	Homo sapiens	pKi		7.1
inactive	9657368	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COCCn1cc(-c2ccncn2)c(-c2ccc(Cl)cc2)n1		CHEMBL1982866	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9657369	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	c1ccc(CSc2nc(-c3ccncc3)n[nH]2)cc1		CHEMBL1968926	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9657370	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(=O)Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1ccccc1		CHEMBL2006609	=	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9657371	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(O)c1ccccc1Nc1ncnc(Nc2cccc(F)c2)n1		CHEMBL1979933	=	Ki	nM	50.12	CHEMBL262	Homo sapiens	pKi		7.3
inactive	9657372	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4ccccc4F)cc3)c12		CHEMBL1965570	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9657373	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Clc1ccc2c(c1)nnc1nnnn12		CHEMBL1986503	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9657374	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)(O)c1cn(-c2ccc3[nH]ncc3c2)nn1		CHEMBL2001641	=	Ki	nM	12589.25	CHEMBL262	Homo sapiens	pKi		4.9
active	9657375	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1c(-c2nc3ccccc3[nH]2)c(O)cc2oc(C)cc(=O)c12		CHEMBL1972355	=	Ki	nM	398.11	CHEMBL262	Homo sapiens	pKi		6.4
active	9657376	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1ccc(-c2cc(-c3cc(Br)ccc3O)[nH]c(=O)c2C#N)s1		CHEMBL1997193	=	Ki	nM	316.23	CHEMBL262	Homo sapiens	pKi		6.5
inactive	9657377	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2cccc(OCC(=O)O)c2)n1		CHEMBL1964902	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9657378	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)(O)CNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL2005387	=	Ki	nM	316.23	CHEMBL262	Homo sapiens	pKi		6.5
inactive	9657379	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cncc2cccc(S(=O)(=O)N3CCCNCC3C)c12		CHEMBL1082440	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9657380	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(CO)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3F)c2-c2ccncn2)CC1		CHEMBL1614705	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9657381	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Clc1cc(-c2c[nH]c3ncccc23)ncn1		CHEMBL1972988	=	Ki	nM	794.33	CHEMBL262	Homo sapiens	pKi		6.1
inactive	9657382	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CNc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2007372	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9657383	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1ccc(OC)c(NC(=O)c2cnn3c(-c4ccccc4)ccnc23)c1		CHEMBL1982167	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9657384	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(=O)c1cccc2[nH]c(-c3ccc(NC(=O)c4cccc(S(=O)(=O)N5CCOCC5)c4)cc3)nc12		CHEMBL1986597	=	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9657385	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1)c1c(F)cccc1F		CHEMBL2006715	=	Ki	nM	501.19	CHEMBL262	Homo sapiens	pKi		6.3
active	9657386	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(=O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1971017	=	Ki	nM	19.95	CHEMBL262	Homo sapiens	pKi		7.7
inactive	9657387	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(=O)c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL1990482	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9657388	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Fc1ccc(-c2nc3cnccn3c2-c2ccnc(NCC3CC3)n2)cc1		CHEMBL1990904	=	Ki	nM	398.11	CHEMBL262	Homo sapiens	pKi		6.4
active	9657389	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1987448	=	Ki	nM	501.19	CHEMBL262	Homo sapiens	pKi		6.3
active	9657390	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(NCC1CCCCC1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL2005475	=	Ki	nM	5011.87	CHEMBL262	Homo sapiens	pKi		5.3
active	9657391	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1		CHEMBL2000104	=	Ki	nM	39.81	CHEMBL262	Homo sapiens	pKi		7.4
inactive	9657392	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2C)c1		CHEMBL183844	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9657393	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC1=NN(c2ccc(Cl)c(Cl)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL1997349	=	Ki	nM	794.33	CHEMBL262	Homo sapiens	pKi		6.1
active	9657394	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL220057	=	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9657395	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1974935	=	Ki	nM	1258.93	CHEMBL262	Homo sapiens	pKi		5.9
inactive	9657396	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cc(OC2CCCC2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL2001224	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9657397	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Ki	nM	1584.89	CHEMBL262	Homo sapiens	pKi		5.8
active	9657398	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CS(=O)(=O)NC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL2005216	=	Ki	nM	15.85	CHEMBL262	Homo sapiens	pKi		7.8
active	9657399	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(NC(CO)c1ccccc1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1964937	=	Ki	nM	1584.89	CHEMBL262	Homo sapiens	pKi		5.8
inactive	9657400	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)Cc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2[nH]ccc12		CHEMBL1980763	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9657401	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(S(N)(=O)=O)cc4)c(=O)c3=O)ccc21		CHEMBL1969506	=	Ki	nM	2511.89	CHEMBL262	Homo sapiens	pKi		5.6
active	9657402	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL590109	=	Ki	nM	1000.0	CHEMBL262	Homo sapiens	pKi		6.0
active	9657403	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(=O)c1ccccc1-c1ncnc2[nH]ccc12		CHEMBL1977931	=	Ki	nM	63095.73	CHEMBL262	Homo sapiens	pKi		4.2
inactive	9657404	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cc(-c2nn(C3CCC(N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL1970879	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9657405	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(=O)N(c1ccncc1)c1c(NC(C)C(C)(C)C)c(=O)c1=O		CHEMBL2005899	=	Ki	nM	5011.87	CHEMBL262	Homo sapiens	pKi		5.3
active	9657406	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)c(NC3CCCCC3)n2c1		CHEMBL1682552	=	Ki	nM	100.0	CHEMBL262	Homo sapiens	pKi		7.0
active	9657407	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCCCNc1nc(N)c(C(=O)c2ccccc2)s1		CHEMBL2007479	=	Ki	nM	158.49	CHEMBL262	Homo sapiens	pKi		6.8
inactive	9657408	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN1CCC1COc1cncc(CCc2ccncc2)c1		CHEMBL1996155	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9657409	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(Cl)c4)c3)cc12		CHEMBL1974870	=	Ki	nM	15.85	CHEMBL262	Homo sapiens	pKi		7.8
active	9657410	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL1970903	=	Ki	nM	10.0	CHEMBL262	Homo sapiens	pKi		8.0
active	9657411	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4ccc(OC(F)F)cc4)cc3)c12		CHEMBL1972220	=	Ki	nM	1258.93	CHEMBL262	Homo sapiens	pKi		5.9
active	9657412	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1973720	=	Ki	nM	398.11	CHEMBL262	Homo sapiens	pKi		6.4
active	9657413	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)c1		CHEMBL1969523	=	Ki	nM	794.33	CHEMBL262	Homo sapiens	pKi		6.1
active	9657414	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1n[nH]c2c1C(c1ccccc1Br)C(C#N)=C(N)O2		CHEMBL2005214	=	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9657415	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cc(C=O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL207995	=	Ki	nM	1584.89	CHEMBL262	Homo sapiens	pKi		5.8
inactive	9657416	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1988995	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9657417	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(=O)N1CCC(Nc2nccc(-c3c(-c4ccc(F)cc4)nc4occn34)n2)CC1		CHEMBL1986781	=	Ki	nM	79.43	CHEMBL262	Homo sapiens	pKi		7.1
inactive	9657418	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C1Nc2cc(CCOc3ccc(N4CCOCC4)cc3)ccc2Nc2cc(-c3cn(Cc4cc(F)c(F)c(F)c4)c4cnccc34)ccc21		CHEMBL2001923	<	Ki	nM	5011.87	CHEMBL262	Homo sapiens	pKi		5.3
active	9657419	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=c1nc(-c2ccc3[nH]ncc3c2)cc(-c2ccccc2)[nH]1		CHEMBL526133	=	Ki	nM	39.81	CHEMBL262	Homo sapiens	pKi		7.4
active	9657420	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)nc2)c1		CHEMBL2003514	=	Ki	nM	1584.89	CHEMBL262	Homo sapiens	pKi		5.8
inactive	9657421	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9657422	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4c(Cl)cccc4Cl)s3)cc2)CC1		CHEMBL1989043	=	Ki	nM	3162.28	CHEMBL262	Homo sapiens	pKi		5.5
active	9657423	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3[nH]2)cc1		CHEMBL1979057	=	Ki	nM	5011.87	CHEMBL262	Homo sapiens	pKi		5.3
active	9657424	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1nn(C)c2sc3c(=O)[nH]cnc3c12		CHEMBL1967538	=	Ki	nM	39810.72	CHEMBL262	Homo sapiens	pKi		4.4
inactive	9657425	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9657426	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1999428	=	Ki	nM	158.49	CHEMBL262	Homo sapiens	pKi		6.8
inactive	9657427	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCN1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1967560	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9657428	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1n[nH]c2ccc(-c3cc(Cc4ccccc4)no3)cc12		CHEMBL1682358	=	Ki	nM	158.49	CHEMBL262	Homo sapiens	pKi		6.8
inactive	9657429	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cccc(NC(=O)Nc2ccc(-c3noc4ncnc(N)c34)cc2)c1		CHEMBL211378	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9657430	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1982465	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9657431	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(NCCCCCCNC(=O)NCc1cccnc1)NCc1cccnc1		CHEMBL2003420	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9657432	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(=O)Nc1ccc(-n2nc3ccc(N)nc3n2)cc1		CHEMBL2002723	=	Ki	nM	1258.93	CHEMBL262	Homo sapiens	pKi		5.9
inactive	9657433	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1ccc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)cc1Cl		CHEMBL272453	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9657434	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C1Nc2ccccc2Nc2nnccc21		CHEMBL1971801	=	Ki	nM	1584.89	CHEMBL262	Homo sapiens	pKi		5.8
active	9657435	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3C)cc2)c1		CHEMBL1970217	=	Ki	nM	251.19	CHEMBL262	Homo sapiens	pKi		6.6
active	9657436	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C1Nc2ccccc2Nc2nnc(Cl)cc21		CHEMBL1968850	=	Ki	nM	199.53	CHEMBL262	Homo sapiens	pKi		6.7
active	9657437	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1973720	=	Ki	nM	398.11	CHEMBL262	Homo sapiens	pKi		6.4
active	9657438	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCOC(=O)c1ccc2[nH]c3c(c2c1)CCNC3=O		CHEMBL2005528	=	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9657439	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)c1		CHEMBL185569	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9657440	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN1CCC(NC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)CC1		CHEMBL1987007	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9657441	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9657442	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=S(=O)(Nc1ccc2c(c1)C(=NO)c1ccccc1-2)c1cccc(Br)c1		CHEMBL1973793	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9657443	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Clc1cc(-c2c[nH]c3ncccc23)cc(NCc2ccccc2)n1		CHEMBL1969588	=	Ki	nM	10.0	CHEMBL262	Homo sapiens	pKi		8.0
active	9657444	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cc(Nc2nccc(Nc3cc(C4CCCCC4)no3)n2)cc(OC)c1OC		CHEMBL1984711	=	Ki	nM	2511.89	CHEMBL262	Homo sapiens	pKi		5.6
inactive	9657445	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cc(OC)c(Nc2ccc3nnc(-c4ccccc4)n3n2)cc1Cl		CHEMBL1990212	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9657446	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	=	Ki	nM	199.53	CHEMBL262	Homo sapiens	pKi		6.7
active	9657447	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(NC(CCO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1986143	=	Ki	nM	1258.93	CHEMBL262	Homo sapiens	pKi		5.9
active	9657448	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=c1c(NCc2cccc(C(F)(F)F)c2)c(Nc2ccncc2)c1=O		CHEMBL1979252	=	Ki	nM	251.19	CHEMBL262	Homo sapiens	pKi		6.6
active	9657449	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1ncnc2sccc12		CHEMBL1972934	=	Ki	nM	15848.93	CHEMBL262	Homo sapiens	pKi		4.8
inactive	9657450	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Cc1ccc(-c2cccnc2)cc1)Nc1ccc(SC(F)F)cc1		CHEMBL1992581	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9657451	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	C#Cc1cc2c(cc1OC)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL1972250	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9657452	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cccc(C=C2SC(=Nc3ccccc3)NC2=O)c1		CHEMBL1972937	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9657453	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccc(F)cc3)cc12		CHEMBL1986499	=	Ki	nM	12.59	CHEMBL262	Homo sapiens	pKi		7.9
active	9657454	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(=O)c1ccc(-c2ccncc2)cc1NCc1ccccc1		CHEMBL2001477	=	Ki	nM	1584.89	CHEMBL262	Homo sapiens	pKi		5.8
inactive	9657455	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C)c2)c1		CHEMBL2004311	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9657456	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Brc1cnc2[nH]cc(-c3ccccc3)c2c1		CHEMBL1992634	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9657457	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Fc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL316264	=	Ki	nM	630.96	CHEMBL262	Homo sapiens	pKi		6.2
inactive	9657458	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(=O)OCCn1nc(-c2cccc(Br)c2)c2c(C(F)(F)F)cc(=O)[nH]c21		CHEMBL1984847	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9657459	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Cc1ccc(OC(F)(F)F)cc1)N1CCC2(CC1)NCCc1c2[nH]c2ccccc12		CHEMBL1996576	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9657460	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1991678	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9657461	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1ncnc2scc(C(=O)Nc3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1988594	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9657462	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL260092	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9657463	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	<	Ki	nM	5011.87	CHEMBL262	Homo sapiens	pKi		5.3
active	9657464	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1n[nH]c2ncc(C#N)c(-c3ccccc3)c12		CHEMBL1965495	=	Ki	nM	1584.89	CHEMBL262	Homo sapiens	pKi		5.8
active	9657465	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CSc1ccc2nc3c(c(Cl)c2c1)CCNC3=O		CHEMBL1985074	=	Ki	nM	398.11	CHEMBL262	Homo sapiens	pKi		6.4
inactive	9657466	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc2n1CC1CC1		CHEMBL1982874	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9657467	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN(C)CC(=O)NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1991725	=	Ki	nM	3162.28	CHEMBL262	Homo sapiens	pKi		5.5
inactive	9657468	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	<	Ki	nM	1995.26	CHEMBL262	Homo sapiens	pKi		5.7
active	9657469	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2007296	=	Ki	nM	1258.93	CHEMBL262	Homo sapiens	pKi		5.9
active	9657470	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3[nH]ncc3c2)n1		CHEMBL396523	=	Ki	nM	7.943	CHEMBL262	Homo sapiens	pKi		8.1
inactive	9657471	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9657472	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	N#CC1=C(c2ccccc2)CC(c2ccc(Cl)cc2)C(C(=O)c2ccccc2)C1=O		CHEMBL1978371	=	Ki	nM	501.19	CHEMBL262	Homo sapiens	pKi		6.3
inactive	9657473	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cc(C)cc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1970203	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9657474	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	c1cnc2[nH]cc(-c3ccnc(NC4CCCCC4)n3)c2c1		CHEMBL385478	=	Ki	nM	31.62	CHEMBL262	Homo sapiens	pKi		7.5
inactive	9657475	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cc(Nc2ncnc3ccc(-c4ccc(CN5CC6C(CO)C6C5)cc4)cc23)ccc1Oc1ccccc1		CHEMBL1999749	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9657476	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cc(C(=O)O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1983006	=	Ki	nM	1584.89	CHEMBL262	Homo sapiens	pKi		5.8
active	9657477	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Clc1ccc(-c2n[nH]cc2-c2ccncn2)cc1Cl		CHEMBL1984191	=	Ki	nM	5011.87	CHEMBL262	Homo sapiens	pKi		5.3
active	9657478	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(N3CCN(C(C)=O)CC3)ccc2OC)ncc1Br		CHEMBL1971029	=	Ki	nM	3162.28	CHEMBL262	Homo sapiens	pKi		5.5
inactive	9657479	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(Cc1cccc2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1985580	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9657480	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL394790	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9657481	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21		CHEMBL226471	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9657482	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1996111	=	Ki	nM	199.53	CHEMBL262	Homo sapiens	pKi		6.7
inactive	9657483	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC1CCN(C(=O)CC#N)CC1c1ncc2cnc3[nH]ccc3n12		CHEMBL1966175	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9657484	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1nccn2c(-c3ccnc(NCC4(O)CC4)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1965589	=	Ki	nM	3162.28	CHEMBL262	Homo sapiens	pKi		5.5
active	9657485	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC#Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL2007375	=	Ki	nM	39.81	CHEMBL262	Homo sapiens	pKi		7.4
inactive	9657486	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(NCCCCCCNC(=O)Nc1cccnc1)Nc1cccnc1		CHEMBL1998193	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9657487	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1[nH]c3ccc(O)cc3c21		CHEMBL379975	=	Ki	nM	1000.0	CHEMBL262	Homo sapiens	pKi		6.0
inactive	9657488	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CS(=O)(=O)c1cccc(C(=O)Nc2nc3ccccc3n2CCCO)c1		CHEMBL1973016	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9657489	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1nnc(-c2cc3c(Oc4ccc(C(F)(F)F)cc4)cncc3s2)o1		CHEMBL1988153	=	Ki	nM	3.981	CHEMBL262	Homo sapiens	pKi		8.4
active	9657490	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1		CHEMBL1969664	=	Ki	nM	100.0	CHEMBL262	Homo sapiens	pKi		7.0
inactive	9657491	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(COc1cc(C=Cc2ccncc2)cnc1Cl)Cc1c[nH]c2ccccc12		CHEMBL1968245	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9657492	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1ccc2c(c1)c(-c1cc3nccnc3[nH]1)cn2C		CHEMBL1233887	=	Ki	nM	1000.0	CHEMBL262	Homo sapiens	pKi		6.0
active	9657493	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CC(C)(C)N)cnc(N)c34)cc2)c1		CHEMBL1979577	=	Ki	nM	1258.93	CHEMBL262	Homo sapiens	pKi		5.9
inactive	9657494	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCC(CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL52387	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9657495	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	OCCNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1989006	=	Ki	nM	199.53	CHEMBL262	Homo sapiens	pKi		6.7
inactive	9657496	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cn1cc(C(CN)c2cncc(C=Cc3ccncc3)c2)c2ccccc21		CHEMBL1979357	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9657497	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCCCOc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1996817	=	Ki	nM	398.11	CHEMBL262	Homo sapiens	pKi		6.4
inactive	9657498	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCOc1nc(C(=O)NCc2ccc(S(N)(=O)=O)cc2)cc(N)c1C#N		CHEMBL2004355	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9657499	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	<	Ki	nM	3162.28	CHEMBL262	Homo sapiens	pKi		5.5
active	9657500	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	C=CCNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1996339	=	Ki	nM	100.0	CHEMBL262	Homo sapiens	pKi		7.0
inactive	9657501	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL256835	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9657502	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN(CCC#N)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1974998	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9657503	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1980142	=	Ki	nM	6.31	CHEMBL262	Homo sapiens	pKi		8.2
inactive	9657504	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccc2nccnc12		CHEMBL2004438	<	Ki	nM	5011.87	CHEMBL262	Homo sapiens	pKi		5.3
active	9657505	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL41783	=	Ki	nM	79.43	CHEMBL262	Homo sapiens	pKi		7.1
inactive	9657506	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)noc12		CHEMBL271381	<	Ki	nM	5011.87	CHEMBL262	Homo sapiens	pKi		5.3
inactive	9657507	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1982466	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9657508	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1996390	=	Ki	nM	398.11	CHEMBL262	Homo sapiens	pKi		6.4
active	9657509	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCNC(=O)NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1992220	=	Ki	nM	100.0	CHEMBL262	Homo sapiens	pKi		7.0
inactive	9657510	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL234085	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9657511	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1n[nH]c2sc(C(=O)NCCc3ccc(Cl)cc3)cc12		CHEMBL1998414	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9657512	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Oc1ccc(Nc2[nH]nc(-c3ccc(O)cc3)c2-c2ccc(O)cc2)cc1		CHEMBL1969042	=	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9657513	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1ncnc2c1c(-c1ccc(Oc3ccc(CO)cc3)cc1)cn2C1CCOC1		CHEMBL1976376	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9657514	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=c1[nH]sc2c1c(=O)c1cc(F)c(NCc3ccccc3)c(F)c1n2C1CC1		CHEMBL1991640	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9657515	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	N#Cc1cccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)n1		CHEMBL1968868	=	Ki	nM	25.12	CHEMBL262	Homo sapiens	pKi		7.6
active	9657516	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1[nH]c(C=C2C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL2007064	=	Ki	nM	1584.89	CHEMBL262	Homo sapiens	pKi		5.8
active	9657517	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1ccccc1CNC(=N)Nc1nccc(-c2cccs2)n1		CHEMBL1997197	=	Ki	nM	2511.89	CHEMBL262	Homo sapiens	pKi		5.6
active	9657518	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=c1[nH]c2sccc2c2nc(-c3ccncc3)nn12		CHEMBL1968151	=	Ki	nM	251.19	CHEMBL262	Homo sapiens	pKi		6.6
inactive	9657519	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Clc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1381197	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9657520	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)c1		CHEMBL1987009	=	Ki	nM	1995.26	CHEMBL262	Homo sapiens	pKi		5.7
active	9657521	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccccc4)c3)cc12		CHEMBL2002726	=	Ki	nM	63.1	CHEMBL262	Homo sapiens	pKi		7.2
active	9657522	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Nc1cnccn1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL2003817	=	Ki	nM	63.1	CHEMBL262	Homo sapiens	pKi		7.2
active	9657523	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1nnc(-c2cc3c(Oc4ccc(Cl)cc4)cncc3s2)o1		CHEMBL1994830	=	Ki	nM	3.162	CHEMBL262	Homo sapiens	pKi		8.5
active	9657524	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(Cl)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1987054	=	Ki	nM	125.89	CHEMBL262	Homo sapiens	pKi		6.9
inactive	9657525	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21		CHEMBL226403	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9657526	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)csc12		CHEMBL2005631	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9657527	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9657528	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1cc(=O)[nH]n1-c1ccccn1		CHEMBL1995765	=	Ki	nM	19952.62	CHEMBL262	Homo sapiens	pKi		4.7
inactive	9657529	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NCCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL1966279	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9657530	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCCNC(=O)c1ccc(Nc2nc(CCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL1984760	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9657531	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(=NNC(=N)N)c1cc(NC(=O)NCCCCCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL1991728	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9661538	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN(C)CC1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL360847	=	Ki	nM	794.33	CHEMBL262	Homo sapiens	pKi		6.1
active	9661539	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cc(F)ccc1F		CHEMBL1995811	=	Ki	nM	1.995	CHEMBL262	Homo sapiens	pKi		8.7
active	9661540	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NC(=O)c1cc2c(-c3ccc(F)cc3F)cncc2s1		CHEMBL1975787	=	Ki	nM	199.53	CHEMBL262	Homo sapiens	pKi		6.7
active	9661541	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cc(C=C(C#N)c2n[nH]c(N)c2C#N)ccc1O		CHEMBL2002407	=	Ki	nM	1258.93	CHEMBL262	Homo sapiens	pKi		5.9
active	9661542	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CNC(=O)c1cc(-c2ccccc2)[nH]n1		CHEMBL1995916	=	Ki	nM	1000.0	CHEMBL262	Homo sapiens	pKi		6.0
inactive	9661543	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Nc1ccc2cn[nH]c2c1)c1ccc(Cl)cc1		CHEMBL1972489	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9661544	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Brc1ccc2[nH]nc(-c3ccccc3)c2c1		CHEMBL1994074	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9661545	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCOC(=O)c1c(NC(=O)C2C(C)(C)C2(C)C)sc2cnccc12		CHEMBL1990541	=	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9661546	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)(CN)CNc1nc(Cl)cc(-c2c[nH]c3ncccc23)n1		CHEMBL1968930	=	Ki	nM	1258.93	CHEMBL262	Homo sapiens	pKi		5.9
inactive	9661547	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL1090356	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9661548	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN(C)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1986328	=	Ki	nM	630.96	CHEMBL262	Homo sapiens	pKi		6.2
active	9661549	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1ccc(-c2ccc(N)cc2)c2cnoc12		CHEMBL2002450	=	Ki	nM	31622.78	CHEMBL262	Homo sapiens	pKi		4.5
inactive	9661550	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9661551	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(O)c1ccccc1Nc1ccnc(NCc2cccc(O)c2)n1		CHEMBL1970950	=	Ki	nM	1258.93	CHEMBL262	Homo sapiens	pKi		5.9
inactive	9661552	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9661553	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	OCCC(Nc1nc2ccc(-c3ccncc3)cc2s1)c1ccccc1		CHEMBL1982122	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9661554	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCOC(=O)C1=c2sc(=Cc3ccco3)c(=O)n2C(N)=C(C#N)C1c1ccco1		CHEMBL1999112	=	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9661555	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	c1ccc(CNc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682546	=	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9661556	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCOC(=O)c1cn(-c2ccc(O)cc2C)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL1996780	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9661557	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCCCCCCCCCCCOc1ccc(NC(=N)N)cc1NC(=N)N		CHEMBL1980715	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9661558	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	N#Cc1ccc2nc(N)n(-c3nc(-c4ccccc4)cs3)c2c1		CHEMBL1996066	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9661559	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Ki	nM	19.95	CHEMBL262	Homo sapiens	pKi		7.7
active	9661560	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(C(=O)O)ccc4F)cc3)c12		CHEMBL1993722	=	Ki	nM	1995.26	CHEMBL262	Homo sapiens	pKi		5.7
active	9661561	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCCC3CCO)nc12		CHEMBL2006674	=	Ki	nM	1258.93	CHEMBL262	Homo sapiens	pKi		5.9
inactive	9661562	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN(C)c1ccc(Nc2cc(-c3csc(Br)c3)[nH]n2)cc1		CHEMBL1984236	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9661563	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(N3CC4COCC4C3)cc12		CHEMBL2002599	=	Ki	nM	7.943	CHEMBL262	Homo sapiens	pKi		8.1
inactive	9661564	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1nc(COc2ccccc2Cl)sc1-c1ccnc(N)n1		CHEMBL1375640	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9661565	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCN4CCOCC4)cc2-3)cn1		CHEMBL249282	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9661566	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)N(CCCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1994318	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9661567	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	N#Cc1c(O)[nH]c(=O)c2c(=N)oc3ccc(Cl)cc3c12		CHEMBL1973711	=	Ki	nM	251.19	CHEMBL262	Homo sapiens	pKi		6.6
active	9661568	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)(C(N)=O)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1967720	=	Ki	nM	5011.87	CHEMBL262	Homo sapiens	pKi		5.3
active	9661569	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(C=Cc1ccc(Br)cc1)Nc1cccc2cnccc12		CHEMBL1967719	=	Ki	nM	1995.26	CHEMBL262	Homo sapiens	pKi		5.7
active	9661570	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1F		CHEMBL1969755	=	Ki	nM	2511.89	CHEMBL262	Homo sapiens	pKi		5.6
inactive	9661571	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1nccn2c(C3CC(CN4CCCC4)C3)nc(-c3cccc(OCc4ccccc4)c3)c12		CHEMBL1991138	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9661572	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NNc1cc(N2CCOCC2)nc(OCCc2ccccn2)n1		CHEMBL1996208	<	Ki	nM	5011.87	CHEMBL262	Homo sapiens	pKi		5.3
active	9661573	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Ki	nM	1995.26	CHEMBL262	Homo sapiens	pKi		5.7
active	9661574	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCOC(=O)c1c(C)n(-c2ccc(I)cc2)c2c1cc(O)c1ccccc12		CHEMBL1970352	=	Ki	nM	3162.28	CHEMBL262	Homo sapiens	pKi		5.5
active	9661575	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CN(C)CC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1965631	=	Ki	nM	6.31	CHEMBL262	Homo sapiens	pKi		8.2
active	9661576	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1ccccc1NC(=O)Nc1ccc(NC(=O)c2csc3ncnc(N)c23)cc1		CHEMBL1980144	=	Ki	nM	2511.89	CHEMBL262	Homo sapiens	pKi		5.6
active	9661577	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2OC)c1		CHEMBL1991188	=	Ki	nM	39.81	CHEMBL262	Homo sapiens	pKi		7.4
inactive	9661578	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1C#N		CHEMBL377408	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9661579	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	<	Ki	nM	1995.26	CHEMBL262	Homo sapiens	pKi		5.7
inactive	9661580	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL231209	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9661581	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL2006765	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9661582	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c12		CHEMBL1976220	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9661583	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CCN)nccn23)n1		CHEMBL1982383	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9661584	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CSc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17370	=	Ki	nM	158.49	CHEMBL262	Homo sapiens	pKi		6.8
inactive	9661585	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	NCc1cc(Nc2ncnc(-c3ccccc3)n2)ccc1O		CHEMBL1980246	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9661586	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9661587	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCNCC4)cc3)n2)s1		CHEMBL1999484	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
inactive	9661588	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cc2cc(-c3csc4c(-c5cccc(S(C)(=O)=O)c5)cnc(N)c34)ccc2[nH]1		CHEMBL1997822	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9661589	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1cc(OCC2CCC(C(=O)O)C2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL1991285	=	Ki	nM	1258.93	CHEMBL262	Homo sapiens	pKi		5.9
inactive	9661590	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cc(-c2ccc3c(c2)NC(=O)c2ccc(-c4ccccc4NS(C)(=O)=O)cc2N3)cc(OC)c1OC		CHEMBL1984038	<	Ki	nM	3981.07	CHEMBL262	Homo sapiens	pKi		5.4
active	9661591	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1cccc(F)c1F		CHEMBL1974416	=	Ki	nM	794.33	CHEMBL262	Homo sapiens	pKi		6.1
inactive	9661592	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	Cc1nn(C)c(C)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)O)[nH]c12		CHEMBL1984039	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
inactive	9661593	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	CSc1nn(-c2ccccn2)c(N)c1C(N)=O		CHEMBL2004615	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
active	9661594	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2		CHEMBL1980391	=	Ki	nM	19.95	CHEMBL262	Homo sapiens	pKi		7.7
inactive	9661595	CHEMBL1963830	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B	F	O=C(c1cccc(-c2cnc3[nH]ccc3c2)c1)N1CCOCC1		CHEMBL1997872	<	Ki	nM	6309.57	CHEMBL262	Homo sapiens	pKi		5.2
	10836831	CHEMBL2013651	Inhibition of GSK-3beta using phospho-glycogen synthase peptide-2 as substrate after 10 mins by liquid scintillation counting	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Ki	nM	770.0	CHEMBL262	Homo sapiens	Ki	nM	770.0
	10836832	CHEMBL2013652	Inhibition of human GSK-3beta using biotin-AAEELDSRAGS(PO3H2)PQL as substrate after 20 mins by liquid scintillation counting	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Ki	nM	38.0	CHEMBL262	Homo sapiens	Ki	nM	38.0
	10838701	CHEMBL2014927	Inhibition of GSK3b at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	27.0	CHEMBL262	Homo sapiens	INH	%	27.0
	10839679	CHEMBL2015019	Inhibition of GSK3b assessed as residual activity at 10 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	92.0	CHEMBL262	Homo sapiens	Activity	%	92.0
	10840384	CHEMBL2016263	Inhibition of GSK3b assessed as residual activity at 1 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	104.0	CHEMBL262	Homo sapiens	Activity	%	104.0
Not Active	10842756	CHEMBL2016348	Inhibition of GSK3beta at 10 uM	B	Cc1c(Nc2ccc(I)cc2F)c(C(=O)NOCCO)c2n(c1=O)CCC2		CHEMBL2012908		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	10842757	CHEMBL2016348	Inhibition of GSK3beta at 10 uM	B	O=C(NOC[C@@H](O)CO)c1c(Nc2ccc(I)cc2F)c(F)c(=O)n2c1CCC2		CHEMBL2012904		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	10842758	CHEMBL2016348	Inhibition of GSK3beta at 10 uM	B	O=C(NOCCO)c1c(Nc2ccc(I)cc2F)c(F)c(=O)n2c1CCC2		CHEMBL2012902		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	10842759	CHEMBL2016348	Inhibition of GSK3beta at 10 uM	B	C#Cc1ccc(Nc2c(C(=O)NOCCO)c3c(n2C)C(=O)CC3)c(F)c1		CHEMBL2012901		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	10842760	CHEMBL2016348	Inhibition of GSK3beta at 10 uM	B	C#Cc1ccc(Nc2c(C(=O)NOCCO)c3c(n2C)C(=O)CCC3)c(F)c1		CHEMBL2012899		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	10842761	CHEMBL2016348	Inhibition of GSK3beta at 10 uM	B	Cn1c(Nc2ccc(I)cc2F)c(C(=O)NOC[C@H](O)CO)c2c1C(=O)CCC2		CHEMBL2012892		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	10843843	CHEMBL2016125	Inhibition of GSK3beta at 1 uM	B	CC(C)Cn1c2ccc(Nc3ncccn3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL2010872		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	10849713	CHEMBL2019672	Inhibition of GSK3beta	B	CSc1ccccc1Nc1nc(N2CCNCC2)nc2c(NCC3CC3)ncnc12		CHEMBL2017214	>	IC50	nM	40000.0	CHEMBL262	Homo sapiens	IC50	uM	40.0
	10850053	CHEMBL2019775	Inhibition of human GSK3beta at 1 uM	B	Cn1cc(-c2cccc(-c3cnc(N)c(C(=O)N[C@H]4C5CC6CC4C[C@@](O)(C6)C5)n3)c2)cn1		CHEMBL2018022	<	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	10875889	CHEMBL2025119	Inhibition of human recombinant GSK3beta after 30 mins by luminescence assay in presence of ATP	B	Br.c1ccc(Cn2s/c(=N/Cc3cccnc3)nc2-c2ccccc2)cc1		CHEMBL2022423	=	IC50	nM	1100.0	CHEMBL262	Homo sapiens	IC50	uM	1.1
	10875890	CHEMBL2025119	Inhibition of human recombinant GSK3beta after 30 mins by luminescence assay in presence of ATP	B	CCOC(=O)C/N=c1\nc(-c2ccccc2)n(-c2ccccc2)s1		CHEMBL2022422	=	IC50	nM	1800.0	CHEMBL262	Homo sapiens	IC50	uM	1.8
	10875891	CHEMBL2025119	Inhibition of human recombinant GSK3beta after 30 mins by luminescence assay in presence of ATP	B	c1ccc(/N=c2\nc(-c3ccccc3)n(-c3ccccc3)s2)cc1		CHEMBL1709775	=	IC50	nM	2800.0	CHEMBL262	Homo sapiens	IC50	uM	2.8
	10875892	CHEMBL2025119	Inhibition of human recombinant GSK3beta after 30 mins by luminescence assay in presence of ATP	B	Br.c1ccc(-c2n/c(=N\CCN3CCOCC3)sn2-c2ccccc2)cc1		CHEMBL2022421	=	IC50	nM	900.0	CHEMBL262	Homo sapiens	IC50	uM	0.9
	10875893	CHEMBL2025119	Inhibition of human recombinant GSK3beta after 30 mins by luminescence assay in presence of ATP	B	CCCCC/N=c1\nc(-c2ccc(OC)cc2)n(-c2ccccc2)s1.Cl		CHEMBL2022420	=	IC50	nM	1100.0	CHEMBL262	Homo sapiens	IC50	uM	1.1
	10875894	CHEMBL2025119	Inhibition of human recombinant GSK3beta after 30 mins by luminescence assay in presence of ATP	B	Cl.c1ccc(-n2s/c(=N/Cc3cccnc3)nc2-c2cccc3ccccc23)cc1		CHEMBL2022419	=	IC50	nM	900.0	CHEMBL262	Homo sapiens	IC50	uM	0.9
	10875895	CHEMBL2025119	Inhibition of human recombinant GSK3beta after 30 mins by luminescence assay in presence of ATP	B	Cl.OCC/N=c1\nc(-c2ccccc2)n(-c2ccccc2)s1		CHEMBL2022418	=	IC50	nM	600.0	CHEMBL262	Homo sapiens	IC50	uM	0.6
	10875896	CHEMBL2025119	Inhibition of human recombinant GSK3beta after 30 mins by luminescence assay in presence of ATP	B	Br.CCCCCc1n/c(=N\Cc2cccnc2)sn1-c1ccccc1		CHEMBL2022417	=	IC50	nM	800.0	CHEMBL262	Homo sapiens	IC50	uM	0.8
	10875897	CHEMBL2025119	Inhibition of human recombinant GSK3beta after 30 mins by luminescence assay in presence of ATP	B	Br.Cc1n/c(=N\Cc2cccnc2)sn1-c1ccccc1		CHEMBL2022416	=	IC50	nM	600.0	CHEMBL262	Homo sapiens	IC50	uM	0.6
	10875898	CHEMBL2025119	Inhibition of human recombinant GSK3beta after 30 mins by luminescence assay in presence of ATP	B	Br.OCC/N=c1\nc(-c2cccc3ccccc23)n(-c2ccccc2)s1		CHEMBL2022415	=	IC50	nM	300.0	CHEMBL262	Homo sapiens	IC50	uM	0.3
	10875899	CHEMBL2025119	Inhibition of human recombinant GSK3beta after 30 mins by luminescence assay in presence of ATP	B	Br.c1ccc(-n2s/c(=N/Cc3cccnc3)nc2-c2cccc3ccccc23)cc1		CHEMBL2022414	=	IC50	nM	2100.0	CHEMBL262	Homo sapiens	IC50	uM	2.1
	10875900	CHEMBL2025119	Inhibition of human recombinant GSK3beta after 30 mins by luminescence assay in presence of ATP	B	Br.OCC/N=c1\nc(-c2ccccc2)n(-c2cccc3ccccc23)s1		CHEMBL2022413	=	IC50	nM	300.0	CHEMBL262	Homo sapiens	IC50	uM	0.3
	10875901	CHEMBL2025119	Inhibition of human recombinant GSK3beta after 30 mins by luminescence assay in presence of ATP	B	Br.c1ccc(-c2n/c(=N\Cc3cccnc3)sn2-c2cccc3ccccc23)cc1		CHEMBL2022412	=	IC50	nM	2000.0	CHEMBL262	Homo sapiens	IC50	uM	2.0
	10875902	CHEMBL2025119	Inhibition of human recombinant GSK3beta after 30 mins by luminescence assay in presence of ATP	B	Br.FC(F)(F)c1ccc(-c2n/c(=N\Cc3cccnc3)sn2-c2ccccc2)cc1		CHEMBL2024375	=	IC50	nM	1600.0	CHEMBL262	Homo sapiens	IC50	uM	1.6
	10875903	CHEMBL2025119	Inhibition of human recombinant GSK3beta after 30 mins by luminescence assay in presence of ATP	B	Br.COc1ccc(-c2n/c(=N\c3ccccc3)sn2-c2ccccc2)cc1		CHEMBL2024374	=	IC50	nM	1100.0	CHEMBL262	Homo sapiens	IC50	uM	1.1
	10875904	CHEMBL2025119	Inhibition of human recombinant GSK3beta after 30 mins by luminescence assay in presence of ATP	B	Br.CCCCC/N=c1\nc(-c2ccc(OC)cc2)n(-c2ccccc2)s1		CHEMBL2024373	=	IC50	nM	300.0	CHEMBL262	Homo sapiens	IC50	uM	0.3
	10875905	CHEMBL2025119	Inhibition of human recombinant GSK3beta after 30 mins by luminescence assay in presence of ATP	B	Br.CCOC(=O)C/N=c1\nc(-c2ccc(OC)cc2)n(-c2ccccc2)s1		CHEMBL2024372	=	IC50	nM	500.0	CHEMBL262	Homo sapiens	IC50	uM	0.5
	10875906	CHEMBL2025119	Inhibition of human recombinant GSK3beta after 30 mins by luminescence assay in presence of ATP	B	Br.COc1ccc(-c2n/c(=N\CCO)sn2-c2ccccc2)cc1		CHEMBL2024371	=	IC50	nM	1200.0	CHEMBL262	Homo sapiens	IC50	uM	1.2
	10875907	CHEMBL2025119	Inhibition of human recombinant GSK3beta after 30 mins by luminescence assay in presence of ATP	B	Br.COc1ccc(-c2n/c(=N\Cc3cccnc3)sn2-c2ccccc2)cc1		CHEMBL2024370	=	IC50	nM	1200.0	CHEMBL262	Homo sapiens	IC50	uM	1.2
	10875908	CHEMBL2025119	Inhibition of human recombinant GSK3beta after 30 mins by luminescence assay in presence of ATP	B	Br.COc1ccc(-n2s/c(=N/CCO)nc2-c2ccccc2)cc1		CHEMBL2024369	=	IC50	nM	4600.0	CHEMBL262	Homo sapiens	IC50	uM	4.6
	10876518	CHEMBL2025119	Inhibition of human recombinant GSK3beta after 30 mins by luminescence assay in presence of ATP	B	Br.CCOC(=O)C/N=c1\nc(-c2ccccc2)n(-c2ccc([N+](=O)[O-])cc2)s1		CHEMBL2024368	=	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	uM	1.0
	10876519	CHEMBL2025119	Inhibition of human recombinant GSK3beta after 30 mins by luminescence assay in presence of ATP	B	Br.O=[N+]([O-])c1ccc(-n2s/c(=N/Cc3cccnc3)nc2-c2ccccc2)cc1		CHEMBL2024367	=	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	uM	1.0
	10876520	CHEMBL2025119	Inhibition of human recombinant GSK3beta after 30 mins by luminescence assay in presence of ATP	B	Br.CCOC(=O)C/N=c1\nc(-c2ccccc2)n(-c2ccc(OC)cc2)s1		CHEMBL2024366	=	IC50	nM	2000.0	CHEMBL262	Homo sapiens	IC50	uM	2.0
	10876521	CHEMBL2025119	Inhibition of human recombinant GSK3beta after 30 mins by luminescence assay in presence of ATP	B	Br.COc1ccc(-n2s/c(=N/Cc3cccnc3)nc2-c2ccccc2)cc1		CHEMBL2024365	=	IC50	nM	4100.0	CHEMBL262	Homo sapiens	IC50	uM	4.1
	10876522	CHEMBL2025119	Inhibition of human recombinant GSK3beta after 30 mins by luminescence assay in presence of ATP	B	Br.c1ccc(-c2n/c(=N\C3CCCCC3)sn2-c2ccccc2)cc1		CHEMBL2024364	=	IC50	nM	2100.0	CHEMBL262	Homo sapiens	IC50	uM	2.1
	10876523	CHEMBL2025119	Inhibition of human recombinant GSK3beta after 30 mins by luminescence assay in presence of ATP	B	Br.c1ccc(/N=c2/nc(-c3ccccc3)n(-c3ccccc3)s2)cc1		CHEMBL558982	=	IC50	nM	900.0	CHEMBL262	Homo sapiens	IC50	uM	0.9
	10876524	CHEMBL2025119	Inhibition of human recombinant GSK3beta after 30 mins by luminescence assay in presence of ATP	B	Br.CCCCC/N=c1\nc(-c2ccccc2)n(-c2ccccc2)s1		CHEMBL2024363	=	IC50	nM	1400.0	CHEMBL262	Homo sapiens	IC50	uM	1.4
	10876525	CHEMBL2025119	Inhibition of human recombinant GSK3beta after 30 mins by luminescence assay in presence of ATP	B	Br.N=c1nc(-c2ccccc2)n(-c2ccccc2)s1		CHEMBL2024362	=	IC50	nM	600.0	CHEMBL262	Homo sapiens	IC50	uM	0.6
	10876526	CHEMBL2025119	Inhibition of human recombinant GSK3beta after 30 mins by luminescence assay in presence of ATP	B	Br.OCC/N=c1\nc(-c2ccccc2)n(-c2ccccc2)s1		CHEMBL2024361	=	IC50	nM	2000.0	CHEMBL262	Homo sapiens	IC50	uM	2.0
	10876527	CHEMBL2025119	Inhibition of human recombinant GSK3beta after 30 mins by luminescence assay in presence of ATP	B	Br.CCOC(=O)C/N=c1\nc(-c2ccccc2)n(-c2ccccc2)s1		CHEMBL2024360	=	IC50	nM	7000.0	CHEMBL262	Homo sapiens	IC50	uM	7.0
	10876528	CHEMBL2025119	Inhibition of human recombinant GSK3beta after 30 mins by luminescence assay in presence of ATP	B	Br.c1ccc(-c2n/c(=N\Cc3cccnc3)sn2-c2ccccc2)cc1		CHEMBL2024359	=	IC50	nM	1300.0	CHEMBL262	Homo sapiens	IC50	uM	1.3
Active	10876529	CHEMBL2025118	Non-competitive inhibition of human recombinant GSK3beta at 0.5 to 2.5 uM after 30 mins by Michaelis-Menten equation in presence of 1 uM ATP	B	Br.OCC/N=c1\nc(-c2ccccc2)n(-c2ccccc2)s1		CHEMBL2024361		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	10876530	CHEMBL2025118	Non-competitive inhibition of human recombinant GSK3beta at 0.5 to 2.5 uM after 30 mins by Michaelis-Menten equation in presence of 1 uM ATP	B	Br.c1ccc(-c2n/c(=N\Cc3cccnc3)sn2-c2ccccc2)cc1		CHEMBL2024359		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	10876531	CHEMBL2025117	Competitive inhibition of human recombinant GSK3beta at 12.5 to 100 uM after 30 mins by Michaelis-Menten equation in presence of 1 uM ATP	B	CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O		CHEMBL2021939		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	10876532	CHEMBL2025116	Non-competitive inhibition of human recombinant GSK3beta at 10 uM after 30 mins by Michaelis-Menten equation in presence of 1 to 50 uM ATP	B	Br.c1ccc(-c2n/c(=N\CCN3CCOCC3)sn2-c2ccccc2)cc1		CHEMBL2022421		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	10876533	CHEMBL2025116	Non-competitive inhibition of human recombinant GSK3beta at 10 uM after 30 mins by Michaelis-Menten equation in presence of 1 to 50 uM ATP	B	Br.OCC/N=c1\nc(-c2ccccc2)n(-c2ccccc2)s1		CHEMBL2024361		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	10876534	CHEMBL2025116	Non-competitive inhibition of human recombinant GSK3beta at 10 uM after 30 mins by Michaelis-Menten equation in presence of 1 to 50 uM ATP	B	Br.c1ccc(-c2n/c(=N\Cc3cccnc3)sn2-c2ccccc2)cc1		CHEMBL2024359		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	10876535	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	c1ccc(/N=C(/N=c2/nc3ccccn3s2)c2ccccc2)cc1		CHEMBL2023126	=	Inhibition	%	14.0	CHEMBL262	Homo sapiens	INH	%	14.0
	10876536	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	Br.c1ccc(Cn2s/c(=N/Cc3cccnc3)nc2-c2ccccc2)cc1		CHEMBL2022423	>	Inhibition	%	60.0	CHEMBL262	Homo sapiens	INH	%	60.0
	10876537	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	CCOC(=O)C/N=c1\nc(-c2ccccc2)n(-c2ccccc2)s1		CHEMBL2022422	>	Inhibition	%	60.0	CHEMBL262	Homo sapiens	INH	%	60.0
	10876538	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	c1ccc(/N=c2\nc(-c3ccccc3)n(-c3ccccc3)s2)cc1		CHEMBL1709775	>	Inhibition	%	60.0	CHEMBL262	Homo sapiens	INH	%	60.0
	10876539	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	Br.c1ccc(-c2n/c(=N\CCN3CCOCC3)sn2-c2ccccc2)cc1		CHEMBL2022421	>	Inhibition	%	60.0	CHEMBL262	Homo sapiens	INH	%	60.0
	10876540	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	CCCCC/N=c1\nc(-c2ccc(OC)cc2)n(-c2ccccc2)s1.Cl		CHEMBL2022420	>	Inhibition	%	60.0	CHEMBL262	Homo sapiens	INH	%	60.0
	10876541	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	Cl.c1ccc(-n2s/c(=N/Cc3cccnc3)nc2-c2cccc3ccccc23)cc1		CHEMBL2022419	>	Inhibition	%	60.0	CHEMBL262	Homo sapiens	INH	%	60.0
	10876542	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	Cl.OCC/N=c1\nc(-c2ccccc2)n(-c2ccccc2)s1		CHEMBL2022418	>	Inhibition	%	60.0	CHEMBL262	Homo sapiens	INH	%	60.0
	10876543	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	Br.CCCCCc1n/c(=N\Cc2cccnc2)sn1-c1ccccc1		CHEMBL2022417	>	Inhibition	%	60.0	CHEMBL262	Homo sapiens	INH	%	60.0
	10876544	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	Br.Cc1n/c(=N\Cc2cccnc2)sn1-c1ccccc1		CHEMBL2022416	>	Inhibition	%	60.0	CHEMBL262	Homo sapiens	INH	%	60.0
	10876545	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	Br.OCC/N=c1\nc(-c2cccc3ccccc23)n(-c2ccccc2)s1		CHEMBL2022415	>	Inhibition	%	60.0	CHEMBL262	Homo sapiens	INH	%	60.0
	10876546	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	Br.c1ccc(-n2s/c(=N/Cc3cccnc3)nc2-c2cccc3ccccc23)cc1		CHEMBL2022414	>	Inhibition	%	60.0	CHEMBL262	Homo sapiens	INH	%	60.0
	10876547	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	Br.OCC/N=c1\nc(-c2ccccc2)n(-c2cccc3ccccc23)s1		CHEMBL2022413	>	Inhibition	%	60.0	CHEMBL262	Homo sapiens	INH	%	60.0
	10876548	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	Br.c1ccc(-c2n/c(=N\Cc3cccnc3)sn2-c2cccc3ccccc23)cc1		CHEMBL2022412	>	Inhibition	%	60.0	CHEMBL262	Homo sapiens	INH	%	60.0
	10876549	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	Br.FC(F)(F)c1ccc(-c2n/c(=N\Cc3cccnc3)sn2-c2ccccc2)cc1		CHEMBL2024375	>	Inhibition	%	60.0	CHEMBL262	Homo sapiens	INH	%	60.0
	10876550	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	Br.COc1ccc(-c2n/c(=N\c3ccccc3)sn2-c2ccccc2)cc1		CHEMBL2024374	>	Inhibition	%	60.0	CHEMBL262	Homo sapiens	INH	%	60.0
	10876551	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	Br.CCCCC/N=c1\nc(-c2ccc(OC)cc2)n(-c2ccccc2)s1		CHEMBL2024373	>	Inhibition	%	60.0	CHEMBL262	Homo sapiens	INH	%	60.0
	10876552	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	Br.CCOC(=O)C/N=c1\nc(-c2ccc(OC)cc2)n(-c2ccccc2)s1		CHEMBL2024372	>	Inhibition	%	60.0	CHEMBL262	Homo sapiens	INH	%	60.0
	10876553	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	Br.COc1ccc(-c2n/c(=N\CCO)sn2-c2ccccc2)cc1		CHEMBL2024371	>	Inhibition	%	60.0	CHEMBL262	Homo sapiens	INH	%	60.0
	10876554	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	Br.COc1ccc(-c2n/c(=N\Cc3cccnc3)sn2-c2ccccc2)cc1		CHEMBL2024370	>	Inhibition	%	60.0	CHEMBL262	Homo sapiens	INH	%	60.0
	10876555	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	Br.COc1ccc(-n2s/c(=N/CCO)nc2-c2ccccc2)cc1		CHEMBL2024369	>	Inhibition	%	60.0	CHEMBL262	Homo sapiens	INH	%	60.0
	10876556	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	Br.CCOC(=O)C/N=c1\nc(-c2ccccc2)n(-c2ccc([N+](=O)[O-])cc2)s1		CHEMBL2024368	>	Inhibition	%	60.0	CHEMBL262	Homo sapiens	INH	%	60.0
	10876557	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	Br.O=[N+]([O-])c1ccc(-n2s/c(=N/Cc3cccnc3)nc2-c2ccccc2)cc1		CHEMBL2024367	>	Inhibition	%	60.0	CHEMBL262	Homo sapiens	INH	%	60.0
	10876558	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	Br.CCOC(=O)C/N=c1\nc(-c2ccccc2)n(-c2ccc(OC)cc2)s1		CHEMBL2024366	>	Inhibition	%	60.0	CHEMBL262	Homo sapiens	INH	%	60.0
	10876559	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	Br.COc1ccc(-n2s/c(=N/Cc3cccnc3)nc2-c2ccccc2)cc1		CHEMBL2024365	>	Inhibition	%	60.0	CHEMBL262	Homo sapiens	INH	%	60.0
	10876560	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	Br.c1ccc(-c2n/c(=N\C3CCCCC3)sn2-c2ccccc2)cc1		CHEMBL2024364	>	Inhibition	%	60.0	CHEMBL262	Homo sapiens	INH	%	60.0
	10876561	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	Br.c1ccc(/N=c2/nc(-c3ccccc3)n(-c3ccccc3)s2)cc1		CHEMBL558982	>	Inhibition	%	60.0	CHEMBL262	Homo sapiens	INH	%	60.0
	10876562	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	Br.CCCCC/N=c1\nc(-c2ccccc2)n(-c2ccccc2)s1		CHEMBL2024363	>	Inhibition	%	60.0	CHEMBL262	Homo sapiens	INH	%	60.0
	10876563	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	Br.N=c1nc(-c2ccccc2)n(-c2ccccc2)s1		CHEMBL2024362	>	Inhibition	%	60.0	CHEMBL262	Homo sapiens	INH	%	60.0
	10876564	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	Br.OCC/N=c1\nc(-c2ccccc2)n(-c2ccccc2)s1		CHEMBL2024361	>	Inhibition	%	60.0	CHEMBL262	Homo sapiens	INH	%	60.0
	10876565	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	Br.CCOC(=O)C/N=c1\nc(-c2ccccc2)n(-c2ccccc2)s1		CHEMBL2024360	>	Inhibition	%	60.0	CHEMBL262	Homo sapiens	INH	%	60.0
	10876566	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	Br.c1ccc(-c2n/c(=N\Cc3cccnc3)sn2-c2ccccc2)cc1		CHEMBL2024359	>	Inhibition	%	60.0	CHEMBL262	Homo sapiens	INH	%	60.0
Not Active	10876567	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	S=C(NCc1ccccn1)N/C(=N/c1ccccc1)c1ccccc1		CHEMBL2023025		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	10876568	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	S=C(NCc1cccnc1)N/C(=N/Cc1ccccc1)c1ccccc1		CHEMBL2023024		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	10876569	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	S=C(NCCN1CCOCC1)N/C(=N/c1ccccc1)c1ccccc1		CHEMBL2023023		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	10876570	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	CCCCC/C(=N\c1ccccc1)NC(=S)NCc1cccnc1		CHEMBL2023022		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	10876571	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	C/C(=N\c1ccccc1)NC(=S)NCc1cccnc1		CHEMBL2023021		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	10876572	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	OCCNC(=S)N/C(=N/c1ccccc1)c1cccc2ccccc12		CHEMBL2023020		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	10876573	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	S=C(NCc1cccnc1)N/C(=N/c1ccccc1)c1cccc2ccccc12		CHEMBL2023019		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	10876574	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	OCCNC(=S)N/C(=N/c1cccc2ccccc12)c1ccccc1		CHEMBL2023018		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	10876575	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	S=C(NCc1cccnc1)N/C(=N/c1cccc2ccccc12)c1ccccc1		CHEMBL2023017		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	10876576	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	FC(F)(F)c1ccc(/C(=N\c2ccccc2)NC(=S)NCc2cccnc2)cc1		CHEMBL2023016		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	10876577	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	COc1ccc(/C(=N\c2ccccc2)NC(=S)Nc2ccccc2)cc1		CHEMBL2023015		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	10876578	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	CCCCCNC(=S)N/C(=N/c1ccccc1)c1ccc(OC)cc1		CHEMBL2023014		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	10876579	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	CCOC(=O)CNC(=S)N/C(=N/c1ccccc1)c1ccc(OC)cc1		CHEMBL2023013		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	10876580	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	COc1ccc(/C(=N\c2ccccc2)NC(=S)NCCO)cc1		CHEMBL2023012		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	10876581	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	COc1ccc(/C(=N\c2ccccc2)NC(=S)NCc2cccnc2)cc1		CHEMBL2023011		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	10876582	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	COc1ccc(/N=C(/NC(=S)NCCO)c2ccccc2)cc1		CHEMBL2023010		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	10876583	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	CCOC(=O)CNC(=S)N/C(=N/c1ccc([N+](=O)[O-])cc1)c1ccccc1		CHEMBL2023009		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	10876584	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	O=[N+]([O-])c1ccc(/N=C(/NC(=S)NCc2cccnc2)c2ccccc2)cc1		CHEMBL2023008		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	10876585	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	CCOC(=O)CNC(=S)N/C(=N/c1ccc(OC)cc1)c1ccccc1		CHEMBL2023007		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	10876586	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	COc1ccc(/N=C(/NC(=S)NCc2cccnc2)c2ccccc2)cc1		CHEMBL2022431		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	10876587	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	S=C(N/C(=N/c1ccccc1)c1ccccc1)NC1CCCCC1		CHEMBL2022430		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	10876588	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	S=C(N/C(=N/c1ccccc1)c1ccccc1)Nc1ccccc1		CHEMBL2022429		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	10876589	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	CCCCCNC(=S)N/C(=N/c1ccccc1)c1ccccc1		CHEMBL2022428		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	10876590	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	NC(=S)N/C(=N/c1ccccc1)c1ccccc1		CHEMBL2022427		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	10876591	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	OCCNC(=S)N/C(=N/c1ccccc1)c1ccccc1		CHEMBL2022426		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	10876592	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	CCOC(=O)CNC(=S)N/C(=N/c1ccccc1)c1ccccc1		CHEMBL2022425		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	10876593	CHEMBL2025115	Inhibition of human recombinant GSK3beta at 10 uM after 30 mins by luminescence assay in presence of ATP	B	S=C(NCc1cccnc1)N/C(=N/c1ccccc1)c1ccccc1		CHEMBL2022424		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	10876629	CHEMBL2025118	Non-competitive inhibition of human recombinant GSK3beta at 0.5 to 2.5 uM after 30 mins by Michaelis-Menten equation in presence of 1 uM ATP	B	Br.c1ccc(-c2n/c(=N\CCN3CCOCC3)sn2-c2ccccc2)cc1		CHEMBL2022421		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	10907142	CHEMBL2039366	Inhibition of GSK3beta	B	CCCCn1c(=O)sn(CC)c1=O		CHEMBL24773	=	IC50	nM	70000.0	CHEMBL262	Homo sapiens	IC50	uM	70.0
	10908175	CHEMBL2039682	Inhibition of human recombinant GSK3beta	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	IC50	nM	4.0	CHEMBL262	Homo sapiens	IC50	nM	4.0
	10908176	CHEMBL2039682	Inhibition of human recombinant GSK3beta	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	IC50	nM	104.0	CHEMBL262	Homo sapiens	IC50	nM	104.0
	10908177	CHEMBL2039683	Inhibition of human recombinant GSK3beta incubated for 30 mins by Kinase Glo luminescent kinase assay	B	CCCCCCCCCCCC(=O)NNC(=O)c1c(O)c2ccccc2n(CC)c1=O		CHEMBL2037482	=	IC50	nM	3010.0	CHEMBL262	Homo sapiens	IC50	uM	3.01
Active	10908178	CHEMBL2039678	Competitive inhibition of human recombinant GSK3beta using GS2 as substrate after 10 mins by Glow type luminescence analysis	B	CCCCCCCCCCCC(=O)NNC(=O)c1c(O)c2ccccc2n(CC)c1=O		CHEMBL2037482		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	10908179	CHEMBL2039679	Non-competitive inhibition of human recombinant GSK3beta using GS2 as substrate after 10 mins by Glow type luminescence analysis in presence of 1 to 50 uM ATP	B	CCCCCCCCCCCC(=O)NNC(=O)c1c(O)c2ccccc2n(CC)c1=O		CHEMBL2037482		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	10908180	CHEMBL2039680	Reversible inhibition of human recombinant GSK3beta using GS2 as substrate after 10 mins by Glow type luminescence analysis	B	CCCCCCCCCCCC(=O)NNC(=O)c1c(O)c2ccccc2n(CC)c1=O		CHEMBL2037482		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	10908181	CHEMBL2039681	Non-competitive inhibition of human recombinant GSK3beta using GS2 as substrate after 10 mins by Glow type luminescence analysis in presence of 1 uM ATP	B	CCCCCCCCCCCC(=O)NNC(=O)c1c(O)c2ccccc2n(CC)c1=O		CHEMBL2037482		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	10923956	CHEMBL2044300	Inhibition of GSK3beta incubated for 30 mins prior to substrate addition study done at apparent ATP Km for enzyme	B	C[C@H](/C=C\C(F)(F)F)Oc1cc(-c2cc(-c3cc(CN(C)C)cs3)cnc2N)ccc1C(N)=O		CHEMBL2042135	=	IC50	nM	70.0	CHEMBL262	Homo sapiens	IC50	uM	0.07
	10923977	CHEMBL2044299	Inhibition of GSK3beta at 1 uM incubated for 30 mins prior to substrate addition study done at apparent ATP Km for enzyme	B	C[C@H](/C=C\C(F)(F)F)Oc1cc(-c2cc(-c3cc(CN(C)C)cs3)cnc2N)ccc1C(N)=O		CHEMBL2042135	=	Inhibition	%	93.0	CHEMBL262	Homo sapiens	INH	%	93.0
	10925176	CHEMBL2046119	Inhibition of human GSK3beta assessed as remaining activity at 0.8 uM after 40 mins by scintillation counting	B	CC(C)Nc1cc(-c2oc3ccccc3c(=O)c2-c2ccc(F)cc2)ccn1		CHEMBL2041958	=	Activity	%	132.0	CHEMBL262	Homo sapiens	Activity	%	132.0
	10925177	CHEMBL2046119	Inhibition of human GSK3beta assessed as remaining activity at 0.8 uM after 40 mins by scintillation counting	B	O=c1c(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)oc2ccccc12		CHEMBL2041962	=	Activity	%	124.0	CHEMBL262	Homo sapiens	Activity	%	124.0
	10934724	CHEMBL2051312	Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting method	B	CCS(=O)(=O)Nc1ccc(CCNC(=O)c2ccc(O)c3[nH]c(-c4ccccc4)nc23)cc1		CHEMBL2048657	=	IC50	nM	47.0	CHEMBL262	Homo sapiens	IC50	nM	47.0
	10934725	CHEMBL2051312	Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting method	B	CCS(=O)(=O)Nc1ccc(CCNC(=O)c2ccnc3[nH]c(-c4ccccc4)nc23)cc1		CHEMBL2048658	=	IC50	nM	14.0	CHEMBL262	Homo sapiens	IC50	nM	14.0
	10934726	CHEMBL2051312	Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting method	B	CCS(=O)(=O)Nc1ccc(CCNC(=O)c2ccnc3[nH]c(-c4ccc(F)cc4)nc23)cc1		CHEMBL2048659	=	IC50	nM	4.0	CHEMBL262	Homo sapiens	IC50	nM	4.0
	10934727	CHEMBL2051312	Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting method	B	CCS(=O)(=O)Nc1ccc(CCNC(=O)c2ccnc3[nH]c(-c4ccc(F)cc4F)nc23)cc1		CHEMBL2048660	=	IC50	nM	2.0	CHEMBL262	Homo sapiens	IC50	nM	2.0
	10934728	CHEMBL2051312	Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting method	B	CCS(=O)(=O)Nc1ccc(CCNC(=O)c2ccnc3[nH]c(-c4cccs4)nc23)cc1		CHEMBL2048661	=	IC50	nM	12.0	CHEMBL262	Homo sapiens	IC50	nM	12.0
	10934729	CHEMBL2051312	Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting method	B	CCS(=O)(=O)Nc1ccc(CCNC(=O)c2ccnc3[nH]c(-c4ccsc4)nc23)cc1		CHEMBL2048662	=	IC50	nM	3.0	CHEMBL262	Homo sapiens	IC50	nM	3.0
	10934730	CHEMBL2051312	Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting method	B	CCS(=O)(=O)Nc1ccc(CCNC(=O)c2ccnc3[nH]c(-c4ccoc4)nc23)cc1		CHEMBL2048663	=	IC50	nM	1.0	CHEMBL262	Homo sapiens	IC50	nM	1.0
	10934731	CHEMBL2051312	Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting method	B	O=C(NCCc1ccc(F)nc1)c1ccnc2[nH]c(-c3ccc(F)cc3)nc12		CHEMBL2048664	=	IC50	nM	17.0	CHEMBL262	Homo sapiens	IC50	nM	17.0
	10934732	CHEMBL2051312	Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting method	B	O=C(Nc1cccnc1)c1ccnc2[nH]c(-c3ccc(F)cc3)nc12		CHEMBL2048665	=	IC50	nM	8.0	CHEMBL262	Homo sapiens	IC50	nM	8.0
	10934733	CHEMBL2051312	Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting method	B	O=C(NCCCc1ccc(Cl)nc1)c1ccnc2[nH]c(-c3ccc(F)cc3)nc12		CHEMBL2046466	=	IC50	nM	17.0	CHEMBL262	Homo sapiens	IC50	nM	17.0
	10934734	CHEMBL2051312	Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting method	B	O=C(NCCc1cccc(O)c1)c1ccnc2[nH]c(-c3ccc(F)cc3)nc12		CHEMBL2048666	=	IC50	nM	14.0	CHEMBL262	Homo sapiens	IC50	nM	14.0
	10934735	CHEMBL2051312	Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting method	B	CS(=O)(=O)Nc1ccc(CCNC(=O)c2ccnc3[nH]c(-c4ccc(F)cc4)nc23)cc1		CHEMBL2048667	=	IC50	nM	44.0	CHEMBL262	Homo sapiens	IC50	nM	44.0
	10934736	CHEMBL2051312	Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting method	B	CN(C)S(=O)(=O)Nc1ccc(CCNC(=O)c2ccnc3[nH]c(-c4ccc(F)cc4)nc23)cc1		CHEMBL2048668	=	IC50	nM	27.0	CHEMBL262	Homo sapiens	IC50	nM	27.0
	10934737	CHEMBL2051312	Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting method	B	CS(=O)(=O)Nc1ccc(CCNC(=O)c2ccnc3[nH]c(-c4ccc(Cl)cc4)nc23)cc1		CHEMBL2048669	=	IC50	nM	10.0	CHEMBL262	Homo sapiens	IC50	nM	10.0
	10934738	CHEMBL2051312	Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting method	B	CS(=O)(=O)Nc1ccc(CCNC(=O)c2ccnc3[nH]c(-c4ccoc4)nc23)cc1		CHEMBL2048670	=	IC50	nM	3.0	CHEMBL262	Homo sapiens	IC50	nM	3.0
	10934739	CHEMBL2051312	Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting method	B	CS(=O)(=O)Nc1ccc(CCNC(=O)c2ccnc3[nH]c(-c4cccs4)nc23)cc1		CHEMBL2048671	=	IC50	nM	12.0	CHEMBL262	Homo sapiens	IC50	nM	12.0
	10934740	CHEMBL2051312	Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting method	B	CN(C)S(=O)(=O)Nc1ccc(CCNC(=O)c2ccnc3[nH]c(-c4ccsc4)nc23)cc1		CHEMBL2048672	=	IC50	nM	9.0	CHEMBL262	Homo sapiens	IC50	nM	9.0
	10934741	CHEMBL2051312	Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting method	B	O=C(NCCc1cccnc1Cl)c1ccnc2[nH]c(-c3ccoc3)nc12		CHEMBL2048673	=	IC50	nM	9.0	CHEMBL262	Homo sapiens	IC50	nM	9.0
	10934742	CHEMBL2051312	Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting method	B	O=C(Nc1cccnc1)c1ccnc2[nH]c(-c3ccsc3)nc12		CHEMBL2048674	=	IC50	nM	13.0	CHEMBL262	Homo sapiens	IC50	nM	13.0
	10934743	CHEMBL2051312	Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting method	B	Cc1ccncc1NC(=O)c1ccnc2[nH]c(N3CCC(c4ccccc4)C3)nc12		CHEMBL2048675	=	IC50	nM	30.0	CHEMBL262	Homo sapiens	IC50	nM	30.0
	10934744	CHEMBL2051312	Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting method	B	CCN(CC)c1ccc(-c2nc3c(C(=O)Nc4cnccc4C)ccnc3[nH]2)cc1		CHEMBL2048676	=	IC50	nM	3.0	CHEMBL262	Homo sapiens	IC50	nM	3.0
	10934745	CHEMBL2051312	Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting method	B	COc1ccncc1NC(=O)c1ccnc2[nH]c(-c3ccc(F)cc3)nc12		CHEMBL2048677	=	IC50	nM	3.0	CHEMBL262	Homo sapiens	IC50	nM	3.0
	10934746	CHEMBL2051312	Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting method	B	CCOc1ccncc1NC(=O)c1ccnc2[nH]c(-c3ccc(F)cc3)nc12		CHEMBL2048678	=	IC50	nM	3.0	CHEMBL262	Homo sapiens	IC50	nM	3.0
	10934747	CHEMBL2051312	Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting method	B	Cc1ccc(NC(=O)c2ccnc3[nH]c(-c4ccc(F)cc4)nc23)cn1		CHEMBL2048679	=	IC50	nM	8.0	CHEMBL262	Homo sapiens	IC50	nM	8.0
	10934748	CHEMBL2051312	Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting method	B	COc1ccc(-c2nc3c(C(=O)Nc4cnccc4C)ccnc3[nH]2)cc1		CHEMBL2048680	=	IC50	nM	2.0	CHEMBL262	Homo sapiens	IC50	nM	2.0
	10934749	CHEMBL2051312	Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting method	B	COc1cccc(-c2nc3c(C(=O)Nc4cnccc4C)ccnc3[nH]2)c1		CHEMBL2048681	=	IC50	nM	3.0	CHEMBL262	Homo sapiens	IC50	nM	3.0
	10934750	CHEMBL2051312	Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting method	B	CCOc1ccncc1NC(=O)c1ccnc2[nH]c(-c3cccnc3)nc12		CHEMBL2048682	=	IC50	nM	3.0	CHEMBL262	Homo sapiens	IC50	nM	3.0
	10934751	CHEMBL2051312	Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting method	B	CCOc1ccncc1NC(=O)c1ccnc2[nH]c(-c3cccc(OC)c3)nc12		CHEMBL2048683	=	IC50	nM	7.0	CHEMBL262	Homo sapiens	IC50	nM	7.0
	10934752	CHEMBL2051312	Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting method	B	COc1ccncc1NC(=O)c1ccnc2[nH]c(-c3cccc(Cl)c3)nc12		CHEMBL2048684	=	IC50	nM	2.0	CHEMBL262	Homo sapiens	IC50	nM	2.0
	10934753	CHEMBL2051312	Inhibition of human GSK3beta using phospho-CREB as substrate by beta counting method	B	COc1ccncc1NC(=O)c1ccnc2[nH]c(-c3ccncc3)nc12		CHEMBL2048685	=	IC50	nM	2.0	CHEMBL262	Homo sapiens	IC50	nM	2.0
Not Determined	10934754	CHEMBL2051313	Inhibition of GSK3B in human Rd cells	B	CCS(=O)(=O)Nc1ccc(CCNC(=O)c2ccc(O)c3[nH]c(-c4ccccc4)nc23)cc1		CHEMBL2048657		EC50			CHEMBL262	Homo sapiens	EC50		
	10934755	CHEMBL2051313	Inhibition of GSK3B in human Rd cells	B	CCS(=O)(=O)Nc1ccc(CCNC(=O)c2ccnc3[nH]c(-c4ccccc4)nc23)cc1		CHEMBL2048658	=	EC50	nM	62.0	CHEMBL262	Homo sapiens	EC50	nM	62.0
	10934756	CHEMBL2051313	Inhibition of GSK3B in human Rd cells	B	CCS(=O)(=O)Nc1ccc(CCNC(=O)c2ccnc3[nH]c(-c4ccc(F)cc4)nc23)cc1		CHEMBL2048659	=	EC50	nM	31.0	CHEMBL262	Homo sapiens	EC50	nM	31.0
	10934757	CHEMBL2051313	Inhibition of GSK3B in human Rd cells	B	CCS(=O)(=O)Nc1ccc(CCNC(=O)c2ccnc3[nH]c(-c4ccc(F)cc4F)nc23)cc1		CHEMBL2048660	=	EC50	nM	290.0	CHEMBL262	Homo sapiens	EC50	nM	290.0
	10934758	CHEMBL2051313	Inhibition of GSK3B in human Rd cells	B	CCS(=O)(=O)Nc1ccc(CCNC(=O)c2ccnc3[nH]c(-c4cccs4)nc23)cc1		CHEMBL2048661	=	EC50	nM	50.0	CHEMBL262	Homo sapiens	EC50	nM	50.0
	10934759	CHEMBL2051313	Inhibition of GSK3B in human Rd cells	B	CCS(=O)(=O)Nc1ccc(CCNC(=O)c2ccnc3[nH]c(-c4ccsc4)nc23)cc1		CHEMBL2048662	=	EC50	nM	10.0	CHEMBL262	Homo sapiens	EC50	nM	10.0
	10934760	CHEMBL2051313	Inhibition of GSK3B in human Rd cells	B	CCS(=O)(=O)Nc1ccc(CCNC(=O)c2ccnc3[nH]c(-c4ccoc4)nc23)cc1		CHEMBL2048663	=	EC50	nM	290.0	CHEMBL262	Homo sapiens	EC50	nM	290.0
	10934761	CHEMBL2051313	Inhibition of GSK3B in human Rd cells	B	O=C(NCCc1ccc(F)nc1)c1ccnc2[nH]c(-c3ccc(F)cc3)nc12		CHEMBL2048664	=	EC50	nM	300.0	CHEMBL262	Homo sapiens	EC50	nM	300.0
	10934762	CHEMBL2051313	Inhibition of GSK3B in human Rd cells	B	O=C(Nc1cccnc1)c1ccnc2[nH]c(-c3ccc(F)cc3)nc12		CHEMBL2048665	=	EC50	nM	130.0	CHEMBL262	Homo sapiens	EC50	nM	130.0
	10934763	CHEMBL2051313	Inhibition of GSK3B in human Rd cells	B	O=C(NCCCc1ccc(Cl)nc1)c1ccnc2[nH]c(-c3ccc(F)cc3)nc12		CHEMBL2046466	=	EC50	nM	250.0	CHEMBL262	Homo sapiens	EC50	nM	250.0
	10934764	CHEMBL2051313	Inhibition of GSK3B in human Rd cells	B	O=C(NCCc1cccc(O)c1)c1ccnc2[nH]c(-c3ccc(F)cc3)nc12		CHEMBL2048666	=	EC50	nM	150.0	CHEMBL262	Homo sapiens	EC50	nM	150.0
	10934765	CHEMBL2051313	Inhibition of GSK3B in human Rd cells	B	CS(=O)(=O)Nc1ccc(CCNC(=O)c2ccnc3[nH]c(-c4ccc(F)cc4)nc23)cc1		CHEMBL2048667	=	EC50	nM	190.0	CHEMBL262	Homo sapiens	EC50	nM	190.0
	10934766	CHEMBL2051313	Inhibition of GSK3B in human Rd cells	B	CN(C)S(=O)(=O)Nc1ccc(CCNC(=O)c2ccnc3[nH]c(-c4ccc(F)cc4)nc23)cc1		CHEMBL2048668	=	EC50	nM	210.0	CHEMBL262	Homo sapiens	EC50	nM	210.0
	10934767	CHEMBL2051313	Inhibition of GSK3B in human Rd cells	B	CS(=O)(=O)Nc1ccc(CCNC(=O)c2ccnc3[nH]c(-c4ccc(Cl)cc4)nc23)cc1		CHEMBL2048669	=	EC50	nM	300.0	CHEMBL262	Homo sapiens	EC50	nM	300.0
	10934768	CHEMBL2051313	Inhibition of GSK3B in human Rd cells	B	CS(=O)(=O)Nc1ccc(CCNC(=O)c2ccnc3[nH]c(-c4ccoc4)nc23)cc1		CHEMBL2048670	=	EC50	nM	180.0	CHEMBL262	Homo sapiens	EC50	nM	180.0
	10934769	CHEMBL2051313	Inhibition of GSK3B in human Rd cells	B	CS(=O)(=O)Nc1ccc(CCNC(=O)c2ccnc3[nH]c(-c4cccs4)nc23)cc1		CHEMBL2048671	=	EC50	nM	150.0	CHEMBL262	Homo sapiens	EC50	nM	150.0
	10934770	CHEMBL2051313	Inhibition of GSK3B in human Rd cells	B	CN(C)S(=O)(=O)Nc1ccc(CCNC(=O)c2ccnc3[nH]c(-c4ccsc4)nc23)cc1		CHEMBL2048672	=	EC50	nM	56.0	CHEMBL262	Homo sapiens	EC50	nM	56.0
	10934771	CHEMBL2051313	Inhibition of GSK3B in human Rd cells	B	O=C(NCCc1cccnc1Cl)c1ccnc2[nH]c(-c3ccoc3)nc12		CHEMBL2048673	=	EC50	nM	310.0	CHEMBL262	Homo sapiens	EC50	nM	310.0
	10934772	CHEMBL2051313	Inhibition of GSK3B in human Rd cells	B	O=C(Nc1cccnc1)c1ccnc2[nH]c(-c3ccsc3)nc12		CHEMBL2048674	=	EC50	nM	240.0	CHEMBL262	Homo sapiens	EC50	nM	240.0
	10934773	CHEMBL2051313	Inhibition of GSK3B in human Rd cells	B	Cc1ccncc1NC(=O)c1ccnc2[nH]c(N3CCC(c4ccccc4)C3)nc12		CHEMBL2048675	=	EC50	nM	40.0	CHEMBL262	Homo sapiens	EC50	nM	40.0
	10934774	CHEMBL2051313	Inhibition of GSK3B in human Rd cells	B	CCN(CC)c1ccc(-c2nc3c(C(=O)Nc4cnccc4C)ccnc3[nH]2)cc1		CHEMBL2048676	=	EC50	nM	23.0	CHEMBL262	Homo sapiens	EC50	nM	23.0
	10934775	CHEMBL2051313	Inhibition of GSK3B in human Rd cells	B	COc1ccncc1NC(=O)c1ccnc2[nH]c(-c3ccc(F)cc3)nc12		CHEMBL2048677	=	EC50	nM	9.0	CHEMBL262	Homo sapiens	EC50	nM	9.0
	10934776	CHEMBL2051313	Inhibition of GSK3B in human Rd cells	B	CCOc1ccncc1NC(=O)c1ccnc2[nH]c(-c3ccc(F)cc3)nc12		CHEMBL2048678	=	EC50	nM	1.5	CHEMBL262	Homo sapiens	EC50	nM	1.5
	10934777	CHEMBL2051313	Inhibition of GSK3B in human Rd cells	B	Cc1ccc(NC(=O)c2ccnc3[nH]c(-c4ccc(F)cc4)nc23)cn1		CHEMBL2048679	=	EC50	nM	80.0	CHEMBL262	Homo sapiens	EC50	nM	80.0
Not Determined	10934778	CHEMBL2051313	Inhibition of GSK3B in human Rd cells	B	COc1ccc(-c2nc3c(C(=O)Nc4cnccc4C)ccnc3[nH]2)cc1		CHEMBL2048680		EC50			CHEMBL262	Homo sapiens	EC50		
Not Determined	10934779	CHEMBL2051313	Inhibition of GSK3B in human Rd cells	B	COc1cccc(-c2nc3c(C(=O)Nc4cnccc4C)ccnc3[nH]2)c1		CHEMBL2048681		EC50			CHEMBL262	Homo sapiens	EC50		
	10934780	CHEMBL2051313	Inhibition of GSK3B in human Rd cells	B	CCOc1ccncc1NC(=O)c1ccnc2[nH]c(-c3cccnc3)nc12		CHEMBL2048682	=	EC50	nM	10.0	CHEMBL262	Homo sapiens	EC50	nM	10.0
	10934781	CHEMBL2051313	Inhibition of GSK3B in human Rd cells	B	CCOc1ccncc1NC(=O)c1ccnc2[nH]c(-c3cccc(OC)c3)nc12		CHEMBL2048683	=	EC50	nM	10.0	CHEMBL262	Homo sapiens	EC50	nM	10.0
	10934782	CHEMBL2051313	Inhibition of GSK3B in human Rd cells	B	COc1ccncc1NC(=O)c1ccnc2[nH]c(-c3cccc(Cl)c3)nc12		CHEMBL2048684	=	EC50	nM	10.0	CHEMBL262	Homo sapiens	EC50	nM	10.0
	10934783	CHEMBL2051313	Inhibition of GSK3B in human Rd cells	B	COc1ccncc1NC(=O)c1ccnc2[nH]c(-c3ccncc3)nc12		CHEMBL2048685	=	EC50	nM	20.0	CHEMBL262	Homo sapiens	EC50	nM	20.0
	10949930	CHEMBL2049462	Inhibition of N-terminus FLAG-tagged GSK3beta expressed in baculovirus expression system using [gamma-33P]-ATP measured after 30 mins by scintillation counting	B	CC(C)(N)C(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc5sncc45)c(Cl)c3)c21		CHEMBL2048912	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	nM	10000.0
	10969598	CHEMBL2067095	Inhibition of recombinant GSK3beta by KinaseGlo assay	B	CC(=O)O[C@H]1C[C@@H](O)C[C@H](O)C[C@@H](O)[C@@H]2O[C@H]2[C@@H](C)[C@@H]([C@@H](C)[C@@H](O)[C@H](C)[C@@H](O)[C@@H](C)[C@@H](C)O[C@H]2CC[C@H](O[C@@H]3CC[C@@H](OC(=O)[C@H](C)[C@@H](O)/C(C)=C/c4ccc5c(c4)C(=O)C=CC5=O)[C@H](C)O3)[C@H](C)O2)OC(=O)/C=C/[C@H](C)[C@@H](O)C[C@H](O)/C=C/CC[C@@H](C)[C@@H](O)[C@H](O)[C@@]2(O)O[C@@H](C1)C[C@@H](O)[C@@H]2O		CHEMBL2063002	=	IC50	nM	2170.0	CHEMBL262	Homo sapiens	IC50	uM	2.17
	10975227	CHEMBL2065459	Inhibition of GSK3beta	B	CC(=O)Nc1ccc2ccn(-c3cc(NC4CC4)n4ncc(C#N)c4n3)c2c1		CHEMBL2062563	=	IC50	nM	130.0	CHEMBL262	Homo sapiens	IC50	uM	0.13
	10975228	CHEMBL2065459	Inhibition of GSK3beta	B	CC(=O)Nc1ccc2cnn(-c3cc(NC4CC4)n4ncc(C#N)c4n3)c2c1		CHEMBL2062564	=	IC50	nM	700.0	CHEMBL262	Homo sapiens	IC50	uM	0.7
	10975229	CHEMBL2065459	Inhibition of GSK3beta	B	CC(=O)Nc1cnc2ccn(-c3cc(NC4CC4)n4ncc(C#N)c4n3)c2c1		CHEMBL2062565	=	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	uM	1.0
	10975230	CHEMBL2065459	Inhibition of GSK3beta	B	CC(=O)Nc1ccc2ccn(-c3cc(NCCCN(C)C)n4ncc(C#N)c4n3)c2c1		CHEMBL2062575	=	IC50	nM	2600.0	CHEMBL262	Homo sapiens	IC50	uM	2.6
	10975231	CHEMBL2065459	Inhibition of GSK3beta	B	CC(=O)N(C)c1ccc2ccn(-c3cc(NC4CC4)n4ncc(C#N)c4n3)c2c1		CHEMBL2062577	=	IC50	nM	1400.0	CHEMBL262	Homo sapiens	IC50	uM	1.4
	10975232	CHEMBL2065459	Inhibition of GSK3beta	B	CC(=O)Nc1ccc2[nH]cc(-c3cc(NC4CC4)n4ncc(C#N)c4n3)c2c1		CHEMBL2062581	=	IC50	nM	250.0	CHEMBL262	Homo sapiens	IC50	uM	0.25
	10975233	CHEMBL2065459	Inhibition of GSK3beta	B	CC(=O)Nc1ccc2c(c1)c(-c1cc(NC3CC3)n3ncc(C#N)c3n1)cn2CCC(=O)O		CHEMBL2062585	=	IC50	nM	6000.0	CHEMBL262	Homo sapiens	IC50	uM	6.0
	10978467	CHEMBL2066240	Inhibition of human recombinant GSK3beta using ulight-CFFKNIVTPRTPPPSQGK-amide as substrate assessed as residual activity at 1 uM after 90 mins by Cerep assay	B	N#Cc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)cc1		CHEMBL2064515	=	Activity	%	27.2	CHEMBL262	Homo sapiens	Activity	%	27.2
	10978554	CHEMBL2066817	Inhibition of human recombinant GSK3beta assessed as remaining enzyme activity using pIRS-1 as substrate at 10 uM preincubated for 15 mins by FRET assay	B	COC(=O)c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL2064520	=	Activity	%	21.0	CHEMBL262	Homo sapiens	Activity	%	21.0
	10978555	CHEMBL2066817	Inhibition of human recombinant GSK3beta assessed as remaining enzyme activity using pIRS-1 as substrate at 10 uM preincubated for 15 mins by FRET assay	B	COC(=O)c1ccc(CSc2nnc(-c3ccc4c(c3)OCO4)o2)cc1		CHEMBL2064523	=	Activity	%	17.0	CHEMBL262	Homo sapiens	Activity	%	17.0
	10978556	CHEMBL2066817	Inhibition of human recombinant GSK3beta assessed as remaining enzyme activity using pIRS-1 as substrate at 10 uM preincubated for 15 mins by FRET assay	B	O=C(O)c1ccc(CSc2nnc(-c3ccc4c(c3)OCO4)o2)cc1		CHEMBL2064524	=	Activity	%	81.0	CHEMBL262	Homo sapiens	Activity	%	81.0
	10978557	CHEMBL2066817	Inhibition of human recombinant GSK3beta assessed as remaining enzyme activity using pIRS-1 as substrate at 10 uM preincubated for 15 mins by FRET assay	B	CC(C)CNC(=O)c1ccc(CSc2nnc(-c3ccc4c(c3)OCO4)o2)cc1		CHEMBL2064525	=	Activity	%	9.0	CHEMBL262	Homo sapiens	Activity	%	9.0
	10978558	CHEMBL2066817	Inhibition of human recombinant GSK3beta assessed as remaining enzyme activity using pIRS-1 as substrate at 10 uM preincubated for 15 mins by FRET assay	B	COC(CNC(=O)c1ccc(CSc2nnc(-c3ccc4c(c3)OCO4)o2)cc1)OC		CHEMBL2064526	=	Activity	%	31.0	CHEMBL262	Homo sapiens	Activity	%	31.0
	10978559	CHEMBL2066817	Inhibition of human recombinant GSK3beta assessed as remaining enzyme activity using pIRS-1 as substrate at 10 uM preincubated for 15 mins by FRET assay	B	O=C(O)c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL2064527	=	Activity	%	102.0	CHEMBL262	Homo sapiens	Activity	%	102.0
	10978560	CHEMBL2066817	Inhibition of human recombinant GSK3beta assessed as remaining enzyme activity using pIRS-1 as substrate at 10 uM preincubated for 15 mins by FRET assay	B	CC(C)CNC(=O)c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL2064528	=	Activity	%	37.0	CHEMBL262	Homo sapiens	Activity	%	37.0
	10978561	CHEMBL2066817	Inhibition of human recombinant GSK3beta assessed as remaining enzyme activity using pIRS-1 as substrate at 10 uM preincubated for 15 mins by FRET assay	B	COC(CNC(=O)c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1)OC		CHEMBL2064529	=	Activity	%	65.0	CHEMBL262	Homo sapiens	Activity	%	65.0
	10978562	CHEMBL2066817	Inhibition of human recombinant GSK3beta assessed as remaining enzyme activity using pIRS-1 as substrate at 10 uM preincubated for 15 mins by FRET assay	B	O=C(NCc1ccccc1)c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL2064530	=	Activity	%	71.0	CHEMBL262	Homo sapiens	Activity	%	71.0
	10978563	CHEMBL2066819	Inhibition of human recombinant GSK3beta using pIRS-1 as substrate preincubated for 15 mins	B	N#Cc1cccc(CSc2nnc(-c3ccc4c(c3)OCO4)o2)c1		CHEMBL2064516	=	IC50	nM	65.0	CHEMBL262	Homo sapiens	IC50	uM	0.065
	10978564	CHEMBL2066819	Inhibition of human recombinant GSK3beta using pIRS-1 as substrate preincubated for 15 mins	B	N#Cc1ccc(CSc2nnc(-c3ccc4c(c3)OCO4)o2)cc1		CHEMBL2064517	=	IC50	nM	130.0	CHEMBL262	Homo sapiens	IC50	uM	0.13
	10978565	CHEMBL2066819	Inhibition of human recombinant GSK3beta using pIRS-1 as substrate preincubated for 15 mins	B	N#Cc1cccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)c1		CHEMBL2064518	=	IC50	nM	86.0	CHEMBL262	Homo sapiens	IC50	uM	0.086
	10978566	CHEMBL2066819	Inhibition of human recombinant GSK3beta using pIRS-1 as substrate preincubated for 15 mins	B	N#Cc1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL2064519	=	IC50	nM	166.0	CHEMBL262	Homo sapiens	IC50	uM	0.166
	10978567	CHEMBL2066819	Inhibition of human recombinant GSK3beta using pIRS-1 as substrate preincubated for 15 mins	B	COC(=O)c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL2064520	=	IC50	nM	36.0	CHEMBL262	Homo sapiens	IC50	uM	0.036
	10978568	CHEMBL2066819	Inhibition of human recombinant GSK3beta using pIRS-1 as substrate preincubated for 15 mins	B	N#Cc1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL2064521	=	IC50	nM	3162.0	CHEMBL262	Homo sapiens	IC50	uM	3.162
	10978569	CHEMBL2066819	Inhibition of human recombinant GSK3beta using pIRS-1 as substrate preincubated for 15 mins	B	N#Cc1ccc(CSc2nnc(-c3ccncc3)o2)cc1		CHEMBL1352577	=	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	10978570	CHEMBL2066819	Inhibition of human recombinant GSK3beta using pIRS-1 as substrate preincubated for 15 mins	B	c1ccc(CSc2nnc(-c3ccncc3)o2)cc1		CHEMBL40439	=	IC50	nM	1318.0	CHEMBL262	Homo sapiens	IC50	uM	1.318
	10978571	CHEMBL2066819	Inhibition of human recombinant GSK3beta using pIRS-1 as substrate preincubated for 15 mins	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	IC50	nM	790.0	CHEMBL262	Homo sapiens	IC50	uM	0.79
	10978572	CHEMBL2066819	Inhibition of human recombinant GSK3beta using pIRS-1 as substrate preincubated for 15 mins	B	c1cc(-c2nnn[nH]2)ccc1CSc1nnc(-c2ccc3c(c2)OCO3)o1		CHEMBL2064522	=	IC50	nM	172.0	CHEMBL262	Homo sapiens	IC50	uM	0.172
	10978573	CHEMBL2066819	Inhibition of human recombinant GSK3beta using pIRS-1 as substrate preincubated for 15 mins	B	c1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)cc1		CHEMBL2064531	=	IC50	nM	176.0	CHEMBL262	Homo sapiens	IC50	uM	0.176
	10978574	CHEMBL2066819	Inhibition of human recombinant GSK3beta using pIRS-1 as substrate preincubated for 15 mins	B	N#Cc1cc(F)ccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCO4)o2)cc1		CHEMBL2064532	=	IC50	nM	22.0	CHEMBL262	Homo sapiens	IC50	uM	0.022
	10978575	CHEMBL2066819	Inhibition of human recombinant GSK3beta using pIRS-1 as substrate preincubated for 15 mins	B	N#Cc1ccccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCO4)o2)cc1		CHEMBL2064533	=	IC50	nM	39.0	CHEMBL262	Homo sapiens	IC50	uM	0.039
	10978576	CHEMBL2066819	Inhibition of human recombinant GSK3beta using pIRS-1 as substrate preincubated for 15 mins	B	N#Cc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)cc1		CHEMBL2064515	=	IC50	nM	316.0	CHEMBL262	Homo sapiens	IC50	uM	0.316
	10978577	CHEMBL2066819	Inhibition of human recombinant GSK3beta using pIRS-1 as substrate preincubated for 15 mins	B	N#Cc1ccccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL2064534	<	IC50	nM	5.0	CHEMBL262	Homo sapiens	IC50	uM	0.005
	10978578	CHEMBL2066819	Inhibition of human recombinant GSK3beta using pIRS-1 as substrate preincubated for 15 mins	B	N#Cc1cc(F)ccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL2064535	=	IC50	nM	185.0	CHEMBL262	Homo sapiens	IC50	uM	0.185
	10978579	CHEMBL2066819	Inhibition of human recombinant GSK3beta using pIRS-1 as substrate preincubated for 15 mins	B	N#Cc1ccccc1-c1ccc(CSc2nnc(-c3ccncc3)o2)cc1		CHEMBL2064536	=	IC50	nM	41.0	CHEMBL262	Homo sapiens	IC50	uM	0.041
	10978580	CHEMBL2066819	Inhibition of human recombinant GSK3beta using pIRS-1 as substrate preincubated for 15 mins	B	COCC1COc2ccc(-c3nnc(SCc4ccc(-c5ccccc5C#N)cc4)o3)cc2O1		CHEMBL2064537	=	IC50	nM	233.0	CHEMBL262	Homo sapiens	IC50	uM	0.233
	10978581	CHEMBL2066819	Inhibition of human recombinant GSK3beta using pIRS-1 as substrate preincubated for 15 mins	B	COC[C@@H]1COc2ccc(-c3nnc(SCc4ccc(-c5ccccc5C#N)cc4)o3)cc2O1		CHEMBL2064538	=	IC50	nM	758.0	CHEMBL262	Homo sapiens	IC50	uM	0.758
	10978582	CHEMBL2066819	Inhibition of human recombinant GSK3beta using pIRS-1 as substrate preincubated for 15 mins	B	COC[C@H]1COc2ccc(-c3nnc(SCc4ccc(-c5ccccc5C#N)cc4)o3)cc2O1		CHEMBL2064539	=	IC50	nM	129.0	CHEMBL262	Homo sapiens	IC50	uM	0.129
	10980018	CHEMBL2067476	Inhibition of GSK3beta	B	CN(C)C[C@@H](OC(=O)N1Cc2c(NC(=O)C(C)(C)C)n[nH]c2C1(C)C)c1ccccc1		CHEMBL2064628	=	IC50	nM	227.0	CHEMBL262	Homo sapiens	IC50	nM	227.0
	10980023	CHEMBL2067482	Inhibition of GSK3beta at 1000 nM	B	CN(C)C[C@@H](OC(=O)N1Cc2c(NC(=O)C(C)(C)C)n[nH]c2C1(C)C)c1ccccc1		CHEMBL2064628	>	Inhibition	%	70.0	CHEMBL262	Homo sapiens	INH	%	70.0
	10980057	CHEMBL2067482	Inhibition of GSK3beta at 1000 nM	B	CN(C)C[C@@H](OC(=O)N1Cc2c(NC(=O)C(C)(C)C(F)(F)F)n[nH]c2C1(C)C)c1ccccc1		CHEMBL2064631	>	Inhibition	%	70.0	CHEMBL262	Homo sapiens	INH	%	70.0
	10980074	CHEMBL2067476	Inhibition of GSK3beta	B	CN(C)C[C@@H](OC(=O)N1Cc2c(NC(=O)C(C)(C)C)n[nH]c2C1(C)C)c1ccccc1		CHEMBL2064628	>	Inhibition	%	40.0	CHEMBL262	Homo sapiens	INH	%	40.0
	10980256	CHEMBL2065117	Inhibition of GSK3B at 10 uM by FRET assay	B	CSc1ccccc1Nc1nc(N2CC3(CNC3)C2)nc2c(NCC3CC3)ncnc12		CHEMBL2017253	=	Inhibition	%	25.0	CHEMBL262	Homo sapiens	INH	%	25.0
	10980257	CHEMBL2065117	Inhibition of GSK3B at 10 uM by FRET assay	B	CSc1ccccc1Nc1nc(N2CCN(C3CCNCC3)CC2)nc2c(NCC3CC3)ncnc12		CHEMBL2063926	<	Inhibition	%	15.0	CHEMBL262	Homo sapiens	INH	%	15.0
	10980303	CHEMBL2065147	Inhibition of GSK3B by FRET assay	B	CSc1ccccc1Nc1nc(N2CCN(C3CCNCC3)CC2)nc2c(NCC3CC3)ncnc12		CHEMBL2063926	<	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	10983967	CHEMBL2072009	Inhibition of GSK3beta by AlphaScreen assay	B	N#Cc1ccc2nc(Nc3ccc(Oc4ncccc4C(F)(F)F)cc3)[nH]c2c1		CHEMBL2071607	=	IC50	nM	30800.0	CHEMBL262	Homo sapiens	IC50	uM	30.8
Not Determined	10983968	CHEMBL2072009	Inhibition of GSK3beta by AlphaScreen assay	B	N#Cc1ccc2nc(Nc3ccc(Oc4ccccc4)cc3)[nH]c2c1		CHEMBL2071608		IC50			CHEMBL262	Homo sapiens	IC50		
	10983969	CHEMBL2072009	Inhibition of GSK3beta by AlphaScreen assay	B	N#Cc1ccc2nc(Nc3ccc(-c4ccccc4)cc3)[nH]c2c1		CHEMBL2071609	=	IC50	nM	30800.0	CHEMBL262	Homo sapiens	IC50	uM	30.8
	10983970	CHEMBL2072009	Inhibition of GSK3beta by AlphaScreen assay	B	N#Cc1ccc2nc(Nc3ccc(-c4cccnc4F)cc3)[nH]c2c1		CHEMBL2071610	=	IC50	nM	24200.0	CHEMBL262	Homo sapiens	IC50	uM	24.2
	10983971	CHEMBL2072009	Inhibition of GSK3beta by AlphaScreen assay	B	CC(C)(C)c1ccc(Nc2nc3ccc(C#N)cc3[nH]2)cc1		CHEMBL2071612	=	IC50	nM	44500.0	CHEMBL262	Homo sapiens	IC50	uM	44.5
	10983972	CHEMBL2072009	Inhibition of GSK3beta by AlphaScreen assay	B	Cc1ccc(Nc2nc3ccc(C#N)cc3[nH]2)cc1		CHEMBL2071613	=	IC50	nM	30100.0	CHEMBL262	Homo sapiens	IC50	uM	30.1
	10983973	CHEMBL2072009	Inhibition of GSK3beta by AlphaScreen assay	B	CC(C)(O)c1ccc(Nc2nc3ccc(C#N)cc3[nH]2)cc1		CHEMBL2071614	=	IC50	nM	60000.0	CHEMBL262	Homo sapiens	IC50	uM	60.0
	10984746	CHEMBL2072042	Inhibition of human GSK3beta at 1 uM	B	Nc1cc(Nc2cnccn2)nc(-c2ccnc(N3CCNCC3)c2)c1		CHEMBL2069349	<	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	10986195	CHEMBL2073511	Inhibition of GSK3beta by TR-FRET analysis	B	Cn1cc(Nc2ncc(Br)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)cn1		CHEMBL2071201	=	IC50	nM	34.0	CHEMBL262	Homo sapiens	IC50	nM	34.0
Not Active	10986538	CHEMBL2072232	Inhibition of GSK3beta at 10 uM	B	NS(=O)(=O)c1cc(-c2nc3ccccc3s2)cs1		CHEMBL2069711		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	11011267	CHEMBL2092319	Inhibition of GSK3beta in human ReNcell VM cells after 3 hrs by immunoblotting technique	B	NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c(Br)cc32)N1		CHEMBL361708	=	IC50	nM	10.0	CHEMBL262	Homo sapiens	IC50	nM	10.0
	12036442	CHEMBL2150413	Inhibition of N-terminal FLAG-tagged GSK3beta expressed in baculovirus after 5 mins by scintillation counter	B	CC(C)(C(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(Cl)c4)c(Cl)c3)c21)S(C)(=O)=O.Cc1ccc(S(=O)(=O)O)cc1		CHEMBL2148053	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	nM	10000.0
Active	12037000	CHEMBL2149646	Inhibition of GSK3beta at 22500 nM by electrophoretic mobility shift assay	B	O=C1/C(=C/c2c[nH]c3ccccc23)Oc2c1ccc(O)c2CN1CCCCCC1		CHEMBL2147758		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	12037012	CHEMBL2149975	Inhibition of GSK3beta at 200 nM by electrophoretic mobility shift assay	B	COc1ccc2c(c1CN1CCNCC1)O/C(=C\c1c[nH]c3ncccc13)C2=O		CHEMBL2147767		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	12046322	CHEMBL2156652	Inhibition of GSK3beta at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	-4.4	CHEMBL262	Homo sapiens	INH	%	-4.4
	12060926	CHEMBL2157041	Binding affinity to GSK3beta at 1 uM by high throughput binding assay relative to control	B	Nc1cc(NS(=O)(=O)c2cccc(C(F)(F)F)c2)cc(-c2cnc3[nH]cc(-c4ccncc4)c3c2)c1		CHEMBL2152288	=	Activity	%	81.0	CHEMBL262	Homo sapiens	Activity	%	81.0
	12070719	CHEMBL2161896	Inhibition of human GSK3beta at 10 uM	B	CC(=O)n1nc(NC(=O)c2ccccc2)c2c1CN(C(=O)c1ccccc1)C2		CHEMBL2160091	=	Inhibition	%	67.0	CHEMBL262	Homo sapiens	INH	%	67.0
	12074637	CHEMBL2161199	Inhibition of GSK3-beta at 1 uM	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	<	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	12076001	CHEMBL2161549	Inhibition of GSK3beta	B	CCN(CC)S(=O)(=O)c1cc(Nc2nccc(-c3ccnc(-c4ccc(NC(=O)NC)cc4)c3)n2)ccc1Cl		CHEMBL2158866	=	IC50	nM	330.0	CHEMBL262	Homo sapiens	IC50	nM	330.0
	12081895	CHEMBL2166769	Inhibition of GSK3beta	B	Oc1cnc2oc3c4ccccc4c(O)cc3c2c1-c1ccccc1		CHEMBL2163771	=	Ki	nM	10.0	CHEMBL262	Homo sapiens	Ki	uM	0.01
	12081896	CHEMBL2166769	Inhibition of GSK3beta	B	Oc1cc2c(oc3ncc(OCc4ccccc4)c(-c4ccccc4)c32)c2ccccc12		CHEMBL2163770	=	Ki	nM	1600.0	CHEMBL262	Homo sapiens	Ki	uM	1.6
	12081897	CHEMBL2166769	Inhibition of GSK3beta	B	Cc1cc2oc3ncc(OCc4ccccc4)c(-c4ccccc4)c3c2cc1O		CHEMBL2163769	=	Ki	nM	5800.0	CHEMBL262	Homo sapiens	Ki	uM	5.8
	12081898	CHEMBL2166769	Inhibition of GSK3beta	B	COc1ccc2oc3ncc(O)c(-c4ccccc4)c3c2c1	Outside typical range	CHEMBL2163768	>	Ki	nM	1000000.0	CHEMBL262	Homo sapiens	Ki	uM	1000.0
	12081899	CHEMBL2166769	Inhibition of GSK3beta	B	COc1ccc2oc3ncc(OCc4ccccc4)c(-c4ccccc4)c3c2c1		CHEMBL2163774	=	Ki	nM	20.0	CHEMBL262	Homo sapiens	Ki	uM	0.02
	12081900	CHEMBL2166769	Inhibition of GSK3beta	B	COc1ccc2oc3ncc(OC)c(-c4ccccc4)c3c2c1	Outside typical range	CHEMBL2163773	>	Ki	nM	1000000.0	CHEMBL262	Homo sapiens	Ki	uM	1000.0
	12081901	CHEMBL2166769	Inhibition of GSK3beta	B	Oc1ccc2oc3ncc(O)c(-c4ccccc4)c3c2c1		CHEMBL2163772	=	Ki	nM	20.0	CHEMBL262	Homo sapiens	Ki	uM	0.02
	12081902	CHEMBL2166769	Inhibition of GSK3beta	B	Oc1ccc2oc3ncc(OCc4ccccc4)c(-c4ccccc4)c3c2c1		CHEMBL1165662	=	Ki	nM	5800.0	CHEMBL262	Homo sapiens	Ki	uM	5.8
	12081903	CHEMBL2166769	Inhibition of GSK3beta	B	COc1cnc2oc3ccc(O)cc3c2c1-c1ccccc1		CHEMBL183408	=	Ki	nM	14800.0	CHEMBL262	Homo sapiens	Ki	uM	14.8
	12094409	CHEMBL2167125	Inhibition of GSK3beta	B	N[C@H]1CC[C@H](Nc2cc(Nc3ccc(F)c(Cl)c3)n3nccc3n2)CC1		CHEMBL2163999	=	IC50	nM	23000.0	CHEMBL262	Homo sapiens	IC50	uM	23.0
Not Active	12104058	CHEMBL2176489	Binding affinity to GSK3beta at 1 uM by radioligand displacement assay	B	CNc1nn2cc3c(nc2c1S(=O)(=O)c1ccccc1)CCN(C)C3		CHEMBL2172192		Activity			CHEMBL262	Homo sapiens	Activity		
	12112564	CHEMBL2174335	Inhibition of GSK3beta using [33P]ATP at 0.5 uM by filter-binding assay	B	O=C(O)c1ccc(Nc2ncc(F)c(Nc3ccccc3Cl)n2)cc1		CHEMBL2170419	>	Inhibition	%	80.0	CHEMBL262	Homo sapiens	INH	%	80.0
	12141244	CHEMBL2182637	Inhibition of human recombinant GSK3beta using biotin- AAEELDSRAGS(PO3H2)PQL as substrate and [gamma32P]ATP after 20 mins by scintillation proximity assay	B	COCCCNC(=O)c1nc(-c2ccc(S(=O)(=O)N3CCN(C)CC3)cc2)cnc1N		CHEMBL2177180	=	Ki	nM	22.0	CHEMBL262	Homo sapiens	Ki	nM	22.0
	12141245	CHEMBL2182637	Inhibition of human recombinant GSK3beta using biotin- AAEELDSRAGS(PO3H2)PQL as substrate and [gamma32P]ATP after 20 mins by scintillation proximity assay	B	COCCNC(=O)c1nc(-c2ccc(S(=O)(=O)N3CCN(C)CC3)cc2)cnc1N		CHEMBL2177179	=	Ki	nM	90.0	CHEMBL262	Homo sapiens	Ki	nM	90.0
	12141246	CHEMBL2182637	Inhibition of human recombinant GSK3beta using biotin- AAEELDSRAGS(PO3H2)PQL as substrate and [gamma32P]ATP after 20 mins by scintillation proximity assay	B	COc1cccc(NC(=O)c2nc(-c3ccc(S(=O)(=O)N4CCN(C)CC4)cc3)cnc2N)c1		CHEMBL2177178	=	Ki	nM	74.0	CHEMBL262	Homo sapiens	Ki	nM	74.0
	12141247	CHEMBL2182637	Inhibition of human recombinant GSK3beta using biotin- AAEELDSRAGS(PO3H2)PQL as substrate and [gamma32P]ATP after 20 mins by scintillation proximity assay	B	CN1CCN(S(=O)(=O)c2ccc(-c3cnc(N)c(C(=O)Nc4ncns4)n3)cc2)CC1		CHEMBL2177177	=	Ki	nM	0.99	CHEMBL262	Homo sapiens	Ki	nM	0.99
	12141248	CHEMBL2182637	Inhibition of human recombinant GSK3beta using biotin- AAEELDSRAGS(PO3H2)PQL as substrate and [gamma32P]ATP after 20 mins by scintillation proximity assay	B	COc1ccc(NC(=O)c2nc(-c3ccc(S(=O)(=O)N4CCN(C)CC4)cc3)cnc2N)cc1		CHEMBL2177176	=	Ki	nM	690.0	CHEMBL262	Homo sapiens	Ki	nM	690.0
	12141249	CHEMBL2182637	Inhibition of human recombinant GSK3beta using biotin- AAEELDSRAGS(PO3H2)PQL as substrate and [gamma32P]ATP after 20 mins by scintillation proximity assay	B	COc1ccccc1NC(=O)c1nc(-c2ccc(S(=O)(=O)N3CCN(C)CC3)cc2)cnc1N		CHEMBL2177175	=	Ki	nM	12.0	CHEMBL262	Homo sapiens	Ki	nM	12.0
	12141250	CHEMBL2182637	Inhibition of human recombinant GSK3beta using biotin- AAEELDSRAGS(PO3H2)PQL as substrate and [gamma32P]ATP after 20 mins by scintillation proximity assay	B	CN(C)Cc1ccncc1NC(=O)c1nc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)cnc1N		CHEMBL2177174	=	Ki	nM	0.48	CHEMBL262	Homo sapiens	Ki	nM	0.48
	12141251	CHEMBL2182637	Inhibition of human recombinant GSK3beta using biotin- AAEELDSRAGS(PO3H2)PQL as substrate and [gamma32P]ATP after 20 mins by scintillation proximity assay	B	CN1CCN(S(=O)(=O)c2ccc(-c3cnc(N)c(C(=O)Nc4cnccc4CN4CCCC4)n3)cc2)CC1		CHEMBL2177173	=	Ki	nM	0.22	CHEMBL262	Homo sapiens	Ki	nM	0.22
	12141252	CHEMBL2182637	Inhibition of human recombinant GSK3beta using biotin- AAEELDSRAGS(PO3H2)PQL as substrate and [gamma32P]ATP after 20 mins by scintillation proximity assay	B	CN1CCN(S(=O)(=O)c2ccc(-c3cncc(C(=O)Nc4cccnc4)n3)cc2)CC1		CHEMBL2177172	=	Ki	nM	370.0	CHEMBL262	Homo sapiens	Ki	nM	370.0
	12141253	CHEMBL2182637	Inhibition of human recombinant GSK3beta using biotin- AAEELDSRAGS(PO3H2)PQL as substrate and [gamma32P]ATP after 20 mins by scintillation proximity assay	B	CN1CCN(S(=O)(=O)c2ccc(-c3cnc(N)c(C(=O)Nc4cccnc4)c3)cc2)CC1		CHEMBL2177171	=	Ki	nM	64.0	CHEMBL262	Homo sapiens	Ki	nM	64.0
	12141254	CHEMBL2182637	Inhibition of human recombinant GSK3beta using biotin- AAEELDSRAGS(PO3H2)PQL as substrate and [gamma32P]ATP after 20 mins by scintillation proximity assay	B	CN1CCN(S(=O)(=O)c2ccc(-c3ccc(N)c(C(=O)Nc4cccnc4)c3)cc2)CC1		CHEMBL2177170	=	Ki	nM	120.0	CHEMBL262	Homo sapiens	Ki	nM	120.0
	12141255	CHEMBL2182637	Inhibition of human recombinant GSK3beta using biotin- AAEELDSRAGS(PO3H2)PQL as substrate and [gamma32P]ATP after 20 mins by scintillation proximity assay	B	CN(C)CCN(C)C(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3cccnc3)n2)cc1		CHEMBL2177169	=	Ki	nM	16.0	CHEMBL262	Homo sapiens	Ki	nM	16.0
	12141256	CHEMBL2182637	Inhibition of human recombinant GSK3beta using biotin- AAEELDSRAGS(PO3H2)PQL as substrate and [gamma32P]ATP after 20 mins by scintillation proximity assay	B	CN1CCN(C(=O)c2ccc(-c3cnc(N)c(C(=O)Nc4cccnc4)n3)cc2)CC1		CHEMBL2177168	=	Ki	nM	3.1	CHEMBL262	Homo sapiens	Ki	nM	3.1
	12141257	CHEMBL2182637	Inhibition of human recombinant GSK3beta using biotin- AAEELDSRAGS(PO3H2)PQL as substrate and [gamma32P]ATP after 20 mins by scintillation proximity assay	B	CCN(CCN(C)C)S(=O)(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3cccnc3)n2)cc1		CHEMBL2177167	=	Ki	nM	8.4	CHEMBL262	Homo sapiens	Ki	nM	8.4
	12141258	CHEMBL2182637	Inhibition of human recombinant GSK3beta using biotin- AAEELDSRAGS(PO3H2)PQL as substrate and [gamma32P]ATP after 20 mins by scintillation proximity assay	B	CN(C)CCNS(=O)(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3cccnc3)n2)cc1		CHEMBL2177166	=	Ki	nM	20.0	CHEMBL262	Homo sapiens	Ki	nM	20.0
	12141259	CHEMBL2182637	Inhibition of human recombinant GSK3beta using biotin- AAEELDSRAGS(PO3H2)PQL as substrate and [gamma32P]ATP after 20 mins by scintillation proximity assay	B	Nc1ncc(-c2ccc(S(=O)(=O)N3CCOCC3)cc2)nc1C(=O)Nc1cccnc1		CHEMBL2177165	=	Ki	nM	0.67	CHEMBL262	Homo sapiens	Ki	nM	0.67
	12141260	CHEMBL2182637	Inhibition of human recombinant GSK3beta using biotin- AAEELDSRAGS(PO3H2)PQL as substrate and [gamma32P]ATP after 20 mins by scintillation proximity assay	B	Nc1ncc(-c2ccc(S(N)(=O)=O)cc2)nc1C(=O)Nc1cccnc1		CHEMBL2177164	=	Ki	nM	12.0	CHEMBL262	Homo sapiens	Ki	nM	12.0
	12141261	CHEMBL2182637	Inhibition of human recombinant GSK3beta using biotin- AAEELDSRAGS(PO3H2)PQL as substrate and [gamma32P]ATP after 20 mins by scintillation proximity assay	B	Nc1ncc(-c2ccc(S(=O)(=O)N3CCCCC3)cc2)nc1C(=O)Nc1cccnc1		CHEMBL2177163	=	Ki	nM	0.4	CHEMBL262	Homo sapiens	Ki	nM	0.4
	12141262	CHEMBL2182637	Inhibition of human recombinant GSK3beta using biotin- AAEELDSRAGS(PO3H2)PQL as substrate and [gamma32P]ATP after 20 mins by scintillation proximity assay	B	Nc1ncc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)nc1C(=O)Nc1cccnc1		CHEMBL2177162	=	Ki	nM	4.4	CHEMBL262	Homo sapiens	Ki	nM	4.4
	12141263	CHEMBL2182637	Inhibition of human recombinant GSK3beta using biotin- AAEELDSRAGS(PO3H2)PQL as substrate and [gamma32P]ATP after 20 mins by scintillation proximity assay	B	CN1CCN(S(=O)(=O)c2ccc(-c3cnc(N)c(C(=O)Nc4cccnc4)n3)cc2)CC1		CHEMBL2177161	=	Ki	nM	4.9	CHEMBL262	Homo sapiens	Ki	nM	4.9
	12141264	CHEMBL2182637	Inhibition of human recombinant GSK3beta using biotin- AAEELDSRAGS(PO3H2)PQL as substrate and [gamma32P]ATP after 20 mins by scintillation proximity assay	B	Nc1ncc(-c2ccc(OCCN3CCCCC3)cc2)nc1C(=O)Nc1cccnc1		CHEMBL2177160	=	Ki	nM	18.0	CHEMBL262	Homo sapiens	Ki	nM	18.0
	12141265	CHEMBL2182637	Inhibition of human recombinant GSK3beta using biotin- AAEELDSRAGS(PO3H2)PQL as substrate and [gamma32P]ATP after 20 mins by scintillation proximity assay	B	COCCNS(=O)(=O)c1ccc(-c2cnc(N)c(C(=O)Nc3cccnc3)n2)cc1		CHEMBL2177159	=	Ki	nM	2.0	CHEMBL262	Homo sapiens	Ki	nM	2.0
	12141266	CHEMBL2182637	Inhibition of human recombinant GSK3beta using biotin- AAEELDSRAGS(PO3H2)PQL as substrate and [gamma32P]ATP after 20 mins by scintillation proximity assay	B	Cc1cc(-c2cnc(N)c(C(=O)Nc3cccnc3)n2)ccc1S(=O)(=O)N1CCN(C)CC1		CHEMBL2177158	=	Ki	nM	6.3	CHEMBL262	Homo sapiens	Ki	nM	6.3
	12141267	CHEMBL2182637	Inhibition of human recombinant GSK3beta using biotin- AAEELDSRAGS(PO3H2)PQL as substrate and [gamma32P]ATP after 20 mins by scintillation proximity assay	B	CN1CCN(S(=O)(=O)c2ccc(-c3cnc(N)c(C(=O)Nc4cccnc4)n3)cc2F)CC1		CHEMBL2177157	=	Ki	nM	9.0	CHEMBL262	Homo sapiens	Ki	nM	9.0
	12141268	CHEMBL2182637	Inhibition of human recombinant GSK3beta using biotin- AAEELDSRAGS(PO3H2)PQL as substrate and [gamma32P]ATP after 20 mins by scintillation proximity assay	B	Cc1cc(S(=O)(=O)N2CCN(C)CC2)c(C)cc1-c1cnc(N)c(C(=O)Nc2cccnc2)n1		CHEMBL2177156	=	Ki	nM	1.5	CHEMBL262	Homo sapiens	Ki	nM	1.5
	12141269	CHEMBL2182637	Inhibition of human recombinant GSK3beta using biotin- AAEELDSRAGS(PO3H2)PQL as substrate and [gamma32P]ATP after 20 mins by scintillation proximity assay	B	CN1CCN(S(=O)(=O)c2ccc(-c3cnc(N)c(C(=O)Nc4cccnc4)n3)c(C(F)(F)F)c2)CC1		CHEMBL2177155	=	Ki	nM	1.1	CHEMBL262	Homo sapiens	Ki	nM	1.1
	12141270	CHEMBL2182637	Inhibition of human recombinant GSK3beta using biotin- AAEELDSRAGS(PO3H2)PQL as substrate and [gamma32P]ATP after 20 mins by scintillation proximity assay	B	Cc1cc(S(=O)(=O)N2CCN(C)CC2)ccc1-c1cnc(N)c(C(=O)Nc2cccnc2)n1		CHEMBL2182002	=	Ki	nM	0.46	CHEMBL262	Homo sapiens	Ki	nM	0.46
	12141271	CHEMBL2182637	Inhibition of human recombinant GSK3beta using biotin- AAEELDSRAGS(PO3H2)PQL as substrate and [gamma32P]ATP after 20 mins by scintillation proximity assay	B	CN1CCN(S(=O)(=O)c2ccc(-c3cnc(N)c(C(=O)Nc4cccnc4)n3)c(F)c2)CC1		CHEMBL2182001	=	Ki	nM	1.3	CHEMBL262	Homo sapiens	Ki	nM	1.3
	12141272	CHEMBL2182637	Inhibition of human recombinant GSK3beta using biotin- AAEELDSRAGS(PO3H2)PQL as substrate and [gamma32P]ATP after 20 mins by scintillation proximity assay	B	CN1CCN(S(=O)(=O)c2ccccc2-c2cnc(N)c(C(=O)Nc3cccnc3)n2)CC1		CHEMBL2182000	=	Ki	nM	300.0	CHEMBL262	Homo sapiens	Ki	nM	300.0
	12141273	CHEMBL2182637	Inhibition of human recombinant GSK3beta using biotin- AAEELDSRAGS(PO3H2)PQL as substrate and [gamma32P]ATP after 20 mins by scintillation proximity assay	B	CN1CCN(S(=O)(=O)c2cccc(-c3cnc(N)c(C(=O)Nc4cccnc4)n3)c2)CC1		CHEMBL2181999	=	Ki	nM	74.0	CHEMBL262	Homo sapiens	Ki	nM	74.0
	12141274	CHEMBL2182241	Inhibition of GSK3beta	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	IC50	nM	104.0	CHEMBL262	Homo sapiens	IC50	nM	104.0
	12141275	CHEMBL2182241	Inhibition of GSK3beta	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714	=	IC50	nM	9.0	CHEMBL262	Homo sapiens	IC50	nM	9.0
	12141753	CHEMBL2187127	Inhibition of human recombinant GSK3beta expressed in insect cells using YRRAAVPPSPSLSRHSSPHQ-phosphoS-EDEEE as substrate and [gamma33P]ATP after 30 mins by scintillation counting	B	O=C1NC(Nc2ccccc2)=N/C1=C\c1ccc2c(c1)OCO2		CHEMBL1802358	=	IC50	nM	380.0	CHEMBL262	Homo sapiens	IC50	uM	0.38
	12141779	CHEMBL2187127	Inhibition of human recombinant GSK3beta expressed in insect cells using YRRAAVPPSPSLSRHSSPHQ-phosphoS-EDEEE as substrate and [gamma33P]ATP after 30 mins by scintillation counting	B	CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1N		CHEMBL485053	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	12141805	CHEMBL2187127	Inhibition of human recombinant GSK3beta expressed in insect cells using YRRAAVPPSPSLSRHSSPHQ-phosphoS-EDEEE as substrate and [gamma33P]ATP after 30 mins by scintillation counting	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	12150592	CHEMBL2188529	Inhibition of human recombinant GSK3beta by radiometric kinase assay	B	CN1CCN(c2ccc(Nc3ncc4nc(Nc5ccccc5)n(C5CCCC5)c4n3)cc2)CC1		CHEMBL2178352	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	12152503	CHEMBL2183641	Inhibition of GSK3beta assessed as enzyme residual activity at 10 uM relative to untreated control	B	COc1cc(C2=C(c3c[nH]c4cnccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL2180882	=	Activity	%	2.0	CHEMBL262	Homo sapiens	Activity	%	2.0
	12152518	CHEMBL2183641	Inhibition of GSK3beta assessed as enzyme residual activity at 10 uM relative to untreated control	B	COc1cc(C2=C(c3c[nH]c4ncccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL2180878	=	Activity	%	50.0	CHEMBL262	Homo sapiens	Activity	%	50.0
	12152525	CHEMBL2183648	Inhibition of GSK3beta	B	COc1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL201511	=	IC50	nM	71.0	CHEMBL262	Homo sapiens	IC50	nM	71.0
	12152526	CHEMBL2183648	Inhibition of GSK3beta	B	COc1cc(C2=C(c3c[nH]c4cnccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL2180882	=	IC50	nM	9.0	CHEMBL262	Homo sapiens	IC50	nM	9.0
	12152527	CHEMBL2183648	Inhibition of GSK3beta	B	COc1cc(C2=C(c3c[nH]c4cccnc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL2180881	=	IC50	nM	215.0	CHEMBL262	Homo sapiens	IC50	nM	215.0
	12152528	CHEMBL2183648	Inhibition of GSK3beta	B	COc1cc(C2=C(c3c[nH]c4ccncc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL2177142	=	IC50	nM	40.0	CHEMBL262	Homo sapiens	IC50	nM	40.0
	12152529	CHEMBL2183648	Inhibition of GSK3beta	B	COc1cc(C2=C(c3c[nH]c4ncccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL2180878	>=	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	nM	10000.0
	12170807	CHEMBL2210331	Inhibition of GSK3b assessed as residual activity at 1 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	119.0	CHEMBL262	Homo sapiens	Activity	%	119.0
	12172108	CHEMBL2213934	Inhibition of GSK3b assessed as residual activity at 10 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	96.0	CHEMBL262	Homo sapiens	Activity	%	96.0
	12173590	CHEMBL2213529	Inhibition of GSK3B assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL262	Homo sapiens	Activity	%	100.0
	12175179	CHEMBL2210704	Inhibition of GSK3beta	B	CN(c1ccc(F)c(NC(=O)c2cccc(OC(C)(C)C#N)c2Cl)c1)c1ccc2nc(NC(=O)C3CC3)sc2n1		CHEMBL2204532	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	nM	10000.0
	12180247	CHEMBL2211468	Inhibition of GSK3beta	B	COc1cnc(COc2cc(F)c(F)cc2C)cc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203565	=	IC50	nM	38100.0	CHEMBL262	Homo sapiens	IC50	uM	38.1
	12180248	CHEMBL2211468	Inhibition of GSK3beta	B	COc1cnc(COc2ccc(F)cc2C)cc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203564	=	IC50	nM	53300.0	CHEMBL262	Homo sapiens	IC50	uM	53.3
	12180249	CHEMBL2211468	Inhibition of GSK3beta	B	COc1cnc(COc2ccc(F)c(F)c2)cc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203563	=	IC50	nM	10800.0	CHEMBL262	Homo sapiens	IC50	uM	10.8
	12180250	CHEMBL2211468	Inhibition of GSK3beta	B	COc1cnc(COc2ccc(F)cc2F)cc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203562	=	IC50	nM	4000.0	CHEMBL262	Homo sapiens	IC50	uM	4.0
	12180251	CHEMBL2211468	Inhibition of GSK3beta	B	COc1cnc(COc2ccc(F)cc2)cc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203561	=	IC50	nM	7830.0	CHEMBL262	Homo sapiens	IC50	uM	7.83
	12180252	CHEMBL2211468	Inhibition of GSK3beta	B	COc1cnc(CCc2ccc(F)cc2)cc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203560	>	IC50	nM	62500.0	CHEMBL262	Homo sapiens	IC50	uM	62.5
	12180253	CHEMBL2211468	Inhibition of GSK3beta	B	COc1cnc(COc2ccc(F)cc2)nc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203559	=	IC50	nM	1120.0	CHEMBL262	Homo sapiens	IC50	uM	1.12
	12180254	CHEMBL2211468	Inhibition of GSK3beta	B	COc1cnc(Oc2ccccc2)nc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203558	>	IC50	nM	62500.0	CHEMBL262	Homo sapiens	IC50	uM	62.5
	12180255	CHEMBL2211468	Inhibition of GSK3beta	B	COc1cnc(OCc2ccc(F)cc2)nc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203557	>	IC50	nM	30000.0	CHEMBL262	Homo sapiens	IC50	uM	30.0
	12180256	CHEMBL2211468	Inhibition of GSK3beta	B	COc1cnc(Nc2ccccc2)nc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203556	=	IC50	nM	16.0	CHEMBL262	Homo sapiens	IC50	uM	0.016
	12180257	CHEMBL2211468	Inhibition of GSK3beta	B	COc1cnc(NCc2ccccc2)nc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203555	=	IC50	nM	98.0	CHEMBL262	Homo sapiens	IC50	uM	0.098
	12180258	CHEMBL2211468	Inhibition of GSK3beta	B	COc1cnc(CCc2ccc(F)cc2)nc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203554	=	IC50	nM	25600.0	CHEMBL262	Homo sapiens	IC50	uM	25.6
	12180259	CHEMBL2211468	Inhibition of GSK3beta	B	COc1cnc(/C=C/c2ccc(F)cc2)nc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203553	=	IC50	nM	1220.0	CHEMBL262	Homo sapiens	IC50	uM	1.22
	12180260	CHEMBL2211468	Inhibition of GSK3beta	B	COc1cnc(-c2cnc3ccccc3c2)nc1-c1cc2c([nH]1)CCNC2=O		CHEMBL2203552	=	IC50	nM	1.491	CHEMBL262	Homo sapiens	IC50	nM	1.491
	12183880	CHEMBL2211507	Inhibition of GSK3B	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL262	Homo sapiens	pIC50		5.0
	12191210	CHEMBL2215705	Inhibition of GSK3beta using [gamma-33P]ATP by AlphaScreen analysis	B	O=C(Nc1cccc(Oc2ccc3nccn3n2)c1)c1cccc(C(F)(F)F)c1		CHEMBL2206666	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	nM	10000.0
Active	12193503	CHEMBL2215280	Non-ATP competitive inhibition of GSK3beta assessed as phosphorylation substrate ATP by double-reciprocal plot analysis	B	O=C1CC(c2ccccc2)Sc2ccccc2N1Cc1ccccc1[N+](=O)[O-]		CHEMBL2207940		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	12193504	CHEMBL2215280	Non-ATP competitive inhibition of GSK3beta assessed as phosphorylation substrate ATP by double-reciprocal plot analysis	B	O=C1CC(c2ccco2)Sc2ccccc2N1Cc1cccc(Cl)c1		CHEMBL2207939		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	12193505	CHEMBL2215280	Non-ATP competitive inhibition of GSK3beta assessed as phosphorylation substrate ATP by double-reciprocal plot analysis	B	O=C1CC(c2ccco2)Sc2ccccc2N1Cc1ccccc1		CHEMBL2207938		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	12193506	CHEMBL2215732	Inhibition of GSK3beta by kinase-glo assay method	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	IC50	nM	1400.0	CHEMBL262	Homo sapiens	IC50	uM	1.4
	12193507	CHEMBL2215732	Inhibition of GSK3beta by kinase-glo assay method	B	O=C1CC(c2ccccc2)Sc2ccccc2N1Cc1ccccc1[N+](=O)[O-]		CHEMBL2207940	=	IC50	nM	25000.0	CHEMBL262	Homo sapiens	IC50	uM	25.0
	12193508	CHEMBL2215732	Inhibition of GSK3beta by kinase-glo assay method	B	O=C1CC(c2ccco2)Sc2ccccc2N1Cc1cccc(Cl)c1		CHEMBL2207939	=	IC50	nM	27000.0	CHEMBL262	Homo sapiens	IC50	uM	27.0
	12193509	CHEMBL2215732	Inhibition of GSK3beta by kinase-glo assay method	B	O=C1CC(c2ccco2)Sc2ccccc2N1Cc1ccccc1		CHEMBL2207938	=	IC50	nM	77200.0	CHEMBL262	Homo sapiens	IC50	uM	77.2
	12193510	CHEMBL2215732	Inhibition of GSK3beta by kinase-glo assay method	B	CC(C)N1C(=O)CC(c2ccco2)Sc2ccccc21		CHEMBL2207947	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	12193511	CHEMBL2215732	Inhibition of GSK3beta by kinase-glo assay method	B	CN1C(=O)CC(c2ccco2)Sc2ccccc21		CHEMBL1492321	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	12193512	CHEMBL2215732	Inhibition of GSK3beta by kinase-glo assay method	B	O=C1CC(c2cccs2)Sc2ccccc2N1Cc1ccccc1		CHEMBL2207946	=	IC50	nM	47500.0	CHEMBL262	Homo sapiens	IC50	uM	47.5
	12193513	CHEMBL2215732	Inhibition of GSK3beta by kinase-glo assay method	B	CC(C)N1C(=O)CC(c2cccs2)Sc2ccccc21		CHEMBL2207945	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	12193514	CHEMBL2215732	Inhibition of GSK3beta by kinase-glo assay method	B	CCN1C(=O)CC(c2cccs2)Sc2ccccc21		CHEMBL2207944	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	12193515	CHEMBL2215732	Inhibition of GSK3beta by kinase-glo assay method	B	CN1C(=O)CC(c2cccs2)Sc2ccccc21	Outside typical range	CHEMBL2207943	=	IC50	nM	480000.0	CHEMBL262	Homo sapiens	IC50	uM	480.0
	12193516	CHEMBL2215732	Inhibition of GSK3beta by kinase-glo assay method	B	O=C1CC(c2cccs2)Sc2ccccc2N1	Outside typical range	CHEMBL2207942	=	IC50	nM	830000.0	CHEMBL262	Homo sapiens	IC50	uM	830.0
	12193517	CHEMBL2215733	Non-ATP competitive inhibition of GSK3beta	B	CC1=C(O)[C@@H](C/C(C)=C/CCC(C)/C=C/C=C(\C)CCCc2ccoc2)OC1=O		CHEMBL464381	=	IC50	nM	4500.0	CHEMBL262	Homo sapiens	IC50	uM	4.5
	12193518	CHEMBL2215733	Non-ATP competitive inhibition of GSK3beta	B	CCCCCCCCCCCCCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](COP(=O)(O)O)C(=O)N1CCC[C@@H]1C(=O)O		CHEMBL2207941	=	IC50	nM	40000.0	CHEMBL262	Homo sapiens	IC50	uM	40.0
	12193519	CHEMBL2215733	Non-ATP competitive inhibition of GSK3beta	B	O[C@]12C=C(c3nccc4c3[nH]c3ccccc34)[C@@H]3CCN(CCCC/C=C\CC1)C[C@@]31C[C@@H]3/C=C\CCCCN3[C@@H]21		CHEMBL403233	=	IC50	nM	10200.0	CHEMBL262	Homo sapiens	IC50	uM	10.2
	12194104	CHEMBL2214707	Inhibition of GSK3beta	B	CC(C)(C)c1ccc(C(=O)Nc2cn3cc(-n4ccnc4)ccc3n2)cc1.Cl		CHEMBL2205637	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	12195429	CHEMBL2210501	Inhibition of recombinant GSK3B after 1 hr by scintillation counter analysis in presence of gamma-[33P]ATP	B	CC(C)(C)Nc1c(Nc2ccnc(Nc3ccc(-c4ccncc4)cc3)n2)c(=O)c1=O		CHEMBL2205426	=	Ki	nM	102.0	CHEMBL262	Homo sapiens	Ki	nM	102.0
	12195611	CHEMBL2212390	Inhibition of human recombinant GSK3beta using Ulight-CFFKNIVTPRTPPPSQGK-amide as substrate assessed as residual activity at 1 uM after 90 mins relative to staurosporine	B	CCN(CC)CCOc1ccc(/C=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL2206008	=	Activity	%	97.0	CHEMBL262	Homo sapiens	Activity	%	97.0
	12228574	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	106.0	CHEMBL262	Homo sapiens	Residual Activity	%	106.0
	12228575	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	31.0	CHEMBL262	Homo sapiens	Residual Activity	%	31.0
	12228576	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	89.0	CHEMBL262	Homo sapiens	Residual Activity	%	89.0
	12228577	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	101.0	CHEMBL262	Homo sapiens	Residual Activity	%	101.0
	12228578	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	106.0	CHEMBL262	Homo sapiens	Residual Activity	%	106.0
	12228579	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	84.0	CHEMBL262	Homo sapiens	Residual Activity	%	84.0
	12228580	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	89.0	CHEMBL262	Homo sapiens	Residual Activity	%	89.0
	12228581	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	91.0	CHEMBL262	Homo sapiens	Residual Activity	%	91.0
	12228582	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	101.0	CHEMBL262	Homo sapiens	Residual Activity	%	101.0
	12228583	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	102.0	CHEMBL262	Homo sapiens	Residual Activity	%	102.0
	12228584	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	97.0	CHEMBL262	Homo sapiens	Residual Activity	%	97.0
	12228585	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	82.0	CHEMBL262	Homo sapiens	Residual Activity	%	82.0
	12228586	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	108.0	CHEMBL262	Homo sapiens	Residual Activity	%	108.0
	12228587	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	103.0	CHEMBL262	Homo sapiens	Residual Activity	%	103.0
	12228588	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	94.0	CHEMBL262	Homo sapiens	Residual Activity	%	94.0
	12228589	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	99.0	CHEMBL262	Homo sapiens	Residual Activity	%	99.0
	12228590	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	109.0	CHEMBL262	Homo sapiens	Residual Activity	%	109.0
	12228591	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	97.0	CHEMBL262	Homo sapiens	Residual Activity	%	97.0
	12228592	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	81.0	CHEMBL262	Homo sapiens	Residual Activity	%	81.0
	12228593	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	90.0	CHEMBL262	Homo sapiens	Residual Activity	%	90.0
	12228594	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	99.0	CHEMBL262	Homo sapiens	Residual Activity	%	99.0
	12228595	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	69.0	CHEMBL262	Homo sapiens	Residual Activity	%	69.0
	12228596	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	108.0	CHEMBL262	Homo sapiens	Residual Activity	%	108.0
	12228597	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	92.0	CHEMBL262	Homo sapiens	Residual Activity	%	92.0
	12228598	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	104.0	CHEMBL262	Homo sapiens	Residual Activity	%	104.0
	12228599	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	89.0	CHEMBL262	Homo sapiens	Residual Activity	%	89.0
	12228600	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	59.0	CHEMBL262	Homo sapiens	Residual Activity	%	59.0
	12228601	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	89.0	CHEMBL262	Homo sapiens	Residual Activity	%	89.0
	12228602	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	99.0	CHEMBL262	Homo sapiens	Residual Activity	%	99.0
	12228603	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	14.0	CHEMBL262	Homo sapiens	Residual Activity	%	14.0
	12228604	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	85.0	CHEMBL262	Homo sapiens	Residual Activity	%	85.0
	12228605	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	104.0	CHEMBL262	Homo sapiens	Residual Activity	%	104.0
	12228606	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	108.0	CHEMBL262	Homo sapiens	Residual Activity	%	108.0
	12228607	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	101.0	CHEMBL262	Homo sapiens	Residual Activity	%	101.0
	12228608	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	106.0	CHEMBL262	Homo sapiens	Residual Activity	%	106.0
	12228609	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	92.0	CHEMBL262	Homo sapiens	Residual Activity	%	92.0
	12228610	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	92.0	CHEMBL262	Homo sapiens	Residual Activity	%	92.0
	12228611	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	96.0	CHEMBL262	Homo sapiens	Residual Activity	%	96.0
	12228612	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	104.0	CHEMBL262	Homo sapiens	Residual Activity	%	104.0
	12228613	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	86.0	CHEMBL262	Homo sapiens	Residual Activity	%	86.0
	12228614	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	103.0	CHEMBL262	Homo sapiens	Residual Activity	%	103.0
	12228615	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	101.0	CHEMBL262	Homo sapiens	Residual Activity	%	101.0
	12228616	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	15.0	CHEMBL262	Homo sapiens	Residual Activity	%	15.0
	12228617	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	14.0	CHEMBL262	Homo sapiens	Residual Activity	%	14.0
	12228618	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	86.0	CHEMBL262	Homo sapiens	Residual Activity	%	86.0
	12228619	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	94.0	CHEMBL262	Homo sapiens	Residual Activity	%	94.0
	12228620	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	98.0	CHEMBL262	Homo sapiens	Residual Activity	%	98.0
	12228621	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	93.0	CHEMBL262	Homo sapiens	Residual Activity	%	93.0
	12228622	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	115.0	CHEMBL262	Homo sapiens	Residual Activity	%	115.0
	12228623	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	101.0	CHEMBL262	Homo sapiens	Residual Activity	%	101.0
	12228624	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	30.0	CHEMBL262	Homo sapiens	Residual Activity	%	30.0
	12228625	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	88.0	CHEMBL262	Homo sapiens	Residual Activity	%	88.0
	12228626	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	4.0	CHEMBL262	Homo sapiens	Residual Activity	%	4.0
	12228627	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	98.0	CHEMBL262	Homo sapiens	Residual Activity	%	98.0
	12228628	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	95.0	CHEMBL262	Homo sapiens	Residual Activity	%	95.0
	12228629	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	87.0	CHEMBL262	Homo sapiens	Residual Activity	%	87.0
	12228630	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	97.0	CHEMBL262	Homo sapiens	Residual Activity	%	97.0
	12228631	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	99.0	CHEMBL262	Homo sapiens	Residual Activity	%	99.0
	12228632	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	95.0	CHEMBL262	Homo sapiens	Residual Activity	%	95.0
	12228633	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	89.0	CHEMBL262	Homo sapiens	Residual Activity	%	89.0
	12228634	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	84.0	CHEMBL262	Homo sapiens	Residual Activity	%	84.0
	12228635	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	39.0	CHEMBL262	Homo sapiens	Residual Activity	%	39.0
	12228636	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	83.0	CHEMBL262	Homo sapiens	Residual Activity	%	83.0
	12228637	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	96.0	CHEMBL262	Homo sapiens	Residual Activity	%	96.0
	12228638	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	95.0	CHEMBL262	Homo sapiens	Residual Activity	%	95.0
	12228639	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	92.0	CHEMBL262	Homo sapiens	Residual Activity	%	92.0
	12231238	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	92.0	CHEMBL262	Homo sapiens	Residual Activity	%	92.0
	12231239	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	78.0	CHEMBL262	Homo sapiens	Residual Activity	%	78.0
	12231240	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	85.0	CHEMBL262	Homo sapiens	Residual Activity	%	85.0
	12231241	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	84.0	CHEMBL262	Homo sapiens	Residual Activity	%	84.0
	12231242	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	88.0	CHEMBL262	Homo sapiens	Residual Activity	%	88.0
	12231243	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	79.0	CHEMBL262	Homo sapiens	Residual Activity	%	79.0
	12231244	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	24.0	CHEMBL262	Homo sapiens	Residual Activity	%	24.0
	12231245	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	104.0	CHEMBL262	Homo sapiens	Residual Activity	%	104.0
	12231246	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	97.0	CHEMBL262	Homo sapiens	Residual Activity	%	97.0
	12231247	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	100.0	CHEMBL262	Homo sapiens	Residual Activity	%	100.0
	12231248	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	93.0	CHEMBL262	Homo sapiens	Residual Activity	%	93.0
	12231249	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	87.0	CHEMBL262	Homo sapiens	Residual Activity	%	87.0
	12231250	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	93.0	CHEMBL262	Homo sapiens	Residual Activity	%	93.0
	12231251	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	13.0	CHEMBL262	Homo sapiens	Residual Activity	%	13.0
	12231252	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	107.0	CHEMBL262	Homo sapiens	Residual Activity	%	107.0
	12231253	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	23.0	CHEMBL262	Homo sapiens	Residual Activity	%	23.0
	12231254	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	103.0	CHEMBL262	Homo sapiens	Residual Activity	%	103.0
	12231255	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	105.0	CHEMBL262	Homo sapiens	Residual Activity	%	105.0
	12231256	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	112.0	CHEMBL262	Homo sapiens	Residual Activity	%	112.0
	12231257	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	102.0	CHEMBL262	Homo sapiens	Residual Activity	%	102.0
	12231258	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	118.0	CHEMBL262	Homo sapiens	Residual Activity	%	118.0
	12231259	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	93.0	CHEMBL262	Homo sapiens	Residual Activity	%	93.0
	12231260	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	106.0	CHEMBL262	Homo sapiens	Residual Activity	%	106.0
	12231261	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	10.0	CHEMBL262	Homo sapiens	Residual Activity	%	10.0
	12231262	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	118.0	CHEMBL262	Homo sapiens	Residual Activity	%	118.0
	12231263	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	89.0	CHEMBL262	Homo sapiens	Residual Activity	%	89.0
	12231264	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	20.0	CHEMBL262	Homo sapiens	Residual Activity	%	20.0
	12231265	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	105.0	CHEMBL262	Homo sapiens	Residual Activity	%	105.0
	12231266	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	102.0	CHEMBL262	Homo sapiens	Residual Activity	%	102.0
	12231267	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	136.0	CHEMBL262	Homo sapiens	Residual Activity	%	136.0
	12231268	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	112.0	CHEMBL262	Homo sapiens	Residual Activity	%	112.0
	12231269	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	117.0	CHEMBL262	Homo sapiens	Residual Activity	%	117.0
	12231270	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	117.0	CHEMBL262	Homo sapiens	Residual Activity	%	117.0
	12231271	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	113.0	CHEMBL262	Homo sapiens	Residual Activity	%	113.0
	12231272	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	26.0	CHEMBL262	Homo sapiens	Residual Activity	%	26.0
	12231273	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	29.0	CHEMBL262	Homo sapiens	Residual Activity	%	29.0
	12231274	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	106.0	CHEMBL262	Homo sapiens	Residual Activity	%	106.0
	12231275	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	40.0	CHEMBL262	Homo sapiens	Residual Activity	%	40.0
	12231276	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	-1.0	CHEMBL262	Homo sapiens	Residual Activity	%	-1.0
	12231277	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	134.0	CHEMBL262	Homo sapiens	Residual Activity	%	134.0
	12231278	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	105.0	CHEMBL262	Homo sapiens	Residual Activity	%	105.0
	12231279	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	120.0	CHEMBL262	Homo sapiens	Residual Activity	%	120.0
	12231280	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	132.0	CHEMBL262	Homo sapiens	Residual Activity	%	132.0
	12231281	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	8.0	CHEMBL262	Homo sapiens	Residual Activity	%	8.0
	12231282	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	73.0	CHEMBL262	Homo sapiens	Residual Activity	%	73.0
	12231283	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	111.0	CHEMBL262	Homo sapiens	Residual Activity	%	111.0
	12231284	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	-3.0	CHEMBL262	Homo sapiens	Residual Activity	%	-3.0
	12231285	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	141.0	CHEMBL262	Homo sapiens	Residual Activity	%	141.0
	12231286	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	105.0	CHEMBL262	Homo sapiens	Residual Activity	%	105.0
	12231287	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	111.0	CHEMBL262	Homo sapiens	Residual Activity	%	111.0
	12231288	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	101.0	CHEMBL262	Homo sapiens	Residual Activity	%	101.0
	12231289	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	123.0	CHEMBL262	Homo sapiens	Residual Activity	%	123.0
	12231290	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	111.0	CHEMBL262	Homo sapiens	Residual Activity	%	111.0
	12231291	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	118.0	CHEMBL262	Homo sapiens	Residual Activity	%	118.0
	12231292	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	79.0	CHEMBL262	Homo sapiens	Residual Activity	%	79.0
	12231293	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	132.0	CHEMBL262	Homo sapiens	Residual Activity	%	132.0
	12231294	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	122.0	CHEMBL262	Homo sapiens	Residual Activity	%	122.0
	12231295	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	43.0	CHEMBL262	Homo sapiens	Residual Activity	%	43.0
	12231296	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	6.0	CHEMBL262	Homo sapiens	Residual Activity	%	6.0
	12231297	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	112.0	CHEMBL262	Homo sapiens	Residual Activity	%	112.0
	12231298	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	134.0	CHEMBL262	Homo sapiens	Residual Activity	%	134.0
	12231299	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	131.0	CHEMBL262	Homo sapiens	Residual Activity	%	131.0
	12231300	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	52.0	CHEMBL262	Homo sapiens	Residual Activity	%	52.0
	12231301	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	4.0	CHEMBL262	Homo sapiens	Residual Activity	%	4.0
	12231302	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	91.0	CHEMBL262	Homo sapiens	Residual Activity	%	91.0
	12231303	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	28.0	CHEMBL262	Homo sapiens	Residual Activity	%	28.0
	12231304	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	74.0	CHEMBL262	Homo sapiens	Residual Activity	%	74.0
	12231305	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	120.0	CHEMBL262	Homo sapiens	Residual Activity	%	120.0
	12231306	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	22.0	CHEMBL262	Homo sapiens	Residual Activity	%	22.0
	12231307	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	115.0	CHEMBL262	Homo sapiens	Residual Activity	%	115.0
	12231308	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	100.0	CHEMBL262	Homo sapiens	Residual Activity	%	100.0
	12231309	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	75.0	CHEMBL262	Homo sapiens	Residual Activity	%	75.0
	12231310	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	-1.0	CHEMBL262	Homo sapiens	Residual Activity	%	-1.0
	12231311	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	108.0	CHEMBL262	Homo sapiens	Residual Activity	%	108.0
	12231312	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	99.0	CHEMBL262	Homo sapiens	Residual Activity	%	99.0
	12231313	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	136.0	CHEMBL262	Homo sapiens	Residual Activity	%	136.0
	12231314	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	98.0	CHEMBL262	Homo sapiens	Residual Activity	%	98.0
	12231315	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	103.0	CHEMBL262	Homo sapiens	Residual Activity	%	103.0
	12231316	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	117.0	CHEMBL262	Homo sapiens	Residual Activity	%	117.0
	12231317	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	51.0	CHEMBL262	Homo sapiens	Residual Activity	%	51.0
	12231318	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	14.0	CHEMBL262	Homo sapiens	Residual Activity	%	14.0
	12231319	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	8.0	CHEMBL262	Homo sapiens	Residual Activity	%	8.0
	12231320	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	100.0	CHEMBL262	Homo sapiens	Residual Activity	%	100.0
	12231321	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	114.0	CHEMBL262	Homo sapiens	Residual Activity	%	114.0
	12231322	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	42.0	CHEMBL262	Homo sapiens	Residual Activity	%	42.0
	12231323	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	125.0	CHEMBL262	Homo sapiens	Residual Activity	%	125.0
	12231324	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	122.0	CHEMBL262	Homo sapiens	Residual Activity	%	122.0
	12231325	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	34.0	CHEMBL262	Homo sapiens	Residual Activity	%	34.0
	12231326	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	113.0	CHEMBL262	Homo sapiens	Residual Activity	%	113.0
	12231327	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	103.0	CHEMBL262	Homo sapiens	Residual Activity	%	103.0
	12231328	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	88.0	CHEMBL262	Homo sapiens	Residual Activity	%	88.0
	12231329	CHEMBL2219096	Millipore: Percentage of residual kinase activity of GSK3B at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	62.0	CHEMBL262	Homo sapiens	Residual Activity	%	62.0
	12231330	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	96.0	CHEMBL262	Homo sapiens	Residual Activity	%	96.0
	12231331	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	6.0	CHEMBL262	Homo sapiens	Residual Activity	%	6.0
	12231332	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	89.0	CHEMBL262	Homo sapiens	Residual Activity	%	89.0
	12231333	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	116.0	CHEMBL262	Homo sapiens	Residual Activity	%	116.0
	12231334	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	117.0	CHEMBL262	Homo sapiens	Residual Activity	%	117.0
	12231335	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	106.0	CHEMBL262	Homo sapiens	Residual Activity	%	106.0
	12231336	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	66.0	CHEMBL262	Homo sapiens	Residual Activity	%	66.0
	12231337	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	77.0	CHEMBL262	Homo sapiens	Residual Activity	%	77.0
	12231338	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	81.0	CHEMBL262	Homo sapiens	Residual Activity	%	81.0
	12231339	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	82.0	CHEMBL262	Homo sapiens	Residual Activity	%	82.0
	12231340	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	82.0	CHEMBL262	Homo sapiens	Residual Activity	%	82.0
	12231341	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	88.0	CHEMBL262	Homo sapiens	Residual Activity	%	88.0
	12231342	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	96.0	CHEMBL262	Homo sapiens	Residual Activity	%	96.0
	12231343	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	65.0	CHEMBL262	Homo sapiens	Residual Activity	%	65.0
	12231344	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	26.0	CHEMBL262	Homo sapiens	Residual Activity	%	26.0
	12231345	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	80.0	CHEMBL262	Homo sapiens	Residual Activity	%	80.0
	12231346	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	116.0	CHEMBL262	Homo sapiens	Residual Activity	%	116.0
	12231347	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	83.0	CHEMBL262	Homo sapiens	Residual Activity	%	83.0
	12231348	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	99.0	CHEMBL262	Homo sapiens	Residual Activity	%	99.0
	12231349	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	83.0	CHEMBL262	Homo sapiens	Residual Activity	%	83.0
	12231350	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	95.0	CHEMBL262	Homo sapiens	Residual Activity	%	95.0
	12231351	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	27.0	CHEMBL262	Homo sapiens	Residual Activity	%	27.0
	12231352	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	74.0	CHEMBL262	Homo sapiens	Residual Activity	%	74.0
	12231353	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	99.0	CHEMBL262	Homo sapiens	Residual Activity	%	99.0
	12231354	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	80.0	CHEMBL262	Homo sapiens	Residual Activity	%	80.0
	12231355	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	52.0	CHEMBL262	Homo sapiens	Residual Activity	%	52.0
	12231356	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	20.0	CHEMBL262	Homo sapiens	Residual Activity	%	20.0
	12231357	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	86.0	CHEMBL262	Homo sapiens	Residual Activity	%	86.0
	12231358	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	148.0	CHEMBL262	Homo sapiens	Residual Activity	%	148.0
	12231359	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	3.0	CHEMBL262	Homo sapiens	Residual Activity	%	3.0
	12231360	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	113.0	CHEMBL262	Homo sapiens	Residual Activity	%	113.0
	12231361	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	94.0	CHEMBL262	Homo sapiens	Residual Activity	%	94.0
	12231362	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	106.0	CHEMBL262	Homo sapiens	Residual Activity	%	106.0
	12231363	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	73.0	CHEMBL262	Homo sapiens	Residual Activity	%	73.0
	12231364	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	80.0	CHEMBL262	Homo sapiens	Residual Activity	%	80.0
	12231365	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	106.0	CHEMBL262	Homo sapiens	Residual Activity	%	106.0
	12231366	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	75.0	CHEMBL262	Homo sapiens	Residual Activity	%	75.0
	12231367	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	122.0	CHEMBL262	Homo sapiens	Residual Activity	%	122.0
	12231368	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	93.0	CHEMBL262	Homo sapiens	Residual Activity	%	93.0
	12231369	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	73.0	CHEMBL262	Homo sapiens	Residual Activity	%	73.0
	12231370	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	129.0	CHEMBL262	Homo sapiens	Residual Activity	%	129.0
	12231371	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	109.0	CHEMBL262	Homo sapiens	Residual Activity	%	109.0
	12231372	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	26.0	CHEMBL262	Homo sapiens	Residual Activity	%	26.0
	12231373	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	8.0	CHEMBL262	Homo sapiens	Residual Activity	%	8.0
	12231374	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	99.0	CHEMBL262	Homo sapiens	Residual Activity	%	99.0
	12231375	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	88.0	CHEMBL262	Homo sapiens	Residual Activity	%	88.0
	12231376	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	103.0	CHEMBL262	Homo sapiens	Residual Activity	%	103.0
	12231377	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	111.0	CHEMBL262	Homo sapiens	Residual Activity	%	111.0
	12231378	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	101.0	CHEMBL262	Homo sapiens	Residual Activity	%	101.0
	12231379	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	83.0	CHEMBL262	Homo sapiens	Residual Activity	%	83.0
	12231380	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	4.0	CHEMBL262	Homo sapiens	Residual Activity	%	4.0
	12231381	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	90.0	CHEMBL262	Homo sapiens	Residual Activity	%	90.0
	12231382	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	0.0	CHEMBL262	Homo sapiens	Residual Activity	%	0.0
	12231383	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	110.0	CHEMBL262	Homo sapiens	Residual Activity	%	110.0
	12231384	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	94.0	CHEMBL262	Homo sapiens	Residual Activity	%	94.0
	12231385	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	88.0	CHEMBL262	Homo sapiens	Residual Activity	%	88.0
	12231386	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	104.0	CHEMBL262	Homo sapiens	Residual Activity	%	104.0
	12231387	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	123.0	CHEMBL262	Homo sapiens	Residual Activity	%	123.0
	12231388	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	67.0	CHEMBL262	Homo sapiens	Residual Activity	%	67.0
	12231389	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	75.0	CHEMBL262	Homo sapiens	Residual Activity	%	75.0
	12231390	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	44.0	CHEMBL262	Homo sapiens	Residual Activity	%	44.0
	12231391	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	19.0	CHEMBL262	Homo sapiens	Residual Activity	%	19.0
	12231392	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	88.0	CHEMBL262	Homo sapiens	Residual Activity	%	88.0
	12231393	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	87.0	CHEMBL262	Homo sapiens	Residual Activity	%	87.0
	12231394	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	64.0	CHEMBL262	Homo sapiens	Residual Activity	%	64.0
	12231395	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	97.0	CHEMBL262	Homo sapiens	Residual Activity	%	97.0
	12231396	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	104.0	CHEMBL262	Homo sapiens	Residual Activity	%	104.0
	12231397	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	84.0	CHEMBL262	Homo sapiens	Residual Activity	%	84.0
	12231398	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	54.0	CHEMBL262	Homo sapiens	Residual Activity	%	54.0
	12231399	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	97.0	CHEMBL262	Homo sapiens	Residual Activity	%	97.0
	12231400	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	106.0	CHEMBL262	Homo sapiens	Residual Activity	%	106.0
	12231401	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	104.0	CHEMBL262	Homo sapiens	Residual Activity	%	104.0
	12231402	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	3.0	CHEMBL262	Homo sapiens	Residual Activity	%	3.0
	12231403	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	119.0	CHEMBL262	Homo sapiens	Residual Activity	%	119.0
	12231404	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	115.0	CHEMBL262	Homo sapiens	Residual Activity	%	115.0
	12231405	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	147.0	CHEMBL262	Homo sapiens	Residual Activity	%	147.0
	12231406	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	90.0	CHEMBL262	Homo sapiens	Residual Activity	%	90.0
	12231407	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	62.0	CHEMBL262	Homo sapiens	Residual Activity	%	62.0
	12231408	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	138.0	CHEMBL262	Homo sapiens	Residual Activity	%	138.0
	12231409	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	4.0	CHEMBL262	Homo sapiens	Residual Activity	%	4.0
	12231410	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	101.0	CHEMBL262	Homo sapiens	Residual Activity	%	101.0
	12231411	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	3.0	CHEMBL262	Homo sapiens	Residual Activity	%	3.0
	12231412	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	57.0	CHEMBL262	Homo sapiens	Residual Activity	%	57.0
	12231413	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	84.0	CHEMBL262	Homo sapiens	Residual Activity	%	84.0
	12231414	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	94.0	CHEMBL262	Homo sapiens	Residual Activity	%	94.0
	12231415	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	79.0	CHEMBL262	Homo sapiens	Residual Activity	%	79.0
	12231416	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	99.0	CHEMBL262	Homo sapiens	Residual Activity	%	99.0
	12231417	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	34.0	CHEMBL262	Homo sapiens	Residual Activity	%	34.0
	12231418	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	66.0	CHEMBL262	Homo sapiens	Residual Activity	%	66.0
	12231419	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	1.0	CHEMBL262	Homo sapiens	Residual Activity	%	1.0
	12231420	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	94.0	CHEMBL262	Homo sapiens	Residual Activity	%	94.0
	12231421	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	49.0	CHEMBL262	Homo sapiens	Residual Activity	%	49.0
	12231422	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	10.0	CHEMBL262	Homo sapiens	Residual Activity	%	10.0
	12231423	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	121.0	CHEMBL262	Homo sapiens	Residual Activity	%	121.0
	12231424	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	56.0	CHEMBL262	Homo sapiens	Residual Activity	%	56.0
	12231425	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	97.0	CHEMBL262	Homo sapiens	Residual Activity	%	97.0
	12231426	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	69.0	CHEMBL262	Homo sapiens	Residual Activity	%	69.0
	12231427	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	121.0	CHEMBL262	Homo sapiens	Residual Activity	%	121.0
	12231428	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	118.0	CHEMBL262	Homo sapiens	Residual Activity	%	118.0
	12231429	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	106.0	CHEMBL262	Homo sapiens	Residual Activity	%	106.0
	12231430	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	29.0	CHEMBL262	Homo sapiens	Residual Activity	%	29.0
	12231431	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	10.0	CHEMBL262	Homo sapiens	Residual Activity	%	10.0
	12231432	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	103.0	CHEMBL262	Homo sapiens	Residual Activity	%	103.0
	12231433	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	23.0	CHEMBL262	Homo sapiens	Residual Activity	%	23.0
	12231434	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	3.0	CHEMBL262	Homo sapiens	Residual Activity	%	3.0
	12231435	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	114.0	CHEMBL262	Homo sapiens	Residual Activity	%	114.0
	12231436	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	63.0	CHEMBL262	Homo sapiens	Residual Activity	%	63.0
	12231437	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	103.0	CHEMBL262	Homo sapiens	Residual Activity	%	103.0
	12231438	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	106.0	CHEMBL262	Homo sapiens	Residual Activity	%	106.0
	12231439	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	7.0	CHEMBL262	Homo sapiens	Residual Activity	%	7.0
	12231440	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	83.0	CHEMBL262	Homo sapiens	Residual Activity	%	83.0
	12231441	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	78.0	CHEMBL262	Homo sapiens	Residual Activity	%	78.0
	12231442	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	0.0	CHEMBL262	Homo sapiens	Residual Activity	%	0.0
	12231443	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	80.0	CHEMBL262	Homo sapiens	Residual Activity	%	80.0
	12231444	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	130.0	CHEMBL262	Homo sapiens	Residual Activity	%	130.0
	12231445	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	102.0	CHEMBL262	Homo sapiens	Residual Activity	%	102.0
	12231446	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	45.0	CHEMBL262	Homo sapiens	Residual Activity	%	45.0
	12231447	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	121.0	CHEMBL262	Homo sapiens	Residual Activity	%	121.0
	12231448	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	64.0	CHEMBL262	Homo sapiens	Residual Activity	%	64.0
	12231449	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	55.0	CHEMBL262	Homo sapiens	Residual Activity	%	55.0
	12231450	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	73.0	CHEMBL262	Homo sapiens	Residual Activity	%	73.0
	12231451	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	136.0	CHEMBL262	Homo sapiens	Residual Activity	%	136.0
	12231452	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	88.0	CHEMBL262	Homo sapiens	Residual Activity	%	88.0
	12231453	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	33.0	CHEMBL262	Homo sapiens	Residual Activity	%	33.0
	12231454	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	6.0	CHEMBL262	Homo sapiens	Residual Activity	%	6.0
	12231455	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	99.0	CHEMBL262	Homo sapiens	Residual Activity	%	99.0
	12231456	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	57.0	CHEMBL262	Homo sapiens	Residual Activity	%	57.0
	12231457	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	114.0	CHEMBL262	Homo sapiens	Residual Activity	%	114.0
	12231458	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	71.0	CHEMBL262	Homo sapiens	Residual Activity	%	71.0
	12231459	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	0.0	CHEMBL262	Homo sapiens	Residual Activity	%	0.0
	12231460	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	102.0	CHEMBL262	Homo sapiens	Residual Activity	%	102.0
	12231461	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	14.0	CHEMBL262	Homo sapiens	Residual Activity	%	14.0
	12231462	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	58.0	CHEMBL262	Homo sapiens	Residual Activity	%	58.0
	12231463	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	93.0	CHEMBL262	Homo sapiens	Residual Activity	%	93.0
	12231464	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	6.0	CHEMBL262	Homo sapiens	Residual Activity	%	6.0
	12231465	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	70.0	CHEMBL262	Homo sapiens	Residual Activity	%	70.0
	12231466	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	80.0	CHEMBL262	Homo sapiens	Residual Activity	%	80.0
	12231467	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	26.0	CHEMBL262	Homo sapiens	Residual Activity	%	26.0
	12231468	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	0.0	CHEMBL262	Homo sapiens	Residual Activity	%	0.0
	12231469	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	107.0	CHEMBL262	Homo sapiens	Residual Activity	%	107.0
	12231470	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	96.0	CHEMBL262	Homo sapiens	Residual Activity	%	96.0
	12231471	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	105.0	CHEMBL262	Homo sapiens	Residual Activity	%	105.0
	12231472	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	41.0	CHEMBL262	Homo sapiens	Residual Activity	%	41.0
	12231473	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	88.0	CHEMBL262	Homo sapiens	Residual Activity	%	88.0
	12234084	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	98.0	CHEMBL262	Homo sapiens	Residual Activity	%	98.0
	12234085	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	45.0	CHEMBL262	Homo sapiens	Residual Activity	%	45.0
	12234086	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	2.0	CHEMBL262	Homo sapiens	Residual Activity	%	2.0
	12234087	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	1.0	CHEMBL262	Homo sapiens	Residual Activity	%	1.0
	12234088	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	93.0	CHEMBL262	Homo sapiens	Residual Activity	%	93.0
	12234089	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	115.0	CHEMBL262	Homo sapiens	Residual Activity	%	115.0
	12234090	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	4.0	CHEMBL262	Homo sapiens	Residual Activity	%	4.0
	12234091	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	106.0	CHEMBL262	Homo sapiens	Residual Activity	%	106.0
	12234092	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	97.0	CHEMBL262	Homo sapiens	Residual Activity	%	97.0
	12234093	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	10.0	CHEMBL262	Homo sapiens	Residual Activity	%	10.0
	12234094	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	100.0	CHEMBL262	Homo sapiens	Residual Activity	%	100.0
	12234095	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	119.0	CHEMBL262	Homo sapiens	Residual Activity	%	119.0
	12234096	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	28.0	CHEMBL262	Homo sapiens	Residual Activity	%	28.0
	12234097	CHEMBL2219097	Millipore: Percentage of residual kinase activity of GSK3B at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	42.0	CHEMBL262	Homo sapiens	Residual Activity	%	42.0
	12421507	CHEMBL3061700	Inhibition of GSK3beta (unknown origin) using GS-l peptide as substrate and [gamma-33P]-ATP after 10 min	B	CCOc1ccc(S(=O)(=O)N2CCN(c3ccccc3)CC2)cc1-c1nc2ncccc2c(=O)[nH]1		CHEMBL2234213	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	12421508	CHEMBL3061700	Inhibition of GSK3beta (unknown origin) using GS-l peptide as substrate and [gamma-33P]-ATP after 10 min	B	CCOc1ccc(S(=O)(=O)N2CCOCC2)cc1-c1nc2ncccc2c(=O)[nH]1		CHEMBL2234212	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	12421509	CHEMBL3061700	Inhibition of GSK3beta (unknown origin) using GS-l peptide as substrate and [gamma-33P]-ATP after 10 min	B	O=c1[nH]cnc2c(-c3ccc(Br)cc3)n[nH]c12		CHEMBL2234211	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	12421510	CHEMBL3061700	Inhibition of GSK3beta (unknown origin) using GS-l peptide as substrate and [gamma-33P]-ATP after 10 min	B	O=c1[nH]cnc2c(-c3ccccc3)n[nH]c12		CHEMBL2234269	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	12421511	CHEMBL3061700	Inhibition of GSK3beta (unknown origin) using GS-l peptide as substrate and [gamma-33P]-ATP after 10 min	B	CCOC(=O)c1[nH]nc(-c2ccc(Br)cc2)c1N		CHEMBL2234268	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	12421512	CHEMBL3061700	Inhibition of GSK3beta (unknown origin) using GS-l peptide as substrate and [gamma-33P]-ATP after 10 min	B	CCOC(=O)c1[nH]nc(-c2ccc(Cl)cc2)c1N		CHEMBL2234220	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	12421513	CHEMBL3061700	Inhibition of GSK3beta (unknown origin) using GS-l peptide as substrate and [gamma-33P]-ATP after 10 min	B	CCOC(=O)c1[nH]nc(-c2ccc(Cl)cc2)c1/N=N/c1ccccc1		CHEMBL2234219	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	12421514	CHEMBL3061700	Inhibition of GSK3beta (unknown origin) using GS-l peptide as substrate and [gamma-33P]-ATP after 10 min	B	CCOC(=O)c1[nH]nc(-c2ccc(F)cc2)c1/N=N/c1ccccc1		CHEMBL2234218	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	12421515	CHEMBL3061700	Inhibition of GSK3beta (unknown origin) using GS-l peptide as substrate and [gamma-33P]-ATP after 10 min	B	O=C1NN=C(c2ccc(Br)cc2)/C(=N/Nc2ccccc2)C1=O		CHEMBL2234217	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	12421516	CHEMBL3061700	Inhibition of GSK3beta (unknown origin) using GS-l peptide as substrate and [gamma-33P]-ATP after 10 min	B	O=C1NN=C(c2ccccc2)/C(=N/Nc2ccccc2)C1=O		CHEMBL2234216	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	12421517	CHEMBL3061700	Inhibition of GSK3beta (unknown origin) using GS-l peptide as substrate and [gamma-33P]-ATP after 10 min	B	CCOC(=O)C(=O)/C(=N\Nc1ccccc1)C(=O)c1ccc(Cl)cc1		CHEMBL2234215	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	12421518	CHEMBL3061700	Inhibition of GSK3beta (unknown origin) using GS-l peptide as substrate and [gamma-33P]-ATP after 10 min	B	CCOC(=O)C(=O)/C(=N\Nc1ccccc1)C(=O)c1ccccc1		CHEMBL2234214	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	12470765	CHEMBL3055876	Inhibition of GSK3beta (unknown origin) expressed in Sf9 cells using GS1 as substrate and [gamma32]ATP after 30 min by scinitllation counting	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	IC50	nM	190.55	CHEMBL262	Homo sapiens	pIC50		6.72
	12470766	CHEMBL3055876	Inhibition of GSK3beta (unknown origin) expressed in Sf9 cells using GS1 as substrate and [gamma32]ATP after 30 min by scinitllation counting	B	CN1CCN(c2cnc(NCCNc3ccc([N+](=O)[O-])c(N)n3)nc2-c2ccc(Cl)cc2Cl)C(=O)C1		CHEMBL427882	=	IC50	nM	3.981	CHEMBL262	Homo sapiens	pIC50		8.4
	12470767	CHEMBL3055876	Inhibition of GSK3beta (unknown origin) expressed in Sf9 cells using GS1 as substrate and [gamma32]ATP after 30 min by scinitllation counting	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714	=	IC50	nM	33.88	CHEMBL262	Homo sapiens	pIC50		7.47
	12470768	CHEMBL3055876	Inhibition of GSK3beta (unknown origin) expressed in Sf9 cells using GS1 as substrate and [gamma32]ATP after 30 min by scinitllation counting	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	IC50	nM	2.512	CHEMBL262	Homo sapiens	pIC50		8.6
	12470769	CHEMBL3055876	Inhibition of GSK3beta (unknown origin) expressed in Sf9 cells using GS1 as substrate and [gamma32]ATP after 30 min by scinitllation counting	B	CN(C)CCNC(=O)c1ccc(/C=N/Nc2ncnc3c2cnn3-c2cccc3[nH]cnc23)cc1		CHEMBL304533	=	IC50	nM	1.585	CHEMBL262	Homo sapiens	pIC50		8.8
	12470770	CHEMBL3055876	Inhibition of GSK3beta (unknown origin) expressed in Sf9 cells using GS1 as substrate and [gamma32]ATP after 30 min by scinitllation counting	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCOCCOCCOCCn1cc2c2ccccc21		CHEMBL340259	=	IC50	nM	21.88	CHEMBL262	Homo sapiens	pIC50		7.66
	12470771	CHEMBL3055876	Inhibition of GSK3beta (unknown origin) expressed in Sf9 cells using GS1 as substrate and [gamma32]ATP after 30 min by scinitllation counting	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCOCCOCCOCCn1cc2c2cccnc21		CHEMBL340935	=	IC50	nM	16.98	CHEMBL262	Homo sapiens	pIC50		7.77
	12470772	CHEMBL3055876	Inhibition of GSK3beta (unknown origin) expressed in Sf9 cells using GS1 as substrate and [gamma32]ATP after 30 min by scinitllation counting	B	COc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1OC		CHEMBL186054	=	Ki	nM	12.02	CHEMBL262	Homo sapiens	pKi		7.92
	12470773	CHEMBL3055876	Inhibition of GSK3beta (unknown origin) expressed in Sf9 cells using GS1 as substrate and [gamma32]ATP after 30 min by scinitllation counting	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Ki	nM	10.0	CHEMBL262	Homo sapiens	pKi		8.0
	12470774	CHEMBL3055876	Inhibition of GSK3beta (unknown origin) expressed in Sf9 cells using GS1 as substrate and [gamma32]ATP after 30 min by scinitllation counting	B	CC(=O)NC1=NC(=O)/C(=C2\CCNC(=O)c3c2cc(Br)n3C(C)=O)N1		CHEMBL398498	=	IC50	nM	128.82	CHEMBL262	Homo sapiens	pIC50		6.89
	12470775	CHEMBL3055876	Inhibition of GSK3beta (unknown origin) expressed in Sf9 cells using GS1 as substrate and [gamma32]ATP after 30 min by scinitllation counting	B	NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c(Br)cc32)N1		CHEMBL361708	=	IC50	nM	10.0	CHEMBL262	Homo sapiens	pIC50		8.0
	12470776	CHEMBL3055876	Inhibition of GSK3beta (unknown origin) expressed in Sf9 cells using GS1 as substrate and [gamma32]ATP after 30 min by scinitllation counting	B	N#Cc1ccc2[nH]c3c(c2c1)CC(=O)Nc1ccccc1-3		CHEMBL299756	=	IC50	nM	10.0	CHEMBL262	Homo sapiens	pIC50		8.0
	12470777	CHEMBL3055876	Inhibition of GSK3beta (unknown origin) expressed in Sf9 cells using GS1 as substrate and [gamma32]ATP after 30 min by scinitllation counting	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	IC50	nM	3.981	CHEMBL262	Homo sapiens	pIC50		8.4
	12470778	CHEMBL3055876	Inhibition of GSK3beta (unknown origin) expressed in Sf9 cells using GS1 as substrate and [gamma32]ATP after 30 min by scinitllation counting	B	O=C1Nc2ccc(Br)cc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL253770	=	IC50	nM	5.012	CHEMBL262	Homo sapiens	pIC50		8.3
	12470779	CHEMBL3055876	Inhibition of GSK3beta (unknown origin) expressed in Sf9 cells using GS1 as substrate and [gamma32]ATP after 30 min by scinitllation counting	B	CC(=O)O/N=C1C(=C2/C(=O)Nc3cc(Cl)c(Cl)cc32)/Nc2ccccc2/1		CHEMBL253769	=	IC50	nM	3.981	CHEMBL262	Homo sapiens	pIC50		8.4
	12470780	CHEMBL3055876	Inhibition of GSK3beta (unknown origin) expressed in Sf9 cells using GS1 as substrate and [gamma32]ATP after 30 min by scinitllation counting	B	O=C1NC(=O)C(c2cncc3ccoc23)=C1c1cn2c3c(cccc13)CN(C(=O)N1CCOCC1)CC2		CHEMBL178766	=	IC50	nM	0.7943	CHEMBL262	Homo sapiens	pIC50		9.1
	12470781	CHEMBL3055876	Inhibition of GSK3beta (unknown origin) expressed in Sf9 cells using GS1 as substrate and [gamma32]ATP after 30 min by scinitllation counting	B	O=C1NC(=O)C(c2cnc3cccnn23)=C1c1cn2c3c(cccc13)CN(C(=O)N1CCCCC1)CC2		CHEMBL181031	=	IC50	nM	0.7079	CHEMBL262	Homo sapiens	pIC50		9.15
	12582826	CHEMBL3075223	Inhibition of GSK3beta (unknown origin)	B	Cc1ccc(-c2c[nH]c(C3COCCN3Cc3c[nH]c4ccccc34)n2)cc1		CHEMBL2297166	=	IC50	nM	120.0	CHEMBL262	Homo sapiens	IC50	umol/L	0.12
	12582827	CHEMBL3075223	Inhibition of GSK3beta (unknown origin)	B	c1ccc2c(c1)nc(NCCN1CCOCC1)c1c3ccccc3[nH]c21	Outside typical range	CHEMBL605320	<	IC50	nM	50000000.0	CHEMBL262	Homo sapiens	IC50	mM	50.0
	12582828	CHEMBL3075223	Inhibition of GSK3beta (unknown origin)	B	CCN(Cc1cn2ccccc2n1)Cc1nc2cc(OC)c(OC)cc2c(=O)[nH]1	Outside typical range	CHEMBL2297165	<	IC50	nM	50000000.0	CHEMBL262	Homo sapiens	IC50	mM	50.0
	12582829	CHEMBL3075223	Inhibition of GSK3beta (unknown origin)	B	CCN(Cc1cn2ccccc2n1)Cc1nc2ccccc2c(=O)[nH]1		CHEMBL2297160	=	IC	nM	2.0	CHEMBL262	Homo sapiens	IC	nM	2.0
	12582830	CHEMBL3075223	Inhibition of GSK3beta (unknown origin)	B	COc1ccc2c(c1)[n-]c1c3ccccc3[s+]cc21		CHEMBL2297159	=	IC	nM	2.0	CHEMBL262	Homo sapiens	IC	nM	2.0
	12582831	CHEMBL3075223	Inhibition of GSK3beta (unknown origin)	B	Cc1cc2[n-]c3c4ccccc4[s+]cc3c2cc1C		CHEMBL2297172	=	IC	nM	2.0	CHEMBL262	Homo sapiens	IC	nM	2.0
	12591443	CHEMBL3071785	Inhibition of Homo sapiens (human) recombinant GSK3beta after 30 min by Kinase-Glo assay	B	C[C@@H]1O[C@@H](O[C@H]2[C@H](Oc3cc(O)c4c(c3)O[C@H](c3ccc(O)cc3)CC4=O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O		CHEMBL451532	=	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	12591444	CHEMBL3071785	Inhibition of Homo sapiens (human) recombinant GSK3beta after 30 min by Kinase-Glo assay	B	COc1ccc([C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2)cc1O		CHEMBL449317	=	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	12591445	CHEMBL3071785	Inhibition of Homo sapiens (human) recombinant GSK3beta after 30 min by Kinase-Glo assay	B	O=C1C[C@@H](c2ccc(O)cc2)Oc2cc(O)cc(O)c21		CHEMBL9352	=	IC50	nM	45700.0	CHEMBL262	Homo sapiens	IC50	uM	45.7
	12591446	CHEMBL3071785	Inhibition of Homo sapiens (human) recombinant GSK3beta after 30 min by Kinase-Glo assay	B	COc1ccc([C@@H]2CC(=O)c3c(O)cc(O)cc3O2)cc1O		CHEMBL399121	=	IC50	nM	26900.0	CHEMBL262	Homo sapiens	IC50	uM	26.9
	12591447	CHEMBL3071785	Inhibition of Homo sapiens (human) recombinant GSK3beta after 30 min by Kinase-Glo assay	B	O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12		CHEMBL28	=	IC50	nM	1900.0	CHEMBL262	Homo sapiens	IC50	uM	1.9
	12591448	CHEMBL3071785	Inhibition of Homo sapiens (human) recombinant GSK3beta after 30 min by Kinase-Glo assay	B	O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12		CHEMBL50	=	IC50	nM	2000.0	CHEMBL262	Homo sapiens	IC50	uM	2.0
	12591449	CHEMBL3071785	Inhibition of Homo sapiens (human) recombinant GSK3beta after 30 min by Kinase-Glo assay	B	O=c1cc(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12		CHEMBL151	=	IC50	nM	1500.0	CHEMBL262	Homo sapiens	IC50	uM	1.5
	12621668	CHEMBL2319812	Inhibition of human recombinant GSK-3beta using GS2 peptide as substrate and [gamma33P]-ATP after 30 mins by scintillation counting	B	CC1=C(O)/C(=C/[C@H](C)CC/C=C(/C)CCCc2coc(Cc3ccoc3)c2)OC1=O		CHEMBL483842	=	IC50	nM	2344.23	CHEMBL262	Homo sapiens	pIC50		5.63
	12621669	CHEMBL2319812	Inhibition of human recombinant GSK-3beta using GS2 peptide as substrate and [gamma33P]-ATP after 30 mins by scintillation counting	B	CC1=C(O)/C(=C/[C@H](C)CCC/C(C)=C/CCc2coc(Cc3ccoc3)c2)OC1=O		CHEMBL483841	=	IC50	nM	794.33	CHEMBL262	Homo sapiens	pIC50		6.1
	12621670	CHEMBL2319812	Inhibition of human recombinant GSK-3beta using GS2 peptide as substrate and [gamma33P]-ATP after 30 mins by scintillation counting	B	CC1=C(O)[C@@H](C/C(C)=C/CCC(C)/C=C/C=C(\C)CCCc2ccoc2)OC1=O		CHEMBL464381	=	IC50	nM	1905.46	CHEMBL262	Homo sapiens	pIC50		5.72
	12621671	CHEMBL2319812	Inhibition of human recombinant GSK-3beta using GS2 peptide as substrate and [gamma33P]-ATP after 30 mins by scintillation counting	B	CCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O		CHEMBL219346	=	IC50	nM	5754.4	CHEMBL262	Homo sapiens	pIC50		5.24
	12621672	CHEMBL2319812	Inhibition of human recombinant GSK-3beta using GS2 peptide as substrate and [gamma33P]-ATP after 30 mins by scintillation counting	B	CCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O		CHEMBL218301	=	IC50	nM	6165.95	CHEMBL262	Homo sapiens	pIC50		5.21
	12621673	CHEMBL2319812	Inhibition of human recombinant GSK-3beta using GS2 peptide as substrate and [gamma33P]-ATP after 30 mins by scintillation counting	B	CCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O		CHEMBL218931	<	IC50	nM	50118.72	CHEMBL262	Homo sapiens	pIC50		4.3
	12621674	CHEMBL2319812	Inhibition of human recombinant GSK-3beta using GS2 peptide as substrate and [gamma33P]-ATP after 30 mins by scintillation counting	B	CC1=C(O)[C@@H](C/C(C)=C/CCC(C)/C=C/C=C(\C)CCCc2ccoc2)OC1=O		CHEMBL464381	=	IC50	nM	2570.4	CHEMBL262	Homo sapiens	pIC50		5.59
	12621675	CHEMBL2319565	Inhibition of human recombinant GSK-3beta using GS2 peptide as substrate and [gamma33P]-ATP at 50 uM after 30 mins by scintillation counting	B	O=C1O[C@H]([C@@H](O)CO)C(O)=C1O		CHEMBL196	=	Inhibition	%	80.0	CHEMBL262	Homo sapiens	INH	%	80.0
	12621676	CHEMBL2319565	Inhibition of human recombinant GSK-3beta using GS2 peptide as substrate and [gamma33P]-ATP at 50 uM after 30 mins by scintillation counting	B	CCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O		CHEMBL218301	=	Inhibition	%	86.0	CHEMBL262	Homo sapiens	INH	%	86.0
	12621677	CHEMBL2319565	Inhibition of human recombinant GSK-3beta using GS2 peptide as substrate and [gamma33P]-ATP at 50 uM after 30 mins by scintillation counting	B	CCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O		CHEMBL218931	=	Inhibition	%	65.0	CHEMBL262	Homo sapiens	INH	%	65.0
Active	12621691	CHEMBL2319808	Non-competitive inhibition of human recombinant GSK-3beta using fixed concentration of [gamma33P]-ATP and GS2 peptide as substrate by double reciprocal plot analysis	B	CC1=C(O)[C@@H](C/C(C)=C/CCC(C)/C=C/C=C(\C)CCCc2ccoc2)OC1=O		CHEMBL464381		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	12621692	CHEMBL2319809	Non-competitive inhibition of human recombinant GSK-3beta using [gamma33P]-ATP and fixed concentration of GS2 peptide as substrate by double reciprocal plot analysis	B	CC1=C(O)[C@@H](C/C(C)=C/CCC(C)/C=C/C=C(\C)CCCc2ccoc2)OC1=O		CHEMBL464381		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	12621695	CHEMBL2319811	Inhibition of GSK-3beta in human SH-SY5Y cells assessed as reduction of tau phosphorylation at 15 to 200 uM after 18 hrs by ELISA sandwich method	B	CC1=C(O)[C@@H](C/C(C)=C/CCC(C)/C=C/C=C(\C)CCCc2ccoc2)OC1=O		CHEMBL464381		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	12621696	CHEMBL2319811	Inhibition of GSK-3beta in human SH-SY5Y cells assessed as reduction of tau phosphorylation at 15 to 200 uM after 18 hrs by ELISA sandwich method	B	CC1=C(O)[C@@H](C/C(C)=C/CCC(C)/C=C/C=C(\C)CCCc2ccoc2)OC1=O		CHEMBL464381		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	12621697	CHEMBL2319812	Inhibition of human recombinant GSK-3beta using GS2 peptide as substrate and [gamma33P]-ATP after 30 mins by scintillation counting	B	CC1=C(O)/C(=C/[C@H](C)CC/C=C(/C)CCCc2coc(Cc3ccoc3)c2)OC1=O		CHEMBL483842	=	IC50	nM	2300.0	CHEMBL262	Homo sapiens	IC50	uM	2.3
	12621698	CHEMBL2319812	Inhibition of human recombinant GSK-3beta using GS2 peptide as substrate and [gamma33P]-ATP after 30 mins by scintillation counting	B	CC1=C(O)/C(=C/[C@H](C)CCC/C(C)=C/CCc2coc(Cc3ccoc3)c2)OC1=O		CHEMBL483841	=	IC50	nM	800.0	CHEMBL262	Homo sapiens	IC50	uM	0.8
	12621699	CHEMBL2319812	Inhibition of human recombinant GSK-3beta using GS2 peptide as substrate and [gamma33P]-ATP after 30 mins by scintillation counting	B	CC1=C(O)[C@@H](C/C(C)=C/CCC(C)/C=C/C=C(\C)CCCc2ccoc2)OC1=O		CHEMBL464381	=	IC50	nM	1900.0	CHEMBL262	Homo sapiens	IC50	uM	1.9
	12621700	CHEMBL2319812	Inhibition of human recombinant GSK-3beta using GS2 peptide as substrate and [gamma33P]-ATP after 30 mins by scintillation counting	B	CCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O		CHEMBL219346	>	IC50	nM	5800.0	CHEMBL262	Homo sapiens	IC50	uM	5.8
	12621701	CHEMBL2319812	Inhibition of human recombinant GSK-3beta using GS2 peptide as substrate and [gamma33P]-ATP after 30 mins by scintillation counting	B	CCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O		CHEMBL218301	=	IC50	nM	6100.0	CHEMBL262	Homo sapiens	IC50	uM	6.1
	12621702	CHEMBL2319812	Inhibition of human recombinant GSK-3beta using GS2 peptide as substrate and [gamma33P]-ATP after 30 mins by scintillation counting	B	CCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O		CHEMBL218931	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	12621703	CHEMBL2319812	Inhibition of human recombinant GSK-3beta using GS2 peptide as substrate and [gamma33P]-ATP after 30 mins by scintillation counting	B	CC1=C(O)[C@@H](C/C(C)=C/CCC(C)/C=C/C=C(\C)CCCc2ccoc2)OC1=O		CHEMBL464381	=	IC50	nM	2600.0	CHEMBL262	Homo sapiens	IC50	uM	2.6
	12628463	CHEMBL2321414	Inhibition of human Nt-GST-tagged GSK-3beta	B	N#Cc1c(N)nc2sc(C(=O)c3ccc(Cl)cc3)c(N)c2c1-c1ccccc1I		CHEMBL2313821	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	12628464	CHEMBL2321414	Inhibition of human Nt-GST-tagged GSK-3beta	B	N#Cc1cccc(C(=O)c2sc3nc(N)c(C#N)c(-c4ccccc4Cl)c3c2N)c1		CHEMBL2314101	=	IC50	nM	8100.0	CHEMBL262	Homo sapiens	IC50	uM	8.1
	12628465	CHEMBL2321414	Inhibition of human Nt-GST-tagged GSK-3beta	B	N#Cc1c(N)nc2sc(C(=O)c3cccc(Cl)c3)c(N)c2c1-c1ccccc1Cl		CHEMBL2313853	=	IC50	nM	3300.0	CHEMBL262	Homo sapiens	IC50	uM	3.3
	12628466	CHEMBL2321414	Inhibition of human Nt-GST-tagged GSK-3beta	B	N#Cc1c(N)nc2sc(C(=O)c3cccc(Cl)c3)c(N)c2c1-c1ccccc1Br		CHEMBL2313850	=	IC50	nM	4000.0	CHEMBL262	Homo sapiens	IC50	uM	4.0
	12628467	CHEMBL2321414	Inhibition of human Nt-GST-tagged GSK-3beta	B	N#Cc1c(N)nc2sc(C(=O)c3cccc(Cl)c3)c(N)c2c1-c1ccccc1I		CHEMBL2313844	=	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	12628468	CHEMBL2321414	Inhibition of human Nt-GST-tagged GSK-3beta	B	COc1ccccc1-c1c(C#N)c(N)nc2sc(C(=O)c3ccccc3)c(N)c12		CHEMBL2314102	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	12629529	CHEMBL2319130	Inhibition of GSK3beta (unknown origin)	B	O=C(NCCCN1CCOC1=O)c1cnc(NCc2cc(Cl)ccc2Cl)nc1NC1CCCC1		CHEMBL2312304	>	IC50	nM	30000.0	CHEMBL262	Homo sapiens	IC50	uM	30.0
	12629530	CHEMBL2319130	Inhibition of GSK3beta (unknown origin)	B	O=C(NCCCN1CCCC1=O)c1cnc(NCc2cc(Cl)ccc2Cl)nc1NC1CCCC1		CHEMBL2312303	>	IC50	nM	30000.0	CHEMBL262	Homo sapiens	IC50	uM	30.0
	12629531	CHEMBL2319130	Inhibition of GSK3beta (unknown origin)	B	COc1ccccc1CNc1ncc(C(=O)NCCCN2CCCC2=O)c(NC2CCCC2)n1		CHEMBL2312301	>	IC50	nM	30000.0	CHEMBL262	Homo sapiens	IC50	uM	30.0
	12629532	CHEMBL2319130	Inhibition of GSK3beta (unknown origin)	B	COc1ccc(CCNc2ncc(C(=O)NCCCN3CCCC3=O)c(NC3CCCC3)n2)cc1OC		CHEMBL2312290	=	IC50	nM	1680.0	CHEMBL262	Homo sapiens	IC50	uM	1.68
	12631687	CHEMBL2317773	Inhibition of GSK3-beta (unknown origin) in presence of ATP	B	Cc1cc(-c2cnc(Nc3cc(Cl)cc(Cl)c3)nc2NC2CCC(N(C)C)CC2)on1		CHEMBL2312654	=	IC50	nM	7740.0	CHEMBL262	Homo sapiens	IC50	uM	7.74
	12631688	CHEMBL2317773	Inhibition of GSK3-beta (unknown origin) in presence of ATP	B	CN1CCC(NC(=O)c2cnc(Nc3cc(Cl)cc(Cl)c3)nc2N[C@@H]2COC[C@H]2O)CC1		CHEMBL2312652	=	IC50	nM	30000.0	CHEMBL262	Homo sapiens	IC50	uM	30.0
	12631689	CHEMBL2317773	Inhibition of GSK3-beta (unknown origin) in presence of ATP	B	CN1CCC(NC(=O)c2cnc(Nc3cc(Cl)cc(Cl)c3)nc2NC2CCC(N(C)C)CC2)CC1		CHEMBL2312649	=	IC50	nM	30000.0	CHEMBL262	Homo sapiens	IC50	uM	30.0
	12631690	CHEMBL2317773	Inhibition of GSK3-beta (unknown origin) in presence of ATP	B	CN1CCC(NC(=O)c2cnc(NCc3cc(Cl)ccc3Cl)nc2NC2CCCC2)CC1		CHEMBL2312646	=	IC50	nM	30000.0	CHEMBL262	Homo sapiens	IC50	uM	30.0
	12631691	CHEMBL2317773	Inhibition of GSK3-beta (unknown origin) in presence of ATP	B	COc1ccccc1CNc1ncc(C(=O)NC2CCN(C)CC2)c(NC2CCCC2)n1		CHEMBL2312645	=	IC50	nM	30000.0	CHEMBL262	Homo sapiens	IC50	uM	30.0
	12647955	CHEMBL2329192	Inhibition of GSK3B (unknown origin) at 1 uM	B	CC(C)(C)[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325895	=	Inhibition	%	3.0	CHEMBL262	Homo sapiens	INH	%	3.0
	12647956	CHEMBL2329192	Inhibition of GSK3B (unknown origin) at 1 uM	B	C[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325894	=	Inhibition	%	27.0	CHEMBL262	Homo sapiens	INH	%	27.0
	12647957	CHEMBL2329192	Inhibition of GSK3B (unknown origin) at 1 uM	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)C#N		CHEMBL2325906	=	Inhibition	%	66.0	CHEMBL262	Homo sapiens	INH	%	66.0
	12647958	CHEMBL2329192	Inhibition of GSK3B (unknown origin) at 1 uM	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)C		CHEMBL2325903	=	Inhibition	%	79.0	CHEMBL262	Homo sapiens	INH	%	79.0
	12649627	CHEMBL2329542	Inhibition of GSK3B (unknown origin) at 10 uM	B	C[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325894	=	Inhibition	%	84.0	CHEMBL262	Homo sapiens	INH	%	84.0
	12649628	CHEMBL2329542	Inhibition of GSK3B (unknown origin) at 10 uM	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)O		CHEMBL2325904	=	Inhibition	%	91.0	CHEMBL262	Homo sapiens	INH	%	91.0
	12649629	CHEMBL2329542	Inhibition of GSK3B (unknown origin) at 10 uM	B	CC(C)NC(=O)c1c[nH]c2ncc(C3CC3)nc12		CHEMBL2325901	=	Inhibition	%	97.0	CHEMBL262	Homo sapiens	INH	%	97.0
	12656753	CHEMBL2328972	Inhibition of human recombinant GSK3beta	B	Clc1cc(-c2c[nH]c3ncccc23)cc(NC2CCCCC2)n1		CHEMBL2322677	=	Ki	nM	58.0	CHEMBL262	Homo sapiens	Ki	nM	58.0
Active	12670840	CHEMBL2338931	Reversible inhibition of human recombinant GSK3beta using 650HSSPHQ(pS)EDEEE as substrate at 25 uM preincubated up to 10 mins prior to substrate addition measured after 30 mins by luminescence assay	B	O=C1CC(Cc2ccccc2)Sc2ccccc2N1Cc1ccccc1[N+](=O)[O-]		CHEMBL2334795		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	12670841	CHEMBL2338932	Reversible inhibition of human recombinant GSK3beta using 650HSSPHQ(pS)EDEEE as substrate at 12.5 uM preincubated up to 10 mins prior to substrate addition measured after 30 mins by luminescence assay	B	O=C1CC(Cc2ccccc2)Sc2ccccc2N1Cc1ccccc1[N+](=O)[O-]		CHEMBL2334795		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	12670842	CHEMBL2338933	Non competitive inhibition of human recombinant GSK3beta using 650HSSPHQ(pS)EDEEE as substrate at 50 uM after 30 mins by double-reciprocal plot analysis in presence of ATP	B	O=C1CC(Cc2ccccc2)Sc2ccccc2N1Cc1ccccc1[N+](=O)[O-]		CHEMBL2334795		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	12670843	CHEMBL2338934	Non competitive inhibition of human recombinant GSK3beta using 650HSSPHQ(pS)EDEEE as substrate at 25 uM after 30 mins by double-reciprocal plot analysis in presence of ATP	B	O=C1CC(Cc2ccccc2)Sc2ccccc2N1Cc1ccccc1[N+](=O)[O-]		CHEMBL2334795		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	12670844	CHEMBL2338935	Inhibition of human recombinant GSK3beta using 650HSSPHQ(pS)EDEEE as substrate after 30 mins by luminescence assay	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	IC50	nM	1400.0	CHEMBL262	Homo sapiens	IC50	uM	1.4
	12670845	CHEMBL2338935	Inhibition of human recombinant GSK3beta using 650HSSPHQ(pS)EDEEE as substrate after 30 mins by luminescence assay	B	O=C1CC(c2ccc(Br)cc2)Sc2ccccc2N1Cc1ccccc1[N+](=O)[O-]		CHEMBL2334798	=	IC50	nM	67800.0	CHEMBL262	Homo sapiens	IC50	uM	67.8
	12670846	CHEMBL2338935	Inhibition of human recombinant GSK3beta using 650HSSPHQ(pS)EDEEE as substrate after 30 mins by luminescence assay	B	O=C1CC(c2ccc(Cl)cc2)Sc2ccccc2N1Cc1ccccc1[N+](=O)[O-]		CHEMBL2334797	=	IC50	nM	71300.0	CHEMBL262	Homo sapiens	IC50	uM	71.3
	12670847	CHEMBL2338935	Inhibition of human recombinant GSK3beta using 650HSSPHQ(pS)EDEEE as substrate after 30 mins by luminescence assay	B	O=C1CC(c2ccc(F)cc2)Sc2ccccc2N1Cc1ccccc1[N+](=O)[O-]		CHEMBL2334796	=	IC50	nM	81500.0	CHEMBL262	Homo sapiens	IC50	uM	81.5
	12670848	CHEMBL2338935	Inhibition of human recombinant GSK3beta using 650HSSPHQ(pS)EDEEE as substrate after 30 mins by luminescence assay	B	O=C1CC(Cc2ccccc2)Sc2ccccc2N1Cc1ccccc1[N+](=O)[O-]		CHEMBL2334795	=	IC50	nM	23000.0	CHEMBL262	Homo sapiens	IC50	uM	23.0
	12670849	CHEMBL2338935	Inhibition of human recombinant GSK3beta using 650HSSPHQ(pS)EDEEE as substrate after 30 mins by luminescence assay	B	O=C(CN1C(=O)CC(c2ccccc2)Sc2ccccc21)c1cccc(Cl)c1		CHEMBL2334794	=	IC50	nM	37800.0	CHEMBL262	Homo sapiens	IC50	uM	37.8
	12670850	CHEMBL2338935	Inhibition of human recombinant GSK3beta using 650HSSPHQ(pS)EDEEE as substrate after 30 mins by luminescence assay	B	COC(=O)c1cccc(CN2C(=O)CC(c3ccccc3)Sc3ccccc32)c1		CHEMBL2334793	=	IC50	nM	27800.0	CHEMBL262	Homo sapiens	IC50	uM	27.8
	12670851	CHEMBL2338935	Inhibition of human recombinant GSK3beta using 650HSSPHQ(pS)EDEEE as substrate after 30 mins by luminescence assay	B	O=C(O)c1cccc(CN2C(=O)CC(c3ccccc3)Sc3ccccc32)c1		CHEMBL2334792	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	12670852	CHEMBL2338935	Inhibition of human recombinant GSK3beta using 650HSSPHQ(pS)EDEEE as substrate after 30 mins by luminescence assay	B	COc1ccc(CN2C(=O)CC(c3ccccc3)Sc3ccccc32)cc1		CHEMBL2334791	=	IC50	nM	73700.0	CHEMBL262	Homo sapiens	IC50	uM	73.7
	12670853	CHEMBL2338935	Inhibition of human recombinant GSK3beta using 650HSSPHQ(pS)EDEEE as substrate after 30 mins by luminescence assay	B	Cc1ccccc1CN1C(=O)CC(c2ccccc2)Sc2ccccc21		CHEMBL2334790	=	IC50	nM	76100.0	CHEMBL262	Homo sapiens	IC50	uM	76.1
	12670854	CHEMBL2338935	Inhibition of human recombinant GSK3beta using 650HSSPHQ(pS)EDEEE as substrate after 30 mins by luminescence assay	B	O=C1CC(c2ccccc2)Sc2ccccc2N1Cc1ccccc1Br		CHEMBL2334789	=	IC50	nM	73900.0	CHEMBL262	Homo sapiens	IC50	uM	73.9
	12670855	CHEMBL2338935	Inhibition of human recombinant GSK3beta using 650HSSPHQ(pS)EDEEE as substrate after 30 mins by luminescence assay	B	O=C1CC(c2ccccc2)Sc2ccccc2N1Cc1ccccc1Cl		CHEMBL2334788	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	12670856	CHEMBL2338935	Inhibition of human recombinant GSK3beta using 650HSSPHQ(pS)EDEEE as substrate after 30 mins by luminescence assay	B	O=C1CC(c2ccccc2)Sc2ccccc2N1Cc1ccccc1F		CHEMBL1397048	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	12670857	CHEMBL2338935	Inhibition of human recombinant GSK3beta using 650HSSPHQ(pS)EDEEE as substrate after 30 mins by luminescence assay	B	N#Cc1ccccc1CN1C(=O)CC(c2ccccc2)Sc2ccccc21		CHEMBL2334787	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	12670858	CHEMBL2338935	Inhibition of human recombinant GSK3beta using 650HSSPHQ(pS)EDEEE as substrate after 30 mins by luminescence assay	B	O=C1CC(c2ccccc2)Sc2ccccc2N1Cc1ccccc1[N+](=O)[O-]		CHEMBL2207940	=	IC50	nM	25000.0	CHEMBL262	Homo sapiens	IC50	uM	25.0
	12670859	CHEMBL2338935	Inhibition of human recombinant GSK3beta using 650HSSPHQ(pS)EDEEE as substrate after 30 mins by luminescence assay	B	O=C1CC(c2ccccc2)Sc2ccccc2N1Cc1ccccc1		CHEMBL2334786	=	IC50	nM	42700.0	CHEMBL262	Homo sapiens	IC50	uM	42.7
	12670860	CHEMBL2338935	Inhibition of human recombinant GSK3beta using 650HSSPHQ(pS)EDEEE as substrate after 30 mins by luminescence assay	B	O=C1CC(c2cccnc2)Sc2ccccc2N1Cc1ccccc1		CHEMBL2334785	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	12670861	CHEMBL2338935	Inhibition of human recombinant GSK3beta using 650HSSPHQ(pS)EDEEE as substrate after 30 mins by luminescence assay	B	CC1CC(=O)N(Cc2ccccc2)c2ccccc2S1		CHEMBL2334784	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	12670862	CHEMBL2338935	Inhibition of human recombinant GSK3beta using 650HSSPHQ(pS)EDEEE as substrate after 30 mins by luminescence assay	B	O=C1CCSc2ccccc2N1Cc1ccccc1		CHEMBL2334783	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	12670863	CHEMBL2338935	Inhibition of human recombinant GSK3beta using 650HSSPHQ(pS)EDEEE as substrate after 30 mins by luminescence assay	B	O=C1CC(c2ccco2)Sc2ccccc2N1Cc1ccccc1		CHEMBL2207938	=	IC50	nM	77200.0	CHEMBL262	Homo sapiens	IC50	uM	77.2
	12670864	CHEMBL2338935	Inhibition of human recombinant GSK3beta using 650HSSPHQ(pS)EDEEE as substrate after 30 mins by luminescence assay	B	O=C1CC(c2cccs2)Sc2ccccc2N1Cc1ccccc1		CHEMBL2207946	=	IC50	nM	47500.0	CHEMBL262	Homo sapiens	IC50	uM	47.5
	12670865	CHEMBL2338935	Inhibition of human recombinant GSK3beta using 650HSSPHQ(pS)EDEEE as substrate after 30 mins by luminescence assay	B	O=C1CC(c2cccs2)Sc2ccccc2N1C(=O)c1ccccc1		CHEMBL2334782	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	12670866	CHEMBL2338935	Inhibition of human recombinant GSK3beta using 650HSSPHQ(pS)EDEEE as substrate after 30 mins by luminescence assay	B	O=C1CC(c2cccs2)Sc2ccccc2N1CC1CCCCC1		CHEMBL2334781	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	12670867	CHEMBL2338935	Inhibition of human recombinant GSK3beta using 650HSSPHQ(pS)EDEEE as substrate after 30 mins by luminescence assay	B	CCCCN1C(=O)CC(c2cccs2)Sc2ccccc21		CHEMBL2334780	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	12670868	CHEMBL2338935	Inhibition of human recombinant GSK3beta using 650HSSPHQ(pS)EDEEE as substrate after 30 mins by luminescence assay	B	CC(C)N1C(=O)CC(c2cccs2)Sc2ccccc21		CHEMBL2207945	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	12670869	CHEMBL2338935	Inhibition of human recombinant GSK3beta using 650HSSPHQ(pS)EDEEE as substrate after 30 mins by luminescence assay	B	CCN1C(=O)CC(c2cccs2)Sc2ccccc21		CHEMBL2207944	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	12670870	CHEMBL2338935	Inhibition of human recombinant GSK3beta using 650HSSPHQ(pS)EDEEE as substrate after 30 mins by luminescence assay	B	CN1C(=O)CC(c2cccs2)Sc2ccccc21	Outside typical range	CHEMBL2207943	=	IC50	nM	480000.0	CHEMBL262	Homo sapiens	IC50	uM	480.0
	12670871	CHEMBL2338935	Inhibition of human recombinant GSK3beta using 650HSSPHQ(pS)EDEEE as substrate after 30 mins by luminescence assay	B	O=C1CC(c2cccs2)Sc2ccccc2N1	Outside typical range	CHEMBL2207942	=	IC50	nM	830000.0	CHEMBL262	Homo sapiens	IC50	uM	830.0
	12670872	CHEMBL2338936	Inhibition of GSK3beta (unknown origin)	B	CC1=C(O)[C@@H](C/C(C)=C/CCC(C)/C=C/C=C(\C)CCCc2ccoc2)OC1=O		CHEMBL464381	=	IC50	nM	4500.0	CHEMBL262	Homo sapiens	IC50	uM	4.5
	12670873	CHEMBL2338936	Inhibition of GSK3beta (unknown origin)	B	CCCCCCCCCCCCCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCP(=O)(O)O)C(=O)N1CCC[C@@H]1C(=O)O		CHEMBL2334799	=	IC50	nM	40000.0	CHEMBL262	Homo sapiens	IC50	uM	40.0
	12671042	CHEMBL2345080	Inhibition of GSK3beta (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)nnc2cc(N3CCOCC3)ccc12		CHEMBL2333120	=	Inhibition	%	42.0	CHEMBL262	Homo sapiens	INH	%	42.0
	12671043	CHEMBL2345080	Inhibition of GSK3beta (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)nnc2ccc(-c3cn[nH]c3)cc12		CHEMBL2333115	=	Inhibition	%	95.0	CHEMBL262	Homo sapiens	INH	%	95.0
	12671044	CHEMBL2345080	Inhibition of GSK3beta (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)nnc2ccc(-c3ccncc3)cc12		CHEMBL2333114	=	Inhibition	%	94.0	CHEMBL262	Homo sapiens	INH	%	94.0
	12671045	CHEMBL2345080	Inhibition of GSK3beta (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)nnc2cc(-c3ccncc3)ccc12		CHEMBL2333112	=	Inhibition	%	88.0	CHEMBL262	Homo sapiens	INH	%	88.0
	12671046	CHEMBL2345080	Inhibition of GSK3beta (unknown origin) at 10 uM relative to control	B	CS(=O)(=O)c1ccc(-c2ccc3c(NC4CCC4)c(C(N)=O)nnc3c2)cc1		CHEMBL2333129	=	Inhibition	%	17.0	CHEMBL262	Homo sapiens	INH	%	17.0
	12671047	CHEMBL2345080	Inhibition of GSK3beta (unknown origin) at 10 uM relative to control	B	C[C@@H](Nc1c(C(N)=O)nnc2cc(-c3ccc(S(C)(=O)=O)cc3)ccc12)C1CC1		CHEMBL2333128	=	Inhibition	%	29.0	CHEMBL262	Homo sapiens	INH	%	29.0
	12671048	CHEMBL2345080	Inhibition of GSK3beta (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)cnc2cc(-c3ccc(S(C)(=O)=O)cc3)ccc12		CHEMBL2333125	=	Inhibition	%	6.0	CHEMBL262	Homo sapiens	INH	%	6.0
	12673039	CHEMBL2339746	Inhibition of recombinant GSK3b (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336379	=	Activity	%	28.0	CHEMBL262	Homo sapiens	Activity	%	28.0
	12673040	CHEMBL2339746	Inhibition of recombinant GSK3b (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336377	=	Activity	%	37.0	CHEMBL262	Homo sapiens	Activity	%	37.0
	12679744	CHEMBL2345855	Inhibition of GSK3beta (unknown origin) at 1 uM	B	Cc1ccc(-c2ccc3ncc4c(c3n2)n(C2CCN(C(=O)[C@H](C)O)CC2)c(=O)n4C)cn1		CHEMBL2331664	=	Inhibition	%	0.5	CHEMBL262	Homo sapiens	INH	%	0.5
	12693232	CHEMBL2343918	Inhibition of GSK3beta (unknown origin)	B	Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F		CHEMBL2333365	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	nM	10000.0
	12700129	CHEMBL2342668	Inhibition of recombinant GSK3B (unknown origin) at 5 uM by FRET-based Z'-LYTE assay	B	O=C1/C(=C/c2ccccn2)CNC/C1=C\c1ccccn1		CHEMBL574646	=	Inhibition	%	17.0	CHEMBL262	Homo sapiens	INH	%	17.0
	12718777	CHEMBL2353276	Inhibition of GSK3beta (unknown origin) after 10 mins by mobility shift assay	B	O=C1Nc2ccccc2/C1=C/c1c[nH]nc1-c1ccccc1[N+](=O)[O-]		CHEMBL2347053	=	IC50	nM	13.0	CHEMBL262	Homo sapiens	IC50	nM	13.0
	12718801	CHEMBL2350685	Inhibition of GSK3beta (unknown origin) at 3 uM after 10 mins by mobility shift assay relative to control	B	O=C1Nc2ccccc2/C1=C/c1c[nH]nc1-c1ccccc1[N+](=O)[O-]		CHEMBL2347053	=	Inhibition	%	37.0	CHEMBL262	Homo sapiens	INH	%	37.0
	12718824	CHEMBL2350708	Inhibition of GSK3beta (unknown origin) at 10 uM after 10 mins by mobility shift assay relative to control	B	O=C1Nc2ccccc2/C1=C/c1c[nH]nc1-c1ccccc1[N+](=O)[O-]		CHEMBL2347053	=	Inhibition	%	40.0	CHEMBL262	Homo sapiens	INH	%	40.0
	12721816	CHEMBL2353801	Inhibition of GSK3b (unknown origin) at 1 uM relative to control	B	CCNC(=O)Nc1nc2ccc(-c3ccccc3OC)cc2s1		CHEMBL2347710	=	Inhibition	%	100.0	CHEMBL262	Homo sapiens	INH	%	100.0
	12723662	CHEMBL2350760	Inhibition of GSK3beta (unknown origin) at 10 uM by single point assay	B	C[C@@H](Nc1c(C#N)cnc2cc(-c3ccc(-n4ccoc4=O)cc3)ccc12)C1CC1		CHEMBL2347818	=	Inhibition	%	1.0	CHEMBL262	Homo sapiens	INH	%	1.0
	12724766	CHEMBL2352281	Inhibition of GSK3beta (unknown origin) at 1 uM by single point assay	B	CC(C)Nc1c(C#N)cnc2cc(-c3cnn(C)c3)ccc12		CHEMBL2347824	=	Inhibition	%	6.0	CHEMBL262	Homo sapiens	INH	%	6.0
	12724767	CHEMBL2352281	Inhibition of GSK3beta (unknown origin) at 1 uM by single point assay	B	CC(C)Nc1c(C#N)cnc2cc(-c3ccc(S(C)(=O)=O)cc3)ccc12		CHEMBL2347823	=	Inhibition	%	28.0	CHEMBL262	Homo sapiens	INH	%	28.0
	12728064	CHEMBL2351279	Inhibition of N-terminal FLAG-tagged GSK3beta (unknown origin) expressed in baculovirus expression system incubated for 5 mins prior to [gamma-33P]ATP addition measured after 30 mins by scintillation counting analysis	B	O=C(NCCO)C1=Cc2c(ncnc2Nc2ccc(Oc3cccc4sccc34)c(Cl)c2)NCC1		CHEMBL2348417	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	nM	10000.0
	12728815	CHEMBL2352888	Inhibition of GSK3beta (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	71.0	CHEMBL262	Homo sapiens	Activity	%	71.0
	12729060	CHEMBL2351966	Inhibition of GSK3beta (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	98.0	CHEMBL262	Homo sapiens	Activity	%	98.0
	12729351	CHEMBL2351451	Inhibition of GSK3beta (unknown origin) at 1 uM	B	FC(F)(F)c1cccc(Sc2ccc3nnc(-c4ccccc4)n3n2)c1		CHEMBL2348936	>	Inhibition	%	18.0	CHEMBL262	Homo sapiens	INH	%	18.0
	12729942	CHEMBL2352178	Inhibition of GSK3B (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	103.0	CHEMBL262	Homo sapiens	Activity	%	103.0
	12730203	CHEMBL2352888	Inhibition of GSK3beta (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	91.0	CHEMBL262	Homo sapiens	Activity	%	91.0
	13279234	CHEMBL2380170	Inhibition of human GSK3beta at 0.1 uM incubated for 15 mins prior to substrate addition measured after 90 mins by P33-radiolabeled assay relative to control	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)sc1C(=O)c1ccccc1[N+](=O)[O-]		CHEMBL2377825	=	Inhibition	%	60.0	CHEMBL262	Homo sapiens	INH	%	60.0
	13279239	CHEMBL2380175	Inhibition of GSK3beta (unknown origin)-mediated phosphorylation of peptide substrate incubated for 15 mins prior to substrate addition measured after 90 mins by P33-radiolabeled assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	15.0	CHEMBL262	Homo sapiens	IC50	nM	15.0
	13279240	CHEMBL2380175	Inhibition of GSK3beta (unknown origin)-mediated phosphorylation of peptide substrate incubated for 15 mins prior to substrate addition measured after 90 mins by P33-radiolabeled assay	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)sc1C(=O)c1ccccc1[N+](=O)[O-]		CHEMBL2377825	=	IC50	nM	107.0	CHEMBL262	Homo sapiens	IC50	nM	107.0
	13281413	CHEMBL2378443	Inhibition of GSK3beta (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3ncn4cc(F)cc(F)c34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376158	=	Inhibition	%	19.0	CHEMBL262	Homo sapiens	INH	%	19.0
	13281414	CHEMBL2378443	Inhibition of GSK3beta (unknown origin) at 10 uM relative to control	B	Cn1nc(-c2cnc3[nH]cc(C(=O)N[C@@H](C(=O)N4CC(C#N)C4)C4CC4)c3n2)c2ccc(Cl)cc21		CHEMBL2376154	=	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	13281415	CHEMBL2378443	Inhibition of GSK3beta (unknown origin) at 10 uM relative to control	B	CC[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376153	=	Inhibition	%	40.0	CHEMBL262	Homo sapiens	INH	%	40.0
	13281416	CHEMBL2378443	Inhibition of GSK3beta (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)cc(F)c34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376152	=	Inhibition	%	59.0	CHEMBL262	Homo sapiens	INH	%	59.0
	13282340	CHEMBL2378443	Inhibition of GSK3beta (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376144	=	Inhibition	%	12.0	CHEMBL262	Homo sapiens	INH	%	12.0
	13282341	CHEMBL2378443	Inhibition of GSK3beta (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3cn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376143	=	Inhibition	%	92.0	CHEMBL262	Homo sapiens	INH	%	92.0
	13319597	CHEMBL2390763	Inhibition of human GSK3beta-mediated YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE phosphorylation	B	O=C1NC(=O)C(c2cn3c4c(cc(F)cc24)CN(C(=O)N2CCOCC2)CC3)=C1c1coc2ccccc12		CHEMBL2386094	=	IC50	nM	0.013	CHEMBL262	Homo sapiens	IC50	nM	0.013
	13319598	CHEMBL2390763	Inhibition of human GSK3beta-mediated YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE phosphorylation	B	O=C1NC(=O)C(c2cn3c4c(cc(F)cc24)CN(C(=O)N2CCC(N4CCCCC4)CC2)CC3)=C1c1coc2ccccc12		CHEMBL2386093	=	IC50	nM	0.53	CHEMBL262	Homo sapiens	IC50	nM	0.53
	13319599	CHEMBL2390763	Inhibition of human GSK3beta-mediated YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE phosphorylation	B	O=C1NC(=O)C(c2cn3c4c(cc(F)cc24)CN(C(=O)N2CCCCC2)CC3)=C1c1coc2ccccc12		CHEMBL2386092	=	IC50	nM	1.9	CHEMBL262	Homo sapiens	IC50	nM	1.9
	13319600	CHEMBL2390763	Inhibition of human GSK3beta-mediated YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE phosphorylation	B	O=C1NC(=O)C(c2cn3c4c(cccc24)CN(C(=O)Cc2ccncc2)CC3)=C1c1coc2ccccc12		CHEMBL2386091	=	IC50	nM	0.59	CHEMBL262	Homo sapiens	IC50	nM	0.59
	13319601	CHEMBL2390763	Inhibition of human GSK3beta-mediated YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE phosphorylation	B	O=C1NC(=O)C(c2cn3c4c(cccc24)CN(C(=O)c2cnccn2)CC3)=C1c1coc2ccccc12		CHEMBL2386090	=	IC50	nM	0.2	CHEMBL262	Homo sapiens	IC50	nM	0.2
	13319602	CHEMBL2390763	Inhibition of human GSK3beta-mediated YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE phosphorylation	B	O=C1NC(=O)C(c2cn3c4c(cc(Br)cc24)CNCC3)=C1c1coc2ccccc12		CHEMBL2386089	=	IC50	nM	11.5	CHEMBL262	Homo sapiens	IC50	nM	11.5
	13319603	CHEMBL2390763	Inhibition of human GSK3beta-mediated YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE phosphorylation	B	O=C1NC(=O)C(c2cn3c4c(cc(F)cc24)CNCC3)=C1c1coc2ccccc12		CHEMBL2386088	=	IC50	nM	3.7	CHEMBL262	Homo sapiens	IC50	nM	3.7
	13319604	CHEMBL2390763	Inhibition of human GSK3beta-mediated YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE phosphorylation	B	O=C1NC(=O)C(c2cn3c4c(cccc24)CNCC3)=C1c1coc2ccccc12		CHEMBL368248	=	IC50	nM	4.2	CHEMBL262	Homo sapiens	IC50	nM	4.2
	13319605	CHEMBL2390763	Inhibition of human GSK3beta-mediated YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE phosphorylation	B	COCCc1cccc2c(C3=C(c4coc5ccccc45)C(=O)NC3=O)cn(CCOC)c12		CHEMBL2386275	=	IC50	nM	114.0	CHEMBL262	Homo sapiens	IC50	nM	114.0
	13319606	CHEMBL2390763	Inhibition of human GSK3beta-mediated YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE phosphorylation	B	Cn1cc(C2=C(c3coc4ccccc34)C(=O)NC2=O)c2cccc(CCOC(C)(C)C)c21		CHEMBL2386274	=	IC50	nM	148.0	CHEMBL262	Homo sapiens	IC50	nM	148.0
	13319607	CHEMBL2390763	Inhibition of human GSK3beta-mediated YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE phosphorylation	B	COCCc1cccc2c(C3=C(c4coc5ccccc45)C(=O)NC3=O)cn(C)c12		CHEMBL2386273	=	IC50	nM	11.2	CHEMBL262	Homo sapiens	IC50	nM	11.2
	13319608	CHEMBL2390763	Inhibition of human GSK3beta-mediated YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE phosphorylation	B	Cn1cc(C2=C(c3cnc4ccccn34)C(=O)NC2=O)c2cc(Br)ccc21		CHEMBL2386272	=	IC50	nM	0.87	CHEMBL262	Homo sapiens	IC50	nM	0.87
	13319609	CHEMBL2390763	Inhibition of human GSK3beta-mediated YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE phosphorylation	B	Cn1cc(C2=C(c3cnc4ccccn34)C(=O)NC2=O)c2cc3c(cc21)OCO3		CHEMBL2386112	=	IC50	nM	5.3	CHEMBL262	Homo sapiens	IC50	nM	5.3
	13319610	CHEMBL2390763	Inhibition of human GSK3beta-mediated YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE phosphorylation	B	COCCn1cc(C2=C(c3coc4ccccc34)C(=O)NC2=O)c2cc(OC)ncc21		CHEMBL2386111	=	IC50	nM	127.0	CHEMBL262	Homo sapiens	IC50	nM	127.0
	13319611	CHEMBL2390763	Inhibition of human GSK3beta-mediated YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE phosphorylation	B	COc1cc2c(C3=C(c4coc5ccccc45)C(=O)NC3=O)cn(C)c2cn1		CHEMBL2386110	=	IC50	nM	65.9	CHEMBL262	Homo sapiens	IC50	nM	65.9
	13319612	CHEMBL2390763	Inhibition of human GSK3beta-mediated YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE phosphorylation	B	COCCn1cc(C2=C(c3coc4ccccc34)C(=O)NC2=O)c2cccnc21		CHEMBL2386109	=	IC50	nM	58.2	CHEMBL262	Homo sapiens	IC50	nM	58.2
	13319613	CHEMBL2390763	Inhibition of human GSK3beta-mediated YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE phosphorylation	B	Cn1cc(C2=C(c3coc4ccccc34)C(=O)NC2=O)c2cccnc21		CHEMBL2386108	=	IC50	nM	17.6	CHEMBL262	Homo sapiens	IC50	nM	17.6
	13319614	CHEMBL2390763	Inhibition of human GSK3beta-mediated YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE phosphorylation	B	COCCn1cc(C2=C(c3coc4ccccc34)C(=O)NC2=O)c2cc(Br)cnc21		CHEMBL2386107	=	IC50	nM	25.2	CHEMBL262	Homo sapiens	IC50	nM	25.2
	13319615	CHEMBL2390763	Inhibition of human GSK3beta-mediated YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE phosphorylation	B	Cn1cc(C2=C(c3coc4ccccc34)C(=O)NC2=O)c2cc(Br)cnc21		CHEMBL2386106	=	IC50	nM	5.3	CHEMBL262	Homo sapiens	IC50	nM	5.3
	13319616	CHEMBL2390763	Inhibition of human GSK3beta-mediated YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE phosphorylation	B	COCCn1cc(C2=C(c3coc4ccccc34)C(=O)NC2=O)c2cc(F)c(F)cc21		CHEMBL2386105	=	IC50	nM	35.7	CHEMBL262	Homo sapiens	IC50	nM	35.7
	13319617	CHEMBL2390763	Inhibition of human GSK3beta-mediated YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE phosphorylation	B	COCCn1cc(C2=C(c3coc4ccccc34)C(=O)NC2=O)c2cc(Br)ccc21		CHEMBL2386104	=	IC50	nM	82.3	CHEMBL262	Homo sapiens	IC50	nM	82.3
	13319618	CHEMBL2390763	Inhibition of human GSK3beta-mediated YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE phosphorylation	B	COCCn1cc(C2=C(c3coc4ccccc34)C(=O)NC2=O)c2cc(F)ccc21		CHEMBL2386103	=	IC50	nM	39.7	CHEMBL262	Homo sapiens	IC50	nM	39.7
	13319619	CHEMBL2390763	Inhibition of human GSK3beta-mediated YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE phosphorylation	B	COCCn1cc(C2=C(c3coc4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL2386102	=	IC50	nM	19.8	CHEMBL262	Homo sapiens	IC50	nM	19.8
	13319620	CHEMBL2390763	Inhibition of human GSK3beta-mediated YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE phosphorylation	B	CNCCCn1cc(C2=C(c3coc4ccccc34)C(=O)NC2=O)c2cc(F)ccc21		CHEMBL2386101	=	IC50	nM	202.0	CHEMBL262	Homo sapiens	IC50	nM	202.0
	13319621	CHEMBL2390763	Inhibition of human GSK3beta-mediated YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE phosphorylation	B	CNCCCn1cc(C2=C(c3coc4ccccc34)C(=O)NC2=O)c2cc(Br)ccc21		CHEMBL2386100	=	IC50	nM	404.0	CHEMBL262	Homo sapiens	IC50	nM	404.0
	13319622	CHEMBL2390763	Inhibition of human GSK3beta-mediated YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE phosphorylation	B	NCCn1cc(C2=C(c3coc4ccccc34)C(=O)NC2=O)c2cc(F)ccc21		CHEMBL2386099	=	IC50	nM	41.1	CHEMBL262	Homo sapiens	IC50	nM	41.1
	13319623	CHEMBL2390763	Inhibition of human GSK3beta-mediated YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE phosphorylation	B	NCCn1cc(C2=C(c3coc4ccccc34)C(=O)NC2=O)c2cc(Br)ccc21		CHEMBL2386098	=	IC50	nM	116.0	CHEMBL262	Homo sapiens	IC50	nM	116.0
	13319624	CHEMBL2390763	Inhibition of human GSK3beta-mediated YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE phosphorylation	B	O=C1NC(=O)C(c2cn(CCCO)c3ccc(F)cc23)=C1c1coc2ccccc12		CHEMBL2386097	=	IC50	nM	15.0	CHEMBL262	Homo sapiens	IC50	nM	15.0
	13319625	CHEMBL2390763	Inhibition of human GSK3beta-mediated YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE phosphorylation	B	O=C1NC(=O)C(c2cn(CCO)c3ccc(F)cc23)=C1c1coc2ccccc12		CHEMBL2386096	=	IC50	nM	4.8	CHEMBL262	Homo sapiens	IC50	nM	4.8
	13319626	CHEMBL2390763	Inhibition of human GSK3beta-mediated YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE phosphorylation	B	O=C1NC(=O)C(c2cn(CCO)c3ccc(Br)cc23)=C1c1coc2ccccc12		CHEMBL2386095	=	IC50	nM	21.4	CHEMBL262	Homo sapiens	IC50	nM	21.4
	13319627	CHEMBL2390763	Inhibition of human GSK3beta-mediated YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE phosphorylation	B	Cn1cc(C2=C(c3coc4ccccc34)C(=O)NC2=O)c2cc(Br)ccc21		CHEMBL489422	=	IC50	nM	21.1	CHEMBL262	Homo sapiens	IC50	nM	21.1
	13321285	CHEMBL2388356	Inhibition of GSK3B (unknown origin)	B	O=C1c2oc(-c3ccc(Cl)cc3)cc2Cc2cc(N3CCNCC3)ccc2N1Cc1ccccc1-c1cccnc1		CHEMBL2385543	>	IC50	nM	30000.0	CHEMBL262	Homo sapiens	IC50	uM	30.0
Not Active	13324725	CHEMBL2390470	Activity at GSK3beta (unknown origin)	B	O=C(O)c1cccc(CN2C(=O)/C(=C(\c3ccccc3)c3ccc(Cl)cc3)c3ccccc32)c1		CHEMBL2386114		Activity			CHEMBL262	Homo sapiens	Activity		
	13327672	CHEMBL2389831	Inhibition of GSK3B (unknown origin) at 1 uM	B	CC(C)(C)c1cc(NC(=O)NCc2ccc(-c3cc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)[nH]n3)cc2)no1		CHEMBL2386802	=	Inhibition	%	2.0	CHEMBL262	Homo sapiens	INH	%	2.0
	13327673	CHEMBL2389831	Inhibition of GSK3B (unknown origin) at 1 uM	B	Cc1cc(-c2cc(NC(=O)c3ccc(CN4CCN(C)CC4)cc3)[nH]n2)ccc1NC(=O)Nc1cc(C(C)(C)C)on1		CHEMBL2386796	=	Inhibition	%	13.0	CHEMBL262	Homo sapiens	INH	%	13.0
Not Active	13328771	CHEMBL2388494	Inhibition of GSK3B (unknown origin)	B	Cc1cccc2nc(Cn3cnc4ccccc43)cc(=O)n12		CHEMBL2386917		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	13337616	CHEMBL2393650	Inhibition of human recombinant GSK3beta using pIRS-1 (RREGGMSRPAS(p)VDG) as substrate assessed as residual activity at 10 uM after 15 mins in presence of 32P[gamma-ATP]	B	CCc1ccc(/C=N/NC(=O)c2ccncc2)cc1		CHEMBL2391116	>	Activity	%	50.0	CHEMBL262	Homo sapiens	Activity	%	50.0
	13337617	CHEMBL2393650	Inhibition of human recombinant GSK3beta using pIRS-1 (RREGGMSRPAS(p)VDG) as substrate assessed as residual activity at 10 uM after 15 mins in presence of 32P[gamma-ATP]	B	N#Cc1ccc(/C=N/NC(=O)c2ccncc2)cc1		CHEMBL443650	>	Activity	%	50.0	CHEMBL262	Homo sapiens	Activity	%	50.0
	13337618	CHEMBL2393650	Inhibition of human recombinant GSK3beta using pIRS-1 (RREGGMSRPAS(p)VDG) as substrate assessed as residual activity at 10 uM after 15 mins in presence of 32P[gamma-ATP]	B	COc1ccc(/C=N/NC(=O)c2ccncc2)cc1		CHEMBL446977	>	Activity	%	50.0	CHEMBL262	Homo sapiens	Activity	%	50.0
	13337619	CHEMBL2393650	Inhibition of human recombinant GSK3beta using pIRS-1 (RREGGMSRPAS(p)VDG) as substrate assessed as residual activity at 10 uM after 15 mins in presence of 32P[gamma-ATP]	B	O=C(N/N=C/c1ccccc1)c1ccncc1		CHEMBL486016	>	Activity	%	50.0	CHEMBL262	Homo sapiens	Activity	%	50.0
	13337620	CHEMBL2393650	Inhibition of human recombinant GSK3beta using pIRS-1 (RREGGMSRPAS(p)VDG) as substrate assessed as residual activity at 10 uM after 15 mins in presence of 32P[gamma-ATP]	B	N#Cc1cccc(CSc2nnc(-c3ccc([N+](=O)[O-])cc3)o2)c1		CHEMBL2391115	>	Activity	%	50.0	CHEMBL262	Homo sapiens	Activity	%	50.0
	13337621	CHEMBL2393650	Inhibition of human recombinant GSK3beta using pIRS-1 (RREGGMSRPAS(p)VDG) as substrate assessed as residual activity at 10 uM after 15 mins in presence of 32P[gamma-ATP]	B	COc1cccc(CSc2nnc(-c3ccc([N+](=O)[O-])cc3)o2)c1		CHEMBL2391114	>	Activity	%	50.0	CHEMBL262	Homo sapiens	Activity	%	50.0
	13337622	CHEMBL2393650	Inhibition of human recombinant GSK3beta using pIRS-1 (RREGGMSRPAS(p)VDG) as substrate assessed as residual activity at 10 uM after 15 mins in presence of 32P[gamma-ATP]	B	N#Cc1ccccc1-c1ccc(CSc2nnc(-c3ccc([N+](=O)[O-])cc3)o2)cc1		CHEMBL2391113	>	Activity	%	50.0	CHEMBL262	Homo sapiens	Activity	%	50.0
	13337623	CHEMBL2393650	Inhibition of human recombinant GSK3beta using pIRS-1 (RREGGMSRPAS(p)VDG) as substrate assessed as residual activity at 10 uM after 15 mins in presence of 32P[gamma-ATP]	B	O=[N+]([O-])c1ccc(-c2nnc(SCc3ccccc3)o2)cc1		CHEMBL2391112	>	Activity	%	50.0	CHEMBL262	Homo sapiens	Activity	%	50.0
	13337624	CHEMBL2393650	Inhibition of human recombinant GSK3beta using pIRS-1 (RREGGMSRPAS(p)VDG) as substrate assessed as residual activity at 10 uM after 15 mins in presence of 32P[gamma-ATP]	B	N#Cc1ccc(-c2nnc(SCc3cccc(C#N)c3)o2)cc1		CHEMBL2391111	>	Activity	%	50.0	CHEMBL262	Homo sapiens	Activity	%	50.0
	13337625	CHEMBL2393650	Inhibition of human recombinant GSK3beta using pIRS-1 (RREGGMSRPAS(p)VDG) as substrate assessed as residual activity at 10 uM after 15 mins in presence of 32P[gamma-ATP]	B	COc1cccc(CSc2nnc(-c3ccc(C#N)cc3)o2)c1		CHEMBL2391110	>	Activity	%	50.0	CHEMBL262	Homo sapiens	Activity	%	50.0
	13337626	CHEMBL2393650	Inhibition of human recombinant GSK3beta using pIRS-1 (RREGGMSRPAS(p)VDG) as substrate assessed as residual activity at 10 uM after 15 mins in presence of 32P[gamma-ATP]	B	N#Cc1ccc(-c2nnc(SCc3ccc(-c4ccccc4C#N)cc3)o2)cc1		CHEMBL2391109	>	Activity	%	50.0	CHEMBL262	Homo sapiens	Activity	%	50.0
	13337627	CHEMBL2393650	Inhibition of human recombinant GSK3beta using pIRS-1 (RREGGMSRPAS(p)VDG) as substrate assessed as residual activity at 10 uM after 15 mins in presence of 32P[gamma-ATP]	B	N#Cc1ccc(-c2nnc(SCc3ccccc3)o2)cc1		CHEMBL2391108	>	Activity	%	50.0	CHEMBL262	Homo sapiens	Activity	%	50.0
	13337628	CHEMBL2393650	Inhibition of human recombinant GSK3beta using pIRS-1 (RREGGMSRPAS(p)VDG) as substrate assessed as residual activity at 10 uM after 15 mins in presence of 32P[gamma-ATP]	B	COc1ccc(-c2nnc(SCc3cccc(C#N)c3)o2)cc1		CHEMBL1577394	>	Activity	%	50.0	CHEMBL262	Homo sapiens	Activity	%	50.0
	13337629	CHEMBL2393650	Inhibition of human recombinant GSK3beta using pIRS-1 (RREGGMSRPAS(p)VDG) as substrate assessed as residual activity at 10 uM after 15 mins in presence of 32P[gamma-ATP]	B	COc1ccc(-c2nnc(SCc3cccc(OC)c3)o2)cc1		CHEMBL2391107	>	Activity	%	50.0	CHEMBL262	Homo sapiens	Activity	%	50.0
	13337630	CHEMBL2393650	Inhibition of human recombinant GSK3beta using pIRS-1 (RREGGMSRPAS(p)VDG) as substrate assessed as residual activity at 10 uM after 15 mins in presence of 32P[gamma-ATP]	B	COc1ccc(-c2nnc(SCc3ccc(-c4ccccc4C#N)cc3)o2)cc1		CHEMBL2391106	>	Activity	%	50.0	CHEMBL262	Homo sapiens	Activity	%	50.0
	13337631	CHEMBL2393650	Inhibition of human recombinant GSK3beta using pIRS-1 (RREGGMSRPAS(p)VDG) as substrate assessed as residual activity at 10 uM after 15 mins in presence of 32P[gamma-ATP]	B	COc1ccc(-c2nnc(SCc3ccccc3)o2)cc1		CHEMBL2391105	>	Activity	%	50.0	CHEMBL262	Homo sapiens	Activity	%	50.0
	13337632	CHEMBL2393650	Inhibition of human recombinant GSK3beta using pIRS-1 (RREGGMSRPAS(p)VDG) as substrate assessed as residual activity at 10 uM after 15 mins in presence of 32P[gamma-ATP]	B	N#Cc1cccc(CSc2nnc(-c3ccccc3)o2)c1		CHEMBL2391104	>	Activity	%	50.0	CHEMBL262	Homo sapiens	Activity	%	50.0
	13337633	CHEMBL2393650	Inhibition of human recombinant GSK3beta using pIRS-1 (RREGGMSRPAS(p)VDG) as substrate assessed as residual activity at 10 uM after 15 mins in presence of 32P[gamma-ATP]	B	COc1cccc(CSc2nnc(-c3ccccc3)o2)c1		CHEMBL2137238	>	Activity	%	50.0	CHEMBL262	Homo sapiens	Activity	%	50.0
	13337634	CHEMBL2393650	Inhibition of human recombinant GSK3beta using pIRS-1 (RREGGMSRPAS(p)VDG) as substrate assessed as residual activity at 10 uM after 15 mins in presence of 32P[gamma-ATP]	B	N#Cc1ccccc1-c1ccc(CSc2nnc(-c3ccccc3)o2)cc1		CHEMBL2391103	>	Activity	%	50.0	CHEMBL262	Homo sapiens	Activity	%	50.0
	13337635	CHEMBL2393650	Inhibition of human recombinant GSK3beta using pIRS-1 (RREGGMSRPAS(p)VDG) as substrate assessed as residual activity at 10 uM after 15 mins in presence of 32P[gamma-ATP]	B	c1ccc(CSc2nnc(-c3ccccc3)o2)cc1		CHEMBL1929302	>	Activity	%	50.0	CHEMBL262	Homo sapiens	Activity	%	50.0
	13337644	CHEMBL2393654	Inhibition of human recombinant GSK3beta by FRET assay	B	N#Cc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCCO5)o3)cc2)cc1		CHEMBL2391127	=	IC50	nM	1995.0	CHEMBL262	Homo sapiens	IC50	uM	1.995
	13337645	CHEMBL2393654	Inhibition of human recombinant GSK3beta by FRET assay	B	Fc1cc(F)cc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCCO5)o3)cc2)c1		CHEMBL2391124	=	IC50	nM	966.0	CHEMBL262	Homo sapiens	IC50	uM	0.966
	13337648	CHEMBL2393654	Inhibition of human recombinant GSK3beta by FRET assay	B	c1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCCO5)o3)cc2)cc1		CHEMBL2391123	=	IC50	nM	234.0	CHEMBL262	Homo sapiens	IC50	uM	0.234
	13337649	CHEMBL2393654	Inhibition of human recombinant GSK3beta by FRET assay	B	N#Cc1cccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCCO5)o3)cc2)c1		CHEMBL2391130	=	IC50	nM	225.0	CHEMBL262	Homo sapiens	IC50	uM	0.225
	13337650	CHEMBL2393654	Inhibition of human recombinant GSK3beta by FRET assay	B	Fc1cc(F)cc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)c1		CHEMBL2391117	=	IC50	nM	195.0	CHEMBL262	Homo sapiens	IC50	uM	0.195
	13337652	CHEMBL2393654	Inhibition of human recombinant GSK3beta by FRET assay	B	COc1ccc(-c2ccc(CSc3nnc(-c4ccncc4)o3)cc2)cc1		CHEMBL2391131	=	IC50	nM	176.0	CHEMBL262	Homo sapiens	IC50	uM	0.176
	13337653	CHEMBL2393654	Inhibition of human recombinant GSK3beta by FRET assay	B	O=[N+]([O-])c1ccccc1-c1ccc(CSc2nnc(-c3ccncc3)o2)cc1		CHEMBL2391133	=	IC50	nM	164.0	CHEMBL262	Homo sapiens	IC50	uM	0.164
	13337654	CHEMBL2393654	Inhibition of human recombinant GSK3beta by FRET assay	B	O=[N+]([O-])c1cccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCCO5)o3)cc2)c1		CHEMBL2391128	=	IC50	nM	164.0	CHEMBL262	Homo sapiens	IC50	uM	0.164
	13337655	CHEMBL2393654	Inhibition of human recombinant GSK3beta by FRET assay	B	N#Cc1ccc(-c2ccc(CSc3nnc(-c4ccncc4)o3)cc2)cc1		CHEMBL2390958	=	IC50	nM	153.0	CHEMBL262	Homo sapiens	IC50	uM	0.153
	13337656	CHEMBL2393654	Inhibition of human recombinant GSK3beta by FRET assay	B	COc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCCO5)o3)cc2)cc1		CHEMBL2391126	=	IC50	nM	127.0	CHEMBL262	Homo sapiens	IC50	uM	0.127
	13337657	CHEMBL2393654	Inhibition of human recombinant GSK3beta by FRET assay	B	O=[N+]([O-])c1ccccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL2391129	=	IC50	nM	90.0	CHEMBL262	Homo sapiens	IC50	uM	0.09
	13337658	CHEMBL2393654	Inhibition of human recombinant GSK3beta by FRET assay	B	O=[N+]([O-])c1cccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)c1		CHEMBL2391120	=	IC50	nM	86.0	CHEMBL262	Homo sapiens	IC50	uM	0.086
	13337659	CHEMBL2393654	Inhibition of human recombinant GSK3beta by FRET assay	B	N#Cc1cccc(-c2ccc(CSc3nnc(-c4ccncc4)o3)cc2)c1		CHEMBL2391132	=	IC50	nM	84.0	CHEMBL262	Homo sapiens	IC50	uM	0.084
	13337660	CHEMBL2393654	Inhibition of human recombinant GSK3beta by FRET assay	B	c1ccc(-c2ccc(CSc3nnc(-c4ccncc4)o3)cc2)cc1		CHEMBL2391099	=	IC50	nM	83.0	CHEMBL262	Homo sapiens	IC50	uM	0.083
	13337662	CHEMBL2393654	Inhibition of human recombinant GSK3beta by FRET assay	B	COc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)cc1		CHEMBL2391119	=	IC50	nM	75.0	CHEMBL262	Homo sapiens	IC50	uM	0.075
	13337663	CHEMBL2393654	Inhibition of human recombinant GSK3beta by FRET assay	B	N#Cc1cc(F)ccc1-c1ccc(CSc2nnc(-c3ccncc3)o2)cc1		CHEMBL2391098	=	IC50	nM	56.0	CHEMBL262	Homo sapiens	IC50	uM	0.056
	13337668	CHEMBL2393654	Inhibition of human recombinant GSK3beta by FRET assay	B	CC(=O)Nc1cc(-c2nnc(SCc3ccccc3)o2)ccn1		CHEMBL2391100	=	IC50	nM	35.0	CHEMBL262	Homo sapiens	IC50	uM	0.035
	13337670	CHEMBL2393654	Inhibition of human recombinant GSK3beta by FRET assay	B	COc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCCO5)o3)cc2)c(C#N)c1		CHEMBL2391125	=	IC50	nM	32.0	CHEMBL262	Homo sapiens	IC50	uM	0.032
	13337671	CHEMBL2393654	Inhibition of human recombinant GSK3beta by FRET assay	B	N#Cc1cccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)c1		CHEMBL2391121	=	IC50	nM	29.0	CHEMBL262	Homo sapiens	IC50	uM	0.029
	13337672	CHEMBL2393654	Inhibition of human recombinant GSK3beta by FRET assay	B	O=[N+]([O-])c1ccccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCO4)o2)cc1		CHEMBL2391122	=	IC50	nM	27.0	CHEMBL262	Homo sapiens	IC50	uM	0.027
	13337675	CHEMBL2393654	Inhibition of human recombinant GSK3beta by FRET assay	B	CC(=O)Nc1cc(-c2nnc(SCc3cccc(C#N)c3)o2)ccn1		CHEMBL2391101	=	IC50	nM	19.0	CHEMBL262	Homo sapiens	IC50	uM	0.019
	13337677	CHEMBL2393654	Inhibition of human recombinant GSK3beta by FRET assay	B	CC(=O)Nc1cc(-c2nnc(SCc3ccc(-c4ccccc4C#N)cc3)o2)ccn1		CHEMBL2391102	=	IC50	nM	17.0	CHEMBL262	Homo sapiens	IC50	uM	0.017
	13337681	CHEMBL2393654	Inhibition of human recombinant GSK3beta by FRET assay	B	COc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)c(C#N)c1		CHEMBL2391118	=	IC50	nM	14.0	CHEMBL262	Homo sapiens	IC50	uM	0.014
	13342320	CHEMBL2396465	Competitive binding affinity to GSK3beta (unknown origin) assessed as enzyme remaining bound to anchored active-site ligand at 10 uM relative to control	B	Clc1ccc(CNc2nccc(-c3ccc4[nH]ncc4c3)n2)cc1Cl		CHEMBL1892019	<	Activity	%	30.0	CHEMBL262	Homo sapiens	Activity	%	30.0
	13351557	CHEMBL2399988	Inhibition of human GSK3beta at 10 uM relative to control	B	Cl.O=c1[nH]nc2c(NCCCc3ccncc3)cc(Cl)cn12		CHEMBL2397859	=	Inhibition	%	90.0	CHEMBL262	Homo sapiens	INH	%	90.0
	13365774	CHEMBL2406338	Inhibition of GSK3beta (unknown origin) after 60 mins	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	13371352	CHEMBL2403999	Inhibition of GSK3 beta (unknown origin) at 10 uM by Z'-LYTE kinase assay	B	c1ccc(-c2csc3ncnc(N4CCc5ccccc5C4)c23)cc1		CHEMBL1483261	=	Inhibition	%	13.04	CHEMBL262	Homo sapiens	INH	%	13.04
	13375847	CHEMBL2405111	Inhibition of GSK3B (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	8.0	CHEMBL262	Homo sapiens	INH	%	8.0
	13389910	CHEMBL2410711	Inhibition of GSK3beta (unknown origin) in presence of [gamma-33P]-ATP	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)nn4c3)ccc2F)n(C)n1		CHEMBL2409778	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	nM	10000.0
	13396876	CHEMBL2410928	Inhibition of GSK3beta (unknown origin)	B	CC(=O)Nc1cc(Nc2cc(NC3CC3)n3ncc(C#N)c3n2)ccc1C		CHEMBL2409175	=	IC50	nM	2600.0	CHEMBL262	Homo sapiens	IC50	uM	2.6
	13414814	CHEMBL2424042	Inhibition of GSK3beta in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(Cc2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420551	<	Inhibition	%	35.0	CHEMBL262	Homo sapiens	INH	%	35.0
	13414815	CHEMBL2424042	Inhibition of GSK3beta in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420555	<	Inhibition	%	35.0	CHEMBL262	Homo sapiens	INH	%	35.0
	13414816	CHEMBL2424042	Inhibition of GSK3beta in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CCC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420573	<	Inhibition	%	35.0	CHEMBL262	Homo sapiens	INH	%	35.0
	13414817	CHEMBL2424042	Inhibition of GSK3beta in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420572	<	Inhibition	%	35.0	CHEMBL262	Homo sapiens	INH	%	35.0
	13414818	CHEMBL2424042	Inhibition of GSK3beta in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC(C)(NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420570	<	Inhibition	%	35.0	CHEMBL262	Homo sapiens	INH	%	35.0
	13414819	CHEMBL2424042	Inhibition of GSK3beta in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CCC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420565	<	Inhibition	%	35.0	CHEMBL262	Homo sapiens	INH	%	35.0
	13414820	CHEMBL2424042	Inhibition of GSK3beta in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(N[C@H](CO)c1ccccc1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420564	<	Inhibition	%	35.0	CHEMBL262	Homo sapiens	INH	%	35.0
	13414821	CHEMBL2424042	Inhibition of GSK3beta in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420562	<	Inhibition	%	35.0	CHEMBL262	Homo sapiens	INH	%	35.0
	13414822	CHEMBL2424042	Inhibition of GSK3beta in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420560	<	Inhibition	%	35.0	CHEMBL262	Homo sapiens	INH	%	35.0
	13414823	CHEMBL2424042	Inhibition of GSK3beta in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420556	<	Inhibition	%	35.0	CHEMBL262	Homo sapiens	INH	%	35.0
	13414824	CHEMBL2424042	Inhibition of GSK3beta in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420587	=	Inhibition	%	96.0	CHEMBL262	Homo sapiens	INH	%	96.0
	13414825	CHEMBL2424042	Inhibition of GSK3beta in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420585	=	Inhibition	%	98.6	CHEMBL262	Homo sapiens	INH	%	98.6
	13415323	CHEMBL2424325	Inhibition of GSK3beta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Inhibition	%	11.0	CHEMBL262	Homo sapiens	INH	%	11.0
	13415324	CHEMBL2424325	Inhibition of GSK3beta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=C(C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1)N1CCOCC1		CHEMBL2420907	=	Inhibition	%	9.0	CHEMBL262	Homo sapiens	INH	%	9.0
	13415325	CHEMBL2424325	Inhibition of GSK3beta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	CN(C)C(=O)C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420906	=	Inhibition	%	7.0	CHEMBL262	Homo sapiens	INH	%	7.0
	13415326	CHEMBL2424325	Inhibition of GSK3beta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	CNC(=O)C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420905	=	Inhibition	%	17.0	CHEMBL262	Homo sapiens	INH	%	17.0
	13415327	CHEMBL2424325	Inhibition of GSK3beta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	OCC1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2417586	=	Inhibition	%	21.0	CHEMBL262	Homo sapiens	INH	%	21.0
	13415328	CHEMBL2424325	Inhibition of GSK3beta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=C(O)C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420904	=	Inhibition	%	28.0	CHEMBL262	Homo sapiens	INH	%	28.0
	13415329	CHEMBL2424325	Inhibition of GSK3beta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	COC(=O)C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420903	=	Inhibition	%	12.0	CHEMBL262	Homo sapiens	INH	%	12.0
	13415330	CHEMBL2424325	Inhibition of GSK3beta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(C2CCC3(CCN(c4ncnc5[nH]cnc45)CC3)NC2)cc1		CHEMBL2420902	=	Inhibition	%	21.0	CHEMBL262	Homo sapiens	INH	%	21.0
	13415331	CHEMBL2424325	Inhibition of GSK3beta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCC3(CCN(c4ncnc5[nH]cnc45)CC3)NC2)cc1		CHEMBL2420901	=	Inhibition	%	14.0	CHEMBL262	Homo sapiens	INH	%	14.0
	13415332	CHEMBL2424325	Inhibition of GSK3beta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420900	=	Inhibition	%	21.0	CHEMBL262	Homo sapiens	INH	%	21.0
	13415333	CHEMBL2424325	Inhibition of GSK3beta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(C2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420899	=	Inhibition	%	20.0	CHEMBL262	Homo sapiens	INH	%	20.0
	13415334	CHEMBL2424325	Inhibition of GSK3beta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CC1)CC(O)CCN2		CHEMBL2420898	=	Inhibition	%	51.0	CHEMBL262	Homo sapiens	INH	%	51.0
	13415335	CHEMBL2424325	Inhibition of GSK3beta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	OC1CCNC2(CCN(c3ncnc4[nH]cnc34)CC2)C1		CHEMBL2420897	=	Inhibition	%	19.0	CHEMBL262	Homo sapiens	INH	%	19.0
	13415336	CHEMBL2424325	Inhibition of GSK3beta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCC(O)CN2)CC1		CHEMBL2420928	=	Inhibition	%	80.0	CHEMBL262	Homo sapiens	INH	%	80.0
	13415337	CHEMBL2424325	Inhibition of GSK3beta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	OC1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420927	=	Inhibition	%	31.0	CHEMBL262	Homo sapiens	INH	%	31.0
	13415338	CHEMBL2424325	Inhibition of GSK3beta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCOC3)CC2)c2nc[nH]c2n1		CHEMBL2420926	=	Inhibition	%	66.0	CHEMBL262	Homo sapiens	INH	%	66.0
	13415339	CHEMBL2424325	Inhibition of GSK3beta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCCO3)CC2)c2nc[nH]c2n1		CHEMBL2420925	=	Inhibition	%	56.0	CHEMBL262	Homo sapiens	INH	%	56.0
	13415340	CHEMBL2424325	Inhibition of GSK3beta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCCC3)CC2)c2nc[nH]c2n1		CHEMBL2420924	=	Inhibition	%	40.0	CHEMBL262	Homo sapiens	INH	%	40.0
	13415341	CHEMBL2424325	Inhibition of GSK3beta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCCC12CCNCC2		CHEMBL2420923	=	Inhibition	%	9.0	CHEMBL262	Homo sapiens	INH	%	9.0
	13415342	CHEMBL2424325	Inhibition of GSK3beta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCCC2(CCCNC2)C1		CHEMBL2420922	=	Inhibition	%	14.0	CHEMBL262	Homo sapiens	INH	%	14.0
	13415343	CHEMBL2424325	Inhibition of GSK3beta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCCC2(CCNCC2)C1		CHEMBL2420921	=	Inhibition	%	3.0	CHEMBL262	Homo sapiens	INH	%	3.0
	13415344	CHEMBL2424325	Inhibition of GSK3beta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCNC2)CC1		CHEMBL2420920	=	Inhibition	%	1.0	CHEMBL262	Homo sapiens	INH	%	1.0
	13415345	CHEMBL2424325	Inhibition of GSK3beta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCCNC2)CC1		CHEMBL2420919	=	Inhibition	%	5.0	CHEMBL262	Homo sapiens	INH	%	5.0
	13415346	CHEMBL2424325	Inhibition of GSK3beta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCCN2)CC1		CHEMBL2420918	=	Inhibition	%	20.0	CHEMBL262	Homo sapiens	INH	%	20.0
	13415347	CHEMBL2424325	Inhibition of GSK3beta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCCCN2)CC1		CHEMBL2420917	=	Inhibition	%	28.0	CHEMBL262	Homo sapiens	INH	%	28.0
	13415348	CHEMBL2424325	Inhibition of GSK3beta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	NC1(Cc2ccccc2)CCN(S(=O)(=O)c2cccc3cnccc23)CC1		CHEMBL2420916	=	Inhibition	%	19.0	CHEMBL262	Homo sapiens	INH	%	19.0
	13415349	CHEMBL2424325	Inhibition of GSK3beta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCCC23CCNCC3)c2nc[nH]c2n1		CHEMBL2420915	=	Inhibition	%	43.0	CHEMBL262	Homo sapiens	INH	%	43.0
	13415350	CHEMBL2424325	Inhibition of GSK3beta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCCC3(CCCNC3)C2)c2nc[nH]c2n1		CHEMBL2420914	=	Inhibition	%	15.0	CHEMBL262	Homo sapiens	INH	%	15.0
	13415351	CHEMBL2424325	Inhibition of GSK3beta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCCC3(CCNCC3)C2)c2nc[nH]c2n1		CHEMBL2420913	=	Inhibition	%	32.0	CHEMBL262	Homo sapiens	INH	%	32.0
	13415352	CHEMBL2424325	Inhibition of GSK3beta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCNC3)CC2)c2nc[nH]c2n1		CHEMBL2420912	=	Inhibition	%	39.0	CHEMBL262	Homo sapiens	INH	%	39.0
	13415353	CHEMBL2424325	Inhibition of GSK3beta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCNC3)CC2)c2nc[nH]c2n1		CHEMBL2420911	=	Inhibition	%	49.0	CHEMBL262	Homo sapiens	INH	%	49.0
	13415354	CHEMBL2424325	Inhibition of GSK3beta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCN3)CC2)c2nc[nH]c2n1		CHEMBL2420910	=	Inhibition	%	19.0	CHEMBL262	Homo sapiens	INH	%	19.0
	13415355	CHEMBL2424325	Inhibition of GSK3beta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCCN3)CC2)c2nc[nH]c2n1		CHEMBL2420909	=	Inhibition	%	28.0	CHEMBL262	Homo sapiens	INH	%	28.0
	13415356	CHEMBL2424325	Inhibition of GSK3beta (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	NC1(Cc2ccccc2)CCN(c2ncnc3[nH]cnc23)CC1		CHEMBL2420908	=	Inhibition	%	53.0	CHEMBL262	Homo sapiens	INH	%	53.0
	13419792	CHEMBL2424118	Inhibition of GSK3beta (unknown origin) by microfluidic mobility shift assay	B	c1nc(N2CCC3(CCCNC3)CC2)c2nc[nH]c2n1		CHEMBL2420911	=	IC50	nM	55000.0	CHEMBL262	Homo sapiens	IC50	uM	55.0
	13420980	CHEMBL2424118	Inhibition of GSK3beta (unknown origin) by microfluidic mobility shift assay	B	c1nc(N2CCC3(CCCCN3)CC2)c2nc[nH]c2n1	Outside typical range	CHEMBL2420909	=	IC50	nM	138000.0	CHEMBL262	Homo sapiens	IC50	uM	138.0
Not Active	13435518	CHEMBL2423505	Inhibition of GSK3beta phosphorylation at Ser9 in human DU145 cells at 0.1 uM after 72 hrs by Western blotting analysis	B	COc1ccc(/C(=C\c2cn(C(C)=O)c3ccc(OCc4ccccc4)cc23)C(=O)O)cc1		CHEMBL2417658		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	13435526	CHEMBL2423512	Inhibition of GSK3beta phosphorylation at Ser9 in human DU145 cells at 1 uM after 72 hrs by Western blotting analysis	B	COc1ccc(/C(=C\c2cn(C(C)=O)c3ccc(OCc4ccccc4)cc23)C(=O)O)cc1		CHEMBL2417658		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	13439838	CHEMBL2426983	Competitive binding affinity to GSK3beta (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	13440862	CHEMBL2429605	Inhibition of GSK3b (unknown origin) at 1 uM by [33P]-ATP filter-binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3cnc4c(N)ncnc43)cc2)cc1	Outside typical range	CHEMBL2425144	=	Inhibition	%	-21.0	CHEMBL262	Homo sapiens	INH	%	-21.0
	13442420	CHEMBL2426983	Competitive binding affinity to GSK3beta (unknown origin) at 10 uM in presence of ATP relative to control	B	CS(=O)(=O)CCCOc1cccc2c1ccn2-c1ccnc(N[C@H]2CC[C@H](C(=O)N3CCC(O)CC3)CC2)n1		CHEMBL2425628	>	Inhibition	%	85.0	CHEMBL262	Homo sapiens	INH	%	85.0
	13442493	CHEMBL2429309	Binding affinity to GSK3B (unknown origin)	B	CS(=O)(=O)CCCOc1cccc2c1ccn2-c1ccnc(N[C@H]2CC[C@H](C(=O)N3CCC(O)CC3)CC2)n1		CHEMBL2425628	=	Kd	nM	5400.0	CHEMBL262	Homo sapiens	Kd	uM	5.4
	13445671	CHEMBL2426983	Competitive binding affinity to GSK3beta (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	=	Inhibition	%	82.0	CHEMBL262	Homo sapiens	INH	%	82.0
	13451658	CHEMBL2426983	Competitive binding affinity to GSK3beta (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	=	Inhibition	%	100.0	CHEMBL262	Homo sapiens	INH	%	100.0
	13453040	CHEMBL2429605	Inhibition of GSK3b (unknown origin) at 1 uM by [33P]-ATP filter-binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-c3cccnc3)cc2)cc1	Outside typical range	CHEMBL2425156	=	Inhibition	%	-14.0	CHEMBL262	Homo sapiens	INH	%	-14.0
	13453088	CHEMBL2429605	Inhibition of GSK3b (unknown origin) at 1 uM by [33P]-ATP filter-binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3cnc(C)c3)cc2)cc1		CHEMBL2425145	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	INH	%	0.0
	13465474	CHEMBL2434223	Inhibition of human GSK3beta assessed as residual activity at 1 uM relative to control	B	CCCC(=O)Nc1n[nH]c2ncc(-c3cccnc3)cc12		CHEMBL407002	=	Activity	%	2.0	CHEMBL262	Homo sapiens	Activity	%	2.0
	13465500	CHEMBL2434614	Inhibition of human GSK3beta assessed as residual activity at 10 uM relative to control	B	CCCC(=O)Nc1n[nH]c2ncc(-c3cccnc3)cc12		CHEMBL407002	=	Activity	%	3.0	CHEMBL262	Homo sapiens	Activity	%	3.0
	13465523	CHEMBL2434197	Inhibition of human GSK3beta assessed as residual activity at 25 uM relative to control	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349	=	Activity	%	74.0	CHEMBL262	Homo sapiens	Activity	%	74.0
	13465546	CHEMBL2434614	Inhibition of human GSK3beta assessed as residual activity at 10 uM relative to control	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Activity	%	88.0	CHEMBL262	Homo sapiens	Activity	%	88.0
	13466474	CHEMBL2434223	Inhibition of human GSK3beta assessed as residual activity at 1 uM relative to control	B	CC(=O)Nc1nccc(-c2c(-c3ccccc3)noc2C)n1		CHEMBL2430324	=	Activity	%	100.57	CHEMBL262	Homo sapiens	Activity	%	100.57
	13466501	CHEMBL2434614	Inhibition of human GSK3beta assessed as residual activity at 10 uM relative to control	B	CC(=O)Nc1nccc(-c2c(-c3ccccc3)noc2C)n1		CHEMBL2430324	=	Activity	%	59.99	CHEMBL262	Homo sapiens	Activity	%	59.99
	13466528	CHEMBL2434223	Inhibition of human GSK3beta assessed as residual activity at 1 uM relative to control	B	CC(=O)Nc1cccc(-c2cnc3[nH]nc(C)c3c2)c1		CHEMBL2430323	=	Activity	%	79.38	CHEMBL262	Homo sapiens	Activity	%	79.38
	13466555	CHEMBL2434614	Inhibition of human GSK3beta assessed as residual activity at 10 uM relative to control	B	CC(=O)Nc1cccc(-c2cnc3[nH]nc(C)c3c2)c1		CHEMBL2430323	=	Activity	%	61.19	CHEMBL262	Homo sapiens	Activity	%	61.19
	13475317	CHEMBL2439763	Inhibition of wild type human GSK3B by high throughput ATP-[33P] radiolabeled assay	B	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5ccc6[nH]ccc6c5)c4c3)cc2)CC1		CHEMBL2436978	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	nM	10000.0
	13477354	CHEMBL2439019	Inhibition of human GSK-3 beta after 30 mins by fluorescence assay	B	Cn1cc(-c2nc(-c3cn(C)c4ncccc34)cs2)c2cc(F)ccc21		CHEMBL2435289	=	IC50	nM	35680.0	CHEMBL262	Homo sapiens	IC50	uM	35.68
	13477355	CHEMBL2439019	Inhibition of human GSK-3 beta after 30 mins by fluorescence assay	B	Cn1cc(-c2csc(-c3c[nH]c4ccccc34)n2)c2cccnc21		CHEMBL2435287	=	IC50	nM	40180.0	CHEMBL262	Homo sapiens	IC50	uM	40.18
	13477356	CHEMBL2439019	Inhibition of human GSK-3 beta after 30 mins by fluorescence assay	B	Cn1cc(-c2nc(-c3c[nH]c4ncccc34)cs2)c2cc(F)ccc21		CHEMBL2435286	=	IC50	nM	42180.0	CHEMBL262	Homo sapiens	IC50	uM	42.18
	13507599	CHEMBL2444006	Inhibition of GSK3beta (unknown origin)	B	CN(C)c1ccc(Oc2cc(O)cc(O)c2-c2cc(C(=O)NC3CCN(C4CCC5(CC4)OCCO5)CC3)no2)cc1		CHEMBL2443026	>	IC50	nM	10.0	CHEMBL262	Homo sapiens	IC50	nM	10.0
	13507600	CHEMBL2444006	Inhibition of GSK3beta (unknown origin)	B	CC(C)Nc1ccc(Oc2cc(O)cc(O)c2-c2cc(C(=O)NC3CCN(C)CC3)no2)cc1		CHEMBL2443139	>	IC50	nM	10.0	CHEMBL262	Homo sapiens	IC50	nM	10.0
	13507601	CHEMBL2444006	Inhibition of GSK3beta (unknown origin)	B	CN1CCC(NC(=O)c2cc(-c3c(O)cc(O)cc3Oc3ccc(N(C)C)cc3)on2)CC1		CHEMBL2443138	>	IC50	nM	10.0	CHEMBL262	Homo sapiens	IC50	nM	10.0
	13507602	CHEMBL2444006	Inhibition of GSK3beta (unknown origin)	B	CN1CCC(NC(=O)c2cc(-c3c(O)cc(O)cc3Oc3ccc([N+](=O)[O-])cc3)on2)CC1		CHEMBL2443044	>	IC50	nM	10.0	CHEMBL262	Homo sapiens	IC50	nM	10.0
	13835442	CHEMBL3090735	Inhibition of GSK3beta (unknown origin) at 1 uM	B	Cc1nn(C)cc1-c1nc2c(Oc3ccc(C(=O)Nc4ccccc4)cc3)c(Cl)cnc2[nH]1		CHEMBL3087784	>	Inhibition	%	80.0	CHEMBL262	Homo sapiens	INH	%	80.0
	13836309	CHEMBL3090917	Inhibition of GSK-3beta (unknown origin) after 90 mins by TR-FRET/IMAP fluorescence polarization assay	B	CNS(=O)(=O)Nc1cccc(Cc2c(C)c3cc(Cl)c(OC(=O)N(C)C)cc3oc2=O)c1		CHEMBL3086065	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	13841060	CHEMBL3097577	Inhibition of human recombinant GSK3beta using prephosphorylated GS1 peptide as substrate after 1 hr by liquid scintillation spectrometry	B	Cn1c(NCC(=O)c2cccc(C#N)c2)nc(-c2ccncc2)cc1=O		CHEMBL3093034	=	IC50	nM	13.0	CHEMBL262	Homo sapiens	IC50	nM	13.0
	13841061	CHEMBL3097577	Inhibition of human recombinant GSK3beta using prephosphorylated GS1 peptide as substrate after 1 hr by liquid scintillation spectrometry	B	Cc1cccc(C(=O)CNc2nc(-c3ccncc3)cc(=O)n2C)c1		CHEMBL3093033	=	IC50	nM	38.0	CHEMBL262	Homo sapiens	IC50	nM	38.0
	13841062	CHEMBL3097577	Inhibition of human recombinant GSK3beta using prephosphorylated GS1 peptide as substrate after 1 hr by liquid scintillation spectrometry	B	Cn1c(NCC(=O)c2cccc(Cl)c2)nc(-c2ccncc2)cc1=O		CHEMBL3093032	=	IC50	nM	13.0	CHEMBL262	Homo sapiens	IC50	nM	13.0
	13841063	CHEMBL3097577	Inhibition of human recombinant GSK3beta using prephosphorylated GS1 peptide as substrate after 1 hr by liquid scintillation spectrometry	B	Cn1c(NCC(=O)c2ccc(F)cc2)nc(-c2ccncc2)cc1=O		CHEMBL3093031	=	IC50	nM	52.0	CHEMBL262	Homo sapiens	IC50	nM	52.0
	13841064	CHEMBL3097577	Inhibition of human recombinant GSK3beta using prephosphorylated GS1 peptide as substrate after 1 hr by liquid scintillation spectrometry	B	Cn1c(NCC(=O)c2cccc(F)c2)nc(-c2ccncc2)cc1=O		CHEMBL3093054	=	IC50	nM	25.0	CHEMBL262	Homo sapiens	IC50	nM	25.0
	13841065	CHEMBL3097577	Inhibition of human recombinant GSK3beta using prephosphorylated GS1 peptide as substrate after 1 hr by liquid scintillation spectrometry	B	Cn1c(NCC(=O)c2ccccc2F)nc(-c2ccncc2)cc1=O		CHEMBL3093053	=	IC50	nM	27.0	CHEMBL262	Homo sapiens	IC50	nM	27.0
	13841066	CHEMBL3097577	Inhibition of human recombinant GSK3beta using prephosphorylated GS1 peptide as substrate after 1 hr by liquid scintillation spectrometry	B	Cn1c(N(CCCCCN)CCc2ccccc2)nc(-c2ccncc2)cc1=O		CHEMBL3093052	=	IC50	nM	150.0	CHEMBL262	Homo sapiens	IC50	nM	150.0
	13841067	CHEMBL3097577	Inhibition of human recombinant GSK3beta using prephosphorylated GS1 peptide as substrate after 1 hr by liquid scintillation spectrometry	B	Cn1c(N(CCCCN)CCc2ccccc2)nc(-c2ccncc2)cc1=O		CHEMBL3093051	=	IC50	nM	130.0	CHEMBL262	Homo sapiens	IC50	nM	130.0
	13841068	CHEMBL3097577	Inhibition of human recombinant GSK3beta using prephosphorylated GS1 peptide as substrate after 1 hr by liquid scintillation spectrometry	B	Cn1c(NCC(=O)c2ccccc2)nc(-c2ccncc2)cc1=O		CHEMBL3091545	=	IC50	nM	8.9	CHEMBL262	Homo sapiens	IC50	nM	8.9
	13841069	CHEMBL3097577	Inhibition of human recombinant GSK3beta using prephosphorylated GS1 peptide as substrate after 1 hr by liquid scintillation spectrometry	B	Cn1c(NCC(O)c2ccccc2)nc(-c2ccncc2)cc1=O		CHEMBL3093050	=	IC50	nM	23.0	CHEMBL262	Homo sapiens	IC50	nM	23.0
	13841070	CHEMBL3097577	Inhibition of human recombinant GSK3beta using prephosphorylated GS1 peptide as substrate after 1 hr by liquid scintillation spectrometry	B	Cn1c(NCCC2CCCCC2)nc(-c2ccncc2)cc1=O		CHEMBL3093049	=	IC50	nM	39.0	CHEMBL262	Homo sapiens	IC50	nM	39.0
	13841071	CHEMBL3097577	Inhibition of human recombinant GSK3beta using prephosphorylated GS1 peptide as substrate after 1 hr by liquid scintillation spectrometry	B	Cn1c(NCCc2ccccc2)nc(-c2ccncc2)cc1=O		CHEMBL3093048	=	IC50	nM	70.0	CHEMBL262	Homo sapiens	IC50	nM	70.0
	13841072	CHEMBL3097577	Inhibition of human recombinant GSK3beta using prephosphorylated GS1 peptide as substrate after 1 hr by liquid scintillation spectrometry	B	Cn1c(OCCc2ccccc2)nc(-c2ccncc2)cc1=O		CHEMBL3093047	=	IC50	nM	200.0	CHEMBL262	Homo sapiens	IC50	nM	200.0
	13841073	CHEMBL3097577	Inhibition of human recombinant GSK3beta using prephosphorylated GS1 peptide as substrate after 1 hr by liquid scintillation spectrometry	B	O=c1cc(-c2ccncc2)nc(CCCc2ccccc2)n1Cc1ccccc1		CHEMBL3093046	=	IC50	nM	2200.0	CHEMBL262	Homo sapiens	IC50	nM	2200.0
	13841074	CHEMBL3097577	Inhibition of human recombinant GSK3beta using prephosphorylated GS1 peptide as substrate after 1 hr by liquid scintillation spectrometry	B	CCCn1c(CCCc2ccccc2)nc(-c2ccncc2)cc1=O		CHEMBL3093045	=	IC50	nM	9800.0	CHEMBL262	Homo sapiens	IC50	nM	9800.0
	13841075	CHEMBL3097577	Inhibition of human recombinant GSK3beta using prephosphorylated GS1 peptide as substrate after 1 hr by liquid scintillation spectrometry	B	CCn1c(CCCc2ccccc2)nc(-c2ccncc2)cc1=O		CHEMBL3093044	=	IC50	nM	1900.0	CHEMBL262	Homo sapiens	IC50	nM	1900.0
	13841076	CHEMBL3097577	Inhibition of human recombinant GSK3beta using prephosphorylated GS1 peptide as substrate after 1 hr by liquid scintillation spectrometry	B	Cn1c(CCCc2ccccc2)nc(-c2ccncc2)cc1=O		CHEMBL3093043	=	IC50	nM	90.0	CHEMBL262	Homo sapiens	IC50	nM	90.0
	13841077	CHEMBL3097577	Inhibition of human recombinant GSK3beta using prephosphorylated GS1 peptide as substrate after 1 hr by liquid scintillation spectrometry	B	O=c1cc(-c2ccncc2)nc(CCCc2ccccc2)[nH]1		CHEMBL3093042	=	IC50	nM	500.0	CHEMBL262	Homo sapiens	IC50	nM	500.0
	13841078	CHEMBL3097577	Inhibition of human recombinant GSK3beta using prephosphorylated GS1 peptide as substrate after 1 hr by liquid scintillation spectrometry	B	O=c1cc(-c2ccncc2)nc(CCc2ccccc2)[nH]1		CHEMBL3093041	=	IC50	nM	8900.0	CHEMBL262	Homo sapiens	IC50	nM	8900.0
	13841079	CHEMBL3097577	Inhibition of human recombinant GSK3beta using prephosphorylated GS1 peptide as substrate after 1 hr by liquid scintillation spectrometry	B	O=c1cc(-c2ccncc2)nc(Cc2ccccc2)[nH]1		CHEMBL3093040	=	IC50	nM	1300.0	CHEMBL262	Homo sapiens	IC50	nM	1300.0
	13841080	CHEMBL3097577	Inhibition of human recombinant GSK3beta using prephosphorylated GS1 peptide as substrate after 1 hr by liquid scintillation spectrometry	B	O=c1cc(-c2ccncc2)nc(-c2ccccc2)[nH]1		CHEMBL3093039	=	IC50	nM	1800.0	CHEMBL262	Homo sapiens	IC50	nM	1800.0
	13841081	CHEMBL3097577	Inhibition of human recombinant GSK3beta using prephosphorylated GS1 peptide as substrate after 1 hr by liquid scintillation spectrometry	B	CC(C)Cc1nc(-c2ccncc2)cc(=O)[nH]1		CHEMBL3093038	=	IC50	nM	2400.0	CHEMBL262	Homo sapiens	IC50	nM	2400.0
	13841082	CHEMBL3097577	Inhibition of human recombinant GSK3beta using prephosphorylated GS1 peptide as substrate after 1 hr by liquid scintillation spectrometry	B	CC(C)c1nc(-c2ccncc2)cc(=O)[nH]1		CHEMBL3093037	=	IC50	nM	2100.0	CHEMBL262	Homo sapiens	IC50	nM	2100.0
	13841083	CHEMBL3097577	Inhibition of human recombinant GSK3beta using prephosphorylated GS1 peptide as substrate after 1 hr by liquid scintillation spectrometry	B	CCCCc1nc(-c2ccncc2)cc(=O)[nH]1		CHEMBL3093036	=	IC50	nM	1300.0	CHEMBL262	Homo sapiens	IC50	nM	1300.0
	13841084	CHEMBL3097577	Inhibition of human recombinant GSK3beta using prephosphorylated GS1 peptide as substrate after 1 hr by liquid scintillation spectrometry	B	Cc1nc(-c2ccncc2)cc(=O)[nH]1		CHEMBL3093035	=	IC50	nM	3000.0	CHEMBL262	Homo sapiens	IC50	nM	3000.0
	13841085	CHEMBL3097577	Inhibition of human recombinant GSK3beta using prephosphorylated GS1 peptide as substrate after 1 hr by liquid scintillation spectrometry	B	[Cl-].[Li+]		CHEMBL69710	=	IC50	nM	6530.0	CHEMBL262	Homo sapiens	IC50	nM	6530.0
	13843771	CHEMBL3097776	Inhibition of human recombinant GSK-3beta using prephosphorylated GS1 peptide and [gamma-32P]ATP as substrate after 1 hr by liquid scintillation spectrometry	B	Cn1c(N2CCO[C@@H](c3c(F)cccc3Cl)C2)nc(-c2ccncn2)cc1=O		CHEMBL3091544	=	IC50	nM	0.64	CHEMBL262	Homo sapiens	IC50	nM	0.64
	13843772	CHEMBL3097776	Inhibition of human recombinant GSK-3beta using prephosphorylated GS1 peptide and [gamma-32P]ATP as substrate after 1 hr by liquid scintillation spectrometry	B	Cn1c(N2CCO[C@@H](c3ccc(C#N)cc3F)C2)nc(-c2ccncn2)cc1=O		CHEMBL3091543	=	IC50	nM	6.5	CHEMBL262	Homo sapiens	IC50	nM	6.5
	13843773	CHEMBL3097776	Inhibition of human recombinant GSK-3beta using prephosphorylated GS1 peptide and [gamma-32P]ATP as substrate after 1 hr by liquid scintillation spectrometry	B	COc1cccc(OC)c1[C@H]1CN(c2nc(-c3ccncn3)cc(=O)n2C)CCO1		CHEMBL3091542	=	IC50	nM	0.23	CHEMBL262	Homo sapiens	IC50	nM	0.23
	13843774	CHEMBL3097776	Inhibition of human recombinant GSK-3beta using prephosphorylated GS1 peptide and [gamma-32P]ATP as substrate after 1 hr by liquid scintillation spectrometry	B	COc1cc(F)ccc1[C@H]1CN(c2nc(-c3ccncn3)cc(=O)n2C)CCO1		CHEMBL3091541	=	IC50	nM	0.47	CHEMBL262	Homo sapiens	IC50	nM	0.47
	13843775	CHEMBL3097776	Inhibition of human recombinant GSK-3beta using prephosphorylated GS1 peptide and [gamma-32P]ATP as substrate after 1 hr by liquid scintillation spectrometry	B	COc1ccccc1[C@H]1CN(c2nc(-c3ccncn3)cc(=O)n2C)CCO1		CHEMBL3091540	=	IC50	nM	0.87	CHEMBL262	Homo sapiens	IC50	nM	0.87
	13843776	CHEMBL3097776	Inhibition of human recombinant GSK-3beta using prephosphorylated GS1 peptide and [gamma-32P]ATP as substrate after 1 hr by liquid scintillation spectrometry	B	Cn1c(N2CCO[C@@H](c3ccccc3F)C2)nc(-c2ccncn2)cc1=O		CHEMBL3091539	=	IC50	nM	3.2	CHEMBL262	Homo sapiens	IC50	nM	3.2
	13843777	CHEMBL3097776	Inhibition of human recombinant GSK-3beta using prephosphorylated GS1 peptide and [gamma-32P]ATP as substrate after 1 hr by liquid scintillation spectrometry	B	COc1cccc([C@H]2CN(c3nc(-c4ccncn4)cc(=O)n3C)CCO2)c1		CHEMBL3091464	=	IC50	nM	4.6	CHEMBL262	Homo sapiens	IC50	nM	4.6
	13843778	CHEMBL3097776	Inhibition of human recombinant GSK-3beta using prephosphorylated GS1 peptide and [gamma-32P]ATP as substrate after 1 hr by liquid scintillation spectrometry	B	COc1ccc([C@H]2CN(c3nc(-c4ccncn4)cc(=O)n3C)CCO2)cc1		CHEMBL3091538	=	IC50	nM	2.9	CHEMBL262	Homo sapiens	IC50	nM	2.9
	13843779	CHEMBL3097776	Inhibition of human recombinant GSK-3beta using prephosphorylated GS1 peptide and [gamma-32P]ATP as substrate after 1 hr by liquid scintillation spectrometry	B	Cn1c(N2CCO[C@@H](c3ccc(C#N)cc3)C2)nc(-c2ccncn2)cc1=O		CHEMBL3091537	=	IC50	nM	13.0	CHEMBL262	Homo sapiens	IC50	nM	13.0
	13843780	CHEMBL3097776	Inhibition of human recombinant GSK-3beta using prephosphorylated GS1 peptide and [gamma-32P]ATP as substrate after 1 hr by liquid scintillation spectrometry	B	Cn1c(N2CCO[C@@H](c3ccc(F)cc3)C2)nc(-c2ccncn2)cc1=O		CHEMBL3091536	=	IC50	nM	12.0	CHEMBL262	Homo sapiens	IC50	nM	12.0
	13843781	CHEMBL3097776	Inhibition of human recombinant GSK-3beta using prephosphorylated GS1 peptide and [gamma-32P]ATP as substrate after 1 hr by liquid scintillation spectrometry	B	Cn1c(N2CCO[C@@H](c3ccc(F)cc3)C2)nc(-c2ccnc(Cl)c2)cc1=O		CHEMBL3091535	=	IC50	nM	903.0	CHEMBL262	Homo sapiens	IC50	nM	903.0
	13843782	CHEMBL3097776	Inhibition of human recombinant GSK-3beta using prephosphorylated GS1 peptide and [gamma-32P]ATP as substrate after 1 hr by liquid scintillation spectrometry	B	COc1cnccc1-c1cc(=O)n(C)c(N2CCO[C@@H](c3ccc(F)cc3)C2)n1		CHEMBL3091534	=	IC50	nM	791.0	CHEMBL262	Homo sapiens	IC50	nM	791.0
	13843783	CHEMBL3097776	Inhibition of human recombinant GSK-3beta using prephosphorylated GS1 peptide and [gamma-32P]ATP as substrate after 1 hr by liquid scintillation spectrometry	B	Cc1cnccc1-c1cc(=O)n(C)c(N2CCO[C@@H](c3ccc(F)cc3)C2)n1		CHEMBL3091533	=	IC50	nM	2466.0	CHEMBL262	Homo sapiens	IC50	nM	2466.0
	13843784	CHEMBL3097776	Inhibition of human recombinant GSK-3beta using prephosphorylated GS1 peptide and [gamma-32P]ATP as substrate after 1 hr by liquid scintillation spectrometry	B	Cn1c(N2CCO[C@@H](c3ccc(F)cc3)C2)nc(-c2ccncc2Cl)cc1=O		CHEMBL3091532	=	IC50	nM	430.0	CHEMBL262	Homo sapiens	IC50	nM	430.0
	13843785	CHEMBL3097776	Inhibition of human recombinant GSK-3beta using prephosphorylated GS1 peptide and [gamma-32P]ATP as substrate after 1 hr by liquid scintillation spectrometry	B	Cn1c(N2CCO[C@@H](c3ccc(F)cc3)C2)nc(-c2ccncc2F)cc1=O		CHEMBL3091531	=	IC50	nM	7.4	CHEMBL262	Homo sapiens	IC50	nM	7.4
	13843786	CHEMBL3097776	Inhibition of human recombinant GSK-3beta using prephosphorylated GS1 peptide and [gamma-32P]ATP as substrate after 1 hr by liquid scintillation spectrometry	B	Cn1c(N2CCO[C@H](c3ccc(F)cc3)C2)nc(-c2ccncc2)cc1=O		CHEMBL3091530	=	IC50	nM	77.0	CHEMBL262	Homo sapiens	IC50	nM	77.0
	13843787	CHEMBL3097776	Inhibition of human recombinant GSK-3beta using prephosphorylated GS1 peptide and [gamma-32P]ATP as substrate after 1 hr by liquid scintillation spectrometry	B	Cn1c(N2CCO[C@@H](c3ccc(F)cc3)C2)nc(-c2ccncc2)cc1=O		CHEMBL3091529	=	IC50	nM	22.0	CHEMBL262	Homo sapiens	IC50	nM	22.0
	13843788	CHEMBL3097776	Inhibition of human recombinant GSK-3beta using prephosphorylated GS1 peptide and [gamma-32P]ATP as substrate after 1 hr by liquid scintillation spectrometry	B	Cn1c(N2CCOC(c3ccc(F)cc3)C2)nc(-c2ccncc2)cc1=O		CHEMBL3091547	=	IC50	nM	27.0	CHEMBL262	Homo sapiens	IC50	nM	27.0
	13843789	CHEMBL3097776	Inhibition of human recombinant GSK-3beta using prephosphorylated GS1 peptide and [gamma-32P]ATP as substrate after 1 hr by liquid scintillation spectrometry	B	Cn1c(N2CCOC(c3ccccc3)C2)nc(-c2ccncc2)cc1=O		CHEMBL3091546	=	IC50	nM	51.0	CHEMBL262	Homo sapiens	IC50	nM	51.0
Active	13863620	CHEMBL3102607	Inhibition of GSK-3beta in human SH-SY5Y cells assessed as reduction of amyloid beta (25 to 35)-induced Tau hyperphosphorylation at Ser396 at 10 uM incubated for 1 hr prior to amyloid beta (25 to 35) induction measured after 6 hrs by Western blotting analysis	B	O=C1NC(=O)C(c2nn(CCCN3CCOCC3)c3ncccc23)=C1c1c[nH]c2ccccc12		CHEMBL3099840		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	13863621	CHEMBL3102607	Inhibition of GSK-3beta in human SH-SY5Y cells assessed as reduction of amyloid beta (25 to 35)-induced Tau hyperphosphorylation at Ser396 at 10 uM incubated for 1 hr prior to amyloid beta (25 to 35) induction measured after 6 hrs by Western blotting analysis	B	O=C1NC(=O)C(c2nn(CCCN3CCOCC3)c3ncccc23)=C1c1cn(CCCn2ccnc2)c2ccccc12		CHEMBL3099839		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	13863622	CHEMBL3102607	Inhibition of GSK-3beta in human SH-SY5Y cells assessed as reduction of amyloid beta (25 to 35)-induced Tau hyperphosphorylation at Ser396 at 10 uM incubated for 1 hr prior to amyloid beta (25 to 35) induction measured after 6 hrs by Western blotting analysis	B	O=C1NC(=O)C(c2nn(CCCN3CCOCC3)c3ncccc23)=C1c1cn(CCCN2CCOCC2)c2ccccc12		CHEMBL3099838		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	13863623	CHEMBL3102607	Inhibition of GSK-3beta in human SH-SY5Y cells assessed as reduction of amyloid beta (25 to 35)-induced Tau hyperphosphorylation at Ser396 at 10 uM incubated for 1 hr prior to amyloid beta (25 to 35) induction measured after 6 hrs by Western blotting analysis	B	CC(C)n1cc(C2=C(c3nn(CCCN4CCOCC4)c4ncccc34)C(=O)NC2=O)c2ccccc21		CHEMBL3099835		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	13863624	CHEMBL3102607	Inhibition of GSK-3beta in human SH-SY5Y cells assessed as reduction of amyloid beta (25 to 35)-induced Tau hyperphosphorylation at Ser396 at 10 uM incubated for 1 hr prior to amyloid beta (25 to 35) induction measured after 6 hrs by Western blotting analysis	B	Cn1cc(C2=C(c3nn(CCN4CCOCC4)c4ncccc34)C(=O)NC2=O)c2ccccc21		CHEMBL3099832		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	13863625	CHEMBL3102607	Inhibition of GSK-3beta in human SH-SY5Y cells assessed as reduction of amyloid beta (25 to 35)-induced Tau hyperphosphorylation at Ser396 at 10 uM incubated for 1 hr prior to amyloid beta (25 to 35) induction measured after 6 hrs by Western blotting analysis	B	Cn1cc(C2=C(c3nn(CCn4ccnc4)c4ncccc34)C(=O)NC2=O)c2ccccc21		CHEMBL563560		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	13863626	CHEMBL3102607	Inhibition of GSK-3beta in human SH-SY5Y cells assessed as reduction of amyloid beta (25 to 35)-induced Tau hyperphosphorylation at Ser396 at 10 uM incubated for 1 hr prior to amyloid beta (25 to 35) induction measured after 6 hrs by Western blotting analysis	B	Cn1cc(C2=C(c3nn(CCCO)c4ncccc34)C(=O)NC2=O)c2ccccc21		CHEMBL560585		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	13863627	CHEMBL3102607	Inhibition of GSK-3beta in human SH-SY5Y cells assessed as reduction of amyloid beta (25 to 35)-induced Tau hyperphosphorylation at Ser396 at 10 uM incubated for 1 hr prior to amyloid beta (25 to 35) induction measured after 6 hrs by Western blotting analysis	B	Cn1cc(C2=C(c3nn(CCCN4CCOCC4)c4ncccc34)C(=O)NC2=O)c2ccccc21		CHEMBL564033		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	13863648	CHEMBL3102612	Inhibition of recombinant GST-tagged GSK-3beta (unknown origin) expressed in Escherichia coli BL21 assessed as phosphate incorporation in CREB at 20 ug/mL relative to control	B	COC(=O)CN1C(=O)C(c2c[nH]c3ccccc23)=C(c2n[nH]c3ncccc23)C1=O		CHEMBL3099848	=	Inhibition	%	51.54	CHEMBL262	Homo sapiens	INH	%	51.54
	13863649	CHEMBL3102612	Inhibition of recombinant GST-tagged GSK-3beta (unknown origin) expressed in Escherichia coli BL21 assessed as phosphate incorporation in CREB at 20 ug/mL relative to control	B	NC(=S)NN1C(=O)C(c2c[nH]c3ccccc23)=C(c2n[nH]c3ncccc23)C1=O		CHEMBL3099847	=	Inhibition	%	33.7	CHEMBL262	Homo sapiens	INH	%	33.7
	13863650	CHEMBL3102612	Inhibition of recombinant GST-tagged GSK-3beta (unknown origin) expressed in Escherichia coli BL21 assessed as phosphate incorporation in CREB at 20 ug/mL relative to control	B	NC(=O)NN1C(=O)C(c2c[nH]c3ccccc23)=C(c2n[nH]c3ncccc23)C1=O		CHEMBL3099846	=	Inhibition	%	-6.81	CHEMBL262	Homo sapiens	INH	%	-6.81
	13863651	CHEMBL3102612	Inhibition of recombinant GST-tagged GSK-3beta (unknown origin) expressed in Escherichia coli BL21 assessed as phosphate incorporation in CREB at 20 ug/mL relative to control	B	O=CNN1C(=O)C(c2c[nH]c3ccccc23)=C(c2n[nH]c3ncccc23)C1=O		CHEMBL3099845	=	Inhibition	%	-7.42	CHEMBL262	Homo sapiens	INH	%	-7.42
	13863652	CHEMBL3102612	Inhibition of recombinant GST-tagged GSK-3beta (unknown origin) expressed in Escherichia coli BL21 assessed as phosphate incorporation in CREB at 20 ug/mL relative to control	B	CC(C)CN1C(=O)C(c2c[nH]c3ccccc23)=C(c2n[nH]c3ncccc23)C1=O		CHEMBL3099844	=	Inhibition	%	45.73	CHEMBL262	Homo sapiens	INH	%	45.73
	13863653	CHEMBL3102612	Inhibition of recombinant GST-tagged GSK-3beta (unknown origin) expressed in Escherichia coli BL21 assessed as phosphate incorporation in CREB at 20 ug/mL relative to control	B	NN1C(=O)C(c2c[nH]c3ccccc23)=C(c2n[nH]c3ncccc23)C1=O		CHEMBL3099843	=	Inhibition	%	28.56	CHEMBL262	Homo sapiens	INH	%	28.56
	13863654	CHEMBL3102612	Inhibition of recombinant GST-tagged GSK-3beta (unknown origin) expressed in Escherichia coli BL21 assessed as phosphate incorporation in CREB at 20 ug/mL relative to control	B	O=C1C(c2c[nH]c3ccccc23)=C(c2n[nH]c3ncccc23)C(=O)N1c1ccccc1		CHEMBL3099841	=	Inhibition	%	4.14	CHEMBL262	Homo sapiens	INH	%	4.14
	13863655	CHEMBL3102613	Inhibition of recombinant GST-tagged GSK-3beta (unknown origin) expressed in Escherichia coli BL21 assessed as phosphate incorporation in CREB	B	O=C1NC(=O)C(c2nn(CCCN3CCOCC3)c3ncccc23)=C1c1c[nH]c2ccccc12		CHEMBL3099840	=	IC50	nM	830.0	CHEMBL262	Homo sapiens	IC50	uM	0.83
	13863656	CHEMBL3102613	Inhibition of recombinant GST-tagged GSK-3beta (unknown origin) expressed in Escherichia coli BL21 assessed as phosphate incorporation in CREB	B	O=C1NC(=O)C(c2nn(CCCN3CCOCC3)c3ncccc23)=C1c1cn(CCCn2ccnc2)c2ccccc12		CHEMBL3099839	=	IC50	nM	680.0	CHEMBL262	Homo sapiens	IC50	uM	0.68
	13863657	CHEMBL3102613	Inhibition of recombinant GST-tagged GSK-3beta (unknown origin) expressed in Escherichia coli BL21 assessed as phosphate incorporation in CREB	B	O=C1NC(=O)C(c2nn(CCCN3CCOCC3)c3ncccc23)=C1c1cn(CCCN2CCOCC2)c2ccccc12		CHEMBL3099838	=	IC50	nM	1290.0	CHEMBL262	Homo sapiens	IC50	uM	1.29
	13863658	CHEMBL3102613	Inhibition of recombinant GST-tagged GSK-3beta (unknown origin) expressed in Escherichia coli BL21 assessed as phosphate incorporation in CREB	B	C=CCn1cc(C2=C(c3nn(CCCN4CCOCC4)c4ncccc34)C(=O)NC2=O)c2ccccc21		CHEMBL3099837	=	IC50	nM	960.0	CHEMBL262	Homo sapiens	IC50	uM	0.96
	13863659	CHEMBL3102613	Inhibition of recombinant GST-tagged GSK-3beta (unknown origin) expressed in Escherichia coli BL21 assessed as phosphate incorporation in CREB	B	O=C1NC(=O)C(c2nn(CCCN3CCOCC3)c3ncccc23)=C1c1cn(Cc2ccccc2)c2ccccc12		CHEMBL3099836	=	IC50	nM	1900.0	CHEMBL262	Homo sapiens	IC50	uM	1.9
	13863660	CHEMBL3102613	Inhibition of recombinant GST-tagged GSK-3beta (unknown origin) expressed in Escherichia coli BL21 assessed as phosphate incorporation in CREB	B	CC(C)n1cc(C2=C(c3nn(CCCN4CCOCC4)c4ncccc34)C(=O)NC2=O)c2ccccc21		CHEMBL3099835	=	IC50	nM	380.0	CHEMBL262	Homo sapiens	IC50	uM	0.38
	13863661	CHEMBL3102613	Inhibition of recombinant GST-tagged GSK-3beta (unknown origin) expressed in Escherichia coli BL21 assessed as phosphate incorporation in CREB	B	C=Cn1cc(C2=C(c3nn(CCCN4CCOCC4)c4ncccc34)C(=O)NC2=O)c2ccccc21		CHEMBL3099834	=	IC50	nM	8840.0	CHEMBL262	Homo sapiens	IC50	uM	8.84
	13863662	CHEMBL3102613	Inhibition of recombinant GST-tagged GSK-3beta (unknown origin) expressed in Escherichia coli BL21 assessed as phosphate incorporation in CREB	B	Cn1cc(C2=C(c3nn(CCCCN4CCOCC4)c4ncccc34)C(=O)NC2=O)c2ccccc21		CHEMBL3099833	=	IC50	nM	460.0	CHEMBL262	Homo sapiens	IC50	uM	0.46
	13863663	CHEMBL3102613	Inhibition of recombinant GST-tagged GSK-3beta (unknown origin) expressed in Escherichia coli BL21 assessed as phosphate incorporation in CREB	B	Cn1cc(C2=C(c3nn(CCN4CCOCC4)c4ncccc34)C(=O)NC2=O)c2ccccc21		CHEMBL3099832	=	IC50	nM	360.0	CHEMBL262	Homo sapiens	IC50	uM	0.36
	13863664	CHEMBL3102613	Inhibition of recombinant GST-tagged GSK-3beta (unknown origin) expressed in Escherichia coli BL21 assessed as phosphate incorporation in CREB	B	Cn1cc(C2=C(c3nn(CCCCn4ccnc4)c4ncccc34)C(=O)NC2=O)c2ccccc21		CHEMBL563685	=	IC50	nM	960.0	CHEMBL262	Homo sapiens	IC50	uM	0.96
	13863665	CHEMBL3102613	Inhibition of recombinant GST-tagged GSK-3beta (unknown origin) expressed in Escherichia coli BL21 assessed as phosphate incorporation in CREB	B	Cn1cc(C2=C(c3nn(CCn4ccnc4)c4ncccc34)C(=O)NC2=O)c2ccccc21		CHEMBL563560	=	IC50	nM	810.0	CHEMBL262	Homo sapiens	IC50	uM	0.81
	13863666	CHEMBL3102613	Inhibition of recombinant GST-tagged GSK-3beta (unknown origin) expressed in Escherichia coli BL21 assessed as phosphate incorporation in CREB	B	CN(C)CCCn1nc(C2=C(c3cn(C)c4ccccc34)C(=O)NC2=O)c2cccnc21		CHEMBL564091	=	IC50	nM	5690.0	CHEMBL262	Homo sapiens	IC50	uM	5.69
	13863667	CHEMBL3102613	Inhibition of recombinant GST-tagged GSK-3beta (unknown origin) expressed in Escherichia coli BL21 assessed as phosphate incorporation in CREB	B	Cn1cc(C2=C(c3nn(CCCn4ccnc4)c4ncccc34)C(=O)NC2=O)c2ccccc21		CHEMBL550052	=	IC50	nM	4890.0	CHEMBL262	Homo sapiens	IC50	uM	4.89
	13864274	CHEMBL3102613	Inhibition of recombinant GST-tagged GSK-3beta (unknown origin) expressed in Escherichia coli BL21 assessed as phosphate incorporation in CREB	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	200.0	CHEMBL262	Homo sapiens	IC50	uM	0.2
	13864275	CHEMBL3102613	Inhibition of recombinant GST-tagged GSK-3beta (unknown origin) expressed in Escherichia coli BL21 assessed as phosphate incorporation in CREB	B	O=C1NC(=O)C(c2n[nH]c3ncccc23)=C1c1c[nH]c2ccccc12		CHEMBL3099842	=	IC50	nM	7310.0	CHEMBL262	Homo sapiens	IC50	uM	7.31
	13864276	CHEMBL3102613	Inhibition of recombinant GST-tagged GSK-3beta (unknown origin) expressed in Escherichia coli BL21 assessed as phosphate incorporation in CREB	B	Cn1cc(C2=C(c3nn(CCCN4CCOCC4)c4ncccc34)C(=O)NC2=O)c2ccccc21		CHEMBL564033	=	IC50	nM	750.0	CHEMBL262	Homo sapiens	IC50	uM	0.75
	13864277	CHEMBL3102613	Inhibition of recombinant GST-tagged GSK-3beta (unknown origin) expressed in Escherichia coli BL21 assessed as phosphate incorporation in CREB	B	Cn1cc(C2=C(c3n[nH]c4ncccc34)C(=O)NC2=O)c2ccccc21		CHEMBL564815	=	IC50	nM	12270.0	CHEMBL262	Homo sapiens	IC50	uM	12.27
	13864278	CHEMBL3102613	Inhibition of recombinant GST-tagged GSK-3beta (unknown origin) expressed in Escherichia coli BL21 assessed as phosphate incorporation in CREB	B	CN1CCN(CCCn2nc(C3=C(c4cn(C)c5ccccc45)C(=O)NC3=O)c3cccnc32)CC1		CHEMBL562709	=	IC50	nM	3340.0	CHEMBL262	Homo sapiens	IC50	uM	3.34
	13864279	CHEMBL3102613	Inhibition of recombinant GST-tagged GSK-3beta (unknown origin) expressed in Escherichia coli BL21 assessed as phosphate incorporation in CREB	B	Cn1cc(C2=C(c3nn(CCCN4CCCCC4)c4ncccc34)C(=O)NC2=O)c2ccccc21		CHEMBL563121	=	IC50	nM	2660.0	CHEMBL262	Homo sapiens	IC50	uM	2.66
	13864280	CHEMBL3102613	Inhibition of recombinant GST-tagged GSK-3beta (unknown origin) expressed in Escherichia coli BL21 assessed as phosphate incorporation in CREB	B	Cn1cc(C2=C(c3nn(CCCO)c4ncccc34)C(=O)NC2=O)c2ccccc21		CHEMBL560585	=	IC50	nM	1090.0	CHEMBL262	Homo sapiens	IC50	uM	1.09
	13872132	CHEMBL3101757	Inhibition of human GSK3beta assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	63.0	CHEMBL262	Homo sapiens	Activity	%	63.0
	13872224	CHEMBL3102530	Inhibition of GSK3-beta (unknown origin) assessed as residual activity at 10 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	92.0	CHEMBL262	Homo sapiens	Activity	%	92.0
	13872254	CHEMBL3100331	Inhibition of GSK3-beta (unknown origin) assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	92.0	CHEMBL262	Homo sapiens	Activity	%	92.0
Not Active	13881597	CHEMBL3108562	Inhibition of human GSK-3beta at 5 x 10'-8 M	B	Oc1ccc(-c2c[nH]c3ncc(-c4ccc(O)c(O)c4)cc23)cc1		CHEMBL3102952		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	13881598	CHEMBL3108562	Inhibition of human GSK-3beta at 5 x 10'-8 M	B	Oc1ccc(-c2c[nH]c3ncc(-c4ccc(O)cc4O)cc23)cc1		CHEMBL3102951		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	13881599	CHEMBL3108562	Inhibition of human GSK-3beta at 5 x 10'-8 M	B	Oc1ccc(-c2cnc3[nH]cc(-c4ccc(O)cc4)c3c2)cc1		CHEMBL3102950		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	13895864	CHEMBL3111602	Inhibition of GSK3beta (unknown origin) at 1 uM	B	CN(C)S(=O)(=O)c1ccc(Nc2cc3[nH]c(-c4cn[nH]c4)cc3cn2)cc1		CHEMBL3109950	=	Inhibition	%	92.0	CHEMBL262	Homo sapiens	INH	%	92.0
	13895865	CHEMBL3111602	Inhibition of GSK3beta (unknown origin) at 1 uM	B	COc1ccc(Nc2cc3[nH]c(-c4cn[nH]c4)cc3cn2)cc1OC		CHEMBL3109932	=	Inhibition	%	90.0	CHEMBL262	Homo sapiens	INH	%	90.0
	13895866	CHEMBL3111602	Inhibition of GSK3beta (unknown origin) at 1 uM	B	c1cnn(Cc2ccc(Nc3cc4[nH]c(-c5cn[nH]c5)cc4cn3)cc2)c1		CHEMBL3109951	=	Inhibition	%	90.0	CHEMBL262	Homo sapiens	INH	%	90.0
	13895872	CHEMBL3111602	Inhibition of GSK3beta (unknown origin) at 1 uM	B	COc1ccc(Nc2cc3[nH]c(-c4cn[nH]c4)cc3cn2)cc1		CHEMBL3109949	=	Inhibition	%	73.0	CHEMBL262	Homo sapiens	INH	%	73.0
	13895877	CHEMBL3111602	Inhibition of GSK3beta (unknown origin) at 1 uM	B	CCOc1ccccc1Nc1cc2[nH]c(-c3cn[nH]c3)cc2cn1		CHEMBL3109954	=	Inhibition	%	61.0	CHEMBL262	Homo sapiens	INH	%	61.0
	13895880	CHEMBL3111602	Inhibition of GSK3beta (unknown origin) at 1 uM	B	c1cc(OCCN2CCOCC2)ccc1Nc1cc2[nH]c(-c3cn[nH]c3)cc2cn1		CHEMBL3109952	=	Inhibition	%	57.0	CHEMBL262	Homo sapiens	INH	%	57.0
	13895883	CHEMBL3111602	Inhibition of GSK3beta (unknown origin) at 1 uM	B	Clc1ccccc1Nc1cc2[nH]c(-c3cn[nH]c3)cc2cn1		CHEMBL3109955	=	Inhibition	%	56.0	CHEMBL262	Homo sapiens	INH	%	56.0
	13895924	CHEMBL3111602	Inhibition of GSK3beta (unknown origin) at 1 uM	B	COc1ccc(Nc2cc3[nH]c(-c4cn[nH]c4)cc3cn2)c(Cl)c1		CHEMBL3109956	=	Inhibition	%	16.0	CHEMBL262	Homo sapiens	INH	%	16.0
	13895928	CHEMBL3111602	Inhibition of GSK3beta (unknown origin) at 1 uM	B	COc1ccccc1Nc1cc2[nH]c(-c3cn[nH]c3)cc2cn1		CHEMBL3109953	=	Inhibition	%	13.0	CHEMBL262	Homo sapiens	INH	%	13.0
Active	13899583	CHEMBL3111850	Inhibition of human GSK-3beta-mediated tau phosphorylation in doxycycline/synthetic tau fibril-induced HEK293 cells assessed as increase in faster-mobility 17025 band at 1 uM after 48 hrs by Immunoblotting analysis	B	Cc1nn(-c2ccc(Cl)cc2Cl)c2c1c1c(c3cccn32)C(=O)NC1=O		CHEMBL3110144		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	13899584	CHEMBL3111851	Inhibition of human GSK-3beta-mediated tau phosphorylation in doxycycline/synthetic tau fibril-induced HEK293 cells assessed as increase in faster-migrating AT180 band at 1 uM after 48 hrs by Immunoblotting analysis	B	Cc1nn(-c2ccc(Cl)cc2Cl)c2c1c1c(c3cccn32)C(=O)NC1=O		CHEMBL3110144		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	13899585	CHEMBL3111859	Inhibition of human GSK-3beta-mediated tau phosphorylation in doxycycline/synthetic tau fibril-induced HEK293 cells assessed as decrease in slow mobility of AT180 band at 1 uM after 48 hrs by Immunoblotting analysis	B	Cc1nn(-c2ccc(Cl)cc2Cl)c2c1c1c(c3cccn32)C(=O)NC1=O		CHEMBL3110144		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	13899586	CHEMBL3111852	Inhibition of GSK3beta in human NCI/ADR-RES cells up to 5 uM	B	Cc1nn(-c2ccc(Cl)cc2Cl)c2c1c1c(c3cccn32)C(=O)NC1=O		CHEMBL3110144		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	13899587	CHEMBL3112016	Inhibition of GSK3beta in human OVCAR8 cells up to 5 uM	B	Cc1nn(-c2ccc(Cl)cc2Cl)c2c1c1c(c3cccn32)C(=O)NC1=O		CHEMBL3110144		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	13899607	CHEMBL3112014	Inhibition of GSK-3beta (unknown origin) using (RREGGMSRPAS(p)VDG as substrate assessed as 32P[gamma-ATP] incorporation into substrate after 15 mins by autoradiography	B	O=Nc1c(-c2c(O)[nH]c3cc(Br)ccc23)[nH]c2ccccc12		CHEMBL355496	=	IC50	nM	174.0	CHEMBL262	Homo sapiens	IC50	uM	0.174
	13899608	CHEMBL3112014	Inhibition of GSK-3beta (unknown origin) using (RREGGMSRPAS(p)VDG as substrate assessed as 32P[gamma-ATP] incorporation into substrate after 15 mins by autoradiography	B	Cc1nn(-c2ccc(Cl)cc2Cl)c2c1c1c(c3cccn32)C(=O)NC1=O		CHEMBL3110144	=	IC50	nM	240.0	CHEMBL262	Homo sapiens	IC50	uM	0.24
	13899609	CHEMBL3112014	Inhibition of GSK-3beta (unknown origin) using (RREGGMSRPAS(p)VDG as substrate assessed as 32P[gamma-ATP] incorporation into substrate after 15 mins by autoradiography	B	Cc1nn(-c2ccccc2Cl)c2c1c1c(c3cccn32)C(=O)NC1=O		CHEMBL3110143	=	IC50	nM	940.0	CHEMBL262	Homo sapiens	IC50	uM	0.94
	13899610	CHEMBL3112014	Inhibition of GSK-3beta (unknown origin) using (RREGGMSRPAS(p)VDG as substrate assessed as 32P[gamma-ATP] incorporation into substrate after 15 mins by autoradiography	B	Cc1ccccc1-n1nc(C)c2c3c(c4cccn4c21)C(=O)NC3=O		CHEMBL3110142	=	IC50	nM	440.0	CHEMBL262	Homo sapiens	IC50	uM	0.44
Not Determined	13899611	CHEMBL3112014	Inhibition of GSK-3beta (unknown origin) using (RREGGMSRPAS(p)VDG as substrate assessed as 32P[gamma-ATP] incorporation into substrate after 15 mins by autoradiography	B	CN1C(=O)c2c(c3cccn3c3c2cnn3-c2ccccc2)C1=O		CHEMBL3110141		IC50			CHEMBL262	Homo sapiens	IC50		
	13899612	CHEMBL3112014	Inhibition of GSK-3beta (unknown origin) using (RREGGMSRPAS(p)VDG as substrate assessed as 32P[gamma-ATP] incorporation into substrate after 15 mins by autoradiography	B	Cc1nn(-c2ccccc2)c2c1c1c(c3cccn32)C(=O)NC1=O		CHEMBL3110140	=	IC50	nM	690.0	CHEMBL262	Homo sapiens	IC50	uM	0.69
	13899613	CHEMBL3112014	Inhibition of GSK-3beta (unknown origin) using (RREGGMSRPAS(p)VDG as substrate assessed as 32P[gamma-ATP] incorporation into substrate after 15 mins by autoradiography	B	COc1ccccc1-n1ncc2c3c(c4cccn4c21)C(=O)NC3=O		CHEMBL3110139	=	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	uM	1.0
	13899614	CHEMBL3112014	Inhibition of GSK-3beta (unknown origin) using (RREGGMSRPAS(p)VDG as substrate assessed as 32P[gamma-ATP] incorporation into substrate after 15 mins by autoradiography	B	Cc1ccccc1-n1ncc2c3c(c4cccn4c21)C(=O)NC3=O		CHEMBL3110138	=	IC50	nM	1210.0	CHEMBL262	Homo sapiens	IC50	uM	1.21
Not Determined	13899615	CHEMBL3112014	Inhibition of GSK-3beta (unknown origin) using (RREGGMSRPAS(p)VDG as substrate assessed as 32P[gamma-ATP] incorporation into substrate after 15 mins by autoradiography	B	O=C1NC(=O)c2c1c1cnn(-c3ccc(Cl)cc3)c1n1cccc21		CHEMBL3110137		IC50			CHEMBL262	Homo sapiens	IC50		
Not Determined	13899616	CHEMBL3112014	Inhibition of GSK-3beta (unknown origin) using (RREGGMSRPAS(p)VDG as substrate assessed as 32P[gamma-ATP] incorporation into substrate after 15 mins by autoradiography	B	O=C1NC(=O)c2c1c1cnn(-c3cccc(Cl)c3)c1n1cccc21		CHEMBL3110136		IC50			CHEMBL262	Homo sapiens	IC50		
	13899617	CHEMBL3112014	Inhibition of GSK-3beta (unknown origin) using (RREGGMSRPAS(p)VDG as substrate assessed as 32P[gamma-ATP] incorporation into substrate after 15 mins by autoradiography	B	O=C1NC(=O)c2c1c1cnn(-c3ccccc3Cl)c1n1cccc21		CHEMBL3110135	=	IC50	nM	810.0	CHEMBL262	Homo sapiens	IC50	uM	0.81
	13899618	CHEMBL3112014	Inhibition of GSK-3beta (unknown origin) using (RREGGMSRPAS(p)VDG as substrate assessed as 32P[gamma-ATP] incorporation into substrate after 15 mins by autoradiography	B	O=C1NC(=O)c2c1c1cnn(-c3ccccc3)c1n1cccc21		CHEMBL3110134	=	IC50	nM	1690.0	CHEMBL262	Homo sapiens	IC50	uM	1.69
	13919566	CHEMBL3118640	Inhibition of GSK3beta (unknown origin)	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	72.0	CHEMBL262	Homo sapiens	IC50	uM	0.072
	13919572	CHEMBL3118645	Inhibition of GSK3beta (unknown origin) at 0.8 ug/ml	B	CC(C)(C)NC(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3112595	=	Inhibition	%	7.2	CHEMBL262	Homo sapiens	INH	%	7.2
	13943694	CHEMBL3131242	Inhibition of GSK3beta (unknown origin) expressed in sf9 cells after 30 mins by scintillation counting analysis in presence of [gamma-32P]ATP	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	IC50	nM	23.0	CHEMBL262	Homo sapiens	IC50	nM	23.0
	13943695	CHEMBL3131243	Inhibition of GSK3beta (unknown origin)	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	IC50	nM	390.0	CHEMBL262	Homo sapiens	IC50	nM	390.0
	13943696	CHEMBL3131243	Inhibition of GSK3beta (unknown origin)	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714	=	IC50	nM	9.0	CHEMBL262	Homo sapiens	IC50	nM	9.0
	13943697	CHEMBL3131243	Inhibition of GSK3beta (unknown origin)	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	IC50	nM	650.0	CHEMBL262	Homo sapiens	IC50	nM	650.0
	13943698	CHEMBL3131243	Inhibition of GSK3beta (unknown origin)	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	IC50	nM	25.0	CHEMBL262	Homo sapiens	IC50	nM	25.0
	13943699	CHEMBL3131243	Inhibition of GSK3beta (unknown origin)	B	O=C1Nc2cc(Br)ccc2/C1=c1/[nH]c2ccccc2/c1=C\O		CHEMBL3125370	=	IC50	nM	5.0	CHEMBL262	Homo sapiens	IC50	nM	5.0
	13948192	CHEMBL3132599	Inhibition of C-terminal FLAG-tagged GSK3beta (unknown origin) expressed in baculovirus system after 30 mins	B	N#Cc1c(Oc2ccc(F)c(NC(=O)Cc3cccc(C(F)(F)F)c3)c2)ccc2nc(NC(=O)C3CC3)sc12		CHEMBL3125890	=	IC50	nM	500.0	CHEMBL262	Homo sapiens	IC50	nmol/L	500.0
Not Active	13950887	CHEMBL3129550	Inhibition of human GSK3 beta at 10 uM	B	C[C@@H]1NC(c2ccc(Br)cc2)=Nc2nc3ccccn3c2C1=O		CHEMBL3125580		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	13953254	CHEMBL3132642	Inhibition of human GSK3beta assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125727	=	Activity	%	102.0	CHEMBL262	Homo sapiens	Activity	%	102.0
	13954607	CHEMBL3132642	Inhibition of human GSK3beta assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125726	=	Activity	%	106.0	CHEMBL262	Homo sapiens	Activity	%	106.0
	13954717	CHEMBL3132642	Inhibition of human GSK3beta assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125728	=	Activity	%	83.0	CHEMBL262	Homo sapiens	Activity	%	83.0
	13966018	CHEMBL3136507	Inhibition of human full length GSK-3 beta expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 1000 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1cnc2[nH]ccc2c1		CHEMBL389685	=	Inhibition	%	32.0	CHEMBL262	Homo sapiens	INH	%	32.0
	13973293	CHEMBL3136886	Inhibition of human full length GSK-3 beta expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.1 uM after 90 mins by microfluidic peptide phosphorylation assay	B	C[C@H](CN(C)C)Oc1nc(Nc2cc3cccc(Cl)c3cn2)cnc1C#N		CHEMBL1928705	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	INH	%	0.0
	13974011	CHEMBL3136475	Inhibition of human full length GSK-3 beta expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.35 uM after 90 mins by microfluidic peptide phosphorylation assay	B	COC(=O)c1cnc(Nc2cnc(C#N)cn2)cc1NCC1CCNCC1		CHEMBL1928692	=	Inhibition	%	3.5	CHEMBL262	Homo sapiens	INH	%	3.5
	13974102	CHEMBL3135613	Inhibition of human full length GSK-3 beta expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 9 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]c4cnccc4c23)CCO1		CHEMBL1928677	=	Inhibition	%	94.0	CHEMBL262	Homo sapiens	INH	%	94.0
	13974193	CHEMBL3137133	Inhibition of human full length GSK-3 beta expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 90 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]cnc23)CCO1		CHEMBL560373	=	Inhibition	%	68.5	CHEMBL262	Homo sapiens	INH	%	68.5
	13974284	CHEMBL3136262	Inhibition of human full length GSK-3 beta expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 420 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1nc(N2CCOCC2)c2nc[nH]c2n1		CHEMBL271138	=	Inhibition	%	90.0	CHEMBL262	Homo sapiens	INH	%	90.0
	13975022	CHEMBL3135982	Inhibition of human full length GSK-3 beta expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.02 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL598194	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	INH	%	0.0
	13975113	CHEMBL3135709	Inhibition of human full length GSK-3 beta expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.06 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL263664	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	INH	%	0.0
	13975204	CHEMBL3135793	Inhibition of human full length GSK-3 beta expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL259141	=	Inhibition	%	5.0	CHEMBL262	Homo sapiens	INH	%	5.0
	13975847	CHEMBL3134770	Inhibition of human full length GSK-3 beta expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 8 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL261249	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	INH	%	0.0
	13975940	CHEMBL3136877	Inhibition of human full length GSK-3 beta expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	Clc1ccc(C2(c3ccc(-c4ncnc5[nH]cnc45)cc3)CCNCC2)cc1		CHEMBL228133	=	Inhibition	%	3.5	CHEMBL262	Homo sapiens	INH	%	3.5
	13976031	CHEMBL3135387	Inhibition of human full length GSK-3 beta expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 95 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL227727	=	Inhibition	%	55.0	CHEMBL262	Homo sapiens	INH	%	55.0
	13976122	CHEMBL3136912	Inhibition of human full length GSK-3 beta expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 70 uM after 90 mins by microfluidic peptide phosphorylation assay	B	CNCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL376388	=	Inhibition	%	37.5	CHEMBL262	Homo sapiens	INH	%	37.5
	14529553	CHEMBL3225499	Inhibition of human recombinant GST-fused GSK-3beta expressed in insect Sf9 cells using RBER-CHKtide as substrate assessed as incorporation of 33Pi after 60 mins by microplate scintillation counting analysis	B	Cc1cc2oc3ncc(OCc4ccccc4)c(-c4ccccc4)c3c2cc1O		CHEMBL2163769	=	Ki	nM	5800.0	CHEMBL262	Homo sapiens	Ki	uM	5.8
ND(Insoluble)	14529554	CHEMBL3225499	Inhibition of human recombinant GST-fused GSK-3beta expressed in insect Sf9 cells using RBER-CHKtide as substrate assessed as incorporation of 33Pi after 60 mins by microplate scintillation counting analysis	B	COc1cc2oc3ncc(OCc4ccccc4)c(-c4ccccc4)c3c2cc1O		CHEMBL3221390		Ki			CHEMBL262	Homo sapiens	Ki		
	14529555	CHEMBL3225499	Inhibition of human recombinant GST-fused GSK-3beta expressed in insect Sf9 cells using RBER-CHKtide as substrate assessed as incorporation of 33Pi after 60 mins by microplate scintillation counting analysis	B	COc1cc2oc3ncc(OCc4ccccc4)c(-c4ccccc4)c3c2c(OC)c1O		CHEMBL3217793	=	Ki	nM	5400.0	CHEMBL262	Homo sapiens	Ki	uM	5.4
	14529556	CHEMBL3225499	Inhibition of human recombinant GST-fused GSK-3beta expressed in insect Sf9 cells using RBER-CHKtide as substrate assessed as incorporation of 33Pi after 60 mins by microplate scintillation counting analysis	B	Oc1cc2c(oc3ncc(OCc4ccccc4)c(-c4ccccc4)c32)c2ccccc12		CHEMBL2163770	=	Ki	nM	1600.0	CHEMBL262	Homo sapiens	Ki	uM	1.6
	14529557	CHEMBL3225499	Inhibition of human recombinant GST-fused GSK-3beta expressed in insect Sf9 cells using RBER-CHKtide as substrate assessed as incorporation of 33Pi after 60 mins by microplate scintillation counting analysis	B	COc1cc2c(oc3ncc(OCc4ccccc4)c(-c4ccccc4)c32)c2ccccc12	Outside typical range	CHEMBL3221391	>	Ki	nM	1000000.0	CHEMBL262	Homo sapiens	Ki	uM	1000.0
	14529558	CHEMBL3225499	Inhibition of human recombinant GST-fused GSK-3beta expressed in insect Sf9 cells using RBER-CHKtide as substrate assessed as incorporation of 33Pi after 60 mins by microplate scintillation counting analysis	B	COc1ccc2oc3ncc(OCc4ccccc4)c(-c4ccccc4)c3c2c1		CHEMBL2163774	=	Ki	nM	20.0	CHEMBL262	Homo sapiens	Ki	uM	0.02
	14529559	CHEMBL3225499	Inhibition of human recombinant GST-fused GSK-3beta expressed in insect Sf9 cells using RBER-CHKtide as substrate assessed as incorporation of 33Pi after 60 mins by microplate scintillation counting analysis	B	CNC(=O)c1cnc2oc3ccc(O)cc3c2c1-c1ccccc1		CHEMBL3221392	=	Ki	nM	9000.0	CHEMBL262	Homo sapiens	Ki	uM	9.0
ND(Insoluble)	14529560	CHEMBL3225499	Inhibition of human recombinant GST-fused GSK-3beta expressed in insect Sf9 cells using RBER-CHKtide as substrate assessed as incorporation of 33Pi after 60 mins by microplate scintillation counting analysis	B	CCNC(=O)c1cnc2oc3ccc(O)cc3c2c1-c1ccccc1		CHEMBL3221393		Ki			CHEMBL262	Homo sapiens	Ki		
	14529561	CHEMBL3225499	Inhibition of human recombinant GST-fused GSK-3beta expressed in insect Sf9 cells using RBER-CHKtide as substrate assessed as incorporation of 33Pi after 60 mins by microplate scintillation counting analysis	B	CCCNC(=O)c1cnc2oc3ccc(O)cc3c2c1-c1ccccc1		CHEMBL3221394	=	Ki	nM	4400.0	CHEMBL262	Homo sapiens	Ki	uM	4.4
	14529562	CHEMBL3225499	Inhibition of human recombinant GST-fused GSK-3beta expressed in insect Sf9 cells using RBER-CHKtide as substrate assessed as incorporation of 33Pi after 60 mins by microplate scintillation counting analysis	B	NCCNC(=O)c1cnc2oc3ccc(O)cc3c2c1-c1ccccc1		CHEMBL3221395	=	Ki	nM	4800.0	CHEMBL262	Homo sapiens	Ki	uM	4.8
Active	14529565	CHEMBL3225499	Inhibition of human recombinant GST-fused GSK-3beta expressed in insect Sf9 cells using RBER-CHKtide as substrate assessed as incorporation of 33Pi after 60 mins by microplate scintillation counting analysis	B	Oc1ccc2oc3ncc(OCc4ccccc4)c(-c4ccccc4)c3c2c1		CHEMBL1165662		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	14540661	CHEMBL3227391	Inhibition of GSK3beta (unknown origin)	B	COc1ccc2[nH]c(-c3ccccc3)c(-c3ccncc3)c2n1		CHEMBL3219057	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	14540662	CHEMBL3227391	Inhibition of GSK3beta (unknown origin)	B	COc1ccc2[nH]c(-c3ccccc3O)c(-c3ccncc3)c2n1		CHEMBL3219058	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	14540663	CHEMBL3227391	Inhibition of GSK3beta (unknown origin)	B	COc1ccc2[nH]c(-c3cccc(O)c3)c(-c3ccncc3)c2n1		CHEMBL3219059	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	14540664	CHEMBL3227391	Inhibition of GSK3beta (unknown origin)	B	COc1ccc2[nH]c(-c3ccc(O)cc3)c(-c3ccncc3)c2n1		CHEMBL3219060	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	14540665	CHEMBL3227391	Inhibition of GSK3beta (unknown origin)	B	COc1ccc2[nH]c(-c3cccc(F)c3)c(-c3ccncc3)c2n1		CHEMBL3219061	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	14540666	CHEMBL3227391	Inhibition of GSK3beta (unknown origin)	B	COc1ccc2[nH]c(-c3ccc4cc(O)ccc4c3)c(-c3ccncc3)c2n1		CHEMBL3219062	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	14540667	CHEMBL3227391	Inhibition of GSK3beta (unknown origin)	B	COc1ccc2[nH]c(-c3cc(O)cc(O)c3)c(-c3ccncc3)c2n1		CHEMBL3219063	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	14540668	CHEMBL3227391	Inhibition of GSK3beta (unknown origin)	B	COc1ccc2[nH]c(-c3cccc(O)c3)c(-c3cccnc3)c2n1		CHEMBL3219064	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	14540669	CHEMBL3227391	Inhibition of GSK3beta (unknown origin)	B	COc1ccc2[nH]c(-c3cccc(O)c3)c(-c3ccccn3)c2n1		CHEMBL3219065	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	14545793	CHEMBL3224463	Inhibition of GSK3beta (unknown origin) assessed as residual activity at 1 uM	B	CS(=O)(=O)O.O=C(NCc1cccc(O)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL3218297	=	Activity	%	91.1	CHEMBL262	Homo sapiens	Activity	%	91.1
	14545816	CHEMBL3224483	Inhibition of GSK3beta (unknown origin)	B	CS(=O)(=O)O.O=C(NCc1cccc(O)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL3218297	=	IC50	nM	7.77	CHEMBL262	Homo sapiens	IC50	nM	7.77
	14582513	CHEMBL3242365	Inhibition of human GSK3beta assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	95.5	CHEMBL262	Homo sapiens	Activity	%	95.5
	14593783	CHEMBL3242872	Inhibition of human GSK3beta	B	Oc1cccc(Nc2ccnc3[nH]c4ccccc4c23)c1		CHEMBL3133821	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	14645934	CHEMBL3270975	Inhibition of GSK3B (unknown origin)	B	Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1nc(Nc2ccc(C(=O)N3CCOCC3)cc2)c2nc[nH]c2n1		CHEMBL3263640	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	14648100	CHEMBL3267007	Inhibition of human GSK-3beta at 1 uM relative to control	B	CC(C)CCNc1ccc(-c2cnc3ccc(NC4CCN(C)CC4)nn23)cn1		CHEMBL2380687	<	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	14648101	CHEMBL3267007	Inhibition of human GSK-3beta at 1 uM relative to control	B	N[C@H]1CC[C@H](Nc2ccc3ncc(-c4cnc(Nc5ncccc5F)nc4)n3n2)CC1		CHEMBL3264059	<	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	14664185	CHEMBL3270877	Inhibition of GSK3B (unknown origin) at 1 uM relative to control	B	CCOC(=O)c1sc(-c2ccncc2)nc1O		CHEMBL3261228	=	Inhibition	%	100.0	CHEMBL262	Homo sapiens	INH	%	100.0
	14664186	CHEMBL3270877	Inhibition of GSK3B (unknown origin) at 1 uM relative to control	B	NC(=O)c1sc(-c2ccnc(N)n2)nc1-c1ccc(Cl)cc1Cl		CHEMBL3261514	=	Inhibition	%	6.4	CHEMBL262	Homo sapiens	INH	%	6.4
	14664187	CHEMBL3270877	Inhibition of GSK3B (unknown origin) at 1 uM relative to control	B	COc1ccc(-c2nc(-c3ccnc(N)n3)sc2C(N)=O)c(Cl)c1		CHEMBL3261517	=	Inhibition	%	6.8	CHEMBL262	Homo sapiens	INH	%	6.8
	14668870	CHEMBL3269293	Inhibition of GSK3-beta kinase (unknown origin) assessed as residual activity at 1 uM	B	CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4ccnc(N)n4)c3c2)n1		CHEMBL3264257	=	Activity	%	77.0	CHEMBL262	Homo sapiens	Activity	%	77.0
	14720912	CHEMBL3293189	Inhibition of GSK-3beta (unknown origin) at 20 uM after 30 mins by scintillation counting analysis relative to control	B	COc1c(C(=O)/C=C/c2ccccc2)c(O)cc2occc12		CHEMBL306708	=	Inhibition	%	28.0	CHEMBL262	Homo sapiens	INH	%	28.0
	14720989	CHEMBL3293189	Inhibition of GSK-3beta (unknown origin) at 20 uM after 30 mins by scintillation counting analysis relative to control	B	COc1ccccc1/C=C/C(=O)c1c(O)cc2occc2c1OC		CHEMBL3291507	=	Inhibition	%	17.0	CHEMBL262	Homo sapiens	INH	%	17.0
	14721052	CHEMBL3293189	Inhibition of GSK-3beta (unknown origin) at 20 uM after 30 mins by scintillation counting analysis relative to control	B	COc1c(C(=O)/C=C/c2ccc(Cl)cc2)c(O)c(Br)c2occc12		CHEMBL3291508	=	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	14723479	CHEMBL3293189	Inhibition of GSK-3beta (unknown origin) at 20 uM after 30 mins by scintillation counting analysis relative to control	B	C=CCc1c(O)c(C(=O)/C=C/c2ccccc2)c(OC)c2ccoc12		CHEMBL3291509	=	Inhibition	%	38.0	CHEMBL262	Homo sapiens	INH	%	38.0
	14723543	CHEMBL3293189	Inhibition of GSK-3beta (unknown origin) at 20 uM after 30 mins by scintillation counting analysis relative to control	B	C=CCc1c(O)c(C(=O)/C=C/c2ccc(Cl)cc2)c(OC)c2ccoc12		CHEMBL3291510	=	Inhibition	%	80.0	CHEMBL262	Homo sapiens	INH	%	80.0
	14723609	CHEMBL3293189	Inhibition of GSK-3beta (unknown origin) at 20 uM after 30 mins by scintillation counting analysis relative to control	B	COc1c2ccoc2c(/C=C/C=O)c2oc(-c3ccccc3)cc(=O)c12		CHEMBL3291512	=	Inhibition	%	58.0	CHEMBL262	Homo sapiens	INH	%	58.0
	14723671	CHEMBL3293189	Inhibition of GSK-3beta (unknown origin) at 20 uM after 30 mins by scintillation counting analysis relative to control	B	COc1ccc(-c2cc(=O)c3c(OC)c4ccoc4c(/C=C/C=O)c3o2)cc1		CHEMBL3291513	=	Inhibition	%	11.0	CHEMBL262	Homo sapiens	INH	%	11.0
	14725948	CHEMBL3293189	Inhibition of GSK-3beta (unknown origin) at 20 uM after 30 mins by scintillation counting analysis relative to control	B	C=CCc1c2c(c(OC)c3ccoc13)C(=O)/C(=C/c1ccccc1OC)O2		CHEMBL3291517	=	Inhibition	%	56.0	CHEMBL262	Homo sapiens	INH	%	56.0
	14726047	CHEMBL3293189	Inhibition of GSK-3beta (unknown origin) at 20 uM after 30 mins by scintillation counting analysis relative to control	B	COc1c2occc2c(OC)c2c(=O)c(CN3CCOCC3)c(/C=C/c3ccc(Cl)cc3)oc12		CHEMBL3286627	=	Inhibition	%	5.0	CHEMBL262	Homo sapiens	INH	%	5.0
	14726148	CHEMBL3293189	Inhibition of GSK-3beta (unknown origin) at 20 uM after 30 mins by scintillation counting analysis relative to control	B	COc1c2occc2c(OC)c2c(=O)c(CN3CCOCC3)c(/C=C/c3ccc(N(C)C)cc3)oc12		CHEMBL3286629	=	Inhibition	%	13.0	CHEMBL262	Homo sapiens	INH	%	13.0
	14741707	CHEMBL3292671	Inhibition of human recombinant GSK-3 beta after 30 mins by luminescence assay	B	Cl.N=C(N)Nc1ccc(Oc2ccc(NC(=N)N)cc2)cc1		CHEMBL3290430	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	14741708	CHEMBL3292671	Inhibition of human recombinant GSK-3 beta after 30 mins by luminescence assay	B	Cl.N=C(N)Nc1ccc(Oc2cccc(NC(=N)N)c2)cc1		CHEMBL3290431	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	14741709	CHEMBL3292671	Inhibition of human recombinant GSK-3 beta after 30 mins by luminescence assay	B	Cl.N=C(N)Nc1ccc(C(=O)c2cccc(NC(=N)N)c2)cc1		CHEMBL3290432	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	14741710	CHEMBL3292671	Inhibition of human recombinant GSK-3 beta after 30 mins by luminescence assay	B	Cl.N=C(N)Nc1ccc(Cc2cccc(NC(=N)N)c2)cc1		CHEMBL3290433	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	14741711	CHEMBL3292671	Inhibition of human recombinant GSK-3 beta after 30 mins by luminescence assay	B	Cl.N=C(N)Nc1ccc(Nc2cccc(NC(=N)N)c2)cc1		CHEMBL3290434	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	14741712	CHEMBL3292671	Inhibition of human recombinant GSK-3 beta after 30 mins by luminescence assay	B	Cl.c1cc(NC2=NCCN2)cc(Oc2ccc(NC3=NCCN3)cc2)c1		CHEMBL3290435	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	14741713	CHEMBL3292671	Inhibition of human recombinant GSK-3 beta after 30 mins by luminescence assay	B	Cl.O=C(c1ccc(NC2=NCCN2)cc1)c1cccc(NC2=NCCN2)c1		CHEMBL3290436	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	14741714	CHEMBL3292671	Inhibition of human recombinant GSK-3 beta after 30 mins by luminescence assay	B	Cl.c1cc(Cc2ccc(NC3=NCCN3)cc2)cc(NC2=NCCN2)c1		CHEMBL3290437	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	14741715	CHEMBL3292671	Inhibition of human recombinant GSK-3 beta after 30 mins by luminescence assay	B	Cl.N=C(N)Nc1cccc(Oc2ccc(NC(=N)Nc3ccccc3)cc2)c1		CHEMBL3290438	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	14741716	CHEMBL3292671	Inhibition of human recombinant GSK-3 beta after 30 mins by luminescence assay	B	Cl.N=C(N)Nc1cccc(C(=O)c2ccc(NC(=N)Nc3ccccc3)cc2)c1		CHEMBL3290687	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	14741717	CHEMBL3292671	Inhibition of human recombinant GSK-3 beta after 30 mins by luminescence assay	B	Cl.N=C(N)Nc1cccc(Cc2ccc(NC(=N)Nc3ccccc3)cc2)c1		CHEMBL3290688	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	14741718	CHEMBL3292671	Inhibition of human recombinant GSK-3 beta after 30 mins by luminescence assay	B	Cl.N=C(N)Nc1cccc(Nc2ccc(NC(=N)Nc3ccccc3)cc2)c1		CHEMBL3290689	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	14741719	CHEMBL3292671	Inhibition of human recombinant GSK-3 beta after 30 mins by luminescence assay	B	Cl.N=C(N)Nc1ccc(Oc2cccc(NC(=N)Nc3ccccc3)c2)cc1		CHEMBL3290690	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	14741720	CHEMBL3292671	Inhibition of human recombinant GSK-3 beta after 30 mins by luminescence assay	B	Cl.N=C(N)Nc1ccc(Cc2cccc(NC(=N)Nc3ccccc3)c2)cc1		CHEMBL3290691	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	14741721	CHEMBL3292671	Inhibition of human recombinant GSK-3 beta after 30 mins by luminescence assay	B	Cl.N=C(N)Nc1cccc(Oc2ccc(NC(=N)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)c1		CHEMBL3290692	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	14741722	CHEMBL3292671	Inhibition of human recombinant GSK-3 beta after 30 mins by luminescence assay	B	Cl.N=C(N)Nc1cccc(C(=O)c2ccc(NC(=N)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)c1		CHEMBL3290693	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	14741723	CHEMBL3292671	Inhibition of human recombinant GSK-3 beta after 30 mins by luminescence assay	B	Cl.N=C(N)Nc1cccc(Cc2ccc(NC(=N)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)c1		CHEMBL3290694	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	14741724	CHEMBL3292671	Inhibition of human recombinant GSK-3 beta after 30 mins by luminescence assay	B	Cl.N=C(N)Nc1cccc(Nc2ccc(NC(=N)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)c1		CHEMBL3290695	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	14741725	CHEMBL3292671	Inhibition of human recombinant GSK-3 beta after 30 mins by luminescence assay	B	Cl.N=C(N)Nc1ccc(Oc2cccc(NC(=N)Nc3ccc(Cl)c(C(F)(F)F)c3)c2)cc1		CHEMBL3290696	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	14741726	CHEMBL3292671	Inhibition of human recombinant GSK-3 beta after 30 mins by luminescence assay	B	Cl.N=C(N)Nc1ccc(Cc2cccc(NC(=N)Nc3ccc(Cl)c(C(F)(F)F)c3)c2)cc1		CHEMBL3290697	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	14741727	CHEMBL3292671	Inhibition of human recombinant GSK-3 beta after 30 mins by luminescence assay	B	CC(=O)Nc1cccc(Oc2ccc(NC(=N)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)c1.Cl		CHEMBL3290698	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	14741728	CHEMBL3292671	Inhibition of human recombinant GSK-3 beta after 30 mins by luminescence assay	B	CC(=O)Nc1cccc(Nc2ccc(NC(=N)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)c1.Cl		CHEMBL3290699	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	14751759	CHEMBL3301276	Inhibition of GSK3beta (unknown origin)	B	CC(C)(C)CNC(=O)CC1CNC(=O)c2cc(-c3ccsc3)cn21		CHEMBL3298400	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	14751760	CHEMBL3301276	Inhibition of GSK3beta (unknown origin)	B	CC(C)(C)CNC(=O)CC1CNC(=O)c2cc(-c3ccncc3)cn21		CHEMBL3298402	=	IC50	nM	4608.0	CHEMBL262	Homo sapiens	IC50	uM	4.608
	14751761	CHEMBL3301276	Inhibition of GSK3beta (unknown origin)	B	O=C(CC1CNC(=O)c2cc(-c3cn[nH]c3)cn21)NCc1cccc(F)c1		CHEMBL3298823	=	IC50	nM	386.0	CHEMBL262	Homo sapiens	IC50	uM	0.386
	14751762	CHEMBL3301276	Inhibition of GSK3beta (unknown origin)	B	CN1CCN(C[C@@H](NC(=O)C[C@H]2CNC(=O)c3cc(-c4cccc(Cl)c4)cn32)C2CCCCC2)CC1		CHEMBL3297762	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	14979426	CHEMBL3372972	Inhibition of GSK3beta (unknown origin) in presence of 1 mM ATP	B	CN(Cc1ccccc1)C(=O)c1ccc(S(=O)(=O)Nc2ccccc2)cc1		CHEMBL3355482	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	14984375	CHEMBL3385000	Inhibition of GSK3beta (unknown origin) at 1 uM	B	CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1		CHEMBL3359895	=	Inhibition	%	92.0	CHEMBL262	Homo sapiens	INH	%	92.0
	14984441	CHEMBL3382486	Inhibition of GSK3beta (unknown origin) at 0.1 uM	B	CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1		CHEMBL3359895	=	Inhibition	%	67.0	CHEMBL262	Homo sapiens	INH	%	67.0
	14992864	CHEMBL3372225	Inhibition of recombinant GSK-3 beta (unknown origin) after 60 mins by z'-lyte kinase assay	B	O=C1/C(=C\c2ccc(O)c(O)c2)Oc2ccccc21		CHEMBL3361128	=	IC50	nM	2630.0	CHEMBL262	Homo sapiens	IC50	uM	2.63
	14994853	CHEMBL3371898	Inhibition of GSK3beta (unknown origin) using peptide substrate GS2 assessed as ATP remaining by Kinase-Glo luminescent kinase assay	B	CCCCCCCCCCCC(=O)NNC(=O)C1Sc2ccccc2N(CC)C1=O		CHEMBL3358802	=	IC50	nM	8000.0	CHEMBL262	Homo sapiens	IC50	uM	8.0
	14994854	CHEMBL3371898	Inhibition of GSK3beta (unknown origin) using peptide substrate GS2 assessed as ATP remaining by Kinase-Glo luminescent kinase assay	B	CCCCCCCCCCCC(=O)NNC(=O)C1Sc2ccccc2N(Cc2ccccc2)C1=O		CHEMBL3358803	=	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	14994855	CHEMBL3371898	Inhibition of GSK3beta (unknown origin) using peptide substrate GS2 assessed as ATP remaining by Kinase-Glo luminescent kinase assay	B	CCCCCCCCCCCCCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](COP(=O)(O)O)C(=O)N1CCC[C@H]1C(N)=O		CHEMBL3358804	=	IC50	nM	40000.0	CHEMBL262	Homo sapiens	IC50	uM	40.0
Active	14994856	CHEMBL3371899	Competitive inhibition of GSK3beta (unknown origin) using peptide substrate GS2 assessed as ATP remaining by Kinase-Glo luminescent kinase assay	B	CCCCCCCCCCCC(=O)NNC(=O)C1Sc2ccccc2N(Cc2ccccc2)C1=O		CHEMBL3358803		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	14994873	CHEMBL3372479	Inhibition of GSK3beta in human HpG2 cells assessed as decrease in ratio of phosphorylated GS/GS at 10 uM after 12 hrs by Western blot analysis	B	CCCCCCCCCCCC(=O)NNC(=O)C1Sc2ccccc2N(Cc2ccccc2)C1=O		CHEMBL3358803		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	14994874	CHEMBL3372479	Inhibition of GSK3beta in human HpG2 cells assessed as decrease in ratio of phosphorylated GS/GS at 10 uM after 12 hrs by Western blot analysis	B	CCCCCCCCCCCC(=O)NNC(=O)C1Sc2ccccc2N(CC)C1=O		CHEMBL3358802		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	14994884	CHEMBL3372488	Inhibition of GSK3beta in human HepG2 cells assessed as decrease in ratio of phosphorylated GS/GS at 34 uM after 12 hrs by Western blot analysis	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	14994885	CHEMBL3372489	Inhibition of GSK3beta in human HepG2 cells assessed as decrease in ratio of phosphorylated GS/GS at 2 uM after 12 hrs by Western blot analysis	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	15003441	CHEMBL3370365	Inhibition of GSK3beta (unknown origin) at 10 uM	B	COc1cc(OC)cc(-c2cn(-c3ccc(O)c(C(=O)Nc4cccc(C(F)(F)F)c4)c3)nn2)c1		CHEMBL1169635		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	15009829	CHEMBL3361645	Inhibition of GSK3b (unknown origin) at 10 uM	B	C[C@H](O)CNc1nccc(-n2ccnc2Cc2cccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c2)n1		CHEMBL3309549	=	Inhibition	%	34.5	CHEMBL262	Homo sapiens	INH	%	34.5
	15014020	CHEMBL3364482	Inhibition of GSK3-beta (unknown origin) at 100 nM	B	CC(C)Nc1ncc2c(n1)CN(C(=O)N[C@H](CO)c1ccc(F)c(Cl)c1)CC2		CHEMBL3297849	>	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	15015246	CHEMBL3372070	Inhibition of GSK3beta (unknown origin) assessed as luminescence intensity by luminometry	B	COc1cc(NCCCN)c2nccc(C)c2c1Oc1cccc(C(F)(F)F)c1		CHEMBL495039	=	IC50	nM	35.0	CHEMBL262	Homo sapiens	IC50	nM	35.0
	15015247	CHEMBL3372070	Inhibition of GSK3beta (unknown origin) assessed as luminescence intensity by luminometry	B	COc1cc(NCc2ccc(O)cc2)c2nccc(C)c2c1Oc1cccc(C(F)(F)F)c1	Outside typical range	CHEMBL3311235	=	IC50	nM	240000.0	CHEMBL262	Homo sapiens	IC50	uM	240.0
	15015248	CHEMBL3372070	Inhibition of GSK3beta (unknown origin) assessed as luminescence intensity by luminometry	B	COc1cc(NCc2cccc3cccnc23)c2nccc(C)c2c1Oc1cccc(C(F)(F)F)c1	Outside typical range	CHEMBL3311239	=	IC50	nM	400000.0	CHEMBL262	Homo sapiens	IC50	uM	400.0
	15015249	CHEMBL3372070	Inhibition of GSK3beta (unknown origin) assessed as luminescence intensity by luminometry	B	Cc1ccnc2c(NCc3ccc(O)cc3)cc(O)c(Oc3cccc(C(F)(F)F)c3)c12	Outside typical range	CHEMBL3311242	=	IC50	nM	750000.0	CHEMBL262	Homo sapiens	IC50	uM	750.0
	15015250	CHEMBL3372070	Inhibition of GSK3beta (unknown origin) assessed as luminescence intensity by luminometry	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	33.0	CHEMBL262	Homo sapiens	IC50	nM	33.0
	15036798	CHEMBL3381075	Inhibition of GSK3beta (unknown origin)	B	Nc1nc2c3c(F)cccc3nc(Cc3ccc4c(c3)OCO4)n2n1		CHEMBL3309990	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	15036799	CHEMBL3381075	Inhibition of GSK3beta (unknown origin)	B	Nc1ccc2c(c1)nc(Cc1ccc3c(c1)OCO3)n1nc(N)nc21		CHEMBL3309995	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	15036800	CHEMBL3381075	Inhibition of GSK3beta (unknown origin)	B	OCCCNc1ccc2c(c1)nc(-c1ccc3c(c1)OCO3)n1ncnc21		CHEMBL3309997	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	15036801	CHEMBL3381075	Inhibition of GSK3beta (unknown origin)	B	Nc1nc2c3ccc(NCCO)cc3nc(Cc3ccc4c(c3)OCO4)n2n1		CHEMBL3309998	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	15036802	CHEMBL3381075	Inhibition of GSK3beta (unknown origin)	B	CN1CCN(c2cc(F)c3c(c2)nc(Cc2ccc4c(c2)OCO4)n2nc(N)nc32)CC1		CHEMBL3310151	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	15037233	CHEMBL3368342	Inhibition of GSK3beta (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2cnc3[nH]cc(-c4ccc(OC)c(OC)c4)c3c2)cc1OC		CHEMBL3102948	=	Inhibition	%	94.0	CHEMBL262	Homo sapiens	INH	%	94.0
	15037234	CHEMBL3368342	Inhibition of GSK3beta (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1cc(-c2c[nH]c3ncc(-c4cccc(N)c4)cc23)cc(OC)c1OC		CHEMBL3319457	=	Inhibition	%	64.0	CHEMBL262	Homo sapiens	INH	%	64.0
	15037235	CHEMBL3368342	Inhibition of GSK3beta (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2c[nH]c3ncc(-c4ccc(C(=O)N5CCOCC5)c(N)c4)cc23)cc1OC		CHEMBL3319467	=	Inhibition	%	63.0	CHEMBL262	Homo sapiens	INH	%	63.0
	15037236	CHEMBL3368342	Inhibition of GSK3beta (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2c[nH]c3ncc(-c4cc(OC)c(OC)c(OC)c4)cc23)cc1OC		CHEMBL3319468	=	Inhibition	%	64.0	CHEMBL262	Homo sapiens	INH	%	64.0
	15037237	CHEMBL3368342	Inhibition of GSK3beta (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2cnc3[nH]cc(-c4ccc(OC)c(OC)c4)c3c2)cc1N		CHEMBL3319470	=	Inhibition	%	87.0	CHEMBL262	Homo sapiens	INH	%	87.0
	15040060	CHEMBL3362671	Inhibition of human GSK3B by FP assay	B	COc1ccc(S(=O)(=O)Nc2c(C)cc(C)cc2C)cc1		CHEMBL3311308	<	IC50	nM	25118.86	CHEMBL262	Homo sapiens	pIC50		4.6
	15046776	CHEMBL3369839	Inhibition of GSK3beta (unknown origin)	B	O=C(O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3ncc(F)cc23)ncc1F		CHEMBL3318007	=	Ki	nM	1600.0	CHEMBL262	Homo sapiens	Ki	uM	1.6
	15053949	CHEMBL3367276	Inhibition of GSK3B (unknown origin)	B	Clc1ccc(-c2ccc(-c3nccn3-c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL3314140	>	IC50	nM	30000.0	CHEMBL262	Homo sapiens	IC50	uM	30.0
	15061120	CHEMBL3376303	Inhibition of GSK3beta (unknown origin) at 1 uM	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCC1CNCCO1		CHEMBL3322987	=	Inhibition	%	11.0	CHEMBL262	Homo sapiens	INH	%	11.0
Not Active	15062593	CHEMBL3370527	Inhibition of human GSK3beta by Off-chip mobility shift assay	B	O=C(Cc1c(F)cccc1Cl)Nc1onc(-c2ccc(F)cc2)c1-c1ccncn1		CHEMBL3310142		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	15072455	CHEMBL3380119	Inhibition of GSK3beta (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay	B	Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1		CHEMBL3338802	=	Activity	%	103.0	CHEMBL262	Homo sapiens	Activity	%	103.0
	15075120	CHEMBL3376332	Inhibition of GSK3beta (unknown origin) at 1 uM	B	CC(C)(O)Cn1cc(-c2ccc(-c3cc4c(Nc5ccncc5)ncnn4c3)cc2)cn1		CHEMBL3326802	=	Inhibition	%	84.0	CHEMBL262	Homo sapiens	INH	%	84.0
	15091092	CHEMBL3381537	Inhibition of human recombinant GSK3beta using Ulight-CFFKNIVTPRTPPPSQGK-amide substrate assessed as remaining enzyme activity at 1 uM after 90 mins relative to control	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Br)c(O)c(Br)c1		CHEMBL2206014	=	Activity	%	87.0	CHEMBL262	Homo sapiens	Activity	%	87.0
	15091119	CHEMBL3390655	Inhibition of human recombinant GSK3beta using CFFKNIVTPRTPPPSQGK-amide substrate after 90 mins incubation by LANCE method	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Br)c(O)c(Br)c1		CHEMBL2206014	=	Inhibition	%	73.0	CHEMBL262	Homo sapiens	INH	%	73.0
	15091120	CHEMBL3390655	Inhibition of human recombinant GSK3beta using CFFKNIVTPRTPPPSQGK-amide substrate after 90 mins incubation by LANCE method	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccc(O)c(Br)c1		CHEMBL3335349	=	Inhibition	%	19.0	CHEMBL262	Homo sapiens	INH	%	19.0
	15091127	CHEMBL3390655	Inhibition of human recombinant GSK3beta using CFFKNIVTPRTPPPSQGK-amide substrate after 90 mins incubation by LANCE method	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	50.0	CHEMBL262	Homo sapiens	IC50	nM	50.0
Not Active	15107519	CHEMBL3375315	Inhibition of human GSK3beta assessed as enzyme activity at 10 uM	B	CN(CCc1c[nH]c2ccccc12)C(=O)c1ccc(-c2ccccc2)cc1		CHEMBL213805		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	15112136	CHEMBL3388148	Inhibition of GSK3beta (unknown origin)	B	COc1ccc(-c2cccc3nc(NC(=O)C4CC4)nn23)cc1		CHEMBL3360318	=	IC50	nM	7114.0	CHEMBL262	Homo sapiens	IC50	nM	7114.0
	15116508	CHEMBL3377062	Inhibition of GSK3beta (unknown origin)	B	CC(=O)c1ccc(N2CCN(C(=O)CN3CC[C@@H](C(=O)Nc4ccc(O)c(Cl)c4)C3)CC2)cc1		CHEMBL3356117	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	15122478	CHEMBL3367688	Inhibition of human GSK3beta assessed as residual activity at 10 uM by KinaseProfiler assay	B	CCOC(=O)C1=C(C)N=c2s/c(=C\c3ccc(O)c(O)c3)c(=O)n2C1c1ccc(Cl)cc1		CHEMBL3331445	=	Activity	%	52.0	CHEMBL262	Homo sapiens	Activity	%	52.0
	15126959	CHEMBL3367688	Inhibition of human GSK3beta assessed as residual activity at 10 uM by KinaseProfiler assay	B	CCOC(=O)C1=C(C)N=c2s/c(=C\c3cc(O)c(O)c(O)c3)c(=O)n2C1c1ccc(Cl)cc1		CHEMBL3331446	=	Activity	%	51.0	CHEMBL262	Homo sapiens	Activity	%	51.0
	15126991	CHEMBL3367688	Inhibition of human GSK3beta assessed as residual activity at 10 uM by KinaseProfiler assay	B	Brc1c(Br)c(Br)c2[nH]nnc2c1Br		CHEMBL177820	=	Activity	%	42.0	CHEMBL262	Homo sapiens	Activity	%	42.0
Dose-dependent effect	15136937	CHEMBL3365418	Inhibition of GSK3beta Ser9 phosphorylation in human K562 cells at 5 to 30 uM after 24 hrs by Western blotting method	B	COc1ccc(N2C(=O)/C(=C3/C(=O)Nc4ccccc43)c3ccccc32)cc1		CHEMBL3329845		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	15137723	CHEMBL3385162	Inhibition of GSK3b (unknown origin) assessed as residual enzyme activity at 10 uM	B	CO[C@H]1CC[C@H](NC(=O)c2n[nH]cc2NC(=O)c2ccccc2)CC1		CHEMBL3335124	=	Activity	%	33.0	CHEMBL262	Homo sapiens	Activity	%	33.0
	15137724	CHEMBL3385162	Inhibition of GSK3b (unknown origin) assessed as residual enzyme activity at 10 uM	B	COc1cccc(OC)c1C(=O)Nc1c[nH]nc1C(=O)N[C@H]1CC[C@H](OC)CC1		CHEMBL3335141	=	Activity	%	0.0	CHEMBL262	Homo sapiens	Activity	%	0.0
	15137725	CHEMBL3385162	Inhibition of GSK3b (unknown origin) assessed as residual enzyme activity at 10 uM	B	CO[C@H]1CC[C@H](NC(=O)c2n[nH]cc2NC(=O)c2ccc(-c3ccccc3)o2)CC1		CHEMBL3335153	=	Activity	%	0.0	CHEMBL262	Homo sapiens	Activity	%	0.0
	15137726	CHEMBL3385162	Inhibition of GSK3b (unknown origin) assessed as residual enzyme activity at 10 uM	B	COc1cccc(OC)c1C(=O)Nc1c[nH]nc1C(=O)NCc1ccccc1		CHEMBL3335161	=	Activity	%	10.0	CHEMBL262	Homo sapiens	Activity	%	10.0
	15146837	CHEMBL3395664	Inhibition of GSK-3 beta (unknown origin) at 1 uM	B	Nc1ncc(-c2ccc3[nH]nc(-c4cnc5ccccc5c4)c3c2)s1		CHEMBL3394059	>	Inhibition	%	90.0	CHEMBL262	Homo sapiens	INH	%	90.0
	15150003	CHEMBL3395932	Inhibition of GSK3beta (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CC2)ccn1		CHEMBL3394102	<	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	15150004	CHEMBL3395932	Inhibition of GSK3beta (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CCCCC2)ccn1		CHEMBL3394105	<	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	15150005	CHEMBL3395932	Inhibition of GSK3beta (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2CC2CCCO2)ccn1		CHEMBL3394108	<	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	15150006	CHEMBL3395932	Inhibition of GSK3beta (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	COC(Cn1c(SC2CCC(C(=O)O)CC2O)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)=O)c1)OC		CHEMBL3394112	<	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	15150007	CHEMBL3395932	Inhibition of GSK3beta (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(Sc3cccc(I)n3)n2C2CCCCC2)ccn1		CHEMBL3394118	<	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	15160291	CHEMBL3398953	Inhibition of recombinant GST-tagged GSK-3beta (unknown origin) expressed in Escherichia coli strain BL21-Codon Plus (DE3) using Ser/Thr 9 peptide substrate by Z'-LYTE kinase assay	B	O=C1NC(=O)C(c2nnc3ccccn23)=C1c1cn(CCCN2CCOCC2)c2ccccc12		CHEMBL3398205	=	IC50	nM	199.7	CHEMBL262	Homo sapiens	IC50	nM	199.7
	15160292	CHEMBL3398953	Inhibition of recombinant GST-tagged GSK-3beta (unknown origin) expressed in Escherichia coli strain BL21-Codon Plus (DE3) using Ser/Thr 9 peptide substrate by Z'-LYTE kinase assay	B	O=C1NC(=O)C(c2nnc3ccccn23)=C1c1cn(CCCO)c2ccccc12		CHEMBL3398204	=	IC50	nM	120.6	CHEMBL262	Homo sapiens	IC50	nM	120.6
	15160293	CHEMBL3398953	Inhibition of recombinant GST-tagged GSK-3beta (unknown origin) expressed in Escherichia coli strain BL21-Codon Plus (DE3) using Ser/Thr 9 peptide substrate by Z'-LYTE kinase assay	B	O=C1NC(=O)C(c2nnc3ccccn23)=C1c1cn(CCCn2ccnc2)c2ccccc12		CHEMBL3398203	=	IC50	nM	36.0	CHEMBL262	Homo sapiens	IC50	nM	36.0
	15160294	CHEMBL3398953	Inhibition of recombinant GST-tagged GSK-3beta (unknown origin) expressed in Escherichia coli strain BL21-Codon Plus (DE3) using Ser/Thr 9 peptide substrate by Z'-LYTE kinase assay	B	CC(C)n1cc(C2=C(c3nnc4ccccn34)C(=O)NC2=O)c2ccccc21		CHEMBL3398202	=	IC50	nM	13.0	CHEMBL262	Homo sapiens	IC50	nM	13.0
	15160295	CHEMBL3398953	Inhibition of recombinant GST-tagged GSK-3beta (unknown origin) expressed in Escherichia coli strain BL21-Codon Plus (DE3) using Ser/Thr 9 peptide substrate by Z'-LYTE kinase assay	B	CCCCn1cc(C2=C(c3nnc4ccccn34)C(=O)NC2=O)c2ccccc21		CHEMBL3398201	=	IC50	nM	69.7	CHEMBL262	Homo sapiens	IC50	nM	69.7
	15160296	CHEMBL3398953	Inhibition of recombinant GST-tagged GSK-3beta (unknown origin) expressed in Escherichia coli strain BL21-Codon Plus (DE3) using Ser/Thr 9 peptide substrate by Z'-LYTE kinase assay	B	C=CCn1cc(C2=C(c3nnc4ccccn34)C(=O)NC2=O)c2ccccc21		CHEMBL3398200	=	IC50	nM	73.6	CHEMBL262	Homo sapiens	IC50	nM	73.6
	15160297	CHEMBL3398953	Inhibition of recombinant GST-tagged GSK-3beta (unknown origin) expressed in Escherichia coli strain BL21-Codon Plus (DE3) using Ser/Thr 9 peptide substrate by Z'-LYTE kinase assay	B	COc1ccc2c(c1)c(C1=C(c3nnc4ccccn34)C(=O)NC1=O)cn2C		CHEMBL3398199	=	IC50	nM	941.8	CHEMBL262	Homo sapiens	IC50	nM	941.8
	15160298	CHEMBL3398953	Inhibition of recombinant GST-tagged GSK-3beta (unknown origin) expressed in Escherichia coli strain BL21-Codon Plus (DE3) using Ser/Thr 9 peptide substrate by Z'-LYTE kinase assay	B	Cn1cc(C2=C(c3nnc4ccccn34)C(=O)NC2=O)c2ccc(Br)cc21		CHEMBL3398198	=	IC50	nM	327.4	CHEMBL262	Homo sapiens	IC50	nM	327.4
	15160299	CHEMBL3398953	Inhibition of recombinant GST-tagged GSK-3beta (unknown origin) expressed in Escherichia coli strain BL21-Codon Plus (DE3) using Ser/Thr 9 peptide substrate by Z'-LYTE kinase assay	B	Cn1cc(C2=C(c3nnc4ccccn34)C(=O)NC2=O)c2cc(Br)ccc21		CHEMBL3398197	=	IC50	nM	63.5	CHEMBL262	Homo sapiens	IC50	nM	63.5
	15160300	CHEMBL3398953	Inhibition of recombinant GST-tagged GSK-3beta (unknown origin) expressed in Escherichia coli strain BL21-Codon Plus (DE3) using Ser/Thr 9 peptide substrate by Z'-LYTE kinase assay	B	Cn1cc(C2=C(c3nnc4ccccn34)C(=O)NC2=O)c2ccc(Cl)cc21		CHEMBL3398196	=	IC50	nM	159.3	CHEMBL262	Homo sapiens	IC50	nM	159.3
	15160301	CHEMBL3398953	Inhibition of recombinant GST-tagged GSK-3beta (unknown origin) expressed in Escherichia coli strain BL21-Codon Plus (DE3) using Ser/Thr 9 peptide substrate by Z'-LYTE kinase assay	B	Cn1cc(C2=C(c3nnc4ccccn34)C(=O)NC2=O)c2cc(Cl)ccc21		CHEMBL3398195	=	IC50	nM	74.1	CHEMBL262	Homo sapiens	IC50	nM	74.1
	15160302	CHEMBL3398953	Inhibition of recombinant GST-tagged GSK-3beta (unknown origin) expressed in Escherichia coli strain BL21-Codon Plus (DE3) using Ser/Thr 9 peptide substrate by Z'-LYTE kinase assay	B	Cn1cc(C2=C(c3nnc4ccccn34)C(=O)NC2=O)c2ccc(F)cc21		CHEMBL3398194	=	IC50	nM	204.1	CHEMBL262	Homo sapiens	IC50	nM	204.1
	15160303	CHEMBL3398953	Inhibition of recombinant GST-tagged GSK-3beta (unknown origin) expressed in Escherichia coli strain BL21-Codon Plus (DE3) using Ser/Thr 9 peptide substrate by Z'-LYTE kinase assay	B	Cn1cc(C2=C(c3nnc4ccccn34)C(=O)NC2=O)c2cc(F)ccc21		CHEMBL3398193	=	IC50	nM	188.0	CHEMBL262	Homo sapiens	IC50	nM	188.0
	15160304	CHEMBL3398953	Inhibition of recombinant GST-tagged GSK-3beta (unknown origin) expressed in Escherichia coli strain BL21-Codon Plus (DE3) using Ser/Thr 9 peptide substrate by Z'-LYTE kinase assay	B	Cc1cccc2c(C3=C(c4nnc5ccccn45)C(=O)NC3=O)cn(C)c12		CHEMBL3398192	=	IC50	nM	105.4	CHEMBL262	Homo sapiens	IC50	nM	105.4
	15160305	CHEMBL3398953	Inhibition of recombinant GST-tagged GSK-3beta (unknown origin) expressed in Escherichia coli strain BL21-Codon Plus (DE3) using Ser/Thr 9 peptide substrate by Z'-LYTE kinase assay	B	Cn1cc(C2=C(c3nnc4ccccn34)C(=O)NC2=O)c2ccccc21		CHEMBL3398191	=	IC50	nM	154.1	CHEMBL262	Homo sapiens	IC50	nM	154.1
	15160306	CHEMBL3398953	Inhibition of recombinant GST-tagged GSK-3beta (unknown origin) expressed in Escherichia coli strain BL21-Codon Plus (DE3) using Ser/Thr 9 peptide substrate by Z'-LYTE kinase assay	B	O=C1NC(=O)C(c2nnc3ccccn23)=C1c1c[nH]c2ccccc12		CHEMBL3398190	=	IC50	nM	477.2	CHEMBL262	Homo sapiens	IC50	nM	477.2
	15160307	CHEMBL3398953	Inhibition of recombinant GST-tagged GSK-3beta (unknown origin) expressed in Escherichia coli strain BL21-Codon Plus (DE3) using Ser/Thr 9 peptide substrate by Z'-LYTE kinase assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	38.0	CHEMBL262	Homo sapiens	IC50	nM	38.0
	15168664	CHEMBL3404147	Inhibition of human recombinant GSK3beta assessed as inhibition of [gamma32P]ATP after 1 hr by liquid scintillation counting in presence of prephosphorylated GS1 peptide	B	Cn1c(N2CCOCC2)nc(-c2ccncc2F)cc1=O		CHEMBL3401114	=	IC50	nM	67.0	CHEMBL262	Homo sapiens	IC50	nM	67.0
	15168665	CHEMBL3404147	Inhibition of human recombinant GSK3beta assessed as inhibition of [gamma32P]ATP after 1 hr by liquid scintillation counting in presence of prephosphorylated GS1 peptide	B	CC(C)C1CN(c2nc(-c3ccncc3F)cc(=O)n2C)CCO1		CHEMBL3401115	=	IC50	nM	17.0	CHEMBL262	Homo sapiens	IC50	nM	17.0
	15168666	CHEMBL3404147	Inhibition of human recombinant GSK3beta assessed as inhibition of [gamma32P]ATP after 1 hr by liquid scintillation counting in presence of prephosphorylated GS1 peptide	B	CCCCC1CN(c2nc(-c3ccncc3F)cc(=O)n2C)CCO1		CHEMBL3401116	=	IC50	nM	12.0	CHEMBL262	Homo sapiens	IC50	nM	12.0
	15168667	CHEMBL3404147	Inhibition of human recombinant GSK3beta assessed as inhibition of [gamma32P]ATP after 1 hr by liquid scintillation counting in presence of prephosphorylated GS1 peptide	B	Cn1c(N2CCOC(C3CCC3)C2)nc(-c2ccncc2F)cc1=O		CHEMBL3401117	=	IC50	nM	12.0	CHEMBL262	Homo sapiens	IC50	nM	12.0
	15168668	CHEMBL3404147	Inhibition of human recombinant GSK3beta assessed as inhibition of [gamma32P]ATP after 1 hr by liquid scintillation counting in presence of prephosphorylated GS1 peptide	B	C[C@@H]1COCCN1c1nc(-c2ccncc2F)cc(=O)n1C		CHEMBL3401118	=	IC50	nM	7.0	CHEMBL262	Homo sapiens	IC50	nM	7.0
	15168669	CHEMBL3404147	Inhibition of human recombinant GSK3beta assessed as inhibition of [gamma32P]ATP after 1 hr by liquid scintillation counting in presence of prephosphorylated GS1 peptide	B	CC[C@@H]1COCCN1c1nc(-c2ccncc2F)cc(=O)n1C		CHEMBL3401119	=	IC50	nM	19.0	CHEMBL262	Homo sapiens	IC50	nM	19.0
	15168670	CHEMBL3404147	Inhibition of human recombinant GSK3beta assessed as inhibition of [gamma32P]ATP after 1 hr by liquid scintillation counting in presence of prephosphorylated GS1 peptide	B	CC(C)[C@@H]1COCCN1c1nc(-c2ccncc2F)cc(=O)n1C		CHEMBL3401120	=	IC50	nM	14.0	CHEMBL262	Homo sapiens	IC50	nM	14.0
	15168671	CHEMBL3404147	Inhibition of human recombinant GSK3beta assessed as inhibition of [gamma32P]ATP after 1 hr by liquid scintillation counting in presence of prephosphorylated GS1 peptide	B	C[C@H]1COCCN1c1nc(-c2ccncc2F)cc(=O)n1C		CHEMBL3401121	=	IC50	nM	23.0	CHEMBL262	Homo sapiens	IC50	nM	23.0
	15168672	CHEMBL3404147	Inhibition of human recombinant GSK3beta assessed as inhibition of [gamma32P]ATP after 1 hr by liquid scintillation counting in presence of prephosphorylated GS1 peptide	B	CC[C@H]1COCCN1c1nc(-c2ccncc2F)cc(=O)n1C		CHEMBL3401122	=	IC50	nM	30.0	CHEMBL262	Homo sapiens	IC50	nM	30.0
	15168673	CHEMBL3404147	Inhibition of human recombinant GSK3beta assessed as inhibition of [gamma32P]ATP after 1 hr by liquid scintillation counting in presence of prephosphorylated GS1 peptide	B	Cn1c(N2CCO[C@@H](c3ccc(F)cc3)C2)nc(-c2ccncn2)cc1=O		CHEMBL3091536	=	IC50	nM	12.0	CHEMBL262	Homo sapiens	IC50	nM	12.0
	15168674	CHEMBL3404147	Inhibition of human recombinant GSK3beta assessed as inhibition of [gamma32P]ATP after 1 hr by liquid scintillation counting in presence of prephosphorylated GS1 peptide	B	C[C@@H]1CN(c2nc(-c3ccncc3F)cc(=O)n2C)[C@H](C)CO1		CHEMBL3401123	=	IC50	nM	453.0	CHEMBL262	Homo sapiens	IC50	nM	453.0
	15168675	CHEMBL3404147	Inhibition of human recombinant GSK3beta assessed as inhibition of [gamma32P]ATP after 1 hr by liquid scintillation counting in presence of prephosphorylated GS1 peptide	B	C[C@H]1CN(c2nc(-c3ccncc3F)cc(=O)n2C)[C@H](C)CO1		CHEMBL3401124	=	IC50	nM	41.0	CHEMBL262	Homo sapiens	IC50	nM	41.0
	15168676	CHEMBL3404147	Inhibition of human recombinant GSK3beta assessed as inhibition of [gamma32P]ATP after 1 hr by liquid scintillation counting in presence of prephosphorylated GS1 peptide	B	C[C@@H]1OCCN(c2nc(-c3ccncc3F)cc(=O)n2C)[C@@H]1C		CHEMBL3401125	=	IC50	nM	16.0	CHEMBL262	Homo sapiens	IC50	nM	16.0
	15168677	CHEMBL3404147	Inhibition of human recombinant GSK3beta assessed as inhibition of [gamma32P]ATP after 1 hr by liquid scintillation counting in presence of prephosphorylated GS1 peptide	B	C[C@@H]1OCCN(c2nc(-c3ccncc3F)cc(=O)n2C)[C@@H]1C		CHEMBL3401125	=	IC50	nM	32.0	CHEMBL262	Homo sapiens	IC50	nM	32.0
	15168678	CHEMBL3404147	Inhibition of human recombinant GSK3beta assessed as inhibition of [gamma32P]ATP after 1 hr by liquid scintillation counting in presence of prephosphorylated GS1 peptide	B	C[C@@H]1OCCN(c2nc(-c3ccncc3F)cc(=O)n2C)[C@H]1C		CHEMBL3401126	=	IC50	nM	19.0	CHEMBL262	Homo sapiens	IC50	nM	19.0
	15168679	CHEMBL3404147	Inhibition of human recombinant GSK3beta assessed as inhibition of [gamma32P]ATP after 1 hr by liquid scintillation counting in presence of prephosphorylated GS1 peptide	B	C[C@H]1OCCN(c2nc(-c3ccncc3F)cc(=O)n2C)[C@@H]1C		CHEMBL3401127	=	IC50	nM	4.9	CHEMBL262	Homo sapiens	IC50	nM	4.9
	15168680	CHEMBL3404147	Inhibition of human recombinant GSK3beta assessed as inhibition of [gamma32P]ATP after 1 hr by liquid scintillation counting in presence of prephosphorylated GS1 peptide	B	CC1N(c2nc(-c3ccncc3F)cc(=O)n2C)CCOC1(C)C		CHEMBL3401128	=	IC50	nM	9.7	CHEMBL262	Homo sapiens	IC50	nM	9.7
	15168681	CHEMBL3404147	Inhibition of human recombinant GSK3beta assessed as inhibition of [gamma32P]ATP after 1 hr by liquid scintillation counting in presence of prephosphorylated GS1 peptide	B	Cn1c(N2CCO[C@@H]3CCC[C@H]32)nc(-c2ccncc2F)cc1=O		CHEMBL3401129	=	IC50	nM	4.2	CHEMBL262	Homo sapiens	IC50	nM	4.2
	15168682	CHEMBL3404147	Inhibition of human recombinant GSK3beta assessed as inhibition of [gamma32P]ATP after 1 hr by liquid scintillation counting in presence of prephosphorylated GS1 peptide	B	Cn1c(N2CCO[C@H]3CCC[C@@H]32)nc(-c2ccncc2F)cc1=O		CHEMBL3401130	=	IC50	nM	35.0	CHEMBL262	Homo sapiens	IC50	nM	35.0
	15168683	CHEMBL3404147	Inhibition of human recombinant GSK3beta assessed as inhibition of [gamma32P]ATP after 1 hr by liquid scintillation counting in presence of prephosphorylated GS1 peptide	B	Cn1c(N2CCO[C@@H]3CCCC[C@H]32)nc(-c2ccncc2F)cc1=O		CHEMBL3401131	=	IC50	nM	3.7	CHEMBL262	Homo sapiens	IC50	nM	3.7
	15168684	CHEMBL3404147	Inhibition of human recombinant GSK3beta assessed as inhibition of [gamma32P]ATP after 1 hr by liquid scintillation counting in presence of prephosphorylated GS1 peptide	B	Cn1c(N2CCO[C@@H]3COC[C@H]32)nc(-c2ccncc2F)cc1=O		CHEMBL3401132	=	IC50	nM	3.1	CHEMBL262	Homo sapiens	IC50	nM	3.1
	15169320	CHEMBL3406488	Inhibition of GSK3beta (unknown origin) at 1 ug/ml relative to control	B	CN(C(=O)c1ccccc1)c1ccc2[nH]c(-c3n[nH]c4ccccc34)cc2n1		CHEMBL3403010	=	Inhibition	%	18.57	CHEMBL262	Homo sapiens	INH	%	18.57
	15169321	CHEMBL3406488	Inhibition of GSK3beta (unknown origin) at 1 ug/ml relative to control	B	CN(C(=O)c1ccc(Cl)cc1)c1ccc2[nH]c(-c3n[nH]c4ccccc34)cc2n1		CHEMBL3403013	=	Inhibition	%	27.75	CHEMBL262	Homo sapiens	INH	%	27.75
	15169322	CHEMBL3406488	Inhibition of GSK3beta (unknown origin) at 1 ug/ml relative to control	B	CN(C(=O)Nc1ccccc1)c1ccc2[nH]c(-c3n[nH]c4ccccc34)cc2n1		CHEMBL3403031	=	Inhibition	%	19.26	CHEMBL262	Homo sapiens	INH	%	19.26
	15191123	CHEMBL3413720	Inhibition of GSK3beta (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1NC(=S)Nc1ccccc1		CHEMBL3408381	=	Inhibition	%	26.0	CHEMBL262	Homo sapiens	INH	%	26.0
	15191124	CHEMBL3413720	Inhibition of GSK3beta (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=c1\sc(-c2ccccc2)nn1-c1ccccc1		CHEMBL3408382	=	Inhibition	%	27.0	CHEMBL262	Homo sapiens	INH	%	27.0
	15191125	CHEMBL3413720	Inhibition of GSK3beta (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CC(=O)c1nn(-c2ccccc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408383	=	Inhibition	%	65.0	CHEMBL262	Homo sapiens	INH	%	65.0
	15191126	CHEMBL3413720	Inhibition of GSK3beta (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CC(=O)c1nn(-c2ccc(C)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408384	=	Inhibition	%	45.0	CHEMBL262	Homo sapiens	INH	%	45.0
	15191127	CHEMBL3413720	Inhibition of GSK3beta (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	COc1ccc(-n2nc(C(C)=O)s/c2=N\c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)cc1		CHEMBL3408385	=	Inhibition	%	66.0	CHEMBL262	Homo sapiens	INH	%	66.0
	15191128	CHEMBL3413720	Inhibition of GSK3beta (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CC(=O)c1nn(-c2ccc(Cl)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408386	=	Inhibition	%	22.0	CHEMBL262	Homo sapiens	INH	%	22.0
	15191129	CHEMBL3413720	Inhibition of GSK3beta (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CCOC(=O)c1nn(-c2ccccc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408387	=	Inhibition	%	14.0	CHEMBL262	Homo sapiens	INH	%	14.0
	15191130	CHEMBL3413720	Inhibition of GSK3beta (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CCOC(=O)c1nn(-c2ccc(C)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408388	=	Inhibition	%	56.0	CHEMBL262	Homo sapiens	INH	%	56.0
	15191131	CHEMBL3413720	Inhibition of GSK3beta (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CCOC(=O)c1nn(-c2ccc(Cl)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408389	=	Inhibition	%	78.0	CHEMBL262	Homo sapiens	INH	%	78.0
	15191132	CHEMBL3413720	Inhibition of GSK3beta (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=c1\sc(C(=O)Nc2ccccc2)nn1-c1ccccc1		CHEMBL3408390	=	Inhibition	%	76.0	CHEMBL262	Homo sapiens	INH	%	76.0
	15191133	CHEMBL3413720	Inhibition of GSK3beta (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=C1\SCC(=O)N1c1ccccc1		CHEMBL3408391	=	Inhibition	%	4.0	CHEMBL262	Homo sapiens	INH	%	4.0
	15191134	CHEMBL3413720	Inhibition of GSK3beta (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=c1\scc(-c2ccccc2)n1-c1ccccc1		CHEMBL3408392	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	INH	%	0.0
	15191135	CHEMBL3413720	Inhibition of GSK3beta (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=C1\S/C(=C2\SC(c3ccccc3)=NN2c2ccccc2)C(=O)N1c1ccccc1		CHEMBL3408393	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	INH	%	0.0
	15191136	CHEMBL3413720	Inhibition of GSK3beta (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CC(=O)C1=NN(c2ccccc2)/C(=C2/S/C(=N\c3nc(-c4ccccc4)cc(-c4ccccc4)c3C#N)N(c3ccccc3)C2=O)S1		CHEMBL3408394	=	Inhibition	%	4.0	CHEMBL262	Homo sapiens	INH	%	4.0
	15191137	CHEMBL3413720	Inhibition of GSK3beta (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CCOC(=O)C1=NN(c2ccccc2)/C(=C2/S/C(=N\c3nc(-c4ccccc4)cc(-c4ccccc4)c3C#N)N(c3ccccc3)C2=O)S1		CHEMBL3408395	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	INH	%	0.0
	15191138	CHEMBL3413720	Inhibition of GSK3beta (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=C1\S/C(=C2\SC(C(=O)Nc3ccccc3)=NN2c2ccccc2)C(=O)N1c1ccccc1		CHEMBL3408396	=	Inhibition	%	4.0	CHEMBL262	Homo sapiens	INH	%	4.0
	15199193	CHEMBL3413879	Inhibition of GSK3beta (unknown origin) activity by competitive binding assay	B	NC(=O)c1ccc(-c2ccnc(NC(=O)C3CC3)c2)nn1		CHEMBL3410112	=	IC50	nM	140.0	CHEMBL262	Homo sapiens	IC50	nM	140.0
	15199194	CHEMBL3413879	Inhibition of GSK3beta (unknown origin) activity by competitive binding assay	B	CC(C)Oc1nc(-c2ccnc(NC(=O)C3CC3)c2)ncc1C(N)=O		CHEMBL3410111	=	IC50	nM	0.83	CHEMBL262	Homo sapiens	IC50	nM	0.83
	15199195	CHEMBL3413879	Inhibition of GSK3beta (unknown origin) activity by competitive binding assay	B	COc1nc(-c2ccnc(NC(=O)C3CC3)c2)ncc1C(N)=O		CHEMBL3410110	=	IC50	nM	5.9	CHEMBL262	Homo sapiens	IC50	nM	5.9
	15199196	CHEMBL3413879	Inhibition of GSK3beta (unknown origin) activity by competitive binding assay	B	NC(=O)c1cnc(-c2ccnc(NC(=O)C3CC3)c2)cn1		CHEMBL3410109	=	IC50	nM	30.0	CHEMBL262	Homo sapiens	IC50	nM	30.0
	15199197	CHEMBL3413879	Inhibition of GSK3beta (unknown origin) activity by competitive binding assay	B	Cn1nc(C(N)=O)cc1-c1ccnc(NC(=O)C2CC2)c1		CHEMBL3410108	=	IC50	nM	24.0	CHEMBL262	Homo sapiens	IC50	nM	24.0
	15199198	CHEMBL3413879	Inhibition of GSK3beta (unknown origin) activity by competitive binding assay	B	CC(C)Oc1cc(-c2ccnc(NC(=O)C3CC3)c2)ncc1C(N)=O		CHEMBL3410107	=	IC50	nM	4.4	CHEMBL262	Homo sapiens	IC50	nM	4.4
	15199199	CHEMBL3413879	Inhibition of GSK3beta (unknown origin) activity by competitive binding assay	B	NC(=O)c1cnc(-c2ccnc(NC(=O)C3CC3)c2)cc1OCC(F)(F)F		CHEMBL3410106	=	IC50	nM	6.8	CHEMBL262	Homo sapiens	IC50	nM	6.8
	15199200	CHEMBL3413879	Inhibition of GSK3beta (unknown origin) activity by competitive binding assay	B	COc1cc(-c2ccnc(NC(=O)C3CC3)c2)ncc1C(N)=O		CHEMBL3410105	=	IC50	nM	22.0	CHEMBL262	Homo sapiens	IC50	nM	22.0
	15199201	CHEMBL3413879	Inhibition of GSK3beta (unknown origin) activity by competitive binding assay	B	COc1cc(-c2ccnc(NC(=O)C3CC3)c2)cnc1C(N)=O		CHEMBL3410104	=	IC50	nM	7.0	CHEMBL262	Homo sapiens	IC50	nM	7.0
	15200378	CHEMBL3413879	Inhibition of GSK3beta (unknown origin) activity by competitive binding assay	B	NC(=O)c1ccc(-c2ccnc(NC(=O)C3CC3)c2)cn1		CHEMBL3410103	=	IC50	nM	90.0	CHEMBL262	Homo sapiens	IC50	nM	90.0
	15200379	CHEMBL3413879	Inhibition of GSK3beta (unknown origin) activity by competitive binding assay	B	O=C(Nc1cc(-c2ccc3ccccc3c2)ccn1)C1CC1		CHEMBL3410102	=	IC50	nM	610.0	CHEMBL262	Homo sapiens	IC50	nM	610.0
	15200380	CHEMBL3413879	Inhibition of GSK3beta (unknown origin) activity by competitive binding assay	B	O=C(Nc1cc(-c2ccc3ncccc3c2)ccn1)C1CC1		CHEMBL3410101	=	IC50	nM	7.5	CHEMBL262	Homo sapiens	IC50	nM	7.5
	15200381	CHEMBL3413879	Inhibition of GSK3beta (unknown origin) activity by competitive binding assay	B	O=C(Nc1cc(-c2ccc3ccncc3c2)ccn1)C1CC1		CHEMBL3410100	=	IC50	nM	74.0	CHEMBL262	Homo sapiens	IC50	nM	74.0
	15200382	CHEMBL3413879	Inhibition of GSK3beta (unknown origin) activity by competitive binding assay	B	O=C(Nc1cc(-c2ccc3cccnc3c2)ccn1)C1CC1		CHEMBL3410099	=	IC50	nM	240.0	CHEMBL262	Homo sapiens	IC50	nM	240.0
	15200383	CHEMBL3413879	Inhibition of GSK3beta (unknown origin) activity by competitive binding assay	B	O=C1CCCc2cc(-c3ccnc(NC(=O)C4CC4)c3)ccc2N1		CHEMBL3410098	=	IC50	nM	730.0	CHEMBL262	Homo sapiens	IC50	nM	730.0
	15200384	CHEMBL3413879	Inhibition of GSK3beta (unknown origin) activity by competitive binding assay	B	O=C1NCCOc2cc(-c3ccnc(NC(=O)C4CC4)c3)ccc21		CHEMBL3410097	=	IC50	nM	4.7	CHEMBL262	Homo sapiens	IC50	nM	4.7
	15200385	CHEMBL3413879	Inhibition of GSK3beta (unknown origin) activity by competitive binding assay	B	O=C1NCCCc2cc(-c3ccnc(NC(=O)C4CC4)c3)ccc21		CHEMBL3410096	=	IC50	nM	2.4	CHEMBL262	Homo sapiens	IC50	nM	2.4
	15200386	CHEMBL3413879	Inhibition of GSK3beta (unknown origin) activity by competitive binding assay	B	O=C1NCc2cc(-c3ccnc(NC(=O)C4CC4)c3)ccc21		CHEMBL3410095	=	IC50	nM	11.0	CHEMBL262	Homo sapiens	IC50	nM	11.0
	15200387	CHEMBL3413879	Inhibition of GSK3beta (unknown origin) activity by competitive binding assay	B	O=C1NCCc2cc(-c3ccnc(NC(=O)C4CC4)c3)ccc21		CHEMBL3410094	=	IC50	nM	2.4	CHEMBL262	Homo sapiens	IC50	nM	2.4
	15200388	CHEMBL3413879	Inhibition of GSK3beta (unknown origin) activity by competitive binding assay	B	COc1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1C(N)=O		CHEMBL3410093	=	IC50	nM	30.0	CHEMBL262	Homo sapiens	IC50	nM	30.0
	15200389	CHEMBL3413879	Inhibition of GSK3beta (unknown origin) activity by competitive binding assay	B	NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OC1CCC1		CHEMBL3410092	=	IC50	nM	0.37	CHEMBL262	Homo sapiens	IC50	nM	0.37
	15200390	CHEMBL3413879	Inhibition of GSK3beta (unknown origin) activity by competitive binding assay	B	NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCC1CC1		CHEMBL3410091	=	IC50	nM	0.29	CHEMBL262	Homo sapiens	IC50	nM	0.29
	15200391	CHEMBL3413879	Inhibition of GSK3beta (unknown origin) activity by competitive binding assay	B	CC(C)Oc1nc(-c2ccnc(NC(=O)C3CC3)c2)sc1C(N)=O		CHEMBL3410090	=	IC50	nM	0.45	CHEMBL262	Homo sapiens	IC50	nM	0.45
	15200392	CHEMBL3413879	Inhibition of GSK3beta (unknown origin) activity by competitive binding assay	B	COc1nc(-c2ccnc(NC(=O)C3CC3)c2)sc1C(N)=O		CHEMBL3410089	=	IC50	nM	1.1	CHEMBL262	Homo sapiens	IC50	nM	1.1
	15200393	CHEMBL3413879	Inhibition of GSK3beta (unknown origin) activity by competitive binding assay	B	Cc1nc(-c2ccnc(NC(=O)C3CC3)c2)sc1C(N)=O		CHEMBL3410088	=	IC50	nM	37.0	CHEMBL262	Homo sapiens	IC50	nM	37.0
	15200394	CHEMBL3413879	Inhibition of GSK3beta (unknown origin) activity by competitive binding assay	B	NC(=O)c1cnc(-c2ccnc(NC(=O)C3CC3)c2)s1		CHEMBL3410087	=	IC50	nM	13.0	CHEMBL262	Homo sapiens	IC50	nM	13.0
	15205887	CHEMBL3413913	Inhibition of GSK3beta (unknown origin)	B	Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)cc2)cn1		CHEMBL3408213	=	IC50	nM	690.0	CHEMBL262	Homo sapiens	IC50	uM	0.69
	15251889	CHEMBL3427813	Inhibition of GSK-3beta (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL443738	=	Activity	%	27.0	CHEMBL262	Homo sapiens	Activity	%	27.0
	15251908	CHEMBL3427813	Inhibition of GSK-3beta (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427170	=	Activity	%	57.0	CHEMBL262	Homo sapiens	Activity	%	57.0
	15252010	CHEMBL3427813	Inhibition of GSK-3beta (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427171	=	Activity	%	37.0	CHEMBL262	Homo sapiens	Activity	%	37.0
	15252655	CHEMBL3427813	Inhibition of GSK-3beta (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427172	=	Activity	%	45.0	CHEMBL262	Homo sapiens	Activity	%	45.0
	15252757	CHEMBL3427813	Inhibition of GSK-3beta (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)CS3)sc2c1		CHEMBL3427173	=	Activity	%	70.0	CHEMBL262	Homo sapiens	Activity	%	70.0
	15252859	CHEMBL3427813	Inhibition of GSK-3beta (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)CS3)sc2c1		CHEMBL3427174	=	Activity	%	66.0	CHEMBL262	Homo sapiens	Activity	%	66.0
	15253533	CHEMBL3427813	Inhibition of GSK-3beta (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427175	=	Activity	%	34.0	CHEMBL262	Homo sapiens	Activity	%	34.0
	15253635	CHEMBL3427813	Inhibition of GSK-3beta (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427176	=	Activity	%	88.0	CHEMBL262	Homo sapiens	Activity	%	88.0
	15253737	CHEMBL3427813	Inhibition of GSK-3beta (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427177	=	Activity	%	56.0	CHEMBL262	Homo sapiens	Activity	%	56.0
	15253799	CHEMBL3429895	Inhibition of human GSK3beta	B	CCn1nc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(C)CC4)c(C(F)(F)F)c3)ccc2C)c2c(N)ncnc21		CHEMBL3426225	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	15254403	CHEMBL3427813	Inhibition of GSK-3beta (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427178	=	Activity	%	49.0	CHEMBL262	Homo sapiens	Activity	%	49.0
	15254505	CHEMBL3427813	Inhibition of GSK-3beta (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@H]1C(=O)O		CHEMBL3427179	=	Activity	%	25.0	CHEMBL262	Homo sapiens	Activity	%	25.0
	15254607	CHEMBL3427813	Inhibition of GSK-3beta (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@@H]1C(=O)O		CHEMBL3427180	=	Activity	%	16.0	CHEMBL262	Homo sapiens	Activity	%	16.0
	15255298	CHEMBL3427813	Inhibition of GSK-3beta (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427181	=	Activity	%	59.0	CHEMBL262	Homo sapiens	Activity	%	59.0
	15255400	CHEMBL3427813	Inhibition of GSK-3beta (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427182	=	Activity	%	73.0	CHEMBL262	Homo sapiens	Activity	%	73.0
	15255503	CHEMBL3427813	Inhibition of GSK-3beta (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427183	=	Activity	%	68.0	CHEMBL262	Homo sapiens	Activity	%	68.0
	15256234	CHEMBL3427813	Inhibition of GSK-3beta (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427184	=	Activity	%	59.0	CHEMBL262	Homo sapiens	Activity	%	59.0
	15258351	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Thermal melting change	degrees C	3.8	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	3.8
	15258411	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Thermal melting change	degrees C	-0.1	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	-0.1
	15258471	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Thermal melting change	degrees C	1.4	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	1.4
	15258531	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Thermal melting change	degrees C	8.6	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	8.6
	15258591	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Thermal melting change	degrees C	7.6	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	7.6
	15258651	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Thermal melting change	degrees C	1.0	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	1.0
	15258711	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Thermal melting change	degrees C	8.4	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	8.4
	15258771	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	O=C(O)Cc1ccc(O)c([N+](=O)[O-])c1		CHEMBL501822	=	Thermal melting change	degrees C	0.6	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	0.6
	15258831	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL319467	=	Thermal melting change	degrees C	4.3	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	4.3
	15258891	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Thermal melting change	degrees C	8.8	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	8.8
	15258951	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	CS(=O)(=O)O.Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL1642	=	Thermal melting change	degrees C	2.5	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	2.5
	15259011	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Thermal melting change	degrees C	11.4	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	11.4
	15259071	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Thermal melting change	degrees C	11.8	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	11.8
	15259131	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL216543	=	Thermal melting change	degrees C	11.0	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	11.0
	15259191	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Thermal melting change	degrees C	8.0	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	8.0
	15259251	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	Cn1cc(/C=C2/C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL3430785	=	Thermal melting change	degrees C	11.6	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	11.6
	15259311	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B			CHEMBL3430786	=	Thermal melting change	degrees C	3.0	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	3.0
	15259371	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	CCOc1ccc(/C=C2/SC(=O)N(CCN)C2=O)cc1		CHEMBL262615	=	Thermal melting change	degrees C	-1.3	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	-1.3
	15259431	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	O=c1c(-c2ccc(F)cc2)c(-c2ccncc2)[nH]n1-c1ccc(Cl)cc1		CHEMBL408678	=	Thermal melting change	degrees C	1.9	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	1.9
	15259491	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Thermal melting change	degrees C	0.0	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	0.0
	15259551	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Thermal melting change	degrees C	0.9	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	0.9
	15259611	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2[C@H]2CC[C@H](O)CC2)n1		CHEMBL97162	=	Thermal melting change	degrees C	0.4	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	0.4
	15259671	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Thermal melting change	degrees C	5.9	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	5.9
	15259731	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Thermal melting change	degrees C	12.1	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	12.1
	15259791	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	CCCNC(=O)Nc1ccc(Oc2ncnc3cc(OC)c(OC)cc23)cc1Cl		CHEMBL406381	=	Thermal melting change	degrees C	0.1	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	0.1
	15259851	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Thermal melting change	degrees C	2.9	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	2.9
	15259911	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Thermal melting change	degrees C	0.4	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	0.4
	15259971	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	Cl.NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL558969	=	Thermal melting change	degrees C	8.1	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	8.1
	15260031	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)c(C)c1C(=O)N1CCN(C)CC1		CHEMBL261641	=	Thermal melting change	degrees C	4.2	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	4.2
	15260091	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Thermal melting change	degrees C	5.0	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	5.0
	15260151	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Thermal melting change	degrees C	2.9	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	2.9
	15260211	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B			CHEMBL3430787	=	Thermal melting change	degrees C	9.7	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	9.7
	15260271	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Thermal melting change	degrees C	1.1	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	1.1
	15260331	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	CN(c1cccnc1)c1cc2c(Nc3ccc(F)c(Cl)c3)c(C#N)cnc2cn1		CHEMBL261238	=	Thermal melting change	degrees C	6.3	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	6.3
	15260391	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Thermal melting change	degrees C	0.2	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	0.2
	15260451	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Thermal melting change	degrees C	0.4	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	0.4
	15260511	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	Cc1nc(N)sc1-c1ccnc(Nc2cccc([N+](=O)[O-])c2)n1		CHEMBL298445	=	Thermal melting change	degrees C	2.1	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	2.1
	15260571	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Thermal melting change	degrees C	1.1	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	1.1
	15260631	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B			CHEMBL3430788	=	Thermal melting change	degrees C	-0.2	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	-0.2
	15260691	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Thermal melting change	degrees C	0.7	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	0.7
	15260751	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Thermal melting change	degrees C	0.0	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	0.0
	15260811	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	CN1CCc2[nH]c(=S)c(C#N)c(-c3cccs3)c2C1		CHEMBL261211	=	Thermal melting change	degrees C	4.0	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	4.0
	15260871	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(O)c1c(F)cccc1F		CHEMBL259605	=	Thermal melting change	degrees C	4.5	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	4.5
	15260931	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Thermal melting change	degrees C	1.9	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	1.9
	15260991	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	Thermal melting change	degrees C	0.3	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	0.3
	15261051	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	CN1CCC(Nc2ncc3ncnc(Nc4ccc(F)c(Cl)c4)c3n2)CC1		CHEMBL258940	=	Thermal melting change	degrees C	1.7	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	1.7
	15261111	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Thermal melting change	degrees C	0.9	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	0.9
	15261194	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Thermal melting change	degrees C	6.9	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	6.9
	15261254	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	Brc1c(Br)c(Br)c2[nH]nnc2c1Br		CHEMBL177820	=	Thermal melting change	degrees C	2.4	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	2.4
	15261314	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	Nc1cc2ncnc(Nc3cccc(Br)c3)c2cc1N		CHEMBL328216	=	Thermal melting change	degrees C	1.2	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	1.2
	15261374	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Thermal melting change	degrees C	2.8	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	2.8
	15261429	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	NC1=N/C(=C2/CCNC(=O)c3[nH]ccc32)C(=O)N1		CHEMBL255465	=	Thermal melting change	degrees C	5.0	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	5.0
	15261489	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	COc1cc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)ccc1O		CHEMBL435734	=	Thermal melting change	degrees C	-0.2	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	-0.2
	15261549	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	O=C1C=C2C(=Nc3c2c2c(c4c3=NC3=C4CCC=C3)C=NC=2)CC1		CHEMBL408953	=	Thermal melting change	degrees C	2.3	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	2.3
	15261609	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC.[Cl-]		CHEMBL258893	=	Thermal melting change	degrees C	-1.5	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	-1.5
	15261682	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OC		CHEMBL29197	=	Thermal melting change	degrees C	1.5	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	1.5
	15261742	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	C[S+]([O-])c1ccc(CSc2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL111456	=	Thermal melting change	degrees C	0.0	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	0.0
	15261802	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12		CHEMBL28	=	Thermal melting change	degrees C	5.0	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	5.0
	15261862	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12		CHEMBL44	=	Thermal melting change	degrees C	1.1	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	1.1
	15261918	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Thermal melting change	degrees C	1.1	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	1.1
	15261978	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	CC(C)c1cc(/C=C(\C#N)C(=O)NCCCc2ccccc2)cc(C(C)C)c1O		CHEMBL261508	=	Thermal melting change	degrees C	-1.2	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	-1.2
	15262038	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Thermal melting change	degrees C	-0.6	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	-0.6
	15262098	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B			CHEMBL3430782	=	Thermal melting change	degrees C	3.6	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	3.6
	15262171	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Thermal melting change	degrees C	0.1	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	0.1
	15262231	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Thermal melting change	degrees C	0.5	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	0.5
	15262291	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL99203	=	Thermal melting change	degrees C	2.0	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	2.0
	15262351	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	O=C(O)c1cc(NCc2cc(O)ccc2O)ccc1O		CHEMBL319620	=	Thermal melting change	degrees C	-0.4	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	-0.4
	15262411	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	OC[C@H]1O[C@@H](n2cnc3cc(Cl)c(Cl)cc32)[C@H](O)[C@@H]1O		CHEMBL375530	=	Thermal melting change	degrees C	0.7	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	0.7
	15262471	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	O=C(O)c1cc(N(Cc2ccccc2O)Cc2cc(O)ccc2O)ccc1O		CHEMBL103552	=	Thermal melting change	degrees C	-0.1	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	-0.1
	15262531	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	O=C1Nc2ccc(I)cc2/C1=C\c1cc(Br)c(O)c(Br)c1		CHEMBL264949	=	Thermal melting change	degrees C	3.6	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	3.6
	15262591	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Thermal melting change	degrees C	0.5	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	0.5
	15262651	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	CN(C)c1ncnc2nc[nH]c12		CHEMBL407391	=	Thermal melting change	degrees C	0.7	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	0.7
	15262711	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	Cc1ccc2c(c1)C(=O)c1cc(O)cc(O)c1C2=O		CHEMBL405992	=	Thermal melting change	degrees C	5.2	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	5.2
	15262771	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	O=c1ccc2ccc(O)c(O)c2o1		CHEMBL244948	=	Thermal melting change	degrees C	0.2	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	0.2
	15262831	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	COc1cc(O)c2c(c1)oc(=O)c1c3cc(O)c(O)cc3oc21		CHEMBL97453	=	Thermal melting change	degrees C	-0.4	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	-0.4
	15262891	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Thermal melting change	degrees C	8.3	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	8.3
	15262951	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Thermal melting change	degrees C	-0.2	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	-0.2
	15263011	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Thermal melting change	degrees C	10.5	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	10.5
	15263071	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Thermal melting change	degrees C	11.9	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	11.9
	15263131	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	N#CC(C#N)=Cc1ccc(O)c(O)c1		CHEMBL76904	=	Thermal melting change	degrees C	0.8	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	0.8
	15263191	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Thermal melting change	degrees C	2.6	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	2.6
	15263251	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)Nc1ccccc1		CHEMBL56731	=	Thermal melting change	degrees C	0.7	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	0.7
	15263311	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	CCOc1cc(/C=C(\C#N)C(N)=O)cc(CSc2ccccc2)c1O		CHEMBL485070	=	Thermal melting change	degrees C	1.1	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	1.1
	15263371	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	C/C(O)=C(\C#N)C(=O)Nc1cc(Br)ccc1Br		CHEMBL228043	=	Thermal melting change	degrees C	1.8	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	1.8
	15263407	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Thermal melting change	degrees C	9.9	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	9.9
	15263467	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Thermal melting change	degrees C	0.6	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	0.6
	15263522	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	O=C1c2ccccc2-c2n[nH]c3cccc1c23		CHEMBL7064	=	Thermal melting change	degrees C	1.6	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	1.6
	15263582	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B			CHEMBL3430783	=	Thermal melting change	degrees C	8.3	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	8.3
	15263642	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	Cc1nc2sccn2c(=O)c1CCN1CCC(=C(c2ccccc2)c2ccc(F)cc2)CC1		CHEMBL259388	=	Thermal melting change	degrees C	2.6	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	2.6
	15263702	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	Cc1c2ccncc2c(C)c2c1[nH]c1ccccc12		CHEMBL123	=	Thermal melting change	degrees C	5.6	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	5.6
	15263776	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12		CHEMBL406821	=	Thermal melting change	degrees C	0.6	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	0.6
	15263836	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Thermal melting change	degrees C	2.3	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	2.3
	15263896	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	CN(C)c1ccc(CC2C(=O)Nc3ccccc32)cc1		CHEMBL1373282	=	Thermal melting change	degrees C	1.2	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	1.2
	15263956	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	O=C1Nc2ccccc2/C1=C/c1cc2c([nH]1)CCC(Br)C2		CHEMBL408565	=	Thermal melting change	degrees C	1.4	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	1.4
	15264010	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	CCOC(=O)c1cnc2oc3ccc(O)cc3c2c1-c1ccccc1		CHEMBL132904	=	Thermal melting change	degrees C	4.3	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	4.3
	15264070	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21.[Cl-]		CHEMBL258765	=	Thermal melting change	degrees C	0.1	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	0.1
	15264130	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	COC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O		CHEMBL278315	=	Thermal melting change	degrees C	0.5	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	0.5
	15264190	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Thermal melting change	degrees C	0.5	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	0.5
	15264263	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	O=C1Nc2ccccc2/C1=C/c1cnc[nH]1		CHEMBL261692	=	Thermal melting change	degrees C	7.1	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	7.1
	15264323	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	O=S(=O)(c1cccc2c(Cl)cccc12)N1CCCNCC1		CHEMBL429298	=	Thermal melting change	degrees C	0.2	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	0.2
	15264383	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O		CHEMBL116438	=	Thermal melting change	degrees C	3.4	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	3.4
	15264443	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c(Br)cc32)N1		CHEMBL361708	=	Thermal melting change	degrees C	7.4	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	7.4
	15264499	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Thermal melting change	degrees C	11.5	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	11.5
	15264559	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	COC(=O)[C@]1(O)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL416056	=	Thermal melting change	degrees C	4.5	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	4.5
	15264619	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Thermal melting change	degrees C	0.0	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	0.0
	15264679	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	Cl.NCCNS(=O)(=O)c1cccc2c(Cl)cccc12		CHEMBL1255867	=	Thermal melting change	degrees C	0.1	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	0.1
	15264751	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	Cc1cc(C=C2C(=O)C=CC2=O)cc(C)c1O		CHEMBL437612	=	Thermal melting change	degrees C	-2.9	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	-2.9
	15264811	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	CC(C)(C)c1cc(C=C2C(=O)C=CC2=O)cc(C(C)(C)C)c1O		CHEMBL258726	=	Thermal melting change	degrees C	-4.0	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	-4.0
	15264871	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Thermal melting change	degrees C	3.0	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	3.0
	15264931	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	CC(C)N(CCO)c1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL126254	=	Thermal melting change	degrees C	2.4	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	2.4
	15264987	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	N=C(N)NCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL143054	=	Thermal melting change	degrees C	0.4	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	0.4
	15265047	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	CNC(=O)c1cc(Oc2ccc(Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL3430784	=	Thermal melting change	degrees C	-0.5	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	-0.5
	15265107	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Thermal melting change	degrees C	7.3	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	7.3
	15265167	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	CCn1cnc2c(N)nc(N(c3cccc(Cl)c3)[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL411901	=	Thermal melting change	degrees C	3.0	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	3.0
	15265240	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Thermal melting change	degrees C	0.8	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	0.8
	15265300	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc21		CHEMBL280074	=	Thermal melting change	degrees C	0.1	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	0.1
	15265360	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	CC(C)n1cnc2c(NCc3ccccc3O)nc(NCCCO)nc21		CHEMBL419931	=	Thermal melting change	degrees C	0.3	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	0.3
	15265420	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Thermal melting change	degrees C	0.8	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	0.8
	15265476	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Thermal melting change	degrees C	-0.6	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	-0.6
	15265536	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	Thermal melting change	degrees C	0.0	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	0.0
	15265596	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Thermal melting change	degrees C	0.1	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	0.1
	15265656	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	C[C@@H]1C[C@H]2O[C@@H]2/C=C\C=C\C(=O)Cc2c(Cl)c(O)cc(O)c2C(=O)O1		CHEMBL414883	=	Thermal melting change	degrees C	-0.3	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	-0.3
	15265728	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Thermal melting change	degrees C	1.1	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	1.1
	15265788	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Thermal melting change	degrees C	0.4	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	0.4
	15265848	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	O=C(O)/C=C/c1cc(CO)ccc1CO		CHEMBL407534	=	Thermal melting change	degrees C	0.1	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	0.1
	15265908	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Thermal melting change	degrees C	0.1	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	0.1
	15265965	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Thermal melting change	degrees C	-0.3	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	-0.3
	15266025	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	Oc1cc(O)cc(/C=C/c2ccc(O)c(O)c2)c1		CHEMBL69863	=	Thermal melting change	degrees C	0.8	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	0.8
	15266085	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	N#C/C(=C(/N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL261237	=	Thermal melting change	degrees C	-0.1	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	-0.1
	15266145	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	O=C1Nc2ccc(I)cc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL411645	=	Thermal melting change	degrees C	8.8	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	8.8
	15266205	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	O=C1Nc2ccc(S(=O)(=O)O)cc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL440411	=	Thermal melting change	degrees C	8.8	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	8.8
	15266217	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	O=C1CC(=O)c2[nH]c3c4[nH]c5c(c4c4cn(Br)cc4c3c2C1)CCC=C5		CHEMBL264685	=	Thermal melting change	degrees C	3.6	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	3.6
	15266277	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Thermal melting change	degrees C	-3.5	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	-3.5
	15266337	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Thermal melting change	degrees C	7.1	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	7.1
	15266397	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	O=C1Nc2ccccc2/C1=C\c1ccc[nH]1		CHEMBL101797	=	Thermal melting change	degrees C	3.3	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	3.3
	15266512	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	CC(=O)O/N=C1C(=C2/C(=O)Nc3cc(Br)ccc32)/Nc2ccccc2/1		CHEMBL430226	=	Thermal melting change	degrees C	9.4	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	9.4
	15266572	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Thermal melting change	degrees C	8.7	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	8.7
	15266632	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	CC(=O)O.Cn1cc(C2=C(c3cn(CCCN)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL3430781	=	Thermal melting change	degrees C	11.9	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	11.9
	15266692	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Thermal melting change	degrees C	7.8	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	7.8
	15266705	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12		CHEMBL50	=	Thermal melting change	degrees C	7.8	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	7.8
	15266765	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Thermal melting change	degrees C	0.4	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	0.4
	15266825	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Thermal melting change	degrees C	8.7	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	8.7
	15266885	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Thermal melting change	degrees C	1.9	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	1.9
	15266945	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Thermal melting change	degrees C	2.2	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	2.2
	15267000	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	CS(=O)(=O)O.Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL1591531	=	Thermal melting change	degrees C	12.8	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	12.8
	15267060	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	Cl.Cn1cc(C2=C(c3ccc4cc5n(c4c3)CCC(CN)C5)C(=O)NC2=O)c2ccccc21		CHEMBL541401	=	Thermal melting change	degrees C	6.7	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	6.7
	15267120	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	CN(C)CC1CCn2c(c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc32)C1		CHEMBL372585	=	Thermal melting change	degrees C	9.2	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	9.2
	15267180	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	CN[C@@H]1CC2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL162	=	Thermal melting change	degrees C	7.9	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	7.9
	15267253	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Thermal melting change	degrees C	0.8	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	0.8
	15267313	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	COc1cc2ncnc(Nc3cccc(O)c3)c2cc1OC		CHEMBL127907	=	Thermal melting change	degrees C	2.2	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	2.2
	15267373	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Thermal melting change	degrees C	4.7	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	4.7
	15267433	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Thermal melting change	degrees C	3.5	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	3.5
	15267488	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	O=c1sn(Cc2ccccc2)c(=S)n1Cc1ccccc1		CHEMBL24338	=	Thermal melting change	degrees C	-1.0	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	-1.0
	15267548	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	C=CNC#N		CHEMBL259526	=	Thermal melting change	degrees C	0.5	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	0.5
	15267608	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(/N)Sc1ccccc1N		CHEMBL100473	=	Thermal melting change	degrees C	-1.1	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	-1.1
	15267668	CHEMBL3430810	Delta TM value showing the stabilisation of GSK3B produced by compound binding	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Thermal melting change	degrees C	0.6	CHEMBL262	Homo sapiens	Thermal melting change	degrees C	0.6
	15463083	CHEMBL3533961	Inhibition of GSK3beta (unknown origin)	B	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2		CHEMBL362558	=	IC50	nM	0.9	CHEMBL262	Homo sapiens	IC50	nM	0.9
	15600499	CHEMBL3580033	Inhibition of human GSK3beta assessed as residual activity at 10 uM relative to control	B	Nc1ncnc2c1c(-c1ccc(Cl)cc1)nn2CC(Cl)c1ccccc1		CHEMBL3578214	=	Activity	%	66.0	CHEMBL262	Homo sapiens	Activity	%	66.0
Dose-dependent effect	15617882	CHEMBL3584608	Activation of GSK-3beta in HEK293 cells assessed as suppression of TCF/beta-catenin transcriptional activity after 24 hrs by SuperTOPFlash reporter gene assay	B	O=c1ccc2nccc3c4ccc(O)cc4n1c23		CHEMBL444160		Activity			CHEMBL262	Homo sapiens	Activity		
Dose-dependent effect	15617883	CHEMBL3584608	Activation of GSK-3beta in HEK293 cells assessed as suppression of TCF/beta-catenin transcriptional activity after 24 hrs by SuperTOPFlash reporter gene assay	B	CC(=O)O[C@@H]1C[C@H]2C(C)(C)C(=O)C=C[C@]2(C)[C@H]2CC[C@]3(C)C(=CC[C@H]3[C@H]3COC(=O)C3)[C@]12C		CHEMBL1774404		Activity			CHEMBL262	Homo sapiens	Activity		
Dose-dependent effect	15617884	CHEMBL3584608	Activation of GSK-3beta in HEK293 cells assessed as suppression of TCF/beta-catenin transcriptional activity after 24 hrs by SuperTOPFlash reporter gene assay	B	O=c1ccc2nccc3c4ccc(O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)cc4n1c23		CHEMBL3120496		Activity			CHEMBL262	Homo sapiens	Activity		
	15617885	CHEMBL3584608	Activation of GSK-3beta in HEK293 cells assessed as suppression of TCF/beta-catenin transcriptional activity after 24 hrs by SuperTOPFlash reporter gene assay	B	O=c1ccc2nccc3c4ccc(O)cc4n1c23		CHEMBL444160	=	IC50	nM	6800.0	CHEMBL262	Homo sapiens	IC50	uM	6.8
	15617886	CHEMBL3584608	Activation of GSK-3beta in HEK293 cells assessed as suppression of TCF/beta-catenin transcriptional activity after 24 hrs by SuperTOPFlash reporter gene assay	B	CC(=O)O[C@@H]1C[C@H]2C(C)(C)C(=O)C=C[C@]2(C)[C@H]2CC[C@]3(C)C(=CC[C@H]3[C@H]3COC(=O)C3)[C@]12C		CHEMBL1774404	=	IC50	nM	3000.0	CHEMBL262	Homo sapiens	IC50	uM	3.0
	15617887	CHEMBL3584608	Activation of GSK-3beta in HEK293 cells assessed as suppression of TCF/beta-catenin transcriptional activity after 24 hrs by SuperTOPFlash reporter gene assay	B	O=c1ccc2nccc3c4ccc(O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)cc4n1c23		CHEMBL3120496	=	IC50	nM	11600.0	CHEMBL262	Homo sapiens	IC50	uM	11.6
Active	15617888	CHEMBL3584612	Activation of GSK-3beta in HEK293T cells assessed as suppression of TCF/beta-catenin transcriptional activity at 5 to 20 uM after 24 hrs by SuperFOPFlash reporter gene assay	B	O=c1ccc2nccc3c4ccc(O)cc4n1c23		CHEMBL444160		Activity			CHEMBL262	Homo sapiens	Activity		
Active	15617889	CHEMBL3584613	Activation of GSK-3beta in HEK293T cells assessed as suppression of TCF/beta-catenin transcriptional activity at 2.5 to 10 uM after 24 hrs by SuperFOPFlash reporter gene assay	B	CC(=O)O[C@@H]1C[C@H]2C(C)(C)C(=O)C=C[C@]2(C)[C@H]2CC[C@]3(C)C(=CC[C@H]3[C@H]3COC(=O)C3)[C@]12C		CHEMBL1774404		Activity			CHEMBL262	Homo sapiens	Activity		
Active	15617890	CHEMBL3584614	Activation of GSK-3beta in HEK293T cells assessed as suppression of TCF/beta-catenin transcriptional activity at 10 to 40 uM after 24 hrs by SuperFOPFlash reporter gene assay	B	O=c1ccc2nccc3c4ccc(O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)cc4n1c23		CHEMBL3120496		Activity			CHEMBL262	Homo sapiens	Activity		
Active	15617914	CHEMBL3582544	Activation of GSK-3beta in human SW480 cells assessed as downregulation of beta-catenin expression in cytosolic fraction at 10 to 30 uM after 24 hrs by Western blot analysis	B	O=c1ccc2nccc3c4ccc(O)cc4n1c23		CHEMBL444160		Activity			CHEMBL262	Homo sapiens	Activity		
Active	15617915	CHEMBL3582545	Activation of GSK-3beta in human SW480 cells assessed as downregulation of beta-catenin expression in nuclear fraction at 10 to 30 uM after 24 hrs by Western blot analysis	B	O=c1ccc2nccc3c4ccc(O)cc4n1c23		CHEMBL444160		Activity			CHEMBL262	Homo sapiens	Activity		
Active	15617916	CHEMBL3582546	Activation of GSK-3beta in human SW480 cells assessed as increase in phosphorylation of beta-catenin at Ser33 at 10 to 30 uM after 24 hrs by Western blot analysis	B	O=c1ccc2nccc3c4ccc(O)cc4n1c23		CHEMBL444160		Activity			CHEMBL262	Homo sapiens	Activity		
Active	15617917	CHEMBL3582547	Activation of GSK-3beta in human SW480 cells assessed as increase in phosphorylation of beta-catenin at Ser37 at 10 to 30 uM after 24 hrs by Western blot analysis	B	O=c1ccc2nccc3c4ccc(O)cc4n1c23		CHEMBL444160		Activity			CHEMBL262	Homo sapiens	Activity		
Active	15617918	CHEMBL3582548	Activation of GSK-3beta in human SW480 cells assessed as increase in phosphorylation of beta-catenin at Thr41 at 10 to 30 uM after 24 hrs by Western blot analysis	B	O=c1ccc2nccc3c4ccc(O)cc4n1c23		CHEMBL444160		Activity			CHEMBL262	Homo sapiens	Activity		
Active	15617922	CHEMBL3582552	Activation of GSK-3beta in human SW480 cells assessed as increase in phosphorylation of beta-catenin at Ser33 at 30 uM after 24 hrs by Western blot analysis in presence of control siRNA	B	O=c1ccc2nccc3c4ccc(O)cc4n1c23		CHEMBL444160		Activity			CHEMBL262	Homo sapiens	Activity		
Active	15617923	CHEMBL3582553	Activation of GSK-3beta in human SW480 cells assessed as increase in phosphorylation of beta-catenin at Ser37 at 30 uM after 24 hrs by Western blot analysis in presence of control siRNA	B	O=c1ccc2nccc3c4ccc(O)cc4n1c23		CHEMBL444160		Activity			CHEMBL262	Homo sapiens	Activity		
Active	15617924	CHEMBL3582554	Activation of GSK-3beta in human SW480 cells assessed as increase in phosphorylation of beta-catenin at Thr41 at 30 uM after 24 hrs by Western blot analysis in presence of control siRNA	B	O=c1ccc2nccc3c4ccc(O)cc4n1c23		CHEMBL444160		Activity			CHEMBL262	Homo sapiens	Activity		
Not Active	15617925	CHEMBL3582555	Activation of GSK-3beta in human SW480 cells assessed as increase in phosphorylation of beta-catenin at Ser33 at 30 uM after 24 hrs by Western blot analysis in presence of GSK-3beta siRNA	B	O=c1ccc2nccc3c4ccc(O)cc4n1c23		CHEMBL444160		Activity			CHEMBL262	Homo sapiens	Activity		
Not Active	15617926	CHEMBL3582556	Activation of GSK-3beta in human SW480 cells assessed as increase in phosphorylation of beta-catenin at Ser37 at 30 uM after 24 hrs by Western blot analysis in presence of GSK-3beta siRNA	B	O=c1ccc2nccc3c4ccc(O)cc4n1c23		CHEMBL444160		Activity			CHEMBL262	Homo sapiens	Activity		
Not Active	15617927	CHEMBL3582557	Activation of GSK-3beta in human SW480 cells assessed as increase in phosphorylation of beta-catenin at Thr41 at 30 uM after 24 hrs by Western blot analysis in presence of GSK-3beta siRNA	B	O=c1ccc2nccc3c4ccc(O)cc4n1c23		CHEMBL444160		Activity			CHEMBL262	Homo sapiens	Activity		
Active	15617928	CHEMBL3582558	Inhibition of GSK-3beta phosphorylation at Ser9 in human SW480 cells at 30 uM after 24 hrs by Western blot analysis in presence of control and GSK-3beta siRNA	B	O=c1ccc2nccc3c4ccc(O)cc4n1c23		CHEMBL444160		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	15617930	CHEMBL3582560	Activation of GSK-3beta in human SW480 cells assessed as increase in phosphorylation of beta-catenin at Ser33 at 30 uM after 24 hrs by Western blot analysis in presence of CK1alpha siRNA	B	O=c1ccc2nccc3c4ccc(O)cc4n1c23		CHEMBL444160		Activity			CHEMBL262	Homo sapiens	Activity		
Active	15617931	CHEMBL3582561	Activation of GSK-3beta in human SW480 cells assessed as increase in phosphorylation of beta-catenin at Ser37 at 30 uM after 24 hrs by Western blot analysis in presence of CK1alpha siRNA	B	O=c1ccc2nccc3c4ccc(O)cc4n1c23		CHEMBL444160		Activity			CHEMBL262	Homo sapiens	Activity		
Active	15617932	CHEMBL3582562	Activation of GSK-3beta in human SW480 cells assessed as increase in phosphorylation of beta-catenin at Thr41 at 30 uM after 24 hrs by Western blot analysis in presence of CK1alpha siRNA	B	O=c1ccc2nccc3c4ccc(O)cc4n1c23		CHEMBL444160		Activity			CHEMBL262	Homo sapiens	Activity		
Active	15617933	CHEMBL3582563	Inhibition of GSK-3beta phosphorylation at Ser9 in human SW480 cells at 30 uM after 24 hrs by Western blot analysis in presence of CK1alpha siRNA	B	O=c1ccc2nccc3c4ccc(O)cc4n1c23		CHEMBL444160		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	15619072	CHEMBL3583839	Binding affinity to GSK-3beta receptor (unknown origin) at 10 uM	B	COc1ccc2[nH]cc(CCc3nnc(C)o3)c2c1		CHEMBL3580916		Activity			CHEMBL262	Homo sapiens	Activity		
	15627195	CHEMBL3587037	Inhibition of GSK3beta (unknown origin) using ATP and GSM peptide substrate by radiometric peptide assay	B	COc1cc(N2CCc3nc(NC(=O)NCCc4cn(CC(F)F)cn4)sc3C2)cnc1Cl		CHEMBL3585362	>	Ki	nM	4000.0	CHEMBL262	Homo sapiens	Ki	uM	4.0
	15627196	CHEMBL3587037	Inhibition of GSK3beta (unknown origin) using ATP and GSM peptide substrate by radiometric peptide assay	B	COc1cncc(N2CCc3nc(NC(=O)NCCc4cn(CC(F)F)cn4)sc3C2)n1		CHEMBL3586678	>	Ki	nM	4000.0	CHEMBL262	Homo sapiens	Ki	uM	4.0
	15637796	CHEMBL3591968	Inhibition of GSK-3beta (unknown origin) at 1 uM preincubated for 5 mins with enzyme and substrate followed by ATP addition relative to control	B	CN(C)CC(=O)N1CCC(c2nc(-c3cnc(N)c(-n4nnc5ccccc54)n3)n(C)n2)CC1		CHEMBL3590222	=	Inhibition	%	60.0	CHEMBL262	Homo sapiens	INH	%	60.0
	15649104	CHEMBL3595089	Inhibition of GSK3beta (unknown origin)	B	N#Cc1ccc(N2CC[C@@H](Nc3c(C(N)=O)cnc4[nH]ccc34)[C@@H](F)C2)nc1		CHEMBL3593777	=	IC50	nM	980.0	CHEMBL262	Homo sapiens	IC50	nM	980.0
	15650147	CHEMBL3595413	Inhibition of human GSK3B at 0.1 uM relative to control	B	CCc1cc(NC(=O)Nc2ccc(-c3cnc(Nc4cc(N5CCN(CC)CC5)nc(C)n4)s3)cc2)no1		CHEMBL3593290	=	Inhibition	%	44.0	CHEMBL262	Homo sapiens	INH	%	44.0
	15654946	CHEMBL3599522	Inhibition of GSK3beta (unknown origin) at 0.5 uM relative to control	B	Nc1nccc(-c2c[nH]c3ccccc23)n1		CHEMBL48082	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	INH	%	0.0
	15654947	CHEMBL3599522	Inhibition of GSK3beta (unknown origin) at 0.5 uM relative to control	B	Nc1nccc(-c2cn(C(=O)N3CCOCC3)c3ccc(Br)cc23)n1		CHEMBL3133762	=	Inhibition	%	22.7	CHEMBL262	Homo sapiens	INH	%	22.7
	15654948	CHEMBL3599522	Inhibition of GSK3beta (unknown origin) at 0.5 uM relative to control	B	Cc1noc(C)c1Cn1cc(-c2ccnc(N)n2)c2ccccc21		CHEMBL3133770	=	Inhibition	%	6.1	CHEMBL262	Homo sapiens	INH	%	6.1
	15665859	CHEMBL3602855	Inhibition of recombinant GSK3B (unknown origin) at 1 uM after 3 hrs	B	CS(=O)(=O)NCc1ccc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nn12		CHEMBL3601472	=	Inhibition	%	-2.0	CHEMBL262	Homo sapiens	INH	%	-2.0
	15679009	CHEMBL3607101	Inhibition of GSK3beta (unknown origin) by radiometric filter binding assay	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	<	IC50	nM	200.0	CHEMBL262	Homo sapiens	IC50	nM	200.0
	15685887	CHEMBL3607963	Inhibition of human GSK3beta	B	NC(=O)c1cc(F)cc2c1C(=O)N(C1CCN(C3CCC(F)(F)CC3)CC1)C2		CHEMBL3606021	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	15686150	CHEMBL3606894	Inhibition of GSK3beta (unknown origin) at 250 nM by radioactive filter-binding assay	B	c1ccc2c(Nc3cc(C4CCC4)[nH]n3)nc(Nc3ccc4[nH]cnc4c3)nc2c1		CHEMBL3605055	>=	Inhibition	%	80.0	CHEMBL262	Homo sapiens	INH	%	80.0
	15711738	CHEMBL3615655	Inhibition of GSK3beta (unknown origin) assessed as residual enzyme activity at 200 nM	B	Cc1ccc(C#N)cc1S(=O)(=O)N(C)CCc1cnn2ccc(Cl)nc12		CHEMBL3612513	=	Activity	%	34.0	CHEMBL262	Homo sapiens	Activity	%	34.0
	15723393	CHEMBL3620001	Inhibition of GSK3b (unknown origin) at 10 uM after 40 mins by scintillation counting analysis	B	Cc1ccc(NC(=O)c2cc(N3CCN(C)CC3)cc(C(F)(F)F)c2)cc1NC(=O)c1cnoc1C		CHEMBL3616960	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	INH	%	0.0
Not Active	15723394	CHEMBL3620001	Inhibition of GSK3b (unknown origin) at 10 uM after 40 mins by scintillation counting analysis	B	Cc1ccccc1C(=O)Nc1cnoc1C		CHEMBL3616990		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	15723441	CHEMBL3620031	Inhibition of GSK3b (unknown origin) after 40 mins by scintillation counting analysis	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	2.62	CHEMBL262	Homo sapiens	IC50	nM	2.62
	15735998	CHEMBL3625842	Inhibition of human recombinant GSK3beta	B	CN(C)CCCNC(=O)c1csc2nc(-c3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)cn12		CHEMBL3623375	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	15747318	CHEMBL3624069	Inhibition of GSK3beta (unknown origin) assessed as residual enzyme activity at 10 uM by kinaseprolier assay	B	NCCn1c(C2CCNCC2)nc2cc(C(N)=O)ccc21		CHEMBL3622826	>	Activity	%	65.0	CHEMBL262	Homo sapiens	Activity	%	65.0
	15754937	CHEMBL3631829	Inhibition of GSK3beta (unknown origin) at 1 uM by FRET method	B	N#Cc1ccnc(Nc2cc(C3CCN(C4COC4)CC3)n(C3CCCC3)n2)c1		CHEMBL3629013	=	Inhibition	%	58.6	CHEMBL262	Homo sapiens	INH	%	58.6
	15754949	CHEMBL3631841	Inhibition of GSK3beta (unknown origin) by FRET method	B	N#Cc1ccnc(Nc2cc(C3CCN(C4COC4)CC3)n(C3CCCC3)n2)c1	Outside typical range	CHEMBL3629013	=	IC50	nM	682000.0	CHEMBL262	Homo sapiens	IC50	mM	0.682
	15755883	CHEMBL3630660	Inhibition of GSK3B (unknown origin) assessed as remaining activity at 10 uM by high-throughput assay relative to control	B	O=C1c2ccccc2-c2c1oc1ccccc1c2=O		CHEMBL3629616	=	Activity	%	77.0	CHEMBL262	Homo sapiens	Activity	%	77.0
	15756966	CHEMBL3630517	Inhibition of GSK3beta (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	34.92	CHEMBL262	Homo sapiens	INH	%	34.92
	15757757	CHEMBL3630517	Inhibition of GSK3beta (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	98.86	CHEMBL262	Homo sapiens	INH	%	98.86
	15758736	CHEMBL3630517	Inhibition of GSK3beta (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	16.86	CHEMBL262	Homo sapiens	INH	%	16.86
	15770159	CHEMBL3635554	Inhibition of human recombinant GSK-3 beta using Ulight-CFFKNIVTPRTPPPSQGK-amide substrate incubated for 90 mins by LANCE method relative to control	B	NC(=O)c1cc(F)ccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL3632824	=	IC50	nM	140.0	CHEMBL262	Homo sapiens	IC50	nM	140.0
	15770160	CHEMBL3635554	Inhibition of human recombinant GSK-3 beta using Ulight-CFFKNIVTPRTPPPSQGK-amide substrate incubated for 90 mins by LANCE method relative to control	B	N#Cc1cc(F)ccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL2064535	>	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	nM	1000.0
Not Active	15770207	CHEMBL3635564	Inhibition of GSK-3 beta in human HL-60 cells assessed as reduction in GSK-3 beta Tyr 216 phosphorylation up to 20 uM after 24 hrs by immunoblotting	B	NC(=O)c1cc(F)ccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL3632824		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	15770208	CHEMBL3635565	Inhibition of GSK-3 beta in human NB4 cells assessed as reduction in GSK-3 beta Tyr 216 phosphorylation up to 20 uM after 24 hrs by immunoblotting	B	NC(=O)c1cc(F)ccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL3632824		Inhibition	%		CHEMBL262	Homo sapiens	INH		
244253	16260652	CHEMBL3707931	Inhibition Assay: Compounds are screened for their ability to inhibit the phosphorylation of tyrosine (TYR) residues through the use of western blotting of Jurkat cells dosed with the compounds. The phosphorylation of the specific TYR residues tested are GSK3α TYR 279 and GSK3β TYR 216.	B	Cc1nc(C2CCOCC2)nc(Nc2n[nH]c3ncc(F)cc23)c1C		CHEMBL3652542	=	IC50	nM	800.0	CHEMBL262	Homo sapiens	IC50	nM	800.0
198670	16263230	CHEMBL3707625	Kinase Assay: The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory concentration (IC50) values determined by Millipore UK Ltd; Gemini Crescent; Dundee Technology Park; Dundee DD2 1SW; UK (IC50Profiler). Detailed protocols can be found at: www.millipore.com/drugdiscovery/dd3/assayprotocols.	B	COc1cc(C2=C(c3cn(CCCO)c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL3699446	=	IC50	nM	2254.0	CHEMBL262	Homo sapiens	IC50	nM	2254.0
251329	16266150	CHEMBL3708002	Inhibition Assay: Compounds of the present invention were screened for their ability to inhibit GSK-3β (AA 1-420) activity using a standard coupled enzyme system (Fox et al., Protein Sci. 1998, 7, 2249). Reactions were carried out in a solution containing 100 mM HEPES (pH 7.5), 10 mM MgCl2, 25 mM NaCl, 300 μM NADH, 1 mM DTT and 1.5% DMSO. Final substrate concentrations in the assay were 20 μM ATP (Sigma Chemicals, St Louis, Mo.) and 300 μM peptide (American Peptide, Sunnyvale, Calif.). Reactions were carried out at 30 C. and 20 nM GSK-3β. Final concentrations of the components of the coupled enzyme system were 2.5 mM phosphoenolpyruvate, 300 μM NADH, 30 μg/ml pyruvate kinase and 10 μg/ml lactate dehydrogenase.	B	Cc1cc(-c2ccccc2Cl)nc(Nc2n[nH]c3ncc(F)cc23)c1C		CHEMBL3661032	=	IC50	nM	300.0	CHEMBL262	Homo sapiens	IC50	nM	300.0
318296	16267924	CHEMBL3707581	HTS Assay: The GSK3beta primary screen was conducted in assay ready 1536 plates (Aurora 29847) that contain 2.5 mL/well of 10 mM compound. Human GSK3beta as a GST fusion expressed in baculoviral system was purchased from BPS Bioscience (San Diego, Calif.). The GSK3beta peptide substrate was from American Peptide (Sunnyvale, Calif.; Cat 311153). 1 L/well of CABPE (22.5 nM GSK3beta , 8 uM peptide in AB buffer (12.5 mM DTT, 0.25 mg/mL BSA, 0.5 unit/mL Heparin)), 0.5 L/well of 125 uM of ATP, and 1 L/well of positive control 50 uM of GW8510 (positive control) or AB (DMSO only neutral control) in respective wells according to plate design using BioRAPTR (Beckman, Brea, Calif.). Reactions were incubated at room temperature for 60 minutes. 2.5 uL/well of ADP-Glo (Promega, V9103) was added with BioRAPTR, and incubated at room temperature for 40 minutes followed by addition of 5 uL/well of ADP-Glo detection reagent (Promega, V9103) with Combi nL (Thermo, Waltham, Mass.).	B	Cc1[nH]nc2c1[C@H](c1ccccc1)C1=C(CC(C)(C)CC1=O)N2		CHEMBL3673983	=	IC50	nM	232.0	CHEMBL262	Homo sapiens	IC50	nM	232.0
244254	16273441	CHEMBL3707931	Inhibition Assay: Compounds are screened for their ability to inhibit the phosphorylation of tyrosine (TYR) residues through the use of western blotting of Jurkat cells dosed with the compounds. The phosphorylation of the specific TYR residues tested are GSK3α TYR 279 and GSK3β TYR 216.	B	Cc1cc(Nc2n[nH]c3ncc(F)cc23)nc(C2CCCCCC2)n1		CHEMBL3652543	=	IC50	nM	10.0	CHEMBL262	Homo sapiens	IC50	nM	10.0
244252	16276359	CHEMBL3707931	Inhibition Assay: Compounds are screened for their ability to inhibit the phosphorylation of tyrosine (TYR) residues through the use of western blotting of Jurkat cells dosed with the compounds. The phosphorylation of the specific TYR residues tested are GSK3α TYR 279 and GSK3β TYR 216.	B	Cc1nc(Nc2n[nH]c3ncc(F)cc23)cc(C2CCC(F)(F)CC2)n1		CHEMBL3652541	=	IC50	nM	20.0	CHEMBL262	Homo sapiens	IC50	nM	20.0
198676	16280314	CHEMBL3707625	Kinase Assay: The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory concentration (IC50) values determined by Millipore UK Ltd; Gemini Crescent; Dundee Technology Park; Dundee DD2 1SW; UK (IC50Profiler). Detailed protocols can be found at: www.millipore.com/drugdiscovery/dd3/assayprotocols.	B	COc1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL201511	>	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	nM	1000.0
244256	16280935	CHEMBL3707931	Inhibition Assay: Compounds are screened for their ability to inhibit the phosphorylation of tyrosine (TYR) residues through the use of western blotting of Jurkat cells dosed with the compounds. The phosphorylation of the specific TYR residues tested are GSK3α TYR 279 and GSK3β TYR 216.	B	Cc1cc(Nc2n[nH]c3ncc(F)cc23)nc(C2CCCCC2)n1		CHEMBL3652545	=	IC50	nM	6.0	CHEMBL262	Homo sapiens	IC50	nM	6.0
244251	16281301	CHEMBL3707931	Inhibition Assay: Compounds are screened for their ability to inhibit the phosphorylation of tyrosine (TYR) residues through the use of western blotting of Jurkat cells dosed with the compounds. The phosphorylation of the specific TYR residues tested are GSK3α TYR 279 and GSK3β TYR 216.	B	Cc1nc(C2CCCCC2)nc(Nc2n[nH]c3ncc(F)cc23)c1C		CHEMBL3652540	=	IC50	nM	13.0	CHEMBL262	Homo sapiens	IC50	nM	13.0
284792	16284740	CHEMBL3707625	Kinase Assay: The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory concentration (IC50) values determined by Millipore UK Ltd; Gemini Crescent; Dundee Technology Park; Dundee DD2 1SW; UK (IC50Profiler). Detailed protocols can be found at: www.millipore.com/drugdiscovery/dd3/assayprotocols.	B	COc1cc(C2=C(c3cn(CCCOC(=O)C(N)CC(C)C)c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL3699443	=	IC50	nM	134.0	CHEMBL262	Homo sapiens	IC50	nM	134.0
244262	16286148	CHEMBL3707931	Inhibition Assay: Compounds are screened for their ability to inhibit the phosphorylation of tyrosine (TYR) residues through the use of western blotting of Jurkat cells dosed with the compounds. The phosphorylation of the specific TYR residues tested are GSK3α TYR 279 and GSK3β TYR 216.	B	CC(C)(O)c1cc(Nc2n[nH]c3ncc(F)cc23)nc(C2CCCCC2)n1		CHEMBL3652550	=	IC50	nM	20.0	CHEMBL262	Homo sapiens	IC50	nM	20.0
244261	16297576	CHEMBL3707931	Inhibition Assay: Compounds are screened for their ability to inhibit the phosphorylation of tyrosine (TYR) residues through the use of western blotting of Jurkat cells dosed with the compounds. The phosphorylation of the specific TYR residues tested are GSK3α TYR 279 and GSK3β TYR 216.	B	Cc1cc(Nc2c[nH]c3ncc(F)cc23)nc(C23CC4CC(CC(C4)C2)C3)n1		CHEMBL3652549	=	IC50	nM	20.0	CHEMBL262	Homo sapiens	IC50	nM	20.0
284791	16299974	CHEMBL3707625	Kinase Assay: The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory concentration (IC50) values determined by Millipore UK Ltd; Gemini Crescent; Dundee Technology Park; Dundee DD2 1SW; UK (IC50Profiler). Detailed protocols can be found at: www.millipore.com/drugdiscovery/dd3/assayprotocols.	B	COc1cc(C2=C(c3cn(CCCNC(=O)C(N)CC(C)C)c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL3699445	=	IC50	nM	208.0	CHEMBL262	Homo sapiens	IC50	nM	208.0
308360	16301142	CHEMBL3707652	In Vitro Kinase Inhibition Assay: In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services providers in order to offer in vitro kinase activity assay services, e.g. the assays offered by Millipore Inc. (worldwide website www(dot)millipore.com), ProQinase GmbH (worldwide website www(dot)proqinase.de) and others. All kinase assays were performed in 96-well FlashPlates from Perkin Elmer/NEN (Boston, Mass., USA) in a 50ul reaction volume. The reaction mixture was pipetted in four steps in the following order: 20ul of assay buffer (standard buffer),5ul of ATP solution (in H2O, 5 ul of test compound (in 10% DMSO), 10ul of substrate/10ul of enzyme solution (premixed)The assay for all enzymes contained 60 mM HEPES-NaOH (pH 7.5), 3 mM MgCl2, 3 mM MnCl2, 3uM Na-Orthovanadate, 1.2 mM DTT, 50 ug/ml PEG2000, 1 uM [33P]-ATP (approx. 5x1005 cpm per well).	B	COc1cc(F)ccc1-c1ccnc(NC(=O)[C@H]2CCC[C@@H](NC(C)=O)C2)c1		CHEMBL3673434	=	IC50	nM	903.0	CHEMBL262	Homo sapiens	IC50	nM	903.0
251330	16301166	CHEMBL3708002	Inhibition Assay: Compounds of the present invention were screened for their ability to inhibit GSK-3β (AA 1-420) activity using a standard coupled enzyme system (Fox et al., Protein Sci. 1998, 7, 2249). Reactions were carried out in a solution containing 100 mM HEPES (pH 7.5), 10 mM MgCl2, 25 mM NaCl, 300 μM NADH, 1 mM DTT and 1.5% DMSO. Final substrate concentrations in the assay were 20 μM ATP (Sigma Chemicals, St Louis, Mo.) and 300 μM peptide (American Peptide, Sunnyvale, Calif.). Reactions were carried out at 30 C. and 20 nM GSK-3β. Final concentrations of the components of the coupled enzyme system were 2.5 mM phosphoenolpyruvate, 300 μM NADH, 30 μg/ml pyruvate kinase and 10 μg/ml lactate dehydrogenase.	B	Cc1cc(Nc2n[nH]c3ncc(F)cc23)nc(-c2ccccc2)c1C		CHEMBL3661033	=	IC50	nM	20.0	CHEMBL262	Homo sapiens	IC50	nM	20.0
308361	16307704	CHEMBL3707652	In Vitro Kinase Inhibition Assay: In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services providers in order to offer in vitro kinase activity assay services, e.g. the assays offered by Millipore Inc. (worldwide website www(dot)millipore.com), ProQinase GmbH (worldwide website www(dot)proqinase.de) and others. All kinase assays were performed in 96-well FlashPlates from Perkin Elmer/NEN (Boston, Mass., USA) in a 50ul reaction volume. The reaction mixture was pipetted in four steps in the following order: 20ul of assay buffer (standard buffer),5ul of ATP solution (in H2O, 5 ul of test compound (in 10% DMSO), 10ul of substrate/10ul of enzyme solution (premixed)The assay for all enzymes contained 60 mM HEPES-NaOH (pH 7.5), 3 mM MgCl2, 3 mM MnCl2, 3uM Na-Orthovanadate, 1.2 mM DTT, 50 ug/ml PEG2000, 1 uM [33P]-ATP (approx. 5x1005 cpm per well).	B	COc1cc(F)ccc1-c1ccnc(NC(=O)C2CCC(NC(C)=O)C2)c1		CHEMBL3673435	=	IC50	nM	857.0	CHEMBL262	Homo sapiens	IC50	nM	857.0
244259	16311062	CHEMBL3707931	Inhibition Assay: Compounds are screened for their ability to inhibit the phosphorylation of tyrosine (TYR) residues through the use of western blotting of Jurkat cells dosed with the compounds. The phosphorylation of the specific TYR residues tested are GSK3α TYR 279 and GSK3β TYR 216.	B	Cc1cc(Nc2n[nH]c3ncc(F)cc23)nc(C2CCOCC2)n1		CHEMBL3652547	=	IC50	nM	30.0	CHEMBL262	Homo sapiens	IC50	nM	30.0
244255	16311751	CHEMBL3707931	Inhibition Assay: Compounds are screened for their ability to inhibit the phosphorylation of tyrosine (TYR) residues through the use of western blotting of Jurkat cells dosed with the compounds. The phosphorylation of the specific TYR residues tested are GSK3α TYR 279 and GSK3β TYR 216.	B	Cc1cc(Nc2n[nH]c3ncc(F)cc23)nc(C2CCCC2)n1		CHEMBL3652544	=	IC50	nM	48.0	CHEMBL262	Homo sapiens	IC50	nM	48.0
251328	16313823	CHEMBL3708002	Inhibition Assay: Compounds of the present invention were screened for their ability to inhibit GSK-3β (AA 1-420) activity using a standard coupled enzyme system (Fox et al., Protein Sci. 1998, 7, 2249). Reactions were carried out in a solution containing 100 mM HEPES (pH 7.5), 10 mM MgCl2, 25 mM NaCl, 300 μM NADH, 1 mM DTT and 1.5% DMSO. Final substrate concentrations in the assay were 20 μM ATP (Sigma Chemicals, St Louis, Mo.) and 300 μM peptide (American Peptide, Sunnyvale, Calif.). Reactions were carried out at 30 C. and 20 nM GSK-3β. Final concentrations of the components of the coupled enzyme system were 2.5 mM phosphoenolpyruvate, 300 μM NADH, 30 μg/ml pyruvate kinase and 10 μg/ml lactate dehydrogenase.	B	Cc1cc(Nc2n[nH]c3ncc(F)cc23)nc(-c2ccccc2Cl)c1		CHEMBL3661031	=	IC50	nM	30.0	CHEMBL262	Homo sapiens	IC50	nM	30.0
284793	16318645	CHEMBL3707625	Kinase Assay: The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory concentration (IC50) values determined by Millipore UK Ltd; Gemini Crescent; Dundee Technology Park; Dundee DD2 1SW; UK (IC50Profiler). Detailed protocols can be found at: www.millipore.com/drugdiscovery/dd3/assayprotocols.	B	COc1cc(C2=C(c3cn(CCOC(=O)C(N)CC(C)C)c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL3699444	=	IC50	nM	12.0	CHEMBL262	Homo sapiens	IC50	nM	12.0
244258	16328729	CHEMBL3707931	Inhibition Assay: Compounds are screened for their ability to inhibit the phosphorylation of tyrosine (TYR) residues through the use of western blotting of Jurkat cells dosed with the compounds. The phosphorylation of the specific TYR residues tested are GSK3α TYR 279 and GSK3β TYR 216.	B	Cc1cc(Nc2n[nH]c3ncc(F)cc23)nc(C2CCCCCC2)n1		CHEMBL3652543	=	IC50	nM	83.0	CHEMBL262	Homo sapiens	IC50	nM	83.0
244263	16330032	CHEMBL3707931	Inhibition Assay: Compounds are screened for their ability to inhibit the phosphorylation of tyrosine (TYR) residues through the use of western blotting of Jurkat cells dosed with the compounds. The phosphorylation of the specific TYR residues tested are GSK3α TYR 279 and GSK3β TYR 216.	B	Cc1cc(Nc2n[nH]c3ccc(F)cc23)nc(C2CCCCC2)n1		CHEMBL3652551	=	IC50	nM	25.0	CHEMBL262	Homo sapiens	IC50	nM	25.0
251326	16334535	CHEMBL3708002	Inhibition Assay: Compounds of the present invention were screened for their ability to inhibit GSK-3β (AA 1-420) activity using a standard coupled enzyme system (Fox et al., Protein Sci. 1998, 7, 2249). Reactions were carried out in a solution containing 100 mM HEPES (pH 7.5), 10 mM MgCl2, 25 mM NaCl, 300 μM NADH, 1 mM DTT and 1.5% DMSO. Final substrate concentrations in the assay were 20 μM ATP (Sigma Chemicals, St Louis, Mo.) and 300 μM peptide (American Peptide, Sunnyvale, Calif.). Reactions were carried out at 30 C. and 20 nM GSK-3β. Final concentrations of the components of the coupled enzyme system were 2.5 mM phosphoenolpyruvate, 300 μM NADH, 30 μg/ml pyruvate kinase and 10 μg/ml lactate dehydrogenase.	B	Fc1cnc2[nH]nc(Nc3cc(C(F)(F)F)cc(-c4ccccc4Cl)n3)c2c1		CHEMBL3661029	=	IC50	nM	50.0	CHEMBL262	Homo sapiens	IC50	nM	50.0
318301	16335910	CHEMBL3707581	HTS Assay: The GSK3beta primary screen was conducted in assay ready 1536 plates (Aurora 29847) that contain 2.5 mL/well of 10 mM compound. Human GSK3beta as a GST fusion expressed in baculoviral system was purchased from BPS Bioscience (San Diego, Calif.). The GSK3beta peptide substrate was from American Peptide (Sunnyvale, Calif.; Cat 311153). 1 L/well of CABPE (22.5 nM GSK3beta , 8 uM peptide in AB buffer (12.5 mM DTT, 0.25 mg/mL BSA, 0.5 unit/mL Heparin)), 0.5 L/well of 125 uM of ATP, and 1 L/well of positive control 50 uM of GW8510 (positive control) or AB (DMSO only neutral control) in respective wells according to plate design using BioRAPTR (Beckman, Brea, Calif.). Reactions were incubated at room temperature for 60 minutes. 2.5 uL/well of ADP-Glo (Promega, V9103) was added with BioRAPTR, and incubated at room temperature for 40 minutes followed by addition of 5 uL/well of ADP-Glo detection reagent (Promega, V9103) with Combi nL (Thermo, Waltham, Mass.).	B	COc1ccccc1C1C2=C(CC(C)(C)CC2=O)Nc2n[nH]c(C)c21		CHEMBL3673984	=	IC50	nM	61.0	CHEMBL262	Homo sapiens	IC50	nM	61.0
244260	16339402	CHEMBL3707931	Inhibition Assay: Compounds are screened for their ability to inhibit the phosphorylation of tyrosine (TYR) residues through the use of western blotting of Jurkat cells dosed with the compounds. The phosphorylation of the specific TYR residues tested are GSK3α TYR 279 and GSK3β TYR 216.	B	Cc1cc(Nc2n[nH]c3ncc(F)cc23)nc([C@H]2CCCC[C@@H]2C)n1		CHEMBL3652548	=	IC50	nM	300.0	CHEMBL262	Homo sapiens	IC50	nM	300.0
244257	16339669	CHEMBL3707931	Inhibition Assay: Compounds are screened for their ability to inhibit the phosphorylation of tyrosine (TYR) residues through the use of western blotting of Jurkat cells dosed with the compounds. The phosphorylation of the specific TYR residues tested are GSK3α TYR 279 and GSK3β TYR 216.	B	Cc1cc(Nc2n[nH]c3ccc(F)cc23)nc(C2CCOCC2)n1		CHEMBL3652546	=	IC50	nM	200.0	CHEMBL262	Homo sapiens	IC50	nM	200.0
318305	16339771	CHEMBL3707581	HTS Assay: The GSK3beta primary screen was conducted in assay ready 1536 plates (Aurora 29847) that contain 2.5 mL/well of 10 mM compound. Human GSK3beta as a GST fusion expressed in baculoviral system was purchased from BPS Bioscience (San Diego, Calif.). The GSK3beta peptide substrate was from American Peptide (Sunnyvale, Calif.; Cat 311153). 1 L/well of CABPE (22.5 nM GSK3beta , 8 uM peptide in AB buffer (12.5 mM DTT, 0.25 mg/mL BSA, 0.5 unit/mL Heparin)), 0.5 L/well of 125 uM of ATP, and 1 L/well of positive control 50 uM of GW8510 (positive control) or AB (DMSO only neutral control) in respective wells according to plate design using BioRAPTR (Beckman, Brea, Calif.). Reactions were incubated at room temperature for 60 minutes. 2.5 uL/well of ADP-Glo (Promega, V9103) was added with BioRAPTR, and incubated at room temperature for 40 minutes followed by addition of 5 uL/well of ADP-Glo detection reagent (Promega, V9103) with Combi nL (Thermo, Waltham, Mass.).	B	COc1ccccc1C1C2=C(CC(C)(C)CC2=O)Nc2n[nH]c(C(F)(F)F)c21		CHEMBL3673985	=	IC50	nM	12.0	CHEMBL262	Homo sapiens	IC50	nM	12.0
304681	16341652	CHEMBL3707753	Enzyme Inhibition Assay: The kinase enzyme binding activities of compounds disclosed herein were determined using a proprietary assay which measures active site-directed competition binding to an immobilized ligand (Fabian, M. A. et al., Nature Biotechnol., 2005, 23:329-336). These assays were conducted by DiscoverX (formerly Ambit; San Diego, Calif.). The Kd value (Dissociation constant value) was calculated as the index of affinity of the compounds to each kinase. The enzyme inhibitory activities of compounds disclosed herein were determined by FRET using synthetic peptides labelled with both donor and acceptor fluorophores (Z-LYTE, Invitrogen Ltd., Paisley, UK). In all cases, the site-specific protease cleaves non-phosphorylated peptide only and eliminates the FRET signal. Phosphorylation levels of each reaction were calculated using the ratio of coumarin emission (donor) over fluorescein emission (acceptor), for which low ratios indicate high phosphorylation and high ratios indicate low phosphorylation levels.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Oc3ccnc(Nc4ccccc4)n3)c3ccccc23)cc1		CHEMBL3701217	=	Kd	nM	1200.0	CHEMBL262	Homo sapiens	Kd	nM	1200.0
251327	16347446	CHEMBL3708002	Inhibition Assay: Compounds of the present invention were screened for their ability to inhibit GSK-3β (AA 1-420) activity using a standard coupled enzyme system (Fox et al., Protein Sci. 1998, 7, 2249). Reactions were carried out in a solution containing 100 mM HEPES (pH 7.5), 10 mM MgCl2, 25 mM NaCl, 300 μM NADH, 1 mM DTT and 1.5% DMSO. Final substrate concentrations in the assay were 20 μM ATP (Sigma Chemicals, St Louis, Mo.) and 300 μM peptide (American Peptide, Sunnyvale, Calif.). Reactions were carried out at 30 C. and 20 nM GSK-3β. Final concentrations of the components of the coupled enzyme system were 2.5 mM phosphoenolpyruvate, 300 μM NADH, 30 μg/ml pyruvate kinase and 10 μg/ml lactate dehydrogenase.	B	Cc1cc(Nc2n[nH]c3ncc(F)cc23)nc(-c2ccccc2Cl)c1C		CHEMBL3661030	=	IC50	nM	200.0	CHEMBL262	Homo sapiens	IC50	nM	200.0
198673	16350434	CHEMBL3707625	Kinase Assay: The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory concentration (IC50) values determined by Millipore UK Ltd; Gemini Crescent; Dundee Technology Park; Dundee DD2 1SW; UK (IC50Profiler). Detailed protocols can be found at: www.millipore.com/drugdiscovery/dd3/assayprotocols.	B	COc1cc(C2=C(c3cn(CCCO)c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL3699446	=	IC50	nM	3386.0	CHEMBL262	Homo sapiens	IC50	nM	3386.0
	16376452	CHEMBL3734476	Inhibition of recombinant human GSK3beta using fluorescein-labeled peptide as substrate by fluorescence-electrophoretic mobility shift assay	B	Cl.NCCN1C(=O)S/C(=C\CCC2CCCCC2)C1=O		CHEMBL3732044	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	INH	%	0.0
	16379659	CHEMBL3738558	Inhibition of GSK3beta (unknown origin) at 200 nM by electrophoretic mobility shift assay	B	COc1ccc2c(c1CN1CCNCC1)O/C(=C\c1n[nH]c3ncccc13)C2=O		CHEMBL3735816	=	Inhibition	%	76.5	CHEMBL262	Homo sapiens	INH	%	76.5
	16379660	CHEMBL3738558	Inhibition of GSK3beta (unknown origin) at 200 nM by electrophoretic mobility shift assay	B	COc1ccc2c(c1C(C)N1CCNCC1)O/C(=C\c1n[nH]c3ncccc13)C2=O		CHEMBL3735890	=	Inhibition	%	95.0	CHEMBL262	Homo sapiens	INH	%	95.0
	16379703	CHEMBL3736656	Inhibition of GSK3beta (unknown origin) by electrophoretic mobility shift assay	B	COc1ccc2c(c1C(C)N1CCNCC1)O/C(=C\c1n[nH]c3ncccc13)C2=O		CHEMBL3735890	=	IC50	nM	6.1	CHEMBL262	Homo sapiens	IC50	nM	6.1
	16380360	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	COCCN1CCC(CNC(=O)c2n[nH]c3ccc(-c4cccc(F)c4F)cc23)CC1		CHEMBL3735506	=	IC50	nM	18.0	CHEMBL262	Homo sapiens	IC50	nM	18.0
	16380361	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	COCCN1CCC(CNC(=O)c2n[nH]c3ccc(-c4ccccc4C)cc23)CC1		CHEMBL3736396	=	IC50	nM	580.0	CHEMBL262	Homo sapiens	IC50	nM	580.0
	16380362	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	COCCN1CCC(CNC(=O)c2n[nH]c3ccc(-c4ccccc4F)cc23)CC1		CHEMBL3735246	=	IC50	nM	72.0	CHEMBL262	Homo sapiens	IC50	nM	72.0
	16380363	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	COCCN1CCC(CNC(=O)c2n[nH]c3ccc(-c4ccccc4)cc23)CC1		CHEMBL3736164	=	IC50	nM	200.0	CHEMBL262	Homo sapiens	IC50	nM	200.0
Not Determined	16380364	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	COCCN1CCC(CNC(=O)c2n[nH]c3ccc(Br)cc23)CC1		CHEMBL3735359		IC50			CHEMBL262	Homo sapiens	IC50		
	16380365	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	Cc1ccc(-c2ccc3[nH]nc(C(=O)NCC4CCN(CCc5ccccc5)CC4)c3c2)cn1		CHEMBL3736449	=	IC50	nM	40.0	CHEMBL262	Homo sapiens	IC50	nM	40.0
	16380366	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	COc1ccncc1-c1ccc2[nH]nc(C(=O)NCC3CCN(CCc4ccccc4)CC3)c2c1		CHEMBL3735603	=	IC50	nM	20.0	CHEMBL262	Homo sapiens	IC50	nM	20.0
	16380367	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	O=C(NCC1CCN(CCc2ccccc2)CC1)c1n[nH]c2ccc(-c3cccnc3)cc12		CHEMBL3735061	=	IC50	nM	39.0	CHEMBL262	Homo sapiens	IC50	nM	39.0
	16380368	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	O=C(NCC1CCN(CCc2ccccc2)CC1)c1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL3735796	=	IC50	nM	67.0	CHEMBL262	Homo sapiens	IC50	nM	67.0
	16380369	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	O=C(NCC1CCN(CCc2ccccc2)CC1)c1n[nH]c2ccc(-c3ccccc3F)cc12		CHEMBL3736215	=	IC50	nM	112.0	CHEMBL262	Homo sapiens	IC50	nM	112.0
Not Determined	16380370	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	O=C(NCC1CCN(CCc2ccccc2)CC1)c1n[nH]c2ccc(Br)cc12		CHEMBL3735878		IC50			CHEMBL262	Homo sapiens	IC50		
	16380371	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	COc1ccc2[nH]nc(C(=O)NCC3CCN(CCCN4C[C@H](C)O[C@H](C)C4)CC3)c2c1		CHEMBL3734776	=	IC50	nM	2100.0	CHEMBL262	Homo sapiens	IC50	uM	2.1
	16380372	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	COc1ccc2[nH]nc(C(=O)NCC3CCN(CCN4C[C@H](C)O[C@H](C)C4)CC3)c2c1		CHEMBL3735882	=	IC50	nM	1400.0	CHEMBL262	Homo sapiens	IC50	uM	1.4
	16380373	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	COC(=O)c1ccoc1CN1CCC(CNC(=O)c2n[nH]c3ccc(OC)cc23)CC1		CHEMBL3735291	=	IC50	nM	230.0	CHEMBL262	Homo sapiens	IC50	uM	0.23
	16380374	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	COc1ccc2[nH]nc(C(=O)NCC3CCN(Cc4noc(C(N)=O)n4)CC3)c2c1		CHEMBL3735347	=	IC50	nM	490.0	CHEMBL262	Homo sapiens	IC50	uM	0.49
	16380375	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	CCOC(=O)c1nc(CN2CCC(CNC(=O)c3n[nH]c4ccc(OC)cc34)CC2)cs1		CHEMBL3734973	=	IC50	nM	950.0	CHEMBL262	Homo sapiens	IC50	uM	0.95
	16380376	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	COC(=O)c1csc(CN2CCC(CNC(=O)c3n[nH]c4ccc(OC)cc34)CC2)n1		CHEMBL3735579	=	IC50	nM	130.0	CHEMBL262	Homo sapiens	IC50	uM	0.13
	16380377	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	COc1ccc2[nH]nc(C(=O)NCC3CCN(Cc4nc(C(=O)O)cs4)CC3)c2c1		CHEMBL3735779	=	IC50	nM	50.0	CHEMBL262	Homo sapiens	IC50	uM	0.05
	16380378	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	COC(=O)c1coc(CN2CCC(CNC(=O)c3n[nH]c4ccc(OC)cc34)CC2)n1		CHEMBL3735500	=	IC50	nM	210.0	CHEMBL262	Homo sapiens	IC50	uM	0.21
	16380379	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	COc1ccc2[nH]nc(C(=O)NCC3CCN(Cc4nc(C(=O)O)co4)CC3)c2c1		CHEMBL3736086	=	IC50	nM	70.0	CHEMBL262	Homo sapiens	IC50	uM	0.07
	16380380	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	CCOC(=O)c1ccc(CN2CCC(CNC(=O)c3n[nH]c4ccc(OC)cc34)CC2)o1		CHEMBL3735529	=	IC50	nM	330.0	CHEMBL262	Homo sapiens	IC50	uM	0.33
	16380381	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	COc1ccc2[nH]nc(C(=O)NCC3CCN(Cc4ccc(C(=O)O)o4)CC3)c2c1		CHEMBL3736399	=	IC50	nM	400.0	CHEMBL262	Homo sapiens	IC50	uM	0.4
	16380382	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	COc1ccc2[nH]nc(C(=O)NCC3CCN(CCC4CCCC(C)C4)CC3)c2c1		CHEMBL3734911	=	IC50	nM	360.0	CHEMBL262	Homo sapiens	IC50	uM	0.36
	16380383	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	COc1ccc2[nH]nc(C(=O)NCC3CCN(CCc4ccncc4)CC3)c2c1		CHEMBL3735863	=	IC50	nM	510.0	CHEMBL262	Homo sapiens	IC50	uM	0.51
	16380384	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	COc1ccc(CCN2CCC(CNC(=O)c3n[nH]c4ccc(OC)cc34)CC2)cc1		CHEMBL3736196	=	IC50	nM	560.0	CHEMBL262	Homo sapiens	IC50	uM	0.56
	16380385	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	COc1ccc2[nH]nc(C(=O)NCC3CCN(CCc4ccc(O)cc4)CC3)c2c1		CHEMBL3736216	=	IC50	nM	350.0	CHEMBL262	Homo sapiens	IC50	uM	0.35
	16380386	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	COc1ccc2[nH]nc(C(=O)NCC3CCN(Cc4ccnc(C(=O)O)c4)CC3)c2c1		CHEMBL3735154	=	IC50	nM	270.0	CHEMBL262	Homo sapiens	IC50	uM	0.27
	16380387	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	COc1ccc2[nH]nc(C(=O)NCC3CCN(Cc4ccc(C(=O)[O-])nc4)CC3)c2c1.[Na+]		CHEMBL3735621	=	IC50	nM	320.0	CHEMBL262	Homo sapiens	IC50	uM	0.32
	16380388	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	COc1ccc2[nH]nc(C(=O)NCC3CCN(Cc4ccc(OCc5ccccc5)cc4)CC3)c2c1		CHEMBL3736462	=	IC50	nM	350.0	CHEMBL262	Homo sapiens	IC50	uM	0.35
	16380389	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	COc1ccc2[nH]nc(C(=O)NCC3CCN(Cc4ccc(Cl)cc4Cl)CC3)c2c1		CHEMBL3734985	=	IC50	nM	310.0	CHEMBL262	Homo sapiens	IC50	uM	0.31
	16380390	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	COc1ccc2[nH]nc(C(=O)NCC3CCN(Cc4ccc(C(F)(F)F)cc4)CC3)c2c1		CHEMBL3735984	=	IC50	nM	640.0	CHEMBL262	Homo sapiens	IC50	uM	0.64
	16380391	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	COc1ccc2[nH]nc(C(=O)NCC3CCN(Cc4ccc(O)cc4)CC3)c2c1		CHEMBL3735837	=	IC50	nM	400.0	CHEMBL262	Homo sapiens	IC50	uM	0.4
	16380392	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	COc1ccc2[nH]nc(C(=O)NCC3CCN(Cc4ccccc4)CC3)c2c1		CHEMBL3735962	=	IC50	nM	250.0	CHEMBL262	Homo sapiens	IC50	uM	0.25
	16380393	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	COc1ccc2[nH]nc(C(=O)NCC3CCN(CCCNC(=O)c4ccccc4)CC3)c2c1		CHEMBL3736418	=	IC50	nM	580.0	CHEMBL262	Homo sapiens	IC50	uM	0.58
	16380394	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	CC#CC(=O)NCCCN1CCC(CNC(=O)c2n[nH]c3ccc(OC)cc23)CC1		CHEMBL3735772	=	IC50	nM	530.0	CHEMBL262	Homo sapiens	IC50	uM	0.53
	16380395	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	C/C=C/C(=O)NCCCN1CCC(CNC(=O)c2n[nH]c3ccc(OC)cc23)CC1		CHEMBL3735527	=	IC50	nM	1510.0	CHEMBL262	Homo sapiens	IC50	uM	1.51
	16380396	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	CCCC(=O)NCCCN1CCC(CNC(=O)c2n[nH]c3ccc(OC)cc23)CC1		CHEMBL3736458	=	IC50	nM	750.0	CHEMBL262	Homo sapiens	IC50	uM	0.75
	16380397	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	CCC(=O)NCCCN1CCC(CNC(=O)c2n[nH]c3ccc(OC)cc23)CC1		CHEMBL3735637	=	IC50	nM	1130.0	CHEMBL262	Homo sapiens	IC50	uM	1.13
	16380398	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	COc1ccc2[nH]nc(C(=O)NCC3CCN(CCCN(C)C)CC3)c2c1		CHEMBL3735220	=	IC50	nM	1700.0	CHEMBL262	Homo sapiens	IC50	uM	1.7
	16380399	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	COc1ccc2[nH]nc(C(=O)NCC3CCN(CCNS(C)(=O)=O)CC3)c2c1		CHEMBL3735681	=	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	uM	1.0
	16380400	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	COCCN1CCC(CNC(=O)c2n[nH]c3ccc(OC)cc23)CC1		CHEMBL3735497	=	IC50	nM	870.0	CHEMBL262	Homo sapiens	IC50	uM	0.87
	16380401	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	COc1ccc2[nH]nc(C(=O)NCC3CCN(CCCC(=O)O)CC3)c2c1		CHEMBL3734956	=	IC50	nM	230.0	CHEMBL262	Homo sapiens	IC50	uM	0.23
	16380402	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	COc1ccc2[nH]nc(C(=O)NCC3CCN(CCC(=O)O)CC3)c2c1		CHEMBL3735293	=	IC50	nM	690.0	CHEMBL262	Homo sapiens	IC50	uM	0.69
	16380403	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	COc1ccc2[nH]nc(C(=O)NCC3CCN(CC(=O)O)CC3)c2c1		CHEMBL3736404	=	IC50	nM	670.0	CHEMBL262	Homo sapiens	IC50	uM	0.67
	16380404	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	COc1ccc2[nH]nc(C(=O)NCC3CCN(C)CC3)c2c1		CHEMBL3735382	=	IC50	nM	1200.0	CHEMBL262	Homo sapiens	IC50	uM	1.2
	16380405	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	COCCN1CCC(CNC(=O)c2n[nH]c3ccc(-c4ccc(OC)cc4)cc23)CC1		CHEMBL3736122	=	IC50	nM	560.0	CHEMBL262	Homo sapiens	IC50	nM	560.0
	16380406	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	COCCN1CCC(CNC(=O)c2n[nH]c3ccc(-c4cccnc4)cc23)CC1		CHEMBL3735967	=	IC50	nM	31.0	CHEMBL262	Homo sapiens	IC50	nM	31.0
	16380407	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	COCCN1CCC(CNC(=O)c2n[nH]c3ccc(-c4cnccc4OC)cc23)CC1		CHEMBL3735079	=	IC50	nM	45.0	CHEMBL262	Homo sapiens	IC50	nM	45.0
	16380408	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	COCCN1CCC(CNC(=O)c2n[nH]c3ccc(-c4cncc(OC)c4)cc23)CC1		CHEMBL3735522	=	IC50	nM	26.0	CHEMBL262	Homo sapiens	IC50	nM	26.0
	16380409	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	COCCN1CCC(CNC(=O)c2n[nH]c3ccc(-c4ccc(OC)nc4)cc23)CC1		CHEMBL3735627	=	IC50	nM	53.0	CHEMBL262	Homo sapiens	IC50	nM	53.0
	16380410	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	COCCN1CCC(CNC(=O)c2n[nH]c3ccc(-c4cccnc4OC)cc23)CC1		CHEMBL3734853	=	IC50	nM	1400.0	CHEMBL262	Homo sapiens	IC50	nM	1400.0
	16380411	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	COCCN1CCC(CNC(=O)c2n[nH]c3ccc(-c4ccc(C)nc4)cc23)CC1		CHEMBL3736223	=	IC50	nM	64.0	CHEMBL262	Homo sapiens	IC50	nM	64.0
	16380412	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	O=C([O-])c1ccc(CN2CCC(CNC(=O)c3n[nH]c4ccc(Br)cc34)CC2)o1.[Na+]		CHEMBL3735730	=	IC50	nM	210.0	CHEMBL262	Homo sapiens	IC50	nM	210.0
	16380413	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	CCOC(=O)c1ccc(CN2CCC(CNC(=O)c3n[nH]c4ccc(Br)cc34)CC2)o1		CHEMBL3735613	=	IC50	nM	260.0	CHEMBL262	Homo sapiens	IC50	nM	260.0
	16380414	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	O=C(O)c1ccc(CN2CCC(CNC(=O)c3n[nH]c4ccc(-c5ccccc5F)cc34)CC2)o1		CHEMBL3735856	=	IC50	nM	17.0	CHEMBL262	Homo sapiens	IC50	nM	17.0
	16380415	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	O=C(O)c1ccc(CN2CCC(CNC(=O)c3n[nH]c4ccc(-c5cccc(F)c5F)cc34)CC2)o1		CHEMBL3735215	=	IC50	nM	12.0	CHEMBL262	Homo sapiens	IC50	nM	12.0
	16380416	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	COc1ccc(-c2ccc3[nH]nc(C(=O)NCC4CCN(Cc5ccc(C(=O)O)o5)CC4)c3c2)cc1		CHEMBL3734895	=	IC50	nM	300.0	CHEMBL262	Homo sapiens	IC50	nM	300.0
	16380417	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	COc1ccncc1-c1ccc2[nH]nc(C(=O)NCC3CCN(Cc4ccc(C(=O)O)o4)CC3)c2c1		CHEMBL3735176	=	IC50	nM	9.6	CHEMBL262	Homo sapiens	IC50	nM	9.6
	16380418	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	COc1ccc(-c2ccc3[nH]nc(C(=O)NCC4CCN(Cc5ccc(C(=O)O)o5)CC4)c3c2)cn1		CHEMBL3736035	=	IC50	nM	21.0	CHEMBL262	Homo sapiens	IC50	nM	21.0
	16380419	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	COc1ncccc1-c1ccc2[nH]nc(C(=O)NCC3CCN(Cc4ccc(C(=O)O)o4)CC3)c2c1		CHEMBL3734924	=	IC50	nM	360.0	CHEMBL262	Homo sapiens	IC50	nM	360.0
	16380420	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	COC(=O)c1coc(CN2CCC(CNC(=O)c3n[nH]c4ccc(Br)cc34)CC2)n1		CHEMBL3736476	=	IC50	nM	360.0	CHEMBL262	Homo sapiens	IC50	nM	360.0
	16380421	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	O=C(O)c1coc(CN2CCC(CNC(=O)c3n[nH]c4ccc(-c5cccc(F)c5F)cc34)CC2)n1		CHEMBL3735986	=	IC50	nM	6.0	CHEMBL262	Homo sapiens	IC50	nM	6.0
	16381003	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	CCOC(=O)CN1CCC(CNC(=O)c2n[nH]c3ccc(Br)cc23)CC1		CHEMBL3735095	=	IC50	nM	530.0	CHEMBL262	Homo sapiens	IC50	nM	530.0
	16381004	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	CCc1ccc2[nH]nc(C(=O)NCC3CCN(CC(=O)O)CC3)c2c1		CHEMBL3735445	=	IC50	nM	541.0	CHEMBL262	Homo sapiens	IC50	nM	541.0
	16381005	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	O=C(O)CN1CCC(CNC(=O)c2n[nH]c3ccc(-c4ccccc4F)cc23)CC1		CHEMBL3735835	=	IC50	nM	45.0	CHEMBL262	Homo sapiens	IC50	nM	45.0
	16381006	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	O=C(O)CN1CCC(CNC(=O)c2n[nH]c3ccc(-c4cccc(F)c4F)cc23)CC1		CHEMBL3736167	=	IC50	nM	27.0	CHEMBL262	Homo sapiens	IC50	nM	27.0
	16381007	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	O=C(O)CN1CCC(CNC(=O)c2n[nH]c3ccc(-c4cccc(Cl)c4Cl)cc23)CC1		CHEMBL3735459	=	IC50	nM	40.0	CHEMBL262	Homo sapiens	IC50	nM	40.0
	16381008	CHEMBL3736787	Inhibition of human recombinant GSK-3beta using Ulight-CFFKNIVTPRTPPPSQQGK-amide as substrate after 90 mins by LANCE assay	B	COc1cncc(-c2ccc3[nH]nc(C(=O)NCC4CCN(CC(=O)O)CC4)c3c2)c1		CHEMBL3736455	=	IC50	nM	18.0	CHEMBL262	Homo sapiens	IC50	nM	18.0
	16381009	CHEMBL3736788	Inhibition of GSK-3beta (unknown origin) expressed in CHO cells assessed as Tau phosphorylation after 2 hrs	B	COc1ccc2[nH]nc(C(=O)NCC3CCN(Cc4ccc(Cl)cc4Cl)CC3)c2c1		CHEMBL3734985	=	IC50	nM	1390.0	CHEMBL262	Homo sapiens	IC50	uM	1.39
	16381010	CHEMBL3736788	Inhibition of GSK-3beta (unknown origin) expressed in CHO cells assessed as Tau phosphorylation after 2 hrs	B	COC(=O)c1coc(CN2CCC(CNC(=O)c3n[nH]c4ccc(OC)cc34)CC2)n1		CHEMBL3735500	=	IC50	nM	5170.0	CHEMBL262	Homo sapiens	IC50	uM	5.17
	16381011	CHEMBL3736788	Inhibition of GSK-3beta (unknown origin) expressed in CHO cells assessed as Tau phosphorylation after 2 hrs	B	COC(=O)c1csc(CN2CCC(CNC(=O)c3n[nH]c4ccc(OC)cc34)CC2)n1		CHEMBL3735579	=	IC50	nM	2130.0	CHEMBL262	Homo sapiens	IC50	uM	2.13
	16381012	CHEMBL3736788	Inhibition of GSK-3beta (unknown origin) expressed in CHO cells assessed as Tau phosphorylation after 2 hrs	B	COC(=O)c1ccoc1CN1CCC(CNC(=O)c2n[nH]c3ccc(OC)cc23)CC1		CHEMBL3735291	=	IC50	nM	820.0	CHEMBL262	Homo sapiens	IC50	uM	0.82
	16381013	CHEMBL3736788	Inhibition of GSK-3beta (unknown origin) expressed in CHO cells assessed as Tau phosphorylation after 2 hrs	B	COCCN1CCC(CNC(=O)c2n[nH]c3ccc(-c4cccc(F)c4F)cc23)CC1		CHEMBL3735506	=	IC50	nM	240.0	CHEMBL262	Homo sapiens	IC50	uM	0.24
	16381014	CHEMBL3736788	Inhibition of GSK-3beta (unknown origin) expressed in CHO cells assessed as Tau phosphorylation after 2 hrs	B	COCCN1CCC(CNC(=O)c2n[nH]c3ccc(-c4cncc(OC)c4)cc23)CC1		CHEMBL3735522	=	IC50	nM	800.0	CHEMBL262	Homo sapiens	IC50	uM	0.8
	16381015	CHEMBL3736788	Inhibition of GSK-3beta (unknown origin) expressed in CHO cells assessed as Tau phosphorylation after 2 hrs	B	COCCN1CCC(CNC(=O)c2n[nH]c3ccc(-c4ccc(OC)nc4)cc23)CC1		CHEMBL3735627	=	IC50	nM	790.0	CHEMBL262	Homo sapiens	IC50	uM	0.79
	16381016	CHEMBL3736788	Inhibition of GSK-3beta (unknown origin) expressed in CHO cells assessed as Tau phosphorylation after 2 hrs	B	COc1ccc(-c2ccc3[nH]nc(C(=O)NCC4CCN(Cc5ccc(C(=O)O)o5)CC4)c3c2)cn1		CHEMBL3736035	=	IC50	nM	70800.0	CHEMBL262	Homo sapiens	IC50	uM	70.8
	16381017	CHEMBL3736788	Inhibition of GSK-3beta (unknown origin) expressed in CHO cells assessed as Tau phosphorylation after 2 hrs	B	O=C(O)c1coc(CN2CCC(CNC(=O)c3n[nH]c4ccc(-c5cccc(F)c5F)cc34)CC2)n1		CHEMBL3735986	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	16381018	CHEMBL3736789	Competitive inhibition of human recombinant GSK-3beta after 60 mins by microfluidic assay in presence of ATP	B	COc1ccc2[nH]nc(C(=O)NCC3CCN(CCC(=O)O)CC3)c2c1		CHEMBL3735293	=	Ki	nM	600.0	CHEMBL262	Homo sapiens	Ki	nM	600.0
	16381019	CHEMBL3736789	Competitive inhibition of human recombinant GSK-3beta after 60 mins by microfluidic assay in presence of ATP	B	COCCN1CCC(CNC(=O)c2n[nH]c3ccc(-c4cccc(F)c4F)cc23)CC1		CHEMBL3735506	=	Ki	nM	15.0	CHEMBL262	Homo sapiens	Ki	nM	15.0
	16381060	CHEMBL3736924	Non-competitive inhibition of human GSK-3beta in presence of ATP	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	IC50	nM	2000.0	CHEMBL262	Homo sapiens	IC50	uM	2.0
	16381061	CHEMBL3736924	Non-competitive inhibition of human GSK-3beta in presence of ATP	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	=	IC50	nM	60.0	CHEMBL262	Homo sapiens	IC50	uM	0.06
	16381062	CHEMBL3736925	Inhibition of GSK-3beta (unknown origin)	B	Cc1ccc2[nH]nc(C(=O)NCC3CCN(CC(=O)Nc4ccccc4)CC3)c2c1		CHEMBL3735755	=	IC50	nM	640.0	CHEMBL262	Homo sapiens	IC50	uM	0.64
	16388244	CHEMBL3737517	Inhibition of GSK3beta (unknown origin) in presence of 10 uM ATP incubated for 1 hr by Z'Lyte assay	B	COc1cc2c(cc1OC)CN(CC(=O)Nc1ccc3c(c1)/C(=C/c1cnc[nH]1)C(=O)N3)CC2		CHEMBL3091673	=	IC50	nM	272.0	CHEMBL262	Homo sapiens	IC50	nM	272.0
	16388302	CHEMBL3737359	Inhibition of GSK3beta (unknown origin) at 1 uM by selectscreen kinase profiling assay in presence of ATP	B	COc1cc2c(cc1OC)CN(CC(=O)Nc1ccc3c(c1)/C(=C/c1cnc[nH]1)C(=O)N3)CC2		CHEMBL3091673	=	Inhibition	%	70.0	CHEMBL262	Homo sapiens	INH	%	70.0
	16413455	CHEMBL3743689	Inhibition of GSK3beta (unknown origin)	B	O=C(O)C1CN(Cc2ccc(OCc3ccc(Cl)c(Cl)c3)cc2)C1		CHEMBL3741589	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	16421960	CHEMBL3749779	Inhibition of GSK3beta (unknown origin)	B	C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1		CHEMBL3651966	=	IC50	nM	1300.0	CHEMBL262	Homo sapiens	IC50	uM	1.3
Not Active	16422028	CHEMBL3749807	Inhibition of GSK-3beta in human MV411 cells assessed as beta-catenin stabilization up to 20 uM by Western blot analysis	B	C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1		CHEMBL3651966		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	16425375	CHEMBL3751217	Inhibition of GSK3 beta (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	11.1	CHEMBL262	Homo sapiens	INH	%	11.1
	16425764	CHEMBL3749462	Inhibition of glycogen synthase kinase-3 beta (unknown origin) using GS-1 as substrate after 20 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	O=C(CCl)c1ccccc1		CHEMBL105712	=	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	16425765	CHEMBL3749462	Inhibition of glycogen synthase kinase-3 beta (unknown origin) using GS-1 as substrate after 20 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	O=C(CCl)c1ccc(Cl)cc1		CHEMBL143090	=	IC50	nM	2500.0	CHEMBL262	Homo sapiens	IC50	uM	2.5
	16425766	CHEMBL3749462	Inhibition of glycogen synthase kinase-3 beta (unknown origin) using GS-1 as substrate after 20 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	O=C(CBr)c1ccc(Cl)cc1		CHEMBL140061	=	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	uM	1.0
	16425767	CHEMBL3749462	Inhibition of glycogen synthase kinase-3 beta (unknown origin) using GS-1 as substrate after 20 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	O=C(CBr)c1ccc(Br)cc1		CHEMBL142826	=	IC50	nM	500.0	CHEMBL262	Homo sapiens	IC50	uM	0.5
	16425768	CHEMBL3749462	Inhibition of glycogen synthase kinase-3 beta (unknown origin) using GS-1 as substrate after 20 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	O=C(CBr)c1ccc(C2C(=O)c3ccccc3C2=O)cc1		CHEMBL3745772	=	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	16425769	CHEMBL3749462	Inhibition of glycogen synthase kinase-3 beta (unknown origin) using GS-1 as substrate after 20 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	O=S=C(CCl)c1ccc(Cl)cc1		CHEMBL3746962	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	16425770	CHEMBL3749462	Inhibition of glycogen synthase kinase-3 beta (unknown origin) using GS-1 as substrate after 20 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	COc1ccc(C(=O)CBr)cc1		CHEMBL103009	=	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	uM	1.0
	16425771	CHEMBL3749462	Inhibition of glycogen synthase kinase-3 beta (unknown origin) using GS-1 as substrate after 20 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	O=C(CBr)c1ccc([N+](=O)[O-])cc1		CHEMBL106072	=	IC50	nM	2000.0	CHEMBL262	Homo sapiens	IC50	uM	2.0
	16425772	CHEMBL3749462	Inhibition of glycogen synthase kinase-3 beta (unknown origin) using GS-1 as substrate after 20 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	O=C(CBr)c1ccccc1		CHEMBL102953	=	IC50	nM	5000.0	CHEMBL262	Homo sapiens	IC50	uM	5.0
	16426370	CHEMBL3749459	Competitive inhibition of glycogen synthase kinase-3 beta (unknown origin) using GS-1 as substrate after 30 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	4.0	CHEMBL262	Homo sapiens	IC50	nM	4.0
	16426371	CHEMBL3749459	Competitive inhibition of glycogen synthase kinase-3 beta (unknown origin) using GS-1 as substrate after 30 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	O=C1Nc2ccccc2/C1=C1/Nc2cc(Br)ccc2C1=O		CHEMBL1830063	=	IC50	nM	4.0	CHEMBL262	Homo sapiens	IC50	nM	4.0
	16426372	CHEMBL3749459	Competitive inhibition of glycogen synthase kinase-3 beta (unknown origin) using GS-1 as substrate after 30 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2C1=O		CHEMBL1276127	=	IC50	nM	4.0	CHEMBL262	Homo sapiens	IC50	nM	4.0
	16426373	CHEMBL3749459	Competitive inhibition of glycogen synthase kinase-3 beta (unknown origin) using GS-1 as substrate after 30 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	O=C1Cc2c([nH]c3ccccc23)-c2ccccc2N1		CHEMBL430574	=	IC50	nM	4.0	CHEMBL262	Homo sapiens	IC50	nM	4.0
	16426374	CHEMBL3749459	Competitive inhibition of glycogen synthase kinase-3 beta (unknown origin) using GS-1 as substrate after 30 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c(Br)cc32)N1		CHEMBL361708	=	IC50	nM	10.0	CHEMBL262	Homo sapiens	IC50	nM	10.0
Active	16436846	CHEMBL3757490	Inhibition of GSK3beta phosphorylation in human HuH7 cells after 24 to 48 hrs by Western blot analysis	B	Cc1ccc(C2=Nn3c(nnc3C(C)c3ccc(CC(C)C)cc3)SC2)cc1		CHEMBL3754438		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	16436847	CHEMBL3757490	Inhibition of GSK3beta phosphorylation in human HuH7 cells after 24 to 48 hrs by Western blot analysis	B	COc1ccc(C2=Nn3c(nnc3C(C)c3ccc(CC(C)C)cc3)SC2)cc1		CHEMBL3754804		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	16436848	CHEMBL3757489	Inhibition of GSK3beta phosphorylation in human Mahlavu cells after 24 to 48 hrs by Western blot analysis	B	Cc1ccc(C2=Nn3c(nnc3C(C)c3ccc(CC(C)C)cc3)SC2)cc1		CHEMBL3754438		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	16436849	CHEMBL3757489	Inhibition of GSK3beta phosphorylation in human Mahlavu cells after 24 to 48 hrs by Western blot analysis	B	COc1ccc(C2=Nn3c(nnc3C(C)c3ccc(CC(C)C)cc3)SC2)cc1		CHEMBL3754804		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	16450863	CHEMBL3762719	Inhibition of GSK3beta (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	41.9	CHEMBL262	Homo sapiens	INH	%	41.9
	16451721	CHEMBL3762719	Inhibition of GSK3beta (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4c(Cl)cccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758602	=	Inhibition	%	61.0	CHEMBL262	Homo sapiens	INH	%	61.0
	16457766	CHEMBL3761576	Inhibition of GSK3B (unknown origin) at 500 nM	B	C[C@@H](Nc1ncnc2sc(-c3ccccc3C(N)=O)cc12)c1ccccc1		CHEMBL3759085	=	Inhibition	%	6.0	CHEMBL262	Homo sapiens	INH	%	6.0
	16457767	CHEMBL3761576	Inhibition of GSK3B (unknown origin) at 500 nM	B	C[C@@H](Nc1ncnc2sc(-c3ccc(C(=O)NCCN(C)C)cc3)cc12)c1ccccc1		CHEMBL3758800	=	Inhibition	%	5.0	CHEMBL262	Homo sapiens	INH	%	5.0
	16457768	CHEMBL3761576	Inhibition of GSK3B (unknown origin) at 500 nM	B	CN(C)CCNC(=O)c1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3s2)cc1		CHEMBL3758376	=	Inhibition	%	3.0	CHEMBL262	Homo sapiens	INH	%	3.0
	16457769	CHEMBL3761576	Inhibition of GSK3B (unknown origin) at 500 nM	B	COc1cc(C(N)=O)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1		CHEMBL3759480	=	Inhibition	%	17.0	CHEMBL262	Homo sapiens	INH	%	17.0
	16457770	CHEMBL3761576	Inhibition of GSK3B (unknown origin) at 500 nM	B	COc1ccc(C(=O)NCCN(C)C)cc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1		CHEMBL3758582	=	Inhibition	%	13.0	CHEMBL262	Homo sapiens	INH	%	13.0
	16457771	CHEMBL3761576	Inhibition of GSK3B (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1		CHEMBL3759559	=	Inhibition	%	7.0	CHEMBL262	Homo sapiens	INH	%	7.0
	16457772	CHEMBL3761576	Inhibition of GSK3B (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1		CHEMBL3758682	=	Inhibition	%	8.0	CHEMBL262	Homo sapiens	INH	%	8.0
	16457773	CHEMBL3761576	Inhibition of GSK3B (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(Nc3ccccc3)ncnc2s1		CHEMBL3758768	=	Inhibition	%	5.0	CHEMBL262	Homo sapiens	INH	%	5.0
	16457774	CHEMBL3761576	Inhibition of GSK3B (unknown origin) at 500 nM	B	C#Cc1cccc(Nc2ncnc3sc(-c4ccc(CO)cc4OC)cc23)c1		CHEMBL3758802	=	Inhibition	%	8.0	CHEMBL262	Homo sapiens	INH	%	8.0
	16457775	CHEMBL3761576	Inhibition of GSK3B (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1		CHEMBL3758351	=	Inhibition	%	4.0	CHEMBL262	Homo sapiens	INH	%	4.0
	16457776	CHEMBL3761576	Inhibition of GSK3B (unknown origin) at 500 nM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	-8.0	CHEMBL262	Homo sapiens	INH	%	-8.0
	16465828	CHEMBL3767841	Inhibition of human GSK3beta at 10 uM	B	Cc1cncn1-c1cc(C(=O)Nc2cccc(CNc3ccc4c(C(=O)N[C@@H](C)C(N)=O)[nH]nc4c3)c2)cc(C(F)(F)F)c1		CHEMBL3764798	=	Inhibition	%	12.35	CHEMBL262	Homo sapiens	INH	%	12.35
	16474689	CHEMBL3767309	Inhibition of GSK3beta (unknown origin) at 10 uM	B	CN1CCN(CCCOc2ccc(N3C(=O)/C(=C/c4ccc(Oc5ccc(F)cc5)cc4)SC3=S)cc2)CC1		CHEMBL3765499	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	INH	%	0.0
	16480122	CHEMBL3769118	Inhibition of human recombinant GSK3-beta using prephosphorylated polypeptide as substrate incubated for 30 mins by Glo-type luminescence assay	B	O=C(/C=C(O)/C=C/c1ccc(OCc2cc(F)cc(F)c2)cc1)/C=C/c1ccc(OCc2cc(F)cc(F)c2)cc1		CHEMBL3765050	=	IC50	nM	8300.0	CHEMBL262	Homo sapiens	IC50	uM	8.3
	16480123	CHEMBL3769118	Inhibition of human recombinant GSK3-beta using prephosphorylated polypeptide as substrate incubated for 30 mins by Glo-type luminescence assay	B	O=C(/C=C(O)/C=C/c1ccc(OCc2ccc(F)cc2F)cc1)/C=C/c1ccc(OCc2ccc(F)cc2F)cc1		CHEMBL3764532	=	IC50	nM	9630.0	CHEMBL262	Homo sapiens	IC50	uM	9.63
	16480124	CHEMBL3769118	Inhibition of human recombinant GSK3-beta using prephosphorylated polypeptide as substrate incubated for 30 mins by Glo-type luminescence assay	B	O=C(/C=C(O)/C=C/c1ccc(OCc2ccccc2)cc1)/C=C/c1ccc(OCc2ccccc2)cc1		CHEMBL3763728	=	IC50	nM	2490.0	CHEMBL262	Homo sapiens	IC50	uM	2.49
	16480125	CHEMBL3769118	Inhibition of human recombinant GSK3-beta using prephosphorylated polypeptide as substrate incubated for 30 mins by Glo-type luminescence assay	B	O=C(/C=C(O)/C=C/c1ccc(OCc2ccccc2)cc1)/C=C/c1ccc(O)cc1		CHEMBL3765061	=	IC50	nM	2010.0	CHEMBL262	Homo sapiens	IC50	uM	2.01
	16480126	CHEMBL3769118	Inhibition of human recombinant GSK3-beta using prephosphorylated polypeptide as substrate incubated for 30 mins by Glo-type luminescence assay	B	COc1ccc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(OCc3ccccc3)cc2)cc1		CHEMBL3763815	=	IC50	nM	2780.0	CHEMBL262	Homo sapiens	IC50	uM	2.78
	16480127	CHEMBL3769118	Inhibition of human recombinant GSK3-beta using prephosphorylated polypeptide as substrate incubated for 30 mins by Glo-type luminescence assay	B	COc1ccc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(OC)cc2)cc1		CHEMBL454662	=	IC50	nM	530.0	CHEMBL262	Homo sapiens	IC50	uM	0.53
	16480128	CHEMBL3769118	Inhibition of human recombinant GSK3-beta using prephosphorylated polypeptide as substrate incubated for 30 mins by Glo-type luminescence assay	B	O=C(/C=C(O)/C=C/c1ccc(O)cc1)/C=C/c1ccc(O)cc1		CHEMBL131770	=	IC50	nM	8390.0	CHEMBL262	Homo sapiens	IC50	uM	8.39
	16480129	CHEMBL3769118	Inhibition of human recombinant GSK3-beta using prephosphorylated polypeptide as substrate incubated for 30 mins by Glo-type luminescence assay	B	COc1cc(/C=C/C(O)=C/C(=O)/C=C/c2ccc(C)cc2)ccc1O		CHEMBL3763318	=	IC50	nM	2090.0	CHEMBL262	Homo sapiens	IC50	uM	2.09
	16480130	CHEMBL3769118	Inhibition of human recombinant GSK3-beta using prephosphorylated polypeptide as substrate incubated for 30 mins by Glo-type luminescence assay	B	COc1cc(/C=C/C(O)=C/C(=O)/C=C/c2ccc(OCc3ccccc3)cc2)ccc1O		CHEMBL3763944	=	IC50	nM	900.0	CHEMBL262	Homo sapiens	IC50	uM	0.9
	16480148	CHEMBL3769118	Inhibition of human recombinant GSK3-beta using prephosphorylated polypeptide as substrate incubated for 30 mins by Glo-type luminescence assay	B	O=C(/C=C(O)/C=C/c1ccc(OCc2ccc(F)cc2)cc1)/C=C/c1ccc(OCc2ccc(F)cc2)cc1		CHEMBL3764465	=	IC50	nM	12810.0	CHEMBL262	Homo sapiens	IC50	uM	12.81
	16480149	CHEMBL3769118	Inhibition of human recombinant GSK3-beta using prephosphorylated polypeptide as substrate incubated for 30 mins by Glo-type luminescence assay	B	O=C(/C=C(O)/C=C/c1ccc(OCc2cccc(F)c2)cc1)/C=C/c1ccc(OCc2cccc(F)c2)cc1		CHEMBL3763264	=	IC50	nM	16990.0	CHEMBL262	Homo sapiens	IC50	uM	16.99
	16480150	CHEMBL3769118	Inhibition of human recombinant GSK3-beta using prephosphorylated polypeptide as substrate incubated for 30 mins by Glo-type luminescence assay	B	COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O		CHEMBL140	=	IC50	nM	17950.0	CHEMBL262	Homo sapiens	IC50	uM	17.95
	16480151	CHEMBL3769118	Inhibition of human recombinant GSK3-beta using prephosphorylated polypeptide as substrate incubated for 30 mins by Glo-type luminescence assay	B	COc1ccc(/C=C/C(=O)CC(=O)/C=C/c2ccc(OC)cc2)cc1		CHEMBL103006	=	IC50	nM	15300.0	CHEMBL262	Homo sapiens	IC50	uM	15.3
	16480152	CHEMBL3769118	Inhibition of human recombinant GSK3-beta using prephosphorylated polypeptide as substrate incubated for 30 mins by Glo-type luminescence assay	B	O=C(/C=C/c1ccc(OCc2ccccc2)cc1)CC(=O)/C=C/c1ccc(OCc2ccccc2)cc1		CHEMBL3765319	=	IC50	nM	5560.0	CHEMBL262	Homo sapiens	IC50	uM	5.56
	16480153	CHEMBL3769118	Inhibition of human recombinant GSK3-beta using prephosphorylated polypeptide as substrate incubated for 30 mins by Glo-type luminescence assay	B	O=C(/C=C/c1ccc(OCc2ccc(F)cc2F)cc1)CC(=O)/C=C/c1ccc(OCc2ccc(F)cc2F)cc1		CHEMBL3765195	=	IC50	nM	9060.0	CHEMBL262	Homo sapiens	IC50	uM	9.06
	16480154	CHEMBL3769118	Inhibition of human recombinant GSK3-beta using prephosphorylated polypeptide as substrate incubated for 30 mins by Glo-type luminescence assay	B	O=C(/C=C/c1ccc(OCc2cc(F)cc(F)c2)cc1)CC(=O)/C=C/c1ccc(OCc2cc(F)cc(F)c2)cc1		CHEMBL3765711	=	IC50	nM	9660.0	CHEMBL262	Homo sapiens	IC50	uM	9.66
	16485728	CHEMBL3771577	Inhibition of human recombinant GSK3B assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control	B	Cc1c(Cl)cccc1NC(=O)c1sc2nc3c(cc2c1N)C(=O)CC3		CHEMBL3771285	=	Activity	%	92.0	CHEMBL262	Homo sapiens	Activity	%	92.0
	16496010	CHEMBL3779705	Inhibition of N-terminal His6-tagged recombinant GSK3beta (unknown origin) expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-10.0	CHEMBL262	Homo sapiens	Activity	%	-10.0
Not Active	16496879	CHEMBL3776614	Inhibition of human GSK3beta (2 to 420 residues) at 1 uM by radioactive [33P]-ATP filter binding assay	B	O=c1[nH]cnc2c(-n3cc(CCN4CCC(c5cccc(Cl)c5)CC4)cn3)nccc12		CHEMBL3774537		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	16506489	CHEMBL3778457	Inhibition of full length recombinant human His-tagged GSK3beta expressed in baculovirus expression system at 5 uM by lantha screen kinase binding assay relative to control	B	O=C1NC(=S)S/C1=C\c1ccc2ncsc2c1		CHEMBL3775393	=	Inhibition	%	8.0	CHEMBL262	Homo sapiens	INH	%	8.0
	16506490	CHEMBL3778654	Inhibition of full length recombinant human His-tagged GSK3beta expressed in baculovirus expression system at 1 uM by lantha screen kinase binding assay relative to control	B	O=C1NC(=S)S/C1=C\c1ccc2ncccc2c1		CHEMBL3774448	=	Inhibition	%	10.0	CHEMBL262	Homo sapiens	INH	%	10.0
	16507177	CHEMBL3778999	Inhibition of recombinant GSK3beta (unknown origin) assessed as residual activity at 1 uM relative to control	B	CC(O)CNc1nc(NCc2ccc(-c3ccccn3)cc2)c2[nH]nc(C(C)C)c2n1		CHEMBL3774632	>=	Activity	%	100.0	CHEMBL262	Homo sapiens	Activity	%	100.0
	16508197	CHEMBL3779705	Inhibition of N-terminal His6-tagged recombinant GSK3beta (unknown origin) expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	-30.0	CHEMBL262	Homo sapiens	Activity	%	-30.0
	16509174	CHEMBL3779705	Inhibition of N-terminal His6-tagged recombinant GSK3beta (unknown origin) expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-26.0	CHEMBL262	Homo sapiens	Activity	%	-26.0
Not Active	16514127	CHEMBL3782175	Inhibition of partial length human GSK3beta expressed in mammalian system at 1 uM	B	Cc1cnc(N)nc1OCC(C)(C)CO		CHEMBL3780032		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	16540799	CHEMBL3789990	Inhibition of GSK3B (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL1614712	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	16540800	CHEMBL3789990	Inhibition of GSK3B (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3787112	=	IC50	nM	1800.0	CHEMBL262	Homo sapiens	IC50	uM	1.8
	16540801	CHEMBL3789990	Inhibition of GSK3B (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OCC34CCC(CC3)O4)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3785500	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	16540802	CHEMBL3789990	Inhibition of GSK3B (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cccc(OC[C@@H]5CCCO5)c4F)c4c(N)ncnc43)C2)CC1		CHEMBL3786167	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	16540803	CHEMBL3789990	Inhibition of GSK3B (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cc(OC[C@@H]5CCCO5)ccc4F)c4c(N)ncnc43)C2)CC1		CHEMBL3785951	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	16559706	CHEMBL3794932	Inhibition of full length human N-terminal GST-tagged GSK3beta (1 to 420 residues) expressed in baculovirus expression system using fluorescence labelled CREBtide-p as substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccccc1)c1n[nH]c2ccccc12		CHEMBL508964	=	Inhibition	%	51.0	CHEMBL262	Homo sapiens	INH	%	51.0
	16559707	CHEMBL3794932	Inhibition of full length human N-terminal GST-tagged GSK3beta (1 to 420 residues) expressed in baculovirus expression system using fluorescence labelled CREBtide-p as substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccc(C(=O)N2CCN(c3ccccc3)CC2)cc1)c1n[nH]c2ccccc12		CHEMBL3793843	=	Inhibition	%	4.9	CHEMBL262	Homo sapiens	INH	%	4.9
	16559708	CHEMBL3794932	Inhibition of full length human N-terminal GST-tagged GSK3beta (1 to 420 residues) expressed in baculovirus expression system using fluorescence labelled CREBtide-p as substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccc(CN2CCN(c3ccccc3)CC2)cc1)c1n[nH]c2ccccc12		CHEMBL3792850	=	Inhibition	%	-3.7	CHEMBL262	Homo sapiens	INH	%	-3.7
	16565624	CHEMBL3803244	Inhibition of full length human recombinant N-terminal GST-tagged GSK3beta expressed in baculovirus infected sf9 cells using GSK3 substrate at 100 uM incubated for 10 mins by scintillation counting method relative to control	B	COc1ccc(/C=N/Nc2cc(C)c3ccccc3n2)cc1		CHEMBL3798597	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	INH	%	0.0
	16565625	CHEMBL3803244	Inhibition of full length human recombinant N-terminal GST-tagged GSK3beta expressed in baculovirus infected sf9 cells using GSK3 substrate at 100 uM incubated for 10 mins by scintillation counting method relative to control	B	C/C(=N\Nc1ccc2ccccc2n1)c1ccccc1O		CHEMBL1892026	=	Inhibition	%	1.0	CHEMBL262	Homo sapiens	INH	%	1.0
	16565626	CHEMBL3803244	Inhibition of full length human recombinant N-terminal GST-tagged GSK3beta expressed in baculovirus infected sf9 cells using GSK3 substrate at 100 uM incubated for 10 mins by scintillation counting method relative to control	B	Cc1cc(N/N=C/c2ccc(O)cc2)nc2ccccc12		CHEMBL3799359	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	INH	%	0.0
	16565627	CHEMBL3803244	Inhibition of full length human recombinant N-terminal GST-tagged GSK3beta expressed in baculovirus infected sf9 cells using GSK3 substrate at 100 uM incubated for 10 mins by scintillation counting method relative to control	B	COc1ccc(-c2nnc3c(NCCN4CCOCC4)cccn23)cc1OC		CHEMBL3798991	=	Inhibition	%	14.0	CHEMBL262	Homo sapiens	INH	%	14.0
Not Active	16565687	CHEMBL3801096	Inhibition of GSK3beta (unknown origin)	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441		Kd			CHEMBL262	Homo sapiens	Kd		
Not Active	16565688	CHEMBL3801096	Inhibition of GSK3beta (unknown origin)	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336		Kd			CHEMBL262	Homo sapiens	Kd		
	16578389	CHEMBL3802261	Inhibition of full length wild type human GSK3beta expressed in mammalian system assessed as enzyme activity at 1 uM relative to control	B	CN(C)S(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1F		CHEMBL3798256	=	Activity	%	100.0	CHEMBL262	Homo sapiens	Activity	%	100.0
	16580629	CHEMBL3802860	Inhibition of N-terminal GST-tagged GSK-3beta (unknown origin) expressed in baculovirus preincubated for 5 mins using GSK3 substrate peptide measured after 60 mins in presence of [gamma-33P]ATP by scintillation counting method	B	C[C@H](c1ccccc1)N1c2cc(-n3c(=O)[nH]c4ncccc43)ccc2C(=O)NC1(C)C		CHEMBL3798011	>	IC50	nM	10.0	CHEMBL262	Homo sapiens	IC50	nM	10.0
	16580664	CHEMBL3803137	Inhibition of N-terminal GST-tagged GSK-3beta (unknown origin) expressed in baculovirus preincubated for 5 mins using GSK3 substrate peptide as substrate at 1 uM measured after 60 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CCN1c2cc(-c3c[nH]c4ncccc34)ccc2C(=O)NC1(C)C		CHEMBL3798713	=	Inhibition	%	64.0	CHEMBL262	Homo sapiens	INH	%	64.0
	16580665	CHEMBL3803137	Inhibition of N-terminal GST-tagged GSK-3beta (unknown origin) expressed in baculovirus preincubated for 5 mins using GSK3 substrate peptide as substrate at 1 uM measured after 60 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CCN1c2cc(-n3c(=O)[nH]c4ncccc43)ccc2C(=O)NC1(C)C		CHEMBL3798933	=	Inhibition	%	27.0	CHEMBL262	Homo sapiens	INH	%	27.0
	16581353	CHEMBL3803771	Inhibition of human recombinant GSK3beta expressed in Escherichia coli using GS-1 as substrate incubated for 20 mins by gamma[32P]ATP-based scintillation counting analysis	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	IC50	nM	1500.0	CHEMBL262	Homo sapiens	IC50	uM	1.5
	16581374	CHEMBL3803771	Inhibition of human recombinant GSK3beta expressed in Escherichia coli using GS-1 as substrate incubated for 20 mins by gamma[32P]ATP-based scintillation counting analysis	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	=	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	uM	1.0
	16581375	CHEMBL3803771	Inhibition of human recombinant GSK3beta expressed in Escherichia coli using GS-1 as substrate incubated for 20 mins by gamma[32P]ATP-based scintillation counting analysis	B	CCCCCCCCCCCC(=O)NNC(=O)c1c(O)c2ccccc2n(CC)c1=O		CHEMBL2037482	=	IC50	nM	2800.0	CHEMBL262	Homo sapiens	IC50	uM	2.8
	16581376	CHEMBL3803771	Inhibition of human recombinant GSK3beta expressed in Escherichia coli using GS-1 as substrate incubated for 20 mins by gamma[32P]ATP-based scintillation counting analysis	B	O=C(CCl)c1scc(Br)c1Br		CHEMBL357136	=	IC50	nM	500.0	CHEMBL262	Homo sapiens	IC50	uM	0.5
	16581377	CHEMBL3803771	Inhibition of human recombinant GSK3beta expressed in Escherichia coli using GS-1 as substrate incubated for 20 mins by gamma[32P]ATP-based scintillation counting analysis	B	COc1ccc(CNC(=O)Nc2nc(C)c(C(C)=O)s2)cc1		CHEMBL3747661	=	IC50	nM	600.0	CHEMBL262	Homo sapiens	IC50	uM	0.6
	16587027	CHEMBL3807439	Inhibition of GSK3beta (unknown origin) in presence of gamma33-ATP	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	16589175	CHEMBL3807595	Inhibition of GSK3beta (unknown origin) at 1 ug/ml after 60 mins by Z-LYTE kinase assay	B	Cn1ncc(Cl)c1-c1cc(C(=O)NC2(c3ccc(Cl)c(Cl)c3)CCNCC2)oc1Cl		CHEMBL3805228	=	Inhibition	%	6.6	CHEMBL262	Homo sapiens	INH	%	6.6
	16589722	CHEMBL3807910	Inhibition of GSK3beta (unknown origin) after 60 mins by Z-LYTE kinase assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	51.6	CHEMBL262	Homo sapiens	IC50	nM	51.6
	16592324	CHEMBL3807328	Inhibition of full length human recombinant His-tagged GSK3beta expressed in baculovirus expression system using Ser/Thr peptide 9 substrate at 1 uM by Z-Lyte assay relative to control	B	NC(=O)c1cc2c(Oc3ccc(Cl)cc3)cncc2s1		CHEMBL118518	>	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	16592325	CHEMBL3807328	Inhibition of full length human recombinant His-tagged GSK3beta expressed in baculovirus expression system using Ser/Thr peptide 9 substrate at 1 uM by Z-Lyte assay relative to control	B	NC(=O)c1cc2c(Oc3ccc(Cl)cc3)cnc(N)c2s1		CHEMBL3805194	>	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	16593492	CHEMBL3812175	Inhibition of GSK3B (unknown origin) at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808884	<	Inhibition	%	40.0	CHEMBL262	Homo sapiens	INH	%	40.0
	16594887	CHEMBL3812431	Inhibition of full length human GSK3B assessed as enzyme activity at 10 uM by KINOMEScan assay	B	O=C1C2=C(C(=O)c3c(O)ccc(O)c31)[C@@H](O)[C@@H](O)[C@@H](O)C2		CHEMBL1987813	=	Activity	%	85.0	CHEMBL262	Homo sapiens	Activity	%	85.0
	16611842	CHEMBL3816756	Inhibition of human GSK3beta (2 to 420 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3815046	=	Activity	%	-94.0	CHEMBL262	Homo sapiens	Activity	%	-94.0
	16611843	CHEMBL3816756	Inhibition of human GSK3beta (2 to 420 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3814140	=	Activity	%	-94.0	CHEMBL262	Homo sapiens	Activity	%	-94.0
	16611844	CHEMBL3816756	Inhibition of human GSK3beta (2 to 420 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncccc23)nc(N)n1		CHEMBL3814340	=	Activity	%	-86.0	CHEMBL262	Homo sapiens	Activity	%	-86.0
	16611845	CHEMBL3816756	Inhibition of human GSK3beta (2 to 420 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	=	Activity	%	-77.0	CHEMBL262	Homo sapiens	Activity	%	-77.0
	16614494	CHEMBL3816692	Inhibition of human GSK3beta at 1 uM using [YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE] as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	5.0	CHEMBL262	Homo sapiens	INH	%	5.0
	16618200	CHEMBL3816354	Inhibition of full length recombinant human His-tagged GSK3-beta expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	16619682	CHEMBL3820250	Inhibition of recombinant human full length His-tagged GSK3beta expressed in Baculovirus at 1 uM relative to control	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Inhibition	%	75.0	CHEMBL262	Homo sapiens	INH	%	75.0
	16621511	CHEMBL3820496	Inhibition of GSK3beta (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN1C(=O)COc2c1cnc1ccc(Sc3nnc4c(F)cc(-c5cnn(C)c5)cn34)cc21		CHEMBL3818247	=	IC50	nM	16184.0	CHEMBL262	Homo sapiens	IC50	nM	16184.0
	16622218	CHEMBL3820496	Inhibition of GSK3beta (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	18.6	CHEMBL262	Homo sapiens	IC50	nM	18.6
	16628481	CHEMBL3820184	Inhibition of human recombinant full-length GSK3beta at 1 uM after 30 mins	B	O=C(Nc1cc(Nc2c(Cl)cnc3c2OCO3)ccn1)C1CC1		CHEMBL3818173	<	Inhibition	%	80.0	CHEMBL262	Homo sapiens	INH	%	80.0
	16641995	CHEMBL3826407	Inhibition of His-tagged full-length recombinant human GSK3 beta expressed in baculovirus system at 100 nM by Z-lyte assay	B	O=C(CNC(=O)c1cccn(Cc2ccc(F)c(F)c2)c1=O)Nc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL3824119	=	Inhibition	%	24.0	CHEMBL262	Homo sapiens	INH	%	24.0
	16649004	CHEMBL3829973	Inhibition of recombinant human N-terminal His-tagged GSK-3beta expressed in Escherichia coli using glycogen synthase-2 as substrate and ATP measured after 30 mins by Kinase-Glo luminescent kinase assay	B	Cc1nc2ccccc2n1Cc1nnc(Nc2ccccc2Br)s1		CHEMBL3828114	=	IC50	nM	190.0	CHEMBL262	Homo sapiens	IC50	nM	190.0
	16649005	CHEMBL3829973	Inhibition of recombinant human N-terminal His-tagged GSK-3beta expressed in Escherichia coli using glycogen synthase-2 as substrate and ATP measured after 30 mins by Kinase-Glo luminescent kinase assay	B	Cc1nc2ccccc2n1CC(=O)NNC(=O)Cc1ccc(Cl)cc1		CHEMBL3827901	=	IC50	nM	131.0	CHEMBL262	Homo sapiens	IC50	nM	131.0
	16649006	CHEMBL3829973	Inhibition of recombinant human N-terminal His-tagged GSK-3beta expressed in Escherichia coli using glycogen synthase-2 as substrate and ATP measured after 30 mins by Kinase-Glo luminescent kinase assay	B	Cc1ccccc1CC(=O)NNC(=O)Cn1c(C)nc2ccccc21		CHEMBL3827219	=	IC50	nM	92.0	CHEMBL262	Homo sapiens	IC50	nM	92.0
	16649007	CHEMBL3829973	Inhibition of recombinant human N-terminal His-tagged GSK-3beta expressed in Escherichia coli using glycogen synthase-2 as substrate and ATP measured after 30 mins by Kinase-Glo luminescent kinase assay	B	COc1ccc(CC(=O)NNC(=O)Cn2c(C)nc3ccccc32)cc1		CHEMBL3828571	=	IC50	nM	379.0	CHEMBL262	Homo sapiens	IC50	nM	379.0
	16649008	CHEMBL3829973	Inhibition of recombinant human N-terminal His-tagged GSK-3beta expressed in Escherichia coli using glycogen synthase-2 as substrate and ATP measured after 30 mins by Kinase-Glo luminescent kinase assay	B	Cc1nc2ccccc2n1CC(=O)NNC(=O)Cc1ccc([N+](=O)[O-])cc1		CHEMBL3828491	=	IC50	nM	205.0	CHEMBL262	Homo sapiens	IC50	nM	205.0
	16649009	CHEMBL3829973	Inhibition of recombinant human N-terminal His-tagged GSK-3beta expressed in Escherichia coli using glycogen synthase-2 as substrate and ATP measured after 30 mins by Kinase-Glo luminescent kinase assay	B	Cc1nc2ccccc2n1CC(=O)NNC(=O)c1c[nH]c2ccccc12		CHEMBL3827726	=	IC50	nM	148.0	CHEMBL262	Homo sapiens	IC50	nM	148.0
	16649010	CHEMBL3829973	Inhibition of recombinant human N-terminal His-tagged GSK-3beta expressed in Escherichia coli using glycogen synthase-2 as substrate and ATP measured after 30 mins by Kinase-Glo luminescent kinase assay	B	Cc1nc2ccccc2n1CC(=O)NNC(=O)c1ccc[nH]1		CHEMBL3828624	=	IC50	nM	124.0	CHEMBL262	Homo sapiens	IC50	nM	124.0
	16649011	CHEMBL3829973	Inhibition of recombinant human N-terminal His-tagged GSK-3beta expressed in Escherichia coli using glycogen synthase-2 as substrate and ATP measured after 30 mins by Kinase-Glo luminescent kinase assay	B	Cc1nc2ccccc2n1CC(=O)NNC(=O)CCC(=O)c1ccc(Oc2ccccc2)cc1		CHEMBL3828240	=	IC50	nM	80.0	CHEMBL262	Homo sapiens	IC50	nM	80.0
	16649012	CHEMBL3829973	Inhibition of recombinant human N-terminal His-tagged GSK-3beta expressed in Escherichia coli using glycogen synthase-2 as substrate and ATP measured after 30 mins by Kinase-Glo luminescent kinase assay	B	Cc1nc2ccccc2n1CC(=O)NNC(=O)Cc1ccccc1		CHEMBL3828609	=	IC50	nM	105.0	CHEMBL262	Homo sapiens	IC50	nM	105.0
	16649013	CHEMBL3829973	Inhibition of recombinant human N-terminal His-tagged GSK-3beta expressed in Escherichia coli using glycogen synthase-2 as substrate and ATP measured after 30 mins by Kinase-Glo luminescent kinase assay	B	Cc1nc2ccccc2n1CC(=O)NNC(=O)C(=O)c1c[nH]c2ccccc12		CHEMBL3828321	=	IC50	nM	72.0	CHEMBL262	Homo sapiens	IC50	nM	72.0
	16649014	CHEMBL3829973	Inhibition of recombinant human N-terminal His-tagged GSK-3beta expressed in Escherichia coli using glycogen synthase-2 as substrate and ATP measured after 30 mins by Kinase-Glo luminescent kinase assay	B	Cc1nc2ccccc2n1CC(=O)NNC(=O)Cc1cc2ccccc2[nH]1		CHEMBL3828098	=	IC50	nM	135.0	CHEMBL262	Homo sapiens	IC50	nM	135.0
	16649015	CHEMBL3829973	Inhibition of recombinant human N-terminal His-tagged GSK-3beta expressed in Escherichia coli using glycogen synthase-2 as substrate and ATP measured after 30 mins by Kinase-Glo luminescent kinase assay	B	Cc1nc2ccccc2n1CC(=O)NNC(=O)Cc1cccc2ccccc12		CHEMBL3827895	=	IC50	nM	157.0	CHEMBL262	Homo sapiens	IC50	nM	157.0
	16649016	CHEMBL3829973	Inhibition of recombinant human N-terminal His-tagged GSK-3beta expressed in Escherichia coli using glycogen synthase-2 as substrate and ATP measured after 30 mins by Kinase-Glo luminescent kinase assay	B	COc1ccc(C(=O)CCC(=O)NNC(=O)Cn2c(C)nc3ccccc32)cc1		CHEMBL3827724	=	IC50	nM	561.0	CHEMBL262	Homo sapiens	IC50	nM	561.0
	16649017	CHEMBL3829973	Inhibition of recombinant human N-terminal His-tagged GSK-3beta expressed in Escherichia coli using glycogen synthase-2 as substrate and ATP measured after 30 mins by Kinase-Glo luminescent kinase assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	54.0	CHEMBL262	Homo sapiens	IC50	nM	54.0
	16649022	CHEMBL3829973	Inhibition of recombinant human N-terminal His-tagged GSK-3beta expressed in Escherichia coli using glycogen synthase-2 as substrate and ATP measured after 30 mins by Kinase-Glo luminescent kinase assay	B	CCCCNc1nnc(Cn2c(C)nc3ccccc32)s1		CHEMBL3828397	=	IC50	nM	582.0	CHEMBL262	Homo sapiens	IC50	nM	582.0
	16649023	CHEMBL3829973	Inhibition of recombinant human N-terminal His-tagged GSK-3beta expressed in Escherichia coli using glycogen synthase-2 as substrate and ATP measured after 30 mins by Kinase-Glo luminescent kinase assay	B	Cc1nc2ccccc2n1Cc1nnc(NC2CCCCC2)s1		CHEMBL3828352	=	IC50	nM	406.0	CHEMBL262	Homo sapiens	IC50	nM	406.0
	16649024	CHEMBL3829973	Inhibition of recombinant human N-terminal His-tagged GSK-3beta expressed in Escherichia coli using glycogen synthase-2 as substrate and ATP measured after 30 mins by Kinase-Glo luminescent kinase assay	B	Cc1nc2ccccc2n1Cc1nnc(Nc2ccc([N+](=O)[O-])cc2)s1		CHEMBL3827727	=	IC50	nM	107.0	CHEMBL262	Homo sapiens	IC50	nM	107.0
	16649025	CHEMBL3829973	Inhibition of recombinant human N-terminal His-tagged GSK-3beta expressed in Escherichia coli using glycogen synthase-2 as substrate and ATP measured after 30 mins by Kinase-Glo luminescent kinase assay	B	CCOc1ccc(Nc2nnc(Cn3c(C)nc4ccccc43)s2)cc1		CHEMBL3827240	=	IC50	nM	293.0	CHEMBL262	Homo sapiens	IC50	nM	293.0
	16649026	CHEMBL3829973	Inhibition of recombinant human N-terminal His-tagged GSK-3beta expressed in Escherichia coli using glycogen synthase-2 as substrate and ATP measured after 30 mins by Kinase-Glo luminescent kinase assay	B	COc1ccccc1Nc1nnc(Cn2c(C)nc3ccccc32)s1		CHEMBL3828150	=	IC50	nM	184.0	CHEMBL262	Homo sapiens	IC50	nM	184.0
	16649027	CHEMBL3829973	Inhibition of recombinant human N-terminal His-tagged GSK-3beta expressed in Escherichia coli using glycogen synthase-2 as substrate and ATP measured after 30 mins by Kinase-Glo luminescent kinase assay	B	COc1ccc(Nc2nnc(Cn3c(C)nc4ccccc43)s2)cc1		CHEMBL3827844	=	IC50	nM	151.0	CHEMBL262	Homo sapiens	IC50	nM	151.0
	16649033	CHEMBL3829973	Inhibition of recombinant human N-terminal His-tagged GSK-3beta expressed in Escherichia coli using glycogen synthase-2 as substrate and ATP measured after 30 mins by Kinase-Glo luminescent kinase assay	B	Cc1nc2ccccc2n1Cc1nnc(Nc2ccccc2F)s1		CHEMBL3828131	=	IC50	nM	76.0	CHEMBL262	Homo sapiens	IC50	nM	76.0
	16649034	CHEMBL3829973	Inhibition of recombinant human N-terminal His-tagged GSK-3beta expressed in Escherichia coli using glycogen synthase-2 as substrate and ATP measured after 30 mins by Kinase-Glo luminescent kinase assay	B	Cc1nc2ccccc2n1Cc1nnc(Nc2ccc(Br)cc2)s1		CHEMBL3828350	=	IC50	nM	173.0	CHEMBL262	Homo sapiens	IC50	nM	173.0
	16649035	CHEMBL3829973	Inhibition of recombinant human N-terminal His-tagged GSK-3beta expressed in Escherichia coli using glycogen synthase-2 as substrate and ATP measured after 30 mins by Kinase-Glo luminescent kinase assay	B	Cc1nc2ccccc2n1Cc1nnc(Nc2ccc(F)cc2)s1		CHEMBL3828006	=	IC50	nM	134.0	CHEMBL262	Homo sapiens	IC50	nM	134.0
	16649036	CHEMBL3829973	Inhibition of recombinant human N-terminal His-tagged GSK-3beta expressed in Escherichia coli using glycogen synthase-2 as substrate and ATP measured after 30 mins by Kinase-Glo luminescent kinase assay	B	Cc1nc2ccccc2n1Cc1nnc(Nc2ccccc2Cl)s1		CHEMBL3827511	=	IC50	nM	122.0	CHEMBL262	Homo sapiens	IC50	nM	122.0
	16649037	CHEMBL3829973	Inhibition of recombinant human N-terminal His-tagged GSK-3beta expressed in Escherichia coli using glycogen synthase-2 as substrate and ATP measured after 30 mins by Kinase-Glo luminescent kinase assay	B	Cc1nc2ccccc2n1Cc1nnc(Nc2ccc(Cl)cc2)s1		CHEMBL3827702	=	IC50	nM	145.0	CHEMBL262	Homo sapiens	IC50	nM	145.0
	16649038	CHEMBL3829973	Inhibition of recombinant human N-terminal His-tagged GSK-3beta expressed in Escherichia coli using glycogen synthase-2 as substrate and ATP measured after 30 mins by Kinase-Glo luminescent kinase assay	B	Cc1nc2ccccc2n1Cc1nnc(Nc2ccccc2)s1		CHEMBL3828407	=	IC50	nM	157.0	CHEMBL262	Homo sapiens	IC50	nM	157.0
	16654148	CHEMBL3829175	Inhibition of human GSK3beta (2 to 420 residues) assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay	B	Cc1cc(=O)c2c(O)cc(O)c([C@H]3CCN(C)C[C@H]3O)c2o1		CHEMBL1077604	=	Activity	%	66.0	CHEMBL262	Homo sapiens	Activity	%	66.0
Active	16672393	CHEMBL3855725	Binding affinity to GSK-3 beta (unknown origin) by STD NMR analysis	B	C[C@H]1Nc2cccnc2NC1=O		CHEMBL3984982		Activity			CHEMBL262	Homo sapiens	Activity		
	16672395	CHEMBL3855723	Inhibition of recombinant full-length N-terminal GST tagged human GSK-3 beta expressed in baculovirus infected Sf9 insect cells using GSM as substrate after 5 mins by ADP-Glo luminescence assay	B	O=C1Nc2ncccc2N[C@@H]1Cc1c[nH]c2ccccc12		CHEMBL3969394	=	IC50	nM	18000.0	CHEMBL262	Homo sapiens	IC50	uM	18.0
	16672396	CHEMBL3855723	Inhibition of recombinant full-length N-terminal GST tagged human GSK-3 beta expressed in baculovirus infected Sf9 insect cells using GSM as substrate after 5 mins by ADP-Glo luminescence assay	B	O=C1Nc2ncccc2N[C@H]1Cc1c[nH]c2ccccc12		CHEMBL3986013	=	IC50	nM	322000.0	CHEMBL262	Homo sapiens	IC50	uM	322.0
	16672397	CHEMBL3855722	Binding affinity to GSK-3 beta (unknown origin) after 30 mins by isothermal titration calorimetry	B	O=C1Nc2ncccc2N[C@@H]1Cc1c[nH]c2ccccc12		CHEMBL3969394	=	Kd	nM	9000.0	CHEMBL262	Homo sapiens	Kd	uM	9.0
	16672398	CHEMBL3855722	Binding affinity to GSK-3 beta (unknown origin) after 30 mins by isothermal titration calorimetry	B	C[C@H]1Nc2cccnc2NC1=O		CHEMBL3984982	=	Kd	nM	600000.0	CHEMBL262	Homo sapiens	Kd	mM	0.6
Active	16672399	CHEMBL3855721	Binding affinity to GSK-3 beta (unknown origin) by WaterLOGSY NMR analysis	B	C[C@H]1Nc2cccnc2NC1=O		CHEMBL3984982		Activity			CHEMBL262	Homo sapiens	Activity		
	16672400	CHEMBL3855720	Inhibition of recombinant full-length N-terminal GST tagged human GSK-3 beta expressed in baculovirus infected Sf9 insect cells at 1 mM using GSM as substrate after 5 mins by ADP-Glo luminescence assay	B	O=C1Nc2ncccc2N[C@@H]1Cc1c[nH]c2ccccc12		CHEMBL3969394	=	Inhibition	%	94.0	CHEMBL262	Homo sapiens	INH	%	94.0
	16672401	CHEMBL3855720	Inhibition of recombinant full-length N-terminal GST tagged human GSK-3 beta expressed in baculovirus infected Sf9 insect cells at 1 mM using GSM as substrate after 5 mins by ADP-Glo luminescence assay	B	O=C1Nc2ncccc2N[C@@H]1Cc1ccc(O)cc1		CHEMBL3898185	=	Inhibition	%	88.0	CHEMBL262	Homo sapiens	INH	%	88.0
	16672402	CHEMBL3855720	Inhibition of recombinant full-length N-terminal GST tagged human GSK-3 beta expressed in baculovirus infected Sf9 insect cells at 1 mM using GSM as substrate after 5 mins by ADP-Glo luminescence assay	B	O=C1Nc2ncccc2N[C@@H]1Cc1ccccc1		CHEMBL3958323	=	Inhibition	%	63.0	CHEMBL262	Homo sapiens	INH	%	63.0
	16672403	CHEMBL3855720	Inhibition of recombinant full-length N-terminal GST tagged human GSK-3 beta expressed in baculovirus infected Sf9 insect cells at 1 mM using GSM as substrate after 5 mins by ADP-Glo luminescence assay	B	O=C1Nc2ncccc2N[C@H]1Cc1c[nH]c2ccccc12		CHEMBL3986013	=	Inhibition	%	76.0	CHEMBL262	Homo sapiens	INH	%	76.0
	16672404	CHEMBL3855720	Inhibition of recombinant full-length N-terminal GST tagged human GSK-3 beta expressed in baculovirus infected Sf9 insect cells at 1 mM using GSM as substrate after 5 mins by ADP-Glo luminescence assay	B	O=C1Nc2ncccc2N[C@H]1Cc1ccc(O)cc1		CHEMBL3949669	=	Inhibition	%	78.0	CHEMBL262	Homo sapiens	INH	%	78.0
	16672405	CHEMBL3855720	Inhibition of recombinant full-length N-terminal GST tagged human GSK-3 beta expressed in baculovirus infected Sf9 insect cells at 1 mM using GSM as substrate after 5 mins by ADP-Glo luminescence assay	B	O=C1Nc2ncccc2N[C@H]1Cc1ccccc1		CHEMBL3928509	=	Inhibition	%	55.0	CHEMBL262	Homo sapiens	INH	%	55.0
	16672406	CHEMBL3855720	Inhibition of recombinant full-length N-terminal GST tagged human GSK-3 beta expressed in baculovirus infected Sf9 insect cells at 1 mM using GSM as substrate after 5 mins by ADP-Glo luminescence assay	B	CC(C)[C@@H]1Nc2cccnc2NC1=O		CHEMBL3940908	=	Inhibition	%	25.0	CHEMBL262	Homo sapiens	INH	%	25.0
	16672407	CHEMBL3855720	Inhibition of recombinant full-length N-terminal GST tagged human GSK-3 beta expressed in baculovirus infected Sf9 insect cells at 1 mM using GSM as substrate after 5 mins by ADP-Glo luminescence assay	B	CC(C)[C@H]1Nc2cccnc2NC1=O		CHEMBL3970452	=	Inhibition	%	57.0	CHEMBL262	Homo sapiens	INH	%	57.0
	16672408	CHEMBL3855720	Inhibition of recombinant full-length N-terminal GST tagged human GSK-3 beta expressed in baculovirus infected Sf9 insect cells at 1 mM using GSM as substrate after 5 mins by ADP-Glo luminescence assay	B	CC1(C)Nc2cccnc2NC1=O		CHEMBL3973364	=	Inhibition	%	26.0	CHEMBL262	Homo sapiens	INH	%	26.0
	16672409	CHEMBL3855720	Inhibition of recombinant full-length N-terminal GST tagged human GSK-3 beta expressed in baculovirus infected Sf9 insect cells at 1 mM using GSM as substrate after 5 mins by ADP-Glo luminescence assay	B	Cc1nc2cccnc2[nH]c1=O		CHEMBL3943847	=	Inhibition	%	35.0	CHEMBL262	Homo sapiens	INH	%	35.0
	16672410	CHEMBL3855720	Inhibition of recombinant full-length N-terminal GST tagged human GSK-3 beta expressed in baculovirus infected Sf9 insect cells at 1 mM using GSM as substrate after 5 mins by ADP-Glo luminescence assay	B	C[C@H]1Nc2cccnc2N(C)C1=O		CHEMBL3901493	=	Inhibition	%	19.0	CHEMBL262	Homo sapiens	INH	%	19.0
	16672411	CHEMBL3855720	Inhibition of recombinant full-length N-terminal GST tagged human GSK-3 beta expressed in baculovirus infected Sf9 insect cells at 1 mM using GSM as substrate after 5 mins by ADP-Glo luminescence assay	B	C[C@@H]1CNc2ncccc2N1		CHEMBL3898976	=	Inhibition	%	17.0	CHEMBL262	Homo sapiens	INH	%	17.0
	16672412	CHEMBL3855720	Inhibition of recombinant full-length N-terminal GST tagged human GSK-3 beta expressed in baculovirus infected Sf9 insect cells at 1 mM using GSM as substrate after 5 mins by ADP-Glo luminescence assay	B	C[C@H]1Nc2ncccc2NC1=O		CHEMBL3962838	=	Inhibition	%	66.0	CHEMBL262	Homo sapiens	INH	%	66.0
	16672413	CHEMBL3855720	Inhibition of recombinant full-length N-terminal GST tagged human GSK-3 beta expressed in baculovirus infected Sf9 insect cells at 1 mM using GSM as substrate after 5 mins by ADP-Glo luminescence assay	B	C[C@H]1Nc2cnccc2NC1=O		CHEMBL3892996	=	Inhibition	%	25.0	CHEMBL262	Homo sapiens	INH	%	25.0
	16672414	CHEMBL3855720	Inhibition of recombinant full-length N-terminal GST tagged human GSK-3 beta expressed in baculovirus infected Sf9 insect cells at 1 mM using GSM as substrate after 5 mins by ADP-Glo luminescence assay	B	C[C@H]1Nc2ccncc2NC1=O		CHEMBL3929754	=	Inhibition	%	61.0	CHEMBL262	Homo sapiens	INH	%	61.0
	16672415	CHEMBL3855720	Inhibition of recombinant full-length N-terminal GST tagged human GSK-3 beta expressed in baculovirus infected Sf9 insect cells at 1 mM using GSM as substrate after 5 mins by ADP-Glo luminescence assay	B	C[C@H]1Nc2ccccc2NC1=O		CHEMBL3916997	=	Inhibition	%	12.0	CHEMBL262	Homo sapiens	INH	%	12.0
	16672416	CHEMBL3855720	Inhibition of recombinant full-length N-terminal GST tagged human GSK-3 beta expressed in baculovirus infected Sf9 insect cells at 1 mM using GSM as substrate after 5 mins by ADP-Glo luminescence assay	B	C[C@H]1Nc2cccnc2NC1=O		CHEMBL3984982	=	Inhibition	%	46.0	CHEMBL262	Homo sapiens	INH	%	46.0
	16672417	CHEMBL3855720	Inhibition of recombinant full-length N-terminal GST tagged human GSK-3 beta expressed in baculovirus infected Sf9 insect cells at 1 mM using GSM as substrate after 5 mins by ADP-Glo luminescence assay	B	C[C@@H]1Nc2ncccc2NC1=O		CHEMBL3908009	=	Inhibition	%	63.0	CHEMBL262	Homo sapiens	INH	%	63.0
	16672418	CHEMBL3855720	Inhibition of recombinant full-length N-terminal GST tagged human GSK-3 beta expressed in baculovirus infected Sf9 insect cells at 1 mM using GSM as substrate after 5 mins by ADP-Glo luminescence assay	B	C[C@@H]1Nc2cnccc2NC1=O		CHEMBL3931483	=	Inhibition	%	29.0	CHEMBL262	Homo sapiens	INH	%	29.0
	16672419	CHEMBL3855720	Inhibition of recombinant full-length N-terminal GST tagged human GSK-3 beta expressed in baculovirus infected Sf9 insect cells at 1 mM using GSM as substrate after 5 mins by ADP-Glo luminescence assay	B	C[C@@H]1Nc2ccncc2NC1=O		CHEMBL3958987	=	Inhibition	%	69.0	CHEMBL262	Homo sapiens	INH	%	69.0
	16672420	CHEMBL3855720	Inhibition of recombinant full-length N-terminal GST tagged human GSK-3 beta expressed in baculovirus infected Sf9 insect cells at 1 mM using GSM as substrate after 5 mins by ADP-Glo luminescence assay	B	C[C@@H]1Nc2ccccc2NC1=O		CHEMBL3818285	=	Inhibition	%	9.0	CHEMBL262	Homo sapiens	INH	%	9.0
	16672421	CHEMBL3855720	Inhibition of recombinant full-length N-terminal GST tagged human GSK-3 beta expressed in baculovirus infected Sf9 insect cells at 1 mM using GSM as substrate after 5 mins by ADP-Glo luminescence assay	B	C[C@@H]1Nc2cccnc2NC1=O		CHEMBL3941552	=	Inhibition	%	19.0	CHEMBL262	Homo sapiens	INH	%	19.0
	16672422	CHEMBL3855719	Binding affinity to GSK-3 beta (unknown origin) assessed as thermal shift at 1.25 mM by differential scanning fluorimetry	B	O=C1Nc2ncccc2N[C@@H]1Cc1c[nH]c2ccccc12		CHEMBL3969394	=	deltaT	degrees C	4.5	CHEMBL262	Homo sapiens	deltaT	degrees C	4.5
	16672423	CHEMBL3855719	Binding affinity to GSK-3 beta (unknown origin) assessed as thermal shift at 1.25 mM by differential scanning fluorimetry	B	O=C1Nc2ncccc2N[C@@H]1Cc1ccc(O)cc1		CHEMBL3898185	=	deltaT	degrees C	2.9	CHEMBL262	Homo sapiens	deltaT	degrees C	2.9
	16672424	CHEMBL3855719	Binding affinity to GSK-3 beta (unknown origin) assessed as thermal shift at 1.25 mM by differential scanning fluorimetry	B	O=C1Nc2ncccc2N[C@@H]1Cc1ccccc1		CHEMBL3958323	=	deltaT	degrees C	1.6	CHEMBL262	Homo sapiens	deltaT	degrees C	1.6
	16672425	CHEMBL3855719	Binding affinity to GSK-3 beta (unknown origin) assessed as thermal shift at 1.25 mM by differential scanning fluorimetry	B	O=C1Nc2ncccc2N[C@H]1Cc1c[nH]c2ccccc12		CHEMBL3986013	=	deltaT	degrees C	1.7	CHEMBL262	Homo sapiens	deltaT	degrees C	1.7
	16672426	CHEMBL3855719	Binding affinity to GSK-3 beta (unknown origin) assessed as thermal shift at 1.25 mM by differential scanning fluorimetry	B	O=C1Nc2ncccc2N[C@H]1Cc1ccc(O)cc1		CHEMBL3949669	=	deltaT	degrees C	2.1	CHEMBL262	Homo sapiens	deltaT	degrees C	2.1
	16672427	CHEMBL3855719	Binding affinity to GSK-3 beta (unknown origin) assessed as thermal shift at 1.25 mM by differential scanning fluorimetry	B	O=C1Nc2ncccc2N[C@H]1Cc1ccccc1		CHEMBL3928509	=	deltaT	degrees C	0.0	CHEMBL262	Homo sapiens	deltaT	degrees C	0.0
	16672428	CHEMBL3855719	Binding affinity to GSK-3 beta (unknown origin) assessed as thermal shift at 1.25 mM by differential scanning fluorimetry	B	CC(C)[C@@H]1Nc2cccnc2NC1=O		CHEMBL3940908	=	deltaT	degrees C	0.0	CHEMBL262	Homo sapiens	deltaT	degrees C	0.0
	16672429	CHEMBL3855719	Binding affinity to GSK-3 beta (unknown origin) assessed as thermal shift at 1.25 mM by differential scanning fluorimetry	B	CC(C)[C@H]1Nc2cccnc2NC1=O		CHEMBL3970452	=	deltaT	degrees C	1.6	CHEMBL262	Homo sapiens	deltaT	degrees C	1.6
	16672430	CHEMBL3855719	Binding affinity to GSK-3 beta (unknown origin) assessed as thermal shift at 1.25 mM by differential scanning fluorimetry	B	Cc1nc2cccnc2[nH]c1=O		CHEMBL3943847	=	deltaT	degrees C	0.5	CHEMBL262	Homo sapiens	deltaT	degrees C	0.5
	16672431	CHEMBL3855719	Binding affinity to GSK-3 beta (unknown origin) assessed as thermal shift at 1.25 mM by differential scanning fluorimetry	B	C[C@H]1Nc2cccnc2NC1=O		CHEMBL3984982	=	deltaT	degrees C	1.0	CHEMBL262	Homo sapiens	deltaT	degrees C	1.0
	16672432	CHEMBL3855719	Binding affinity to GSK-3 beta (unknown origin) assessed as thermal shift at 1.25 mM by differential scanning fluorimetry	B	C[C@@H]1Nc2cccnc2NC1=O		CHEMBL3941552	=	deltaT	degrees C	0.0	CHEMBL262	Homo sapiens	deltaT	degrees C	0.0
	16672433	CHEMBL3855718	Binding affinity to GSK-3 beta (unknown origin) assessed as assessed as thermal shift at 2.5 mM by differential scanning fluorimetry	B	CC(C)[C@H]1Nc2cccnc2NC1=O		CHEMBL3970452	=	deltaT	degrees C	2.3	CHEMBL262	Homo sapiens	deltaT	degrees C	2.3
	16672434	CHEMBL3855718	Binding affinity to GSK-3 beta (unknown origin) assessed as assessed as thermal shift at 2.5 mM by differential scanning fluorimetry	B	CC1(C)Nc2cccnc2NC1=O		CHEMBL3973364	=	deltaT	degrees C	0.7	CHEMBL262	Homo sapiens	deltaT	degrees C	0.7
	16672435	CHEMBL3855718	Binding affinity to GSK-3 beta (unknown origin) assessed as assessed as thermal shift at 2.5 mM by differential scanning fluorimetry	B	C[C@H]1Nc2cccnc2N(C)C1=O		CHEMBL3901493	=	deltaT	degrees C	0.0	CHEMBL262	Homo sapiens	deltaT	degrees C	0.0
	16672436	CHEMBL3855718	Binding affinity to GSK-3 beta (unknown origin) assessed as assessed as thermal shift at 2.5 mM by differential scanning fluorimetry	B	C[C@@H]1CNc2ncccc2N1		CHEMBL3898976	=	deltaT	degrees C	0.0	CHEMBL262	Homo sapiens	deltaT	degrees C	0.0
	16672437	CHEMBL3855718	Binding affinity to GSK-3 beta (unknown origin) assessed as assessed as thermal shift at 2.5 mM by differential scanning fluorimetry	B	C[C@H]1Nc2ncccc2NC1=O		CHEMBL3962838	=	deltaT	degrees C	1.4	CHEMBL262	Homo sapiens	deltaT	degrees C	1.4
	16672438	CHEMBL3855718	Binding affinity to GSK-3 beta (unknown origin) assessed as assessed as thermal shift at 2.5 mM by differential scanning fluorimetry	B	C[C@H]1Nc2cnccc2NC1=O		CHEMBL3892996	=	deltaT	degrees C	0.5	CHEMBL262	Homo sapiens	deltaT	degrees C	0.5
	16672439	CHEMBL3855718	Binding affinity to GSK-3 beta (unknown origin) assessed as assessed as thermal shift at 2.5 mM by differential scanning fluorimetry	B	C[C@H]1Nc2ccncc2NC1=O		CHEMBL3929754	=	deltaT	degrees C	1.6	CHEMBL262	Homo sapiens	deltaT	degrees C	1.6
	16672440	CHEMBL3855718	Binding affinity to GSK-3 beta (unknown origin) assessed as assessed as thermal shift at 2.5 mM by differential scanning fluorimetry	B	C[C@H]1Nc2ccccc2NC1=O		CHEMBL3916997	=	deltaT	degrees C	0.0	CHEMBL262	Homo sapiens	deltaT	degrees C	0.0
	16672441	CHEMBL3855718	Binding affinity to GSK-3 beta (unknown origin) assessed as assessed as thermal shift at 2.5 mM by differential scanning fluorimetry	B	C[C@H]1Nc2cccnc2NC1=O		CHEMBL3984982	=	deltaT	degrees C	1.7	CHEMBL262	Homo sapiens	deltaT	degrees C	1.7
	16672442	CHEMBL3855718	Binding affinity to GSK-3 beta (unknown origin) assessed as assessed as thermal shift at 2.5 mM by differential scanning fluorimetry	B	C[C@@H]1Nc2ncccc2NC1=O		CHEMBL3908009	=	deltaT	degrees C	1.0	CHEMBL262	Homo sapiens	deltaT	degrees C	1.0
	16672443	CHEMBL3855718	Binding affinity to GSK-3 beta (unknown origin) assessed as assessed as thermal shift at 2.5 mM by differential scanning fluorimetry	B	C[C@@H]1Nc2cnccc2NC1=O		CHEMBL3931483	=	deltaT	degrees C	0.5	CHEMBL262	Homo sapiens	deltaT	degrees C	0.5
	16672444	CHEMBL3855718	Binding affinity to GSK-3 beta (unknown origin) assessed as assessed as thermal shift at 2.5 mM by differential scanning fluorimetry	B	C[C@@H]1Nc2ccncc2NC1=O		CHEMBL3958987	=	deltaT	degrees C	1.4	CHEMBL262	Homo sapiens	deltaT	degrees C	1.4
	16672445	CHEMBL3855718	Binding affinity to GSK-3 beta (unknown origin) assessed as assessed as thermal shift at 2.5 mM by differential scanning fluorimetry	B	C[C@@H]1Nc2ccccc2NC1=O		CHEMBL3818285	=	deltaT	degrees C	0.0	CHEMBL262	Homo sapiens	deltaT	degrees C	0.0
	16672446	CHEMBL3855718	Binding affinity to GSK-3 beta (unknown origin) assessed as assessed as thermal shift at 2.5 mM by differential scanning fluorimetry	B	O=C1Nc2ncccc2N[C@H]1CO		CHEMBL3932582	=	deltaT	degrees C	0.5	CHEMBL262	Homo sapiens	deltaT	degrees C	0.5
	16672447	CHEMBL3855718	Binding affinity to GSK-3 beta (unknown origin) assessed as assessed as thermal shift at 2.5 mM by differential scanning fluorimetry	B	O=C1Nc2ncccc2N2C[C@H](O)C[C@@H]12		CHEMBL3913572	=	deltaT	degrees C	0.8	CHEMBL262	Homo sapiens	deltaT	degrees C	0.8
	16672448	CHEMBL3855718	Binding affinity to GSK-3 beta (unknown origin) assessed as assessed as thermal shift at 2.5 mM by differential scanning fluorimetry	B	C[C@@H]1Nc2cccnc2NC1=O		CHEMBL3941552	=	deltaT	degrees C	0.5	CHEMBL262	Homo sapiens	deltaT	degrees C	0.5
	16739382	CHEMBL3857032	Inhibition of His tagged recombinant full length human GSK3B expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN(C)C)cc3)cc12)c1ccccc1		CHEMBL3901622	=	Inhibition	%	4.0	CHEMBL262	Homo sapiens	INH	%	4.0
	16739383	CHEMBL3857032	Inhibition of His tagged recombinant full length human GSK3B expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN4CCCCC4)cc3)cc12)c1ccccc1		CHEMBL3891846	=	Inhibition	%	4.0	CHEMBL262	Homo sapiens	INH	%	4.0
	16739384	CHEMBL3857032	Inhibition of His tagged recombinant full length human GSK3B expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	-8.0	CHEMBL262	Homo sapiens	INH	%	-8.0
	16743293	CHEMBL3858026	Inhibition of His-tagged full length human recombinant GSK-3beta expressed in Baculovirus at 0.5 uM using Ser/Thr9 peptide as substrate by Z' LYTE assay relative to control	B	O=C1N/C(=N/c2ccccc2)S/C1=C\c1ccc(O)cc1		CHEMBL3968891	>	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	16743294	CHEMBL3858026	Inhibition of His-tagged full length human recombinant GSK-3beta expressed in Baculovirus at 0.5 uM using Ser/Thr9 peptide as substrate by Z' LYTE assay relative to control	B	O=C1N/C(=N/c2ccccc2)S/C1=C\c1ccc(F)cc1		CHEMBL3969996	>	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	16743295	CHEMBL3858026	Inhibition of His-tagged full length human recombinant GSK-3beta expressed in Baculovirus at 0.5 uM using Ser/Thr9 peptide as substrate by Z' LYTE assay relative to control	B	O=C1N/C(=N/Cc2ccccc2)S/C1=C\c1ccc(Cl)c([N+](=O)[O-])c1		CHEMBL3940448	>	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	16743296	CHEMBL3858026	Inhibition of His-tagged full length human recombinant GSK-3beta expressed in Baculovirus at 0.5 uM using Ser/Thr9 peptide as substrate by Z' LYTE assay relative to control	B	O=C1N=C(NCc2ccccc2)S/C1=C\c1ccc(O)cc1		CHEMBL2206750	>	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	16743297	CHEMBL3858026	Inhibition of His-tagged full length human recombinant GSK-3beta expressed in Baculovirus at 0.5 uM using Ser/Thr9 peptide as substrate by Z' LYTE assay relative to control	B	COc1ccc(/C=C2\S/C(=N\Cc3ccccc3)NC2=O)cc1[N+](=O)[O-]		CHEMBL3949218	>	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	16743298	CHEMBL3858026	Inhibition of His-tagged full length human recombinant GSK-3beta expressed in Baculovirus at 0.5 uM using Ser/Thr9 peptide as substrate by Z' LYTE assay relative to control	B	CCOc1cc(/C=C2\S/C(=N\Cc3ccccc3)NC2=O)ccc1O		CHEMBL3950215	>	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	16743299	CHEMBL3858026	Inhibition of His-tagged full length human recombinant GSK-3beta expressed in Baculovirus at 0.5 uM using Ser/Thr9 peptide as substrate by Z' LYTE assay relative to control	B	COc1ccc(/C=C2\S/C(=N\Cc3ccccc3)NC2=O)cc1OC		CHEMBL3922494	>	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	16743300	CHEMBL3858026	Inhibition of His-tagged full length human recombinant GSK-3beta expressed in Baculovirus at 0.5 uM using Ser/Thr9 peptide as substrate by Z' LYTE assay relative to control	B	COc1ccc(/C=C2\SC(=N)NC2=O)cc1OC		CHEMBL567958	>	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	16743301	CHEMBL3858026	Inhibition of His-tagged full length human recombinant GSK-3beta expressed in Baculovirus at 0.5 uM using Ser/Thr9 peptide as substrate by Z' LYTE assay relative to control	B	COc1cc(/C=C2\SC(=N)NC2=O)ccc1O		CHEMBL576038	>	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	16743302	CHEMBL3858026	Inhibition of His-tagged full length human recombinant GSK-3beta expressed in Baculovirus at 0.5 uM using Ser/Thr9 peptide as substrate by Z' LYTE assay relative to control	B	N=C1NC(=O)/C(=C/c2ccc(O)c(C(=O)O)c2)S1		CHEMBL3926696	>	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	16743303	CHEMBL3858027	Inhibition of His-tagged full length human recombinant GSK-3beta expressed in Baculovirus using Ser/Thr9 peptide as substrate by Z' LYTE assay	B	O=C1N/C(=N/c2ccccc2)S/C1=C\c1ccc(O)cc1		CHEMBL3968891	=	IC50	nM	27.7	CHEMBL262	Homo sapiens	IC50	nM	27.7
	16743304	CHEMBL3858027	Inhibition of His-tagged full length human recombinant GSK-3beta expressed in Baculovirus using Ser/Thr9 peptide as substrate by Z' LYTE assay	B	O=C1N/C(=N/c2ccccc2)S/C1=C\c1ccc(F)cc1		CHEMBL3969996	=	IC50	nM	40.0	CHEMBL262	Homo sapiens	IC50	nM	40.0
	16743305	CHEMBL3858027	Inhibition of His-tagged full length human recombinant GSK-3beta expressed in Baculovirus using Ser/Thr9 peptide as substrate by Z' LYTE assay	B	O=C1N/C(=N/Cc2ccccc2)S/C1=C\c1ccc(Cl)c([N+](=O)[O-])c1		CHEMBL3940448	=	IC50	nM	24.0	CHEMBL262	Homo sapiens	IC50	nM	24.0
	16743306	CHEMBL3858027	Inhibition of His-tagged full length human recombinant GSK-3beta expressed in Baculovirus using Ser/Thr9 peptide as substrate by Z' LYTE assay	B	O=C1N=C(NCc2ccccc2)S/C1=C\c1ccc(O)cc1		CHEMBL2206750	=	IC50	nM	27.1	CHEMBL262	Homo sapiens	IC50	nM	27.1
	16743307	CHEMBL3858027	Inhibition of His-tagged full length human recombinant GSK-3beta expressed in Baculovirus using Ser/Thr9 peptide as substrate by Z' LYTE assay	B	COc1ccc(/C=C2\S/C(=N\Cc3ccccc3)NC2=O)cc1[N+](=O)[O-]		CHEMBL3949218	=	IC50	nM	2.1	CHEMBL262	Homo sapiens	IC50	nM	2.1
	16743308	CHEMBL3858027	Inhibition of His-tagged full length human recombinant GSK-3beta expressed in Baculovirus using Ser/Thr9 peptide as substrate by Z' LYTE assay	B	CCOc1cc(/C=C2\S/C(=N\Cc3ccccc3)NC2=O)ccc1O		CHEMBL3950215	=	IC50	nM	51.7	CHEMBL262	Homo sapiens	IC50	nM	51.7
	16743309	CHEMBL3858027	Inhibition of His-tagged full length human recombinant GSK-3beta expressed in Baculovirus using Ser/Thr9 peptide as substrate by Z' LYTE assay	B	COc1ccc(/C=C2\S/C(=N\Cc3ccccc3)NC2=O)cc1OC		CHEMBL3922494	=	IC50	nM	44.3	CHEMBL262	Homo sapiens	IC50	nM	44.3
	16743310	CHEMBL3858027	Inhibition of His-tagged full length human recombinant GSK-3beta expressed in Baculovirus using Ser/Thr9 peptide as substrate by Z' LYTE assay	B	COc1ccc(/C=C2\SC(=N)NC2=O)cc1OC		CHEMBL567958	=	IC50	nM	80.5	CHEMBL262	Homo sapiens	IC50	nM	80.5
	16743311	CHEMBL3858027	Inhibition of His-tagged full length human recombinant GSK-3beta expressed in Baculovirus using Ser/Thr9 peptide as substrate by Z' LYTE assay	B	N=C1NC(=O)/C(=C/c2ccc(O)c(C(=O)O)c2)S1		CHEMBL3926696	=	IC50	nM	84.8	CHEMBL262	Homo sapiens	IC50	nM	84.8
	16777167	CHEMBL3864829	Competitive binding affinity to full length wild type human GSK3B expressed in mammalian expression system at 10 uM by kinomescan method relative to control	B	C[C@@H]1C[C@H](N)CN(c2ccncc2Nc2ncc3ccc(-c4c(F)cccc4F)nn23)C1		CHEMBL3942186	=	Activity	%	2.3	CHEMBL262	Homo sapiens	Activity	%	2.3
	16786932	CHEMBL3866472	Inhibition of GSK-3beta (unknown origin) assessed as inhibition of phosphorylation using Ser/Thr 9 peptide as substrate by FRET-based Z-LYTE assay	B	Cc1cc2c(cc1Br)NC(=O)/C2=N\NC(=O)c1ccccc1O		CHEMBL3978908	=	IC50	nM	15790.0	CHEMBL262	Homo sapiens	IC50	uM	15.79
	16798141	CHEMBL3868254	Inhibition of human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate in presence of gamma-33P-ATP	B	O=C(CNC(=O)c1cnc2[nH]cc(-c3ccccc3)c2c1)NCCc1c[nH]c2ccccc12		CHEMBL3911190	=	IC50	nM	1450.0	CHEMBL262	Homo sapiens	IC50	uM	1.45
	16798142	CHEMBL3868254	Inhibition of human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate in presence of gamma-33P-ATP	B	O=C(CNC(=O)c1cnc2[nH]ccc2c1)NCCc1c[nH]c2ccccc12		CHEMBL3939142	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	16798143	CHEMBL3868254	Inhibition of human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate in presence of gamma-33P-ATP	B	O=C(CNC(=O)c1cnc2[nH]c(-c3ccccc3)cc2c1)NCCc1c[nH]c2ccccc12		CHEMBL3912650	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	16798144	CHEMBL3868254	Inhibition of human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate in presence of gamma-33P-ATP	B	O=C(CNC(=O)c1cnc2[nH]cc(C(=O)c3ccccc3)c2c1)NCCc1c[nH]c2ccccc12		CHEMBL3971275	=	IC50	nM	15700.0	CHEMBL262	Homo sapiens	IC50	uM	15.7
	16798145	CHEMBL3868254	Inhibition of human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate in presence of gamma-33P-ATP	B	O=C(CNC(=O)c1ccc2[nH]cc(-c3ccccc3)c2c1)NCCc1c[nH]c2ccccc12		CHEMBL3909173	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	16798146	CHEMBL3868254	Inhibition of human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate in presence of gamma-33P-ATP	B	O=C(CNC(=O)c1cnc2[nH]cc(-c3ccccc3)c2c1)NCCc1c[nH]cn1		CHEMBL3979434	=	IC50	nM	2610.0	CHEMBL262	Homo sapiens	IC50	uM	2.61
	16798147	CHEMBL3868254	Inhibition of human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate in presence of gamma-33P-ATP	B	O=C(/C=C/c1cnc2[nH]cc(-c3ccccc3)c2c1)NCCc1c[nH]c2ccccc12		CHEMBL3943352	=	IC50	nM	356.0	CHEMBL262	Homo sapiens	IC50	uM	0.356
	16798148	CHEMBL3868254	Inhibition of human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate in presence of gamma-33P-ATP	B	O=C(CCc1cnc2[nH]cc(-c3ccccc3)c2c1)NCCc1c[nH]c2ccccc12		CHEMBL3951486	=	IC50	nM	1030.0	CHEMBL262	Homo sapiens	IC50	uM	1.03
	16798149	CHEMBL3868254	Inhibition of human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate in presence of gamma-33P-ATP	B	O=C(/C=C/c1cnc2[nH]cc(-c3ccccc3)c2c1)NCCN1CCOCC1		CHEMBL3891139	=	IC50	nM	46.0	CHEMBL262	Homo sapiens	IC50	nM	46.0
	16798150	CHEMBL3868254	Inhibition of human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate in presence of gamma-33P-ATP	B	O=C(/C=C/c1cnc2[nH]cc(-c3ccccc3)c2c1)NCCc1c[nH]cn1		CHEMBL3960209	=	IC50	nM	49.0	CHEMBL262	Homo sapiens	IC50	nM	49.0
	16798151	CHEMBL3868254	Inhibition of human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate in presence of gamma-33P-ATP	B	O=C(/C=C/c1cnc2[nH]cc(-c3ccccc3)c2c1)NCCc1ccccc1		CHEMBL3961252	=	IC50	nM	248.0	CHEMBL262	Homo sapiens	IC50	nM	248.0
	16798152	CHEMBL3868254	Inhibition of human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate in presence of gamma-33P-ATP	B	C[C@@H](NC(=O)/C=C/c1cnc2[nH]cc(-c3ccccc3)c2c1)[C@@H](O)c1ccccc1		CHEMBL3933780	=	IC50	nM	180.0	CHEMBL262	Homo sapiens	IC50	nM	180.0
	16798153	CHEMBL3868254	Inhibition of human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate in presence of gamma-33P-ATP	B	O=C(/C=C/c1cnc2[nH]cc(-c3ccccc3)c2c1)N[C@@H](CO)Cc1ccccc1		CHEMBL3901767	=	IC50	nM	752.0	CHEMBL262	Homo sapiens	IC50	nM	752.0
	16798154	CHEMBL3868254	Inhibition of human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate in presence of gamma-33P-ATP	B	O=C(/C=C/c1cnc2[nH]cc(-c3ccccc3)c2c1)NCCc1ccncc1		CHEMBL3929715	=	IC50	nM	44.0	CHEMBL262	Homo sapiens	IC50	nM	44.0
	16798155	CHEMBL3868254	Inhibition of human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate in presence of gamma-33P-ATP	B	O=C(/C=C/c1cnc2[nH]cc(-c3ccccc3)c2c1)NCCc1cccnc1		CHEMBL3919553	=	IC50	nM	32.0	CHEMBL262	Homo sapiens	IC50	nM	32.0
	16798156	CHEMBL3868254	Inhibition of human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate in presence of gamma-33P-ATP	B	O=C(/C=C/c1cnc2[nH]cc(-c3ccccc3)c2c1)NCCc1ccccn1		CHEMBL3938724	=	IC50	nM	19.0	CHEMBL262	Homo sapiens	IC50	nM	19.0
	16837416	CHEMBL3876087	Inhibition of human recombinant full length His-tagged GSK3B expressed in baculovirus expression system	B	CC1(C)C(=O)N([C@H]2CCc3c(O)cccc32)c2nc(Nc3ccccc3)ncc21		CHEMBL3884319	=	IC50	nM	2988.0	CHEMBL262	Homo sapiens	IC50	nM	2988.0
213534	17602912	CHEMBL3705253	Biochemical Assay: The ingredients required for this purpose are mixed in a black 384-well microtiter plate with transparent base (from Greiner, catalog number 781092). The requirements in this connection for each well of the 384-well microtiter plate are 5 nM GSK3β (from Upstate, catalog number xy), 40 μM GSK3β substrate GSM (sequence H-RRRPASVPPSPSLSRHS-(pS)-HQRR, from Upstate, catalog number 2-533), 30 μM nicotinamide adenine dinucleotide NADH (Roche Diagnostics, catalog number 10107735), 50 μM adenosine triphosphate ATP (from Sigma, catalog number A7966) and 2 mM phosphoenolpyruvate (from Roche, catalog number 128112). The required reaction buffer in which the biochemical reaction takes place consists of 50 mM Trizma hydrochloride Tris-HCl pH: 7.5 (from Sigma, catalog number T3253), 5 mM magnesium chloride MgCl2 (from Sigma, catalog number M8266), 0.2 mM DL-dithiothreitol DTT (from Sigma, catalog number D9779), 2 mM ethylenediaminetetraacetic acid EDTA (from Sigma, catalog number E6758), 0.01% Triton X-100 (from Sigma, catalog number T8787) and 0.05% bovine serum albumin BSA (from Sigma, catalog number B4287). Active substances are dissolved in dimethyl sulfoxide DMSO (from Sigma, catalog number D8418) in a concentration of 10 mM. Active substances are added in serial concentrations of 10 μM, 1 μM, 0.1 μM, 0.01 μM, 0.001 μM, 0.0001 μM, 0.00001 μM, 0.000001 μM to the mixtures of the biochemical reaction. As control, dimethyl sulfoxide is added instead of substance in a final concentration of 0.1%. The reaction is incubated at 30° C. for 2 hours and then the resulting fluorescence is measured in a Tecan Safire-XFLUOR4 instrument, version V4.50 (serial number 12901300283) with the specifications: measurement mode−fluorescence measured from below, extinction wavelength 340 nm, emission wavelength 465 nm, slit width extinction 5 nm, slit width emission 5 nm, gain mode 120, delay 0 μs, number of light flashes per measurement 3, and an integration time of 40 μs.	B	N#Cc1sc(NCCNc2nc(-c3ccc(Cl)cc3Cl)cn3ccnc23)nc1N		CHEMBL3647950	=	IC50	nM	16.0	CHEMBL262	Homo sapiens	IC50	nM	16.0
213535	17602913	CHEMBL3705253	Biochemical Assay: The ingredients required for this purpose are mixed in a black 384-well microtiter plate with transparent base (from Greiner, catalog number 781092). The requirements in this connection for each well of the 384-well microtiter plate are 5 nM GSK3β (from Upstate, catalog number xy), 40 μM GSK3β substrate GSM (sequence H-RRRPASVPPSPSLSRHS-(pS)-HQRR, from Upstate, catalog number 2-533), 30 μM nicotinamide adenine dinucleotide NADH (Roche Diagnostics, catalog number 10107735), 50 μM adenosine triphosphate ATP (from Sigma, catalog number A7966) and 2 mM phosphoenolpyruvate (from Roche, catalog number 128112). The required reaction buffer in which the biochemical reaction takes place consists of 50 mM Trizma hydrochloride Tris-HCl pH: 7.5 (from Sigma, catalog number T3253), 5 mM magnesium chloride MgCl2 (from Sigma, catalog number M8266), 0.2 mM DL-dithiothreitol DTT (from Sigma, catalog number D9779), 2 mM ethylenediaminetetraacetic acid EDTA (from Sigma, catalog number E6758), 0.01% Triton X-100 (from Sigma, catalog number T8787) and 0.05% bovine serum albumin BSA (from Sigma, catalog number B4287). Active substances are dissolved in dimethyl sulfoxide DMSO (from Sigma, catalog number D8418) in a concentration of 10 mM. Active substances are added in serial concentrations of 10 μM, 1 μM, 0.1 μM, 0.01 μM, 0.001 μM, 0.0001 μM, 0.00001 μM, 0.000001 μM to the mixtures of the biochemical reaction. As control, dimethyl sulfoxide is added instead of substance in a final concentration of 0.1%. The reaction is incubated at 30° C. for 2 hours and then the resulting fluorescence is measured in a Tecan Safire-XFLUOR4 instrument, version V4.50 (serial number 12901300283) with the specifications: measurement mode−fluorescence measured from below, extinction wavelength 340 nm, emission wavelength 465 nm, slit width extinction 5 nm, slit width emission 5 nm, gain mode 120, delay 0 μs, number of light flashes per measurement 3, and an integration time of 40 μs.	B	N#Cc1ccc(NCCNc2nc(-c3ccc(Cl)cc3Cl)cn3nc(C(=O)O)cc23)nc1		CHEMBL3647951	=	IC50	nM	21.0	CHEMBL262	Homo sapiens	IC50	nM	21.0
213536	17602914	CHEMBL3705253	Biochemical Assay: The ingredients required for this purpose are mixed in a black 384-well microtiter plate with transparent base (from Greiner, catalog number 781092). The requirements in this connection for each well of the 384-well microtiter plate are 5 nM GSK3β (from Upstate, catalog number xy), 40 μM GSK3β substrate GSM (sequence H-RRRPASVPPSPSLSRHS-(pS)-HQRR, from Upstate, catalog number 2-533), 30 μM nicotinamide adenine dinucleotide NADH (Roche Diagnostics, catalog number 10107735), 50 μM adenosine triphosphate ATP (from Sigma, catalog number A7966) and 2 mM phosphoenolpyruvate (from Roche, catalog number 128112). The required reaction buffer in which the biochemical reaction takes place consists of 50 mM Trizma hydrochloride Tris-HCl pH: 7.5 (from Sigma, catalog number T3253), 5 mM magnesium chloride MgCl2 (from Sigma, catalog number M8266), 0.2 mM DL-dithiothreitol DTT (from Sigma, catalog number D9779), 2 mM ethylenediaminetetraacetic acid EDTA (from Sigma, catalog number E6758), 0.01% Triton X-100 (from Sigma, catalog number T8787) and 0.05% bovine serum albumin BSA (from Sigma, catalog number B4287). Active substances are dissolved in dimethyl sulfoxide DMSO (from Sigma, catalog number D8418) in a concentration of 10 mM. Active substances are added in serial concentrations of 10 μM, 1 μM, 0.1 μM, 0.01 μM, 0.001 μM, 0.0001 μM, 0.00001 μM, 0.000001 μM to the mixtures of the biochemical reaction. As control, dimethyl sulfoxide is added instead of substance in a final concentration of 0.1%. The reaction is incubated at 30° C. for 2 hours and then the resulting fluorescence is measured in a Tecan Safire-XFLUOR4 instrument, version V4.50 (serial number 12901300283) with the specifications: measurement mode−fluorescence measured from below, extinction wavelength 340 nm, emission wavelength 465 nm, slit width extinction 5 nm, slit width emission 5 nm, gain mode 120, delay 0 μs, number of light flashes per measurement 3, and an integration time of 40 μs.	B	CN1CCN(CCNC(=O)c2cc3c(NCCNc4ccc(C#N)cn4)nc(-c4ccc(Cl)cc4Cl)cn3n2)CC1		CHEMBL3647952	=	IC50	nM	30.0	CHEMBL262	Homo sapiens	IC50	nM	30.0
213537	17602915	CHEMBL3705253	Biochemical Assay: The ingredients required for this purpose are mixed in a black 384-well microtiter plate with transparent base (from Greiner, catalog number 781092). The requirements in this connection for each well of the 384-well microtiter plate are 5 nM GSK3β (from Upstate, catalog number xy), 40 μM GSK3β substrate GSM (sequence H-RRRPASVPPSPSLSRHS-(pS)-HQRR, from Upstate, catalog number 2-533), 30 μM nicotinamide adenine dinucleotide NADH (Roche Diagnostics, catalog number 10107735), 50 μM adenosine triphosphate ATP (from Sigma, catalog number A7966) and 2 mM phosphoenolpyruvate (from Roche, catalog number 128112). The required reaction buffer in which the biochemical reaction takes place consists of 50 mM Trizma hydrochloride Tris-HCl pH: 7.5 (from Sigma, catalog number T3253), 5 mM magnesium chloride MgCl2 (from Sigma, catalog number M8266), 0.2 mM DL-dithiothreitol DTT (from Sigma, catalog number D9779), 2 mM ethylenediaminetetraacetic acid EDTA (from Sigma, catalog number E6758), 0.01% Triton X-100 (from Sigma, catalog number T8787) and 0.05% bovine serum albumin BSA (from Sigma, catalog number B4287). Active substances are dissolved in dimethyl sulfoxide DMSO (from Sigma, catalog number D8418) in a concentration of 10 mM. Active substances are added in serial concentrations of 10 μM, 1 μM, 0.1 μM, 0.01 μM, 0.001 μM, 0.0001 μM, 0.00001 μM, 0.000001 μM to the mixtures of the biochemical reaction. As control, dimethyl sulfoxide is added instead of substance in a final concentration of 0.1%. The reaction is incubated at 30° C. for 2 hours and then the resulting fluorescence is measured in a Tecan Safire-XFLUOR4 instrument, version V4.50 (serial number 12901300283) with the specifications: measurement mode−fluorescence measured from below, extinction wavelength 340 nm, emission wavelength 465 nm, slit width extinction 5 nm, slit width emission 5 nm, gain mode 120, delay 0 μs, number of light flashes per measurement 3, and an integration time of 40 μs.	B	Cc1nc(C)n2nc(-c3ccccc3)nc(NCCNc3ccc(C#N)cn3)c12		CHEMBL3647953	=	IC50	nM	310.0	CHEMBL262	Homo sapiens	IC50	nM	310.0
213538	17602916	CHEMBL3705253	Biochemical Assay: The ingredients required for this purpose are mixed in a black 384-well microtiter plate with transparent base (from Greiner, catalog number 781092). The requirements in this connection for each well of the 384-well microtiter plate are 5 nM GSK3β (from Upstate, catalog number xy), 40 μM GSK3β substrate GSM (sequence H-RRRPASVPPSPSLSRHS-(pS)-HQRR, from Upstate, catalog number 2-533), 30 μM nicotinamide adenine dinucleotide NADH (Roche Diagnostics, catalog number 10107735), 50 μM adenosine triphosphate ATP (from Sigma, catalog number A7966) and 2 mM phosphoenolpyruvate (from Roche, catalog number 128112). The required reaction buffer in which the biochemical reaction takes place consists of 50 mM Trizma hydrochloride Tris-HCl pH: 7.5 (from Sigma, catalog number T3253), 5 mM magnesium chloride MgCl2 (from Sigma, catalog number M8266), 0.2 mM DL-dithiothreitol DTT (from Sigma, catalog number D9779), 2 mM ethylenediaminetetraacetic acid EDTA (from Sigma, catalog number E6758), 0.01% Triton X-100 (from Sigma, catalog number T8787) and 0.05% bovine serum albumin BSA (from Sigma, catalog number B4287). Active substances are dissolved in dimethyl sulfoxide DMSO (from Sigma, catalog number D8418) in a concentration of 10 mM. Active substances are added in serial concentrations of 10 μM, 1 μM, 0.1 μM, 0.01 μM, 0.001 μM, 0.0001 μM, 0.00001 μM, 0.000001 μM to the mixtures of the biochemical reaction. As control, dimethyl sulfoxide is added instead of substance in a final concentration of 0.1%. The reaction is incubated at 30° C. for 2 hours and then the resulting fluorescence is measured in a Tecan Safire-XFLUOR4 instrument, version V4.50 (serial number 12901300283) with the specifications: measurement mode−fluorescence measured from below, extinction wavelength 340 nm, emission wavelength 465 nm, slit width extinction 5 nm, slit width emission 5 nm, gain mode 120, delay 0 μs, number of light flashes per measurement 3, and an integration time of 40 μs.	B	CCOC(=O)c1cc2c(N3CCCC(Nc4nc(N)c(C(C)=O)s4)C3)nc(-c3ccc(Cl)cc3Cl)cn2n1		CHEMBL3647954	=	IC50	nM	8.0	CHEMBL262	Homo sapiens	IC50	nM	8.0
213539	17602917	CHEMBL3705253	Biochemical Assay: The ingredients required for this purpose are mixed in a black 384-well microtiter plate with transparent base (from Greiner, catalog number 781092). The requirements in this connection for each well of the 384-well microtiter plate are 5 nM GSK3β (from Upstate, catalog number xy), 40 μM GSK3β substrate GSM (sequence H-RRRPASVPPSPSLSRHS-(pS)-HQRR, from Upstate, catalog number 2-533), 30 μM nicotinamide adenine dinucleotide NADH (Roche Diagnostics, catalog number 10107735), 50 μM adenosine triphosphate ATP (from Sigma, catalog number A7966) and 2 mM phosphoenolpyruvate (from Roche, catalog number 128112). The required reaction buffer in which the biochemical reaction takes place consists of 50 mM Trizma hydrochloride Tris-HCl pH: 7.5 (from Sigma, catalog number T3253), 5 mM magnesium chloride MgCl2 (from Sigma, catalog number M8266), 0.2 mM DL-dithiothreitol DTT (from Sigma, catalog number D9779), 2 mM ethylenediaminetetraacetic acid EDTA (from Sigma, catalog number E6758), 0.01% Triton X-100 (from Sigma, catalog number T8787) and 0.05% bovine serum albumin BSA (from Sigma, catalog number B4287). Active substances are dissolved in dimethyl sulfoxide DMSO (from Sigma, catalog number D8418) in a concentration of 10 mM. Active substances are added in serial concentrations of 10 μM, 1 μM, 0.1 μM, 0.01 μM, 0.001 μM, 0.0001 μM, 0.00001 μM, 0.000001 μM to the mixtures of the biochemical reaction. As control, dimethyl sulfoxide is added instead of substance in a final concentration of 0.1%. The reaction is incubated at 30° C. for 2 hours and then the resulting fluorescence is measured in a Tecan Safire-XFLUOR4 instrument, version V4.50 (serial number 12901300283) with the specifications: measurement mode−fluorescence measured from below, extinction wavelength 340 nm, emission wavelength 465 nm, slit width extinction 5 nm, slit width emission 5 nm, gain mode 120, delay 0 μs, number of light flashes per measurement 3, and an integration time of 40 μs.	B	N#Cc1sc(NC2CCCN(c3nc(-c4ccc(Cl)cc4Cl)cn4nc(C(=O)O)cc34)C2)nc1N		CHEMBL3647955	=	IC50	nM	3.0	CHEMBL262	Homo sapiens	IC50	nM	3.0
213540	17602918	CHEMBL3705253	Biochemical Assay: The ingredients required for this purpose are mixed in a black 384-well microtiter plate with transparent base (from Greiner, catalog number 781092). The requirements in this connection for each well of the 384-well microtiter plate are 5 nM GSK3β (from Upstate, catalog number xy), 40 μM GSK3β substrate GSM (sequence H-RRRPASVPPSPSLSRHS-(pS)-HQRR, from Upstate, catalog number 2-533), 30 μM nicotinamide adenine dinucleotide NADH (Roche Diagnostics, catalog number 10107735), 50 μM adenosine triphosphate ATP (from Sigma, catalog number A7966) and 2 mM phosphoenolpyruvate (from Roche, catalog number 128112). The required reaction buffer in which the biochemical reaction takes place consists of 50 mM Trizma hydrochloride Tris-HCl pH: 7.5 (from Sigma, catalog number T3253), 5 mM magnesium chloride MgCl2 (from Sigma, catalog number M8266), 0.2 mM DL-dithiothreitol DTT (from Sigma, catalog number D9779), 2 mM ethylenediaminetetraacetic acid EDTA (from Sigma, catalog number E6758), 0.01% Triton X-100 (from Sigma, catalog number T8787) and 0.05% bovine serum albumin BSA (from Sigma, catalog number B4287). Active substances are dissolved in dimethyl sulfoxide DMSO (from Sigma, catalog number D8418) in a concentration of 10 mM. Active substances are added in serial concentrations of 10 μM, 1 μM, 0.1 μM, 0.01 μM, 0.001 μM, 0.0001 μM, 0.00001 μM, 0.000001 μM to the mixtures of the biochemical reaction. As control, dimethyl sulfoxide is added instead of substance in a final concentration of 0.1%. The reaction is incubated at 30° C. for 2 hours and then the resulting fluorescence is measured in a Tecan Safire-XFLUOR4 instrument, version V4.50 (serial number 12901300283) with the specifications: measurement mode−fluorescence measured from below, extinction wavelength 340 nm, emission wavelength 465 nm, slit width extinction 5 nm, slit width emission 5 nm, gain mode 120, delay 0 μs, number of light flashes per measurement 3, and an integration time of 40 μs.	B	N#Cc1sc(NCCNc2nc(-c3ccc(Cl)cc3Cl)cn3nc(C(=O)NCC(=O)O)cc23)nc1N		CHEMBL3647956	=	IC50	nM	5.0	CHEMBL262	Homo sapiens	IC50	nM	5.0
213541	17602919	CHEMBL3705253	Biochemical Assay: The ingredients required for this purpose are mixed in a black 384-well microtiter plate with transparent base (from Greiner, catalog number 781092). The requirements in this connection for each well of the 384-well microtiter plate are 5 nM GSK3β (from Upstate, catalog number xy), 40 μM GSK3β substrate GSM (sequence H-RRRPASVPPSPSLSRHS-(pS)-HQRR, from Upstate, catalog number 2-533), 30 μM nicotinamide adenine dinucleotide NADH (Roche Diagnostics, catalog number 10107735), 50 μM adenosine triphosphate ATP (from Sigma, catalog number A7966) and 2 mM phosphoenolpyruvate (from Roche, catalog number 128112). The required reaction buffer in which the biochemical reaction takes place consists of 50 mM Trizma hydrochloride Tris-HCl pH: 7.5 (from Sigma, catalog number T3253), 5 mM magnesium chloride MgCl2 (from Sigma, catalog number M8266), 0.2 mM DL-dithiothreitol DTT (from Sigma, catalog number D9779), 2 mM ethylenediaminetetraacetic acid EDTA (from Sigma, catalog number E6758), 0.01% Triton X-100 (from Sigma, catalog number T8787) and 0.05% bovine serum albumin BSA (from Sigma, catalog number B4287). Active substances are dissolved in dimethyl sulfoxide DMSO (from Sigma, catalog number D8418) in a concentration of 10 mM. Active substances are added in serial concentrations of 10 μM, 1 μM, 0.1 μM, 0.01 μM, 0.001 μM, 0.0001 μM, 0.00001 μM, 0.000001 μM to the mixtures of the biochemical reaction. As control, dimethyl sulfoxide is added instead of substance in a final concentration of 0.1%. The reaction is incubated at 30° C. for 2 hours and then the resulting fluorescence is measured in a Tecan Safire-XFLUOR4 instrument, version V4.50 (serial number 12901300283) with the specifications: measurement mode−fluorescence measured from below, extinction wavelength 340 nm, emission wavelength 465 nm, slit width extinction 5 nm, slit width emission 5 nm, gain mode 120, delay 0 μs, number of light flashes per measurement 3, and an integration time of 40 μs.	B	N#Cc1ccc(NCCNc2nc(-c3ccc(Cl)cc3Cl)cn3nc(CNC4CC4)cc23)nc1		CHEMBL3647957	=	IC50	nM	80.0	CHEMBL262	Homo sapiens	IC50	nM	80.0
246654	17630029	CHEMBL3705182	Inhibition Assay: The GSK-3β activity was determined by incubation of a mixture of recombinant human GSK-3 enzyme, a phosphate source and GSK-3 substrate in the presence and in the absence of the corresponding test compound, and by measuring the GSK-3 activity of this mixture.Recombinant human glycogen synthase kinase 313 was assayed in MOPS 8 mM pH 7.3, EDTA 0.2 mM, MgCl2 10 mM and sodium orthovanadate 0.25 mM in the presence of 62.5 μM of Phospho-Glycogen Synthase Peptide-2 (GS-2), 0.5 μCi γ-33P-ATP and unlabelled ATP at a final concentration of 12.5 μM. The final assay volume was 20 μl. After incubation for 30 minutes at 30° C., 15 μl aliquots were spotted onto P81 phosphocellulose papers. Filters were washed four times for at least 10 minutes each and counted with 1.5 ml of scintillation cocktail in a scintillation counter.	B	O=C(NCc1ccccc1)Nc1cccc2ccccc12		CHEMBL1347394	=	IC50	nM	17.1	CHEMBL262	Homo sapiens	IC50	nM	17.1
246655	17630030	CHEMBL3705182	Inhibition Assay: The GSK-3β activity was determined by incubation of a mixture of recombinant human GSK-3 enzyme, a phosphate source and GSK-3 substrate in the presence and in the absence of the corresponding test compound, and by measuring the GSK-3 activity of this mixture.Recombinant human glycogen synthase kinase 313 was assayed in MOPS 8 mM pH 7.3, EDTA 0.2 mM, MgCl2 10 mM and sodium orthovanadate 0.25 mM in the presence of 62.5 μM of Phospho-Glycogen Synthase Peptide-2 (GS-2), 0.5 μCi γ-33P-ATP and unlabelled ATP at a final concentration of 12.5 μM. The final assay volume was 20 μl. After incubation for 30 minutes at 30° C., 15 μl aliquots were spotted onto P81 phosphocellulose papers. Filters were washed four times for at least 10 minutes each and counted with 1.5 ml of scintillation cocktail in a scintillation counter.	B	O=C(NCc1ccccc1)Nc1ccc2c(c1)OCO2		CHEMBL3670690	=	IC50	nM	38.4	CHEMBL262	Homo sapiens	IC50	nM	38.4
335716	17713934	CHEMBL3887394	LanthaScreen TR-FRET Assay: Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screening assay, compounds were tested in duplicate at a concentration of 10 uM.Human recombinant enzyme GSK-3beta was incubated for 90 minutes at 22° C. in the presence of compounds or vehicle in a reaction buffer containing ATP plus 100 nM unphosphorylated specific substrate peptide (Ulight-CFFKNIVTPRTPPPSQGK-amide). Substrate phosphorylation was measured by LANCE technology (PerkinElmer, Conn., USA). The results, reported in the following Table 4, are expressed as a percent of inhibition of control specific activity obtained in the presence of the test compounds (as % inhibition at 10 um). In a second assay, the same compounds were assayed at five concentrations ranging from 100 uM to 10 nM with ten-fold dilutions in duplicate.	B	COc1ccc2[nH]nc(C(=O)NCC3CCN(CCc4ccc(O)cc4)CC3)c2c1		CHEMBL3736216	=	IC50	nM	350.0	CHEMBL262	Homo sapiens	IC50	nM	350.0
335717	17713935	CHEMBL3887394	LanthaScreen TR-FRET Assay: Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screening assay, compounds were tested in duplicate at a concentration of 10 uM.Human recombinant enzyme GSK-3beta was incubated for 90 minutes at 22° C. in the presence of compounds or vehicle in a reaction buffer containing ATP plus 100 nM unphosphorylated specific substrate peptide (Ulight-CFFKNIVTPRTPPPSQGK-amide). Substrate phosphorylation was measured by LANCE technology (PerkinElmer, Conn., USA). The results, reported in the following Table 4, are expressed as a percent of inhibition of control specific activity obtained in the presence of the test compounds (as % inhibition at 10 um). In a second assay, the same compounds were assayed at five concentrations ranging from 100 uM to 10 nM with ten-fold dilutions in duplicate.	B	COc1ccc(CCN2CCC(CNC(=O)c3n[nH]c4ccc(OC)cc34)CC2)cc1		CHEMBL3736196	=	IC50	nM	560.0	CHEMBL262	Homo sapiens	IC50	nM	560.0
335718	17713936	CHEMBL3887394	LanthaScreen TR-FRET Assay: Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screening assay, compounds were tested in duplicate at a concentration of 10 uM.Human recombinant enzyme GSK-3beta was incubated for 90 minutes at 22° C. in the presence of compounds or vehicle in a reaction buffer containing ATP plus 100 nM unphosphorylated specific substrate peptide (Ulight-CFFKNIVTPRTPPPSQGK-amide). Substrate phosphorylation was measured by LANCE technology (PerkinElmer, Conn., USA). The results, reported in the following Table 4, are expressed as a percent of inhibition of control specific activity obtained in the presence of the test compounds (as % inhibition at 10 um). In a second assay, the same compounds were assayed at five concentrations ranging from 100 uM to 10 nM with ten-fold dilutions in duplicate.	B	COc1ccc2[nH]nc(C(=O)NCC3CCN(Cc4ccc(Cl)cc4Cl)CC3)c2c1		CHEMBL3734985	=	IC50	nM	310.0	CHEMBL262	Homo sapiens	IC50	nM	310.0
335719	17713937	CHEMBL3887394	LanthaScreen TR-FRET Assay: Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screening assay, compounds were tested in duplicate at a concentration of 10 uM.Human recombinant enzyme GSK-3beta was incubated for 90 minutes at 22° C. in the presence of compounds or vehicle in a reaction buffer containing ATP plus 100 nM unphosphorylated specific substrate peptide (Ulight-CFFKNIVTPRTPPPSQGK-amide). Substrate phosphorylation was measured by LANCE technology (PerkinElmer, Conn., USA). The results, reported in the following Table 4, are expressed as a percent of inhibition of control specific activity obtained in the presence of the test compounds (as % inhibition at 10 um). In a second assay, the same compounds were assayed at five concentrations ranging from 100 uM to 10 nM with ten-fold dilutions in duplicate.	B	COc1ccc2[nH]nc(C(=O)NCC3CCN(Cc4ccc(C(F)(F)F)cc4)CC3)c2c1		CHEMBL3735984	=	IC50	nM	640.0	CHEMBL262	Homo sapiens	IC50	nM	640.0
335720	17713938	CHEMBL3887394	LanthaScreen TR-FRET Assay: Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screening assay, compounds were tested in duplicate at a concentration of 10 uM.Human recombinant enzyme GSK-3beta was incubated for 90 minutes at 22° C. in the presence of compounds or vehicle in a reaction buffer containing ATP plus 100 nM unphosphorylated specific substrate peptide (Ulight-CFFKNIVTPRTPPPSQGK-amide). Substrate phosphorylation was measured by LANCE technology (PerkinElmer, Conn., USA). The results, reported in the following Table 4, are expressed as a percent of inhibition of control specific activity obtained in the presence of the test compounds (as % inhibition at 10 um). In a second assay, the same compounds were assayed at five concentrations ranging from 100 uM to 10 nM with ten-fold dilutions in duplicate.	B	COc1ccc2[nH]nc(C(=O)NCC3CCN(Cc4ccc(OCc5ccccc5)cc4)CC3)c2c1		CHEMBL3736462	=	IC50	nM	350.0	CHEMBL262	Homo sapiens	IC50	nM	350.0
335721	17713939	CHEMBL3887394	LanthaScreen TR-FRET Assay: Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screening assay, compounds were tested in duplicate at a concentration of 10 uM.Human recombinant enzyme GSK-3beta was incubated for 90 minutes at 22° C. in the presence of compounds or vehicle in a reaction buffer containing ATP plus 100 nM unphosphorylated specific substrate peptide (Ulight-CFFKNIVTPRTPPPSQGK-amide). Substrate phosphorylation was measured by LANCE technology (PerkinElmer, Conn., USA). The results, reported in the following Table 4, are expressed as a percent of inhibition of control specific activity obtained in the presence of the test compounds (as % inhibition at 10 um). In a second assay, the same compounds were assayed at five concentrations ranging from 100 uM to 10 nM with ten-fold dilutions in duplicate.	B	COc1ccc2[nH]nc(C(=O)NCC3CCN(Cc4ccc(O)cc4)CC3)c2c1		CHEMBL3735837	=	IC50	nM	400.0	CHEMBL262	Homo sapiens	IC50	nM	400.0
335722	17713940	CHEMBL3887394	LanthaScreen TR-FRET Assay: Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screening assay, compounds were tested in duplicate at a concentration of 10 uM.Human recombinant enzyme GSK-3beta was incubated for 90 minutes at 22° C. in the presence of compounds or vehicle in a reaction buffer containing ATP plus 100 nM unphosphorylated specific substrate peptide (Ulight-CFFKNIVTPRTPPPSQGK-amide). Substrate phosphorylation was measured by LANCE technology (PerkinElmer, Conn., USA). The results, reported in the following Table 4, are expressed as a percent of inhibition of control specific activity obtained in the presence of the test compounds (as % inhibition at 10 um). In a second assay, the same compounds were assayed at five concentrations ranging from 100 uM to 10 nM with ten-fold dilutions in duplicate.	B	COC(=O)c1csc(CN2CCC(CNC(=O)c3n[nH]c4ccc(OC)cc34)CC2)n1		CHEMBL3735579	=	IC50	nM	130.0	CHEMBL262	Homo sapiens	IC50	nM	130.0
335723	17713941	CHEMBL3887394	LanthaScreen TR-FRET Assay: Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screening assay, compounds were tested in duplicate at a concentration of 10 uM.Human recombinant enzyme GSK-3beta was incubated for 90 minutes at 22° C. in the presence of compounds or vehicle in a reaction buffer containing ATP plus 100 nM unphosphorylated specific substrate peptide (Ulight-CFFKNIVTPRTPPPSQGK-amide). Substrate phosphorylation was measured by LANCE technology (PerkinElmer, Conn., USA). The results, reported in the following Table 4, are expressed as a percent of inhibition of control specific activity obtained in the presence of the test compounds (as % inhibition at 10 um). In a second assay, the same compounds were assayed at five concentrations ranging from 100 uM to 10 nM with ten-fold dilutions in duplicate.	B	COc1ccc2[nH]nc(C(=O)NCC3CCN(Cc4nc(C(=O)O)cs4)CC3)c2c1		CHEMBL3735779	=	IC50	nM	170.0	CHEMBL262	Homo sapiens	IC50	nM	170.0
335724	17713942	CHEMBL3887394	LanthaScreen TR-FRET Assay: Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screening assay, compounds were tested in duplicate at a concentration of 10 uM.Human recombinant enzyme GSK-3beta was incubated for 90 minutes at 22° C. in the presence of compounds or vehicle in a reaction buffer containing ATP plus 100 nM unphosphorylated specific substrate peptide (Ulight-CFFKNIVTPRTPPPSQGK-amide). Substrate phosphorylation was measured by LANCE technology (PerkinElmer, Conn., USA). The results, reported in the following Table 4, are expressed as a percent of inhibition of control specific activity obtained in the presence of the test compounds (as % inhibition at 10 um). In a second assay, the same compounds were assayed at five concentrations ranging from 100 uM to 10 nM with ten-fold dilutions in duplicate.	B	COC(=O)c1coc(CN2CCC(CNC(=O)c3n[nH]c4ccc(OC)cc34)CC2)n1		CHEMBL3735500	=	IC50	nM	210.0	CHEMBL262	Homo sapiens	IC50	nM	210.0
335725	17713943	CHEMBL3887394	LanthaScreen TR-FRET Assay: Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screening assay, compounds were tested in duplicate at a concentration of 10 uM.Human recombinant enzyme GSK-3beta was incubated for 90 minutes at 22° C. in the presence of compounds or vehicle in a reaction buffer containing ATP plus 100 nM unphosphorylated specific substrate peptide (Ulight-CFFKNIVTPRTPPPSQGK-amide). Substrate phosphorylation was measured by LANCE technology (PerkinElmer, Conn., USA). The results, reported in the following Table 4, are expressed as a percent of inhibition of control specific activity obtained in the presence of the test compounds (as % inhibition at 10 um). In a second assay, the same compounds were assayed at five concentrations ranging from 100 uM to 10 nM with ten-fold dilutions in duplicate.	B	COc1ccc2[nH]nc(C(=O)NCC3CCN(Cc4nc(C(=O)O)co4)CC3)c2c1		CHEMBL3736086	=	IC50	nM	310.0	CHEMBL262	Homo sapiens	IC50	nM	310.0
335726	17713944	CHEMBL3887394	LanthaScreen TR-FRET Assay: Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screening assay, compounds were tested in duplicate at a concentration of 10 uM.Human recombinant enzyme GSK-3beta was incubated for 90 minutes at 22° C. in the presence of compounds or vehicle in a reaction buffer containing ATP plus 100 nM unphosphorylated specific substrate peptide (Ulight-CFFKNIVTPRTPPPSQGK-amide). Substrate phosphorylation was measured by LANCE technology (PerkinElmer, Conn., USA). The results, reported in the following Table 4, are expressed as a percent of inhibition of control specific activity obtained in the presence of the test compounds (as % inhibition at 10 um). In a second assay, the same compounds were assayed at five concentrations ranging from 100 uM to 10 nM with ten-fold dilutions in duplicate.	B	COC(=O)c1coc(CN2CCC(CNC(=O)c3n[nH]c4ccc(Br)cc34)CC2)n1		CHEMBL3736476	=	IC50	nM	360.0	CHEMBL262	Homo sapiens	IC50	nM	360.0
335727	17713945	CHEMBL3887394	LanthaScreen TR-FRET Assay: Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screening assay, compounds were tested in duplicate at a concentration of 10 uM.Human recombinant enzyme GSK-3beta was incubated for 90 minutes at 22° C. in the presence of compounds or vehicle in a reaction buffer containing ATP plus 100 nM unphosphorylated specific substrate peptide (Ulight-CFFKNIVTPRTPPPSQGK-amide). Substrate phosphorylation was measured by LANCE technology (PerkinElmer, Conn., USA). The results, reported in the following Table 4, are expressed as a percent of inhibition of control specific activity obtained in the presence of the test compounds (as % inhibition at 10 um). In a second assay, the same compounds were assayed at five concentrations ranging from 100 uM to 10 nM with ten-fold dilutions in duplicate.	B	O=C(O)c1coc(CN2CCC(CNC(=O)c3n[nH]c4ccc(-c5cccc(F)c5F)cc34)CC2)n1		CHEMBL3735986	=	IC50	nM	10.0	CHEMBL262	Homo sapiens	IC50	nM	10.0
335728	17713946	CHEMBL3887394	LanthaScreen TR-FRET Assay: Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screening assay, compounds were tested in duplicate at a concentration of 10 uM.Human recombinant enzyme GSK-3beta was incubated for 90 minutes at 22° C. in the presence of compounds or vehicle in a reaction buffer containing ATP plus 100 nM unphosphorylated specific substrate peptide (Ulight-CFFKNIVTPRTPPPSQGK-amide). Substrate phosphorylation was measured by LANCE technology (PerkinElmer, Conn., USA). The results, reported in the following Table 4, are expressed as a percent of inhibition of control specific activity obtained in the presence of the test compounds (as % inhibition at 10 um). In a second assay, the same compounds were assayed at five concentrations ranging from 100 uM to 10 nM with ten-fold dilutions in duplicate.	B	CCOC(=O)c1nc(CN2CCC(CNC(=O)c3n[nH]c4ccc(OC)cc34)CC2)cs1		CHEMBL3734973	=	IC50	nM	950.0	CHEMBL262	Homo sapiens	IC50	nM	950.0
335729	17713947	CHEMBL3887394	LanthaScreen TR-FRET Assay: Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screening assay, compounds were tested in duplicate at a concentration of 10 uM.Human recombinant enzyme GSK-3beta was incubated for 90 minutes at 22° C. in the presence of compounds or vehicle in a reaction buffer containing ATP plus 100 nM unphosphorylated specific substrate peptide (Ulight-CFFKNIVTPRTPPPSQGK-amide). Substrate phosphorylation was measured by LANCE technology (PerkinElmer, Conn., USA). The results, reported in the following Table 4, are expressed as a percent of inhibition of control specific activity obtained in the presence of the test compounds (as % inhibition at 10 um). In a second assay, the same compounds were assayed at five concentrations ranging from 100 uM to 10 nM with ten-fold dilutions in duplicate.	B	COC(=O)c1ccoc1CN1CCC(CNC(=O)c2n[nH]c3ccc(OC)cc23)CC1		CHEMBL3735291	=	IC50	nM	230.0	CHEMBL262	Homo sapiens	IC50	nM	230.0
335730	17713948	CHEMBL3887394	LanthaScreen TR-FRET Assay: Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screening assay, compounds were tested in duplicate at a concentration of 10 uM.Human recombinant enzyme GSK-3beta was incubated for 90 minutes at 22° C. in the presence of compounds or vehicle in a reaction buffer containing ATP plus 100 nM unphosphorylated specific substrate peptide (Ulight-CFFKNIVTPRTPPPSQGK-amide). Substrate phosphorylation was measured by LANCE technology (PerkinElmer, Conn., USA). The results, reported in the following Table 4, are expressed as a percent of inhibition of control specific activity obtained in the presence of the test compounds (as % inhibition at 10 um). In a second assay, the same compounds were assayed at five concentrations ranging from 100 uM to 10 nM with ten-fold dilutions in duplicate.	B	CCOC(=O)c1ccc(CN2CCC(CNC(=O)c3n[nH]c4ccc(Br)cc34)CC2)o1		CHEMBL3735613	=	IC50	nM	260.0	CHEMBL262	Homo sapiens	IC50	nM	260.0
335731	17713949	CHEMBL3887394	LanthaScreen TR-FRET Assay: Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screening assay, compounds were tested in duplicate at a concentration of 10 uM.Human recombinant enzyme GSK-3beta was incubated for 90 minutes at 22° C. in the presence of compounds or vehicle in a reaction buffer containing ATP plus 100 nM unphosphorylated specific substrate peptide (Ulight-CFFKNIVTPRTPPPSQGK-amide). Substrate phosphorylation was measured by LANCE technology (PerkinElmer, Conn., USA). The results, reported in the following Table 4, are expressed as a percent of inhibition of control specific activity obtained in the presence of the test compounds (as % inhibition at 10 um). In a second assay, the same compounds were assayed at five concentrations ranging from 100 uM to 10 nM with ten-fold dilutions in duplicate.	B	COc1ncccc1-c1ccc2[nH]nc(C(=O)NCC3CCN(Cc4ccc(C(=O)O)o4)CC3)c2c1		CHEMBL3734924	=	IC50	nM	360.0	CHEMBL262	Homo sapiens	IC50	nM	360.0
335732	17713950	CHEMBL3887394	LanthaScreen TR-FRET Assay: Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screening assay, compounds were tested in duplicate at a concentration of 10 uM.Human recombinant enzyme GSK-3beta was incubated for 90 minutes at 22° C. in the presence of compounds or vehicle in a reaction buffer containing ATP plus 100 nM unphosphorylated specific substrate peptide (Ulight-CFFKNIVTPRTPPPSQGK-amide). Substrate phosphorylation was measured by LANCE technology (PerkinElmer, Conn., USA). The results, reported in the following Table 4, are expressed as a percent of inhibition of control specific activity obtained in the presence of the test compounds (as % inhibition at 10 um). In a second assay, the same compounds were assayed at five concentrations ranging from 100 uM to 10 nM with ten-fold dilutions in duplicate.	B	COc1ccc(-c2ccc3[nH]nc(C(=O)NCC4CCN(Cc5ccc(C(=O)O)o5)CC4)c3c2)cn1		CHEMBL3736035	=	IC50	nM	20.0	CHEMBL262	Homo sapiens	IC50	nM	20.0
335733	17713951	CHEMBL3887394	LanthaScreen TR-FRET Assay: Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screening assay, compounds were tested in duplicate at a concentration of 10 uM.Human recombinant enzyme GSK-3beta was incubated for 90 minutes at 22° C. in the presence of compounds or vehicle in a reaction buffer containing ATP plus 100 nM unphosphorylated specific substrate peptide (Ulight-CFFKNIVTPRTPPPSQGK-amide). Substrate phosphorylation was measured by LANCE technology (PerkinElmer, Conn., USA). The results, reported in the following Table 4, are expressed as a percent of inhibition of control specific activity obtained in the presence of the test compounds (as % inhibition at 10 um). In a second assay, the same compounds were assayed at five concentrations ranging from 100 uM to 10 nM with ten-fold dilutions in duplicate.	B	COc1ccc(-c2ccc3[nH]nc(C(=O)NCC4CCN(Cc5ccc(C(=O)O)o5)CC4)c3c2)cc1		CHEMBL3734895	=	IC50	nM	300.0	CHEMBL262	Homo sapiens	IC50	nM	300.0
335734	17713952	CHEMBL3887394	LanthaScreen TR-FRET Assay: Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screening assay, compounds were tested in duplicate at a concentration of 10 uM.Human recombinant enzyme GSK-3beta was incubated for 90 minutes at 22° C. in the presence of compounds or vehicle in a reaction buffer containing ATP plus 100 nM unphosphorylated specific substrate peptide (Ulight-CFFKNIVTPRTPPPSQGK-amide). Substrate phosphorylation was measured by LANCE technology (PerkinElmer, Conn., USA). The results, reported in the following Table 4, are expressed as a percent of inhibition of control specific activity obtained in the presence of the test compounds (as % inhibition at 10 um). In a second assay, the same compounds were assayed at five concentrations ranging from 100 uM to 10 nM with ten-fold dilutions in duplicate.	B	O=C(O)c1ccc(CN2CCC(CNC(=O)c3n[nH]c4ccc(-c5cccc(F)c5F)cc34)CC2)o1		CHEMBL3735215	=	IC50	nM	10.0	CHEMBL262	Homo sapiens	IC50	nM	10.0
335735	17713953	CHEMBL3887394	LanthaScreen TR-FRET Assay: Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screening assay, compounds were tested in duplicate at a concentration of 10 uM.Human recombinant enzyme GSK-3beta was incubated for 90 minutes at 22° C. in the presence of compounds or vehicle in a reaction buffer containing ATP plus 100 nM unphosphorylated specific substrate peptide (Ulight-CFFKNIVTPRTPPPSQGK-amide). Substrate phosphorylation was measured by LANCE technology (PerkinElmer, Conn., USA). The results, reported in the following Table 4, are expressed as a percent of inhibition of control specific activity obtained in the presence of the test compounds (as % inhibition at 10 um). In a second assay, the same compounds were assayed at five concentrations ranging from 100 uM to 10 nM with ten-fold dilutions in duplicate.	B	O=C(O)c1ccc(CN2CCC(CNC(=O)c3n[nH]c4ccc(-c5ccccc5F)cc34)CC2)o1		CHEMBL3735856	=	IC50	nM	20.0	CHEMBL262	Homo sapiens	IC50	nM	20.0
335736	17713954	CHEMBL3887394	LanthaScreen TR-FRET Assay: Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screening assay, compounds were tested in duplicate at a concentration of 10 uM.Human recombinant enzyme GSK-3beta was incubated for 90 minutes at 22° C. in the presence of compounds or vehicle in a reaction buffer containing ATP plus 100 nM unphosphorylated specific substrate peptide (Ulight-CFFKNIVTPRTPPPSQGK-amide). Substrate phosphorylation was measured by LANCE technology (PerkinElmer, Conn., USA). The results, reported in the following Table 4, are expressed as a percent of inhibition of control specific activity obtained in the presence of the test compounds (as % inhibition at 10 um). In a second assay, the same compounds were assayed at five concentrations ranging from 100 uM to 10 nM with ten-fold dilutions in duplicate.	B	COc1ccncc1-c1ccc2[nH]nc(C(=O)NCC3CCN(Cc4ccc(C(=O)O)o4)CC3)c2c1		CHEMBL3735176	=	IC50	nM	10.0	CHEMBL262	Homo sapiens	IC50	nM	10.0
335737	17713955	CHEMBL3887394	LanthaScreen TR-FRET Assay: Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screening assay, compounds were tested in duplicate at a concentration of 10 uM.Human recombinant enzyme GSK-3beta was incubated for 90 minutes at 22° C. in the presence of compounds or vehicle in a reaction buffer containing ATP plus 100 nM unphosphorylated specific substrate peptide (Ulight-CFFKNIVTPRTPPPSQGK-amide). Substrate phosphorylation was measured by LANCE technology (PerkinElmer, Conn., USA). The results, reported in the following Table 4, are expressed as a percent of inhibition of control specific activity obtained in the presence of the test compounds (as % inhibition at 10 um). In a second assay, the same compounds were assayed at five concentrations ranging from 100 uM to 10 nM with ten-fold dilutions in duplicate.	B	O=C(O)c1ccc(CN2CCC(CNC(=O)c3n[nH]c4ccc(Br)cc34)CC2)o1		CHEMBL3736600	=	IC50	nM	210.0	CHEMBL262	Homo sapiens	IC50	nM	210.0
335738	17713956	CHEMBL3887394	LanthaScreen TR-FRET Assay: Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screening assay, compounds were tested in duplicate at a concentration of 10 uM.Human recombinant enzyme GSK-3beta was incubated for 90 minutes at 22° C. in the presence of compounds or vehicle in a reaction buffer containing ATP plus 100 nM unphosphorylated specific substrate peptide (Ulight-CFFKNIVTPRTPPPSQGK-amide). Substrate phosphorylation was measured by LANCE technology (PerkinElmer, Conn., USA). The results, reported in the following Table 4, are expressed as a percent of inhibition of control specific activity obtained in the presence of the test compounds (as % inhibition at 10 um). In a second assay, the same compounds were assayed at five concentrations ranging from 100 uM to 10 nM with ten-fold dilutions in duplicate.	B	CCOC(=O)c1ccc(CN2CCC(CNC(=O)c3n[nH]c4ccc(OC)cc34)CC2)o1		CHEMBL3735529	=	IC50	nM	330.0	CHEMBL262	Homo sapiens	IC50	nM	330.0
335739	17713957	CHEMBL3887394	LanthaScreen TR-FRET Assay: Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screening assay, compounds were tested in duplicate at a concentration of 10 uM.Human recombinant enzyme GSK-3beta was incubated for 90 minutes at 22° C. in the presence of compounds or vehicle in a reaction buffer containing ATP plus 100 nM unphosphorylated specific substrate peptide (Ulight-CFFKNIVTPRTPPPSQGK-amide). Substrate phosphorylation was measured by LANCE technology (PerkinElmer, Conn., USA). The results, reported in the following Table 4, are expressed as a percent of inhibition of control specific activity obtained in the presence of the test compounds (as % inhibition at 10 um). In a second assay, the same compounds were assayed at five concentrations ranging from 100 uM to 10 nM with ten-fold dilutions in duplicate.	B	COc1ccc2[nH]nc(C(=O)NCC3CCN(Cc4ccc(C(=O)O)o4)CC3)c2c1		CHEMBL3736399	=	IC50	nM	400.0	CHEMBL262	Homo sapiens	IC50	nM	400.0
335740	17713958	CHEMBL3887394	LanthaScreen TR-FRET Assay: Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screening assay, compounds were tested in duplicate at a concentration of 10 uM.Human recombinant enzyme GSK-3beta was incubated for 90 minutes at 22° C. in the presence of compounds or vehicle in a reaction buffer containing ATP plus 100 nM unphosphorylated specific substrate peptide (Ulight-CFFKNIVTPRTPPPSQGK-amide). Substrate phosphorylation was measured by LANCE technology (PerkinElmer, Conn., USA). The results, reported in the following Table 4, are expressed as a percent of inhibition of control specific activity obtained in the presence of the test compounds (as % inhibition at 10 um). In a second assay, the same compounds were assayed at five concentrations ranging from 100 uM to 10 nM with ten-fold dilutions in duplicate.	B	COc1ccc2[nH]nc(C(=O)NCC3CCN(CCN4C[C@H](C)O[C@H](C)C4)CC3)c2c1		CHEMBL3735882	=	IC50	nM	1400.0	CHEMBL262	Homo sapiens	IC50	nM	1400.0
335741	17713959	CHEMBL3887394	LanthaScreen TR-FRET Assay: Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screening assay, compounds were tested in duplicate at a concentration of 10 uM.Human recombinant enzyme GSK-3beta was incubated for 90 minutes at 22° C. in the presence of compounds or vehicle in a reaction buffer containing ATP plus 100 nM unphosphorylated specific substrate peptide (Ulight-CFFKNIVTPRTPPPSQGK-amide). Substrate phosphorylation was measured by LANCE technology (PerkinElmer, Conn., USA). The results, reported in the following Table 4, are expressed as a percent of inhibition of control specific activity obtained in the presence of the test compounds (as % inhibition at 10 um). In a second assay, the same compounds were assayed at five concentrations ranging from 100 uM to 10 nM with ten-fold dilutions in duplicate.	B	COc1ccc2[nH]nc(C(=O)NCC3CCN(CCCN4C[C@H](C)O[C@H](C)C4)CC3)c2c1		CHEMBL3734776	=	IC50	nM	2100.0	CHEMBL262	Homo sapiens	IC50	nM	2100.0
335742	17713960	CHEMBL3887394	LanthaScreen TR-FRET Assay: Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screening assay, compounds were tested in duplicate at a concentration of 10 uM.Human recombinant enzyme GSK-3beta was incubated for 90 minutes at 22° C. in the presence of compounds or vehicle in a reaction buffer containing ATP plus 100 nM unphosphorylated specific substrate peptide (Ulight-CFFKNIVTPRTPPPSQGK-amide). Substrate phosphorylation was measured by LANCE technology (PerkinElmer, Conn., USA). The results, reported in the following Table 4, are expressed as a percent of inhibition of control specific activity obtained in the presence of the test compounds (as % inhibition at 10 um). In a second assay, the same compounds were assayed at five concentrations ranging from 100 uM to 10 nM with ten-fold dilutions in duplicate.	B	COc1ccc2[nH]nc(C(=O)NCC3CCN(CCC4CCCC(C)C4)CC3)c2c1		CHEMBL3734911	=	IC50	nM	310.0	CHEMBL262	Homo sapiens	IC50	nM	310.0
335743	17713961	CHEMBL3887394	LanthaScreen TR-FRET Assay: Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screening assay, compounds were tested in duplicate at a concentration of 10 uM.Human recombinant enzyme GSK-3beta was incubated for 90 minutes at 22° C. in the presence of compounds or vehicle in a reaction buffer containing ATP plus 100 nM unphosphorylated specific substrate peptide (Ulight-CFFKNIVTPRTPPPSQGK-amide). Substrate phosphorylation was measured by LANCE technology (PerkinElmer, Conn., USA). The results, reported in the following Table 4, are expressed as a percent of inhibition of control specific activity obtained in the presence of the test compounds (as % inhibition at 10 um). In a second assay, the same compounds were assayed at five concentrations ranging from 100 uM to 10 nM with ten-fold dilutions in duplicate.	B	COc1ccc2[nH]nc(C(=O)NCC3CCN(Cc4ccnc(C(=O)O)c4)CC3)c2c1		CHEMBL3735154	=	IC50	nM	450.0	CHEMBL262	Homo sapiens	IC50	nM	450.0
335744	17713962	CHEMBL3887394	LanthaScreen TR-FRET Assay: Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screening assay, compounds were tested in duplicate at a concentration of 10 uM.Human recombinant enzyme GSK-3beta was incubated for 90 minutes at 22° C. in the presence of compounds or vehicle in a reaction buffer containing ATP plus 100 nM unphosphorylated specific substrate peptide (Ulight-CFFKNIVTPRTPPPSQGK-amide). Substrate phosphorylation was measured by LANCE technology (PerkinElmer, Conn., USA). The results, reported in the following Table 4, are expressed as a percent of inhibition of control specific activity obtained in the presence of the test compounds (as % inhibition at 10 um). In a second assay, the same compounds were assayed at five concentrations ranging from 100 uM to 10 nM with ten-fold dilutions in duplicate.	B	COc1ccc2[nH]nc(C(=O)NCC3CCN(Cc4ccc(C(=O)O)nc4)CC3)c2c1		CHEMBL3736599	=	IC50	nM	320.0	CHEMBL262	Homo sapiens	IC50	nM	320.0
335745	17713963	CHEMBL3887394	LanthaScreen TR-FRET Assay: Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screening assay, compounds were tested in duplicate at a concentration of 10 uM.Human recombinant enzyme GSK-3beta was incubated for 90 minutes at 22° C. in the presence of compounds or vehicle in a reaction buffer containing ATP plus 100 nM unphosphorylated specific substrate peptide (Ulight-CFFKNIVTPRTPPPSQGK-amide). Substrate phosphorylation was measured by LANCE technology (PerkinElmer, Conn., USA). The results, reported in the following Table 4, are expressed as a percent of inhibition of control specific activity obtained in the presence of the test compounds (as % inhibition at 10 um). In a second assay, the same compounds were assayed at five concentrations ranging from 100 uM to 10 nM with ten-fold dilutions in duplicate.	B	COc1ccc2[nH]nc(C(=O)NCC3CCN(Cc4noc(C(N)=O)n4)CC3)c2c1		CHEMBL3735347	=	IC50	nM	310.0	CHEMBL262	Homo sapiens	IC50	nM	310.0
335746	17713964	CHEMBL3887394	LanthaScreen TR-FRET Assay: Activity on human GSK-3beta was assessed using the following methods (according to Meijer et al., Chem. Biol., 2003-10:1255-1266).In a first screening assay, compounds were tested in duplicate at a concentration of 10 uM.Human recombinant enzyme GSK-3beta was incubated for 90 minutes at 22° C. in the presence of compounds or vehicle in a reaction buffer containing ATP plus 100 nM unphosphorylated specific substrate peptide (Ulight-CFFKNIVTPRTPPPSQGK-amide). Substrate phosphorylation was measured by LANCE technology (PerkinElmer, Conn., USA). The results, reported in the following Table 4, are expressed as a percent of inhibition of control specific activity obtained in the presence of the test compounds (as % inhibition at 10 um). In a second assay, the same compounds were assayed at five concentrations ranging from 100 uM to 10 nM with ten-fold dilutions in duplicate.	B	O=C(NCC1CCN(Cc2cccc([N+](=O)[O-])c2)CC1)c1n[nH]c2ccccc12		CHEMBL3931871	=	IC50	nM	7200.0	CHEMBL262	Homo sapiens	IC50	nM	7200.0
410864	17775680	CHEMBL3888609	Kinase Inhibition Assay: The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory concentration (IC50) values determined by Millipore UK Ltd; Gemini Crescent; Dundee Technology Park; Dundee DD2 1SW; UK (IC50Profiler). Detailed protocols can be found at: www.millipore.com/drugdiscovery/dd3/assayprotocols.	B	COc1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL201511	=	IC50	nM	1100.0	CHEMBL262	Homo sapiens	IC50	nM	1100.0
410865	17775681	CHEMBL3888609	Kinase Inhibition Assay: The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory concentration (IC50) values determined by Millipore UK Ltd; Gemini Crescent; Dundee Technology Park; Dundee DD2 1SW; UK (IC50Profiler). Detailed protocols can be found at: www.millipore.com/drugdiscovery/dd3/assayprotocols.	B	COc1cc(C2=C(c3c[nH]c4ncccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL2180878	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	nM	10000.0
410866	17775682	CHEMBL3888609	Kinase Inhibition Assay: The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory concentration (IC50) values determined by Millipore UK Ltd; Gemini Crescent; Dundee Technology Park; Dundee DD2 1SW; UK (IC50Profiler). Detailed protocols can be found at: www.millipore.com/drugdiscovery/dd3/assayprotocols.	B	COc1cc(C2=C(c3c[nH]c4cnccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL2180882	<	IC50	nM	10.0	CHEMBL262	Homo sapiens	IC50	nM	10.0
410867	17775683	CHEMBL3888609	Kinase Inhibition Assay: The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory concentration (IC50) values determined by Millipore UK Ltd; Gemini Crescent; Dundee Technology Park; Dundee DD2 1SW; UK (IC50Profiler). Detailed protocols can be found at: www.millipore.com/drugdiscovery/dd3/assayprotocols.	B	COc1cc(C2=C(c3c[nH]c4ccncc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL2177142	=	IC50	nM	50.0	CHEMBL262	Homo sapiens	IC50	nM	50.0
410868	17775684	CHEMBL3888609	Kinase Inhibition Assay: The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory concentration (IC50) values determined by Millipore UK Ltd; Gemini Crescent; Dundee Technology Park; Dundee DD2 1SW; UK (IC50Profiler). Detailed protocols can be found at: www.millipore.com/drugdiscovery/dd3/assayprotocols.	B	COc1cc(C2=C(c3c[nH]c4cccnc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL2180881	=	IC50	nM	215.0	CHEMBL262	Homo sapiens	IC50	nM	215.0
410869	17775685	CHEMBL3888609	Kinase Inhibition Assay: The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory concentration (IC50) values determined by Millipore UK Ltd; Gemini Crescent; Dundee Technology Park; Dundee DD2 1SW; UK (IC50Profiler). Detailed protocols can be found at: www.millipore.com/drugdiscovery/dd3/assayprotocols.	B	COc1cc(C2=C(c3cn(CCN)c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL3983434	=	IC50	nM	195.0	CHEMBL262	Homo sapiens	IC50	nM	195.0
410870	17775686	CHEMBL3888609	Kinase Inhibition Assay: The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory concentration (IC50) values determined by Millipore UK Ltd; Gemini Crescent; Dundee Technology Park; Dundee DD2 1SW; UK (IC50Profiler). Detailed protocols can be found at: www.millipore.com/drugdiscovery/dd3/assayprotocols.	B	COc1cc(C2=C(c3cn(CCCN)c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL3919644	=	IC50	nM	129.0	CHEMBL262	Homo sapiens	IC50	nM	129.0
410871	17775687	CHEMBL3888609	Kinase Inhibition Assay: The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory concentration (IC50) values determined by Millipore UK Ltd; Gemini Crescent; Dundee Technology Park; Dundee DD2 1SW; UK (IC50Profiler). Detailed protocols can be found at: www.millipore.com/drugdiscovery/dd3/assayprotocols.	B	COc1cc(C2=C(c3cn(CCO)c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL3969156	=	IC50	nM	3.0	CHEMBL262	Homo sapiens	IC50	nM	3.0
410872	17775688	CHEMBL3888609	Kinase Inhibition Assay: The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory concentration (IC50) values determined by Millipore UK Ltd; Gemini Crescent; Dundee Technology Park; Dundee DD2 1SW; UK (IC50Profiler). Detailed protocols can be found at: www.millipore.com/drugdiscovery/dd3/assayprotocols.	B	COc1cc(C2=C(c3cn(CCCO)c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL3699446	=	IC50	nM	2.0	CHEMBL262	Homo sapiens	IC50	nM	2.0
410873	17775689	CHEMBL3888609	Kinase Inhibition Assay: The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory concentration (IC50) values determined by Millipore UK Ltd; Gemini Crescent; Dundee Technology Park; Dundee DD2 1SW; UK (IC50Profiler). Detailed protocols can be found at: www.millipore.com/drugdiscovery/dd3/assayprotocols.	B	COc1cc(C2=C(c3cn(CCN(C)C)c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL3961887	=	IC50	nM	3582.0	CHEMBL262	Homo sapiens	IC50	nM	3582.0
410874	17775690	CHEMBL3888609	Kinase Inhibition Assay: The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory concentration (IC50) values determined by Millipore UK Ltd; Gemini Crescent; Dundee Technology Park; Dundee DD2 1SW; UK (IC50Profiler). Detailed protocols can be found at: www.millipore.com/drugdiscovery/dd3/assayprotocols.	B	COc1cc(C2=C(c3cn(CCCN(C)C)c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL3934384	>	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	nM	1000.0
410875	17775691	CHEMBL3888609	Kinase Inhibition Assay: The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory concentration (IC50) values determined by Millipore UK Ltd; Gemini Crescent; Dundee Technology Park; Dundee DD2 1SW; UK (IC50Profiler). Detailed protocols can be found at: www.millipore.com/drugdiscovery/dd3/assayprotocols.	B	COc1cc(C2=C(c3cn(CCN4CCCCC4)c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL3956492	>	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	nM	1000.0
410876	17775692	CHEMBL3888609	Kinase Inhibition Assay: The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory concentration (IC50) values determined by Millipore UK Ltd; Gemini Crescent; Dundee Technology Park; Dundee DD2 1SW; UK (IC50Profiler). Detailed protocols can be found at: www.millipore.com/drugdiscovery/dd3/assayprotocols.	B	COc1cc(C2=C(c3cn(CCN4CCOCC4)c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL3925481	=	IC50	nM	657.0	CHEMBL262	Homo sapiens	IC50	nM	657.0
410877	17775693	CHEMBL3888609	Kinase Inhibition Assay: The effect of test compounds on the activity of the protein kinases GSK-3β, VEGFR-2 and FLT-3 was evaluated based on half maximal inhibitory concentration (IC50) values determined by Millipore UK Ltd; Gemini Crescent; Dundee Technology Park; Dundee DD2 1SW; UK (IC50Profiler). Detailed protocols can be found at: www.millipore.com/drugdiscovery/dd3/assayprotocols.	B	COc1cc(C2=C(c3cn(CCCN4CCN(C)CC4)c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL3947828	=	IC50	nM	3238.0	CHEMBL262	Homo sapiens	IC50	nM	3238.0
438358	17798103	CHEMBL3889160	GSKbeta Assay: Types of GSK-3 assay used to test the selectivity/off target potential compounds of the invention with respect to PKC Î±/Î¸ inhibition activity includes the following: Type 1: The GSK-3 specific peptide used in this assay was derived from the phosphorylation site of glycogen synthase and its sequence is: YRRAAVPPSPSLSRHSSPHQ(S)EDEEE (SEQ ID NO: 1). (S) is pre-phosphorylated as is glycogen synthase in vivo and the three consensus sites for GSK-3 specific phosphorylation are underlined. The buffer used to make up the glycogen synthase peptide and [γ-33P] ATP consisted of MOPS 25 mM, EDTA 0.2 mM, magnesium acetate 10 mM, Tween-20 0.01% and mercaptoethanol 7.5 mM at pH 7.00. The compounds were dissolved in dimethyl sulphoxide (DMSO) to a final concentration of 100 mM. Various concentrations were made up in DMSO and mixed with the substrate (GSK-3 peptide) solution (to a final concentration 20 uM) described in the above section along with rabbit or human GSK-3α and GSK-3β (final concentration 0.5 uM/mL enzyme). The reactions were initiated with the addition of [γ-33P] ATP (500 cpm/pmole) spiked into a mixture of ATP (final concentration of 10 uM). After 30 minutes at room temperature the reaction was terminated by the addition of 10 uL of H3PO4/O.OP/0 Tween-20 (2.5%). A volume (10 uL) of the mixture was spotted onto P-30 phosphocellulose paper (Wallac & Berthold, EG&G Instruments Ltd, Milton Keynes). The paper was washed four times in H3PO4 (0.5%), 2 minutes for each wash, air dried and the radioactive phosphate incorporated into the synthetic glycogen synthase peptide, which binds to the P-30 phosphocellulose paper, was counted in a Wallac microbeta scintillation counter Analysis of Data: Values for IC50 for each inhibitor were calculated by fitting a four-parameter logistic curve to the model: cpm=lower+(upper-lower)/(I+(concentration IC50)).	B	Nc1ncc(-c2ccccc2C(F)(F)F)nc1C(=O)Nc1cnccc1N1CCCC(N)C1		CHEMBL3949162	=	IC50	nM	97.0	CHEMBL262	Homo sapiens	IC50	nM	97.0
438359	17798104	CHEMBL3889160	GSKbeta Assay: Types of GSK-3 assay used to test the selectivity/off target potential compounds of the invention with respect to PKC Î±/Î¸ inhibition activity includes the following: Type 1: The GSK-3 specific peptide used in this assay was derived from the phosphorylation site of glycogen synthase and its sequence is: YRRAAVPPSPSLSRHSSPHQ(S)EDEEE (SEQ ID NO: 1). (S) is pre-phosphorylated as is glycogen synthase in vivo and the three consensus sites for GSK-3 specific phosphorylation are underlined. The buffer used to make up the glycogen synthase peptide and [γ-33P] ATP consisted of MOPS 25 mM, EDTA 0.2 mM, magnesium acetate 10 mM, Tween-20 0.01% and mercaptoethanol 7.5 mM at pH 7.00. The compounds were dissolved in dimethyl sulphoxide (DMSO) to a final concentration of 100 mM. Various concentrations were made up in DMSO and mixed with the substrate (GSK-3 peptide) solution (to a final concentration 20 uM) described in the above section along with rabbit or human GSK-3α and GSK-3β (final concentration 0.5 uM/mL enzyme). The reactions were initiated with the addition of [γ-33P] ATP (500 cpm/pmole) spiked into a mixture of ATP (final concentration of 10 uM). After 30 minutes at room temperature the reaction was terminated by the addition of 10 uL of H3PO4/O.OP/0 Tween-20 (2.5%). A volume (10 uL) of the mixture was spotted onto P-30 phosphocellulose paper (Wallac & Berthold, EG&G Instruments Ltd, Milton Keynes). The paper was washed four times in H3PO4 (0.5%), 2 minutes for each wash, air dried and the radioactive phosphate incorporated into the synthetic glycogen synthase peptide, which binds to the P-30 phosphocellulose paper, was counted in a Wallac microbeta scintillation counter Analysis of Data: Values for IC50 for each inhibitor were calculated by fitting a four-parameter logistic curve to the model: cpm=lower+(upper-lower)/(I+(concentration IC50)).	B	Nc1ncc(-c2ccccc2F)nc1C(=O)Nc1cnccc1N1CCC(N)CC1		CHEMBL3895998	=	IC50	nM	0.1	CHEMBL262	Homo sapiens	IC50	nM	0.1
438360	17798105	CHEMBL3889160	GSKbeta Assay: Types of GSK-3 assay used to test the selectivity/off target potential compounds of the invention with respect to PKC Î±/Î¸ inhibition activity includes the following: Type 1: The GSK-3 specific peptide used in this assay was derived from the phosphorylation site of glycogen synthase and its sequence is: YRRAAVPPSPSLSRHSSPHQ(S)EDEEE (SEQ ID NO: 1). (S) is pre-phosphorylated as is glycogen synthase in vivo and the three consensus sites for GSK-3 specific phosphorylation are underlined. The buffer used to make up the glycogen synthase peptide and [γ-33P] ATP consisted of MOPS 25 mM, EDTA 0.2 mM, magnesium acetate 10 mM, Tween-20 0.01% and mercaptoethanol 7.5 mM at pH 7.00. The compounds were dissolved in dimethyl sulphoxide (DMSO) to a final concentration of 100 mM. Various concentrations were made up in DMSO and mixed with the substrate (GSK-3 peptide) solution (to a final concentration 20 uM) described in the above section along with rabbit or human GSK-3α and GSK-3β (final concentration 0.5 uM/mL enzyme). The reactions were initiated with the addition of [γ-33P] ATP (500 cpm/pmole) spiked into a mixture of ATP (final concentration of 10 uM). After 30 minutes at room temperature the reaction was terminated by the addition of 10 uL of H3PO4/O.OP/0 Tween-20 (2.5%). A volume (10 uL) of the mixture was spotted onto P-30 phosphocellulose paper (Wallac & Berthold, EG&G Instruments Ltd, Milton Keynes). The paper was washed four times in H3PO4 (0.5%), 2 minutes for each wash, air dried and the radioactive phosphate incorporated into the synthetic glycogen synthase peptide, which binds to the P-30 phosphocellulose paper, was counted in a Wallac microbeta scintillation counter Analysis of Data: Values for IC50 for each inhibitor were calculated by fitting a four-parameter logistic curve to the model: cpm=lower+(upper-lower)/(I+(concentration IC50)).	B	Nc1ncc(-c2ccccc2)nc1C(=O)Nc1ccccc1N1CCC(N)CC1		CHEMBL3943813	=	IC50	nM	1.0	CHEMBL262	Homo sapiens	IC50	nM	1.0
438361	17798106	CHEMBL3889160	GSKbeta Assay: Types of GSK-3 assay used to test the selectivity/off target potential compounds of the invention with respect to PKC Î±/Î¸ inhibition activity includes the following: Type 1: The GSK-3 specific peptide used in this assay was derived from the phosphorylation site of glycogen synthase and its sequence is: YRRAAVPPSPSLSRHSSPHQ(S)EDEEE (SEQ ID NO: 1). (S) is pre-phosphorylated as is glycogen synthase in vivo and the three consensus sites for GSK-3 specific phosphorylation are underlined. The buffer used to make up the glycogen synthase peptide and [γ-33P] ATP consisted of MOPS 25 mM, EDTA 0.2 mM, magnesium acetate 10 mM, Tween-20 0.01% and mercaptoethanol 7.5 mM at pH 7.00. The compounds were dissolved in dimethyl sulphoxide (DMSO) to a final concentration of 100 mM. Various concentrations were made up in DMSO and mixed with the substrate (GSK-3 peptide) solution (to a final concentration 20 uM) described in the above section along with rabbit or human GSK-3α and GSK-3β (final concentration 0.5 uM/mL enzyme). The reactions were initiated with the addition of [γ-33P] ATP (500 cpm/pmole) spiked into a mixture of ATP (final concentration of 10 uM). After 30 minutes at room temperature the reaction was terminated by the addition of 10 uL of H3PO4/O.OP/0 Tween-20 (2.5%). A volume (10 uL) of the mixture was spotted onto P-30 phosphocellulose paper (Wallac & Berthold, EG&G Instruments Ltd, Milton Keynes). The paper was washed four times in H3PO4 (0.5%), 2 minutes for each wash, air dried and the radioactive phosphate incorporated into the synthetic glycogen synthase peptide, which binds to the P-30 phosphocellulose paper, was counted in a Wallac microbeta scintillation counter Analysis of Data: Values for IC50 for each inhibitor were calculated by fitting a four-parameter logistic curve to the model: cpm=lower+(upper-lower)/(I+(concentration IC50)).	B	Nc1ncc(-c2ccccc2)nc1C(=O)Nc1cnccc1N1CCC(N)CC1		CHEMBL3963605	=	IC50	nM	0.2	CHEMBL262	Homo sapiens	IC50	nM	0.2
438362	17798107	CHEMBL3889160	GSKbeta Assay: Types of GSK-3 assay used to test the selectivity/off target potential compounds of the invention with respect to PKC Î±/Î¸ inhibition activity includes the following: Type 1: The GSK-3 specific peptide used in this assay was derived from the phosphorylation site of glycogen synthase and its sequence is: YRRAAVPPSPSLSRHSSPHQ(S)EDEEE (SEQ ID NO: 1). (S) is pre-phosphorylated as is glycogen synthase in vivo and the three consensus sites for GSK-3 specific phosphorylation are underlined. The buffer used to make up the glycogen synthase peptide and [γ-33P] ATP consisted of MOPS 25 mM, EDTA 0.2 mM, magnesium acetate 10 mM, Tween-20 0.01% and mercaptoethanol 7.5 mM at pH 7.00. The compounds were dissolved in dimethyl sulphoxide (DMSO) to a final concentration of 100 mM. Various concentrations were made up in DMSO and mixed with the substrate (GSK-3 peptide) solution (to a final concentration 20 uM) described in the above section along with rabbit or human GSK-3α and GSK-3β (final concentration 0.5 uM/mL enzyme). The reactions were initiated with the addition of [γ-33P] ATP (500 cpm/pmole) spiked into a mixture of ATP (final concentration of 10 uM). After 30 minutes at room temperature the reaction was terminated by the addition of 10 uL of H3PO4/O.OP/0 Tween-20 (2.5%). A volume (10 uL) of the mixture was spotted onto P-30 phosphocellulose paper (Wallac & Berthold, EG&G Instruments Ltd, Milton Keynes). The paper was washed four times in H3PO4 (0.5%), 2 minutes for each wash, air dried and the radioactive phosphate incorporated into the synthetic glycogen synthase peptide, which binds to the P-30 phosphocellulose paper, was counted in a Wallac microbeta scintillation counter Analysis of Data: Values for IC50 for each inhibitor were calculated by fitting a four-parameter logistic curve to the model: cpm=lower+(upper-lower)/(I+(concentration IC50)).	B	COc1ccc(-c2cnc(N)c(C(=O)Nc3cnccc3N3CCC(N)CC3)n2)cc1		CHEMBL3942619	=	IC50	nM	0.2	CHEMBL262	Homo sapiens	IC50	nM	0.2
438363	17798108	CHEMBL3889160	GSKbeta Assay: Types of GSK-3 assay used to test the selectivity/off target potential compounds of the invention with respect to PKC Î±/Î¸ inhibition activity includes the following: Type 1: The GSK-3 specific peptide used in this assay was derived from the phosphorylation site of glycogen synthase and its sequence is: YRRAAVPPSPSLSRHSSPHQ(S)EDEEE (SEQ ID NO: 1). (S) is pre-phosphorylated as is glycogen synthase in vivo and the three consensus sites for GSK-3 specific phosphorylation are underlined. The buffer used to make up the glycogen synthase peptide and [γ-33P] ATP consisted of MOPS 25 mM, EDTA 0.2 mM, magnesium acetate 10 mM, Tween-20 0.01% and mercaptoethanol 7.5 mM at pH 7.00. The compounds were dissolved in dimethyl sulphoxide (DMSO) to a final concentration of 100 mM. Various concentrations were made up in DMSO and mixed with the substrate (GSK-3 peptide) solution (to a final concentration 20 uM) described in the above section along with rabbit or human GSK-3α and GSK-3β (final concentration 0.5 uM/mL enzyme). The reactions were initiated with the addition of [γ-33P] ATP (500 cpm/pmole) spiked into a mixture of ATP (final concentration of 10 uM). After 30 minutes at room temperature the reaction was terminated by the addition of 10 uL of H3PO4/O.OP/0 Tween-20 (2.5%). A volume (10 uL) of the mixture was spotted onto P-30 phosphocellulose paper (Wallac & Berthold, EG&G Instruments Ltd, Milton Keynes). The paper was washed four times in H3PO4 (0.5%), 2 minutes for each wash, air dried and the radioactive phosphate incorporated into the synthetic glycogen synthase peptide, which binds to the P-30 phosphocellulose paper, was counted in a Wallac microbeta scintillation counter Analysis of Data: Values for IC50 for each inhibitor were calculated by fitting a four-parameter logistic curve to the model: cpm=lower+(upper-lower)/(I+(concentration IC50)).	B	Nc1ncc(-c2ccccc2F)nc1C(=O)Nc1cnccc1N1CCNCC1		CHEMBL3957649	=	IC50	nM	0.2	CHEMBL262	Homo sapiens	IC50	nM	0.2
438364	17798109	CHEMBL3889160	GSKbeta Assay: Types of GSK-3 assay used to test the selectivity/off target potential compounds of the invention with respect to PKC Î±/Î¸ inhibition activity includes the following: Type 1: The GSK-3 specific peptide used in this assay was derived from the phosphorylation site of glycogen synthase and its sequence is: YRRAAVPPSPSLSRHSSPHQ(S)EDEEE (SEQ ID NO: 1). (S) is pre-phosphorylated as is glycogen synthase in vivo and the three consensus sites for GSK-3 specific phosphorylation are underlined. The buffer used to make up the glycogen synthase peptide and [γ-33P] ATP consisted of MOPS 25 mM, EDTA 0.2 mM, magnesium acetate 10 mM, Tween-20 0.01% and mercaptoethanol 7.5 mM at pH 7.00. The compounds were dissolved in dimethyl sulphoxide (DMSO) to a final concentration of 100 mM. Various concentrations were made up in DMSO and mixed with the substrate (GSK-3 peptide) solution (to a final concentration 20 uM) described in the above section along with rabbit or human GSK-3α and GSK-3β (final concentration 0.5 uM/mL enzyme). The reactions were initiated with the addition of [γ-33P] ATP (500 cpm/pmole) spiked into a mixture of ATP (final concentration of 10 uM). After 30 minutes at room temperature the reaction was terminated by the addition of 10 uL of H3PO4/O.OP/0 Tween-20 (2.5%). A volume (10 uL) of the mixture was spotted onto P-30 phosphocellulose paper (Wallac & Berthold, EG&G Instruments Ltd, Milton Keynes). The paper was washed four times in H3PO4 (0.5%), 2 minutes for each wash, air dried and the radioactive phosphate incorporated into the synthetic glycogen synthase peptide, which binds to the P-30 phosphocellulose paper, was counted in a Wallac microbeta scintillation counter Analysis of Data: Values for IC50 for each inhibitor were calculated by fitting a four-parameter logistic curve to the model: cpm=lower+(upper-lower)/(I+(concentration IC50)).	B	Nc1ncc(-c2ncccc2C(F)(F)F)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3890986	=	IC50	nM	5500.0	CHEMBL262	Homo sapiens	IC50	nM	5500.0
438373	17798117	CHEMBL3889160	GSKbeta Assay: Types of GSK-3 assay used to test the selectivity/off target potential compounds of the invention with respect to PKC Î±/Î¸ inhibition activity includes the following: Type 1: The GSK-3 specific peptide used in this assay was derived from the phosphorylation site of glycogen synthase and its sequence is: YRRAAVPPSPSLSRHSSPHQ(S)EDEEE (SEQ ID NO: 1). (S) is pre-phosphorylated as is glycogen synthase in vivo and the three consensus sites for GSK-3 specific phosphorylation are underlined. The buffer used to make up the glycogen synthase peptide and [γ-33P] ATP consisted of MOPS 25 mM, EDTA 0.2 mM, magnesium acetate 10 mM, Tween-20 0.01% and mercaptoethanol 7.5 mM at pH 7.00. The compounds were dissolved in dimethyl sulphoxide (DMSO) to a final concentration of 100 mM. Various concentrations were made up in DMSO and mixed with the substrate (GSK-3 peptide) solution (to a final concentration 20 uM) described in the above section along with rabbit or human GSK-3α and GSK-3β (final concentration 0.5 uM/mL enzyme). The reactions were initiated with the addition of [γ-33P] ATP (500 cpm/pmole) spiked into a mixture of ATP (final concentration of 10 uM). After 30 minutes at room temperature the reaction was terminated by the addition of 10 uL of H3PO4/O.OP/0 Tween-20 (2.5%). A volume (10 uL) of the mixture was spotted onto P-30 phosphocellulose paper (Wallac & Berthold, EG&G Instruments Ltd, Milton Keynes). The paper was washed four times in H3PO4 (0.5%), 2 minutes for each wash, air dried and the radioactive phosphate incorporated into the synthetic glycogen synthase peptide, which binds to the P-30 phosphocellulose paper, was counted in a Wallac microbeta scintillation counter Analysis of Data: Values for IC50 for each inhibitor were calculated by fitting a four-parameter logistic curve to the model: cpm=lower+(upper-lower)/(I+(concentration IC50)).	B	Nc1ncc(-c2ncccc2OC(F)(F)F)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3915489	=	IC50	nM	2400.0	CHEMBL262	Homo sapiens	IC50	nM	2400.0
438374	17798118	CHEMBL3889160	GSKbeta Assay: Types of GSK-3 assay used to test the selectivity/off target potential compounds of the invention with respect to PKC Î±/Î¸ inhibition activity includes the following: Type 1: The GSK-3 specific peptide used in this assay was derived from the phosphorylation site of glycogen synthase and its sequence is: YRRAAVPPSPSLSRHSSPHQ(S)EDEEE (SEQ ID NO: 1). (S) is pre-phosphorylated as is glycogen synthase in vivo and the three consensus sites for GSK-3 specific phosphorylation are underlined. The buffer used to make up the glycogen synthase peptide and [γ-33P] ATP consisted of MOPS 25 mM, EDTA 0.2 mM, magnesium acetate 10 mM, Tween-20 0.01% and mercaptoethanol 7.5 mM at pH 7.00. The compounds were dissolved in dimethyl sulphoxide (DMSO) to a final concentration of 100 mM. Various concentrations were made up in DMSO and mixed with the substrate (GSK-3 peptide) solution (to a final concentration 20 uM) described in the above section along with rabbit or human GSK-3α and GSK-3β (final concentration 0.5 uM/mL enzyme). The reactions were initiated with the addition of [γ-33P] ATP (500 cpm/pmole) spiked into a mixture of ATP (final concentration of 10 uM). After 30 minutes at room temperature the reaction was terminated by the addition of 10 uL of H3PO4/O.OP/0 Tween-20 (2.5%). A volume (10 uL) of the mixture was spotted onto P-30 phosphocellulose paper (Wallac & Berthold, EG&G Instruments Ltd, Milton Keynes). The paper was washed four times in H3PO4 (0.5%), 2 minutes for each wash, air dried and the radioactive phosphate incorporated into the synthetic glycogen synthase peptide, which binds to the P-30 phosphocellulose paper, was counted in a Wallac microbeta scintillation counter Analysis of Data: Values for IC50 for each inhibitor were calculated by fitting a four-parameter logistic curve to the model: cpm=lower+(upper-lower)/(I+(concentration IC50)).	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3nc(N4CCOCC4)cc4ccccc34)cnc2N)CC1		CHEMBL3892099	=	IC50	nM	3100.0	CHEMBL262	Homo sapiens	IC50	nM	3100.0
438375	17798119	CHEMBL3889160	GSKbeta Assay: Types of GSK-3 assay used to test the selectivity/off target potential compounds of the invention with respect to PKC Î±/Î¸ inhibition activity includes the following: Type 1: The GSK-3 specific peptide used in this assay was derived from the phosphorylation site of glycogen synthase and its sequence is: YRRAAVPPSPSLSRHSSPHQ(S)EDEEE (SEQ ID NO: 1). (S) is pre-phosphorylated as is glycogen synthase in vivo and the three consensus sites for GSK-3 specific phosphorylation are underlined. The buffer used to make up the glycogen synthase peptide and [γ-33P] ATP consisted of MOPS 25 mM, EDTA 0.2 mM, magnesium acetate 10 mM, Tween-20 0.01% and mercaptoethanol 7.5 mM at pH 7.00. The compounds were dissolved in dimethyl sulphoxide (DMSO) to a final concentration of 100 mM. Various concentrations were made up in DMSO and mixed with the substrate (GSK-3 peptide) solution (to a final concentration 20 uM) described in the above section along with rabbit or human GSK-3α and GSK-3β (final concentration 0.5 uM/mL enzyme). The reactions were initiated with the addition of [γ-33P] ATP (500 cpm/pmole) spiked into a mixture of ATP (final concentration of 10 uM). After 30 minutes at room temperature the reaction was terminated by the addition of 10 uL of H3PO4/O.OP/0 Tween-20 (2.5%). A volume (10 uL) of the mixture was spotted onto P-30 phosphocellulose paper (Wallac & Berthold, EG&G Instruments Ltd, Milton Keynes). The paper was washed four times in H3PO4 (0.5%), 2 minutes for each wash, air dried and the radioactive phosphate incorporated into the synthetic glycogen synthase peptide, which binds to the P-30 phosphocellulose paper, was counted in a Wallac microbeta scintillation counter Analysis of Data: Values for IC50 for each inhibitor were calculated by fitting a four-parameter logistic curve to the model: cpm=lower+(upper-lower)/(I+(concentration IC50)).	B	Nc1ncc(-c2ncccc2OC(F)(F)F)nc1C(=O)Nc1ncccc1N1CCC(N)(CO)CC1		CHEMBL3901073	=	IC50	nM	1300.0	CHEMBL262	Homo sapiens	IC50	nM	1300.0
438376	17798120	CHEMBL3889160	GSKbeta Assay: Types of GSK-3 assay used to test the selectivity/off target potential compounds of the invention with respect to PKC Î±/Î¸ inhibition activity includes the following: Type 1: The GSK-3 specific peptide used in this assay was derived from the phosphorylation site of glycogen synthase and its sequence is: YRRAAVPPSPSLSRHSSPHQ(S)EDEEE (SEQ ID NO: 1). (S) is pre-phosphorylated as is glycogen synthase in vivo and the three consensus sites for GSK-3 specific phosphorylation are underlined. The buffer used to make up the glycogen synthase peptide and [γ-33P] ATP consisted of MOPS 25 mM, EDTA 0.2 mM, magnesium acetate 10 mM, Tween-20 0.01% and mercaptoethanol 7.5 mM at pH 7.00. The compounds were dissolved in dimethyl sulphoxide (DMSO) to a final concentration of 100 mM. Various concentrations were made up in DMSO and mixed with the substrate (GSK-3 peptide) solution (to a final concentration 20 uM) described in the above section along with rabbit or human GSK-3α and GSK-3β (final concentration 0.5 uM/mL enzyme). The reactions were initiated with the addition of [γ-33P] ATP (500 cpm/pmole) spiked into a mixture of ATP (final concentration of 10 uM). After 30 minutes at room temperature the reaction was terminated by the addition of 10 uL of H3PO4/O.OP/0 Tween-20 (2.5%). A volume (10 uL) of the mixture was spotted onto P-30 phosphocellulose paper (Wallac & Berthold, EG&G Instruments Ltd, Milton Keynes). The paper was washed four times in H3PO4 (0.5%), 2 minutes for each wash, air dried and the radioactive phosphate incorporated into the synthetic glycogen synthase peptide, which binds to the P-30 phosphocellulose paper, was counted in a Wallac microbeta scintillation counter Analysis of Data: Values for IC50 for each inhibitor were calculated by fitting a four-parameter logistic curve to the model: cpm=lower+(upper-lower)/(I+(concentration IC50)).	B	Nc1ncc(-c2csc(N3CCOCC3)n2)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3914252	=	IC50	nM	210.0	CHEMBL262	Homo sapiens	IC50	nM	210.0
438377	17798121	CHEMBL3889160	GSKbeta Assay: Types of GSK-3 assay used to test the selectivity/off target potential compounds of the invention with respect to PKC Î±/Î¸ inhibition activity includes the following: Type 1: The GSK-3 specific peptide used in this assay was derived from the phosphorylation site of glycogen synthase and its sequence is: YRRAAVPPSPSLSRHSSPHQ(S)EDEEE (SEQ ID NO: 1). (S) is pre-phosphorylated as is glycogen synthase in vivo and the three consensus sites for GSK-3 specific phosphorylation are underlined. The buffer used to make up the glycogen synthase peptide and [γ-33P] ATP consisted of MOPS 25 mM, EDTA 0.2 mM, magnesium acetate 10 mM, Tween-20 0.01% and mercaptoethanol 7.5 mM at pH 7.00. The compounds were dissolved in dimethyl sulphoxide (DMSO) to a final concentration of 100 mM. Various concentrations were made up in DMSO and mixed with the substrate (GSK-3 peptide) solution (to a final concentration 20 uM) described in the above section along with rabbit or human GSK-3α and GSK-3β (final concentration 0.5 uM/mL enzyme). The reactions were initiated with the addition of [γ-33P] ATP (500 cpm/pmole) spiked into a mixture of ATP (final concentration of 10 uM). After 30 minutes at room temperature the reaction was terminated by the addition of 10 uL of H3PO4/O.OP/0 Tween-20 (2.5%). A volume (10 uL) of the mixture was spotted onto P-30 phosphocellulose paper (Wallac & Berthold, EG&G Instruments Ltd, Milton Keynes). The paper was washed four times in H3PO4 (0.5%), 2 minutes for each wash, air dried and the radioactive phosphate incorporated into the synthetic glycogen synthase peptide, which binds to the P-30 phosphocellulose paper, was counted in a Wallac microbeta scintillation counter Analysis of Data: Values for IC50 for each inhibitor were calculated by fitting a four-parameter logistic curve to the model: cpm=lower+(upper-lower)/(I+(concentration IC50)).	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncccc3C(F)(F)F)cnc2N)CC1		CHEMBL3982723	=	IC50	nM	3100.0	CHEMBL262	Homo sapiens	IC50	nM	3100.0
438378	17798122	CHEMBL3889160	GSKbeta Assay: Types of GSK-3 assay used to test the selectivity/off target potential compounds of the invention with respect to PKC Î±/Î¸ inhibition activity includes the following: Type 1: The GSK-3 specific peptide used in this assay was derived from the phosphorylation site of glycogen synthase and its sequence is: YRRAAVPPSPSLSRHSSPHQ(S)EDEEE (SEQ ID NO: 1). (S) is pre-phosphorylated as is glycogen synthase in vivo and the three consensus sites for GSK-3 specific phosphorylation are underlined. The buffer used to make up the glycogen synthase peptide and [γ-33P] ATP consisted of MOPS 25 mM, EDTA 0.2 mM, magnesium acetate 10 mM, Tween-20 0.01% and mercaptoethanol 7.5 mM at pH 7.00. The compounds were dissolved in dimethyl sulphoxide (DMSO) to a final concentration of 100 mM. Various concentrations were made up in DMSO and mixed with the substrate (GSK-3 peptide) solution (to a final concentration 20 uM) described in the above section along with rabbit or human GSK-3α and GSK-3β (final concentration 0.5 uM/mL enzyme). The reactions were initiated with the addition of [γ-33P] ATP (500 cpm/pmole) spiked into a mixture of ATP (final concentration of 10 uM). After 30 minutes at room temperature the reaction was terminated by the addition of 10 uL of H3PO4/O.OP/0 Tween-20 (2.5%). A volume (10 uL) of the mixture was spotted onto P-30 phosphocellulose paper (Wallac & Berthold, EG&G Instruments Ltd, Milton Keynes). The paper was washed four times in H3PO4 (0.5%), 2 minutes for each wash, air dried and the radioactive phosphate incorporated into the synthetic glycogen synthase peptide, which binds to the P-30 phosphocellulose paper, was counted in a Wallac microbeta scintillation counter Analysis of Data: Values for IC50 for each inhibitor were calculated by fitting a four-parameter logistic curve to the model: cpm=lower+(upper-lower)/(I+(concentration IC50)).	B	CC1(N)CCN(c2cccnc2NC(=O)c2nc(-c3ncccc3OC(F)(F)F)cnc2N)CC1		CHEMBL3954062	=	IC50	nM	2100.0	CHEMBL262	Homo sapiens	IC50	nM	2100.0
438379	17798123	CHEMBL3889160	GSKbeta Assay: Types of GSK-3 assay used to test the selectivity/off target potential compounds of the invention with respect to PKC Î±/Î¸ inhibition activity includes the following: Type 1: The GSK-3 specific peptide used in this assay was derived from the phosphorylation site of glycogen synthase and its sequence is: YRRAAVPPSPSLSRHSSPHQ(S)EDEEE (SEQ ID NO: 1). (S) is pre-phosphorylated as is glycogen synthase in vivo and the three consensus sites for GSK-3 specific phosphorylation are underlined. The buffer used to make up the glycogen synthase peptide and [γ-33P] ATP consisted of MOPS 25 mM, EDTA 0.2 mM, magnesium acetate 10 mM, Tween-20 0.01% and mercaptoethanol 7.5 mM at pH 7.00. The compounds were dissolved in dimethyl sulphoxide (DMSO) to a final concentration of 100 mM. Various concentrations were made up in DMSO and mixed with the substrate (GSK-3 peptide) solution (to a final concentration 20 uM) described in the above section along with rabbit or human GSK-3α and GSK-3β (final concentration 0.5 uM/mL enzyme). The reactions were initiated with the addition of [γ-33P] ATP (500 cpm/pmole) spiked into a mixture of ATP (final concentration of 10 uM). After 30 minutes at room temperature the reaction was terminated by the addition of 10 uL of H3PO4/O.OP/0 Tween-20 (2.5%). A volume (10 uL) of the mixture was spotted onto P-30 phosphocellulose paper (Wallac & Berthold, EG&G Instruments Ltd, Milton Keynes). The paper was washed four times in H3PO4 (0.5%), 2 minutes for each wash, air dried and the radioactive phosphate incorporated into the synthetic glycogen synthase peptide, which binds to the P-30 phosphocellulose paper, was counted in a Wallac microbeta scintillation counter Analysis of Data: Values for IC50 for each inhibitor were calculated by fitting a four-parameter logistic curve to the model: cpm=lower+(upper-lower)/(I+(concentration IC50)).	B	COc1ccnc(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(C)(N)CC3)n2)c1C(F)(F)F		CHEMBL3899197	=	IC50	nM	2100.0	CHEMBL262	Homo sapiens	IC50	nM	2100.0
438380	17798124	CHEMBL3889160	GSKbeta Assay: Types of GSK-3 assay used to test the selectivity/off target potential compounds of the invention with respect to PKC Î±/Î¸ inhibition activity includes the following: Type 1: The GSK-3 specific peptide used in this assay was derived from the phosphorylation site of glycogen synthase and its sequence is: YRRAAVPPSPSLSRHSSPHQ(S)EDEEE (SEQ ID NO: 1). (S) is pre-phosphorylated as is glycogen synthase in vivo and the three consensus sites for GSK-3 specific phosphorylation are underlined. The buffer used to make up the glycogen synthase peptide and [γ-33P] ATP consisted of MOPS 25 mM, EDTA 0.2 mM, magnesium acetate 10 mM, Tween-20 0.01% and mercaptoethanol 7.5 mM at pH 7.00. The compounds were dissolved in dimethyl sulphoxide (DMSO) to a final concentration of 100 mM. Various concentrations were made up in DMSO and mixed with the substrate (GSK-3 peptide) solution (to a final concentration 20 uM) described in the above section along with rabbit or human GSK-3α and GSK-3β (final concentration 0.5 uM/mL enzyme). The reactions were initiated with the addition of [γ-33P] ATP (500 cpm/pmole) spiked into a mixture of ATP (final concentration of 10 uM). After 30 minutes at room temperature the reaction was terminated by the addition of 10 uL of H3PO4/O.OP/0 Tween-20 (2.5%). A volume (10 uL) of the mixture was spotted onto P-30 phosphocellulose paper (Wallac & Berthold, EG&G Instruments Ltd, Milton Keynes). The paper was washed four times in H3PO4 (0.5%), 2 minutes for each wash, air dried and the radioactive phosphate incorporated into the synthetic glycogen synthase peptide, which binds to the P-30 phosphocellulose paper, was counted in a Wallac microbeta scintillation counter Analysis of Data: Values for IC50 for each inhibitor were calculated by fitting a four-parameter logistic curve to the model: cpm=lower+(upper-lower)/(I+(concentration IC50)).	B	Nc1ncc(-c2nc(N3CCOCC3)ccc2C(F)(F)F)nc1C(=O)Nc1ncccc1N1C[C@@H]2CC[C@H](C1)[C@H]2N		CHEMBL3928145	=	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	nM	10000.0
438381	17798125	CHEMBL3889160	GSKbeta Assay: Types of GSK-3 assay used to test the selectivity/off target potential compounds of the invention with respect to PKC Î±/Î¸ inhibition activity includes the following: Type 1: The GSK-3 specific peptide used in this assay was derived from the phosphorylation site of glycogen synthase and its sequence is: YRRAAVPPSPSLSRHSSPHQ(S)EDEEE (SEQ ID NO: 1). (S) is pre-phosphorylated as is glycogen synthase in vivo and the three consensus sites for GSK-3 specific phosphorylation are underlined. The buffer used to make up the glycogen synthase peptide and [γ-33P] ATP consisted of MOPS 25 mM, EDTA 0.2 mM, magnesium acetate 10 mM, Tween-20 0.01% and mercaptoethanol 7.5 mM at pH 7.00. The compounds were dissolved in dimethyl sulphoxide (DMSO) to a final concentration of 100 mM. Various concentrations were made up in DMSO and mixed with the substrate (GSK-3 peptide) solution (to a final concentration 20 uM) described in the above section along with rabbit or human GSK-3α and GSK-3β (final concentration 0.5 uM/mL enzyme). The reactions were initiated with the addition of [γ-33P] ATP (500 cpm/pmole) spiked into a mixture of ATP (final concentration of 10 uM). After 30 minutes at room temperature the reaction was terminated by the addition of 10 uL of H3PO4/O.OP/0 Tween-20 (2.5%). A volume (10 uL) of the mixture was spotted onto P-30 phosphocellulose paper (Wallac & Berthold, EG&G Instruments Ltd, Milton Keynes). The paper was washed four times in H3PO4 (0.5%), 2 minutes for each wash, air dried and the radioactive phosphate incorporated into the synthetic glycogen synthase peptide, which binds to the P-30 phosphocellulose paper, was counted in a Wallac microbeta scintillation counter Analysis of Data: Values for IC50 for each inhibitor were calculated by fitting a four-parameter logistic curve to the model: cpm=lower+(upper-lower)/(I+(concentration IC50)).	B	COc1ccnc(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(C)(N)CC3)n2)c1F		CHEMBL3891166	=	IC50	nM	2100.0	CHEMBL262	Homo sapiens	IC50	nM	2100.0
438382	17798126	CHEMBL3889160	GSKbeta Assay: Types of GSK-3 assay used to test the selectivity/off target potential compounds of the invention with respect to PKC Î±/Î¸ inhibition activity includes the following: Type 1: The GSK-3 specific peptide used in this assay was derived from the phosphorylation site of glycogen synthase and its sequence is: YRRAAVPPSPSLSRHSSPHQ(S)EDEEE (SEQ ID NO: 1). (S) is pre-phosphorylated as is glycogen synthase in vivo and the three consensus sites for GSK-3 specific phosphorylation are underlined. The buffer used to make up the glycogen synthase peptide and [γ-33P] ATP consisted of MOPS 25 mM, EDTA 0.2 mM, magnesium acetate 10 mM, Tween-20 0.01% and mercaptoethanol 7.5 mM at pH 7.00. The compounds were dissolved in dimethyl sulphoxide (DMSO) to a final concentration of 100 mM. Various concentrations were made up in DMSO and mixed with the substrate (GSK-3 peptide) solution (to a final concentration 20 uM) described in the above section along with rabbit or human GSK-3α and GSK-3β (final concentration 0.5 uM/mL enzyme). The reactions were initiated with the addition of [γ-33P] ATP (500 cpm/pmole) spiked into a mixture of ATP (final concentration of 10 uM). After 30 minutes at room temperature the reaction was terminated by the addition of 10 uL of H3PO4/O.OP/0 Tween-20 (2.5%). A volume (10 uL) of the mixture was spotted onto P-30 phosphocellulose paper (Wallac & Berthold, EG&G Instruments Ltd, Milton Keynes). The paper was washed four times in H3PO4 (0.5%), 2 minutes for each wash, air dried and the radioactive phosphate incorporated into the synthetic glycogen synthase peptide, which binds to the P-30 phosphocellulose paper, was counted in a Wallac microbeta scintillation counter Analysis of Data: Values for IC50 for each inhibitor were calculated by fitting a four-parameter logistic curve to the model: cpm=lower+(upper-lower)/(I+(concentration IC50)).	B	Nc1ncc(-c2ncnc3c2CCCC3)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3909349	=	IC50	nM	1500.0	CHEMBL262	Homo sapiens	IC50	nM	1500.0
438383	17798127	CHEMBL3889160	GSKbeta Assay: Types of GSK-3 assay used to test the selectivity/off target potential compounds of the invention with respect to PKC Î±/Î¸ inhibition activity includes the following: Type 1: The GSK-3 specific peptide used in this assay was derived from the phosphorylation site of glycogen synthase and its sequence is: YRRAAVPPSPSLSRHSSPHQ(S)EDEEE (SEQ ID NO: 1). (S) is pre-phosphorylated as is glycogen synthase in vivo and the three consensus sites for GSK-3 specific phosphorylation are underlined. The buffer used to make up the glycogen synthase peptide and [γ-33P] ATP consisted of MOPS 25 mM, EDTA 0.2 mM, magnesium acetate 10 mM, Tween-20 0.01% and mercaptoethanol 7.5 mM at pH 7.00. The compounds were dissolved in dimethyl sulphoxide (DMSO) to a final concentration of 100 mM. Various concentrations were made up in DMSO and mixed with the substrate (GSK-3 peptide) solution (to a final concentration 20 uM) described in the above section along with rabbit or human GSK-3α and GSK-3β (final concentration 0.5 uM/mL enzyme). The reactions were initiated with the addition of [γ-33P] ATP (500 cpm/pmole) spiked into a mixture of ATP (final concentration of 10 uM). After 30 minutes at room temperature the reaction was terminated by the addition of 10 uL of H3PO4/O.OP/0 Tween-20 (2.5%). A volume (10 uL) of the mixture was spotted onto P-30 phosphocellulose paper (Wallac & Berthold, EG&G Instruments Ltd, Milton Keynes). The paper was washed four times in H3PO4 (0.5%), 2 minutes for each wash, air dried and the radioactive phosphate incorporated into the synthetic glycogen synthase peptide, which binds to the P-30 phosphocellulose paper, was counted in a Wallac microbeta scintillation counter Analysis of Data: Values for IC50 for each inhibitor were calculated by fitting a four-parameter logistic curve to the model: cpm=lower+(upper-lower)/(I+(concentration IC50)).	B	COc1ccnc(-c2cnc(N)c(C(=O)Nc3ncccc3N3CCC(C)(N)CC3)n2)c1C#N		CHEMBL3933598	=	IC50	nM	2400.0	CHEMBL262	Homo sapiens	IC50	nM	2400.0
438384	17798128	CHEMBL3889160	GSKbeta Assay: Types of GSK-3 assay used to test the selectivity/off target potential compounds of the invention with respect to PKC Î±/Î¸ inhibition activity includes the following: Type 1: The GSK-3 specific peptide used in this assay was derived from the phosphorylation site of glycogen synthase and its sequence is: YRRAAVPPSPSLSRHSSPHQ(S)EDEEE (SEQ ID NO: 1). (S) is pre-phosphorylated as is glycogen synthase in vivo and the three consensus sites for GSK-3 specific phosphorylation are underlined. The buffer used to make up the glycogen synthase peptide and [γ-33P] ATP consisted of MOPS 25 mM, EDTA 0.2 mM, magnesium acetate 10 mM, Tween-20 0.01% and mercaptoethanol 7.5 mM at pH 7.00. The compounds were dissolved in dimethyl sulphoxide (DMSO) to a final concentration of 100 mM. Various concentrations were made up in DMSO and mixed with the substrate (GSK-3 peptide) solution (to a final concentration 20 uM) described in the above section along with rabbit or human GSK-3α and GSK-3β (final concentration 0.5 uM/mL enzyme). The reactions were initiated with the addition of [γ-33P] ATP (500 cpm/pmole) spiked into a mixture of ATP (final concentration of 10 uM). After 30 minutes at room temperature the reaction was terminated by the addition of 10 uL of H3PO4/O.OP/0 Tween-20 (2.5%). A volume (10 uL) of the mixture was spotted onto P-30 phosphocellulose paper (Wallac & Berthold, EG&G Instruments Ltd, Milton Keynes). The paper was washed four times in H3PO4 (0.5%), 2 minutes for each wash, air dried and the radioactive phosphate incorporated into the synthetic glycogen synthase peptide, which binds to the P-30 phosphocellulose paper, was counted in a Wallac microbeta scintillation counter Analysis of Data: Values for IC50 for each inhibitor were calculated by fitting a four-parameter logistic curve to the model: cpm=lower+(upper-lower)/(I+(concentration IC50)).	B	Nc1ncc(-c2cc(N3CCOCC3)ccc2C(F)(F)F)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3980746	=	IC50	nM	6500.0	CHEMBL262	Homo sapiens	IC50	nM	6500.0
438385	17798129	CHEMBL3889160	GSKbeta Assay: Types of GSK-3 assay used to test the selectivity/off target potential compounds of the invention with respect to PKC Î±/Î¸ inhibition activity includes the following: Type 1: The GSK-3 specific peptide used in this assay was derived from the phosphorylation site of glycogen synthase and its sequence is: YRRAAVPPSPSLSRHSSPHQ(S)EDEEE (SEQ ID NO: 1). (S) is pre-phosphorylated as is glycogen synthase in vivo and the three consensus sites for GSK-3 specific phosphorylation are underlined. The buffer used to make up the glycogen synthase peptide and [γ-33P] ATP consisted of MOPS 25 mM, EDTA 0.2 mM, magnesium acetate 10 mM, Tween-20 0.01% and mercaptoethanol 7.5 mM at pH 7.00. The compounds were dissolved in dimethyl sulphoxide (DMSO) to a final concentration of 100 mM. Various concentrations were made up in DMSO and mixed with the substrate (GSK-3 peptide) solution (to a final concentration 20 uM) described in the above section along with rabbit or human GSK-3α and GSK-3β (final concentration 0.5 uM/mL enzyme). The reactions were initiated with the addition of [γ-33P] ATP (500 cpm/pmole) spiked into a mixture of ATP (final concentration of 10 uM). After 30 minutes at room temperature the reaction was terminated by the addition of 10 uL of H3PO4/O.OP/0 Tween-20 (2.5%). A volume (10 uL) of the mixture was spotted onto P-30 phosphocellulose paper (Wallac & Berthold, EG&G Instruments Ltd, Milton Keynes). The paper was washed four times in H3PO4 (0.5%), 2 minutes for each wash, air dried and the radioactive phosphate incorporated into the synthetic glycogen synthase peptide, which binds to the P-30 phosphocellulose paper, was counted in a Wallac microbeta scintillation counter Analysis of Data: Values for IC50 for each inhibitor were calculated by fitting a four-parameter logistic curve to the model: cpm=lower+(upper-lower)/(I+(concentration IC50)).	B	Nc1ncc(-c2nc(N3CCOCC3)ccc2C(F)(F)F)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3966643	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	nM	10000.0
438386	17798130	CHEMBL3889160	GSKbeta Assay: Types of GSK-3 assay used to test the selectivity/off target potential compounds of the invention with respect to PKC Î±/Î¸ inhibition activity includes the following: Type 1: The GSK-3 specific peptide used in this assay was derived from the phosphorylation site of glycogen synthase and its sequence is: YRRAAVPPSPSLSRHSSPHQ(S)EDEEE (SEQ ID NO: 1). (S) is pre-phosphorylated as is glycogen synthase in vivo and the three consensus sites for GSK-3 specific phosphorylation are underlined. The buffer used to make up the glycogen synthase peptide and [γ-33P] ATP consisted of MOPS 25 mM, EDTA 0.2 mM, magnesium acetate 10 mM, Tween-20 0.01% and mercaptoethanol 7.5 mM at pH 7.00. The compounds were dissolved in dimethyl sulphoxide (DMSO) to a final concentration of 100 mM. Various concentrations were made up in DMSO and mixed with the substrate (GSK-3 peptide) solution (to a final concentration 20 uM) described in the above section along with rabbit or human GSK-3α and GSK-3β (final concentration 0.5 uM/mL enzyme). The reactions were initiated with the addition of [γ-33P] ATP (500 cpm/pmole) spiked into a mixture of ATP (final concentration of 10 uM). After 30 minutes at room temperature the reaction was terminated by the addition of 10 uL of H3PO4/O.OP/0 Tween-20 (2.5%). A volume (10 uL) of the mixture was spotted onto P-30 phosphocellulose paper (Wallac & Berthold, EG&G Instruments Ltd, Milton Keynes). The paper was washed four times in H3PO4 (0.5%), 2 minutes for each wash, air dried and the radioactive phosphate incorporated into the synthetic glycogen synthase peptide, which binds to the P-30 phosphocellulose paper, was counted in a Wallac microbeta scintillation counter Analysis of Data: Values for IC50 for each inhibitor were calculated by fitting a four-parameter logistic curve to the model: cpm=lower+(upper-lower)/(I+(concentration IC50)).	B	Nc1ncc(-c2nc(N3CCOCC3)cc3ccccc23)nc1C(=O)Nc1ncccc1N1CCC(N)CC1		CHEMBL3966595	=	IC50	nM	3400.0	CHEMBL262	Homo sapiens	IC50	nM	3400.0
Inactive	17905258	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905259	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905260	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905261	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905262	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905263	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905264	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905265	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905266	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905267	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905268	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Active	17905269	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	=	Kd	nM	428.0	CHEMBL262	Homo sapiens	Kd apparent	nM	428.0
Inactive	17905270	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Active	17905271	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	=	Kd	nM	425.0	CHEMBL262	Homo sapiens	Kd apparent	nM	425.0
Inactive	17905272	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905273	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905274	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905275	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Active	17905276	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	=	Kd	nM	58.0	CHEMBL262	Homo sapiens	Kd apparent	nM	58.0
Inactive	17905277	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905278	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905279	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Active	17905280	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	=	Kd	nM	6168.0	CHEMBL262	Homo sapiens	Kd apparent	nM	6168.0
Inactive	17905281	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905282	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905283	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905284	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905285	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905286	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Active	17905287	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	=	Kd	nM	2722.0	CHEMBL262	Homo sapiens	Kd apparent	nM	2722.0
Inactive	17905288	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905289	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905290	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905291	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905292	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905293	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905294	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Active	17905295	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Kd	nM	13.0	CHEMBL262	Homo sapiens	Kd apparent	nM	13.0
Active	17905296	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	=	Kd	nM	447.0	CHEMBL262	Homo sapiens	Kd apparent	nM	447.0
Inactive	17905297	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905298	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905299	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905300	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905301	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905302	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905303	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Active	17905304	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	5063.0	CHEMBL262	Homo sapiens	Kd apparent	nM	5063.0
Inactive	17905305	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905306	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905307	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905308	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905309	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905310	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905311	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905312	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905313	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905314	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905315	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905316	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905317	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905318	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905319	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905320	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905321	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905322	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905323	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905324	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905325	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905326	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905327	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Active	17905328	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	=	Kd	nM	190.0	CHEMBL262	Homo sapiens	Kd apparent	nM	190.0
Inactive	17905329	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905330	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905331	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905332	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905333	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905334	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Active	17905335	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Kd	nM	707.0	CHEMBL262	Homo sapiens	Kd apparent	nM	707.0
Inactive	17905336	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905337	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905338	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905339	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905340	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905341	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905342	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905343	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905344	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905345	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905346	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905347	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905348	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905349	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905350	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905351	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905352	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905353	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905354	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905355	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905356	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905357	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905358	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905359	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905360	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905361	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905362	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905363	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905364	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905365	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905366	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905367	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905368	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905369	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905370	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905371	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905372	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905373	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905374	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905375	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905376	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905377	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905378	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905379	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905380	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905381	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905382	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905383	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905384	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905385	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905386	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905387	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905388	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905389	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905390	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905391	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905392	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905393	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905394	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905395	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905396	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905397	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Active	17905398	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	740.0	CHEMBL262	Homo sapiens	Kd apparent	nM	740.0
Inactive	17905399	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905400	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Active	17905401	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	=	Kd	nM	599.0	CHEMBL262	Homo sapiens	Kd apparent	nM	599.0
Active	17905402	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	=	Kd	nM	62.0	CHEMBL262	Homo sapiens	Kd apparent	nM	62.0
Inactive	17905403	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905404	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905405	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905406	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905407	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905408	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905409	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905410	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905411	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905412	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905413	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905414	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905415	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905416	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905417	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905418	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905419	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905420	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Active	17905421	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	=	Kd	nM	12.0	CHEMBL262	Homo sapiens	Kd apparent	nM	12.0
Inactive	17905422	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905423	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905424	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905425	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905426	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905427	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905428	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905429	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905430	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905431	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905432	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905433	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905434	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905435	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905436	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905437	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905438	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905439	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Active	17905440	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	=	Kd	nM	1322.0	CHEMBL262	Homo sapiens	Kd apparent	nM	1322.0
Inactive	17905441	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Active	17905442	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	=	Kd	nM	709.0	CHEMBL262	Homo sapiens	Kd apparent	nM	709.0
Active	17905443	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	Kd	nM	299.0	CHEMBL262	Homo sapiens	Kd apparent	nM	299.0
Inactive	17905444	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905445	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905446	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905447	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Active	17905448	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	80.0	CHEMBL262	Homo sapiens	Kd apparent	nM	80.0
Inactive	17905449	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905450	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905451	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905452	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905453	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17905454	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	=	Kd	nM	8793.0	CHEMBL262	Homo sapiens	Kd apparent	nM	8793.0
Inactive	17905455	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Active	17905456	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	=	Kd	nM	667.0	CHEMBL262	Homo sapiens	Kd apparent	nM	667.0
Inactive	17905457	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905458	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Active	17905459	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	=	Kd	nM	924.0	CHEMBL262	Homo sapiens	Kd apparent	nM	924.0
Inactive	17905460	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Active	17905461	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Kd	nM	7.0	CHEMBL262	Homo sapiens	Kd apparent	nM	7.0
Inactive	17905462	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905463	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905464	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905465	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905466	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905467	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905468	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905469	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905470	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905471	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905472	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905473	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905474	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905475	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905476	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905477	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905478	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905479	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905480	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905481	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905482	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905483	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905484	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905485	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905486	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905487	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905488	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905489	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905490	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905491	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Active	17905492	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	=	Kd	nM	8.0	CHEMBL262	Homo sapiens	Kd apparent	nM	8.0
Inactive	17905493	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Active	17905494	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	=	Kd	nM	1430.0	CHEMBL262	Homo sapiens	Kd apparent	nM	1430.0
Inactive	17905495	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905496	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Active	17905497	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	=	Kd	nM	4850.0	CHEMBL262	Homo sapiens	Kd apparent	nM	4850.0
Inactive	17905498	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905499	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17905500	CHEMBL3991727	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL262	Homo sapiens	Kd apparent	nM	30000.0
	17964905	CHEMBL3995014	Inhibition of full length human GSK3B (M1 to T433 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by KINOMEscan assay relative to control	B	CNc1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)on3)c(C)c2)ncn1		CHEMBL4060295	=	Activity	%	100.0	CHEMBL262	Homo sapiens	Activity	%	100.0
	17979250	CHEMBL3998055	Inhibition of full length recombinant human His-tagged GSK3beta expressed in baculovirus expression system at 10 uM by Z'-LYTE assay relative to control	B	CC1=Nc2c(Sc3ccccc3)ncnc2Sc2ccccc21		CHEMBL4061152	=	Inhibition	%	7.0	CHEMBL262	Homo sapiens	INH	%	7.0
	17985359	CHEMBL3999013	Inhibition of full-length recombinant human N-terminal GST-tagged GSK3beta expressed in baculovirus infected sf9 cells assessed as residual activity at 100 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate by ADP-Glo bioluminescence assay relative to control relative to control	B	CC(=O)c1cccc(Nc2nc(-c3sc(NC(=O)OC(C)(C)C)nc3C)cs2)c1		CHEMBL4085374	=	Activity	%	79.0	CHEMBL262	Homo sapiens	Activity	%	79.0
	17995730	CHEMBL4001301	Inhibition of bisamide probe binding to GSK3-beta in human SKOV3 cells by SILAC-based quantitative mass spectrometry pull down assay	B	Cc1ccc(NC(=O)c2ccc3c(c2)OCCO3)cc1NC(=O)c1ccc2c(c1)CCCN2		CHEMBL4096048	=	AC50	nM	10000.0	CHEMBL262	Homo sapiens	AC50	uM	10.0
	17995731	CHEMBL4001301	Inhibition of bisamide probe binding to GSK3-beta in human SKOV3 cells by SILAC-based quantitative mass spectrometry pull down assay	B	Cc1ccc(NC(=O)c2ccc3c(c2)OCCO3)cc1NC(=O)c1ccc2nc(OCCN3CCCC3)ccc2c1		CHEMBL4087666	=	AC50	nM	1200.0	CHEMBL262	Homo sapiens	AC50	uM	1.2
	18006639	CHEMBL4003373	Inhibition of human GSK3beta using Biotin-labeled GSP-2 peptide substrate after 90 mins in presence of [gamma33-P]ATP by scintillation proximity assay	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	IC50	nM	210.0	CHEMBL262	Homo sapiens	IC50	nM	210.0
	18008353	CHEMBL4003706	Inhibition of GSK3beta (unknown origin)	B	CN(C)CCn1cc(-c2ccn3c(-c4ccc(C(N)=O)c(OCc5cccc(F)c5)c4)cnc3c2)cn1		CHEMBL4062453	=	IC50	nM	91.0	CHEMBL262	Homo sapiens	IC50	nM	91.0
	18031718	CHEMBL4007711	Inhibition of GSK3B (unknown origin) after 60 mins by TR-FRET assay	B	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL2006765	=	IC50	nM	9410.0	CHEMBL262	Homo sapiens	IC50	uM	9.41
	18031719	CHEMBL4007711	Inhibition of GSK3B (unknown origin) after 60 mins by TR-FRET assay	B	FC(F)(F)CNc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2ccoc12		CHEMBL4078893	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	18031720	CHEMBL4007711	Inhibition of GSK3B (unknown origin) after 60 mins by TR-FRET assay	B	FC(F)(F)CNc1nc(Nc2ccc3cn[nH]c3c2)nc2ccoc12		CHEMBL4066664	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	18031721	CHEMBL4007711	Inhibition of GSK3B (unknown origin) after 60 mins by TR-FRET assay	B	CC1(C)OCC(=O)Nc2cc(Nc3nc(NCC(F)(F)F)c4occc4n3)ccc21		CHEMBL4069365	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	18031722	CHEMBL4007711	Inhibition of GSK3B (unknown origin) after 60 mins by TR-FRET assay	B	Cc1n[nH]c2cc(Nc3nc(NC4CC4)c4occc4n3)ccc12		CHEMBL4062803	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	18048967	CHEMBL4011139	Inhibition of recombinant full length human His-tagged GSK3B expressed in baculovirus expression system	B	CC(C)(C)c1ccc(C(=O)Nc2cn3cc(-n4ccnc4)ccc3n2)cc1		CHEMBL1642655	=	IC50	nM	831.76	CHEMBL262	Homo sapiens	pIC50		6.08
	18048968	CHEMBL4011139	Inhibition of recombinant full length human His-tagged GSK3B expressed in baculovirus expression system	B	COCCn1cc(NC(=O)c2csc(-c3nncn3C(C)C)n2)cn1		CHEMBL4073198	=	IC50	nM	457.09	CHEMBL262	Homo sapiens	pIC50		6.34
	18052912	CHEMBL4011924	Inhibition of GSK3beta (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4089159	=	Inhibition	%	63.7	CHEMBL262	Homo sapiens	INH	%	63.7
	18052938	CHEMBL4011951	Inhibition of GSK3beta (unknown origin) pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4089159	=	IC50	nM	51.0	CHEMBL262	Homo sapiens	IC50	nM	51.0
	18064939	CHEMBL4014121	Inhibition of recombinant human GSK3beta expressed in fall armyworm sf21 cells using Phospho-glycogen synthase peptide-2 as substrate in presence of [gamma-32]-ATP	B	C[C@@H](c1ccc(F)cc1)n1nnc2cnc3ccc(-c4ccc5ocnc5c4)cc3c21		CHEMBL4083249	=	IC50	nM	1594.0	CHEMBL262	Homo sapiens	IC50	nM	1594.0
Not Determined	18066739	CHEMBL4014543	Inhibition of human GSK3beta	B	COc1ccc(-c2cnc3scc(NC(=O)C4CCCCC4)c3c2)cc1OC		CHEMBL3334979		IC50			CHEMBL262	Homo sapiens	IC50		
	18066740	CHEMBL4014543	Inhibition of human GSK3beta	B	CCOc1cc(/C=C2\Oc3ccc(OC)cc3C2=O)ccc1O		CHEMBL4105195	=	IC50	nM	5010.0	CHEMBL262	Homo sapiens	IC50	uM	5.01
	18066741	CHEMBL4014543	Inhibition of human GSK3beta	B	COc1ccc2c(c1)C(=O)/C(=C/c1ccc(O)c(O)c1)O2		CHEMBL4087337	=	IC50	nM	5300.0	CHEMBL262	Homo sapiens	IC50	uM	5.3
	18066742	CHEMBL4014543	Inhibition of human GSK3beta	B	O=C1/C(=C/c2ccc(O)c(O)c2)Oc2cc(O)ccc21		CHEMBL490355	=	IC50	nM	1950.0	CHEMBL262	Homo sapiens	IC50	uM	1.95
	18078038	CHEMBL4016684	Allosteric inhibition of human recombinant full length N-terminal GST-tagged GSK3beta expressed in fall armyworm Sf9 cells after 30 min in presence of ATP by kinase glo luminescent assay	B	CCCCCCCCCCCC(=O)NNC(=O)c1c(O)c2cc(Cl)ccc2[nH]c1=O		CHEMBL4096612	=	IC50	nM	3810.0	CHEMBL262	Homo sapiens	IC50	uM	3.81
	18078039	CHEMBL4016684	Allosteric inhibition of human recombinant full length N-terminal GST-tagged GSK3beta expressed in fall armyworm Sf9 cells after 30 min in presence of ATP by kinase glo luminescent assay	B	CCCCCCCCCCCC(=O)NNC(=O)c1c(O)c2cc(F)ccc2[nH]c1=O		CHEMBL4093852	=	IC50	nM	5800.0	CHEMBL262	Homo sapiens	IC50	uM	5.8
	18078040	CHEMBL4016684	Allosteric inhibition of human recombinant full length N-terminal GST-tagged GSK3beta expressed in fall armyworm Sf9 cells after 30 min in presence of ATP by kinase glo luminescent assay	B	CCCCCCCC(=O)NNC(=O)c1c(O)c2cc(F)ccc2[nH]c1=O		CHEMBL4073164	>	IC50	nM	20000.0	CHEMBL262	Homo sapiens	IC50	uM	20.0
	18078041	CHEMBL4016684	Allosteric inhibition of human recombinant full length N-terminal GST-tagged GSK3beta expressed in fall armyworm Sf9 cells after 30 min in presence of ATP by kinase glo luminescent assay	B	CCCCCCCCCCCC(=O)NNC(=O)c1c(O)c2cc(Cl)ccc2n(C)c1=O		CHEMBL4069382	=	IC50	nM	5950.0	CHEMBL262	Homo sapiens	IC50	uM	5.95
	18078042	CHEMBL4016684	Allosteric inhibition of human recombinant full length N-terminal GST-tagged GSK3beta expressed in fall armyworm Sf9 cells after 30 min in presence of ATP by kinase glo luminescent assay	B	CCCCCCCC(=O)NNC(=O)c1c(O)c2cc(Cl)ccc2n(C)c1=O		CHEMBL4104341	=	IC50	nM	8480.0	CHEMBL262	Homo sapiens	IC50	uM	8.48
	18078043	CHEMBL4016684	Allosteric inhibition of human recombinant full length N-terminal GST-tagged GSK3beta expressed in fall armyworm Sf9 cells after 30 min in presence of ATP by kinase glo luminescent assay	B	CCCCCCCCCCCC(=O)NNC(=O)c1c(O)c2cc(Cl)ccc2n(CC)c1=O		CHEMBL4080101	=	IC50	nM	3180.0	CHEMBL262	Homo sapiens	IC50	uM	3.18
	18078044	CHEMBL4016684	Allosteric inhibition of human recombinant full length N-terminal GST-tagged GSK3beta expressed in fall armyworm Sf9 cells after 30 min in presence of ATP by kinase glo luminescent assay	B	CCCCCCCC(=O)NNC(=O)c1c(O)c2cc(Cl)ccc2n(CC)c1=O		CHEMBL4066679	=	IC50	nM	9420.0	CHEMBL262	Homo sapiens	IC50	uM	9.42
	18078045	CHEMBL4016684	Allosteric inhibition of human recombinant full length N-terminal GST-tagged GSK3beta expressed in fall armyworm Sf9 cells after 30 min in presence of ATP by kinase glo luminescent assay	B	CCCCCCCCCCCC(=O)NNC(=O)c1c(O)c2cc(Br)ccc2[nH]c1=O		CHEMBL4087974	=	IC50	nM	3540.0	CHEMBL262	Homo sapiens	IC50	uM	3.54
	18078046	CHEMBL4016684	Allosteric inhibition of human recombinant full length N-terminal GST-tagged GSK3beta expressed in fall armyworm Sf9 cells after 30 min in presence of ATP by kinase glo luminescent assay	B	CCCCCCCCCCCC(=O)NNC(=O)c1c(O)c2cc(Br)ccc2n(C)c1=O		CHEMBL4077675	=	IC50	nM	4280.0	CHEMBL262	Homo sapiens	IC50	uM	4.28
	18078047	CHEMBL4016684	Allosteric inhibition of human recombinant full length N-terminal GST-tagged GSK3beta expressed in fall armyworm Sf9 cells after 30 min in presence of ATP by kinase glo luminescent assay	B	CCCCCCCC(=O)NNC(=O)c1c(O)c2cc(Br)ccc2n(C)c1=O		CHEMBL4095689	=	IC50	nM	6280.0	CHEMBL262	Homo sapiens	IC50	uM	6.28
	18078048	CHEMBL4016684	Allosteric inhibition of human recombinant full length N-terminal GST-tagged GSK3beta expressed in fall armyworm Sf9 cells after 30 min in presence of ATP by kinase glo luminescent assay	B	CCCCCCCCCCCC(=O)NNC(=O)c1c(O)c2cc(Br)ccc2n(CC)c1=O		CHEMBL4085521	=	IC50	nM	2010.0	CHEMBL262	Homo sapiens	IC50	uM	2.01
	18078049	CHEMBL4016684	Allosteric inhibition of human recombinant full length N-terminal GST-tagged GSK3beta expressed in fall armyworm Sf9 cells after 30 min in presence of ATP by kinase glo luminescent assay	B	CCCCCCCC(=O)NNC(=O)c1c(O)c2cc(Br)ccc2n(CC)c1=O		CHEMBL4103448	=	IC50	nM	7340.0	CHEMBL262	Homo sapiens	IC50	uM	7.34
	18078050	CHEMBL4016684	Allosteric inhibition of human recombinant full length N-terminal GST-tagged GSK3beta expressed in fall armyworm Sf9 cells after 30 min in presence of ATP by kinase glo luminescent assay	B	CCCCCCCCCCCC(=O)NNC(=O)c1c(O)c2ccc(Cl)cc2[nH]c1=O		CHEMBL4095283	=	IC50	nM	3120.0	CHEMBL262	Homo sapiens	IC50	uM	3.12
	18078051	CHEMBL4016684	Allosteric inhibition of human recombinant full length N-terminal GST-tagged GSK3beta expressed in fall armyworm Sf9 cells after 30 min in presence of ATP by kinase glo luminescent assay	B	CCCCCCCC(=O)NNC(=O)c1c(O)c2ccc(Cl)cc2[nH]c1=O		CHEMBL4074837	=	IC50	nM	9000.0	CHEMBL262	Homo sapiens	IC50	uM	9.0
	18078052	CHEMBL4016684	Allosteric inhibition of human recombinant full length N-terminal GST-tagged GSK3beta expressed in fall armyworm Sf9 cells after 30 min in presence of ATP by kinase glo luminescent assay	B	CCCCCCCCCCCC(=O)NNC(=O)c1c(O)c2ccc(Cl)cc2n(C)c1=O		CHEMBL4103031	=	IC50	nM	4030.0	CHEMBL262	Homo sapiens	IC50	uM	4.03
	18078053	CHEMBL4016684	Allosteric inhibition of human recombinant full length N-terminal GST-tagged GSK3beta expressed in fall armyworm Sf9 cells after 30 min in presence of ATP by kinase glo luminescent assay	B	CCCCCCCC(=O)NNC(=O)c1c(O)c2ccc(Cl)cc2n(C)c1=O		CHEMBL4085086	=	IC50	nM	6660.0	CHEMBL262	Homo sapiens	IC50	uM	6.66
	18078054	CHEMBL4016684	Allosteric inhibition of human recombinant full length N-terminal GST-tagged GSK3beta expressed in fall armyworm Sf9 cells after 30 min in presence of ATP by kinase glo luminescent assay	B	CCCCCCCCCCCC(=O)NNC(=O)c1c(O)c2ccc(Cl)cc2n(CC)c1=O		CHEMBL4079704	=	IC50	nM	2480.0	CHEMBL262	Homo sapiens	IC50	uM	2.48
	18078055	CHEMBL4016684	Allosteric inhibition of human recombinant full length N-terminal GST-tagged GSK3beta expressed in fall armyworm Sf9 cells after 30 min in presence of ATP by kinase glo luminescent assay	B	CCCCCCCC(=O)NNC(=O)c1c(O)c2ccc(Cl)cc2n(CC)c1=O		CHEMBL4103963	=	IC50	nM	4830.0	CHEMBL262	Homo sapiens	IC50	uM	4.83
	18078056	CHEMBL4016684	Allosteric inhibition of human recombinant full length N-terminal GST-tagged GSK3beta expressed in fall armyworm Sf9 cells after 30 min in presence of ATP by kinase glo luminescent assay	B	CCCCCCCCCCCC(=O)NNC(=O)c1c(O)c2ccc(Cl)cc2n(Cc2ccccc2)c1=O		CHEMBL4087584	=	IC50	nM	5990.0	CHEMBL262	Homo sapiens	IC50	uM	5.99
	18078057	CHEMBL4016684	Allosteric inhibition of human recombinant full length N-terminal GST-tagged GSK3beta expressed in fall armyworm Sf9 cells after 30 min in presence of ATP by kinase glo luminescent assay	B	CCCCCCCC(=O)NNC(=O)c1c(O)c2ccc(Cl)cc2n(Cc2ccccc2)c1=O		CHEMBL4066219	=	IC50	nM	5960.0	CHEMBL262	Homo sapiens	IC50	uM	5.96
	18078058	CHEMBL4016684	Allosteric inhibition of human recombinant full length N-terminal GST-tagged GSK3beta expressed in fall armyworm Sf9 cells after 30 min in presence of ATP by kinase glo luminescent assay	B	CCCCCCNC(=O)c1c(O)c2ccccc2n(C)c1=O		CHEMBL4084115	>	IC50	nM	20000.0	CHEMBL262	Homo sapiens	IC50	uM	20.0
	18078059	CHEMBL4016684	Allosteric inhibition of human recombinant full length N-terminal GST-tagged GSK3beta expressed in fall armyworm Sf9 cells after 30 min in presence of ATP by kinase glo luminescent assay	B	Cn1c(=O)c(C(=O)NCC(=O)NCC(=O)OCc2ccccc2)c(O)c2ccccc21		CHEMBL4062407	>	IC50	nM	20000.0	CHEMBL262	Homo sapiens	IC50	uM	20.0
	18078060	CHEMBL4016684	Allosteric inhibition of human recombinant full length N-terminal GST-tagged GSK3beta expressed in fall armyworm Sf9 cells after 30 min in presence of ATP by kinase glo luminescent assay	B	Cn1c(=O)c(C(=O)NNCCC#N)c(O)c2ccccc21		CHEMBL4070861	>	IC50	nM	20000.0	CHEMBL262	Homo sapiens	IC50	uM	20.0
Active	18078061	CHEMBL4016685	Non-competitive allosteric inhibition of human recombinant full length N-terminal GST-tagged GSK3beta expressed in fall armyworm Sf9 cells at 2.5 to 5 uM using GS2 as substrate measured at constant substrate levels and varying ATP levels after 30 mins by ADP-Glo kinase Assay	B	CCCCCCCCCCCC(=O)NNC(=O)c1c(O)c2cc(Br)ccc2n(CC)c1=O		CHEMBL4085521		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	18078062	CHEMBL4016685	Non-competitive allosteric inhibition of human recombinant full length N-terminal GST-tagged GSK3beta expressed in fall armyworm Sf9 cells at 2.5 to 5 uM using GS2 as substrate measured at constant substrate levels and varying ATP levels after 30 mins by ADP-Glo kinase Assay	B	CCCCCCCCCCCC(=O)NNC(=O)c1c(O)c2ccc(Cl)cc2n(CC)c1=O		CHEMBL4079704		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	18078063	CHEMBL4016686	Non-competitive allosteric inhibition of human recombinant full length N-terminal GST-tagged GSK3beta expressed in fall armyworm Sf9 cells at 2 to 5 uM using GS2 as substrate measured at varying substrate levels and constant ATP levels after 30 mins by Double-reciprocal plot analysis	B	CCCCCCCCCCCC(=O)NNC(=O)c1c(O)c2cc(Br)ccc2n(CC)c1=O		CHEMBL4085521		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	18078064	CHEMBL4016686	Non-competitive allosteric inhibition of human recombinant full length N-terminal GST-tagged GSK3beta expressed in fall armyworm Sf9 cells at 2 to 5 uM using GS2 as substrate measured at varying substrate levels and constant ATP levels after 30 mins by Double-reciprocal plot analysis	B	CCCCCCCCCCCC(=O)NNC(=O)c1c(O)c2ccc(Cl)cc2n(CC)c1=O		CHEMBL4079704		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	18078065	CHEMBL4016687	Allosteric inhibition of GSK3beta in human LN18 cells assessed as decrease in beta-catenin translocation from cytoplasm to nucleus at 10 uM after 72 hrs by DAPI-satining based confocal microscopic analysis	B	CCCCCCCCCCCC(=O)NNC(=O)c1c(O)c2ccccc2n(CC)c1=O		CHEMBL2037482		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	18078066	CHEMBL4016687	Allosteric inhibition of GSK3beta in human LN18 cells assessed as decrease in beta-catenin translocation from cytoplasm to nucleus at 10 uM after 72 hrs by DAPI-satining based confocal microscopic analysis	B	CCCCCCCCCCCC(=O)NNC(=O)c1c(O)c2cc(Br)ccc2n(CC)c1=O		CHEMBL4085521		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	18078067	CHEMBL4016687	Allosteric inhibition of GSK3beta in human LN18 cells assessed as decrease in beta-catenin translocation from cytoplasm to nucleus at 10 uM after 72 hrs by DAPI-satining based confocal microscopic analysis	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	18078068	CHEMBL4016687	Allosteric inhibition of GSK3beta in human LN18 cells assessed as decrease in beta-catenin translocation from cytoplasm to nucleus at 10 uM after 72 hrs by DAPI-satining based confocal microscopic analysis	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	18078069	CHEMBL4016688	Allosteric inhibition of GSK3beta in human SH-Y5Y cells assessed as decrease in beta-catenin translocation from cytoplasm to nucleus at 10 uM after 72 hrs by DAPI-satining based confocal microscopic analysis	B	CCCCCCCCCCCC(=O)NNC(=O)c1c(O)c2ccccc2n(CC)c1=O		CHEMBL2037482		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	18078070	CHEMBL4016688	Allosteric inhibition of GSK3beta in human SH-Y5Y cells assessed as decrease in beta-catenin translocation from cytoplasm to nucleus at 10 uM after 72 hrs by DAPI-satining based confocal microscopic analysis	B	CCCCCCCCCCCC(=O)NNC(=O)c1c(O)c2cc(Br)ccc2n(CC)c1=O		CHEMBL4085521		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	18078071	CHEMBL4016688	Allosteric inhibition of GSK3beta in human SH-Y5Y cells assessed as decrease in beta-catenin translocation from cytoplasm to nucleus at 10 uM after 72 hrs by DAPI-satining based confocal microscopic analysis	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	18078072	CHEMBL4016688	Allosteric inhibition of GSK3beta in human SH-Y5Y cells assessed as decrease in beta-catenin translocation from cytoplasm to nucleus at 10 uM after 72 hrs by DAPI-satining based confocal microscopic analysis	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	18078080	CHEMBL4016684	Allosteric inhibition of human recombinant full length N-terminal GST-tagged GSK3beta expressed in fall armyworm Sf9 cells after 30 min in presence of ATP by kinase glo luminescent assay	B	CCCCCCCCCCCC(=O)NNC(=O)c1c(O)c2ccccc2n(Cc2ccccc2)c1=O		CHEMBL4094737	=	IC50	nM	5510.0	CHEMBL262	Homo sapiens	IC50	uM	5.51
	18078081	CHEMBL4016684	Allosteric inhibition of human recombinant full length N-terminal GST-tagged GSK3beta expressed in fall armyworm Sf9 cells after 30 min in presence of ATP by kinase glo luminescent assay	B	CCCCCCCCCCCC(=O)NNC(=O)c1c(O)c2ccccc2n(CC2CC2)c1=O		CHEMBL4067286	=	IC50	nM	5250.0	CHEMBL262	Homo sapiens	IC50	uM	5.25
	18078082	CHEMBL4016684	Allosteric inhibition of human recombinant full length N-terminal GST-tagged GSK3beta expressed in fall armyworm Sf9 cells after 30 min in presence of ATP by kinase glo luminescent assay	B	CCCCCCCC(=O)NNC(=O)c1c(O)c2ccccc2n(CC=C(C)C)c1=O		CHEMBL4102484	=	IC50	nM	7110.0	CHEMBL262	Homo sapiens	IC50	uM	7.11
	18078083	CHEMBL4016684	Allosteric inhibition of human recombinant full length N-terminal GST-tagged GSK3beta expressed in fall armyworm Sf9 cells after 30 min in presence of ATP by kinase glo luminescent assay	B	CCCCCCCCCCCC(=O)NNC(=O)c1c(O)c2ccccc2n(CC=C(C)C)c1=O		CHEMBL4078207	=	IC50	nM	7780.0	CHEMBL262	Homo sapiens	IC50	uM	7.78
	18078084	CHEMBL4016684	Allosteric inhibition of human recombinant full length N-terminal GST-tagged GSK3beta expressed in fall armyworm Sf9 cells after 30 min in presence of ATP by kinase glo luminescent assay	B	CCCCCCCCCCCC(=O)NNC(=O)c1c(O)c2ccccc2n(CC(C)C)c1=O		CHEMBL4079175	>	IC50	nM	20000.0	CHEMBL262	Homo sapiens	IC50	uM	20.0
	18078085	CHEMBL4016684	Allosteric inhibition of human recombinant full length N-terminal GST-tagged GSK3beta expressed in fall armyworm Sf9 cells after 30 min in presence of ATP by kinase glo luminescent assay	B	CCn1c(=O)c(C(=O)NNC(=O)CCc2ccc(O)cc2)c(O)c2ccccc21		CHEMBL4097190	>	IC50	nM	20000.0	CHEMBL262	Homo sapiens	IC50	uM	20.0
	18078086	CHEMBL4016684	Allosteric inhibition of human recombinant full length N-terminal GST-tagged GSK3beta expressed in fall armyworm Sf9 cells after 30 min in presence of ATP by kinase glo luminescent assay	B	CCn1c(=O)c(C(=O)NNC(=O)CCc2c[nH]c3ccccc23)c(O)c2ccccc21		CHEMBL4087036	>	IC50	nM	20000.0	CHEMBL262	Homo sapiens	IC50	uM	20.0
	18078087	CHEMBL4016684	Allosteric inhibition of human recombinant full length N-terminal GST-tagged GSK3beta expressed in fall armyworm Sf9 cells after 30 min in presence of ATP by kinase glo luminescent assay	B	CCCCCCCC(=O)NNC(=O)c1c(O)c2ccccc2n(CC)c1=O		CHEMBL1428911	>	IC50	nM	20000.0	CHEMBL262	Homo sapiens	IC50	uM	20.0
	18078088	CHEMBL4016684	Allosteric inhibition of human recombinant full length N-terminal GST-tagged GSK3beta expressed in fall armyworm Sf9 cells after 30 min in presence of ATP by kinase glo luminescent assay	B	Cn1c(=O)c(C(=O)NNC(=O)CCc2c[nH]c3ccccc23)c(O)c2ccccc21		CHEMBL4093528	>	IC50	nM	20000.0	CHEMBL262	Homo sapiens	IC50	uM	20.0
	18078089	CHEMBL4016684	Allosteric inhibition of human recombinant full length N-terminal GST-tagged GSK3beta expressed in fall armyworm Sf9 cells after 30 min in presence of ATP by kinase glo luminescent assay	B	Cn1c(=O)c(C(=O)NNC(=O)Cc2ccccc2)c(O)c2ccccc21		CHEMBL4072819	>	IC50	nM	20000.0	CHEMBL262	Homo sapiens	IC50	uM	20.0
	18078090	CHEMBL4016684	Allosteric inhibition of human recombinant full length N-terminal GST-tagged GSK3beta expressed in fall armyworm Sf9 cells after 30 min in presence of ATP by kinase glo luminescent assay	B	CC(=O)NNC(=O)c1c(O)c2ccccc2n(C)c1=O		CHEMBL4101267	>	IC50	nM	20000.0	CHEMBL262	Homo sapiens	IC50	uM	20.0
	18078091	CHEMBL4016684	Allosteric inhibition of human recombinant full length N-terminal GST-tagged GSK3beta expressed in fall armyworm Sf9 cells after 30 min in presence of ATP by kinase glo luminescent assay	B	Cn1c(=O)c(C(=O)NNC(=O)c2ccccc2)c(O)c2ccccc21		CHEMBL4083267	>	IC50	nM	20000.0	CHEMBL262	Homo sapiens	IC50	uM	20.0
	18078092	CHEMBL4016684	Allosteric inhibition of human recombinant full length N-terminal GST-tagged GSK3beta expressed in fall armyworm Sf9 cells after 30 min in presence of ATP by kinase glo luminescent assay	B	CCCCCCCC(=O)NNC(=O)c1c(O)c2ccccc2n(C)c1=O		CHEMBL4091061	=	IC50	nM	8700.0	CHEMBL262	Homo sapiens	IC50	uM	8.7
	18078093	CHEMBL4016684	Allosteric inhibition of human recombinant full length N-terminal GST-tagged GSK3beta expressed in fall armyworm Sf9 cells after 30 min in presence of ATP by kinase glo luminescent assay	B	CCCCCCCCCCCC(=O)NNC(=O)c1c(O)c2ccccc2n(C)c1=O		CHEMBL4071797	=	IC50	nM	7300.0	CHEMBL262	Homo sapiens	IC50	uM	7.3
	18078094	CHEMBL4016684	Allosteric inhibition of human recombinant full length N-terminal GST-tagged GSK3beta expressed in fall armyworm Sf9 cells after 30 min in presence of ATP by kinase glo luminescent assay	B	CCCCCCCC(=O)NNC(=O)c1c(O)nc2ccccc2c1O		CHEMBL1483920	>	IC50	nM	20000.0	CHEMBL262	Homo sapiens	IC50	uM	20.0
	18078095	CHEMBL4016684	Allosteric inhibition of human recombinant full length N-terminal GST-tagged GSK3beta expressed in fall armyworm Sf9 cells after 30 min in presence of ATP by kinase glo luminescent assay	B	CCCCCCCCCCCC(=O)NNC(=O)c1c(O)c2ccccc2[nH]c1=O		CHEMBL4082305	=	IC50	nM	4500.0	CHEMBL262	Homo sapiens	IC50	uM	4.5
	18078096	CHEMBL4016684	Allosteric inhibition of human recombinant full length N-terminal GST-tagged GSK3beta expressed in fall armyworm Sf9 cells after 30 min in presence of ATP by kinase glo luminescent assay	B	CCCCCCCCCCCC(=O)NNC(=O)c1c(O)c2ccccc2n(CC)c1=O		CHEMBL2037482	=	IC50	nM	2800.0	CHEMBL262	Homo sapiens	IC50	uM	2.8
	18078202	CHEMBL4016701	Inhibition of recombinant GSK3beta (unknown origin) after 10 mins in presence of [gamma32P]ATP by beta counting method	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCC(O)CO		CHEMBL1276317	=	IC50	nM	110.0	CHEMBL262	Homo sapiens	IC50	uM	0.11
Not Determined	18078203	CHEMBL4016701	Inhibition of recombinant GSK3beta (unknown origin) after 10 mins in presence of [gamma32P]ATP by beta counting method	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727		IC50			CHEMBL262	Homo sapiens	IC50		
	18078204	CHEMBL4016701	Inhibition of recombinant GSK3beta (unknown origin) after 10 mins in presence of [gamma32P]ATP by beta counting method	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O		CHEMBL4100916	=	IC50	nM	810.0	CHEMBL262	Homo sapiens	IC50	uM	0.81
	18078205	CHEMBL4016701	Inhibition of recombinant GSK3beta (unknown origin) after 10 mins in presence of [gamma32P]ATP by beta counting method	B	COc1ccc2c(c1)/C(=C1\Nc3ccccc3\C1=N/OCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C(=O)N2		CHEMBL4085289	=	IC50	nM	100.0	CHEMBL262	Homo sapiens	IC50	uM	0.1
Not Determined	18078206	CHEMBL4016701	Inhibition of recombinant GSK3beta (unknown origin) after 10 mins in presence of [gamma32P]ATP by beta counting method	B	COc1ccc2c(c1)/C(=C1/Nc3ccccc3/C1=N\OCC(O)CO)C(=O)N2		CHEMBL4065365		IC50			CHEMBL262	Homo sapiens	IC50		
	18078207	CHEMBL4016701	Inhibition of recombinant GSK3beta (unknown origin) after 10 mins in presence of [gamma32P]ATP by beta counting method	B	Cc1ccc2c(c1)/C(=C1/Nc3ccccc3/C1=N\OCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C(=O)N2		CHEMBL4100748	=	IC50	nM	290.0	CHEMBL262	Homo sapiens	IC50	uM	0.29
	18078208	CHEMBL4016701	Inhibition of recombinant GSK3beta (unknown origin) after 10 mins in presence of [gamma32P]ATP by beta counting method	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2C1=O		CHEMBL1276127	=	IC50	nM	600.0	CHEMBL262	Homo sapiens	IC50	uM	0.6
	18078209	CHEMBL4016701	Inhibition of recombinant GSK3beta (unknown origin) after 10 mins in presence of [gamma32P]ATP by beta counting method	B	COc1ccc2c(c1)/C(=C1/Nc3ccccc3/C1=N\O)C(=O)N2		CHEMBL1830064	=	IC50	nM	90.0	CHEMBL262	Homo sapiens	IC50	uM	0.09
Not Determined	18078210	CHEMBL4016701	Inhibition of recombinant GSK3beta (unknown origin) after 10 mins in presence of [gamma32P]ATP by beta counting method	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762		IC50			CHEMBL262	Homo sapiens	IC50		
Active	18078211	CHEMBL4016702	Inhibition of human N-terminal GST/His6-tagged GSK3beta (M1 to T420 residues) expressed in baculovirus infected sf9 cells at 1 uM using RBER-IRStide as substrate by filter binding assay	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCC(O)CO		CHEMBL1276317		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	18078212	CHEMBL4016702	Inhibition of human N-terminal GST/His6-tagged GSK3beta (M1 to T420 residues) expressed in baculovirus infected sf9 cells at 1 uM using RBER-IRStide as substrate by filter binding assay	B	CN1CCN(CCO/N=C2C(=C3/C(=O)Nc4ccccc43)/Nc3ccccc3/2)CC1.Cl		CHEMBL4084775		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	18078213	CHEMBL4016702	Inhibition of human N-terminal GST/His6-tagged GSK3beta (M1 to T420 residues) expressed in baculovirus infected sf9 cells at 1 uM using RBER-IRStide as substrate by filter binding assay	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	18078214	CHEMBL4016702	Inhibition of human N-terminal GST/His6-tagged GSK3beta (M1 to T420 residues) expressed in baculovirus infected sf9 cells at 1 uM using RBER-IRStide as substrate by filter binding assay	B	Cc1ccc2c(c1)NC(=O)/C2=C1\Nc2ccccc2\C1=N/O		CHEMBL4067175		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	18078235	CHEMBL4016708	Inhibition of human N-terminal GST/His6-tagged GSK3beta (M1 to T420 residues) expressed in baculovirus infected sf9 cells using RBER-IRStide as substrate by filter binding assay	B	CN1CCN(CCO/N=C2C(=C3/C(=O)Nc4cc(Br)ccc43)/Nc3ccccc3/2)CC1.Cl		CHEMBL492244	=	IC50	nM	5.0	CHEMBL262	Homo sapiens	IC50	uM	0.005
Not Active	18091338	CHEMBL4019847	Inhibition of GSK3beta (unknown origin) at 10 uM	B	O/N=c1\cc(-c2cc3cccn3cn2)oc2ccc(OCCN3CCOCC3)cc12		CHEMBL4067875		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	18092340	CHEMBL4020196	Inhibition of GSK3beta (unknown origin)	B	Fc1cccc(Cl)c1CNc1nc(-c2ccco2)n[nH]1		CHEMBL1354522		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	18102163	CHEMBL4022208	Inhibition of GSK3beta phosphorylation at ser9 in human U87MG cells at >1 uM by Western blot analysis relative to control	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	=	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	18105658	CHEMBL4022682	Inhibition of GSK3beta (unknown origin)	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL216543	=	IC50	nM	200.0	CHEMBL262	Homo sapiens	IC50	nM	200.0
	18105659	CHEMBL4022682	Inhibition of GSK3beta (unknown origin)	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	IC50	nM	200.0	CHEMBL262	Homo sapiens	IC50	nM	200.0
	18106096	CHEMBL4022757	Inhibition of human GSK3beta using biotin-CREB peptide substrate after 1 hr by scintillation counting method	B	Nc1nc(NCCNc2ncc(-n3ccnc3)c(-c3ccc(Cl)cc3Cl)n2)ccc1[N+](=O)[O-]		CHEMBL3185148	=	IC50	nM	0.6	CHEMBL262	Homo sapiens	IC50	uM	0.0006
	18106097	CHEMBL4022757	Inhibition of human GSK3beta using biotin-CREB peptide substrate after 1 hr by scintillation counting method	B	Nc1nc(NCCNc2ncc(-c3ncc[nH]3)c(-c3ccc(Cl)cc3Cl)n2)ccc1[N+](=O)[O-]		CHEMBL1080901	=	IC50	nM	0.6	CHEMBL262	Homo sapiens	IC50	uM	0.0006
	18106098	CHEMBL4022757	Inhibition of human GSK3beta using biotin-CREB peptide substrate after 1 hr by scintillation counting method	B	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	=	IC50	nM	4.9	CHEMBL262	Homo sapiens	IC50	uM	0.0049
	18114326	CHEMBL4025168	Inhibition of wild-type human full length GSK3B (M1 to T433 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	87.0	CHEMBL262	Homo sapiens	Activity	%	87.0
	18115020	CHEMBL4025572	Inhibition of GSK3beta phosphorylation at Ser9 in human Hep3B cells assessed as ratio of phosphorylated GSK3beta to beta-actin level at 10 uM after 48 hrs by Western blot analysis	B	O=C1COc2ccccc2N1Cc1cn(CCC2OCCO2)nn1		CHEMBL4104878	=	Ratio		0.7	CHEMBL262	Homo sapiens	Ratio		0.7
	18119890	CHEMBL4026402	Inhibition of recombinant human GSK3beta using prephosphorylated polypeptide as substrate preincubated for 30 mins followed by addition of kinase-glo stop solution measured after 10 mins by Kinase-Glo luminescence assay	B	NC1=NC(c2ccc(F)cc2)NC(=O)N1		CHEMBL3752684	=	IC50	nM	14700.0	CHEMBL262	Homo sapiens	IC50	uM	14.7
	18134484	CHEMBL4029520	Inhibition of GSK3beta (unknown origin) at 1 uM using GSK3 substrate peptide preincubated for 5 mins followed by substrate addition measured after 30 mins in presence of [gamma33P]ATP by scintillation counter method relative to control	B	COCCNC(=O)c1ccc(Oc2sc(C(N)=O)c3c2-c2sncc2CC3)cn1		CHEMBL4066819	=	Inhibition	%	31.0	CHEMBL262	Homo sapiens	INH	%	31.0
	18134511	CHEMBL4029520	Inhibition of GSK3beta (unknown origin) at 1 uM using GSK3 substrate peptide preincubated for 5 mins followed by substrate addition measured after 30 mins in presence of [gamma33P]ATP by scintillation counter method relative to control	B	CSc1sc(C(N)=O)c2c1-c1sncc1CC2		CHEMBL4082469	=	Inhibition	%	64.0	CHEMBL262	Homo sapiens	INH	%	64.0
	18135438	CHEMBL4029690	Inhibition of full length wild type human GSK3B (M1 to T433 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by KINOMEscan assay relative to control	B	O=C1NC(=S)S/C1=C\c1cscn1		CHEMBL4061891	=	Activity	%	28.0	CHEMBL262	Homo sapiens	Activity	%	28.0
	18135455	CHEMBL4029690	Inhibition of full length wild type human GSK3B (M1 to T433 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by KINOMEscan assay relative to control	B	O=C1NC(=S)S/C1=C\c1csc(-c2ccc(C(F)(F)F)cc2)n1		CHEMBL4075290	=	Activity	%	4.0	CHEMBL262	Homo sapiens	Activity	%	4.0
	18135472	CHEMBL4029690	Inhibition of full length wild type human GSK3B (M1 to T433 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by KINOMEscan assay relative to control	B	O=C1NC(=S)N2C(=O)C3Nc4cc(Cl)cc(Cl)c4C3C=C12		CHEMBL4096175	=	Activity	%	68.0	CHEMBL262	Homo sapiens	Activity	%	68.0
	18135489	CHEMBL4029690	Inhibition of full length wild type human GSK3B (M1 to T433 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by KINOMEscan assay relative to control	B	N=C1NC(=O)/C(=C/c2csc(-c3ccc(C(F)(F)F)cc3)n2)S1		CHEMBL4064860	=	Activity	%	6.0	CHEMBL262	Homo sapiens	Activity	%	6.0
Not Active	18140420	CHEMBL4031015	Inhibition of human GSK3-beta at 30 uM	B	CCN(CC)c1ccc(NC(=O)c2c(-c3ccccc3)noc2C)cc1		CHEMBL361366		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	18147064	CHEMBL4032514	Inhibition of GSK3b (unknown origin) at 100 nM relative to control	B	Nc1nccc(-c2c[nH]c3ncc(-c4ccc(F)cc4)cc23)n1		CHEMBL4095226	=	Inhibition	%	25.9	CHEMBL262	Homo sapiens	INH	%	25.9
	18147065	CHEMBL4032514	Inhibition of GSK3b (unknown origin) at 100 nM relative to control	B	COc1ccnc2[nH]cc(-c3ccnc(N)n3)c12		CHEMBL270686	=	Inhibition	%	13.4	CHEMBL262	Homo sapiens	INH	%	13.4
	18147100	CHEMBL4032534	Inhibition of GSK3b (unknown origin) at 500 nM relative to control	B	Nc1nccc(-c2c[nH]c3ncc(-c4ccc(F)cc4)cc23)n1		CHEMBL4095226	=	Inhibition	%	52.3	CHEMBL262	Homo sapiens	INH	%	52.3
	18147101	CHEMBL4032534	Inhibition of GSK3b (unknown origin) at 500 nM relative to control	B	COc1ccnc2[nH]cc(-c3ccnc(N)n3)c12		CHEMBL270686	=	Inhibition	%	13.7	CHEMBL262	Homo sapiens	INH	%	13.7
	18152963	CHEMBL4034242	Inhibition of full-length recombinant human His-tagged GSK3B recombinant in baculovirus expression system using Alexa-Fluor tracer-236 incubated for 60 mins by TR-FRET based Lantha-screen Eu kinase assay	B	Fc1ccc(Cn2cc(-c3ccncc3)c3ccncc32)cc1		CHEMBL4069163	=	IC50	nM	1010.0	CHEMBL262	Homo sapiens	IC50	uM	1.01
Not Active	18152964	CHEMBL4034242	Inhibition of full-length recombinant human His-tagged GSK3B recombinant in baculovirus expression system using Alexa-Fluor tracer-236 incubated for 60 mins by TR-FRET based Lantha-screen Eu kinase assay	B	c1ccc2c(-c3c[nH]c4cnccc34)ccnc2c1		CHEMBL4066607		IC50			CHEMBL262	Homo sapiens	IC50		
	18152965	CHEMBL4034242	Inhibition of full-length recombinant human His-tagged GSK3B recombinant in baculovirus expression system using Alexa-Fluor tracer-236 incubated for 60 mins by TR-FRET based Lantha-screen Eu kinase assay	B	c1cncc(-c2c[nH]c3cnccc23)c1		CHEMBL4102903	=	IC50	nM	31010.0	CHEMBL262	Homo sapiens	IC50	uM	31.01
	18152966	CHEMBL4034242	Inhibition of full-length recombinant human His-tagged GSK3B recombinant in baculovirus expression system using Alexa-Fluor tracer-236 incubated for 60 mins by TR-FRET based Lantha-screen Eu kinase assay	B	N#Cc1cccc2c(-c3ccnc(N)n3)c[nH]c12		CHEMBL4072138	=	IC50	nM	5160.0	CHEMBL262	Homo sapiens	IC50	uM	5.16
	18152967	CHEMBL4034242	Inhibition of full-length recombinant human His-tagged GSK3B recombinant in baculovirus expression system using Alexa-Fluor tracer-236 incubated for 60 mins by TR-FRET based Lantha-screen Eu kinase assay	B	Nc1nccc(-c2c[nH]c3cc(Cl)ccc23)n1		CHEMBL4065388	=	IC50	nM	10690.0	CHEMBL262	Homo sapiens	IC50	uM	10.69
Not Active	18152968	CHEMBL4034242	Inhibition of full-length recombinant human His-tagged GSK3B recombinant in baculovirus expression system using Alexa-Fluor tracer-236 incubated for 60 mins by TR-FRET based Lantha-screen Eu kinase assay	B	Cc1nccc(-c2c[nH]c3cnccc23)n1		CHEMBL3421979		IC50			CHEMBL262	Homo sapiens	IC50		
	18152976	CHEMBL4034242	Inhibition of full-length recombinant human His-tagged GSK3B recombinant in baculovirus expression system using Alexa-Fluor tracer-236 incubated for 60 mins by TR-FRET based Lantha-screen Eu kinase assay	B	CC(C)n1cc(-c2ccncc2)c2ccncc21		CHEMBL4064316	=	IC50	nM	660.0	CHEMBL262	Homo sapiens	IC50	uM	0.66
Not Active	18152977	CHEMBL4034242	Inhibition of full-length recombinant human His-tagged GSK3B recombinant in baculovirus expression system using Alexa-Fluor tracer-236 incubated for 60 mins by TR-FRET based Lantha-screen Eu kinase assay	B	Fc1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4098505		IC50			CHEMBL262	Homo sapiens	IC50		
	18152978	CHEMBL4034242	Inhibition of full-length recombinant human His-tagged GSK3B recombinant in baculovirus expression system using Alexa-Fluor tracer-236 incubated for 60 mins by TR-FRET based Lantha-screen Eu kinase assay	B	Nc1nccc(-c2c[nH]c3cnccc23)n1		CHEMBL4079572	=	IC50	nM	12300.0	CHEMBL262	Homo sapiens	IC50	uM	12.3
	18152979	CHEMBL4034242	Inhibition of full-length recombinant human His-tagged GSK3B recombinant in baculovirus expression system using Alexa-Fluor tracer-236 incubated for 60 mins by TR-FRET based Lantha-screen Eu kinase assay	B	COc1ccc2c(-c3ccnc(N)n3)c[nH]c2c1		CHEMBL4095479	=	IC50	nM	7960.0	CHEMBL262	Homo sapiens	IC50	uM	7.96
Not Active	18152980	CHEMBL4034242	Inhibition of full-length recombinant human His-tagged GSK3B recombinant in baculovirus expression system using Alexa-Fluor tracer-236 incubated for 60 mins by TR-FRET based Lantha-screen Eu kinase assay	B	Nc1nccc(-c2c[nH]c3c(Cl)cccc23)n1		CHEMBL4073997		IC50			CHEMBL262	Homo sapiens	IC50		
Not Active	18152981	CHEMBL4034242	Inhibition of full-length recombinant human His-tagged GSK3B recombinant in baculovirus expression system using Alexa-Fluor tracer-236 incubated for 60 mins by TR-FRET based Lantha-screen Eu kinase assay	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538		IC50			CHEMBL262	Homo sapiens	IC50		
	18152990	CHEMBL4034242	Inhibition of full-length recombinant human His-tagged GSK3B recombinant in baculovirus expression system using Alexa-Fluor tracer-236 incubated for 60 mins by TR-FRET based Lantha-screen Eu kinase assay	B	c1cc(-c2cn(CCC3CC3)c3cnccc23)ccn1		CHEMBL4105629	=	IC50	nM	1140.0	CHEMBL262	Homo sapiens	IC50	uM	1.14
Not Active	18152991	CHEMBL4034242	Inhibition of full-length recombinant human His-tagged GSK3B recombinant in baculovirus expression system using Alexa-Fluor tracer-236 incubated for 60 mins by TR-FRET based Lantha-screen Eu kinase assay	B	COc1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4095156		IC50			CHEMBL262	Homo sapiens	IC50		
	18152992	CHEMBL4034242	Inhibition of full-length recombinant human His-tagged GSK3B recombinant in baculovirus expression system using Alexa-Fluor tracer-236 incubated for 60 mins by TR-FRET based Lantha-screen Eu kinase assay	B	Nc1nccc(-c2c[nH]c3cc(C(F)(F)F)ccc23)n1		CHEMBL4087456	=	IC50	nM	15290.0	CHEMBL262	Homo sapiens	IC50	uM	15.29
	18152993	CHEMBL4034242	Inhibition of full-length recombinant human His-tagged GSK3B recombinant in baculovirus expression system using Alexa-Fluor tracer-236 incubated for 60 mins by TR-FRET based Lantha-screen Eu kinase assay	B	COc1cccc2c(-c3ccnc(N)n3)c[nH]c12		CHEMBL4090889	=	IC50	nM	15840.0	CHEMBL262	Homo sapiens	IC50	uM	15.84
	18152994	CHEMBL4034242	Inhibition of full-length recombinant human His-tagged GSK3B recombinant in baculovirus expression system using Alexa-Fluor tracer-236 incubated for 60 mins by TR-FRET based Lantha-screen Eu kinase assay	B	Nc1nccc(-c2c[nH]c3c([N+](=O)[O-])cccc23)n1		CHEMBL1802401	=	IC50	nM	9950.0	CHEMBL262	Homo sapiens	IC50	uM	9.95
	18153099	CHEMBL4034333	Inhibition of GSK3B Lysine 2 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	-1.9	CHEMBL262	Homo sapiens	INH	%	-1.9
	18153149	CHEMBL4034242	Inhibition of full-length recombinant human His-tagged GSK3B recombinant in baculovirus expression system using Alexa-Fluor tracer-236 incubated for 60 mins by TR-FRET based Lantha-screen Eu kinase assay	B	c1cc(-c2cn(CCCN3CCOCC3)c3cnccc23)ccn1		CHEMBL4095674	=	IC50	nM	7580.0	CHEMBL262	Homo sapiens	IC50	uM	7.58
	18153150	CHEMBL4034242	Inhibition of full-length recombinant human His-tagged GSK3B recombinant in baculovirus expression system using Alexa-Fluor tracer-236 incubated for 60 mins by TR-FRET based Lantha-screen Eu kinase assay	B	Clc1cnccc1-c1c[nH]c2cnccc12		CHEMBL4075648	=	IC50	nM	9610.0	CHEMBL262	Homo sapiens	IC50	uM	9.61
	18153151	CHEMBL4034242	Inhibition of full-length recombinant human His-tagged GSK3B recombinant in baculovirus expression system using Alexa-Fluor tracer-236 incubated for 60 mins by TR-FRET based Lantha-screen Eu kinase assay	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	IC50	nM	9230.0	CHEMBL262	Homo sapiens	IC50	uM	9.23
	18153152	CHEMBL4034242	Inhibition of full-length recombinant human His-tagged GSK3B recombinant in baculovirus expression system using Alexa-Fluor tracer-236 incubated for 60 mins by TR-FRET based Lantha-screen Eu kinase assay	B	COc1ccc2c(-c3ccnc(N)c3)c[nH]c2c1		CHEMBL4098364	=	IC50	nM	12700.0	CHEMBL262	Homo sapiens	IC50	uM	12.7
Not Active	18153153	CHEMBL4034242	Inhibition of full-length recombinant human His-tagged GSK3B recombinant in baculovirus expression system using Alexa-Fluor tracer-236 incubated for 60 mins by TR-FRET based Lantha-screen Eu kinase assay	B	Nc1cc(-c2c[nH]c3c(Cl)cccc23)ccn1		CHEMBL4086818		IC50			CHEMBL262	Homo sapiens	IC50		
	18153154	CHEMBL4034242	Inhibition of full-length recombinant human His-tagged GSK3B recombinant in baculovirus expression system using Alexa-Fluor tracer-236 incubated for 60 mins by TR-FRET based Lantha-screen Eu kinase assay	B	Nc1nccc(-c2c[nH]c3ccccc23)n1		CHEMBL48082	=	IC50	nM	14810.0	CHEMBL262	Homo sapiens	IC50	uM	14.81
	18153162	CHEMBL4034242	Inhibition of full-length recombinant human His-tagged GSK3B recombinant in baculovirus expression system using Alexa-Fluor tracer-236 incubated for 60 mins by TR-FRET based Lantha-screen Eu kinase assay	B	COCCn1cc(-c2ccncc2)c2ccncc21		CHEMBL4091320	=	IC50	nM	3000.0	CHEMBL262	Homo sapiens	IC50	uM	3.0
Not Active	18153163	CHEMBL4034242	Inhibition of full-length recombinant human His-tagged GSK3B recombinant in baculovirus expression system using Alexa-Fluor tracer-236 incubated for 60 mins by TR-FRET based Lantha-screen Eu kinase assay	B	Cc1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4080488		IC50			CHEMBL262	Homo sapiens	IC50		
Not Active	18153164	CHEMBL4034242	Inhibition of full-length recombinant human His-tagged GSK3B recombinant in baculovirus expression system using Alexa-Fluor tracer-236 incubated for 60 mins by TR-FRET based Lantha-screen Eu kinase assay	B	Nc1cc(-c2c[nH]c3cc(C(F)(F)F)ccc23)ccn1		CHEMBL4103831		IC50			CHEMBL262	Homo sapiens	IC50		
Not Active	18153165	CHEMBL4034242	Inhibition of full-length recombinant human His-tagged GSK3B recombinant in baculovirus expression system using Alexa-Fluor tracer-236 incubated for 60 mins by TR-FRET based Lantha-screen Eu kinase assay	B	COc1cccc2c(-c3ccnc(N)c3)c[nH]c12		CHEMBL4068096		IC50			CHEMBL262	Homo sapiens	IC50		
Not Active	18153166	CHEMBL4034242	Inhibition of full-length recombinant human His-tagged GSK3B recombinant in baculovirus expression system using Alexa-Fluor tracer-236 incubated for 60 mins by TR-FRET based Lantha-screen Eu kinase assay	B	Nc1cc(-c2c[nH]c3c([N+](=O)[O-])cccc23)ccn1		CHEMBL4094549		IC50			CHEMBL262	Homo sapiens	IC50		
	18153176	CHEMBL4034242	Inhibition of full-length recombinant human His-tagged GSK3B recombinant in baculovirus expression system using Alexa-Fluor tracer-236 incubated for 60 mins by TR-FRET based Lantha-screen Eu kinase assay	B	Cn1cc(-c2ccncc2)c2ccncc21		CHEMBL4077010	=	IC50	nM	4780.0	CHEMBL262	Homo sapiens	IC50	uM	4.78
Not Active	18153177	CHEMBL4034242	Inhibition of full-length recombinant human His-tagged GSK3B recombinant in baculovirus expression system using Alexa-Fluor tracer-236 incubated for 60 mins by TR-FRET based Lantha-screen Eu kinase assay	B	Nc1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4074685		IC50			CHEMBL262	Homo sapiens	IC50		
	18153178	CHEMBL4034242	Inhibition of full-length recombinant human His-tagged GSK3B recombinant in baculovirus expression system using Alexa-Fluor tracer-236 incubated for 60 mins by TR-FRET based Lantha-screen Eu kinase assay	B	N#Cc1cccc2c(-c3ccnc(N)c3)c[nH]c12		CHEMBL4066075	=	IC50	nM	13860.0	CHEMBL262	Homo sapiens	IC50	uM	13.86
Not Active	18153179	CHEMBL4034242	Inhibition of full-length recombinant human His-tagged GSK3B recombinant in baculovirus expression system using Alexa-Fluor tracer-236 incubated for 60 mins by TR-FRET based Lantha-screen Eu kinase assay	B	Nc1cc(-c2c[nH]c3cc(Cl)ccc23)ccn1		CHEMBL4069088		IC50			CHEMBL262	Homo sapiens	IC50		
	18153180	CHEMBL4034242	Inhibition of full-length recombinant human His-tagged GSK3B recombinant in baculovirus expression system using Alexa-Fluor tracer-236 incubated for 60 mins by TR-FRET based Lantha-screen Eu kinase assay	B	Nc1nccc(-c2c[nH]c3c(Br)cccc23)n1		CHEMBL1802963	=	IC50	nM	22450.0	CHEMBL262	Homo sapiens	IC50	uM	22.45
	18168197	CHEMBL4036885	Binding affinity to full length wild type human GSK3beta (M1 to T433 residues) expressed in mammalian expression system by KINOMEscan assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)CNC(=O)C(N)CCCCn1cc(CCCCNC(=O)CCCCCn2nc(N)c3cc(-c4c(-c5ccccc5)nn5ccccc45)nnc32)nn1)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C		CHEMBL4079223	>	Kd	nM	2500.0	CHEMBL262	Homo sapiens	Kd	uM	2.5
Dose-dependent effect	18171183	CHEMBL4037720	Inhibition of TGF-beta1-induced GSK-3beta phosphorylation in human HCT116 cells after 48 hrs by Western blot analysis	B	Cc1nc(C)c(/C=C/C(=O)N2CCC=C(Cl)C2=O)nc1C		CHEMBL4062698		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	18171185	CHEMBL4037722	Inhibition of TGF-beta1-induced GSK-3beta phosphorylation in human HCT116 cells at 50 nM after 48 hrs by Western blot analysis	B	COc1cc(/C=C/C(=O)N2CCC=CC2=O)cc(OC)c1OC		CHEMBL465843		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	18185970	CHEMBL4040604	Inhibition of human N-terminal GST-tagged GSK3beta at 10 uM relative to control	B	N#Cc1c[nH]c2nc(N)nc(-c3ccc(S(N)(=O)=O)cc3)c12		CHEMBL4089551	>	Inhibition	%	80.0	CHEMBL262	Homo sapiens	INH	%	80.0
	18191677	CHEMBL4041842	Inhibition of GSK3beta (unknown origin)	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	=	IC50	nM	2000.0	CHEMBL262	Homo sapiens	IC50	uM	2.0
	18191678	CHEMBL4041842	Inhibition of GSK3beta (unknown origin)	B	[Li+]	Outside typical range	CHEMBL1234004	=	IC50	nM	2000000.0	CHEMBL262	Homo sapiens	IC50	mM	2.0
	18191679	CHEMBL4041842	Inhibition of GSK3beta (unknown origin)	B	[Zn]		CHEMBL1201279	=	IC50	nM	15000.0	CHEMBL262	Homo sapiens	IC50	uM	15.0
	18191680	CHEMBL4041849	Inhibition of recombinant human GSK3beta	B	C/C(=C\C=C\[C@@H](C)CC/C=C(\C)CC1OC(=O)C(=O)C1=O)CCCc1ccoc1		CHEMBL4100087	=	IC50	nM	7500.0	CHEMBL262	Homo sapiens	IC50	uM	7.5
	18191681	CHEMBL4041842	Inhibition of GSK3beta (unknown origin)	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	IC50	nM	1500.0	CHEMBL262	Homo sapiens	IC50	uM	1.5
	18191682	CHEMBL4041842	Inhibition of GSK3beta (unknown origin)	B	NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c(Br)cc32)N1		CHEMBL361708	=	IC50	nM	10.0	CHEMBL262	Homo sapiens	IC50	nM	10.0
	18191683	CHEMBL4041842	Inhibition of GSK3beta (unknown origin)	B	N=C1N[C@H]2c3c([nH]c(Br)c3Br)C(=O)C3CCC[C@@]32N1		CHEMBL4073799	=	IC50	nM	3000.0	CHEMBL262	Homo sapiens	IC50	uM	3.0
	18191684	CHEMBL4041842	Inhibition of GSK3beta (unknown origin)	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	IC50	nM	20.0	CHEMBL262	Homo sapiens	IC50	nM	20.0
	18191685	CHEMBL4041842	Inhibition of GSK3beta (unknown origin)	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714	=	IC50	nM	34.0	CHEMBL262	Homo sapiens	IC50	nM	34.0
	18191686	CHEMBL4041843	Inhibition of recombinant human GSK3beta using biotin-AAEELDSRAGS(PO3H2)PQL as substrate preincubated for 10 to 15 mins followed by [gamma33P]ATP addition after 20 mins by scintillation proximity assay	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	IC50	nM	100.0	CHEMBL262	Homo sapiens	IC50	nM	100.0
	18191687	CHEMBL4041844	Inhibition of GST-tagged GSK3beta (unknown origin) expressed in Escherichia coli BL21-CodonPlus (DE3) by Z'-LYTE assay	B	Cn1cc(C2=C(c3nn(CCCN4CCOCC4)c4ncccc34)C(=O)NC2=O)c2ccccc21		CHEMBL564033	=	IC50	nM	340.0	CHEMBL262	Homo sapiens	IC50	uM	0.34
	18191688	CHEMBL4041845	Inhibition of full length recombinant human His-tagged GSK3beta expressed in baculovirus expression system using Ser/Thr 9 peptide substrate by Z'-LYTE assay	B	O=C1NC(=O)C(c2cn(CCC3N=CC=N3)c3ccccc23)=C1c1noc2ccccc12		CHEMBL4084151	=	IC50	nM	0.73	CHEMBL262	Homo sapiens	IC50	nM	0.73
	18191689	CHEMBL4041846	Inhibition of GSK3beta (unknown origin) expressed in sf9 cells using GS-1 as substrate after 30 mins in presence of [gamma32P]ATP	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2C1=O		CHEMBL1276127	=	IC50	nM	5.0	CHEMBL262	Homo sapiens	IC50	nM	5.0
	18191691	CHEMBL4041847	Inhibition of human GSK3beta using YRRAAVPPSPSLSRHSSPHQS(PO4)EDEEENH as substrate after 60 mins in presence of [gamma32P]ATP by TopCount method	B	Nc1nonc1-n1nnc(-c2n[nH]c(-c3ccncc3)n2)c1CN1CCCCC1		CHEMBL326705	=	IC50	nM	280.0	CHEMBL262	Homo sapiens	IC50	uM	0.28
	18191692	CHEMBL4041848	Inhibition of recombinant human GSK3beta using GS-2 as substrate	B	O=c1[nH]nc2c(NCCc3ccncc3)cc(Cl)cn12		CHEMBL4074938	=	IC50	nM	111.0	CHEMBL262	Homo sapiens	IC50	uM	0.111
	18191693	CHEMBL4041849	Inhibition of recombinant human GSK3beta	B	CC1=C(O)[C@@H](C/C(C)=C/CC[C@H](C)/C=C/C=C(\C)CCCc2ccoc2)OC1=O		CHEMBL4097781	=	IC50	nM	4500.0	CHEMBL262	Homo sapiens	IC50	uM	4.5
	18203692	CHEMBL4043979	Inhibition of wild-type human full length GSK3B (M1 to T433 residues) expressed in HEK293 cells assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL262	Homo sapiens	Activity	%	100.0
	18211602	CHEMBL4045689	Inhibition of GSK3B conserved Lys2 (DIKPQNLLLDPDTAVLK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-21.7	CHEMBL262	Homo sapiens	INH	%	-21.7
	18211834	CHEMBL4045930	Inhibition of GSK3B conserved Lys2 (DIKPQNLLLDPDTAVLK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	-10.0	CHEMBL262	Homo sapiens	INH	%	-10.0
	18212136	CHEMBL4046154	Inhibition of Gsk3beta (unknown origin) at 1 uM relative to control	B	Cc1c(-c2ccncc2)c[nH]c1C(N)=O		CHEMBL4100387	<	Inhibition	%	20.0	CHEMBL262	Homo sapiens	INH	%	20.0
	18232206	CHEMBL4050300	Inhibition of human GSK3beta assessed as residual activity at 1 uM in presence of 33P-ATP by filter-binding assay relative to control	B	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O		CHEMBL4077554	=	Activity	%	26.0	CHEMBL262	Homo sapiens	Activity	%	26.0
	18248596	CHEMBL4053879	Inhibition of GSK3B (unknown origin) at 1 uM relative to control	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn4c5c(cccc35)CCC4)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4104658	=	Inhibition	%	7.0	CHEMBL262	Homo sapiens	INH	%	7.0
	18250350	CHEMBL4054237	Inhibition of GSK3beta (unknown origin)	B	O=C1Cc2cc(Br)ccc2/C1=c1/[nH]c2ccccc2/c1=C\O		CHEMBL4077172	=	IC50	nM	5.0	CHEMBL262	Homo sapiens	IC50	nM	5.0
	18250351	CHEMBL4054237	Inhibition of GSK3beta (unknown origin)	B	N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1		CHEMBL1969664	=	IC50	nM	31.0	CHEMBL262	Homo sapiens	IC50	nM	31.0
	18250352	CHEMBL4054238	Inhibition of recombinant N-terminal His6-tagged human GSK3beta H350L mutant expressed in baculovirus infected Sf21 insect cells using polypeptide GS-2 as substrate after 30 mins in presence of ATP by kinase-glo luminescence assay	B	CCCCCCCCCCCCNC(=O)C1Sc2ccccc2N(CC)C1=O		CHEMBL4097321	=	IC50	nM	22900.0	CHEMBL262	Homo sapiens	IC50	uM	22.9
	18250353	CHEMBL4054238	Inhibition of recombinant N-terminal His6-tagged human GSK3beta H350L mutant expressed in baculovirus infected Sf21 insect cells using polypeptide GS-2 as substrate after 30 mins in presence of ATP by kinase-glo luminescence assay	B	CCCCCCCCC(=O)N1CCC(NC(=O)C2Sc3ccccc3N(CC)C2=O)CC1		CHEMBL4082948	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	18250354	CHEMBL4054238	Inhibition of recombinant N-terminal His6-tagged human GSK3beta H350L mutant expressed in baculovirus infected Sf21 insect cells using polypeptide GS-2 as substrate after 30 mins in presence of ATP by kinase-glo luminescence assay	B	CCCCCCCCCC(=O)N1CCC(NC(=O)C2Sc3ccccc3N(CC)C2=O)CC1		CHEMBL4100927	=	IC50	nM	74900.0	CHEMBL262	Homo sapiens	IC50	uM	74.9
	18250355	CHEMBL4054238	Inhibition of recombinant N-terminal His6-tagged human GSK3beta H350L mutant expressed in baculovirus infected Sf21 insect cells using polypeptide GS-2 as substrate after 30 mins in presence of ATP by kinase-glo luminescence assay	B	CCCCCCCCCCC(=O)N1CCC(NC(=O)C2Sc3ccccc3N(CC)C2=O)CC1		CHEMBL4083384	=	IC50	nM	44300.0	CHEMBL262	Homo sapiens	IC50	uM	44.3
	18250356	CHEMBL4054238	Inhibition of recombinant N-terminal His6-tagged human GSK3beta H350L mutant expressed in baculovirus infected Sf21 insect cells using polypeptide GS-2 as substrate after 30 mins in presence of ATP by kinase-glo luminescence assay	B	CCCCCCCCCCCC(=O)N1CCC(NC(=O)C2Sc3ccccc3N(CC)C2=O)CC1		CHEMBL4060722	=	IC50	nM	29700.0	CHEMBL262	Homo sapiens	IC50	uM	29.7
	18250357	CHEMBL4054238	Inhibition of recombinant N-terminal His6-tagged human GSK3beta H350L mutant expressed in baculovirus infected Sf21 insect cells using polypeptide GS-2 as substrate after 30 mins in presence of ATP by kinase-glo luminescence assay	B	CCCCCCCCCCCCCC(=O)N1CCC(NC(=O)C2Sc3ccccc3N(CC)C2=O)CC1		CHEMBL4102694	=	IC50	nM	27300.0	CHEMBL262	Homo sapiens	IC50	uM	27.3
	18250358	CHEMBL4054238	Inhibition of recombinant N-terminal His6-tagged human GSK3beta H350L mutant expressed in baculovirus infected Sf21 insect cells using polypeptide GS-2 as substrate after 30 mins in presence of ATP by kinase-glo luminescence assay	B	CCCCCCCCCCCCCCCC(=O)N1CCC(NC(=O)C2Sc3ccccc3N(CC)C2=O)CC1		CHEMBL4078439	=	IC50	nM	18600.0	CHEMBL262	Homo sapiens	IC50	uM	18.6
	18250359	CHEMBL4054238	Inhibition of recombinant N-terminal His6-tagged human GSK3beta H350L mutant expressed in baculovirus infected Sf21 insect cells using polypeptide GS-2 as substrate after 30 mins in presence of ATP by kinase-glo luminescence assay	B	CCCCCCCCCCCCCCC(=O)N1CCC(NC(=O)C2Sc3ccccc3N(CC)C2=O)CC1		CHEMBL4064819	=	IC50	nM	17900.0	CHEMBL262	Homo sapiens	IC50	uM	17.9
	18250360	CHEMBL4054238	Inhibition of recombinant N-terminal His6-tagged human GSK3beta H350L mutant expressed in baculovirus infected Sf21 insect cells using polypeptide GS-2 as substrate after 30 mins in presence of ATP by kinase-glo luminescence assay	B	CCCCCCCCC(=O)NC1CCN(C(=O)C2Sc3ccccc3N(CC)C2=O)CC1		CHEMBL4086298	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	18250361	CHEMBL4054238	Inhibition of recombinant N-terminal His6-tagged human GSK3beta H350L mutant expressed in baculovirus infected Sf21 insect cells using polypeptide GS-2 as substrate after 30 mins in presence of ATP by kinase-glo luminescence assay	B	CCCCCCCCCC(=O)NC1CCN(C(=O)C2Sc3ccccc3N(CC)C2=O)CC1		CHEMBL4073420	=	IC50	nM	68300.0	CHEMBL262	Homo sapiens	IC50	uM	68.3
	18250362	CHEMBL4054238	Inhibition of recombinant N-terminal His6-tagged human GSK3beta H350L mutant expressed in baculovirus infected Sf21 insect cells using polypeptide GS-2 as substrate after 30 mins in presence of ATP by kinase-glo luminescence assay	B	CCCCCCCCCCC(=O)NC1CCN(C(=O)C2Sc3ccccc3N(CC)C2=O)CC1		CHEMBL4094063	=	IC50	nM	45900.0	CHEMBL262	Homo sapiens	IC50	uM	45.9
	18250363	CHEMBL4054238	Inhibition of recombinant N-terminal His6-tagged human GSK3beta H350L mutant expressed in baculovirus infected Sf21 insect cells using polypeptide GS-2 as substrate after 30 mins in presence of ATP by kinase-glo luminescence assay	B	CCCCCCCCCCCC(=O)NC1CCN(C(=O)C2Sc3ccccc3N(CC)C2=O)CC1		CHEMBL4090172	=	IC50	nM	33400.0	CHEMBL262	Homo sapiens	IC50	uM	33.4
	18250364	CHEMBL4054238	Inhibition of recombinant N-terminal His6-tagged human GSK3beta H350L mutant expressed in baculovirus infected Sf21 insect cells using polypeptide GS-2 as substrate after 30 mins in presence of ATP by kinase-glo luminescence assay	B	CCCCCCCCCCCCCC(=O)NC1CCN(C(=O)C2Sc3ccccc3N(CC)C2=O)CC1		CHEMBL4082108	=	IC50	nM	33400.0	CHEMBL262	Homo sapiens	IC50	uM	33.4
	18250365	CHEMBL4054238	Inhibition of recombinant N-terminal His6-tagged human GSK3beta H350L mutant expressed in baculovirus infected Sf21 insect cells using polypeptide GS-2 as substrate after 30 mins in presence of ATP by kinase-glo luminescence assay	B	CCCCCCCCCCCCCCCC(=O)NC1CCN(C(=O)C2Sc3ccccc3N(CC)C2=O)CC1		CHEMBL4064706	=	IC50	nM	11700.0	CHEMBL262	Homo sapiens	IC50	uM	11.7
	18250366	CHEMBL4054238	Inhibition of recombinant N-terminal His6-tagged human GSK3beta H350L mutant expressed in baculovirus infected Sf21 insect cells using polypeptide GS-2 as substrate after 30 mins in presence of ATP by kinase-glo luminescence assay	B	CCCCCCCCCCCCCCC(=O)NC1CCN(C(=O)C2Sc3ccccc3N(CC)C2=O)CC1		CHEMBL4081419	=	IC50	nM	22400.0	CHEMBL262	Homo sapiens	IC50	uM	22.4
	18250367	CHEMBL4054238	Inhibition of recombinant N-terminal His6-tagged human GSK3beta H350L mutant expressed in baculovirus infected Sf21 insect cells using polypeptide GS-2 as substrate after 30 mins in presence of ATP by kinase-glo luminescence assay	B	CCCCCCCCCCCCCCCCC(=O)NC1CCN(C(=O)C2Sc3ccccc3N(CC)C2=O)CC1		CHEMBL4075286	=	IC50	nM	46700.0	CHEMBL262	Homo sapiens	IC50	uM	46.7
	18250368	CHEMBL4054238	Inhibition of recombinant N-terminal His6-tagged human GSK3beta H350L mutant expressed in baculovirus infected Sf21 insect cells using polypeptide GS-2 as substrate after 30 mins in presence of ATP by kinase-glo luminescence assay	B	CCN1C(=O)C(C(=O)N2CCC(NC(=O)CCCCCc3ccccc3)CC2)Sc2ccccc21		CHEMBL4076856	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	18250369	CHEMBL4054238	Inhibition of recombinant N-terminal His6-tagged human GSK3beta H350L mutant expressed in baculovirus infected Sf21 insect cells using polypeptide GS-2 as substrate after 30 mins in presence of ATP by kinase-glo luminescence assay	B	CCCCCCCCC(=O)N1CCN(C(=O)C2Sc3ccccc3N(CC)C2=O)CC1		CHEMBL4083930	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	18250370	CHEMBL4054238	Inhibition of recombinant N-terminal His6-tagged human GSK3beta H350L mutant expressed in baculovirus infected Sf21 insect cells using polypeptide GS-2 as substrate after 30 mins in presence of ATP by kinase-glo luminescence assay	B	CCCCCCCCCC(=O)N1CCN(C(=O)C2Sc3ccccc3N(CC)C2=O)CC1		CHEMBL4062211	=	IC50	nM	51700.0	CHEMBL262	Homo sapiens	IC50	uM	51.7
	18250371	CHEMBL4054238	Inhibition of recombinant N-terminal His6-tagged human GSK3beta H350L mutant expressed in baculovirus infected Sf21 insect cells using polypeptide GS-2 as substrate after 30 mins in presence of ATP by kinase-glo luminescence assay	B	CCCCCCCCCCC(=O)N1CCN(C(=O)C2Sc3ccccc3N(CC)C2=O)CC1		CHEMBL4073006	=	IC50	nM	27100.0	CHEMBL262	Homo sapiens	IC50	uM	27.1
	18250372	CHEMBL4054238	Inhibition of recombinant N-terminal His6-tagged human GSK3beta H350L mutant expressed in baculovirus infected Sf21 insect cells using polypeptide GS-2 as substrate after 30 mins in presence of ATP by kinase-glo luminescence assay	B	CCCCCCCCCCCC(=O)N1CCN(C(=O)C2Sc3ccccc3N(CC)C2=O)CC1		CHEMBL4070897	=	IC50	nM	23200.0	CHEMBL262	Homo sapiens	IC50	uM	23.2
	18250373	CHEMBL4054238	Inhibition of recombinant N-terminal His6-tagged human GSK3beta H350L mutant expressed in baculovirus infected Sf21 insect cells using polypeptide GS-2 as substrate after 30 mins in presence of ATP by kinase-glo luminescence assay	B	CCCCCCCCCCCCCC(=O)N1CCN(C(=O)C2Sc3ccccc3N(CC)C2=O)CC1		CHEMBL4076026	=	IC50	nM	18900.0	CHEMBL262	Homo sapiens	IC50	uM	18.9
	18250374	CHEMBL4054238	Inhibition of recombinant N-terminal His6-tagged human GSK3beta H350L mutant expressed in baculovirus infected Sf21 insect cells using polypeptide GS-2 as substrate after 30 mins in presence of ATP by kinase-glo luminescence assay	B	CCCCCCCCCCCCCCCC(=O)N1CCN(C(=O)C2Sc3ccccc3N(CC)C2=O)CC1		CHEMBL4092659	=	IC50	nM	8700.0	CHEMBL262	Homo sapiens	IC50	uM	8.7
	18250375	CHEMBL4054238	Inhibition of recombinant N-terminal His6-tagged human GSK3beta H350L mutant expressed in baculovirus infected Sf21 insect cells using polypeptide GS-2 as substrate after 30 mins in presence of ATP by kinase-glo luminescence assay	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	IC50	nM	1400.0	CHEMBL262	Homo sapiens	IC50	uM	1.4
Active	18250424	CHEMBL4054241	Non-competitive inhibition of recombinant N-terminal His6-tagged human GSK3beta H350L mutant expressed in baculovirus infected Sf21 insect cells at 20 to 50 uM in presence of varying levels of ATP and constant GS-2 substrate concentration after 30 mins by double reciprocal plot analysis	B	CCCCCCCCCCCCCCCC(=O)NC1CCN(C(=O)C2Sc3ccccc3N(CC)C2=O)CC1		CHEMBL4064706		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	18250425	CHEMBL4054242	Non-competitive inhibition of recombinant N-terminal His6-tagged human GSK3beta H350L mutant expressed in baculovirus infected Sf21 insect cells at 6.25 to 12.5 uM in presence of varying levels of ATP and constant GS-2 substrate concentration after 30 mins by double reciprocal plot analysis	B	CCCCCCCCCCCCCCCC(=O)N1CCN(C(=O)C2Sc3ccccc3N(CC)C2=O)CC1		CHEMBL4092659		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	18250426	CHEMBL4054243	Non-competitive inhibition of recombinant N-terminal His6-tagged human GSK3beta H350L mutant expressed in baculovirus infected Sf21 insect cells at 20 to 50 uM in presence of constant levels of ATP and varying GS-2 substrate concentration after 30 mins by double reciprocal plot analysis	B	CCCCCCCCCCCCCCCC(=O)NC1CCN(C(=O)C2Sc3ccccc3N(CC)C2=O)CC1		CHEMBL4064706		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	18250427	CHEMBL4054244	Non-competitive inhibition of recombinant N-terminal His6-tagged human GSK3beta H350L mutant expressed in baculovirus infected Sf21 insect cells at 6.25 to 12.5 uM in presence of constant levels of ATP and varying GS-2 substrate concentration after 30 mins by double reciprocal plot analysis	B	CCCCCCCCCCCCCCCC(=O)N1CCN(C(=O)C2Sc3ccccc3N(CC)C2=O)CC1		CHEMBL4092659		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	18250428	CHEMBL4054245	Inhibition of recombinant human GSK3beta using Poly (Glu, Tyr) 4:1 as substrate at 100 uM after 60 mins by spectrophotometric analysis	B	CCCCCCCCCCCCCCC(=O)NC1CCN(C(=O)C2Sc3ccccc3N(CC)C2=O)CC1		CHEMBL4081419	=	Inhibition	%	94.3	CHEMBL262	Homo sapiens	INH	%	94.3
	18250484	CHEMBL4054238	Inhibition of recombinant N-terminal His6-tagged human GSK3beta H350L mutant expressed in baculovirus infected Sf21 insect cells using polypeptide GS-2 as substrate after 30 mins in presence of ATP by kinase-glo luminescence assay	B	CCCCCCCCCCCC(=O)NNC(=O)C1Sc2ccccc2N(CC)C1=O		CHEMBL3358802	=	IC50	nM	11900.0	CHEMBL262	Homo sapiens	IC50	uM	11.9
	18253823	CHEMBL4055196	Inhibition of wild-type human full length GSK3B (M1 to T433 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	100.0	CHEMBL262	Homo sapiens	Activity	%	100.0
	18253824	CHEMBL4055196	Inhibition of wild-type human full length GSK3B (M1 to T433 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	86.0	CHEMBL262	Homo sapiens	Activity	%	86.0
	18265836	CHEMBL4057286	Inhibition of GSK3b (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	1.3	CHEMBL262	Homo sapiens	INH	%	1.3
	18266032	CHEMBL4057482	Inhibition of GSK3b (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	6.7	CHEMBL262	Homo sapiens	INH	%	6.7
	18266196	CHEMBL4057646	Inhibition of GSK3b (unknown origin) at 0.078 uM relative to control	B	COC(=O)Nc1noc2cc(-c3c(-c4ccccn4)n[nH]c3C)ccc12		CHEMBL4066592	=	Inhibition	%	10.0	CHEMBL262	Homo sapiens	INH	%	10.0
	18267107	CHEMBL4057839	Inhibition of human GSK-3beta using prephosphorylated-GS1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric analysis	B	COC(=O)N1CCN(c2nc(-c3ccncn3)cc(=O)n2C)[C@H](C)C1		CHEMBL4076038	=	IC50	nM	70.0	CHEMBL262	Homo sapiens	IC50	nM	70.0
	18267108	CHEMBL4057839	Inhibition of human GSK-3beta using prephosphorylated-GS1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric analysis	B	C[C@@H]1CN(C(=O)c2ccccc2)CCN1c1nc(-c2ccncn2)cc(=O)n1C		CHEMBL4071773	=	IC50	nM	21.0	CHEMBL262	Homo sapiens	IC50	nM	21.0
	18267109	CHEMBL4057839	Inhibition of human GSK-3beta using prephosphorylated-GS1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric analysis	B	CC(=O)N1CCN(c2nc(-c3ccncn3)cc(=O)n2C)[C@H](C)C1		CHEMBL4067909	=	IC50	nM	49.0	CHEMBL262	Homo sapiens	IC50	nM	49.0
	18267110	CHEMBL4057839	Inhibition of human GSK-3beta using prephosphorylated-GS1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric analysis	B	C[C@@H]1CN(c2ccccc2)CCN1c1nc(-c2ccncn2)cc(=O)n1C		CHEMBL3719193	=	IC50	nM	1.4	CHEMBL262	Homo sapiens	IC50	nM	1.4
	18267111	CHEMBL4057839	Inhibition of human GSK-3beta using prephosphorylated-GS1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric analysis	B	C[C@@H]1CN(Cc2ccccc2)CCN1c1nc(-c2ccncn2)cc(=O)n1C		CHEMBL4082198	=	IC50	nM	8.3	CHEMBL262	Homo sapiens	IC50	nM	8.3
	18267112	CHEMBL4057839	Inhibition of human GSK-3beta using prephosphorylated-GS1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric analysis	B	CC(C)N1CCN(c2nc(-c3ccncn3)cc(=O)n2C)[C@H](C)C1		CHEMBL4064440	=	IC50	nM	13.0	CHEMBL262	Homo sapiens	IC50	nM	13.0
	18267113	CHEMBL4057839	Inhibition of human GSK-3beta using prephosphorylated-GS1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric analysis	B	CN1CCN(c2nc(-c3ccncn3)cc(=O)n2C)CC1		CHEMBL4071667	=	IC50	nM	630.0	CHEMBL262	Homo sapiens	IC50	nM	630.0
	18267114	CHEMBL4057839	Inhibition of human GSK-3beta using prephosphorylated-GS1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric analysis	B	C[C@H]1CN(C)CCN1c1nc(-c2ccncn2)cc(=O)n1C		CHEMBL4059511	>	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	nM	1000.0
	18267115	CHEMBL4057839	Inhibition of human GSK-3beta using prephosphorylated-GS1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric analysis	B	C[C@H]1CNCCN1c1nc(-c2ccncn2)cc(=O)n1C		CHEMBL4100141	=	IC50	nM	76.0	CHEMBL262	Homo sapiens	IC50	nM	76.0
	18267116	CHEMBL4057839	Inhibition of human GSK-3beta using prephosphorylated-GS1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric analysis	B	C[C@H]1CN(C)CCN1c1nc(-c2ccncc2)cc(=O)n1C		CHEMBL4074146	>	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	nM	1000.0
	18267117	CHEMBL4057839	Inhibition of human GSK-3beta using prephosphorylated-GS1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric analysis	B	C[C@H]1CNCCN1c1nc(-c2ccncc2)cc(=O)n1C		CHEMBL4090044	=	IC50	nM	920.0	CHEMBL262	Homo sapiens	IC50	nM	920.0
	18267118	CHEMBL4057839	Inhibition of human GSK-3beta using prephosphorylated-GS1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric analysis	B	C[C@@H]1CN(C)CCN1c1nc(-c2ccncn2)cc(=O)n1C		CHEMBL4068965	=	IC50	nM	22.0	CHEMBL262	Homo sapiens	IC50	nM	22.0
	18267119	CHEMBL4057839	Inhibition of human GSK-3beta using prephosphorylated-GS1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric analysis	B	C[C@@H]1CNCCN1c1nc(-c2ccncn2)cc(=O)n1C		CHEMBL4068148	=	IC50	nM	13.0	CHEMBL262	Homo sapiens	IC50	nM	13.0
	18267120	CHEMBL4057839	Inhibition of human GSK-3beta using prephosphorylated-GS1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric analysis	B	C[C@@H]1CN(C)CCN1c1nc(-c2ccncc2)cc(=O)n1C		CHEMBL4089331	=	IC50	nM	80.0	CHEMBL262	Homo sapiens	IC50	nM	80.0
	18267121	CHEMBL4057839	Inhibition of human GSK-3beta using prephosphorylated-GS1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric analysis	B	C[C@@H]1CNCCN1c1nc(-c2ccncc2)cc(=O)n1C		CHEMBL4098678	=	IC50	nM	29.0	CHEMBL262	Homo sapiens	IC50	nM	29.0
	18267138	CHEMBL4057839	Inhibition of human GSK-3beta using prephosphorylated-GS1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric analysis	B	C[C@@H]1CN(S(C)(=O)=O)CCN1c1nc(-c2ccncn2)cc(=O)n1C		CHEMBL4078643	=	IC50	nM	46.0	CHEMBL262	Homo sapiens	IC50	nM	46.0
	18267139	CHEMBL4057839	Inhibition of human GSK-3beta using prephosphorylated-GS1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric analysis	B	Cc1ccc(S(=O)(=O)N2CCN(c3nc(-c4ccncn4)cc(=O)n3C)[C@H](C)C2)cc1		CHEMBL4102920	=	IC50	nM	19.0	CHEMBL262	Homo sapiens	IC50	nM	19.0
	18267140	CHEMBL4057839	Inhibition of human GSK-3beta using prephosphorylated-GS1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric analysis	B	C[C@H]1CN(c2nc(-c3ccncn3)cc(=O)n2C)CCN1Cc1ccccc1		CHEMBL4101984	=	IC50	nM	780.0	CHEMBL262	Homo sapiens	IC50	nM	780.0
	18267141	CHEMBL4057839	Inhibition of human GSK-3beta using prephosphorylated-GS1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric analysis	B	C[C@@H]1CN(c2nc(-c3ccncn3)cc(=O)n2C)CCN1Cc1ccccc1		CHEMBL4083994	>	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	nM	1000.0
	18267142	CHEMBL4057839	Inhibition of human GSK-3beta using prephosphorylated-GS1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric analysis	B	CC[C@@H]1CN(Cc2ccccc2)CCN1c1nc(-c2ccncn2)cc(=O)n1C		CHEMBL4078869	=	IC50	nM	43.0	CHEMBL262	Homo sapiens	IC50	nM	43.0
	18267143	CHEMBL4057839	Inhibition of human GSK-3beta using prephosphorylated-GS1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric analysis	B	C[C@@H]1CN(c2ccccc2F)CCN1c1nc(-c2ccncn2)cc(=O)n1C		CHEMBL4077376	=	IC50	nM	0.2	CHEMBL262	Homo sapiens	IC50	nM	0.2
	18267144	CHEMBL4057839	Inhibition of human GSK-3beta using prephosphorylated-GS1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric analysis	B	C[C@@H]1CN(c2cccc(F)c2)CCN1c1nc(-c2ccncn2)cc(=O)n1C		CHEMBL4095848	=	IC50	nM	0.5	CHEMBL262	Homo sapiens	IC50	nM	0.5
	18267145	CHEMBL4057839	Inhibition of human GSK-3beta using prephosphorylated-GS1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric analysis	B	C[C@@H]1CN(c2ccc(F)cc2)CCN1c1nc(-c2ccncn2)cc(=O)n1C		CHEMBL4076060	=	IC50	nM	0.4	CHEMBL262	Homo sapiens	IC50	nM	0.4
	18267146	CHEMBL4057839	Inhibition of human GSK-3beta using prephosphorylated-GS1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric analysis	B	C[C@@H]1CN(c2ccc(Cl)cc2)CCN1c1nc(-c2ccncn2)cc(=O)n1C		CHEMBL4077048	=	IC50	nM	1.2	CHEMBL262	Homo sapiens	IC50	nM	1.2
	18267147	CHEMBL4057839	Inhibition of human GSK-3beta using prephosphorylated-GS1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric analysis	B	COc1ccccc1N1CCN(c2nc(-c3ccncn3)cc(=O)n2C)[C@H](C)C1		CHEMBL4065818	=	IC50	nM	0.8	CHEMBL262	Homo sapiens	IC50	nM	0.8
	18267148	CHEMBL4057839	Inhibition of human GSK-3beta using prephosphorylated-GS1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric analysis	B	COc1cccc(N2CCN(c3nc(-c4ccncn4)cc(=O)n3C)[C@H](C)C2)c1		CHEMBL4063206	=	IC50	nM	0.2	CHEMBL262	Homo sapiens	IC50	nM	0.2
	18267149	CHEMBL4057839	Inhibition of human GSK-3beta using prephosphorylated-GS1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric analysis	B	COc1ccc(N2CCN(c3nc(-c4ccncn4)cc(=O)n3C)[C@H](C)C2)cc1		CHEMBL4084855	=	IC50	nM	0.1	CHEMBL262	Homo sapiens	IC50	nM	0.1
	18267150	CHEMBL4057839	Inhibition of human GSK-3beta using prephosphorylated-GS1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric analysis	B	C[C@@H]1CN(c2ccccc2C#N)CCN1c1nc(-c2ccncn2)cc(=O)n1C		CHEMBL4101293	=	IC50	nM	4.2	CHEMBL262	Homo sapiens	IC50	nM	4.2
	18267151	CHEMBL4057839	Inhibition of human GSK-3beta using prephosphorylated-GS1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric analysis	B	C[C@@H]1CN(c2cccc(C#N)c2)CCN1c1nc(-c2ccncn2)cc(=O)n1C		CHEMBL4074586	=	IC50	nM	2.2	CHEMBL262	Homo sapiens	IC50	nM	2.2
	18267152	CHEMBL4057839	Inhibition of human GSK-3beta using prephosphorylated-GS1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric analysis	B	C[C@@H]1CN(c2ccc(C#N)cc2)CCN1c1nc(-c2ccncn2)cc(=O)n1C		CHEMBL4093559	=	IC50	nM	2.7	CHEMBL262	Homo sapiens	IC50	nM	2.7
	18267153	CHEMBL4057839	Inhibition of human GSK-3beta using prephosphorylated-GS1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric analysis	B	C[C@@H]1CN(c2ccncc2)CCN1c1nc(-c2ccncn2)cc(=O)n1C		CHEMBL4065956	=	IC50	nM	3.8	CHEMBL262	Homo sapiens	IC50	nM	3.8
	18267154	CHEMBL4057839	Inhibition of human GSK-3beta using prephosphorylated-GS1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric analysis	B	C[C@@H]1CN(c2cccnc2)CCN1c1nc(-c2ccncn2)cc(=O)n1C		CHEMBL4067170	=	IC50	nM	3.9	CHEMBL262	Homo sapiens	IC50	nM	3.9
	18267155	CHEMBL4057839	Inhibition of human GSK-3beta using prephosphorylated-GS1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric analysis	B	C[C@@H]1CN(c2ccccn2)CCN1c1nc(-c2ccncn2)cc(=O)n1C		CHEMBL4093930	=	IC50	nM	4.1	CHEMBL262	Homo sapiens	IC50	nM	4.1
	18267156	CHEMBL4057839	Inhibition of human GSK-3beta using prephosphorylated-GS1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric analysis	B	C[C@@H]1CN(c2ncccn2)CCN1c1nc(-c2ccncn2)cc(=O)n1C		CHEMBL4067737	=	IC50	nM	24.0	CHEMBL262	Homo sapiens	IC50	nM	24.0
	18267157	CHEMBL4057839	Inhibition of human GSK-3beta using prephosphorylated-GS1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric analysis	B	C[C@@H]1CN(c2cncnc2)CCN1c1nc(-c2ccncn2)cc(=O)n1C		CHEMBL4095163	=	IC50	nM	14.0	CHEMBL262	Homo sapiens	IC50	nM	14.0
	18267249	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	Cl.Cn1c(N2CCNC(c3ccccc3)C2)nc(-c2ccncc2)cc1=O		CHEMBL4103742	=	IC50	nM	18.0	CHEMBL262	Homo sapiens	IC50	nM	18.0
	18267250	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	COc1ccccc1C1CN(c2nc(-c3ccncc3)cc(=O)n2C)CCN1.Cl		CHEMBL4085821	=	IC50	nM	1.8	CHEMBL262	Homo sapiens	IC50	nM	1.8
	18267251	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	COc1ccccc1C1CN(c2nc(-c3ccncn3)cc(=O)n2C)CCN1.Cl		CHEMBL4065624	=	IC50	nM	1.8	CHEMBL262	Homo sapiens	IC50	nM	1.8
	18267252	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	CCOc1ccccc1C1CN(c2nc(-c3ccncc3)cc(=O)n2C)CCN1.Cl		CHEMBL4075525	=	IC50	nM	25.0	CHEMBL262	Homo sapiens	IC50	nM	25.0
	18267253	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	CCOc1ccccc1C1CN(c2nc(-c3ccncn3)cc(=O)n2C)CCN1.Cl		CHEMBL4088266	=	IC50	nM	20.0	CHEMBL262	Homo sapiens	IC50	nM	20.0
	18267254	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	Cl.Cn1c(N2CCNC(c3ccccc3F)C2)nc(-c2ccncc2)cc1=O		CHEMBL4066990	=	IC50	nM	11.0	CHEMBL262	Homo sapiens	IC50	nM	11.0
	18267255	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	Cl.Cn1c(N2CCNC(c3ccccc3F)C2)nc(-c2ccncn2)cc1=O		CHEMBL4080416	=	IC50	nM	8.2	CHEMBL262	Homo sapiens	IC50	nM	8.2
	18267256	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	Cn1c(N2CCNC(c3ccccc3Cl)C2)nc(-c2ccncc2)cc1=O		CHEMBL4104642	=	IC50	nM	9.6	CHEMBL262	Homo sapiens	IC50	nM	9.6
	18267257	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	Cn1c(N2CCNC(c3ccccc3Cl)C2)nc(-c2ccncn2)cc1=O		CHEMBL4073837	=	IC50	nM	2.6	CHEMBL262	Homo sapiens	IC50	nM	2.6
	18267258	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	Cn1c(N2CCNC(c3ccccc3Br)C2)nc(-c2ccncc2)cc1=O		CHEMBL4095172	=	IC50	nM	13.0	CHEMBL262	Homo sapiens	IC50	nM	13.0
	18267264	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	Cl.Cn1c(N2CCN[C@H](c3ccc(Cl)cc3)C2)nc(-c2ccncn2)cc1=O		CHEMBL4076883	=	IC50	nM	26.0	CHEMBL262	Homo sapiens	IC50	nM	26.0
	18267265	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	Cl.Cn1c(N2CCN[C@@H](c3ccc(Cl)cc3)C2)nc(-c2ccncn2)cc1=O		CHEMBL4105346	=	IC50	nM	1.2	CHEMBL262	Homo sapiens	IC50	nM	1.2
	18267266	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	Cl.Cn1c(N2CCN[C@H](c3ccc(Cl)cc3)C2)nc(-c2ccncc2)cc1=O		CHEMBL4075801	=	IC50	nM	110.0	CHEMBL262	Homo sapiens	IC50	nM	110.0
	18267267	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	Cl.Cn1c(N2CCN[C@@H](c3ccc(Cl)cc3)C2)nc(-c2ccncc2)cc1=O		CHEMBL4076001	=	IC50	nM	11.0	CHEMBL262	Homo sapiens	IC50	nM	11.0
	18267268	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	COc1cc(F)ccc1C1CN(c2nc(-c3ccncn3)cc(=O)n2C)CCN1C(C)=O		CHEMBL4070626	=	IC50	nM	1500.0	CHEMBL262	Homo sapiens	IC50	nM	1500.0
	18267269	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	COc1cc(F)ccc1C1CN(c2nc(-c3ccncc3)cc(=O)n2C)CCN1C(C)=O		CHEMBL4077350	=	IC50	nM	1700.0	CHEMBL262	Homo sapiens	IC50	nM	1700.0
	18267270	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	COc1cc(F)ccc1C1CN(c2nc(-c3ccncn3)cc(=O)n2C)CCN1Cc1ccccc1.Cl		CHEMBL4077867	=	IC50	nM	220.0	CHEMBL262	Homo sapiens	IC50	nM	220.0
	18267271	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	COc1cc(F)ccc1C1CN(c2nc(-c3ccncc3)cc(=O)n2C)CCN1Cc1ccccc1.Cl		CHEMBL4070575	=	IC50	nM	1200.0	CHEMBL262	Homo sapiens	IC50	nM	1200.0
	18267272	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	COc1cc(F)ccc1C1CN(c2nc(-c3ccncn3)cc(=O)n2C)CCN1C.Cl		CHEMBL4076461	=	IC50	nM	26.0	CHEMBL262	Homo sapiens	IC50	nM	26.0
	18267273	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	COc1cc(F)ccc1C1CN(c2nc(-c3ccncc3)cc(=O)n2C)CCN1C.Cl		CHEMBL4082385	=	IC50	nM	56.0	CHEMBL262	Homo sapiens	IC50	nM	56.0
	18267274	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	COc1cc(F)ccc1C1CN(c2nc(-c3ccncn3)cc(=O)n2C)CCN1.Cl		CHEMBL4076186	=	IC50	nM	0.25	CHEMBL262	Homo sapiens	IC50	nM	0.25
	18267275	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	COc1cc(F)ccc1C1CN(c2nc(-c3ccncn3)cc(=O)n2C)CCN1.Cl		CHEMBL4076186	=	IC50	nM	44.0	CHEMBL262	Homo sapiens	IC50	nM	44.0
	18267276	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	COc1cc(F)ccc1C1CN(c2nc(-c3ccncc3)cc(=O)n2C)CCN1.Cl		CHEMBL4087402	=	IC50	nM	0.4	CHEMBL262	Homo sapiens	IC50	nM	0.4
	18267277	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	COc1cc(F)ccc1C1CN(c2nc(-c3ccncc3)cc(=O)n2C)CCN1.Cl		CHEMBL4087402	=	IC50	nM	54.0	CHEMBL262	Homo sapiens	IC50	nM	54.0
	18267278	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	Cn1c(N2CCNC(c3ccccc3Br)C2)nc(-c2ccncn2)cc1=O		CHEMBL4089702	=	IC50	nM	4.3	CHEMBL262	Homo sapiens	IC50	nM	4.3
	18267279	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	Cn1c(N2CCNC(c3ccc(Cl)c(Cl)c3)C2)nc(-c2ccncn2)cc1=O		CHEMBL4072455	=	IC50	nM	2.3	CHEMBL262	Homo sapiens	IC50	nM	2.3
	18267280	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	Cn1c(N2CCNC(c3ccc(Cl)c(Cl)c3)C2)nc(-c2ccncc2)cc1=O		CHEMBL4100923	=	IC50	nM	4.3	CHEMBL262	Homo sapiens	IC50	nM	4.3
	18267281	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	COc1ccc(C2CN(c3nc(-c4ccncn4)cc(=O)n3C)CCN2)cc1OC		CHEMBL4082944	=	IC50	nM	7.8	CHEMBL262	Homo sapiens	IC50	nM	7.8
	18267282	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	COc1ccc(C2CN(c3nc(-c4ccncc4)cc(=O)n3C)CCN2)cc1OC		CHEMBL4062791	=	IC50	nM	5.2	CHEMBL262	Homo sapiens	IC50	nM	5.2
	18267283	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	COc1cccc(C2CN(c3nc(-c4ccncc4)cc(=O)n3C)CCN2)c1.Cl		CHEMBL4061578	=	IC50	nM	11.0	CHEMBL262	Homo sapiens	IC50	nM	11.0
	18267284	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	COc1cccc(C2CN(c3nc(-c4ccncn4)cc(=O)n3C)CCN2)c1.Cl		CHEMBL4097431	=	IC50	nM	6.7	CHEMBL262	Homo sapiens	IC50	nM	6.7
	18267285	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	Cl.Cn1c(N2CCNC(c3cccc(F)c3)C2)nc(-c2ccncc2)cc1=O		CHEMBL4070244	=	IC50	nM	22.0	CHEMBL262	Homo sapiens	IC50	nM	22.0
	18267286	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	Cl.Cn1c(N2CCNC(c3cccc(F)c3)C2)nc(-c2ccncn2)cc1=O		CHEMBL4064936	=	IC50	nM	12.0	CHEMBL262	Homo sapiens	IC50	nM	12.0
	18267287	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	Cn1c(N2CCNC(c3cccc(Cl)c3)C2)nc(-c2ccncc2)cc1=O		CHEMBL4080891	=	IC50	nM	5.4	CHEMBL262	Homo sapiens	IC50	nM	5.4
	18267288	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	Cn1c(N2CCNC(c3cccc(Cl)c3)C2)nc(-c2ccncn2)cc1=O		CHEMBL4067532	=	IC50	nM	1.1	CHEMBL262	Homo sapiens	IC50	nM	1.1
	18267289	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	Cl.Cn1c(N2CCNC(c3cccc(Br)c3)C2)nc(-c2ccncn2)cc1=O		CHEMBL4088777	=	IC50	nM	2.0	CHEMBL262	Homo sapiens	IC50	nM	2.0
	18267290	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	COc1ccc(C2CN(c3nc(-c4ccncc4)cc(=O)n3C)CCN2)cc1.Cl		CHEMBL4078436	=	IC50	nM	4.7	CHEMBL262	Homo sapiens	IC50	nM	4.7
	18267291	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	COc1ccc(C2CN(c3nc(-c4ccncn4)cc(=O)n3C)CCN2)cc1.Cl		CHEMBL4096472	=	IC50	nM	3.5	CHEMBL262	Homo sapiens	IC50	nM	3.5
	18267292	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	Cn1c(N2CCNC(c3ccc(F)cc3)C2)nc(-c2ccncc2)cc1=O		CHEMBL4069785	=	IC50	nM	18.0	CHEMBL262	Homo sapiens	IC50	nM	18.0
	18267293	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	Cn1c(N2CCNC(c3ccc(F)cc3)C2)nc(-c2ccncn2)cc1=O		CHEMBL4096984	=	IC50	nM	8.6	CHEMBL262	Homo sapiens	IC50	nM	8.6
	18267294	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	Cn1c(N2CCNC(c3ccc(Cl)cc3)C2)nc(-c2ccncc2)cc1=O		CHEMBL4080483	=	IC50	nM	6.6	CHEMBL262	Homo sapiens	IC50	nM	6.6
	18267295	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	Cn1c(N2CCNC(c3ccc(Cl)cc3)C2)nc(-c2ccncn2)cc1=O		CHEMBL4104714	=	IC50	nM	1.7	CHEMBL262	Homo sapiens	IC50	nM	1.7
	18267296	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	Cl.Cn1c(N2CCNC(c3ccc(Br)cc3)C2)nc(-c2ccncc2)cc1=O		CHEMBL4099428	=	IC50	nM	22.0	CHEMBL262	Homo sapiens	IC50	nM	22.0
	18267297	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	Cl.Cn1c(N2CCNC(c3ccc(Br)cc3)C2)nc(-c2ccncn2)cc1=O		CHEMBL4081408	=	IC50	nM	8.1	CHEMBL262	Homo sapiens	IC50	nM	8.1
	18267298	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	Cl.Cn1c(N2CCNC(c3ccc(C#N)cc3)C2)nc(-c2ccncc2)cc1=O		CHEMBL4075400	=	IC50	nM	15.0	CHEMBL262	Homo sapiens	IC50	nM	15.0
	18267299	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	Cl.Cn1c(N2CCNC(c3ccc(C#N)cc3)C2)nc(-c2ccncn2)cc1=O		CHEMBL4089283	=	IC50	nM	7.4	CHEMBL262	Homo sapiens	IC50	nM	7.4
	18267300	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	COc1cc(F)ccc1C1CN(c2nc(-c3ccncc3)cc(=O)n2C)CCN1.Cl		CHEMBL4087402	=	IC50	nM	0.9	CHEMBL262	Homo sapiens	IC50	nM	0.9
	18267301	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	COc1cc(F)ccc1C1CN(c2nc(-c3ccncn3)cc(=O)n2C)CCN1.Cl		CHEMBL4076186	=	IC50	nM	0.72	CHEMBL262	Homo sapiens	IC50	nM	0.72
	18267302	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	COc1cc(F)cc(F)c1C1CN(c2nc(-c3ccncc3)cc(=O)n2C)CCN1.Cl		CHEMBL4098458	=	IC50	nM	2.0	CHEMBL262	Homo sapiens	IC50	nM	2.0
	18267303	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	COc1cc(F)cc(F)c1C1CN(c2nc(-c3ccncn3)cc(=O)n2C)CCN1.Cl		CHEMBL4071429	=	IC50	nM	1.7	CHEMBL262	Homo sapiens	IC50	nM	1.7
	18267304	CHEMBL4057861	Inhibition of recombinant human GSK-3beta using prephosphorylated GS-1 peptide as substrate after 1 hr in presence of [gamma-32P]ATP by liquid scintillation spectrometric method	B	Cc1cc(F)ccc1C1CN(c2nc(-c3ccncc3)cc(=O)n2C)CCN1.Cl		CHEMBL4090743	=	IC50	nM	24.0	CHEMBL262	Homo sapiens	IC50	nM	24.0
	18274929	CHEMBL4118355	Inhibition of GSK3B in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DIKPQNLLLDPDTAVLK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	Inhibition	%	-6.6	CHEMBL262	Homo sapiens	INH	%	-6.6
	18274930	CHEMBL4118355	Inhibition of GSK3B in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DIKPQNLLLDPDTAVLK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839	=	Inhibition	%	17.0	CHEMBL262	Homo sapiens	INH	%	17.0
	18274931	CHEMBL4118355	Inhibition of GSK3B in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DIKPQNLLLDPDTAVLK probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Inhibition	%	3.0	CHEMBL262	Homo sapiens	INH	%	3.0
Active	18275835	CHEMBL4118795	Binding affinity to GSK3B in human NCI-H23 cells at 1 uM by mass spectrometry based pull down assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(CCOCCOCCOCCNC(=O)CCCC[C@@H]4SC[C@@H]5NC(=O)N[C@H]45)CC3)cc2)ncc1Cl		CHEMBL4129274		Activity			CHEMBL262	Homo sapiens	Activity		
Active	18275977	CHEMBL4118937	Binding affinity to GSK3B in human NCI-H358 cells at 1 uM by mass spectrometry based pull down assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(CCOCCOCCOCCNC(=O)CCCC[C@@H]4SC[C@@H]5NC(=O)N[C@H]45)CC3)cc2)ncc1Cl		CHEMBL4129274		Activity			CHEMBL262	Homo sapiens	Activity		
	18282084	CHEMBL4120039	Inhibition of recombinant full length His-tagged human GSK3beta expressed in baculovirus expression system at 1 uM by FRET relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	11.3	CHEMBL262	Homo sapiens	INH	%	11.3
	18282403	CHEMBL4120039	Inhibition of recombinant full length His-tagged human GSK3beta expressed in baculovirus expression system at 1 uM by FRET relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	1.3	CHEMBL262	Homo sapiens	INH	%	1.3
	18282709	CHEMBL4120294	Inhibition of GSK3b (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	1.3	CHEMBL262	Homo sapiens	INH	%	1.3
	18282895	CHEMBL4120480	Inhibition of GSK3b (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	3.3	CHEMBL262	Homo sapiens	INH	%	3.3
	18283109	CHEMBL4120694	Inhibition of GSK3b (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12	Outside typical range	CHEMBL4129737	=	Inhibition	%	-19.3	CHEMBL262	Homo sapiens	INH	%	-19.3
	18286305	CHEMBL4121540	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system at 10 uM in presence of ATP relative to control	B	CC(C)(C)NS(=O)(=O)c1ccc(-c2sc(C(=O)N[C@H]3C[C@H](C(=O)O)C3)nc2CC2CCCCC2)c2ccccc12		CHEMBL4128926	=	Inhibition	%	-3.0	CHEMBL262	Homo sapiens	INH	%	-3.0
	18287349	CHEMBL4121731	Inhibition of GSK3beta (unknown origin)	B	O=C(O)c1ccc(-c2ccnc(Nc3cccc(-c4ccccc4)c3)n2)cc1		CHEMBL4127319	=	IC50	nM	398.11	CHEMBL262	Homo sapiens	pIC50		6.4
	18287350	CHEMBL4121731	Inhibition of GSK3beta (unknown origin)	B	NC(=O)c1ccc(-c2ccnc(Nc3cccc(-c4ccccc4)c3)n2)cc1		CHEMBL4126566	=	IC50	nM	31.62	CHEMBL262	Homo sapiens	pIC50		7.5
	18287351	CHEMBL4121731	Inhibition of GSK3beta (unknown origin)	B	NC(=O)c1ccc(-c2ccnc(Nc3cc(-c4ccccc4)ccc3F)n2)cc1		CHEMBL4129843	=	IC50	nM	2511.89	CHEMBL262	Homo sapiens	pIC50		5.6
	18287352	CHEMBL4121731	Inhibition of GSK3beta (unknown origin)	B	Cc1ccc(-c2ccccc2)cc1Nc1nccc(-c2ccc(C(N)=O)cc2)n1		CHEMBL4129991	<	IC50	nM	25118.86	CHEMBL262	Homo sapiens	pIC50		4.6
	18287353	CHEMBL4121731	Inhibition of GSK3beta (unknown origin)	B	COc1ccc(-c2ccccc2)cc1Nc1nccc(-c2ccc(C(N)=O)cc2)n1		CHEMBL4128625	<	IC50	nM	25118.86	CHEMBL262	Homo sapiens	pIC50		4.6
	18287354	CHEMBL4121731	Inhibition of GSK3beta (unknown origin)	B	COc1ccccc1Nc1nccc(-c2ccc(C(N)=O)cc2)n1		CHEMBL4129040	<	IC50	nM	25118.86	CHEMBL262	Homo sapiens	pIC50		4.6
	18287355	CHEMBL4121731	Inhibition of GSK3beta (unknown origin)	B	COc1ccccc1Nc1nccc(-c2ccc(C(N)=O)c(C(C)C)c2)n1		CHEMBL4127640	<	IC50	nM	25118.86	CHEMBL262	Homo sapiens	pIC50		4.6
	18287356	CHEMBL4121731	Inhibition of GSK3beta (unknown origin)	B	COc1ccccc1Nc1ncc(F)c(-c2ccc(C(N)=O)c(C(C)C)c2)n1		CHEMBL4127797	=	IC50	nM	7943.28	CHEMBL262	Homo sapiens	pIC50		5.1
	18287357	CHEMBL4121731	Inhibition of GSK3beta (unknown origin)	B	COc1ccccc1Nc1ncc(Cl)c(-c2ccc(C(N)=O)c(C(C)C)c2)n1		CHEMBL4126413	=	IC50	nM	19952.62	CHEMBL262	Homo sapiens	pIC50		4.7
	18287358	CHEMBL4121731	Inhibition of GSK3beta (unknown origin)	B	COc1ccccc1Nc1nccc(-c2ccc(C(=O)O)cc2)n1		CHEMBL4126300	<	IC50	nM	25118.86	CHEMBL262	Homo sapiens	pIC50		4.6
	18287359	CHEMBL4121731	Inhibition of GSK3beta (unknown origin)	B	COc1ccccc1Nc1nccc(-c2ccc(C(=O)O)c(C(C)C)c2)n1		CHEMBL4129590	=	IC50	nM	15848.93	CHEMBL262	Homo sapiens	pIC50		4.8
	18287360	CHEMBL4121731	Inhibition of GSK3beta (unknown origin)	B	COc1ccccc1Nc1ncc(F)c(-c2ccc(C(=O)O)c(C(C)C)c2)n1		CHEMBL4129219	=	IC50	nM	7943.28	CHEMBL262	Homo sapiens	pIC50		5.1
	18300340	CHEMBL4124642	Inhibition of GSK3beta (unknown origin) assessed as residual activity at 1 uM relative to control	B	CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4ccc(N)c(C#N)c4)c3c2)n1		CHEMBL4126750	=	Activity	%	94.0	CHEMBL262	Homo sapiens	Activity	%	94.0
	18313316	CHEMBL4132631	Inhibition of GSK3beta (unknown origin) at 50 uM using GSM substrate after 30 mins by Kinase-Glo reagent based luminescence assay relative to control	B	COc1cc(/C=C/C(=O)c2cccnc2)ccc1O		CHEMBL4169514	=	Inhibition	%	37.18	CHEMBL262	Homo sapiens	INH	%	37.18
	18313317	CHEMBL4132631	Inhibition of GSK3beta (unknown origin) at 50 uM using GSM substrate after 30 mins by Kinase-Glo reagent based luminescence assay relative to control	B	CCOc1cc(/C=C/C(=O)c2cccnc2)ccc1O		CHEMBL4177374	=	Inhibition	%	39.55	CHEMBL262	Homo sapiens	INH	%	39.55
	18313318	CHEMBL4132631	Inhibition of GSK3beta (unknown origin) at 50 uM using GSM substrate after 30 mins by Kinase-Glo reagent based luminescence assay relative to control	B	O=C(/C=C/c1ccc(O)c(O)c1)c1cccnc1		CHEMBL4166095	=	Inhibition	%	100.0	CHEMBL262	Homo sapiens	INH	%	100.0
	18313319	CHEMBL4132631	Inhibition of GSK3beta (unknown origin) at 50 uM using GSM substrate after 30 mins by Kinase-Glo reagent based luminescence assay relative to control	B	O=C(/C=C/c1ccc(O)cc1)c1cccnc1		CHEMBL4174015	=	Inhibition	%	25.18	CHEMBL262	Homo sapiens	INH	%	25.18
	18313320	CHEMBL4132631	Inhibition of GSK3beta (unknown origin) at 50 uM using GSM substrate after 30 mins by Kinase-Glo reagent based luminescence assay relative to control	B	O=C(/C=C/c1cccc(O)c1)c1cccnc1		CHEMBL1517429	=	Inhibition	%	43.55	CHEMBL262	Homo sapiens	INH	%	43.55
	18313321	CHEMBL4132631	Inhibition of GSK3beta (unknown origin) at 50 uM using GSM substrate after 30 mins by Kinase-Glo reagent based luminescence assay relative to control	B	CCOC(=O)/C=C/c1ccc(O)c(OC)c1		CHEMBL286796	=	Inhibition	%	21.38	CHEMBL262	Homo sapiens	INH	%	21.38
Not Determined	18313322	CHEMBL4132632	Inhibition of GSK3beta (unknown origin) using GSM substrate after 30 mins by Kinase-Glo reagent based luminescence assay	B	COc1cc(/C=C/C(=O)c2cccnc2)ccc1O		CHEMBL4169514		IC50			CHEMBL262	Homo sapiens	IC50		
Not Determined	18313323	CHEMBL4132632	Inhibition of GSK3beta (unknown origin) using GSM substrate after 30 mins by Kinase-Glo reagent based luminescence assay	B	CCOc1cc(/C=C/C(=O)c2cccnc2)ccc1O		CHEMBL4177374		IC50			CHEMBL262	Homo sapiens	IC50		
	18313324	CHEMBL4132632	Inhibition of GSK3beta (unknown origin) using GSM substrate after 30 mins by Kinase-Glo reagent based luminescence assay	B	O=C(/C=C/c1ccc(O)c(O)c1)c1cccnc1		CHEMBL4166095	=	IC50	nM	24360.0	CHEMBL262	Homo sapiens	IC50	uM	24.36
Not Determined	18313325	CHEMBL4132632	Inhibition of GSK3beta (unknown origin) using GSM substrate after 30 mins by Kinase-Glo reagent based luminescence assay	B	O=C(/C=C/c1ccc(O)cc1)c1cccnc1		CHEMBL4174015		IC50			CHEMBL262	Homo sapiens	IC50		
Not Determined	18313326	CHEMBL4132632	Inhibition of GSK3beta (unknown origin) using GSM substrate after 30 mins by Kinase-Glo reagent based luminescence assay	B	O=C(/C=C/c1cccc(O)c1)c1cccnc1		CHEMBL1517429		IC50			CHEMBL262	Homo sapiens	IC50		
Not Determined	18313327	CHEMBL4132632	Inhibition of GSK3beta (unknown origin) using GSM substrate after 30 mins by Kinase-Glo reagent based luminescence assay	B	CCOC(=O)/C=C/c1ccc(O)c(OC)c1		CHEMBL286796		IC50			CHEMBL262	Homo sapiens	IC50		
	18327907	CHEMBL4135737	Inhibition of GSK3beta (unknown origin) after 1 hr by fluorescence polarization assay	B	O=C(Nc1n[nH]c2cc(-c3ccc(O)cc3)ccc12)C1CC1		CHEMBL260163	=	IC50	nM	100.0	CHEMBL262	Homo sapiens	pIC50		7.0
	18327908	CHEMBL4135737	Inhibition of GSK3beta (unknown origin) after 1 hr by fluorescence polarization assay	B	O=C(Nc1cc(-c2ccc(O)cc2)cc2[nH]ncc12)C1CC1		CHEMBL4172211	=	IC50	nM	630.96	CHEMBL262	Homo sapiens	pIC50		6.2
	18327909	CHEMBL4135737	Inhibition of GSK3beta (unknown origin) after 1 hr by fluorescence polarization assay	B	O=C(Nc1cc(-c2ccccc2)cc2[nH]ncc12)C1CC1		CHEMBL4168859	=	IC50	nM	31622.78	CHEMBL262	Homo sapiens	pIC50		4.5
	18327910	CHEMBL4135737	Inhibition of GSK3beta (unknown origin) after 1 hr by fluorescence polarization assay	B	O=C(Nc1cc(-c2cccc(O)c2)cc2[nH]ncc12)C1CC1		CHEMBL4176717	=	IC50	nM	1258.93	CHEMBL262	Homo sapiens	pIC50		5.9
	18327911	CHEMBL4135737	Inhibition of GSK3beta (unknown origin) after 1 hr by fluorescence polarization assay	B	O=C(Nc1cc(-c2cccc(O)c2)cc2[nH]ncc12)c1ccccn1		CHEMBL4174177	=	IC50	nM	1584.89	CHEMBL262	Homo sapiens	pIC50		5.8
	18327912	CHEMBL4135737	Inhibition of GSK3beta (unknown origin) after 1 hr by fluorescence polarization assay	B	O=C(Nc1cc(-c2cccc3[nH]ccc23)cc2[nH]ncc12)C1CC1		CHEMBL4163479	=	IC50	nM	7943.28	CHEMBL262	Homo sapiens	pIC50		5.1
	18327913	CHEMBL4135737	Inhibition of GSK3beta (unknown origin) after 1 hr by fluorescence polarization assay	B	O=C(Nc1cc(-c2cccc3[nH]ccc23)cc2[nH]ncc12)c1ccccn1		CHEMBL4165288	=	IC50	nM	3162.28	CHEMBL262	Homo sapiens	pIC50		5.5
	18327914	CHEMBL4135737	Inhibition of GSK3beta (unknown origin) after 1 hr by fluorescence polarization assay	B	O=C(Nc1cc(-c2ccc3cc[nH]c3c2)cc2[nH]ncc12)c1ccccn1		CHEMBL4175904	<	IC50	nM	25118.86	CHEMBL262	Homo sapiens	pIC50		4.6
	18327915	CHEMBL4135738	Inhibition of human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate in presence of [gamma-33P]-ATP	B	O=C(Nc1cc(-c2ccc(O)cc2)cc2[nH]ncc12)c1ccccn1		CHEMBL4161596	=	IC50	nM	1584.89	CHEMBL262	Homo sapiens	pIC50		5.8
	18327916	CHEMBL4135738	Inhibition of human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate in presence of [gamma-33P]-ATP	B	O=C(Nc1cc(-c2cccc3[nH]ccc23)cc2[nH]ncc12)c1ccccn1		CHEMBL4165288	=	IC50	nM	19952.62	CHEMBL262	Homo sapiens	pIC50		4.7
	18333227	CHEMBL4136607	Inhibition of recombinant GSK3beta (unknown origin) using HSSPHQ(Sp)EDEEE as substrate by pyruvate kinase-lactate dehydrogenase coupled assay	A	N#Cc1cccc(-c2nc(Nc3cc(C4CC4)[nH]n3)c3cc(Cl)ccc3n2)c1		CHEMBL4173877	>	Ki	nM	4000.0	CHEMBL262	Homo sapiens	Ki	nM	4000.0
	18333240	CHEMBL4136607	Inhibition of recombinant GSK3beta (unknown origin) using HSSPHQ(Sp)EDEEE as substrate by pyruvate kinase-lactate dehydrogenase coupled assay	A	N#Cc1ccc(-c2nc(Nc3cc(C4CC4)[nH]n3)c3cc(Cl)ccc3n2)cc1		CHEMBL4167265	=	Ki	nM	190.0	CHEMBL262	Homo sapiens	Ki	nM	190.0
	18333250	CHEMBL4136607	Inhibition of recombinant GSK3beta (unknown origin) using HSSPHQ(Sp)EDEEE as substrate by pyruvate kinase-lactate dehydrogenase coupled assay	A	N#Cc1cccc(-c2nc(Nc3cc(C4CC4)[nH]n3)c3ccccc3n2)c1		CHEMBL4174082	=	Ki	nM	9.0	CHEMBL262	Homo sapiens	Ki	nM	9.0
	18333254	CHEMBL4136607	Inhibition of recombinant GSK3beta (unknown origin) using HSSPHQ(Sp)EDEEE as substrate by pyruvate kinase-lactate dehydrogenase coupled assay	A	N#Cc1ccc(-c2nc(Nc3cc(C4CC4)[nH]n3)c3ccccc3n2)cc1		CHEMBL4166840	=	Ki	nM	70.0	CHEMBL262	Homo sapiens	Ki	nM	70.0
	18379921	CHEMBL4145822	Inhibition of GSK3beta (unknown origin) at 10 uM relative to control	B	COc1cc(NC(=O)Nc2cnc(Nc3ccc(N4CCOCC4)cc3)nc2Oc2ccc(C)cc2OC)cc(OC)c1		CHEMBL4159506	=	Inhibition	%	-1.25	CHEMBL262	Homo sapiens	INH	%	-1.25
	18379973	CHEMBL4145874	Inhibition of GSK3beta (unknown origin)	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	5.38	CHEMBL262	Homo sapiens	IC50	nM	5.38
	18384281	CHEMBL4146565	Inhibition of recombinant GSK3-beta (unknown origin) assessed as decrease in phosphorylation of CREB at serine-129 in presence of ATP[gamma-33P] by filter binding assay	B	O=CN1Cc2cc(F)cc3c(C4=C(c5cnc6ccccn56)C(=O)NC4=O)cn(c23)CC1N1CCCCC1		CHEMBL4165510	=	IC50	nM	1.1	CHEMBL262	Homo sapiens	IC50	uM	0.0011
	18384283	CHEMBL4146565	Inhibition of recombinant GSK3-beta (unknown origin) assessed as decrease in phosphorylation of CREB at serine-129 in presence of ATP[gamma-33P] by filter binding assay	B	CN(C)C1Cn2cc(C3=C(c4cnc5ccccn45)C(=O)NC3=O)c3cccc(c32)CN1C=O		CHEMBL4169204	=	IC50	nM	1.6	CHEMBL262	Homo sapiens	IC50	uM	0.0016
	18384284	CHEMBL4146565	Inhibition of recombinant GSK3-beta (unknown origin) assessed as decrease in phosphorylation of CREB at serine-129 in presence of ATP[gamma-33P] by filter binding assay	B	O=CN1Cc2cccc3c(C4=C(c5cnc6ccccn56)C(=O)NC4=O)cn(c23)CC1N1CCOCC1		CHEMBL4162850	=	IC50	nM	1.3	CHEMBL262	Homo sapiens	IC50	uM	0.0013
	18384285	CHEMBL4146565	Inhibition of recombinant GSK3-beta (unknown origin) assessed as decrease in phosphorylation of CREB at serine-129 in presence of ATP[gamma-33P] by filter binding assay	B	Cc1ccc2ncc(C3=C(c4cn5c6c(cccc46)CN(C=O)C(N4CCCCC4)C5)C(=O)NC3=O)n2c1		CHEMBL4161007	=	IC50	nM	5.2	CHEMBL262	Homo sapiens	IC50	uM	0.0052
	18384287	CHEMBL4146565	Inhibition of recombinant GSK3-beta (unknown origin) assessed as decrease in phosphorylation of CREB at serine-129 in presence of ATP[gamma-33P] by filter binding assay	B	O=CN1Cc2cccc3c(C4=C(c5cnc6ccccn56)C(=O)NC4=O)cn(c23)CC1N1CCCCC1		CHEMBL4172295	=	IC50	nM	2.0	CHEMBL262	Homo sapiens	IC50	uM	0.002
	18384288	CHEMBL4146565	Inhibition of recombinant GSK3-beta (unknown origin) assessed as decrease in phosphorylation of CREB at serine-129 in presence of ATP[gamma-33P] by filter binding assay	B	CC(C)OC1Cn2cc(C3=C(c4cnc5ccccn45)C(=O)NC3=O)c3cccc(c32)CN1C=O		CHEMBL4164416	=	IC50	nM	1.3	CHEMBL262	Homo sapiens	IC50	uM	0.0013
	18384291	CHEMBL4146571	Inhibition of GSK3beta (unknown origin) at 20 uM using FITC-RRRRAAEELDSRAGS(PO4)PQL as substrate after 10 mins by capillary electrophoresis relative to control	B	O=C1Nc2ccccc2C1=Cc1cc(CN2CCN(c3ccccc3Cl)CC2)on1		CHEMBL4160598	=	Inhibition	%	72.0	CHEMBL262	Homo sapiens	INH	%	72.0
	18384293	CHEMBL4146568	Inhibition of human GSK3beta using YRRAAVPPSPSLSRHSSPHQS(PO4)EDEEE-NH2 as substrate after 60 mins in presence of [33gammaP]-ATP by topcount method	B	CCNC(=O)c1nnn(-c2nonc2N)c1CN1CCCCC1		CHEMBL4176856	=	IC50	nM	280.0	CHEMBL262	Homo sapiens	IC50	uM	0.28
	18384296	CHEMBL4146574	Inhibition of human GSK3beta by scintillation proximity assay	B	O=C(Nc1ncnc2oc(-c3cccnc3)cc12)C1CCCC1		CHEMBL182419	=	IC50	nM	5.0	CHEMBL262	Homo sapiens	IC50	uM	0.005
	18384303	CHEMBL4146562	Inhibition of GSK-3beta (unknown origin)	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1ncc(C(F)(F)F)cc1Cl		CHEMBL111620	=	IC50	nM	26.0	CHEMBL262	Homo sapiens	IC50	uM	0.026
	18384305	CHEMBL4146562	Inhibition of GSK-3beta (unknown origin)	B	COc1ccccc1C1=C(c2cn(CCCNC(=O)OC(C)(C)C)c3ncccc23)C(=O)NC1=O		CHEMBL109981	=	IC50	nM	7.0	CHEMBL262	Homo sapiens	IC50	uM	0.007
Active	18409141	CHEMBL4151665	Competitive inhibition of GSK3beta (unknown origin) at 10 uM using fixed level of GS-2 peptide substrate and varying ATP levels incubated for 30 mins by kinase-Glo luminescent assay	B	COc1ccc2c(c1)c(/C=C1\SC(=O)NC1=O)cn2C		CHEMBL4160653		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	18409142	CHEMBL4151665	Competitive inhibition of GSK3beta (unknown origin) at 10 uM using fixed level of GS-2 peptide substrate and varying ATP levels incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/c2c[nH]c3ccccc23)S1		CHEMBL1910509		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	18409143	CHEMBL4151664	Reversible inhibition of GSK3beta (unknown origin) pre-incubated for 30 mins followed by 100 fold dilution into buffer containing ULight-GS (Ser641/pSer657) peptide substrate and cofactors by TR-FRET assay based jump-dilution assay	B	COc1ccc2c(c1)c(/C=C1\SC(=O)NC1=O)cn2C		CHEMBL4160653		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	18409144	CHEMBL4151663	Inhibition of GSK3beta (unknown origin) pre-incubated for 30 mins followed by ULight-GS (Ser641/pSer657) peptide substrate addition and measured after 1 hr by TR-FRET assay	B	COc1ccc2c(c1)c(/C=C1\SC(=O)NC1=O)cn2C		CHEMBL4160653	=	IC50	nM	5500.0	CHEMBL262	Homo sapiens	IC50	uM	5.5
	18409145	CHEMBL4151663	Inhibition of GSK3beta (unknown origin) pre-incubated for 30 mins followed by ULight-GS (Ser641/pSer657) peptide substrate addition and measured after 1 hr by TR-FRET assay	B	O=C1NC(=O)/C(=C/c2c[nH]c3ccccc23)S1		CHEMBL1910509	=	IC50	nM	21000.0	CHEMBL262	Homo sapiens	IC50	uM	21.0
	18409146	CHEMBL4151662	Inhibition of GSK3beta (unknown origin) using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	IC50	nM	690.0	CHEMBL262	Homo sapiens	IC50	uM	0.69
	18409147	CHEMBL4151662	Inhibition of GSK3beta (unknown origin) using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	COc1ccc2nc(Cl)c(/C=C3\SC(=O)NC3=O)cc2c1		CHEMBL4169102	=	IC50	nM	3550.0	CHEMBL262	Homo sapiens	IC50	uM	3.55
	18409148	CHEMBL4151662	Inhibition of GSK3beta (unknown origin) using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/c2cc3ccccc3nc2Cl)S1		CHEMBL4173598	=	IC50	nM	6130.0	CHEMBL262	Homo sapiens	IC50	uM	6.13
	18409149	CHEMBL4151662	Inhibition of GSK3beta (unknown origin) using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	COc1cc(/C=C2\SC(=O)NC2=O)cc2c1OCO2		CHEMBL4165680	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	18409156	CHEMBL4151680	Inhibition of GSK3beta (unknown origin) at 10 uM	B	COc1ccc2c(c1)c(/C=C1\SC(=O)NC1=O)cn2C		CHEMBL4160653	=	Inhibition	%	100.0	CHEMBL262	Homo sapiens	INH	%	100.0
	18409157	CHEMBL4151680	Inhibition of GSK3beta (unknown origin) at 10 uM	B	O=C1NC(=O)/C(=C/c2c[nH]c3ccccc23)S1		CHEMBL1910509	=	Inhibition	%	95.0	CHEMBL262	Homo sapiens	INH	%	95.0
Active	18409158	CHEMBL4151679	Inhibition of okadaic acid-induced GSK-3beta-mediated tau hyperphosphorylation in human SH-SY5Y cells assessed as increase in cell viability pre-incubated for 1 hr before okadaic acid stimulation for 24 hrs by MTT assay	B	COc1ccc2c(c1)c(/C=C1\SC(=O)NC1=O)cn2C		CHEMBL4160653		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	18409159	CHEMBL4151679	Inhibition of okadaic acid-induced GSK-3beta-mediated tau hyperphosphorylation in human SH-SY5Y cells assessed as increase in cell viability pre-incubated for 1 hr before okadaic acid stimulation for 24 hrs by MTT assay	B	O=C1NC(=O)/C(=C/c2c[nH]c3ccccc23)S1		CHEMBL1910509		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	18409180	CHEMBL4151662	Inhibition of GSK3beta (unknown origin) using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OCCO3)S1		CHEMBL4170146	=	IC50	nM	7010.0	CHEMBL262	Homo sapiens	IC50	uM	7.01
	18409181	CHEMBL4151662	Inhibition of GSK3beta (unknown origin) using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/c2ccccc2OCc2ccccc2)S1		CHEMBL181852	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	18409182	CHEMBL4151662	Inhibition of GSK3beta (unknown origin) using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/c2ccc(-c3ccccc3)cc2)S1		CHEMBL1645386	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	18409183	CHEMBL4151662	Inhibition of GSK3beta (unknown origin) using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/c2c(-c3ccccc3)[nH]c3ccccc23)S1		CHEMBL4177365	=	IC50	nM	6030.0	CHEMBL262	Homo sapiens	IC50	uM	6.03
	18409184	CHEMBL4151662	Inhibition of GSK3beta (unknown origin) using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	Cn1c(/C=C2\SC(=O)NC2=O)nc2ccccc21		CHEMBL4171258	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	18409185	CHEMBL4151662	Inhibition of GSK3beta (unknown origin) using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	COc1ccc2c(c1)c(/C=C1\SC(=O)NC1=O)cn2C		CHEMBL4160653	=	IC50	nM	890.0	CHEMBL262	Homo sapiens	IC50	uM	0.89
	18409186	CHEMBL4151662	Inhibition of GSK3beta (unknown origin) using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	COc1ccc2[nH]cc(/C=C3\SC(=O)NC3=O)c2c1		CHEMBL4174706	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	18409187	CHEMBL4151662	Inhibition of GSK3beta (unknown origin) using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/c2c[nH]c3ccccc23)S1		CHEMBL1910509	=	IC50	nM	4930.0	CHEMBL262	Homo sapiens	IC50	uM	4.93
	18409188	CHEMBL4151662	Inhibition of GSK3beta (unknown origin) using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	CN(C)c1ccc(/C=C/C=C2\SC(=O)NC2=O)cc1		CHEMBL4159585	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	18409189	CHEMBL4151662	Inhibition of GSK3beta (unknown origin) using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/C=C/c2ccccc2)S1		CHEMBL4167499	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	18409190	CHEMBL4151662	Inhibition of GSK3beta (unknown origin) using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/c2c3ccccc3cc3ccccc23)S1		CHEMBL4162943	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	18409191	CHEMBL4151662	Inhibition of GSK3beta (unknown origin) using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/c2ccc3ccccc3c2)S1		CHEMBL457715	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	18409192	CHEMBL4151662	Inhibition of GSK3beta (unknown origin) using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/c2cc3ccccc3s2)S1		CHEMBL4166399	=	IC50	nM	7470.0	CHEMBL262	Homo sapiens	IC50	uM	7.47
	18409193	CHEMBL4151662	Inhibition of GSK3beta (unknown origin) using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/c2cccs2)S1		CHEMBL1957780	=	IC50	nM	7990.0	CHEMBL262	Homo sapiens	IC50	uM	7.99
	18409194	CHEMBL4151662	Inhibition of GSK3beta (unknown origin) using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/c2cc3ccccc3o2)S1		CHEMBL4162792	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	18409195	CHEMBL4151662	Inhibition of GSK3beta (unknown origin) using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/c2ccco2)S1		CHEMBL1957783	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	18409196	CHEMBL4151662	Inhibition of GSK3beta (unknown origin) using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/c2ccncc2)S1		CHEMBL3911800	=	IC50	nM	1420.0	CHEMBL262	Homo sapiens	IC50	uM	1.42
	18409197	CHEMBL4151662	Inhibition of GSK3beta (unknown origin) using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/c2cccnc2)S1		CHEMBL2016642	=	IC50	nM	8750.0	CHEMBL262	Homo sapiens	IC50	uM	8.75
	18409198	CHEMBL4151662	Inhibition of GSK3beta (unknown origin) using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/c2ccccn2)S1		CHEMBL1303022	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	18409199	CHEMBL4151662	Inhibition of GSK3beta (unknown origin) using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	CN(C)c1ccc(/C=C2\SC(=O)NC2=O)cc1		CHEMBL493847	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	18409200	CHEMBL4151662	Inhibition of GSK3beta (unknown origin) using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	CN(C)c1cccc(/C=C2\SC(=O)NC2=O)c1		CHEMBL4164291	=	IC50	nM	8540.0	CHEMBL262	Homo sapiens	IC50	uM	8.54
	18409201	CHEMBL4151662	Inhibition of GSK3beta (unknown origin) using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	CN(C)c1ccccc1/C=C1\SC(=O)NC1=O		CHEMBL4174941	=	IC50	nM	9220.0	CHEMBL262	Homo sapiens	IC50	uM	9.22
	18409202	CHEMBL4151662	Inhibition of GSK3beta (unknown origin) using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/c2ccc(F)cc2)S1		CHEMBL496786	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	18409203	CHEMBL4151662	Inhibition of GSK3beta (unknown origin) using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/c2cccc(F)c2)S1		CHEMBL448443	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	18409204	CHEMBL4151662	Inhibition of GSK3beta (unknown origin) using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/c2ccccc2F)S1		CHEMBL601199	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	18409205	CHEMBL4151662	Inhibition of GSK3beta (unknown origin) using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/c2ccc(O)c([N+](=O)[O-])c2)S1		CHEMBL4174355	=	IC50	nM	9220.0	CHEMBL262	Homo sapiens	IC50	uM	9.22
	18409206	CHEMBL4151662	Inhibition of GSK3beta (unknown origin) using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	COc1cc(/C=C2\SC(=O)NC2=O)ccc1O		CHEMBL232380	=	IC50	nM	6010.0	CHEMBL262	Homo sapiens	IC50	uM	6.01
	18409207	CHEMBL4151662	Inhibition of GSK3beta (unknown origin) using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	COc1ccc(/C=C2\SC(=O)NC2=O)c(O)c1		CHEMBL4175809	=	IC50	nM	7080.0	CHEMBL262	Homo sapiens	IC50	uM	7.08
	18409208	CHEMBL4151662	Inhibition of GSK3beta (unknown origin) using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/c2ccc(O)cc2)S1		CHEMBL87706	=	IC50	nM	8990.0	CHEMBL262	Homo sapiens	IC50	uM	8.99
	18409209	CHEMBL4151662	Inhibition of GSK3beta (unknown origin) using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/c2cccc(O)c2)S1		CHEMBL568200	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	18409210	CHEMBL4151662	Inhibition of GSK3beta (unknown origin) using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/c2ccccc2O)S1		CHEMBL2047717	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	18409211	CHEMBL4151662	Inhibition of GSK3beta (unknown origin) using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/c2ccccc2)S1		CHEMBL85105	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	18409212	CHEMBL4151661	Inhibition of GSK3beta (unknown origin) at 10 uM using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	COc1ccc2nc(Cl)c(/C=C3\SC(=O)NC3=O)cc2c1		CHEMBL4169102	>=	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	18409213	CHEMBL4151661	Inhibition of GSK3beta (unknown origin) at 10 uM using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/c2cc3ccccc3nc2Cl)S1		CHEMBL4173598	>=	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	18409214	CHEMBL4151661	Inhibition of GSK3beta (unknown origin) at 10 uM using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	COc1cc(/C=C2\SC(=O)NC2=O)cc2c1OCO2		CHEMBL4165680	>=	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	18409215	CHEMBL4151661	Inhibition of GSK3beta (unknown origin) at 10 uM using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OCCO3)S1		CHEMBL4170146	>=	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	18409216	CHEMBL4151661	Inhibition of GSK3beta (unknown origin) at 10 uM using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/c2ccccc2OCc2ccccc2)S1		CHEMBL181852	>=	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	18409217	CHEMBL4151661	Inhibition of GSK3beta (unknown origin) at 10 uM using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/c2ccc(-c3ccccc3)cc2)S1		CHEMBL1645386	>=	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	18409218	CHEMBL4151661	Inhibition of GSK3beta (unknown origin) at 10 uM using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/c2c(-c3ccccc3)[nH]c3ccccc23)S1		CHEMBL4177365	>=	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	18409219	CHEMBL4151661	Inhibition of GSK3beta (unknown origin) at 10 uM using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	Cn1c(/C=C2\SC(=O)NC2=O)nc2ccccc21		CHEMBL4171258	>=	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	18409220	CHEMBL4151661	Inhibition of GSK3beta (unknown origin) at 10 uM using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	COc1ccc2c(c1)c(/C=C1\SC(=O)NC1=O)cn2C		CHEMBL4160653	>=	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	18409221	CHEMBL4151661	Inhibition of GSK3beta (unknown origin) at 10 uM using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	COc1ccc2[nH]cc(/C=C3\SC(=O)NC3=O)c2c1		CHEMBL4174706	>=	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	18409222	CHEMBL4151661	Inhibition of GSK3beta (unknown origin) at 10 uM using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/c2c[nH]c3ccccc23)S1		CHEMBL1910509	>=	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	18409223	CHEMBL4151661	Inhibition of GSK3beta (unknown origin) at 10 uM using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	CN(C)c1ccc(/C=C/C=C2\SC(=O)NC2=O)cc1		CHEMBL4159585	>=	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	18409224	CHEMBL4151661	Inhibition of GSK3beta (unknown origin) at 10 uM using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/C=C/c2ccccc2)S1		CHEMBL4167499	>=	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	18409225	CHEMBL4151661	Inhibition of GSK3beta (unknown origin) at 10 uM using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/c2c3ccccc3cc3ccccc23)S1		CHEMBL4162943	>=	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	18409226	CHEMBL4151661	Inhibition of GSK3beta (unknown origin) at 10 uM using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/c2ccc3ccccc3c2)S1		CHEMBL457715	>=	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	18409227	CHEMBL4151661	Inhibition of GSK3beta (unknown origin) at 10 uM using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/c2cc3ccccc3s2)S1		CHEMBL4166399	>=	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	18409228	CHEMBL4151661	Inhibition of GSK3beta (unknown origin) at 10 uM using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/c2cccs2)S1		CHEMBL1957780	>=	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	18409229	CHEMBL4151661	Inhibition of GSK3beta (unknown origin) at 10 uM using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/c2cc3ccccc3o2)S1		CHEMBL4162792	>=	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	18409230	CHEMBL4151661	Inhibition of GSK3beta (unknown origin) at 10 uM using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/c2ccco2)S1		CHEMBL1957783	>=	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	18409231	CHEMBL4151661	Inhibition of GSK3beta (unknown origin) at 10 uM using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/c2ccncc2)S1		CHEMBL3911800	>=	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	18409232	CHEMBL4151661	Inhibition of GSK3beta (unknown origin) at 10 uM using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/c2cccnc2)S1		CHEMBL2016642	>=	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	18409233	CHEMBL4151661	Inhibition of GSK3beta (unknown origin) at 10 uM using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/c2ccccn2)S1		CHEMBL1303022	>=	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	18409234	CHEMBL4151661	Inhibition of GSK3beta (unknown origin) at 10 uM using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	CN(C)c1ccc(/C=C2\SC(=O)NC2=O)cc1		CHEMBL493847	>=	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	18409235	CHEMBL4151661	Inhibition of GSK3beta (unknown origin) at 10 uM using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	CN(C)c1cccc(/C=C2\SC(=O)NC2=O)c1		CHEMBL4164291	>=	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	18409236	CHEMBL4151661	Inhibition of GSK3beta (unknown origin) at 10 uM using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	CN(C)c1ccccc1/C=C1\SC(=O)NC1=O		CHEMBL4174941	>=	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	18409237	CHEMBL4151661	Inhibition of GSK3beta (unknown origin) at 10 uM using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/c2ccc(F)cc2)S1		CHEMBL496786	>=	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	18409238	CHEMBL4151661	Inhibition of GSK3beta (unknown origin) at 10 uM using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/c2cccc(F)c2)S1		CHEMBL448443	>=	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	18409239	CHEMBL4151661	Inhibition of GSK3beta (unknown origin) at 10 uM using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/c2ccccc2F)S1		CHEMBL601199	>=	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	18409240	CHEMBL4151661	Inhibition of GSK3beta (unknown origin) at 10 uM using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/c2ccc(O)c([N+](=O)[O-])c2)S1		CHEMBL4174355	>=	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	18409241	CHEMBL4151661	Inhibition of GSK3beta (unknown origin) at 10 uM using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	COc1cc(/C=C2\SC(=O)NC2=O)ccc1O		CHEMBL232380	>=	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	18409242	CHEMBL4151661	Inhibition of GSK3beta (unknown origin) at 10 uM using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	COc1ccc(/C=C2\SC(=O)NC2=O)c(O)c1		CHEMBL4175809	>=	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	18409243	CHEMBL4151661	Inhibition of GSK3beta (unknown origin) at 10 uM using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/c2ccc(O)cc2)S1		CHEMBL87706	>=	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	18409244	CHEMBL4151661	Inhibition of GSK3beta (unknown origin) at 10 uM using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/c2cccc(O)c2)S1		CHEMBL568200	>=	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	18409245	CHEMBL4151661	Inhibition of GSK3beta (unknown origin) at 10 uM using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/c2ccccc2O)S1		CHEMBL2047717	>=	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	18409246	CHEMBL4151661	Inhibition of GSK3beta (unknown origin) at 10 uM using GS-2 peptide substrate incubated for 30 mins by kinase-Glo luminescent assay	B	O=C1NC(=O)/C(=C/c2ccccc2)S1		CHEMBL85105	>=	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	18409247	CHEMBL4151663	Inhibition of GSK3beta (unknown origin) pre-incubated for 30 mins followed by ULight-GS (Ser641/pSer657) peptide substrate addition and measured after 1 hr by TR-FRET assay	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714	=	IC50	nM	11.4	CHEMBL262	Homo sapiens	IC50	nM	11.4
Active	18409912	CHEMBL4151784	Inhibition of human full length GSK3beta expressed in mammalian expression system at 1 uM	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	18409913	CHEMBL4151784	Inhibition of human full length GSK3beta expressed in mammalian expression system at 1 uM	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	18409914	CHEMBL4151784	Inhibition of human full length GSK3beta expressed in mammalian expression system at 1 uM	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	18409915	CHEMBL4151784	Inhibition of human full length GSK3beta expressed in mammalian expression system at 1 uM	B	O=C(N[C@H]1CC[C@H](O)CC1)c1n[nH]cc1NC(=O)c1c(F)cccc1F		CHEMBL457177		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	18410240	CHEMBL4151860	Inhibition of human GSK3beta expressed in mammalian expression system at 10 uM	B	COc1ccc(N)cc1-c1cnc(N)c(C(=O)c2cccnc2)n1		CHEMBL4167484		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	18410241	CHEMBL4151861	Inhibition of human GSK3beta expressed in mammalian expression system at 1 uM	B	O=c1ccc2cnc3ccc(-c4cn[nH]c4)cc3c2n1-c1ccc(F)cc1C(F)(F)F		CHEMBL1765714		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	18420970	CHEMBL4153935	Inhibition of DNA-tagged GSK3beta (unknown origin) expressed in HEK293 cells at 10 uM after 1 hr by real-time fluorescent quantitative PCR analysis	B	Fc1ccc(Nc2nc(N3CCOCC3)c3nc[nH]c3n2)cc1		CHEMBL4175978	=	Inhibition	%	47.0	CHEMBL262	Homo sapiens	INH	%	47.0
	18431061	CHEMBL4155742	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system at 1 uM by Z'-Lyte relative to control	B	O=C1Nc2ccc(C(=O)N[C@H](CO)c3ccccc3)cc2/C1=C(\c1ccccc1)c1ncc[nH]1		CHEMBL4160587	=	Inhibition	%	101.0	CHEMBL262	Homo sapiens	INH	%	101.0
	18434115	CHEMBL4156098	Inhibition of recombinant full-length human His-tagged GSK3beta expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control	B	OC[C@@H](Nc1ncnc2sc(-c3ccc(O)cc3)cc12)c1ccccc1		CHEMBL4177361	=	Inhibition	%	6.0	CHEMBL262	Homo sapiens	INH	%	6.0
	18434229	CHEMBL4156098	Inhibition of recombinant full-length human His-tagged GSK3beta expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control	B	CCC(=O)Nc1ccc(-c2c[nH]c3ncnc(N[C@H](C)c4ccccc4)c23)cc1		CHEMBL4167749	=	Inhibition	%	31.0	CHEMBL262	Homo sapiens	INH	%	31.0
	18434289	CHEMBL4156098	Inhibition of recombinant full-length human His-tagged GSK3beta expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control	B	CN(C)CCn1cc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL4159505	=	Inhibition	%	7.0	CHEMBL262	Homo sapiens	INH	%	7.0
	18434361	CHEMBL4156098	Inhibition of recombinant full-length human His-tagged GSK3beta expressed in baculovirus expression system at 500 nM by Z-LYTE assay relative to control	B	OCc1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)cc1		CHEMBL4175024	=	Inhibition	%	10.0	CHEMBL262	Homo sapiens	INH	%	10.0
	18440234	CHEMBL4157058	Binding affinity to wild-type human full length GSK3B (M1 to T433 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	100.0	CHEMBL262	Homo sapiens	Activity	%	100.0
	18443293	CHEMBL4157908	Inhibition of human GSK3beta assessed as enzyme residual activity at 100 nM by radiometric filter binding assay relative to control	B	NCCCC[C@@H](NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)CCCCCNC(=O)CCC(=O)Nc1ncc(-c2ccc(C(=O)O)cc2)s1)C(=O)O		CHEMBL4177303	=	Activity	%	19.0	CHEMBL262	Homo sapiens	Activity	%	19.0
	18449846	CHEMBL4178085	Inhibition of human GSK3beta (2 to 420 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	112.0	CHEMBL262	Homo sapiens	Activity	%	112.0
	18450271	CHEMBL4178307	Inhibition of recombinant human full length N-terminal GST/His tagged GSK3beta expressed in baculovirus infected Sf9 cells assessed as change in enzyme activity at 1 uM in presence of 1 uM ATP relative to control	B	CCN1CCN(Cc2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)cc(F)c7C6=O)c5CO)ccnc4[nH]3)nc2)CC1		CHEMBL3967108	=	Activity	%	2.0	CHEMBL262	Homo sapiens	Activity	%	2.0
	18450321	CHEMBL4178307	Inhibition of recombinant human full length N-terminal GST/His tagged GSK3beta expressed in baculovirus infected Sf9 cells assessed as change in enzyme activity at 1 uM in presence of 1 uM ATP relative to control	B	O=C1c2c(F)cc(C3CC3)cc2OCCN1c1cccc(-c2ccnc3[nH]c(C4=CCN(C5COC5)CC4)cc23)c1CO		CHEMBL3966346	=	Activity	%	-2.0	CHEMBL262	Homo sapiens	Activity	%	-2.0
Active	18461755	CHEMBL4180749	Inhibition of 6-OHDA induced GSK3beta phosphorylation in human SH-SY5Y cells at 2.5 to 10 uM pretreated for 1 hr followed by 6-OHDA addition after 1 hr by Western blot analysis	B	COc1ccc(-c2cc(=O)c3c(O)cc(O)cc3o2)cc1		CHEMBL243664		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	18462168	CHEMBL4180855	Inhibition of human full length GSK3b assessed as residual activity at 1 uM after 30 mins in presence of [gamma-33P]ATP relative to control	B	CC(C)=CCC/C(C)=C/Cn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4203120	=	Activity	%	75.0	CHEMBL262	Homo sapiens	Activity	%	75.0
	18463754	CHEMBL4181170	Inhibition of recombinant human N-terminal His6-tagged GSK3beta H350L mutant expressed in baculovirus Sf21 insect cells at 10 uM by filter binding radioactive ATP transferase assay relative to control	B	C=C(C)n1c(=O)n(C(C)=O)c2cc(Br)cnc21		CHEMBL4212680	=	Inhibition	%	6.0	CHEMBL262	Homo sapiens	INH	%	6.0
	18470580	CHEMBL4182574	Inhibition of human GSK3beta at 10 uM by ADP-Glo kinase assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Inhibition	%	8.0	CHEMBL262	Homo sapiens	INH	%	8.0
	18470751	CHEMBL4182574	Inhibition of human GSK3beta at 10 uM by ADP-Glo kinase assay	B	Cc1nc(N)c2ccn(C3CCN(C(=O)c4ccc(S(=O)(=O)F)cc4)CC3)c2n1		CHEMBL4206295	=	Inhibition	%	48.0	CHEMBL262	Homo sapiens	INH	%	48.0
	18470752	CHEMBL4182574	Inhibition of human GSK3beta at 10 uM by ADP-Glo kinase assay	B	Nc1ncnc2c1ccn2C1CCN(C(=O)c2ccc(S(=O)(=O)F)cc2)CC1		CHEMBL4218073	=	Inhibition	%	9.0	CHEMBL262	Homo sapiens	INH	%	9.0
	18471259	CHEMBL4182665	Inhibition of human GSK-3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE substrate peptide and [gamma-33P-ATP] incubated for 40 mins by scintillation counting method	B	O=C1NC(=S)S/C1=C\c1cccc(OCCOc2ccccc2)c1		CHEMBL4206546	=	Inhibition	%	70.0	CHEMBL262	Homo sapiens	INH	%	70.0
	18471260	CHEMBL4182665	Inhibition of human GSK-3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE substrate peptide and [gamma-33P-ATP] incubated for 40 mins by scintillation counting method	B	O=C1NC(=S)S/C1=C\c1cc(/N=N/c2ccccc2)ccc1O		CHEMBL4212986	=	Inhibition	%	93.0	CHEMBL262	Homo sapiens	INH	%	93.0
	18471261	CHEMBL4182665	Inhibition of human GSK-3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE substrate peptide and [gamma-33P-ATP] incubated for 40 mins by scintillation counting method	B	O=C(Cc1ccc([N+](=O)[O-])cc1)N/N=C1\C(=O)Nc2cc(Br)ccc21		CHEMBL4214215	=	Inhibition	%	71.0	CHEMBL262	Homo sapiens	INH	%	71.0
	18471262	CHEMBL4182665	Inhibition of human GSK-3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE substrate peptide and [gamma-33P-ATP] incubated for 40 mins by scintillation counting method	B	Cc1cc2c(cc1Br)NC(=O)/C2=N\NC(N)=S		CHEMBL4214903	=	Inhibition	%	59.0	CHEMBL262	Homo sapiens	INH	%	59.0
	18471263	CHEMBL4182665	Inhibition of human GSK-3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE substrate peptide and [gamma-33P-ATP] incubated for 40 mins by scintillation counting method	B	Cc1cc(Br)cc2c1NC(=O)/C2=N\NC(N)=S		CHEMBL4205137	=	Inhibition	%	63.0	CHEMBL262	Homo sapiens	INH	%	63.0
	18471264	CHEMBL4182665	Inhibition of human GSK-3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE substrate peptide and [gamma-33P-ATP] incubated for 40 mins by scintillation counting method	B	NC(=S)N/N=C1\C(=O)Nc2ccccc21		CHEMBL240095	=	Inhibition	%	16.0	CHEMBL262	Homo sapiens	INH	%	16.0
	18471265	CHEMBL4182665	Inhibition of human GSK-3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE substrate peptide and [gamma-33P-ATP] incubated for 40 mins by scintillation counting method	B	O=C1Nc2ccc(I)cc2/C1=C1/S/C(=N/c2ccccc2)N(c2ccccc2)C1=O		CHEMBL4202731	=	Inhibition	%	73.0	CHEMBL262	Homo sapiens	INH	%	73.0
	18471266	CHEMBL4182665	Inhibition of human GSK-3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE substrate peptide and [gamma-33P-ATP] incubated for 40 mins by scintillation counting method	B	O=C1N/C(=N\c2ccc(O)cc2)S/C1=C1\C(=O)Nc2ccc(Br)cc21		CHEMBL4203444	=	Inhibition	%	75.0	CHEMBL262	Homo sapiens	INH	%	75.0
	18471267	CHEMBL4182665	Inhibition of human GSK-3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE substrate peptide and [gamma-33P-ATP] incubated for 40 mins by scintillation counting method	B	O=C1N/C(=N\N=C2\C(=O)Nc3ccccc32)S/C1=C1\C(=O)Nc2ccccc21		CHEMBL4217762	=	Inhibition	%	47.0	CHEMBL262	Homo sapiens	INH	%	47.0
	18471268	CHEMBL4182664	Inhibition of human GSK-3beta using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE substrate peptide and [gamma-33P-ATP] incubated for 40 mins by scintillation counting method	B	COc1ccncc1NC(=O)c1ccnc(NC(=O)C2CC2)c1		CHEMBL4213175	=	IC50	nM	3.4	CHEMBL262	Homo sapiens	IC50	nM	3.4
	18471269	CHEMBL4182664	Inhibition of human GSK-3beta using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE substrate peptide and [gamma-33P-ATP] incubated for 40 mins by scintillation counting method	B	O=C(Nc1cccnc1)c1ccnc2[nH]c(-c3ccsc3)nc12		CHEMBL2048674	=	IC50	nM	13.0	CHEMBL262	Homo sapiens	IC50	nM	13.0
	18471270	CHEMBL4182664	Inhibition of human GSK-3beta using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE substrate peptide and [gamma-33P-ATP] incubated for 40 mins by scintillation counting method	B	COc1ccc(-n2cnc3ccc(-c4n[nH]c(=S)o4)cc32)cc1		CHEMBL1230134	=	IC50	nM	2.3	CHEMBL262	Homo sapiens	IC50	nM	2.3
	18471271	CHEMBL4182664	Inhibition of human GSK-3beta using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE substrate peptide and [gamma-33P-ATP] incubated for 40 mins by scintillation counting method	B	CN(C)c1nc2ccc1CCCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CCC2		CHEMBL1231352	=	IC50	nM	3.0	CHEMBL262	Homo sapiens	IC50	nM	3.0
	18471272	CHEMBL4182664	Inhibition of human GSK-3beta using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE substrate peptide and [gamma-33P-ATP] incubated for 40 mins by scintillation counting method	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	IC50	nM	4.0	CHEMBL262	Homo sapiens	IC50	nM	4.0
	18471273	CHEMBL4182664	Inhibition of human GSK-3beta using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE substrate peptide and [gamma-33P-ATP] incubated for 40 mins by scintillation counting method	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	15.0	CHEMBL262	Homo sapiens	IC50	nM	15.0
	18471274	CHEMBL4182664	Inhibition of human GSK-3beta using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE substrate peptide and [gamma-33P-ATP] incubated for 40 mins by scintillation counting method	B	O=C1NC(=O)N(c2ccccc2)/C1=C/Nc1ccc([N+](=O)[O-])cc1		CHEMBL4207719	=	IC50	nM	2350.0	CHEMBL262	Homo sapiens	IC50	uM	2.35
	18471275	CHEMBL4182664	Inhibition of human GSK-3beta using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE substrate peptide and [gamma-33P-ATP] incubated for 40 mins by scintillation counting method	B	O=C1NC(=S)S/C1=C\c1ccccc1OCOc1ccccc1/C=C1/SC(=S)NC1=O		CHEMBL4209448	=	IC50	nM	8750.0	CHEMBL262	Homo sapiens	IC50	uM	8.75
	18471276	CHEMBL4182664	Inhibition of human GSK-3beta using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE substrate peptide and [gamma-33P-ATP] incubated for 40 mins by scintillation counting method	B	O=C1NC(=S)S/C1=C\c1cccc(OCCOc2ccc([N+](=O)[O-])cc2)c1		CHEMBL4204627	=	IC50	nM	2570.0	CHEMBL262	Homo sapiens	IC50	uM	2.57
	18471277	CHEMBL4182664	Inhibition of human GSK-3beta using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE substrate peptide and [gamma-33P-ATP] incubated for 40 mins by scintillation counting method	B	O=C1NC(=S)S/C1=C\c1cccc(OCCOc2ccc(Br)cc2)c1		CHEMBL4210171	=	IC50	nM	3570.0	CHEMBL262	Homo sapiens	IC50	uM	3.57
	18471278	CHEMBL4182664	Inhibition of human GSK-3beta using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE substrate peptide and [gamma-33P-ATP] incubated for 40 mins by scintillation counting method	B	O=C1NC(=S)S/C1=C\c1cccc(OCCOc2ccccc2)c1		CHEMBL4206546	=	IC50	nM	5540.0	CHEMBL262	Homo sapiens	IC50	uM	5.54
	18471279	CHEMBL4182664	Inhibition of human GSK-3beta using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE substrate peptide and [gamma-33P-ATP] incubated for 40 mins by scintillation counting method	B	O=C1NC(=S)S/C1=C\c1cc(/N=N/c2ccccc2)ccc1O		CHEMBL4212986	=	IC50	nM	3960.0	CHEMBL262	Homo sapiens	IC50	uM	3.96
	18471280	CHEMBL4182664	Inhibition of human GSK-3beta using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE substrate peptide and [gamma-33P-ATP] incubated for 40 mins by scintillation counting method	B	O=C(Cc1ccc([N+](=O)[O-])cc1)N/N=C1\C(=O)Nc2cc(Br)ccc21		CHEMBL4214215	=	IC50	nM	4160.0	CHEMBL262	Homo sapiens	IC50	uM	4.16
	18471281	CHEMBL4182664	Inhibition of human GSK-3beta using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE substrate peptide and [gamma-33P-ATP] incubated for 40 mins by scintillation counting method	B	Cc1cc2c(cc1Br)NC(=O)/C2=N\NC(N)=S		CHEMBL4214903	=	IC50	nM	5960.0	CHEMBL262	Homo sapiens	IC50	uM	5.96
	18471282	CHEMBL4182664	Inhibition of human GSK-3beta using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE substrate peptide and [gamma-33P-ATP] incubated for 40 mins by scintillation counting method	B	Cc1cc(Br)cc2c1NC(=O)/C2=N\NC(N)=S		CHEMBL4205137	=	IC50	nM	8100.0	CHEMBL262	Homo sapiens	IC50	uM	8.1
	18471283	CHEMBL4182664	Inhibition of human GSK-3beta using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE substrate peptide and [gamma-33P-ATP] incubated for 40 mins by scintillation counting method	B	O=C1Nc2ccc(I)cc2/C1=C1/S/C(=N/c2ccccc2)N(c2ccccc2)C1=O		CHEMBL4202731	=	IC50	nM	1150.0	CHEMBL262	Homo sapiens	IC50	uM	1.15
	18471284	CHEMBL4182664	Inhibition of human GSK-3beta using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE substrate peptide and [gamma-33P-ATP] incubated for 40 mins by scintillation counting method	B	O=C1N/C(=N\c2ccc(O)cc2)S/C1=C1\C(=O)Nc2ccc(Br)cc21		CHEMBL4203444	=	IC50	nM	1440.0	CHEMBL262	Homo sapiens	IC50	uM	1.44
	18471285	CHEMBL4182664	Inhibition of human GSK-3beta using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE substrate peptide and [gamma-33P-ATP] incubated for 40 mins by scintillation counting method	B	O=C1Nc2ccccc2/C1=N/NC(=O)c1ccccc1O		CHEMBL394683	=	IC50	nM	18230.0	CHEMBL262	Homo sapiens	IC50	uM	18.23
	18471286	CHEMBL4182664	Inhibition of human GSK-3beta using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE substrate peptide and [gamma-33P-ATP] incubated for 40 mins by scintillation counting method	B	O=C1N=C(Nc2ccccc2Cl)S/C1=C/c1ccc(Cl)cc1		CHEMBL4210679	=	IC50	nM	18030.0	CHEMBL262	Homo sapiens	IC50	uM	18.03
	18471287	CHEMBL4182664	Inhibition of human GSK-3beta using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE substrate peptide and [gamma-33P-ATP] incubated for 40 mins by scintillation counting method	B	O=C(O)CCC(=O)N1N=C(c2c(O)nc3ccc(Cl)cc3c2-c2ccccc2)CC1c1ccco1		CHEMBL1518160	=	IC50	nM	13680.0	CHEMBL262	Homo sapiens	IC50	uM	13.68
	18471288	CHEMBL4182664	Inhibition of human GSK-3beta using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE substrate peptide and [gamma-33P-ATP] incubated for 40 mins by scintillation counting method	B	CSc1cc(-c2ccccc2)nc2[nH]nc(N)c12		CHEMBL4207133	=	IC50	nM	12940.0	CHEMBL262	Homo sapiens	IC50	uM	12.94
	18471289	CHEMBL4182664	Inhibition of human GSK-3beta using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE substrate peptide and [gamma-33P-ATP] incubated for 40 mins by scintillation counting method	B	O=C(COc1ccccc1)Nc1ccc(Oc2ccc3c(c2)C(=O)NC3=O)cc1		CHEMBL4204026	=	IC50	nM	12450.0	CHEMBL262	Homo sapiens	IC50	uM	12.45
	18471290	CHEMBL4182664	Inhibition of human GSK-3beta using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE substrate peptide and [gamma-33P-ATP] incubated for 40 mins by scintillation counting method	B	O=C1NN(c2ccc(F)cc2)C(=O)/C1=C\c1cccc(OCc2ccccc2F)c1		CHEMBL2029696	=	IC50	nM	11800.0	CHEMBL262	Homo sapiens	IC50	uM	11.8
	18471291	CHEMBL4182664	Inhibition of human GSK-3beta using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE substrate peptide and [gamma-33P-ATP] incubated for 40 mins by scintillation counting method	B	O=C(Nc1ccccc1)Nc1[nH]nc2nnc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL198058	=	IC50	nM	7360.0	CHEMBL262	Homo sapiens	IC50	uM	7.36
	18471292	CHEMBL4182664	Inhibition of human GSK-3beta using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE substrate peptide and [gamma-33P-ATP] incubated for 40 mins by scintillation counting method	B	O=C1N/C(=N\c2ccccc2Cl)S/C1=C/C=C/c1ccccc1		CHEMBL4210913	=	IC50	nM	6080.0	CHEMBL262	Homo sapiens	IC50	uM	6.08
	18471293	CHEMBL4182664	Inhibition of human GSK-3beta using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE substrate peptide and [gamma-33P-ATP] incubated for 40 mins by scintillation counting method	B	Nc1n[nH]c(Nc2ccccc2)c1-c1nc2ccccc2s1		CHEMBL4212059	=	IC50	nM	6050.0	CHEMBL262	Homo sapiens	IC50	uM	6.05
	18471294	CHEMBL4182664	Inhibition of human GSK-3beta using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE substrate peptide and [gamma-33P-ATP] incubated for 40 mins by scintillation counting method	B	O=C(O)c1ccc(NC2=C/C(=N/S(=O)(=O)c3ccc4ccccc4c3)c3ccccc3C2=O)cc1		CHEMBL4208450	=	IC50	nM	6030.0	CHEMBL262	Homo sapiens	IC50	uM	6.03
	18471295	CHEMBL4182664	Inhibition of human GSK-3beta using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE substrate peptide and [gamma-33P-ATP] incubated for 40 mins by scintillation counting method	B	O=C1NC(=O)N(c2ccccc2)/C1=C/Nc1ccc(C(=O)O)cc1		CHEMBL4204286	=	IC50	nM	3510.0	CHEMBL262	Homo sapiens	IC50	uM	3.51
	18471296	CHEMBL4182664	Inhibition of human GSK-3beta using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE substrate peptide and [gamma-33P-ATP] incubated for 40 mins by scintillation counting method	B	Cc1cccc(OCCOc2cccc(/C=C3\SC(=S)NC3=O)c2)c1		CHEMBL4213020	=	IC50	nM	2600.0	CHEMBL262	Homo sapiens	IC50	uM	2.6
	18471297	CHEMBL4182664	Inhibition of human GSK-3beta using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE substrate peptide and [gamma-33P-ATP] incubated for 40 mins by scintillation counting method	B	Cc1ccc2c(c1Br)/C(=N/NC(N)=S)C(=O)N2		CHEMBL4204814	=	IC50	nM	2460.0	CHEMBL262	Homo sapiens	IC50	uM	2.46
	18471298	CHEMBL4182664	Inhibition of human GSK-3beta using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE substrate peptide and [gamma-33P-ATP] incubated for 40 mins by scintillation counting method	B	O=C1Nc2ccccc2/C1=C1/S/C(=N/N=C2/C(=O)Nc3ccccc32)N(c2ccc(O)cc2)C1=O		CHEMBL4216485	=	IC50	nM	710.0	CHEMBL262	Homo sapiens	IC50	uM	0.71
	18471299	CHEMBL4182664	Inhibition of human GSK-3beta using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE substrate peptide and [gamma-33P-ATP] incubated for 40 mins by scintillation counting method	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	IC50	nM	220.0	CHEMBL262	Homo sapiens	IC50	uM	0.22
	18471300	CHEMBL4182665	Inhibition of human GSK-3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE substrate peptide and [gamma-33P-ATP] incubated for 40 mins by scintillation counting method	B	O=C1NC(=S)S/C1=C\c1cccc(OCCOc2ccc(Br)cc2)c1		CHEMBL4210171	=	Inhibition	%	66.0	CHEMBL262	Homo sapiens	INH	%	66.0
	18471301	CHEMBL4182665	Inhibition of human GSK-3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE substrate peptide and [gamma-33P-ATP] incubated for 40 mins by scintillation counting method	B	O=C1NC(=S)S/C1=C\c1cccc(OCCOc2ccc([N+](=O)[O-])cc2)c1		CHEMBL4204627	=	Inhibition	%	87.0	CHEMBL262	Homo sapiens	INH	%	87.0
	18471302	CHEMBL4182665	Inhibition of human GSK-3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE substrate peptide and [gamma-33P-ATP] incubated for 40 mins by scintillation counting method	B	CCN1C(=O)/C(=C/c2cccc(OCCOc3ccccc3)c2)SC1=S		CHEMBL4217470	=	Inhibition	%	13.0	CHEMBL262	Homo sapiens	INH	%	13.0
	18471303	CHEMBL4182665	Inhibition of human GSK-3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE substrate peptide and [gamma-33P-ATP] incubated for 40 mins by scintillation counting method	B	O=C1NC(=S)S/C1=C\c1ccccc1OCOc1ccccc1/C=C1/SC(=S)NC1=O		CHEMBL4209448	=	Inhibition	%	54.0	CHEMBL262	Homo sapiens	INH	%	54.0
	18471304	CHEMBL4182665	Inhibition of human GSK-3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE substrate peptide and [gamma-33P-ATP] incubated for 40 mins by scintillation counting method	B	O=C1NC(=O)N(c2ccccc2)/C1=C/Nc1ccc([N+](=O)[O-])cc1		CHEMBL4207719	=	Inhibition	%	81.0	CHEMBL262	Homo sapiens	INH	%	81.0
	18471305	CHEMBL4182665	Inhibition of human GSK-3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE substrate peptide and [gamma-33P-ATP] incubated for 40 mins by scintillation counting method	B	Cc1ccc(N/C=C2\C(=O)NC(=O)N2c2ccccc2)cc1		CHEMBL4206003	=	Inhibition	%	42.0	CHEMBL262	Homo sapiens	INH	%	42.0
Active	18471306	CHEMBL4182666	Inhibition of GSK-3beta in human SH-SY5Y cells assessed as reduction in amyloid beta (25 to 35) -induced toxicity at 10 uM pre-incubated for 1 hrs before amyloid beta (25 to 35) addition and measured after 72 hrs post Abeta25-35 addition by MTT assay	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	18471307	CHEMBL4182666	Inhibition of GSK-3beta in human SH-SY5Y cells assessed as reduction in amyloid beta (25 to 35) -induced toxicity at 10 uM pre-incubated for 1 hrs before amyloid beta (25 to 35) addition and measured after 72 hrs post Abeta25-35 addition by MTT assay	B	O=C1Nc2ccccc2/C1=C1/S/C(=N/N=C2/C(=O)Nc3ccccc32)N(c2ccc(O)cc2)C1=O		CHEMBL4216485		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	18471308	CHEMBL4182666	Inhibition of GSK-3beta in human SH-SY5Y cells assessed as reduction in amyloid beta (25 to 35) -induced toxicity at 10 uM pre-incubated for 1 hrs before amyloid beta (25 to 35) addition and measured after 72 hrs post Abeta25-35 addition by MTT assay	B	Cc1ccc2c(c1Br)/C(=N/NC(N)=S)C(=O)N2		CHEMBL4204814		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	18471309	CHEMBL4182666	Inhibition of GSK-3beta in human SH-SY5Y cells assessed as reduction in amyloid beta (25 to 35) -induced toxicity at 10 uM pre-incubated for 1 hrs before amyloid beta (25 to 35) addition and measured after 72 hrs post Abeta25-35 addition by MTT assay	B	Cc1cccc(OCCOc2cccc(/C=C3\SC(=S)NC3=O)c2)c1		CHEMBL4213020		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	18471310	CHEMBL4182666	Inhibition of GSK-3beta in human SH-SY5Y cells assessed as reduction in amyloid beta (25 to 35) -induced toxicity at 10 uM pre-incubated for 1 hrs before amyloid beta (25 to 35) addition and measured after 72 hrs post Abeta25-35 addition by MTT assay	B	O=C1NC(=O)N(c2ccccc2)/C1=C/Nc1ccc(C(=O)O)cc1		CHEMBL4204286		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	18471311	CHEMBL4182666	Inhibition of GSK-3beta in human SH-SY5Y cells assessed as reduction in amyloid beta (25 to 35) -induced toxicity at 10 uM pre-incubated for 1 hrs before amyloid beta (25 to 35) addition and measured after 72 hrs post Abeta25-35 addition by MTT assay	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	18471312	CHEMBL4182667	Inhibition of GSK-3beta in human SH-SY5Y cells assessed as reduction in amyloid beta (25 to 35) -induced toxicity at 30 uM pre-incubated for 1 hrs before amyloid beta (25 to 35) addition and measured after 72 hrs post Abeta25-35 addition by MTT assay	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	18471313	CHEMBL4182667	Inhibition of GSK-3beta in human SH-SY5Y cells assessed as reduction in amyloid beta (25 to 35) -induced toxicity at 30 uM pre-incubated for 1 hrs before amyloid beta (25 to 35) addition and measured after 72 hrs post Abeta25-35 addition by MTT assay	B	O=C1Nc2ccccc2/C1=C1/S/C(=N/N=C2/C(=O)Nc3ccccc32)N(c2ccc(O)cc2)C1=O		CHEMBL4216485		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	18471314	CHEMBL4182667	Inhibition of GSK-3beta in human SH-SY5Y cells assessed as reduction in amyloid beta (25 to 35) -induced toxicity at 30 uM pre-incubated for 1 hrs before amyloid beta (25 to 35) addition and measured after 72 hrs post Abeta25-35 addition by MTT assay	B	Cc1ccc2c(c1Br)/C(=N/NC(N)=S)C(=O)N2		CHEMBL4204814		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	18471315	CHEMBL4182667	Inhibition of GSK-3beta in human SH-SY5Y cells assessed as reduction in amyloid beta (25 to 35) -induced toxicity at 30 uM pre-incubated for 1 hrs before amyloid beta (25 to 35) addition and measured after 72 hrs post Abeta25-35 addition by MTT assay	B	Cc1cccc(OCCOc2cccc(/C=C3\SC(=S)NC3=O)c2)c1		CHEMBL4213020		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	18471316	CHEMBL4182667	Inhibition of GSK-3beta in human SH-SY5Y cells assessed as reduction in amyloid beta (25 to 35) -induced toxicity at 30 uM pre-incubated for 1 hrs before amyloid beta (25 to 35) addition and measured after 72 hrs post Abeta25-35 addition by MTT assay	B	O=C1NC(=O)N(c2ccccc2)/C1=C/Nc1ccc(C(=O)O)cc1		CHEMBL4204286		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	18471317	CHEMBL4182667	Inhibition of GSK-3beta in human SH-SY5Y cells assessed as reduction in amyloid beta (25 to 35) -induced toxicity at 30 uM pre-incubated for 1 hrs before amyloid beta (25 to 35) addition and measured after 72 hrs post Abeta25-35 addition by MTT assay	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	18471319	CHEMBL4182669	Inhibition of GSK-3beta (unknown origin)	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	=	IC50	nM	78.0	CHEMBL262	Homo sapiens	IC50	nM	78.0
	18484190	CHEMBL4185837	Binding affinity to wild-type human full length GSK3B (M1 to T433 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	92.0	CHEMBL262	Homo sapiens	Activity	%	92.0
	18484674	CHEMBL4185837	Binding affinity to wild-type human full length GSK3B (M1 to T433 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	82.0	CHEMBL262	Homo sapiens	Activity	%	82.0
	18489516	CHEMBL4187257	Inhibition of wild-type human full length GSK3B (M1 to T433 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	Fc1cc(F)cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)c1		CHEMBL4207079	=	Activity	%	79.0	CHEMBL262	Homo sapiens	Activity	%	79.0
	18506019	CHEMBL4190479	Inhibition of recombinant human GST-tagged GSK3beta expressed in baculovirus infected Sf9 insect cells using RBER-CHKtide as substrate after 60 mins in presence of [gamma33P]ATP by scintillation counting method	B	COc1ccc(CNc2ccnc3oc4ccccc4c23)cc1	Non standard unit for type	CHEMBL1290072	>	INH	uM	100.0	CHEMBL262	Homo sapiens	INH	uM	100.0
	18507769	CHEMBL4190993	Inhibition of recombinant human GSK3beta (2 to end residues) at 1 uM using YRRAAVPPSPSLSRHSSPHQS(p)EDEEE (phospho GS2 peptide) as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	2.0	CHEMBL262	Homo sapiens	INH	%	2.0
	18513463	CHEMBL4192331	Inhibition of recombinant human His-tagged GSK3beta using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method	B	O=C1c2cccn2-c2ccccc2SC1c1cccc2ccccc12		CHEMBL4214720	=	Ki	nM	16000.0	CHEMBL262	Homo sapiens	Ki	uM	16.0
Not Determined	18513488	CHEMBL4192331	Inhibition of recombinant human His-tagged GSK3beta using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method	B	CCC1(c2ccc(CSc3ccccc3)cc2)Oc2ccccc2-n2cccc2C1=O		CHEMBL1688496		IC50			CHEMBL262	Homo sapiens	IC50		
	18513489	CHEMBL4192331	Inhibition of recombinant human His-tagged GSK3beta using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method	B	O=C1c2cccn2-c2ccccc2SC1c1cccc2ccccc12		CHEMBL4214720	=	IC50	nM	16000.0	CHEMBL262	Homo sapiens	IC50	uM	16.0
	18513490	CHEMBL4192331	Inhibition of recombinant human His-tagged GSK3beta using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method	B	O=C1C(c2cccc3ccccc23)Oc2ccccc2N1Cc1ccccc1		CHEMBL4203063	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	18513491	CHEMBL4192331	Inhibition of recombinant human His-tagged GSK3beta using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method	B	Cc1ccc(CN2C(=O)C(c3cccc4ccccc34)Oc3ccccc32)cc1		CHEMBL4204473	=	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	18513492	CHEMBL4192331	Inhibition of recombinant human His-tagged GSK3beta using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method	B	O=C1C(c2cccc3ccccc23)Oc2ccccc2N1Cc1ccc(F)cc1		CHEMBL4216137	=	IC50	nM	5400.0	CHEMBL262	Homo sapiens	IC50	uM	5.4
	18513493	CHEMBL4192331	Inhibition of recombinant human His-tagged GSK3beta using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method	B	O=C1C(c2cccc3ccccc23)Oc2ccccc2N1Cc1ccc(Cl)cc1		CHEMBL4216653	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	18513494	CHEMBL4192331	Inhibition of recombinant human His-tagged GSK3beta using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method	B	O=C1C(c2cccc3ccccc23)Oc2ccccc2N1Cc1ccc([N+](=O)[O-])cc1		CHEMBL4211676	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	18513495	CHEMBL4192331	Inhibition of recombinant human His-tagged GSK3beta using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method	B	COc1ccc(CN2C(=O)C(c3cccc4ccccc34)Oc3ccccc32)cc1		CHEMBL4213199	=	IC50	nM	8100.0	CHEMBL262	Homo sapiens	IC50	uM	8.1
	18513496	CHEMBL4192331	Inhibition of recombinant human His-tagged GSK3beta using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method	B	O=C1C(c2ccc3ccccc3c2)Oc2ccccc2N1Cc1ccc(F)cc1		CHEMBL4208269	=	IC50	nM	8700.0	CHEMBL262	Homo sapiens	IC50	uM	8.7
	18513497	CHEMBL4192331	Inhibition of recombinant human His-tagged GSK3beta using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method	B	O=C(c1ccccc1)N1CC(c2cccc3ccccc23)Oc2ccccc21		CHEMBL4208804	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	18513498	CHEMBL4192331	Inhibition of recombinant human His-tagged GSK3beta using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method	B	O=S(=O)(c1ccccc1)N1CC(c2cccc3ccccc23)Oc2ccccc21		CHEMBL4203924	=	IC50	nM	4100.0	CHEMBL262	Homo sapiens	IC50	uM	4.1
	18513499	CHEMBL4192331	Inhibition of recombinant human His-tagged GSK3beta using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method	B	O=C1C(c2cccc3ccccc23)Oc2cc(F)ccc2N1Cc1ccc(F)cc1		CHEMBL4205360	=	IC50	nM	21200.0	CHEMBL262	Homo sapiens	IC50	uM	21.2
	18513500	CHEMBL4192331	Inhibition of recombinant human His-tagged GSK3beta using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method	B	O=C1C(c2cccc3ccccc23)Oc2cc(N3CCOCC3)ccc2N1Cc1ccc(F)cc1		CHEMBL4217077	=	IC50	nM	10100.0	CHEMBL262	Homo sapiens	IC50	uM	10.1
	18513501	CHEMBL4192331	Inhibition of recombinant human His-tagged GSK3beta using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method	B	O=C1C(c2cccc3ccccc23)Oc2cc3c(cc2N1Cc1ccccc1)OCO3		CHEMBL4216522	=	IC50	nM	6400.0	CHEMBL262	Homo sapiens	IC50	uM	6.4
	18513502	CHEMBL4192331	Inhibition of recombinant human His-tagged GSK3beta using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method	B	O=C1C(c2cccc3ccccc23)Oc2cc3c(cc2N1Cc1ccc(F)cc1)OCO3		CHEMBL4204838	=	IC50	nM	8100.0	CHEMBL262	Homo sapiens	IC50	uM	8.1
	18513503	CHEMBL4192331	Inhibition of recombinant human His-tagged GSK3beta using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method	B	CN1C(=O)C(c2cccc3ccccc23)Oc2cc3c(cc21)OCO3		CHEMBL4212073	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	18513504	CHEMBL4192331	Inhibition of recombinant human His-tagged GSK3beta using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method	B	CCN1C(=O)C(c2cccc3ccccc23)Oc2cc3c(cc21)OCO3		CHEMBL4217051	=	IC50	nM	25600.0	CHEMBL262	Homo sapiens	IC50	uM	25.6
	18513505	CHEMBL4192331	Inhibition of recombinant human His-tagged GSK3beta using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method	B	O=C1C(c2ccc3ccccc3c2)Oc2cc3c(cc2N1Cc1ccccc1)OCO3		CHEMBL4208658	=	IC50	nM	6900.0	CHEMBL262	Homo sapiens	IC50	uM	6.9
	18513506	CHEMBL4192331	Inhibition of recombinant human His-tagged GSK3beta using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method	B	O=C1Nc2cc3c(c(Cc4ccccc4)c2OC1c1ccccc1)OCO3		CHEMBL4213595	=	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	18513507	CHEMBL4192331	Inhibition of recombinant human His-tagged GSK3beta using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method	B	CN1C(=O)C(c2ccccc2)Oc2cc3c(cc21)OCO3		CHEMBL4204332	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	18513508	CHEMBL4192331	Inhibition of recombinant human His-tagged GSK3beta using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method	B	CCN1C(=O)C(c2ccccc2)Oc2cc3c(cc21)OCO3		CHEMBL4209197	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	18513509	CHEMBL4192331	Inhibition of recombinant human His-tagged GSK3beta using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method	B	CC(=O)Oc1[nH]c2ccccc2c1-c1ccc(C)cc1		CHEMBL4215567	=	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	18513510	CHEMBL4192331	Inhibition of recombinant human His-tagged GSK3beta using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method	B	CC(=O)Oc1[nH]c2ccccc2c1-c1cccc2ccccc12		CHEMBL4203890	=	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	18513511	CHEMBL4192331	Inhibition of recombinant human His-tagged GSK3beta using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method	B	CCN(CC)C(=O)Oc1[nH]c2ccccc2c1-c1cccc2ccccc12		CHEMBL4207131	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	18513520	CHEMBL4192333	Inhibition of recombinant human His-tagged GSK3beta at 50 uM using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method relative to control	B	O=C1C(c2cccc3ccccc23)Oc2ccccc2N1Cc1ccccc1		CHEMBL4203063	=	Inhibition	%	48.0	CHEMBL262	Homo sapiens	INH	%	48.0
	18513521	CHEMBL4192333	Inhibition of recombinant human His-tagged GSK3beta at 50 uM using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method relative to control	B	O=C1C(c2cccc3ccccc23)Oc2ccccc2N1Cc1ccc(Cl)cc1		CHEMBL4216653	=	Inhibition	%	46.0	CHEMBL262	Homo sapiens	INH	%	46.0
	18513522	CHEMBL4192333	Inhibition of recombinant human His-tagged GSK3beta at 50 uM using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method relative to control	B	O=C1C(c2cccc3ccccc23)Oc2ccccc2N1Cc1ccc([N+](=O)[O-])cc1		CHEMBL4211676	=	Inhibition	%	40.0	CHEMBL262	Homo sapiens	INH	%	40.0
	18513523	CHEMBL4192333	Inhibition of recombinant human His-tagged GSK3beta at 50 uM using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method relative to control	B	O=C(c1ccccc1)N1CC(c2cccc3ccccc23)Oc2ccccc21		CHEMBL4208804	=	Inhibition	%	25.0	CHEMBL262	Homo sapiens	INH	%	25.0
	18513524	CHEMBL4192333	Inhibition of recombinant human His-tagged GSK3beta at 50 uM using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method relative to control	B	CN1C(=O)C(c2ccccc2)Oc2cc3c(cc21)OCO3		CHEMBL4204332	=	Inhibition	%	8.0	CHEMBL262	Homo sapiens	INH	%	8.0
	18513525	CHEMBL4192333	Inhibition of recombinant human His-tagged GSK3beta at 50 uM using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method relative to control	B	CCN1C(=O)C(c2ccccc2)Oc2cc3c(cc21)OCO3		CHEMBL4209197	=	Inhibition	%	15.0	CHEMBL262	Homo sapiens	INH	%	15.0
	18513526	CHEMBL4192333	Inhibition of recombinant human His-tagged GSK3beta at 50 uM using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method relative to control	B	CCN(CC)C(=O)Oc1[nH]c2ccccc2c1-c1cccc2ccccc12		CHEMBL4207131	=	Inhibition	%	38.0	CHEMBL262	Homo sapiens	INH	%	38.0
	18513527	CHEMBL4192335	Inhibition of recombinant human His-tagged GSK3beta assessed as substrate Vmax at 1.25 uM using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method (Rvb = 5872 +/- 560 cpm)	B	O=C1C(c2cccc3ccccc23)Oc2ccccc2N1Cc1ccc(F)cc1		CHEMBL4216137	=	Vmax	cpm	4539.0	CHEMBL262	Homo sapiens	Vmax	cpm	4539.0
	18513528	CHEMBL4192336	Inhibition of recombinant human His-tagged GSK3beta assessed as substrate Vmax at 2.5 uM using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method (Rvb = 5872 +/- 560 cpm)	B	O=C1C(c2cccc3ccccc23)Oc2ccccc2N1Cc1ccc(F)cc1		CHEMBL4216137	=	Vmax	cpm	4026.0	CHEMBL262	Homo sapiens	Vmax	cpm	4026.0
	18513529	CHEMBL4192337	Inhibition of recombinant human His-tagged GSK3beta assessed as substrate Vmax at 5 uM using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method (Rvb = 5872 +/- 560 cpm)	B	O=C1C(c2cccc3ccccc23)Oc2ccccc2N1Cc1ccc(F)cc1		CHEMBL4216137	=	Vmax	cpm	3300.0	CHEMBL262	Homo sapiens	Vmax	cpm	3300.0
	18513530	CHEMBL4192338	Inhibition of recombinant human His-tagged GSK3beta assessed as substrate Vmax at 7.5 uM using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method (Rvb = 5872 +/- 560 cpm)	B	O=C1C(c2cccc3ccccc23)Oc2ccccc2N1Cc1ccc(F)cc1		CHEMBL4216137	=	Vmax	cpm	2748.0	CHEMBL262	Homo sapiens	Vmax	cpm	2748.0
	18513531	CHEMBL4192339	Inhibition of recombinant human His-tagged GSK3beta assessed as substrate Km at 1.25 uM using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method (Rvb = 11.8 +/- 2.2 uM)	B	O=C1C(c2cccc3ccccc23)Oc2ccccc2N1Cc1ccc(F)cc1		CHEMBL4216137	=	Km	nM	9500.0	CHEMBL262	Homo sapiens	Km	uM	9.5
	18513532	CHEMBL4192340	Inhibition of recombinant human His-tagged GSK3beta assessed as substrate Km at 2.5 uM using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method (Rvb = 11.8 +/- 2.2 uM)	B	O=C1C(c2cccc3ccccc23)Oc2ccccc2N1Cc1ccc(F)cc1		CHEMBL4216137	=	Km	nM	10100.0	CHEMBL262	Homo sapiens	Km	uM	10.1
	18513533	CHEMBL4192341	Inhibition of recombinant human His-tagged GSK3beta assessed as substrate Km at 5 uM using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method (Rvb = 11.8 +/- 2.2 uM)	B	O=C1C(c2cccc3ccccc23)Oc2ccccc2N1Cc1ccc(F)cc1		CHEMBL4216137	=	Km	nM	9300.0	CHEMBL262	Homo sapiens	Km	uM	9.3
	18513534	CHEMBL4192342	Inhibition of recombinant human His-tagged GSK3beta assessed as substrate Km at 7.5 uM using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method (Rvb = 11.8 +/- 2.2 uM)	B	O=C1C(c2cccc3ccccc23)Oc2ccccc2N1Cc1ccc(F)cc1		CHEMBL4216137	=	Km	nM	11000.0	CHEMBL262	Homo sapiens	Km	uM	11.0
	18513535	CHEMBL4192343	Inhibition of recombinant human His-tagged GSK3beta assessed as substrate Vmax at 3 uM using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method (Rvb = 19490 +/- 852 cpm)	B	O=C1C(c2cccc3ccccc23)Oc2cc3c(cc2N1Cc1ccccc1)OCO3		CHEMBL4216522	=	Vmax	cpm	14022.0	CHEMBL262	Homo sapiens	Vmax	cpm	14022.0
	18513536	CHEMBL4192344	Inhibition of recombinant human His-tagged GSK3beta assessed as substrate Vmax at 6 uM using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method (Rvb = 19490 +/- 852 cpm)	B	O=C1C(c2cccc3ccccc23)Oc2cc3c(cc2N1Cc1ccccc1)OCO3		CHEMBL4216522	=	Vmax	cpm	10301.0	CHEMBL262	Homo sapiens	Vmax	cpm	10301.0
	18513537	CHEMBL4192345	Inhibition of recombinant human His-tagged GSK3beta assessed as substrate Vmax at 9 uM using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method (Rvb = 19490 +/- 852 cpm)	B	O=C1C(c2cccc3ccccc23)Oc2cc3c(cc2N1Cc1ccccc1)OCO3		CHEMBL4216522	=	Vmax	cpm	7982.0	CHEMBL262	Homo sapiens	Vmax	cpm	7982.0
	18513538	CHEMBL4192346	Inhibition of recombinant human His-tagged GSK3beta assessed as substrate Vmax at 12 uM using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method (Rvb = 19490 +/- 852 cpm)	B	O=C1C(c2cccc3ccccc23)Oc2cc3c(cc2N1Cc1ccccc1)OCO3		CHEMBL4216522	=	Vmax	cpm	5291.0	CHEMBL262	Homo sapiens	Vmax	cpm	5291.0
	18513539	CHEMBL4192347	Inhibition of recombinant human His-tagged GSK3beta assessed as substrate Km at 3 uM using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method (Rvb = 9.9 +/- 0.9 uM)	B	O=C1C(c2cccc3ccccc23)Oc2cc3c(cc2N1Cc1ccccc1)OCO3		CHEMBL4216522	=	Km	nM	10300.0	CHEMBL262	Homo sapiens	Km	uM	10.3
	18513540	CHEMBL4192348	Inhibition of recombinant human His-tagged GSK3beta assessed as substrate Km at 6 uM using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method (Rvb = 9.9 +/- 0.9 uM)	B	O=C1C(c2cccc3ccccc23)Oc2cc3c(cc2N1Cc1ccccc1)OCO3		CHEMBL4216522	=	Km	nM	9900.0	CHEMBL262	Homo sapiens	Km	uM	9.9
	18513541	CHEMBL4192349	Inhibition of recombinant human His-tagged GSK3beta assessed as substrate Km at 9 uM using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method (Rvb = 9.9 +/- 0.9 uM)	B	O=C1C(c2cccc3ccccc23)Oc2cc3c(cc2N1Cc1ccccc1)OCO3		CHEMBL4216522	=	Km	nM	10900.0	CHEMBL262	Homo sapiens	Km	uM	10.9
	18513542	CHEMBL4192350	Inhibition of recombinant human His-tagged GSK3beta assessed as substrate Km at 12 uM using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method (Rvb = 9.9 +/- 0.9 uM)	B	O=C1C(c2cccc3ccccc23)Oc2cc3c(cc2N1Cc1ccccc1)OCO3		CHEMBL4216522	=	Km	nM	10200.0	CHEMBL262	Homo sapiens	Km	uM	10.2
	18513543	CHEMBL4192351	Non-competitive inhibition of recombinant human His-tagged GSK3beta using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method	B	O=C1C(c2cccc3ccccc23)Oc2ccccc2N1Cc1ccc(F)cc1		CHEMBL4216137	=	Ki	nM	5600.0	CHEMBL262	Homo sapiens	Ki	uM	5.6
	18513544	CHEMBL4192351	Non-competitive inhibition of recombinant human His-tagged GSK3beta using GS-2 peptide as substrate in presence of [33P]gamma-ATP after 15 mins by microbeta counting method	B	O=C1C(c2cccc3ccccc23)Oc2cc3c(cc2N1Cc1ccccc1)OCO3		CHEMBL4216522	=	Ki	nM	6300.0	CHEMBL262	Homo sapiens	Ki	uM	6.3
	18577632	CHEMBL4222218	Inhibition of recombinant full-length human His-tagged GSK3beta expressed in baculovirus expression system at 1 uM using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay relative to control	B	C=CC(=O)Nc1cccc(NC(=O)Nc2ccnc(Nc3ccc(N4CCC(N5CCOCC5)CC4)cc3OC)n2)c1		CHEMBL4225781	=	Inhibition	%	5.9	CHEMBL262	Homo sapiens	INH	%	5.9
	18577656	CHEMBL4222218	Inhibition of recombinant full-length human His-tagged GSK3beta expressed in baculovirus expression system at 1 uM using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay relative to control	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	=	Inhibition	%	1.7	CHEMBL262	Homo sapiens	INH	%	1.7
	18577680	CHEMBL4222218	Inhibition of recombinant full-length human His-tagged GSK3beta expressed in baculovirus expression system at 1 uM using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay relative to control	B	C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3699588	=	Inhibition	%	3.0	CHEMBL262	Homo sapiens	INH	%	3.0
	18578800	CHEMBL4222459	Inhibition of GSK3b (unknown origin)	B	CCN(CCO)Cc1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1		CHEMBL4228240	>	IC50	nM	500.0	CHEMBL262	Homo sapiens	IC50	nM	500.0
	18578801	CHEMBL4222459	Inhibition of GSK3b (unknown origin)	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cc3ccccn3)ns2)n1		CHEMBL4227082	>	IC50	nM	500.0	CHEMBL262	Homo sapiens	IC50	nM	500.0
	18578802	CHEMBL4222459	Inhibition of GSK3b (unknown origin)	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C(NC(C)(C)C)c3ccccn3)ns2)n1		CHEMBL4225923	>	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	uM	1.0
	18580283	CHEMBL4222683	Inhibition of GSK3beta (unknown origin)	B	CC(C)Nc1ccc2cnn(-c3cncc(-c4ccc(C(=O)O)cc4)n3)c2c1		CHEMBL4228654	=	IC50	nM	260.0	CHEMBL262	Homo sapiens	IC50	uM	0.26
	18580310	CHEMBL4222704	Inhibition of GSK3beta (unknown origin) at 1 uM	B	CC(C)Nc1ccc2cnn(-c3cncc(-c4ccc(C(=O)O)cc4)n3)c2c1		CHEMBL4228654	>	Inhibition	%	70.0	CHEMBL262	Homo sapiens	INH	%	70.0
	18653611	CHEMBL4230098	Inhibition of GSK-3-beta (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	19.0	CHEMBL262	Homo sapiens	INH	%	19.0
	18653612	CHEMBL4230098	Inhibition of GSK-3-beta (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	3.0	CHEMBL262	Homo sapiens	INH	%	3.0
	18655498	CHEMBL4230737	Binding affinity to wild-type human full length GSK3B (M1 to T433 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	87.0	CHEMBL262	Homo sapiens	Activity	%	87.0
	18663912	CHEMBL4232896	Inhibition of full length human GSK3B (M1 to T433 residues) expressed in mammalian expression system assessed as residual activity at 5 uM by KINOMEscan assay relative to control	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	=	Activity	%	100.0	CHEMBL262	Homo sapiens	Activity	%	100.0
	18664009	CHEMBL4232993	Binding affinity to full length human GSK3B (M1 to T433 residues) expressed in mammalian expression system by KINOMEscan assay	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	>=	Kd	nM	5000.0	CHEMBL262	Homo sapiens	Kd	uM	5.0
	18665415	CHEMBL4233332	Inhibition of GSK3beta (unknown origin)	B	O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4245507	>	IC50	nM	2500.0	CHEMBL262	Homo sapiens	IC50	nM	2500.0
	18665483	CHEMBL4233332	Inhibition of GSK3beta (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4251324	>	IC50	nM	3300.0	CHEMBL262	Homo sapiens	IC50	nM	3300.0
	18674690	CHEMBL4235364	Inhibition of GSK3beta (unknown origin)	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1		CHEMBL4249925	=	Ki	nM	400.0	CHEMBL262	Homo sapiens	Ki	nM	400.0
	18674691	CHEMBL4235364	Inhibition of GSK3beta (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1		CHEMBL4245242	=	Ki	nM	1900.0	CHEMBL262	Homo sapiens	Ki	nM	1900.0
	18674692	CHEMBL4235364	Inhibition of GSK3beta (unknown origin)	B	CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1		CHEMBL4248525	=	Ki	nM	2100.0	CHEMBL262	Homo sapiens	Ki	nM	2100.0
	18693991	CHEMBL4253444	Inhibition of recombinant human full length His-tagged GSK3beta expressed in baculovirus expression system at 0.1 uM by Z'-Lyte assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	12.0	CHEMBL262	Homo sapiens	INH	%	12.0
	18694073	CHEMBL4253526	Inhibition of recombinant human full length His-tagged GSK3beta expressed in baculovirus expression system at 1 uM by Z'-Lyte assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	81.0	CHEMBL262	Homo sapiens	INH	%	81.0
	18697641	CHEMBL4254314	Inhibition of wild-type human full length GSK3B (M1 to T433 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCNc1cc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2C(F)(F)F)ccn1		CHEMBL4281348	=	Activity	%	80.0	CHEMBL262	Homo sapiens	Activity	%	80.0
	18702495	CHEMBL4255112	Inhibition of recombinant human full length His-tagged GSK3beta expressed in baculovirus expression system at 1 uM relative to control	B	COc1ccc(S(N)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4278211	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	INH	%	0.0
	18702544	CHEMBL4255112	Inhibition of recombinant human full length His-tagged GSK3beta expressed in baculovirus expression system at 1 uM relative to control	B	COc1ccc(C(N)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4282644	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	INH	%	0.0
	18702588	CHEMBL4255112	Inhibition of recombinant human full length His-tagged GSK3beta expressed in baculovirus expression system at 1 uM relative to control	B	COc1ccc(S(C)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4287097	=	Inhibition	%	-1.0	CHEMBL262	Homo sapiens	INH	%	-1.0
	18702640	CHEMBL4255112	Inhibition of recombinant human full length His-tagged GSK3beta expressed in baculovirus expression system at 1 uM relative to control	B	COc1cc(C)c(S(N)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4283739	=	Inhibition	%	6.0	CHEMBL262	Homo sapiens	INH	%	6.0
	18702684	CHEMBL4255112	Inhibition of recombinant human full length His-tagged GSK3beta expressed in baculovirus expression system at 1 uM relative to control	B	COc1cc(C)c(C(N)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4294318	=	Inhibition	%	7.0	CHEMBL262	Homo sapiens	INH	%	7.0
	18702727	CHEMBL4255112	Inhibition of recombinant human full length His-tagged GSK3beta expressed in baculovirus expression system at 1 uM relative to control	B	COc1cc(C)c(S(C)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4289040	=	Inhibition	%	3.0	CHEMBL262	Homo sapiens	INH	%	3.0
Dose-dependent effect	18703567	CHEMBL4255364	Inhibition of human GSK-3beta using peptide substrate	B	Cc1ccc2c(c1)CC[C@H]1[C@@](C)(CO)CCC[C@]21C		CHEMBL4288015		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	18703574	CHEMBL4255366	Inhibition of human GSK-3beta at 200 uM using peptide substrate	B	Cc1ccc2c(c1CCC(C)(C)O)CCCC2(C)C		CHEMBL4293648		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	18703577	CHEMBL4255364	Inhibition of human GSK-3beta using peptide substrate	B	Cc1ccc2c(c1)CC[C@H]1[C@@](C)(CO)CCC[C@]21C	Outside typical range	CHEMBL4288015	=	IC50	nM	178000.0	CHEMBL262	Homo sapiens	IC50	uM	178.0
	18704611	CHEMBL4255630	Inhibition of recombinant human full length N-terminal GST-tagged GSK-3beta expressed in Sf9 insect cells using prephosphorylated polypeptide as substrate after 30 mins by kinase-Glo reagent based luminescence assay	B	COc1ccc2nc3c(c(NCCCNC(=O)c4sc(-c5ccnc(NC(=O)C6CC6)c5)nc4OC)c2c1)CCCC3		CHEMBL4278287	=	IC50	nM	65.0	CHEMBL262	Homo sapiens	IC50	nM	65.0
	18704612	CHEMBL4255630	Inhibition of recombinant human full length N-terminal GST-tagged GSK-3beta expressed in Sf9 insect cells using prephosphorylated polypeptide as substrate after 30 mins by kinase-Glo reagent based luminescence assay	B	COc1ccc2nc3c(c(NCCNC(=O)c4sc(-c5ccnc(NC(=O)C6CC6)c5)nc4OC)c2c1)CCCC3		CHEMBL4285581	=	IC50	nM	83.0	CHEMBL262	Homo sapiens	IC50	nM	83.0
	18704613	CHEMBL4255630	Inhibition of recombinant human full length N-terminal GST-tagged GSK-3beta expressed in Sf9 insect cells using prephosphorylated polypeptide as substrate after 30 mins by kinase-Glo reagent based luminescence assay	B	COc1nc(-c2ccnc(NC(=O)C3CC3)c2)sc1C(=O)NCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2		CHEMBL4293418	=	IC50	nM	98.0	CHEMBL262	Homo sapiens	IC50	nM	98.0
	18704614	CHEMBL4255630	Inhibition of recombinant human full length N-terminal GST-tagged GSK-3beta expressed in Sf9 insect cells using prephosphorylated polypeptide as substrate after 30 mins by kinase-Glo reagent based luminescence assay	B	COc1nc(-c2ccnc(NC(=O)C3CC3)c2)sc1C(=O)NCCNc1c2c(nc3cc(Cl)ccc13)CCCC2		CHEMBL4282154	=	IC50	nM	63.0	CHEMBL262	Homo sapiens	IC50	nM	63.0
	18704615	CHEMBL4255630	Inhibition of recombinant human full length N-terminal GST-tagged GSK-3beta expressed in Sf9 insect cells using prephosphorylated polypeptide as substrate after 30 mins by kinase-Glo reagent based luminescence assay	B	COc1nc(-c2ccnc(NC(=O)C3CC3)c2)sc1C(=O)NCCCCCCNc1c2c(nc3ccccc13)CCCC2		CHEMBL4290039	=	IC50	nM	18.0	CHEMBL262	Homo sapiens	IC50	nM	18.0
	18704616	CHEMBL4255630	Inhibition of recombinant human full length N-terminal GST-tagged GSK-3beta expressed in Sf9 insect cells using prephosphorylated polypeptide as substrate after 30 mins by kinase-Glo reagent based luminescence assay	B	COc1nc(-c2ccnc(NC(=O)C3CC3)c2)sc1C(=O)NCCCNc1c2c(nc3ccccc13)CCCC2		CHEMBL4278686	=	IC50	nM	66.0	CHEMBL262	Homo sapiens	IC50	nM	66.0
	18704617	CHEMBL4255630	Inhibition of recombinant human full length N-terminal GST-tagged GSK-3beta expressed in Sf9 insect cells using prephosphorylated polypeptide as substrate after 30 mins by kinase-Glo reagent based luminescence assay	B	COc1nc(-c2ccnc(NC(=O)C3CC3)c2)sc1C(=O)NCCNc1c2c(nc3ccccc13)CCCC2		CHEMBL4286601	=	IC50	nM	68.0	CHEMBL262	Homo sapiens	IC50	nM	68.0
	18704618	CHEMBL4255630	Inhibition of recombinant human full length N-terminal GST-tagged GSK-3beta expressed in Sf9 insect cells using prephosphorylated polypeptide as substrate after 30 mins by kinase-Glo reagent based luminescence assay	B	COC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCNc1c2c(nc3ccccc13)CCCC2		CHEMBL4278164	=	IC50	nM	99.0	CHEMBL262	Homo sapiens	IC50	nM	99.0
	18704619	CHEMBL4255630	Inhibition of recombinant human full length N-terminal GST-tagged GSK-3beta expressed in Sf9 insect cells using prephosphorylated polypeptide as substrate after 30 mins by kinase-Glo reagent based luminescence assay	B	NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCNc1c2c(nc3ccccc13)CCCC2		CHEMBL4288850	=	IC50	nM	34.0	CHEMBL262	Homo sapiens	IC50	nM	34.0
	18704620	CHEMBL4255630	Inhibition of recombinant human full length N-terminal GST-tagged GSK-3beta expressed in Sf9 insect cells using prephosphorylated polypeptide as substrate after 30 mins by kinase-Glo reagent based luminescence assay	B	O=C(O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCNc1c2c(nc3ccccc13)CCCC2		CHEMBL4293305	=	IC50	nM	270.0	CHEMBL262	Homo sapiens	IC50	nM	270.0
	18704621	CHEMBL4255630	Inhibition of recombinant human full length N-terminal GST-tagged GSK-3beta expressed in Sf9 insect cells using prephosphorylated polypeptide as substrate after 30 mins by kinase-Glo reagent based luminescence assay	B	CCOC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCNc1c2c(nc3ccccc13)CCCC2		CHEMBL4285481	=	IC50	nM	180.0	CHEMBL262	Homo sapiens	IC50	nM	180.0
	18706762	CHEMBL4256124	Inhibition of GSK3b (unknown origin) at 50 ug/ml by mobility shift assay relative to control	B	CC(C)c1ccc2c(c1)CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(=O)O		CHEMBL12850	=	Inhibition	%	20.1	CHEMBL262	Homo sapiens	INH	%	20.1
	18706780	CHEMBL4256137	Inhibition of GSK3b (unknown origin) by mobility shift assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	24.0	CHEMBL262	Homo sapiens	IC50	nM	24.0
	18708941	CHEMBL4256661	Inhibition of GSK3beta (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Nc1ccc[nH]c1=O		CHEMBL4286709	=	Inhibition	%	17.0	CHEMBL262	Homo sapiens	INH	%	17.0
	18708964	CHEMBL4256661	Inhibition of GSK3beta (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Cn1cc(-c2c[nH]c(=O)c(N)c2)cn1		CHEMBL4288628	=	Inhibition	%	68.0	CHEMBL262	Homo sapiens	INH	%	68.0
	18708999	CHEMBL4256661	Inhibition of GSK3beta (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Nc1cc(-c2ccncc2)c[nH]c1=O		CHEMBL12856	=	Inhibition	%	9.0	CHEMBL262	Homo sapiens	INH	%	9.0
	18709031	CHEMBL4256661	Inhibition of GSK3beta (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	COc1ncc(-c2ccncc2)cc1N		CHEMBL4291350	=	Inhibition	%	26.0	CHEMBL262	Homo sapiens	INH	%	26.0
	18709060	CHEMBL4256661	Inhibition of GSK3beta (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Nc1cc(-c2ccnc3ccccc23)c[nH]c1=O		CHEMBL4280308	=	Inhibition	%	20.0	CHEMBL262	Homo sapiens	INH	%	20.0
	18709089	CHEMBL4256661	Inhibition of GSK3beta (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	CNc1nccc(-c2c[nH]c(=O)c(N)c2)n1		CHEMBL4292538	=	Inhibition	%	89.0	CHEMBL262	Homo sapiens	INH	%	89.0
	18709118	CHEMBL4256661	Inhibition of GSK3beta (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Nc1cc(-c2ccnc(NC3CC3)n2)c[nH]c1=O		CHEMBL4282263	=	Inhibition	%	87.0	CHEMBL262	Homo sapiens	INH	%	87.0
	18709165	CHEMBL4256661	Inhibition of GSK3beta (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Cc1nc(O)c(N)cc1-c1ccncc1		CHEMBL302219	=	Inhibition	%	39.0	CHEMBL262	Homo sapiens	INH	%	39.0
	18709195	CHEMBL4256687	Inhibition of GSK3beta (unknown origin) at 30 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	O=C(Nc1cc(-c2ccncc2)c[nH]c1=O)c1ccccc1		CHEMBL1738828	=	Inhibition	%	92.0	CHEMBL262	Homo sapiens	INH	%	92.0
	18709224	CHEMBL4256661	Inhibition of GSK3beta (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	COc1cccc(C(=O)Nc2cc(-c3ccncc3)c[nH]c2=O)c1		CHEMBL4285109	=	Inhibition	%	93.0	CHEMBL262	Homo sapiens	INH	%	93.0
	18709266	CHEMBL4256687	Inhibition of GSK3beta (unknown origin) at 30 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	CN1CCN(c2ccc(C(=O)Nc3cc(-c4ccncc4)c[nH]c3=O)cc2)CC1		CHEMBL4286130	=	Inhibition	%	94.0	CHEMBL262	Homo sapiens	INH	%	94.0
	18709299	CHEMBL4256687	Inhibition of GSK3beta (unknown origin) at 30 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	O=C(Nc1cc(-c2ccnc(NC3CC3)n2)c[nH]c1=O)c1ccccc1		CHEMBL4291472	=	Inhibition	%	99.0	CHEMBL262	Homo sapiens	INH	%	99.0
	18721453	CHEMBL4258150	Inhibition of GSK3beta (unknown origin)	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	72.2	CHEMBL262	Homo sapiens	IC50	nM	72.2
	18721454	CHEMBL4258150	Inhibition of GSK3beta (unknown origin)	B	CCCn1cnc(C2C=C(C3=C(c4noc5ccccc45)C(=O)NC3=O)c3ccccc32)c1		CHEMBL4802108	=	IC50	nM	0.73	CHEMBL262	Homo sapiens	IC50	nM	0.73
	18725387	CHEMBL4259084	Inhibition of GSK3-beta (unknown origin)	B	CC(=O)n1nc(C)c(-c2ccc(Cl)c(Cl)c2)c1N		CHEMBL4276946	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
Not Active	18728875	CHEMBL4259705	Inhibition of GSK3beta (unknown origin) at 1 uM after 40 mins by scintillation counting method relative to control	B	O=C(N1CCN(c2ncnc3[nH]nc(Cl)c23)CC1)C1(c2ccc(Cl)c(Cl)c2)CCNCC1		CHEMBL4285143		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	18731282	CHEMBL4260239	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system at 11 uM using ser/thr-9 peptide as substrate measured after 1 hr by Z'-Lyte assay relative to control	B	CCCN(C(=O)Nc1cccc(C(=O)OCC)c1)C1CCc2nc(NCc3ccc(C(=O)OC)cc3)sc2C1		CHEMBL4289709	>	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	18731283	CHEMBL4260239	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system at 11 uM using ser/thr-9 peptide as substrate measured after 1 hr by Z'-Lyte assay relative to control	B	CCCN(C(=O)Nc1ccc(C(=O)OCC)cc1)C1CCc2nc(NCc3ccc(C(=O)OC)cc3)sc2C1		CHEMBL4290122	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	18731284	CHEMBL4260239	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system at 11 uM using ser/thr-9 peptide as substrate measured after 1 hr by Z'-Lyte assay relative to control	B	CCCN(C(=O)Nc1ccc(OC)cc1)C1CCc2nc(NCc3ccc(C(=O)OC)cc3)sc2C1		CHEMBL4286291	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	18731285	CHEMBL4260239	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system at 11 uM using ser/thr-9 peptide as substrate measured after 1 hr by Z'-Lyte assay relative to control	B	CCCN(C(=O)Nc1ccccc1F)C1CCc2nc(NCc3ccc(C(=O)O)cc3)sc2C1		CHEMBL4294175	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	18731286	CHEMBL4260239	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system at 11 uM using ser/thr-9 peptide as substrate measured after 1 hr by Z'-Lyte assay relative to control	B	CCCN(C(=O)Nc1cccc(F)c1)C1CCc2nc(NCc3ccc(C(=O)O)cc3)sc2C1		CHEMBL4282908	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	18731287	CHEMBL4260239	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system at 11 uM using ser/thr-9 peptide as substrate measured after 1 hr by Z'-Lyte assay relative to control	B	CCCN(C(=O)Nc1ccc(F)cc1)C1CCc2nc(NCc3ccc(C(=O)O)cc3)sc2C1		CHEMBL4287186	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	18731288	CHEMBL4260239	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system at 11 uM using ser/thr-9 peptide as substrate measured after 1 hr by Z'-Lyte assay relative to control	B	CCCN(C(=O)Nc1cccc(C(=O)O)c1)C1CCc2nc(NCc3ccc(C(=O)O)cc3)sc2C1		CHEMBL4279439	>	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	18731289	CHEMBL4260239	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system at 11 uM using ser/thr-9 peptide as substrate measured after 1 hr by Z'-Lyte assay relative to control	B	CCCN(C(=O)Nc1ccc(C(=O)O)cc1)C1CCc2nc(NCc3ccc(C(=O)O)cc3)sc2C1		CHEMBL4287360	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	18731290	CHEMBL4260239	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system at 11 uM using ser/thr-9 peptide as substrate measured after 1 hr by Z'-Lyte assay relative to control	B	CCCN(C(=O)Nc1ccc(OC)cc1)C1CCc2nc(NCc3ccc(C(=O)O)cc3)sc2C1		CHEMBL4292130	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	18731291	CHEMBL4260240	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system using ser/thr-9 peptide as substrate measured after 1 hr by Z'-Lyte assay	B	CCOC(=O)c1cccc(NC(=O)Nc2nc3c(s2)CC(N2C(=O)c4ccccc4C2=O)CC3)c1		CHEMBL4286639	=	IC50	nM	5300.0	CHEMBL262	Homo sapiens	IC50	uM	5.3
	18731292	CHEMBL4260240	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system using ser/thr-9 peptide as substrate measured after 1 hr by Z'-Lyte assay	B	CCOC(O)(Nc1cccc(C(=O)O)c1)Nc1nc2c(s1)CC(N1C(=O)c3ccccc3C1=O)CC2		CHEMBL4277917	=	IC50	nM	670.0	CHEMBL262	Homo sapiens	IC50	uM	0.67
	18731293	CHEMBL4260240	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system using ser/thr-9 peptide as substrate measured after 1 hr by Z'-Lyte assay	B	CCOC(O)(Nc1ccc(C(=O)O)cc1)Nc1nc2c(s1)CC(N1C(=O)c3ccccc3C1=O)CC2		CHEMBL4288568	=	IC50	nM	4600.0	CHEMBL262	Homo sapiens	IC50	uM	4.6
	18731294	CHEMBL4260240	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system using ser/thr-9 peptide as substrate measured after 1 hr by Z'-Lyte assay	B	CCCN(C(=O)Nc1cccc(C(=O)O)c1)C1CCc2nc(NC(=O)Nc3cccc(C(=O)O)c3)sc2C1		CHEMBL4283652	=	IC50	nM	1500.0	CHEMBL262	Homo sapiens	IC50	uM	1.5
	18731338	CHEMBL4260239	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system at 11 uM using ser/thr-9 peptide as substrate measured after 1 hr by Z'-Lyte assay relative to control	B	CCCN(C(=O)Nc1ccc(F)cc1)C1CCc2nc(NCc3ccc(C(=O)OC)cc3)sc2C1		CHEMBL4282490	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	18731339	CHEMBL4260239	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system at 11 uM using ser/thr-9 peptide as substrate measured after 1 hr by Z'-Lyte assay relative to control	B	CCCN(C(=O)Nc1cccc(F)c1)C1CCc2nc(NCc3ccc(C(=O)OC)cc3)sc2C1		CHEMBL4282680	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	18731340	CHEMBL4260239	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system at 11 uM using ser/thr-9 peptide as substrate measured after 1 hr by Z'-Lyte assay relative to control	B	CCCN(C(=O)Nc1ccccc1F)C1CCc2nc(NCc3ccc(C(=O)OC)cc3)sc2C1		CHEMBL4283767	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	18731341	CHEMBL4260239	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system at 11 uM using ser/thr-9 peptide as substrate measured after 1 hr by Z'-Lyte assay relative to control	B	O=C(Nc1ccc(C(=O)O)cc1)Nc1nc2c(s1)CC(NC(=O)Nc1ccc(C(=O)O)cc1)CC2		CHEMBL4293946	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	18731342	CHEMBL4260239	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system at 11 uM using ser/thr-9 peptide as substrate measured after 1 hr by Z'-Lyte assay relative to control	B	O=C(Nc1cccc(C(=O)O)c1)Nc1nc2c(s1)CC(NC(=O)Nc1cccc(C(=O)O)c1)CC2		CHEMBL4279366	>	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	18731343	CHEMBL4260239	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system at 11 uM using ser/thr-9 peptide as substrate measured after 1 hr by Z'-Lyte assay relative to control	B	COc1ccc(NC(=O)Nc2nc3c(s2)CC(NC(=O)Nc2ccc(OC)cc2)CC3)cc1		CHEMBL4290542	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	18731344	CHEMBL4260239	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system at 11 uM using ser/thr-9 peptide as substrate measured after 1 hr by Z'-Lyte assay relative to control	B	CCOC(=O)c1ccc(NC(=O)Nc2nc3c(s2)CC(NC(=O)Nc2ccc(C(=O)OCC)cc2)CC3)cc1		CHEMBL4279892	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	18731345	CHEMBL4260239	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system at 11 uM using ser/thr-9 peptide as substrate measured after 1 hr by Z'-Lyte assay relative to control	B	CCOC(=O)c1cccc(NC(=O)Nc2nc3c(s2)CC(NC(=O)Nc2cccc(C(=O)OCC)c2)CC3)c1		CHEMBL4291453	>	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	18731346	CHEMBL4260239	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system at 11 uM using ser/thr-9 peptide as substrate measured after 1 hr by Z'-Lyte assay relative to control	B	O=C(Nc1ccc(F)cc1)Nc1nc2c(s1)CC(NC(=O)Nc1ccc(F)cc1)CC2		CHEMBL4282748	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	18731347	CHEMBL4260239	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system at 11 uM using ser/thr-9 peptide as substrate measured after 1 hr by Z'-Lyte assay relative to control	B	O=C(Nc1cccc(F)c1)Nc1nc2c(s1)CC(NC(=O)Nc1cccc(F)c1)CC2		CHEMBL4278794	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	18731348	CHEMBL4260239	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system at 11 uM using ser/thr-9 peptide as substrate measured after 1 hr by Z'-Lyte assay relative to control	B	O=C(Nc1nc2c(s1)CC(NC(=O)Nc1ccccc1F)CC2)Nc1ccccc1F		CHEMBL4281341	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	18731349	CHEMBL4260239	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system at 11 uM using ser/thr-9 peptide as substrate measured after 1 hr by Z'-Lyte assay relative to control	B	CCCN(C(=O)Nc1ccc(C(=O)O)cc1)C1CCc2nc(NC(=O)Nc3ccc(C(=O)O)cc3)sc2C1		CHEMBL4288927	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	18731350	CHEMBL4260239	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system at 11 uM using ser/thr-9 peptide as substrate measured after 1 hr by Z'-Lyte assay relative to control	B	CCCN(C(=O)Nc1cccc(C(=O)O)c1)C1CCc2nc(NC(=O)Nc3cccc(C(=O)O)c3)sc2C1		CHEMBL4283652	>	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	18731351	CHEMBL4260239	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system at 11 uM using ser/thr-9 peptide as substrate measured after 1 hr by Z'-Lyte assay relative to control	B	CCCN(C(=O)Nc1ccc(OC)cc1)C1CCc2nc(NC(=O)Nc3ccc(OC)cc3)sc2C1		CHEMBL4294233	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	18731352	CHEMBL4260239	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system at 11 uM using ser/thr-9 peptide as substrate measured after 1 hr by Z'-Lyte assay relative to control	B	CCCN(C(=O)Nc1ccc(C(=O)OCC)cc1)C1CCc2nc(NC(=O)Nc3ccc(C(=O)OCC)cc3)sc2C1		CHEMBL4280201	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	18731353	CHEMBL4260239	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system at 11 uM using ser/thr-9 peptide as substrate measured after 1 hr by Z'-Lyte assay relative to control	B	CCCN(C(=O)Nc1cccc(C(=O)OCC)c1)C1CCc2nc(NC(=O)Nc3cccc(C(=O)OCC)c3)sc2C1		CHEMBL4290835	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	18731354	CHEMBL4260239	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system at 11 uM using ser/thr-9 peptide as substrate measured after 1 hr by Z'-Lyte assay relative to control	B	CCCN(C(=O)Nc1ccc(F)cc1)C1CCc2nc(NC(=O)Nc3ccc(F)cc3)sc2C1		CHEMBL4276769	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	18731355	CHEMBL4260239	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system at 11 uM using ser/thr-9 peptide as substrate measured after 1 hr by Z'-Lyte assay relative to control	B	CCCN(C(=O)Nc1cccc(F)c1)C1CCc2nc(NC(=O)Nc3cccc(F)c3)sc2C1		CHEMBL4287424	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	18731356	CHEMBL4260239	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system at 11 uM using ser/thr-9 peptide as substrate measured after 1 hr by Z'-Lyte assay relative to control	B	CCCN(C(=O)Nc1ccccc1F)C1CCc2nc(NC(=O)Nc3ccccc3F)sc2C1		CHEMBL4291923	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	18731357	CHEMBL4260239	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system at 11 uM using ser/thr-9 peptide as substrate measured after 1 hr by Z'-Lyte assay relative to control	B	CCOC(O)(Nc1ccc(C(=O)O)cc1)Nc1nc2c(s1)CC(N1C(=O)c3ccccc3C1=O)CC2		CHEMBL4288568	>	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	18731358	CHEMBL4260239	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system at 11 uM using ser/thr-9 peptide as substrate measured after 1 hr by Z'-Lyte assay relative to control	B	CCOC(O)(Nc1cccc(C(=O)O)c1)Nc1nc2c(s1)CC(N1C(=O)c3ccccc3C1=O)CC2		CHEMBL4277917	>	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	18731359	CHEMBL4260239	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system at 11 uM using ser/thr-9 peptide as substrate measured after 1 hr by Z'-Lyte assay relative to control	B	COc1ccc(NC(=O)Nc2nc3c(s2)CC(N2C(=O)c4ccccc4C2=O)CC3)cc1		CHEMBL4283288	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	18731360	CHEMBL4260239	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system at 11 uM using ser/thr-9 peptide as substrate measured after 1 hr by Z'-Lyte assay relative to control	B	CCOC(=O)c1ccc(NC(=O)Nc2nc3c(s2)CC(N2C(=O)c4ccccc4C2=O)CC3)cc1		CHEMBL4291140	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	18731361	CHEMBL4260239	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system at 11 uM using ser/thr-9 peptide as substrate measured after 1 hr by Z'-Lyte assay relative to control	B	CCOC(=O)c1cccc(NC(=O)Nc2nc3c(s2)CC(N2C(=O)c4ccccc4C2=O)CC3)c1		CHEMBL4286639	>	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	18731362	CHEMBL4260239	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system at 11 uM using ser/thr-9 peptide as substrate measured after 1 hr by Z'-Lyte assay relative to control	B	O=C(Nc1ccc(F)cc1)Nc1nc2c(s1)CC(N1C(=O)c3ccccc3C1=O)CC2		CHEMBL4294548	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	18731363	CHEMBL4260239	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system at 11 uM using ser/thr-9 peptide as substrate measured after 1 hr by Z'-Lyte assay relative to control	B	O=C(Nc1cccc(F)c1)Nc1nc2c(s1)CC(N1C(=O)c3ccccc3C1=O)CC2		CHEMBL4290076	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	18731364	CHEMBL4260239	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system at 11 uM using ser/thr-9 peptide as substrate measured after 1 hr by Z'-Lyte assay relative to control	B	O=C(Nc1nc2c(s1)CC(N1C(=O)c3ccccc3C1=O)CC2)Nc1ccccc1F		CHEMBL4279395	<	Inhibition	%	30.0	CHEMBL262	Homo sapiens	INH	%	30.0
	18731367	CHEMBL4260240	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system using ser/thr-9 peptide as substrate measured after 1 hr by Z'-Lyte assay	B	CCOC(=O)c1cccc(NC(=O)Nc2nc3c(s2)CC(NC(=O)Nc2cccc(C(=O)OCC)c2)CC3)c1		CHEMBL4291453	=	IC50	nM	2500.0	CHEMBL262	Homo sapiens	IC50	uM	2.5
	18731368	CHEMBL4260240	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system using ser/thr-9 peptide as substrate measured after 1 hr by Z'-Lyte assay	B	O=C(Nc1cccc(C(=O)O)c1)Nc1nc2c(s1)CC(NC(=O)Nc1cccc(C(=O)O)c1)CC2		CHEMBL4279366	=	IC50	nM	6000.0	CHEMBL262	Homo sapiens	IC50	uM	6.0
	18731369	CHEMBL4260240	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system using ser/thr-9 peptide as substrate measured after 1 hr by Z'-Lyte assay	B	CCCN(C(=O)Nc1cccc(C(=O)OCC)c1)C1CCc2nc(NCc3ccc(C(=O)OC)cc3)sc2C1		CHEMBL4289709	=	IC50	nM	13600.0	CHEMBL262	Homo sapiens	IC50	uM	13.6
	18731370	CHEMBL4260240	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system using ser/thr-9 peptide as substrate measured after 1 hr by Z'-Lyte assay	B	CCCN(C(=O)Nc1cccc(C(=O)O)c1)C1CCc2nc(NCc3ccc(C(=O)O)cc3)sc2C1		CHEMBL4279439	=	IC50	nM	11400.0	CHEMBL262	Homo sapiens	IC50	uM	11.4
	18731371	CHEMBL4260240	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system using ser/thr-9 peptide as substrate measured after 1 hr by Z'-Lyte assay	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	IC50	nM	2.07	CHEMBL262	Homo sapiens	IC50	nM	2.07
	18751098	CHEMBL4263816	Inhibition of GSK-3-BETA (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	3.0	CHEMBL262	Homo sapiens	INH	%	3.0
	18751577	CHEMBL4264326	Binding affinity to wild-type human full length GSK3B (M1 to T433 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	98.0	CHEMBL262	Homo sapiens	Activity	%	98.0
	18753878	CHEMBL4264848	Binding affinity to full length wild type human GSK3beta (M1 to T433 residues) expressed in mammalian expression system assessed as fraction of unbound kinase to substrate at 0.1 uM after 1 hr by KinomeScan assay	B	O=C(Nc1ccc(Oc2c(Br)cnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL4285809	=	Activity	%	0.0	CHEMBL262	Homo sapiens	Activity	%	0.0
	18753879	CHEMBL4264848	Binding affinity to full length wild type human GSK3beta (M1 to T433 residues) expressed in mammalian expression system assessed as fraction of unbound kinase to substrate at 0.1 uM after 1 hr by KinomeScan assay	B	O=C(Nc1ccc(Oc2ccnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL4277499	=	Activity	%	0.0	CHEMBL262	Homo sapiens	Activity	%	0.0
	18753880	CHEMBL4264848	Binding affinity to full length wild type human GSK3beta (M1 to T433 residues) expressed in mammalian expression system assessed as fraction of unbound kinase to substrate at 0.1 uM after 1 hr by KinomeScan assay	B	CC(C)c1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)ccnc2[nH]1		CHEMBL4285448	=	Activity	%	0.0	CHEMBL262	Homo sapiens	Activity	%	0.0
	18753881	CHEMBL4264848	Binding affinity to full length wild type human GSK3beta (M1 to T433 residues) expressed in mammalian expression system assessed as fraction of unbound kinase to substrate at 0.1 uM after 1 hr by KinomeScan assay	B	Cc1cnc2[nH]cnc2c1Oc1ccc(NC(=O)c2cccn(-c3ccc(F)cc3)c2=O)cc1F		CHEMBL4293688	=	Activity	%	2.0	CHEMBL262	Homo sapiens	Activity	%	2.0
	18753882	CHEMBL4264849	Binding affinity to full length wild type human GSK3beta (M1 to T433 residues) expressed in mammalian expression system assessed as fraction of unbound kinase to substrate at 1 uM after 1 hr by KinomeScan assay	B	O=C(Nc1ccc(Oc2c(Br)cnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL4285809	=	Activity	%	1.0	CHEMBL262	Homo sapiens	Activity	%	1.0
	18753883	CHEMBL4264849	Binding affinity to full length wild type human GSK3beta (M1 to T433 residues) expressed in mammalian expression system assessed as fraction of unbound kinase to substrate at 1 uM after 1 hr by KinomeScan assay	B	O=C(Nc1ccc(Oc2ccnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL4277499	=	Activity	%	5.0	CHEMBL262	Homo sapiens	Activity	%	5.0
	18753884	CHEMBL4264849	Binding affinity to full length wild type human GSK3beta (M1 to T433 residues) expressed in mammalian expression system assessed as fraction of unbound kinase to substrate at 1 uM after 1 hr by KinomeScan assay	B	CC(C)c1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)ccnc2[nH]1		CHEMBL4285448	=	Activity	%	0.0	CHEMBL262	Homo sapiens	Activity	%	0.0
	18753885	CHEMBL4264849	Binding affinity to full length wild type human GSK3beta (M1 to T433 residues) expressed in mammalian expression system assessed as fraction of unbound kinase to substrate at 1 uM after 1 hr by KinomeScan assay	B	Cc1cnc2[nH]cnc2c1Oc1ccc(NC(=O)c2cccn(-c3ccc(F)cc3)c2=O)cc1F		CHEMBL4293688	=	Activity	%	5.0	CHEMBL262	Homo sapiens	Activity	%	5.0
	18753886	CHEMBL4264850	Binding affinity to full length wild type human GSK3beta (M1 to T433 residues) expressed in mammalian expression system assessed as fraction of unbound kinase to substrate at 10 uM after 1 hr by KinomeScan assay	B	O=C(Nc1ccc(Oc2c(Br)cnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL4285809	=	Activity	%	0.0	CHEMBL262	Homo sapiens	Activity	%	0.0
	18753887	CHEMBL4264850	Binding affinity to full length wild type human GSK3beta (M1 to T433 residues) expressed in mammalian expression system assessed as fraction of unbound kinase to substrate at 10 uM after 1 hr by KinomeScan assay	B	O=C(Nc1ccc(Oc2ccnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL4277499	=	Activity	%	6.0	CHEMBL262	Homo sapiens	Activity	%	6.0
	18753888	CHEMBL4264850	Binding affinity to full length wild type human GSK3beta (M1 to T433 residues) expressed in mammalian expression system assessed as fraction of unbound kinase to substrate at 10 uM after 1 hr by KinomeScan assay	B	CC(C)c1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)ccnc2[nH]1		CHEMBL4285448	=	Activity	%	0.0	CHEMBL262	Homo sapiens	Activity	%	0.0
	18753889	CHEMBL4264850	Binding affinity to full length wild type human GSK3beta (M1 to T433 residues) expressed in mammalian expression system assessed as fraction of unbound kinase to substrate at 10 uM after 1 hr by KinomeScan assay	B	Cc1cnc2[nH]cnc2c1Oc1ccc(NC(=O)c2cccn(-c3ccc(F)cc3)c2=O)cc1F		CHEMBL4293688	=	Activity	%	0.0	CHEMBL262	Homo sapiens	Activity	%	0.0
	18761519	CHEMBL4266572	Inhibition of recombinant human N-terminal His6-tagged GSK3beta H350L mutant expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1		CHEMBL4279192	=	Inhibition	%	18.0	CHEMBL262	Homo sapiens	INH	%	18.0
	18761790	CHEMBL4266572	Inhibition of recombinant human N-terminal His6-tagged GSK3beta H350L mutant expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1		CHEMBL4278882	=	Inhibition	%	-4.0	CHEMBL262	Homo sapiens	INH	%	-4.0
	18761953	CHEMBL4266572	Inhibition of recombinant human N-terminal His6-tagged GSK3beta H350L mutant expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1		CHEMBL4290222	=	Inhibition	%	32.0	CHEMBL262	Homo sapiens	INH	%	32.0
	18764518	CHEMBL4267075	Inhibition of human GSK3beta at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)cc3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4288103	<	Inhibition	%	70.0	CHEMBL262	Homo sapiens	INH	%	70.0
	18764519	CHEMBL4267075	Inhibition of human GSK3beta at 100 nM	B	CN1CCC(c2nc(-c3cccc(S(C)(=O)=O)c3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4286880	<	Inhibition	%	70.0	CHEMBL262	Homo sapiens	INH	%	70.0
	18764520	CHEMBL4267075	Inhibition of human GSK3beta at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)c(NS(C)(=O)=O)c3)c(-c3ccnc(NCC4CC4)n3)s2)CC1		CHEMBL4286841	<	Inhibition	%	70.0	CHEMBL262	Homo sapiens	INH	%	70.0
	18772824	CHEMBL4268694	Inhibition of GSK3beta (unknown origin)	B	COc1cccc(OCc2cc(C)ccn2)c1-c1ccc2c(c1)CCNCC2		CHEMBL4291402	=	IC50	nM	5011.87	CHEMBL262	Homo sapiens	pIC50		5.3
	18782825	CHEMBL4270691	Inhibition of GSK3beta (unknown origin) assessed as residual enzyme activity at 1 uM relative to untreated control	B	Cc1cccc(-c2nn3c(c2-c2ccc(O)cc2)C(C)C(C)(C)C3)n1		CHEMBL4277021	=	Activity	%	60.0	CHEMBL262	Homo sapiens	Activity	%	60.0
Active	18811987	CHEMBL4276179	Non-ATP competitive inhibition of recombinant N-terminal His6-tagged human GSK-3beta expressed in Baculovirus infected SF9 cells at 20 to 30 uM using prephosphorylated-GS2 polypeptide as substrate after 30 mins by kinase-Glo reagent based luminescence assay	B	O=C1CC(c2ccc(C(=O)NCc3cccc(Cl)c3)cc2)Sc2ccccc2N1		CHEMBL4277682		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	18811988	CHEMBL4276178	Non-ATP competitive inhibition of recombinant N-terminal His6-tagged human GSK-3beta expressed in Baculovirus infected SF9 cells at 15 to 25 uM using prephosphorylated-GS2 polypeptide as substrate after 30 mins by kinase-Glo reagent based luminescence assay	B	O=C(NCc1ccccc1)c1ccc(C2CC(=O)N(Cc3ccccc3[N+](=O)[O-])c3ccccc3S2)cc1		CHEMBL4281295		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	18811989	CHEMBL4276177	Inhibition of human recombinant N-terminal His6-tagged human GSK-3beta expressed in Baculovirus infected SF9 cells using prephosphorylated-GS2 polypeptide as substrate after 30 mins by kinase-Glo reagent based luminescence assay	B	CS(=O)(=O)c1cccc(N2C(=O)CC(c3ccc(C(=O)NCc4cccc(Cl)c4)cc3)Sc3ccccc32)c1		CHEMBL4284111	=	IC50	nM	18000.0	CHEMBL262	Homo sapiens	IC50	uM	18.0
	18811990	CHEMBL4276177	Inhibition of human recombinant N-terminal His6-tagged human GSK-3beta expressed in Baculovirus infected SF9 cells using prephosphorylated-GS2 polypeptide as substrate after 30 mins by kinase-Glo reagent based luminescence assay	B	NC(=O)c1ccccc1CN1C(=O)CC(c2ccc(C(=O)NCc3ccccc3)cc2)Sc2ccccc21		CHEMBL4294709	=	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	18811991	CHEMBL4276177	Inhibition of human recombinant N-terminal His6-tagged human GSK-3beta expressed in Baculovirus infected SF9 cells using prephosphorylated-GS2 polypeptide as substrate after 30 mins by kinase-Glo reagent based luminescence assay	B	O=C(NCc1ccco1)c1ccc(C2CC(=O)N(Cc3ccccc3[N+](=O)[O-])c3ccccc3S2)cc1		CHEMBL4287484	=	IC50	nM	27000.0	CHEMBL262	Homo sapiens	IC50	uM	27.0
	18811992	CHEMBL4276177	Inhibition of human recombinant N-terminal His6-tagged human GSK-3beta expressed in Baculovirus infected SF9 cells using prephosphorylated-GS2 polypeptide as substrate after 30 mins by kinase-Glo reagent based luminescence assay	B	CS(=O)(=O)Nc1ccccc1CN1C(=O)CC(c2ccc(C(=O)NCc3cccc(Cl)c3)cc2)Sc2ccccc21		CHEMBL4279567	=	IC50	nM	17000.0	CHEMBL262	Homo sapiens	IC50	uM	17.0
	18811993	CHEMBL4276177	Inhibition of human recombinant N-terminal His6-tagged human GSK-3beta expressed in Baculovirus infected SF9 cells using prephosphorylated-GS2 polypeptide as substrate after 30 mins by kinase-Glo reagent based luminescence assay	B	COc1ccc(CNC(=O)c2ccc(C3CC(=O)N(Cc4ccccc4[N+](=O)[O-])c4ccccc4S3)cc2)cc1		CHEMBL4290903	=	IC50	nM	27000.0	CHEMBL262	Homo sapiens	IC50	uM	27.0
	18811994	CHEMBL4276177	Inhibition of human recombinant N-terminal His6-tagged human GSK-3beta expressed in Baculovirus infected SF9 cells using prephosphorylated-GS2 polypeptide as substrate after 30 mins by kinase-Glo reagent based luminescence assay	B	Cc1ccc(CNC(=O)c2ccc(C3CC(=O)N(Cc4ccccc4[N+](=O)[O-])c4ccccc4S3)cc2)cc1		CHEMBL4283032	=	IC50	nM	18000.0	CHEMBL262	Homo sapiens	IC50	uM	18.0
	18811995	CHEMBL4276177	Inhibition of human recombinant N-terminal His6-tagged human GSK-3beta expressed in Baculovirus infected SF9 cells using prephosphorylated-GS2 polypeptide as substrate after 30 mins by kinase-Glo reagent based luminescence assay	B	O=C(NCc1ccc(Br)cc1)c1ccc(C2CC(=O)N(Cc3ccccc3[N+](=O)[O-])c3ccccc3S2)cc1		CHEMBL4294290	=	IC50	nM	25000.0	CHEMBL262	Homo sapiens	IC50	uM	25.0
	18811996	CHEMBL4276177	Inhibition of human recombinant N-terminal His6-tagged human GSK-3beta expressed in Baculovirus infected SF9 cells using prephosphorylated-GS2 polypeptide as substrate after 30 mins by kinase-Glo reagent based luminescence assay	B	O=C(NCc1ccc(Cl)cc1)c1ccc(C2CC(=O)N(Cc3ccccc3[N+](=O)[O-])c3ccccc3S2)cc1		CHEMBL4286404	=	IC50	nM	33000.0	CHEMBL262	Homo sapiens	IC50	uM	33.0
	18811997	CHEMBL4276177	Inhibition of human recombinant N-terminal His6-tagged human GSK-3beta expressed in Baculovirus infected SF9 cells using prephosphorylated-GS2 polypeptide as substrate after 30 mins by kinase-Glo reagent based luminescence assay	B	O=C(NCc1cccc(Cl)c1)c1ccc(C2CC(=O)N(Cc3ccccc3[N+](=O)[O-])c3ccccc3S2)cc1		CHEMBL4279766	=	IC50	nM	35000.0	CHEMBL262	Homo sapiens	IC50	uM	35.0
	18811998	CHEMBL4276177	Inhibition of human recombinant N-terminal His6-tagged human GSK-3beta expressed in Baculovirus infected SF9 cells using prephosphorylated-GS2 polypeptide as substrate after 30 mins by kinase-Glo reagent based luminescence assay	B	O=C(NCc1ccc(F)cc1)c1ccc(C2CC(=O)N(Cc3ccccc3[N+](=O)[O-])c3ccccc3S2)cc1		CHEMBL4290418	=	IC50	nM	18000.0	CHEMBL262	Homo sapiens	IC50	uM	18.0
	18811999	CHEMBL4276177	Inhibition of human recombinant N-terminal His6-tagged human GSK-3beta expressed in Baculovirus infected SF9 cells using prephosphorylated-GS2 polypeptide as substrate after 30 mins by kinase-Glo reagent based luminescence assay	B	O=C(NCc1cccc(F)c1)c1ccc(C2CC(=O)N(Cc3ccccc3[N+](=O)[O-])c3ccccc3S2)cc1		CHEMBL4293500	=	IC50	nM	19000.0	CHEMBL262	Homo sapiens	IC50	uM	19.0
	18812000	CHEMBL4276177	Inhibition of human recombinant N-terminal His6-tagged human GSK-3beta expressed in Baculovirus infected SF9 cells using prephosphorylated-GS2 polypeptide as substrate after 30 mins by kinase-Glo reagent based luminescence assay	B	O=C(NCc1ccccc1F)c1ccc(C2CC(=O)N(Cc3ccccc3[N+](=O)[O-])c3ccccc3S2)cc1		CHEMBL4287006	=	IC50	nM	20000.0	CHEMBL262	Homo sapiens	IC50	uM	20.0
	18812001	CHEMBL4276177	Inhibition of human recombinant N-terminal His6-tagged human GSK-3beta expressed in Baculovirus infected SF9 cells using prephosphorylated-GS2 polypeptide as substrate after 30 mins by kinase-Glo reagent based luminescence assay	B	O=C(NCCc1ccccc1)c1ccc(C2CC(=O)N(Cc3ccccc3[N+](=O)[O-])c3ccccc3S2)cc1		CHEMBL4287420	=	IC50	nM	21000.0	CHEMBL262	Homo sapiens	IC50	uM	21.0
	18812002	CHEMBL4276177	Inhibition of human recombinant N-terminal His6-tagged human GSK-3beta expressed in Baculovirus infected SF9 cells using prephosphorylated-GS2 polypeptide as substrate after 30 mins by kinase-Glo reagent based luminescence assay	B	O=C(NCc1ccccc1)c1ccc(C2CC(=O)N(Cc3ccccc3[N+](=O)[O-])c3ccccc3S2)cc1		CHEMBL4281295	=	IC50	nM	28000.0	CHEMBL262	Homo sapiens	IC50	uM	28.0
	18812003	CHEMBL4276177	Inhibition of human recombinant N-terminal His6-tagged human GSK-3beta expressed in Baculovirus infected SF9 cells using prephosphorylated-GS2 polypeptide as substrate after 30 mins by kinase-Glo reagent based luminescence assay	B	O=C(Nc1ccccn1)c1ccc(C2CC(=O)N(Cc3ccccc3[N+](=O)[O-])c3ccccc3S2)cc1		CHEMBL4289675	=	IC50	nM	35000.0	CHEMBL262	Homo sapiens	IC50	uM	35.0
	18812004	CHEMBL4276177	Inhibition of human recombinant N-terminal His6-tagged human GSK-3beta expressed in Baculovirus infected SF9 cells using prephosphorylated-GS2 polypeptide as substrate after 30 mins by kinase-Glo reagent based luminescence assay	B	O=C(NCc1ccccn1)c1ccc(C2CC(=O)N(Cc3ccccc3[N+](=O)[O-])c3ccccc3S2)cc1		CHEMBL4280203	=	IC50	nM	75000.0	CHEMBL262	Homo sapiens	IC50	uM	75.0
	18812005	CHEMBL4276177	Inhibition of human recombinant N-terminal His6-tagged human GSK-3beta expressed in Baculovirus infected SF9 cells using prephosphorylated-GS2 polypeptide as substrate after 30 mins by kinase-Glo reagent based luminescence assay	B	CN1CCN(NC(=O)c2ccc(C3CC(=O)N(Cc4ccccc4[N+](=O)[O-])c4ccccc4S3)cc2)CC1		CHEMBL4284711	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	18812006	CHEMBL4276177	Inhibition of human recombinant N-terminal His6-tagged human GSK-3beta expressed in Baculovirus infected SF9 cells using prephosphorylated-GS2 polypeptide as substrate after 30 mins by kinase-Glo reagent based luminescence assay	B	O=C(NN1CCCCC1)c1ccc(C2CC(=O)N(Cc3ccccc3[N+](=O)[O-])c3ccccc3S2)cc1		CHEMBL4277428	=	IC50	nM	49000.0	CHEMBL262	Homo sapiens	IC50	uM	49.0
	18812007	CHEMBL4276177	Inhibition of human recombinant N-terminal His6-tagged human GSK-3beta expressed in Baculovirus infected SF9 cells using prephosphorylated-GS2 polypeptide as substrate after 30 mins by kinase-Glo reagent based luminescence assay	B	O=C(NC1CCCCC1)c1ccc(C2CC(=O)N(Cc3ccccc3[N+](=O)[O-])c3ccccc3S2)cc1		CHEMBL4294291	=	IC50	nM	32000.0	CHEMBL262	Homo sapiens	IC50	uM	32.0
	18812008	CHEMBL4276177	Inhibition of human recombinant N-terminal His6-tagged human GSK-3beta expressed in Baculovirus infected SF9 cells using prephosphorylated-GS2 polypeptide as substrate after 30 mins by kinase-Glo reagent based luminescence assay	B	O=C(NC1CC1)c1ccc(C2CC(=O)N(Cc3ccccc3[N+](=O)[O-])c3ccccc3S2)cc1		CHEMBL4283719	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	18812009	CHEMBL4276177	Inhibition of human recombinant N-terminal His6-tagged human GSK-3beta expressed in Baculovirus infected SF9 cells using prephosphorylated-GS2 polypeptide as substrate after 30 mins by kinase-Glo reagent based luminescence assay	B	CCN(CC)C(=O)c1ccc(C2CC(=O)N(Cc3ccccc3[N+](=O)[O-])c3ccccc3S2)cc1		CHEMBL4279152	=	IC50	nM	90000.0	CHEMBL262	Homo sapiens	IC50	uM	90.0
	18812010	CHEMBL4276177	Inhibition of human recombinant N-terminal His6-tagged human GSK-3beta expressed in Baculovirus infected SF9 cells using prephosphorylated-GS2 polypeptide as substrate after 30 mins by kinase-Glo reagent based luminescence assay	B	CC(C)(C)NC(=O)c1ccc(C2CC(=O)N(Cc3ccccc3[N+](=O)[O-])c3ccccc3S2)cc1		CHEMBL4287074	=	IC50	nM	48000.0	CHEMBL262	Homo sapiens	IC50	uM	48.0
	18812011	CHEMBL4276177	Inhibition of human recombinant N-terminal His6-tagged human GSK-3beta expressed in Baculovirus infected SF9 cells using prephosphorylated-GS2 polypeptide as substrate after 30 mins by kinase-Glo reagent based luminescence assay	B	CCCCNC(=O)c1ccc(C2CC(=O)N(Cc3ccccc3[N+](=O)[O-])c3ccccc3S2)cc1		CHEMBL4282621	=	IC50	nM	22000.0	CHEMBL262	Homo sapiens	IC50	uM	22.0
	18812012	CHEMBL4276177	Inhibition of human recombinant N-terminal His6-tagged human GSK-3beta expressed in Baculovirus infected SF9 cells using prephosphorylated-GS2 polypeptide as substrate after 30 mins by kinase-Glo reagent based luminescence assay	B	COC(=O)c1ccccc1C1CC(=O)N(Cc2ccccc2[N+](=O)[O-])c2ccccc2S1		CHEMBL4290490	=	IC50	nM	80000.0	CHEMBL262	Homo sapiens	IC50	uM	80.0
	18812013	CHEMBL4276177	Inhibition of human recombinant N-terminal His6-tagged human GSK-3beta expressed in Baculovirus infected SF9 cells using prephosphorylated-GS2 polypeptide as substrate after 30 mins by kinase-Glo reagent based luminescence assay	B	COC(=O)c1cccc(C2CC(=O)N(Cc3ccccc3[N+](=O)[O-])c3ccccc3S2)c1		CHEMBL4285999	=	IC50	nM	66000.0	CHEMBL262	Homo sapiens	IC50	uM	66.0
	18812014	CHEMBL4276177	Inhibition of human recombinant N-terminal His6-tagged human GSK-3beta expressed in Baculovirus infected SF9 cells using prephosphorylated-GS2 polypeptide as substrate after 30 mins by kinase-Glo reagent based luminescence assay	B	COC(=O)c1ccc(C2CC(=O)N(Cc3ccccc3[N+](=O)[O-])c3ccccc3S2)cc1		CHEMBL4293899	=	IC50	nM	35000.0	CHEMBL262	Homo sapiens	IC50	uM	35.0
	18812015	CHEMBL4276177	Inhibition of human recombinant N-terminal His6-tagged human GSK-3beta expressed in Baculovirus infected SF9 cells using prephosphorylated-GS2 polypeptide as substrate after 30 mins by kinase-Glo reagent based luminescence assay	B	N#Cc1ccc(C2CC(=O)N(Cc3ccccc3[N+](=O)[O-])c3ccccc3S2)cc1		CHEMBL4289419	=	IC50	nM	45000.0	CHEMBL262	Homo sapiens	IC50	uM	45.0
	18812016	CHEMBL4276177	Inhibition of human recombinant N-terminal His6-tagged human GSK-3beta expressed in Baculovirus infected SF9 cells using prephosphorylated-GS2 polypeptide as substrate after 30 mins by kinase-Glo reagent based luminescence assay	B	Cc1ccc(C2CC(=O)N(Cc3ccccc3[N+](=O)[O-])c3ccccc3S2)cc1		CHEMBL4278749	=	IC50	nM	20000.0	CHEMBL262	Homo sapiens	IC50	uM	20.0
	18812017	CHEMBL4276177	Inhibition of human recombinant N-terminal His6-tagged human GSK-3beta expressed in Baculovirus infected SF9 cells using prephosphorylated-GS2 polypeptide as substrate after 30 mins by kinase-Glo reagent based luminescence assay	B	O=C1CC(c2ccc(-c3ccccc3)cc2)Sc2ccccc2N1Cc1ccccc1[N+](=O)[O-]		CHEMBL4277269	=	IC50	nM	51000.0	CHEMBL262	Homo sapiens	IC50	uM	51.0
	18812018	CHEMBL4276177	Inhibition of human recombinant N-terminal His6-tagged human GSK-3beta expressed in Baculovirus infected SF9 cells using prephosphorylated-GS2 polypeptide as substrate after 30 mins by kinase-Glo reagent based luminescence assay	B	O=C1CC(c2ccc(Cl)cc2)Sc2ccccc2N1Cc1ccccc1[N+](=O)[O-]		CHEMBL2334797	=	IC50	nM	71000.0	CHEMBL262	Homo sapiens	IC50	uM	71.0
	18812019	CHEMBL4276177	Inhibition of human recombinant N-terminal His6-tagged human GSK-3beta expressed in Baculovirus infected SF9 cells using prephosphorylated-GS2 polypeptide as substrate after 30 mins by kinase-Glo reagent based luminescence assay	B	O=C1CC(c2ccc(F)cc2)Sc2ccccc2N1Cc1ccccc1[N+](=O)[O-]		CHEMBL2334796	=	IC50	nM	82000.0	CHEMBL262	Homo sapiens	IC50	uM	82.0
	18812020	CHEMBL4276177	Inhibition of human recombinant N-terminal His6-tagged human GSK-3beta expressed in Baculovirus infected SF9 cells using prephosphorylated-GS2 polypeptide as substrate after 30 mins by kinase-Glo reagent based luminescence assay	B	O=C1CC(c2ccc(C(=O)NCc3cccc(Cl)c3)cc2)Sc2ccccc2N1		CHEMBL4277682	=	IC50	nM	25000.0	CHEMBL262	Homo sapiens	IC50	uM	25.0
Not Active	18847315	CHEMBL4304905	Inhibition of wild-type human full length GSK3B (M1 to T433 residues) expressed in mammalian expression system at 1 uM by Kinomescan method	B	O=C(Nc1ccc2[nH]nc(-c3ccc4[nH]ccc4c3)c2c1)c1c(Cl)cccc1Cl		CHEMBL4517719		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	18857990	CHEMBL4307836	Binding affinity to wild-type human full length GSK3B (M1 to T433 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	84.0	CHEMBL262	Homo sapiens	Activity	%	84.0
	18860131	CHEMBL4308530	Inhibition of GSK3beta (unknown origin) by ADP-Glo assay	B	Cc1nc(-c2ccccc2O)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4561980	=	IC50	nM	11.0	CHEMBL262	Homo sapiens	IC50	uM	0.011
	18860132	CHEMBL4308530	Inhibition of GSK3beta (unknown origin) by ADP-Glo assay	B	Cc1nc(-c2cccc(O)c2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4514346	=	IC50	nM	43.0	CHEMBL262	Homo sapiens	IC50	uM	0.043
	18860133	CHEMBL4308530	Inhibition of GSK3beta (unknown origin) by ADP-Glo assay	B	Cc1nc(-c2ccc(O)cc2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4453072	=	IC50	nM	893.0	CHEMBL262	Homo sapiens	IC50	uM	0.893
	18860134	CHEMBL4308530	Inhibition of GSK3beta (unknown origin) by ADP-Glo assay	B	Cc1nc(-c2cccs2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4576003	=	IC50	nM	69.0	CHEMBL262	Homo sapiens	IC50	uM	0.069
	18860135	CHEMBL4308530	Inhibition of GSK3beta (unknown origin) by ADP-Glo assay	B	Cc1nc(-c2ccco2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4460515	=	IC50	nM	99.0	CHEMBL262	Homo sapiens	IC50	uM	0.099
	18860136	CHEMBL4308530	Inhibition of GSK3beta (unknown origin) by ADP-Glo assay	B	COc1ccccc1-c1nc(C)[nH]c1-c1ccnc(NC(=O)C2CC2)c1		CHEMBL4586627	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	18860137	CHEMBL4308530	Inhibition of GSK3beta (unknown origin) by ADP-Glo assay	B	Cc1nc(-c2cncnc2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4456865	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	18860138	CHEMBL4308530	Inhibition of GSK3beta (unknown origin) by ADP-Glo assay	B	Cc1nc(-c2ccc3ccccc3c2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4435496	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	18860139	CHEMBL4308530	Inhibition of GSK3beta (unknown origin) by ADP-Glo assay	B	Cc1nc(-c2ccc(F)c(F)c2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4474740	=	IC50	nM	59.0	CHEMBL262	Homo sapiens	IC50	uM	0.059
	18860140	CHEMBL4308530	Inhibition of GSK3beta (unknown origin) by ADP-Glo assay	B	Cc1nc(C2CC2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4584996	=	IC50	nM	3090.0	CHEMBL262	Homo sapiens	IC50	uM	3.09
	18860141	CHEMBL4308530	Inhibition of GSK3beta (unknown origin) by ADP-Glo assay	B	Cc1nc(C2CCC2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4444424	=	IC50	nM	4110.0	CHEMBL262	Homo sapiens	IC50	uM	4.11
	18860142	CHEMBL4308530	Inhibition of GSK3beta (unknown origin) by ADP-Glo assay	B	Cc1nc(C2CCCC2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4575638	=	IC50	nM	5460.0	CHEMBL262	Homo sapiens	IC50	uM	5.46
	18860143	CHEMBL4308530	Inhibition of GSK3beta (unknown origin) by ADP-Glo assay	B	Cc1nc(C2CCCCC2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4475448	=	IC50	nM	4640.0	CHEMBL262	Homo sapiens	IC50	uM	4.64
	18860144	CHEMBL4308530	Inhibition of GSK3beta (unknown origin) by ADP-Glo assay	B	Cc1nc(-c2ccc3c(c2)OCO3)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4518273	=	IC50	nM	467.0	CHEMBL262	Homo sapiens	IC50	uM	0.467
	18860145	CHEMBL4308530	Inhibition of GSK3beta (unknown origin) by ADP-Glo assay	B	Cc1nc(-c2ccc(F)c(C)c2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4457174	=	IC50	nM	117.0	CHEMBL262	Homo sapiens	IC50	uM	0.117
	18860146	CHEMBL4308530	Inhibition of GSK3beta (unknown origin) by ADP-Glo assay	B	Cc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)CCn3cncn3)c2)[nH]1		CHEMBL4557420	=	IC50	nM	82.0	CHEMBL262	Homo sapiens	IC50	uM	0.082
	18860147	CHEMBL4308530	Inhibition of GSK3beta (unknown origin) by ADP-Glo assay	B	Cc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)CCn3cnnn3)c2)[nH]1		CHEMBL4466208	=	IC50	nM	72.0	CHEMBL262	Homo sapiens	IC50	uM	0.072
	18860148	CHEMBL4308530	Inhibition of GSK3beta (unknown origin) by ADP-Glo assay	B	Cc1nc(-c2ccccc2)c(-c2ccnc(NC(=O)CCn3cncn3)c2)[nH]1		CHEMBL4575716	=	IC50	nM	5180.0	CHEMBL262	Homo sapiens	IC50	uM	5.18
	18860149	CHEMBL4308530	Inhibition of GSK3beta (unknown origin) by ADP-Glo assay	B	Cc1nc(-c2ccccc2)c(-c2ccnc(NC(=O)CCn3cnnn3)c2)[nH]1		CHEMBL4517450	=	IC50	nM	4420.0	CHEMBL262	Homo sapiens	IC50	uM	4.42
	18860150	CHEMBL4308530	Inhibition of GSK3beta (unknown origin) by ADP-Glo assay	B	CCOC(=O)c1ncc(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4446123	=	IC50	nM	739.0	CHEMBL262	Homo sapiens	IC50	uM	0.739
	18860151	CHEMBL4308530	Inhibition of GSK3beta (unknown origin) by ADP-Glo assay	B	NC(=O)c1ncc(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4456432	=	IC50	nM	47.0	CHEMBL262	Homo sapiens	IC50	uM	0.047
	18860152	CHEMBL4308530	Inhibition of GSK3beta (unknown origin) by ADP-Glo assay	B	CCOC(=O)c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4518634	=	IC50	nM	899.0	CHEMBL262	Homo sapiens	IC50	uM	0.899
	18860153	CHEMBL4308530	Inhibition of GSK3beta (unknown origin) by ADP-Glo assay	B	NC(=O)c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4452444	=	IC50	nM	39.0	CHEMBL262	Homo sapiens	IC50	uM	0.039
	18860154	CHEMBL4308530	Inhibition of GSK3beta (unknown origin) by ADP-Glo assay	B	O=C(Nc1cc(-c2[nH]c(CO)nc2-c2ccc(F)cc2)ccn1)C1CC1		CHEMBL4451444	=	IC50	nM	91.0	CHEMBL262	Homo sapiens	IC50	uM	0.091
	18860155	CHEMBL4308530	Inhibition of GSK3beta (unknown origin) by ADP-Glo assay	B	Cc1nc(C(N)=O)[nH]c1-c1ccnc(NC(=O)C2CC2)c1		CHEMBL4445449	=	IC50	nM	13.0	CHEMBL262	Homo sapiens	IC50	uM	0.013
	18860156	CHEMBL4308530	Inhibition of GSK3beta (unknown origin) by ADP-Glo assay	B	NC(=O)c1nc(C2CC2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4483032	=	IC50	nM	3.0	CHEMBL262	Homo sapiens	IC50	uM	0.003
	18860157	CHEMBL4308530	Inhibition of GSK3beta (unknown origin) by ADP-Glo assay	B	NC(=O)c1nc(C2CCCCC2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4526183	=	IC50	nM	3.0	CHEMBL262	Homo sapiens	IC50	uM	0.003
	18860158	CHEMBL4308530	Inhibition of GSK3beta (unknown origin) by ADP-Glo assay	B	NC(=O)c1nc(-c2ccccc2O)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4475312	=	IC50	nM	23.0	CHEMBL262	Homo sapiens	IC50	uM	0.023
	18860159	CHEMBL4308530	Inhibition of GSK3beta (unknown origin) by ADP-Glo assay	B	COc1ccccc1-c1nc(C(N)=O)[nH]c1-c1ccnc(NC(=O)C2CC2)c1		CHEMBL4456961	=	IC50	nM	265.0	CHEMBL262	Homo sapiens	IC50	uM	0.265
	18860160	CHEMBL4308530	Inhibition of GSK3beta (unknown origin) by ADP-Glo assay	B	NC(=O)c1nc(-c2ccc(F)c(C(F)(F)F)c2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4461695	=	IC50	nM	79.0	CHEMBL262	Homo sapiens	IC50	uM	0.079
	18860161	CHEMBL4308530	Inhibition of GSK3beta (unknown origin) by ADP-Glo assay	B	CC(=O)Nc1cc(-c2[nH]c(C(N)=O)nc2-c2ccc(F)cc2)ccn1		CHEMBL4564217	=	IC50	nM	47.0	CHEMBL262	Homo sapiens	IC50	uM	0.047
	18860162	CHEMBL4308530	Inhibition of GSK3beta (unknown origin) by ADP-Glo assay	B	NC(=O)c1nc(-c2cccc(OC(F)(F)F)c2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4529679	=	IC50	nM	352.0	CHEMBL262	Homo sapiens	IC50	uM	0.352
Active	18860191	CHEMBL4308540	Inhibition of GSK3beta in human SH-SY5Y cells assessed as increase in GSK3alpha/beta phosphorylation at S21/S9 residues at 1 uM after 1 hr by Western blot analysis	B	NC(=O)c1nc(C2CC2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4483032		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	18860200	CHEMBL4308530	Inhibition of GSK3beta (unknown origin) by ADP-Glo assay	B	NC(=O)c1ncc(-c2cc(NC(=O)C3CC3)ncc2Br)[nH]1		CHEMBL4439815	=	IC50	nM	354.0	CHEMBL262	Homo sapiens	IC50	uM	0.354
Active	18860216	CHEMBL4308550	Inhibition of GSK3beta (unknown origin) using GSM peptide as substrate measured after 30 mins by ESI-QTOF analysis	B	Cc1nc(-c2ccccc2O)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4561980		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	18860217	CHEMBL4308550	Inhibition of GSK3beta (unknown origin) using GSM peptide as substrate measured after 30 mins by ESI-QTOF analysis	B	Cc1nc(-c2ccc(F)c(F)c2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4474740		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	18860218	CHEMBL4308550	Inhibition of GSK3beta (unknown origin) using GSM peptide as substrate measured after 30 mins by ESI-QTOF analysis	B	NC(=O)c1ncc(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4456432		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	18860219	CHEMBL4308550	Inhibition of GSK3beta (unknown origin) using GSM peptide as substrate measured after 30 mins by ESI-QTOF analysis	B	NC(=O)c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4452444		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	18860220	CHEMBL4308550	Inhibition of GSK3beta (unknown origin) using GSM peptide as substrate measured after 30 mins by ESI-QTOF analysis	B	Cc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4455711		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	18883551	CHEMBL4312740	Activity at human GSK3beta at 10 uM	B	CS(=O)(=O)c1ccc(Oc2cc(F)cc(C#N)c2)c2c1[C@H](O)[C@H](F)[C@@H]2F		CHEMBL4585668		Activity			CHEMBL262	Homo sapiens	Activity		
	18886144	CHEMBL4313407	Inhibition of human GSK3B at 10 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate by [gamma-33P]-ATP assay relative to control	B	COc1ccc(-c2nn(-c3cccc(NC(=O)c4cccc(C(F)(F)F)c4)c3)cc2-c2ccncc2)cc1Cl		CHEMBL4553144	=	Inhibition	%	-6.34	CHEMBL262	Homo sapiens	INH	%	-6.34
	18892883	CHEMBL4314849	Inhibition of recombinant human GSK3beta H350L mutant (2 to end residues) assessed as residual activity at 10 uM using phospho GS2 peptide as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	112.5	CHEMBL262	Homo sapiens	Activity	%	112.5
	18904273	CHEMBL4317071	Inhibition of GSK3beta in human human MM1S cells	B	Cn1ncc(NC(=O)c2nc(-c3c(F)cccc3F)sc2N)c1N1CC[C@@H](N)[C@H](F)CC1		CHEMBL3648680	=	IC50	nM	23000.0	CHEMBL262	Homo sapiens	IC50	uM	23.0
	18919538	CHEMBL4322894	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged GSK3B (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	230.0	CHEMBL262	Homo sapiens	Kd	nM	230.0
	18919726	CHEMBL4322894	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged GSK3B (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	148.0	CHEMBL262	Homo sapiens	Kd	nM	148.0
	18928746	CHEMBL4325175	Inhibition of human GSK3beta using biotinylated-aminohexyl-Ala-Ala-Ala-Lys-Arg-Arg-Glu-Ile-Leu-Ser-Arg-Arg-Pro-Ser(PO3)-Tyr-Arg-amide as substrate after 40 mins in presence of [gamma-32P]ATP by scintillation proximity assay	A	c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359554	=	IC50	nM	19.95	CHEMBL262	Homo sapiens	pIC50		7.7
	18928747	CHEMBL4325175	Inhibition of human GSK3beta using biotinylated-aminohexyl-Ala-Ala-Ala-Lys-Arg-Arg-Glu-Ile-Leu-Ser-Arg-Arg-Pro-Ser(PO3)-Tyr-Arg-amide as substrate after 40 mins in presence of [gamma-32P]ATP by scintillation proximity assay	A	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189665	<	IC50	nM	31622.78	CHEMBL262	Homo sapiens	pIC50		4.5
	18928748	CHEMBL4325175	Inhibition of human GSK3beta using biotinylated-aminohexyl-Ala-Ala-Ala-Lys-Arg-Arg-Glu-Ile-Leu-Ser-Arg-Arg-Pro-Ser(PO3)-Tyr-Arg-amide as substrate after 40 mins in presence of [gamma-32P]ATP by scintillation proximity assay	A	Cc1ccccc1Nc1nccc(-c2cnn3ncccc23)n1		CHEMBL366259	=	IC50	nM	6309.57	CHEMBL262	Homo sapiens	pIC50		5.2
	18928749	CHEMBL4325175	Inhibition of human GSK3beta using biotinylated-aminohexyl-Ala-Ala-Ala-Lys-Arg-Arg-Glu-Ile-Leu-Ser-Arg-Arg-Pro-Ser(PO3)-Tyr-Arg-amide as substrate after 40 mins in presence of [gamma-32P]ATP by scintillation proximity assay	A	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	IC50	nM	10.0	CHEMBL262	Homo sapiens	pIC50		8.0
	18928750	CHEMBL4325175	Inhibition of human GSK3beta using biotinylated-aminohexyl-Ala-Ala-Ala-Lys-Arg-Arg-Glu-Ile-Leu-Ser-Arg-Arg-Pro-Ser(PO3)-Tyr-Arg-amide as substrate after 40 mins in presence of [gamma-32P]ATP by scintillation proximity assay	A	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	IC50	nM	50.12	CHEMBL262	Homo sapiens	pIC50		7.3
	18928751	CHEMBL4325175	Inhibition of human GSK3beta using biotinylated-aminohexyl-Ala-Ala-Ala-Lys-Arg-Arg-Glu-Ile-Leu-Ser-Arg-Arg-Pro-Ser(PO3)-Tyr-Arg-amide as substrate after 40 mins in presence of [gamma-32P]ATP by scintillation proximity assay	A	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	IC50	nM	12.59	CHEMBL262	Homo sapiens	pIC50		7.9
	18928752	CHEMBL4325175	Inhibition of human GSK3beta using biotinylated-aminohexyl-Ala-Ala-Ala-Lys-Arg-Arg-Glu-Ile-Leu-Ser-Arg-Arg-Pro-Ser(PO3)-Tyr-Arg-amide as substrate after 40 mins in presence of [gamma-32P]ATP by scintillation proximity assay	A	Cc1cc(C)cc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL186101	=	IC50	nM	1.0	CHEMBL262	Homo sapiens	pIC50		9.0
	18928753	CHEMBL4325175	Inhibition of human GSK3beta using biotinylated-aminohexyl-Ala-Ala-Ala-Lys-Arg-Arg-Glu-Ile-Leu-Ser-Arg-Arg-Pro-Ser(PO3)-Tyr-Arg-amide as substrate after 40 mins in presence of [gamma-32P]ATP by scintillation proximity assay	A	Fc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1F		CHEMBL364370	=	IC50	nM	10.0	CHEMBL262	Homo sapiens	pIC50		8.0
	18928754	CHEMBL4325175	Inhibition of human GSK3beta using biotinylated-aminohexyl-Ala-Ala-Ala-Lys-Arg-Arg-Glu-Ile-Leu-Ser-Arg-Arg-Pro-Ser(PO3)-Tyr-Arg-amide as substrate after 40 mins in presence of [gamma-32P]ATP by scintillation proximity assay	A	Fc1ccc(Nc2nccc(-c3c(C4CC4)nn4ncccc34)n2)cc1F		CHEMBL185516	=	IC50	nM	25118.86	CHEMBL262	Homo sapiens	pIC50		4.6
	18928755	CHEMBL4325175	Inhibition of human GSK3beta using biotinylated-aminohexyl-Ala-Ala-Ala-Lys-Arg-Arg-Glu-Ile-Leu-Ser-Arg-Arg-Pro-Ser(PO3)-Tyr-Arg-amide as substrate after 40 mins in presence of [gamma-32P]ATP by scintillation proximity assay	A	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	IC50	nM	1.0	CHEMBL262	Homo sapiens	pIC50		9.0
	18928756	CHEMBL4325175	Inhibition of human GSK3beta using biotinylated-aminohexyl-Ala-Ala-Ala-Lys-Arg-Arg-Glu-Ile-Leu-Ser-Arg-Arg-Pro-Ser(PO3)-Tyr-Arg-amide as substrate after 40 mins in presence of [gamma-32P]ATP by scintillation proximity assay	A	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	IC50	nM	50.12	CHEMBL262	Homo sapiens	pIC50		7.3
	18928757	CHEMBL4325175	Inhibition of human GSK3beta using biotinylated-aminohexyl-Ala-Ala-Ala-Lys-Arg-Arg-Glu-Ile-Leu-Ser-Arg-Arg-Pro-Ser(PO3)-Tyr-Arg-amide as substrate after 40 mins in presence of [gamma-32P]ATP by scintillation proximity assay	A	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	IC50	nM	5011.87	CHEMBL262	Homo sapiens	pIC50		5.3
	18928758	CHEMBL4325175	Inhibition of human GSK3beta using biotinylated-aminohexyl-Ala-Ala-Ala-Lys-Arg-Arg-Glu-Ile-Leu-Ser-Arg-Arg-Pro-Ser(PO3)-Tyr-Arg-amide as substrate after 40 mins in presence of [gamma-32P]ATP by scintillation proximity assay	A	CC(C)(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL364587	=	IC50	nM	50.12	CHEMBL262	Homo sapiens	pIC50		7.3
	18928759	CHEMBL4325175	Inhibition of human GSK3beta using biotinylated-aminohexyl-Ala-Ala-Ala-Lys-Arg-Arg-Glu-Ile-Leu-Ser-Arg-Arg-Pro-Ser(PO3)-Tyr-Arg-amide as substrate after 40 mins in presence of [gamma-32P]ATP by scintillation proximity assay	A	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	IC50	nM	39.81	CHEMBL262	Homo sapiens	pIC50		7.4
	18929170	CHEMBL4325187	Inhibition of human GSK3beta at 1 uM relative to control	A	c1cncc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL4436808	>	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	18929171	CHEMBL4325187	Inhibition of human GSK3beta at 1 uM relative to control	A	COc1ccc2c(-c3ccnc(Nc4cccc(C#N)c4)n3)c(CO)nn2n1		CHEMBL4445914	=	Inhibition	%	49.0	CHEMBL262	Homo sapiens	INH	%	49.0
	18929172	CHEMBL4325187	Inhibition of human GSK3beta at 1 uM relative to control	A	N#Cc1cccc(Nc2nccc(-c3c(CO)nn4nc(N5CCOCC5)ccc34)n2)c1		CHEMBL4465474	=	Inhibition	%	75.0	CHEMBL262	Homo sapiens	INH	%	75.0
	18929173	CHEMBL4325187	Inhibition of human GSK3beta at 1 uM relative to control	A	c1cncc(Nc2nccc(-c3c(C4CC4)nn4ncccc34)n2)c1		CHEMBL4556458	=	Inhibition	%	21.0	CHEMBL262	Homo sapiens	INH	%	21.0
	18929174	CHEMBL4325187	Inhibition of human GSK3beta at 1 uM relative to control	A	COc1ccc2c(-c3ccnc(Nc4cccnc4)n3)cnn2n1		CHEMBL4473418	=	Inhibition	%	89.0	CHEMBL262	Homo sapiens	INH	%	89.0
	18929175	CHEMBL4325187	Inhibition of human GSK3beta at 1 uM relative to control	A	COc1ccc2c(-c3ccnc(Nc4cccnc4)n3)c(C3CC3)nn2n1		CHEMBL4536553	=	Inhibition	%	65.0	CHEMBL262	Homo sapiens	INH	%	65.0
	18929176	CHEMBL4325187	Inhibition of human GSK3beta at 1 uM relative to control	A	c1cncc(Nc2nccc(-c3c(C4CC4)nn4nc(N5CCOCC5)ccc34)n2)c1		CHEMBL4538725	=	Inhibition	%	34.0	CHEMBL262	Homo sapiens	INH	%	34.0
	18929177	CHEMBL4325187	Inhibition of human GSK3beta at 1 uM relative to control	A	c1cncc(Nc2nccc(-c3cnn4nc(N5CCOCC5)ccc34)n2)c1		CHEMBL4580246	=	Inhibition	%	81.0	CHEMBL262	Homo sapiens	INH	%	81.0
Not Determined	18929789	CHEMBL4325341	Inhibition of recombinant full-length human His-tagged GSK3beta expressed in baculovirus expression system by Z'-LYTE assay	B	Cc1n[nH]cc1-c1cc2nc([C@@H]3CCCCN3)[nH]c(=O)c2s1.Cl.Cl		CHEMBL4439133		IC50			CHEMBL262	Homo sapiens	IC50		
	18929804	CHEMBL4325356	Inhibition of recombinant full-length human His-tagged GSK3beta expressed in baculovirus expression system at 1000 nM by Z'-LYTE assay relative to control	B	Cc1n[nH]cc1-c1cc2nc([C@@H]3CCCCN3)[nH]c(=O)c2s1.Cl.Cl		CHEMBL4439133	=	Inhibition	%	89.0	CHEMBL262	Homo sapiens	INH	%	89.0
	18937971	CHEMBL4327712	Inhibition of human GSK3B assessed as residual activity at 1 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	97.92	CHEMBL262	Homo sapiens	Activity	%	97.92
	18937972	CHEMBL4327712	Inhibition of human GSK3B assessed as residual activity at 1 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	93.57	CHEMBL262	Homo sapiens	Activity	%	93.57
	18938556	CHEMBL4328076	Inhibition of human GSK3B assessed as residual activity at 100 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL262	Homo sapiens	Activity	%	65.0
	18938934	CHEMBL4328440	Inhibition of human GSK3B using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	5.53	CHEMBL262	Homo sapiens	IC50	10'-9M	5.53
	18950232	CHEMBL4331084	Inhibition of human GSK3B assessed as residual activity at 10 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition and measured after 120 mins by Hotspot assay relative to control	B	CN1CCC(Nc2ccc(C(=O)Nc3cc(-c4cc(C#N)cs4)n[nH]3)cc2)CC1		CHEMBL4473820	=	Activity	%	72.78	CHEMBL262	Homo sapiens	Activity	%	72.78
	18953695	CHEMBL4331922	Inhibition of GSK3b (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(NC3CCCCC3)c12		CHEMBL4440433	=	Inhibition	%	23.0	CHEMBL262	Homo sapiens	INH	%	23.0
	18953761	CHEMBL4331922	Inhibition of GSK3b (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(Nc3ccccc3F)c12		CHEMBL4449552	=	Inhibition	%	53.0	CHEMBL262	Homo sapiens	INH	%	53.0
	18953836	CHEMBL4331922	Inhibition of GSK3b (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(OC3CCCCC3)c12		CHEMBL4524629	=	Inhibition	%	73.0	CHEMBL262	Homo sapiens	INH	%	73.0
	18953928	CHEMBL4331981	Inhibition of GSK3b (unknown origin) at 1 uM relative to control	B	CC(C)n1cc(-c2n[nH]c3ccnc(OC4CCOCC4)c23)cn1		CHEMBL4589022	=	Inhibition	%	90.0	CHEMBL262	Homo sapiens	INH	%	90.0
	18953992	CHEMBL4331981	Inhibition of GSK3b (unknown origin) at 1 uM relative to control	B	c1cc(-c2n[nH]c3ccnc(OC4CCOCC4)c23)cc(N2CCOCC2)n1		CHEMBL4460272	=	Inhibition	%	36.0	CHEMBL262	Homo sapiens	INH	%	36.0
	18954059	CHEMBL4331922	Inhibition of GSK3b (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(Nc3ccc4ncsc4c3)c12		CHEMBL4588446	=	Inhibition	%	71.0	CHEMBL262	Homo sapiens	INH	%	71.0
	18957394	CHEMBL4332973	Inhibition of GSK3beta (unknown origin) at 1 uM after 60 mins by Z-LYTE assay relative to control	B	C=CC(=O)N1CCN(c2ccc([N+](=O)[O-])c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c2)CC1		CHEMBL4450627	>	Inhibition	%	80.0	CHEMBL262	Homo sapiens	INH	%	80.0
	18958903	CHEMBL4333425	Binding affinity to wild-type human full length GSK3B (M1 to T433 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	97.0	CHEMBL262	Homo sapiens	Activity	%	97.0
Not Determined	18960706	CHEMBL4334135	Inhibition of GSK3B (unknown origin) at 10 uM relative to control	B	COc1ccc2cc3n(c(=O)c2c1OC)CCc1cc2c(cc1-3)OCO2		CHEMBL11531		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Determined	18960707	CHEMBL4334135	Inhibition of GSK3B (unknown origin) at 10 uM relative to control	B	COc1cc2c(cc1Oc1c3c(cc(OC)c1OC)CCN(C)C3)C(=O)N(C)CC2		CHEMBL4434785		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Determined	18960708	CHEMBL4334135	Inhibition of GSK3B (unknown origin) at 10 uM relative to control	B	CCN(CC)Cc1cc2cc(c1O)Oc1ccc(cc1)C[C@H]1c3cc(c(OC)cc3CCN1C)Oc1c(OC)c(OC)cc3c1[C@@H](C2)N(C)CC3		CHEMBL4590539		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Determined	18960709	CHEMBL4334135	Inhibition of GSK3B (unknown origin) at 10 uM relative to control	B	COc1cc2c(cc1Oc1c3c(cc(OC)c1OC)CCN(C)C3)C(Cc1ccc(O)cc1)N(C)CC2		CHEMBL4585711		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Determined	18960710	CHEMBL4334135	Inhibition of GSK3B (unknown origin) at 10 uM relative to control	B	COc1cc2c3cc1Oc1c(OC)c(OC)cc4c1[C@@H](Cc1ccc(O)c(c1)Oc1ccc(cc1)C[C@@H]3N(C)CC2)N(C)CC4		CHEMBL504323		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	18960711	CHEMBL4334135	Inhibition of GSK3B (unknown origin) at 10 uM relative to control	B	COc1cc2c3cc1Oc1c(O)c(OC)cc4c1[C@H](Cc1ccc(cc1)Oc1cc(ccc1O)C[C@H]3N(C)CC2)N(C)CC4		CHEMBL508781	=	Inhibition	%	10.0	CHEMBL262	Homo sapiens	INH	%	10.0
Not Determined	18960712	CHEMBL4334135	Inhibition of GSK3B (unknown origin) at 10 uM relative to control	B	COc1cc2c3cc1Oc1c(O)c(OC)cc4c1[C@@H](Cc1ccc(O)c(c1)Oc1ccc(cc1)C[C@@H]3N(C)CC2)N(C)CC4		CHEMBL452895		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Determined	18960713	CHEMBL4334135	Inhibition of GSK3B (unknown origin) at 10 uM relative to control	B	COc1cc2c(cc1O)C(Cc1ccc(O)c(Oc3cc(CC4c5cc(O)c(OC)cc5CCN4C)ccc3OC)c1)N(C)CC2		CHEMBL4548293		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Determined	18960714	CHEMBL4334135	Inhibition of GSK3B (unknown origin) at 10 uM relative to control	B	COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2		CHEMBL295124		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Determined	18960715	CHEMBL4334135	Inhibition of GSK3B (unknown origin) at 10 uM relative to control	B	COc1cc2c(cc1OC)-c1cc3ccc(OC)c(OC)c3c[n+]1CC2		CHEMBL206106		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Determined	18960716	CHEMBL4334135	Inhibition of GSK3B (unknown origin) at 10 uM relative to control	B	COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2		CHEMBL659		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Determined	18960717	CHEMBL4334135	Inhibition of GSK3B (unknown origin) at 10 uM relative to control	B	C/C=C1\[C@H]2C=C(C)C[C@]1(N)c1ccc(=O)[nH]c1C2		CHEMBL395280		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Determined	18960718	CHEMBL4334135	Inhibition of GSK3B (unknown origin) at 10 uM relative to control	B	O=C[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)OCc1ccccc1		CHEMBL79993		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	18963754	CHEMBL4334908	Inhibition of human GSK-3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured in presence of [gamma-33P]ATP by radiometric assay	A	c1ccc(-c2noc(CSc3nnc(-c4ccncc4)o3)n2)cc1		CHEMBL4545000	=	IC50	nM	521.0	CHEMBL262	Homo sapiens	IC50	nM	521.0
	18963755	CHEMBL4334908	Inhibition of human GSK-3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured in presence of [gamma-33P]ATP by radiometric assay	A	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2		CHEMBL362558	=	IC50	nM	0.9	CHEMBL262	Homo sapiens	IC50	nM	0.9
	18963757	CHEMBL4334910	Inhibition of human GSK-3beta by mobility shift micro-fluidic assay	A	CC[C@@]1(c2ccccc2)C2=C(CC(C)(C)CC2=O)Nc2n[nH]cc21		CHEMBL4438334	=	IC50	nM	515.0	CHEMBL262	Homo sapiens	IC50	nM	515.0
	18963892	CHEMBL4334913	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2		CHEMBL362558	=	Inhibition	%	97.0	CHEMBL262	Homo sapiens	INH	%	97.0
	18963893	CHEMBL4334913	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	N=C1NC(=O)/C(=C\c2ccc(-c3ccc(Cl)c(Cl)c3)o2)S1		CHEMBL4592453	=	Inhibition	%	75.0	CHEMBL262	Homo sapiens	INH	%	75.0
	18963894	CHEMBL4334913	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	CN1C(=N)NC(=O)/C1=C\c1ccc(-c2ccc(F)cc2)o1		CHEMBL3437678	=	Inhibition	%	78.0	CHEMBL262	Homo sapiens	INH	%	78.0
	18963895	CHEMBL4334913	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	Cc1ccc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)c(Br)c1		CHEMBL4467604	=	Inhibition	%	62.0	CHEMBL262	Homo sapiens	INH	%	62.0
Not Determined	18963896	CHEMBL4334913	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	O=C1N/C(=N/c2ccccc2)S/C1=C/c1ccco1		CHEMBL4443427		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Determined	18963897	CHEMBL4334913	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	O=C1N/C(=N/c2ccccc2)S/C1=C/c1ccc(-c2ccccc2)o1		CHEMBL4539454		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Determined	18963898	CHEMBL4334913	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	O=C1N/C(=N/Cc2ccccc2)S/C1=C/c1ccc(-c2ccccc2)o1		CHEMBL4589530		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	18963899	CHEMBL4334913	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	N=C1NC(=O)/C(=C\c2ccc(-c3ccccc3Cl)o2)S1		CHEMBL4537545	=	Inhibition	%	95.0	CHEMBL262	Homo sapiens	INH	%	95.0
	18963900	CHEMBL4334913	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	NC1=NC(=O)/C(=C\c2ccc(-c3ccccc3[N+](=O)[O-])o2)S1		CHEMBL1878704	=	Inhibition	%	82.0	CHEMBL262	Homo sapiens	INH	%	82.0
Not Determined	18963901	CHEMBL4334913	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	CC(=O)/N=C1/NC(=O)/C(=C\c2ccc(-c3ccccc3C(=O)O)o2)S1		CHEMBL4437351		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	18963902	CHEMBL4334913	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	N=C1NC(=O)/C(=C\c2ccc(-c3cccc(Cl)c3)o2)S1		CHEMBL4558089	=	Inhibition	%	88.0	CHEMBL262	Homo sapiens	INH	%	88.0
Not Determined	18963903	CHEMBL4334913	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	Cc1cc(C)cc(/N=C2/NC(=O)/C(=C\c3ccc(-c4cccc(Cl)c4)o3)S2)c1		CHEMBL4579205		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	18963904	CHEMBL4334913	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Inhibition	%	95.0	CHEMBL262	Homo sapiens	INH	%	95.0
	18963905	CHEMBL4334913	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	N=C1NC(=O)/C(=C\c2ccc(-c3cccc(C(=O)O)c3)o2)S1		CHEMBL4572532	=	Inhibition	%	93.0	CHEMBL262	Homo sapiens	INH	%	93.0
Not Determined	18963906	CHEMBL4334913	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	O=C1N/C(=N/c2ccccc2)S/C1=C/c1ccc(-c2cccc(C(=O)O)c2)o1		CHEMBL4575432		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Determined	18963907	CHEMBL4334913	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	COC(=O)c1ccc(-c2ccc(/C=C3\C(=O)NC(=N)N3C)o2)cc1		CHEMBL3437676		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	18963908	CHEMBL4334913	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	CC(=O)/N=C1/NC(=O)/C(=C\c2ccc(-c3ccc(C(=O)O)cc3)o2)S1		CHEMBL4442366	=	Inhibition	%	72.0	CHEMBL262	Homo sapiens	INH	%	72.0
Not Determined	18963909	CHEMBL4334913	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	O=C1N/C(=N/c2ccccc2)S/C1=C/c1ccc(Sc2ccc(Cl)cc2)o1		CHEMBL4577014		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Determined	18963910	CHEMBL4334913	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	CC(=O)/N=C1/NC(=O)/C(=C\c2ccc(-c3ccc(F)cc3F)o2)S1		CHEMBL4469930		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	18963911	CHEMBL4334913	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	N=C1NC(=O)/C(=C\c2ccc(-c3ccc(Cl)cc3Cl)o2)S1		CHEMBL4444620	=	Inhibition	%	93.0	CHEMBL262	Homo sapiens	INH	%	93.0
Not Determined	18963912	CHEMBL4334913	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	N=C1NC(=O)/C(=C\c2ccc(-c3ccc([N+](=O)[O-])cc3Cl)o2)S1		CHEMBL4515342		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Determined	18963913	CHEMBL4334913	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	Cc1cc([N+](=O)[O-])ccc1-c1ccc(/C=C2/SC(=N)NC2=O)o1		CHEMBL4467699		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Determined	18963914	CHEMBL4334913	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	COc1cc([N+](=O)[O-])ccc1-c1ccc(/C=C2/SC(=N)NC2=O)o1		CHEMBL4468449		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	18963915	CHEMBL4334913	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	Cc1ccc(-c2ccc(/C=C3/SC(=N)NC3=O)o2)c([N+](=O)[O-])c1		CHEMBL4561377	=	Inhibition	%	89.0	CHEMBL262	Homo sapiens	INH	%	89.0
Not Determined	18963916	CHEMBL4334913	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	Cc1ccc(Cl)cc1-c1ccc(/C=C2/S/C(=N\c3ccccc3)NC2=O)o1		CHEMBL4593954		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	18963917	CHEMBL4334913	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	N=C1NC(=O)/C(=C\c2ccc(-c3cc([N+](=O)[O-])ccc3Cl)o2)S1		CHEMBL4459001	=	Inhibition	%	65.0	CHEMBL262	Homo sapiens	INH	%	65.0
Not Determined	18963918	CHEMBL4334913	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	COc1ccc([N+](=O)[O-])cc1-c1ccc(/C=C2/SC(=N)NC2=O)o1		CHEMBL4463806		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Determined	18963919	CHEMBL4334913	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	COc1ccc([N+](=O)[O-])cc1-c1ccc(/C=C2/S/C(=N\C(C)=O)NC2=O)o1		CHEMBL4443667		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	18963920	CHEMBL4334913	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	Cc1ccc(-c2ccc(/C=C3/SC(=N)NC3=O)o2)cc1Cl		CHEMBL4519366	=	Inhibition	%	77.0	CHEMBL262	Homo sapiens	INH	%	77.0
Not Determined	18963921	CHEMBL4334913	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	CC(=O)/N=C1/NC(=O)/C(=C\c2ccc(-c3ccc(C)c(Cl)c3)o2)S1		CHEMBL4459906		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Determined	18963922	CHEMBL4334913	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	N=C1NC(=O)/C(=C\c2ccc(-c3ccc(Cl)c([N+](=O)[O-])c3)o2)S1		CHEMBL4465279		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	18963923	CHEMBL4334913	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	Cc1c(-c2ccc(/C=C3/SC(=N)NC3=O)o2)ccc([N+](=O)[O-])c1C		CHEMBL4536515	=	Inhibition	%	66.0	CHEMBL262	Homo sapiens	INH	%	66.0
	18963924	CHEMBL4334913	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	O=C1NC(=S)N/C1=C/c1ccc(-c2ccccc2Cl)o1		CHEMBL4456469	=	Inhibition	%	86.0	CHEMBL262	Homo sapiens	INH	%	86.0
Not Determined	18963925	CHEMBL4334913	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	CN1C(=O)/C(=C\c2ccc(-c3cccc(Cl)c3)o2)N(C)C1=S		CHEMBL4541565		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	18963926	CHEMBL4334913	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	O=C1NC(=S)N/C1=C/c1ccc(-c2cccc(C(=O)O)c2)o1		CHEMBL4526685	=	Inhibition	%	96.0	CHEMBL262	Homo sapiens	INH	%	96.0
Not Determined	18963927	CHEMBL4334913	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	CCCN1C(=O)/C(=C\c2ccc(-c3ccc(Cl)cc3)o2)NC1=S		CHEMBL4535203		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	18963928	CHEMBL4334913	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	O=C1NC(=S)N/C1=C/c1ccc(-c2ccc(C(=O)O)cc2)o1		CHEMBL4452978	=	Inhibition	%	91.0	CHEMBL262	Homo sapiens	INH	%	91.0
Not Determined	18963929	CHEMBL4334913	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	CCN1C(=O)/C(=C\c2ccc(-c3ccc(C(=O)O)cc3)o2)N(CC)C1=S		CHEMBL4541734		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	18963930	CHEMBL4334913	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	O=C1NC(=S)N/C1=C/c1ccc(-c2ccc([N+](=O)[O-])cc2)o1		CHEMBL4566633	=	Inhibition	%	72.0	CHEMBL262	Homo sapiens	INH	%	72.0
Not Determined	18963931	CHEMBL4334913	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	O=C1NC(=S)N/C1=C/c1ccc(Sc2ccc(Cl)cc2)o1		CHEMBL4584696		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Determined	18963932	CHEMBL4334913	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	CCN1C(=O)/C(=C\c2ccc(-c3ccc(Cl)cc3Cl)o2)NC1=S		CHEMBL4555724		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Determined	18963933	CHEMBL4334913	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	O=C1NC(=S)N/C1=C/c1ccc(-c2cc([N+](=O)[O-])ccc2Cl)o1		CHEMBL4535815		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	18963934	CHEMBL4334913	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	Cc1ccc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)cc1Cl		CHEMBL4519757	=	Inhibition	%	72.0	CHEMBL262	Homo sapiens	INH	%	72.0
	18963935	CHEMBL4334913	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	O=C1NC(=S)N/C1=C/c1ccc(-c2ccc(Cl)c(Cl)c2)o1		CHEMBL4436862	=	Inhibition	%	59.0	CHEMBL262	Homo sapiens	INH	%	59.0
	18963936	CHEMBL4334913	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	CCCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4452888	=	Inhibition	%	81.0	CHEMBL262	Homo sapiens	INH	%	81.0
	18963937	CHEMBL4334913	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Inhibition	%	92.0	CHEMBL262	Homo sapiens	INH	%	92.0
	18963938	CHEMBL4334913	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	CCCCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4444495	=	Inhibition	%	55.0	CHEMBL262	Homo sapiens	INH	%	55.0
Not Determined	18963939	CHEMBL4334913	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	O=C1NC(=S)N/C1=C/c1ccc(-c2c(Br)cc([N+](=O)[O-])cc2Br)o1		CHEMBL1408125		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	18963940	CHEMBL4334914	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	A	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2		CHEMBL362558	=	IC50	nM	1.29	CHEMBL262	Homo sapiens	IC50	nM	1.29
	18963941	CHEMBL4334914	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	A	N=C1NC(=O)/C(=C\c2ccc(-c3ccc(Cl)c(Cl)c3)o2)S1		CHEMBL4592453	=	IC50	nM	576.0	CHEMBL262	Homo sapiens	IC50	nM	576.0
	18963942	CHEMBL4334914	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	A	CN1C(=N)NC(=O)/C1=C\c1ccc(-c2ccc(F)cc2)o1		CHEMBL3437678	=	IC50	nM	1895.0	CHEMBL262	Homo sapiens	IC50	nM	1895.0
	18963943	CHEMBL4334914	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	A	Cc1ccc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)c(Br)c1		CHEMBL4467604	=	IC50	nM	862.0	CHEMBL262	Homo sapiens	IC50	nM	862.0
Not Determined	18963944	CHEMBL4334914	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	A	O=C1N/C(=N/c2ccccc2)S/C1=C/c1ccco1		CHEMBL4443427		IC50			CHEMBL262	Homo sapiens	IC50		
Not Determined	18963945	CHEMBL4334914	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	A	O=C1N/C(=N/c2ccccc2)S/C1=C/c1ccc(-c2ccccc2)o1		CHEMBL4539454		IC50			CHEMBL262	Homo sapiens	IC50		
Not Determined	18963946	CHEMBL4334914	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	A	O=C1N/C(=N/Cc2ccccc2)S/C1=C/c1ccc(-c2ccccc2)o1		CHEMBL4589530		IC50			CHEMBL262	Homo sapiens	IC50		
	18963947	CHEMBL4334914	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	A	N=C1NC(=O)/C(=C\c2ccc(-c3ccccc3Cl)o2)S1		CHEMBL4537545	=	IC50	nM	565.0	CHEMBL262	Homo sapiens	IC50	nM	565.0
	18963948	CHEMBL4334914	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	A	NC1=NC(=O)/C(=C\c2ccc(-c3ccccc3[N+](=O)[O-])o2)S1		CHEMBL1878704	=	IC50	nM	2495.0	CHEMBL262	Homo sapiens	IC50	nM	2495.0
Not Determined	18963949	CHEMBL4334914	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	A	CC(=O)/N=C1/NC(=O)/C(=C\c2ccc(-c3ccccc3C(=O)O)o2)S1		CHEMBL4437351		IC50			CHEMBL262	Homo sapiens	IC50		
	18963950	CHEMBL4334914	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	A	N=C1NC(=O)/C(=C\c2ccc(-c3cccc(Cl)c3)o2)S1		CHEMBL4558089	=	IC50	nM	767.0	CHEMBL262	Homo sapiens	IC50	nM	767.0
Not Determined	18963951	CHEMBL4334914	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	A	Cc1cc(C)cc(/N=C2/NC(=O)/C(=C\c3ccc(-c4cccc(Cl)c4)o3)S2)c1		CHEMBL4579205		IC50			CHEMBL262	Homo sapiens	IC50		
	18963952	CHEMBL4334914	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	A	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	IC50	nM	110.0	CHEMBL262	Homo sapiens	IC50	nM	110.0
	18963953	CHEMBL4334914	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	A	N=C1NC(=O)/C(=C\c2ccc(-c3cccc(C(=O)O)c3)o2)S1		CHEMBL4572532	=	IC50	nM	308.0	CHEMBL262	Homo sapiens	IC50	nM	308.0
Not Determined	18963954	CHEMBL4334914	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	A	O=C1N/C(=N/c2ccccc2)S/C1=C/c1ccc(-c2cccc(C(=O)O)c2)o1		CHEMBL4575432		IC50			CHEMBL262	Homo sapiens	IC50		
Not Determined	18963955	CHEMBL4334914	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	A	COC(=O)c1ccc(-c2ccc(/C=C3\C(=O)NC(=N)N3C)o2)cc1		CHEMBL3437676		IC50			CHEMBL262	Homo sapiens	IC50		
	18963956	CHEMBL4334914	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	A	CC(=O)/N=C1/NC(=O)/C(=C\c2ccc(-c3ccc(C(=O)O)cc3)o2)S1		CHEMBL4442366	=	IC50	nM	3724.0	CHEMBL262	Homo sapiens	IC50	nM	3724.0
Not Determined	18963957	CHEMBL4334914	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	A	O=C1N/C(=N/c2ccccc2)S/C1=C/c1ccc(Sc2ccc(Cl)cc2)o1		CHEMBL4577014		IC50			CHEMBL262	Homo sapiens	IC50		
Not Determined	18963958	CHEMBL4334914	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	A	CC(=O)/N=C1/NC(=O)/C(=C\c2ccc(-c3ccc(F)cc3F)o2)S1		CHEMBL4469930		IC50			CHEMBL262	Homo sapiens	IC50		
	18963959	CHEMBL4334914	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	A	N=C1NC(=O)/C(=C\c2ccc(-c3ccc(Cl)cc3Cl)o2)S1		CHEMBL4444620	=	IC50	nM	1196.0	CHEMBL262	Homo sapiens	IC50	nM	1196.0
Not Determined	18963960	CHEMBL4334914	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	A	N=C1NC(=O)/C(=C\c2ccc(-c3ccc([N+](=O)[O-])cc3Cl)o2)S1		CHEMBL4515342		IC50			CHEMBL262	Homo sapiens	IC50		
Not Determined	18963961	CHEMBL4334914	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	A	Cc1cc([N+](=O)[O-])ccc1-c1ccc(/C=C2/SC(=N)NC2=O)o1		CHEMBL4467699		IC50			CHEMBL262	Homo sapiens	IC50		
Not Determined	18963962	CHEMBL4334914	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	A	COc1cc([N+](=O)[O-])ccc1-c1ccc(/C=C2/SC(=N)NC2=O)o1		CHEMBL4468449		IC50			CHEMBL262	Homo sapiens	IC50		
	18963963	CHEMBL4334914	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	A	Cc1ccc(-c2ccc(/C=C3/SC(=N)NC3=O)o2)c([N+](=O)[O-])c1		CHEMBL4561377	=	IC50	nM	320.0	CHEMBL262	Homo sapiens	IC50	nM	320.0
Not Determined	18963964	CHEMBL4334914	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	A	Cc1ccc(Cl)cc1-c1ccc(/C=C2/S/C(=N\c3ccccc3)NC2=O)o1		CHEMBL4593954		IC50			CHEMBL262	Homo sapiens	IC50		
	18963965	CHEMBL4334914	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	A	N=C1NC(=O)/C(=C\c2ccc(-c3cc([N+](=O)[O-])ccc3Cl)o2)S1		CHEMBL4459001	=	IC50	nM	1758.0	CHEMBL262	Homo sapiens	IC50	nM	1758.0
Not Determined	18963966	CHEMBL4334914	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	A	COc1ccc([N+](=O)[O-])cc1-c1ccc(/C=C2/SC(=N)NC2=O)o1		CHEMBL4463806		IC50			CHEMBL262	Homo sapiens	IC50		
Not Determined	18963967	CHEMBL4334914	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	A	COc1ccc([N+](=O)[O-])cc1-c1ccc(/C=C2/S/C(=N\C(C)=O)NC2=O)o1		CHEMBL4443667		IC50			CHEMBL262	Homo sapiens	IC50		
	18963968	CHEMBL4334914	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	A	Cc1ccc(-c2ccc(/C=C3/SC(=N)NC3=O)o2)cc1Cl		CHEMBL4519366	=	IC50	nM	1429.0	CHEMBL262	Homo sapiens	IC50	nM	1429.0
Not Determined	18963969	CHEMBL4334914	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	A	CC(=O)/N=C1/NC(=O)/C(=C\c2ccc(-c3ccc(C)c(Cl)c3)o2)S1		CHEMBL4459906		IC50			CHEMBL262	Homo sapiens	IC50		
Not Determined	18963970	CHEMBL4334914	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	A	N=C1NC(=O)/C(=C\c2ccc(-c3ccc(Cl)c([N+](=O)[O-])c3)o2)S1		CHEMBL4465279		IC50			CHEMBL262	Homo sapiens	IC50		
	18963971	CHEMBL4334914	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	A	Cc1c(-c2ccc(/C=C3/SC(=N)NC3=O)o2)ccc([N+](=O)[O-])c1C		CHEMBL4536515	=	IC50	nM	571.0	CHEMBL262	Homo sapiens	IC50	nM	571.0
	18963972	CHEMBL4334914	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	A	O=C1NC(=S)N/C1=C/c1ccc(-c2ccccc2Cl)o1		CHEMBL4456469	=	IC50	nM	917.0	CHEMBL262	Homo sapiens	IC50	nM	917.0
Not Determined	18963973	CHEMBL4334914	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	A	CN1C(=O)/C(=C\c2ccc(-c3cccc(Cl)c3)o2)N(C)C1=S		CHEMBL4541565		IC50			CHEMBL262	Homo sapiens	IC50		
	18963974	CHEMBL4334914	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	A	O=C1NC(=S)N/C1=C/c1ccc(-c2cccc(C(=O)O)c2)o1		CHEMBL4526685	=	IC50	nM	338.0	CHEMBL262	Homo sapiens	IC50	nM	338.0
Not Determined	18963975	CHEMBL4334914	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	A	CCCN1C(=O)/C(=C\c2ccc(-c3ccc(Cl)cc3)o2)NC1=S		CHEMBL4535203		IC50			CHEMBL262	Homo sapiens	IC50		
	18963976	CHEMBL4334914	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	A	O=C1NC(=S)N/C1=C/c1ccc(-c2ccc(C(=O)O)cc2)o1		CHEMBL4452978	=	IC50	nM	743.0	CHEMBL262	Homo sapiens	IC50	nM	743.0
Not Determined	18963977	CHEMBL4334914	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	A	CCN1C(=O)/C(=C\c2ccc(-c3ccc(C(=O)O)cc3)o2)N(CC)C1=S		CHEMBL4541734		IC50			CHEMBL262	Homo sapiens	IC50		
	18963978	CHEMBL4334914	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	A	O=C1NC(=S)N/C1=C/c1ccc(-c2ccc([N+](=O)[O-])cc2)o1		CHEMBL4566633	=	IC50	nM	584.0	CHEMBL262	Homo sapiens	IC50	nM	584.0
Not Determined	18963979	CHEMBL4334914	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	A	O=C1NC(=S)N/C1=C/c1ccc(Sc2ccc(Cl)cc2)o1		CHEMBL4584696		IC50			CHEMBL262	Homo sapiens	IC50		
Not Determined	18963980	CHEMBL4334914	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	A	CCN1C(=O)/C(=C\c2ccc(-c3ccc(Cl)cc3Cl)o2)NC1=S		CHEMBL4555724		IC50			CHEMBL262	Homo sapiens	IC50		
Not Determined	18963981	CHEMBL4334914	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	A	O=C1NC(=S)N/C1=C/c1ccc(-c2cc([N+](=O)[O-])ccc2Cl)o1		CHEMBL4535815		IC50			CHEMBL262	Homo sapiens	IC50		
	18963982	CHEMBL4334914	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	A	Cc1ccc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)cc1Cl		CHEMBL4519757	=	IC50	nM	1291.0	CHEMBL262	Homo sapiens	IC50	nM	1291.0
	18963983	CHEMBL4334914	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	A	O=C1NC(=S)N/C1=C/c1ccc(-c2ccc(Cl)c(Cl)c2)o1		CHEMBL4436862	=	IC50	nM	678.0	CHEMBL262	Homo sapiens	IC50	nM	678.0
	18963984	CHEMBL4334914	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	A	CCCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4452888	=	IC50	nM	405.0	CHEMBL262	Homo sapiens	IC50	nM	405.0
	18963985	CHEMBL4334914	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	A	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	IC50	nM	218.0	CHEMBL262	Homo sapiens	IC50	nM	218.0
	18963986	CHEMBL4334914	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	A	CCCCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4444495	=	IC50	nM	1193.0	CHEMBL262	Homo sapiens	IC50	nM	1193.0
Not Determined	18963987	CHEMBL4334914	Inhibition of human GSK-3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay	A	O=C1NC(=S)N/C1=C/c1ccc(-c2c(Br)cc([N+](=O)[O-])cc2Br)o1		CHEMBL1408125		IC50			CHEMBL262	Homo sapiens	IC50		
	18964335	CHEMBL4335105	Inhibition of human GSK-3beta H350L mutant (2 to end residues) assessed as residual activity at 1 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	17.0	CHEMBL262	Homo sapiens	Activity	%	17.0
	18964336	CHEMBL4335105	Inhibition of human GSK-3beta H350L mutant (2 to end residues) assessed as residual activity at 1 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	A	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	31.0	CHEMBL262	Homo sapiens	Activity	%	31.0
Dose-dependent effect	18966546	CHEMBL4336118	Inhibition of GSK-3beta in human SH-SY5Y cells harboring with pCAX/FLAG-tagged APP and pRK5/EGFP-tagged Tau P301L mutant assessed as reduction in tau phosphorylation at S396 residues after 12 to 24 hrs by Western blot analysis	B	COc1cc(CCc2cc(OC)c(O)c(OC)c2)ccc1O		CHEMBL374047		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Dose-dependent effect	18966547	CHEMBL4336119	Inhibition of GSK-3beta in human SH-SY5Y cells harboring with pCAX/FLAG-tagged APP and pRK5/EGFP-tagged Tau P301L mutant assessed as reduction in tau phosphorylation at S404 residues after 12 to 24 hrs by Western blot analysis	B	COc1cc(CCc2cc(OC)c(O)c(OC)c2)ccc1O		CHEMBL374047		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	18966552	CHEMBL4336125	Inhibition of GSK3beta in human SH-SY5Y cells assessed as reduction in tau phosphorylation at S202/T205 residues at 0.1 to 5 uM pretreated for 12 to 24 hrs followed by OA addition and measured after 6 hrs by Western blot analysis	B	COc1cc(CCc2cc(OC)c(O)c(OC)c2)ccc1O		CHEMBL374047		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	18966553	CHEMBL4336126	Inhibition of GSK3beta in human SH-SY5Y cells assessed as reduction in tau phosphorylation at S262 residues at 0.1 to 5 uM pretreated for 12 to 24 hrs followed by OA addition and measured after 6 hrs by Western blot analysis	B	COc1cc(CCc2cc(OC)c(O)c(OC)c2)ccc1O		CHEMBL374047		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	18966558	CHEMBL4336129	Inhibition of GSK-3beta in human SH-SY5Y cells harboring with pCAX/FLAG-tagged APP and pRK5/EGFP-tagged Tau P301L mutant at 0.1 to 10 uM assessed as reduction in GSK-3beta phosphorylation at Tyr216 residues after 24 hrs by Western blot analysis	B	COc1cc(CCc2cc(OC)c(O)c(OC)c2)ccc1O		CHEMBL374047		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	18966559	CHEMBL4336130	Inhibition of GSK-3beta in human SH-SY5Y cells harboring with pCAX/FLAG-tagged APP and pRK5/EGFP-tagged Tau P301L mutant at 0.1 to 10 uM assessed as increase in GSK-3beta phosphorylation at Ser9 residues after 24 hrs by Western blot analysis	B	COc1cc(CCc2cc(OC)c(O)c(OC)c2)ccc1O		CHEMBL374047		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	18966560	CHEMBL4336111	Inhibition of GSK-3beta in human SH-SY5Y cells assessed as reduction in GSK-3beta phosphorylation at Tyr216 residues at 0.1 to 5 uM pretreated for 24 hrs followed by OA addition and measured after 6 hrs by Western blot analysis	B	COc1cc(CCc2cc(OC)c(O)c(OC)c2)ccc1O		CHEMBL374047		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	18966561	CHEMBL4336131	Inhibition of GSK-3beta in human SH-SY5Y cells assessed as increase in GSK-3beta phosphorylation at Ser9 residues at 0.1 to 5 uM pretreated for 24 hrs followed by OA addition and measured after 6 hrs by Western blot analysis	B	COc1cc(CCc2cc(OC)c(O)c(OC)c2)ccc1O		CHEMBL374047		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	18971922	CHEMBL4336932	Inhibition of human GSK-3beta H350L mutant (2 to end residues) assessed as residual activity at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	81.0	CHEMBL262	Homo sapiens	Activity	%	81.0
	18972847	CHEMBL4337346	Inhibition of full-length N-terminal GST-tagged human GSK3beta (1 to 420 residues) expressed in baculovirus expression system at 10 uM using propeptide-15 as substrate after 3 hrs by electrophoretic mobility shift assay relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1NC(=O)c1ccc2c(c1)OCCO2		CHEMBL4580637	=	Inhibition	%	7.0	CHEMBL262	Homo sapiens	INH	%	7.0
Not Active	18986549	CHEMBL4340157	inhibition of GSK3beta (unknown origin) by LANCE Ultra TR-FRET assay	A	CCCCCCCOCC12c3ccccc3C(c3ccccc31)C1C(=O)NC(=O)C12		CHEMBL4541878		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	18989433	CHEMBL4340799	Inhibition of GSK-3beta (unknown origin) at 1 uM using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition by caliper assay relative to control	B	Nc1ncc(-c2ccncc2)cc1NCc1ccnc(NC(=O)C2CC2)c1		CHEMBL4449556	=	Inhibition	%	27.0	CHEMBL262	Homo sapiens	INH	%	27.0
	18989434	CHEMBL4340799	Inhibition of GSK-3beta (unknown origin) at 1 uM using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition by caliper assay relative to control	B	Cc1csc(-c2cnc(N)c(NCc3ccnc(NC(=O)C4CC4)c3)c2)c1		CHEMBL4470125	=	Inhibition	%	17.0	CHEMBL262	Homo sapiens	INH	%	17.0
	18989435	CHEMBL4340799	Inhibition of GSK-3beta (unknown origin) at 1 uM using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition by caliper assay relative to control	B	Cc1ccc(-c2cnc(N)c(NCc3ccnc(NC(=O)C4CC4)c3)c2)cc1		CHEMBL4465292	=	Inhibition	%	28.0	CHEMBL262	Homo sapiens	INH	%	28.0
	18989436	CHEMBL4340799	Inhibition of GSK-3beta (unknown origin) at 1 uM using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition by caliper assay relative to control	B	Nc1ncc(-c2ccccc2)cc1NCc1ccnc(NC(=O)C2CC2)c1		CHEMBL4465193	=	Inhibition	%	27.0	CHEMBL262	Homo sapiens	INH	%	27.0
	18989437	CHEMBL4340799	Inhibition of GSK-3beta (unknown origin) at 1 uM using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition by caliper assay relative to control	B	Nc1ncccc1NCc1ccnc(NC(=O)C2CC2)c1		CHEMBL4472641	=	Inhibition	%	33.0	CHEMBL262	Homo sapiens	INH	%	33.0
	18989438	CHEMBL4340799	Inhibition of GSK-3beta (unknown origin) at 1 uM using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition by caliper assay relative to control	B	Nc1ncc(-c2ccc(F)cc2)cc1NC(=O)c1ccnc(NC(=O)C2CC2)c1		CHEMBL4550261	=	Inhibition	%	95.0	CHEMBL262	Homo sapiens	INH	%	95.0
	18989439	CHEMBL4340799	Inhibition of GSK-3beta (unknown origin) at 1 uM using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition by caliper assay relative to control	B	Nc1ncc(-c2ccncc2)cc1NC(=O)c1ccnc(NC(=O)C2CC2)c1		CHEMBL4535643	=	Inhibition	%	99.0	CHEMBL262	Homo sapiens	INH	%	99.0
	18989440	CHEMBL4340799	Inhibition of GSK-3beta (unknown origin) at 1 uM using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition by caliper assay relative to control	B	Cc1csc(-c2cnc(N)c(NC(=O)c3ccnc(NC(=O)C4CC4)c3)c2)c1		CHEMBL4578996	=	Inhibition	%	102.0	CHEMBL262	Homo sapiens	INH	%	102.0
	18989441	CHEMBL4340799	Inhibition of GSK-3beta (unknown origin) at 1 uM using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition by caliper assay relative to control	B	Cc1ccc(-c2cnc(N)c(NC(=O)c3ccnc(NC(=O)C4CC4)c3)c2)cc1		CHEMBL4472042	=	Inhibition	%	99.0	CHEMBL262	Homo sapiens	INH	%	99.0
	18989442	CHEMBL4340799	Inhibition of GSK-3beta (unknown origin) at 1 uM using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition by caliper assay relative to control	B	Nc1ncc(-c2ccccc2)cc1NC(=O)c1ccnc(NC(=O)C2CC2)c1		CHEMBL4515584	=	Inhibition	%	98.0	CHEMBL262	Homo sapiens	INH	%	98.0
	18989443	CHEMBL4340799	Inhibition of GSK-3beta (unknown origin) at 1 uM using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition by caliper assay relative to control	B	Nc1ncccc1NC(=O)c1ccnc(NC(=O)C2CC2)c1		CHEMBL4442834	=	Inhibition	%	77.0	CHEMBL262	Homo sapiens	INH	%	77.0
	18989444	CHEMBL4340801	Inhibition of GSK-3beta (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition by caliper assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	24.0	CHEMBL262	Homo sapiens	IC50	nM	24.0
	18989445	CHEMBL4340801	Inhibition of GSK-3beta (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition by caliper assay	B	Nc1nccc(-c2ccc(Cl)cc2)c1/N=C/c1ccnc(NC(=O)C2CC2)c1		CHEMBL4453426	>	IC50	nM	2000.0	CHEMBL262	Homo sapiens	IC50	nM	2000.0
	18989446	CHEMBL4340801	Inhibition of GSK-3beta (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition by caliper assay	B	Nc1nccc(-c2cccc(F)c2)c1/N=C/c1ccnc(NC(=O)C2CC2)c1		CHEMBL4462480	=	IC50	nM	891.0	CHEMBL262	Homo sapiens	IC50	nM	891.0
	18989447	CHEMBL4340801	Inhibition of GSK-3beta (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition by caliper assay	B	Nc1nccc(-c2ccc(F)cc2)c1/N=C/c1ccnc(NC(=O)C2CC2)c1		CHEMBL4539700	=	IC50	nM	1204.0	CHEMBL262	Homo sapiens	IC50	nM	1204.0
	18989448	CHEMBL4340801	Inhibition of GSK-3beta (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition by caliper assay	B	Cc1ccc(-c2ccnc(N)c2/N=C/c2ccnc(NC(=O)C3CC3)c2)cc1		CHEMBL4460479	=	IC50	nM	1252.0	CHEMBL262	Homo sapiens	IC50	nM	1252.0
	18989449	CHEMBL4340801	Inhibition of GSK-3beta (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition by caliper assay	B	Nc1nccc(-c2ccccc2)c1/N=C/c1ccnc(NC(=O)C2CC2)c1		CHEMBL4580131	=	IC50	nM	633.0	CHEMBL262	Homo sapiens	IC50	nM	633.0
	18989450	CHEMBL4340801	Inhibition of GSK-3beta (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition by caliper assay	B	Nc1ncc(-c2ccc(F)cc2)cc1/N=C/c1ccnc(NC(=O)C2CC2)c1		CHEMBL4455516	=	IC50	nM	418.0	CHEMBL262	Homo sapiens	IC50	nM	418.0
	18989451	CHEMBL4340801	Inhibition of GSK-3beta (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition by caliper assay	B	Nc1ncc(-c2ccncc2)cc1/N=C/c1ccnc(NC(=O)C2CC2)c1		CHEMBL4454448	=	IC50	nM	38.0	CHEMBL262	Homo sapiens	IC50	nM	38.0
	18989452	CHEMBL4340801	Inhibition of GSK-3beta (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition by caliper assay	B	Cc1csc(-c2cnc(N)c(/N=C/c3ccnc(NC(=O)C4CC4)c3)c2)c1		CHEMBL4474810	=	IC50	nM	315.0	CHEMBL262	Homo sapiens	IC50	nM	315.0
	18989453	CHEMBL4340801	Inhibition of GSK-3beta (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition by caliper assay	B	Cc1ccc(-c2cnc(N)c(/N=C/c3ccnc(NC(=O)C4CC4)c3)c2)cc1		CHEMBL4458206	=	IC50	nM	372.0	CHEMBL262	Homo sapiens	IC50	nM	372.0
	18989454	CHEMBL4340801	Inhibition of GSK-3beta (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition by caliper assay	B	Nc1ncc(-c2ccccc2)cc1/N=C/c1ccnc(NC(=O)C2CC2)c1		CHEMBL4559169	=	IC50	nM	49.0	CHEMBL262	Homo sapiens	IC50	nM	49.0
	18989455	CHEMBL4340801	Inhibition of GSK-3beta (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition by caliper assay	B	Nc1ncccc1/N=C/c1ccnc(NC(=O)C2CC2)c1		CHEMBL4467668	=	IC50	nM	71.0	CHEMBL262	Homo sapiens	IC50	nM	71.0
	18989456	CHEMBL4340801	Inhibition of GSK-3beta (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition by caliper assay	B	Nc1ncc(-c2ccc(F)cc2)cc1NC(=O)c1ccnc(NC(=O)C2CC2)c1		CHEMBL4550261	=	IC50	nM	240.0	CHEMBL262	Homo sapiens	IC50	nM	240.0
	18989457	CHEMBL4340801	Inhibition of GSK-3beta (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition by caliper assay	B	Nc1ncc(-c2ccncc2)cc1NC(=O)c1ccnc(NC(=O)C2CC2)c1		CHEMBL4535643	=	IC50	nM	199.0	CHEMBL262	Homo sapiens	IC50	nM	199.0
	18989458	CHEMBL4340801	Inhibition of GSK-3beta (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition by caliper assay	B	Cc1csc(-c2cnc(N)c(NC(=O)c3ccnc(NC(=O)C4CC4)c3)c2)c1		CHEMBL4578996	=	IC50	nM	219.0	CHEMBL262	Homo sapiens	IC50	nM	219.0
	18989459	CHEMBL4340801	Inhibition of GSK-3beta (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition by caliper assay	B	Cc1ccc(-c2cnc(N)c(NC(=O)c3ccnc(NC(=O)C4CC4)c3)c2)cc1		CHEMBL4472042	=	IC50	nM	127.0	CHEMBL262	Homo sapiens	IC50	nM	127.0
	18989460	CHEMBL4340801	Inhibition of GSK-3beta (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition by caliper assay	B	Nc1ncc(-c2ccccc2)cc1NC(=O)c1ccnc(NC(=O)C2CC2)c1		CHEMBL4515584	=	IC50	nM	148.0	CHEMBL262	Homo sapiens	IC50	nM	148.0
	18989461	CHEMBL4340801	Inhibition of GSK-3beta (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition by caliper assay	B	Nc1ncccc1NC(=O)c1ccnc(NC(=O)C2CC2)c1		CHEMBL4442834	=	IC50	nM	629.0	CHEMBL262	Homo sapiens	IC50	nM	629.0
Dose-dependent effect	18989550	CHEMBL4340826	Inhibition of GSK3bbeta in human SH-SY5Y cells assessed as reduction in human amyloid beta (25 to 35) peptide-induced tau hyperphosphorylation at Ser396 residue preincubated for 1 hr followed by amyloid beta-stimulation and measured after 6 hrs by Western blot analysis	B	Nc1ncccc1/N=C/c1ccnc(NC(=O)C2CC2)c1		CHEMBL4467668		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Dose-dependent effect	18989551	CHEMBL4340826	Inhibition of GSK3bbeta in human SH-SY5Y cells assessed as reduction in human amyloid beta (25 to 35) peptide-induced tau hyperphosphorylation at Ser396 residue preincubated for 1 hr followed by amyloid beta-stimulation and measured after 6 hrs by Western blot analysis	B	Nc1ncc(-c2ccccc2)cc1/N=C/c1ccnc(NC(=O)C2CC2)c1		CHEMBL4559169		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Dose-dependent effect	18989552	CHEMBL4340826	Inhibition of GSK3bbeta in human SH-SY5Y cells assessed as reduction in human amyloid beta (25 to 35) peptide-induced tau hyperphosphorylation at Ser396 residue preincubated for 1 hr followed by amyloid beta-stimulation and measured after 6 hrs by Western blot analysis	B	Nc1ncc(-c2ccncc2)cc1/N=C/c1ccnc(NC(=O)C2CC2)c1		CHEMBL4454448		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	18989553	CHEMBL4340823	Inhibition of GSK3bbeta in human SH-SY5Y cells assessed as reduction in human amyloid beta (25 to 35) peptide-induced tau hyperphosphorylation at Ser396 residue at 25 uM preincubated for 1 hr followed by amyloid beta-stimulation and measured after 6 hrs by Western blot analysis relative to control	B	Nc1ncccc1/N=C/c1ccnc(NC(=O)C2CC2)c1		CHEMBL4467668	<=	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	18989554	CHEMBL4340823	Inhibition of GSK3bbeta in human SH-SY5Y cells assessed as reduction in human amyloid beta (25 to 35) peptide-induced tau hyperphosphorylation at Ser396 residue at 25 uM preincubated for 1 hr followed by amyloid beta-stimulation and measured after 6 hrs by Western blot analysis relative to control	B	Nc1ncc(-c2ccccc2)cc1/N=C/c1ccnc(NC(=O)C2CC2)c1		CHEMBL4559169	<=	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	18989555	CHEMBL4340823	Inhibition of GSK3bbeta in human SH-SY5Y cells assessed as reduction in human amyloid beta (25 to 35) peptide-induced tau hyperphosphorylation at Ser396 residue at 25 uM preincubated for 1 hr followed by amyloid beta-stimulation and measured after 6 hrs by Western blot analysis relative to control	B	Nc1ncc(-c2ccncc2)cc1/N=C/c1ccnc(NC(=O)C2CC2)c1		CHEMBL4454448	<=	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
Active	18989569	CHEMBL4340837	Inhibition of GSK3bbeta in human SH-SY5Y cells assessed as reduction in human amyloid beta (25 to 35) peptide-induced tau hyperphosphorylation at Ser396 residue at 20 mM preincubated for 1 hr followed by amyloid beta-stimulation and measured after 6 hrs by Western blot analysis	B	[Cl-].[Li+]		CHEMBL69710		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	18996676	CHEMBL4342538	Inhibition of GSK3beta (unknown origin) using GS-1 peptide as a substrate after 30 mins in presence of [gamma32P]ATP by scintillation counting method	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	uM	1.0
	19021502	CHEMBL4347723	Inhibition of recombinant human GSK3beta at 20 nM using Ulight-CFFKNIVTPRTPPPSQGK-amide as substrate measured after 90 mins by LANCE method relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	8.0	CHEMBL262	Homo sapiens	INH	%	8.0
	19021503	CHEMBL4347724	Inhibition of recombinant human GSK3beta at 200 nM using Ulight-CFFKNIVTPRTPPPSQGK-amide as substrate measured after 90 mins by LANCE method relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	48.0	CHEMBL262	Homo sapiens	INH	%	48.0
	19032189	CHEMBL4349782	Inhibition of recombinant human full length N-terminal GST/His6-tagged GSK3-beta (M1 to T420) expressed in Sf9 insect cells at 20 nM using phosphatidylserine as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cn1cc(-c2n[nH]c3ccc(NCc4cc(F)ccc4S(C)(=O)=O)cc23)cn1		CHEMBL4555442	=	Inhibition	%	11.0	CHEMBL262	Homo sapiens	INH	%	11.0
	19035307	CHEMBL4350403	Inhibition of human GSK3B assessed as residual activity at 10 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate by [gamma-33P]-ATP assay	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1ccncn1)c2=O		CHEMBL4439094	=	Activity	%	100.0	CHEMBL262	Homo sapiens	Activity	%	100.0
Not Active	19039759	CHEMBL4351883	Inhibition of recombinant human GSK3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	19041131	CHEMBL4352392	Inhibition of human GSK3B at 10 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	19042445	CHEMBL4352766	Inhibition of human GSK3beta	B	CC(C)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3cc(-c4ccccc4)no3)n2)cc1		CHEMBL4440048	=	Ki	nM	650.0	CHEMBL262	Homo sapiens	Ki	nM	650.0
	19042446	CHEMBL4352766	Inhibition of human GSK3beta	B	CC(C)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3cc(-c4ccccc4)on3)n2)cc1		CHEMBL4530813	=	Ki	nM	530.0	CHEMBL262	Homo sapiens	Ki	nM	530.0
	19042447	CHEMBL4352766	Inhibition of human GSK3beta	B	CC(C)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3nnc(-c4ccccc4)o3)n2)cc1		CHEMBL4467820	=	Ki	nM	22.0	CHEMBL262	Homo sapiens	Ki	nM	22.0
	19042448	CHEMBL4352766	Inhibition of human GSK3beta	B	CNCc1ccc(-c2cc(-c3nc(-c4ccc(S(=O)(=O)C(C)C)cc4)cnc3N)on2)cc1		CHEMBL3989870	=	Ki	nM	140.0	CHEMBL262	Homo sapiens	Ki	nM	140.0
	19043584	CHEMBL4353128	Inhibition of GSK3beta (unknown origin)	B	COc1cc(/C=C/C(O)=C/C(=O)/C=C/c2ccc(OCc3ccccc3)cc2)ccc1O		CHEMBL3763944	=	IC50	nM	900.0	CHEMBL262	Homo sapiens	IC50	uM	0.9
	19051958	CHEMBL4355141	Inhibition of recombinant human N-terminal His6-tagged GK3beta H350L mutant using prephosphorylated polypeptide as substrate incubated for 30 mins by Kinase-Glo luminescent assay	B	NC1=NC(c2ccc(F)cc2)NC(=O)N1		CHEMBL3752684	=	IC50	nM	14670.0	CHEMBL262	Homo sapiens	IC50	uM	14.67
	19059614	CHEMBL4357915	Binding affinity to wild-type human full length GSK3B (M1 to T433 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	98.0	CHEMBL262	Homo sapiens	Activity	%	98.0
	19090180	CHEMBL4365754	Inhibition of wild-type human full length GSK3B (M1 to T433 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	100.0	CHEMBL262	Homo sapiens	Activity	%	100.0
	19091949	CHEMBL4366423	Inhibition of human GSK3B at 100 nM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1	Outside typical range	CHEMBL4528675	=	Inhibition	%	-10.68	CHEMBL262	Homo sapiens	INH	%	-10.68
	19121964	CHEMBL4373022	Inhibition of GSK3beta (unknown origin) at 0.1 uM relative to control	B	COCCC#Cc1c(Cl)c2c(Cl)cc(C(N)=O)nc2n1[C@H]1CCCNC1		CHEMBL4540910	=	Inhibition	%	48.0	CHEMBL262	Homo sapiens	INH	%	48.0
	19121972	CHEMBL4373030	Inhibition of GSK3beta (unknown origin) at 1 uM relative to control	B	COCCC#Cc1c(Cl)c2c(Cl)cc(C(N)=O)nc2n1[C@H]1CCCNC1		CHEMBL4540910	=	Inhibition	%	90.0	CHEMBL262	Homo sapiens	INH	%	90.0
	19124921	CHEMBL4373455	Binding affinity to recombinant full length human N-terminal GST-tagged GSK3beta expressed in sf9 cells by SPR analysis	B	Cc1ccccc1-n1nnc(C(=O)Nc2ccc3ccccc3n2)c1C		CHEMBL4454905	=	Kd	nM	4300.0	CHEMBL262	Homo sapiens	Kd	uM	4.3
	19140819	CHEMBL4376583	Inhibition of GSK3beta (unknown origin) at 1 uM using biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 to 60 mins in presence of ATP by HTRF assay relative to control	B	Cn1cc(-c2ccc(F)cc2)c(=O)c2c(Nc3ccc(Oc4ccnc(NC(=O)C5CC5)c4)c(F)c3)nccc21		CHEMBL4584949	<	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	19144863	CHEMBL4377879	Inhibition of human recombinant GSK3beta H350L mutant (2 to end residues) at 1 uM using YRRAAVPPSPSLSR as substrate incubated for 40 mins in presence of [gamma-33P]ATP at Km concentration by radiometric assay relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	32.0	CHEMBL262	Homo sapiens	INH	%	32.0
	19146948	CHEMBL4378844	Inhibition of recombinant human GSK3beta H350L mutant (2 to end residues) at 10 uM using phospho GS2 peptide as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CS(=O)(=O)Nc1ccc(Cc2ccc3ccccc3c2)cc1		CHEMBL4459587	=	Inhibition	%	-2.0	CHEMBL262	Homo sapiens	INH	%	-2.0
	19147873	CHEMBL4379347	Inhibition of human GSK-3beta H350L mutant (2 to end residues) using YRRAAVPPSPSLSR as substrate after 40 mins by [gamma-33ATP] radiometric assay	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	19159442	CHEMBL4382546	Binding affinity to wild-type human full length GSK3B (M1 to T433 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	93.0	CHEMBL262	Homo sapiens	Activity	%	93.0
	19172371	CHEMBL4385141	Inhibition of GSK3B (unknown origin)	B	CS(=O)(=O)Nc1cc(-c2ccncc2)cnc1Cl		CHEMBL4474208	<	IC50	nM	10000.0	CHEMBL262	Homo sapiens	pIC50		5.0
	19174665	CHEMBL4385763	Inhibition of human recombinant GSK-3beta using 19F peptide as substrate measured after 1.5 hrs by fluorescence method	B	O=c1[nH]c(=O)c2cc[nH]c2[nH]1		CHEMBL122899	=	IC50	nM	700.0	CHEMBL262	Homo sapiens	IC50	uM	0.7
	19181044	CHEMBL4387255	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system at 0.1 uM using serine/threonine-9 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	96.0	CHEMBL262	Homo sapiens	INH	%	96.0
	19181270	CHEMBL4387255	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system at 0.1 uM using serine/threonine-9 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	30.5	CHEMBL262	Homo sapiens	INH	%	30.5
	19191565	CHEMBL4389265	Inhibition of wild-type human full length GSK3B (M1 to T433 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	77.0	CHEMBL262	Homo sapiens	INH	%	77.0
	19191928	CHEMBL4389742	Inhibition of wild-type human full length GSK3B (M1 to T433 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	83.0	CHEMBL262	Homo sapiens	INH	%	83.0
	19200184	CHEMBL4391368	Binding affinity to wild-type human full length GSK3B (M1 to T433 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	17.0	CHEMBL262	Homo sapiens	Activity	%	17.0
Active	19208793	CHEMBL4392765	Time-dependent irreversible inhibition of recombinant human GSK3beta at 0.05 to 0.2 uM using prephosphorylated peptide as substrate by Kinase-glo luminescence assay	B	COc1ccc(CNC(=O)Nc2nc3ccc(C(=O)CBr)cc3[nH]2)cc1		CHEMBL4546384		TDI			CHEMBL262	Homo sapiens	TDI		
Active	19208794	CHEMBL4392764	Time-dependent irreversible inhibition of recombinant human GSK3beta at 0.05 to 0.1 uM using prephosphorylated peptide as substrate by Kinase-glo luminescence assay	B	COc1ccc(CNC(=O)Nc2nc3ccc(C#N)cc3[nH]2)cc1		CHEMBL4447545		TDI			CHEMBL262	Homo sapiens	TDI		
	19208795	CHEMBL4392763	Inhibition of recombinant human GSK3beta using prephosphorylated peptide as substrate measured after 30 mins by Kinase-glo luminescence assay	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	IC50	nM	72.0	CHEMBL262	Homo sapiens	IC50	uM	0.072
	19208796	CHEMBL4392763	Inhibition of recombinant human GSK3beta using prephosphorylated peptide as substrate measured after 30 mins by Kinase-glo luminescence assay	B	C=CC(=O)Nc1ccc2nc(NC(=O)NCc3ccc(OC)cc3)[nH]c2c1		CHEMBL4437756	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	19208797	CHEMBL4392763	Inhibition of recombinant human GSK3beta using prephosphorylated peptide as substrate measured after 30 mins by Kinase-glo luminescence assay	B	C#CC(=O)c1ccc2nc(NC(=O)NCc3ccc(OC)cc3)[nH]c2c1		CHEMBL4556827	=	IC50	nM	2470.0	CHEMBL262	Homo sapiens	IC50	uM	2.47
	19208798	CHEMBL4392763	Inhibition of recombinant human GSK3beta using prephosphorylated peptide as substrate measured after 30 mins by Kinase-glo luminescence assay	B	C=CC(=O)c1ccc2nc(NC(=O)NCc3ccc(OC)cc3)[nH]c2c1		CHEMBL4516941	=	IC50	nM	1820.0	CHEMBL262	Homo sapiens	IC50	uM	1.82
	19208799	CHEMBL4392763	Inhibition of recombinant human GSK3beta using prephosphorylated peptide as substrate measured after 30 mins by Kinase-glo luminescence assay	B	COc1ccc(CNC(=O)Nc2nc3ccc(C(=O)CBr)cc3[nH]2)cc1		CHEMBL4546384	=	IC50	nM	130.0	CHEMBL262	Homo sapiens	IC50	uM	0.13
	19208800	CHEMBL4392763	Inhibition of recombinant human GSK3beta using prephosphorylated peptide as substrate measured after 30 mins by Kinase-glo luminescence assay	B	COc1ccc(CNC(=O)Nc2nc3ccc(C(C)=O)cc3[nH]2)cc1		CHEMBL4452731	=	IC50	nM	260.0	CHEMBL262	Homo sapiens	IC50	uM	0.26
	19208801	CHEMBL4392763	Inhibition of recombinant human GSK3beta using prephosphorylated peptide as substrate measured after 30 mins by Kinase-glo luminescence assay	B	COc1ccc(CNC(=O)Nc2nc3ccc(C#N)cc3[nH]2)cc1		CHEMBL4447545	=	IC50	nM	86.0	CHEMBL262	Homo sapiens	IC50	uM	0.086
	19208802	CHEMBL4392763	Inhibition of recombinant human GSK3beta using prephosphorylated peptide as substrate measured after 30 mins by Kinase-glo luminescence assay	B	C=CC(=O)Nc1ccc2nc(NC(=O)NCc3ccc(OC)cc3)sc2c1		CHEMBL4461606	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	19208803	CHEMBL4392763	Inhibition of recombinant human GSK3beta using prephosphorylated peptide as substrate measured after 30 mins by Kinase-glo luminescence assay	B	C#CC(=O)c1ccc2nc(NC(=O)NCc3ccc(OC)cc3)sc2c1		CHEMBL4571262	=	IC50	nM	4210.0	CHEMBL262	Homo sapiens	IC50	uM	4.21
	19208804	CHEMBL4392763	Inhibition of recombinant human GSK3beta using prephosphorylated peptide as substrate measured after 30 mins by Kinase-glo luminescence assay	B	C=CC(=O)c1ccc2nc(NC(=O)NCc3ccc(OC)cc3)sc2c1		CHEMBL4573681	=	IC50	nM	4050.0	CHEMBL262	Homo sapiens	IC50	uM	4.05
	19208805	CHEMBL4392763	Inhibition of recombinant human GSK3beta using prephosphorylated peptide as substrate measured after 30 mins by Kinase-glo luminescence assay	B	COc1ccc(CNC(=O)Nc2nc3ccc(C(=O)CBr)cc3s2)cc1		CHEMBL4532931	=	IC50	nM	770.0	CHEMBL262	Homo sapiens	IC50	uM	0.77
	19208806	CHEMBL4392763	Inhibition of recombinant human GSK3beta using prephosphorylated peptide as substrate measured after 30 mins by Kinase-glo luminescence assay	B	COc1ccc(CNC(=O)Nc2nc3ccc(C(C)=O)cc3s2)cc1		CHEMBL4452831	=	IC50	nM	2260.0	CHEMBL262	Homo sapiens	IC50	uM	2.26
	19208807	CHEMBL4392763	Inhibition of recombinant human GSK3beta using prephosphorylated peptide as substrate measured after 30 mins by Kinase-glo luminescence assay	B	COc1ccc(CNC(=O)Nc2nc3ccc(C#N)cc3s2)cc1		CHEMBL1824333	=	IC50	nM	110.0	CHEMBL262	Homo sapiens	IC50	uM	0.11
	19210493	CHEMBL4393036	Inhibition of recombinant human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay	B	O=C1Nc2ccccc2C1=Cc1cccnc1		CHEMBL4520227	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	19210494	CHEMBL4393036	Inhibition of recombinant human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay	B	COC(=O)Nc1ccc2c(c1)C(=Cc1ccc([N+](=O)[O-])cc1)C(=O)N2		CHEMBL4514599	=	IC50	nM	347.9	CHEMBL262	Homo sapiens	IC50	uM	0.3479
	19210495	CHEMBL4393036	Inhibition of recombinant human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay	B	COC(=O)Nc1ccc2c(c1)/C(=C/c1ccc(Br)cc1)C(=O)N2		CHEMBL4525020	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	19210496	CHEMBL4393036	Inhibition of recombinant human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay	B	COC(=O)Nc1ccc2c(c1)/C(=C/c1ccc(O)cc1)C(=O)N2		CHEMBL4474153	=	IC50	nM	155.4	CHEMBL262	Homo sapiens	IC50	uM	0.1554
	19210497	CHEMBL4393036	Inhibition of recombinant human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay	B	COc1cc(/C=C2\C(=O)Nc3ccc(NC(C)=O)cc32)cc(OC)c1OC		CHEMBL4450851	=	IC50	nM	232.9	CHEMBL262	Homo sapiens	IC50	uM	0.2329
	19210498	CHEMBL4393036	Inhibition of recombinant human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay	B	CC(=O)Nc1ccc2c(c1)/C(=C/c1cccc(O)c1)C(=O)N2		CHEMBL4537467	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	19210499	CHEMBL4393036	Inhibition of recombinant human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay	B	O=C1Nc2ccc(Nc3ccco3)cc2C1=Cc1ccc(O)cc1		CHEMBL4438406	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	19210500	CHEMBL4393036	Inhibition of recombinant human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay	B	COc1cc(/C=C2\C(=O)Nc3ccc(Nc4ccco4)cc32)cc(OC)c1OC		CHEMBL4516094	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	19210501	CHEMBL4393036	Inhibition of recombinant human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay	B	O=C1Nc2ccc(NC(=O)c3ccccc3)cc2/C1=C/c1ccc(O)cc1		CHEMBL4454916	=	IC50	nM	4343.0	CHEMBL262	Homo sapiens	IC50	uM	4.343
	19210502	CHEMBL4393036	Inhibition of recombinant human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay	B	O=C1Nc2ccc(Br)cc2C1=Cc1ccc(Br)cc1		CHEMBL4580857	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	19210503	CHEMBL4393036	Inhibition of recombinant human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay	B	O=C1Nc2ccccc2/C1=C/c1ccccn1		CHEMBL2094331	=	IC50	nM	4.19	CHEMBL262	Homo sapiens	IC50	uM	0.00419
	19210504	CHEMBL4393035	Inhibition of recombinant human GSK3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay relative to control	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714	=	Inhibition	%	93.23	CHEMBL262	Homo sapiens	INH	%	93.23
	19210505	CHEMBL4393035	Inhibition of recombinant human GSK3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C1Nc2ccccc2C12CC2c1ccccn1		CHEMBL4440139	=	Inhibition	%	71.29	CHEMBL262	Homo sapiens	INH	%	71.29
	19210506	CHEMBL4393035	Inhibition of recombinant human GSK3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay relative to control	B	Cc1ccc(C(=O)/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL4545169	=	Inhibition	%	27.87	CHEMBL262	Homo sapiens	INH	%	27.87
	19210507	CHEMBL4393035	Inhibition of recombinant human GSK3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay relative to control	B	CCC(=O)Nc1cc(NC(=O)CC)c2c(c1)C(CC#N)(OC(=O)CC)C(=O)N2		CHEMBL4101711	=	Inhibition	%	4.45	CHEMBL262	Homo sapiens	INH	%	4.45
	19210508	CHEMBL4393035	Inhibition of recombinant human GSK3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay relative to control	B	COc1cc(NC(C)=O)c2c(c1)C(CC#N)(OC(C)=O)C(=O)N2		CHEMBL4085946	=	Inhibition	%	6.98	CHEMBL262	Homo sapiens	INH	%	6.98
	19210509	CHEMBL4393035	Inhibition of recombinant human GSK3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay relative to control	B	CC(=O)Nc1ccc2c(c1)C(CC(=O)O)(OC(C)=O)C(=O)N2		CHEMBL4544396	=	Inhibition	%	0.65	CHEMBL262	Homo sapiens	INH	%	0.65
	19210510	CHEMBL4393035	Inhibition of recombinant human GSK3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay relative to control	B	COc1ccc2c(c1)/C(=C/C#N)C(=O)N2Cc1ccccc1		CHEMBL4464997	=	Inhibition	%	12.56	CHEMBL262	Homo sapiens	INH	%	12.56
	19210511	CHEMBL4393035	Inhibition of recombinant human GSK3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay relative to control	B	N#CCC1(O)C(=O)Nc2ccc(NC(=O)c3ccccc3)cc21		CHEMBL4449604	=	Inhibition	%	3.89	CHEMBL262	Homo sapiens	INH	%	3.89
	19210512	CHEMBL4393035	Inhibition of recombinant human GSK3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay relative to control	B	COc1ccc2c(c1)/C(=C/C(=O)O)C(=O)N2		CHEMBL4442846	=	Inhibition	%	3.44	CHEMBL262	Homo sapiens	INH	%	3.44
	19210513	CHEMBL4393035	Inhibition of recombinant human GSK3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay relative to control	B	COc1ccc(C(=O)CC2(O)C(=O)Nc3ccccc32)cc1		CHEMBL3360387	=	Inhibition	%	14.58	CHEMBL262	Homo sapiens	INH	%	14.58
	19210514	CHEMBL4393035	Inhibition of recombinant human GSK3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay relative to control	B	Cc1ccc(C(=O)CC2(O)C(=O)Nc3ccccc32)cc1		CHEMBL4586793	=	Inhibition	%	11.28	CHEMBL262	Homo sapiens	INH	%	11.28
	19210515	CHEMBL4393035	Inhibition of recombinant human GSK3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay relative to control	B	Cc1ccc(C(=O)CC2(O)C(=O)Nc3ccc(Nc4ccco4)cc32)cc1		CHEMBL4529655	=	Inhibition	%	64.25	CHEMBL262	Homo sapiens	INH	%	64.25
	19210516	CHEMBL4393035	Inhibition of recombinant human GSK3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay relative to control	B	COc1ccc(C(=O)CC2(O)C(=O)Nc3ccc(Br)cc32)cc1		CHEMBL4577668	=	Inhibition	%	6.98	CHEMBL262	Homo sapiens	INH	%	6.98
	19210517	CHEMBL4393035	Inhibition of recombinant human GSK3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay relative to control	B	Cc1ccc(C(=O)CC2(O)C(=O)Nc3ccc(Br)cc32)cc1		CHEMBL4549051	=	Inhibition	%	3.89	CHEMBL262	Homo sapiens	INH	%	3.89
	19210518	CHEMBL4393035	Inhibition of recombinant human GSK3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay relative to control	B	COc1ccc2c(c1)C(O)(CC(=O)c1ccc(C)cc1)C(=O)N2		CHEMBL4585682	=	Inhibition	%	-4.68	CHEMBL262	Homo sapiens	INH	%	-4.68
	19210519	CHEMBL4393035	Inhibition of recombinant human GSK3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C1Nc2ccc([N+](=O)[O-])cc2/C1=C/c1ccco1		CHEMBL4436958	=	Inhibition	%	80.13	CHEMBL262	Homo sapiens	INH	%	80.13
	19210520	CHEMBL4393035	Inhibition of recombinant human GSK3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C1Nc2ccc([N+](=O)[O-])cc2C1=Cc1ccncc1		CHEMBL4452454	=	Inhibition	%	42.11	CHEMBL262	Homo sapiens	INH	%	42.11
	19210521	CHEMBL4393035	Inhibition of recombinant human GSK3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C1Nc2ccc([N+](=O)[O-])cc2C1=Cc1cccnc1		CHEMBL4451858	=	Inhibition	%	34.05	CHEMBL262	Homo sapiens	INH	%	34.05
	19210522	CHEMBL4393035	Inhibition of recombinant human GSK3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C1Nc2ccc([N+](=O)[O-])cc2/C1=C\c1ccccn1		CHEMBL4465183	=	Inhibition	%	87.6	CHEMBL262	Homo sapiens	INH	%	87.6
	19210523	CHEMBL4393035	Inhibition of recombinant human GSK3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C1Nc2ccc(Br)cc2C1=Cc1ccco1		CHEMBL4517715	=	Inhibition	%	29.65	CHEMBL262	Homo sapiens	INH	%	29.65
	19210524	CHEMBL4393035	Inhibition of recombinant human GSK3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C1Nc2ccc(Br)cc2C1=Cc1cccs1		CHEMBL4467292	=	Inhibition	%	34.99	CHEMBL262	Homo sapiens	INH	%	34.99
	19210525	CHEMBL4393035	Inhibition of recombinant human GSK3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C1Nc2ccc(Br)cc2C1=Cc1ccncc1		CHEMBL4469665	=	Inhibition	%	53.69	CHEMBL262	Homo sapiens	INH	%	53.69
	19210526	CHEMBL4393035	Inhibition of recombinant human GSK3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C1Nc2ccc(Br)cc2C1=Cc1cccnc1		CHEMBL4578156	=	Inhibition	%	52.48	CHEMBL262	Homo sapiens	INH	%	52.48
	19210527	CHEMBL4393035	Inhibition of recombinant human GSK3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C1Nc2ccc(Br)cc2/C1=C\c1ccccn1		CHEMBL4476606	=	Inhibition	%	48.08	CHEMBL262	Homo sapiens	INH	%	48.08
	19210528	CHEMBL4393035	Inhibition of recombinant human GSK3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccco1		CHEMBL2347073	=	Inhibition	%	2.03	CHEMBL262	Homo sapiens	INH	%	2.03
	19210529	CHEMBL4393035	Inhibition of recombinant human GSK3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C1Nc2ccccc2/C1=C/c1cccs1		CHEMBL3633203	=	Inhibition	%	28.22	CHEMBL262	Homo sapiens	INH	%	28.22
	19210530	CHEMBL4393035	Inhibition of recombinant human GSK3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C1Nc2ccccc2C1=Cc1ccncc1		CHEMBL4448193	=	Inhibition	%	37.5	CHEMBL262	Homo sapiens	INH	%	37.5
	19210531	CHEMBL4393035	Inhibition of recombinant human GSK3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C1Nc2ccccc2C1=Cc1cccnc1		CHEMBL4520227	=	Inhibition	%	18.93	CHEMBL262	Homo sapiens	INH	%	18.93
	19210532	CHEMBL4393035	Inhibition of recombinant human GSK3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay relative to control	B	COC(=O)Nc1ccc2c(c1)C(=Cc1ccc([N+](=O)[O-])cc1)C(=O)N2		CHEMBL4514599	=	Inhibition	%	69.29	CHEMBL262	Homo sapiens	INH	%	69.29
	19210533	CHEMBL4393035	Inhibition of recombinant human GSK3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay relative to control	B	COC(=O)Nc1ccc2c(c1)/C(=C/c1ccc(Br)cc1)C(=O)N2		CHEMBL4525020	=	Inhibition	%	-3.55	CHEMBL262	Homo sapiens	INH	%	-3.55
	19210534	CHEMBL4393035	Inhibition of recombinant human GSK3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay relative to control	B	COC(=O)Nc1ccc2c(c1)/C(=C/c1ccc(O)cc1)C(=O)N2		CHEMBL4474153	=	Inhibition	%	91.82	CHEMBL262	Homo sapiens	INH	%	91.82
	19210535	CHEMBL4393035	Inhibition of recombinant human GSK3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay relative to control	B	COc1cc(/C=C2\C(=O)Nc3ccc(NC(C)=O)cc32)cc(OC)c1OC		CHEMBL4450851	=	Inhibition	%	84.16	CHEMBL262	Homo sapiens	INH	%	84.16
	19210536	CHEMBL4393035	Inhibition of recombinant human GSK3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay relative to control	B	CC(=O)Nc1ccc2c(c1)/C(=C/c1cccc(O)c1)C(=O)N2		CHEMBL4537467	=	Inhibition	%	39.9	CHEMBL262	Homo sapiens	INH	%	39.9
	19210537	CHEMBL4393035	Inhibition of recombinant human GSK3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C1Nc2ccc(Nc3ccco3)cc2C1=Cc1ccc(O)cc1		CHEMBL4438406	=	Inhibition	%	36.82	CHEMBL262	Homo sapiens	INH	%	36.82
	19210538	CHEMBL4393035	Inhibition of recombinant human GSK3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay relative to control	B	COc1cc(/C=C2\C(=O)Nc3ccc(Nc4ccco4)cc32)cc(OC)c1OC		CHEMBL4516094	=	Inhibition	%	26.93	CHEMBL262	Homo sapiens	INH	%	26.93
	19210539	CHEMBL4393035	Inhibition of recombinant human GSK3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C1Nc2ccc(NC(=O)c3ccccc3)cc2/C1=C/c1ccc(O)cc1		CHEMBL4454916	=	Inhibition	%	58.94	CHEMBL262	Homo sapiens	INH	%	58.94
	19210540	CHEMBL4393035	Inhibition of recombinant human GSK3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C1Nc2ccc(Br)cc2C1=Cc1ccc(Br)cc1		CHEMBL4580857	=	Inhibition	%	43.83	CHEMBL262	Homo sapiens	INH	%	43.83
	19210541	CHEMBL4393035	Inhibition of recombinant human GSK3beta at 10 uM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccccn1		CHEMBL2094331	=	Inhibition	%	95.7	CHEMBL262	Homo sapiens	INH	%	95.7
	19210542	CHEMBL4393036	Inhibition of recombinant human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay	B	O=C1Nc2ccccc2C1=Cc1ccncc1		CHEMBL4448193	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	19210543	CHEMBL4393036	Inhibition of recombinant human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay	B	O=C1Nc2ccccc2/C1=C/c1cccs1		CHEMBL3633203	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	19210544	CHEMBL4393036	Inhibition of recombinant human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay	B	O=C1Nc2ccccc2/C1=C/c1ccco1		CHEMBL2347073	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	19210545	CHEMBL4393036	Inhibition of recombinant human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay	B	O=C1Nc2ccc(Br)cc2/C1=C\c1ccccn1		CHEMBL4476606	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	19210546	CHEMBL4393036	Inhibition of recombinant human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay	B	O=C1Nc2ccc(Br)cc2C1=Cc1cccnc1		CHEMBL4578156	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	19210547	CHEMBL4393036	Inhibition of recombinant human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay	B	O=C1Nc2ccc(Br)cc2C1=Cc1ccncc1		CHEMBL4469665	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	19210548	CHEMBL4393036	Inhibition of recombinant human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay	B	O=C1Nc2ccc(Br)cc2C1=Cc1cccs1		CHEMBL4467292	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	19210549	CHEMBL4393036	Inhibition of recombinant human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay	B	O=C1Nc2ccc(Br)cc2C1=Cc1ccco1		CHEMBL4517715	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	19210550	CHEMBL4393036	Inhibition of recombinant human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay	B	O=C1Nc2ccc([N+](=O)[O-])cc2/C1=C\c1ccccn1		CHEMBL4465183	=	IC50	nM	20000.0	CHEMBL262	Homo sapiens	IC50	uM	20.0
	19210551	CHEMBL4393036	Inhibition of recombinant human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay	B	O=C1Nc2ccc([N+](=O)[O-])cc2C1=Cc1cccnc1		CHEMBL4451858	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	19210552	CHEMBL4393036	Inhibition of recombinant human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay	B	O=C1Nc2ccc([N+](=O)[O-])cc2C1=Cc1ccncc1		CHEMBL4452454	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	19210553	CHEMBL4393036	Inhibition of recombinant human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay	B	O=C1Nc2ccc([N+](=O)[O-])cc2/C1=C/c1ccco1		CHEMBL4436958	=	IC50	nM	12750.0	CHEMBL262	Homo sapiens	IC50	uM	12.75
	19210554	CHEMBL4393036	Inhibition of recombinant human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay	B	COc1ccc2c(c1)C(O)(CC(=O)c1ccc(C)cc1)C(=O)N2		CHEMBL4585682	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	19210555	CHEMBL4393036	Inhibition of recombinant human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay	B	Cc1ccc(C(=O)CC2(O)C(=O)Nc3ccc(Br)cc32)cc1		CHEMBL4549051	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	19210556	CHEMBL4393036	Inhibition of recombinant human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay	B	COc1ccc(C(=O)CC2(O)C(=O)Nc3ccc(Br)cc32)cc1		CHEMBL4577668	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	19210557	CHEMBL4393036	Inhibition of recombinant human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay	B	Cc1ccc(C(=O)CC2(O)C(=O)Nc3ccc(Nc4ccco4)cc32)cc1		CHEMBL4529655	=	IC50	nM	1717.0	CHEMBL262	Homo sapiens	IC50	uM	1.717
	19210558	CHEMBL4393036	Inhibition of recombinant human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay	B	Cc1ccc(C(=O)CC2(O)C(=O)Nc3ccccc32)cc1		CHEMBL4586793	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	19210559	CHEMBL4393036	Inhibition of recombinant human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay	B	COc1ccc(C(=O)CC2(O)C(=O)Nc3ccccc32)cc1		CHEMBL3360387	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	19210560	CHEMBL4393036	Inhibition of recombinant human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay	B	COc1ccc2c(c1)/C(=C/C(=O)O)C(=O)N2		CHEMBL4442846	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	19210561	CHEMBL4393036	Inhibition of recombinant human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay	B	N#CCC1(O)C(=O)Nc2ccc(NC(=O)c3ccccc3)cc21		CHEMBL4449604	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	19210562	CHEMBL4393036	Inhibition of recombinant human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay	B	COc1ccc2c(c1)/C(=C/C#N)C(=O)N2Cc1ccccc1		CHEMBL4464997	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	19210563	CHEMBL4393036	Inhibition of recombinant human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay	B	CC(=O)Nc1ccc2c(c1)C(CC(=O)O)(OC(C)=O)C(=O)N2		CHEMBL4544396	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	19210564	CHEMBL4393036	Inhibition of recombinant human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay	B	COc1cc(NC(C)=O)c2c(c1)C(CC#N)(OC(C)=O)C(=O)N2		CHEMBL4085946	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	19210565	CHEMBL4393036	Inhibition of recombinant human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay	B	CCC(=O)Nc1cc(NC(=O)CC)c2c(c1)C(CC#N)(OC(=O)CC)C(=O)N2		CHEMBL4101711	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	19210566	CHEMBL4393036	Inhibition of recombinant human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay	B	Cc1ccc(C(=O)/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL4545169	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	19210567	CHEMBL4393036	Inhibition of recombinant human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay	B	O=C1Nc2ccccc2C12CC2c1ccccn1		CHEMBL4440139	=	IC50	nM	1231.0	CHEMBL262	Homo sapiens	IC50	uM	1.231
	19210568	CHEMBL4393036	Inhibition of recombinant human GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate measured after 60 mins by ADP-Glo luminescence assay	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714	=	IC50	nM	8.35	CHEMBL262	Homo sapiens	IC50	uM	0.00835
	19225355	CHEMBL4395841	Competitive inhibition of human recombinant full length GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 25 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	COc1cc(CCC(=O)Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)cc(OC)c1OC		CHEMBL4520113	=	IC50	nM	363.0	CHEMBL262	Homo sapiens	IC50	nM	363.0
	19225356	CHEMBL4395841	Competitive inhibition of human recombinant full length GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 25 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)=O)c2)[nH]1		CHEMBL1773425	=	IC50	nM	152.0	CHEMBL262	Homo sapiens	IC50	nM	152.0
	19225357	CHEMBL4395841	Competitive inhibition of human recombinant full length GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 25 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4474903	=	IC50	nM	18.46	CHEMBL262	Homo sapiens	IC50	nM	18.46
	19225358	CHEMBL4395841	Competitive inhibition of human recombinant full length GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 25 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CCCC3)c2)[nH]1		CHEMBL4574237	=	IC50	nM	136.0	CHEMBL262	Homo sapiens	IC50	nM	136.0
	19225359	CHEMBL4395841	Competitive inhibition of human recombinant full length GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 25 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	COc1cc(CC(=O)Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)cc(OC)c1OC		CHEMBL4513323	=	IC50	nM	510.0	CHEMBL262	Homo sapiens	IC50	nM	510.0
	19225360	CHEMBL4395841	Competitive inhibition of human recombinant full length GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 25 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	COc1ccc(CCC(=O)Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)cc1		CHEMBL4547931	=	IC50	nM	542.0	CHEMBL262	Homo sapiens	IC50	nM	542.0
	19225361	CHEMBL4395841	Competitive inhibition of human recombinant full length GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 25 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	COc1cccc(CCC(=O)Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)c1		CHEMBL4592870	=	IC50	nM	471.0	CHEMBL262	Homo sapiens	IC50	nM	471.0
	19225362	CHEMBL4395841	Competitive inhibition of human recombinant full length GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 25 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)Cc3ccc(C(F)(F)F)cc3)c2)[nH]1		CHEMBL4555766	=	IC50	nM	3242.0	CHEMBL262	Homo sapiens	IC50	nM	3242.0
	19225363	CHEMBL4395841	Competitive inhibition of human recombinant full length GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 25 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)CCc3ccc(C(F)(F)F)cc3)c2)[nH]1		CHEMBL4518955	=	IC50	nM	956.0	CHEMBL262	Homo sapiens	IC50	nM	956.0
	19225364	CHEMBL4395841	Competitive inhibition of human recombinant full length GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 25 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3(C(F)(F)F)CC3)c2)[nH]1		CHEMBL4454724	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	nM	10000.0
	19225365	CHEMBL4395841	Competitive inhibition of human recombinant full length GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 25 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)[C@@H]3C[C@H]3c3ccccc3)c2)[nH]1		CHEMBL4442468	=	IC50	nM	808.0	CHEMBL262	Homo sapiens	IC50	nM	808.0
	19225366	CHEMBL4395841	Competitive inhibition of human recombinant full length GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 25 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)CC3CC3)c2)[nH]1		CHEMBL4434855	=	IC50	nM	215.0	CHEMBL262	Homo sapiens	IC50	nM	215.0
	19225367	CHEMBL4395841	Competitive inhibition of human recombinant full length GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 25 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CCC3)c2)[nH]1		CHEMBL4561291	=	IC50	nM	132.0	CHEMBL262	Homo sapiens	IC50	nM	132.0
	19225368	CHEMBL4395841	Competitive inhibition of human recombinant full length GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 25 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC(=O)C3)c2)[nH]1		CHEMBL4458096	=	IC50	nM	183.0	CHEMBL262	Homo sapiens	IC50	nM	183.0
	19225369	CHEMBL4395841	Competitive inhibition of human recombinant full length GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 25 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)[C@H]3C[C@H](Cl)C3)c2)[nH]1		CHEMBL4435922	=	IC50	nM	395.0	CHEMBL262	Homo sapiens	IC50	nM	395.0
	19225370	CHEMBL4395841	Competitive inhibition of human recombinant full length GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 25 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)[C@H]3C[C@@H](Cl)C3)c2)[nH]1		CHEMBL4446355	=	IC50	nM	170.0	CHEMBL262	Homo sapiens	IC50	nM	170.0
	19225371	CHEMBL4395841	Competitive inhibition of human recombinant full length GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 25 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CCC(=O)C3)c2)[nH]1		CHEMBL4571942	=	IC50	nM	73.0	CHEMBL262	Homo sapiens	IC50	nM	73.0
	19225372	CHEMBL4395841	Competitive inhibition of human recombinant full length GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 25 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CCCO3)c2)[nH]1		CHEMBL4441042	=	IC50	nM	527.0	CHEMBL262	Homo sapiens	IC50	nM	527.0
	19225373	CHEMBL4395841	Competitive inhibition of human recombinant full length GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 25 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)CN3CCCC3=O)c2)[nH]1		CHEMBL4566059	=	IC50	nM	126.0	CHEMBL262	Homo sapiens	IC50	nM	126.0
	19225374	CHEMBL4395841	Competitive inhibition of human recombinant full length GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 25 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)c3ccoc3)c2)[nH]1		CHEMBL4555253	=	IC50	nM	3654.0	CHEMBL262	Homo sapiens	IC50	nM	3654.0
	19225375	CHEMBL4395841	Competitive inhibition of human recombinant full length GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 25 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)c3ccccn3)c2)[nH]1		CHEMBL4475119	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	nM	10000.0
	19225376	CHEMBL4395841	Competitive inhibition of human recombinant full length GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 25 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NCC3CC3)c2)[nH]1		CHEMBL4446519	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	nM	10000.0
	19225377	CHEMBL4395841	Competitive inhibition of human recombinant full length GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 25 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3)c2)n1C		CHEMBL1272270	=	IC50	nM	638.0	CHEMBL262	Homo sapiens	IC50	nM	638.0
	19225378	CHEMBL4395841	Competitive inhibition of human recombinant full length GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 25 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	CSc1nc(-c2ccnc(NC(=O)C3CC3)c2)c(-c2ccc(F)cc2)n1C		CHEMBL4449296	=	IC50	nM	1780.0	CHEMBL262	Homo sapiens	IC50	nM	1780.0
	19225379	CHEMBL4395841	Competitive inhibition of human recombinant full length GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 25 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	COc1cc(CCC(=O)Nc2cc(-c3[nH]c(SCc4ccccc4)nc3-c3ccc(F)cc3)ccn2)cc(OC)c1OC		CHEMBL4452736	=	IC50	nM	1149.0	CHEMBL262	Homo sapiens	IC50	nM	1149.0
	19225380	CHEMBL4395841	Competitive inhibition of human recombinant full length GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 25 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	CC(=O)Nc1cc(-c2[nH]c(SCc3ccccc3)nc2-c2ccc(F)cc2)ccn1		CHEMBL4591390	=	IC50	nM	560.0	CHEMBL262	Homo sapiens	IC50	nM	560.0
	19225381	CHEMBL4395841	Competitive inhibition of human recombinant full length GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 25 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	O=C(Nc1cc(-c2[nH]c(SCc3ccccc3)nc2-c2ccc(F)cc2)ccn1)C1CC1		CHEMBL4546015	=	IC50	nM	229.0	CHEMBL262	Homo sapiens	IC50	nM	229.0
	19225382	CHEMBL4395841	Competitive inhibition of human recombinant full length GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 25 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	O=C(Nc1cc(-c2[nH]c(SCc3ccccc3)nc2-c2ccc(F)cc2)ccn1)C1CCCC1		CHEMBL4437018	=	IC50	nM	663.0	CHEMBL262	Homo sapiens	IC50	nM	663.0
	19225383	CHEMBL4395841	Competitive inhibition of human recombinant full length GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 25 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	O=C(Cc1ccc(F)cc1)Nc1cc(-c2[nH]c(SCc3ccccc3)nc2-c2ccc(F)cc2)ccn1		CHEMBL4452170	=	IC50	nM	1499.0	CHEMBL262	Homo sapiens	IC50	nM	1499.0
	19225384	CHEMBL4395841	Competitive inhibition of human recombinant full length GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 25 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	C[S+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4589431	=	IC50	nM	236.0	CHEMBL262	Homo sapiens	IC50	nM	236.0
	19225385	CHEMBL4395841	Competitive inhibition of human recombinant full length GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 25 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	C[S+]([O-])c1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CCC3)c2)[nH]1		CHEMBL4449570	=	IC50	nM	428.0	CHEMBL262	Homo sapiens	IC50	nM	428.0
	19225386	CHEMBL4395841	Competitive inhibition of human recombinant full length GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 25 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	O=C(Nc1cc(-c2[nH]cnc2-c2ccc(F)cc2)ccn1)C1CC1		CHEMBL4457096	=	IC50	nM	64.0	CHEMBL262	Homo sapiens	IC50	nM	64.0
	19225387	CHEMBL4395841	Competitive inhibition of human recombinant full length GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 25 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	Cc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4455711	=	IC50	nM	53.0	CHEMBL262	Homo sapiens	IC50	nM	53.0
	19225388	CHEMBL4395841	Competitive inhibition of human recombinant full length GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 25 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	CCc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4536012	=	IC50	nM	35.0	CHEMBL262	Homo sapiens	IC50	nM	35.0
	19225389	CHEMBL4395841	Competitive inhibition of human recombinant full length GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 25 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	O=C(Nc1cc(-c2[nH]c(-c3ccccc3)nc2-c2ccc(F)cc2)ccn1)C1CC1		CHEMBL4568095	=	IC50	nM	570.0	CHEMBL262	Homo sapiens	IC50	nM	570.0
	19225390	CHEMBL4395841	Competitive inhibition of human recombinant full length GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 25 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	O=C(Nc1cc(-c2[nH]c(Cc3ccccc3)nc2-c2ccc(F)cc2)ccn1)C1CC1		CHEMBL4476724	=	IC50	nM	59.0	CHEMBL262	Homo sapiens	IC50	nM	59.0
	19225391	CHEMBL4395841	Competitive inhibition of human recombinant full length GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 25 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	O=C(Nc1cc(-c2[nH]c(CCc3ccccc3)nc2-c2ccc(F)cc2)ccn1)C1CC1		CHEMBL4473730	=	IC50	nM	133.0	CHEMBL262	Homo sapiens	IC50	nM	133.0
	19225392	CHEMBL4395841	Competitive inhibition of human recombinant full length GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 25 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	O=C(Nc1cc(-c2[nH]c(-c3ccco3)nc2-c2ccc(F)cc2)ccn1)C1CC1		CHEMBL4476843	=	IC50	nM	156.0	CHEMBL262	Homo sapiens	IC50	nM	156.0
	19225393	CHEMBL4395841	Competitive inhibition of human recombinant full length GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 25 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	Cc1ncc(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4582385	=	IC50	nM	1684.0	CHEMBL262	Homo sapiens	IC50	nM	1684.0
	19225400	CHEMBL4395844	Competitive inhibition of human recombinant full length GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 100 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4474903	=	IC50	nM	174.3	CHEMBL262	Homo sapiens	IC50	nM	174.3
	19225401	CHEMBL4395844	Competitive inhibition of human recombinant full length GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 100 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	CCc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4536012	=	IC50	nM	108.4	CHEMBL262	Homo sapiens	IC50	nM	108.4
	19225402	CHEMBL4395845	Competitive inhibition of human recombinant full length GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 500 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4474903	=	IC50	nM	423.0	CHEMBL262	Homo sapiens	IC50	nM	423.0
	19225403	CHEMBL4395845	Competitive inhibition of human recombinant full length GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 500 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	CCc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4536012	=	IC50	nM	492.1	CHEMBL262	Homo sapiens	IC50	nM	492.1
	19225466	CHEMBL4395886	Inhibition of human recombinant GSK3beta at 1 uM using Ulight-CFFKNIVTPRTPPPSQGK-amide as substrate measured after 90 mins in presence of ATP by LANCE assay relative to control	B	CCc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4536012	=	Inhibition	%	96.97	CHEMBL262	Homo sapiens	INH	%	96.97
	19225496	CHEMBL4395841	Competitive inhibition of human recombinant full length GSK3beta using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated with enzyme for 10 mins followed by substrate and 25 uM ATP addition measured after 60 mins by ADP-Glo luminescence assay	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714	=	IC50	nM	89.0	CHEMBL262	Homo sapiens	IC50	nM	89.0
	19230861	CHEMBL4397160	Inhibition of N-terminal FLAG-tagged GSK3beta (unknown origin) expressed in baculovirus expression system at 100 nM using pGS peptide as substrate preincubated for 5 mins followed by [gamma-33P]ATP addition and measured after 30 mins by topcount scintillation counting method relative to control	B	Cc1cc(-n2cc(C(=O)N3CCO[C@@H](C)C3)c3ccc(O[C@@H](C)c4ccc(F)cn4)nc32)n[nH]1		CHEMBL4440381	=	Inhibition	%	3.0	CHEMBL262	Homo sapiens	INH	%	3.0
	19240669	CHEMBL4399588	Inhibition of GSK-3beta (unknown origin) using HSSPHQS(PO3H2)EDEEE peptide as substrate measured after 15 mins in presence of ATP by spectrophotometric analysis	B	CC(C)(C#N)c1cccc(-c2ccnc3[nH]ccc23)n1		CHEMBL4453941	=	Ki	nM	210.0	CHEMBL262	Homo sapiens	Ki	nM	210.0
	19242723	CHEMBL4400058	Inhibition of human recombinant GSK3beta H350L mutant (2 to end residues) assessed as residual activity at 10 uM using YRRAAVPPSPSLSR as substrate incubated for 40 mins in presence of [gamma-33P]ATP at Km concentration by radiometric assay relative to control	B	COc1ccc2c(CCNc3nc(NCc4ccc(=O)[nH]c4)c4nc[nH]c4n3)c[nH]c2c1		CHEMBL4555782	=	Activity	%	63.0	CHEMBL262	Homo sapiens	Activity	%	63.0
Not Active	19250389	CHEMBL4401412	Inhibition of human N-terminal His-tagged GSK3beta expressed in baculovirus expression system assessed as residual activity at 100 nM relative to control	B	C=CS(=O)(=O)Nc1ccc2c(c1)/C(=C/c1[nH]c(C)c(C(=O)NCCN(CC)CC)c1C)C(=O)N2		CHEMBL4553725		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	19250446	CHEMBL4401436	Inhibition of human N-terminal His-tagged GSK3beta expressed in baculovirus expression system at 1 uM relative to control	B	c1ccc(Nc2nccc(Nc3cc(C4CC4)[nH]n3)n2)cc1		CHEMBL4454763	=	Inhibition	%	76.0	CHEMBL262	Homo sapiens	INH	%	76.0
	19250447	CHEMBL4401436	Inhibition of human N-terminal His-tagged GSK3beta expressed in baculovirus expression system at 1 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755	=	Inhibition	%	-6.0	CHEMBL262	Homo sapiens	INH	%	-6.0
	19266445	CHEMBL4405395	Inhibition of wild-type human full length GSK3B (M1 to T433 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	19272032	CHEMBL4406977	Inhibition of wild-type human full length GSK3B (M1 to T433 residues) expressed in mammalian expression system assessed as enzyme remaining activity at 1000 nM by Kinomescan method relative to control	B	O=C(Nc1cccc(Br)c1)Nc1cc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2)ccc1F		CHEMBL4465561	=	Activity	%	100.0	CHEMBL262	Homo sapiens	Activity	%	100.0
	19274916	CHEMBL4407588	Inhibition of recombinant human full-length His-tagged GSK3B expressed in baculovirus expression system at 25 uM using FRET-labeled Ser/Thr 09 peptide as substrate measured after 1 hr by Z'-lyte assay relative to control	A	Nc1ncc2cc(-c3c(Br)cccc3Br)c(N)nc2n1		CHEMBL57531	=	Inhibition	%	6.0	CHEMBL262	Homo sapiens	INH	%	6.0
	19274917	CHEMBL4407588	Inhibition of recombinant human full-length His-tagged GSK3B expressed in baculovirus expression system at 25 uM using FRET-labeled Ser/Thr 09 peptide as substrate measured after 1 hr by Z'-lyte assay relative to control	A	Nc1ncc2cc(-c3c(Cl)cccc3-c3cccnc3)c(N3C[C@H]4[C@H](N)[C@H]4C3)nc2n1		CHEMBL4453148	=	Inhibition	%	4.0	CHEMBL262	Homo sapiens	INH	%	4.0
	19274918	CHEMBL4407588	Inhibition of recombinant human full-length His-tagged GSK3B expressed in baculovirus expression system at 25 uM using FRET-labeled Ser/Thr 09 peptide as substrate measured after 1 hr by Z'-lyte assay relative to control	A	CC(C)COc1cccc(Cl)c1-c1cc2cnc(N)nc2nc1N1C[C@H]2[C@H](N)[C@H]2C1		CHEMBL4546703	=	Inhibition	%	7.0	CHEMBL262	Homo sapiens	INH	%	7.0
Dose-dependent effect	19293912	CHEMBL4412002	Inhibition of GSK3beta (unknown origin) pre-incubated for 30 mins followed by ULight-GS (Ser641/pSer657) peptide substrate addition and measured after 1 hr by TR-FRET assay	B	O=C1NC(=O)C2C1C1(Cl)c3ccccc3C2(Cl)c2ccccc21		CHEMBL4590632		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Dose-dependent effect	19293913	CHEMBL4412002	Inhibition of GSK3beta (unknown origin) pre-incubated for 30 mins followed by ULight-GS (Ser641/pSer657) peptide substrate addition and measured after 1 hr by TR-FRET assay	B	O=C1NC(=O)C2C1C1c3ccccc3C2(/C=N/Cc2ccccc2)c2ccccc21		CHEMBL4549511		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Dose-dependent effect	19293914	CHEMBL4412002	Inhibition of GSK3beta (unknown origin) pre-incubated for 30 mins followed by ULight-GS (Ser641/pSer657) peptide substrate addition and measured after 1 hr by TR-FRET assay	B	CCCCCCCNC(=O)C12c3ccccc3C(c3ccccc31)C1C(=O)NC(=O)C12		CHEMBL4449273		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	19293915	CHEMBL4412002	Inhibition of GSK3beta (unknown origin) pre-incubated for 30 mins followed by ULight-GS (Ser641/pSer657) peptide substrate addition and measured after 1 hr by TR-FRET assay	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714	=	IC50	nM	11.4	CHEMBL262	Homo sapiens	IC50	nM	11.4
	19293916	CHEMBL4412003	Inhibition of GSK3beta (unknown origin) assessed as residual activity at 3.12 uM pre-incubated for 30 mins followed by ULight-GS (Ser641/pSer657) peptide substrate addition and measured after 1 hr by TR-FRET assay relative to control	B	CCCCCCCNC(=O)C12c3ccccc3C(c3ccccc31)C1C(=O)NC(=O)C12		CHEMBL4449273	=	Activity	%	55.0	CHEMBL262	Homo sapiens	Activity	%	55.0
	19293917	CHEMBL4412004	Inhibition of GSK3beta (unknown origin) assessed as residual activity at 50 uM pre-incubated for 30 mins followed by ULight-GS (Ser641/pSer657) peptide substrate addition and measured after 1 hr by TR-FRET assay relative to control	B	O=C1NC(=O)C2C1C1(Cl)c3ccccc3C2(Cl)c2ccccc21		CHEMBL4590632	=	Activity	%	48.0	CHEMBL262	Homo sapiens	Activity	%	48.0
	19293918	CHEMBL4412004	Inhibition of GSK3beta (unknown origin) assessed as residual activity at 50 uM pre-incubated for 30 mins followed by ULight-GS (Ser641/pSer657) peptide substrate addition and measured after 1 hr by TR-FRET assay relative to control	B	O=C1NC(=O)C2C1C1c3ccccc3C2(/C=N/Cc2ccccc2)c2ccccc21		CHEMBL4549511	=	Activity	%	51.0	CHEMBL262	Homo sapiens	Activity	%	51.0
	19293919	CHEMBL4412004	Inhibition of GSK3beta (unknown origin) assessed as residual activity at 50 uM pre-incubated for 30 mins followed by ULight-GS (Ser641/pSer657) peptide substrate addition and measured after 1 hr by TR-FRET assay relative to control	B	CCCCCCCNC(=O)C12c3ccccc3C(c3ccccc31)C1C(=O)NC(=O)C12		CHEMBL4449273	=	Activity	%	10.0	CHEMBL262	Homo sapiens	Activity	%	10.0
	19296347	CHEMBL4412523	Inhibition of GSK3b (unknown origin) at 1 uM by LanthaScreen Eu kinase binding assay relative to control	B	Cc1cc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)ccc1-c1cnc(NC2CC2)c2nccn12		CHEMBL4586372	=	Inhibition	%	51.0	CHEMBL262	Homo sapiens	INH	%	51.0
	19303742	CHEMBL4414152	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system assessed as reduction in enzyme activity at 5 uM in presence of ATP relative to control	B	O=C(O)c1ccc(Nc2nc(-c3ccc4ccccc4c3)cs2)cc1O		CHEMBL4520531	=	Inhibition	%	41.0	CHEMBL262	Homo sapiens	INH	%	41.0
	19303767	CHEMBL4414219	Inhibition of GSK3beta (unknown origin) assessed as residual activity at 50 uM relative to control	B	O=C(O)c1ccc(Nc2nc(-c3cccc([N+](=O)[O-])c3)cs2)cc1		CHEMBL4462082	=	Activity	%	79.0	CHEMBL262	Homo sapiens	Activity	%	79.0
	19303823	CHEMBL4414219	Inhibition of GSK3beta (unknown origin) assessed as residual activity at 50 uM relative to control	B	O=C(O)c1ccc(Nc2nc(-c3cccc(Br)c3)cs2)cc1		CHEMBL4458300	=	Activity	%	29.0	CHEMBL262	Homo sapiens	Activity	%	29.0
Not Active	19314279	CHEMBL4416726	Inhibition of GSK3beta (unknown origin) at 1 uM	B	O=C(O)[C@H]1C2CCC(CC2)[C@@H]1Nc1nc(-c2c[nH]c3c(F)cc(F)cc23)ncc1F		CHEMBL4575293		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	19371130	CHEMBL4424884	Inhibition of human N-terminal His6-tagged GSK3beta H350L mutant expressed in baculovirus infected Sf21 insect cells using phosphoglycogen synthase peptide-2 as substrate	A	COc1cc(C2CN(C(=O)c3cc(COC[C@@H](O)CO)ccn3)C2)ccc1OCc1ccc(C2CC2)cc1		CHEMBL4474690	>	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	nM	1000.0
	19411473	CHEMBL4427692	Inhibition of GSK3beta (unknown origin)	B	Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(CC(N)=O)c2cnccc21		CHEMBL4564126	>=	IC50	nM	5000.0	CHEMBL262	Homo sapiens	IC50	uM	5.0
	19411529	CHEMBL4427636	Inhibition of GSK3beta (unknown origin) at 1 uM relative to control	B	Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(CC(N)=O)c2cnccc21		CHEMBL4564126	<=	Inhibition	%	16.0	CHEMBL262	Homo sapiens	INH	%	16.0
	19439549	CHEMBL4431132	Inhibition of His-tagged full length human recombinant GSK3beta using [YRRAAVPPSPSLSRHSSPHQ-(pS)EDEEE] substrate and pre-incubarted for 20 mins before [gamma-33P]ATP addition and measured after 2 hrs by radiometric kinase assay	B	O=C(CNC(=O)c1ccc2noc(-c3ccccc3)c2c1)NCCc1c[nH]c2ccccc12		CHEMBL4459306	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	nM	50000.0
	19439550	CHEMBL4431132	Inhibition of His-tagged full length human recombinant GSK3beta using [YRRAAVPPSPSLSRHSSPHQ-(pS)EDEEE] substrate and pre-incubarted for 20 mins before [gamma-33P]ATP addition and measured after 2 hrs by radiometric kinase assay	B	O=C(CNC(=O)c1cnc2[nH]cc(-c3ccncc3)c2c1)NCCc1c[nH]c2ccccc12		CHEMBL4472277	=	IC50	nM	994.0	CHEMBL262	Homo sapiens	IC50	nM	994.0
	19439551	CHEMBL4431132	Inhibition of His-tagged full length human recombinant GSK3beta using [YRRAAVPPSPSLSRHSSPHQ-(pS)EDEEE] substrate and pre-incubarted for 20 mins before [gamma-33P]ATP addition and measured after 2 hrs by radiometric kinase assay	B	O=C(CNC(=O)c1ccc2[nH]cc(-c3ccncc3)c2c1)NCCc1c[nH]c2ccccc12		CHEMBL4449662	=	IC50	nM	33800.0	CHEMBL262	Homo sapiens	IC50	nM	33800.0
	19439552	CHEMBL4431132	Inhibition of His-tagged full length human recombinant GSK3beta using [YRRAAVPPSPSLSRHSSPHQ-(pS)EDEEE] substrate and pre-incubarted for 20 mins before [gamma-33P]ATP addition and measured after 2 hrs by radiometric kinase assay	B	O=C(CNC(=O)c1cnc2[nH]cc(-c3ccccc3)c2c1)NCCc1c[nH]c2ccccc12		CHEMBL3911190	=	IC50	nM	1450.0	CHEMBL262	Homo sapiens	IC50	nM	1450.0
	19439553	CHEMBL4431132	Inhibition of His-tagged full length human recombinant GSK3beta using [YRRAAVPPSPSLSRHSSPHQ-(pS)EDEEE] substrate and pre-incubarted for 20 mins before [gamma-33P]ATP addition and measured after 2 hrs by radiometric kinase assay	B	O=C(C/C=C/c1cnc2[nH]cc(-c3ccccc3)c2c1)NCCc1ccccc1		CHEMBL4436175	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	nM	50000.0
	19439554	CHEMBL4431132	Inhibition of His-tagged full length human recombinant GSK3beta using [YRRAAVPPSPSLSRHSSPHQ-(pS)EDEEE] substrate and pre-incubarted for 20 mins before [gamma-33P]ATP addition and measured after 2 hrs by radiometric kinase assay	B	O=C(/C=C/c1cnc2[nH]cc(-c3ccccc3)c2c1)NCCc1c[nH]c2ccccc12		CHEMBL3943352	=	IC50	nM	356.0	CHEMBL262	Homo sapiens	IC50	nM	356.0
	19439555	CHEMBL4431132	Inhibition of His-tagged full length human recombinant GSK3beta using [YRRAAVPPSPSLSRHSSPHQ-(pS)EDEEE] substrate and pre-incubarted for 20 mins before [gamma-33P]ATP addition and measured after 2 hrs by radiometric kinase assay	B	O=C(CCc1cnc2[nH]cc(-c3ccccc3)c2c1)NCCc1c[nH]c2ccccc12		CHEMBL3951486	=	IC50	nM	1030.0	CHEMBL262	Homo sapiens	IC50	nM	1030.0
	19439556	CHEMBL4431132	Inhibition of His-tagged full length human recombinant GSK3beta using [YRRAAVPPSPSLSRHSSPHQ-(pS)EDEEE] substrate and pre-incubarted for 20 mins before [gamma-33P]ATP addition and measured after 2 hrs by radiometric kinase assay	B	O=C(/C=C/c1cnc2[nH]cc(-c3ccccc3)c2c1)NCCc1ccncc1		CHEMBL3929715	=	IC50	nM	43.5	CHEMBL262	Homo sapiens	IC50	nM	43.5
	19439557	CHEMBL4431132	Inhibition of His-tagged full length human recombinant GSK3beta using [YRRAAVPPSPSLSRHSSPHQ-(pS)EDEEE] substrate and pre-incubarted for 20 mins before [gamma-33P]ATP addition and measured after 2 hrs by radiometric kinase assay	B	O=C(/C=C/c1cnc2[nH]cc(-c3ccccc3)c2c1)NCCN1CCOCC1		CHEMBL3891139	=	IC50	nM	45.7	CHEMBL262	Homo sapiens	IC50	nM	45.7
	19439558	CHEMBL4431132	Inhibition of His-tagged full length human recombinant GSK3beta using [YRRAAVPPSPSLSRHSSPHQ-(pS)EDEEE] substrate and pre-incubarted for 20 mins before [gamma-33P]ATP addition and measured after 2 hrs by radiometric kinase assay	B	O=C(/C=C/c1cnc2[nH]cc(-c3ccccc3)c2c1)NCCc1ccccc1		CHEMBL3961252	=	IC50	nM	248.0	CHEMBL262	Homo sapiens	IC50	nM	248.0
	19439559	CHEMBL4431132	Inhibition of His-tagged full length human recombinant GSK3beta using [YRRAAVPPSPSLSRHSSPHQ-(pS)EDEEE] substrate and pre-incubarted for 20 mins before [gamma-33P]ATP addition and measured after 2 hrs by radiometric kinase assay	B	O=C(/C=C/c1cnc2[nH]cc(-c3ccccc3)c2c1)NCCc1c[nH]c2ncccc12		CHEMBL4519014	=	IC50	nM	128.0	CHEMBL262	Homo sapiens	IC50	nM	128.0
	19439560	CHEMBL4431132	Inhibition of His-tagged full length human recombinant GSK3beta using [YRRAAVPPSPSLSRHSSPHQ-(pS)EDEEE] substrate and pre-incubarted for 20 mins before [gamma-33P]ATP addition and measured after 2 hrs by radiometric kinase assay	B	CC(=O)c1ccc(-c2c[nH]c3ncc(/C=C/C(=O)NCCc4ccccn4)cc23)cc1		CHEMBL4521500	=	IC50	nM	1.37	CHEMBL262	Homo sapiens	IC50	nM	1.37
	19439561	CHEMBL4431132	Inhibition of His-tagged full length human recombinant GSK3beta using [YRRAAVPPSPSLSRHSSPHQ-(pS)EDEEE] substrate and pre-incubarted for 20 mins before [gamma-33P]ATP addition and measured after 2 hrs by radiometric kinase assay	B	O=C(/C=C/c1cnc2[nH]cc(-c3ccccc3)c2c1)NCc1ccncc1		CHEMBL4463440	=	IC50	nM	3.59	CHEMBL262	Homo sapiens	IC50	nM	3.59
	19439562	CHEMBL4431132	Inhibition of His-tagged full length human recombinant GSK3beta using [YRRAAVPPSPSLSRHSSPHQ-(pS)EDEEE] substrate and pre-incubarted for 20 mins before [gamma-33P]ATP addition and measured after 2 hrs by radiometric kinase assay	B	O=C(/C=C/c1cnc2[nH]cc(-c3ccccc3)c2c1)NCc1ccc2c(c1)CCO2		CHEMBL4569903	=	IC50	nM	103.0	CHEMBL262	Homo sapiens	IC50	nM	103.0
	19439563	CHEMBL4431132	Inhibition of His-tagged full length human recombinant GSK3beta using [YRRAAVPPSPSLSRHSSPHQ-(pS)EDEEE] substrate and pre-incubarted for 20 mins before [gamma-33P]ATP addition and measured after 2 hrs by radiometric kinase assay	B	O=C(/C=C/c1cnc2[nH]cc(-c3ccccc3)c2c1)NCc1ccc2[nH]ccc2c1		CHEMBL4559431	=	IC50	nM	462.0	CHEMBL262	Homo sapiens	IC50	nM	462.0
	19439564	CHEMBL4431132	Inhibition of His-tagged full length human recombinant GSK3beta using [YRRAAVPPSPSLSRHSSPHQ-(pS)EDEEE] substrate and pre-incubarted for 20 mins before [gamma-33P]ATP addition and measured after 2 hrs by radiometric kinase assay	B	O=C(/C=C/c1cnc2[nH]cc(-c3ccccc3)c2c1)NCc1nc2ccccc2[nH]1		CHEMBL4451197	=	IC50	nM	62.1	CHEMBL262	Homo sapiens	IC50	nM	62.1
	19439565	CHEMBL4431132	Inhibition of His-tagged full length human recombinant GSK3beta using [YRRAAVPPSPSLSRHSSPHQ-(pS)EDEEE] substrate and pre-incubarted for 20 mins before [gamma-33P]ATP addition and measured after 2 hrs by radiometric kinase assay	B	O=C(/C=C/c1cnc2[nH]cc(-c3ccccc3)c2c1)NCc1ccco1		CHEMBL4522289	=	IC50	nM	77.1	CHEMBL262	Homo sapiens	IC50	nM	77.1
	19439566	CHEMBL4431132	Inhibition of His-tagged full length human recombinant GSK3beta using [YRRAAVPPSPSLSRHSSPHQ-(pS)EDEEE] substrate and pre-incubarted for 20 mins before [gamma-33P]ATP addition and measured after 2 hrs by radiometric kinase assay	B	O=C(/C=C/c1cnc2[nH]cc(-c3ccccc3)c2c1)NCc1ccccn1		CHEMBL4472601	=	IC50	nM	167.0	CHEMBL262	Homo sapiens	IC50	nM	167.0
	19439567	CHEMBL4431132	Inhibition of His-tagged full length human recombinant GSK3beta using [YRRAAVPPSPSLSRHSSPHQ-(pS)EDEEE] substrate and pre-incubarted for 20 mins before [gamma-33P]ATP addition and measured after 2 hrs by radiometric kinase assay	B	O=C(/C=C/c1cnc2[nH]cc(-c3ccccc3)c2c1)NCc1cccnc1		CHEMBL4583030	=	IC50	nM	64.2	CHEMBL262	Homo sapiens	IC50	nM	64.2
	19439568	CHEMBL4431132	Inhibition of His-tagged full length human recombinant GSK3beta using [YRRAAVPPSPSLSRHSSPHQ-(pS)EDEEE] substrate and pre-incubarted for 20 mins before [gamma-33P]ATP addition and measured after 2 hrs by radiometric kinase assay	B	O=C(/C=C/c1cnc2[nH]cc(-c3ccncc3)c2c1)NCc1ccncc1		CHEMBL4449746	=	IC50	nM	2.75	CHEMBL262	Homo sapiens	IC50	nM	2.75
	19439569	CHEMBL4431132	Inhibition of His-tagged full length human recombinant GSK3beta using [YRRAAVPPSPSLSRHSSPHQ-(pS)EDEEE] substrate and pre-incubarted for 20 mins before [gamma-33P]ATP addition and measured after 2 hrs by radiometric kinase assay	B	O=C(/C=C/c1cnc2[nH]cc(-c3cccnc3)c2c1)NCc1ccncc1		CHEMBL4527984	=	IC50	nM	16.5	CHEMBL262	Homo sapiens	IC50	nM	16.5
	19439570	CHEMBL4431132	Inhibition of His-tagged full length human recombinant GSK3beta using [YRRAAVPPSPSLSRHSSPHQ-(pS)EDEEE] substrate and pre-incubarted for 20 mins before [gamma-33P]ATP addition and measured after 2 hrs by radiometric kinase assay	B	O=C(/C=C/c1cnc2[nH]cc(-c3ccc(F)cc3)c2c1)NCc1ccncc1		CHEMBL4443821	=	IC50	nM	22.8	CHEMBL262	Homo sapiens	IC50	nM	22.8
	19439571	CHEMBL4431132	Inhibition of His-tagged full length human recombinant GSK3beta using [YRRAAVPPSPSLSRHSSPHQ-(pS)EDEEE] substrate and pre-incubarted for 20 mins before [gamma-33P]ATP addition and measured after 2 hrs by radiometric kinase assay	B	N#Cc1ccc(-c2c[nH]c3ncc(/C=C/C(=O)NCc4ccncc4)cc23)cc1		CHEMBL4556527	=	IC50	nM	63.1	CHEMBL262	Homo sapiens	IC50	nM	63.1
	19439572	CHEMBL4431132	Inhibition of His-tagged full length human recombinant GSK3beta using [YRRAAVPPSPSLSRHSSPHQ-(pS)EDEEE] substrate and pre-incubarted for 20 mins before [gamma-33P]ATP addition and measured after 2 hrs by radiometric kinase assay	B	CC(=O)c1ccc(-c2c[nH]c3ncc(/C=C/C(=O)NCc4ccncc4)cc23)cc1		CHEMBL4579826	=	IC50	nM	1.42	CHEMBL262	Homo sapiens	IC50	nM	1.42
	19439573	CHEMBL4431132	Inhibition of His-tagged full length human recombinant GSK3beta using [YRRAAVPPSPSLSRHSSPHQ-(pS)EDEEE] substrate and pre-incubarted for 20 mins before [gamma-33P]ATP addition and measured after 2 hrs by radiometric kinase assay	B	NC(=O)c1ccc(-c2c[nH]c3ncc(/C=C/C(=O)NCc4ccncc4)cc23)cc1		CHEMBL4543687	=	IC50	nM	4.43	CHEMBL262	Homo sapiens	IC50	nM	4.43
	19439574	CHEMBL4431132	Inhibition of His-tagged full length human recombinant GSK3beta using [YRRAAVPPSPSLSRHSSPHQ-(pS)EDEEE] substrate and pre-incubarted for 20 mins before [gamma-33P]ATP addition and measured after 2 hrs by radiometric kinase assay	B	CS(=O)(=O)c1ccc(-c2c[nH]c3ncc(/C=C/C(=O)NCc4ccncc4)cc23)cc1		CHEMBL4557360	=	IC50	nM	220.0	CHEMBL262	Homo sapiens	IC50	nM	220.0
	19439575	CHEMBL4431132	Inhibition of His-tagged full length human recombinant GSK3beta using [YRRAAVPPSPSLSRHSSPHQ-(pS)EDEEE] substrate and pre-incubarted for 20 mins before [gamma-33P]ATP addition and measured after 2 hrs by radiometric kinase assay	B	COc1ccc(-c2c[nH]c3ncc(/C=C/C(=O)NCc4ccncc4)cc23)cc1		CHEMBL4468662	=	IC50	nM	0.508	CHEMBL262	Homo sapiens	IC50	nM	0.508
	19439576	CHEMBL4431132	Inhibition of His-tagged full length human recombinant GSK3beta using [YRRAAVPPSPSLSRHSSPHQ-(pS)EDEEE] substrate and pre-incubarted for 20 mins before [gamma-33P]ATP addition and measured after 2 hrs by radiometric kinase assay	B	O=C(C/C=C/c1cnc2[nH]cc(-c3ccccc3)c2c1)NCCc1c[nH]c2ccccc12		CHEMBL4442898	=	IC50	nM	3760.0	CHEMBL262	Homo sapiens	IC50	nM	3760.0
	19439577	CHEMBL4431132	Inhibition of His-tagged full length human recombinant GSK3beta using [YRRAAVPPSPSLSRHSSPHQ-(pS)EDEEE] substrate and pre-incubarted for 20 mins before [gamma-33P]ATP addition and measured after 2 hrs by radiometric kinase assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	4.21	CHEMBL262	Homo sapiens	IC50	nM	4.21
	19439579	CHEMBL4431134	Inhibition of GSK3beta (unknown origin) assessed as remaining enzyme activity at 1 uM	B	CC(=O)c1ccc(-c2c[nH]c3ncc(/C=C/C(=O)NCCc4ccccn4)cc23)cc1		CHEMBL4521500	=	Activity	%	3.4	CHEMBL262	Homo sapiens	Activity	%	3.4
	19439580	CHEMBL4431134	Inhibition of GSK3beta (unknown origin) assessed as remaining enzyme activity at 1 uM	B	COc1ccc(-c2c[nH]c3ncc(/C=C/C(=O)NCc4ccncc4)cc23)cc1		CHEMBL4468662	=	Activity	%	1.2	CHEMBL262	Homo sapiens	Activity	%	1.2
Not Active	19450763	CHEMBL4433653	Inhibition of human recombinant GSK3beta up to 50 uM using GSM as substrate incubated for 30 mins by luminescence based assay	B	O=C(CCCCCCC(=O)Nc1ccccc1)NO		CHEMBL98		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	19450764	CHEMBL4433652	Inhibition of human recombinant GSK3beta using GSM as substrate incubated for 30 mins by luminescence based assay	B	O=C1NC(=O)c2ccccc21		CHEMBL277294	=	IC50	nM	20220.0	CHEMBL262	Homo sapiens	IC50	uM	20.22
	19450765	CHEMBL4433652	Inhibition of human recombinant GSK3beta using GSM as substrate incubated for 30 mins by luminescence based assay	B	O=C(CCCCCNC(=S)Nc1ccc2c(c1)C(=O)NC2=O)NO		CHEMBL4449010	=	IC50	nM	2690.0	CHEMBL262	Homo sapiens	IC50	uM	2.69
	19450766	CHEMBL4433652	Inhibition of human recombinant GSK3beta using GSM as substrate incubated for 30 mins by luminescence based assay	B	O=C(CCCCNC(=S)Nc1ccc2c(c1)C(=O)NC2=O)NO		CHEMBL4575045	=	IC50	nM	4110.0	CHEMBL262	Homo sapiens	IC50	uM	4.11
	19450767	CHEMBL4433652	Inhibition of human recombinant GSK3beta using GSM as substrate incubated for 30 mins by luminescence based assay	B	O=C(CCCNC(=S)Nc1ccc2c(c1)C(=O)NC2=O)NO		CHEMBL4590543	=	IC50	nM	9850.0	CHEMBL262	Homo sapiens	IC50	uM	9.85
	19450768	CHEMBL4433652	Inhibition of human recombinant GSK3beta using GSM as substrate incubated for 30 mins by luminescence based assay	B	O=C(CCNC(=S)Nc1ccc2c(c1)C(=O)NC2=O)NO		CHEMBL4443876	=	IC50	nM	19960.0	CHEMBL262	Homo sapiens	IC50	uM	19.96
	19450769	CHEMBL4433652	Inhibition of human recombinant GSK3beta using GSM as substrate incubated for 30 mins by luminescence based assay	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	IC50	nM	50.0	CHEMBL262	Homo sapiens	IC50	uM	0.05
Active	19450790	CHEMBL4433661	Inhibition of GSK3beta in human SH-SY5Y cells assessed as reduction in copper-induced tau hyperphosphorylation at 10 uM preincubated for 1 hr followed by copper addition and measured after 26 hrs by ELISA	B	O=C1NC(=O)c2ccccc21		CHEMBL277294		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	19450791	CHEMBL4433661	Inhibition of GSK3beta in human SH-SY5Y cells assessed as reduction in copper-induced tau hyperphosphorylation at 10 uM preincubated for 1 hr followed by copper addition and measured after 26 hrs by ELISA	B	O=C(CCCCCNC(=S)Nc1ccc2c(c1)C(=O)NC2=O)NO		CHEMBL4449010		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	19450792	CHEMBL4433661	Inhibition of GSK3beta in human SH-SY5Y cells assessed as reduction in copper-induced tau hyperphosphorylation at 10 uM preincubated for 1 hr followed by copper addition and measured after 26 hrs by ELISA	B	O=C(CCCCCCC(=O)Nc1ccccc1)NO		CHEMBL98		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	19450818	CHEMBL4433687	Inhibition of GSK3beta in human SH-SY5Y cells assessed as reduction in copper-induced tau hyperphosphorylation at 10 mM preincubated for 1 hr followed by copper addition and measured after 26 hrs by ELISA	B	[Cl-].[Li+]		CHEMBL69710		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	19469104	CHEMBL4478199	Inhibition of GSK3beta (unknown origin)	B	CCC(CC)CNc1c(C(N)=O)cnc2ccc(C#N)cc12		CHEMBL4593348	=	IC50	nM	550.0	CHEMBL262	Homo sapiens	IC50	uM	0.55
	19469105	CHEMBL4478199	Inhibition of GSK3beta (unknown origin)	B	CCC(CC)CNc1c(C(N)=O)cnc2ccc(-c3ccc(COC)nc3)cc12		CHEMBL4560522	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	19469106	CHEMBL4478199	Inhibition of GSK3beta (unknown origin)	B	COCc1ccc(-c2ccc3ncc(C(N)=O)c(N[C@@H](C)C4CCOCC4)c3c2)cn1		CHEMBL4218734	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	19469107	CHEMBL4478199	Inhibition of GSK3beta (unknown origin)	B	COCc1ccc(-c2cc3c(N[C@@H](C)c4ccn(C)n4)c(C(N)=O)cnc3cc2F)cn1		CHEMBL4166405	>	IC50	nM	100000.0	CHEMBL262	Homo sapiens	IC50	uM	100.0
	19474312	CHEMBL4479302	Inhibition of human GSK3beta	B	CCC(=O)Nc1nc(C)c(-c2csc(Nc3cc(OC)ccc3OC)n2)s1		CHEMBL4537058	>	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	19474679	CHEMBL4479368	Inhibition of GSK3beta (unknown origin)	B	COc1ncc(-c2cc3c(c(NC(=O)CN4CCOCC4)c2)COC3)cc1NS(C)(=O)=O		CHEMBL4561692	<	IC50	nM	10000.0	CHEMBL262	Homo sapiens	pIC50		5.0
	19476577	CHEMBL4479725	Inhibition of full-length recombinant human His-tagged GSK3B expressed in baculovirus expression system by Z'-LYTE assay	B	O=C(NCC(F)(F)F)c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)cs1		CHEMBL4569508	=	IC50	nM	220.0	CHEMBL262	Homo sapiens	IC50	nM	220.0
	19476677	CHEMBL4479725	Inhibition of full-length recombinant human His-tagged GSK3B expressed in baculovirus expression system by Z'-LYTE assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)NCC(F)(F)F)c4)cnn3c2)cn1		CHEMBL4550702	=	IC50	nM	84.0	CHEMBL262	Homo sapiens	IC50	nM	84.0
	19476777	CHEMBL4479725	Inhibition of full-length recombinant human His-tagged GSK3B expressed in baculovirus expression system by Z'-LYTE assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)N[C@@H]5CCCC[C@@H]5N)c4)cnn3c2)cn1		CHEMBL4568087	=	IC50	nM	23.0	CHEMBL262	Homo sapiens	IC50	nM	23.0
	19476877	CHEMBL4479725	Inhibition of full-length recombinant human His-tagged GSK3B expressed in baculovirus expression system by Z'-LYTE assay	B	Cc1sc(C(=O)N[C@@H]2[C@H](N)CCCC2(F)F)cc1-c1cnn2cc(Cl)cnc12		CHEMBL4552628	=	IC50	nM	150.0	CHEMBL262	Homo sapiens	IC50	nM	150.0
	20597829	CHEMBL4602766	Inhibition of Glycogen synthase kinase-3 beta (unknown origin)	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	IC50	nM	30.0	CHEMBL262	Homo sapiens	IC50	nM	30.0
	20597830	CHEMBL4602767	Inhibition of Glycogen synthase kinase-3 beta (unknown origin) expressing CHO-IR cells	B	Cc1c[nH]c(-c2ncc(NCCNc3ccc(C#N)cc3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL4643408	=	EC50	nM	763.0	CHEMBL262	Homo sapiens	EC50	uM	0.763
	20597833	CHEMBL4602770	Inhibition of full length recombinant His-tagged human Glycogen synthase kinase-3 beta expressed in Baculovirus expression system	B	COc1ccccc1C1=C(c2cn(CCCNC(=O)OC(C)(C)C)c3ncccc23)C(=O)NC1=O		CHEMBL109981	=	IC50	nM	7.0	CHEMBL262	Homo sapiens	IC50	uM	0.007
	20597834	CHEMBL4602770	Inhibition of full length recombinant His-tagged human Glycogen synthase kinase-3 beta expressed in Baculovirus expression system	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1ncc(C(F)(F)F)cc1Cl		CHEMBL111620	=	IC50	nM	26.0	CHEMBL262	Homo sapiens	IC50	uM	0.026
	20597835	CHEMBL4602770	Inhibition of full length recombinant His-tagged human Glycogen synthase kinase-3 beta expressed in Baculovirus expression system	B	NCCCn1cc(C2=C(c3cccc4ccccc34)C(=O)NC2=O)c2cccnc21		CHEMBL4643095	=	IC50	nM	31.0	CHEMBL262	Homo sapiens	IC50	uM	0.031
	20597836	CHEMBL4602770	Inhibition of full length recombinant His-tagged human Glycogen synthase kinase-3 beta expressed in Baculovirus expression system	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1ccccc1Cl		CHEMBL326971	=	IC50	nM	10.0	CHEMBL262	Homo sapiens	IC50	uM	0.01
	20597837	CHEMBL4602770	Inhibition of full length recombinant His-tagged human Glycogen synthase kinase-3 beta expressed in Baculovirus expression system	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1ccccc1C(F)(F)F		CHEMBL325817	=	IC50	nM	14.0	CHEMBL262	Homo sapiens	IC50	uM	0.014
	20597838	CHEMBL4602770	Inhibition of full length recombinant His-tagged human Glycogen synthase kinase-3 beta expressed in Baculovirus expression system	B	COc1ccccc1C1=C(c2cn(CCCO)c3ncccc23)C(=O)NC1=O		CHEMBL111298	=	IC50	nM	4.0	CHEMBL262	Homo sapiens	IC50	uM	0.004
	20597839	CHEMBL4602770	Inhibition of full length recombinant His-tagged human Glycogen synthase kinase-3 beta expressed in Baculovirus expression system	B	CN(C)CCCn1cc(C2=C(c3cccc4ccccc34)C(=O)NC2=O)c2cccnc21		CHEMBL326688	=	IC50	nM	140.0	CHEMBL262	Homo sapiens	IC50	uM	0.14
	20597840	CHEMBL4602766	Inhibition of Glycogen synthase kinase-3 beta (unknown origin)	B	O=C(Nc1ncnc2oc(-c3cccnc3)cc12)C1CCCC1		CHEMBL182419	=	IC50	nM	5.0	CHEMBL262	Homo sapiens	IC50	uM	0.005
	20597841	CHEMBL4602766	Inhibition of Glycogen synthase kinase-3 beta (unknown origin)	B	O=C(Nc1ncnc2oc(-c3cccnc3)cc12)C1CC1		CHEMBL361196	=	IC50	nM	5.0	CHEMBL262	Homo sapiens	IC50	uM	0.005
	20597842	CHEMBL4602766	Inhibition of Glycogen synthase kinase-3 beta (unknown origin)	B	COc1ccc(-c2cc3c(NC(=O)C4CCCC4)ncnc3o2)cc1		CHEMBL181959	=	IC50	nM	32.0	CHEMBL262	Homo sapiens	IC50	uM	0.032
	20597843	CHEMBL4602766	Inhibition of Glycogen synthase kinase-3 beta (unknown origin)	B	O=C(Nc1ncnc2oc(-c3ccccc3)cc12)C1CCCC1		CHEMBL183038	=	IC50	nM	23.0	CHEMBL262	Homo sapiens	IC50	uM	0.023
	20597844	CHEMBL4602766	Inhibition of Glycogen synthase kinase-3 beta (unknown origin)	B	COc1ccc(-c2cc3c(NC(=O)C4CCCCC4)ncnc3o2)cc1		CHEMBL360340	=	IC50	nM	1820.0	CHEMBL262	Homo sapiens	IC50	uM	1.82
	20597845	CHEMBL4602766	Inhibition of Glycogen synthase kinase-3 beta (unknown origin)	B	COc1ccc(-c2cc3c(NC(=O)N4CCOCC4)ncnc3o2)cc1		CHEMBL181147	>	IC50	nM	34000.0	CHEMBL262	Homo sapiens	IC50	uM	34.0
	20597846	CHEMBL4602766	Inhibition of Glycogen synthase kinase-3 beta (unknown origin)	B	COc1ccc(-c2cc3c(NC(=O)c4cccc(F)c4)ncnc3o2)cc1		CHEMBL427325	>	IC50	nM	35000.0	CHEMBL262	Homo sapiens	IC50	uM	35.0
	20597847	CHEMBL4602766	Inhibition of Glycogen synthase kinase-3 beta (unknown origin)	B	O=C(CSc1nnc(Cn2c(C(F)(F)F)nc3ccccc32)o1)Nc1ccccc1		CHEMBL4634672	=	IC50	nM	130.0	CHEMBL262	Homo sapiens	IC50	uM	0.13
	20597848	CHEMBL4602766	Inhibition of Glycogen synthase kinase-3 beta (unknown origin)	B	O=C(CSc1nnc(Cn2c(C(F)(F)F)nc3ccccc32)o1)Nc1ccc(F)cc1		CHEMBL4637474	=	IC50	nM	200.0	CHEMBL262	Homo sapiens	IC50	uM	0.2
	20597849	CHEMBL4602766	Inhibition of Glycogen synthase kinase-3 beta (unknown origin)	B	COc1cc2c(CNC3CCN(S(=O)(=O)c4ccc([N+](=O)[O-])cc4)CC3)cc3c(c2cc1OC)C(=O)NC3=O		CHEMBL4646272	=	IC50	nM	310.0	CHEMBL262	Homo sapiens	IC50	uM	0.31
	20597850	CHEMBL4602766	Inhibition of Glycogen synthase kinase-3 beta (unknown origin)	B	COc1cc2c(CNC3CCN(S(C)(=O)=O)CC3)cc3c(c2cc1OC)C(=O)NC3=O		CHEMBL4632910	=	IC50	nM	360.0	CHEMBL262	Homo sapiens	IC50	uM	0.36
	20597851	CHEMBL4602766	Inhibition of Glycogen synthase kinase-3 beta (unknown origin)	B	CCCCCCCCCCCCCCCC(=O)NC1CCN(C(=O)C2Sc3ccccc3N(CC)C2=O)CC1		CHEMBL4064706	=	IC50	nM	11700.0	CHEMBL262	Homo sapiens	IC50	uM	11.7
	20597852	CHEMBL4602766	Inhibition of Glycogen synthase kinase-3 beta (unknown origin)	B	CCCCCCCCCCCCCCC(=O)NC1CCN(C(=O)C2Sc3ccccc3N(CC)C2=O)CC1		CHEMBL4081419	=	IC50	nM	22400.0	CHEMBL262	Homo sapiens	IC50	uM	22.4
	20597853	CHEMBL4602766	Inhibition of Glycogen synthase kinase-3 beta (unknown origin)	B	CCCCCCCCCCCC(=O)N1CCN(C(=O)C2Sc3ccccc3N(CC)C2=O)CC1		CHEMBL4070897	=	IC50	nM	23200.0	CHEMBL262	Homo sapiens	IC50	uM	23.2
	20597854	CHEMBL4602766	Inhibition of Glycogen synthase kinase-3 beta (unknown origin)	B	CCCCCCCCCCCCCC(=O)N1CCN(C(=O)C2Sc3ccccc3N(CC)C2=O)CC1		CHEMBL4076026	=	IC50	nM	18900.0	CHEMBL262	Homo sapiens	IC50	uM	18.9
	20597855	CHEMBL4602766	Inhibition of Glycogen synthase kinase-3 beta (unknown origin)	B	CCCCCCCCCCCCCCCC(=O)N1CCN(C(=O)C2Sc3ccccc3N(CC)C2=O)CC1		CHEMBL4092659	=	IC50	nM	8700.0	CHEMBL262	Homo sapiens	IC50	uM	8.7
	20597856	CHEMBL4602771	Inhibition of Glycogen synthase kinase-3 beta (unknown origin) after 30 mins by Kinase-Glo assay	B	CCc1ccc(-n2cc(CSC3=NC(c4ccccc4)CC(=O)N3C)nn2)cc1		CHEMBL4641105	=	IC50	nM	94.0	CHEMBL262	Homo sapiens	IC50	uM	0.094
	20597857	CHEMBL4602771	Inhibition of Glycogen synthase kinase-3 beta (unknown origin) after 30 mins by Kinase-Glo assay	B	CN1C(=O)CC(c2ccccc2)N=C1SCc1cn(-c2ccccc2F)nn1		CHEMBL4647289	=	IC50	nM	122.0	CHEMBL262	Homo sapiens	IC50	uM	0.122
	20597858	CHEMBL4602771	Inhibition of Glycogen synthase kinase-3 beta (unknown origin) after 30 mins by Kinase-Glo assay	B	Cc1ccc(-n2cc(CSC3=NC(c4ccccc4)CC(=O)N3C)nn2)cc1C		CHEMBL4635819	=	IC50	nM	82.0	CHEMBL262	Homo sapiens	IC50	uM	0.082
	20597859	CHEMBL4602771	Inhibition of Glycogen synthase kinase-3 beta (unknown origin) after 30 mins by Kinase-Glo assay	B	CN1C(=O)CC(c2ccccc2)N=C1SCc1cn(-c2cccc([N+](=O)[O-])c2)nn1		CHEMBL4637462	=	IC50	nM	153.0	CHEMBL262	Homo sapiens	IC50	uM	0.153
	20597860	CHEMBL4602771	Inhibition of Glycogen synthase kinase-3 beta (unknown origin) after 30 mins by Kinase-Glo assay	B	CN1C(=O)CC(c2ccccc2)N=C1SCc1cn(-c2ccccc2)nn1		CHEMBL4647588	=	IC50	nM	916.0	CHEMBL262	Homo sapiens	IC50	uM	0.916
	20597861	CHEMBL4602771	Inhibition of Glycogen synthase kinase-3 beta (unknown origin) after 30 mins by Kinase-Glo assay	B	CN1C(=O)CC(c2ccccc2)N=C1SCc1cn(-c2ccc(C(C)(C)C)cc2)nn1		CHEMBL4645499	=	IC50	nM	1340.0	CHEMBL262	Homo sapiens	IC50	uM	1.34
	20597862	CHEMBL4602771	Inhibition of Glycogen synthase kinase-3 beta (unknown origin) after 30 mins by Kinase-Glo assay	B	COc1ccccc1-n1cc(CSC2=NC(c3ccccc3)CC(=O)N2C)nn1		CHEMBL4642636	=	IC50	nM	1314.0	CHEMBL262	Homo sapiens	IC50	uM	1.314
	20597863	CHEMBL4602766	Inhibition of Glycogen synthase kinase-3 beta (unknown origin)	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	40.0	CHEMBL262	Homo sapiens	IC50	uM	0.04
	20597864	CHEMBL4602771	Inhibition of Glycogen synthase kinase-3 beta (unknown origin) after 30 mins by Kinase-Glo assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	54.0	CHEMBL262	Homo sapiens	IC50	uM	0.054
	20597865	CHEMBL4602766	Inhibition of Glycogen synthase kinase-3 beta (unknown origin)	B	COc1ccc(NC(=O)c2ccc(NC3=C(c4ccc(OC)cc4)C(=O)NC3=O)cc2)cc1		CHEMBL4641587	=	IC50	nM	90.0	CHEMBL262	Homo sapiens	IC50	uM	0.09
	20597866	CHEMBL4602766	Inhibition of Glycogen synthase kinase-3 beta (unknown origin)	B	COc1ccc(NC(=O)c2ccc(NC3=C(c4ccccc4)C(=O)NC3=O)cc2)cc1		CHEMBL4644518	=	IC50	nM	120.0	CHEMBL262	Homo sapiens	IC50	uM	0.12
	20597867	CHEMBL4602766	Inhibition of Glycogen synthase kinase-3 beta (unknown origin)	B	COc1ccc(C2=C(Nc3ccc(C(=O)Nc4ccccc4)cc3)C(=O)NC2=O)cc1		CHEMBL4647915	=	IC50	nM	170.0	CHEMBL262	Homo sapiens	IC50	uM	0.17
	20597868	CHEMBL4602766	Inhibition of Glycogen synthase kinase-3 beta (unknown origin)	B	COc1ccc(C2=C(Nc3ccc(C(=O)Nc4ccc(Cl)cc4)cc3)C(=O)NC2=O)cc1		CHEMBL4632671	=	IC50	nM	190.0	CHEMBL262	Homo sapiens	IC50	uM	0.19
	20597869	CHEMBL4602766	Inhibition of Glycogen synthase kinase-3 beta (unknown origin)	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccc(C(=O)Nc2ccccc2)cc1		CHEMBL4636075	=	IC50	nM	210.0	CHEMBL262	Homo sapiens	IC50	uM	0.21
	20597870	CHEMBL4602766	Inhibition of Glycogen synthase kinase-3 beta (unknown origin)	B	FC(F)(F)c1nc2ccccc2n1Cc1nnc(SCc2cn(-c3cccnc3)nn2)o1		CHEMBL4648941	=	IC50	nM	150.0	CHEMBL262	Homo sapiens	IC50	uM	0.15
	20597871	CHEMBL4602766	Inhibition of Glycogen synthase kinase-3 beta (unknown origin)	B	Fc1ccccc1-n1cc(CSc2nnc(Cn3c(C(F)(F)F)nc4ccccc43)o2)nn1		CHEMBL4639781	=	IC50	nM	270.0	CHEMBL262	Homo sapiens	IC50	uM	0.27
	20597872	CHEMBL4602766	Inhibition of Glycogen synthase kinase-3 beta (unknown origin)	B	FC(F)(F)c1nc2ccccc2n1Cc1nnc(SCc2cn(-c3ccccc3)nn2)o1		CHEMBL4633926	=	IC50	nM	320.0	CHEMBL262	Homo sapiens	IC50	uM	0.32
	20597873	CHEMBL4602766	Inhibition of Glycogen synthase kinase-3 beta (unknown origin)	B	CCc1ccc(-n2cc(CSc3nnc(Cn4c(C(F)(F)F)nc5ccccc54)o3)nn2)cc1		CHEMBL4643895	=	IC50	nM	390.0	CHEMBL262	Homo sapiens	IC50	uM	0.39
	20597874	CHEMBL4602766	Inhibition of Glycogen synthase kinase-3 beta (unknown origin)	B	CC(C)n1cc(C2=C(c3cccc(NC(=O)CF)c3)C(=O)NC2=O)c2cccnc21		CHEMBL4645337	=	IC50	nM	17.0	CHEMBL262	Homo sapiens	IC50	uM	0.017
	20597875	CHEMBL4602766	Inhibition of Glycogen synthase kinase-3 beta (unknown origin)	B	C=CC(=O)Nc1cccc(C2=C(c3cn(C(C)C)c4ncccc34)C(=O)NC2=O)c1		CHEMBL4648050	=	IC50	nM	34.0	CHEMBL262	Homo sapiens	IC50	uM	0.034
	20597876	CHEMBL4602766	Inhibition of Glycogen synthase kinase-3 beta (unknown origin)	B	C=CC(=O)Nc1cccc(C2=C(c3cn(C)c4ccc(F)cc34)C(=O)NC2=O)c1		CHEMBL4649363	=	IC50	nM	150.0	CHEMBL262	Homo sapiens	IC50	uM	0.15
	20597877	CHEMBL4602766	Inhibition of Glycogen synthase kinase-3 beta (unknown origin)	B	C=CC(=O)Nc1cccc(C2=C(c3cn(C)c4cc(F)ccc34)C(=O)NC2=O)c1		CHEMBL4632696	=	IC50	nM	199.0	CHEMBL262	Homo sapiens	IC50	uM	0.199
	20597878	CHEMBL4602766	Inhibition of Glycogen synthase kinase-3 beta (unknown origin)	B	C=CC(=O)Nc1cccc(C2=C(c3cn(C)c4cc(OC)ccc34)C(=O)NC2=O)c1		CHEMBL4647220	=	IC50	nM	690.0	CHEMBL262	Homo sapiens	IC50	uM	0.69
	20597879	CHEMBL4602772	Inhibition of Glycogen synthase kinase-3 beta in human SH-SY5Y cells after 2 hrs by ELISA	B	COc1ccc(-c2cc(=O)c3c(OC)c([C@H]4O[C@H](C(=O)N[C@@H](C)C(F)(F)F)[C@@H](O)[C@H](O)[C@H]4O)c(OC)cc3o2)cc1OC		CHEMBL4640300	=	IC50	nM	590.0	CHEMBL262	Homo sapiens	IC50	uM	0.59
	20597880	CHEMBL4602772	Inhibition of Glycogen synthase kinase-3 beta in human SH-SY5Y cells after 2 hrs by ELISA	B	COc1ccc(-c2cc(=O)c3c(OC)c([C@H]4O[C@H](C(=O)N[C@H](C)C(F)(F)F)[C@@H](O)[C@H](O)[C@H]4O)c(OC)cc3o2)cc1OC		CHEMBL4646033	=	IC50	nM	2300.0	CHEMBL262	Homo sapiens	IC50	uM	2.3
	20597881	CHEMBL4602772	Inhibition of Glycogen synthase kinase-3 beta in human SH-SY5Y cells after 2 hrs by ELISA	B	COc1ccc(-c2cc(=O)c3c(OC)c([C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)c(OC)cc3o2)cc1OC	Outside typical range	CHEMBL4643516	=	IC50	nM	239200.0	CHEMBL262	Homo sapiens	IC50	uM	239.2
	20597882	CHEMBL4602772	Inhibition of Glycogen synthase kinase-3 beta in human SH-SY5Y cells after 2 hrs by ELISA	B	COc1ccc(-c2cc(=O)c3c(OC)c([C@H]4O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]4O)c(OC)cc3o2)cc1OC	Outside typical range	CHEMBL4645199	=	IC50	nM	237300.0	CHEMBL262	Homo sapiens	IC50	uM	237.3
	20597883	CHEMBL4602766	Inhibition of Glycogen synthase kinase-3 beta (unknown origin)	B	COc1ccc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(OC)cc2)cc1		CHEMBL454662	=	IC50	nM	530.0	CHEMBL262	Homo sapiens	IC50	uM	0.53
	20597884	CHEMBL4602766	Inhibition of Glycogen synthase kinase-3 beta (unknown origin)	B	COc1ccc(/C=C/C(O)=C/C(=O)/C=C/c2ccc(OCc3ccccc3)cc2)cc1OC		CHEMBL4636722	=	IC50	nM	900.0	CHEMBL262	Homo sapiens	IC50	uM	0.9
	20597885	CHEMBL4602766	Inhibition of Glycogen synthase kinase-3 beta (unknown origin)	B	O=C(/C=C(O)/C=C/c1ccc(OCc2cccc(F)c2)cc1)/C=C/c1ccc(OCc2cccc(F)c2)cc1		CHEMBL3763264	=	IC50	nM	16990.0	CHEMBL262	Homo sapiens	IC50	uM	16.99
	20597886	CHEMBL4602766	Inhibition of Glycogen synthase kinase-3 beta (unknown origin)	B	COc1ccc2[nH]nc(C(=O)NCC3CCN(CCc4ccc(O)cc4)CC3)c2c1		CHEMBL3736216	=	IC50	nM	350.0	CHEMBL262	Homo sapiens	IC50	uM	0.35
	20597887	CHEMBL4602766	Inhibition of Glycogen synthase kinase-3 beta (unknown origin)	B	Cc1ccc2[nH]nc(C(=O)NCC3CCN(C(=O)Nc4ccccc4)CC3)c2c1		CHEMBL4632385	=	IC50	nM	640.0	CHEMBL262	Homo sapiens	IC50	uM	0.64
	20600440	CHEMBL4603309	Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system using serine/threonine-9 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	=	IC50	nM	28110.0	CHEMBL262	Homo sapiens	IC50	uM	28.11
	20604071	CHEMBL4604469	Inhibition of N-Terminal His tagged human GSK3B expressed in baculovirus expression system at 10 uM after 1 hr by Z'-LYTE assay relative to control	B	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COC(=O)c2ccc[nH]2)[C@@H](O)[C@H]1O		CHEMBL4633057	=	Inhibition	%	100.0	CHEMBL262	Homo sapiens	INH	%	100.0
	20604072	CHEMBL4604469	Inhibition of N-Terminal His tagged human GSK3B expressed in baculovirus expression system at 10 uM after 1 hr by Z'-LYTE assay relative to control	B	O=C(OC[C@H]1O[C@@H](n2cnc3c(=O)[nH]cnc32)[C@H](O)[C@@H]1O)c1ccc[nH]1		CHEMBL4636133	=	Inhibition	%	94.0	CHEMBL262	Homo sapiens	INH	%	94.0
	20604073	CHEMBL4604469	Inhibition of N-Terminal His tagged human GSK3B expressed in baculovirus expression system at 10 uM after 1 hr by Z'-LYTE assay relative to control	B	Nc1nc2c(ncn2[C@@H]2O[C@H](COC(=O)c3ccc[nH]3)[C@@H](O)[C@H]2O)c(=O)[nH]1		CHEMBL4642516	=	Inhibition	%	98.0	CHEMBL262	Homo sapiens	INH	%	98.0
	20604074	CHEMBL4604469	Inhibition of N-Terminal His tagged human GSK3B expressed in baculovirus expression system at 10 uM after 1 hr by Z'-LYTE assay relative to control	B	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COC(=O)c2cc[nH]c2)[C@@H](O)[C@H]1O		CHEMBL4647499	=	Inhibition	%	98.0	CHEMBL262	Homo sapiens	INH	%	98.0
	20604075	CHEMBL4604469	Inhibition of N-Terminal His tagged human GSK3B expressed in baculovirus expression system at 10 uM after 1 hr by Z'-LYTE assay relative to control	B	O=C(OC[C@H]1O[C@@H](n2cnc3c(=O)[nH]cnc32)[C@H](O)[C@@H]1O)c1cc[nH]c1		CHEMBL4637966	=	Inhibition	%	99.0	CHEMBL262	Homo sapiens	INH	%	99.0
	20604076	CHEMBL4604469	Inhibition of N-Terminal His tagged human GSK3B expressed in baculovirus expression system at 10 uM after 1 hr by Z'-LYTE assay relative to control	B	Nc1nc2c(ncn2[C@@H]2O[C@H](COC(=O)c3cc[nH]c3)[C@@H](O)[C@H]2O)c(=O)[nH]1		CHEMBL4634615	=	Inhibition	%	96.0	CHEMBL262	Homo sapiens	INH	%	96.0
	20606104	CHEMBL4604955	Inhibition of GSK3beta (unknown origin)	B	Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL99203	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	20606105	CHEMBL4604955	Inhibition of GSK3beta (unknown origin)	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	20606115	CHEMBL4604962	Inhibition of recombinant human GSK3beta (1 to 433 residues) expressed in mammalian expression system by Kinomescan method	B	Nc1ncc(-c2ccccc2)nc1C(=O)Nc1cnccc1N1CCC(C(=O)O)CC1		CHEMBL4638292	=	IC50	nM	40.0	CHEMBL262	Homo sapiens	IC50	uM	0.04
	20606116	CHEMBL4604962	Inhibition of recombinant human GSK3beta (1 to 433 residues) expressed in mammalian expression system by Kinomescan method	B	CC(C)Oc1ccc(F)c(-c2cnc(N)c(C(=O)Nc3cnccc3N3CCC[C@@H](C(=O)O)C3)n2)c1		CHEMBL4647659	=	IC50	nM	16.0	CHEMBL262	Homo sapiens	IC50	uM	0.016
	20606141	CHEMBL4604968	Inhibition of recombinant human His/GST-tagged GSK3beta (2 to 433 residues) expressed in baculovirus infected Sf9 cells using Ulight-glycogen synthase peptide as substrate incubated for 30 mins by TR-FRET LANCE method	B	CC(C)Cn1cc(-c2ccncc2)c2ccncc21		CHEMBL4634969	>	IC50	nM	8300.0	CHEMBL262	Homo sapiens	IC50	uM	8.3
	20606142	CHEMBL4604968	Inhibition of recombinant human His/GST-tagged GSK3beta (2 to 433 residues) expressed in baculovirus infected Sf9 cells using Ulight-glycogen synthase peptide as substrate incubated for 30 mins by TR-FRET LANCE method	B	c1cc(-c2cn(CC3CC3)c3cnccc23)ccn1		CHEMBL4648945	>	IC50	nM	8300.0	CHEMBL262	Homo sapiens	IC50	uM	8.3
	20606143	CHEMBL4604968	Inhibition of recombinant human His/GST-tagged GSK3beta (2 to 433 residues) expressed in baculovirus infected Sf9 cells using Ulight-glycogen synthase peptide as substrate incubated for 30 mins by TR-FRET LANCE method	B	COCCn1cc(-c2ccncc2)c2ccncc21		CHEMBL4091320	=	IC50	nM	29600.0	CHEMBL262	Homo sapiens	IC50	uM	29.6
	20606144	CHEMBL4604968	Inhibition of recombinant human His/GST-tagged GSK3beta (2 to 433 residues) expressed in baculovirus infected Sf9 cells using Ulight-glycogen synthase peptide as substrate incubated for 30 mins by TR-FRET LANCE method	B	CC1(Cn2cc(-c3ccncc3)c3ccncc32)COC1		CHEMBL4644898	>	IC50	nM	28500.0	CHEMBL262	Homo sapiens	IC50	uM	28.5
	20606145	CHEMBL4604968	Inhibition of recombinant human His/GST-tagged GSK3beta (2 to 433 residues) expressed in baculovirus infected Sf9 cells using Ulight-glycogen synthase peptide as substrate incubated for 30 mins by TR-FRET LANCE method	B	c1cc(-c2cn(C3CCOCC3)c3cnccc23)ccn1		CHEMBL4640598	=	IC50	nM	44480.0	CHEMBL262	Homo sapiens	IC50	uM	44.48
	20606146	CHEMBL4604968	Inhibition of recombinant human His/GST-tagged GSK3beta (2 to 433 residues) expressed in baculovirus infected Sf9 cells using Ulight-glycogen synthase peptide as substrate incubated for 30 mins by TR-FRET LANCE method	B	c1ccc(Cn2cc(-c3ccncc3)c3ccncc32)cc1		CHEMBL4638460	>	IC50	nM	12400.0	CHEMBL262	Homo sapiens	IC50	uM	12.4
	20606147	CHEMBL4604968	Inhibition of recombinant human His/GST-tagged GSK3beta (2 to 433 residues) expressed in baculovirus infected Sf9 cells using Ulight-glycogen synthase peptide as substrate incubated for 30 mins by TR-FRET LANCE method	B	c1ccc(-n2cc(-c3ccncc3)c3ccncc32)cc1		CHEMBL4648742	>	IC50	nM	8300.0	CHEMBL262	Homo sapiens	IC50	uM	8.3
	20606148	CHEMBL4604968	Inhibition of recombinant human His/GST-tagged GSK3beta (2 to 433 residues) expressed in baculovirus infected Sf9 cells using Ulight-glycogen synthase peptide as substrate incubated for 30 mins by TR-FRET LANCE method	B	Nc1cc(-c2cn(-c3ccccc3)c3cnccc23)ccn1		CHEMBL4640465	=	IC50	nM	1950.0	CHEMBL262	Homo sapiens	IC50	uM	1.95
	20606149	CHEMBL4604968	Inhibition of recombinant human His/GST-tagged GSK3beta (2 to 433 residues) expressed in baculovirus infected Sf9 cells using Ulight-glycogen synthase peptide as substrate incubated for 30 mins by TR-FRET LANCE method	B	O=C(Nc1cc(-c2cn(-c3ccccc3)c3cnccc23)ccn1)C1CC1		CHEMBL4648047	=	IC50	nM	630.0	CHEMBL262	Homo sapiens	IC50	uM	0.63
	20606150	CHEMBL4604968	Inhibition of recombinant human His/GST-tagged GSK3beta (2 to 433 residues) expressed in baculovirus infected Sf9 cells using Ulight-glycogen synthase peptide as substrate incubated for 30 mins by TR-FRET LANCE method	B	O=C(Nc1cc(-c2cn(-c3ccccc3)c3cnccc23)ccn1)NC1CC1		CHEMBL4645474	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	20606151	CHEMBL4604968	Inhibition of recombinant human His/GST-tagged GSK3beta (2 to 433 residues) expressed in baculovirus infected Sf9 cells using Ulight-glycogen synthase peptide as substrate incubated for 30 mins by TR-FRET LANCE method	B	O=C(Nc1cc(-c2cn(C3CCOCC3)c3cnccc23)ccn1)NC1CC1		CHEMBL4641631	=	IC50	nM	5640.0	CHEMBL262	Homo sapiens	IC50	uM	5.64
	20606152	CHEMBL4604968	Inhibition of recombinant human His/GST-tagged GSK3beta (2 to 433 residues) expressed in baculovirus infected Sf9 cells using Ulight-glycogen synthase peptide as substrate incubated for 30 mins by TR-FRET LANCE method	B	CC1(C)CN(C(=O)Nc2cc(-c3cn(C4CCOCC4)c4cnccc34)ccn2)C1		CHEMBL4649473	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	20606153	CHEMBL4604968	Inhibition of recombinant human His/GST-tagged GSK3beta (2 to 433 residues) expressed in baculovirus infected Sf9 cells using Ulight-glycogen synthase peptide as substrate incubated for 30 mins by TR-FRET LANCE method	B	O=C(Nc1cc(-c2cn(C3CCOCC3)c3cnccc23)ccn1)N1CCOCC1		CHEMBL4641672	=	IC50	nM	46500.0	CHEMBL262	Homo sapiens	IC50	uM	46.5
	20606154	CHEMBL4604968	Inhibition of recombinant human His/GST-tagged GSK3beta (2 to 433 residues) expressed in baculovirus infected Sf9 cells using Ulight-glycogen synthase peptide as substrate incubated for 30 mins by TR-FRET LANCE method	B	C[C@H]1CN(C(=O)Nc2cc(-c3cn(C4CCOCC4)c4cnccc34)ccn2)C[C@@H](C)O1		CHEMBL4641839	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	20606155	CHEMBL4604968	Inhibition of recombinant human His/GST-tagged GSK3beta (2 to 433 residues) expressed in baculovirus infected Sf9 cells using Ulight-glycogen synthase peptide as substrate incubated for 30 mins by TR-FRET LANCE method	B	C[C@H]1CN(C(=O)Nc2cc(-c3cn([C@H]4CC[C@@](C)(O)CC4)c4cnccc34)ccn2)C[C@@H](C)O1		CHEMBL4640031	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	20606156	CHEMBL4604968	Inhibition of recombinant human His/GST-tagged GSK3beta (2 to 433 residues) expressed in baculovirus infected Sf9 cells using Ulight-glycogen synthase peptide as substrate incubated for 30 mins by TR-FRET LANCE method	B	CCN1CCN(C(=O)Nc2cc(-c3cn(C4CCOCC4)c4cnccc34)ccn2)CC1		CHEMBL4636064	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	20635324	CHEMBL4611599	Inhibition of wild-type human full length GSK3B (M1 to T433 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control	B	CN1CCN(c2ccc(NCCNc3ccc([N+](=O)[O-])c(N)n3)nc2-c2ccc(Cl)cc2Cl)C(=O)C1		CHEMBL1242830	=	Inhibition	%	95.8	CHEMBL262	Homo sapiens	INH	%	95.8
	20651716	CHEMBL4615928	Inhibition of recombinant full length human N-terminal GST-tagged GSK3beta (1 to 420 end residues) expressed in baculovirus expression system using unphosphorylated peptide as substrate incubated enzyme-substrate mixture for 90 mins in presence of ATP by LANCE assay	B	COCCN1CCC(CNC(=O)c2n[nH]c3ccc(-c4cccc(F)c4F)cc23)CC1		CHEMBL3735506	=	IC50	nM	18.0	CHEMBL262	Homo sapiens	IC50	uM	0.018
	20651717	CHEMBL4615928	Inhibition of recombinant full length human N-terminal GST-tagged GSK3beta (1 to 420 end residues) expressed in baculovirus expression system using unphosphorylated peptide as substrate incubated enzyme-substrate mixture for 90 mins in presence of ATP by LANCE assay	B	O=C(NCC1CCOCC1)c1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL4641082	=	IC50	nM	14.0	CHEMBL262	Homo sapiens	IC50	uM	0.014
	20651718	CHEMBL4615928	Inhibition of recombinant full length human N-terminal GST-tagged GSK3beta (1 to 420 end residues) expressed in baculovirus expression system using unphosphorylated peptide as substrate incubated enzyme-substrate mixture for 90 mins in presence of ATP by LANCE assay	B	O=C(NCC1CCCOC1)c1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL4635680	=	IC50	nM	20.0	CHEMBL262	Homo sapiens	IC50	uM	0.02
	20651719	CHEMBL4615928	Inhibition of recombinant full length human N-terminal GST-tagged GSK3beta (1 to 420 end residues) expressed in baculovirus expression system using unphosphorylated peptide as substrate incubated enzyme-substrate mixture for 90 mins in presence of ATP by LANCE assay	B	O=C(NCC1CCOC1)c1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL4634867	=	IC50	nM	26.0	CHEMBL262	Homo sapiens	IC50	uM	0.026
	20651720	CHEMBL4615928	Inhibition of recombinant full length human N-terminal GST-tagged GSK3beta (1 to 420 end residues) expressed in baculovirus expression system using unphosphorylated peptide as substrate incubated enzyme-substrate mixture for 90 mins in presence of ATP by LANCE assay	B	O=C(NCC1CCCO1)c1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL4635900	=	IC50	nM	55.0	CHEMBL262	Homo sapiens	IC50	uM	0.055
	20651721	CHEMBL4615928	Inhibition of recombinant full length human N-terminal GST-tagged GSK3beta (1 to 420 end residues) expressed in baculovirus expression system using unphosphorylated peptide as substrate incubated enzyme-substrate mixture for 90 mins in presence of ATP by LANCE assay	B	O=C(NC1CCOCC1)c1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL4633727	=	IC50	nM	22.0	CHEMBL262	Homo sapiens	IC50	uM	0.022
	20651722	CHEMBL4615928	Inhibition of recombinant full length human N-terminal GST-tagged GSK3beta (1 to 420 end residues) expressed in baculovirus expression system using unphosphorylated peptide as substrate incubated enzyme-substrate mixture for 90 mins in presence of ATP by LANCE assay	B	O=C(NC1CCCOC1)c1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL4633607	=	IC50	nM	31.0	CHEMBL262	Homo sapiens	IC50	uM	0.031
	20651723	CHEMBL4615928	Inhibition of recombinant full length human N-terminal GST-tagged GSK3beta (1 to 420 end residues) expressed in baculovirus expression system using unphosphorylated peptide as substrate incubated enzyme-substrate mixture for 90 mins in presence of ATP by LANCE assay	B	O=C(NC1CCOC1)c1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL4633141	=	IC50	nM	130.0	CHEMBL262	Homo sapiens	IC50	uM	0.13
	20651724	CHEMBL4615928	Inhibition of recombinant full length human N-terminal GST-tagged GSK3beta (1 to 420 end residues) expressed in baculovirus expression system using unphosphorylated peptide as substrate incubated enzyme-substrate mixture for 90 mins in presence of ATP by LANCE assay	B	O=C(NC1CCS(=O)(=O)CC1)c1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL4645145	=	IC50	nM	39.0	CHEMBL262	Homo sapiens	IC50	uM	0.039
	20651725	CHEMBL4615928	Inhibition of recombinant full length human N-terminal GST-tagged GSK3beta (1 to 420 end residues) expressed in baculovirus expression system using unphosphorylated peptide as substrate incubated enzyme-substrate mixture for 90 mins in presence of ATP by LANCE assay	B	O=C(NC1CCS(=O)(=O)C1)c1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL4633136	=	IC50	nM	14.0	CHEMBL262	Homo sapiens	IC50	uM	0.014
	20651726	CHEMBL4615928	Inhibition of recombinant full length human N-terminal GST-tagged GSK3beta (1 to 420 end residues) expressed in baculovirus expression system using unphosphorylated peptide as substrate incubated enzyme-substrate mixture for 90 mins in presence of ATP by LANCE assay	B	O=C(NCC1CCOCC1)c1n[nH]c2ccc(-c3cccnc3)cc12		CHEMBL4638321	=	IC50	nM	22.0	CHEMBL262	Homo sapiens	IC50	uM	0.022
	20651727	CHEMBL4615928	Inhibition of recombinant full length human N-terminal GST-tagged GSK3beta (1 to 420 end residues) expressed in baculovirus expression system using unphosphorylated peptide as substrate incubated enzyme-substrate mixture for 90 mins in presence of ATP by LANCE assay	B	CC(C)Oc1cncc(-c2ccc3[nH]nc(C(=O)NCC4CCOCC4)c3c2)c1		CHEMBL4632807	=	IC50	nM	4.0	CHEMBL262	Homo sapiens	IC50	uM	0.004
	20651728	CHEMBL4615928	Inhibition of recombinant full length human N-terminal GST-tagged GSK3beta (1 to 420 end residues) expressed in baculovirus expression system using unphosphorylated peptide as substrate incubated enzyme-substrate mixture for 90 mins in presence of ATP by LANCE assay	B	COCc1cncc(-c2ccc3[nH]nc(C(=O)NCC4CCOCC4)c3c2)c1		CHEMBL4643920	=	IC50	nM	6.0	CHEMBL262	Homo sapiens	IC50	uM	0.006
	20651729	CHEMBL4615928	Inhibition of recombinant full length human N-terminal GST-tagged GSK3beta (1 to 420 end residues) expressed in baculovirus expression system using unphosphorylated peptide as substrate incubated enzyme-substrate mixture for 90 mins in presence of ATP by LANCE assay	B	O=C(NCC1CCOCC1)c1n[nH]c2ccc(-c3cncc(CO)c3)cc12		CHEMBL4640019	=	IC50	nM	4.0	CHEMBL262	Homo sapiens	IC50	uM	0.004
	20651730	CHEMBL4615928	Inhibition of recombinant full length human N-terminal GST-tagged GSK3beta (1 to 420 end residues) expressed in baculovirus expression system using unphosphorylated peptide as substrate incubated enzyme-substrate mixture for 90 mins in presence of ATP by LANCE assay	B	COCc1ccncc1-c1ccc2[nH]nc(C(=O)NCC3CCOCC3)c2c1		CHEMBL4636306	=	IC50	nM	28.0	CHEMBL262	Homo sapiens	IC50	uM	0.028
	20651731	CHEMBL4615928	Inhibition of recombinant full length human N-terminal GST-tagged GSK3beta (1 to 420 end residues) expressed in baculovirus expression system using unphosphorylated peptide as substrate incubated enzyme-substrate mixture for 90 mins in presence of ATP by LANCE assay	B	O=C(NCC1CCOCC1)c1n[nH]c2ccc(-c3cnccc3CO)cc12		CHEMBL4641148	=	IC50	nM	33.0	CHEMBL262	Homo sapiens	IC50	uM	0.033
	20651732	CHEMBL4615928	Inhibition of recombinant full length human N-terminal GST-tagged GSK3beta (1 to 420 end residues) expressed in baculovirus expression system using unphosphorylated peptide as substrate incubated enzyme-substrate mixture for 90 mins in presence of ATP by LANCE assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	53.0	CHEMBL262	Homo sapiens	IC50	uM	0.053
	20651749	CHEMBL4615930	Inhibition of GSK3beta (unknown origin) transfected in HEK cells co-transfected with tau assessed as reduction in tau phosphorylation incubated for 18 hrs in presence of 1ug/ml doxycycline	B	O=C(NCC1CCOCC1)c1n[nH]c2ccc(-c3cncc(CO)c3)cc12		CHEMBL4640019	=	IC50	nM	3400.0	CHEMBL262	Homo sapiens	IC50	uM	3.4
	20651783	CHEMBL4615963	Inhibition of recombinant full length human GSK3beta expressed in Sf21 insect cells using biotinylated-AAEELDSRAGS(PO3H2)PQL peptide as substrate preincubated enzyme-substrate mixture for 15 to 20 mins followed by [gamma-33P]ATP addition and measured after 20 mins by scintillation proximity assay	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	IC50	nM	104.0	CHEMBL262	Homo sapiens	IC50	uM	0.104
	20651784	CHEMBL4615963	Inhibition of recombinant full length human GSK3beta expressed in Sf21 insect cells using biotinylated-AAEELDSRAGS(PO3H2)PQL peptide as substrate preincubated enzyme-substrate mixture for 15 to 20 mins followed by [gamma-33P]ATP addition and measured after 20 mins by scintillation proximity assay	B	N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1		CHEMBL1969664	=	Ki	nM	31.0	CHEMBL262	Homo sapiens	Ki	uM	0.031
	20680045	CHEMBL4622605	Inhibition of GSK3beta (unknown origin) at 1 uM by PanQinase assay relative to control	B	c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359554	=	Inhibition	%	76.0	CHEMBL262	Homo sapiens	INH	%	76.0
	20680046	CHEMBL4622605	Inhibition of GSK3beta (unknown origin) at 1 uM by PanQinase assay relative to control	B	CN(c1ccccc1)c1nccc(-c2cnn3ncccc23)n1		CHEMBL360866	=	Inhibition	%	13.0	CHEMBL262	Homo sapiens	INH	%	13.0
	20680068	CHEMBL4622616	Inhibition of recombinant human full length GSK3beta (1 to 433 residues) expressed in mammalian expression system at 1 uM by DiscoverX competition binding assay relative to control	B	Cc1cccc(N(C)c2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL4637319	=	Inhibition	%	4.0	CHEMBL262	Homo sapiens	INH	%	4.0
	20714310	CHEMBL4629861	Binding affinity to GSK3beta (unknown origin) assessed as change in melting temperature at 10 uM by SYPRO Orange dye based fluorescence assay	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Delta Tm	degrees C	3.4	CHEMBL262	Homo sapiens	deltaTm	degrees C	3.4
	20714311	CHEMBL4629861	Binding affinity to GSK3beta (unknown origin) assessed as change in melting temperature at 10 uM by SYPRO Orange dye based fluorescence assay	B	CNC(=O)c1cnc(NCCN)nc1Nc1cccc(C(F)(F)F)c1		CHEMBL2426221	=	Delta Tm	degrees C	-0.27	CHEMBL262	Homo sapiens	deltaTm	degrees C	-0.27
	20714312	CHEMBL4629861	Binding affinity to GSK3beta (unknown origin) assessed as change in melting temperature at 10 uM by SYPRO Orange dye based fluorescence assay	B	CN(CCN)c1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL4642539	=	Delta Tm	degrees C	0.84	CHEMBL262	Homo sapiens	deltaTm	degrees C	0.84
	20714313	CHEMBL4629861	Binding affinity to GSK3beta (unknown origin) assessed as change in melting temperature at 10 uM by SYPRO Orange dye based fluorescence assay	B	CNCCN(C)c1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL4632887	=	Delta Tm	degrees C	0.7	CHEMBL262	Homo sapiens	deltaTm	degrees C	0.7
	20714314	CHEMBL4629861	Binding affinity to GSK3beta (unknown origin) assessed as change in melting temperature at 10 uM by SYPRO Orange dye based fluorescence assay	B	CN(C)CCN(C)c1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL474652	=	Delta Tm	degrees C	0.76	CHEMBL262	Homo sapiens	deltaTm	degrees C	0.76
	20714315	CHEMBL4629861	Binding affinity to GSK3beta (unknown origin) assessed as change in melting temperature at 10 uM by SYPRO Orange dye based fluorescence assay	B	NC(=O)c1cnc(N2CCCC(N)C2)nc1Nc1cccc(C(F)(F)F)c1		CHEMBL4644912	=	Delta Tm	degrees C	2.31	CHEMBL262	Homo sapiens	deltaTm	degrees C	2.31
	20714316	CHEMBL4629861	Binding affinity to GSK3beta (unknown origin) assessed as change in melting temperature at 10 uM by SYPRO Orange dye based fluorescence assay	B	NC(=O)c1cnc(N2CCC[C@@H](N)C2)nc1Nc1cccc(C(F)(F)F)c1		CHEMBL4640950	=	Delta Tm	degrees C	1.7	CHEMBL262	Homo sapiens	deltaTm	degrees C	1.7
	20714317	CHEMBL4629861	Binding affinity to GSK3beta (unknown origin) assessed as change in melting temperature at 10 uM by SYPRO Orange dye based fluorescence assay	B	NC(=O)c1cnc(N2CCC[C@H](N)C2)nc1Nc1cccc(C(F)(F)F)c1		CHEMBL1835063	=	Delta Tm	degrees C	2.5	CHEMBL262	Homo sapiens	deltaTm	degrees C	2.5
	22391707	CHEMBL4666975	Inhibition of recombinant human N-terminal GST-tagged full length GSK3beta expressed in baculovirus expression system using Ser/Thr 09 as substrate at 0.1 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	O=C(Nc1c[nH]nc1-c1cc(Cl)ccc1OC(F)F)c1cnn2cccnc12		CHEMBL4744172	=	Inhibition	%	7.0	CHEMBL262	Homo sapiens	INH	%	7.0
	22391708	CHEMBL4666975	Inhibition of recombinant human N-terminal GST-tagged full length GSK3beta expressed in baculovirus expression system using Ser/Thr 09 as substrate at 0.1 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	Cn1cc(NC(=O)c2cnn3cccnc23)c(-c2cc(Cl)ccc2OC(F)F)n1		CHEMBL4777342	=	Inhibition	%	-3.0	CHEMBL262	Homo sapiens	INH	%	-3.0
	22391709	CHEMBL4666975	Inhibition of recombinant human N-terminal GST-tagged full length GSK3beta expressed in baculovirus expression system using Ser/Thr 09 as substrate at 0.1 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	O=C(Nc1c[nH]nc1-c1cc2ccccc2cc1OC(F)F)c1cnn2cccnc12		CHEMBL4745474	=	Inhibition	%	7.0	CHEMBL262	Homo sapiens	INH	%	7.0
	22392068	CHEMBL4667163	Inhibition of recombinant human N-terminal GST-tagged full length GSK3beta expressed in baculovirus expression system using Ser/Thr 09 as substrate at 10 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	14.5	CHEMBL262	Homo sapiens	INH	%	14.5
Dose-dependent effect	22393928	CHEMBL4667734	Inhibition of GSK3beta (unknown origin) using PASVPPSPSLSRHSSPHQpSED as substrate preincubated for 10 mins followed by substrate addition and measured after 30 mins by TR-FRET assay	B	Cl.NCCO/N=C1C(=C2/C(=O)Nc3ccc([N+](=O)[O-])cc32)/Nc2ccc(O)cc2/1		CHEMBL4763626		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	22393929	CHEMBL4667734	Inhibition of GSK3beta (unknown origin) using PASVPPSPSLSRHSSPHQpSED as substrate preincubated for 10 mins followed by substrate addition and measured after 30 mins by TR-FRET assay	B	Cl.NCCO/N=C1C(=C2/C(=O)Nc3ccc([N+](=O)[O-])cc32)/Nc2ccc(O)cc2/1		CHEMBL4763626	=	IC50	nM	5.46	CHEMBL262	Homo sapiens	IC50	nM	5.46
	22393932	CHEMBL4667736	Inhibition of GSK3beta (unknown origin) using PASVPPSPSLSRHSSPHQpSED as substrate at 1 uM preincubated for 10 mins followed by substrate addition and measured after 30 mins by TR-FRET assay relative to control	B	Cl.NCCO/N=C1C(=C2/C(=O)Nc3ccc([N+](=O)[O-])cc32)/Nc2ccc(O)cc2/1		CHEMBL4763626	=	Inhibition	%	99.8	CHEMBL262	Homo sapiens	INH	%	99.8
	22399406	CHEMBL4669259	Inhibition of wild-type human full length GSK3B (M1 to T433 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	COc1ccc(Nc2nc(N)c(C(=O)c3ccc(OC)c(OC)c3)s2)cc1		CHEMBL552462	=	Activity	%	27.0	CHEMBL262	Homo sapiens	Activity	%	27.0
	22419089	CHEMBL4672955	Inhibition of N-terminal His6-tagged human recombinant GSK3beta H350L mutant expressed in baculovirus-infected Sf21 cells assessed as reduction in production of ADP using 5-FAMKRREILSRRPpSYR-COOH peptide as substrate preincubated with enzyme for 15 mins followed by further incubation with ATP for 30 mins by fluorescence-based microfluidic mobility shift assay	B	COc1ccc(CC(=O)Nc2cc([C@H]3CC[C@@H](OC(=O)N4CCC4(C)C)C3)[nH]n2)cn1		CHEMBL4744945	=	Ki	nM	1.26	CHEMBL262	Homo sapiens	Ki	nM	1.26
	22419090	CHEMBL4672955	Inhibition of N-terminal His6-tagged human recombinant GSK3beta H350L mutant expressed in baculovirus-infected Sf21 cells assessed as reduction in production of ADP using 5-FAMKRREILSRRPpSYR-COOH peptide as substrate preincubated with enzyme for 15 mins followed by further incubation with ATP for 30 mins by fluorescence-based microfluidic mobility shift assay	B	COc1ccc(CC(=O)Nc2cc([C@@H]3CC[C@H](OC(=O)N4CCC4(C)C)C3)[nH]n2)cn1		CHEMBL4764153	=	Ki	nM	0.95	CHEMBL262	Homo sapiens	Ki	nM	0.95
	22419091	CHEMBL4672955	Inhibition of N-terminal His6-tagged human recombinant GSK3beta H350L mutant expressed in baculovirus-infected Sf21 cells assessed as reduction in production of ADP using 5-FAMKRREILSRRPpSYR-COOH peptide as substrate preincubated with enzyme for 15 mins followed by further incubation with ATP for 30 mins by fluorescence-based microfluidic mobility shift assay	B	COc1ccc(CC(=O)Nc2cc([C@H]3CC[C@@H](OC(=O)N4C[C@@H](C#N)[C@@H]4C)C3)[nH]n2)cn1		CHEMBL4758595	=	Ki	nM	0.78	CHEMBL262	Homo sapiens	Ki	nM	0.78
	22419092	CHEMBL4672955	Inhibition of N-terminal His6-tagged human recombinant GSK3beta H350L mutant expressed in baculovirus-infected Sf21 cells assessed as reduction in production of ADP using 5-FAMKRREILSRRPpSYR-COOH peptide as substrate preincubated with enzyme for 15 mins followed by further incubation with ATP for 30 mins by fluorescence-based microfluidic mobility shift assay	B	Cc1ncc(CC(=O)Nc2cc([C@H]3CC[C@@H](OC(=O)N4C[C@@H](C#N)[C@@H]4C)C3)[nH]n2)s1		CHEMBL4758192	=	Ki	nM	1.72	CHEMBL262	Homo sapiens	Ki	nM	1.72
	22419093	CHEMBL4672955	Inhibition of N-terminal His6-tagged human recombinant GSK3beta H350L mutant expressed in baculovirus-infected Sf21 cells assessed as reduction in production of ADP using 5-FAMKRREILSRRPpSYR-COOH peptide as substrate preincubated with enzyme for 15 mins followed by further incubation with ATP for 30 mins by fluorescence-based microfluidic mobility shift assay	B	CCC(CO)CNC(=O)O[C@@H]1CC[C@H](c2cc(NC(=O)Cc3ccc(OC)nc3)n[nH]2)C1		CHEMBL4763408	=	Ki	nM	1.41	CHEMBL262	Homo sapiens	Ki	nM	1.41
	22419094	CHEMBL4672955	Inhibition of N-terminal His6-tagged human recombinant GSK3beta H350L mutant expressed in baculovirus-infected Sf21 cells assessed as reduction in production of ADP using 5-FAMKRREILSRRPpSYR-COOH peptide as substrate preincubated with enzyme for 15 mins followed by further incubation with ATP for 30 mins by fluorescence-based microfluidic mobility shift assay	B	COc1ccc(CC(=O)Nc2cc([C@@H]3CC[C@H](OC(=O)N[C@H]4CC[C@H](O)CC4)C3)[nH]n2)cn1		CHEMBL4744114	=	Ki	nM	1.85	CHEMBL262	Homo sapiens	Ki	nM	1.85
	22419409	CHEMBL4673020	Inhibition of GSK3B (unknown origin) at 0.1 uM in presence of ATP at Km concentration by Kinase Glo luminescent assay relative to control	B	Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4nc3N3CCC(O)CC3)co2)ccn1		CHEMBL4750630	=	Inhibition	%	46.0	CHEMBL262	Homo sapiens	INH	%	46.0
	22419410	CHEMBL4673020	Inhibition of GSK3B (unknown origin) at 0.1 uM in presence of ATP at Km concentration by Kinase Glo luminescent assay relative to control	B	Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4nc3N3CCC(F)CC3)co2)ccn1		CHEMBL4784665	=	Inhibition	%	47.0	CHEMBL262	Homo sapiens	INH	%	47.0
	22419411	CHEMBL4673020	Inhibition of GSK3B (unknown origin) at 0.1 uM in presence of ATP at Km concentration by Kinase Glo luminescent assay relative to control	B	Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4nc3N3CC[C@@H](O)C3)co2)ccn1		CHEMBL4783351	=	Inhibition	%	0.0	CHEMBL262	Homo sapiens	INH	%	0.0
	22419412	CHEMBL4673020	Inhibition of GSK3B (unknown origin) at 0.1 uM in presence of ATP at Km concentration by Kinase Glo luminescent assay relative to control	B	Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4nc3N3CC[C@H](O)C3)co2)ccn1		CHEMBL4741488	=	Inhibition	%	12.0	CHEMBL262	Homo sapiens	INH	%	12.0
	22419413	CHEMBL4673021	Inhibition of GSK3B (unknown origin) at 1 uM in presence of ATP at Km concentration by Kinase Glo luminescent assay relative to control	B	Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4nc3N3CCC(O)CC3)co2)ccn1		CHEMBL4750630	=	Inhibition	%	86.0	CHEMBL262	Homo sapiens	INH	%	86.0
	22419414	CHEMBL4673021	Inhibition of GSK3B (unknown origin) at 1 uM in presence of ATP at Km concentration by Kinase Glo luminescent assay relative to control	B	Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4nc3N3CCC(F)CC3)co2)ccn1		CHEMBL4784665	=	Inhibition	%	84.0	CHEMBL262	Homo sapiens	INH	%	84.0
	22419415	CHEMBL4673021	Inhibition of GSK3B (unknown origin) at 1 uM in presence of ATP at Km concentration by Kinase Glo luminescent assay relative to control	B	Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4nc3N3CC[C@@H](O)C3)co2)ccn1		CHEMBL4783351	=	Inhibition	%	6.0	CHEMBL262	Homo sapiens	INH	%	6.0
	22419416	CHEMBL4673021	Inhibition of GSK3B (unknown origin) at 1 uM in presence of ATP at Km concentration by Kinase Glo luminescent assay relative to control	B	Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4nc3N3CC[C@H](O)C3)co2)ccn1		CHEMBL4741488	=	Inhibition	%	16.0	CHEMBL262	Homo sapiens	INH	%	16.0
	22423573	CHEMBL4674362	Inhibition of human GSK3B using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	100.56	CHEMBL262	Homo sapiens	Activity	%	100.56
	22423574	CHEMBL4674362	Inhibition of human GSK3B using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	51.15	CHEMBL262	Homo sapiens	Activity	%	51.15
	22441938	CHEMBL4678872	Inhibition of GSK3beta (unknown origin) at 0.1 uM incubated for 60 mins by TR-FRET based LanthaScreen Eu kinase binding assay relative to control	B	CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CC(C)(C)C4)c(Cl)cn2)C1		CHEMBL4462530	=	Inhibition	%	100.0	CHEMBL262	Homo sapiens	INH	%	100.0
	22441957	CHEMBL4678885	Inhibition of human recombinant GSK3beta using YRRAAVPPSPSLSR as substrate at 1 uM incubated for 40 mins in presence of [gamma32P]-ATP by scintillation counting method relative to control	B	CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CCCC4)c(Cl)cn2)C1		CHEMBL4754399	=	Inhibition	%	100.0	CHEMBL262	Homo sapiens	INH	%	100.0
	22441958	CHEMBL4678885	Inhibition of human recombinant GSK3beta using YRRAAVPPSPSLSR as substrate at 1 uM incubated for 40 mins in presence of [gamma32P]-ATP by scintillation counting method relative to control	B	CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CC(C)(C)C4)c(Cl)cn2)C1		CHEMBL4462530	=	Inhibition	%	104.0	CHEMBL262	Homo sapiens	INH	%	104.0
	22441959	CHEMBL4678885	Inhibition of human recombinant GSK3beta using YRRAAVPPSPSLSR as substrate at 1 uM incubated for 40 mins in presence of [gamma32P]-ATP by scintillation counting method relative to control	B	CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CC(C)(C)C4)c(F)cn2)C1		CHEMBL4754081	=	Inhibition	%	101.0	CHEMBL262	Homo sapiens	INH	%	101.0
	22442116	CHEMBL4678913	Inhibition of GSK3beta (unknown origin) in presence of 5 mM ATP	B	CC(=O)N[C@@H]1CCC[C@H](C(=O)Nc2cc(-c3cnn4c3CC(C)(C)C4)c(Cl)cn2)C1		CHEMBL4462530	=	IC50	nM	247.0	CHEMBL262	Homo sapiens	IC50	uM	0.247
	22445681	CHEMBL4679486	Inhibition of human GSK3beta	B	CS(=O)(=O)c1cccc(CNc2nc(Nc3ccc4c(c3)CCC(=O)N4)ncc2C(F)(F)F)c1		CHEMBL514554	<	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	uM	1.0
	22446968	CHEMBL4679710	Inhibition of GSK3B (unknown origin)	B	Cc1nc(NC(=O)NCCc2cn(CC(F)F)cn2)sc1C#Cc1cccnc1		CHEMBL4795990	>	Ki	nM	4000.0	CHEMBL262	Homo sapiens	Ki	uM	4.0
	22446969	CHEMBL4679710	Inhibition of GSK3B (unknown origin)	B	COc1cc(C#Cc2sc(NC(=O)NCCOCC3CC3)nc2C)cnc1OC		CHEMBL4759283	>	Ki	nM	4000.0	CHEMBL262	Homo sapiens	Ki	uM	4.0
	22446970	CHEMBL4679710	Inhibition of GSK3B (unknown origin)	B	Cc1nc(NC(=O)NCCOCC2CC2)sc1C#Cc1ccc2cncn2c1		CHEMBL4764646	>	Ki	nM	4000.0	CHEMBL262	Homo sapiens	Ki	uM	4.0
	22446971	CHEMBL4679710	Inhibition of GSK3B (unknown origin)	B	Cc1cncc(C#Cc2sc(NC(=O)NC[C@H](C)OCC3CC3)nc2C)c1		CHEMBL4784202	>	Ki	nM	4000.0	CHEMBL262	Homo sapiens	Ki	uM	4.0
	22446972	CHEMBL4679710	Inhibition of GSK3B (unknown origin)	B	Cc1cc(C#Cc2sc(NC(=O)NC[C@H](C)OCC3CC3)nc2C)cnc1C		CHEMBL4756664	>	Ki	nM	4000.0	CHEMBL262	Homo sapiens	Ki	uM	4.0
Active	22470567	CHEMBL4685046	Inhibition of GSK3beta phosphorylation at S473 residue in human Huh-7 cells at 0.1 to 0.2 uM by Western blot analysis	B	O=C(C(CNC1CCCC1)c1ccc(Cl)cc1)N1CCN(c2ncnc3sc4c(c23)CCC4)CC1		CHEMBL4757904		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	22479241	CHEMBL4686931	Inhibition of human recombinant GSK3 beta H350L mutant assessed as residual activity using YRRAAVPPSPSLSR as substrate at 1 uM incubated for 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis	B	C[C@H](CO)n1cnnc1-c1cccc(NC(=O)Nc2cc3ccccn3n2)n1		CHEMBL4796925	<	Activity	%	10.0	CHEMBL262	Homo sapiens	Activity	%	10.0
	22479253	CHEMBL4686941	Inhibition of human recombinant GSK3 beta H350L mutant using YRRAAVPPSPSLSR as substrate incubated for 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis	B	C[C@H](CO)n1cnnc1-c1cccc(NC(=O)Nc2cc3ccccn3n2)n1		CHEMBL4796925	=	IC50	nM	282.9	CHEMBL262	Homo sapiens	IC50	nM	282.9
	22479254	CHEMBL4686941	Inhibition of human recombinant GSK3 beta H350L mutant using YRRAAVPPSPSLSR as substrate incubated for 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	63.8	CHEMBL262	Homo sapiens	IC50	nM	63.8
	22482651	CHEMBL4687857	Inhibition of human GSK3beta assessed as residual activity at 10 uM relative to control	A	CN1CCC(CNC2=NC(=O)/C(=C/c3csc(-c4ccc(OC(F)(F)F)cc4)n3)S2)CC1		CHEMBL4757567	=	Activity	%	147.0	CHEMBL262	Homo sapiens	Activity	%	147.0
	22485713	CHEMBL4688567	Inhibition of recombinant human N-terminal His6-tagged GSK3beta H350L mutant expressed in baculovirus infected Sf21 cells using prephosphorylated polypeptide as substrate incubated for 1 min followed by substrate addition and measured after 30 mins by Kinase-Glo luminescence assay	B	NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCCC1CCN(Cc2ccc(F)cc2)CC1		CHEMBL4747992	=	IC50	nM	3.0	CHEMBL262	Homo sapiens	IC50	uM	0.003
	22485714	CHEMBL4688567	Inhibition of recombinant human N-terminal His6-tagged GSK3beta H350L mutant expressed in baculovirus infected Sf21 cells using prephosphorylated polypeptide as substrate incubated for 1 min followed by substrate addition and measured after 30 mins by Kinase-Glo luminescence assay	B	NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCCC1CCN(Cc2cccc(F)c2)CC1		CHEMBL4776811	=	IC50	nM	9.0	CHEMBL262	Homo sapiens	IC50	uM	0.009000000000000001
	22485715	CHEMBL4688567	Inhibition of recombinant human N-terminal His6-tagged GSK3beta H350L mutant expressed in baculovirus infected Sf21 cells using prephosphorylated polypeptide as substrate incubated for 1 min followed by substrate addition and measured after 30 mins by Kinase-Glo luminescence assay	B	NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCCC1CCN(Cc2ccccc2F)CC1		CHEMBL4748993	=	IC50	nM	15.0	CHEMBL262	Homo sapiens	IC50	uM	0.015
	22485716	CHEMBL4688567	Inhibition of recombinant human N-terminal His6-tagged GSK3beta H350L mutant expressed in baculovirus infected Sf21 cells using prephosphorylated polypeptide as substrate incubated for 1 min followed by substrate addition and measured after 30 mins by Kinase-Glo luminescence assay	B	NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCCC1CCN(Cc2ccccc2)CC1		CHEMBL4794823	=	IC50	nM	8.0	CHEMBL262	Homo sapiens	IC50	uM	0.008
	22485717	CHEMBL4688567	Inhibition of recombinant human N-terminal His6-tagged GSK3beta H350L mutant expressed in baculovirus infected Sf21 cells using prephosphorylated polypeptide as substrate incubated for 1 min followed by substrate addition and measured after 30 mins by Kinase-Glo luminescence assay	B	NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCC1CCN(Cc2ccc(F)c(F)c2)CC1		CHEMBL4756451	=	IC50	nM	10.0	CHEMBL262	Homo sapiens	IC50	uM	0.01
	22485718	CHEMBL4688567	Inhibition of recombinant human N-terminal His6-tagged GSK3beta H350L mutant expressed in baculovirus infected Sf21 cells using prephosphorylated polypeptide as substrate incubated for 1 min followed by substrate addition and measured after 30 mins by Kinase-Glo luminescence assay	B	NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCC1CCN(Cc2c(F)cccc2F)CC1		CHEMBL4755445	=	IC50	nM	5.0	CHEMBL262	Homo sapiens	IC50	uM	0.005
	22485719	CHEMBL4688567	Inhibition of recombinant human N-terminal His6-tagged GSK3beta H350L mutant expressed in baculovirus infected Sf21 cells using prephosphorylated polypeptide as substrate incubated for 1 min followed by substrate addition and measured after 30 mins by Kinase-Glo luminescence assay	B	NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCC1CCN(Cc2ccc(F)cc2)CC1		CHEMBL4764558	=	IC50	nM	38.0	CHEMBL262	Homo sapiens	IC50	uM	0.038
	22485720	CHEMBL4688567	Inhibition of recombinant human N-terminal His6-tagged GSK3beta H350L mutant expressed in baculovirus infected Sf21 cells using prephosphorylated polypeptide as substrate incubated for 1 min followed by substrate addition and measured after 30 mins by Kinase-Glo luminescence assay	B	NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCC1CCN(Cc2cccc(F)c2)CC1		CHEMBL4795876	=	IC50	nM	26.0	CHEMBL262	Homo sapiens	IC50	uM	0.026000000000000002
	22485721	CHEMBL4688567	Inhibition of recombinant human N-terminal His6-tagged GSK3beta H350L mutant expressed in baculovirus infected Sf21 cells using prephosphorylated polypeptide as substrate incubated for 1 min followed by substrate addition and measured after 30 mins by Kinase-Glo luminescence assay	B	NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCC1CCN(Cc2ccccc2Cl)CC1		CHEMBL4742138	=	IC50	nM	27.0	CHEMBL262	Homo sapiens	IC50	uM	0.027000000000000003
	22485722	CHEMBL4688567	Inhibition of recombinant human N-terminal His6-tagged GSK3beta H350L mutant expressed in baculovirus infected Sf21 cells using prephosphorylated polypeptide as substrate incubated for 1 min followed by substrate addition and measured after 30 mins by Kinase-Glo luminescence assay	B	NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCC1CCN(Cc2ccccn2)CC1		CHEMBL4749550	=	IC50	nM	193.0	CHEMBL262	Homo sapiens	IC50	uM	0.193
	22485723	CHEMBL4688567	Inhibition of recombinant human N-terminal His6-tagged GSK3beta H350L mutant expressed in baculovirus infected Sf21 cells using prephosphorylated polypeptide as substrate incubated for 1 min followed by substrate addition and measured after 30 mins by Kinase-Glo luminescence assay	B	NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCC1CCN(Cc2ccccc2F)CC1		CHEMBL4759253	=	IC50	nM	261.0	CHEMBL262	Homo sapiens	IC50	uM	0.261
	22485724	CHEMBL4688567	Inhibition of recombinant human N-terminal His6-tagged GSK3beta H350L mutant expressed in baculovirus infected Sf21 cells using prephosphorylated polypeptide as substrate incubated for 1 min followed by substrate addition and measured after 30 mins by Kinase-Glo luminescence assay	B	NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCC1CCN(Cc2ccccc2)CC1		CHEMBL4796437	=	IC50	nM	19.0	CHEMBL262	Homo sapiens	IC50	uM	0.019
	22485725	CHEMBL4688567	Inhibition of recombinant human N-terminal His6-tagged GSK3beta H350L mutant expressed in baculovirus infected Sf21 cells using prephosphorylated polypeptide as substrate incubated for 1 min followed by substrate addition and measured after 30 mins by Kinase-Glo luminescence assay	B	NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCC1CCN(Cc2ccccc2)CC1		CHEMBL4753478	=	IC50	nM	94.0	CHEMBL262	Homo sapiens	IC50	uM	0.094
	22485726	CHEMBL4688567	Inhibition of recombinant human N-terminal His6-tagged GSK3beta H350L mutant expressed in baculovirus infected Sf21 cells using prephosphorylated polypeptide as substrate incubated for 1 min followed by substrate addition and measured after 30 mins by Kinase-Glo luminescence assay	B	NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1O		CHEMBL4787873	=	IC50	nM	11.0	CHEMBL262	Homo sapiens	IC50	uM	0.011000000000000001
	22485727	CHEMBL4688567	Inhibition of recombinant human N-terminal His6-tagged GSK3beta H350L mutant expressed in baculovirus infected Sf21 cells using prephosphorylated polypeptide as substrate incubated for 1 min followed by substrate addition and measured after 30 mins by Kinase-Glo luminescence assay	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714	=	IC50	nM	20.0	CHEMBL262	Homo sapiens	IC50	uM	0.02
	22485728	CHEMBL4688567	Inhibition of recombinant human N-terminal His6-tagged GSK3beta H350L mutant expressed in baculovirus infected Sf21 cells using prephosphorylated polypeptide as substrate incubated for 1 min followed by substrate addition and measured after 30 mins by Kinase-Glo luminescence assay	B	COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2		CHEMBL502	>	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	uM	1.0
	22485729	CHEMBL4688567	Inhibition of recombinant human N-terminal His6-tagged GSK3beta H350L mutant expressed in baculovirus infected Sf21 cells using prephosphorylated polypeptide as substrate incubated for 1 min followed by substrate addition and measured after 30 mins by Kinase-Glo luminescence assay	B	Nc1c2c(nc3ccccc13)CCCC2		CHEMBL95	>	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	uM	1.0
	22485730	CHEMBL4688567	Inhibition of recombinant human N-terminal His6-tagged GSK3beta H350L mutant expressed in baculovirus infected Sf21 cells using prephosphorylated polypeptide as substrate incubated for 1 min followed by substrate addition and measured after 30 mins by Kinase-Glo luminescence assay	B	CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCC1CCN(Cc2cccc([N+](=O)[O-])c2)CC1		CHEMBL4792678	=	IC50	nM	5.0	CHEMBL262	Homo sapiens	IC50	uM	0.005
	22485731	CHEMBL4688567	Inhibition of recombinant human N-terminal His6-tagged GSK3beta H350L mutant expressed in baculovirus infected Sf21 cells using prephosphorylated polypeptide as substrate incubated for 1 min followed by substrate addition and measured after 30 mins by Kinase-Glo luminescence assay	B	CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCC1CCN(Cc2ccc(Cl)cc2)CC1		CHEMBL4791089	=	IC50	nM	45.0	CHEMBL262	Homo sapiens	IC50	uM	0.045
	22485732	CHEMBL4688567	Inhibition of recombinant human N-terminal His6-tagged GSK3beta H350L mutant expressed in baculovirus infected Sf21 cells using prephosphorylated polypeptide as substrate incubated for 1 min followed by substrate addition and measured after 30 mins by Kinase-Glo luminescence assay	B	CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCC1CCN(Cc2cccc(Br)c2)CC1		CHEMBL4785551	=	IC50	nM	49.0	CHEMBL262	Homo sapiens	IC50	uM	0.049
	22485733	CHEMBL4688567	Inhibition of recombinant human N-terminal His6-tagged GSK3beta H350L mutant expressed in baculovirus infected Sf21 cells using prephosphorylated polypeptide as substrate incubated for 1 min followed by substrate addition and measured after 30 mins by Kinase-Glo luminescence assay	B	CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCC1CCN(Cc2ccc(Br)cc2)CC1		CHEMBL4792741	=	IC50	nM	26.0	CHEMBL262	Homo sapiens	IC50	uM	0.026000000000000002
	22485734	CHEMBL4688567	Inhibition of recombinant human N-terminal His6-tagged GSK3beta H350L mutant expressed in baculovirus infected Sf21 cells using prephosphorylated polypeptide as substrate incubated for 1 min followed by substrate addition and measured after 30 mins by Kinase-Glo luminescence assay	B	CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCC1CCN(Cc2ccc(Cl)c(Cl)c2)CC1		CHEMBL4746460	=	IC50	nM	41.0	CHEMBL262	Homo sapiens	IC50	uM	0.040999999999999995
	22485735	CHEMBL4688567	Inhibition of recombinant human N-terminal His6-tagged GSK3beta H350L mutant expressed in baculovirus infected Sf21 cells using prephosphorylated polypeptide as substrate incubated for 1 min followed by substrate addition and measured after 30 mins by Kinase-Glo luminescence assay	B	CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCC1CCN(Cc2ccc(F)c(F)c2)CC1		CHEMBL4741669	=	IC50	nM	62.0	CHEMBL262	Homo sapiens	IC50	uM	0.062
	22485736	CHEMBL4688567	Inhibition of recombinant human N-terminal His6-tagged GSK3beta H350L mutant expressed in baculovirus infected Sf21 cells using prephosphorylated polypeptide as substrate incubated for 1 min followed by substrate addition and measured after 30 mins by Kinase-Glo luminescence assay	B	CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCC1CCN(Cc2ccccc2F)CC1		CHEMBL4753139	=	IC50	nM	14.0	CHEMBL262	Homo sapiens	IC50	uM	0.013999999999999999
	22485737	CHEMBL4688567	Inhibition of recombinant human N-terminal His6-tagged GSK3beta H350L mutant expressed in baculovirus infected Sf21 cells using prephosphorylated polypeptide as substrate incubated for 1 min followed by substrate addition and measured after 30 mins by Kinase-Glo luminescence assay	B	CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCC1CCN(Cc2ccccc2)CC1		CHEMBL4748792	=	IC50	nM	16.0	CHEMBL262	Homo sapiens	IC50	uM	0.016
	22485738	CHEMBL4688567	Inhibition of recombinant human N-terminal His6-tagged GSK3beta H350L mutant expressed in baculovirus infected Sf21 cells using prephosphorylated polypeptide as substrate incubated for 1 min followed by substrate addition and measured after 30 mins by Kinase-Glo luminescence assay	B	CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OC1CCN(Cc2ccccc2)CC1		CHEMBL4752296	=	IC50	nM	7.0	CHEMBL262	Homo sapiens	IC50	uM	0.006999999999999999
	22485829	CHEMBL4688577	Inhibition of GSK3beta (unknown origin) by ATP competitive based analysis	B	NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCCC1CCN(Cc2ccc(F)cc2)CC1		CHEMBL4747992	=	IC50	nM	16.1	CHEMBL262	Homo sapiens	IC50	nM	16.1
	22488098	CHEMBL4689197	Inhibition of human GSK3beta assessed as residual activity at 10 uM by ADP-Glo assay relative to control	B	Cc1ccc(-n2cc(COc3cccc4cnc(Nc5cccc(Cl)c5)nc34)nn2)cc1[N+](=O)[O-]		CHEMBL4758072	=	Activity	%	14.0	CHEMBL262	Homo sapiens	Activity	%	14.0
	22488099	CHEMBL4689197	Inhibition of human GSK3beta assessed as residual activity at 10 uM by ADP-Glo assay relative to control	B	Clc1cccc(Nc2ncc3cccc(OCc4cn(Cc5ccccc5)nn4)c3n2)c1		CHEMBL4743511	=	Activity	%	48.0	CHEMBL262	Homo sapiens	Activity	%	48.0
	22488100	CHEMBL4689197	Inhibition of human GSK3beta assessed as residual activity at 10 uM by ADP-Glo assay relative to control	B	Clc1cccc(Nc2ncc3cccc(OCc4cn(Cc5c(Cl)cccc5Cl)nn4)c3n2)c1		CHEMBL4795706	=	Activity	%	58.0	CHEMBL262	Homo sapiens	Activity	%	58.0
	22488101	CHEMBL4689197	Inhibition of human GSK3beta assessed as residual activity at 10 uM by ADP-Glo assay relative to control	B	O=[N+]([O-])c1ccc(Cn2cc(COc3cccc4cnc(Nc5cccc(Cl)c5)nc34)nn2)cc1		CHEMBL4776549	=	Activity	%	60.0	CHEMBL262	Homo sapiens	Activity	%	60.0
	22488102	CHEMBL4689197	Inhibition of human GSK3beta assessed as residual activity at 10 uM by ADP-Glo assay relative to control	B	Cc1ccc(-n2cc(COc3cccc4cnc(Nc5cccc(Cl)c5)nc34)nn2)c([N+](=O)[O-])c1		CHEMBL4783398	=	Activity	%	57.0	CHEMBL262	Homo sapiens	Activity	%	57.0
	22488103	CHEMBL4689197	Inhibition of human GSK3beta assessed as residual activity at 10 uM by ADP-Glo assay relative to control	B	Clc1cccc(Nc2ncc3cccc(OCc4cn(-c5cc(Cl)cc(Cl)c5)nn4)c3n2)c1		CHEMBL4761834	=	Activity	%	35.0	CHEMBL262	Homo sapiens	Activity	%	35.0
	22488104	CHEMBL4689197	Inhibition of human GSK3beta assessed as residual activity at 10 uM by ADP-Glo assay relative to control	B	COc1cccc(-n2cc(COc3cccc4cnc(Nc5cccc(Cl)c5)nc34)nn2)c1		CHEMBL4754002	=	Activity	%	47.0	CHEMBL262	Homo sapiens	Activity	%	47.0
	22488105	CHEMBL4689197	Inhibition of human GSK3beta assessed as residual activity at 10 uM by ADP-Glo assay relative to control	B	COc1ccccc1-n1cc(COc2cccc3cnc(Nc4cccc(Cl)c4)nc23)nn1		CHEMBL4751143	=	Activity	%	61.0	CHEMBL262	Homo sapiens	Activity	%	61.0
	22488106	CHEMBL4689197	Inhibition of human GSK3beta assessed as residual activity at 10 uM by ADP-Glo assay relative to control	B	O=[N+]([O-])c1ccc(-n2cc(COc3cccc4cnc(Nc5cccc(Cl)c5)nc34)nn2)cc1		CHEMBL4797753	=	Activity	%	87.0	CHEMBL262	Homo sapiens	Activity	%	87.0
	22488107	CHEMBL4689197	Inhibition of human GSK3beta assessed as residual activity at 10 uM by ADP-Glo assay relative to control	B	COc1ccc(-n2cc(COc3cccc4cnc(Nc5cccc(Cl)c5)nc34)nn2)cc1		CHEMBL4761479	=	Activity	%	47.0	CHEMBL262	Homo sapiens	Activity	%	47.0
	22488108	CHEMBL4689197	Inhibition of human GSK3beta assessed as residual activity at 10 uM by ADP-Glo assay relative to control	B	Clc1cccc(Nc2ncc3cccc(OCc4cn(-c5ccc(Br)cc5)nn4)c3n2)c1		CHEMBL4793064	=	Activity	%	77.0	CHEMBL262	Homo sapiens	Activity	%	77.0
	22488109	CHEMBL4689197	Inhibition of human GSK3beta assessed as residual activity at 10 uM by ADP-Glo assay relative to control	B	Clc1ccc(-n2cc(COc3cccc4cnc(Nc5cccc(Cl)c5)nc34)nn2)cc1		CHEMBL4760556	=	Activity	%	87.0	CHEMBL262	Homo sapiens	Activity	%	87.0
	22488693	CHEMBL4689285	Inhibition of human recombinant GSK3beta assessed as residual activity at 10 uM using GSK3 peptide as substrate preincubated for 15 mins followed by ATP addition and measured after 90 mins by ADP-Glo kinase assay	B	CN(C)/C=N/c1nc(OC[C@H](O)COC(c2ccccc2)(c2ccccc2)c2ccccc2)ns1		CHEMBL4762594	=	Activity	%	72.0	CHEMBL262	Homo sapiens	Activity	%	72.0
	22488694	CHEMBL4689285	Inhibition of human recombinant GSK3beta assessed as residual activity at 10 uM using GSK3 peptide as substrate preincubated for 15 mins followed by ATP addition and measured after 90 mins by ADP-Glo kinase assay	B	Cl.Nc1nc(=O)[nH]s1		CHEMBL4797349	=	Activity	%	78.0	CHEMBL262	Homo sapiens	Activity	%	78.0
	22488695	CHEMBL4689285	Inhibition of human recombinant GSK3beta assessed as residual activity at 10 uM using GSK3 peptide as substrate preincubated for 15 mins followed by ATP addition and measured after 90 mins by ADP-Glo kinase assay	B	CN(C)/C=N/c1nc(=O)n(C[C@H](O)COC(c2ccccc2)(c2ccccc2)c2ccccc2)s1		CHEMBL4741923	=	Activity	%	64.0	CHEMBL262	Homo sapiens	Activity	%	64.0
	22488696	CHEMBL4689285	Inhibition of human recombinant GSK3beta assessed as residual activity at 10 uM using GSK3 peptide as substrate preincubated for 15 mins followed by ATP addition and measured after 90 mins by ADP-Glo kinase assay	B	CC(C)OP(=O)(CO[C@H](CO)Cn1sc(NC(=O)OCC2c3ccccc3-c3ccccc32)nc1=O)OC(C)C		CHEMBL4740934	=	Activity	%	76.0	CHEMBL262	Homo sapiens	Activity	%	76.0
	22488697	CHEMBL4689285	Inhibition of human recombinant GSK3beta assessed as residual activity at 10 uM using GSK3 peptide as substrate preincubated for 15 mins followed by ATP addition and measured after 90 mins by ADP-Glo kinase assay	B	O=C(/N=c1\s[nH]c(=O)n1C[C@H](O)COC(c1ccccc1)(c1ccccc1)c1ccccc1)c1ccccc1		CHEMBL4791863	=	Activity	%	59.0	CHEMBL262	Homo sapiens	Activity	%	59.0
	22488698	CHEMBL4689285	Inhibition of human recombinant GSK3beta assessed as residual activity at 10 uM using GSK3 peptide as substrate preincubated for 15 mins followed by ATP addition and measured after 90 mins by ADP-Glo kinase assay	B	CCOC(=O)Nc1nc(=O)n(CCOCP(=O)(O)O)s1		CHEMBL4752567	=	Activity	%	87.0	CHEMBL262	Homo sapiens	Activity	%	87.0
	22488699	CHEMBL4689285	Inhibition of human recombinant GSK3beta assessed as residual activity at 10 uM using GSK3 peptide as substrate preincubated for 15 mins followed by ATP addition and measured after 90 mins by ADP-Glo kinase assay	B	CC(C)OP(=O)(COCCOc1nsc(/N=C/N(C)C)n1)OC(C)C		CHEMBL4777309	=	Activity	%	102.0	CHEMBL262	Homo sapiens	Activity	%	102.0
	22488700	CHEMBL4689285	Inhibition of human recombinant GSK3beta assessed as residual activity at 10 uM using GSK3 peptide as substrate preincubated for 15 mins followed by ATP addition and measured after 90 mins by ADP-Glo kinase assay	B	CN(C)/C=N/c1nc(=O)[nH]s1		CHEMBL4790689	=	Activity	%	97.0	CHEMBL262	Homo sapiens	Activity	%	97.0
	22488701	CHEMBL4689285	Inhibition of human recombinant GSK3beta assessed as residual activity at 10 uM using GSK3 peptide as substrate preincubated for 15 mins followed by ATP addition and measured after 90 mins by ADP-Glo kinase assay	B	O=C(Nc1nc(=O)n(CCOCP(=O)(O)O)s1)OCC1c2ccccc2-c2ccccc21		CHEMBL4753880	=	Activity	%	85.0	CHEMBL262	Homo sapiens	Activity	%	85.0
	22488702	CHEMBL4689285	Inhibition of human recombinant GSK3beta assessed as residual activity at 10 uM using GSK3 peptide as substrate preincubated for 15 mins followed by ATP addition and measured after 90 mins by ADP-Glo kinase assay	B	CC(=O)Nc1nc(=O)[nH]s1		CHEMBL4782522	=	Activity	%	82.0	CHEMBL262	Homo sapiens	Activity	%	82.0
	22488703	CHEMBL4689285	Inhibition of human recombinant GSK3beta assessed as residual activity at 10 uM using GSK3 peptide as substrate preincubated for 15 mins followed by ATP addition and measured after 90 mins by ADP-Glo kinase assay	B	CC(C)OP(=O)(COCCOc1nsc(N)n1)OC(C)C		CHEMBL4762316	=	Activity	%	113.0	CHEMBL262	Homo sapiens	Activity	%	113.0
	22488704	CHEMBL4689285	Inhibition of human recombinant GSK3beta assessed as residual activity at 10 uM using GSK3 peptide as substrate preincubated for 15 mins followed by ATP addition and measured after 90 mins by ADP-Glo kinase assay	B	CC(C)OP(=O)(COCCn1sc(NC(=O)c2ccccc2)nc1=O)OC(C)C		CHEMBL4778558	=	Activity	%	87.0	CHEMBL262	Homo sapiens	Activity	%	87.0
	22488705	CHEMBL4689285	Inhibition of human recombinant GSK3beta assessed as residual activity at 10 uM using GSK3 peptide as substrate preincubated for 15 mins followed by ATP addition and measured after 90 mins by ADP-Glo kinase assay	B	CCOC(=O)Nc1nc(=O)n(C[C@@H](CO)OCP(=O)(OC(C)C)OC(C)C)s1		CHEMBL4759710	=	Activity	%	110.0	CHEMBL262	Homo sapiens	Activity	%	110.0
	22488706	CHEMBL4689285	Inhibition of human recombinant GSK3beta assessed as residual activity at 10 uM using GSK3 peptide as substrate preincubated for 15 mins followed by ATP addition and measured after 90 mins by ADP-Glo kinase assay	B	O=C(Nc1nc(=O)[nH]s1)c1ccccc1		CHEMBL259516	=	Activity	%	85.0	CHEMBL262	Homo sapiens	Activity	%	85.0
	22488707	CHEMBL4689285	Inhibition of human recombinant GSK3beta assessed as residual activity at 10 uM using GSK3 peptide as substrate preincubated for 15 mins followed by ATP addition and measured after 90 mins by ADP-Glo kinase assay	B	O=C(Nc1nc(=O)n(C[C@@H](CO)OCP(=O)(O)O)s1)OCC1c2ccccc2-c2ccccc21		CHEMBL4778188	=	Activity	%	98.0	CHEMBL262	Homo sapiens	Activity	%	98.0
	22488708	CHEMBL4689285	Inhibition of human recombinant GSK3beta assessed as residual activity at 10 uM using GSK3 peptide as substrate preincubated for 15 mins followed by ATP addition and measured after 90 mins by ADP-Glo kinase assay	B	CCOC(=O)Nc1nc(=O)n(CCOCP(=O)(OC(C)C)OC(C)C)s1		CHEMBL4756684	=	Activity	%	154.0	CHEMBL262	Homo sapiens	Activity	%	154.0
	22488709	CHEMBL4689285	Inhibition of human recombinant GSK3beta assessed as residual activity at 10 uM using GSK3 peptide as substrate preincubated for 15 mins followed by ATP addition and measured after 90 mins by ADP-Glo kinase assay	B	Nc1nc(OCCOCP(=O)(O)O)ns1		CHEMBL4747111	=	Activity	%	106.0	CHEMBL262	Homo sapiens	Activity	%	106.0
	22488710	CHEMBL4689285	Inhibition of human recombinant GSK3beta assessed as residual activity at 10 uM using GSK3 peptide as substrate preincubated for 15 mins followed by ATP addition and measured after 90 mins by ADP-Glo kinase assay	B	O=C(Nc1nc(=O)n(CCOCP(=O)(O)O)s1)c1ccccc1		CHEMBL4779756	=	Activity	%	75.0	CHEMBL262	Homo sapiens	Activity	%	75.0
	22488711	CHEMBL4689285	Inhibition of human recombinant GSK3beta assessed as residual activity at 10 uM using GSK3 peptide as substrate preincubated for 15 mins followed by ATP addition and measured after 90 mins by ADP-Glo kinase assay	B	O=C(Nc1nc(=O)n(C[C@@H](CO)OCP(=O)(O)O)s1)c1ccccc1		CHEMBL4741856	=	Activity	%	106.0	CHEMBL262	Homo sapiens	Activity	%	106.0
	22488712	CHEMBL4689285	Inhibition of human recombinant GSK3beta assessed as residual activity at 10 uM using GSK3 peptide as substrate preincubated for 15 mins followed by ATP addition and measured after 90 mins by ADP-Glo kinase assay	B	CC(C)OP(=O)(CO[C@H](CO)Cn1sc(NC(=O)c2ccccc2)nc1=O)OC(C)C		CHEMBL4793802	=	Activity	%	81.0	CHEMBL262	Homo sapiens	Activity	%	81.0
	22488713	CHEMBL4689285	Inhibition of human recombinant GSK3beta assessed as residual activity at 10 uM using GSK3 peptide as substrate preincubated for 15 mins followed by ATP addition and measured after 90 mins by ADP-Glo kinase assay	B	CCOC(=O)Nc1nc(=O)n(C[C@@H](CO)OCP(=O)(O)O)s1		CHEMBL4763526	=	Activity	%	101.0	CHEMBL262	Homo sapiens	Activity	%	101.0
	22488714	CHEMBL4689285	Inhibition of human recombinant GSK3beta assessed as residual activity at 10 uM using GSK3 peptide as substrate preincubated for 15 mins followed by ATP addition and measured after 90 mins by ADP-Glo kinase assay	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	=	Activity	%	70.0	CHEMBL262	Homo sapiens	Activity	%	70.0
	22488715	CHEMBL4689285	Inhibition of human recombinant GSK3beta assessed as residual activity at 10 uM using GSK3 peptide as substrate preincubated for 15 mins followed by ATP addition and measured after 90 mins by ADP-Glo kinase assay	B	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	=	Activity	%	10.0	CHEMBL262	Homo sapiens	Activity	%	10.0
	22488986	CHEMBL4689299	Inhibition of human recombinant GSK3beta using GSK3 peptide as substrate preincubated for 15 mins followed by ATP addition and measured after 90 mins by ADP-Glo kinase assay	B	CN(C)/C=N/c1nc(OC[C@H](O)COC(c2ccccc2)(c2ccccc2)c2ccccc2)ns1		CHEMBL4762594	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	22488987	CHEMBL4689299	Inhibition of human recombinant GSK3beta using GSK3 peptide as substrate preincubated for 15 mins followed by ATP addition and measured after 90 mins by ADP-Glo kinase assay	B	Cl.Nc1nc(=O)[nH]s1		CHEMBL4797349	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	22488988	CHEMBL4689299	Inhibition of human recombinant GSK3beta using GSK3 peptide as substrate preincubated for 15 mins followed by ATP addition and measured after 90 mins by ADP-Glo kinase assay	B	CN(C)/C=N/c1nc(=O)n(C[C@H](O)COC(c2ccccc2)(c2ccccc2)c2ccccc2)s1		CHEMBL4741923	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	22488989	CHEMBL4689299	Inhibition of human recombinant GSK3beta using GSK3 peptide as substrate preincubated for 15 mins followed by ATP addition and measured after 90 mins by ADP-Glo kinase assay	B	CC(C)OP(=O)(CO[C@H](CO)Cn1sc(NC(=O)OCC2c3ccccc3-c3ccccc32)nc1=O)OC(C)C		CHEMBL4740934	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	22488990	CHEMBL4689299	Inhibition of human recombinant GSK3beta using GSK3 peptide as substrate preincubated for 15 mins followed by ATP addition and measured after 90 mins by ADP-Glo kinase assay	B	O=C(/N=c1\s[nH]c(=O)n1C[C@H](O)COC(c1ccccc1)(c1ccccc1)c1ccccc1)c1ccccc1		CHEMBL4791863	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	22488991	CHEMBL4689299	Inhibition of human recombinant GSK3beta using GSK3 peptide as substrate preincubated for 15 mins followed by ATP addition and measured after 90 mins by ADP-Glo kinase assay	B	CCOC(=O)Nc1nc(=O)n(CCOCP(=O)(O)O)s1		CHEMBL4752567	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	22488992	CHEMBL4689299	Inhibition of human recombinant GSK3beta using GSK3 peptide as substrate preincubated for 15 mins followed by ATP addition and measured after 90 mins by ADP-Glo kinase assay	B	CC(C)OP(=O)(COCCOc1nsc(/N=C/N(C)C)n1)OC(C)C		CHEMBL4777309	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	22488993	CHEMBL4689299	Inhibition of human recombinant GSK3beta using GSK3 peptide as substrate preincubated for 15 mins followed by ATP addition and measured after 90 mins by ADP-Glo kinase assay	B	CN(C)/C=N/c1nc(=O)[nH]s1		CHEMBL4790689	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	22488994	CHEMBL4689299	Inhibition of human recombinant GSK3beta using GSK3 peptide as substrate preincubated for 15 mins followed by ATP addition and measured after 90 mins by ADP-Glo kinase assay	B	O=C(Nc1nc(=O)n(CCOCP(=O)(O)O)s1)OCC1c2ccccc2-c2ccccc21		CHEMBL4753880	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	22488995	CHEMBL4689299	Inhibition of human recombinant GSK3beta using GSK3 peptide as substrate preincubated for 15 mins followed by ATP addition and measured after 90 mins by ADP-Glo kinase assay	B	CC(=O)Nc1nc(=O)[nH]s1		CHEMBL4782522	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	22488996	CHEMBL4689299	Inhibition of human recombinant GSK3beta using GSK3 peptide as substrate preincubated for 15 mins followed by ATP addition and measured after 90 mins by ADP-Glo kinase assay	B	CC(C)OP(=O)(COCCOc1nsc(N)n1)OC(C)C		CHEMBL4762316	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	22488997	CHEMBL4689299	Inhibition of human recombinant GSK3beta using GSK3 peptide as substrate preincubated for 15 mins followed by ATP addition and measured after 90 mins by ADP-Glo kinase assay	B	CC(C)OP(=O)(COCCn1sc(NC(=O)c2ccccc2)nc1=O)OC(C)C		CHEMBL4778558	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	22488998	CHEMBL4689299	Inhibition of human recombinant GSK3beta using GSK3 peptide as substrate preincubated for 15 mins followed by ATP addition and measured after 90 mins by ADP-Glo kinase assay	B	CCOC(=O)Nc1nc(=O)n(C[C@@H](CO)OCP(=O)(OC(C)C)OC(C)C)s1		CHEMBL4759710	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	22488999	CHEMBL4689299	Inhibition of human recombinant GSK3beta using GSK3 peptide as substrate preincubated for 15 mins followed by ATP addition and measured after 90 mins by ADP-Glo kinase assay	B	O=C(Nc1nc(=O)[nH]s1)c1ccccc1		CHEMBL259516	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	22489000	CHEMBL4689299	Inhibition of human recombinant GSK3beta using GSK3 peptide as substrate preincubated for 15 mins followed by ATP addition and measured after 90 mins by ADP-Glo kinase assay	B	O=C(Nc1nc(=O)n(C[C@@H](CO)OCP(=O)(O)O)s1)OCC1c2ccccc2-c2ccccc21		CHEMBL4778188	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	22489001	CHEMBL4689299	Inhibition of human recombinant GSK3beta using GSK3 peptide as substrate preincubated for 15 mins followed by ATP addition and measured after 90 mins by ADP-Glo kinase assay	B	CCOC(=O)Nc1nc(=O)n(CCOCP(=O)(OC(C)C)OC(C)C)s1		CHEMBL4756684	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	22489002	CHEMBL4689299	Inhibition of human recombinant GSK3beta using GSK3 peptide as substrate preincubated for 15 mins followed by ATP addition and measured after 90 mins by ADP-Glo kinase assay	B	Nc1nc(OCCOCP(=O)(O)O)ns1		CHEMBL4747111	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	22489003	CHEMBL4689299	Inhibition of human recombinant GSK3beta using GSK3 peptide as substrate preincubated for 15 mins followed by ATP addition and measured after 90 mins by ADP-Glo kinase assay	B	O=C(Nc1nc(=O)n(CCOCP(=O)(O)O)s1)c1ccccc1		CHEMBL4779756	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	22489004	CHEMBL4689299	Inhibition of human recombinant GSK3beta using GSK3 peptide as substrate preincubated for 15 mins followed by ATP addition and measured after 90 mins by ADP-Glo kinase assay	B	O=C(Nc1nc(=O)n(C[C@@H](CO)OCP(=O)(O)O)s1)c1ccccc1		CHEMBL4741856	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	22489005	CHEMBL4689299	Inhibition of human recombinant GSK3beta using GSK3 peptide as substrate preincubated for 15 mins followed by ATP addition and measured after 90 mins by ADP-Glo kinase assay	B	CC(C)OP(=O)(CO[C@H](CO)Cn1sc(NC(=O)c2ccccc2)nc1=O)OC(C)C		CHEMBL4793802	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	22489006	CHEMBL4689299	Inhibition of human recombinant GSK3beta using GSK3 peptide as substrate preincubated for 15 mins followed by ATP addition and measured after 90 mins by ADP-Glo kinase assay	B	CCOC(=O)Nc1nc(=O)n(C[C@@H](CO)OCP(=O)(O)O)s1		CHEMBL4763526	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	22489007	CHEMBL4689299	Inhibition of human recombinant GSK3beta using GSK3 peptide as substrate preincubated for 15 mins followed by ATP addition and measured after 90 mins by ADP-Glo kinase assay	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	22489008	CHEMBL4689299	Inhibition of human recombinant GSK3beta using GSK3 peptide as substrate preincubated for 15 mins followed by ATP addition and measured after 90 mins by ADP-Glo kinase assay	B	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	=	IC50	nM	9.9	CHEMBL262	Homo sapiens	IC50	nM	9.9
	22752731	CHEMBL4700188	Inhibition of human GSK-3beta by kinase-profiling analysis	B	C#Cc1nc(Nc2ccccc2)nc2[nH]cnc12		CHEMBL4094562	=	IC50	nM	7400.0	CHEMBL262	Homo sapiens	IC50	uM	7.4
Not Determined	22752732	CHEMBL4700188	Inhibition of human GSK-3beta by kinase-profiling analysis	B	C#Cc1nc(Nc2ccc(S(N)(=O)=O)cc2)nc2[nH]cnc12		CHEMBL4074015		IC50			CHEMBL262	Homo sapiens	IC50		
	22758191	CHEMBL4701382	Inhibition of human GSK3beta	B	COc1cc(F)ccc1-c1ncnc(Nc2cccc(CS(C)(=N)=O)c2)n1		CHEMBL4286578	=	IC50	nM	87.0	CHEMBL262	Homo sapiens	IC50	nM	87.0
	22759639	CHEMBL4701767	Inhibition of human GSK3B at 1 uM using fluorescently labeled peptide substrate measured after 3 hrs by microfluidic mobility shift assay relative to control	B	CN(C)C(=O)c1ccc(Oc2nc(-c3cnc(N)s3)nc(N3CCOCC3)n2)cc1		CHEMBL4782133	=	Inhibition	%	-1.0	CHEMBL262	Homo sapiens	INH	%	-1.0
	22798830	CHEMBL4711074	Inhibition of GSK-3beta (unknown origin) at 300 nM relative to control	B	CNC(=O)c1sc(-c2ccnc(NC(=O)CNCCNc3c4c(nc5ccccc35)CCCC4)c2)nc1OCC1CC1		CHEMBL4789145	=	Inhibition	%	86.29	CHEMBL262	Homo sapiens	INH	%	86.29
	22798916	CHEMBL4711086	Inhibition of recombinant human N-terminal His6-tagged GSK-3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCOCc1cn(-c2c3c(nc4ccccc24)CCCC3)nn1		CHEMBL4777926	=	IC50	nM	83.9	CHEMBL262	Homo sapiens	IC50	nM	83.9
	22798917	CHEMBL4711086	Inhibition of recombinant human N-terminal His6-tagged GSK-3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCc1cn(-c2c3c(nc4ccccc24)CCCC3)nn1		CHEMBL4791286	=	IC50	nM	51.7	CHEMBL262	Homo sapiens	IC50	nM	51.7
	22798918	CHEMBL4711086	Inhibition of recombinant human N-terminal His6-tagged GSK-3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCc1cn(-c2c3c(nc4ccccc24)CCCC3)nn1		CHEMBL4747410	=	IC50	nM	6.5	CHEMBL262	Homo sapiens	IC50	nM	6.5
	22798919	CHEMBL4711086	Inhibition of recombinant human N-terminal His6-tagged GSK-3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCc1cn(CCNc2c3c(nc4cc(Cl)ccc24)CCCC3)nn1		CHEMBL4741219	=	IC50	nM	46.7	CHEMBL262	Homo sapiens	IC50	nM	46.7
	22798920	CHEMBL4711086	Inhibition of recombinant human N-terminal His6-tagged GSK-3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCc1cn(CCNc2c3c(nc4ccccc24)CCCC3)nn1		CHEMBL4796602	=	IC50	nM	72.0	CHEMBL262	Homo sapiens	IC50	nM	72.0
	22798921	CHEMBL4711086	Inhibition of recombinant human N-terminal His6-tagged GSK-3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCCc1cn(CCNc2c3c(nc4ccccc24)CCCC3)nn1		CHEMBL4760288	=	IC50	nM	64.3	CHEMBL262	Homo sapiens	IC50	nM	64.3
	22798922	CHEMBL4711086	Inhibition of recombinant human N-terminal His6-tagged GSK-3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCc1cn(CCNc2c3c(nc4ccc(OC)cc24)CCCC3)nn1		CHEMBL4787590	=	IC50	nM	37.1	CHEMBL262	Homo sapiens	IC50	nM	37.1
	22798923	CHEMBL4711086	Inhibition of recombinant human N-terminal His6-tagged GSK-3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCCc1cn(CCNc2c3c(nc4ccc(OC)cc24)CCCC3)nn1		CHEMBL4744911	=	IC50	nM	14.6	CHEMBL262	Homo sapiens	IC50	nM	14.6
	22798924	CHEMBL4711086	Inhibition of recombinant human N-terminal His6-tagged GSK-3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCOCc1cn(CCNc2c3c(nc4cc(Cl)ccc24)CCCC3)nn1		CHEMBL4756424	=	IC50	nM	26.3	CHEMBL262	Homo sapiens	IC50	nM	26.3
	22798925	CHEMBL4711086	Inhibition of recombinant human N-terminal His6-tagged GSK-3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCOCc1cn(CCNc2c3c(nc4ccccc24)CCCC3)nn1		CHEMBL4779478	=	IC50	nM	20.8	CHEMBL262	Homo sapiens	IC50	nM	20.8
	22798926	CHEMBL4711086	Inhibition of recombinant human N-terminal His6-tagged GSK-3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCOCc1cn(CCNc2c3c(nc4ccc(OC)cc24)CCCC3)nn1		CHEMBL4799661	=	IC50	nM	31.0	CHEMBL262	Homo sapiens	IC50	nM	31.0
	22798927	CHEMBL4711086	Inhibition of recombinant human N-terminal His6-tagged GSK-3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	Nc1c2c(nc3ccccc13)CCCC2		CHEMBL95	>	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	nM	1000.0
	22798928	CHEMBL4711086	Inhibition of recombinant human N-terminal His6-tagged GSK-3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	COc1nc(-c2ccnc(NC(=O)C3CC3)c2)sc1C(N)=O		CHEMBL3410089	=	IC50	nM	17.2	CHEMBL262	Homo sapiens	IC50	nM	17.2
	22798929	CHEMBL4711086	Inhibition of recombinant human N-terminal His6-tagged GSK-3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714	=	IC50	nM	19.8	CHEMBL262	Homo sapiens	IC50	nM	19.8
	22798930	CHEMBL4711086	Inhibition of recombinant human N-terminal His6-tagged GSK-3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	O=C(NCCCNc1c2c(nc3ccccc13)CCCC2)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCC1CC1		CHEMBL4781117	=	IC50	nM	103.6	CHEMBL262	Homo sapiens	IC50	nM	103.6
	22798931	CHEMBL4711086	Inhibition of recombinant human N-terminal His6-tagged GSK-3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	O=C(NCCCNc1c2c(nc3ccccc13)CCCC2)c1sc(-c2ccnc(NC(=O)C3CCC3)c2)nc1OCC1CC1		CHEMBL4754192	=	IC50	nM	80.7	CHEMBL262	Homo sapiens	IC50	nM	80.7
	22798932	CHEMBL4711086	Inhibition of recombinant human N-terminal His6-tagged GSK-3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	CC(=O)Nc1cc(-c2nc(OCC3CC3)c(C(=O)NCCCNc3c4c(nc5ccccc35)CCCC4)s2)ccn1		CHEMBL4758531	=	IC50	nM	92.8	CHEMBL262	Homo sapiens	IC50	nM	92.8
	22798933	CHEMBL4711086	Inhibition of recombinant human N-terminal His6-tagged GSK-3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	CNC(=O)c1sc(-c2ccnc(NC(=O)CNCCNc3c4c(nc5ccccc35)CCCC4)c2)nc1OCC1CC1		CHEMBL4789145	=	IC50	nM	22.0	CHEMBL262	Homo sapiens	IC50	nM	22.0
	22798934	CHEMBL4711086	Inhibition of recombinant human N-terminal His6-tagged GSK-3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	CNC(=O)c1sc(-c2ccnc(NC(=O)CNCCNc3c4c(nc5cc(Cl)ccc35)CCCC4)c2)nc1OCC1CC1		CHEMBL4777788	=	IC50	nM	62.6	CHEMBL262	Homo sapiens	IC50	nM	62.6
	22798935	CHEMBL4711086	Inhibition of recombinant human N-terminal His6-tagged GSK-3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	CNC(=O)c1sc(-c2ccnc(NC(=O)CNCCNc3c4c(nc5ccc(OC)cc35)CCCC4)c2)nc1OCC1CC1		CHEMBL4785004	=	IC50	nM	39.3	CHEMBL262	Homo sapiens	IC50	nM	39.3
	22798936	CHEMBL4711086	Inhibition of recombinant human N-terminal His6-tagged GSK-3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	CCNC(=O)c1sc(-c2ccnc(NC(=O)CNCCNc3c4c(nc5ccccc35)CCCC4)c2)nc1OCC1CC1		CHEMBL4761239	=	IC50	nM	114.4	CHEMBL262	Homo sapiens	IC50	nM	114.4
	22798937	CHEMBL4711086	Inhibition of recombinant human N-terminal His6-tagged GSK-3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	CCCNC(=O)c1sc(-c2ccnc(NC(=O)CNCCNc3c4c(nc5ccccc35)CCCC4)c2)nc1OCC1CC1		CHEMBL4746403	=	IC50	nM	239.3	CHEMBL262	Homo sapiens	IC50	nM	239.3
	22798938	CHEMBL4711086	Inhibition of recombinant human N-terminal His6-tagged GSK-3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	NC(=O)c1sc(-c2ccnc(NC(=O)CNCCNc3c4c(nc5ccccc35)CCCC4)c2)nc1OCC1CC1		CHEMBL4753347	=	IC50	nM	42.6	CHEMBL262	Homo sapiens	IC50	nM	42.6
	22798939	CHEMBL4711086	Inhibition of recombinant human N-terminal His6-tagged GSK-3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	CNC(=O)c1sc(-c2ccnc(NC(=O)CNCCCCNc3c4c(nc5ccccc35)CCCC4)c2)nc1OCC1CC1		CHEMBL4756997	=	IC50	nM	41.6	CHEMBL262	Homo sapiens	IC50	nM	41.6
	22798940	CHEMBL4711086	Inhibition of recombinant human N-terminal His6-tagged GSK-3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	CNC(=O)c1sc(-c2ccnc(NC(=O)CNCCCCCCNc3c4c(nc5ccccc35)CCCC4)c2)nc1OCC1CC1		CHEMBL4800403	=	IC50	nM	62.0	CHEMBL262	Homo sapiens	IC50	nM	62.0
	22798941	CHEMBL4711086	Inhibition of recombinant human N-terminal His6-tagged GSK-3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	CNC(=O)c1sc(-c2ccnc(NC(=O)CNCCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c2)nc1OCC1CC1		CHEMBL4798419	=	IC50	nM	62.2	CHEMBL262	Homo sapiens	IC50	nM	62.2
	22798942	CHEMBL4711086	Inhibition of recombinant human N-terminal His6-tagged GSK-3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	CNC(=O)c1sc(-c2ccnc(NC(=O)CNCCNc3c4c(nc5ccccc35)CCCC4)c2)nc1OC		CHEMBL4749327	=	IC50	nM	41.1	CHEMBL262	Homo sapiens	IC50	nM	41.1
	22798943	CHEMBL4711086	Inhibition of recombinant human N-terminal His6-tagged GSK-3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	CNC(=O)c1sc(-c2ccnc(NC(=O)CNCCNc3c4c(nc5ccccc35)CCCC4)c2)nc1OCC1CCC1		CHEMBL4749678	=	IC50	nM	130.4	CHEMBL262	Homo sapiens	IC50	nM	130.4
	22798944	CHEMBL4711086	Inhibition of recombinant human N-terminal His6-tagged GSK-3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	CNC(=O)c1sc(-c2ccnc(NC(=O)CNCCNc3c4c(nc5ccccc35)CCCC4)c2)nc1OCC(C)(C)C		CHEMBL4759230	=	IC50	nM	165.3	CHEMBL262	Homo sapiens	IC50	nM	165.3
	22798945	CHEMBL4711086	Inhibition of recombinant human N-terminal His6-tagged GSK-3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	CNC(=O)c1sc(-c2ccnc(NC(=O)CNCCNc3c4c(nc5ccccc35)CCCC4)c2)nc1OC(C)C		CHEMBL4787169	=	IC50	nM	71.6	CHEMBL262	Homo sapiens	IC50	nM	71.6
	22798946	CHEMBL4711086	Inhibition of recombinant human N-terminal His6-tagged GSK-3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	CNC(=O)c1sc(-c2ccnc(NC(=O)CNCCNc3c4c(nc5ccccc35)CCCC4)c2)nc1OCC(C)C		CHEMBL4750284	=	IC50	nM	132.4	CHEMBL262	Homo sapiens	IC50	nM	132.4
	22801292	CHEMBL4711569	Inhibition of GSK3beta (unknown origin) measured after 40 mins by ADP-Glo assay	B	O=[N+]([O-])c1ccc(S(=O)(=O)Nc2ccc(-c3nc(-c4ccnc(Nc5ccc(OC(F)(F)F)cc5)c4)no3)cc2)cc1		CHEMBL4758669	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	22801293	CHEMBL4711569	Inhibition of GSK3beta (unknown origin) measured after 40 mins by ADP-Glo assay	B	COc1ccc(S(=O)(=O)Nc2ccc(-c3nc(-c4ccnc(Nc5ccc(OC(F)(F)F)cc5)c4)no3)cc2)cc1		CHEMBL4790790	=	IC50	nM	15390.0	CHEMBL262	Homo sapiens	IC50	uM	15.39
	22801294	CHEMBL4711569	Inhibition of GSK3beta (unknown origin) measured after 40 mins by ADP-Glo assay	B	CC(C)(C)c1ccc(S(=O)(=O)Nc2ccc(-c3nc(-c4ccnc(Nc5ccc(OC(F)(F)F)cc5)c4)no3)cc2)cc1		CHEMBL4792401	=	IC50	nM	7660.0	CHEMBL262	Homo sapiens	IC50	uM	7.66
	22801295	CHEMBL4711569	Inhibition of GSK3beta (unknown origin) measured after 40 mins by ADP-Glo assay	B	O=[N+]([O-])c1cccc(S(=O)(=O)Nc2ccc(-c3nc(-c4ccnc(Nc5ccc(OC(F)(F)F)cc5)c4)no3)cc2)c1		CHEMBL4748212	=	IC50	nM	8320.0	CHEMBL262	Homo sapiens	IC50	uM	8.32
	22801296	CHEMBL4711569	Inhibition of GSK3beta (unknown origin) measured after 40 mins by ADP-Glo assay	B	CC(=O)c1ccc(S(=O)(=O)Nc2ccc(-c3nc(-c4ccnc(Nc5ccc(OC(F)(F)F)cc5)c4)no3)cc2)cc1		CHEMBL4777194	=	IC50	nM	1020.0	CHEMBL262	Homo sapiens	IC50	uM	1.02
	22801297	CHEMBL4711569	Inhibition of GSK3beta (unknown origin) measured after 40 mins by ADP-Glo assay	B	O=S(=O)(Nc1ccc(-c2nc(-c3ccnc(Nc4ccc(OC(F)(F)F)cc4)c3)no2)cc1)c1ccccc1OC(F)(F)F		CHEMBL4781092	=	IC50	nM	1210.0	CHEMBL262	Homo sapiens	IC50	uM	1.21
	22801298	CHEMBL4711569	Inhibition of GSK3beta (unknown origin) measured after 40 mins by ADP-Glo assay	B	O=S(=O)(Nc1ccc(-c2nc(-c3ccnc(Nc4ccc(OC(F)(F)F)cc4)c3)no2)cc1)c1cccc(C(F)(F)F)c1		CHEMBL4792749	=	IC50	nM	2630.0	CHEMBL262	Homo sapiens	IC50	uM	2.63
	22801299	CHEMBL4711569	Inhibition of GSK3beta (unknown origin) measured after 40 mins by ADP-Glo assay	B	CC(=O)Nc1cccc(S(=O)(=O)Nc2ccc(-c3nc(-c4ccnc(Nc5ccc(OC(F)(F)F)cc5)c4)no3)cc2)c1		CHEMBL4746226	=	IC50	nM	2170.0	CHEMBL262	Homo sapiens	IC50	uM	2.17
	22801300	CHEMBL4711569	Inhibition of GSK3beta (unknown origin) measured after 40 mins by ADP-Glo assay	B	O=S(=O)(Nc1ccc(-c2nc(-c3ccnc(Nc4ccc(OC(F)(F)F)cc4)c3)no2)cc1)c1ccc(OC(F)(F)F)cc1		CHEMBL4759305	=	IC50	nM	8740.0	CHEMBL262	Homo sapiens	IC50	uM	8.74
	22801301	CHEMBL4711569	Inhibition of GSK3beta (unknown origin) measured after 40 mins by ADP-Glo assay	B	O=S(=O)(Nc1ccc(-c2nc(-c3ccnc(Nc4ccc(OC(F)(F)F)cc4)c3)no2)cc1)c1ccc(F)c(Cl)c1		CHEMBL4785368	=	IC50	nM	18950.0	CHEMBL262	Homo sapiens	IC50	uM	18.95
	22801302	CHEMBL4711569	Inhibition of GSK3beta (unknown origin) measured after 40 mins by ADP-Glo assay	B	O=S(=O)(Nc1ccc(-c2nc(-c3ccnc(Nc4ccc(OC(F)(F)F)cc4)c3)no2)cc1)c1ccc(F)cc1		CHEMBL4741761	=	IC50	nM	2690.0	CHEMBL262	Homo sapiens	IC50	uM	2.69
	22801303	CHEMBL4711569	Inhibition of GSK3beta (unknown origin) measured after 40 mins by ADP-Glo assay	B	O=S(=O)(Nc1ccc(-c2nc(-c3ccnc(Nc4ccc(OC(F)(F)F)cc4)c3)no2)cc1)c1ccc(Br)cc1		CHEMBL4743208	=	IC50	nM	3120.0	CHEMBL262	Homo sapiens	IC50	uM	3.12
	22801304	CHEMBL4711569	Inhibition of GSK3beta (unknown origin) measured after 40 mins by ADP-Glo assay	B	O=S(=O)(Nc1ccc(-c2nc(-c3ccnc(Nc4ccc(OC(F)(F)F)cc4)c3)no2)cc1)c1cccs1		CHEMBL4740478	=	IC50	nM	7630.0	CHEMBL262	Homo sapiens	IC50	uM	7.63
	22801305	CHEMBL4711569	Inhibition of GSK3beta (unknown origin) measured after 40 mins by ADP-Glo assay	B	COC(=O)c1ccc(S(=O)(=O)Nc2ccc(-c3nc(-c4ccnc(Nc5ccc(OC(F)(F)F)cc5)c4)no3)cc2)s1		CHEMBL4748786	=	IC50	nM	1190.0	CHEMBL262	Homo sapiens	IC50	uM	1.19
	22801306	CHEMBL4711569	Inhibition of GSK3beta (unknown origin) measured after 40 mins by ADP-Glo assay	B	O=S(=O)(Nc1ccc(-c2nc(-c3ccnc(Nc4ccc(OC(F)(F)F)cc4)c3)no2)cc1)c1ccc(Cl)s1		CHEMBL4797249	=	IC50	nM	2980.0	CHEMBL262	Homo sapiens	IC50	uM	2.98
	22801307	CHEMBL4711569	Inhibition of GSK3beta (unknown origin) measured after 40 mins by ADP-Glo assay	B	CC(C)(C)c1ccc(S(=O)(=O)Nc2ccc(-c3nc(-c4ccnc(Nc5ccc(F)c(C(F)(F)F)c5)c4)no3)cc2)cc1		CHEMBL4753278	=	IC50	nM	3930.0	CHEMBL262	Homo sapiens	IC50	uM	3.93
	22801308	CHEMBL4711569	Inhibition of GSK3beta (unknown origin) measured after 40 mins by ADP-Glo assay	B	CC(C)(C)c1ccc(S(=O)(=O)Nc2ccc(-c3nc(-c4ccnc(Nc5cccc(Cl)c5)c4)no3)cc2)cc1		CHEMBL4783062	=	IC50	nM	190.0	CHEMBL262	Homo sapiens	IC50	uM	0.19
	22801309	CHEMBL4711569	Inhibition of GSK3beta (unknown origin) measured after 40 mins by ADP-Glo assay	B	CC(C)(C)c1ccc(Nc2cc(-c3noc(-c4ccc(NS(=O)(=O)c5ccc(C(C)(C)C)cc5)cc4)n3)ccn2)cc1		CHEMBL4791654	=	IC50	nM	560.0	CHEMBL262	Homo sapiens	IC50	uM	0.56
	22801310	CHEMBL4711569	Inhibition of GSK3beta (unknown origin) measured after 40 mins by ADP-Glo assay	B	CC(C)(C)c1ccc(S(=O)(=O)Nc2ccc(-c3nc(-c4ccnc(Nc5ccc(C(F)(F)F)cc5)c4)no3)cc2)cc1		CHEMBL4761660	=	IC50	nM	1490.0	CHEMBL262	Homo sapiens	IC50	uM	1.49
	22801311	CHEMBL4711569	Inhibition of GSK3beta (unknown origin) measured after 40 mins by ADP-Glo assay	B	CC(C)(C)c1ccc(S(=O)(=O)Nc2ccc(-c3nc(-c4ccnc(Nc5ccc(F)c(F)c5)c4)no3)cc2)cc1		CHEMBL4799574	=	IC50	nM	1320.0	CHEMBL262	Homo sapiens	IC50	uM	1.32
	22801312	CHEMBL4711569	Inhibition of GSK3beta (unknown origin) measured after 40 mins by ADP-Glo assay	B	CCc1ccc(Nc2cc(-c3noc(-c4ccc(NS(=O)(=O)c5ccc(C(C)(C)C)cc5)cc4)n3)ccn2)cc1		CHEMBL4752122	=	IC50	nM	3240.0	CHEMBL262	Homo sapiens	IC50	uM	3.24
	22801313	CHEMBL4711569	Inhibition of GSK3beta (unknown origin) measured after 40 mins by ADP-Glo assay	B	CC(C)(C)c1ccc(S(=O)(=O)Nc2ccc(-c3nc(-c4ccnc(Nc5ccc(Cl)cc5F)c4)no3)cc2)cc1		CHEMBL4792822	=	IC50	nM	2850.0	CHEMBL262	Homo sapiens	IC50	uM	2.85
	22801314	CHEMBL4711569	Inhibition of GSK3beta (unknown origin) measured after 40 mins by ADP-Glo assay	B	COc1ccc(Nc2cc(-c3noc(-c4ccc(NS(=O)(=O)c5ccc(C(C)(C)C)cc5)cc4)n3)ccn2)cc1		CHEMBL4757059	=	IC50	nM	9890.0	CHEMBL262	Homo sapiens	IC50	uM	9.89
	22801315	CHEMBL4711569	Inhibition of GSK3beta (unknown origin) measured after 40 mins by ADP-Glo assay	B	CC(C)c1ccc(Nc2cc(-c3noc(-c4ccc(NS(=O)(=O)c5ccc(C(C)(C)C)cc5)cc4)n3)ccn2)cc1		CHEMBL4794583	=	IC50	nM	2070.0	CHEMBL262	Homo sapiens	IC50	uM	2.07
	22801316	CHEMBL4711569	Inhibition of GSK3beta (unknown origin) measured after 40 mins by ADP-Glo assay	B	Cc1ccccc1Nc1cc(-c2noc(-c3ccc(NS(=O)(=O)c4ccc(C(C)(C)C)cc4)cc3)n2)ccn1		CHEMBL4794134	=	IC50	nM	2290.0	CHEMBL262	Homo sapiens	IC50	uM	2.29
	22801317	CHEMBL4711569	Inhibition of GSK3beta (unknown origin) measured after 40 mins by ADP-Glo assay	B	Cc1ccc(Nc2cc(-c3noc(-c4ccc(NS(=O)(=O)c5ccc(C(C)(C)C)cc5)cc4)n3)ccn2)cc1		CHEMBL4793635	=	IC50	nM	4560.0	CHEMBL262	Homo sapiens	IC50	uM	4.56
	22801318	CHEMBL4711569	Inhibition of GSK3beta (unknown origin) measured after 40 mins by ADP-Glo assay	B	Cc1cccc(Nc2cc(-c3noc(-c4ccc(NS(=O)(=O)c5ccc(C(C)(C)C)cc5)cc4)n3)ccn2)c1		CHEMBL4751438	=	IC50	nM	940.0	CHEMBL262	Homo sapiens	IC50	uM	0.94
Dose-dependent effect	22801488	CHEMBL4711588	Inhibition of GSK-3beta in human SH-SY5Y cells assessed as decrease in amyloid beta-induced Tau hyperphosphorylation at Ser396 pretreated for 1 hr followed Amyloid beta addition measured after 6 hrs by Western blot analysis	B	CC(=O)c1ccc(S(=O)(=O)Nc2ccc(-c3nc(-c4ccnc(Nc5ccc(OC(F)(F)F)cc5)c4)no3)cc2)cc1		CHEMBL4777194		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Dose-dependent effect	22801489	CHEMBL4711588	Inhibition of GSK-3beta in human SH-SY5Y cells assessed as decrease in amyloid beta-induced Tau hyperphosphorylation at Ser396 pretreated for 1 hr followed Amyloid beta addition measured after 6 hrs by Western blot analysis	B	CC(C)(C)c1ccc(S(=O)(=O)Nc2ccc(-c3nc(-c4ccnc(Nc5cccc(Cl)c5)c4)no3)cc2)cc1		CHEMBL4783062		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	22809777	CHEMBL4713312	Inhibition of recombinant human GSK3beta (2 to end residues) assessed as residual activity at 1 uM using YRRAAVPPSPSLSR as substrate incubated for 40 mins in presence of Km ATP by radiometric scintillation counting analysis relative to control	B	CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(Cl)cc2)[C@H](C)C1		CHEMBL4761365	=	Activity	%	76.0	CHEMBL262	Homo sapiens	Activity	%	76.0
	22822931	CHEMBL4716840	Inhibition of GSK3beta (unknown origin)	B	Cc1cc(Nc2nc(Nc3ccccc3S(=O)(=O)C(C)C)c3c(C)[nH]nc3n2)c(OC(C)C)cc1C1CCN(C)CC1		CHEMBL3651854	=	IC50	nM	4300.0	CHEMBL262	Homo sapiens	IC50	uM	4.3
	22836246	CHEMBL4718863	Inhibition of recombinant full-length human His-tagged GSK3beta expressed in baculovirus expression system at 500 nM using Ser/Thr 09 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	-8.0	CHEMBL262	Homo sapiens	INH	%	-8.0
	22836247	CHEMBL4718863	Inhibition of recombinant full-length human His-tagged GSK3beta expressed in baculovirus expression system at 500 nM using Ser/Thr 09 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	OCC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1		CHEMBL4786776	=	Inhibition	%	8.0	CHEMBL262	Homo sapiens	INH	%	8.0
	22836248	CHEMBL4718863	Inhibition of recombinant full-length human His-tagged GSK3beta expressed in baculovirus expression system at 500 nM using Ser/Thr 09 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	CN(C)CCNCc1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)cc1F		CHEMBL4748367	=	Inhibition	%	8.0	CHEMBL262	Homo sapiens	INH	%	8.0
	22836249	CHEMBL4718863	Inhibition of recombinant full-length human His-tagged GSK3beta expressed in baculovirus expression system at 500 nM using Ser/Thr 09 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	CCOc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1		CHEMBL4776396	=	Inhibition	%	13.0	CHEMBL262	Homo sapiens	INH	%	13.0
	22836250	CHEMBL4718863	Inhibition of recombinant full-length human His-tagged GSK3beta expressed in baculovirus expression system at 500 nM using Ser/Thr 09 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	COc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1		CHEMBL4783569	=	Inhibition	%	6.0	CHEMBL262	Homo sapiens	INH	%	6.0
	22836251	CHEMBL4718863	Inhibition of recombinant full-length human His-tagged GSK3beta expressed in baculovirus expression system at 500 nM using Ser/Thr 09 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	OC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1		CHEMBL4780286	=	Inhibition	%	8.0	CHEMBL262	Homo sapiens	INH	%	8.0
	22840042	CHEMBL4719512	Binding affinity to GSK3B (unknown origin) assessed as change in melting temperature of protein at 10 uM by Sypro-orange dye based DSF assay	B	COC(=N)c1nc2ccc3ncnc(Nc4ccc(Cl)cc4Cl)c3c2s1		CHEMBL2386747	=	Delta Tm	degrees C	5.0	CHEMBL262	Homo sapiens	deltaTm	degrees C	5.0
	22840043	CHEMBL4719512	Binding affinity to GSK3B (unknown origin) assessed as change in melting temperature of protein at 10 uM by Sypro-orange dye based DSF assay	B	COC(=N)c1nc2ccc3ncnc(Nc4ccc(OC)cc4F)c3c2s1		CHEMBL3894571	=	Delta Tm	degrees C	5.0	CHEMBL262	Homo sapiens	deltaTm	degrees C	5.0
	22840060	CHEMBL4719521	Inhibition of GSK3B (unknown origin)	B	COC(=N)c1nc2ccc3ncnc(Nc4ccc(OC)cc4F)c3c2s1		CHEMBL3894571	=	IC50	nM	143.0	CHEMBL262	Homo sapiens	IC50	nM	143.0
	22840061	CHEMBL4719521	Inhibition of GSK3B (unknown origin)	B	COC(=N)c1nc2ccc3ncnc(Nc4ccc(Cl)cc4Cl)c3c2s1		CHEMBL2386747	=	IC50	nM	221.0	CHEMBL262	Homo sapiens	IC50	nM	221.0
	22843724	CHEMBL4720710	Inhibition of human GSK3B using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	5.28	CHEMBL262	Homo sapiens	IC50	10^-9M	5.28
	22844076	CHEMBL4721062	Inhibition of human GSK3B assessed as residual activity using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	95.55	CHEMBL262	Homo sapiens	Activity	%	95.55
	22844728	CHEMBL4721403	Inhibition of wild-type human full length GSK3B (M1 to T433 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	95.9	CHEMBL262	Homo sapiens	Activity	%	95.9
	22852080	CHEMBL4723896	Inhibition of GSK3beta (unknown origin)	B	C[C@H]1C[C@@H](c2ccncc2NC(=O)c2nc(-c3ncccc3F)ccc2N)C[C@@H](O)[C@]1(C)O		CHEMBL4781112	=	IC50	nM	540.0	CHEMBL262	Homo sapiens	IC50	uM	0.54
	22886555	CHEMBL4728261	Binding affinity to GSK3B (unknown origin) assessed as change in melting temperature at 10 uM incubated for 10 mins using SYPRO orange dye by RT-PCR-based fluorescence assay	B	CC(=O)c1cccc(-c2cnc3ccc(NCC4CC4)nn23)c1		CHEMBL200528	>	Delta Tm	degrees C	4.0	CHEMBL262	Homo sapiens	deltaTm	degrees C	4.0
	22886593	CHEMBL4728296	Inhibition of human GSK3B assessed as residual activity at 1 uM relative to control	B	Cn1cc(-c2ccc3occ(-c4cccc(-c5ccncc5)c4)c3n2)cn1		CHEMBL4754195	<	Activity	%	50.0	CHEMBL262	Homo sapiens	Activity	%	50.0
Not Active	22889513	CHEMBL4729032	Inhibition of wild-type human full length GSK3B (M1 to T433 residues) expressed in mammalian expression system at 1 uM by Kinomescan method	B	COc1cc(OCc2ccnc(Nc3cnn(C)c3)n2)cc2sc(N[C@H]3CCCC[C@@H]3O)nc12		CHEMBL4748740		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	22908719	CHEMBL4733694	Inhibition of N-terminal His6-tagged recombinant human GSK3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by Kinase-Glo luminescent assay	B	COc1nc(-c2ccnc(NC(=O)C3CC3)c2)sc1C(=O)NCCCNC(=O)COc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O		CHEMBL4748741	=	IC50	nM	874.3	CHEMBL262	Homo sapiens	IC50	nM	874.3
	22908720	CHEMBL4733694	Inhibition of N-terminal His6-tagged recombinant human GSK3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by Kinase-Glo luminescent assay	B	COc1nc(-c2ccnc(NC(=O)C3CC3)c2)sc1C(=O)NCCCCNC(=O)COc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O		CHEMBL4788432	=	IC50	nM	639.2	CHEMBL262	Homo sapiens	IC50	nM	639.2
	22908721	CHEMBL4733694	Inhibition of N-terminal His6-tagged recombinant human GSK3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by Kinase-Glo luminescent assay	B	COc1nc(-c2ccnc(NC(=O)C3CC3)c2)sc1C(=O)NCCCCCCNC(=O)COc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O		CHEMBL4788108	=	IC50	nM	242.7	CHEMBL262	Homo sapiens	IC50	nM	242.7
	22908722	CHEMBL4733694	Inhibition of N-terminal His6-tagged recombinant human GSK3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by Kinase-Glo luminescent assay	B	CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCCCCCCCn1cc(COc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)nn1		CHEMBL4749204	=	IC50	nM	83.1	CHEMBL262	Homo sapiens	IC50	nM	83.1
	22908723	CHEMBL4733694	Inhibition of N-terminal His6-tagged recombinant human GSK3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by Kinase-Glo luminescent assay	B	CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCOCCOCCn1cc(COc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)nn1		CHEMBL4794527	=	IC50	nM	46.9	CHEMBL262	Homo sapiens	IC50	nM	46.9
	22908724	CHEMBL4733694	Inhibition of N-terminal His6-tagged recombinant human GSK3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by Kinase-Glo luminescent assay	B	CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCOCCOCCOCCn1cc(COc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)nn1		CHEMBL4797405	=	IC50	nM	79.5	CHEMBL262	Homo sapiens	IC50	nM	79.5
	22908725	CHEMBL4733694	Inhibition of N-terminal His6-tagged recombinant human GSK3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by Kinase-Glo luminescent assay	B	CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCC#Cc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O		CHEMBL4745838	>	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	nM	1000.0
	22908726	CHEMBL4733694	Inhibition of N-terminal His6-tagged recombinant human GSK3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by Kinase-Glo luminescent assay	B	CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCCC#Cc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O		CHEMBL4777312	=	IC50	nM	294.7	CHEMBL262	Homo sapiens	IC50	nM	294.7
	22908727	CHEMBL4733694	Inhibition of N-terminal His6-tagged recombinant human GSK3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by Kinase-Glo luminescent assay	B	CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCOCC#Cc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O		CHEMBL4761297	=	IC50	nM	49.2	CHEMBL262	Homo sapiens	IC50	nM	49.2
	22908728	CHEMBL4733694	Inhibition of N-terminal His6-tagged recombinant human GSK3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by Kinase-Glo luminescent assay	B	NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCOCC#Cc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O		CHEMBL4755345	=	IC50	nM	63.8	CHEMBL262	Homo sapiens	IC50	nM	63.8
	22908729	CHEMBL4733694	Inhibition of N-terminal His6-tagged recombinant human GSK3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by Kinase-Glo luminescent assay	B	NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCC#Cc1ccc2c(c1)C(=O)N(C1CCC(=O)NC1=O)C2=O		CHEMBL4745133	>	IC50	nM	1000.0	CHEMBL262	Homo sapiens	IC50	nM	1000.0
	22908730	CHEMBL4733694	Inhibition of N-terminal His6-tagged recombinant human GSK3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by Kinase-Glo luminescent assay	B	CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCCC#Cc1ccc2c(c1)C(=O)N(C1CCC(=O)NC1=O)C2=O		CHEMBL4787924	=	IC50	nM	79.1	CHEMBL262	Homo sapiens	IC50	nM	79.1
	22908731	CHEMBL4733694	Inhibition of N-terminal His6-tagged recombinant human GSK3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by Kinase-Glo luminescent assay	B	NC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCOCC#Cc1ccc2c(c1)C(=O)N(C1CCC(=O)NC1=O)C2=O		CHEMBL4787336	=	IC50	nM	27.7	CHEMBL262	Homo sapiens	IC50	nM	27.7
	22908732	CHEMBL4733694	Inhibition of N-terminal His6-tagged recombinant human GSK3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by Kinase-Glo luminescent assay	B	CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCOCC#Cc1ccc2c(c1)C(=O)N(C1CCC(=O)NC1=O)C2=O		CHEMBL4757470	=	IC50	nM	19.7	CHEMBL262	Homo sapiens	IC50	nM	19.7
	22908733	CHEMBL4733694	Inhibition of N-terminal His6-tagged recombinant human GSK3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by Kinase-Glo luminescent assay	B	CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCCCCCOc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O		CHEMBL4761372	=	IC50	nM	71.6	CHEMBL262	Homo sapiens	IC50	nM	71.6
	22908734	CHEMBL4733694	Inhibition of N-terminal His6-tagged recombinant human GSK3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by Kinase-Glo luminescent assay	B	CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCCCCCCCOc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O		CHEMBL4760111	=	IC50	nM	23.8	CHEMBL262	Homo sapiens	IC50	nM	23.8
	22908735	CHEMBL4733694	Inhibition of N-terminal His6-tagged recombinant human GSK3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by Kinase-Glo luminescent assay	B	CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCCCCCCCCCOc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O		CHEMBL4749972	=	IC50	nM	70.4	CHEMBL262	Homo sapiens	IC50	nM	70.4
	22908736	CHEMBL4733694	Inhibition of N-terminal His6-tagged recombinant human GSK3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by Kinase-Glo luminescent assay	B	CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCCCCCCCCCCCOc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O		CHEMBL4751968	=	IC50	nM	98.0	CHEMBL262	Homo sapiens	IC50	nM	98.0
	22908737	CHEMBL4733694	Inhibition of N-terminal His6-tagged recombinant human GSK3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by Kinase-Glo luminescent assay	B	CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCOCCOCCOc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O		CHEMBL4782211	=	IC50	nM	104.9	CHEMBL262	Homo sapiens	IC50	nM	104.9
	22908738	CHEMBL4733694	Inhibition of N-terminal His6-tagged recombinant human GSK3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by Kinase-Glo luminescent assay	B	CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCOCCOCCOCCOc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O		CHEMBL4763674	=	IC50	nM	73.2	CHEMBL262	Homo sapiens	IC50	nM	73.2
	22908739	CHEMBL4733694	Inhibition of N-terminal His6-tagged recombinant human GSK3beta H350L mutant expressed in baculovirus infected Sf21 cells using GSM as substrate incubated for 30 mins in presence of ATP by Kinase-Glo luminescent assay	B	CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCOCCOCCOCCOCCOc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O		CHEMBL4791065	=	IC50	nM	69.3	CHEMBL262	Homo sapiens	IC50	nM	69.3
	22908757	CHEMBL4733696	Inhibition of GSK3beta (unknown origin)	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	IC50	nM	23.0	CHEMBL262	Homo sapiens	IC50	nM	23.0
	22908758	CHEMBL4733696	Inhibition of GSK3beta (unknown origin)	B	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	=	IC50	nM	7.0	CHEMBL262	Homo sapiens	IC50	nM	7.0
	22908759	CHEMBL4733696	Inhibition of GSK3beta (unknown origin)	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	IC50	nM	4.0	CHEMBL262	Homo sapiens	IC50	nM	4.0
	22908760	CHEMBL4733696	Inhibition of GSK3beta (unknown origin)	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	=	IC50	nM	5.0	CHEMBL262	Homo sapiens	IC50	nM	5.0
	22908761	CHEMBL4733696	Inhibition of GSK3beta (unknown origin)	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	IC50	nM	2000.0	CHEMBL262	Homo sapiens	IC50	uM	2.0
	22908762	CHEMBL4733696	Inhibition of GSK3beta (unknown origin)	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714	=	IC50	nM	34.0	CHEMBL262	Homo sapiens	IC50	nM	34.0
	22908763	CHEMBL4733696	Inhibition of GSK3beta (unknown origin)	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	IC50	nM	30.0	CHEMBL262	Homo sapiens	IC50	nM	30.0
	22908764	CHEMBL4733696	Inhibition of GSK3beta (unknown origin)	B	CN1CCN(S(=O)(=O)c2ccc(-c3cnc(N)c(C(=O)Nc4cccnc4)n3)cc2)CC1		CHEMBL2177161	=	IC50	nM	5.0	CHEMBL262	Homo sapiens	IC50	nM	5.0
	22908782	CHEMBL4733714	Inhibition of GSK3beta (unknown origin) at 300 nM relative to control	B	CNC(=O)c1sc(-c2ccnc(NC(=O)C3CC3)c2)nc1OCCCCCCCCn1cc(COc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)nn1		CHEMBL4749204	=	Inhibition	%	81.48	CHEMBL262	Homo sapiens	INH	%	81.48
Not Active	22909910	CHEMBL4734064	Inhibition of recombinant human full length His-tagged GSK3B expressed in baculovirus expression system using serine/threonine-09 peptide as substrate at 10 uM incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	c1ccc(CSc2ncnc3[nH]cnc23)cc1		CHEMBL397434		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	22909911	CHEMBL4734064	Inhibition of recombinant human full length His-tagged GSK3B expressed in baculovirus expression system using serine/threonine-09 peptide as substrate at 10 uM incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	Clc1cccc(CSc2ncnc3[nH]cnc23)c1		CHEMBL4754930		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	22909912	CHEMBL4734064	Inhibition of recombinant human full length His-tagged GSK3B expressed in baculovirus expression system using serine/threonine-09 peptide as substrate at 10 uM incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	Brc1ccccc1CSc1ncnc2[nH]cnc12		CHEMBL4776788		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	22922032	CHEMBL4736839	Inhibition of recombinant human GSK-3beta using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	COc1ccccc1-c1ccnc(N[C@H]2CO[C@@H]3[C@@H](NC(=O)Nc4cccc(C(F)(F)F)c4)CO[C@H]23)n1		CHEMBL4793155	=	IC50	nM	26960.0	CHEMBL262	Homo sapiens	IC50	uM	26.96
	22922033	CHEMBL4736839	Inhibition of recombinant human GSK-3beta using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	COc1ccc(-c2ccnc(N[C@H]3CO[C@@H]4[C@@H](NC(=O)Nc5cccc(C(F)(F)F)c5)CO[C@H]34)n2)cc1		CHEMBL4780397	=	IC50	nM	9750.0	CHEMBL262	Homo sapiens	IC50	uM	9.75
	22922034	CHEMBL4736839	Inhibition of recombinant human GSK-3beta using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CO[C@@H]2[C@@H](OC(=O)Nc3ccc(Oc4ccccc4)cc3)CO[C@H]12		CHEMBL4761344	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	22922035	CHEMBL4736839	Inhibition of recombinant human GSK-3beta using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CO[C@@H]2[C@@H](n3nnnc3-c3cccc(CN4CCCC4)c3)CO[C@H]12		CHEMBL4752933	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	22922036	CHEMBL4736839	Inhibition of recombinant human GSK-3beta using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	Cc1nn(-c2ccccc2[N+](=O)[O-])c(C)c1[C@@H]1C=C[C@@H](NC(=O)Nc2cccc(C#N)c2)C1		CHEMBL4761175	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	22922037	CHEMBL4736839	Inhibition of recombinant human GSK-3beta using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	CSc1cccc(NC(=O)NC2C[C@@H]3CCCN2CC3CN(C)c2ccccc2)c1		CHEMBL4782972	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	22922038	CHEMBL4736839	Inhibition of recombinant human GSK-3beta using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	COC(=O)c1ccc2c(c1)nc1n2[C@@H](CNC(=O)Nc2ccccc2)COC1		CHEMBL4750704	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	22922039	CHEMBL4736839	Inhibition of recombinant human GSK-3beta using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	CSCC(=O)N1C[C@@H](NC(=O)Nc2cccc(SC)c2)C[C@H]1C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(N)=O		CHEMBL4745537	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	22922040	CHEMBL4736839	Inhibition of recombinant human GSK-3beta using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	Cn1cccc1C(=O)N1C[C@H](NC(=O)Nc2ccc(F)cc2F)C[C@@H]1C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(N)=O		CHEMBL4780360	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	22922041	CHEMBL4736839	Inhibition of recombinant human GSK-3beta using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	CC(C)=CC(=O)N1CC(NC(=O)Nc2ccc(F)cc2F)CC1C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(N)=O		CHEMBL4753110	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	22922042	CHEMBL4736839	Inhibition of recombinant human GSK-3beta using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	COc1ccc2nc(CO[C@H]3CN(Cc4ccnc5ccccc45)C[C@H]3F)[nH]c2c1		CHEMBL4749336	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	22922043	CHEMBL4736839	Inhibition of recombinant human GSK-3beta using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	Cn1c(CO[C@H]2CN(Cc3c[nH]c4ccccc34)C[C@H]2F)nc2ccccc21		CHEMBL4777246	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	22922044	CHEMBL4736839	Inhibition of recombinant human GSK-3beta using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	Cc1cc2nc(CO[C@H]3CN(Cc4cccnc4)C[C@H]3F)[nH]c2cc1C		CHEMBL4764080	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	22922045	CHEMBL4736839	Inhibition of recombinant human GSK-3beta using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	CC(=O)Nc1ccc(CN2C[C@H](OCc3nc4cc(C)c(C)cc4[nH]3)[C@H](F)C2)cc1		CHEMBL4787122	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	22922046	CHEMBL4736839	Inhibition of recombinant human GSK-3beta using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	N#Cc1ccc(CN2C[C@H](OCc3nc4cc(C(F)(F)F)ccc4[nH]3)[C@H](F)C2)cc1		CHEMBL4781720	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	22922047	CHEMBL4736839	Inhibition of recombinant human GSK-3beta using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	CS(=O)(=O)c1ccc(CN2C[C@H](OCc3nc4cc(C(F)(F)F)ccc4[nH]3)[C@H](F)C2)cc1		CHEMBL4780303	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	22922048	CHEMBL4736839	Inhibition of recombinant human GSK-3beta using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	O=C(c1ccncc1)N1C[C@H](OCc2nc3ccc(F)cc3[nH]2)[C@H](F)C1		CHEMBL4764234	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	22922049	CHEMBL4736839	Inhibition of recombinant human GSK-3beta using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	O=C(c1ccccc1)N1C[C@H](OCc2nc3cc(C(F)(F)F)ccc3[nH]2)[C@H](F)C1		CHEMBL4780185	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	22922050	CHEMBL4736839	Inhibition of recombinant human GSK-3beta using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	COc1ccc(C(=O)N2C[C@H](OCc3nc4cc(C(F)(F)F)ccc4[nH]3)[C@H](F)C2)cc1		CHEMBL4741666	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	22922051	CHEMBL4736839	Inhibition of recombinant human GSK-3beta using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	O=C(c1cccnc1)N1C[C@H](OCc2nc3cc(C(F)(F)F)ccc3[nH]2)[C@H](F)C1		CHEMBL4744645	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	22922052	CHEMBL4736839	Inhibition of recombinant human GSK-3beta using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	COc1ccc(-c2ccnc(N[C@H]3CO[C@@H]4[C@@H](NC(=O)Nc5ccccc5)CO[C@H]34)n2)cc1		CHEMBL4741384	=	IC50	nM	560.0	CHEMBL262	Homo sapiens	IC50	uM	0.56
	22922053	CHEMBL4736839	Inhibition of recombinant human GSK-3beta using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	COc1ccc(-c2ccnc(N[C@H]3CO[C@@H]4[C@@H](NC(=O)Nc5cccc(C#N)c5)CO[C@H]34)n2)cc1		CHEMBL4747194	=	IC50	nM	87.0	CHEMBL262	Homo sapiens	IC50	uM	0.087
	22922054	CHEMBL4736839	Inhibition of recombinant human GSK-3beta using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	COc1ccc(-c2ccnc(N[C@H]3CO[C@@H]4[C@@H](NC(=O)Nc5ccc(C(C)=O)cc5)CO[C@H]34)n2)cc1		CHEMBL4758751	=	IC50	nM	412.0	CHEMBL262	Homo sapiens	IC50	uM	0.41200000000000003
	22922055	CHEMBL4736839	Inhibition of recombinant human GSK-3beta using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	COc1ccc(-c2ccnc(N[C@H]3CO[C@@H]4[C@@H](NC(=O)Nc5cc(OC)cc(OC)c5)CO[C@H]34)n2)cc1		CHEMBL4751581	=	IC50	nM	421.0	CHEMBL262	Homo sapiens	IC50	uM	0.42100000000000004
	22922056	CHEMBL4736839	Inhibition of recombinant human GSK-3beta using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CO[C@@H]2[C@@H](Nc3nccc(-c4cccc(F)c4)n3)CO[C@H]12		CHEMBL4781499	=	IC50	nM	2060.0	CHEMBL262	Homo sapiens	IC50	uM	2.06
	22922057	CHEMBL4736839	Inhibition of recombinant human GSK-3beta using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	CN(C)c1ccc(-c2ccnc(N[C@H]3CO[C@@H]4[C@@H](NC(=O)Nc5cccc(C(F)(F)F)c5)CO[C@H]34)n2)cc1		CHEMBL4752822	=	IC50	nM	5660.0	CHEMBL262	Homo sapiens	IC50	uM	5.66
	22922058	CHEMBL4736839	Inhibition of recombinant human GSK-3beta using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	COc1ccccc1-c1ccnc(N[C@H]2CO[C@@H]3[C@@H](NC(=O)Nc4cccc(C#N)c4)CO[C@H]23)n1		CHEMBL4797635	=	IC50	nM	6080.0	CHEMBL262	Homo sapiens	IC50	uM	6.08
	22922059	CHEMBL4736839	Inhibition of recombinant human GSK-3beta using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	N#Cc1cccc(NC(=O)N[C@H]2CO[C@@H]3[C@@H](Nc4nccc(-c5cccc(F)c5)n4)CO[C@H]23)c1		CHEMBL4779572	=	IC50	nM	2080.0	CHEMBL262	Homo sapiens	IC50	uM	2.08
	22922060	CHEMBL4736839	Inhibition of recombinant human GSK-3beta using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CO[C@@H]2[C@@H](Nc3nccc(-c4cccs4)n3)CO[C@H]12		CHEMBL4744440	=	IC50	nM	4042.0	CHEMBL262	Homo sapiens	IC50	uM	4.042
	22922061	CHEMBL4736839	Inhibition of recombinant human GSK-3beta using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	CC(C)(C)c1ccnc(N[C@H]2CO[C@@H]3[C@@H](NC(=O)Nc4cccc(C(F)(F)F)c4)CO[C@H]23)n1		CHEMBL4746644	=	IC50	nM	14050.0	CHEMBL262	Homo sapiens	IC50	uM	14.05
	22922062	CHEMBL4736839	Inhibition of recombinant human GSK-3beta using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CO[C@@H]2[C@@H](Nc3nccc(C4CCCC4)n3)CO[C@H]12		CHEMBL4750854	=	IC50	nM	11900.0	CHEMBL262	Homo sapiens	IC50	uM	11.9
	22922063	CHEMBL4736839	Inhibition of recombinant human GSK-3beta using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CO[C@@H]2[C@@H](Nc3nccc(-c4ccco4)n3)CO[C@H]12		CHEMBL4792670	=	IC50	nM	2950.0	CHEMBL262	Homo sapiens	IC50	uM	2.95
	22922064	CHEMBL4736839	Inhibition of recombinant human GSK-3beta using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	O=C(Nc1ccccc1)N[C@H]1CO[C@@H]2[C@@H](Nc3nccc(-c4cccs4)n3)CO[C@H]12		CHEMBL4757545	=	IC50	nM	2700.0	CHEMBL262	Homo sapiens	IC50	uM	2.7
	22922065	CHEMBL4736839	Inhibition of recombinant human GSK-3beta using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	CCNC(=O)N[C@H]1CO[C@@H]2[C@@H](Nc3nccc(-c4ccc(OC)cc4)n3)CO[C@H]12		CHEMBL4755365	=	IC50	nM	117.0	CHEMBL262	Homo sapiens	IC50	uM	0.11699999999999999
	22922066	CHEMBL4736839	Inhibition of recombinant human GSK-3beta using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	O=C(Nc1cccc(C(F)(F)F)c1)O[C@@H]1CO[C@@H]2[C@@H](Nc3nccc(-c4ccc5c(c4)OCO5)n3)CO[C@H]12		CHEMBL4751957	=	IC50	nM	1080.0	CHEMBL262	Homo sapiens	IC50	uM	1.08
	22922067	CHEMBL4736839	Inhibition of recombinant human GSK-3beta using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	O=C(Nc1cccc2ccccc12)N[C@H]1CO[C@@H]2[C@H](OC(=O)Nc3ccccc3)CO[C@H]12		CHEMBL4791130	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	22922068	CHEMBL4736839	Inhibition of recombinant human GSK-3beta using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CO[C@@H]2[C@H](OC(=O)Nc3cccc4ccccc34)CO[C@H]12		CHEMBL4741367	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	22922069	CHEMBL4736839	Inhibition of recombinant human GSK-3beta using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	COC(=O)c1cccc(NC(=S)N[C@H]2CO[C@@H]3[C@H](OC(=O)Nc4cccc(C(F)(F)F)c4)CO[C@H]23)c1		CHEMBL4791344	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	22922070	CHEMBL4736839	Inhibition of recombinant human GSK-3beta using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	O=C(Nc1cccc(C(F)(F)F)c1)O[C@@H]1CO[C@@H]2[C@@H](NC(=S)Nc3ccc(Cl)cc3)CO[C@H]12		CHEMBL4758361	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	22922071	CHEMBL4736839	Inhibition of recombinant human GSK-3beta using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	O=C(Nc1cccc2ccccc12)O[C@@H]1CO[C@@H]2[C@@H](NC(=S)Nc3ccc(Cl)cc3)CO[C@H]12		CHEMBL4778874	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	22922072	CHEMBL4736839	Inhibition of recombinant human GSK-3beta using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	32640.0	CHEMBL262	Homo sapiens	IC50	uM	32.64
	22922073	CHEMBL4736840	Inhibition of recombinant human GSK-3beta at 50 uM using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay relative to control	B	O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CO[C@@H]2[C@@H](OC(=O)Nc3ccc(Oc4ccccc4)cc3)CO[C@H]12		CHEMBL4761344	=	Inhibition	%	42.0	CHEMBL262	Homo sapiens	INH	%	42.0
	22922074	CHEMBL4736840	Inhibition of recombinant human GSK-3beta at 50 uM using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay relative to control	B	O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CO[C@@H]2[C@@H](n3nnnc3-c3cccc(CN4CCCC4)c3)CO[C@H]12		CHEMBL4752933	=	Inhibition	%	7.0	CHEMBL262	Homo sapiens	INH	%	7.0
	22922075	CHEMBL4736840	Inhibition of recombinant human GSK-3beta at 50 uM using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay relative to control	B	Cc1nn(-c2ccccc2[N+](=O)[O-])c(C)c1[C@@H]1C=C[C@@H](NC(=O)Nc2cccc(C#N)c2)C1		CHEMBL4761175	=	Inhibition	%	26.0	CHEMBL262	Homo sapiens	INH	%	26.0
	22922076	CHEMBL4736840	Inhibition of recombinant human GSK-3beta at 50 uM using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay relative to control	B	CSc1cccc(NC(=O)NC2C[C@@H]3CCCN2CC3CN(C)c2ccccc2)c1		CHEMBL4782972	=	Inhibition	%	1.0	CHEMBL262	Homo sapiens	INH	%	1.0
	22922077	CHEMBL4736840	Inhibition of recombinant human GSK-3beta at 50 uM using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay relative to control	B	COC(=O)c1ccc2c(c1)nc1n2[C@@H](CNC(=O)Nc2ccccc2)COC1		CHEMBL4750704	=	Inhibition	%	1.0	CHEMBL262	Homo sapiens	INH	%	1.0
	22922078	CHEMBL4736840	Inhibition of recombinant human GSK-3beta at 50 uM using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay relative to control	B	CSCC(=O)N1C[C@@H](NC(=O)Nc2cccc(SC)c2)C[C@H]1C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(N)=O		CHEMBL4745537	=	Inhibition	%	5.0	CHEMBL262	Homo sapiens	INH	%	5.0
	22922079	CHEMBL4736840	Inhibition of recombinant human GSK-3beta at 50 uM using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay relative to control	B	Cn1cccc1C(=O)N1C[C@H](NC(=O)Nc2ccc(F)cc2F)C[C@@H]1C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(N)=O		CHEMBL4780360	=	Inhibition	%	6.0	CHEMBL262	Homo sapiens	INH	%	6.0
	22922080	CHEMBL4736840	Inhibition of recombinant human GSK-3beta at 50 uM using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay relative to control	B	CC(C)=CC(=O)N1CC(NC(=O)Nc2ccc(F)cc2F)CC1C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(N)=O		CHEMBL4753110	=	Inhibition	%	5.0	CHEMBL262	Homo sapiens	INH	%	5.0
	22922081	CHEMBL4736840	Inhibition of recombinant human GSK-3beta at 50 uM using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay relative to control	B	COc1ccc2nc(CO[C@H]3CN(Cc4ccnc5ccccc45)C[C@H]3F)[nH]c2c1		CHEMBL4749336	=	Inhibition	%	13.0	CHEMBL262	Homo sapiens	INH	%	13.0
	22922082	CHEMBL4736840	Inhibition of recombinant human GSK-3beta at 50 uM using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay relative to control	B	Cn1c(CO[C@H]2CN(Cc3c[nH]c4ccccc34)C[C@H]2F)nc2ccccc21		CHEMBL4777246	=	Inhibition	%	14.0	CHEMBL262	Homo sapiens	INH	%	14.0
	22922083	CHEMBL4736840	Inhibition of recombinant human GSK-3beta at 50 uM using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay relative to control	B	Cc1cc2nc(CO[C@H]3CN(Cc4cccnc4)C[C@H]3F)[nH]c2cc1C		CHEMBL4764080	=	Inhibition	%	5.0	CHEMBL262	Homo sapiens	INH	%	5.0
	22922084	CHEMBL4736840	Inhibition of recombinant human GSK-3beta at 50 uM using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay relative to control	B	CC(=O)Nc1ccc(CN2C[C@H](OCc3nc4cc(C)c(C)cc4[nH]3)[C@H](F)C2)cc1		CHEMBL4787122	=	Inhibition	%	2.0	CHEMBL262	Homo sapiens	INH	%	2.0
	22922085	CHEMBL4736840	Inhibition of recombinant human GSK-3beta at 50 uM using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay relative to control	B	N#Cc1ccc(CN2C[C@H](OCc3nc4cc(C(F)(F)F)ccc4[nH]3)[C@H](F)C2)cc1		CHEMBL4781720	=	Inhibition	%	2.0	CHEMBL262	Homo sapiens	INH	%	2.0
	22922086	CHEMBL4736840	Inhibition of recombinant human GSK-3beta at 50 uM using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay relative to control	B	CS(=O)(=O)c1ccc(CN2C[C@H](OCc3nc4cc(C(F)(F)F)ccc4[nH]3)[C@H](F)C2)cc1		CHEMBL4780303	=	Inhibition	%	19.0	CHEMBL262	Homo sapiens	INH	%	19.0
	22922087	CHEMBL4736840	Inhibition of recombinant human GSK-3beta at 50 uM using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay relative to control	B	O=C(c1ccncc1)N1C[C@H](OCc2nc3ccc(F)cc3[nH]2)[C@H](F)C1		CHEMBL4764234	=	Inhibition	%	19.0	CHEMBL262	Homo sapiens	INH	%	19.0
	22922088	CHEMBL4736840	Inhibition of recombinant human GSK-3beta at 50 uM using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay relative to control	B	O=C(c1ccccc1)N1C[C@H](OCc2nc3cc(C(F)(F)F)ccc3[nH]2)[C@H](F)C1		CHEMBL4780185	=	Inhibition	%	7.0	CHEMBL262	Homo sapiens	INH	%	7.0
	22922089	CHEMBL4736840	Inhibition of recombinant human GSK-3beta at 50 uM using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay relative to control	B	COc1ccc(C(=O)N2C[C@H](OCc3nc4cc(C(F)(F)F)ccc4[nH]3)[C@H](F)C2)cc1		CHEMBL4741666	=	Inhibition	%	33.0	CHEMBL262	Homo sapiens	INH	%	33.0
	22922090	CHEMBL4736840	Inhibition of recombinant human GSK-3beta at 50 uM using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay relative to control	B	O=C(c1cccnc1)N1C[C@H](OCc2nc3cc(C(F)(F)F)ccc3[nH]2)[C@H](F)C1		CHEMBL4744645	=	Inhibition	%	14.0	CHEMBL262	Homo sapiens	INH	%	14.0
	22922091	CHEMBL4736840	Inhibition of recombinant human GSK-3beta at 50 uM using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay relative to control	B	O=C(Nc1cccc2ccccc12)N[C@H]1CO[C@@H]2[C@H](OC(=O)Nc3ccccc3)CO[C@H]12		CHEMBL4791130	=	Inhibition	%	21.0	CHEMBL262	Homo sapiens	INH	%	21.0
	22922092	CHEMBL4736840	Inhibition of recombinant human GSK-3beta at 50 uM using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay relative to control	B	O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CO[C@@H]2[C@H](OC(=O)Nc3cccc4ccccc34)CO[C@H]12		CHEMBL4741367	=	Inhibition	%	35.0	CHEMBL262	Homo sapiens	INH	%	35.0
	22922093	CHEMBL4736840	Inhibition of recombinant human GSK-3beta at 50 uM using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay relative to control	B	COC(=O)c1cccc(NC(=S)N[C@H]2CO[C@@H]3[C@H](OC(=O)Nc4cccc(C(F)(F)F)c4)CO[C@H]23)c1		CHEMBL4791344	=	Inhibition	%	21.0	CHEMBL262	Homo sapiens	INH	%	21.0
	22922094	CHEMBL4736840	Inhibition of recombinant human GSK-3beta at 50 uM using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay relative to control	B	O=C(Nc1cccc(C(F)(F)F)c1)O[C@@H]1CO[C@@H]2[C@@H](NC(=S)Nc3ccc(Cl)cc3)CO[C@H]12		CHEMBL4758361	=	Inhibition	%	41.0	CHEMBL262	Homo sapiens	INH	%	41.0
	22922095	CHEMBL4736840	Inhibition of recombinant human GSK-3beta at 50 uM using phosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by kinase-glo luminescence assay relative to control	B	O=C(Nc1cccc2ccccc12)O[C@@H]1CO[C@@H]2[C@@H](NC(=S)Nc3ccc(Cl)cc3)CO[C@H]12		CHEMBL4778874	=	Inhibition	%	49.0	CHEMBL262	Homo sapiens	INH	%	49.0
	22922096	CHEMBL4736841	Inhibition of human GSK-3beta using Ser/Thr 6 peptide as substrate preincubated for 60 mins followed by ATP and substrate addition and measured after 45 mins by Z'lyte assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	8300.0	CHEMBL262	Homo sapiens	IC50	uM	8.3
	22922097	CHEMBL4736841	Inhibition of human GSK-3beta using Ser/Thr 6 peptide as substrate preincubated for 60 mins followed by ATP and substrate addition and measured after 45 mins by Z'lyte assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(F)(F)F)c(Cl)cc3OCCCC(=O)O)cc2)ccn1		CHEMBL4761851	=	IC50	nM	860.0	CHEMBL262	Homo sapiens	IC50	uM	0.86
	22922098	CHEMBL4736841	Inhibition of human GSK-3beta using Ser/Thr 6 peptide as substrate preincubated for 60 mins followed by ATP and substrate addition and measured after 45 mins by Z'lyte assay	B	O=C(O)CCCNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL4747475	=	IC50	nM	3300.0	CHEMBL262	Homo sapiens	IC50	uM	3.3
	22922099	CHEMBL4736841	Inhibition of human GSK-3beta using Ser/Thr 6 peptide as substrate preincubated for 60 mins followed by ATP and substrate addition and measured after 45 mins by Z'lyte assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	IC50	nM	37000.0	CHEMBL262	Homo sapiens	IC50	uM	37.0
	22922100	CHEMBL4736841	Inhibition of human GSK-3beta using Ser/Thr 6 peptide as substrate preincubated for 60 mins followed by ATP and substrate addition and measured after 45 mins by Z'lyte assay	B	CCOC(=O)Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL4748737	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	22922101	CHEMBL4736841	Inhibition of human GSK-3beta using Ser/Thr 6 peptide as substrate preincubated for 60 mins followed by ATP and substrate addition and measured after 45 mins by Z'lyte assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)n(-c2cccc(N)c2)n1		CHEMBL344800	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	22922102	CHEMBL4736841	Inhibition of human GSK-3beta using Ser/Thr 6 peptide as substrate preincubated for 60 mins followed by ATP and substrate addition and measured after 45 mins by Z'lyte assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)cc2)cc1		CHEMBL101035	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	22922103	CHEMBL4736841	Inhibition of human GSK-3beta using Ser/Thr 6 peptide as substrate preincubated for 60 mins followed by ATP and substrate addition and measured after 45 mins by Z'lyte assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Cl)cc2)n(-c2cccc(N)c2)n1		CHEMBL498947	>	IC50	nM	50000.0	CHEMBL262	Homo sapiens	IC50	uM	50.0
	22926816	CHEMBL4737724	Inhibition of human GSKbeta H350L mutant (2 to 3nd residues) at 1 uM using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	O=C1NCCC12CCN(c1c(Cl)cncc1-c1cc3ccccc3o1)CC2		CHEMBL4777349	>	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	22926817	CHEMBL4737724	Inhibition of human GSKbeta H350L mutant (2 to 3nd residues) at 1 uM using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	O=C1NCCC12CCN(c1c(Cl)cncc1-c1cc3ccccc3s1)CC2		CHEMBL4791586	>	Inhibition	%	50.0	CHEMBL262	Homo sapiens	INH	%	50.0
	22926823	CHEMBL4737727	Inhibition of human GSKbeta H350L mutant (2 to 3nd residues) using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method	B	Cn1cc(-c2ccc(-c3cncc(Cl)c3N3CCC4(CCNC4=O)CC3)cc2)cn1		CHEMBL3408213	=	Ki	nM	345.0	CHEMBL262	Homo sapiens	Ki	uM	0.345
	22926824	CHEMBL4737727	Inhibition of human GSKbeta H350L mutant (2 to 3nd residues) using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method	B	O=C1NCCC12CCN(c1c(Cl)cncc1-c1cc3ccccc3o1)CC2		CHEMBL4777349	=	Ki	nM	18.0	CHEMBL262	Homo sapiens	Ki	uM	0.018000000000000002
	22926825	CHEMBL4737727	Inhibition of human GSKbeta H350L mutant (2 to 3nd residues) using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method	B	O=C1NCCC12CCN(c1c(Cl)cncc1-c1cc3ccccc3s1)CC2		CHEMBL4791586	=	Ki	nM	4.0	CHEMBL262	Homo sapiens	Ki	uM	0.004
Not Active	22936042	CHEMBL4739739	Inhibition of human GSK3beta at 1 uM using substrate peptide by off-chip mobility shift assay	B	CC(=O)c1ccc(C(N)=O)cc1Oc1ccc(OCCOC2CCOCC2)cc1		CHEMBL4749965		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	22949144	CHEMBL4765751	Inhibition of human GSK3-beta assessed as residual activity at 0.1 uM relative to control	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(OC)cc13)C(=O)N2		CHEMBL104519	=	Activity	%	90.0	CHEMBL262	Homo sapiens	Activity	%	90.0
	22949145	CHEMBL4765751	Inhibition of human GSK3-beta assessed as residual activity at 0.1 uM relative to control	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(O)cc13)C(=O)N2		CHEMBL4798255	=	Activity	%	99.0	CHEMBL262	Homo sapiens	Activity	%	99.0
	22949146	CHEMBL4765751	Inhibition of human GSK3-beta assessed as residual activity at 0.1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(=O)(=O)N(C)C)cc31)cn2C		CHEMBL322153	=	Activity	%	98.0	CHEMBL262	Homo sapiens	Activity	%	98.0
	22949147	CHEMBL4765751	Inhibition of human GSK3-beta assessed as residual activity at 0.1 uM relative to control	B	COc1ccc2[nH]cc(/C=C3\C(=O)Nc4ccc(S(N)(=O)=O)cc43)c2c1		CHEMBL106226	=	Activity	%	103.0	CHEMBL262	Homo sapiens	Activity	%	103.0
	22949148	CHEMBL4765751	Inhibition of human GSK3-beta assessed as residual activity at 0.1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(N)(=O)=O)cc31)cn2C		CHEMBL104333	=	Activity	%	93.0	CHEMBL262	Homo sapiens	Activity	%	93.0
	22949149	CHEMBL4765751	Inhibition of human GSK3-beta assessed as residual activity at 0.1 uM relative to control	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Activity	%	104.0	CHEMBL262	Homo sapiens	Activity	%	104.0
	22949150	CHEMBL4765752	Inhibition of human GSK3-beta assessed as residual activity at 1 uM relative to control	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(OC)cc13)C(=O)N2		CHEMBL104519	=	Activity	%	90.0	CHEMBL262	Homo sapiens	Activity	%	90.0
	22949151	CHEMBL4765752	Inhibition of human GSK3-beta assessed as residual activity at 1 uM relative to control	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(O)cc13)C(=O)N2		CHEMBL4798255	=	Activity	%	92.0	CHEMBL262	Homo sapiens	Activity	%	92.0
	22949152	CHEMBL4765752	Inhibition of human GSK3-beta assessed as residual activity at 1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(=O)(=O)N(C)C)cc31)cn2C		CHEMBL322153	=	Activity	%	97.0	CHEMBL262	Homo sapiens	Activity	%	97.0
	22949153	CHEMBL4765752	Inhibition of human GSK3-beta assessed as residual activity at 1 uM relative to control	B	COc1ccc2[nH]cc(/C=C3\C(=O)Nc4ccc(S(N)(=O)=O)cc43)c2c1		CHEMBL106226	=	Activity	%	79.0	CHEMBL262	Homo sapiens	Activity	%	79.0
	22949154	CHEMBL4765752	Inhibition of human GSK3-beta assessed as residual activity at 1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(N)(=O)=O)cc31)cn2C		CHEMBL104333	=	Activity	%	83.0	CHEMBL262	Homo sapiens	Activity	%	83.0
	22949155	CHEMBL4765752	Inhibition of human GSK3-beta assessed as residual activity at 1 uM relative to control	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Activity	%	92.0	CHEMBL262	Homo sapiens	Activity	%	92.0
	22952857	CHEMBL4766794	Inhibition of human GSK-3beta (2 to end residues) assessed as residual activity at 10 uM using phospho GS2 peptide as substrate after 40 mins by [gamma-33ATP] radiometric assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	112.0	CHEMBL262	Homo sapiens	Activity	%	112.0
	22967826	CHEMBL4769987	Inhibition of human GSK3beta assessed as residual activity at 10 uM in presence of ATP by ADP-glo luminescent assay relative to control	B	CN1CC=C(c2c(O)cc(O)c3c(=O)cc(-c4ccc(Sc5nc6ccccc6[nH]5)cc4)oc23)CC1		CHEMBL4790926	=	Activity	%	-8.0	CHEMBL262	Homo sapiens	Activity	%	-8.0
	22967827	CHEMBL4769987	Inhibition of human GSK3beta assessed as residual activity at 10 uM in presence of ATP by ADP-glo luminescent assay relative to control	B	CN1CC=C(c2c(O)cc(O)c3c(=O)cc(-c4ccc(Sc5nc(-c6ccccc6)c[nH]5)cc4)oc23)CC1		CHEMBL4787876	=	Activity	%	6.0	CHEMBL262	Homo sapiens	Activity	%	6.0
	22967828	CHEMBL4769987	Inhibition of human GSK3beta assessed as residual activity at 10 uM in presence of ATP by ADP-glo luminescent assay relative to control	B	CN1CC=C(c2c(O)cc(O)c3c(=O)cc(-c4ccc(Sc5nc6ccccc6n5C)cc4)oc23)CC1		CHEMBL4781618	=	Activity	%	-3.0	CHEMBL262	Homo sapiens	Activity	%	-3.0
	22967829	CHEMBL4769987	Inhibition of human GSK3beta assessed as residual activity at 10 uM in presence of ATP by ADP-glo luminescent assay relative to control	B	CN1CC=C(c2c(O)cc(O)c3c(=O)cc(-c4ccc(Sc5nc6ccccc6[nH]5)cc4Cl)oc23)CC1		CHEMBL4793858	=	Activity	%	4.0	CHEMBL262	Homo sapiens	Activity	%	4.0
	22967830	CHEMBL4769987	Inhibition of human GSK3beta assessed as residual activity at 10 uM in presence of ATP by ADP-glo luminescent assay relative to control	B	CN1CC=C(c2c(O)cc(O)c3c(=O)cc(-c4ccc(Sc5nc6ccccc6n5C)cc4Cl)oc23)CC1		CHEMBL4788045	=	Activity	%	2.0	CHEMBL262	Homo sapiens	Activity	%	2.0
	22967831	CHEMBL4769987	Inhibition of human GSK3beta assessed as residual activity at 10 uM in presence of ATP by ADP-glo luminescent assay relative to control	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Activity	%	10.0	CHEMBL262	Homo sapiens	Activity	%	10.0
	22967832	CHEMBL4769988	Inhibition of human GSK3beta assessed as residual activity at 1 uM in presence of ATP by ADP-glo luminescent assay relative to control	B	CN1CC=C(c2c(O)cc(O)c3c(=O)cc(-c4ccc(Sc5nc6ccccc6[nH]5)cc4)oc23)CC1		CHEMBL4790926	=	Activity	%	6.0	CHEMBL262	Homo sapiens	Activity	%	6.0
	22967833	CHEMBL4769988	Inhibition of human GSK3beta assessed as residual activity at 1 uM in presence of ATP by ADP-glo luminescent assay relative to control	B	CN1CC=C(c2c(O)cc(O)c3c(=O)cc(-c4ccc(Sc5nc(-c6ccccc6)c[nH]5)cc4)oc23)CC1		CHEMBL4787876	=	Activity	%	25.0	CHEMBL262	Homo sapiens	Activity	%	25.0
	22967834	CHEMBL4769988	Inhibition of human GSK3beta assessed as residual activity at 1 uM in presence of ATP by ADP-glo luminescent assay relative to control	B	CN1CC=C(c2c(O)cc(O)c3c(=O)cc(-c4ccc(Sc5nc6ccccc6n5C)cc4)oc23)CC1		CHEMBL4781618	=	Activity	%	31.0	CHEMBL262	Homo sapiens	Activity	%	31.0
	22967835	CHEMBL4769988	Inhibition of human GSK3beta assessed as residual activity at 1 uM in presence of ATP by ADP-glo luminescent assay relative to control	B	CN1CC=C(c2c(O)cc(O)c3c(=O)cc(-c4ccc(Sc5nc6ccccc6[nH]5)cc4Cl)oc23)CC1		CHEMBL4793858	=	Activity	%	14.0	CHEMBL262	Homo sapiens	Activity	%	14.0
	22967836	CHEMBL4769988	Inhibition of human GSK3beta assessed as residual activity at 1 uM in presence of ATP by ADP-glo luminescent assay relative to control	B	CN1CC=C(c2c(O)cc(O)c3c(=O)cc(-c4ccc(Sc5nc6ccccc6n5C)cc4Cl)oc23)CC1		CHEMBL4788045	=	Activity	%	12.0	CHEMBL262	Homo sapiens	Activity	%	12.0
	22967837	CHEMBL4769988	Inhibition of human GSK3beta assessed as residual activity at 1 uM in presence of ATP by ADP-glo luminescent assay relative to control	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Activity	%	50.0	CHEMBL262	Homo sapiens	Activity	%	50.0
	22967904	CHEMBL4770000	Inhibition of human GSK3beta in presence of ATP by ADP-glo luminescent assay	B	CN1CC=C(c2c(O)cc(O)c3c(=O)cc(-c4ccc(Sc5nc6ccccc6[nH]5)cc4)oc23)CC1		CHEMBL4790926	=	IC50	nM	117.0	CHEMBL262	Homo sapiens	IC50	uM	0.11699999999999999
	22967905	CHEMBL4770000	Inhibition of human GSK3beta in presence of ATP by ADP-glo luminescent assay	B	CN1CC=C(c2c(O)cc(O)c3c(=O)cc(-c4ccc(Sc5nc(-c6ccccc6)c[nH]5)cc4)oc23)CC1		CHEMBL4787876	=	IC50	nM	356.0	CHEMBL262	Homo sapiens	IC50	uM	0.35600000000000004
	22967906	CHEMBL4770000	Inhibition of human GSK3beta in presence of ATP by ADP-glo luminescent assay	B	CN1CC=C(c2c(O)cc(O)c3c(=O)cc(-c4ccc(Sc5nc6ccccc6n5C)cc4)oc23)CC1		CHEMBL4781618	=	IC50	nM	160.0	CHEMBL262	Homo sapiens	IC50	uM	0.16
	22967907	CHEMBL4770000	Inhibition of human GSK3beta in presence of ATP by ADP-glo luminescent assay	B	CN1CC=C(c2c(O)cc(O)c3c(=O)cc(-c4ccc(Sc5nc6ccccc6[nH]5)cc4Cl)oc23)CC1		CHEMBL4793858	=	IC50	nM	216.0	CHEMBL262	Homo sapiens	IC50	uM	0.21600000000000003
	22967908	CHEMBL4770000	Inhibition of human GSK3beta in presence of ATP by ADP-glo luminescent assay	B	CN1CC=C(c2c(O)cc(O)c3c(=O)cc(-c4ccc(Sc5nc6ccccc6n5C)cc4Cl)oc23)CC1		CHEMBL4788045	=	IC50	nM	59.0	CHEMBL262	Homo sapiens	IC50	uM	0.059000000000000004
	22967909	CHEMBL4770000	Inhibition of human GSK3beta in presence of ATP by ADP-glo luminescent assay	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	IC50	nM	1184.0	CHEMBL262	Homo sapiens	IC50	uM	1.1840000000000002
Active	22967910	CHEMBL4770001	ATP competitive inhibition of human GSK3beta at 500 nM in presence of ATP by ADP-glo luminescent assay	B	CN1CC=C(c2c(O)cc(O)c3c(=O)cc(-c4ccc(Sc5nc6ccccc6n5C)cc4Cl)oc23)CC1		CHEMBL4788045		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	22967933	CHEMBL4770024	Potency index, ratio of flavopiridol IC50 to test compound IC50 for human GSK3beta in presence of ATP by ADP-glo luminescent assay	B	CN1CC=C(c2c(O)cc(O)c3c(=O)cc(-c4ccc(Sc5nc6ccccc6n5C)cc4Cl)oc23)CC1		CHEMBL4788045	=	Ratio IC50		20.0	CHEMBL262	Homo sapiens	Ratio IC50		20.0
	23120431	CHEMBL4804388	Inhibition of GSK3B in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	IC50	nM	88400.0	CHEMBL262	Homo sapiens	IC50	uM	88.4
	23120432	CHEMBL4804388	Inhibition of GSK3B in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	IC50	nM	96400.0	CHEMBL262	Homo sapiens	IC50	uM	96.4
	23120433	CHEMBL4804388	Inhibition of GSK3B in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	IC50	nM	90400.0	CHEMBL262	Homo sapiens	IC50	uM	90.4
	23120434	CHEMBL4804388	Inhibition of GSK3B in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	IC50	nM	90200.0	CHEMBL262	Homo sapiens	IC50	uM	90.2
	23120435	CHEMBL4804388	Inhibition of GSK3B in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	IC50	nM	90000.0	CHEMBL262	Homo sapiens	IC50	uM	90.0
	23120436	CHEMBL4804388	Inhibition of GSK3B in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	IC50	nM	97200.0	CHEMBL262	Homo sapiens	IC50	uM	97.2
	23121470	CHEMBL4804570	Inhibition of GSK3B in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	Inhibition	%	75.0	CHEMBL262	Homo sapiens	INH	%	75.0
	23121471	CHEMBL4804570	Inhibition of GSK3B in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	>	Inhibition	%	90.0	CHEMBL262	Homo sapiens	INH	%	90.0
	23121472	CHEMBL4804570	Inhibition of GSK3B in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	>	Inhibition	%	90.0	CHEMBL262	Homo sapiens	INH	%	90.0
	23121473	CHEMBL4804570	Inhibition of GSK3B in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	>	Inhibition	%	90.0	CHEMBL262	Homo sapiens	INH	%	90.0
	23121474	CHEMBL4804570	Inhibition of GSK3B in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	>	Inhibition	%	90.0	CHEMBL262	Homo sapiens	INH	%	90.0
	23121475	CHEMBL4804570	Inhibition of GSK3B in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	>	Inhibition	%	90.0	CHEMBL262	Homo sapiens	INH	%	90.0
	23122600	CHEMBL4804951	Inhibition of human GSK3B assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	67.0	CHEMBL262	Homo sapiens	Activity	%	67.0
	23123295	CHEMBL4805539	Inhibition of human GSK3B assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	72.0	CHEMBL262	Homo sapiens	Activity	%	72.0
	23123602	CHEMBL4805846	Inhibition of DNA-tagged human GSK3B assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	90.0	CHEMBL262	Homo sapiens	Activity	%	90.0
	23124207	CHEMBL4806306	Inhibition of GSK3b (unknown origin)	B	Cn1cc(-n2cnc3c(NCc4nc5cc(Cl)c(Cl)cc5[nH]4)nc(N4CCOCC4)nc32)cn1		CHEMBL4877117	=	IC50	nM	810.0	CHEMBL262	Homo sapiens	IC50	nM	810.0
	23124261	CHEMBL4806334	Inhibition of GSK3b (unknown origin) at 10 uM relative to control	B	Cn1cc(-n2cnc3c(NCc4nc5cc(Cl)c(Cl)cc5[nH]4)nc(N4CCOCC4)nc32)cn1		CHEMBL4877117	=	Inhibition	%	89.0	CHEMBL262	Homo sapiens	INH	%	89.0
	23124680	CHEMBL4806556	Inhibition of human GSK3B assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	79.0	CHEMBL262	Homo sapiens	Activity	%	79.0
	23124681	CHEMBL4806556	Inhibition of human GSK3B assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	77.0	CHEMBL262	Homo sapiens	Activity	%	77.0
	23128152	CHEMBL4807859	Inhibition of GSK3beta (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL262	Homo sapiens	Activity	%	75.0
	23128153	CHEMBL4807859	Inhibition of GSK3beta (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL262	Homo sapiens	Activity	%	75.0
	23128154	CHEMBL4807859	Inhibition of GSK3beta (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL262	Homo sapiens	Activity	%	75.0
Dose-Dependent Effect	23144325	CHEMBL4808963	Inhibition of GSK3beta phosphorylation at serine 9 in human HCT-116 cells after 24 hrs by Western blot analysis	B	O=C(NCCO)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL4860630		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	23152066	CHEMBL4810640	Inhibition of wild-type human full length GSK3B (M1 to T433 residues) expressed in mammalian expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	CN(C)c1nccc(-c2cnn3ncccc23)n1		CHEMBL4848254	=	Activity	%	94.0	CHEMBL262	Homo sapiens	Activity	%	94.0
	23152067	CHEMBL4810640	Inhibition of wild-type human full length GSK3B (M1 to T433 residues) expressed in mammalian expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	CN(c1nccc(-c2cnn3ncccc23)n1)C1CC1		CHEMBL4848696	=	Activity	%	91.0	CHEMBL262	Homo sapiens	Activity	%	91.0
	23152068	CHEMBL4810640	Inhibition of wild-type human full length GSK3B (M1 to T433 residues) expressed in mammalian expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	c1cnn2ncc(-c3ccnc(N4CCC45COC5)n3)c2c1		CHEMBL4845809	=	Activity	%	75.0	CHEMBL262	Homo sapiens	Activity	%	75.0
	23152069	CHEMBL4810640	Inhibition of wild-type human full length GSK3B (M1 to T433 residues) expressed in mammalian expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	CC1CCCN1c1nccc(-c2cnn3ncccc23)n1		CHEMBL4859912	=	Activity	%	92.0	CHEMBL262	Homo sapiens	Activity	%	92.0
	23152070	CHEMBL4810640	Inhibition of wild-type human full length GSK3B (M1 to T433 residues) expressed in mammalian expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	C[C@H]1CCN(c2nccc(-c3cnn4ncccc34)n2)C1		CHEMBL4853444	=	Activity	%	77.0	CHEMBL262	Homo sapiens	Activity	%	77.0
	23152071	CHEMBL4810640	Inhibition of wild-type human full length GSK3B (M1 to T433 residues) expressed in mammalian expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	C[C@@H]1CCN(c2nccc(-c3cnn4ncccc34)n2)C1		CHEMBL4870121	=	Activity	%	100.0	CHEMBL262	Homo sapiens	Activity	%	100.0
	23152072	CHEMBL4810640	Inhibition of wild-type human full length GSK3B (M1 to T433 residues) expressed in mammalian expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	F[C@@H]1CCN(c2nccc(-c3cnn4ncccc34)n2)C1		CHEMBL4852944	=	Activity	%	98.0	CHEMBL262	Homo sapiens	Activity	%	98.0
	23152073	CHEMBL4810640	Inhibition of wild-type human full length GSK3B (M1 to T433 residues) expressed in mammalian expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	N[C@H]1CCN(c2nccc(-c3cnn4ncccc34)n2)C1		CHEMBL4877372	=	Activity	%	100.0	CHEMBL262	Homo sapiens	Activity	%	100.0
	23152074	CHEMBL4810640	Inhibition of wild-type human full length GSK3B (M1 to T433 residues) expressed in mammalian expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	N[C@@H]1CCN(c2nccc(-c3cnn4ncccc34)n2)C1		CHEMBL4876980	=	Activity	%	100.0	CHEMBL262	Homo sapiens	Activity	%	100.0
	23152075	CHEMBL4810640	Inhibition of wild-type human full length GSK3B (M1 to T433 residues) expressed in mammalian expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	Cc1cnn2ncc(-c3ccnc(N(C)C)n3)c2c1		CHEMBL4851717	=	Activity	%	100.0	CHEMBL262	Homo sapiens	Activity	%	100.0
	23152076	CHEMBL4810640	Inhibition of wild-type human full length GSK3B (M1 to T433 residues) expressed in mammalian expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	COc1ccnn2ncc(-c3ccnc(N(C)C)n3)c12		CHEMBL4874923	=	Activity	%	100.0	CHEMBL262	Homo sapiens	Activity	%	100.0
	23152077	CHEMBL4810640	Inhibition of wild-type human full length GSK3B (M1 to T433 residues) expressed in mammalian expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	CN(C)c1nccc(-c2cnc3ncccn23)n1		CHEMBL4872408	=	Activity	%	77.0	CHEMBL262	Homo sapiens	Activity	%	77.0
	23152078	CHEMBL4810640	Inhibition of wild-type human full length GSK3B (M1 to T433 residues) expressed in mammalian expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	CN(C)c1ncc(F)c(-c2cnn3ncccc23)n1		CHEMBL4861396	=	Activity	%	93.0	CHEMBL262	Homo sapiens	Activity	%	93.0
	23161093	CHEMBL4812413	Inhibition of GSK3beta (unknown origin) assessed as residual activity at 1 uM relative to control	B	O=C1NCCC12CCN(c1c(Cl)cncc1-c1ccc(-c3ccccc3)s1)CC2		CHEMBL4871899	=	Activity	%	74.0	CHEMBL262	Homo sapiens	Activity	%	74.0
	23161094	CHEMBL4812413	Inhibition of GSK3beta (unknown origin) assessed as residual activity at 1 uM relative to control	B	Nc1ncc(-c2cc3ccccc3o2)c(N2CCC3(CCNC3=O)CC2)c1Cl		CHEMBL4878007	=	Activity	%	61.0	CHEMBL262	Homo sapiens	Activity	%	61.0
Tde	23213374	CHEMBL4822931	Inhibition of human GSK-3beta assessed as decrease in relative fluorescence unit measured upto 60 mins by kinase-profiling analysis	B	OC1(c2ccccc2)CSC(=S)N1Cc1ccncc1		CHEMBL4861930		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	23213375	CHEMBL4822932	Reversible inhibition of recombinant human GSK-3beta at 70 uM preincubated for 3 hrs followed by diluted with substrate and ATP master mix solution measured upto 1.5 hrs by jump dilution assays	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	23213376	CHEMBL4822932	Reversible inhibition of recombinant human GSK-3beta at 70 uM preincubated for 3 hrs followed by diluted with substrate and ATP master mix solution measured upto 1.5 hrs by jump dilution assays	B	COc1cc(O)c2c(c1)[C@H]1O[C@@H]1C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL471474		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	23213377	CHEMBL4822933	Reversible inhibition of recombinant human GSK-3beta at 20 uM preincubated for 3 hrs followed by diluted with substrate and ATP master mix solution measured upto 1.5 hrs by jump dilution assays	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	23213378	CHEMBL4822933	Reversible inhibition of recombinant human GSK-3beta at 20 uM preincubated for 3 hrs followed by diluted with substrate and ATP master mix solution measured upto 1.5 hrs by jump dilution assays	B	COc1cc(O)c2c(c1)[C@H]1O[C@@H]1C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL471474		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	23213379	CHEMBL4822934	Reversible inhibition of recombinant human GSK-3beta at 400 nM preincubated for 3 hrs followed by diluted with substrate and ATP master mix solution measured upto 1.5 hrs by jump dilution assays	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Tde	23213380	CHEMBL4822935	Reversible inhibition of recombinant human GSK-3beta at 10 uM preincubated for 3 hrs followed by diluted with substrate and ATP master mix solution measured upto 1.5 hrs by jump dilution assays	B	OC1(c2ccccc2)CSC(=S)N1Cc1ccncc1		CHEMBL4861930		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	23213381	CHEMBL4822936	Reversible inhibition of recombinant human GSK-3beta at 10 uM preincubated for 3 hrs followed by diluted with substrate and ATP master mix solution measured first 30 mins by jump dilution assays	B	OC1(c2ccccc2)CSC(=S)N1Cc1ccncc1		CHEMBL4861930		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	23213382	CHEMBL4822937	Reversible inhibition of recombinant human GSK-3beta at 70 uM preincubated for 3 hrs followed by diluted with substrate and ATP master mix solution measured upto 1.5 hrs by jump dilution assays relative to control	B	OC1(c2ccccc2)CSC(=S)N1Cc1ccncc1		CHEMBL4861930		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	23213383	CHEMBL4822938	Reversible inhibition of recombinant human GSK-3beta at 700 nM incubated with substrate and ATP master mix solution by jump dilution assays	B	OC1(c2ccccc2)CSC(=S)N1Cc1ccncc1		CHEMBL4861930		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	23213384	CHEMBL4822938	Reversible inhibition of recombinant human GSK-3beta at 700 nM incubated with substrate and ATP master mix solution by jump dilution assays	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	23213385	CHEMBL4822938	Reversible inhibition of recombinant human GSK-3beta at 700 nM incubated with substrate and ATP master mix solution by jump dilution assays	B	COc1cc(O)c2c(c1)[C@H]1O[C@@H]1C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL471474		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	23213386	CHEMBL4822939	Reversible inhibition of recombinant human GSK-3beta at 200 nM incubated with substrate and ATP master mix solution by jump dilution assays	B	OC1(c2ccccc2)CSC(=S)N1Cc1ccncc1		CHEMBL4861930		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	23213387	CHEMBL4822939	Reversible inhibition of recombinant human GSK-3beta at 200 nM incubated with substrate and ATP master mix solution by jump dilution assays	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	23213388	CHEMBL4822939	Reversible inhibition of recombinant human GSK-3beta at 200 nM incubated with substrate and ATP master mix solution by jump dilution assays	B	COc1cc(O)c2c(c1)[C@H]1O[C@@H]1C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL471474		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	23213389	CHEMBL4822940	Reversible inhibition of recombinant human GSK-3beta at 100 nM incubated with substrate and ATP master mix solution by jump dilution assays	B	OC1(c2ccccc2)CSC(=S)N1Cc1ccncc1		CHEMBL4861930		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	23213390	CHEMBL4822940	Reversible inhibition of recombinant human GSK-3beta at 100 nM incubated with substrate and ATP master mix solution by jump dilution assays	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	23213391	CHEMBL4822940	Reversible inhibition of recombinant human GSK-3beta at 100 nM incubated with substrate and ATP master mix solution by jump dilution assays	B	COc1cc(O)c2c(c1)[C@H]1O[C@@H]1C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL471474		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	23213392	CHEMBL4822941	Inhibition of human GSK-3beta incubated with substrate in presence of ATP measured by serial dilution assay	B	OC1(c2ccccc2)CSC(=S)N1Cc1ccncc1		CHEMBL4861930	=	IC50	nM	370.0	CHEMBL262	Homo sapiens	IC50	nM	370.0
	23213393	CHEMBL4822941	Inhibition of human GSK-3beta incubated with substrate in presence of ATP measured by serial dilution assay	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	=	IC50	nM	1780.0	CHEMBL262	Homo sapiens	IC50	nM	1780.0
	23213394	CHEMBL4822941	Inhibition of human GSK-3beta incubated with substrate in presence of ATP measured by serial dilution assay	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	IC50	nM	6.5	CHEMBL262	Homo sapiens	IC50	nM	6.5
	23213395	CHEMBL4822941	Inhibition of human GSK-3beta incubated with substrate in presence of ATP measured by serial dilution assay	B	COc1cc(O)c2c(c1)[C@H]1O[C@@H]1C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL471474	=	IC50	nM	11300.0	CHEMBL262	Homo sapiens	IC50	nM	11300.0
	23213396	CHEMBL4822942	Inhibition of human GSK-3beta preincubated for 3 hrs followed by ATP and substrate addition measured by serial dilution assay	B	OC1(c2ccccc2)CSC(=S)N1Cc1ccncc1		CHEMBL4861930	=	IC50	nM	102.0	CHEMBL262	Homo sapiens	IC50	nM	102.0
	23213397	CHEMBL4822942	Inhibition of human GSK-3beta preincubated for 3 hrs followed by ATP and substrate addition measured by serial dilution assay	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	=	IC50	nM	139.0	CHEMBL262	Homo sapiens	IC50	nM	139.0
	23213398	CHEMBL4822942	Inhibition of human GSK-3beta preincubated for 3 hrs followed by ATP and substrate addition measured by serial dilution assay	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	IC50	nM	7.9	CHEMBL262	Homo sapiens	IC50	nM	7.9
	23213399	CHEMBL4822942	Inhibition of human GSK-3beta preincubated for 3 hrs followed by ATP and substrate addition measured by serial dilution assay	B	COc1cc(O)c2c(c1)[C@H]1O[C@@H]1C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL471474	=	IC50	nM	663.0	CHEMBL262	Homo sapiens	IC50	nM	663.0
Not Active	23213400	CHEMBL4822943	Inhibition of human GSK-3beta at 10 uM in presence of 2 mM DTT by kinase-profiling analysis	B	OC1(c2ccccc2)CSC(=S)N1Cc1ccncc1		CHEMBL4861930		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	23213401	CHEMBL4822943	Inhibition of human GSK-3beta at 10 uM in presence of 2 mM DTT by kinase-profiling analysis	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	23213402	CHEMBL4822943	Inhibition of human GSK-3beta at 10 uM in presence of 2 mM DTT by kinase-profiling analysis	B	COc1cc(O)c2c(c1)[C@H]1O[C@@H]1C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL471474		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	23213403	CHEMBL4822943	Inhibition of human GSK-3beta at 10 uM in presence of 2 mM DTT by kinase-profiling analysis	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	23213404	CHEMBL4822944	Inhibition of human GSK-3beta at 10 uM in presence of 2 mM TCEP by kinase-profiling analysis	B	OC1(c2ccccc2)CSC(=S)N1Cc1ccncc1		CHEMBL4861930		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	23213405	CHEMBL4822944	Inhibition of human GSK-3beta at 10 uM in presence of 2 mM TCEP by kinase-profiling analysis	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	23213406	CHEMBL4822944	Inhibition of human GSK-3beta at 10 uM in presence of 2 mM TCEP by kinase-profiling analysis	B	COc1cc(O)c2c(c1)[C@H]1O[C@@H]1C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL471474		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	23213407	CHEMBL4822944	Inhibition of human GSK-3beta at 10 uM in presence of 2 mM TCEP by kinase-profiling analysis	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	23213408	CHEMBL4822945	Inhibition of human GSK-3beta at 10 uM in presence of 2 mM GSH by kinase-profiling analysis	B	OC1(c2ccccc2)CSC(=S)N1Cc1ccncc1		CHEMBL4861930		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	23213409	CHEMBL4822945	Inhibition of human GSK-3beta at 10 uM in presence of 2 mM GSH by kinase-profiling analysis	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Not Active	23213410	CHEMBL4822945	Inhibition of human GSK-3beta at 10 uM in presence of 2 mM GSH by kinase-profiling analysis	B	COc1cc(O)c2c(c1)[C@H]1O[C@@H]1C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL471474		Inhibition	%		CHEMBL262	Homo sapiens	INH		
Active	23213411	CHEMBL4822945	Inhibition of human GSK-3beta at 10 uM in presence of 2 mM GSH by kinase-profiling analysis	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850		Inhibition	%		CHEMBL262	Homo sapiens	INH		
	23213419	CHEMBL4822953	Inhibition of human recombinant GSK3B in presence of ATP by Z-lyte kinase assay	B	OC1(c2ccccc2)CSC(=S)N1Cc1ccncc1		CHEMBL4861930	=	Inhibition	%	89.0	CHEMBL262	Homo sapiens	INH	%	89.0
	23213448	CHEMBL4822982	Inhibition of human GSK-3beta C199A mutant incubated with substrate in presence of ATP measured by serial dilution assay	B	OC1(c2ccccc2)CSC(=S)N1Cc1ccncc1	Outside typical range	CHEMBL4861930	=	IC50	nM	121000.0	CHEMBL262	Homo sapiens	IC50	nM	121000.0
	23218892	CHEMBL4824377	Inhibition of human recombinant full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate at 10 uM by ADP-Glo kinase assay relative to control	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	Inhibition	%	29.0	CHEMBL262	Homo sapiens	INH	%	29.0
	23218893	CHEMBL4824377	Inhibition of human recombinant full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate at 10 uM by ADP-Glo kinase assay relative to control	B	COc1ccc2c(c1)[nH]c1cnc(C)cc12		CHEMBL4859020	=	Inhibition	%	15.3	CHEMBL262	Homo sapiens	INH	%	15.3
	23218894	CHEMBL4824377	Inhibition of human recombinant full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate at 10 uM by ADP-Glo kinase assay relative to control	B	O=C(Nc1cc2c(cn1)[nH]c1cc(F)ccc12)C1CC1		CHEMBL4875836	=	Inhibition	%	47.4	CHEMBL262	Homo sapiens	INH	%	47.4
	23218895	CHEMBL4824377	Inhibition of human recombinant full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate at 10 uM by ADP-Glo kinase assay relative to control	B	O=C(Nc1nccc2c1[nH]c1cc(F)ccc12)C1CC1		CHEMBL4871399	=	Inhibition	%	76.9	CHEMBL262	Homo sapiens	INH	%	76.9
	23218896	CHEMBL4824377	Inhibition of human recombinant full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate at 10 uM by ADP-Glo kinase assay relative to control	B	O=C(Nc1cc2c(cn1)[nH]c1cc(Cl)ccc12)C1CC1		CHEMBL4854983	=	Inhibition	%	39.0	CHEMBL262	Homo sapiens	INH	%	39.0
	23218897	CHEMBL4824377	Inhibition of human recombinant full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate at 10 uM by ADP-Glo kinase assay relative to control	B	O=C(Nc1nccc2c1[nH]c1cc(Cl)ccc12)C1CC1		CHEMBL4854952	=	Inhibition	%	71.6	CHEMBL262	Homo sapiens	INH	%	71.6
	23218898	CHEMBL4824377	Inhibition of human recombinant full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate at 10 uM by ADP-Glo kinase assay relative to control	B	O=C(Nc1cc2c(cn1)[nH]c1cc(OC(F)(F)F)ccc12)C1CC1		CHEMBL4878139	=	Inhibition	%	19.0	CHEMBL262	Homo sapiens	INH	%	19.0
	23218899	CHEMBL4824377	Inhibition of human recombinant full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate at 10 uM by ADP-Glo kinase assay relative to control	B	O=C(Nc1nccc2c1[nH]c1cc(OC(F)(F)F)ccc12)C1CC1		CHEMBL4878234	=	Inhibition	%	57.3	CHEMBL262	Homo sapiens	INH	%	57.3
	23218900	CHEMBL4824377	Inhibition of human recombinant full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate at 10 uM by ADP-Glo kinase assay relative to control	B	O=C(Nc1cc2c(cn1)[nH]c1cc(C(F)(F)F)ccc12)C1CC1		CHEMBL4848873	=	Inhibition	%	38.6	CHEMBL262	Homo sapiens	INH	%	38.6
	23218901	CHEMBL4824377	Inhibition of human recombinant full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate at 10 uM by ADP-Glo kinase assay relative to control	B	O=C(Nc1nccc2c1[nH]c1cc(C(F)(F)F)ccc12)C1CC1		CHEMBL4870826	=	Inhibition	%	49.4	CHEMBL262	Homo sapiens	INH	%	49.4
	23218902	CHEMBL4824377	Inhibition of human recombinant full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate at 10 uM by ADP-Glo kinase assay relative to control	B	COc1ccc2c(c1)[nH]c1cnc(NC(=O)C3CC3)cc12		CHEMBL4869592	=	Inhibition	%	56.6	CHEMBL262	Homo sapiens	INH	%	56.6
	23218903	CHEMBL4824377	Inhibition of human recombinant full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate at 10 uM by ADP-Glo kinase assay relative to control	B	COc1ccc2c(c1)[nH]c1c(NC(=O)C3CC3)nccc12		CHEMBL4846517	=	Inhibition	%	99.0	CHEMBL262	Homo sapiens	INH	%	99.0
	23218904	CHEMBL4824377	Inhibition of human recombinant full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate at 10 uM by ADP-Glo kinase assay relative to control	B	N#Cc1ccc2c(c1)[nH]c1cnc(NC(=O)C3CC3)cc12		CHEMBL4863925	=	Inhibition	%	31.8	CHEMBL262	Homo sapiens	INH	%	31.8
	23218905	CHEMBL4824377	Inhibition of human recombinant full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate at 10 uM by ADP-Glo kinase assay relative to control	B	N#Cc1ccc2c(c1)[nH]c1c(NC(=O)C3CC3)nccc12		CHEMBL4856645	=	Inhibition	%	44.1	CHEMBL262	Homo sapiens	INH	%	44.1
	23218906	CHEMBL4824377	Inhibition of human recombinant full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate at 10 uM by ADP-Glo kinase assay relative to control	B	O=Cc1ccc2c(c1)[nH]c1cnc(NC(=O)C3CC3)cc12		CHEMBL4868963	=	Inhibition	%	43.8	CHEMBL262	Homo sapiens	INH	%	43.8
	23218907	CHEMBL4824377	Inhibition of human recombinant full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate at 10 uM by ADP-Glo kinase assay relative to control	B	O=Cc1ccc2c(c1)[nH]c1c(NC(=O)C3CC3)nccc12		CHEMBL4873680	=	Inhibition	%	91.6	CHEMBL262	Homo sapiens	INH	%	91.6
	23218908	CHEMBL4824377	Inhibition of human recombinant full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate at 10 uM by ADP-Glo kinase assay relative to control	B	COc1ccc(-c2ccc3c(c2)[nH]c2cnc(NC(=O)C4CC4)cc23)cc1		CHEMBL4875404	=	Inhibition	%	27.3	CHEMBL262	Homo sapiens	INH	%	27.3
	23218909	CHEMBL4824377	Inhibition of human recombinant full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate at 10 uM by ADP-Glo kinase assay relative to control	B	O=C(Nc1cc2c(cn1)[nH]c1cc(-c3cccnc3)ccc12)C1CC1		CHEMBL4866620	=	Inhibition	%	36.1	CHEMBL262	Homo sapiens	INH	%	36.1
	23218910	CHEMBL4824377	Inhibition of human recombinant full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate at 10 uM by ADP-Glo kinase assay relative to control	B	O=C(Nc1nccc2c1[nH]c1cc(-c3ccccc3)ccc12)C1CC1		CHEMBL4845857	=	Inhibition	%	59.5	CHEMBL262	Homo sapiens	INH	%	59.5
	23218911	CHEMBL4824377	Inhibition of human recombinant full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate at 10 uM by ADP-Glo kinase assay relative to control	B	COc1ccc(-c2ccc3c(c2)[nH]c2c(NC(=O)C4CC4)nccc23)cc1		CHEMBL4861340	=	Inhibition	%	21.6	CHEMBL262	Homo sapiens	INH	%	21.6
	23218912	CHEMBL4824377	Inhibition of human recombinant full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate at 10 uM by ADP-Glo kinase assay relative to control	B	O=C(Nc1nccc2c1[nH]c1cc(-c3cccnc3)ccc12)C1CC1		CHEMBL4861480	=	Inhibition	%	29.9	CHEMBL262	Homo sapiens	INH	%	29.9
	23218913	CHEMBL4824377	Inhibition of human recombinant full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate at 10 uM by ADP-Glo kinase assay relative to control	B	NC(=O)c1ccc2c(c1)[nH]c1cnc(NC(=O)C3CC3)cc12		CHEMBL4860218	=	Inhibition	%	39.7	CHEMBL262	Homo sapiens	INH	%	39.7
	23218914	CHEMBL4824377	Inhibition of human recombinant full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate at 10 uM by ADP-Glo kinase assay relative to control	B	NC(=O)c1ccc2c(c1)[nH]c1c(NC(=O)C3CC3)nccc12		CHEMBL4872945	=	Inhibition	%	99.0	CHEMBL262	Homo sapiens	INH	%	99.0
	23218915	CHEMBL4824377	Inhibition of human recombinant full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate at 10 uM by ADP-Glo kinase assay relative to control	B	COC(=O)c1ccc2c(c1)[nH]c1cnc(NC(=O)C3CC3)cc12		CHEMBL4873051	=	Inhibition	%	38.1	CHEMBL262	Homo sapiens	INH	%	38.1
	23218916	CHEMBL4824377	Inhibition of human recombinant full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate at 10 uM by ADP-Glo kinase assay relative to control	B	COC(=O)c1ccc2c(c1)[nH]c1c(NC(=O)C3CC3)nccc12		CHEMBL4849247	=	Inhibition	%	99.0	CHEMBL262	Homo sapiens	INH	%	99.0
	23218917	CHEMBL4824377	Inhibition of human recombinant full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate at 10 uM by ADP-Glo kinase assay relative to control	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	Inhibition	%	99.4	CHEMBL262	Homo sapiens	INH	%	99.4
	23218918	CHEMBL4824377	Inhibition of human recombinant full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate at 10 uM by ADP-Glo kinase assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Inhibition	%	99.9	CHEMBL262	Homo sapiens	INH	%	99.9
	23218919	CHEMBL4824378	Inhibition of human full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate by ADP-Glo kinase assay	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	IC50	nM	32100.0	CHEMBL262	Homo sapiens	IC50	uM	32.1
	23218920	CHEMBL4824378	Inhibition of human full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate by ADP-Glo kinase assay	B	COc1ccc2c(c1)[nH]c1cnc(C)cc12		CHEMBL4859020	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	23218921	CHEMBL4824378	Inhibition of human full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate by ADP-Glo kinase assay	B	O=C(Nc1cc2c(cn1)[nH]c1cc(F)ccc12)C1CC1		CHEMBL4875836	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	23218922	CHEMBL4824378	Inhibition of human full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate by ADP-Glo kinase assay	B	O=C(Nc1nccc2c1[nH]c1cc(F)ccc12)C1CC1		CHEMBL4871399	=	IC50	nM	4800.0	CHEMBL262	Homo sapiens	IC50	uM	4.8
	23218923	CHEMBL4824378	Inhibition of human full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate by ADP-Glo kinase assay	B	O=C(Nc1cc2c(cn1)[nH]c1cc(Cl)ccc12)C1CC1		CHEMBL4854983	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	23218924	CHEMBL4824378	Inhibition of human full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate by ADP-Glo kinase assay	B	O=C(Nc1nccc2c1[nH]c1cc(Cl)ccc12)C1CC1		CHEMBL4854952	=	IC50	nM	5150.0	CHEMBL262	Homo sapiens	IC50	uM	5.15
	23218925	CHEMBL4824378	Inhibition of human full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate by ADP-Glo kinase assay	B	O=C(Nc1cc2c(cn1)[nH]c1cc(OC(F)(F)F)ccc12)C1CC1		CHEMBL4878139	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	23218926	CHEMBL4824378	Inhibition of human full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate by ADP-Glo kinase assay	B	O=C(Nc1nccc2c1[nH]c1cc(OC(F)(F)F)ccc12)C1CC1		CHEMBL4878234	=	IC50	nM	7620.0	CHEMBL262	Homo sapiens	IC50	uM	7.62
	23218927	CHEMBL4824378	Inhibition of human full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate by ADP-Glo kinase assay	B	O=C(Nc1cc2c(cn1)[nH]c1cc(C(F)(F)F)ccc12)C1CC1		CHEMBL4848873	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	23218928	CHEMBL4824378	Inhibition of human full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate by ADP-Glo kinase assay	B	O=C(Nc1nccc2c1[nH]c1cc(C(F)(F)F)ccc12)C1CC1		CHEMBL4870826	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	23218929	CHEMBL4824378	Inhibition of human full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate by ADP-Glo kinase assay	B	COc1ccc2c(c1)[nH]c1cnc(NC(=O)C3CC3)cc12		CHEMBL4869592	=	IC50	nM	8100.0	CHEMBL262	Homo sapiens	IC50	uM	8.1
	23218930	CHEMBL4824378	Inhibition of human full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate by ADP-Glo kinase assay	B	COc1ccc2c(c1)[nH]c1c(NC(=O)C3CC3)nccc12		CHEMBL4846517	=	IC50	nM	144.0	CHEMBL262	Homo sapiens	IC50	uM	0.14400000000000002
	23218931	CHEMBL4824378	Inhibition of human full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate by ADP-Glo kinase assay	B	N#Cc1ccc2c(c1)[nH]c1cnc(NC(=O)C3CC3)cc12		CHEMBL4863925	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	23218932	CHEMBL4824378	Inhibition of human full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate by ADP-Glo kinase assay	B	N#Cc1ccc2c(c1)[nH]c1c(NC(=O)C3CC3)nccc12		CHEMBL4856645	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	23218933	CHEMBL4824378	Inhibition of human full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate by ADP-Glo kinase assay	B	O=Cc1ccc2c(c1)[nH]c1cnc(NC(=O)C3CC3)cc12		CHEMBL4868963	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	23218934	CHEMBL4824378	Inhibition of human full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate by ADP-Glo kinase assay	B	O=Cc1ccc2c(c1)[nH]c1c(NC(=O)C3CC3)nccc12		CHEMBL4873680	=	IC50	nM	400.0	CHEMBL262	Homo sapiens	IC50	uM	0.4
	23218935	CHEMBL4824378	Inhibition of human full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate by ADP-Glo kinase assay	B	COc1ccc(-c2ccc3c(c2)[nH]c2cnc(NC(=O)C4CC4)cc23)cc1		CHEMBL4875404	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	23218936	CHEMBL4824378	Inhibition of human full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate by ADP-Glo kinase assay	B	O=C(Nc1cc2c(cn1)[nH]c1cc(-c3cccnc3)ccc12)C1CC1		CHEMBL4866620	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	23218937	CHEMBL4824378	Inhibition of human full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate by ADP-Glo kinase assay	B	O=C(Nc1nccc2c1[nH]c1cc(-c3ccccc3)ccc12)C1CC1		CHEMBL4845857	=	IC50	nM	6590.0	CHEMBL262	Homo sapiens	IC50	uM	6.59
	23218938	CHEMBL4824378	Inhibition of human full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate by ADP-Glo kinase assay	B	COc1ccc(-c2ccc3c(c2)[nH]c2c(NC(=O)C4CC4)nccc23)cc1		CHEMBL4861340	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	23218939	CHEMBL4824378	Inhibition of human full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate by ADP-Glo kinase assay	B	O=C(Nc1nccc2c1[nH]c1cc(-c3cccnc3)ccc12)C1CC1		CHEMBL4861480	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	23218940	CHEMBL4824378	Inhibition of human full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate by ADP-Glo kinase assay	B	NC(=O)c1ccc2c(c1)[nH]c1cnc(NC(=O)C3CC3)cc12		CHEMBL4860218	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	23218941	CHEMBL4824378	Inhibition of human full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate by ADP-Glo kinase assay	B	NC(=O)c1ccc2c(c1)[nH]c1c(NC(=O)C3CC3)nccc12		CHEMBL4872945	=	IC50	nM	200.0	CHEMBL262	Homo sapiens	IC50	uM	0.2
	23218942	CHEMBL4824378	Inhibition of human full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate by ADP-Glo kinase assay	B	COC(=O)c1ccc2c(c1)[nH]c1cnc(NC(=O)C3CC3)cc12		CHEMBL4873051	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	23218943	CHEMBL4824378	Inhibition of human full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate by ADP-Glo kinase assay	B	COC(=O)c1ccc2c(c1)[nH]c1c(NC(=O)C3CC3)nccc12		CHEMBL4849247	=	IC50	nM	71.0	CHEMBL262	Homo sapiens	IC50	uM	0.071
	23218944	CHEMBL4824378	Inhibition of human full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate by ADP-Glo kinase assay	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	IC50	nM	54.0	CHEMBL262	Homo sapiens	IC50	uM	0.054000000000000006
	23218945	CHEMBL4824378	Inhibition of human full length GSK3beta expressed in baculovirus in Sf9 insect cells using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate by ADP-Glo kinase assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	30.0	CHEMBL262	Homo sapiens	IC50	uM	0.03
	23219015	CHEMBL4824382	Inhibition of human full length GSK3beta expressed in baculovirus in Sf9 insect cells assessed as enzyme activity using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate at 0.7 uM by ADP-Glo kinase assay relative to control	B	COC(=O)c1ccc2c(c1)[nH]c1c(NC(=O)C3CC3)nccc12		CHEMBL4849247	=	Activity	%	1.0	CHEMBL262	Homo sapiens	Activity	%	1.0
	23219016	CHEMBL4824383	Inhibition of human full length GSK3beta expressed in baculovirus in Sf9 insect cells assessed as enzyme activity using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate at 0.14 uM by ADP-Glo kinase assay relative to control	B	COC(=O)c1ccc2c(c1)[nH]c1c(NC(=O)C3CC3)nccc12		CHEMBL4849247	=	Activity	%	10.0	CHEMBL262	Homo sapiens	Activity	%	10.0
Active	23219020	CHEMBL4824387	Inhibition of GSK3beta in human SH-SY5Y cells assessed as decrease in OKA-induce tau-S396 hyperphosphorylation at 250 to 1000 nM by Western blot analysis	B	COC(=O)c1ccc2c(c1)[nH]c1c(NC(=O)C3CC3)nccc12		CHEMBL4849247		Activity			CHEMBL262	Homo sapiens	Activity		
Dose-Dependent Effect	23219022	CHEMBL4824389	Inhibition of GSK3beta in human SH-SY5Y cells assessed as increase in OKA-induce GSK3beta at serine 9 hyperphosphorylation by Western blot analysis	B	COC(=O)c1ccc2c(c1)[nH]c1c(NC(=O)C3CC3)nccc12		CHEMBL4849247		Activity			CHEMBL262	Homo sapiens	Activity		
Active	23219023	CHEMBL4824390	Inhibition of GSK3beta phosphorylation expression in human SH-SY5Y cells at 250 to 1000 nM by Western blot analysis	B	COC(=O)c1ccc2c(c1)[nH]c1c(NC(=O)C3CC3)nccc12		CHEMBL4849247		Activity			CHEMBL262	Homo sapiens	Activity		
	23248227	CHEMBL4830410	Inhibition of human GSK3B using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate incubated for 2 hrs by [gamma-33P]-ATP assay	B	CC(C)c1c2cc(-c3ccnc(Nc4ccc5c(N6CCN(C)CC6)ccnc5c4)n3)ccc2nn1C		CHEMBL4856177	=	IC50	nM	0.8	CHEMBL262	Homo sapiens	IC50	nM	0.8
	23248228	CHEMBL4830410	Inhibition of human GSK3B using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate incubated for 2 hrs by [gamma-33P]-ATP assay	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	IC50	nM	491.0	CHEMBL262	Homo sapiens	IC50	nM	491.0
	23248229	CHEMBL4830410	Inhibition of human GSK3B using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate incubated for 2 hrs by [gamma-33P]-ATP assay	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	=	IC50	nM	324.0	CHEMBL262	Homo sapiens	IC50	nM	324.0
	23248237	CHEMBL4830414	Inhibition of human GSK3B using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate assessed as enzyme activity incubated for 2 hrs by [gamma-33P]-ATP assay relative to control	B	CC(C)c1c2cc(-c3ccnc(Nc4ccc5c(N6CCN(C)CC6)ccnc5c4)n3)ccc2nn1C		CHEMBL4856177	<	Activity	%	20.0	CHEMBL262	Homo sapiens	Activity	%	20.0
	23256013	CHEMBL4831996	Inhibition of human recombinant N-terminal His-tagged GSK3beta expressed in Escherichia coli using RRRPASVPPSPSLS RHS(pS)HQRR as substrate incubated for 30 mins in presence of ATP by Kinase-Glo reagent based luminescence assay	B	O=C(NCC1CCN(Cc2ccccc2)CC1)c1n[nH]c2ccc(-c3cccnc3)cc12		CHEMBL4873162	=	IC50	nM	95.0	CHEMBL262	Homo sapiens	IC50	uM	0.095
	23256014	CHEMBL4831996	Inhibition of human recombinant N-terminal His-tagged GSK3beta expressed in Escherichia coli using RRRPASVPPSPSLS RHS(pS)HQRR as substrate incubated for 30 mins in presence of ATP by Kinase-Glo reagent based luminescence assay	B	O=C(NCC1CCN(Cc2ccccc2F)CC1)c1n[nH]c2ccc(-c3cccnc3)cc12		CHEMBL4854572	=	IC50	nM	79.0	CHEMBL262	Homo sapiens	IC50	uM	0.079
	23256015	CHEMBL4831996	Inhibition of human recombinant N-terminal His-tagged GSK3beta expressed in Escherichia coli using RRRPASVPPSPSLS RHS(pS)HQRR as substrate incubated for 30 mins in presence of ATP by Kinase-Glo reagent based luminescence assay	B	O=C(CC1CCN(Cc2ccccc2)CC1)Nc1n[nH]c2cc(-c3cccnc3)ccc12		CHEMBL4870877	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	23256016	CHEMBL4831996	Inhibition of human recombinant N-terminal His-tagged GSK3beta expressed in Escherichia coli using RRRPASVPPSPSLS RHS(pS)HQRR as substrate incubated for 30 mins in presence of ATP by Kinase-Glo reagent based luminescence assay	B	O=C(CC1CCN(Cc2ccccc2F)CC1)Nc1n[nH]c2cc(-c3cccnc3)ccc12		CHEMBL4846646	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	23256017	CHEMBL4831996	Inhibition of human recombinant N-terminal His-tagged GSK3beta expressed in Escherichia coli using RRRPASVPPSPSLS RHS(pS)HQRR as substrate incubated for 30 mins in presence of ATP by Kinase-Glo reagent based luminescence assay	B	O=C(CC1CCN(Cc2ccc(F)cc2)CC1)Nc1n[nH]c2cc(-c3cccnc3)ccc12		CHEMBL4859041	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	23256018	CHEMBL4831996	Inhibition of human recombinant N-terminal His-tagged GSK3beta expressed in Escherichia coli using RRRPASVPPSPSLS RHS(pS)HQRR as substrate incubated for 30 mins in presence of ATP by Kinase-Glo reagent based luminescence assay	B	COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2		CHEMBL502	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	23256019	CHEMBL4831996	Inhibition of human recombinant N-terminal His-tagged GSK3beta expressed in Escherichia coli using RRRPASVPPSPSLS RHS(pS)HQRR as substrate incubated for 30 mins in presence of ATP by Kinase-Glo reagent based luminescence assay	B	O=C(NCC1CCN(Cc2ccccc2)CC1)c1cncc(NC(=O)c2ccnc(NC(=O)C3CC3)c2)c1		CHEMBL4851835	=	IC50	nM	305.0	CHEMBL262	Homo sapiens	IC50	uM	0.305
	23256020	CHEMBL4831996	Inhibition of human recombinant N-terminal His-tagged GSK3beta expressed in Escherichia coli using RRRPASVPPSPSLS RHS(pS)HQRR as substrate incubated for 30 mins in presence of ATP by Kinase-Glo reagent based luminescence assay	B	O=C(NCC1CCN(Cc2ccccc2F)CC1)c1cncc(NC(=O)c2ccnc(NC(=O)C3CC3)c2)c1		CHEMBL4870746	=	IC50	nM	164.0	CHEMBL262	Homo sapiens	IC50	uM	0.16399999999999998
	23256021	CHEMBL4831996	Inhibition of human recombinant N-terminal His-tagged GSK3beta expressed in Escherichia coli using RRRPASVPPSPSLS RHS(pS)HQRR as substrate incubated for 30 mins in presence of ATP by Kinase-Glo reagent based luminescence assay	B	O=C(NCC1CCN(Cc2cccc(F)c2)CC1)c1cncc(NC(=O)c2ccnc(NC(=O)C3CC3)c2)c1		CHEMBL4866150	=	IC50	nM	97.0	CHEMBL262	Homo sapiens	IC50	uM	0.09699999999999999
	23256022	CHEMBL4831996	Inhibition of human recombinant N-terminal His-tagged GSK3beta expressed in Escherichia coli using RRRPASVPPSPSLS RHS(pS)HQRR as substrate incubated for 30 mins in presence of ATP by Kinase-Glo reagent based luminescence assay	B	O=C(NCC1CCN(Cc2ccc(F)cc2)CC1)c1cncc(NC(=O)c2ccnc(NC(=O)C3CC3)c2)c1		CHEMBL4868956	=	IC50	nM	244.0	CHEMBL262	Homo sapiens	IC50	uM	0.244
	23256023	CHEMBL4831996	Inhibition of human recombinant N-terminal His-tagged GSK3beta expressed in Escherichia coli using RRRPASVPPSPSLS RHS(pS)HQRR as substrate incubated for 30 mins in presence of ATP by Kinase-Glo reagent based luminescence assay	B	O=C(NCC1CCN(Cc2ccc(F)c(F)c2)CC1)c1cncc(NC(=O)c2ccnc(NC(=O)C3CC3)c2)c1		CHEMBL4865615	=	IC50	nM	279.0	CHEMBL262	Homo sapiens	IC50	uM	0.27899999999999997
	23256024	CHEMBL4831996	Inhibition of human recombinant N-terminal His-tagged GSK3beta expressed in Escherichia coli using RRRPASVPPSPSLS RHS(pS)HQRR as substrate incubated for 30 mins in presence of ATP by Kinase-Glo reagent based luminescence assay	B	O=C(NCC1CCN(Cc2cccc(Cl)c2)CC1)c1cncc(NC(=O)c2ccnc(NC(=O)C3CC3)c2)c1		CHEMBL4864059	=	IC50	nM	231.0	CHEMBL262	Homo sapiens	IC50	uM	0.231
	23256025	CHEMBL4831996	Inhibition of human recombinant N-terminal His-tagged GSK3beta expressed in Escherichia coli using RRRPASVPPSPSLS RHS(pS)HQRR as substrate incubated for 30 mins in presence of ATP by Kinase-Glo reagent based luminescence assay	B	Cc1ccccc1CN1CCC(CNC(=O)c2cncc(NC(=O)c3ccnc(NC(=O)C4CC4)c3)c2)CC1		CHEMBL4872690	=	IC50	nM	157.0	CHEMBL262	Homo sapiens	IC50	uM	0.157
	23256026	CHEMBL4831996	Inhibition of human recombinant N-terminal His-tagged GSK3beta expressed in Escherichia coli using RRRPASVPPSPSLS RHS(pS)HQRR as substrate incubated for 30 mins in presence of ATP by Kinase-Glo reagent based luminescence assay	B	Cc1cccc(CN2CCC(CNC(=O)c3cncc(NC(=O)c4ccnc(NC(=O)C5CC5)c4)c3)CC2)c1		CHEMBL4851865	=	IC50	nM	198.0	CHEMBL262	Homo sapiens	IC50	uM	0.198
	23256027	CHEMBL4831996	Inhibition of human recombinant N-terminal His-tagged GSK3beta expressed in Escherichia coli using RRRPASVPPSPSLS RHS(pS)HQRR as substrate incubated for 30 mins in presence of ATP by Kinase-Glo reagent based luminescence assay	B	COc1cccc(CN2CCC(CNC(=O)c3cncc(NC(=O)c4ccnc(NC(=O)C5CC5)c4)c3)CC2)c1		CHEMBL4857680	=	IC50	nM	126.0	CHEMBL262	Homo sapiens	IC50	uM	0.126
	23256028	CHEMBL4831996	Inhibition of human recombinant N-terminal His-tagged GSK3beta expressed in Escherichia coli using RRRPASVPPSPSLS RHS(pS)HQRR as substrate incubated for 30 mins in presence of ATP by Kinase-Glo reagent based luminescence assay	B	O=C(Nc1cncc(C(=O)NC2CCN(Cc3ccccc3)CC2)c1)c1ccnc(NC(=O)C2CC2)c1		CHEMBL4857955	=	IC50	nM	81.0	CHEMBL262	Homo sapiens	IC50	uM	0.081
	23256029	CHEMBL4831996	Inhibition of human recombinant N-terminal His-tagged GSK3beta expressed in Escherichia coli using RRRPASVPPSPSLS RHS(pS)HQRR as substrate incubated for 30 mins in presence of ATP by Kinase-Glo reagent based luminescence assay	B	O=C(Nc1cncc(C(=O)NC2CCN(Cc3cccc(Cl)c3)CC2)c1)c1ccnc(NC(=O)C2CC2)c1		CHEMBL4854209	=	IC50	nM	63.0	CHEMBL262	Homo sapiens	IC50	uM	0.063
	23256030	CHEMBL4831996	Inhibition of human recombinant N-terminal His-tagged GSK3beta expressed in Escherichia coli using RRRPASVPPSPSLS RHS(pS)HQRR as substrate incubated for 30 mins in presence of ATP by Kinase-Glo reagent based luminescence assay	B	O=C(NCCC1CCN(Cc2cccc(Cl)c2)CC1)c1cncc(NC(=O)c2cccc(NC(=O)C3CC3)c2)c1		CHEMBL4853675	=	IC50	nM	152.0	CHEMBL262	Homo sapiens	IC50	uM	0.152
	23256031	CHEMBL4831996	Inhibition of human recombinant N-terminal His-tagged GSK3beta expressed in Escherichia coli using RRRPASVPPSPSLS RHS(pS)HQRR as substrate incubated for 30 mins in presence of ATP by Kinase-Glo reagent based luminescence assay	B	O=C(Nc1cncc(OCC2CCN(Cc3ccccc3)CC2)c1)c1ccnc(NC(=O)C2CC2)c1		CHEMBL4863960	=	IC50	nM	23.0	CHEMBL262	Homo sapiens	IC50	uM	0.023
	23256032	CHEMBL4831996	Inhibition of human recombinant N-terminal His-tagged GSK3beta expressed in Escherichia coli using RRRPASVPPSPSLS RHS(pS)HQRR as substrate incubated for 30 mins in presence of ATP by Kinase-Glo reagent based luminescence assay	B	O=C(Nc1cncc(OCC2CCN(Cc3ccccc3F)CC2)c1)c1ccnc(NC(=O)C2CC2)c1		CHEMBL4865061	=	IC50	nM	77.0	CHEMBL262	Homo sapiens	IC50	uM	0.077
	23256033	CHEMBL4831996	Inhibition of human recombinant N-terminal His-tagged GSK3beta expressed in Escherichia coli using RRRPASVPPSPSLS RHS(pS)HQRR as substrate incubated for 30 mins in presence of ATP by Kinase-Glo reagent based luminescence assay	B	O=C(Nc1cncc(OCC2CCN(Cc3ccc(F)cc3)CC2)c1)c1ccnc(NC(=O)C2CC2)c1		CHEMBL4873612	=	IC50	nM	31.0	CHEMBL262	Homo sapiens	IC50	uM	0.031
	23256034	CHEMBL4831996	Inhibition of human recombinant N-terminal His-tagged GSK3beta expressed in Escherichia coli using RRRPASVPPSPSLS RHS(pS)HQRR as substrate incubated for 30 mins in presence of ATP by Kinase-Glo reagent based luminescence assay	B	O=C(Nc1cncc(OCC2CCN(Cc3ccccc3Cl)CC2)c1)c1ccnc(NC(=O)C2CC2)c1		CHEMBL4867249	=	IC50	nM	79.0	CHEMBL262	Homo sapiens	IC50	uM	0.079
	23256035	CHEMBL4831996	Inhibition of human recombinant N-terminal His-tagged GSK3beta expressed in Escherichia coli using RRRPASVPPSPSLS RHS(pS)HQRR as substrate incubated for 30 mins in presence of ATP by Kinase-Glo reagent based luminescence assay	B	O=C(Nc1cncc(OC2CCN(Cc3ccccc3)CC2)c1)c1ccnc(NC(=O)C2CC2)c1		CHEMBL4855714	=	IC50	nM	734.0	CHEMBL262	Homo sapiens	IC50	uM	0.7340000000000001
	23256036	CHEMBL4831996	Inhibition of human recombinant N-terminal His-tagged GSK3beta expressed in Escherichia coli using RRRPASVPPSPSLS RHS(pS)HQRR as substrate incubated for 30 mins in presence of ATP by Kinase-Glo reagent based luminescence assay	B	CC(=O)Nc1cc(C(=O)Nc2cncc(OCC3CCN(Cc4ccc(F)cc4)CC3)c2)ccn1		CHEMBL4875903	=	IC50	nM	3508.0	CHEMBL262	Homo sapiens	IC50	uM	3.508
	23256037	CHEMBL4831996	Inhibition of human recombinant N-terminal His-tagged GSK3beta expressed in Escherichia coli using RRRPASVPPSPSLS RHS(pS)HQRR as substrate incubated for 30 mins in presence of ATP by Kinase-Glo reagent based luminescence assay	B	O=C(Nc1cccc(OCC2CCN(Cc3ccccc3)CC2)c1)c1ccnc(NC(=O)C2CC2)c1		CHEMBL4855201	=	IC50	nM	9748.0	CHEMBL262	Homo sapiens	IC50	uM	9.748
	23256038	CHEMBL4831996	Inhibition of human recombinant N-terminal His-tagged GSK3beta expressed in Escherichia coli using RRRPASVPPSPSLS RHS(pS)HQRR as substrate incubated for 30 mins in presence of ATP by Kinase-Glo reagent based luminescence assay	B	O=C(Nc1cccc(OCC2CCN(Cc3ccc(F)cc3)CC2)c1)c1ccnc(NC(=O)C2CC2)c1		CHEMBL4850776	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	23256039	CHEMBL4831996	Inhibition of human recombinant N-terminal His-tagged GSK3beta expressed in Escherichia coli using RRRPASVPPSPSLS RHS(pS)HQRR as substrate incubated for 30 mins in presence of ATP by Kinase-Glo reagent based luminescence assay	B	CC(=O)Nc1cc(C(=O)Nc2cccc(OCC3CCN(Cc4ccccc4)CC3)c2)ccn1		CHEMBL4877556	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	23256040	CHEMBL4831996	Inhibition of human recombinant N-terminal His-tagged GSK3beta expressed in Escherichia coli using RRRPASVPPSPSLS RHS(pS)HQRR as substrate incubated for 30 mins in presence of ATP by Kinase-Glo reagent based luminescence assay	B	CC(=O)Nc1cc(C(=O)Nc2cccc(OCC3CCN(Cc4ccc(F)cc4)CC3)c2)ccn1		CHEMBL4846945	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	23256041	CHEMBL4831996	Inhibition of human recombinant N-terminal His-tagged GSK3beta expressed in Escherichia coli using RRRPASVPPSPSLS RHS(pS)HQRR as substrate incubated for 30 mins in presence of ATP by Kinase-Glo reagent based luminescence assay	B	O=C(NCC1CCN(Cc2cccc(Cl)c2)CC1)c1cncc(NC(=O)c2ccnc3[nH]ccc23)c1		CHEMBL4870273	>	IC50	nM	10000.0	CHEMBL262	Homo sapiens	IC50	uM	10.0
	23256042	CHEMBL4831996	Inhibition of human recombinant N-terminal His-tagged GSK3beta expressed in Escherichia coli using RRRPASVPPSPSLS RHS(pS)HQRR as substrate incubated for 30 mins in presence of ATP by Kinase-Glo reagent based luminescence assay	B	O=C(NC1CCN(Cc2ccccc2)CC1)c1cncc(NC(=O)c2ccnc3[nH]ccc23)c1		CHEMBL4862811	=	IC50	nM	6804.0	CHEMBL262	Homo sapiens	IC50	uM	6.803999999999999
	23256043	CHEMBL4831996	Inhibition of human recombinant N-terminal His-tagged GSK3beta expressed in Escherichia coli using RRRPASVPPSPSLS RHS(pS)HQRR as substrate incubated for 30 mins in presence of ATP by Kinase-Glo reagent based luminescence assay	B	O=C(NC1CCN(Cc2ccc(F)cc2)CC1)c1cncc(NC(=O)c2ccnc3[nH]ccc23)c1		CHEMBL4849828	=	IC50	nM	4935.0	CHEMBL262	Homo sapiens	IC50	uM	4.935
	23256044	CHEMBL4831996	Inhibition of human recombinant N-terminal His-tagged GSK3beta expressed in Escherichia coli using RRRPASVPPSPSLS RHS(pS)HQRR as substrate incubated for 30 mins in presence of ATP by Kinase-Glo reagent based luminescence assay	B	O=C(Nc1cncc(OCC2CCN(Cc3ccccc3)CC2)c1)c1ccnc2[nH]ccc12		CHEMBL4877175	=	IC50	nM	837.0	CHEMBL262	Homo sapiens	IC50	uM	0.8370000000000001
	23256045	CHEMBL4831996	Inhibition of human recombinant N-terminal His-tagged GSK3beta expressed in Escherichia coli using RRRPASVPPSPSLS RHS(pS)HQRR as substrate incubated for 30 mins in presence of ATP by Kinase-Glo reagent based luminescence assay	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714	=	IC50	nM	29.0	CHEMBL262	Homo sapiens	IC50	uM	0.028999999999999998
	23258729	CHEMBL4832759	Inhibition of GSK-3beta (unknown origin) at 5 uM relative to control	B	COCCOc1cc2ncnc(Sc3nc[nH]n3)c2cc1OCCOC		CHEMBL4868123	=	Inhibition	%	13.0	CHEMBL262	Homo sapiens	INH	%	13.0
	23290875	CHEMBL4839433	Inhibition of GSK3beta (unknown origin) assessed as transfer of radiolabelled phosphate group from ATP by reaction biology method	B	COc1ccccc1C1=C(Nc2cccc(Cl)c2)C(=O)NC1=O		CHEMBL156277	=	IC50	nM	14.0	CHEMBL262	Homo sapiens	IC50	nM	14.0
	23290876	CHEMBL4839433	Inhibition of GSK3beta (unknown origin) assessed as transfer of radiolabelled phosphate group from ATP by reaction biology method	B	COc1ccccc1C1=C(Nc2cccc(C#N)c2)C(=O)NC1=O		CHEMBL4875188	=	IC50	nM	36.0	CHEMBL262	Homo sapiens	IC50	nM	36.0
	23290877	CHEMBL4839433	Inhibition of GSK3beta (unknown origin) assessed as transfer of radiolabelled phosphate group from ATP by reaction biology method	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	5.1	CHEMBL262	Homo sapiens	IC50	nM	5.1
Not Active	23317435	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	79.0	CHEMBL262	Homo sapiens	% Control	%	79.0
Not Active	23317903	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23318571	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	93.0	CHEMBL262	Homo sapiens	% Control	%	93.0
Not Active	23319053	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23319690	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23320165	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23320843	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	93.0	CHEMBL262	Homo sapiens	% Control	%	93.0
Not Active	23321311	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	78.0	CHEMBL262	Homo sapiens	% Control	%	78.0
Not Active	23321941	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	73.0	CHEMBL262	Homo sapiens	% Control	%	73.0
Not Active	23322409	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23323098	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	92.0	CHEMBL262	Homo sapiens	% Control	%	92.0
Not Active	23323566	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23324024	CHEMBL4880643	GSK3beta (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1	Outside typical range	CHEMBL4593677		Inhibition	%	-15.0	CHEMBL262	Homo sapiens	% inhibition	%	-15.0
Not Active	23324420	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	69.6	CHEMBL262	Homo sapiens	% Control	%	69.6
Not Active	23325055	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23325523	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23326170	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	80.0	CHEMBL262	Homo sapiens	% Control	%	80.0
Not Active	23326638	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23327338	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	87.0	CHEMBL262	Homo sapiens	% Control	%	87.0
Not Active	23327806	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	90.0	CHEMBL262	Homo sapiens	% Control	%	90.0
Not Active	23328393	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	88.0	CHEMBL262	Homo sapiens	% Control	%	88.0
Not Active	23328861	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23329362	CHEMBL4881069	GSK3beta (h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	99.0	CHEMBL262	Homo sapiens	% residual kinase activity	%	99.0
Not Active	23329807	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23330275	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23331031	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23331499	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	92.0	CHEMBL262	Homo sapiens	% Control	%	92.0
Not Active	23332086	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	85.9	CHEMBL262	Homo sapiens	% Control	%	85.9
Not Active	23332552	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	85.4	CHEMBL262	Homo sapiens	% Control	%	85.4
Not Active	23333270	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23333909	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	90.0	CHEMBL262	Homo sapiens	% Control	%	90.0
Not Active	23334377	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23334901	CHEMBL4881524	GSK3beta (h) Upstate kinase activity assay	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		Inhibition	%	-1.0	CHEMBL262	Homo sapiens	% inhibition	%	-1.0
Not Active	23335356	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	98.0	CHEMBL262	Homo sapiens	% Control	%	98.0
Not Active	23335824	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	90.0	CHEMBL262	Homo sapiens	% Control	%	90.0
Not Active	23336451	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	98.0	CHEMBL262	Homo sapiens	% Control	%	98.0
Not Active	23336919	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23337613	CHEMBL4881984	GSK3B Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	95.5	CHEMBL262	Homo sapiens	% Ctrl	%	95.5
Not Active	23338000	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23338468	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	81.0	CHEMBL262	Homo sapiens	% Control	%	81.0
Not Active	23339080	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23339548	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	90.0	CHEMBL262	Homo sapiens	% Control	%	90.0
Not Active	23340185	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	85.0	CHEMBL262	Homo sapiens	% Control	%	85.0
Not Active	23340653	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23341310	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	85.0	CHEMBL262	Homo sapiens	% Control	%	85.0
Not Active	23341778	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	88.0	CHEMBL262	Homo sapiens	% Control	%	88.0
Not Active	23342394	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	81.0	CHEMBL262	Homo sapiens	% Control	%	81.0
Not Active	23342862	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	96.0	CHEMBL262	Homo sapiens	% Control	%	96.0
Active	23343255	CHEMBL4882440	GSK3B Invitrogen selectivity data (BI)	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Ctrl	%	6.0	CHEMBL262	Homo sapiens	% Ctrl	%	6.0
Not Active	23343492	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	95.0	CHEMBL262	Homo sapiens	% Control	%	95.0
Not Active	23343960	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	78.0	CHEMBL262	Homo sapiens	% Control	%	78.0
Not Active	23344598	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	86.0	CHEMBL262	Homo sapiens	% Control	%	86.0
Not Active	23345171	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23345639	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	89.0	CHEMBL262	Homo sapiens	% Control	%	89.0
Not Active	23346216	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23346685	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	95.6	CHEMBL262	Homo sapiens	% Control	%	95.6
Not Active	23347081	CHEMBL4882608	Invitrogen kinase screen (GSK3B)	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1	Non standard unit for type	CHEMBL4538174		IC50	µM	0.54	CHEMBL262	Homo sapiens	IC50	µM	0.54
Not Active	23347288	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23347776	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23348355	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23348823	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	97.0	CHEMBL262	Homo sapiens	% Control	%	97.0
Not Active	23349410	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23350028	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23350496	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	85.0	CHEMBL262	Homo sapiens	% Control	%	85.0
Not Active	23351101	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	93.0	CHEMBL262	Homo sapiens	% Control	%	93.0
Not Active	23351569	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	85.0	CHEMBL262	Homo sapiens	% Control	%	85.0
Not Active	23352064	CHEMBL4882755	GSK3B (GSK3 beta) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	3.529	CHEMBL262	Homo sapiens	% Inhibition	%	3.5294
Not Active	23352593	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	90.0	CHEMBL262	Homo sapiens	% Control	%	90.0
Not Active	23353061	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	91.0	CHEMBL262	Homo sapiens	% Control	%	91.0
Not Active	23353943	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23354411	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23355143	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23355611	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23356247	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23356715	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23357324	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23357971	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23358439	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	77.0	CHEMBL262	Homo sapiens	% Control	%	77.0
Not Active	23359025	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	62.6	CHEMBL262	Homo sapiens	% Control	%	62.6
Not Active	23359623	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	95.0	CHEMBL262	Homo sapiens	% Control	%	95.0
Not Active	23360091	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	88.0	CHEMBL262	Homo sapiens	% Control	%	88.0
Not Active	23360676	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23361144	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23361717	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	65.0	CHEMBL262	Homo sapiens	% Control	%	65.0
Not Active	23362253	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	98.0	CHEMBL262	Homo sapiens	% Control	%	98.0
Not Active	23362721	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23363254	CHEMBL4883243	GSK3B (GSK3 beta) Kinase activity screen	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1		CHEMBL4531334		Inhibition	%	-3.109	CHEMBL262	Homo sapiens	% inhibition	%	-3.1089
Not Active	23363255	CHEMBL4883243	GSK3B (GSK3 beta) Kinase activity screen	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1		CHEMBL4531334		Inhibition	%	-3.215	CHEMBL262	Homo sapiens	% inhibition	%	-3.2146
Not Active	23364363	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23364831	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23365570	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	93.0	CHEMBL262	Homo sapiens	% Control	%	93.0
Not Active	23366113	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	90.0	CHEMBL262	Homo sapiens	% Control	%	90.0
Not Active	23366703	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23367171	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23367590	CHEMBL4883943	GSK3-beta ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	97.0	CHEMBL262	Homo sapiens	% Residual activity with Skepinone-L	%	97.0
Not Active	23368049	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23368517	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23369116	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23369584	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23370084	CHEMBL4884328	GSK3β(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	58.0	CHEMBL262	Homo sapiens	% residual kinase activity	%	58.0
Not Active	23370552	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23371020	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	81.0	CHEMBL262	Homo sapiens	% Control	%	81.0
Not Active	23371829	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23372297	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
	23372757	CHEMBL4884722	GSK3beta(GS3BLGM1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL262	Homo sapiens	pIC50		6.0
	23373166	CHEMBL4885013	GSK3beta(GS3BLGM1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL262	Homo sapiens	pIC50		6.0
	23373527	CHEMBL4885304	GSK3beta(GS3BLGM1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL262	Homo sapiens	pIC50		6.0
Not Active	23374992	CHEMBL4885985	GSK3_beta Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	7.8	CHEMBL262	Homo sapiens	% Inhibition	%	7.8
Not Active	23375264	CHEMBL4886246	glycogen synthase kinase 3 beta Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	-1.0	CHEMBL262	Homo sapiens	% inhibition	%	-1.0
Not Active	23375724	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	96.0	CHEMBL262	Homo sapiens	% Control	%	96.0
Not Active	23376192	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	96.0	CHEMBL262	Homo sapiens	% Control	%	96.0
Not Active	23376769	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	74.0	CHEMBL262	Homo sapiens	% Control	%	74.0
Not Active	23377237	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	65.0	CHEMBL262	Homo sapiens	% Control	%	65.0
Not Active	23378097	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	82.0	CHEMBL262	Homo sapiens	% Control	%	82.0
Not Active	23378565	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	95.0	CHEMBL262	Homo sapiens	% Control	%	95.0
Not Active	23379732	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23380200	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23380894	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23381542	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23382010	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23382403	CHEMBL4887122	GSK3beta Invitrogen kinase activity assay	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		Inhibition	%	83.0	CHEMBL262	Homo sapiens	% inhibition	%	83.0
	23382404	CHEMBL4887122	GSK3beta Invitrogen kinase activity assay	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		IC50	nM	416.0	CHEMBL262	Homo sapiens	IC50	nM	416.0
Not Active	23382634	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	87.0	CHEMBL262	Homo sapiens	% Control	%	87.0
Not Active	23383102	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	57.0	CHEMBL262	Homo sapiens	% Control	%	57.0
Not Active	23383809	CHEMBL4887444	GSK3B Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	93.0	CHEMBL262	Homo sapiens	% Ctrl	%	93.0
Not Active	23383810	CHEMBL4887444	GSK3B Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	87.0	CHEMBL262	Homo sapiens	% Ctrl	%	87.0
Not Active	23384039	CHEMBL4887637	GSK3B DUNDEE kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	74.4	CHEMBL262	Homo sapiens	% Ctrl	%	74.4
Not Active	23384292	CHEMBL4887887	GSK3beta(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	-0.05	CHEMBL262	Homo sapiens	% inhibition	%	-0.05
Not Active	23384659	CHEMBL4888185	GSK3B (GSK3 beta) SelectScreen Kinase panel (LifeTechnologies)	B	C=CC(=O)Nc1ccc2[nH]c(=O)n(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)c2c1		CHEMBL4795065		Inhibition	%	20.0	CHEMBL262	Homo sapiens	% Inhibition	%	20.0
Not Active	23385017	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23385484	CHEMBL4879741	KinomeScan assay: inhibition of GSK3B	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	100.0	CHEMBL262	Homo sapiens	% Control	%	100.0
Not Active	23385883	CHEMBL4888356	GSK3beta Invitrogen kinase panel	B	COc1nc2ccc([C@@](O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1Cc1ccc(-n2cccn2)cc1		CHEMBL4802042		Inhibition	%	3.0	CHEMBL262	Homo sapiens	% inhibition	%	3.0
